{"meta":{"query_hash":"9eb487237f84","filters":{"venue":"European Urology"},"cohort_total":951,"direct_labels_cover":3,"predictions_cover":951,"exported":951,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/9eb487237f84","api":"https://metacan.xera.ac/api/v1/cohort?venue=European+Urology"},"results":[{"id":"W1271572098","doi":"10.1016/j.eururo.2015.08.037","title":"Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes","year":2015,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":683,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Incidence (geometry); Oncology; Internal medicine; Disease; Gynecology","score_opus":0.07411168531003823,"score_gpt":0.40867853247551467,"score_spread":0.33456684716547647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1271572098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000114380455,0.9818406,0.0000031107436,0.0004258212,0.00022454433,0.001174028,0.00042331737,0.00003088597,0.015866233],"genre_scores_gemma":[0.000042546173,0.99613565,0.000119621516,0.0029262742,0.00015296035,0.000082554216,0.00015934726,0.00007025569,0.00031076864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997334,0.0011367033,0.00062150724,0.0005579368,0.00008513487,0.000264707],"domain_scores_gemma":[0.9986761,0.00016508186,0.00040529072,0.0003632155,0.00020463331,0.00018566096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050359685,0.0004410468,0.0027819145,0.00014317183,0.000034238667,0.0000041709736,0.00011592788,0.00021385287,0.00017290363],"category_scores_gemma":[0.00017870392,0.0002866722,0.00015731384,0.00019642629,0.0005437047,0.00002068492,0.00018195847,0.0003429947,0.000036625035],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006334358,0.000099282566,0.0022224379,0.048939463,0.002595191,0.00012196796,0.00018205657,1.3056844e-8,7.95179e-7,0.00045034508,0.014782976,0.9305421],"study_design_scores_gemma":[0.00095922546,0.0006994726,0.0009619382,0.0043528494,0.0045691854,0.00027559666,0.000009741682,9.910212e-8,1.0737111e-7,0.00004081819,0.98793805,0.00019289617],"about_ca_topic_score_codex":0.000024012214,"about_ca_topic_score_gemma":0.0000038141106,"teacher_disagreement_score":0.9731551,"about_ca_system_score_codex":0.000038594597,"about_ca_system_score_gemma":0.00054372376,"threshold_uncertainty_score":0.9999585},"labels":[],"label_agreement":null},{"id":"W1480673074","doi":"10.1016/j.eururo.2015.07.042","title":"Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Taxane; Medicine; Chemotherapy; Oncology; Salvage therapy; Internal medicine; Urothelial carcinoma; Urology; Bladder cancer; Cancer; Breast cancer","score_opus":0.057090370389691066,"score_gpt":0.30394700175432815,"score_spread":0.2468566313646371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1480673074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95193684,0.0010040895,0.00058489514,0.0027860908,0.0014353974,0.0013350867,0.000023737584,0.00018782493,0.04070605],"genre_scores_gemma":[0.99129725,0.0000646276,0.0006912301,0.0055712434,0.0006445784,0.00007536259,0.00011421664,0.00013439302,0.0014071228],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99826163,0.00023551869,0.00031956672,0.00049253297,0.00023998965,0.00045075966],"domain_scores_gemma":[0.99886626,0.000121686004,0.00017471459,0.00039574396,0.00018473646,0.0002568355],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033838666,0.00029828484,0.00038792662,0.000116985175,0.00009895427,0.000024437846,0.00017021122,0.000087246124,0.0001441355],"category_scores_gemma":[0.00018528798,0.0002681307,0.00014242866,0.000119805234,0.00010157869,0.000083766674,0.000034603043,0.00017678594,0.00021374885],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1849097,0.0039322143,0.01857423,0.00008191553,0.0013024493,0.0012683432,0.009996294,0.0001196492,0.104331754,0.0022526572,0.012292872,0.6609379],"study_design_scores_gemma":[0.19386317,0.08416544,0.025705036,0.00002929159,0.00035927238,0.00029676055,0.0007897924,0.00020617829,0.033479344,0.00048695118,0.6597704,0.0008483375],"about_ca_topic_score_codex":0.000045549925,"about_ca_topic_score_gemma":0.000006853675,"teacher_disagreement_score":0.6600896,"about_ca_system_score_codex":0.0001669001,"about_ca_system_score_gemma":0.00016831305,"threshold_uncertainty_score":0.9999771},"labels":[],"label_agreement":null},{"id":"W1482910062","doi":"10.1016/j.eururo.2015.03.023","title":"Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary–Early Detection Research Network Active Surveillance Biopsy Risk Calculator","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Biopsy; Prostate cancer; Confidence interval; Odds ratio; Prostate biopsy; Receiver operating characteristic; Cancer; Logistic regression; Prostate; Area under the curve; Prostate-specific antigen; Internal medicine; Radiology; Surgery","score_opus":0.04851986195409095,"score_gpt":0.33619432973664837,"score_spread":0.2876744677825574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1482910062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932111,0.0016412308,0.00013340398,0.0016254149,0.00062017207,0.0018216167,0.00009597729,0.000024477067,0.0008266115],"genre_scores_gemma":[0.9985404,0.00043503172,0.00017007129,0.000104373365,0.0002864651,0.00026401883,0.000026433901,0.000045982073,0.00012722609],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99676305,0.0012514015,0.00048622646,0.000510673,0.0003968979,0.0005917361],"domain_scores_gemma":[0.997937,0.00057180005,0.00030273577,0.0003967108,0.0006135604,0.00017817527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027755774,0.00020227223,0.00045776306,0.0001393095,0.00018164775,0.000006121546,0.00018441436,0.00007192106,0.000011412016],"category_scores_gemma":[0.00083273713,0.0001329904,0.000056859357,0.00064662256,0.0002788361,0.00004579203,0.00015416779,0.00039477,0.000007836072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008045002,0.00022447603,0.7710516,0.000057023764,0.00026313588,0.000054991848,0.007659655,0.0010272462,0.0011575036,0.000020223897,0.0018943207,0.20854485],"study_design_scores_gemma":[0.0039016951,0.0016036545,0.97471195,0.00010108103,0.00002472213,0.0000129898635,0.00018539016,0.00018875653,0.002917082,0.00011132295,0.016121835,0.00011949982],"about_ca_topic_score_codex":0.002931598,"about_ca_topic_score_gemma":0.00877617,"teacher_disagreement_score":0.20842536,"about_ca_system_score_codex":0.0006525748,"about_ca_system_score_gemma":0.00051485957,"threshold_uncertainty_score":0.5423192},"labels":[],"label_agreement":null},{"id":"W1494521255","doi":"10.1016/j.eururo.2015.08.038","title":"Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use","year":2015,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":541,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"National Institutes of Health","keywords":"Medicine; Prostate cancer; Prostatitis; Prostate; Context (archaeology); Magnetic resonance imaging; Biopsy; Radiology; Artificial intelligence; Cancer; Computer science; Internal medicine","score_opus":0.06155939012744741,"score_gpt":0.3432370916277551,"score_spread":0.2816777015003077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1494521255","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036525603,0.13614681,0.0005049954,0.04801895,0.7893217,0.010698548,0.010886868,0.00015450727,0.00061506225],"genre_scores_gemma":[0.01666834,0.043325853,0.07225782,0.010159587,0.8250718,0.00402017,0.005956317,0.0011847783,0.021355333],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998129,0.0001969644,0.0006193553,0.0005369151,0.00019980739,0.0003179296],"domain_scores_gemma":[0.99594516,0.0015629431,0.00037847814,0.0005138252,0.0014955014,0.000104070896],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0007186059,0.00028236918,0.0005338063,0.0001647936,0.00009915308,0.000030812665,0.00017452656,0.00011154485,0.000005674169],"category_scores_gemma":[0.008417824,0.00019769132,0.00014934553,0.00018366701,0.00017218218,0.000051532184,0.0001471076,0.00023624641,0.000003096474],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040304085,0.00009341653,0.0018819431,0.00013788011,0.000046375855,0.0000074577597,0.000108356195,0.0000033443794,0.000008028293,0.000011644823,0.9261053,0.07119317],"study_design_scores_gemma":[0.0041311127,0.001343681,0.0025711423,0.0001825603,0.0005988981,0.000007921618,0.000017250715,0.0004105677,0.000023890745,0.000066053166,0.9904917,0.00015525409],"about_ca_topic_score_codex":0.000060377923,"about_ca_topic_score_gemma":0.000016928303,"teacher_disagreement_score":0.09282096,"about_ca_system_score_codex":0.000088849745,"about_ca_system_score_gemma":0.000245237,"threshold_uncertainty_score":0.9999347},"labels":[],"label_agreement":null},{"id":"W1508662657","doi":"10.1016/j.eururo.2015.05.042","title":"Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":247,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Medicine; Prostatectomy; Biochemical recurrence; Prostate cancer; Cohort; Oncology; Internal medicine; Proportional hazards model; Cumulative incidence; Clinical endpoint; Prostate-specific antigen; Receiver operating characteristic; Adjuvant therapy; Cancer; Clinical trial","score_opus":0.01266125735443125,"score_gpt":0.23638417195143524,"score_spread":0.223722914597004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1508662657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949181,0.002701166,0.000028874374,0.00027356538,0.00025825368,0.00056984776,0.00006689941,0.000026488406,0.0011568059],"genre_scores_gemma":[0.9985948,0.00048342938,0.00021965195,0.0003041837,0.00004495504,0.000018893983,0.00021842401,0.00002850993,0.000087153596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875885,0.0003253083,0.0003206078,0.00030543428,0.00011067096,0.00017910573],"domain_scores_gemma":[0.99921083,0.000064576205,0.00024081003,0.00025120308,0.0001077619,0.00012484174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042690177,0.00014083163,0.00027312856,0.00013127828,0.000016329956,0.000004675707,0.00006956059,0.000039632734,0.000024733687],"category_scores_gemma":[0.00013782724,0.00012244616,0.0000247933,0.000052339547,0.00015019803,0.000040955725,0.000041749205,0.0002050137,0.000029967452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013255102,0.00032178836,0.9715847,0.000037517868,0.00013368104,0.00020455026,0.0014657407,0.00009722072,0.0025870851,0.00003341122,0.0013064443,0.02090237],"study_design_scores_gemma":[0.005000176,0.0021165912,0.9851058,0.000014038877,0.0001785388,0.000006522327,0.00006158719,0.000454704,0.0017339685,0.000040937823,0.0051862723,0.00010082126],"about_ca_topic_score_codex":0.00060423015,"about_ca_topic_score_gemma":0.000082607796,"teacher_disagreement_score":0.020801548,"about_ca_system_score_codex":0.00038119516,"about_ca_system_score_gemma":0.00015889181,"threshold_uncertainty_score":0.49932092},"labels":[],"label_agreement":null},{"id":"W1512031039","doi":"10.1016/j.eururo.2015.05.046","title":"Prostate Cancer Registries: Current Status and Future Directions","year":2015,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"World Health Organization","keywords":"Medicine; Prostate cancer; MEDLINE; Population; Disease; Health care; Epidemiology; Intensive care medicine; Family medicine; Cancer; Environmental health; Internal medicine","score_opus":0.05354605539643377,"score_gpt":0.3587697050098412,"score_spread":0.3052236496134074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1512031039","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020268588,0.99065506,3.91063e-7,0.0008673436,0.001635771,0.0010978642,0.00045357976,0.00010053108,0.0051692156],"genre_scores_gemma":[0.0000046235664,0.9963107,0.000017928083,0.00019273773,0.0016954273,0.00028392812,0.00047600636,0.0001059584,0.0009126825],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980417,0.0003579147,0.0004207808,0.00060945353,0.00013948057,0.00043069647],"domain_scores_gemma":[0.99873114,0.000056388726,0.0002829477,0.00042929308,0.00011957632,0.00038068544],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019748734,0.00042337726,0.0012682058,0.00014717727,0.00008024986,0.000027473032,0.00007717305,0.00009870477,0.00008540098],"category_scores_gemma":[0.000035768848,0.00029676774,0.00017347965,0.00021889344,0.00015674194,0.000032757896,0.00011936898,0.00052744395,0.00013081338],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029730998,0.00009593592,0.00022747928,0.003018709,0.00025094024,0.00017162653,0.00022094711,5.558667e-8,7.960303e-9,0.000055620258,0.020845829,0.9750831],"study_design_scores_gemma":[0.0007179768,0.00052965665,0.00035371596,0.001336283,0.002148946,0.00015808255,0.000013024179,1.8429478e-7,4.104037e-8,0.000009149421,0.9945128,0.0002201644],"about_ca_topic_score_codex":0.000027544962,"about_ca_topic_score_gemma":0.000012330229,"teacher_disagreement_score":0.97486293,"about_ca_system_score_codex":0.00027868216,"about_ca_system_score_gemma":0.00064082834,"threshold_uncertainty_score":0.99994844},"labels":[],"label_agreement":null},{"id":"W1536286673","doi":"10.1016/j.eururo.2015.07.006","title":"Long-term Safety of Sunitinib in Metastatic Renal Cell Carcinoma","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"National Cancer Institute; Pfizer","keywords":"Medicine; Sunitinib; Dysgeusia; Internal medicine; Cumulative incidence; Population; Adverse effect; Incidence (geometry); Renal cell carcinoma; Nausea; Oncology; Gastroenterology; Cohort","score_opus":0.05135493585488278,"score_gpt":0.27188920483757223,"score_spread":0.22053426898268946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1536286673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8987664,0.00082166743,0.0000752929,0.0002704193,0.000095079784,0.00026775725,0.0000075941907,0.000022394845,0.09967341],"genre_scores_gemma":[0.9979784,0.0000132070145,0.0004096132,0.00034588666,0.000077116616,0.0000037518143,0.00006890935,0.000043708886,0.0010594225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980849,0.00066246674,0.0004657302,0.00028577764,0.00019642214,0.00030471888],"domain_scores_gemma":[0.9990149,0.00010679028,0.00013801848,0.000422283,0.00009590735,0.00022205767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005744533,0.00017701773,0.00041527618,0.00021289334,0.00001410569,0.0000035539913,0.00013517412,0.000032722113,0.00015310045],"category_scores_gemma":[0.00009913437,0.00014906639,0.000086458036,0.00017417017,0.00013060862,0.000031908196,0.000099507466,0.00021811263,0.00028483057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036614342,0.0010488199,0.9518221,0.00019450212,0.00010193742,0.020803077,0.0020811076,0.00013561104,0.014952813,0.00020022705,0.001236497,0.0037618696],"study_design_scores_gemma":[0.00582733,0.0025696154,0.9820806,0.000013259606,0.0001821528,0.0005490148,0.000055635188,0.000026122403,0.007183031,0.000019848732,0.0013729769,0.00012042837],"about_ca_topic_score_codex":0.00004177801,"about_ca_topic_score_gemma":0.000024107805,"teacher_disagreement_score":0.099212006,"about_ca_system_score_codex":0.000073610216,"about_ca_system_score_gemma":0.00012276946,"threshold_uncertainty_score":0.6078751},"labels":[],"label_agreement":null},{"id":"W1549522748","doi":"10.1016/j.eururo.2015.04.032","title":"Impact of Bone-targeted Therapies in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer Patients Treated with Abiraterone Acetate: Post Hoc Analysis of Study COU-AA-302","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Alberta Cancer Foundation; Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Abiraterone acetate; Concomitant; Prednisone; Prostate cancer; Interim analysis; Post-hoc analysis; Hazard ratio; Internal medicine; Oncology; Placebo; Cancer; Urology; Surgery; Androgen deprivation therapy; Clinical trial; Confidence interval; Pathology","score_opus":0.02907524792620767,"score_gpt":0.3280388085479521,"score_spread":0.2989635606217444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1549522748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691504,0.0011510318,0.0000015257673,0.00018797172,0.000018649174,0.0012798555,0.0002448586,0.000021969507,0.00017911804],"genre_scores_gemma":[0.9991216,0.00014936409,0.00003883131,0.00005237565,0.00001016674,0.000042655047,0.00030857473,0.000049606984,0.00022682792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774337,0.00058897934,0.00057091913,0.00036217485,0.0003776924,0.00035685985],"domain_scores_gemma":[0.9984579,0.000053058284,0.00032838064,0.00033290792,0.0006766782,0.00015103786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043411186,0.00026312648,0.00085457636,0.000642557,0.000028658422,0.000012030017,0.00010143213,0.000029723158,0.00013342994],"category_scores_gemma":[0.00003580929,0.00016084511,0.00012029402,0.0011440173,0.0002196964,0.00008436336,0.00002880247,0.00015276737,0.000005252388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027716992,0.0025339192,0.934388,0.00003614661,0.006352819,0.00030067813,0.012005946,0.00063419633,0.014727742,8.209795e-7,0.000054630807,0.0012481291],"study_design_scores_gemma":[0.01754834,0.02320549,0.9561471,0.000018731778,0.0012877573,0.0000029507698,0.0007661652,0.00016015448,0.00071625685,0.0000016114276,0.000016010878,0.0001294578],"about_ca_topic_score_codex":0.0014527305,"about_ca_topic_score_gemma":0.00093781075,"teacher_disagreement_score":0.021759093,"about_ca_system_score_codex":0.0001631675,"about_ca_system_score_gemma":0.0002988907,"threshold_uncertainty_score":0.65590733},"labels":[],"label_agreement":null},{"id":"W1571729775","doi":"10.1016/j.eururo.2015.05.038","title":"Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Smoking cessation; Cigarette smoking; Oncology; Biochemical recurrence; Urology; Internal medicine; Prostate; Gynecology; Cancer; Pathology","score_opus":0.012135317038627013,"score_gpt":0.24080867377512125,"score_spread":0.22867335673649422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1571729775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983167,0.0003467486,0.000004122827,0.00043688182,0.000026069623,0.00044254793,0.00003438923,0.000014037646,0.00037851025],"genre_scores_gemma":[0.9996156,0.00012111163,0.00003946736,0.00008197271,0.000015016638,0.000028610912,0.000063783016,0.00001957567,0.000014826427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989558,0.00013985824,0.00025306633,0.00023913759,0.00023685381,0.0001753002],"domain_scores_gemma":[0.9992688,0.000044996126,0.00028854908,0.000103894854,0.0002167981,0.00007698131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002702043,0.00011658769,0.00026452166,0.00009323632,0.000012740815,0.000004604337,0.000033325017,0.00004418039,0.000005498905],"category_scores_gemma":[0.000078694255,0.000082264756,0.000012565711,0.00020354461,0.00010880658,0.00005353701,0.000024579836,0.00014244147,2.0706752e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001463758,0.00019910476,0.99293673,0.000051166273,0.00013348482,0.000026401862,0.00069502846,0.000028426757,0.00009713065,0.0000059035724,0.0000956686,0.0042672195],"study_design_scores_gemma":[0.008670728,0.0028581533,0.9813406,0.00024805526,0.00020228096,0.000004327293,0.000023870201,0.000035053046,0.0063388236,0.0000066055536,0.00018888776,0.00008265721],"about_ca_topic_score_codex":0.00007086573,"about_ca_topic_score_gemma":0.000017181568,"teacher_disagreement_score":0.011596149,"about_ca_system_score_codex":0.00016711293,"about_ca_system_score_gemma":0.00008136853,"threshold_uncertainty_score":0.33546594},"labels":[],"label_agreement":null},{"id":"W1577157491","doi":"10.1016/j.eururo.2015.07.003","title":"Prediction of Complications Following Partial Nephrectomy: Implications for Ablative Techniques Candidates","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Perioperative; Logistic regression; Kidney cancer; Complication; Kidney disease; Renal cell carcinoma; Surgery; Odds ratio; Internal medicine; Comorbidity; Cancer; Urology; Kidney","score_opus":0.07984670587099317,"score_gpt":0.3096110459365195,"score_spread":0.22976434006552632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1577157491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8621789,0.0005810206,0.035286475,0.0063462025,0.00023331016,0.0028499463,0.00025823514,0.0004279706,0.09183793],"genre_scores_gemma":[0.99342847,0.0000056791932,0.0055199196,0.00027819528,0.00012284129,0.00020754652,0.00025792775,0.000026889345,0.00015251288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921066,0.00011416908,0.00025531763,0.00020847018,0.00006178166,0.00014959526],"domain_scores_gemma":[0.99921674,0.000106368396,0.000105772124,0.00030129327,0.00015708353,0.00011271938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023275314,0.00009636931,0.00019398652,0.00009142411,0.00005385283,0.0000044708427,0.00007326177,0.00003392268,0.0000049717287],"category_scores_gemma":[0.00014274509,0.00008457039,0.00009641027,0.000107500884,0.00007118476,0.00003850388,0.00003401022,0.000066639775,0.000021367647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014922485,0.0011557842,0.71181947,0.00008231059,0.0011084353,0.000043772172,0.0027374998,0.00007986967,0.20612128,0.013427295,0.036947764,0.024984267],"study_design_scores_gemma":[0.0029268337,0.0037712145,0.7683722,0.000022473814,0.0007142665,0.00013593871,0.000073408606,0.0004280844,0.032602917,0.0015736643,0.18922034,0.00015865212],"about_ca_topic_score_codex":0.000019336916,"about_ca_topic_score_gemma":0.0000033645235,"teacher_disagreement_score":0.17351837,"about_ca_system_score_codex":0.000060472,"about_ca_system_score_gemma":0.00007564847,"threshold_uncertainty_score":0.34486803},"labels":[],"label_agreement":null},{"id":"W1592504557","doi":"10.1016/j.eururo.2015.04.036","title":"Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives","year":2015,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Oncology; Primary tumor; Radiation therapy; Cancer; Regimen; Randomized controlled trial; Internal medicine; Clinical trial; Multimodal therapy; Retrospective cohort study; Metastasis","score_opus":0.06470803242639699,"score_gpt":0.40190043351056,"score_spread":0.337192401084163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1592504557","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009122343,0.9937751,7.657726e-8,0.00067976984,0.00030289864,0.0020350616,0.00015578997,0.000014203531,0.0021248478],"genre_scores_gemma":[0.00027597262,0.9982161,0.000014164998,0.00003098715,0.00033759497,0.00014930718,0.00007051159,0.000054896234,0.000850444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997661,0.0010050213,0.00039785466,0.0004396768,0.00019243192,0.00030400947],"domain_scores_gemma":[0.99910754,0.000077171295,0.0002525679,0.00035122727,0.00009245026,0.00011903194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021574921,0.00033953812,0.0014295114,0.00015874095,0.000035591343,0.000007861843,0.00013452514,0.000037558733,0.000032404358],"category_scores_gemma":[0.000020625932,0.00016649143,0.00020346824,0.00025668778,0.00039982353,0.000023119586,0.00011214505,0.0003292466,0.000013440822],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001528192,0.00032645333,0.00054014893,0.00407103,0.0002823413,0.00033769294,0.002643018,1.9142794e-7,8.7212754e-7,0.000039708662,0.00026682354,0.9913389],"study_design_scores_gemma":[0.002313962,0.0009790848,0.0014927123,0.0008292531,0.0010376852,0.0001840533,0.0002016671,8.522358e-7,7.170011e-7,0.000007710602,0.9928316,0.000120719036],"about_ca_topic_score_codex":0.000021394575,"about_ca_topic_score_gemma":0.000008180382,"teacher_disagreement_score":0.99256474,"about_ca_system_score_codex":0.00044853793,"about_ca_system_score_gemma":0.0009924355,"threshold_uncertainty_score":0.67893237},"labels":[],"label_agreement":null},{"id":"W1595374633","doi":"10.1016/j.eururo.2015.05.011","title":"Management of Small Renal Mass: An Opportunity to Address a Growing Problem in Early Stage Kidney Cancer","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Renal mass; Kidney cancer; Stage (stratigraphy); Intervention (counseling); Kidney; General surgery; Surgery; Intensive care medicine; Cancer; Urology; Internal medicine; Nephrectomy; Nursing","score_opus":0.07646830547592356,"score_gpt":0.28584453888636896,"score_spread":0.2093762334104454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1595374633","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38234046,0.000768702,0.00012512966,0.36812913,0.00083142944,0.004770084,0.00057953486,0.0002394097,0.24221613],"genre_scores_gemma":[0.064192936,0.00016666105,0.007053812,0.88459724,0.0025768527,0.00033067673,0.0018140355,0.00054250285,0.03872527],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996225,0.0010415504,0.0007167027,0.0008617312,0.0004640231,0.0006909855],"domain_scores_gemma":[0.9977408,0.00003527799,0.0003025413,0.0009771099,0.00016395941,0.0007803125],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008211025,0.0004852424,0.00083285436,0.0005287404,0.00002619047,0.000018172594,0.00046456055,0.0002660537,0.00035906874],"category_scores_gemma":[0.00005453211,0.00043791273,0.00013296683,0.00023965884,0.000094622075,0.00006885114,0.00030511478,0.0013241514,0.00010692484],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018122141,0.0004705191,0.010478401,0.0022460488,0.0012171544,0.19695361,0.0020709923,0.00029695267,0.0014308298,0.00006898951,0.77621984,0.0067344643],"study_design_scores_gemma":[0.0029024845,0.003231862,0.023031894,0.0005897697,0.0006179397,0.000087760134,0.000046532565,0.000014453257,0.00015939286,0.000025246101,0.96882945,0.0004632143],"about_ca_topic_score_codex":0.00076618145,"about_ca_topic_score_gemma":0.000041580457,"teacher_disagreement_score":0.5164681,"about_ca_system_score_codex":0.00031488345,"about_ca_system_score_gemma":0.00036881547,"threshold_uncertainty_score":0.99980724},"labels":[],"label_agreement":null},{"id":"W1599124340","doi":"10.1016/j.eururo.2015.06.054","title":"The UGT2B28 Sex-steroid Inactivation Pathway Is a Regulator of Steroidogenesis and Modifies the Risk of Prostate Cancer Progression","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Androgen; Dihydrotestosterone; Internal medicine; Endocrinology; Medicine; Glucuronidation; Testosterone (patch); Prostate; Steroid hormone; Sex steroid; Cancer research; Prostate-specific antigen; Hormone; Cancer; Steroid; Biology; Enzyme","score_opus":0.033078212054541735,"score_gpt":0.30294599947776335,"score_spread":0.2698677874232216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1599124340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888298,0.0058668563,0.0000068971885,0.0036719262,0.00007216605,0.00054301636,0.000024960746,0.00001322931,0.0009711388],"genre_scores_gemma":[0.99649996,0.0017106181,0.000026751042,0.00011125131,0.00006251709,0.000032618827,0.000005847524,0.000020571899,0.0015298593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873555,0.00047717354,0.00021938757,0.00017526156,0.00021538445,0.00017726916],"domain_scores_gemma":[0.99913514,0.000113637725,0.00020465278,0.00029395966,0.00018495998,0.00006765866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068525266,0.00010111574,0.00017631987,0.00004556094,0.00010281764,0.000009876761,0.00009814177,0.000031122705,0.0000065017584],"category_scores_gemma":[0.00009432574,0.000045847046,0.000034849854,0.00011095821,0.00040621246,0.000039586874,0.00011273446,0.00012575781,0.0000036723725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007797795,0.00024988287,0.5266451,0.00019809758,0.00058738526,0.0000412741,0.021792404,0.000041303578,0.059308186,0.000121652025,0.002814902,0.380402],"study_design_scores_gemma":[0.009321623,0.0063159917,0.6203739,0.00015941376,0.00041285146,0.00007043741,0.0028913901,0.0010649143,0.29356,0.00058868324,0.06498161,0.00025916068],"about_ca_topic_score_codex":0.000057987305,"about_ca_topic_score_gemma":0.000009742821,"teacher_disagreement_score":0.38014284,"about_ca_system_score_codex":0.000027217573,"about_ca_system_score_gemma":0.000103489314,"threshold_uncertainty_score":0.18695882},"labels":[],"label_agreement":null},{"id":"W1607198229","doi":"10.1016/j.eururo.2015.04.033","title":"Characterization of 1577 Primary Prostate Cancers Reveals Novel Biological and Clinicopathologic Insights into Molecular Subtypes","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Erg; Prostatectomy; Subtyping; Oncology; Prostate; Tissue microarray; Gene expression profiling; Internal medicine; Logistic regression; Microarray; Gene expression; Pathology; Cancer; Gene; Biology; Genetics","score_opus":0.03397507536165334,"score_gpt":0.27098055585753367,"score_spread":0.23700548049588033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1607198229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99444354,0.002025014,0.00019473355,0.0008034974,0.00013869964,0.00039174824,0.000013507101,0.000030083125,0.001959154],"genre_scores_gemma":[0.9953817,0.0014251561,0.0004929485,0.0023876303,0.000059516977,0.000017763918,0.00016741003,0.00001963849,0.000048209415],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99887675,0.0002280641,0.00031711883,0.00032787572,0.00008675702,0.00016345555],"domain_scores_gemma":[0.99933726,0.00003928496,0.00017472422,0.0001969185,0.000112126334,0.00013967104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031423703,0.00013843848,0.00033811346,0.00006808202,0.00002345858,0.0000056334156,0.000057835376,0.00005955499,0.000009602456],"category_scores_gemma":[0.00013035233,0.00009918638,0.000037471185,0.00009553129,0.00020707022,0.000039920233,0.000092053815,0.00010271479,0.000021782604],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010554229,0.00037771693,0.22667907,0.00007695061,0.000088802735,0.00067509647,0.001565803,0.000011730751,0.758294,0.00040611607,0.000101397396,0.010667917],"study_design_scores_gemma":[0.0034065277,0.005828516,0.96717334,0.00004336342,0.00011388756,0.000101574136,0.000032391796,0.000022804323,0.010803857,0.00034744677,0.011956049,0.00017022088],"about_ca_topic_score_codex":0.0000075325124,"about_ca_topic_score_gemma":0.0000013216683,"teacher_disagreement_score":0.7474901,"about_ca_system_score_codex":0.00006911178,"about_ca_system_score_gemma":0.00009078975,"threshold_uncertainty_score":0.4044703},"labels":[],"label_agreement":null},{"id":"W1749926766","doi":"10.1016/j.eururo.2015.10.009","title":"Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Prostate-specific antigen; Hazard ratio; Biochemical recurrence; Interquartile range; Urology; Androgen deprivation therapy; Proportional hazards model; Surgical margin; Cancer; Internal medicine; Confidence interval","score_opus":0.02936663757006434,"score_gpt":0.28072777959672834,"score_spread":0.251361142026664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1749926766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951391,0.0012038512,0.00020299053,0.0009361514,0.00012143068,0.0019269529,0.000015315094,0.00004187489,0.00041233466],"genre_scores_gemma":[0.99788076,0.00012949582,0.0008023434,0.0006775529,0.00013036832,0.00021284497,0.00007951306,0.00006269149,0.000024424364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986085,0.0002572259,0.00025397615,0.00034913755,0.00018205344,0.0003490976],"domain_scores_gemma":[0.9993306,0.000082314255,0.000108746724,0.00024759455,0.000109368295,0.000121368896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004485903,0.00017997643,0.00022415143,0.00008786844,0.00006579726,0.00007327516,0.000080034515,0.000037949747,0.000014031546],"category_scores_gemma":[0.00003536205,0.000107401975,0.000043773292,0.00013619757,0.00013174438,0.00017222358,0.000029376617,0.00017731376,0.000025782136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006215581,0.00043231325,0.9465146,0.000009553144,0.00006448109,0.00016439715,0.0022099996,0.00009074251,0.000034048317,0.000009858873,0.0004922686,0.043762177],"study_design_scores_gemma":[0.011317057,0.0045146365,0.9552106,0.000024463527,0.000025655285,0.000004999215,0.000041388885,0.00008292588,0.00014512456,0.000010707644,0.02850365,0.00011873816],"about_ca_topic_score_codex":0.000007912966,"about_ca_topic_score_gemma":0.0000012058043,"teacher_disagreement_score":0.04364344,"about_ca_system_score_codex":0.00010359531,"about_ca_system_score_gemma":0.00008315303,"threshold_uncertainty_score":0.43797255},"labels":[],"label_agreement":null},{"id":"W1753476710","doi":"10.1016/j.eururo.2015.10.018","title":"Should Prebiopsy Multiparametric Magnetic Resonance Imaging be Offered to All Biopsy-naïve Men Undergoing Prostate Biopsy?","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prostate cancer; Nomogram; Biopsy; Prostate biopsy; Prostate; Magnetic resonance imaging; Radiology; Cancer; Gold standard (test); Urology; Oncology; Internal medicine","score_opus":0.04952979342400804,"score_gpt":0.29055712444285675,"score_spread":0.2410273310188487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1753476710","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012276665,0.033242896,0.0000638915,0.91234994,0.0015616016,0.004065847,0.000732072,0.00057946617,0.035127614],"genre_scores_gemma":[0.03732927,0.0014381594,0.0030096998,0.9370291,0.003276672,0.00039723289,0.001946663,0.0007311682,0.014842013],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941116,0.0007650551,0.0009428341,0.0019077772,0.0007232716,0.0015494674],"domain_scores_gemma":[0.9967114,0.00047444302,0.00039090667,0.0015226947,0.00035683313,0.0005437785],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066142954,0.0010266675,0.0012514814,0.0009272739,0.00011644712,0.00011944613,0.00057664927,0.0003911441,0.00018941877],"category_scores_gemma":[0.00059461064,0.0009024781,0.000272585,0.00076464383,0.00026454075,0.00009577928,0.0005315713,0.0018221507,0.0010922945],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004936703,0.00021662262,0.008309501,0.00021048688,0.0001924663,0.019163033,0.00067488564,0.000012523756,0.00028737722,0.000008455338,0.95188826,0.018542731],"study_design_scores_gemma":[0.0041917632,0.0023131755,0.020984229,0.00023476174,0.0007004157,0.0014618858,0.000035043948,0.00014442948,0.0000898423,0.00004900678,0.9689893,0.0008061501],"about_ca_topic_score_codex":0.00013718693,"about_ca_topic_score_gemma":0.00000738151,"teacher_disagreement_score":0.031804737,"about_ca_system_score_codex":0.00060703914,"about_ca_system_score_gemma":0.0003680583,"threshold_uncertainty_score":0.99968547},"labels":[],"label_agreement":null},{"id":"W1824496400","doi":"10.1016/j.eururo.2015.09.031","title":"Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"National Cancer Institute","keywords":"Androgen receptor; Prostate cancer; Medicine; Prostatectomy; Prostate; Cohort; Cancer; Androgen; Internal medicine; Endocrinology; Oncology; Cancer research; Hormone","score_opus":0.02677328838147414,"score_gpt":0.3189734396350947,"score_spread":0.2922001512536206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1824496400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99073523,0.0042472184,0.000067188295,0.0023479527,0.000100609606,0.00036987205,0.000008497095,0.000035558012,0.0020878569],"genre_scores_gemma":[0.99862087,0.00021960576,0.00019222322,0.0004945379,0.00009872655,0.000026869084,0.000050586375,0.000026396005,0.000270217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899393,0.00026964323,0.00016112876,0.0002444654,0.00010938708,0.00022143852],"domain_scores_gemma":[0.9995665,0.000025695379,0.000047019083,0.000115359384,0.00011993189,0.00012550369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040070942,0.000094076655,0.00014922621,0.00014936393,0.000038330723,0.000013744888,0.000046624442,0.000023442255,0.00003931225],"category_scores_gemma":[0.00012184047,0.000080414466,0.000015886959,0.00024240061,0.00007406903,0.000050070146,0.00004008156,0.00015176734,0.00005587311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01154329,0.00075381744,0.6133318,0.00028033397,0.00055194454,0.0045203073,0.019024523,0.0014267465,0.29212868,0.0017863422,0.004034264,0.050617933],"study_design_scores_gemma":[0.08761773,0.017543063,0.4652473,0.00060521334,0.0013357537,0.001147391,0.0017312424,0.013245949,0.17226002,0.004849606,0.23165229,0.0027644238],"about_ca_topic_score_codex":0.00006158854,"about_ca_topic_score_gemma":0.00003603752,"teacher_disagreement_score":0.22761804,"about_ca_system_score_codex":0.0001011624,"about_ca_system_score_gemma":0.0002481645,"threshold_uncertainty_score":0.32792068},"labels":[],"label_agreement":null},{"id":"W1827911007","doi":"10.1016/j.eururo.2015.08.052","title":"PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2937,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"National Institutes of Health","keywords":"Medicine; Prostate cancer; Terminology; Prostate; Medical physics; Standardization; Magnetic resonance imaging; Radiology; Cancer; Internal medicine","score_opus":0.05632476977432498,"score_gpt":0.32068972904352444,"score_spread":0.26436495926919945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1827911007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9089548,0.015078296,0.00015645564,0.013898535,0.0010630889,0.00077533314,0.0000691963,0.0003433532,0.059660956],"genre_scores_gemma":[0.9980788,0.00014178063,0.0003214911,0.00077486446,0.00019022121,0.0000045821776,0.00019079953,0.00003318041,0.00026426205],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986361,0.00014758683,0.00041105982,0.00045188543,0.00012187015,0.00023145233],"domain_scores_gemma":[0.998719,0.00002569634,0.0003361688,0.0006348652,0.00007581802,0.00020846815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010871885,0.00012075782,0.00023306468,0.000054715838,0.000056441782,0.00002232791,0.00010046838,0.000016758275,0.0000075951493],"category_scores_gemma":[0.0003589358,0.00009669715,0.000018805535,0.000058210404,0.00006856607,0.00010539993,0.00036652538,0.00011191801,0.00014981633],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006130092,0.00019973332,0.7731868,0.00028150325,0.00017262959,0.014875702,0.001281255,0.000015446143,0.00070204993,0.00019504965,0.17103817,0.03743868],"study_design_scores_gemma":[0.007937716,0.0017480573,0.23705013,0.0002828382,0.0006556466,0.0056740954,0.0008942904,0.003607677,0.00030151944,0.000035607387,0.7414343,0.00037816976],"about_ca_topic_score_codex":0.000042642863,"about_ca_topic_score_gemma":0.0000019156,"teacher_disagreement_score":0.57039607,"about_ca_system_score_codex":0.000066046196,"about_ca_system_score_gemma":0.000066885485,"threshold_uncertainty_score":0.39431953},"labels":[],"label_agreement":null},{"id":"W1831945879","doi":"10.1016/j.eururo.2015.06.012","title":"Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in Noncompliers","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Prostate cancer; Watchful waiting; Prostate-specific antigen; Gynecology; Internal medicine; Biopsy; Proportional hazards model; Discontinuation; Cancer; Oncology","score_opus":0.1316341867374044,"score_gpt":0.41221282682072874,"score_spread":0.28057864008332434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1831945879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77036846,0.00054236886,0.00004432016,0.15732989,0.00020704321,0.052913196,0.00009858671,0.00006424221,0.018431904],"genre_scores_gemma":[0.977095,0.00008933448,0.000054843968,0.0008205064,0.00010021668,0.021489253,0.000027130234,0.0000213542,0.00030235428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986853,0.0004555235,0.00013046933,0.00031772305,0.00020008716,0.0002108878],"domain_scores_gemma":[0.99916136,0.00012222653,0.00007167418,0.00020804112,0.00025588734,0.00018078975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062167255,0.000098919976,0.00012653564,0.0000681529,0.000062995,0.000025819414,0.000106908185,0.000013907254,0.000017564369],"category_scores_gemma":[0.0001395592,0.000059482685,0.000011187053,0.00016526977,0.0002967196,0.000056648678,0.00006795435,0.00021820079,0.000026311856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010976313,0.00033706357,0.9509241,0.00005210546,0.00009134363,0.00031485278,0.0020315405,0.00015847012,0.00021047122,0.0003730844,0.0098058265,0.02472484],"study_design_scores_gemma":[0.0035139325,0.00055922766,0.9067446,0.000053288608,0.000008320701,0.00001137962,0.00019132558,0.00029867873,0.000068845715,0.00010754371,0.088373505,0.000069328315],"about_ca_topic_score_codex":0.000060434315,"about_ca_topic_score_gemma":0.00011733409,"teacher_disagreement_score":0.20672655,"about_ca_system_score_codex":0.00017458186,"about_ca_system_score_gemma":0.0002201025,"threshold_uncertainty_score":0.24256335},"labels":[],"label_agreement":null},{"id":"W1836606401","doi":"10.1016/j.eururo.2015.06.037","title":"Personalized Medicine in Kidney Cancer: Learning How to Walk Before We Run","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Renal cell carcinoma; Radiogenomics; Clear cell renal cell carcinoma; Kidney cancer; Metastasis; Oncology; Internal medicine; Personalized medicine; Cancer; Gene signature; Pathology; Bioinformatics; Gene expression; Gene; Radiology","score_opus":0.035113287264943366,"score_gpt":0.2735569426563131,"score_spread":0.23844365539136972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1836606401","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012126414,0.004133543,0.000010382066,0.94018996,0.0008799201,0.0007929839,0.000026389109,0.00015080694,0.04168958],"genre_scores_gemma":[0.037554134,0.00038079088,0.00015591757,0.8451104,0.010689282,0.000054313598,0.0010620859,0.0003483484,0.10464471],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99561864,0.0012884671,0.0004934431,0.0010375014,0.00067123346,0.0008906969],"domain_scores_gemma":[0.99812907,0.00012741097,0.00026181067,0.0006825861,0.00020001915,0.00059907744],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007364559,0.0006666152,0.0013384955,0.00070278073,0.000058609756,0.000017732538,0.00037525847,0.00044688082,0.0011201894],"category_scores_gemma":[0.0008805361,0.0005130278,0.00017755313,0.00034818792,0.00027630248,0.00003340623,0.00022563984,0.003193257,0.0008241763],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036427137,0.000029706918,0.0039222827,0.00024177818,0.00018162046,0.02578303,0.0031053792,0.000010254505,0.00026329976,0.000005804312,0.9624601,0.0036324433],"study_design_scores_gemma":[0.0041547217,0.0035516645,0.0052148737,0.0004257391,0.00044481098,0.00067201164,0.00008746409,0.000021218422,0.000009824591,0.000017357454,0.98507303,0.00032727723],"about_ca_topic_score_codex":0.00029148645,"about_ca_topic_score_gemma":0.00004508755,"teacher_disagreement_score":0.09507956,"about_ca_system_score_codex":0.00056985265,"about_ca_system_score_gemma":0.00037406266,"threshold_uncertainty_score":0.9999538},"labels":[],"label_agreement":null},{"id":"W1855250570","doi":"10.1016/j.eururo.2015.09.014","title":"Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"TFAM; Angiogenesis; Cancer research; Clear cell renal cell carcinoma; Mitochondrion; Apoptosis; Hypoxia-inducible factors; Biology; Cell growth; Pyruvate dehydrogenase kinase; Pyruvate dehydrogenase complex; Medicine; Endocrinology; Internal medicine; Cell biology; Biochemistry; Renal cell carcinoma; Mitochondrial biogenesis; Enzyme","score_opus":0.007000896224311825,"score_gpt":0.1967210788549563,"score_spread":0.18972018263064447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1855250570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938378,0.0021479998,0.0012183195,0.0000381052,0.00024185794,0.00015417126,0.000059452814,0.000013053957,0.002289241],"genre_scores_gemma":[0.99794,0.00027508877,0.00032680627,0.0001290547,0.0006780415,0.000004782892,0.00005466792,0.00006165985,0.0005298886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846584,0.0003389036,0.00034465364,0.00043680845,0.00012791577,0.00028587287],"domain_scores_gemma":[0.9988844,0.000012615655,0.00027722577,0.000557769,0.00013349594,0.0001345246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026938532,0.00020173634,0.000289476,0.00008750221,0.000036839454,0.0000045994043,0.00022251799,0.00008677466,0.000029613513],"category_scores_gemma":[0.00002478913,0.00014635338,0.0000947763,0.00009940861,0.0002337594,0.000011297238,0.00010502747,0.00007248352,0.000014009595],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080615113,0.00015026757,0.0012955056,0.000018473233,0.000025034775,0.0000071479726,0.000100276535,0.00014723335,0.99382395,0.000044604767,0.0002591552,0.0033222176],"study_design_scores_gemma":[0.002318616,0.0014206572,0.019042911,0.000003805387,0.00008256458,0.000013045208,0.000014506214,0.000030847692,0.9229054,0.000014008368,0.05396285,0.00019082609],"about_ca_topic_score_codex":0.00002895555,"about_ca_topic_score_gemma":0.000028058863,"teacher_disagreement_score":0.07091857,"about_ca_system_score_codex":0.00000395561,"about_ca_system_score_gemma":0.000069781556,"threshold_uncertainty_score":0.5968118},"labels":[],"label_agreement":null},{"id":"W1880813018","doi":"10.1016/j.eururo.2015.10.008","title":"Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Prostate cancer; Docetaxel; Hazard ratio; Internal medicine; Response Evaluation Criteria in Solid Tumors; Confidence interval; Proportional hazards model; Oncology; Urology; Prostate-specific antigen; Cancer; Progressive disease; Chemotherapy","score_opus":0.04632432652286356,"score_gpt":0.30313933970059315,"score_spread":0.2568150131777296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1880813018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99170214,0.00046753985,0.0000031934658,0.0041875322,0.00008478366,0.00044698382,0.00005241003,0.000023140914,0.0030322925],"genre_scores_gemma":[0.99710536,0.00013074238,0.000106122156,0.0001237905,0.00009210681,0.000020404397,0.00012128219,0.000027180713,0.0022729987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986458,0.0003758546,0.00016726872,0.0002513086,0.00027477424,0.0002850112],"domain_scores_gemma":[0.9993569,0.000101228026,0.00011043207,0.00011238005,0.00018093058,0.00013807463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071414275,0.000117665346,0.00024140494,0.000114621944,0.000043465156,0.000024598572,0.000046466008,0.000025678739,0.000017941176],"category_scores_gemma":[0.00018035217,0.00008508975,0.000011199629,0.00017067815,0.000054334494,0.000066587665,0.00004098474,0.00017711593,0.000013918381],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010354565,0.00006367336,0.989468,0.00002681754,0.00014347426,0.00007214726,0.0008424188,0.000005571526,0.00006736524,0.0000041196995,0.00033349052,0.00793747],"study_design_scores_gemma":[0.006057793,0.001354008,0.98826677,0.000029943527,0.00012814037,0.0000013400143,0.000078082274,0.000009065227,0.000036966852,0.000015524514,0.0039343317,0.00008801771],"about_ca_topic_score_codex":0.00021248637,"about_ca_topic_score_gemma":0.00091305724,"teacher_disagreement_score":0.007849452,"about_ca_system_score_codex":0.00020998422,"about_ca_system_score_gemma":0.000108479675,"threshold_uncertainty_score":0.34698594},"labels":[],"label_agreement":null},{"id":"W1930757702","doi":"10.1016/j.eururo.2015.06.039","title":"Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options","year":2015,"lang":"en","type":"review","venue":"European Urology","topic":"Bone health and treatments","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Janssen Pharmaceuticals; Sanofi; Bavarian Nordic; Bayer Fund; Takeda Pharmaceuticals U.S.A.; Astellas Pharma US","keywords":"Medicine; Prostate cancer; Prostate; Oncology; Cancer; General surgery; Internal medicine","score_opus":0.08252470059190517,"score_gpt":0.3752154976624536,"score_spread":0.29269079707054846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1930757702","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006216917,0.994642,0.000002400927,0.0017407577,0.00012823034,0.0016080484,0.000047731857,0.000030803378,0.0017378473],"genre_scores_gemma":[0.0004660584,0.99495393,0.00006246288,0.0015983703,0.00006223849,0.00019950625,0.00003498054,0.000060526912,0.0025619122],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979879,0.000969074,0.00035167878,0.0003351741,0.00009299359,0.00026316437],"domain_scores_gemma":[0.99905634,0.00021805924,0.00020820573,0.00028083782,0.00004427794,0.00019227096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006445814,0.00025645993,0.0010882807,0.00006884843,0.000094876246,0.000014924356,0.00005675001,0.000046181678,0.000018219951],"category_scores_gemma":[0.00004591731,0.00013264007,0.00007773258,0.00010636766,0.00040532736,0.000013071476,0.000056818102,0.00036343455,0.000078727826],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012701668,0.00003536954,0.000032904052,0.0022758176,0.0003169688,0.00018023993,0.00019751908,1.4902193e-7,4.0018545e-8,0.0004373215,0.0005307018,0.99586594],"study_design_scores_gemma":[0.0021934337,0.000237622,0.00022152539,0.00030339957,0.0032609634,0.00070485804,0.000006735471,0.0000060855914,7.499063e-9,0.00010495672,0.99286515,0.00009528589],"about_ca_topic_score_codex":0.000056660258,"about_ca_topic_score_gemma":0.000012799843,"teacher_disagreement_score":0.9957707,"about_ca_system_score_codex":0.00002907722,"about_ca_system_score_gemma":0.00027445453,"threshold_uncertainty_score":0.54089046},"labels":[],"label_agreement":null},{"id":"W1932671340","doi":"10.1016/j.eururo.2015.07.051","title":"Identifying the Most Informative Prediction Tool for Cancer-specific Mortality After Radical Prostatectomy: Comparative Analysis of Three Commonly Used Preoperative Prediction Models","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Prostate cancer; Prostatectomy; Generalizability theory; Capra; Receiver operating characteristic; Brier score; Oncology; Cancer; Urology; Statistics; Nuclear medicine; Internal medicine; Mathematics","score_opus":0.11150457048447628,"score_gpt":0.33036712579166494,"score_spread":0.21886255530718868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1932671340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97481674,0.001340674,0.01764018,0.0004473554,0.0002547212,0.002359902,0.0017647303,0.0000693466,0.0013063308],"genre_scores_gemma":[0.9977263,0.00018882725,0.00021911955,0.00031974577,0.00011961538,0.000787103,0.00059128867,0.000020338623,0.000027616812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806625,0.000348561,0.00064787,0.0003531089,0.00031275995,0.0002714303],"domain_scores_gemma":[0.99853885,0.00017083176,0.00029461266,0.00040290994,0.00046643705,0.0001263777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006618917,0.00022945963,0.0006012954,0.00018001077,0.000121041245,0.00003523972,0.00012449687,0.000060308397,0.000034269193],"category_scores_gemma":[0.000036369256,0.00015368179,0.00017543393,0.00052745204,0.00034330576,0.00031291693,0.00007972825,0.00022582129,0.0000065537633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058410577,0.00081004115,0.87677807,0.0001134012,0.0097347135,0.000044861237,0.051608592,0.046978936,0.00017932733,0.0017293459,0.003920009,0.002261679],"study_design_scores_gemma":[0.0041231387,0.0019296019,0.9112749,0.000045938745,0.003223838,0.0000074012964,0.0006781306,0.07488853,0.0006925125,0.00032189535,0.0026706345,0.00014347117],"about_ca_topic_score_codex":0.000081915794,"about_ca_topic_score_gemma":0.00023763278,"teacher_disagreement_score":0.050930463,"about_ca_system_score_codex":0.00023062389,"about_ca_system_score_gemma":0.00016297124,"threshold_uncertainty_score":0.6266961},"labels":[],"label_agreement":null},{"id":"W1963765725","doi":"10.1016/j.eururo.2013.09.024","title":"The Prognostic Importance of Metastatic Site in Men with Metastatic Castration-resistant Prostate Cancer","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":198,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Docetaxel; Prostate cancer; Internal medicine; Oncology; Metastasis; Lymph node; Proportional hazards model; Bone metastasis; Urology; Cancer","score_opus":0.02300769354330687,"score_gpt":0.2933294950658087,"score_spread":0.2703218015225018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963765725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837152,0.0032701315,0.000009753924,0.0046271477,0.000027016424,0.001654249,0.000021473857,0.000021896007,0.0066531324],"genre_scores_gemma":[0.9962658,0.00038581944,0.00028366616,0.00020516283,0.000021585864,0.00025401782,0.000031354066,0.000036173216,0.0025163905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835783,0.00034585045,0.0003839601,0.00026698053,0.00024081685,0.0004045616],"domain_scores_gemma":[0.99902344,0.0002491576,0.00016209255,0.00028984962,0.00017360887,0.000101828635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004330957,0.00015939528,0.0002823502,0.00009358189,0.000075687065,0.000024479905,0.00011255885,0.000011731284,0.00015199036],"category_scores_gemma":[0.000106298074,0.00008401748,0.000036684465,0.00029075608,0.00030250128,0.000083697254,0.000038958675,0.00020111639,0.00007325981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003604611,0.0004980117,0.9507907,0.0003694316,0.0007974588,0.0021915906,0.003100564,0.0002809881,0.02663082,0.00044931917,0.0032261931,0.008060335],"study_design_scores_gemma":[0.0047491156,0.0021667476,0.9881824,0.00007353002,0.00026495603,0.00008189166,0.00046942296,0.0006510723,0.0005952418,0.00020609412,0.002403056,0.00015643593],"about_ca_topic_score_codex":0.0003073785,"about_ca_topic_score_gemma":0.0006721924,"teacher_disagreement_score":0.03739176,"about_ca_system_score_codex":0.000051121206,"about_ca_system_score_gemma":0.00021921839,"threshold_uncertainty_score":0.34261334},"labels":[],"label_agreement":null},{"id":"W1964444824","doi":"10.1016/j.eururo.2008.01.074","title":"Perspectives on Prostate Cancer Biomarkers","year":2008,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Prostate disease; Prostate; Cancer; Oncology; Gynecology; Internal medicine","score_opus":0.016973879192088984,"score_gpt":0.3171113776083485,"score_spread":0.30013749841625953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964444824","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005062456,0.02684022,0.0000013102205,0.005571478,0.8048944,0.0012384448,0.0005229058,0.0002922883,0.15557653],"genre_scores_gemma":[0.0063084792,0.058098085,0.000035872814,0.00039056604,0.8787944,0.000091902366,0.0008532416,0.0002714846,0.055155993],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972588,0.0004091306,0.00026450996,0.0008602238,0.00060396304,0.0006033643],"domain_scores_gemma":[0.9985111,0.00030354082,0.0001381024,0.00051669346,0.0003050192,0.00022559705],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026439113,0.00040418957,0.00053286104,0.00033147127,0.00014579519,0.000019701538,0.00022281804,0.00031254342,0.00037035794],"category_scores_gemma":[0.00044054422,0.00030317868,0.00018685038,0.00019292644,0.0004833719,0.00002879255,0.00011664945,0.0012872566,0.0008730668],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037620568,0.00020632155,0.00030788456,0.00007228016,0.0006861036,0.0034407235,0.0014916545,0.0000019808542,0.00008774253,0.0000067702144,0.9866971,0.0032394251],"study_design_scores_gemma":[0.0032401918,0.0023353125,0.0014496034,0.00007794664,0.00016362425,0.000027961578,0.00011925481,0.0000027835647,0.000034148856,0.0000041399626,0.9923008,0.0002442171],"about_ca_topic_score_codex":0.00007036004,"about_ca_topic_score_gemma":0.000006229767,"teacher_disagreement_score":0.100420535,"about_ca_system_score_codex":0.00034105458,"about_ca_system_score_gemma":0.00072406844,"threshold_uncertainty_score":0.999942},"labels":[],"label_agreement":null},{"id":"W1965505850","doi":"10.1016/j.eururo.2011.12.021","title":"The Impact of Germline Genetic Variations in Hydroxysteroid (17-Beta) Dehydrogenases on Prostate Cancer Outcomes After Prostatectomy","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Medicine; Prostate cancer; Single-nucleotide polymorphism; Internal medicine; Hazard ratio; Proportional hazards model; Oncology; Prostatectomy; Biochemical recurrence; Cancer; Haplotype; Prostate; Disease; Endocrinology; Genotype; Gene; Genetics; Biology; Confidence interval","score_opus":0.024898680842994254,"score_gpt":0.28304583443289383,"score_spread":0.2581471535898996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965505850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942187,0.0006475505,0.000011815644,0.0007198912,0.0000538431,0.00039951663,0.000013043248,0.000024828913,0.0039107744],"genre_scores_gemma":[0.9984834,0.00010803637,0.000073004194,0.00057676557,0.00003613716,0.00002924438,0.000007657127,0.000031478914,0.00065427466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887395,0.00022245511,0.00034740142,0.00019642132,0.00012523677,0.00023455852],"domain_scores_gemma":[0.99936205,0.00008485074,0.00011350955,0.00028369945,0.00007538481,0.00008047572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021089545,0.00014013797,0.00024551942,0.00012876731,0.000043686367,0.000005150106,0.00007809189,0.000033638324,0.0001668825],"category_scores_gemma":[0.000067814304,0.000078701974,0.00010418099,0.00012993555,0.00010174141,0.000022441327,0.000037380654,0.00014027655,0.00006916606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018885556,0.00030558847,0.98359,0.0000092698865,0.00014099729,0.00040001146,0.0012766452,0.00022337474,0.0037318633,0.00007938309,0.0002347508,0.008119549],"study_design_scores_gemma":[0.0012286423,0.0007520876,0.99505955,0.000014445978,0.000045889075,0.00004558615,0.0000067177775,0.0007406213,0.00032407985,0.00004146246,0.0016679714,0.00007293549],"about_ca_topic_score_codex":0.00012807612,"about_ca_topic_score_gemma":0.00012410287,"teacher_disagreement_score":0.011469549,"about_ca_system_score_codex":0.000034529203,"about_ca_system_score_gemma":0.00006814256,"threshold_uncertainty_score":0.32093734},"labels":[],"label_agreement":null},{"id":"W1966345283","doi":"10.1016/j.eururo.2009.07.002","title":"Impact of Tumor Location on Prognosis for Patients with Upper Tract Urothelial Carcinoma Managed by Radical Nephroureterectomy","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Urothelial carcinoma; Urology; Upper urinary tract; Carcinoma; Ureteral neoplasm; Oncology; Internal medicine; Urinary system; Transitional cell carcinoma; Cancer; Bladder cancer","score_opus":0.009835714756104225,"score_gpt":0.25616525607675317,"score_spread":0.24632954132064894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966345283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948684,0.000062653206,0.00020156136,0.0004715388,0.00005422861,0.0011292107,0.00008094323,0.000042917665,0.0030885546],"genre_scores_gemma":[0.99772507,0.000002844405,0.00023866788,0.0015513485,0.00013795757,0.000023441042,0.00016897549,0.000046916513,0.00010477744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988601,0.00014869701,0.00023095842,0.00031516145,0.00016660607,0.0002784602],"domain_scores_gemma":[0.9993829,0.000052026448,0.00011344402,0.00022698683,0.0001003475,0.0001242825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090689806,0.0002037089,0.0002972453,0.00009505584,0.00004695757,0.000007732628,0.000093351664,0.000040576182,0.0000713421],"category_scores_gemma":[0.000048025813,0.00013884479,0.00012614629,0.00011215827,0.00007685469,0.000043171854,0.000007708713,0.00013575632,0.000022895012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01409232,0.0036539186,0.95319706,0.000041385134,0.000266544,0.00006849674,0.00029117873,0.0000127976655,0.0010351393,0.000035559,0.00794368,0.019361917],"study_design_scores_gemma":[0.00901749,0.030890029,0.9564656,0.000016765545,0.00022342004,0.000022521022,0.0000029306327,0.000028068189,0.00046187695,0.000011430427,0.0027410106,0.00011886279],"about_ca_topic_score_codex":0.0000196534,"about_ca_topic_score_gemma":4.764593e-7,"teacher_disagreement_score":0.027236111,"about_ca_system_score_codex":0.000061357074,"about_ca_system_score_gemma":0.000070360584,"threshold_uncertainty_score":0.5661926},"labels":[],"label_agreement":null},{"id":"W1966629200","doi":"10.1016/j.eururo.2008.07.026","title":"Re: Bevacizumab plus Interferon alfa-2a for Treatment of Metastatic Renal Cell Carcinoma: A Randomised, Double-Blind Phase III Trial","year":2008,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Bevacizumab; Oncology; Internal medicine; Interferon alfa; Interferon; Urology; Chemotherapy; Immunotherapy; Cancer; Immunology","score_opus":0.09391503087787555,"score_gpt":0.31515652726630383,"score_spread":0.22124149638842827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966629200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.830867,0.01117923,0.0011032259,0.08741695,0.0030283227,0.030585127,0.00080667454,0.00024112569,0.03477234],"genre_scores_gemma":[0.90756387,0.00052098726,0.0010619002,0.046426587,0.009422376,0.0016561341,0.00861852,0.00071384205,0.024015766],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99389315,0.0012043059,0.0019131996,0.0014158941,0.0005563797,0.0010170446],"domain_scores_gemma":[0.9959234,0.000867647,0.0011709592,0.0014951364,0.00025581833,0.00028704078],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046573297,0.0011837578,0.0032739027,0.00069960416,0.00013622908,0.000024147404,0.00041471823,0.00047051394,0.0003699315],"category_scores_gemma":[0.000064635,0.00091102504,0.0015492635,0.00019178443,0.00037844025,0.000052450476,0.00011682186,0.00077066786,0.00015659038],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7320153,0.0015039723,0.000002202929,0.00030318185,0.0011284649,0.015100556,0.0009229161,0.000013618058,0.00046258257,0.0000014113708,0.24758615,0.0009596523],"study_design_scores_gemma":[0.6400213,0.05081619,0.0000034045058,0.00002444565,0.00495456,0.00067236996,0.00002046627,0.000043156928,0.0035872972,0.00000428931,0.29947546,0.00037705255],"about_ca_topic_score_codex":0.00010758728,"about_ca_topic_score_gemma":0.0000113686465,"teacher_disagreement_score":0.09199399,"about_ca_system_score_codex":0.00071652664,"about_ca_system_score_gemma":0.0006179479,"threshold_uncertainty_score":0.99933404},"labels":[],"label_agreement":null},{"id":"W1966925928","doi":"10.1016/j.eururo.2013.08.051","title":"Slow and Steady Wins the Race: Practical (and Philosophical) Considerations of Treatment Activity Evaluation When Novel Anticancer Agents Just Slow Neoplastic Progression","year":2013,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Race (biology); Oncology; Pharmacology; Internal medicine","score_opus":0.1197997273907254,"score_gpt":0.3496696631711289,"score_spread":0.2298699357804035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966925928","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33987272,0.00059839897,0.00009890554,0.65374047,0.0003033993,0.0026165238,0.000048182173,0.000033809873,0.0026875725],"genre_scores_gemma":[0.9531147,0.00019382701,0.0008594585,0.043528955,0.0013270167,0.00014923971,0.00016428788,0.000087253895,0.00057529507],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9966204,0.0014022533,0.0004262273,0.0006950744,0.0005085254,0.00034750137],"domain_scores_gemma":[0.9972325,0.0013527998,0.00042294632,0.00061238586,0.00024307141,0.00013627198],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004818601,0.00043459338,0.0006723435,0.00013344927,0.00017966358,0.000049533384,0.00006637944,0.00039202638,0.00026356967],"category_scores_gemma":[0.0005515137,0.0002640818,0.00010051778,0.000054916683,0.0005911842,0.00008973439,0.00013576877,0.001163911,0.00005938336],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029995919,0.004384679,0.011877628,0.0013008835,0.005621787,0.00662506,0.005728722,0.00012434261,0.019049013,0.0008401984,0.9008994,0.04054867],"study_design_scores_gemma":[0.035008416,0.03280372,0.53248054,0.0007598335,0.031180445,0.01642949,0.00013686862,0.023102833,0.0014883489,0.0021042814,0.32250658,0.0019986196],"about_ca_topic_score_codex":0.00003584165,"about_ca_topic_score_gemma":0.0000064948053,"teacher_disagreement_score":0.6132419,"about_ca_system_score_codex":0.00020989825,"about_ca_system_score_gemma":0.00039962528,"threshold_uncertainty_score":0.99998116},"labels":[],"label_agreement":null},{"id":"W1967347194","doi":"10.1016/j.eururo.2006.09.019","title":"Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Pelvic floor disorders treatments","field":"Medicine","cited_by":2604,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Pfizer","keywords":"Medicine; Overactive bladder; Nocturia; Lower urinary tract symptoms; Urinary incontinence; Population; Cohort; Gynecology; Cross-sectional study; Demography; Urology; Urinary system; Internal medicine; Environmental health; Prostate","score_opus":0.011216300480520679,"score_gpt":0.2576984939142871,"score_spread":0.24648219343376643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967347194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933895,0.00024373365,0.0000017964728,0.00017497502,0.00008910775,0.00061036984,0.000121641984,0.000014000823,0.0053548897],"genre_scores_gemma":[0.9992445,0.000004569711,0.0000128470965,0.0002731652,0.00002129878,0.000005188653,0.000043596152,0.000029177887,0.0003656489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977777,0.0010301346,0.0005106011,0.000314248,0.00018680248,0.00018049189],"domain_scores_gemma":[0.9985843,0.00057815894,0.00031659796,0.0004035769,0.0000877474,0.000029645265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005730627,0.00016693566,0.00037059825,0.00014678622,0.000032996722,0.0000031577408,0.00011646529,0.000050898903,0.000039862924],"category_scores_gemma":[0.00032379816,0.00012386387,0.00004487573,0.00023719693,0.00017031303,0.00004425229,0.000062765714,0.00016313074,0.000007702389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031563768,0.004638894,0.99091256,0.000014097188,0.00007649542,0.00031072256,0.00042571998,0.00024435378,0.000029165369,0.0000081723965,0.00011961778,0.00006382247],"study_design_scores_gemma":[0.009222471,0.0035029757,0.986593,0.000027603597,0.000084529616,0.00004439769,0.000054119242,0.0001601751,0.000012059491,0.000016710967,0.00019841202,0.00008352541],"about_ca_topic_score_codex":0.0064379936,"about_ca_topic_score_gemma":0.0005589906,"teacher_disagreement_score":0.0060660946,"about_ca_system_score_codex":0.000032476994,"about_ca_system_score_gemma":0.00006462811,"threshold_uncertainty_score":0.9732363},"labels":[],"label_agreement":null},{"id":"W1967520004","doi":"10.1016/j.eururo.2006.07.051","title":"Should We Replace the Gleason Score with the Amount of High-Grade Prostate Cancer?","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prostate cancer; Prostate; Prostatectomy; Urology; Oncology; Cancer; Gynecology; Internal medicine","score_opus":0.020499955546321086,"score_gpt":0.2519932691960906,"score_spread":0.23149331364976952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967520004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89130723,0.008696402,0.00001579612,0.09487839,0.00013166656,0.0007216542,0.000036443096,0.00004762728,0.0041648024],"genre_scores_gemma":[0.9942025,0.001203191,0.000045827815,0.0028016046,0.00023784942,0.00007844519,0.000022223014,0.000043910943,0.0013644705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883765,0.0002176396,0.00020154759,0.00028901678,0.00018364521,0.00027052188],"domain_scores_gemma":[0.9990935,0.00011795472,0.0001682647,0.0005072519,0.00006812562,0.000044944885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023026804,0.00016880769,0.00023784241,0.000029383806,0.000100776284,0.0000124585895,0.00015288145,0.000025873165,0.00005899433],"category_scores_gemma":[0.000013271883,0.000073345385,0.000054749773,0.00015554775,0.00031924163,0.000023718734,0.000057375175,0.00021637141,0.000025876107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00619357,0.0016607202,0.5752513,0.00031369668,0.0011562261,0.0020452924,0.0043378156,0.006426928,0.006057715,0.0135860015,0.34146985,0.041500907],"study_design_scores_gemma":[0.0034217192,0.0026802418,0.57812023,0.000097050746,0.00048870547,0.0001517708,0.00012209956,0.000046344197,0.005510338,0.00014472188,0.40905762,0.00015917633],"about_ca_topic_score_codex":0.0008710669,"about_ca_topic_score_gemma":0.00038412586,"teacher_disagreement_score":0.10289527,"about_ca_system_score_codex":0.000057842288,"about_ca_system_score_gemma":0.00007294166,"threshold_uncertainty_score":0.2990938},"labels":[],"label_agreement":null},{"id":"W1967855918","doi":"10.1016/j.eururo.2011.05.051","title":"Mechanical Stimuli-induced Urothelial Differentiation in a Human Tissue-engineered Tubular Genitourinary Graft","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"","keywords":"Urothelium; Immunostaining; Cell biology; Pathology; Medicine; Urinary bladder; Anatomy; Biology; Immunohistochemistry; Internal medicine","score_opus":0.04123231779297865,"score_gpt":0.26950136993627294,"score_spread":0.2282690521432943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967855918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98925894,0.0005070578,0.0065124603,0.00040811003,0.000608008,0.0003175358,0.0000024748445,0.00019240529,0.0021929927],"genre_scores_gemma":[0.9967063,0.000009949183,0.0007005745,0.00010706005,0.0007617768,0.000010775016,0.000038535145,0.0000730561,0.0015919864],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985544,0.00026420923,0.000345176,0.0003477623,0.00015253416,0.00033589668],"domain_scores_gemma":[0.99939376,0.000027118745,0.00005014806,0.00031801258,0.00004302926,0.00016790994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026685855,0.00022376432,0.0003568803,0.0002607766,0.00004889939,0.0000042689912,0.0001299038,0.00009969562,0.00038373607],"category_scores_gemma":[0.00012223794,0.00018991104,0.000056113848,0.0001545305,0.000048151043,0.000029626815,0.00006240645,0.0004543544,0.00015270183],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001912668,0.00038763022,0.000982088,0.000040526418,0.0000752228,0.0025224693,0.0010828807,0.00006849152,0.99037963,0.0022786828,0.00031105528,0.0016800638],"study_design_scores_gemma":[0.018093523,0.016541183,0.6946815,0.00017553112,0.00060037506,0.0018445876,0.0001387795,0.004629968,0.23619871,0.0003220703,0.025516596,0.0012571426],"about_ca_topic_score_codex":0.000027717739,"about_ca_topic_score_gemma":0.0000052741884,"teacher_disagreement_score":0.7541809,"about_ca_system_score_codex":0.0000307195,"about_ca_system_score_gemma":0.00001645027,"threshold_uncertainty_score":0.77443475},"labels":[],"label_agreement":null},{"id":"W1968298168","doi":"10.1016/j.eururo.2005.02.019","title":"An Evaluation of an Alternative Dosing Regimen with Tadalafil, 3 Times/Week, for Men with Erectile Dysfunction: SURE Study in 14 European Countries","year":2005,"lang":"en","type":"article","venue":"European Urology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Tadalafil; Erectile dysfunction; Dosing; Regimen; Urology; Gynecology; Internal medicine","score_opus":0.04394820137059814,"score_gpt":0.31404492564021724,"score_spread":0.2700967242696191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968298168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91051465,0.0001125707,0.001418276,0.00055993657,0.00020023788,0.0014445856,0.000009654427,0.00012793305,0.08561218],"genre_scores_gemma":[0.99610937,0.0000064311093,0.00045203778,0.0007631324,0.00061100017,0.00004280914,0.00006588827,0.00007697392,0.001872355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996769,0.0014919023,0.00040276893,0.0005638429,0.0005081351,0.0002643367],"domain_scores_gemma":[0.99826944,0.00012921011,0.00024558598,0.00043451594,0.0008073266,0.00011394425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026109826,0.00024718992,0.00039866244,0.0002645908,0.00015757527,0.000026850546,0.0001064531,0.000034110682,0.00029503406],"category_scores_gemma":[0.00012495306,0.00018381962,0.000029110042,0.0002577543,0.00016095683,0.0002863658,0.000031168525,0.0002085279,0.000055028595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12530942,0.014901406,0.58410144,0.00020083258,0.00376459,0.0006232521,0.06482774,0.086987115,0.002835036,0.0010406828,0.02543735,0.08997115],"study_design_scores_gemma":[0.042777795,0.07180946,0.7738202,0.0000658109,0.0016417241,0.0003244439,0.01400209,0.01658911,0.0005466068,0.000020483447,0.07774232,0.0006599051],"about_ca_topic_score_codex":0.000056158486,"about_ca_topic_score_gemma":0.0003921882,"teacher_disagreement_score":0.18971881,"about_ca_system_score_codex":0.000097271426,"about_ca_system_score_gemma":0.00010321478,"threshold_uncertainty_score":0.7495946},"labels":[],"label_agreement":null},{"id":"W1968554623","doi":"10.1016/j.eururo.2007.10.017","title":"Contemporary Prostate Cancer Prevalence among T1c Biopsy-Referred Men with a Prostate-Specific Antigen Level ≤ 4.0ng per Milliliter","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Universität Hamburg","keywords":"Medicine; Prostate cancer; Biopsy; Prostate biopsy; Prostate-specific antigen; Rectal examination; Urology; Prostate; Population; Logistic regression; Gynecology; Cancer; Internal medicine","score_opus":0.04246753563307383,"score_gpt":0.2738571121741281,"score_spread":0.2313895765410543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968554623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9506656,0.01188313,0.00010706076,0.0015439545,0.00019471342,0.001856621,0.00021279098,0.00017065059,0.033365503],"genre_scores_gemma":[0.9904306,0.0024461541,0.00044705573,0.0011773567,0.00024100448,0.00013304564,0.00013696922,0.00013389243,0.0048539243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972452,0.0002125743,0.00056318933,0.0008989917,0.0003170553,0.00076297566],"domain_scores_gemma":[0.99848926,0.00008474577,0.0002423959,0.00060862314,0.00022809113,0.00034690785],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006349826,0.00043073585,0.00049882324,0.00018443946,0.00013632573,0.000041383966,0.0001838895,0.00008015301,0.00028059474],"category_scores_gemma":[0.000019173296,0.00030808744,0.00010077328,0.00024070029,0.00045007048,0.00018443434,0.00010695373,0.00034617246,0.00018458522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056713913,0.0004568303,0.95921755,0.00018381407,0.00035347807,0.003555491,0.0036650659,0.0000142636545,0.005632372,0.00002434776,0.012089648,0.009135765],"study_design_scores_gemma":[0.004030543,0.0018824637,0.89250356,0.00017388482,0.00009535382,0.00013308745,0.0001517589,0.000014413744,0.0019603805,0.000006918902,0.09872479,0.00032283517],"about_ca_topic_score_codex":0.0001459693,"about_ca_topic_score_gemma":0.000028845088,"teacher_disagreement_score":0.08663514,"about_ca_system_score_codex":0.0001532906,"about_ca_system_score_gemma":0.00016331296,"threshold_uncertainty_score":0.9999371},"labels":[],"label_agreement":null},{"id":"W1969979201","doi":"10.1016/j.eururo.2015.01.032","title":"Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature","year":2015,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Predictive modelling; Disease; Risk assessment; MEDLINE; Intensive care medicine; Oncology; Cancer; Internal medicine; Machine learning; Computer science","score_opus":0.06722718343894528,"score_gpt":0.3468141931814235,"score_spread":0.2795870097424782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969979201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030879164,0.993279,3.1103875e-7,0.0003335351,0.0003174989,0.0020239486,0.0004156674,0.000019051362,0.0035801434],"genre_scores_gemma":[0.000049847218,0.99752814,0.000010198835,0.0015836888,0.00023710207,0.000101492325,0.00017330248,0.000052150317,0.00026409223],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99790215,0.0008834324,0.0005199188,0.00035069862,0.00016101352,0.00018276523],"domain_scores_gemma":[0.9990008,0.000100063735,0.0002726385,0.0003924992,0.00015504366,0.00007894626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020727498,0.0002880565,0.0013247213,0.00009258315,0.000020462807,0.000008681246,0.00013946014,0.00012544743,0.00004442324],"category_scores_gemma":[0.00016063581,0.00016340357,0.00018554265,0.0003580412,0.000120798184,0.00003125306,0.000121555895,0.0005188605,0.000016205926],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039699953,0.00008375355,0.0006122014,0.101208426,0.00032695394,0.00016216312,0.00020493731,1.6318404e-7,4.272609e-7,0.000011211218,0.007503872,0.8898462],"study_design_scores_gemma":[0.00056565914,0.00032076097,0.00305473,0.08424429,0.0022558318,0.00044397023,0.000002309799,3.6775322e-7,8.631744e-8,0.0000051725915,0.90902,0.00008683098],"about_ca_topic_score_codex":0.000007536657,"about_ca_topic_score_gemma":0.0000025323673,"teacher_disagreement_score":0.90151614,"about_ca_system_score_codex":0.000058818256,"about_ca_system_score_gemma":0.0003322492,"threshold_uncertainty_score":0.6663404},"labels":[],"label_agreement":null},{"id":"W1970984074","doi":"10.1016/j.eururo.2014.11.002","title":"Steroids in Prostate Cancer: The Jury Is Still Out... and Even More Confused","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Jury; Prostate cancer; Prostate; Cancer; Gynecology; Prostate disease; General surgery; Oncology; Internal medicine; Law","score_opus":0.03192176005783713,"score_gpt":0.3097317675125048,"score_spread":0.27781000745466766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970984074","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030059334,0.005004298,0.0000023625607,0.95420825,0.00037385066,0.001044888,0.000120843535,0.000052023126,0.009134168],"genre_scores_gemma":[0.056220517,0.0027737028,0.000009557418,0.9006866,0.0020712325,0.00008831923,0.00027737,0.0001473556,0.03772531],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99752706,0.0006564837,0.00032151197,0.00060437486,0.00027259573,0.0006179562],"domain_scores_gemma":[0.9989684,0.00016860898,0.00012915634,0.0005619802,0.00008080317,0.00009104831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040777703,0.0003418654,0.0005496779,0.00018267875,0.000061398074,0.000033488035,0.0002563963,0.0002085075,0.00015888781],"category_scores_gemma":[0.000039032293,0.00020705035,0.00007554318,0.00009544573,0.00051163696,0.00002692267,0.00019085819,0.001959783,0.00018110045],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039370515,0.000024204768,0.0074856114,0.00018274099,0.0001708275,0.0027386213,0.0028841975,0.0000011068934,0.00007409143,0.0000018446996,0.97978586,0.0062571648],"study_design_scores_gemma":[0.0028911037,0.0006107397,0.014774554,0.000060686176,0.00013953818,0.00010597951,0.000021826692,0.000023680392,0.000026377633,0.000019151803,0.9811428,0.00018354548],"about_ca_topic_score_codex":0.00009016632,"about_ca_topic_score_gemma":0.000025507532,"teacher_disagreement_score":0.053521596,"about_ca_system_score_codex":0.00007708673,"about_ca_system_score_gemma":0.00015243416,"threshold_uncertainty_score":0.8514391},"labels":[],"label_agreement":null},{"id":"W1971189047","doi":"10.1016/j.eururo.2013.04.036","title":"Lymphadenectomy for Bladder Cancer at the Time of Radical Cystectomy","year":2013,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Lymphadenectomy; Cystectomy; Medicine; Bladder cancer; Lymph node; Dissection (medical); Urology; General surgery; Oncology; Surgery; Cancer; Internal medicine","score_opus":0.04329181635981125,"score_gpt":0.33696965689818237,"score_spread":0.2936778405383711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971189047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000056835685,0.98155254,0.000019237556,0.00040819796,0.00036457807,0.0024964781,0.00022643163,0.00005296179,0.014822743],"genre_scores_gemma":[0.00004813559,0.97387344,0.000059440517,0.0011915491,0.0009847432,0.0005356199,0.00018596032,0.00019571927,0.022925394],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976865,0.0005451086,0.00063045556,0.0005209866,0.00019456714,0.00042237985],"domain_scores_gemma":[0.9983082,0.00040802787,0.00037144197,0.00067568047,0.00009000947,0.00014668006],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00025714433,0.00044975043,0.0016997474,0.000111942754,0.00008995163,0.0000090904305,0.00034748786,0.00020907981,0.0032720014],"category_scores_gemma":[0.00007575414,0.00024767988,0.0006993276,0.00015357949,0.00033758095,0.000019727191,0.00017758996,0.00024068142,0.0018858043],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016723755,0.00012920254,0.000027391428,0.003943784,0.002122847,0.00008012171,0.00009249055,5.4600014e-7,0.00001485227,0.0000287588,0.08008626,0.91330653],"study_design_scores_gemma":[0.0018875393,0.00055614446,0.00004649575,0.000562478,0.0044238525,0.00040053236,0.0000014383428,0.0000036436372,0.0000096149215,0.0000056714252,0.99191564,0.00018696753],"about_ca_topic_score_codex":0.000048213773,"about_ca_topic_score_gemma":0.000004964167,"teacher_disagreement_score":0.91311955,"about_ca_system_score_codex":0.00014666743,"about_ca_system_score_gemma":0.0003786975,"threshold_uncertainty_score":0.99999756},"labels":[],"label_agreement":null},{"id":"W1971660671","doi":"10.1016/j.eururo.2004.08.016","title":"Skeletal Morbidity in Men with Prostate Cancer: Quality-of-Life Considerations throughout the Continuum of Care","year":2004,"lang":"en","type":"review","venue":"European Urology","topic":"Bone health and treatments","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Prostate cancer; Zoledronic acid; Cancer; Androgen deprivation therapy; Quality of life (healthcare); Prostate; Vitamin D and neurology; Internal medicine; Palliative care; Oncology; Intensive care medicine","score_opus":0.0766232404564855,"score_gpt":0.4094471988352254,"score_spread":0.3328239583787399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971660671","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017226794,0.98524654,0.000001917331,0.0006194799,0.00010433928,0.0018062184,0.00022777016,0.00002059992,0.0102504585],"genre_scores_gemma":[0.06952681,0.9294013,0.000079017205,0.0003865341,0.00006163123,0.00008494763,0.00018593563,0.00005917253,0.00021468266],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971545,0.0011516341,0.0009387601,0.00031778484,0.00016082503,0.0002765366],"domain_scores_gemma":[0.9983171,0.00029800253,0.00069056475,0.0004551189,0.00013509348,0.000104101404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035977617,0.00027066047,0.0017033682,0.000090461515,0.000056004053,0.0000037194163,0.00009266269,0.00009790101,0.000044448916],"category_scores_gemma":[0.00019669074,0.00015424438,0.00016616355,0.00016314007,0.00032803818,0.000020428186,0.000050808667,0.0004690754,0.000023266195],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003455915,0.0027759583,0.082431056,0.26583847,0.0059808637,0.0031836843,0.025834072,0.00007532983,0.000005428837,0.007426844,0.006214608,0.5967778],"study_design_scores_gemma":[0.0074133594,0.0021081844,0.034670644,0.0054210154,0.002164358,0.00020295088,0.00020217775,5.645908e-7,0.0000026747698,0.0000661889,0.9474004,0.00034751542],"about_ca_topic_score_codex":0.0016475918,"about_ca_topic_score_gemma":0.0020638115,"teacher_disagreement_score":0.9411858,"about_ca_system_score_codex":0.00008589717,"about_ca_system_score_gemma":0.0017061358,"threshold_uncertainty_score":0.6289903},"labels":[],"label_agreement":null},{"id":"W1972240152","doi":"10.1016/j.eururo.2012.02.018","title":"Stage-Specific Impact of Tumor Location on Oncologic Outcomes in Patients With Upper and Lower Tract Urothelial Carcinoma Following Radical Surgery","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Lymphovascular invasion; Cystectomy; Urology; Stage (stratigraphy); Upper urinary tract; Lymphadenectomy; Ureteroscopy; Ureteral neoplasm; Lymph node; Metastasis; Ureter; Surgery; Urinary system; Bladder cancer; Transitional cell carcinoma; Internal medicine; Cancer","score_opus":0.021069980951452377,"score_gpt":0.26982252813135094,"score_spread":0.24875254717989856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972240152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972099,0.00022695842,0.000010522403,0.00011568792,0.00023092993,0.00036544204,0.00001454053,0.000020475543,0.0018055094],"genre_scores_gemma":[0.99916506,0.0000072345333,0.00003946302,0.0005449751,0.000099911835,0.0000066408766,0.000020998199,0.000041429652,0.00007431633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868226,0.00027606337,0.00028499498,0.00023801115,0.00018126656,0.00033741936],"domain_scores_gemma":[0.9993107,0.00019461167,0.00010058738,0.00021659606,0.000031515112,0.00014599763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029037354,0.0001935399,0.00044776616,0.00014523516,0.000030043455,0.000005363148,0.000049938168,0.000045455396,0.0001380075],"category_scores_gemma":[0.00007505542,0.00012482547,0.00012254814,0.00011948891,0.00009485969,0.00008248682,0.00002567784,0.00018085507,0.00003734645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022491976,0.0013509785,0.9941001,0.000010696782,0.000074916636,0.00013853969,0.00021906177,0.000007931391,0.00005829565,0.000010207127,0.0001292534,0.0016508306],"study_design_scores_gemma":[0.0043787034,0.0036054498,0.99112767,0.000015505593,0.00006342589,0.000013796677,0.000011755128,0.0000024146354,0.00003923111,0.0000017089908,0.0006347584,0.0001055792],"about_ca_topic_score_codex":0.00004640305,"about_ca_topic_score_gemma":0.0000018173879,"teacher_disagreement_score":0.0029724198,"about_ca_system_score_codex":0.000104575076,"about_ca_system_score_gemma":0.00008284665,"threshold_uncertainty_score":0.5090235},"labels":[],"label_agreement":null},{"id":"W1972589687","doi":"10.1016/j.eururo.2008.03.024","title":"Re: Cumulative Association of Five Genetic Variants with Prostate Cancer","year":2008,"lang":"en","type":"letter","venue":"European Urology","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Oncology; Prostate; Internal medicine; Cancer; Gynecology","score_opus":0.007903548148755735,"score_gpt":0.22305095829221264,"score_spread":0.2151474101434569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972589687","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7120685,0.016683452,0.00062162365,0.23092374,0.0021709767,0.0026120755,0.0038928436,0.0001254935,0.030901296],"genre_scores_gemma":[0.41385734,0.01046392,0.0011541558,0.52118456,0.01119637,0.00011899409,0.005121954,0.00046770656,0.036435],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977394,0.0006455664,0.00035828652,0.00062617083,0.00023382982,0.00039680037],"domain_scores_gemma":[0.99855477,0.00003661988,0.00052919437,0.0004690396,0.00033971824,0.000070687114],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000121270234,0.00031117137,0.00032142174,0.00008315225,0.00007177315,0.000011123494,0.00025967346,0.00039106313,0.000063862746],"category_scores_gemma":[0.000108297136,0.0002980589,0.000112861446,0.00008243841,0.00016993599,0.0000025037155,0.00010530941,0.00039180717,0.000029036064],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047349796,0.000072405564,0.0076801893,0.000082803504,0.000350883,0.0003894971,0.0002301894,0.00045453192,0.0020437022,5.469169e-7,0.9880339,0.0001878434],"study_design_scores_gemma":[0.0020323503,0.0010935355,0.044076093,0.000029222287,0.00028167455,0.000029815417,0.00001698447,0.0000224544,0.0010463193,0.000041884265,0.9508138,0.00051586813],"about_ca_topic_score_codex":0.000036681053,"about_ca_topic_score_gemma":0.000039624738,"teacher_disagreement_score":0.29821113,"about_ca_system_score_codex":0.000034985835,"about_ca_system_score_gemma":0.00019481532,"threshold_uncertainty_score":0.99994713},"labels":[],"label_agreement":null},{"id":"W1972642455","doi":"10.1016/j.eururo.2007.01.072","title":"Editorial Comment on: Collecting Duct Renal Cell Carcinoma: A Matched Analysis of 41 Cases","year":2007,"lang":"en","type":"editorial","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Renal cell carcinoma; Carcinoma; General surgery; Urology; Pathology","score_opus":0.023795537560253696,"score_gpt":0.27817511336439327,"score_spread":0.25437957580413956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972642455","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06003325,0.00048565035,0.000014378723,0.00028528957,0.90973586,0.00061974704,0.00027579657,0.00008688172,0.028463127],"genre_scores_gemma":[0.22286275,0.000036027974,0.000105599014,0.0003964203,0.773745,0.000012987914,0.0013945976,0.0001556343,0.0012910085],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99400145,0.0010866846,0.0012988198,0.001148628,0.001675067,0.00078935735],"domain_scores_gemma":[0.99310714,0.0035484112,0.0009907373,0.0012593713,0.00073276705,0.00036155735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016708312,0.00078406534,0.0023082802,0.0015654651,0.00014996322,0.000027680693,0.0004148999,0.0007505301,0.00027486496],"category_scores_gemma":[0.0013716349,0.00069493137,0.0009318661,0.0011692296,0.00022928164,0.000024301107,0.00026991384,0.001908031,0.00015204826],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039944514,0.00071271276,0.00043531272,0.0001523099,0.002139448,0.005725476,0.0003951685,0.000092518094,0.0006885762,0.0000024257572,0.9855776,0.00008402444],"study_design_scores_gemma":[0.0044008014,0.007871851,0.0024720954,0.000036313344,0.013250658,0.000052864736,0.00007369574,0.000020276222,0.0012334362,0.0000014577788,0.97013766,0.000448919],"about_ca_topic_score_codex":0.0005481275,"about_ca_topic_score_gemma":0.00004728726,"teacher_disagreement_score":0.16282949,"about_ca_system_score_codex":0.0005760273,"about_ca_system_score_gemma":0.0005377516,"threshold_uncertainty_score":0.99955016},"labels":[],"label_agreement":null},{"id":"W1973366283","doi":"10.1016/s0302-2838(03)00296-3","title":"Early Prostate Cancer: Prevention, Treatment Modalities, and Quality of Life Issues","year":2003,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Quality of life (healthcare); Clinical trial; Psychological intervention; Modalities; Prostate; Cancer; Prostate-specific antigen; Oncology; Intensive care medicine; Adjuvant; Gynecology; Internal medicine","score_opus":0.10422971565067786,"score_gpt":0.3871207717790666,"score_spread":0.2828910561283888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973366283","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002426679,0.9919593,0.0000014102719,0.00026642493,0.00017773107,0.0015413531,0.00030602806,0.000038889,0.0032822287],"genre_scores_gemma":[0.0005174849,0.99181205,0.0000725652,0.00017275735,0.00015029387,0.00028655172,0.00019038982,0.000086117165,0.0067118015],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99697304,0.0011134672,0.0009146452,0.00055723666,0.00014074495,0.00030084618],"domain_scores_gemma":[0.9985487,0.00010324355,0.00058336713,0.00047183805,0.00008624575,0.00020658998],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003392263,0.00043959916,0.002168078,0.00011871344,0.000046629288,0.000013584125,0.000077755874,0.0001092455,0.00013689169],"category_scores_gemma":[0.000053681,0.0003129005,0.00032858615,0.000118017364,0.00016562648,0.000031756783,0.000053828688,0.000154546,0.000036831352],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012114418,0.00050522364,0.0037633134,0.008849691,0.0015440474,0.00007357352,0.00046291933,4.833159e-7,3.7413577e-7,0.00071192154,0.00065266294,0.98331463],"study_design_scores_gemma":[0.0016264812,0.0025007091,0.0035925463,0.0013085667,0.0018062652,0.00002216358,0.000010547811,1.0567502e-7,0.0000017619299,0.000034995446,0.988892,0.00020382825],"about_ca_topic_score_codex":0.00036708338,"about_ca_topic_score_gemma":0.000020493913,"teacher_disagreement_score":0.98823935,"about_ca_system_score_codex":0.00016609098,"about_ca_system_score_gemma":0.0004575654,"threshold_uncertainty_score":0.9999323},"labels":[],"label_agreement":null},{"id":"W1973706081","doi":"10.1016/s0302-2838(02)00552-3","title":"Percutaneous Tibial Nerve Stimulation as Neuromodulative Treatment of Chronic Pelvic Pain","year":2003,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pelvic pain; Visual analogue scale; McGill Pain Questionnaire; Quality of life (healthcare); Placebo; Chronic pain; Physical therapy; Surgery; Anesthesia","score_opus":0.028625718942450185,"score_gpt":0.29973720965438827,"score_spread":0.2711114907119381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973706081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9214017,0.0008475862,0.00024226565,0.00038894164,0.00010216146,0.00045199855,0.0000065110057,0.00004558032,0.076513276],"genre_scores_gemma":[0.9965886,0.000085908694,0.00008625319,0.00014565617,0.00014666986,0.0000019679776,0.00004251537,0.000039729068,0.0028626916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974057,0.0016282379,0.00022807372,0.00028720676,0.00015857018,0.0002922236],"domain_scores_gemma":[0.99920225,0.0002531755,0.00007401413,0.0002827176,0.00006788635,0.00011995076],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003778422,0.00014646347,0.0002453226,0.00011503246,0.000055870358,0.0000058482674,0.000054213906,0.000042305044,0.00091388414],"category_scores_gemma":[0.00023563324,0.00012190335,0.00008699676,0.00012936078,0.00011649263,0.00002296023,0.00001827781,0.00012685765,0.00034049674],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011444081,0.009910499,0.08193112,0.000592854,0.0016023677,0.06794257,0.021232165,0.012011274,0.3310076,0.0043589417,0.0035801353,0.4543864],"study_design_scores_gemma":[0.018571554,0.29968935,0.17439376,0.000061549195,0.0008430252,0.027033066,0.0003453184,0.029390834,0.010348827,0.0011826854,0.43705004,0.0010900097],"about_ca_topic_score_codex":0.000034410456,"about_ca_topic_score_gemma":0.0000050697927,"teacher_disagreement_score":0.4532964,"about_ca_system_score_codex":0.000080561054,"about_ca_system_score_gemma":0.00013500502,"threshold_uncertainty_score":0.9999994},"labels":[],"label_agreement":null},{"id":"W1975246874","doi":"10.1016/j.eururo.2012.01.049","title":"Lymph Node–Positive Bladder Cancer Treated With Radical Cystectomy and Lymphadenectomy: Effect of the Level of Node Positivity","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Medicine; Cystectomy; Lymphadenectomy; Lymph node; Bladder cancer; Hazard ratio; Proportional hazards model; Stage (stratigraphy); Urology; Dissection (medical); Lymph; Internal medicine; Perioperative; Oncology; Cancer; Confidence interval; Surgery; Pathology","score_opus":0.019608506078240183,"score_gpt":0.2696612730785929,"score_spread":0.2500527670003527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975246874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880637,0.0014521915,0.00008137052,0.00043848762,0.000094646646,0.00041548128,0.00012327352,0.00002476848,0.009306103],"genre_scores_gemma":[0.998771,0.000036691705,0.000054953296,0.00066889165,0.00013523223,0.000016598775,0.000008821884,0.00004815375,0.00025964482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830437,0.0007338045,0.00021064433,0.00024541013,0.00018796687,0.00031783522],"domain_scores_gemma":[0.9991627,0.00019462775,0.0001399761,0.00030182773,0.00006380756,0.00013707667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023982381,0.00022786566,0.0004873615,0.00006342691,0.000060518938,0.000003364104,0.00009806427,0.000069807305,0.00007025836],"category_scores_gemma":[0.00004078594,0.00012611228,0.00008983581,0.00016943712,0.0004670616,0.000051398216,0.00007962482,0.000116368305,0.000008739439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030589004,0.00025108148,0.9719167,0.00008799235,0.00075592083,0.000057408764,0.0005272366,0.000006772787,0.019529458,0.000030498028,0.00009951631,0.0036785456],"study_design_scores_gemma":[0.0075501455,0.0010588998,0.924743,0.00007121085,0.0010214135,0.00036104908,0.000007778394,0.000017524057,0.06481798,0.000001085555,0.00024262824,0.00010726891],"about_ca_topic_score_codex":0.00056351157,"about_ca_topic_score_gemma":0.000011080233,"teacher_disagreement_score":0.04717365,"about_ca_system_score_codex":0.000056558005,"about_ca_system_score_gemma":0.000082393286,"threshold_uncertainty_score":0.51427096},"labels":[],"label_agreement":null},{"id":"W1975677927","doi":"10.1016/j.eururo.2011.09.017","title":"The Impact of Tumor Multifocality on Outcomes in Patients Treated With Radical Nephroureterectomy","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Medicine; Lymphovascular invasion; Interquartile range; Renal pelvis; Urology; Hazard ratio; Ureter; Tumor progression; Cancer; Ureteral neoplasm; Internal medicine; Oncology; Bladder cancer; Metastasis; Transitional cell carcinoma; Confidence interval","score_opus":0.023668713601147664,"score_gpt":0.27423576392268906,"score_spread":0.2505670503215414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975677927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816404,0.000016432632,0.0000027078045,0.00006366004,0.0000328878,0.00031053956,0.000013722712,0.000023180686,0.01789649],"genre_scores_gemma":[0.99944323,0.0000030934402,0.000034368244,0.0003678851,0.000018276623,0.000005811989,0.00000804782,0.000025999954,0.00009327637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989364,0.0003252973,0.00021492786,0.00018911419,0.00011000068,0.00022424465],"domain_scores_gemma":[0.999431,0.00007781746,0.00007891138,0.00029195764,0.0000370183,0.00008330144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001280879,0.00014715026,0.00027041647,0.000054678174,0.000032350214,0.0000027498481,0.000097596545,0.000024527315,0.00009785723],"category_scores_gemma":[0.00006122618,0.00006851247,0.00008609631,0.000085782645,0.00018239408,0.000017511065,0.000022877675,0.00016072937,0.00005000897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055313203,0.00073639036,0.9911418,0.0000025617207,0.0001648269,0.00012373652,0.00025057886,0.0000012053348,0.000020741878,0.000011917019,0.0001128237,0.0019021223],"study_design_scores_gemma":[0.0062782085,0.007944583,0.9852666,0.0000072664047,0.000051544626,0.000010410183,0.0000054220454,0.000009024771,0.00017160777,0.000008374474,0.00018794439,0.000059009217],"about_ca_topic_score_codex":0.0004904733,"about_ca_topic_score_gemma":0.000022497306,"teacher_disagreement_score":0.017803213,"about_ca_system_score_codex":0.00004445508,"about_ca_system_score_gemma":0.000037270718,"threshold_uncertainty_score":0.27938575},"labels":[],"label_agreement":null},{"id":"W1975816424","doi":"10.1016/j.eururo.2006.12.035","title":"Prospective Clinical Trial Comparing Obtape® and DUPS to TVT: One-Year Safety and Efficacy Results","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Urological Disorders and Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Urinary retention; Surgery; Prospective cohort study; Perforation; Randomized controlled trial; Hematoma; Interim analysis; Cystoscopy; Urology; Urinary system; Internal medicine","score_opus":0.07536603833887295,"score_gpt":0.35289768183513215,"score_spread":0.2775316434962592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975816424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91995615,0.00014983045,0.0002003598,0.0013700918,0.00016447062,0.0007623892,0.0000051079046,0.00006822782,0.07732338],"genre_scores_gemma":[0.9966614,0.00008802705,0.00068996364,0.0018564636,0.0003040161,0.0000017151613,0.000012949917,0.000022806626,0.00036264025],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99825585,0.0002591304,0.0005212767,0.0005367714,0.00010910562,0.0003178561],"domain_scores_gemma":[0.9989073,0.00044089125,0.00008129665,0.00022566796,0.000038233746,0.00030655513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011312899,0.0001529379,0.00043230507,0.00006688664,0.00009257076,0.000013100757,0.00006343599,0.00008503268,0.000020904792],"category_scores_gemma":[0.0010491415,0.00012022105,0.00005567361,0.00009725057,0.0001955659,0.000020840573,0.00017057068,0.0003121203,0.00016554417],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48252633,0.0020716093,0.47439617,0.0000101079,0.00033098305,0.0007349421,0.0006636306,0.0000041890726,0.000073623894,0.0015949884,0.0006365912,0.036956817],"study_design_scores_gemma":[0.08551701,0.00868598,0.88874805,0.0000053071303,0.00011287026,0.00002755758,0.000017560398,0.000011272317,0.0000035040462,0.00006339078,0.016711991,0.00009548435],"about_ca_topic_score_codex":0.000008583755,"about_ca_topic_score_gemma":0.00001663938,"teacher_disagreement_score":0.4143519,"about_ca_system_score_codex":0.0000131781635,"about_ca_system_score_gemma":0.000011710065,"threshold_uncertainty_score":0.49024722},"labels":[],"label_agreement":null},{"id":"W1975848770","doi":"10.1016/j.eururo.2014.02.038","title":"Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review","year":2014,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":358,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Urology; Radiation therapy; Cystoscopy; Chemotherapy; Multimodal therapy; Surgery; Oncology; Cancer; Internal medicine; Urinary system","score_opus":0.04263597856081241,"score_gpt":0.35430476559137764,"score_spread":0.3116687870305652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975848770","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040096467,0.9916018,0.000055569155,0.00019650199,0.00011073457,0.0026043495,0.00006276857,0.000043517695,0.0052846423],"genre_scores_gemma":[0.0026562759,0.9943056,0.00004502521,0.0019947558,0.00016884657,0.00039186404,0.00010594421,0.00015443026,0.00017725512],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99454045,0.0021702175,0.0015887219,0.0008250367,0.00036975904,0.00050581916],"domain_scores_gemma":[0.9970351,0.00084055925,0.0006746397,0.001056052,0.00020146766,0.00019219508],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078307197,0.00067702704,0.007627784,0.0007919168,0.00003752852,0.000014397714,0.00035640245,0.0001858961,0.00059616205],"category_scores_gemma":[0.00050671713,0.00042513505,0.000995825,0.0013483199,0.00022093985,0.000040348506,0.00007708641,0.00063776557,0.0001031396],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013975315,0.00044095467,0.00023119588,0.9131034,0.020023596,0.00088929513,0.0001822479,0.0000075163025,9.836525e-7,0.00007872053,0.00030373523,0.064598575],"study_design_scores_gemma":[0.0036628272,0.0036015867,0.0013231491,0.559666,0.2731777,0.00038732437,0.000022199301,0.000026259067,0.0000016285798,0.000007062305,0.15708376,0.0010405154],"about_ca_topic_score_codex":0.00014142973,"about_ca_topic_score_gemma":0.00013536998,"teacher_disagreement_score":0.35343745,"about_ca_system_score_codex":0.00012147555,"about_ca_system_score_gemma":0.00055751967,"threshold_uncertainty_score":0.99982005},"labels":[],"label_agreement":null},{"id":"W1976116238","doi":"10.1016/j.eururo.2012.04.017","title":"The Trade-off Between Sensitivity and Specificity of Clinical Protocols for Identification of Insignificant Prostate Cancer","year":2012,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Prostate cancer; Identification (biology); Cancer; Oncology; Prostate; Sensitivity (control systems); Internal medicine; Gynecology","score_opus":0.08856864513245345,"score_gpt":0.3749539952946217,"score_spread":0.28638535016216826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976116238","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19917156,0.005406329,0.00021178761,0.72119224,0.001211172,0.067754544,0.004048858,0.00007863851,0.00092490256],"genre_scores_gemma":[0.9397205,0.0037171443,0.0001407642,0.042046316,0.0068028984,0.006224611,0.00066587765,0.00017840404,0.0005034805],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99676245,0.001020755,0.0012302059,0.0004561595,0.00020024728,0.00033018985],"domain_scores_gemma":[0.9966638,0.00140425,0.0011665934,0.0005233935,0.00016083264,0.00008113901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021780927,0.00024074975,0.00088886893,0.0000588796,0.000073605435,0.000012388064,0.0001033317,0.0002233083,0.000006027305],"category_scores_gemma":[0.0002505453,0.00015903721,0.00020343892,0.0000649963,0.0005776422,0.000031422194,0.00006644848,0.0006577435,0.000003894926],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015739637,0.0004929825,0.34922174,0.0016317219,0.0013683008,0.00017837882,0.0005879093,0.0000023453158,0.0012832654,0.00007525748,0.32638177,0.3172024],"study_design_scores_gemma":[0.0010354904,0.00081240706,0.41648898,0.000064817556,0.0004375507,0.000007636848,0.0000053191916,0.0000070948327,0.0013540542,0.000019436193,0.5796774,0.00008983316],"about_ca_topic_score_codex":0.000019235158,"about_ca_topic_score_gemma":0.000007804361,"teacher_disagreement_score":0.74054897,"about_ca_system_score_codex":0.00003572666,"about_ca_system_score_gemma":0.00013534297,"threshold_uncertainty_score":0.64853495},"labels":[],"label_agreement":null},{"id":"W1976554576","doi":"10.1016/j.eururo.2015.04.016","title":"Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk Men","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Medicine; Cumulative incidence; Prostate cancer; Prostatectomy; Metastasis; Biochemical recurrence; Internal medicine; Oncology; Cohort; Incidence (geometry); Prostate-specific antigen; Proportional hazards model; Confidence interval; Urology; Surgery; Cancer","score_opus":0.021146285499140195,"score_gpt":0.26831243788033265,"score_spread":0.24716615238119247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976554576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99013174,0.008092486,0.0002248022,0.000095651114,0.00020607817,0.00033884187,0.00014448253,0.000016875636,0.0007490349],"genre_scores_gemma":[0.9981072,0.0009835003,0.0006744945,0.000118654556,0.00003909783,0.000017138887,0.000029352246,0.000023587698,0.0000069926955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984519,0.0004313026,0.00040903475,0.0003594192,0.00016403558,0.00018430584],"domain_scores_gemma":[0.9990331,0.0002767905,0.00021457745,0.00029227836,0.00007224699,0.00011101415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000524706,0.00014370166,0.00045560728,0.000117884876,0.00000960329,0.0000023672121,0.00007703694,0.00005543091,0.000043148622],"category_scores_gemma":[0.0002911889,0.000113085865,0.000050053157,0.00005615598,0.00029794723,0.000055517175,0.00014595216,0.0002876343,0.0000049070663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046843872,0.00026891287,0.9519994,0.000019390001,0.00011396923,0.00031640969,0.0022853927,0.000027105505,0.00002869736,0.00004004921,0.00070376566,0.039512467],"study_design_scores_gemma":[0.0039440417,0.0005426857,0.9899219,0.00008830007,0.0001978819,0.0000074566956,0.00004233184,0.0028908842,0.00008448371,0.001623532,0.0005774124,0.00007905221],"about_ca_topic_score_codex":0.00056412007,"about_ca_topic_score_gemma":0.00013895119,"teacher_disagreement_score":0.039433412,"about_ca_system_score_codex":0.00012436905,"about_ca_system_score_gemma":0.00009817185,"threshold_uncertainty_score":0.4611508},"labels":[],"label_agreement":null},{"id":"W1976721928","doi":"10.1159/000052488","title":"Organ and Species Specificity in the Stimulation of Transitional Epithelial Cell Growth by Fibroblasts","year":2001,"lang":"en","type":"article","venue":"European Urology","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Urothelial Cell; Urothelium; Fibroblast; Ureter; Urinary bladder; Cell culture; Epithelium; Cell growth; Medicine; Pathology; Cell biology; Biology; Urology","score_opus":0.0101373715992531,"score_gpt":0.20675899806556933,"score_spread":0.19662162646631623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976721928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873247,0.0008709993,0.003649873,0.0026945942,0.00007082901,0.00009959043,0.000009273319,0.000014210884,0.005265936],"genre_scores_gemma":[0.9978927,0.00008922195,0.00013693358,0.0001398949,0.00028751788,5.382629e-7,0.00003069121,0.000011251002,0.0014112536],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99939084,0.00015010405,0.00014743974,0.000116946605,0.000095359464,0.000099299075],"domain_scores_gemma":[0.99975836,0.00007998145,0.000026958485,0.00007865394,0.00002518259,0.00003086251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002089909,0.0000749212,0.0001329247,0.000060191327,0.000021882748,0.0000022764118,0.00004077489,0.00002312948,0.00013195137],"category_scores_gemma":[0.000035224904,0.000049141512,0.000016944014,0.00010234828,0.00012040734,0.000014220571,0.000007502748,0.00013617262,0.00000988826],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004681455,0.0003595885,0.039040033,0.00008052384,0.000026618503,0.0003964661,0.004518076,0.0011307918,0.9449124,0.0020487006,0.0060047894,0.0010139181],"study_design_scores_gemma":[0.0028545198,0.0011561472,0.9420742,0.000022995102,0.000043762062,0.00032121898,0.00016309765,0.0007156175,0.008654213,0.00003383282,0.04384994,0.00011047391],"about_ca_topic_score_codex":0.0000048539223,"about_ca_topic_score_gemma":0.0000019541912,"teacher_disagreement_score":0.93625814,"about_ca_system_score_codex":0.0000055526752,"about_ca_system_score_gemma":0.000006120492,"threshold_uncertainty_score":0.20039326},"labels":[],"label_agreement":null},{"id":"W1976958242","doi":"10.1016/j.eururo.2015.04.023","title":"Survivorship and Improving Quality of Life in Men with Prostate Cancer","year":2015,"lang":"en","type":"review","venue":"European Urology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Institute for Health and Care Research; U.S. Department of Veterans Affairs","keywords":"Medicine; Psychological intervention; Quality of life (healthcare); Survivorship curve; Referral; MEDLINE; Prostate cancer; Gerontology; Randomized controlled trial; Clinical trial; Disease; Cancer; Family medicine; Physical therapy; Psychiatry; Nursing; Internal medicine","score_opus":0.07350515034270001,"score_gpt":0.3491676093690209,"score_spread":0.2756624590263209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976958242","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003632321,0.9812309,0.0000029747139,0.00010646994,0.00015088802,0.00067791407,0.00006248984,0.000030741216,0.014105299],"genre_scores_gemma":[0.0106657185,0.9879229,0.000012477154,0.00022213574,0.00020178469,0.000043247644,0.000057097637,0.000099625606,0.00077501166],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99682575,0.0014822264,0.0007052267,0.00048254765,0.00020473344,0.0002995308],"domain_scores_gemma":[0.99862164,0.00015789834,0.0004776692,0.00040972547,0.00012363301,0.00020941996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017937208,0.0003152548,0.0019357078,0.0001896515,0.000015239533,0.000008561965,0.00014038915,0.0001297202,0.00003314523],"category_scores_gemma":[0.0001832335,0.00022424448,0.00009772994,0.00027062916,0.00017674193,0.000030172674,0.0001335314,0.0005312748,0.000010328152],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009390337,0.00006354176,0.017035319,0.0302191,0.00020269804,0.00016514807,0.0017456353,8.706985e-7,0.0000016884842,0.00006667972,0.00032763628,0.94923264],"study_design_scores_gemma":[0.001429509,0.000574658,0.0067755748,0.0018284661,0.0005352996,0.000047770256,0.00013595304,0.0000021814826,1.7624991e-7,0.000005733648,0.9883467,0.00031800856],"about_ca_topic_score_codex":0.0057430454,"about_ca_topic_score_gemma":0.008326364,"teacher_disagreement_score":0.98801905,"about_ca_system_score_codex":0.000070801994,"about_ca_system_score_gemma":0.0006698333,"threshold_uncertainty_score":0.9144424},"labels":[],"label_agreement":null},{"id":"W1977431296","doi":"10.1016/j.eururo.2008.09.039","title":"Rebuttal from Authors re: Christian Bolenz, Yair Lotan. Decision Making in the Management of Renal Cell Carcinoma: Can Nomograms Assist? Eur Urol 2009;55:296–8","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nomogram; Rebuttal; Renal cell carcinoma; Clear cell renal cell carcinoma; General surgery; Oncology; Internal medicine; Archaeology","score_opus":0.024488285206212382,"score_gpt":0.24674092197198688,"score_spread":0.2222526367657745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977431296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96581787,0.0022783047,0.00050024013,0.00080738874,0.00031655235,0.0007010647,0.000043799737,0.00006170995,0.029473044],"genre_scores_gemma":[0.9959274,0.000085451284,0.0021544169,0.0009640297,0.00026040705,0.000019267585,0.00010048864,0.000095651296,0.00039287776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961325,0.0009095868,0.0008731306,0.0008216181,0.0006218051,0.0006413672],"domain_scores_gemma":[0.9979916,0.00023275513,0.00033641106,0.001179905,0.00007536008,0.00018396649],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000786745,0.00042364208,0.00058496423,0.00027123635,0.0001550453,0.00001771948,0.0005602252,0.00012499734,0.00017478848],"category_scores_gemma":[0.000047106372,0.00031864046,0.00024325363,0.00046039338,0.00025798808,0.0000433988,0.00027021684,0.00061459444,0.00022839212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010662591,0.0056437063,0.5570669,0.000501711,0.0010210776,0.25912973,0.03124576,0.0012593075,0.008181468,0.00043472488,0.057385553,0.06746747],"study_design_scores_gemma":[0.0037044534,0.0013366141,0.98388594,0.00008904058,0.00040605981,0.00059959345,0.0005325082,0.00017590846,0.00060524006,0.00007614357,0.008307985,0.00028048598],"about_ca_topic_score_codex":0.00037531357,"about_ca_topic_score_gemma":0.00012716753,"teacher_disagreement_score":0.42681906,"about_ca_system_score_codex":0.00014232172,"about_ca_system_score_gemma":0.00006551848,"threshold_uncertainty_score":0.99992657},"labels":[],"label_agreement":null},{"id":"W1977948413","doi":"10.1016/s0302-2838(03)00367-1","title":"Alpha-Blocker Therapy Can Be Withdrawn in the Majority of Men Following Initial Combination Therapy with the Dual 5α-Reductase Inhibitor Dutasteride","year":2003,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Humber River Regional Hospital","funders":"","keywords":"Tamsulosin; Dutasteride; Medicine; Urology; Placebo; Combination therapy; Internal medicine; Prostate; Hyperplasia","score_opus":0.03243093841807441,"score_gpt":0.30167130130853215,"score_spread":0.2692403628904577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977948413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96899766,0.00051589217,0.000012952272,0.012899835,0.000097201955,0.0007708563,0.000011448133,0.00001868526,0.016675452],"genre_scores_gemma":[0.99678004,0.00011930492,0.00004118021,0.0026125994,0.00013276386,0.000023867056,0.000037094633,0.00003992297,0.00021325643],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965467,0.0021849566,0.00026373466,0.0002672865,0.0003813638,0.00035598924],"domain_scores_gemma":[0.9991197,0.00025204872,0.00008391881,0.00040305767,0.00007618596,0.00006509028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017047416,0.00018337848,0.00024958025,0.00011356069,0.0001474059,0.000026611173,0.00018637006,0.000043459146,0.000097549244],"category_scores_gemma":[0.00006607678,0.00009569586,0.00007016873,0.0003119043,0.00030281628,0.000060936443,0.00003541931,0.00047292854,0.000008448834],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05941644,0.0150966495,0.2745953,0.00025111513,0.003717916,0.026034832,0.20255058,0.0000953544,0.28643993,0.008982172,0.05111353,0.071706176],"study_design_scores_gemma":[0.07107765,0.05147185,0.484127,0.00009279724,0.00029669396,0.004390079,0.012250829,0.0001575924,0.06710997,0.0009258001,0.30692792,0.0011717993],"about_ca_topic_score_codex":0.00009061064,"about_ca_topic_score_gemma":0.000032621614,"teacher_disagreement_score":0.2558144,"about_ca_system_score_codex":0.000018485818,"about_ca_system_score_gemma":0.00015202475,"threshold_uncertainty_score":0.3902364},"labels":[],"label_agreement":null},{"id":"W1978505438","doi":"10.1016/j.eururo.2012.10.042","title":"National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) Symptom Evaluation in Multinational Cohorts of Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Prostatitis; Pelvic pain; Chronic prostatitis/chronic pelvic pain syndrome; Quality of life (healthcare); Physical therapy; Chronic pain; Interstitial cystitis; Pain assessment; Internal medicine; Urinary system; Surgery; Prostate; Pain management","score_opus":0.017743872204028732,"score_gpt":0.2966986048054632,"score_spread":0.27895473260143444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978505438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890737,0.0044971616,0.00041217933,0.0006076531,0.00019469828,0.0029371106,0.00016421171,0.00003869699,0.002074575],"genre_scores_gemma":[0.9974569,0.00017971023,0.0001908904,0.00017002772,0.00015595762,0.00012152707,0.0015471746,0.000063940504,0.0001138636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944273,0.0020486058,0.00094394386,0.0004554082,0.0013739563,0.0007507477],"domain_scores_gemma":[0.9978227,0.00037472392,0.0004941158,0.0003026182,0.00081645657,0.0001894115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004760314,0.00027844287,0.00057710113,0.0006180488,0.0001053803,0.0000109775,0.00017633483,0.00008920341,0.00050988776],"category_scores_gemma":[0.0005029751,0.00025262646,0.000066418834,0.0005563088,0.00042362718,0.00033438558,0.000119727585,0.0004396251,0.0000455666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033567994,0.0011665683,0.9682821,0.0010589508,0.00017349326,0.000034728284,0.0010540829,0.0013124069,0.000097558084,0.00036735876,0.00041792847,0.025699165],"study_design_scores_gemma":[0.00696215,0.0074647362,0.97844857,0.00026622438,0.00004496573,0.00009258665,0.000020076852,0.004189943,0.000036792757,0.00005477969,0.0022207808,0.00019839322],"about_ca_topic_score_codex":0.00012350213,"about_ca_topic_score_gemma":0.00018888664,"teacher_disagreement_score":0.02550077,"about_ca_system_score_codex":0.0012261616,"about_ca_system_score_gemma":0.0035903081,"threshold_uncertainty_score":0.9999926},"labels":[],"label_agreement":null},{"id":"W1978801336","doi":"10.1016/j.eururo.2010.09.029","title":"Decreasing Rate and Extent of Lymph Node Staging in Patients Undergoing Radical Prostatectomy May Undermine the Rate of Diagnosis of Lymph Node Metastases in Prostate Cancer","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Prostatectomy; Lymph node; Prostate cancer; Urology; Lymph; Oncology; Cancer; Internal medicine; Pathology","score_opus":0.013813493860718343,"score_gpt":0.2643043401236126,"score_spread":0.25049084626289425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978801336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958376,0.0014397955,0.000008706905,0.0014335715,0.00012635028,0.00077568257,0.00013548524,0.000012470644,0.00023030445],"genre_scores_gemma":[0.9964856,0.0024874348,0.00026806546,0.0005434405,0.000020837217,0.00009178414,0.000039213064,0.000049760747,0.000013888374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762017,0.00065915816,0.00076671777,0.00040731346,0.00016155237,0.00038510154],"domain_scores_gemma":[0.99830526,0.00070146023,0.00042342182,0.00034195636,0.00011916478,0.00010870967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091199175,0.00024670112,0.00061620655,0.00024982978,0.000040380575,0.000009764002,0.0001256026,0.000041744384,0.00003921083],"category_scores_gemma":[0.00039858645,0.00017545887,0.00007050429,0.00030156499,0.00045564704,0.0000798658,0.00015252833,0.00020228006,0.0000013264881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00100611,0.00075312215,0.98542565,0.000300946,0.00012578418,0.00013298656,0.0006936612,0.00026532254,0.0023867579,0.00015477744,0.000017646724,0.008737216],"study_design_scores_gemma":[0.009663165,0.00039994155,0.97474325,0.00039327375,0.0001839957,0.000010638555,0.00010415722,0.00017639603,0.013885904,0.000102918166,0.0002018701,0.00013447301],"about_ca_topic_score_codex":0.00077954686,"about_ca_topic_score_gemma":0.00020003646,"teacher_disagreement_score":0.011499146,"about_ca_system_score_codex":0.00009052081,"about_ca_system_score_gemma":0.00022503415,"threshold_uncertainty_score":0.71550053},"labels":[],"label_agreement":null},{"id":"W1979612532","doi":"10.1016/s0302-2838(02)00065-9","title":"The Urologist View of BPH Progression: Results of an International Survey","year":2002,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"GlaxoSmithKline","keywords":"Medicine; Quality of life (healthcare); Disease; Urology; Hyperplasia; Gynecology; Internal medicine; Nursing","score_opus":0.08081546212861827,"score_gpt":0.36104107499099347,"score_spread":0.2802256128623752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979612532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7172685,0.0029278712,0.00001963742,0.008376062,0.0003740354,0.00043510477,0.000113755115,0.000046360317,0.2704386],"genre_scores_gemma":[0.9972671,0.0009888421,0.00008219726,0.00017704826,0.00009793363,0.0000021027229,0.00006240497,0.000014956434,0.0013073811],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978299,0.0012067151,0.00035510704,0.00019176173,0.0002286804,0.00018783567],"domain_scores_gemma":[0.99884045,0.00036094114,0.00012346184,0.0004094529,0.00019205823,0.000073660034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018680142,0.000075956785,0.00016230652,0.00005797994,0.000051782008,0.000006541112,0.0003062802,0.0000318767,0.0002229216],"category_scores_gemma":[0.0006913355,0.000046649107,0.000041484636,0.00012235602,0.00039795827,0.000037376394,0.00012831362,0.00020999653,0.00007530957],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021697069,0.002731854,0.1570176,0.00014793054,0.00049823266,0.0015664115,0.0019024421,0.00003287072,0.0032060295,0.0007893953,0.02989472,0.78051543],"study_design_scores_gemma":[0.001933893,0.00511668,0.72210026,0.000011959152,0.000018072751,0.00019930987,0.000015062804,0.0005440086,0.00039786389,0.0000294419,0.26957083,0.00006261252],"about_ca_topic_score_codex":0.000019772375,"about_ca_topic_score_gemma":0.000012311932,"teacher_disagreement_score":0.78045285,"about_ca_system_score_codex":0.0000047436133,"about_ca_system_score_gemma":0.000018258983,"threshold_uncertainty_score":0.24408352},"labels":[],"label_agreement":null},{"id":"W1980536257","doi":"10.1016/j.eururo.2011.12.026","title":"Propensity-Score-Matched Comparison of Perioperative Outcomes Between Open and Laparoscopic Nephroureterectomy: A National Series","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Propensity score matching; Perioperative; Odds ratio; Logistic regression; Cohort; Blood transfusion; Population; Urology; Retrospective cohort study; Surgery; Internal medicine","score_opus":0.14568261030978968,"score_gpt":0.3435386316819542,"score_spread":0.19785602137216451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980536257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9205687,0.00011044895,0.000022229771,0.0005378844,0.00006882902,0.00050530036,0.000026312397,0.000027265798,0.07813304],"genre_scores_gemma":[0.99712175,0.000008251584,0.0008494657,0.00083480135,0.00005695842,0.000012595442,0.000023714148,0.00002524411,0.0010672241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895424,0.00023894352,0.0002728254,0.00025499891,0.0001222351,0.00015678044],"domain_scores_gemma":[0.99949545,0.000036849033,0.000104995706,0.00016182683,0.00011686939,0.0000840192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017050214,0.0001530553,0.00057927193,0.00005665116,0.00007067375,0.000017771605,0.0001508615,0.00004094386,0.00021205592],"category_scores_gemma":[0.000060358056,0.00011382758,0.000036641242,0.000065479464,0.00021540943,0.000119763725,0.00021323294,0.00013654177,0.000041998526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005210741,0.00013220505,0.99188346,0.000021337795,0.00024224345,0.000024484472,0.005303518,1.8720719e-7,0.0005963428,0.00052031054,0.00015442005,0.0006004289],"study_design_scores_gemma":[0.002747173,0.0019210016,0.988533,0.000012867993,0.00014769145,0.000030121142,0.00012238504,0.0000020822854,0.0032517991,0.00009474394,0.003040581,0.000096531556],"about_ca_topic_score_codex":0.0001243687,"about_ca_topic_score_gemma":0.000041994674,"teacher_disagreement_score":0.07706582,"about_ca_system_score_codex":0.000018384799,"about_ca_system_score_gemma":0.00009575288,"threshold_uncertainty_score":0.4641754},"labels":[],"label_agreement":null},{"id":"W1980536878","doi":"10.1016/j.eururo.2012.08.069","title":"In-hospital Mortality and Failure to Rescue After Cytoreductive Nephrectomy","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Logistic regression; Emergency medicine; Respiratory failure; Internal medicine; Complication; Mortality rate; Surgery; Kidney","score_opus":0.016346348922537283,"score_gpt":0.2649701342892702,"score_spread":0.2486237853667329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980536878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98551184,0.0005439439,0.000008894114,0.0029788383,0.0002482075,0.00035284203,0.000003564228,0.00002778021,0.010324104],"genre_scores_gemma":[0.99682033,0.0000063780853,0.0005257669,0.0017257921,0.0005410714,0.000023168726,0.000005299333,0.000033245295,0.0003189384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887425,0.00021979268,0.00016848417,0.0002805908,0.00009835334,0.0003585431],"domain_scores_gemma":[0.99936885,0.000028894297,0.000023362241,0.00028293396,0.000027351796,0.00026863554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022566905,0.00015123382,0.00021692975,0.000105291656,0.000018145398,0.000006463944,0.000049283695,0.00004234408,0.00013941329],"category_scores_gemma":[0.000069337446,0.00012452014,0.000040941148,0.000104914434,0.00008155744,0.00009002352,0.00011258266,0.00018026293,0.0004366243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049804844,0.0003496794,0.9885836,0.000017713575,0.00008087946,0.0015285109,0.00350949,0.000002008048,0.0019668234,0.00014141525,0.002772586,0.0005491971],"study_design_scores_gemma":[0.0007367182,0.00087693805,0.9561329,0.000004888896,0.000066933746,0.0001813765,0.00006113527,0.0000010407202,0.0005048659,0.000013083403,0.041314494,0.000105630024],"about_ca_topic_score_codex":0.00004841885,"about_ca_topic_score_gemma":0.000028269966,"teacher_disagreement_score":0.038541906,"about_ca_system_score_codex":0.00005883625,"about_ca_system_score_gemma":0.000015703801,"threshold_uncertainty_score":0.56120676},"labels":[],"label_agreement":null},{"id":"W1980666888","doi":"10.1016/j.eururo.2010.09.022","title":"Re: A Sequence Variant at 4p16.3 Confers Susceptibility to Urinary Bladder Cancer","year":2010,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Bladder cancer; Urinary system; Sequence (biology); Urinary bladder; Urothelial cancer; Internal medicine; Cancer; Oncology; Urology; Genetics","score_opus":0.04304983162542378,"score_gpt":0.30730577106967893,"score_spread":0.2642559394442552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980666888","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02296529,0.0005799284,0.00004827752,0.88519806,0.0030035998,0.0016086003,0.0006280079,0.0003232882,0.085644975],"genre_scores_gemma":[0.08667981,0.0001280289,0.00023814879,0.8753633,0.0063914405,0.000110015484,0.00044733923,0.00027298316,0.030368967],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959631,0.0006537805,0.0005403235,0.0014651854,0.00042464674,0.0009529744],"domain_scores_gemma":[0.99753463,0.00014452441,0.0002001985,0.0015687254,0.00018414795,0.00036776558],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000348725,0.00067875104,0.00087489514,0.00020525644,0.00016058674,0.000028355922,0.000474991,0.0010123206,0.008591575],"category_scores_gemma":[0.00013715078,0.00058411236,0.00026818374,0.00018237544,0.00037975752,0.00004336569,0.00042460326,0.0038707312,0.0032397108],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069945847,0.00013536311,0.0027913132,0.00012303745,0.00043869432,0.024556339,0.00043083655,0.0000025144761,0.001994377,0.00000543558,0.96752393,0.0012986788],"study_design_scores_gemma":[0.0015966783,0.0020123278,0.011097354,0.000041381903,0.00070066965,0.0011329032,0.000007991382,0.000004613739,0.00012518877,0.000027604363,0.9827694,0.00048382767],"about_ca_topic_score_codex":0.00050443364,"about_ca_topic_score_gemma":0.0003308917,"teacher_disagreement_score":0.06371452,"about_ca_system_score_codex":0.00036289004,"about_ca_system_score_gemma":0.00046609147,"threshold_uncertainty_score":0.999661},"labels":[],"label_agreement":null},{"id":"W1980968263","doi":"10.1016/j.eururo.2007.07.027","title":"Nerve-Sparing Radical Retropubic Prostatectomy in Patients Previously Submitted to Holmium Laser Enucleation of the Prostate for Bladder Outlet Obstruction Due to Benign Prostatic Enlargement","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Enucleation; Urology; Prostate; International Prostate Symptom Score; Prostatectomy; Prostate cancer; Radical retropubic prostatectomy; Urinary continence; Urinary incontinence; Lower urinary tract symptoms; Open Prostatectomy; Bladder outlet obstruction; Surgery; Cancer; Internal medicine","score_opus":0.014305628340992029,"score_gpt":0.26886399412101963,"score_spread":0.2545583657800276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980968263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905137,0.000028687078,0.0008284804,0.0018301437,0.00024867943,0.0055047977,0.000028804643,0.000044145316,0.00097260566],"genre_scores_gemma":[0.9970653,0.0000047288677,0.0010550475,0.00086906593,0.00010543897,0.00010014747,0.00009189869,0.00007781622,0.0006305353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99716717,0.00042470574,0.0006991801,0.00051683903,0.00043288016,0.0007592109],"domain_scores_gemma":[0.99874026,0.000121413024,0.00014907189,0.00045106452,0.0002839386,0.00025426428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016765558,0.00022016936,0.00035358596,0.00036086218,0.00010829458,0.00002186633,0.00021169179,0.00006975448,0.0000412197],"category_scores_gemma":[0.00066965044,0.00017127319,0.00008833001,0.00061884336,0.00010083115,0.000083395564,0.00021486648,0.00035845436,0.000051999865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020136176,0.0017470868,0.8876997,0.00086268544,0.00024872844,0.00035987998,0.015615658,0.000671574,0.01754876,0.00018302164,0.0056566857,0.049270004],"study_design_scores_gemma":[0.004702255,0.005101161,0.9713233,0.000066045264,0.000062839674,0.00003084611,0.00011560828,0.000102424,0.0059420606,0.000053879143,0.012311903,0.00018764149],"about_ca_topic_score_codex":0.00002824762,"about_ca_topic_score_gemma":0.00003721982,"teacher_disagreement_score":0.083623596,"about_ca_system_score_codex":0.00013900042,"about_ca_system_score_gemma":0.000075712574,"threshold_uncertainty_score":0.6984318},"labels":[],"label_agreement":null},{"id":"W1981266090","doi":"10.1016/j.eururo.2013.06.009","title":"Immediate Post–Transurethral Resection of Bladder Tumor Intravesical Chemotherapy Prevents Non–Muscle-invasive Bladder Cancer Recurrences: An Updated Meta-analysis on 2548 Patients and Quality-of-Evidence Review","year":2013,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Mount Sinai Hospital; University Health Network; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Bladder cancer; Urology; Meta-analysis; Chemotherapy; Resection; Surgery; Cancer; Internal medicine","score_opus":0.20667770559402393,"score_gpt":0.41737984948953066,"score_spread":0.21070214389550673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981266090","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004593747,0.9906325,0.000015624102,0.00040392418,0.00024912294,0.0030996285,0.0006352307,0.000032753018,0.0003375186],"genre_scores_gemma":[0.0073001264,0.98886263,0.0000947808,0.002143454,0.00016532179,0.00022879786,0.0008508316,0.00012473608,0.00022929144],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9919526,0.0036174052,0.0020461304,0.0012199339,0.00068579265,0.00047815542],"domain_scores_gemma":[0.9958811,0.00044705518,0.0017324494,0.0010093242,0.00061119004,0.00031889885],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012083824,0.00083860965,0.0058448855,0.000482624,0.000065751316,0.000016647396,0.00044481526,0.00024917454,0.0026937018],"category_scores_gemma":[0.00031979394,0.0005182303,0.0017533449,0.00090973853,0.0003753888,0.00017155318,0.00008340025,0.0007361291,0.000061822546],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015877312,0.0027113874,0.0011333998,0.045382377,0.25710028,0.00007664226,0.0009681756,0.000003603757,0.00008807118,0.00002015287,0.0028867242,0.68804145],"study_design_scores_gemma":[0.004653146,0.016200734,0.017894065,0.009474308,0.8158144,0.00003530207,0.00002795349,0.0000050226486,0.00016146804,0.000022703289,0.13424468,0.0014662186],"about_ca_topic_score_codex":0.00043360508,"about_ca_topic_score_gemma":0.00008870896,"teacher_disagreement_score":0.68657523,"about_ca_system_score_codex":0.000073165465,"about_ca_system_score_gemma":0.00038739474,"threshold_uncertainty_score":0.99972695},"labels":[],"label_agreement":null},{"id":"W1982544915","doi":"10.1016/j.eururo.2014.06.026","title":"Prevalence of Inflammation and Benign Prostatic Hyperplasia on Autopsy in Asian and Caucasian Men","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Sunnybrook Health Science Centre; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hyperplasia; Autopsy; Internal medicine; Logistic regression; Inflammation; Odds ratio; Prostate; Gastroenterology; Prostate cancer; Cancer","score_opus":0.011275241110979233,"score_gpt":0.26237362840882456,"score_spread":0.25109838729784534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982544915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9147414,0.00011033924,0.000012378129,0.0021735928,0.000013956333,0.00029278686,0.0000028333684,0.000014768613,0.08263793],"genre_scores_gemma":[0.9990362,0.00011370306,0.00012476793,0.00008725463,0.00003970741,0.0000044278545,0.000005266085,0.000015857158,0.0005728343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988779,0.00044350544,0.00018831888,0.00021075035,0.00010614516,0.000173405],"domain_scores_gemma":[0.99958074,0.0001057876,0.000043270455,0.00016178635,0.000024603705,0.00008380877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058948033,0.00008444407,0.00015340897,0.00014728904,0.000026391599,0.0000065421327,0.000044962893,0.000031124568,0.000028917839],"category_scores_gemma":[0.00018234826,0.00007240101,0.000010470329,0.000070701586,0.00013088492,0.000040090643,0.000048354363,0.00014053386,0.000019305702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021954216,0.00033053683,0.58128357,0.0022926799,0.00006777954,0.0005965309,0.0140772015,0.000016671025,0.019667337,0.007815636,0.00039546294,0.37126115],"study_design_scores_gemma":[0.0014719139,0.0031683175,0.9903006,0.000043923796,0.000022774222,0.00023181237,0.00007286532,0.00083797774,0.0003581977,0.00028276944,0.003140991,0.000067852794],"about_ca_topic_score_codex":0.000007267581,"about_ca_topic_score_gemma":0.000005031511,"teacher_disagreement_score":0.40901703,"about_ca_system_score_codex":0.0000076153146,"about_ca_system_score_gemma":0.000020440759,"threshold_uncertainty_score":0.29524273},"labels":[],"label_agreement":null},{"id":"W1982580136","doi":"10.1016/j.eururo.2005.11.030","title":"The Actual Value of the Surgical Margin Status as a Predictor of Disease Progression in Men with Early Prostate Cancer","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Prostatectomy; Surgical margin; Prostate cancer; Urology; Stage (stratigraphy); Biochemical recurrence; Prostate-specific antigen; Prostate; Population; Proportional hazards model; Cancer; Oncology; Surgery; Internal medicine","score_opus":0.005818724261299519,"score_gpt":0.25008368456346675,"score_spread":0.24426496030216724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982580136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988548,0.0026556908,4.489684e-7,0.002656022,0.000051540923,0.00083230896,0.00006710638,0.000012705362,0.005176207],"genre_scores_gemma":[0.998667,0.00055138546,0.000012304472,0.00008177388,0.00006032108,0.00008638916,0.000013260784,0.000024737099,0.00050279795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871904,0.0003134246,0.0002620099,0.00020432478,0.00022456856,0.0002766364],"domain_scores_gemma":[0.99929523,0.00011335164,0.00016270012,0.00028175267,0.000058596474,0.00008835078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018656482,0.0001207455,0.00019701042,0.000032139997,0.000044750446,0.000006064391,0.000100073965,0.000019549721,0.00002464142],"category_scores_gemma":[0.000031125994,0.000053471576,0.00005088244,0.00013618237,0.0003183616,0.000023930355,0.00007473484,0.00013169901,0.0000036303825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005688875,0.00041834952,0.9873198,0.000038734303,0.00006441773,0.00030940268,0.0005076423,0.00013495183,0.000115348026,0.0006455476,0.00063540327,0.004121529],"study_design_scores_gemma":[0.0036766143,0.0014854922,0.977485,0.000116848954,0.00010251123,0.000008531794,0.000023703435,0.000047298236,0.000551074,0.00007057109,0.016380578,0.000051762672],"about_ca_topic_score_codex":0.00037387054,"about_ca_topic_score_gemma":0.00005884362,"teacher_disagreement_score":0.015745174,"about_ca_system_score_codex":0.000051643394,"about_ca_system_score_gemma":0.00021974907,"threshold_uncertainty_score":0.21805076},"labels":[],"label_agreement":null},{"id":"W1982821040","doi":"10.1016/j.eururo.2011.06.024","title":"Re: Jürgen Pannek. Mozart, the Brain, and the Bladder: Clinical Usefulness of Near-Infrared Spectroscopy for the Detection of Detrusor Overactivity. Eur Urol 2011;59:763–4","year":2011,"lang":"en","type":"letter","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Medicine; MOZART; Urology","score_opus":0.05892793931090754,"score_gpt":0.3208359491841686,"score_spread":0.261908009873261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982821040","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05574405,0.0077185156,0.0032430354,0.9020421,0.0022632477,0.007573912,0.00037664548,0.00012702282,0.02091148],"genre_scores_gemma":[0.65700215,0.0032229498,0.00017231473,0.31975874,0.007329335,0.00024752686,0.00014164428,0.00043275938,0.011692553],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.992771,0.004404606,0.0009981357,0.00069147337,0.000463559,0.000671182],"domain_scores_gemma":[0.9874231,0.009951065,0.0007168953,0.0015147311,0.00029800375,0.000096176555],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004800353,0.00042559602,0.0009879261,0.0001252407,0.00037172658,0.000042815398,0.0007408158,0.00042359703,0.00039275765],"category_scores_gemma":[0.001797465,0.00021388414,0.0004956758,0.00017512577,0.002360941,0.00007582208,0.0004125779,0.0031842156,0.000071819384],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01483837,0.00024139826,0.0016818118,0.0003582827,0.0017581601,0.0003004717,0.001611979,0.0000030187953,0.0010900013,0.000045425917,0.9684424,0.009628681],"study_design_scores_gemma":[0.0050575337,0.0045332215,0.022486776,0.00002201939,0.0010477469,0.0003074505,0.00008098118,0.0004929226,0.0011318476,0.0005405619,0.96405315,0.00024579652],"about_ca_topic_score_codex":0.00011444707,"about_ca_topic_score_gemma":0.000026110509,"teacher_disagreement_score":0.6012581,"about_ca_system_score_codex":0.000016302096,"about_ca_system_score_gemma":0.00020822772,"threshold_uncertainty_score":0.99911547},"labels":[],"label_agreement":null},{"id":"W1983094092","doi":"10.1016/j.eururo.2008.11.026","title":"Tolterodine Treatment Improves Storage Symptoms Suggestive of Overactive Bladder in Men Treated With α-Blockers","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Tolterodine; Overactive bladder; Medicine; Placebo; Urology; Clinical endpoint; International Prostate Symptom Score; Urinary incontinence; Lower urinary tract symptoms; Randomized controlled trial; Urinary system; Internal medicine; Prostate","score_opus":0.017898090484838286,"score_gpt":0.26403185758860304,"score_spread":0.24613376710376475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983094092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9553147,0.00029294923,0.000010249916,0.00050391845,0.000016362897,0.0005291284,0.000020993913,0.000038644663,0.043273043],"genre_scores_gemma":[0.99614847,0.00026521552,0.00008579405,0.000104267754,0.000056007335,0.000016473607,0.00005765817,0.000046161596,0.0032199589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998431,0.00039489465,0.00024768777,0.00037414613,0.00017830328,0.00037395893],"domain_scores_gemma":[0.9992511,0.00015237101,0.000084960906,0.000278419,0.00009389181,0.00013925241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014695707,0.000214742,0.0004096722,0.00024468708,0.000048960555,0.0000033561994,0.00008105575,0.000046826397,0.00014979136],"category_scores_gemma":[0.000035988764,0.00015036359,0.00005538194,0.00024716294,0.00030604636,0.00006596869,0.000047958943,0.00022553829,0.000055449236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04495332,0.0059504877,0.7657491,0.00010879851,0.0028544832,0.041666765,0.018545995,0.0002641991,0.09722518,0.00008196229,0.0041728024,0.018426886],"study_design_scores_gemma":[0.00973871,0.027443398,0.9477526,0.000020463829,0.00014358276,0.001202973,0.00023057309,0.00026672805,0.008775439,0.0000042954202,0.004210913,0.00021031403],"about_ca_topic_score_codex":0.00028071468,"about_ca_topic_score_gemma":0.000016763235,"teacher_disagreement_score":0.18200348,"about_ca_system_score_codex":0.000098226046,"about_ca_system_score_gemma":0.00011972991,"threshold_uncertainty_score":0.6131649},"labels":[],"label_agreement":null},{"id":"W1983145936","doi":"10.1016/j.eururo.2010.10.039","title":"EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1497,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Prostate cancer; Watchful waiting; Prostatectomy; Androgen deprivation therapy; Population; Prostate-specific antigen; Randomized controlled trial; Radiation therapy; Life expectancy; Prostate; Cancer; Gynecology; Internal medicine","score_opus":0.05855973843559332,"score_gpt":0.3509674328759666,"score_spread":0.2924076944403733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983145936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756808,0.0035835207,0.000009504514,0.01776898,0.00043483928,0.00080038904,0.0002025434,0.000063381,0.0014560001],"genre_scores_gemma":[0.9743643,0.018874474,0.0005977308,0.0047251065,0.0005691233,0.00025532572,0.00008663912,0.00005526853,0.0004720744],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841624,0.00012297845,0.0005875107,0.00046495048,0.00013707705,0.0002712655],"domain_scores_gemma":[0.9986555,0.00017495139,0.0002061625,0.00043698307,0.00014664372,0.00037974142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021618974,0.0002298172,0.00040720904,0.000063530526,0.000055855857,0.000010538535,0.00006818675,0.000044424076,0.0001983656],"category_scores_gemma":[0.00028235052,0.00016255026,0.000112281174,0.00006687325,0.0002471249,0.000025232972,0.00004360791,0.00012557325,0.000030548596],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017717887,0.0010382814,0.7732309,0.000026823982,0.00017946828,0.00048745333,0.00013032419,0.00004182239,0.00012921664,0.00012577078,0.007240651,0.2155975],"study_design_scores_gemma":[0.0046808543,0.0063416976,0.46442655,0.000075773154,0.0003722163,0.000012544045,0.000007599032,0.00011015911,0.0004770395,0.000028844514,0.523324,0.00014269404],"about_ca_topic_score_codex":0.00009330362,"about_ca_topic_score_gemma":0.000059190294,"teacher_disagreement_score":0.51608336,"about_ca_system_score_codex":0.00002228674,"about_ca_system_score_gemma":0.00009288688,"threshold_uncertainty_score":0.6628607},"labels":[],"label_agreement":null},{"id":"W1983639729","doi":"10.1016/j.eururo.2008.04.099","title":"Assessment of Pathological Prostate Cancer Characteristics in Men with Favorable Biopsy Features on Predominantly Sextant Biopsy","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Biopsy; Pathological; Prostate; Prostate biopsy; Prostate disease; Urology; Cancer; Radiology; Internal medicine","score_opus":0.017014793290451833,"score_gpt":0.277020971911116,"score_spread":0.26000617862066416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983639729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832387,0.00045500544,0.00001220294,0.0011538088,0.00007823938,0.00059212116,0.0001110429,0.000034909528,0.0143239545],"genre_scores_gemma":[0.99645126,0.0016257922,0.0005659349,0.0005150448,0.000064387394,0.00008759777,0.000057581125,0.000038024216,0.0005943739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847764,0.00022046592,0.00034489937,0.0004294243,0.00018286167,0.00034472175],"domain_scores_gemma":[0.9992507,0.00006430862,0.00019622479,0.00030966048,0.000074784184,0.00010429987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022611157,0.0002229293,0.0005093309,0.00011741107,0.000052993026,0.000005832678,0.00009034699,0.000055594366,0.0000623266],"category_scores_gemma":[0.000030433474,0.00014280714,0.00004773261,0.00016942549,0.00023039941,0.000029070225,0.000052715568,0.00026454782,0.000013225103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016187883,0.0012162891,0.97407526,0.000060519917,0.00010232027,0.011923581,0.0006367557,0.000057640536,0.0067122653,0.00024564576,0.0005401129,0.00281083],"study_design_scores_gemma":[0.0030755221,0.004261404,0.98926,0.00009848956,0.000071520626,0.00080623553,0.00003500883,0.00004755158,0.0009293209,0.000007016703,0.0012720426,0.00013589901],"about_ca_topic_score_codex":0.000053610995,"about_ca_topic_score_gemma":0.0000057485795,"teacher_disagreement_score":0.015184738,"about_ca_system_score_codex":0.00010869946,"about_ca_system_score_gemma":0.00015198808,"threshold_uncertainty_score":0.5823506},"labels":[],"label_agreement":null},{"id":"W1983956184","doi":"10.1016/j.eururo.2007.03.036","title":"Platelet Count and Preoperative Haemoglobin Do Not Significantly Increase the Performance of Established Predictors of Renal Cell Carcinoma-Specific Mortality","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Thrombocytosis; Internal medicine; Platelet; Carcinoma; Stage (stratigraphy); Gastroenterology; Oncology; Urology","score_opus":0.01360818166330451,"score_gpt":0.22724560549994083,"score_spread":0.2136374238366363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983956184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98891,0.0006112244,0.00003588449,0.00006494689,0.00014964941,0.0005905666,0.0000804949,0.00003098257,0.009526214],"genre_scores_gemma":[0.9993172,0.00007008427,0.00011720021,0.00023394717,0.00013713594,0.0000064781734,0.000028350325,0.00003380042,0.000055773864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978428,0.0004677829,0.0006617697,0.00037497297,0.00032600889,0.0003267054],"domain_scores_gemma":[0.998467,0.00026532143,0.00030669008,0.0005631891,0.00022614402,0.000171612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020739685,0.00021634685,0.00037229573,0.00012799085,0.00008981064,0.000011769834,0.0002352835,0.00007812471,0.0001011747],"category_scores_gemma":[0.0001354287,0.00015581596,0.00007664355,0.00019676323,0.00090201874,0.00007960279,0.00015357588,0.00027113975,0.0000082248935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041583157,0.00023591577,0.9478817,0.0002169959,0.00014501672,0.00041460822,0.0014629221,0.000027338883,0.043047257,0.00010265418,0.0016971192,0.0006101485],"study_design_scores_gemma":[0.0015601236,0.0008380572,0.8998298,0.000021554986,0.00016718397,0.000056921737,0.00014769052,0.00016492476,0.095580906,0.0000019274578,0.0015100656,0.00012083524],"about_ca_topic_score_codex":0.000023760924,"about_ca_topic_score_gemma":0.000004220493,"teacher_disagreement_score":0.052533645,"about_ca_system_score_codex":0.000032455886,"about_ca_system_score_gemma":0.00009874959,"threshold_uncertainty_score":0.63539904},"labels":[],"label_agreement":null},{"id":"W1983995597","doi":"10.1016/j.eururo.2004.12.023","title":"Randomized Clinical Trial Comparing Suprapubic Arch Sling (SPARC) and Tension-Free Vaginal Tape (TVT): One-Year Results","year":2005,"lang":"en","type":"article","venue":"European Urology","topic":"Pelvic floor disorders treatments","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Urinary incontinence; Randomized controlled trial; Surgery; Sling (weapon); Urinary system; Urology; Significant difference; Hematoma; Internal medicine","score_opus":0.07179897365995908,"score_gpt":0.3399401959213058,"score_spread":0.26814122226134673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983995597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9446029,0.0007120176,0.00019079172,0.0074883457,0.0004611439,0.0011054784,0.000006961964,0.00016669932,0.045265652],"genre_scores_gemma":[0.9912782,0.00031242077,0.0041384078,0.0020851395,0.0012108514,0.000012646653,0.00006605472,0.000066500725,0.0008297852],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9948927,0.002324876,0.0011833993,0.00075250113,0.00030852223,0.0005379614],"domain_scores_gemma":[0.9969431,0.0015923775,0.00025612587,0.0008088689,0.000092543414,0.0003069732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004100499,0.00028528154,0.0012273879,0.00020423948,0.00012101839,0.000026446094,0.00026764907,0.000121900004,0.00007698509],"category_scores_gemma":[0.004809274,0.00024110265,0.00022592192,0.00012821899,0.00057246664,0.00007156212,0.00034841255,0.0006809406,0.00045312077],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97280824,0.0009547059,0.011562392,0.000016188842,0.0004630755,0.00028702628,0.00033908564,0.000022981938,0.00011595866,0.00018002672,0.003924321,0.009325998],"study_design_scores_gemma":[0.948218,0.0018627367,0.028812943,0.000032222357,0.00057018397,0.00012923873,0.000025240772,0.0024323983,0.0000102807235,0.00011128424,0.017586423,0.00020904897],"about_ca_topic_score_codex":0.00003846325,"about_ca_topic_score_gemma":0.000035452376,"teacher_disagreement_score":0.046675283,"about_ca_system_score_codex":0.000029961073,"about_ca_system_score_gemma":0.00007578069,"threshold_uncertainty_score":0.9831881},"labels":[],"label_agreement":null},{"id":"W1984592028","doi":"10.1016/j.eururo.2008.02.018","title":"Radical Prostatectomy for Incidental (Stage T1a–T1b) Prostate Cancer: Analysis of Predictors for Residual Disease and Biochemical Recurrence","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Radical retropubic prostatectomy; Prostatectomy; Prostate cancer; Urology; Biochemical recurrence; Stage (stratigraphy); Prostate-specific antigen; Prostate; Cancer; Internal medicine","score_opus":0.020129561701112762,"score_gpt":0.28600155355318113,"score_spread":0.2658719918520684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984592028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908846,0.0039988416,0.00011150312,0.0010516555,0.00009945452,0.0016706594,0.0020467355,0.000043402284,0.00009314353],"genre_scores_gemma":[0.9957102,0.0019995004,0.00041847987,0.00038389495,0.00012789971,0.00042849494,0.00065651676,0.000038500795,0.0002365136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984783,0.000092095856,0.00040041885,0.00052937155,0.00015738215,0.00034241093],"domain_scores_gemma":[0.9989339,0.00020750039,0.00017022034,0.00024747374,0.00012438741,0.0003164805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021200137,0.00019882187,0.00049093895,0.00019377188,0.000098236196,0.0000068132385,0.000088117755,0.0000441648,0.000033082022],"category_scores_gemma":[0.0002491926,0.00016567543,0.00017355842,0.00023733094,0.00049502944,0.000037845963,0.000073074014,0.00010550698,0.0000014936606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008554692,0.0007078269,0.9716419,0.00043425855,0.0023251497,0.00035037062,0.001152617,0.00006888033,0.002167393,0.00019149033,0.009342499,0.0030629407],"study_design_scores_gemma":[0.007943532,0.003333408,0.9553805,0.00006731048,0.004510462,0.000030637737,0.000037937007,0.0008351873,0.0053869355,0.00004630598,0.022154069,0.00027371323],"about_ca_topic_score_codex":0.000027558492,"about_ca_topic_score_gemma":0.000008263092,"teacher_disagreement_score":0.016261378,"about_ca_system_score_codex":0.00006549287,"about_ca_system_score_gemma":0.00017136324,"threshold_uncertainty_score":0.6756048},"labels":[],"label_agreement":null},{"id":"W1984836574","doi":"10.1016/j.eururo.2009.03.072","title":"Comparison of Oncologic Outcomes for Open and Laparoscopic Nephroureterectomy: A Multi-Institutional Analysis of 1249 Cases","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Lymphovascular invasion; Hazard ratio; Stage (stratigraphy); Urology; Internal medicine; Urothelial carcinoma; Cancer; Concomitant; Ureter; Oncology; Bladder cancer; Gastroenterology; Gynecology; Surgery; Confidence interval; Metastasis","score_opus":0.10324741687264638,"score_gpt":0.41502763658185116,"score_spread":0.3117802197092048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984836574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946214,0.0005250235,0.00062833476,0.0006306833,0.00006534328,0.0004899306,0.00008796248,0.000015438287,0.0029358957],"genre_scores_gemma":[0.99588746,0.00001595509,0.0025530148,0.0012977998,0.000021235317,0.0000071057666,0.000050695202,0.000006746563,0.0001599771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999195,0.000108716,0.00029996186,0.0002027937,0.00006710737,0.00012645664],"domain_scores_gemma":[0.99942464,0.000150735,0.00014111944,0.00016618294,0.00006150305,0.000055823526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013854724,0.00011275456,0.00075940485,0.00014506264,0.000043971533,0.000005680028,0.000113633934,0.00003774312,0.000057280376],"category_scores_gemma":[0.0001251697,0.00007987535,0.00011159159,0.00015631254,0.00012370186,0.00003114049,0.00005047809,0.000058348698,0.0000023832379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009524353,0.0008202551,0.9887698,0.000025458785,0.0012676897,0.000050969276,0.0003948461,0.00008041717,0.0014469159,0.00041195552,0.0002881219,0.0054911156],"study_design_scores_gemma":[0.0047383364,0.0036783703,0.9862894,0.000006794633,0.0021489542,0.000016839967,0.000031048185,0.00044659013,0.0005601056,0.000024179919,0.0019977505,0.00006166564],"about_ca_topic_score_codex":0.00006722483,"about_ca_topic_score_gemma":0.000067526395,"teacher_disagreement_score":0.00542945,"about_ca_system_score_codex":0.000018136509,"about_ca_system_score_gemma":0.0000592354,"threshold_uncertainty_score":0.32572225},"labels":[],"label_agreement":null},{"id":"W1985364355","doi":"10.1016/j.eururo.2006.10.050","title":"Sunitinib Relieves Renal Cell Carcinoma Spinal Cord Compression","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Spinal cord compression; Spinal cord; Surgery; Urology; Internal medicine","score_opus":0.022365588023510696,"score_gpt":0.26473189561899485,"score_spread":0.24236630759548417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985364355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7051502,0.00033656092,0.0005618242,0.0010922032,0.00014905166,0.00019637097,0.000006461489,0.00009236822,0.29241496],"genre_scores_gemma":[0.9876874,0.0000057307557,0.0012448259,0.0026273958,0.00033245608,0.0000034134578,0.00012333183,0.000046869576,0.007928538],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.998381,0.00041052964,0.0003290618,0.00033633204,0.00022415402,0.00031888182],"domain_scores_gemma":[0.99921155,0.000042889125,0.00012515263,0.00042301926,0.00005486358,0.00014255117],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003119068,0.00017217765,0.00023536758,0.00013629679,0.00007254786,0.000014219889,0.00015559755,0.000029063933,0.0007089811],"category_scores_gemma":[0.000052668103,0.0001543877,0.00008325989,0.00010018243,0.00012439444,0.00003456678,0.00014059697,0.00021630552,0.0008315399],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023082508,0.003971726,0.09480518,0.00085728,0.0001293216,0.02758344,0.0001982283,0.00010563236,0.07342156,0.008567266,0.7259858,0.041292034],"study_design_scores_gemma":[0.0030211227,0.0024829349,0.76984364,0.000016307751,0.00022703863,0.000090847636,0.00003074757,0.00014159938,0.0006229466,0.00013212183,0.22321916,0.00017155906],"about_ca_topic_score_codex":0.000024181563,"about_ca_topic_score_gemma":0.0000013441871,"teacher_disagreement_score":0.67503846,"about_ca_system_score_codex":0.000012410731,"about_ca_system_score_gemma":0.000026014768,"threshold_uncertainty_score":0.9999464},"labels":[],"label_agreement":null},{"id":"W1985623608","doi":"10.1016/j.eururo.2010.08.023","title":"Re: The Index Lesion and Focal Therapy: An Analysis of the Pathological Characteristics of Prostate Cancer","year":2010,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Pathological; Prostate cancer; Prostate; Lesion; Cancer; Oncology; Pathology; Radiology; Internal medicine","score_opus":0.028824682777112753,"score_gpt":0.28182401357972997,"score_spread":0.2529993308026172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985623608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76341444,0.001049474,0.00000332008,0.23434764,0.0002258738,0.00044893255,0.00027163615,0.000012892888,0.00022576952],"genre_scores_gemma":[0.8033546,0.0029267534,0.000008643026,0.19288921,0.0004354735,0.000029807763,0.0001699596,0.00003474658,0.00015078494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982398,0.0005665823,0.0003959251,0.00037569777,0.00020562392,0.00021634802],"domain_scores_gemma":[0.9985073,0.0001648244,0.00046379768,0.0007050039,0.00011694886,0.000042113825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034828077,0.00022747672,0.0006619852,0.00010205152,0.00006283624,0.000009629848,0.00022668642,0.00033292914,0.000101203805],"category_scores_gemma":[0.00005468016,0.0001030362,0.00018966262,0.00020263113,0.00058461237,0.000014956349,0.0001368718,0.0014418946,0.0000014185292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006434187,0.0003077644,0.8952556,0.00009163632,0.0017407216,0.0006875349,0.0013701575,0.000007149526,0.0008322647,0.000018286639,0.034409042,0.06463638],"study_design_scores_gemma":[0.0005627499,0.0008955763,0.81712276,0.000020120646,0.0015131468,0.000013205428,0.000012140126,0.000046362195,0.000103535414,0.000012483184,0.1796154,0.00008255708],"about_ca_topic_score_codex":0.00006843514,"about_ca_topic_score_gemma":0.000045278837,"teacher_disagreement_score":0.14520635,"about_ca_system_score_codex":0.000020061832,"about_ca_system_score_gemma":0.00006256046,"threshold_uncertainty_score":0.62643945},"labels":[],"label_agreement":null},{"id":"W1985701058","doi":"10.1016/j.eururo.2014.04.027","title":"Metformin Use and Prostate Cancer Risk","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":141,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Metformin; Prostate cancer; Prostate; Oncology; Gynecology; Prostate disease; Urology; Cancer; Internal medicine","score_opus":0.007524317572639515,"score_gpt":0.21560494917721934,"score_spread":0.20808063160457982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985701058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92625904,0.07077135,0.0002399644,0.00003726916,0.00026200124,0.00008771778,0.00003124534,0.000016381138,0.0022950463],"genre_scores_gemma":[0.92724943,0.068462186,0.00024419592,0.0024891149,0.0005679554,0.000013661265,0.000031863892,0.000042754906,0.0008988351],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988455,0.00037990705,0.00013938866,0.00033248658,0.000050376846,0.0002523361],"domain_scores_gemma":[0.99948823,0.000020063477,0.00008314577,0.0002762649,0.00004396423,0.00008835556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003731488,0.00012951824,0.0001332605,0.000027564805,0.000065340006,0.000025216952,0.00011449643,0.00005283354,0.000042815576],"category_scores_gemma":[0.00019162313,0.00011278579,0.000037644942,0.000035099078,0.00011113396,0.000004974721,0.00011577949,0.00009898113,0.000035328732],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021249356,0.000044244105,0.055149205,0.000021295898,0.00013904547,0.000009085821,0.00024476452,0.000116725445,0.03423654,0.00044909422,0.016291514,0.893086],"study_design_scores_gemma":[0.00051194435,0.00019834333,0.025739826,0.0000014163521,0.000041715874,0.000006930601,0.000004973861,0.000051450003,0.0055257715,0.0000689188,0.9677063,0.000142402],"about_ca_topic_score_codex":0.00003649004,"about_ca_topic_score_gemma":0.000049307248,"teacher_disagreement_score":0.9514148,"about_ca_system_score_codex":0.0000025009049,"about_ca_system_score_gemma":0.000015701202,"threshold_uncertainty_score":0.4599271},"labels":[],"label_agreement":null},{"id":"W1985734141","doi":"10.1016/j.eururo.2014.02.056","title":"Updated Interim Efficacy Analysis and Long-term Safety of Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Without Prior Chemotherapy (COU-AA-302)","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":273,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal; Alberta Cancer Foundation","funders":"National Cancer Institute","keywords":"Abiraterone acetate; Medicine; Prednisone; Prostate cancer; Interim analysis; Hazard ratio; Internal medicine; Urology; Adverse effect; Oncology; Proportional hazards model; Androgen deprivation therapy; Surgery; Cancer; Randomized controlled trial; Confidence interval","score_opus":0.020455949766307106,"score_gpt":0.3179439517988702,"score_spread":0.2974880020325631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985734141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977942,0.0002995423,0.00010414201,0.0005857434,0.000049033242,0.0007688771,0.000046439454,0.000026326214,0.0003256736],"genre_scores_gemma":[0.9984316,0.00037306768,0.00014638758,0.00031600133,0.000024364368,0.000019043093,0.00022202969,0.00004286262,0.00042459808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980349,0.00047811176,0.0005238301,0.00042296754,0.00019335128,0.00034686792],"domain_scores_gemma":[0.9991688,0.000056897818,0.00020965522,0.00028496573,0.00014771518,0.00013193405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042672124,0.00021795333,0.000587848,0.000342728,0.000049654544,0.00001889748,0.00010633556,0.000033904158,0.0001863718],"category_scores_gemma":[0.00004413274,0.00016267394,0.00007306854,0.0004380346,0.00023898737,0.000068476504,0.00006063459,0.00018662744,0.000013646292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008504653,0.0005612432,0.9469569,0.00012664017,0.0012039971,0.00008879599,0.0016212726,0.00007503418,0.018740723,0.000005747417,0.000027436701,0.022087568],"study_design_scores_gemma":[0.011744071,0.0013166259,0.98347914,0.00004073681,0.0005431121,0.0000041340736,0.000013283001,0.00033552703,0.0020992458,0.0000034938726,0.0002904635,0.00013017973],"about_ca_topic_score_codex":0.000097889206,"about_ca_topic_score_gemma":0.00033748616,"teacher_disagreement_score":0.03652224,"about_ca_system_score_codex":0.00006609171,"about_ca_system_score_gemma":0.000064812775,"threshold_uncertainty_score":0.66336507},"labels":[],"label_agreement":null},{"id":"W1985763519","doi":"10.1016/j.eururo.2010.12.012","title":"Disease-Free Survival Following Salvage Cryotherapy for Biopsy-Proven Radio-Recurrent Prostate Cancer","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cryotherapy; Prostate cancer; Perioperative; Salvage therapy; Surgery; Prostate-specific antigen; Biopsy; Prostate; Radiation therapy; Cancer; Urology; Internal medicine; Chemotherapy","score_opus":0.01738454361838155,"score_gpt":0.29058666820030965,"score_spread":0.2732021245819281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985763519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728059,0.004763555,0.00013577027,0.013295478,0.004840649,0.0016735662,0.00040762272,0.00017725799,0.001900162],"genre_scores_gemma":[0.9941534,0.0006149984,0.0006694446,0.0019360132,0.0010819896,0.00042530996,0.00015367515,0.00013497774,0.00083023816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841756,0.00011252742,0.0002802811,0.00053207536,0.00016779616,0.00048973784],"domain_scores_gemma":[0.99873674,0.00012381673,0.00010861805,0.00063915254,0.00006753663,0.00032413856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032846848,0.00025938058,0.00036056357,0.00007788786,0.000117690295,0.000028419272,0.00021659292,0.00004514394,0.00013847151],"category_scores_gemma":[0.0001540414,0.00020948373,0.00025816233,0.00009559195,0.0000987339,0.000056504716,0.000078244586,0.0002451162,0.000052352654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076424535,0.0021782238,0.6775082,0.00038212168,0.0019213028,0.0027889502,0.0016273559,0.000031666146,0.049687568,0.0033139954,0.042725652,0.21019252],"study_design_scores_gemma":[0.0112230005,0.0017638319,0.49338573,0.000051790812,0.0005605508,0.000019947676,0.00001798707,0.00014097663,0.00085757294,0.00051587133,0.491066,0.0003967154],"about_ca_topic_score_codex":0.000028693587,"about_ca_topic_score_gemma":0.000048133472,"teacher_disagreement_score":0.44834036,"about_ca_system_score_codex":0.000057163197,"about_ca_system_score_gemma":0.00013114019,"threshold_uncertainty_score":0.85424984},"labels":[],"label_agreement":null},{"id":"W1986277796","doi":"10.1016/j.eururo.2012.06.008","title":"Pathologic Nodal Staging Score for Bladder Cancer: A Decision Tool for Adjuvant Therapy After Radical Cystectomy","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Lymph node; Lymphovascular invasion; Dissection (medical); Stage (stratigraphy); Urology; Neoadjuvant therapy; Metastasis; Radiology; Surgery; Cancer; Internal medicine","score_opus":0.03386154086211229,"score_gpt":0.31167138229151675,"score_spread":0.27780984142940446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986277796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.968646,0.008652118,0.017154967,0.0010337108,0.0010456791,0.0019878752,0.00017035441,0.00012705348,0.0011822444],"genre_scores_gemma":[0.9868358,0.00026292528,0.0031124344,0.0072903824,0.0014426014,0.00056117534,0.00004086012,0.00009633885,0.0003574852],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983677,0.00014328411,0.0003038796,0.00039739767,0.00014634435,0.0006413683],"domain_scores_gemma":[0.9991212,0.00021694301,0.00008000843,0.0003206878,0.00008232768,0.0001788681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004214692,0.0002495053,0.00038667314,0.00009052846,0.00010351166,0.000014482452,0.00012107627,0.00009048405,0.0003780243],"category_scores_gemma":[0.00010068811,0.00017814121,0.0002020923,0.00007530781,0.000108540866,0.000078370475,0.00005073912,0.00016078666,0.00006949145],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026306877,0.0010909577,0.3158116,0.00012309565,0.0005848257,0.00046476032,0.0026424446,0.000011146516,0.006025012,0.00016514414,0.011740931,0.6350332],"study_design_scores_gemma":[0.024130194,0.004976933,0.42558858,0.000061348175,0.0004992065,0.00037569078,0.000049891572,0.00011884824,0.0012492025,0.00024506982,0.54222625,0.0004787927],"about_ca_topic_score_codex":0.000008256174,"about_ca_topic_score_gemma":0.0000023828115,"teacher_disagreement_score":0.63455445,"about_ca_system_score_codex":0.000057845173,"about_ca_system_score_gemma":0.00007430234,"threshold_uncertainty_score":0.72643876},"labels":[],"label_agreement":null},{"id":"W1987068717","doi":"10.1016/j.eururo.2008.10.037","title":"The Influence of Baseline Parameters on Changes in International Prostate Symptom Score with Dutasteride, Tamsulosin, and Combination Therapy among Men with Symptomatic Benign Prostatic Hyperplasia and an Enlarged Prostate: 2-Year Data from the CombAT Study","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Dutasteride; Medicine; Tamsulosin; International Prostate Symptom Score; Urology; Prostate; Lower urinary tract symptoms; Hyperplasia; Combination therapy; Gynecology; Internal medicine","score_opus":0.033291047681773114,"score_gpt":0.2831177428785294,"score_spread":0.24982669519675632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987068717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99549323,0.00015849018,0.0000038874496,0.0017694301,0.000015444424,0.0022916335,0.0001078093,0.000024451794,0.00013560535],"genre_scores_gemma":[0.99835724,0.00077170075,0.00009650103,0.00029251297,0.000019215677,0.000059116443,0.00030302964,0.00004229568,0.000058365455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736154,0.0011781767,0.00030219997,0.00048242905,0.00040855425,0.00026711286],"domain_scores_gemma":[0.9982755,0.0006862112,0.00016555465,0.0006401184,0.00014059478,0.00009202953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011927282,0.00021228887,0.0002747997,0.00011108323,0.00019212619,0.000054794287,0.0003318566,0.000025439047,0.000006456749],"category_scores_gemma":[0.00014704856,0.000108937194,0.000007960662,0.00019307151,0.00073552725,0.00021105791,0.00018166678,0.00032133557,0.0000023055422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006437401,0.00063963386,0.9797815,0.000024518342,0.00018670097,0.00032216287,0.010121626,0.00008618517,0.000391442,0.000017180084,0.00005747088,0.0019341741],"study_design_scores_gemma":[0.0065630353,0.012363081,0.97626853,0.00009527299,0.000045846817,0.00016942625,0.0017465806,0.0024171374,0.000087508466,0.000022265454,0.000100253026,0.00012104163],"about_ca_topic_score_codex":0.0001843029,"about_ca_topic_score_gemma":0.00034190566,"teacher_disagreement_score":0.011723448,"about_ca_system_score_codex":0.000014729136,"about_ca_system_score_gemma":0.0000641307,"threshold_uncertainty_score":0.444233},"labels":[],"label_agreement":null},{"id":"W1987398824","doi":"10.1016/j.eururo.2014.08.005","title":"Reply from Authors re: David Margel. Metformin to Prevent Prostate Cancer: A Call to Unite. Eur Urol 2014;66:1021–2","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Metformin; Randomized controlled trial; Clinical trial; Prostate cancer; Internal medicine; Cancer; Polycystic ovary; Oncology; Breast cancer; Adjuvant; Gynecology; Insulin resistance; Obesity","score_opus":0.012007755625558302,"score_gpt":0.24733323154353495,"score_spread":0.23532547591797665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987398824","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10377866,0.27230403,0.0015762539,0.5810508,0.013137945,0.0059301327,0.0052124695,0.00042705188,0.016582618],"genre_scores_gemma":[0.0018365765,0.010709976,0.0006079617,0.9447514,0.012736899,0.00035537058,0.0030269518,0.0004543374,0.025520539],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99327165,0.0019329636,0.0009140104,0.002138898,0.00041970078,0.0013227485],"domain_scores_gemma":[0.9965916,0.000071346105,0.00045327382,0.0021181498,0.00025632826,0.0005092816],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001084934,0.0008972428,0.00096436066,0.00026185013,0.000135728,0.00008518365,0.0014108605,0.00070992304,0.00058922305],"category_scores_gemma":[0.0003737079,0.00086659205,0.00032837506,0.00022268177,0.00013184568,0.0000075548237,0.00085082254,0.0013599312,0.0013418625],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023833037,0.0000465151,0.000100042744,0.000054974873,0.00027473402,0.0002545818,0.00025803907,0.00009963725,0.004731666,0.0000041565936,0.9684589,0.025478415],"study_design_scores_gemma":[0.0005911986,0.00088178704,0.00026972572,0.00003493127,0.00027824604,0.000019984982,0.0000058077444,0.000006672338,0.0037497452,0.000044642995,0.9931667,0.0009505682],"about_ca_topic_score_codex":0.0004153074,"about_ca_topic_score_gemma":0.0001642085,"teacher_disagreement_score":0.36370057,"about_ca_system_score_codex":0.000059660368,"about_ca_system_score_gemma":0.00024209157,"threshold_uncertainty_score":0.9994357},"labels":[],"label_agreement":null},{"id":"W1987710508","doi":"10.1016/j.eururo.2013.12.019","title":"Suppression of Heat Shock Protein 27 Using OGX-427 Induces Endoplasmic Reticulum Stress and Potentiates Heat Shock Protein 90 Inhibitors to Delay Castrate-resistant Prostate Cancer","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"LNCaP; Hsp27; Heat shock protein; Cancer research; Prostate cancer; Medicine; Unfolded protein response; Protein kinase B; Hsp90; Endoplasmic reticulum; Endocrinology; Biology; Hsp70; Internal medicine; Cell biology; Signal transduction; Cancer; Biochemistry","score_opus":0.012187223859812402,"score_gpt":0.2601099180931523,"score_spread":0.2479226942333399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987710508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956405,0.0008560674,0.00026518395,0.0005784503,0.00015286426,0.001884363,0.00011847436,0.00003127329,0.00047280552],"genre_scores_gemma":[0.99810046,0.000051217154,0.0007459959,0.00012439644,0.00027747906,0.00010514541,0.00006269165,0.00011616258,0.00041642244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957861,0.001371496,0.00063830905,0.0009915511,0.00035752158,0.0008550398],"domain_scores_gemma":[0.9986075,0.000026808299,0.000111995505,0.0006422092,0.0002500198,0.00036142784],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007320137,0.00042622094,0.00043634165,0.00019979556,0.0002044875,0.000068332265,0.0004090171,0.00023382288,0.000046079902],"category_scores_gemma":[0.00031160563,0.00037894864,0.00009171031,0.00021883773,0.00032130032,0.000019678357,0.00073455233,0.00039996623,0.000016323882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080826145,0.000102169746,0.0018112267,0.00018975897,0.000059138845,0.000063021354,0.00018325998,0.001626786,0.99435544,0.000013024338,0.00014693204,0.00064100104],"study_design_scores_gemma":[0.00093640044,0.0020486938,0.0011964504,0.00021302306,0.000028087805,0.000049142498,0.00007602744,0.00066329574,0.99065673,0.000015041748,0.0037294775,0.00038764448],"about_ca_topic_score_codex":0.0006415138,"about_ca_topic_score_gemma":0.00023107734,"teacher_disagreement_score":0.0036987045,"about_ca_system_score_codex":0.000036896607,"about_ca_system_score_gemma":0.00018196175,"threshold_uncertainty_score":0.99986625},"labels":[],"label_agreement":null},{"id":"W1988460002","doi":"10.1016/j.eururo.2008.01.043","title":"Considerations on the Use of Urine Markers for Bladder Cancer","year":2008,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Urine; Bladder cancer; Urine cytology; Urinary system; Urology; Gold standard (test); Cancer; Internal medicine","score_opus":0.10792495287673107,"score_gpt":0.29287376769328916,"score_spread":0.1849488148165581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988460002","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019234644,0.00047781246,0.000060835573,0.97664225,0.000763235,0.0014965466,0.00072028406,0.00005729558,0.017858295],"genre_scores_gemma":[0.011993814,0.00040259634,0.00022896483,0.9697988,0.0027295747,0.00013575485,0.00023571681,0.00013473052,0.014340063],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99851966,0.00033314858,0.00031902367,0.00036273163,0.00017066977,0.00029474017],"domain_scores_gemma":[0.99815804,0.0009371449,0.00017288342,0.0005463875,0.00014136697,0.000044194552],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008372326,0.00026915612,0.0004130377,0.00010551745,0.0001130853,0.000010427549,0.00009634489,0.00017773648,0.0013638044],"category_scores_gemma":[0.0002309001,0.00017478301,0.00020870578,0.000055880617,0.00026796633,0.00002001525,0.00003539565,0.0006894028,0.00008474409],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030345205,0.00005551216,0.00017660463,0.00003496152,0.00065486546,0.0005663583,0.00008575884,0.000020310172,0.00003140593,0.00005753893,0.9976608,0.00035239136],"study_design_scores_gemma":[0.0012990898,0.0010076415,0.002247467,0.0000275361,0.00054241496,0.00016672985,0.0000019238562,0.000015231464,0.0000746532,0.000037007336,0.9944505,0.00012981614],"about_ca_topic_score_codex":0.00007682993,"about_ca_topic_score_gemma":0.0000125185925,"teacher_disagreement_score":0.01007035,"about_ca_system_score_codex":0.000037145615,"about_ca_system_score_gemma":0.0001900033,"threshold_uncertainty_score":0.9995491},"labels":[],"label_agreement":null},{"id":"W1988778024","doi":"10.1016/j.eururo.2008.02.031","title":"Rebuttal from Author re: Massimo Lazzeri and Giacomo Novara. Urinary Incontinence: Ensure That the Patient's Voice is Heard. Eur Urol 2008;53:1125–27","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Pelvic floor disorders treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Transcranial direct-current stimulation; Context (archaeology); Physical medicine and rehabilitation; Deep brain stimulation; Urinary incontinence; Transcranial magnetic stimulation; Brain stimulation; Neuroscience; Stimulation; Disease; Parkinson's disease; Physical therapy; Surgery; Internal medicine; Psychology","score_opus":0.024733826675096864,"score_gpt":0.24746390678324368,"score_spread":0.22273008010814682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988778024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9472561,0.004676357,0.000031347678,0.01940814,0.0006454471,0.0005967274,0.00013164285,0.0001949406,0.027059307],"genre_scores_gemma":[0.98171717,0.0004171305,0.0004408305,0.010640888,0.00031013752,0.00001341239,0.00012480593,0.000116151656,0.0062194495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968141,0.00081353966,0.0004649314,0.0008514659,0.000416094,0.0006399067],"domain_scores_gemma":[0.9981638,0.00026073176,0.00022691383,0.0009856563,0.00009354552,0.00026931],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030468786,0.00045100946,0.0005358939,0.00012482358,0.00033017067,0.000025397387,0.00032230312,0.00016972546,0.0005399064],"category_scores_gemma":[0.00022339557,0.00033447126,0.00014454777,0.00024391386,0.0005816815,0.00012492355,0.00038609584,0.0007092829,0.0013468172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026545187,0.0015055316,0.56801796,0.000049376496,0.0008205517,0.0138525395,0.009939838,0.0000093896215,0.0024230995,0.00002295843,0.39108434,0.009619876],"study_design_scores_gemma":[0.0043597026,0.0024695683,0.67264557,0.00002672891,0.0002703807,0.0016683073,0.0002240663,0.00012105786,0.00016788385,0.00005314993,0.31766403,0.00032955082],"about_ca_topic_score_codex":0.00016189256,"about_ca_topic_score_gemma":0.000016964173,"teacher_disagreement_score":0.10462761,"about_ca_system_score_codex":0.000037609145,"about_ca_system_score_gemma":0.00007727478,"threshold_uncertainty_score":0.9999107},"labels":[],"label_agreement":null},{"id":"W1989537267","doi":"10.1016/j.eururo.2004.04.020","title":"Erectile and Urinary Dysfunction after Radical Prostatectomy for Prostate Cancer in Quebec: A Population-Based Study of 2415 Men","year":2004,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"Canadian Urological Oncology Group; AstraZeneca","keywords":"Medicine; Prostatectomy; Prostate cancer; Erectile dysfunction; Urology; Cohort; Gynecology; Population; Internal medicine; Cancer","score_opus":0.009948146820375411,"score_gpt":0.26269078361237375,"score_spread":0.2527426367919983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989537267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99589735,0.0006656946,0.000043985616,0.0009313906,0.0000868558,0.0021214578,0.000034480203,0.000028996355,0.00018981508],"genre_scores_gemma":[0.9986107,0.000038361653,0.00014022134,0.00026656094,0.00004912284,0.00071802194,0.00003564027,0.000032844062,0.000108534885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900377,0.000113595124,0.00027535637,0.00032096266,0.00009074845,0.00019557535],"domain_scores_gemma":[0.9995964,0.000051228682,0.000084716485,0.00014920584,0.00004843799,0.00007001661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014890269,0.00013402605,0.000259554,0.00012839392,0.0000309187,0.0000073106476,0.000027935146,0.0000305559,0.00003945511],"category_scores_gemma":[0.000025385903,0.00011061088,0.000032440345,0.0001094162,0.000035272133,0.000045980552,0.000023431663,0.0000954518,0.0000026197572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005212889,0.0018031449,0.97709364,0.00013042381,0.0000848495,0.0002980164,0.0016330319,0.00078667747,0.000149684,0.000020092188,0.000052836378,0.0127347205],"study_design_scores_gemma":[0.013898952,0.006632447,0.97807497,0.00005591061,0.000117928685,0.000010033468,0.00011261701,0.00007245949,0.0001790099,0.00005442326,0.0007005326,0.00009069419],"about_ca_topic_score_codex":0.004620707,"about_ca_topic_score_gemma":0.0031607228,"teacher_disagreement_score":0.012644026,"about_ca_system_score_codex":0.00016246727,"about_ca_system_score_gemma":0.00009336639,"threshold_uncertainty_score":0.6985158},"labels":[],"label_agreement":null},{"id":"W1990374528","doi":"10.1016/j.eururo.2011.02.013","title":"Re: Management of Disseminated Nonseminomatous Germ Cell Tumors with Risk-Based Chemotherapy Followed by Response-Guided Postchemotherapy Surgery","year":2011,"lang":"en","type":"letter","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Chemotherapy; Germ cell tumors; Germ cell; Surgery; General surgery; Oncology","score_opus":0.011966100897905962,"score_gpt":0.22946355651053835,"score_spread":0.2174974556126324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990374528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92241824,0.002782151,0.00015609857,0.06452359,0.00023294798,0.0018888458,0.0005220449,0.00040317953,0.007072894],"genre_scores_gemma":[0.79630435,0.00036922985,0.0010648527,0.19132648,0.00022393366,0.00006650584,0.0023051095,0.0006689365,0.0076706284],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959898,0.0011628694,0.0007704983,0.0009458746,0.0004425772,0.00068838877],"domain_scores_gemma":[0.9964896,0.00065897027,0.0011261336,0.0013785328,0.00013932807,0.00020743463],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054410746,0.0007749528,0.001194954,0.0003417124,0.00007777411,0.000016288908,0.00032973394,0.0003242203,0.000593044],"category_scores_gemma":[0.0000661492,0.0006127184,0.00048338092,0.00029828976,0.00027693028,0.000024025032,0.00004853706,0.00073139503,0.00012188396],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009576548,0.0009654346,0.041742675,0.00046919263,0.0012800312,0.032145742,0.000105333376,0.0000010405458,0.0005879689,2.96738e-7,0.9120127,0.0011130349],"study_design_scores_gemma":[0.020801052,0.0063670794,0.3501941,0.0010325132,0.005873047,0.00061368535,0.000060166938,0.000030933275,0.010808374,0.000011331797,0.6022554,0.0019523202],"about_ca_topic_score_codex":0.000054259246,"about_ca_topic_score_gemma":6.169625e-7,"teacher_disagreement_score":0.3097573,"about_ca_system_score_codex":0.00008287401,"about_ca_system_score_gemma":0.00019136492,"threshold_uncertainty_score":0.9996324},"labels":[],"label_agreement":null},{"id":"W1990786792","doi":"10.1016/j.eururo.2014.10.036","title":"A Genomic Classifier Improves Prediction of Metastatic Disease Within 5 Years After Surgery in Node-negative High-risk Prostate Cancer Patients Managed by Radical Prostatectomy Without Adjuvant Therapy","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Medicine; Prostatectomy; Nomogram; Prostate cancer; Interquartile range; Concordance; Adjuvant therapy; Internal medicine; Cohort; Oncology; Surgical margin; Biochemical recurrence; Prostate-specific antigen; Odds ratio; Metastasis; Population; Logistic regression; Surgery; Cancer","score_opus":0.009293437693236496,"score_gpt":0.22303810083397127,"score_spread":0.2137446631407348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990786792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959391,0.0012605633,0.000030136634,0.0003459416,0.0002697604,0.0014214256,0.0006274933,0.00004620657,0.000059392987],"genre_scores_gemma":[0.99635917,0.0016949011,0.00015698357,0.0008906202,0.00005457787,0.00046575972,0.0002053456,0.00008423528,0.00008838784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973193,0.0008640249,0.00065522897,0.0005554448,0.00023202096,0.0003740047],"domain_scores_gemma":[0.998768,0.00020981327,0.00040265056,0.00031970246,0.00008005715,0.000219809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053746597,0.00027428323,0.0005918498,0.00018906854,0.000036333633,0.000014040183,0.00008016976,0.00003419298,0.000050822455],"category_scores_gemma":[0.00019775314,0.00021367581,0.00010614433,0.00016479359,0.00027171042,0.000087386994,0.000054035296,0.00028034393,0.000020811187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058209808,0.0008598436,0.97113705,0.00009225558,0.000280646,0.00014437754,0.0010291925,0.000059380225,0.0006294941,0.0000063118177,0.0006357157,0.019304741],"study_design_scores_gemma":[0.0076642074,0.0012623364,0.9878377,0.0000906002,0.00025129647,0.000002084314,0.000018133047,0.00039877498,0.0005127514,0.000103677994,0.0016977295,0.0001607613],"about_ca_topic_score_codex":0.00024175488,"about_ca_topic_score_gemma":0.00002837231,"teacher_disagreement_score":0.01914398,"about_ca_system_score_codex":0.00013030457,"about_ca_system_score_gemma":0.000119818134,"threshold_uncertainty_score":0.8713447},"labels":[],"label_agreement":null},{"id":"W1990894210","doi":"10.1159/000020356","title":"Prostate Volume and Serum Prostate–Specific Antigen as Predictors of Acute Urinary Retention","year":2000,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Finasteride; Medicine; Urology; Prostate; Prostate cancer; Urinary retention; Prostate-specific antigen; Placebo; Lower urinary tract symptoms; Incidence (geometry); Urinary system; Internal medicine; Gynecology; Cancer; Pathology","score_opus":0.0187085725465021,"score_gpt":0.268987112527251,"score_spread":0.2502785399807489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990894210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9523925,0.0010981393,0.000006666018,0.0016504586,0.000118476564,0.00076395995,0.000110105495,0.00011493432,0.043744758],"genre_scores_gemma":[0.9566639,0.0059587723,0.00017353015,0.00024361875,0.00017188063,0.000009726244,0.00021546234,0.0000766509,0.036486477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762267,0.0005166383,0.00045232463,0.0005483696,0.00030629712,0.00055368495],"domain_scores_gemma":[0.99900365,0.00003678626,0.00009427502,0.00047924535,0.000121118974,0.00026489835],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006214929,0.00023408135,0.00036352684,0.00020475598,0.0001295092,0.000024336101,0.00014983596,0.00008407772,0.002271216],"category_scores_gemma":[0.000023676794,0.0002084972,0.00009006445,0.00025780138,0.00042863947,0.00014093495,0.00014451082,0.0004174761,0.0010565353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018994216,0.0015395178,0.7764271,0.0005928524,0.0012904886,0.0075953454,0.00890512,0.00002120408,0.056319308,0.00010575918,0.033469822,0.09473929],"study_design_scores_gemma":[0.0017468985,0.007169849,0.6114235,0.000026893924,0.000097591466,0.001511154,0.000034128723,0.000031340434,0.00030249325,0.000092181814,0.37740073,0.00016322016],"about_ca_topic_score_codex":0.000013923675,"about_ca_topic_score_gemma":6.446225e-7,"teacher_disagreement_score":0.3439309,"about_ca_system_score_codex":0.00001899177,"about_ca_system_score_gemma":0.00007370925,"threshold_uncertainty_score":0.9997212},"labels":[],"label_agreement":null},{"id":"W1991359895","doi":"10.1016/j.eururo.2013.05.048","title":"The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review","year":2013,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":362,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Prostate Cancer UK","keywords":"Medicine; Prostate cancer; Radiation therapy; Prostatectomy; Cancer; Prostate; Population; Perioperative; Biopsy; Surgery; Radiology; Internal medicine","score_opus":0.029206254253982974,"score_gpt":0.31671233501221807,"score_spread":0.2875060807582351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991359895","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013574918,0.98702466,6.238972e-7,0.0005551277,0.00007204428,0.009177815,0.000026416079,0.000010125378,0.0031195988],"genre_scores_gemma":[0.0002660606,0.9962781,0.000009761565,0.0006635221,0.000030459578,0.0025322507,0.00003035349,0.0000497609,0.00013970697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964004,0.001615423,0.0011976641,0.00028641926,0.0002381912,0.00026189256],"domain_scores_gemma":[0.99784553,0.00030978184,0.00084536814,0.0008844275,0.00007396603,0.000040947838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011855206,0.00031054855,0.0021447858,0.000060898783,0.000032888238,0.000008788456,0.00045531776,0.000046345336,0.000029958881],"category_scores_gemma":[0.000024641824,0.0001257821,0.00037083225,0.00027113326,0.00015345286,0.0000135944765,0.00008536825,0.00024000941,0.000047671565],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019231687,0.00012923333,0.000013231932,0.46855924,0.0008087839,0.000078038305,0.00010968396,2.3973618e-7,6.801314e-8,0.00030244948,0.00046976146,0.52951],"study_design_scores_gemma":[0.00053844287,0.0006723975,0.00004452515,0.26710787,0.0033841701,0.000040966595,0.000046579684,0.0000016048019,8.192891e-7,0.000022781946,0.72804916,0.00009068134],"about_ca_topic_score_codex":0.00003359597,"about_ca_topic_score_gemma":0.0000038168914,"teacher_disagreement_score":0.7275794,"about_ca_system_score_codex":0.00006561259,"about_ca_system_score_gemma":0.00008817092,"threshold_uncertainty_score":0.5129245},"labels":[],"label_agreement":null},{"id":"W1991491869","doi":"10.1016/j.eururo.2014.05.036","title":"Positive Surgical Margins: Race or Surgeon?","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Race (biology); General surgery; Surgery","score_opus":0.021168953435851918,"score_gpt":0.26565094162367164,"score_spread":0.24448198818781972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991491869","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029967793,0.0015390054,0.000017978688,0.90225995,0.0007934055,0.00063959573,0.0001129901,0.00014830397,0.091491975],"genre_scores_gemma":[0.016179444,0.0011881256,0.00006647742,0.95102334,0.0066306796,0.00004791284,0.001523196,0.0002058709,0.023134964],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99699795,0.00093245687,0.00040435334,0.0007761247,0.00025006285,0.0006390265],"domain_scores_gemma":[0.99820817,0.00068940496,0.00020018307,0.00064202904,0.00010230028,0.00015790618],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032703072,0.00045478245,0.0008921021,0.00015537524,0.000072138304,0.000024503028,0.00018323601,0.00034872864,0.0016108439],"category_scores_gemma":[0.00009151028,0.0003180884,0.00025784763,0.00010467598,0.00018790812,0.00002413328,0.00013476971,0.0014238635,0.0027149734],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004886994,0.00010013735,0.0012925244,0.00007184909,0.00032380325,0.10042569,0.000058987276,6.8316797e-7,0.0000028135128,0.000025772526,0.8947023,0.0025067148],"study_design_scores_gemma":[0.0023371354,0.0022040843,0.010695632,0.000080903046,0.00043532177,0.0030451736,0.0000021995627,0.0000041414687,0.000019798483,0.000010714096,0.9808815,0.0002833888],"about_ca_topic_score_codex":0.000023587043,"about_ca_topic_score_gemma":0.0000024618787,"teacher_disagreement_score":0.09738052,"about_ca_system_score_codex":0.000116888354,"about_ca_system_score_gemma":0.00012099985,"threshold_uncertainty_score":0.9999271},"labels":[],"label_agreement":null},{"id":"W1991832547","doi":"10.1159/000052420","title":"Long–Term Effectiveness of Sacral Nerve Stimulation for Refractory Urge Incontinence","year":2001,"lang":"en","type":"article","venue":"European Urology","topic":"Pelvic floor disorders treatments","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Royal Victoria Hospital; Toronto Western Hospital","funders":"","keywords":"Medicine; Urinary incontinence; Sacral nerve stimulation; Surgery; Refractory (planetary science); Percutaneous; Urge incontinence; Stimulation; Urinary system; Lumbosacral plexus; Urology; Internal medicine","score_opus":0.021473391930305515,"score_gpt":0.2949494742270881,"score_spread":0.2734760822967826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991832547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98806995,0.00037178688,0.0051065623,0.00013400757,0.00022666466,0.00060633186,0.0000108249415,0.000069240385,0.005404608],"genre_scores_gemma":[0.9983516,0.000023008255,0.00043242937,0.00019854534,0.00010776555,0.000016847489,0.00017113953,0.00004694633,0.00065172923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985845,0.00042575094,0.00028566844,0.0003204136,0.00011627481,0.00026740305],"domain_scores_gemma":[0.9989157,0.00037554558,0.00014678105,0.00035828532,0.00011856866,0.000085172345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004673605,0.00016548447,0.00033914225,0.00012304247,0.000043493426,0.0000042449087,0.00010977441,0.00006577833,0.00008968044],"category_scores_gemma":[0.00037345142,0.00015087076,0.00010883758,0.00012181879,0.00011306754,0.00006967952,0.00005414468,0.00011891242,0.00011130535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055142143,0.00087175827,0.9478283,0.00023389388,0.00021321645,0.00029792252,0.00025889406,0.00015263635,0.029560281,0.00007523609,0.00040112596,0.014592516],"study_design_scores_gemma":[0.006186588,0.0013913844,0.984866,0.000045133907,0.0001667422,0.00009404281,0.0000035614964,0.00015304542,0.000297681,0.00008416289,0.006596703,0.00011493452],"about_ca_topic_score_codex":0.00001962865,"about_ca_topic_score_gemma":0.000013926039,"teacher_disagreement_score":0.037037715,"about_ca_system_score_codex":0.00004350985,"about_ca_system_score_gemma":0.00003601435,"threshold_uncertainty_score":0.6152331},"labels":[],"label_agreement":null},{"id":"W1992242899","doi":"10.1016/j.eururo.2014.07.023","title":"Reply to Marc Bjurlin, Elena Elkin, and William Huang's Letter to the Editor re: Maxine Sun, Andreas Becker, Zhe Tian, et al. Management of Localized Kidney Cancer: Calculating Cancer-specific Mortality and Competing Risks of Death for Surgery and Nonsurgical Management. Eur Urol 2014;65:235–41","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Cancer; Tian; Kidney cancer; Gerontology; Internal medicine; Literature","score_opus":0.07250835637253691,"score_gpt":0.32316587763048393,"score_spread":0.25065752125794705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992242899","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18462087,0.00949356,0.001423647,0.79235315,0.002608942,0.006028223,0.0007322638,0.00011628632,0.0026230505],"genre_scores_gemma":[0.086308345,0.00740232,0.0027605558,0.89276856,0.00796189,0.0005095903,0.00068852794,0.00038016122,0.0012200765],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99446946,0.001239842,0.0012970817,0.0015230502,0.0006468959,0.00082365616],"domain_scores_gemma":[0.99663246,0.0008341182,0.00074386405,0.0011451951,0.00024820433,0.00039617255],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002524346,0.00075284304,0.0015993043,0.0003441473,0.00016266065,0.00005290002,0.00030720906,0.00021945908,0.00008146401],"category_scores_gemma":[0.00012235671,0.0005740232,0.00024689973,0.00021802884,0.00032479689,0.00004682293,0.00061746745,0.0008459835,0.000009415842],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010745178,0.00006933988,0.035366043,0.001537388,0.0010887677,0.001297456,0.00013678243,0.000041956417,0.000094656985,0.000020553387,0.95506346,0.004209057],"study_design_scores_gemma":[0.0024290981,0.0005217594,0.09472212,0.00054083247,0.0012500231,0.00009267549,0.000019565618,0.000097607735,0.000054248045,0.0000057463517,0.89984655,0.0004197441],"about_ca_topic_score_codex":0.0007878706,"about_ca_topic_score_gemma":0.000054092936,"teacher_disagreement_score":0.10041537,"about_ca_system_score_codex":0.0001064086,"about_ca_system_score_gemma":0.000050133327,"threshold_uncertainty_score":0.9996711},"labels":[],"label_agreement":null},{"id":"W1992312512","doi":"10.1016/j.eururo.2006.11.004","title":"Advanced Age Is Associated with Poorer Bladder Cancer-Specific Survival in Patients Treated with Radical Cystectomy","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; Urothelial cancer; Oncology; Cancer; Internal medicine","score_opus":0.01021228672030671,"score_gpt":0.2268626580059223,"score_spread":0.2166503712856156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992312512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96572226,0.0002879485,0.000014787764,0.00042321475,0.00009718003,0.00056020153,0.0000616014,0.00012223529,0.03271058],"genre_scores_gemma":[0.9967656,0.000027802507,0.000054499837,0.0011043153,0.00013430245,0.00003273398,0.0002417951,0.00011044342,0.0015284729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997959,0.00031606588,0.00031485668,0.0005609411,0.00032266628,0.00052642997],"domain_scores_gemma":[0.99927574,0.00005203987,0.00012384406,0.0003123472,0.00010645471,0.00012955916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010905402,0.00032329638,0.000511614,0.00014791517,0.00006383257,0.000014933209,0.00011592158,0.00008752692,0.0003959274],"category_scores_gemma":[0.000013689883,0.00022577241,0.000054948927,0.00040350904,0.00021724505,0.00005733505,0.000029284338,0.00030902782,0.00007590375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004341832,0.0009701583,0.98774475,0.000008043475,0.00027787036,0.0024084444,0.00019374276,0.00005039839,0.00021988041,0.000023626804,0.0016248834,0.0021363646],"study_design_scores_gemma":[0.022268768,0.0030141172,0.9617378,0.000046042052,0.00016425866,0.00002161036,0.000011292363,0.0000073774995,0.00018621043,0.0000058598253,0.012296963,0.00023966709],"about_ca_topic_score_codex":0.00042501316,"about_ca_topic_score_gemma":0.0004622211,"teacher_disagreement_score":0.031182105,"about_ca_system_score_codex":0.00017111844,"about_ca_system_score_gemma":0.00007242639,"threshold_uncertainty_score":0.9206732},"labels":[],"label_agreement":null},{"id":"W1992328908","doi":"10.1016/j.eururo.2015.03.030","title":"Toward Optimal Prediction of Prognosis in T1 Urothelial Carcinoma of the Bladder","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Urothelial carcinoma; Urology; Oncology; Carcinoma; Internal medicine; Bladder cancer; Cancer","score_opus":0.043720574068286895,"score_gpt":0.25224740001852924,"score_spread":0.20852682595024236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992328908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45301208,0.0024508273,0.000055151326,0.41669136,0.003808233,0.004182542,0.0016671885,0.00013563246,0.11799698],"genre_scores_gemma":[0.9226776,0.000031167838,0.00008900042,0.07309748,0.0022387165,0.000036225072,0.00014149096,0.000119799784,0.0015685456],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99762785,0.00061828655,0.00059553044,0.00041843244,0.0004069004,0.0003330017],"domain_scores_gemma":[0.9988966,0.00005180814,0.0003076021,0.00051767327,0.00017058112,0.000055765544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027992664,0.0002959826,0.0006313729,0.00019838157,0.000018612032,0.0000040680065,0.00031764433,0.00034234428,0.0001653786],"category_scores_gemma":[0.00009411959,0.00020579071,0.00022443564,0.0001969989,0.0002997782,0.000027762733,0.00015558345,0.0010460854,0.000037499296],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009307428,0.0003852027,0.11574247,0.00038727224,0.00049894856,0.001242956,0.0017978224,0.000029037923,0.00056380493,0.000009264028,0.8769919,0.0014205441],"study_design_scores_gemma":[0.0077684084,0.0051272963,0.30613887,0.00015659594,0.0014482121,0.00057143567,0.00005035334,0.000060643197,0.0019650257,0.000041806965,0.6763692,0.00030213114],"about_ca_topic_score_codex":0.00012923463,"about_ca_topic_score_gemma":0.000004098775,"teacher_disagreement_score":0.4696655,"about_ca_system_score_codex":0.0000712541,"about_ca_system_score_gemma":0.00034976963,"threshold_uncertainty_score":0.8391901},"labels":[],"label_agreement":null},{"id":"W1992508730","doi":"10.1016/s0302-2838(01)00039-2","title":"Androgen Replacement Therapy and Prostate Safety","year":2002,"lang":"en","type":"review","venue":"European Urology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston General Hospital","funders":"","keywords":"Medicine; Prostate cancer; Androgen; Testosterone (patch); Prostate; Androgen deprivation therapy; Oncology; Internal medicine; Dehydroepiandrosterone; Prostatectomy; Gynecology; Urology; Endocrinology; Cancer; Hormone","score_opus":0.07183160004409163,"score_gpt":0.3097750133597617,"score_spread":0.2379434133156701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992508730","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047417056,0.94631356,0.0000012970436,0.00044922397,0.00013769315,0.00083569996,0.000015460875,0.00005122273,0.052148424],"genre_scores_gemma":[0.000038889615,0.9908632,0.000036293488,0.00030395016,0.00048557887,0.000016781165,0.000041545823,0.000066205605,0.00814753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981729,0.00045201054,0.00040033265,0.00062124967,0.000104318504,0.00024918653],"domain_scores_gemma":[0.9992756,0.000054600398,0.00015687745,0.00037841557,0.00004648912,0.000088001696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041339902,0.00031472987,0.0012042915,0.00009006519,0.000092824164,0.0000063578827,0.00007216668,0.0000650289,0.00011042164],"category_scores_gemma":[0.00006470183,0.00018736794,0.00016739509,0.000099025376,0.00021127956,0.000012123975,0.00014903797,0.00033742623,0.00034712953],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001418333,0.000059977978,0.000045887264,0.0011086053,0.00049134844,0.00027054726,0.0001873117,2.0472752e-8,4.5111568e-7,0.00003674358,0.0020709366,0.99558634],"study_design_scores_gemma":[0.0006183195,0.001090396,0.00040591587,0.00029974268,0.00040037156,0.0007008678,0.000007909282,2.1931343e-7,2.0620814e-7,0.00000527077,0.9963073,0.00016347389],"about_ca_topic_score_codex":0.0000010335748,"about_ca_topic_score_gemma":2.1855126e-7,"teacher_disagreement_score":0.99542284,"about_ca_system_score_codex":0.000020985643,"about_ca_system_score_gemma":0.000026582977,"threshold_uncertainty_score":0.7640643},"labels":[],"label_agreement":null},{"id":"W1993222946","doi":"10.1016/j.eururo.2012.06.029","title":"Impact of Smoking on Oncologic Outcomes of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Urothelial carcinoma; Smoking cessation; Logistic regression; Retrospective cohort study; Risk factor; Lymph node; Internal medicine; Odds ratio; Cancer; Urology; Surgery; Bladder cancer; Pathology","score_opus":0.02577046879959099,"score_gpt":0.3120124866048538,"score_spread":0.2862420178052628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993222946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785183,0.00036864294,0.000019014902,0.0002144836,0.0002921917,0.0002719905,0.0000414758,0.0000299991,0.020243898],"genre_scores_gemma":[0.9980669,0.000011630955,0.00012742881,0.001212796,0.00035360453,0.000009087802,0.0000108790055,0.000049713333,0.00015795654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984505,0.00036779206,0.00036408025,0.00021583537,0.00019542372,0.00040637143],"domain_scores_gemma":[0.99914557,0.00015041353,0.00014426968,0.00033815095,0.000039348954,0.0001822357],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002546126,0.00022646057,0.00054934603,0.00014458636,0.000022643715,0.0000028331515,0.00011323844,0.00009558498,0.0011451915],"category_scores_gemma":[0.00009079275,0.0001490406,0.00036246586,0.000087054854,0.00018117984,0.00005136479,0.0000468932,0.0002541512,0.00007664992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019597684,0.000910087,0.99161017,0.00001645209,0.0002753515,0.00012333078,0.0005490469,0.0000019418032,0.0012378581,0.000034492987,0.00025034836,0.0030311807],"study_design_scores_gemma":[0.0034563178,0.005196026,0.98743546,0.0000098210485,0.0002928134,0.00014415577,0.000008783438,0.0000023006232,0.0005976947,0.000010269471,0.002740467,0.00010591944],"about_ca_topic_score_codex":0.000066646964,"about_ca_topic_score_gemma":6.7090326e-7,"teacher_disagreement_score":0.020085942,"about_ca_system_score_codex":0.00007607953,"about_ca_system_score_gemma":0.000082001614,"threshold_uncertainty_score":0.9997679},"labels":[],"label_agreement":null},{"id":"W1994847620","doi":"10.1016/j.eururo.2005.12.027","title":"Substaging Pathologically Organ Confined (pT2) Prostate Cancer: An Exercise in Futility?","year":2006,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Cystoprostatectomy; Cystectomy; Metastasis; Prostatectomy; Urology; Renal sinus; Prostate; Prostate cancer; Perineural invasion; Pathology; Bladder cancer; Nephrectomy; Cancer; Kidney; Internal medicine","score_opus":0.018786042990268755,"score_gpt":0.25841687075511116,"score_spread":0.2396308277648424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994847620","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49515712,0.0085601425,0.0000082069455,0.48160955,0.00089330366,0.002431807,0.00044675326,0.0004206813,0.010472431],"genre_scores_gemma":[0.3935122,0.003835145,0.00020726147,0.5916902,0.0020072758,0.0003925984,0.004217442,0.00034959833,0.0037883064],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961007,0.00067639607,0.0007418573,0.0012581222,0.00027621866,0.0009466606],"domain_scores_gemma":[0.9984542,0.00009290581,0.00029182975,0.00086009316,0.00013909783,0.0001618574],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004245279,0.0006209517,0.0010790159,0.0003018736,0.00007562761,0.000044893317,0.0002956187,0.00040682263,0.0005948748],"category_scores_gemma":[0.00003526611,0.0005170989,0.0001521737,0.00024926843,0.00026516392,0.00006819496,0.00013066985,0.0017602079,0.0002101514],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007434357,0.0008515521,0.20686431,0.00054671016,0.00014099867,0.10098864,0.0009313677,0.000040682415,0.00033975497,0.00001720813,0.643262,0.045273285],"study_design_scores_gemma":[0.0034654934,0.0012858511,0.3197057,0.00027093472,0.00036536355,0.00012243076,0.000015565274,0.000019915515,0.00010666626,0.00008997247,0.6740407,0.00051143375],"about_ca_topic_score_codex":0.0003621074,"about_ca_topic_score_gemma":0.0001265182,"teacher_disagreement_score":0.11284139,"about_ca_system_score_codex":0.0002415646,"about_ca_system_score_gemma":0.00020883624,"threshold_uncertainty_score":0.9997281},"labels":[],"label_agreement":null},{"id":"W1994940252","doi":"10.1016/j.eururo.2013.02.038","title":"Obesity Is Associated with Increased Prostate Growth and Attenuated Prostate Volume Reduction by Dutasteride","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Dutasteride; Medicine; Prostate cancer; Urology; Body mass index; Prostate; Placebo; Prostate biopsy; Obesity; Internal medicine; Gynecology; Cancer; Pathology","score_opus":0.006434708737950489,"score_gpt":0.19790668807770584,"score_spread":0.19147197933975535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994940252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99065244,0.00038120808,0.000008196322,0.0059558693,0.000063805346,0.0010765023,0.000101304264,0.0001395619,0.0016210813],"genre_scores_gemma":[0.99553365,0.00027020628,0.000060154412,0.0023074846,0.000046584795,0.00008546535,0.00040085329,0.00006353617,0.0012320506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984175,0.00028553102,0.0002627398,0.0004967193,0.00014537576,0.00039214155],"domain_scores_gemma":[0.99911696,0.00003253261,0.00017443001,0.00022652377,0.00021629274,0.00023326249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017522226,0.0002444158,0.00033615573,0.00007013196,0.00011074198,0.00004506544,0.000054557997,0.000050957497,0.00014760991],"category_scores_gemma":[0.00008824993,0.00018717936,0.000030939722,0.00019663686,0.00020492548,0.00014674624,0.00006158257,0.00019295882,0.00021217427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010970737,0.0011421635,0.8587473,0.000099620425,0.0007577149,0.00069518527,0.0018734774,0.0000020629607,0.038203273,0.00001351785,0.091625996,0.0057426263],"study_design_scores_gemma":[0.0054832627,0.0045970543,0.97812474,0.00007046325,0.0003110753,0.00033493535,0.000062193016,0.00012156712,0.006184432,0.00004732838,0.0043724035,0.00029055917],"about_ca_topic_score_codex":0.00035055712,"about_ca_topic_score_gemma":0.0000045816023,"teacher_disagreement_score":0.119377434,"about_ca_system_score_codex":0.00006709716,"about_ca_system_score_gemma":0.00004865602,"threshold_uncertainty_score":0.7632953},"labels":[],"label_agreement":null},{"id":"W1995025521","doi":"10.1016/j.eururo.2007.06.048","title":"Daily Administration of Phosphodiesterase Type 5 Inhibitors for Urological and Nonurological Indications","year":2007,"lang":"en","type":"review","venue":"European Urology","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; St Joseph's Health Care; University of Ottawa","funders":"","keywords":"Medicine; Sildenafil; Dosing; Erectile dysfunction; cGMP-specific phosphodiesterase type 5; Intensive care medicine; Tadalafil; MEDLINE; Radical retropubic prostatectomy; Pharmacology; Prostatectomy; Internal medicine; Prostate cancer","score_opus":0.04872011665052495,"score_gpt":0.33104157231863757,"score_spread":0.2823214556681126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995025521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029967937,0.99202913,0.0021172296,0.00008219663,0.0005803362,0.00072865514,0.00007744734,0.000029399718,0.0013588017],"genre_scores_gemma":[0.022431994,0.97357506,0.0006078482,0.00047269795,0.0005547913,0.000036658806,0.0018267952,0.000063814514,0.00043034978],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981119,0.0003547528,0.00064714754,0.0005561339,0.000085689324,0.00024438923],"domain_scores_gemma":[0.99886715,0.00014208865,0.00044686353,0.00032800785,0.000110091576,0.00010577517],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005549485,0.0003072443,0.00058604014,0.00012128012,0.000093709474,0.000015520056,0.00017881964,0.0004653814,0.000020051602],"category_scores_gemma":[0.00033492502,0.00024624457,0.00020790462,0.00013096954,0.00030393372,0.0000038574626,0.00013855929,0.00020322268,0.000016961632],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001389138,0.00038480092,0.00021944041,0.0017173459,0.00034526855,0.000038962637,0.00006208126,0.000006992116,0.0008223184,0.00088739104,0.006915657,0.98721063],"study_design_scores_gemma":[0.00033372617,0.0021785412,0.00039557854,0.000051647807,0.00024694455,0.0001567407,0.0000041233643,0.0000038446833,0.000099432604,0.000022124119,0.9962855,0.00022180249],"about_ca_topic_score_codex":5.3542607e-7,"about_ca_topic_score_gemma":0.000002588897,"teacher_disagreement_score":0.9893698,"about_ca_system_score_codex":0.000008544404,"about_ca_system_score_gemma":0.000105356245,"threshold_uncertainty_score":0.999999},"labels":[],"label_agreement":null},{"id":"W1996199735","doi":"10.1016/j.eururo.2011.10.011","title":"Clinical Nodal Staging Scores for Bladder Cancer: A Proposal for Preoperative Risk Assessment","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University; Université de Montréal; McGill University Health Centre; Université Laval","funders":"","keywords":"Medicine; Bladder cancer; Risk assessment; General surgery; Urology; Cancer; Oncology; Surgery; Internal medicine","score_opus":0.06342455850407365,"score_gpt":0.3796507864853996,"score_spread":0.316226227981326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996199735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79003966,0.0014144912,0.09621772,0.005570103,0.003979784,0.011761495,0.0013632535,0.00050615345,0.08914732],"genre_scores_gemma":[0.9651648,0.0001587691,0.029295627,0.0023818344,0.0010628067,0.00044486808,0.00005168631,0.00009604634,0.0013435952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819446,0.0003557295,0.0004206748,0.0005246983,0.000105950436,0.00039847786],"domain_scores_gemma":[0.99901575,0.00017921106,0.00015915194,0.00028354404,0.00019986992,0.00016244603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059235905,0.00021220156,0.00039337305,0.000058690457,0.00015510633,0.00001430411,0.00013206166,0.00006589154,0.0002822909],"category_scores_gemma":[0.00014527637,0.00016152218,0.00019878158,0.00005133808,0.0001748496,0.000063022424,0.00006117002,0.00024629635,0.00003248264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056794095,0.0011776184,0.9112597,0.00009978518,0.0015911983,0.00009699948,0.0023533076,0.0000078709045,0.00020930248,0.0024095653,0.012194344,0.06292087],"study_design_scores_gemma":[0.016196748,0.015809586,0.9131316,0.00003666596,0.0019399677,0.00003437585,0.00015073463,0.0010324419,0.00066945085,0.0013859321,0.049218077,0.00039439928],"about_ca_topic_score_codex":0.00009733124,"about_ca_topic_score_gemma":0.00006241769,"teacher_disagreement_score":0.17512509,"about_ca_system_score_codex":0.00004619864,"about_ca_system_score_gemma":0.00048190268,"threshold_uncertainty_score":0.65866834},"labels":[],"label_agreement":null},{"id":"W1997151992","doi":"10.1016/j.eururo.2009.11.021","title":"Re: XMRV Is Present in Malignant Prostate Epithelium and Is Associated With Prostate Cancer, Especially High-grade Tumors","year":2009,"lang":"en","type":"letter","venue":"European Urology","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Prostate cancer; Prostate; Epithelium; Oncology; Cancer; Urology; Internal medicine; Pathology","score_opus":0.014773416433783541,"score_gpt":0.2511045857184922,"score_spread":0.23633116928470865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997151992","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24423674,0.0014456145,0.0000025782304,0.7373299,0.0003735366,0.002268767,0.000571765,0.00020088816,0.013570224],"genre_scores_gemma":[0.16126907,0.0019939009,0.000112458336,0.7813655,0.0021940828,0.00016036857,0.0007380496,0.00035503405,0.051811505],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966666,0.0006201273,0.0005854189,0.0009632612,0.00033775563,0.000826827],"domain_scores_gemma":[0.9987345,0.00009252184,0.00037828414,0.0005275891,0.000119549244,0.00014756863],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030417362,0.0005850673,0.00089079916,0.0003604082,0.0001148682,0.000050840612,0.0001428957,0.00033240908,0.00033718924],"category_scores_gemma":[0.000043043106,0.00044101095,0.000091765214,0.00033188632,0.00022909803,0.00005806068,0.00009118232,0.0015449432,0.00010894016],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000591056,0.0004626446,0.021354519,0.00008324238,0.000737817,0.03299328,0.0016121622,0.000013344216,0.000023341272,0.000004280798,0.9307063,0.01141798],"study_design_scores_gemma":[0.0042982902,0.0019918643,0.0813057,0.00030990483,0.00038978425,0.00018936863,0.000009584083,0.000013301629,0.00008501481,0.000067515,0.91093135,0.00040833614],"about_ca_topic_score_codex":0.0007447609,"about_ca_topic_score_gemma":0.00039119885,"teacher_disagreement_score":0.08296767,"about_ca_system_score_codex":0.00021614894,"about_ca_system_score_gemma":0.00023574797,"threshold_uncertainty_score":0.99980414},"labels":[],"label_agreement":null},{"id":"W1998068623","doi":"10.1016/j.eururo.2007.01.108","title":"Percentage of Positive Biopsy Cores Can Improve the Ability to Predict Lymph Node Invasion in Patients Undergoing Radical Prostatectomy and Extended Pelvic Lymph Node Dissection","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Nomogram; Lymphadenectomy; Urology; Biopsy; Lymph node; Stage (stratigraphy); Radical retropubic prostatectomy; Logistic regression; T-stage; Dissection (medical); Prostate cancer; Surgery; Radiology; Cancer; Internal medicine","score_opus":0.007945495778567986,"score_gpt":0.2435547817051655,"score_spread":0.23560928592659752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998068623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968693,0.00013781048,0.000103971906,0.0007684402,0.00017265842,0.0009520788,0.00006048961,0.000029122582,0.00090611144],"genre_scores_gemma":[0.998743,0.000080105296,0.00009568838,0.0008984035,0.00005361016,0.000019316021,0.000067433204,0.00003082058,0.000011637571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983803,0.00026922446,0.00038324934,0.00044959827,0.00017895382,0.00033868867],"domain_scores_gemma":[0.99913,0.00024947873,0.00010833938,0.00027821516,0.000068447516,0.00016552447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050856057,0.00018469173,0.00027379472,0.00012356663,0.000081924605,0.000010883418,0.00007841084,0.00005251067,0.000013331824],"category_scores_gemma":[0.00019572482,0.0001283075,0.000050468392,0.00014410567,0.00022339846,0.000041341926,0.00012154814,0.00013674854,0.000005584273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002032925,0.0006725332,0.9797235,0.00007618423,0.000043380092,0.00013350703,0.0013466366,0.000011835421,0.007412254,0.000039330534,0.00001511993,0.008492811],"study_design_scores_gemma":[0.0051382557,0.0014865766,0.9905617,0.00008171359,0.00007367301,0.00004590024,0.00018623995,0.000045972105,0.0022194453,0.000032993416,0.000027445765,0.00010005824],"about_ca_topic_score_codex":0.00023734118,"about_ca_topic_score_gemma":0.0000747773,"teacher_disagreement_score":0.010838242,"about_ca_system_score_codex":0.00030059097,"about_ca_system_score_gemma":0.00007639291,"threshold_uncertainty_score":0.5232228},"labels":[],"label_agreement":null},{"id":"W1998583412","doi":"10.1016/j.eururo.2013.12.033","title":"Re: Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Computational biology; Evolutionary biology","score_opus":0.011723250444577695,"score_gpt":0.21832025435841498,"score_spread":0.20659700391383728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998583412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59503406,0.01574004,0.018078906,0.35836124,0.0027707838,0.0013144591,0.00054064597,0.0001686855,0.007991184],"genre_scores_gemma":[0.57705826,0.00043529077,0.0001557571,0.4160668,0.004216396,0.000011468096,0.0014898424,0.00012070929,0.00044547094],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977657,0.00056394265,0.00033262206,0.0008132172,0.00009799577,0.00042650118],"domain_scores_gemma":[0.9989284,0.00006591645,0.0002465755,0.00060440565,0.000067875815,0.0000868071],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032138542,0.00035082726,0.00032055227,0.000056151042,0.00009959307,0.00003980749,0.00027117014,0.00052101916,0.0000071957465],"category_scores_gemma":[0.00024575446,0.0003785015,0.000101923055,0.000041881412,0.00019197926,0.0000022978074,0.0002252698,0.00063190924,0.000039188733],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051157585,0.0000083771165,0.0002688728,0.000041807685,0.000053146483,0.000086440945,0.000015859123,0.000032258577,0.053685065,0.000005233707,0.9453294,0.00042235263],"study_design_scores_gemma":[0.0006674377,0.00042835495,0.00061035383,0.000012375283,0.00007450066,0.00013975332,0.000003649835,0.00010793238,0.001121109,0.000037124864,0.99635535,0.0004420399],"about_ca_topic_score_codex":0.000037197344,"about_ca_topic_score_gemma":0.00005477382,"teacher_disagreement_score":0.057705566,"about_ca_system_score_codex":0.000058054527,"about_ca_system_score_gemma":0.000068268746,"threshold_uncertainty_score":0.99986666},"labels":[],"label_agreement":null},{"id":"W1998628385","doi":"10.1016/j.eururo.2011.06.041","title":"Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review","year":2011,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":331,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Disease; Oncology; Internal medicine; MEDLINE; Stage (stratigraphy); Natural history; Clinical significance; Carcinoma; Pathology","score_opus":0.1062311787085082,"score_gpt":0.28351132202892954,"score_spread":0.17728014332042133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998628385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008103734,0.926802,0.0000161178,0.000027246095,0.000099518744,0.003172329,0.00006561873,0.00005375797,0.068953075],"genre_scores_gemma":[0.050057728,0.9483456,0.000043251122,0.00026846363,0.00010486918,0.000115220995,0.00047507786,0.00016905453,0.00042071976],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99565154,0.001689289,0.0010517288,0.0009741777,0.00017481837,0.00045847055],"domain_scores_gemma":[0.99813426,0.00029760852,0.0004984582,0.0006863822,0.00006766413,0.00031563902],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050998473,0.0007815042,0.0029128324,0.00036689872,0.000034869445,0.000008677639,0.00023595031,0.00022507262,0.00005987006],"category_scores_gemma":[0.00012662454,0.0005317378,0.00041724028,0.00024768343,0.00019705914,0.000069925256,0.0002638202,0.00092410675,0.00013814589],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009823815,0.0030262978,0.030745976,0.4949351,0.0017999732,0.055851158,0.0028779479,0.000003222911,0.000004357358,0.00025631062,0.021015676,0.3885016],"study_design_scores_gemma":[0.0014994494,0.0036688717,0.008525795,0.021074222,0.005203209,0.0014151937,0.000010426789,0.000013425761,0.0000012348579,0.000027538521,0.9579399,0.0006207109],"about_ca_topic_score_codex":0.000034335582,"about_ca_topic_score_gemma":0.000002006994,"teacher_disagreement_score":0.9369242,"about_ca_system_score_codex":0.000121518045,"about_ca_system_score_gemma":0.00039108717,"threshold_uncertainty_score":0.9997134},"labels":[],"label_agreement":null},{"id":"W1999879391","doi":"10.1016/j.eururo.2006.07.021","title":"Initial Biopsy Outcome Prediction—Head-to-Head Comparison of a Logistic Regression-Based Nomogram versus Artificial Neural Network","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Prostate cancer; Logistic regression; Biopsy; Rectal examination; Prostate; Radiology; Oncology; Cancer; Internal medicine","score_opus":0.11312724373437393,"score_gpt":0.38237374248178096,"score_spread":0.269246498747407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999879391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98866963,0.00053077843,0.00092471624,0.0021764608,0.0020588893,0.00055062014,0.000102200866,0.00015577218,0.004830945],"genre_scores_gemma":[0.99718684,0.000003001298,0.0006111042,0.0007113035,0.0011431648,0.000029099534,0.00023548793,0.00004315945,0.000036841502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802196,0.00026736458,0.00068481173,0.00040086938,0.0002005528,0.0004244601],"domain_scores_gemma":[0.9988958,0.00027555387,0.00019585332,0.00037400617,0.000094668285,0.0001640968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019938327,0.00022965748,0.00051013957,0.00012734154,0.00010130268,0.000013110793,0.000112699,0.000073188625,0.000105907835],"category_scores_gemma":[0.0001283847,0.00018553634,0.00013875142,0.00026203928,0.00019557652,0.000020443274,0.00005716264,0.00023845011,0.00012099614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007191012,0.0017493668,0.9319731,0.000062948966,0.000111323614,0.0010057534,0.00008171056,0.033968553,0.0005151098,0.00035323153,0.007374028,0.01561384],"study_design_scores_gemma":[0.006643047,0.0092889285,0.9601832,0.00008240891,0.0004907129,0.00004592821,0.000018959168,0.009692866,0.000440182,0.0000610606,0.012806367,0.00024632728],"about_ca_topic_score_codex":0.000086655054,"about_ca_topic_score_gemma":0.00008486674,"teacher_disagreement_score":0.028210092,"about_ca_system_score_codex":0.00006887762,"about_ca_system_score_gemma":0.00005916372,"threshold_uncertainty_score":0.75659525},"labels":[],"label_agreement":null},{"id":"W2000102387","doi":"10.1016/j.eururo.2006.12.010","title":"Prediction of Pathological Stage is Inaccurate in Men with PSA Values above 20ng/mL","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Stage (stratigraphy); Pathological; Urology; Internal medicine","score_opus":0.02244807875055826,"score_gpt":0.24992115342224158,"score_spread":0.22747307467168332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000102387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93623537,0.00059573585,0.00006783702,0.0010632867,0.0000412862,0.00028464457,0.00008069195,0.00004071697,0.061590422],"genre_scores_gemma":[0.9978349,0.00024599346,0.00019321028,0.0006700612,0.00008315308,0.000016507189,0.000059593804,0.000020320278,0.000876217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989929,0.00017170093,0.00026158974,0.00027154654,0.00010602221,0.00019622427],"domain_scores_gemma":[0.9995614,0.000041948253,0.00010389047,0.00020350248,0.00004588324,0.000043332577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020196517,0.0001210592,0.00024500882,0.000077649165,0.000019466965,0.000004348991,0.00005061127,0.000039893417,0.00015331902],"category_scores_gemma":[0.00001828606,0.000083057006,0.0000339913,0.000112416965,0.00011678584,0.00003709351,0.00003420061,0.0001263035,0.000037530837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010205947,0.00087392365,0.98040515,0.00004512928,0.00006754423,0.0022569671,0.00062314037,0.00017260501,0.0028249263,0.0006666652,0.008861146,0.0021822078],"study_design_scores_gemma":[0.0029420839,0.0034149608,0.98287445,0.000023044084,0.00006691586,0.000050989802,0.00004995834,0.00010432907,0.0018718017,0.00013072905,0.008405521,0.00006519876],"about_ca_topic_score_codex":0.000072805284,"about_ca_topic_score_gemma":0.000010674593,"teacher_disagreement_score":0.061599568,"about_ca_system_score_codex":0.00004495948,"about_ca_system_score_gemma":0.000025658437,"threshold_uncertainty_score":0.33869666},"labels":[],"label_agreement":null},{"id":"W2000215414","doi":"10.1016/j.eururo.2012.05.023","title":"Mapping of Pain Phenotypes in Female Patients with Bladder Pain Syndrome/Interstitial Cystitis and Controls","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen's University","funders":"","keywords":"Interstitial cystitis; Medicine; Bladder Pain Syndrome; Phenotype; Urology; Internal medicine; Urinary system; Gene","score_opus":0.013927986644972115,"score_gpt":0.2387058797145244,"score_spread":0.2247778930695523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000215414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904113,0.0007312914,0.0011932256,0.00032974422,0.0000500066,0.00036035848,0.000014241277,0.000019528305,0.0068902937],"genre_scores_gemma":[0.9988806,0.000018936074,0.0002032626,0.00060969224,0.000068605426,0.00000502749,0.00003431214,0.000028029142,0.00015150975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790376,0.0011776288,0.00021835214,0.0001804296,0.00013974213,0.00038008977],"domain_scores_gemma":[0.99930155,0.0003058516,0.000053670916,0.00015350479,0.00005024851,0.00013515065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015675024,0.00011669492,0.00026572525,0.00017209086,0.000028980565,0.000005781964,0.00006214477,0.000036108242,0.00019838513],"category_scores_gemma":[0.0002662508,0.00009297143,0.00002399304,0.000114242335,0.00017470852,0.00006737605,0.000067603825,0.00020314909,0.00002561682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010585237,0.0004224168,0.9765483,0.00012156577,0.00012377331,0.00050230563,0.0027119857,0.000005101907,0.00030411652,0.000056185785,0.0004271848,0.017718518],"study_design_scores_gemma":[0.0035847214,0.0042440696,0.98539466,0.000055487515,0.000025699697,0.000126002,0.00019604948,0.000091463786,0.000017391694,0.000011047883,0.0061391783,0.00011424015],"about_ca_topic_score_codex":0.000034300156,"about_ca_topic_score_gemma":0.000007451262,"teacher_disagreement_score":0.017604278,"about_ca_system_score_codex":0.000013096683,"about_ca_system_score_gemma":0.000020856005,"threshold_uncertainty_score":0.3791265},"labels":[],"label_agreement":null},{"id":"W2000500614","doi":"10.1016/j.eururo.2009.03.029","title":"Prostate Cancer Gene 3 (PCA3): Development and Internal Validation of a Novel Biopsy Nomogram","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Nomogram; Prostate cancer; PCA3; Biopsy; Prostate biopsy; Oncology; Prostate; Cancer; Internal medicine","score_opus":0.02193812286328415,"score_gpt":0.27608613671145293,"score_spread":0.25414801384816876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000500614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99428254,0.0009344928,0.00027779376,0.0015199624,0.000096225594,0.00024276644,0.000013913434,0.000025758227,0.0026065705],"genre_scores_gemma":[0.99569446,0.00029971777,0.0027917256,0.0008666333,0.00006497245,0.000013618057,0.000034053824,0.000013681682,0.00022116094],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99930364,0.00003183113,0.00022311755,0.00021030591,0.00007657285,0.00015456154],"domain_scores_gemma":[0.99965185,0.00001122885,0.00009684317,0.000112439186,0.00005015092,0.00007749098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012010085,0.000105326726,0.00017177565,0.00006792727,0.000025579182,0.0000069174557,0.000039400085,0.00002015426,0.000028544742],"category_scores_gemma":[0.000014259833,0.00008483265,0.000025152456,0.00006396142,0.000048171692,0.000025636302,0.000029962182,0.00006595468,0.00000938245],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010994372,0.0020489758,0.26861742,0.0001049202,0.0004730221,0.000588479,0.004646264,0.00010542751,0.117897004,0.00040309923,0.0009784392,0.60303754],"study_design_scores_gemma":[0.0038540156,0.0015894652,0.8913523,0.00006031023,0.000113009475,0.00021309724,0.000014434389,0.000055430934,0.079387404,0.00001991889,0.023207081,0.00013355151],"about_ca_topic_score_codex":0.000016523238,"about_ca_topic_score_gemma":0.0000022205472,"teacher_disagreement_score":0.62273484,"about_ca_system_score_codex":0.00003854855,"about_ca_system_score_gemma":0.00004394259,"threshold_uncertainty_score":0.34593752},"labels":[],"label_agreement":null},{"id":"W2000774400","doi":"10.1159/000020364","title":"p53 Immunohistochemistry as a Prognostic Marker in Bladder Cancer","year":2000,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Bladder cancer; Confusion; Clinical trial; Cancer; Oncology; MEDLINE; Internal medicine; Immunohistochemistry","score_opus":0.028662969122277226,"score_gpt":0.3457627609918029,"score_spread":0.3170997918695257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000774400","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011947936,0.7825521,4.0369588e-7,0.000082164785,0.00023204448,0.0008656552,0.00004432939,0.00006741319,0.21603638],"genre_scores_gemma":[0.00029806653,0.9817941,0.000019220439,0.0013539362,0.00049748673,0.0002852838,0.00021000125,0.00020772118,0.015334171],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99741477,0.00045464758,0.00066683127,0.0007461212,0.00018069676,0.0005369458],"domain_scores_gemma":[0.99886864,0.000106748754,0.00018645015,0.0006380208,0.00003275805,0.00016735312],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001746482,0.0005744362,0.0015549639,0.00019922627,0.000042458272,0.000014771092,0.0002716482,0.00027814653,0.005137204],"category_scores_gemma":[0.000078541496,0.00046540968,0.00039041665,0.00027843876,0.00014455196,0.000024171533,0.00008975966,0.00087234535,0.0024440386],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021089215,0.0002628565,0.00022834245,0.0030707077,0.00061856816,0.0032249307,0.000080198355,3.762326e-7,0.0000036792314,0.000004009667,0.0060208905,0.98627454],"study_design_scores_gemma":[0.001149615,0.00031513674,0.00057078275,0.0023781054,0.002140426,0.0010670566,0.0000023467398,4.4179137e-7,5.223141e-7,0.000010273513,0.9920381,0.00032724324],"about_ca_topic_score_codex":0.00010349538,"about_ca_topic_score_gemma":0.000005251223,"teacher_disagreement_score":0.98601717,"about_ca_system_score_codex":0.0002227075,"about_ca_system_score_gemma":0.0007393409,"threshold_uncertainty_score":0.99977976},"labels":[],"label_agreement":null},{"id":"W2000837090","doi":"10.1016/j.eururo.2009.09.022","title":"The Pathologist’s Mean Grade Is Constant and Individualizes the Prognostic Value of Bladder Cancer Grading","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Grading (engineering); Bladder cancer; Value (mathematics); Oncology; Gynecology; Internal medicine; Cancer; Statistics","score_opus":0.028125011249887234,"score_gpt":0.2955603973532535,"score_spread":0.26743538610336626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000837090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9275812,0.018039482,0.000057269932,0.029228596,0.0003165844,0.0008017269,0.000069314796,0.000073514035,0.023832351],"genre_scores_gemma":[0.99103844,0.0014329422,0.000050181523,0.0070508993,0.00012114572,0.000010508504,0.000003978914,0.000019527837,0.00027235126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987335,0.00036416546,0.00024053302,0.00023908995,0.00015337794,0.00026931174],"domain_scores_gemma":[0.9992584,0.00022813088,0.00011373881,0.00028909036,0.00004304845,0.00006762179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036799844,0.00015185181,0.00021384722,0.000035403562,0.00019947147,0.000018638633,0.00014971054,0.000036704616,0.000054215227],"category_scores_gemma":[0.00009758004,0.00007626835,0.000058585487,0.00010201397,0.00052302424,0.000021104344,0.00004992945,0.00019511343,0.000014162879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015642986,0.00093272026,0.6915073,0.000096032076,0.0020971238,0.0014126472,0.028558688,0.00002254502,0.009538774,0.04018892,0.042266794,0.18181416],"study_design_scores_gemma":[0.002558557,0.0022646957,0.94979477,0.000041599127,0.00085659424,0.0004540837,0.00037997338,0.00005342911,0.0010681624,0.0032250977,0.03912294,0.00018008245],"about_ca_topic_score_codex":0.000041938536,"about_ca_topic_score_gemma":0.000012162293,"teacher_disagreement_score":0.2582875,"about_ca_system_score_codex":0.000013234446,"about_ca_system_score_gemma":0.00005407972,"threshold_uncertainty_score":0.3110133},"labels":[],"label_agreement":null},{"id":"W2001196048","doi":"10.1016/j.eururo.2015.03.042","title":"Reply to Kevin Lu's Letter to the Editor re: Arun A. Azad, Bernhard J. Eigl, Raya Leibowitz-Amit, et al. Outcomes with Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Who Have Poor Performance Status. Eur Urol 2015;67:441–7","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Abiraterone acetate; Prostate cancer; Gynecology; Oncology; Internal medicine; Urology; Cancer; Androgen deprivation therapy","score_opus":0.025518869083985617,"score_gpt":0.300155917069719,"score_spread":0.2746370479857334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001196048","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14493515,0.0008541467,0.000014149029,0.84488076,0.0020162482,0.004947708,0.0011092678,0.00009482771,0.001147752],"genre_scores_gemma":[0.023478488,0.0006982513,0.00031992336,0.94091785,0.0038880997,0.0009907522,0.0016787685,0.0004612368,0.027566629],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918521,0.001748586,0.0011992414,0.0016715031,0.001614724,0.0019138696],"domain_scores_gemma":[0.996483,0.0002552157,0.000527833,0.0013801237,0.0008001897,0.0005536265],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001577205,0.0011036433,0.0014182321,0.0006553327,0.00021241064,0.00020482614,0.00070606015,0.00019360546,0.00015874898],"category_scores_gemma":[0.00028792402,0.0006711071,0.00016225078,0.0005208329,0.00032231543,0.00029949815,0.0004118178,0.0029618475,0.0007470086],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046356414,0.00017883154,0.039330292,0.00019961184,0.00053372467,0.0022994038,0.0026311965,0.00027287213,0.00011178363,3.0526752e-7,0.9484613,0.0013450487],"study_design_scores_gemma":[0.0056566135,0.004364943,0.088615924,0.00023554671,0.00032752057,0.000025075193,0.000072657436,0.000034575532,0.00008199288,0.0000015987465,0.89993894,0.0006445862],"about_ca_topic_score_codex":0.00061915943,"about_ca_topic_score_gemma":0.0008800212,"teacher_disagreement_score":0.12145667,"about_ca_system_score_codex":0.0006183441,"about_ca_system_score_gemma":0.0007615113,"threshold_uncertainty_score":0.999574},"labels":[],"label_agreement":null},{"id":"W2001291545","doi":"10.1016/j.eururo.2011.10.015","title":"Re: Should Intervening Benign Tissue Be Included in the Measurement of Discontinuous Foci of Cancer on Prostate Needle Biopsy? Correlation With Radical Prostatectomy Findings","year":2011,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Urology; Biopsy; Prostate; Needle biopsy; Cancer; Radiology; Internal medicine","score_opus":0.056925944247878335,"score_gpt":0.2896726359663845,"score_spread":0.23274669171850615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001291545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56995744,0.0036362747,0.00017077292,0.40739447,0.00069263286,0.0066128434,0.00034340855,0.000089655776,0.01110254],"genre_scores_gemma":[0.9455906,0.00012893323,0.00011471985,0.053076673,0.00026938063,0.00026170348,0.000283035,0.000111977344,0.00016294209],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99703944,0.00055238116,0.00077652466,0.00056616106,0.00063449825,0.00043097942],"domain_scores_gemma":[0.9985116,0.00013074724,0.00060146936,0.0005229861,0.00017974034,0.000053455587],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085802237,0.00041137502,0.00081566506,0.00028581545,0.000056251174,0.000015899195,0.00027309835,0.00021757385,0.00010048099],"category_scores_gemma":[0.000090372676,0.00025163678,0.00012299044,0.00025007591,0.00039712843,0.000044777622,0.0000932833,0.0013081867,0.000007747455],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023959188,0.0045933155,0.25316033,0.004638843,0.004351011,0.01987321,0.118316986,0.00048617175,0.0028780478,0.0003258863,0.52039343,0.047023606],"study_design_scores_gemma":[0.022890374,0.042972054,0.21096542,0.006245246,0.0033563725,0.00029931965,0.0008640508,0.000113414346,0.012721911,0.00017252332,0.6979469,0.0014523971],"about_ca_topic_score_codex":0.0004889199,"about_ca_topic_score_gemma":0.00018110265,"teacher_disagreement_score":0.3756332,"about_ca_system_score_codex":0.00020701537,"about_ca_system_score_gemma":0.00015668775,"threshold_uncertainty_score":0.99999356},"labels":[],"label_agreement":null},{"id":"W2002288165","doi":"10.1016/j.eururo.2014.08.033","title":"Androgen Deprivation Therapy in Prostate Cancer: Looking Beyond Prostate-specific Antigen and Testosterone Levels","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Prostate-specific antigen; Androgen deprivation therapy; Testosterone (patch); Prostate; Oncology; Urology; Androgen; Internal medicine; Gynecology; Cancer; Hormone","score_opus":0.04367162678622694,"score_gpt":0.29078069573304177,"score_spread":0.24710906894681484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002288165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6475495,0.01882308,0.000010584423,0.32772177,0.0002977735,0.0021526536,0.0000950465,0.00011050308,0.0032390505],"genre_scores_gemma":[0.5262204,0.033868432,0.0001945136,0.42847908,0.003479364,0.00023990798,0.0016779065,0.00046924176,0.005371166],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968419,0.0005987362,0.0005021908,0.00092212355,0.00033883442,0.0007962141],"domain_scores_gemma":[0.9988865,0.00013453393,0.00022906347,0.0005076667,0.00012794309,0.00011423748],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005595753,0.00046500895,0.0006772584,0.00046752093,0.000113494316,0.00006693216,0.00020202486,0.00027271433,0.0001231416],"category_scores_gemma":[0.000029410974,0.0003746141,0.00006916037,0.00024624835,0.00031481357,0.00008794205,0.00014522788,0.0015004792,0.0000886328],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003018796,0.00020982666,0.38432595,0.0005894724,0.0005433351,0.013882577,0.00353806,0.000020326426,0.01600235,0.000013217481,0.38910332,0.18875274],"study_design_scores_gemma":[0.005357411,0.0016709047,0.106001,0.00012947047,0.000037449066,0.00020789409,0.0000113394135,0.000022017362,0.0007346587,0.00006745614,0.885399,0.0003614337],"about_ca_topic_score_codex":0.000055729946,"about_ca_topic_score_gemma":0.0000117529835,"teacher_disagreement_score":0.49629563,"about_ca_system_score_codex":0.00013849366,"about_ca_system_score_gemma":0.00014870979,"threshold_uncertainty_score":0.9998706},"labels":[],"label_agreement":null},{"id":"W2003251793","doi":"10.1016/j.eururo.2005.12.045","title":"Natural History and Treatment of Bone Complications in Prostate Cancer","year":2006,"lang":"en","type":"review","venue":"European Urology","topic":"Bone health and treatments","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Prostate cancer; Cancer; Bone resorption; Bone pain; Prostate; Spinal cord compression; Bone remodeling; Bone metastasis; Pathology; Internal medicine; Spinal cord","score_opus":0.05998183545183984,"score_gpt":0.3481391588982672,"score_spread":0.28815732344642736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003251793","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004888649,0.9918954,1.172957e-7,0.00020764793,0.00014377253,0.0008593084,0.000043159733,0.000018124672,0.0063436483],"genre_scores_gemma":[0.0012783902,0.9944263,0.00005156582,0.0001703116,0.000039376664,0.000096191274,0.00027905783,0.000039677238,0.0036191242],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988184,0.00021657963,0.000452069,0.00027526976,0.000046980866,0.00019072453],"domain_scores_gemma":[0.9993846,0.000055457112,0.00023274233,0.00022967208,0.000022298871,0.00007524946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056070065,0.00020070367,0.0010198315,0.00018424664,0.00001575363,8.796531e-7,0.000027127211,0.00005044526,0.00001742203],"category_scores_gemma":[0.000008112012,0.00014566862,0.00009469116,0.00006940547,0.000106119456,0.000008630717,0.00001719189,0.00014198435,0.0000334388],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004125443,0.00033978678,0.0015689493,0.0021660575,0.00008273075,0.00033273723,0.0000847109,1.1284809e-7,3.7203523e-7,0.000036479007,0.0012211994,0.9941256],"study_design_scores_gemma":[0.0011036859,0.00042194893,0.022170411,0.00042947524,0.00048854866,0.00020267518,4.857163e-7,0.000001295441,2.9885097e-8,0.0000014823404,0.9751083,0.000071656614],"about_ca_topic_score_codex":0.0005497908,"about_ca_topic_score_gemma":0.00022804881,"teacher_disagreement_score":0.99405396,"about_ca_system_score_codex":0.00038728167,"about_ca_system_score_gemma":0.00023920671,"threshold_uncertainty_score":0.59401935},"labels":[],"label_agreement":null},{"id":"W2003312705","doi":"10.1016/j.eururo.2011.06.020","title":"SRD5A Polymorphisms and Biochemical Failure After Radical Prostatectomy","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Biochemical recurrence; Single-nucleotide polymorphism; Hazard ratio; Internal medicine; Medicine; breakpoint cluster region; Prostatectomy; Prostate cancer; Endocrinology; Proportional hazards model; Oncology; Confidence interval; Cancer; Genetics; Biology; Genotype; Gene","score_opus":0.013337184729551928,"score_gpt":0.2150968060142476,"score_spread":0.20175962128469568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003312705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833322,0.0020692146,0.000030048435,0.002298246,0.000086126674,0.00029661087,0.00001264814,0.0000792928,0.011795589],"genre_scores_gemma":[0.9955498,0.00014021163,0.00092167495,0.0029993332,0.00012560278,0.00003909345,0.000017520852,0.000036456357,0.00017030346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990592,0.00008579844,0.00016598651,0.00033969554,0.00007643344,0.00027286483],"domain_scores_gemma":[0.99947834,0.000021837941,0.000035576173,0.00022404222,0.000022980243,0.0002171954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000928427,0.00015126726,0.00020097486,0.00005746352,0.000028555123,0.000007013729,0.000051567524,0.00005372357,0.0005512707],"category_scores_gemma":[0.000026416788,0.00011491333,0.000049068203,0.000058661324,0.00027085564,0.000028815748,0.00008542671,0.00016776402,0.00024163612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006457495,0.0022033108,0.87101847,0.00017922067,0.00074842165,0.020759195,0.0048866663,1.4351646e-7,0.022061925,0.0025509233,0.03147526,0.03765899],"study_design_scores_gemma":[0.004061428,0.0024575307,0.89448524,0.000033216173,0.00023257697,0.0010898906,0.00002321883,0.0000057789866,0.01214722,0.00023965193,0.08498597,0.00023825892],"about_ca_topic_score_codex":0.000007876581,"about_ca_topic_score_gemma":0.000001330607,"teacher_disagreement_score":0.05351071,"about_ca_system_score_codex":0.00001986004,"about_ca_system_score_gemma":0.000023906301,"threshold_uncertainty_score":0.60360277},"labels":[],"label_agreement":null},{"id":"W2003683662","doi":"10.1016/j.eururo.2006.02.011","title":"Safety of MRI at 1.5Tesla in Patients with Implanted Sacral Nerve Neurostimulator","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Pain Management and Treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Magnetic resonance imaging; Isocenter; Radiology; Pelvis; Surgery; Nuclear medicine; Radiation therapy","score_opus":0.004455321913247068,"score_gpt":0.1962325542355853,"score_spread":0.19177723232233823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003683662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746557,0.000045732562,0.000049023045,0.00029099642,0.00005370892,0.00031518604,0.000012674806,0.000035987538,0.024541022],"genre_scores_gemma":[0.99825746,0.0000029444416,0.00011301255,0.00042509576,0.000036921232,0.0000015401833,0.0001787998,0.000026789166,0.0009574644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990132,0.00018083707,0.00024594515,0.00022231194,0.00011629233,0.00022145461],"domain_scores_gemma":[0.9995624,0.000054768923,0.000087443754,0.0002263857,0.000028451608,0.00004056958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012221467,0.00012719612,0.00022246694,0.000109835375,0.000025031653,0.0000020895232,0.00006219584,0.000022702987,0.00007808747],"category_scores_gemma":[0.00001562573,0.000095390744,0.00003688614,0.000120188284,0.00006420262,0.000021207477,0.000073624135,0.00008101854,0.00009328538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019725277,0.00044056965,0.9949086,0.000014593929,0.00004057886,0.0005163522,0.000025718598,0.00031719028,0.000122152,0.00010812124,0.0012729772,0.0002606492],"study_design_scores_gemma":[0.007963833,0.0012611485,0.98406196,0.000009315265,0.00007496872,0.000009397551,0.0000013916771,0.00015330905,0.00004749111,0.000008408635,0.006336768,0.000072034396],"about_ca_topic_score_codex":0.000028869255,"about_ca_topic_score_gemma":0.000026177864,"teacher_disagreement_score":0.023601765,"about_ca_system_score_codex":0.000032707267,"about_ca_system_score_gemma":0.0000073221913,"threshold_uncertainty_score":0.38899216},"labels":[],"label_agreement":null},{"id":"W2003985842","doi":"10.1016/j.eururo.2012.01.023","title":"Comment on the US Preventive Services Task Force's Draft Recommendation on Screening for Prostate Cancer","year":2012,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Task force; Prostate cancer; Prostate cancer screening; Cancer; Task (project management); Gynecology; Medical physics; Prostate-specific antigen; Internal medicine; Management","score_opus":0.028320752729850882,"score_gpt":0.28691181345593064,"score_spread":0.25859106072607974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003985842","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024549155,0.0005467898,0.00008213521,0.98514545,0.00089939346,0.0031455152,0.0007983738,0.0000709407,0.0068564713],"genre_scores_gemma":[0.023458382,0.0005729229,0.000086581145,0.96475923,0.0031859854,0.0012055066,0.003815407,0.00016612695,0.0027498694],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976225,0.00060662976,0.00037530053,0.00058731175,0.0001962591,0.0006120268],"domain_scores_gemma":[0.998335,0.00056171557,0.0004259094,0.00048970507,0.000103820916,0.0000838375],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004794931,0.000443217,0.00046180858,0.00011469665,0.00022022652,0.000039669758,0.00020299434,0.0001719436,0.00044786886],"category_scores_gemma":[0.000023173918,0.00028598914,0.00020311071,0.00006949569,0.00007032169,0.000047802547,0.000102701335,0.0009387038,0.00017232519],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061880203,0.00018553923,0.0019358456,0.00021837189,0.00065364665,0.000085930864,0.0005424966,0.000019867766,0.00000932109,0.00006351983,0.97384346,0.02182318],"study_design_scores_gemma":[0.0018401573,0.0028490284,0.004517566,0.000318372,0.0006057508,0.000009785908,0.000019160123,0.000051805833,0.0001786125,0.00003904524,0.98933595,0.00023478965],"about_ca_topic_score_codex":0.00006480937,"about_ca_topic_score_gemma":0.000015004216,"teacher_disagreement_score":0.02158839,"about_ca_system_score_codex":0.00020422495,"about_ca_system_score_gemma":0.000038461974,"threshold_uncertainty_score":0.99995923},"labels":[],"label_agreement":null},{"id":"W2004023311","doi":"10.1016/j.eururo.2014.08.006","title":"Combination AZD5363 with Enzalutamide Significantly Delays Enzalutamide-resistant Prostate Cancer in Preclinical Models","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Enzalutamide; LNCaP; Medicine; Prostate cancer; Protein kinase B; Cancer research; PI3K/AKT/mTOR pathway; Androgen receptor; Apoptosis; Cell growth; Internal medicine; Pharmacology; Cancer; Biology; Biochemistry","score_opus":0.03715134515925831,"score_gpt":0.31742567586234643,"score_spread":0.2802743307030881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004023311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650002,0.0010490156,0.0005680789,0.004486362,0.00013903555,0.0010038665,0.000030408159,0.000121843776,0.027601182],"genre_scores_gemma":[0.99630874,0.00046119775,0.00021031583,0.0009180039,0.00012840683,0.00008557858,0.00005674823,0.00007919256,0.0017518045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719495,0.0007798861,0.00047219047,0.0006142903,0.0003373781,0.0006012994],"domain_scores_gemma":[0.9988087,0.00026315876,0.00013285216,0.00040971403,0.00016391792,0.00022165354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010312154,0.00024967256,0.000432755,0.00022508354,0.00008445459,0.000025621812,0.00017749707,0.000087351174,0.000097880016],"category_scores_gemma":[0.00013749751,0.00018064145,0.00006496863,0.00028844964,0.00028633402,0.00011732731,0.00008600404,0.0005163972,0.00009527807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.104288094,0.0074035693,0.47411874,0.0012348541,0.001715445,0.008374775,0.013131739,0.040440843,0.12168569,0.021583319,0.005992488,0.20003043],"study_design_scores_gemma":[0.06041945,0.022403428,0.7895057,0.0006356693,0.00078493956,0.00025560366,0.00040134854,0.07455176,0.007173741,0.0072257677,0.034937605,0.0017049392],"about_ca_topic_score_codex":0.0001228683,"about_ca_topic_score_gemma":0.00021558751,"teacher_disagreement_score":0.31538698,"about_ca_system_score_codex":0.00014364792,"about_ca_system_score_gemma":0.00020634834,"threshold_uncertainty_score":0.7366345},"labels":[],"label_agreement":null},{"id":"W2004102863","doi":"10.1016/j.eururo.2012.08.025","title":"Impact of Smoking and Smoking Cessation on Oncologic Outcomes in Primary Non–muscle-invasive Bladder Cancer","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Smoking cessation; Bladder cancer; Logistic regression; Cumulative incidence; Internal medicine; Risk factor; Retrospective cohort study; Cancer; Incidence (geometry); Cohort; Pathology","score_opus":0.03007639531880168,"score_gpt":0.3217532945338444,"score_spread":0.2916768992150427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004102863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747628,0.000596856,0.000009467309,0.00028452027,0.00022021249,0.00025100325,0.000014947851,0.000022376098,0.02383785],"genre_scores_gemma":[0.9978402,0.00018598433,0.000030430512,0.0016084748,0.00017730433,0.000013415331,0.000013919213,0.000032106323,0.0000981259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989135,0.00018889619,0.0002447496,0.00021353783,0.00012896681,0.00031031668],"domain_scores_gemma":[0.999407,0.00015937767,0.00013088703,0.00017466824,0.000032973752,0.00009512841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002556857,0.00016847893,0.0003549752,0.00016047407,0.00003315058,0.0000046399537,0.00005801535,0.00006955227,0.0001685395],"category_scores_gemma":[0.000072771014,0.00012263985,0.00007690936,0.00010429303,0.00007469275,0.00007978011,0.000052383646,0.00020642902,0.000009449972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021188178,0.00028298644,0.9839336,0.000024079653,0.0002114869,0.000047044396,0.0009835183,0.000040495815,0.0015361232,0.000012594876,0.00012221118,0.012593939],"study_design_scores_gemma":[0.002754393,0.0013865746,0.9950929,0.00002984442,0.00016715251,0.000017342418,0.000028310553,0.00000499673,0.00019655113,0.000013184626,0.0002146555,0.00009405222],"about_ca_topic_score_codex":0.00026417617,"about_ca_topic_score_gemma":0.000027281161,"teacher_disagreement_score":0.023739723,"about_ca_system_score_codex":0.00019128405,"about_ca_system_score_gemma":0.00009189553,"threshold_uncertainty_score":0.5001108},"labels":[],"label_agreement":null},{"id":"W2004361934","doi":"10.1016/j.eururo.2014.04.015","title":"Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cabazitaxel; Medicine; Docetaxel; Androgen receptor; Oncology; Prostate cancer; Pharmacology; Androgen; Enzalutamide; Internal medicine; Antiandrogen; Chemotherapy; Androgen deprivation therapy; Cancer","score_opus":0.01093037077359175,"score_gpt":0.25004330030359995,"score_spread":0.2391129295300082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004361934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913486,0.0011099817,0.00006608064,0.0012928068,0.0001767396,0.0006116587,0.000072082024,0.00006605413,0.0052559813],"genre_scores_gemma":[0.997384,0.00005134204,0.00043655882,0.00079333736,0.00012307642,0.000049624534,0.00024485082,0.000066550965,0.0008506328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816763,0.0004098546,0.00025752166,0.00043407062,0.00022448029,0.0005064601],"domain_scores_gemma":[0.99932367,0.00006417827,0.000092956536,0.00027909817,0.000091627575,0.00014846015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033684153,0.00021760556,0.00031579053,0.00014839238,0.00007367456,0.000021199847,0.00012086517,0.00007961466,0.00013857734],"category_scores_gemma":[0.00013976093,0.00016231154,0.00007609301,0.00018539361,0.00017429933,0.000089803376,0.00008744669,0.00030292274,0.00013730503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010100877,0.0024313093,0.84249485,0.000077919554,0.00042151465,0.00021483359,0.005291683,0.0000018019757,0.07868465,0.000036376437,0.0059595443,0.054284636],"study_design_scores_gemma":[0.021672055,0.0043969913,0.8214207,0.000091479385,0.00007479472,0.0000134985985,0.00013521375,0.00007662589,0.011966132,0.000027203463,0.13966577,0.00045951392],"about_ca_topic_score_codex":0.000007761812,"about_ca_topic_score_gemma":0.000009350098,"teacher_disagreement_score":0.13370623,"about_ca_system_score_codex":0.00009170431,"about_ca_system_score_gemma":0.000048162656,"threshold_uncertainty_score":0.6618872},"labels":[],"label_agreement":null},{"id":"W2004457875","doi":"10.1016/j.eururo.2011.10.026","title":"A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Interquartile range; Stage (stratigraphy); Bladder cancer; Cystectomy; Cancer; Carcinoma in situ; Prostatectomy; Urology; Internal medicine; Prostate cancer; Oncology; Surgery; Biology","score_opus":0.027397002619967803,"score_gpt":0.25572363752729904,"score_spread":0.22832663490733124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004457875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8262411,0.0022543923,0.0008525958,0.002222444,0.00072873064,0.0010592,0.000036079095,0.00031918648,0.16628627],"genre_scores_gemma":[0.99192935,0.00004525309,0.00047881706,0.001935392,0.00037783652,0.000024547391,0.000005454755,0.00006436669,0.0051389975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989167,0.00011415776,0.00018492722,0.0003707836,0.00010370549,0.0003097615],"domain_scores_gemma":[0.99927586,0.000022259397,0.00004420147,0.00026589457,0.00003461271,0.00035714204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008282582,0.00017907692,0.0002476514,0.00007790018,0.00005067831,0.000010767935,0.000093245384,0.000039814542,0.00043078794],"category_scores_gemma":[0.00002236345,0.00013874237,0.000041176856,0.00010228764,0.00004627271,0.000032244847,0.0000756402,0.00011458235,0.0005585854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005205765,0.00071610475,0.7779342,0.0005261595,0.0018935085,0.007862777,0.025313923,0.000007766818,0.005510101,0.006600085,0.0497545,0.11867514],"study_design_scores_gemma":[0.0034256892,0.0024675059,0.91988415,0.000073383395,0.00070781546,0.0003843101,0.00015744647,0.000016068823,0.0005530582,0.000021796719,0.0720242,0.00028459704],"about_ca_topic_score_codex":0.0005983999,"about_ca_topic_score_gemma":0.00010387633,"teacher_disagreement_score":0.16568825,"about_ca_system_score_codex":0.00003603138,"about_ca_system_score_gemma":0.000074588395,"threshold_uncertainty_score":0.71796715},"labels":[],"label_agreement":null},{"id":"W2004509655","doi":"10.1016/j.eururo.2011.08.041","title":"Androgen-Deprivation Therapy and the Risk of Stroke in Patients With Prostate Cancer","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Cohort; Stroke (engine); Internal medicine; Population; Relative risk; Cohort study; Confidence interval; Gynecology; Surgery; Cancer","score_opus":0.021627332309026148,"score_gpt":0.24790607305865345,"score_spread":0.2262787407496273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004509655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99498034,0.0011425446,0.000002917873,0.00024635685,0.000019338677,0.00047967734,0.00001295246,0.0000070638857,0.0031088095],"genre_scores_gemma":[0.9973757,0.002213684,0.000038311115,0.00014529003,0.000012728737,0.000014178757,0.000007220572,0.000012800853,0.00018003931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935424,0.00022528874,0.000104283004,0.0001192308,0.00008039255,0.00011658278],"domain_scores_gemma":[0.9997011,0.000029134277,0.00006435,0.00012495827,0.000053825617,0.00002663737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002313414,0.000060791193,0.000121111065,0.00005137909,0.00002439638,0.0000020007074,0.000040537303,0.000013657226,0.000040473824],"category_scores_gemma":[0.000017566561,0.000028727642,0.000013868882,0.00006871978,0.00023376865,0.00002306963,0.000023851884,0.00010828561,0.0000031232964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0121975215,0.00009587876,0.9699095,0.0000055089567,0.00008158417,0.000009779927,0.0020205972,0.0000011951303,0.000036473615,0.000040545834,0.00001724165,0.015584205],"study_design_scores_gemma":[0.013641543,0.0010337847,0.98432446,0.0000061526334,0.000026790967,0.0000011082367,0.000022501736,0.000012208386,0.0003593891,0.000034624383,0.00050884363,0.000028585071],"about_ca_topic_score_codex":0.0001287782,"about_ca_topic_score_gemma":0.00001902041,"teacher_disagreement_score":0.015555621,"about_ca_system_score_codex":0.0000085410275,"about_ca_system_score_gemma":0.000022934608,"threshold_uncertainty_score":0.11714792},"labels":[],"label_agreement":null},{"id":"W2005019641","doi":"10.1016/j.eururo.2013.10.035","title":"Evaluation of Prostate-specific Antigen Response Following Cessation of Abiraterone Acetate: Is There Evidence for a Withdrawal Syndrome?","year":2013,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Abiraterone acetate; Prostate-specific antigen; Abiraterone; Prostate; Withdrawal syndrome; Internal medicine; Oncology; Prostate cancer; Androgen deprivation therapy; Androgen receptor; Cancer","score_opus":0.11147554840757741,"score_gpt":0.3597510663210894,"score_spread":0.248275517913512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005019641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8833301,0.009937301,0.0000578387,0.10274805,0.0003060474,0.0031075536,0.00007799137,0.000030918178,0.00040418174],"genre_scores_gemma":[0.984284,0.000689734,0.00022455389,0.010953224,0.00033880144,0.00019688254,0.00039185287,0.00013709613,0.0027838773],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99511635,0.002206673,0.00063750474,0.0005840463,0.0010239922,0.0004314545],"domain_scores_gemma":[0.9972681,0.00052760757,0.0005015543,0.00062582147,0.0010183317,0.000058600166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040470436,0.00030345394,0.00067938823,0.0003537606,0.000067064735,0.000021000309,0.00025066576,0.0002711704,0.000334314],"category_scores_gemma":[0.00045915335,0.0002349231,0.00023125016,0.00021906022,0.00023531857,0.00014223659,0.0000804424,0.00054693973,0.00008859901],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027578093,0.00037211986,0.013226866,0.002618806,0.003257355,0.0022745188,0.0067278678,0.000064963206,0.11344035,0.000004277166,0.8111824,0.019252406],"study_design_scores_gemma":[0.034646157,0.03136084,0.46720818,0.0037599567,0.0056055645,0.00043388578,0.00031394127,0.0012823909,0.02597059,0.00046346567,0.4275701,0.0013849495],"about_ca_topic_score_codex":0.000023370652,"about_ca_topic_score_gemma":9.2927866e-7,"teacher_disagreement_score":0.4539813,"about_ca_system_score_codex":0.00016303018,"about_ca_system_score_gemma":0.0005033126,"threshold_uncertainty_score":0.9579887},"labels":[],"label_agreement":null},{"id":"W2005375324","doi":"10.1016/j.eururo.2014.11.054","title":"Characterizing the Impact of Lymph Node Metastases on the Survival Outcome for Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapies","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Queen Elizabeth II Health Sciences Centre; University of British Columbia; BC Cancer Agency; Princess Margaret Cancer Centre; Dalhousie University; University Health Network; University of Toronto; Sunnybrook Health Science Centre; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Lymph node; Oncology; Overall survival; Internal medicine","score_opus":0.034714979863734695,"score_gpt":0.2609921918801777,"score_spread":0.226277212016443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005375324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950898,0.00010539506,0.0001081587,0.00059703516,0.000055713113,0.00080730347,0.00011784987,0.000031954456,0.0030867597],"genre_scores_gemma":[0.9986115,0.0000034231875,0.00013780514,0.00072127575,0.00007315421,0.00003547893,0.00018023973,0.00007968396,0.0001574134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973045,0.0013454754,0.0004105919,0.00032527978,0.00023705052,0.00037713212],"domain_scores_gemma":[0.9978307,0.00096932607,0.00033493296,0.00063227786,0.00014212617,0.00009063071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070554885,0.000330625,0.0005435435,0.000100620135,0.0001330194,0.00001709431,0.00022616373,0.000024431403,0.0000747602],"category_scores_gemma":[0.00017038877,0.00013333463,0.00027926543,0.00014032594,0.00019439249,0.00003195048,0.000045485223,0.00014551687,0.000034722805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057175187,0.0009231237,0.9565841,0.00006797512,0.0011363296,0.00008273976,0.0011386573,0.00013865117,0.03268721,0.00015686716,0.0002855615,0.0010812914],"study_design_scores_gemma":[0.004189498,0.006459085,0.97879404,0.000008503651,0.0006047645,0.000021203388,0.00006010792,0.00018030727,0.00914383,0.000007823028,0.0003983972,0.0001324532],"about_ca_topic_score_codex":0.00010136798,"about_ca_topic_score_gemma":0.000002552447,"teacher_disagreement_score":0.023543378,"about_ca_system_score_codex":0.00005472817,"about_ca_system_score_gemma":0.000034909597,"threshold_uncertainty_score":0.54372287},"labels":[],"label_agreement":null},{"id":"W2005776405","doi":"10.1016/j.eururo.2010.06.027","title":"Corrigendum to “Real-Time Magnetic Resonance Imaging–Guided Focal Laser Therapy in Patients with Low-Risk Prostate Cancer” [Eur Urol 2010;58:173–77]","year":2010,"lang":"en","type":"erratum","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Prostate cancer; Magnetic resonance imaging; Laser therapy; Radiology; Urology; Cancer; Laser; Internal medicine; Optics","score_opus":0.007682722654594899,"score_gpt":0.22971807075510464,"score_spread":0.22203534810050973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005776405","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8483458,0.026471041,0.0000073868728,0.010007071,0.043385,0.0114639215,0.0033818833,0.0005913231,0.056346532],"genre_scores_gemma":[0.14841147,0.058543175,0.00075641554,0.031891037,0.006719973,0.0027924383,0.006255218,0.0024917203,0.74213856],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99492663,0.00062737346,0.00092403824,0.0016630028,0.0005868273,0.0012721509],"domain_scores_gemma":[0.99706364,0.00008428536,0.0005420186,0.0013314682,0.00042240327,0.0005562164],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00042795547,0.0010038688,0.0012555756,0.00043541176,0.00013724063,0.00006127901,0.00049171824,0.0003057316,0.0011318846],"category_scores_gemma":[0.00014848172,0.0007814663,0.00017389805,0.00041991775,0.00030928582,0.00008946846,0.00021823186,0.0020407867,0.0009429324],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002714621,0.0007260359,0.31832498,0.00004307864,0.000076141216,0.0011212191,0.0003690138,0.000012460818,0.000029094255,0.0000013418995,0.63601696,0.040565033],"study_design_scores_gemma":[0.006900725,0.0045500644,0.5087516,0.00018194293,0.0001536343,0.000016596206,0.0000029699704,0.000042557313,0.000026881698,0.000007022908,0.47891733,0.00044872114],"about_ca_topic_score_codex":0.0012986753,"about_ca_topic_score_gemma":0.0005758966,"teacher_disagreement_score":0.69993436,"about_ca_system_score_codex":0.0002962036,"about_ca_system_score_gemma":0.0006164709,"threshold_uncertainty_score":0.99983495},"labels":[],"label_agreement":null},{"id":"W2005878196","doi":"10.1016/j.eururo.2011.11.048","title":"Re: Hendrik Van Poppel, Luigi Da Pozzo, Walter Albrecht, et al. A Prospective, Randomized EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma. Eur Urol 2011;59:543–52","year":2011,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Surgery; Urology; Randomized controlled trial; Prospective cohort study; Kidney; Internal medicine","score_opus":0.058095455503794156,"score_gpt":0.30386802831206233,"score_spread":0.24577257280826817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005878196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9338085,0.0020432153,0.0010209545,0.03482165,0.0010800861,0.012535834,0.00010098997,0.00023303262,0.014355763],"genre_scores_gemma":[0.8797685,0.00008017894,0.0003429882,0.115761526,0.0009197709,0.0006175154,0.0003577497,0.00036993914,0.0017818304],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98694295,0.006386957,0.0024425236,0.002122452,0.00068928086,0.0014158491],"domain_scores_gemma":[0.9912509,0.004793819,0.0017456561,0.0015632274,0.0003181831,0.0003282136],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004496596,0.0014528247,0.004684621,0.00080822164,0.00026295634,0.000093918716,0.0007507281,0.00046876963,0.000259158],"category_scores_gemma":[0.0006277126,0.0010002032,0.0011475432,0.00026740646,0.0010894669,0.00015452162,0.00076187536,0.0037407796,0.00007697459],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20423746,0.0046926625,0.22360495,0.00088120624,0.004004319,0.014525233,0.004525881,0.000020222,0.0012068584,0.00004835156,0.54162467,0.00062819244],"study_design_scores_gemma":[0.5237964,0.025317509,0.08957338,0.00027875783,0.010762545,0.0017819706,0.00048176578,0.0008775515,0.0019077396,0.00018317158,0.34200627,0.003032984],"about_ca_topic_score_codex":0.00035522121,"about_ca_topic_score_gemma":0.000069607646,"teacher_disagreement_score":0.31955892,"about_ca_system_score_codex":0.00039804488,"about_ca_system_score_gemma":0.00027229195,"threshold_uncertainty_score":0.99982214},"labels":[],"label_agreement":null},{"id":"W2006035699","doi":"10.1016/j.eururo.2009.08.005","title":"Re: Clinical Phenotyping in Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Interstitial Cystitis: A Management Strategy for Urologic Chronic Pelvic Pain Syndromes","year":2009,"lang":"en","type":"letter","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; Interstitial cystitis; Pelvic pain; Prostatitis; Chronic prostatitis/chronic pelvic pain syndrome; Urology; Chronic pain; Bladder Pain Syndrome; Surgery; Physical therapy; Prostate; Internal medicine; Urinary system","score_opus":0.05258962778262587,"score_gpt":0.33623397308272046,"score_spread":0.2836443453000946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006035699","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032158397,0.13759221,0.015453022,0.7352673,0.0033243815,0.030493017,0.0008394978,0.0016885279,0.04318369],"genre_scores_gemma":[0.7431933,0.011350412,0.00061579375,0.22570828,0.0075840005,0.0006199057,0.0032918977,0.00063557684,0.0070008235],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98581433,0.00721921,0.0018058299,0.0022484455,0.0005707731,0.0023414332],"domain_scores_gemma":[0.9961045,0.001873364,0.00045469243,0.0011046046,0.00012304899,0.00033980698],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008090864,0.0010501185,0.0018268306,0.0009913269,0.00023157761,0.0001513542,0.00075239816,0.000947518,0.00061265775],"category_scores_gemma":[0.000506545,0.0010226821,0.0004301622,0.00043052295,0.0008601777,0.00016068216,0.0005029545,0.004875367,0.00029236948],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017377136,0.00047904687,0.0011855233,0.011854624,0.0013914208,0.17609452,0.00028957278,0.0002711777,0.000029151386,0.0002017201,0.52449137,0.28197414],"study_design_scores_gemma":[0.010436055,0.065590225,0.014568586,0.0013568469,0.00068365276,0.00414398,0.00008616373,0.0059445887,8.928025e-7,0.00080190797,0.8950912,0.001295898],"about_ca_topic_score_codex":0.000057769317,"about_ca_topic_score_gemma":0.00023672871,"teacher_disagreement_score":0.71103495,"about_ca_system_score_codex":0.0014869598,"about_ca_system_score_gemma":0.0011227239,"threshold_uncertainty_score":0.99922234},"labels":[],"label_agreement":null},{"id":"W2007268427","doi":"10.1016/j.eururo.2014.04.001","title":"Reply from Authors re: Andrea Gallina, Alessandro Nini, Francesco Montorsi, Alberto Briganti. Metabolic Syndrome as a Marker for Prostate Cancer: Still a Work in Progress. Eur Urol 2015;67:71–2","year":2014,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Lower urinary tract symptoms; Urology; International Prostate Symptom Score; Tadalafil; Prostate cancer; Gynecology; Prostate; Internal medicine; Cancer; Erectile dysfunction","score_opus":0.013366993330854029,"score_gpt":0.30569772286199254,"score_spread":0.29233072953113853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007268427","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17253442,0.18646133,0.000050183604,0.018959088,0.6012082,0.012471484,0.0030128772,0.0006639389,0.004638491],"genre_scores_gemma":[0.21291709,0.038274206,0.0011591468,0.003236696,0.6262782,0.004954289,0.011827458,0.0021434561,0.09920946],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99132043,0.0015590746,0.0014423071,0.0025335765,0.0012324192,0.0019122034],"domain_scores_gemma":[0.99505377,0.0012524206,0.00085194217,0.001516353,0.00059767155,0.00072782097],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019871162,0.0012330358,0.0025884137,0.0006635147,0.00019210001,0.00014789398,0.00090886035,0.0009772677,0.00041314622],"category_scores_gemma":[0.0014557783,0.001029454,0.00049604423,0.000720514,0.00070839125,0.0001674582,0.0003892213,0.0025450485,0.00038811663],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01874363,0.00046299247,0.029085482,0.00040054217,0.0012188209,0.0047324207,0.0013410063,0.00001447025,0.000018754245,0.0000046599544,0.9359236,0.008053663],"study_design_scores_gemma":[0.0122270305,0.0027700763,0.03647225,0.00074932503,0.0010192754,0.00006164035,0.000021512891,0.0000688715,0.000026907197,0.00008205967,0.94565225,0.0008488277],"about_ca_topic_score_codex":0.0021323115,"about_ca_topic_score_gemma":0.0004787695,"teacher_disagreement_score":0.14818712,"about_ca_system_score_codex":0.0002441786,"about_ca_system_score_gemma":0.001089848,"threshold_uncertainty_score":0.9997561},"labels":[],"label_agreement":null},{"id":"W2008033739","doi":"10.1016/j.eururo.2012.08.054","title":"Impact of Age and Comorbidities on Long-term Survival of Patients with High-risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-institutional Competing-risks Analysis","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Prostate; Term (time); Urology; Proportional hazards model; Cancer; Survival analysis; Oncology; Internal medicine","score_opus":0.024844792037284985,"score_gpt":0.29012057388775525,"score_spread":0.2652757818504703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008033739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978389,0.00044119082,0.000044224773,0.00003178504,0.000036397287,0.0006400932,0.00080209883,0.000028021175,0.00013725765],"genre_scores_gemma":[0.9987997,0.0003460382,0.00015698743,0.000037669917,0.00003738161,0.00003422095,0.00053309515,0.00003458716,0.000020330272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850565,0.00030094644,0.00032918784,0.00029474084,0.00023664869,0.00033281307],"domain_scores_gemma":[0.99893254,0.00012727827,0.0003533512,0.00023585884,0.00015731835,0.00019365392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018790792,0.00026809523,0.00067129853,0.00020704302,0.00006974214,0.0000075438647,0.000055533365,0.000036989364,0.00006796229],"category_scores_gemma":[0.00003463141,0.00015043582,0.00010037334,0.00027992317,0.00063292816,0.000060622533,0.00003843088,0.00017405146,0.0000027855162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049595106,0.0016538895,0.9873375,0.00006241784,0.0031253726,0.00018514844,0.0005580913,0.00056910794,0.000030904073,0.00002622241,0.0000063563343,0.001485464],"study_design_scores_gemma":[0.009553574,0.006609759,0.98119307,0.00007271639,0.002124849,0.0000072684284,0.000010602989,0.000025490925,0.00023897928,4.2897625e-7,0.000023842256,0.00013940014],"about_ca_topic_score_codex":0.0009070408,"about_ca_topic_score_gemma":0.00016100783,"teacher_disagreement_score":0.006144426,"about_ca_system_score_codex":0.000101088925,"about_ca_system_score_gemma":0.00008909959,"threshold_uncertainty_score":0.61345947},"labels":[],"label_agreement":null},{"id":"W2009146193","doi":"10.1016/j.eururo.2009.06.029","title":"No Role for Routine Chest Radiography in Stage I Seminoma Surveillance","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Sunnybrook Health Science Centre; Health Sciences Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Seminoma; Radiology; Stage (stratigraphy); Pelvis; Abdomen; Radiation therapy; Thorax (insect anatomy); Radiography; Surgery; Chemotherapy","score_opus":0.008912516182829677,"score_gpt":0.24474759479013183,"score_spread":0.23583507860730216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009146193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9656865,0.0030487943,0.00015060183,0.0008462591,0.00010406349,0.00048402773,0.000053642485,0.000104403916,0.02952169],"genre_scores_gemma":[0.99687517,0.0000331225,0.0005279208,0.0014488524,0.0001510857,0.000005998069,0.000115041046,0.000023006032,0.0008198274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991456,0.000090937545,0.00017818813,0.00026168057,0.000059982056,0.00026357072],"domain_scores_gemma":[0.99949306,0.000055099154,0.00005677272,0.00024627324,0.000036254092,0.00011252078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014963103,0.00012555148,0.00021922786,0.000101903584,0.000026809823,0.0000066986295,0.000069635265,0.00002966852,0.00005680506],"category_scores_gemma":[0.00013486331,0.0001100619,0.00010984225,0.00012631241,0.000032935404,0.00001932178,0.000014800542,0.000077010256,0.00010652261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067938596,0.00065460603,0.98023987,0.000023530465,0.00006405257,0.0008989036,0.00006444229,0.000023015751,0.00095011963,0.0002729048,0.0011121909,0.015017006],"study_design_scores_gemma":[0.002982306,0.0012792383,0.9484444,0.000005362163,0.00003593905,0.000034086148,0.0000045862375,0.00022012783,0.000020340922,0.000035097153,0.046853103,0.000085396816],"about_ca_topic_score_codex":0.000012330742,"about_ca_topic_score_gemma":0.000005252024,"teacher_disagreement_score":0.045740914,"about_ca_system_score_codex":0.000014624434,"about_ca_system_score_gemma":0.00001697625,"threshold_uncertainty_score":0.4488194},"labels":[],"label_agreement":null},{"id":"W2010908714","doi":"10.1016/j.eururo.2013.11.006","title":"Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Mitotane; Medicine; Adrenocortical carcinoma; Hazard ratio; Internal medicine; Stage (stratigraphy); Clinical endpoint; Confidence interval; Adjuvant therapy; Gastroenterology; Adjuvant; Cancer; Oncology; Urology; Clinical trial","score_opus":0.006836118928981754,"score_gpt":0.2117988701528206,"score_spread":0.20496275122383883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010908714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99354076,0.00019122307,0.000011230491,0.0002749323,0.000045315774,0.00044011508,0.000007477251,0.000026357746,0.005462614],"genre_scores_gemma":[0.9987473,0.0000039588213,0.000087660934,0.0009071183,0.000049689974,0.000019476538,0.000033449902,0.000028270017,0.00012310021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999015,0.00012559269,0.0002737902,0.00020741229,0.00012187015,0.00025635777],"domain_scores_gemma":[0.99950737,0.000045213095,0.00006248479,0.00015359299,0.00012337681,0.000107971944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045746594,0.000119646924,0.00026604222,0.00007853459,0.000018357961,0.000004167886,0.0000831976,0.00003157445,0.0007751],"category_scores_gemma":[0.0000718362,0.00008346391,0.000024812016,0.00016707173,0.00012722157,0.000042779317,0.000047339076,0.00019111129,0.0002456424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037021525,0.00034065873,0.9938704,0.000015427893,0.000033142816,0.00036124734,0.00024629207,0.00006735422,0.00072627724,0.00011440259,0.00026511657,0.0035894725],"study_design_scores_gemma":[0.001950953,0.0010828387,0.9955148,0.00003008393,0.00004196287,0.00011965235,0.00001493773,0.00041889396,0.000066443485,0.000020421736,0.00064929575,0.00008969733],"about_ca_topic_score_codex":0.00027672912,"about_ca_topic_score_gemma":0.00003433581,"teacher_disagreement_score":0.0053395135,"about_ca_system_score_codex":0.000013385372,"about_ca_system_score_gemma":0.00004608359,"threshold_uncertainty_score":0.8486802},"labels":[],"label_agreement":null},{"id":"W2011521085","doi":"10.1016/j.eururo.2014.01.007","title":"Systematic Review and Meta-analysis of Candidate Gene Association Studies of Lower Urinary Tract Symptoms in Men","year":2014,"lang":"en","type":"review","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute for Health and Care Research","keywords":"Medicine; Meta-analysis; Odds ratio; Confidence interval; Lower urinary tract symptoms; Publication bias; Candidate gene; Systematic review; Internal medicine; MEDLINE; Bioinformatics; Genetics; Gene; Biology; Prostate","score_opus":0.08715941176377959,"score_gpt":0.39418597233565067,"score_spread":0.30702656057187105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011521085","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042730826,0.99608505,0.0000014805601,0.0002179895,0.000018489185,0.0016554813,0.00009537561,0.00000881071,0.0018745834],"genre_scores_gemma":[0.0011195582,0.99685603,0.000010813407,0.00019546918,0.000017716235,0.00006971014,0.00011843921,0.000041856223,0.0015704092],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9923672,0.0049055032,0.0017443473,0.00040115754,0.00031814913,0.00026363635],"domain_scores_gemma":[0.99633044,0.0014801909,0.0013080506,0.0006026231,0.00020276668,0.00007594077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005077574,0.0003251343,0.010965973,0.0007140513,0.00001971092,0.000004017302,0.00018191083,0.000110691995,0.00013249957],"category_scores_gemma":[0.0011938019,0.00020354244,0.0012354588,0.00073640794,0.000090350324,0.000027016973,0.00016630896,0.00037777453,0.000024960931],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018943168,0.0002014431,0.000034751934,0.76200813,0.23657003,0.0003327101,0.00009928429,5.78176e-7,3.3980487e-7,0.0000053495583,0.0002239397,0.00050448877],"study_design_scores_gemma":[0.00022965751,0.0013888851,0.0001169192,0.008554553,0.9641861,0.00023595811,0.0000060399298,0.0000036754248,1.4810705e-7,0.000002066647,0.025130888,0.00014514313],"about_ca_topic_score_codex":0.000013092391,"about_ca_topic_score_gemma":0.0000023581501,"teacher_disagreement_score":0.7534536,"about_ca_system_score_codex":0.00007466449,"about_ca_system_score_gemma":0.00007151887,"threshold_uncertainty_score":0.830022},"labels":[],"label_agreement":null},{"id":"W2011714290","doi":"10.1016/j.eururo.2009.01.040","title":"Bladder Tumor Infiltrating Mature Dendritic Cells and Macrophages as Predictors of Response to Bacillus Calmette-Guérin Immunotherapy","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Université Laval","funders":"","keywords":"Medicine; CD68; Immunotherapy; Infiltration (HVAC); Immune system; Bladder cancer; Dendritic cell; Hazard ratio; Immunohistochemistry; Population; Pathology; Internal medicine; Immunology; Cancer","score_opus":0.007782394543545465,"score_gpt":0.2525258158049442,"score_spread":0.24474342126139875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011714290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98898226,0.0012354144,0.00004528108,0.0021343401,0.0002035997,0.00038632652,0.00003792588,0.00006730583,0.0069075315],"genre_scores_gemma":[0.9879056,0.00005024893,0.00057622074,0.009931566,0.00017380915,0.000004614783,0.0000056963554,0.000044548768,0.0013076735],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99844867,0.00042589352,0.00031420143,0.0003377827,0.0001630586,0.00031040568],"domain_scores_gemma":[0.999232,0.00012421297,0.00007808479,0.00033071486,0.000057217778,0.0001777685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029192446,0.00021415559,0.00034296873,0.00014713402,0.000060898506,0.000014483937,0.000112968584,0.000055780194,0.00024036852],"category_scores_gemma":[0.00012292608,0.00018172164,0.00006647139,0.0001551773,0.000102177844,0.000037420898,0.000035751596,0.00022439455,0.00010932009],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0093965875,0.00028657247,0.00681155,0.000036408463,0.00026926934,0.002112737,0.0023940767,0.000025279229,0.96364546,0.00004469523,0.0033158248,0.01166153],"study_design_scores_gemma":[0.009081795,0.019154891,0.8231383,0.00008047064,0.00032147483,0.0016570783,0.00020262582,0.000017195678,0.09460506,0.00008274543,0.05121277,0.00044559335],"about_ca_topic_score_codex":0.00002252416,"about_ca_topic_score_gemma":0.0000022868874,"teacher_disagreement_score":0.8690404,"about_ca_system_score_codex":0.000023376922,"about_ca_system_score_gemma":0.000063121086,"threshold_uncertainty_score":0.74103934},"labels":[],"label_agreement":null},{"id":"W2012273940","doi":"10.1016/j.eururo.2013.04.023","title":"Re: Intermittent Androgen Suppression for Rising PSA Level After Radiotherapy","year":2013,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Androgen suppression; Androgen; Urology; Radiation therapy; Oncology; Internal medicine; Hormone","score_opus":0.038568960580213724,"score_gpt":0.2843520077687776,"score_spread":0.2457830471885639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012273940","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015189904,0.011883714,0.0010383157,0.9629754,0.002169569,0.002617039,0.00042101342,0.00015162551,0.0035534338],"genre_scores_gemma":[0.027143061,0.0012084187,0.0014610998,0.9554114,0.006323694,0.0004887198,0.0010538009,0.00030172538,0.0066081234],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978963,0.00027727347,0.00041103747,0.0007053286,0.00016484555,0.0005452049],"domain_scores_gemma":[0.9987857,0.00016582209,0.0002012715,0.0006413217,0.00009525366,0.000110677254],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016356457,0.00042264766,0.00063337304,0.00015111553,0.0000620881,0.000041316387,0.00017856318,0.00031588474,0.000843991],"category_scores_gemma":[0.000034947738,0.00031711653,0.0002968606,0.00004430561,0.000104836115,0.00004556572,0.00008967192,0.00073670497,0.0002470869],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035255152,0.00008118523,0.0016702736,0.00015396143,0.00037219835,0.0023165455,0.0001962628,6.757352e-7,0.00011010185,0.000001036126,0.9690058,0.025739364],"study_design_scores_gemma":[0.002668146,0.0016726186,0.007712772,0.00015579491,0.00035323566,0.00015421961,0.0000048366146,0.00002587457,0.00027579235,0.000024562421,0.9866828,0.00026938936],"about_ca_topic_score_codex":0.000011518715,"about_ca_topic_score_gemma":0.0000016369971,"teacher_disagreement_score":0.025469974,"about_ca_system_score_codex":0.00015325207,"about_ca_system_score_gemma":0.000051077808,"threshold_uncertainty_score":0.9999281},"labels":[],"label_agreement":null},{"id":"W2012318195","doi":"10.1016/j.eururo.2006.03.026","title":"High Incidence of Prostate Cancer Detected by Saturation Biopsy after Previous Negative Biopsy Series","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Biopsy; Prostate cancer; Prostate biopsy; Prostate; Urology; Prostate-specific antigen; Cancer; Internal medicine","score_opus":0.005619682191881058,"score_gpt":0.22860295906482345,"score_spread":0.2229832768729424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012318195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287117,0.0038486265,0.000024200703,0.001759824,0.00017441544,0.00052134064,0.00016974266,0.00006495455,0.00056571345],"genre_scores_gemma":[0.99751437,0.00057405303,0.00049614965,0.0003559142,0.000121329846,0.00012587816,0.00010220735,0.000035451878,0.0006746338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988268,0.00016737636,0.00032452855,0.00032405657,0.00012166189,0.00023554661],"domain_scores_gemma":[0.9993266,0.000044361426,0.00019309958,0.00022576624,0.00015099946,0.000059189086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008698464,0.0001806752,0.00027007572,0.00006444681,0.00003937077,0.000011117682,0.0000603433,0.000044371795,0.00013601629],"category_scores_gemma":[0.00004188595,0.00014267651,0.000049659528,0.00017446764,0.00019644632,0.00009613869,0.0000457221,0.000114842434,0.000036377674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007184743,0.0010024443,0.7089257,0.0003313719,0.0005109269,0.0019719447,0.0024445418,0.00016721763,0.24522495,0.00040145134,0.011428168,0.020406505],"study_design_scores_gemma":[0.0017496377,0.0013941025,0.9321266,0.00006829856,0.00018800504,0.0001530244,0.000018339526,0.000010382664,0.060271464,0.00015141781,0.0037012564,0.00016746754],"about_ca_topic_score_codex":0.0006541882,"about_ca_topic_score_gemma":0.00009145162,"teacher_disagreement_score":0.22320087,"about_ca_system_score_codex":0.00007078981,"about_ca_system_score_gemma":0.00005322797,"threshold_uncertainty_score":0.5818179},"labels":[],"label_agreement":null},{"id":"W2012690520","doi":"10.1016/j.eururo.2008.05.018","title":"Impact of Surgical Volume on the Rate of Lymph Node Metastases in Patients Undergoing Radical Prostatectomy and Extended Pelvic Lymph Node Dissection for Clinically Localized Prostate Cancer","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Lymph node; Dissection (medical); Prostate cancer; Stage (stratigraphy); Urology; Biochemical recurrence; Lymph; Laparoscopic radical prostatectomy; Surgery; Cohort; Radiology; Cancer; Internal medicine; Pathology","score_opus":0.021251872963966717,"score_gpt":0.3020890606793489,"score_spread":0.28083718771538213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012690520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969996,0.0005142989,0.000034864286,0.00087080465,0.00008781101,0.0010753667,0.00018752959,0.000021066835,0.00020861258],"genre_scores_gemma":[0.9972138,0.0020265696,0.00009072366,0.00033752568,0.000040622737,0.00010918711,0.0000834626,0.000046057718,0.000052079216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977625,0.00062752236,0.0006989849,0.0004151642,0.00015161606,0.00034418603],"domain_scores_gemma":[0.99837226,0.00077225553,0.00032255205,0.00026642255,0.00014111045,0.00012542523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005688151,0.0002307429,0.00059411017,0.00011584851,0.00007393396,0.00000630641,0.00008094922,0.000055074986,0.000054139615],"category_scores_gemma":[0.00033112103,0.00014225362,0.00018630686,0.00017420879,0.00040623036,0.000045337907,0.00005558042,0.00012919583,0.0000044453986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01335764,0.001476334,0.9799271,0.0001083017,0.00030266418,0.00017282928,0.00030204328,0.00039738356,0.00012342003,0.000058694284,0.00022239938,0.0035511788],"study_design_scores_gemma":[0.019970508,0.004569468,0.97376204,0.00011972089,0.00016397428,0.000042915013,0.000015748621,0.0005389859,0.00027516368,0.000052937838,0.00036619147,0.00012236484],"about_ca_topic_score_codex":0.0001283977,"about_ca_topic_score_gemma":0.0000069316143,"teacher_disagreement_score":0.0066128685,"about_ca_system_score_codex":0.0001436917,"about_ca_system_score_gemma":0.0002557701,"threshold_uncertainty_score":0.58009344},"labels":[],"label_agreement":null},{"id":"W2014461997","doi":"10.1016/j.eururo.2009.02.026","title":"Prevalence, Severity, and Symptom Bother of Lower Urinary Tract Symptoms among Men in the EPIC Study: Impact of Overactive Bladder","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Lower urinary tract symptoms; Overactive bladder; Nocturia; International Prostate Symptom Score; Population; Internal medicine; Urology; Gynecology; Urinary system; Prostate","score_opus":0.014527809283572316,"score_gpt":0.31475606510595794,"score_spread":0.3002282558223856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014461997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93905294,0.00046494105,0.000001796111,0.00024667743,0.00001683381,0.00072161155,0.000011806067,0.000011721743,0.05947168],"genre_scores_gemma":[0.9990554,0.00018900153,0.0000064814617,0.00013835587,0.000050441155,0.0000040180716,0.0000032996195,0.000021760532,0.00053125096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773455,0.001102386,0.00032089438,0.00028508445,0.0002593291,0.00029775215],"domain_scores_gemma":[0.99907714,0.00027777237,0.00011496833,0.00039433193,0.000058744026,0.000077052704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009820074,0.00016660939,0.00033649366,0.00018404424,0.000032156695,0.000008075314,0.00018997307,0.000048336868,0.00034706367],"category_scores_gemma":[0.00007006821,0.000107623986,0.00009034556,0.00021014195,0.00023140287,0.00010939859,0.00007873851,0.00039891645,0.00001026389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020180726,0.0047138194,0.98177546,0.00005035761,0.00022675692,0.001793391,0.0056371246,0.000016170436,0.0007684622,0.000017980616,0.0003190391,0.0026633667],"study_design_scores_gemma":[0.0017414594,0.023053745,0.9740168,0.00002058874,0.00009329809,0.00052698015,0.00020686793,0.00007124472,0.00001657462,0.000074350544,0.00009306809,0.00008504427],"about_ca_topic_score_codex":0.00008055785,"about_ca_topic_score_gemma":0.0000012907547,"teacher_disagreement_score":0.060002457,"about_ca_system_score_codex":0.00002015872,"about_ca_system_score_gemma":0.0000549496,"threshold_uncertainty_score":0.43887788},"labels":[],"label_agreement":null},{"id":"W2014803533","doi":"10.1016/j.eururo.2013.11.040","title":"Gender-specific Differences in Clinicopathologic Outcomes Following Radical Cystectomy: An International Multi-institutional Study of More Than 8000 Patients","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Western University; Dalhousie University; Université Laval; McGill University","funders":"","keywords":"Medicine; Cystectomy; Lymphovascular invasion; Stage (stratigraphy); Internal medicine; Oncology; Male gender; Disease; Bladder cancer; Gynecology; Urology; Cancer; Metastasis","score_opus":0.07302302400206007,"score_gpt":0.3270469623309494,"score_spread":0.2540239383288893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014803533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996359,0.000069574635,0.000074547985,0.00013740304,0.000721896,0.0006571477,0.000012984728,0.00004462268,0.0019228306],"genre_scores_gemma":[0.99905986,0.000011993912,0.0002928123,0.0003936102,0.0000747772,0.000033335877,0.000047698908,0.000021277236,0.00006461563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982127,0.00040174337,0.00047942554,0.00040696547,0.00027855686,0.00022060641],"domain_scores_gemma":[0.99938875,0.00006501679,0.00010738033,0.00027207815,0.00006265514,0.000104126775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019528743,0.0001927006,0.00042146727,0.0001784295,0.000051877854,0.000012810829,0.00024563746,0.00005758353,0.00021062096],"category_scores_gemma":[0.000091376955,0.0001332774,0.00010689317,0.00009115599,0.00013243541,0.00012632152,0.00009566062,0.00021643705,0.000098575474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001286082,0.003392014,0.992009,0.0000040330374,0.00010781212,0.00025697434,0.0015269048,0.000007485509,0.00006483571,0.000022535822,0.000013175833,0.0024666155],"study_design_scores_gemma":[0.009426737,0.001911316,0.9879524,0.0000072232997,0.000048282523,0.000010905151,0.00032556025,0.00007156571,0.0000055304695,0.000018124581,0.00012279548,0.00009954395],"about_ca_topic_score_codex":0.00009226505,"about_ca_topic_score_gemma":0.000022140206,"teacher_disagreement_score":0.009298129,"about_ca_system_score_codex":0.000045844226,"about_ca_system_score_gemma":0.000040761406,"threshold_uncertainty_score":0.54348946},"labels":[],"label_agreement":null},{"id":"W2015025295","doi":"10.1016/j.eururo.2009.11.007","title":"Reply to A. Edward Friedman’s Letter to the Editor re: Kim N. Chi, Anders Bjartell, David Dearnaley, et al. Castration-resistant Prostate Cancer: From New Pathophysiology to New Treatment Targets. Eur Urol 2009;56:594–605","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Pathophysiology; Psychoanalysis; Gynecology; Gerontology; Internal medicine; Cancer","score_opus":0.021125117700257556,"score_gpt":0.2981560969134668,"score_spread":0.27703097921320924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015025295","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13313046,0.003443057,0.0004360859,0.85424685,0.0027359298,0.0032421243,0.000297125,0.00019714296,0.002271214],"genre_scores_gemma":[0.16261886,0.0018120309,0.002532797,0.7844466,0.019577883,0.00020022005,0.0005362503,0.00021197266,0.02806341],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961521,0.000661797,0.0005641304,0.0011835041,0.00043633665,0.0010021003],"domain_scores_gemma":[0.9975198,0.00013631773,0.00013794085,0.0009922783,0.00013643298,0.0010772486],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036603963,0.0005218857,0.0006110756,0.00021470578,0.00022826492,0.000084216015,0.00039496805,0.00008840157,0.00043886207],"category_scores_gemma":[0.00015551454,0.00034919957,0.00019263232,0.00039046173,0.000076646764,0.00009636063,0.0001411407,0.000491529,0.0012232234],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005379617,0.00019008484,0.00051090843,0.000004263307,0.00022574519,0.0008362345,0.0041166274,0.0005195155,0.030751213,0.000010110097,0.93386346,0.023592196],"study_design_scores_gemma":[0.0032656551,0.0087381555,0.030411813,0.000032274056,0.00016670825,0.000013553493,0.00007133604,0.000012078154,0.0012604351,0.000087287495,0.9556217,0.0003190114],"about_ca_topic_score_codex":0.0033280891,"about_ca_topic_score_gemma":0.0008629467,"teacher_disagreement_score":0.06980027,"about_ca_system_score_codex":0.00027902276,"about_ca_system_score_gemma":0.000648283,"threshold_uncertainty_score":0.999896},"labels":[],"label_agreement":null},{"id":"W2015195944","doi":"10.1016/s0302-2838(03)00046-0","title":"Digital Rectal Exam Following Prostatectomy: Is It Still Necessary with the Use of PSA?","year":2003,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Rectal examination; Prostatectomy; Radical retropubic prostatectomy; Prostate-specific antigen; Surgery; Urology; Prostate cancer; General surgery; Internal medicine; Cancer","score_opus":0.036612029439406356,"score_gpt":0.25343858042512046,"score_spread":0.2168265509857141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015195944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651248,0.00056156004,0.000078725425,0.0040146024,0.00011823305,0.00046884618,0.000032821532,0.00003921377,0.02956119],"genre_scores_gemma":[0.99393034,0.00007397364,0.00016594764,0.004049399,0.00003468902,0.000016597589,0.000019288964,0.00004473912,0.0016650344],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989691,0.00016075053,0.00019234241,0.00028105313,0.0001431271,0.0002536599],"domain_scores_gemma":[0.99925536,0.00017432765,0.000095467025,0.00034039447,0.000052573112,0.0000818806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014190622,0.00016063881,0.00024361955,0.000045448953,0.000047810936,0.00002954615,0.000072100906,0.000025433326,0.000082313505],"category_scores_gemma":[0.00010740379,0.00009194526,0.000088285626,0.00014583374,0.00012495421,0.000121457735,0.00003831929,0.00014869604,0.000061038176],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024150144,0.0016202093,0.8285645,0.00013516156,0.002271901,0.006868759,0.008585883,0.00021161434,0.0012682274,0.0004468051,0.09832837,0.049283557],"study_design_scores_gemma":[0.0038667277,0.004347475,0.07537531,0.00006282982,0.00038380988,0.00028945188,0.00019402942,0.000020344438,0.0023725822,0.000014579119,0.91286695,0.00020590091],"about_ca_topic_score_codex":0.00000779516,"about_ca_topic_score_gemma":0.000004034545,"teacher_disagreement_score":0.8145386,"about_ca_system_score_codex":0.000027009697,"about_ca_system_score_gemma":0.00006590425,"threshold_uncertainty_score":0.3749419},"labels":[],"label_agreement":null},{"id":"W2016145602","doi":"10.1016/j.eururo.2006.08.015","title":"Complications and Other Surgical Outcomes Associated with Extended Pelvic Lymphadenectomy in Men with Localized Prostate Cancer","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":438,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Dissection (medical); Lymph node; Lymphadenectomy; Prostatectomy; Lymphocele; Prostate cancer; Complication; Urology; Surgery; Cancer; Internal medicine","score_opus":0.012837327043838108,"score_gpt":0.2669463461427052,"score_spread":0.2541090190988671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016145602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94793516,0.0011883077,0.00001214028,0.005419338,0.000014464163,0.00064487994,0.000041238316,0.00007795731,0.04466651],"genre_scores_gemma":[0.9974084,0.0000920241,0.000074941374,0.0013947106,0.000020354582,0.00013471655,0.00005054873,0.000046095793,0.0007782199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890023,0.00017612617,0.0002004389,0.0003374673,0.00011269609,0.00027303855],"domain_scores_gemma":[0.99949896,0.000102201295,0.000092438444,0.00017986802,0.00004849896,0.00007801933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011814959,0.00017210303,0.0003227923,0.00007699167,0.00004662808,0.000013757208,0.000045405028,0.000029894854,0.000040692834],"category_scores_gemma":[0.000009260909,0.00010743999,0.000023239838,0.00015327483,0.00017190205,0.000027104496,0.000024560535,0.00009007203,0.000013339255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004971478,0.0004397609,0.99602515,0.000007989389,0.00014141087,0.0007076375,0.00014061785,0.00008358745,0.000020376498,0.00035639555,0.00033338415,0.0012465237],"study_design_scores_gemma":[0.0121332025,0.0006565225,0.96344626,0.000042988322,0.00011596018,0.00009785877,0.000017299935,0.00010232961,0.00002845542,0.00003727662,0.023198117,0.00012374204],"about_ca_topic_score_codex":0.00048476996,"about_ca_topic_score_gemma":0.00066117704,"teacher_disagreement_score":0.049473222,"about_ca_system_score_codex":0.00009973691,"about_ca_system_score_gemma":0.00006140478,"threshold_uncertainty_score":0.43812755},"labels":[],"label_agreement":null},{"id":"W2016190178","doi":"10.1016/j.eururo.2014.10.018","title":"Patterns of Declining Use and the Adverse Effect of Primary Androgen Deprivation on All-cause Mortality in Elderly Men with Prostate Cancer","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Proportional hazards model; Prostate-specific antigen; Internal medicine; Surveillance, Epidemiology, and End Results; Cancer; Oncology; Cancer registry","score_opus":0.024737156222124003,"score_gpt":0.27792165244058536,"score_spread":0.25318449621846134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016190178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982101,0.00016382895,0.000014364173,0.0003496927,0.000019058954,0.0005878599,0.000014862424,0.000008618527,0.0006316668],"genre_scores_gemma":[0.9986744,0.0006592235,0.000018232946,0.00053812965,0.000017748303,0.000039605773,0.00002312615,0.000017475291,0.000012067259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988615,0.00050030404,0.00022707527,0.0001941618,0.000096734635,0.00012024823],"domain_scores_gemma":[0.9991559,0.00038581892,0.00016439572,0.00022498447,0.000032251603,0.00003666786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058330863,0.00010585987,0.0003065349,0.000046120724,0.000013804444,0.0000030159877,0.000040016257,0.000020054524,0.000005773576],"category_scores_gemma":[0.00008158578,0.000058456015,0.000026889282,0.000047446458,0.00009360669,0.000039307757,0.000033293294,0.00009155508,0.0000010751857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035685962,0.0000729945,0.98747116,0.00008926413,0.00029949666,0.000046036337,0.00061956095,0.000119021235,0.00020123574,0.000054442487,0.000015595913,0.0074426117],"study_design_scores_gemma":[0.009029916,0.003537313,0.98447394,0.00009546829,0.000408166,0.000006848308,0.0000102198055,0.00008898461,0.0020691154,0.0000069751463,0.00022470736,0.000048324844],"about_ca_topic_score_codex":0.00029762625,"about_ca_topic_score_gemma":0.00011305934,"teacher_disagreement_score":0.007394287,"about_ca_system_score_codex":0.000024477953,"about_ca_system_score_gemma":0.000019491283,"threshold_uncertainty_score":0.2383767},"labels":[],"label_agreement":null},{"id":"W2016426743","doi":"10.1016/j.eururo.2014.09.005","title":"MicroRNA Expression Profile of Primary Prostate Cancer Stem Cells as a Source of Biomarkers and Therapeutic Targets","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Prostate cancer; microRNA; Medicine; Biomarker; Cancer research; Stem cell; Prostate; Oncology; Cancer; Pathology; Internal medicine; Biology; Gene","score_opus":0.008117419916393977,"score_gpt":0.2126205975979311,"score_spread":0.2045031776815371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016426743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9273006,0.041571982,0.0006797861,0.023075268,0.00064369186,0.0019259589,0.00035388145,0.00005246471,0.0043964116],"genre_scores_gemma":[0.82673234,0.0012340242,0.0006271788,0.1619994,0.0017191636,0.00006858374,0.001615309,0.0004367669,0.0055672107],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979219,0.0007195047,0.00040367703,0.0005491707,0.0001305814,0.00027515306],"domain_scores_gemma":[0.9987245,0.000028167487,0.0006042195,0.0004904315,0.00010327546,0.000049406706],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022346641,0.00028815167,0.00036622077,0.00009081299,0.000032397293,0.000007269298,0.00026463132,0.0003501763,0.000046462505],"category_scores_gemma":[0.00000889476,0.00026329828,0.00011233818,0.000046489327,0.00035856193,0.0000019601325,0.00023521022,0.0002469069,0.000011117449],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024188004,0.0000218309,0.00019633304,0.00041941315,0.000153622,0.000014971252,0.00007376772,0.000015982963,0.838468,3.6195073e-7,0.15726751,0.0031263148],"study_design_scores_gemma":[0.00044375143,0.00027196264,0.00069419586,0.000044539906,0.00008700028,0.00001904257,0.000003925988,0.000009068007,0.42952043,0.000004945451,0.5687057,0.00019547102],"about_ca_topic_score_codex":0.000011888137,"about_ca_topic_score_gemma":5.6343237e-7,"teacher_disagreement_score":0.41143817,"about_ca_system_score_codex":0.000012661218,"about_ca_system_score_gemma":0.00009401914,"threshold_uncertainty_score":0.99998194},"labels":[],"label_agreement":null},{"id":"W2016904984","doi":"10.1016/j.eururo.2010.07.035","title":"Corrigendum to “The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study” [Eur Urol 2010;57:123–31]","year":2010,"lang":"en","type":"erratum","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Tamsulosin; Dutasteride; Urology; Gynecology; Hyperplasia; General surgery; Internal medicine; Prostate","score_opus":0.028284328523248022,"score_gpt":0.3061825640129076,"score_spread":0.2778982354896596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016904984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756308,0.00028757335,0.0000060565717,0.006903015,0.003027348,0.006780383,0.00014955678,0.000049490962,0.007165737],"genre_scores_gemma":[0.96816415,0.00044967444,0.00007372885,0.002103398,0.00041857528,0.00014955831,0.00040239727,0.00020173883,0.028036755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935396,0.0033599322,0.00093973806,0.00088725856,0.0007528948,0.00052061427],"domain_scores_gemma":[0.9951042,0.002754355,0.000451303,0.0013055678,0.00017444941,0.00021014437],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0021719565,0.0005416434,0.0011754374,0.00024725366,0.00015486378,0.000060385595,0.00056674454,0.00023311007,0.000016953343],"category_scores_gemma":[0.0009637577,0.00026260444,0.0000839763,0.00030449533,0.00049286016,0.00005051199,0.00023426299,0.0027981773,0.00009418688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039486848,0.0057281842,0.54495347,0.00034535915,0.0019447556,0.0030692113,0.01318852,0.0000062019044,0.00014843504,0.000034968143,0.38513017,0.005963881],"study_design_scores_gemma":[0.016772857,0.057786554,0.9020976,0.00026813205,0.00031094623,0.00008956984,0.00039677636,0.00006790161,0.000012895561,0.000016989767,0.021911591,0.0002682299],"about_ca_topic_score_codex":0.00026615208,"about_ca_topic_score_gemma":0.0004911924,"teacher_disagreement_score":0.36321858,"about_ca_system_score_codex":0.000028832039,"about_ca_system_score_gemma":0.0002538215,"threshold_uncertainty_score":0.9999826},"labels":[],"label_agreement":null},{"id":"W2018607732","doi":"10.1016/j.eururo.2005.12.009","title":"The 2002 AJCC pT2 Substages Confer No Prognostic Information on the Rate of Biochemical Recurrence After Radical Prostatectomy","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Universität Hamburg","keywords":"Medicine; Nomogram; Prostatectomy; Biochemical recurrence; Prostate cancer; Urology; Proportional hazards model; Multivariate statistics; Multivariate analysis; Prostate-specific antigen; Univariate; Cohort; Internal medicine; Cancer; Oncology; Statistics","score_opus":0.008152566800249245,"score_gpt":0.2185195331721663,"score_spread":0.21036696637191704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018607732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734554,0.0010175996,0.00002244947,0.008037476,0.00019444413,0.00093782885,0.000036942107,0.000037715912,0.016260086],"genre_scores_gemma":[0.99741954,0.0002736538,0.000018281422,0.0017848653,0.00010807528,0.00011328681,0.000045647816,0.000013965816,0.00022268211],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9988895,0.0002652497,0.0003177077,0.00015580194,0.00012454839,0.00024719056],"domain_scores_gemma":[0.9989799,0.00043122578,0.00012570375,0.00028240122,0.0001298363,0.00005090125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038187054,0.0001379183,0.00015350021,0.00003494436,0.0000735523,0.000024356346,0.000109882014,0.000035516725,0.0001443848],"category_scores_gemma":[0.00030474973,0.00006865352,0.000057384837,0.00009480337,0.0003803565,0.000046006444,0.000043697048,0.00020752764,0.0005776136],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018303832,0.0032977746,0.33175665,0.0005941102,0.0008363518,0.001189862,0.0021601326,0.000100952864,0.008686692,0.03386197,0.54987746,0.04933421],"study_design_scores_gemma":[0.0023934192,0.0021035408,0.5975537,0.00009902146,0.00013038357,0.00004218961,0.000022446979,0.00012980249,0.010290908,0.00019356406,0.38687935,0.00016168077],"about_ca_topic_score_codex":0.0000085015245,"about_ca_topic_score_gemma":0.0000016810116,"teacher_disagreement_score":0.26579702,"about_ca_system_score_codex":0.000025868398,"about_ca_system_score_gemma":0.000046938887,"threshold_uncertainty_score":0.74242467},"labels":[],"label_agreement":null},{"id":"W2018740760","doi":"10.1016/j.eururo.2012.07.047","title":"Patients with Lynch Syndrome Mismatch Repair Gene Mutations Are at Higher Risk for Not Only Upper Tract Urothelial Cancer but Also Bladder Cancer","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Lynch syndrome; MLH1; MSH2; PMS2; MSH6; Medicine; Microsatellite instability; Bladder cancer; Population; Cancer; Colorectal cancer; Oncology; DNA mismatch repair; Internal medicine; Cancer research; Genetics; Biology; Gene","score_opus":0.018593772034594863,"score_gpt":0.26335523169938646,"score_spread":0.2447614596647916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018740760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920331,0.00096168526,0.000065563705,0.0012752879,0.0019231886,0.0012242522,0.0009909292,0.00018287907,0.0013431056],"genre_scores_gemma":[0.9869653,0.00009578437,0.0011930806,0.004125957,0.0008831544,0.00027646407,0.00013565557,0.00021051473,0.0061141057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747777,0.0003004455,0.00043158472,0.00061442447,0.00036253597,0.00081321225],"domain_scores_gemma":[0.9983159,0.00020399418,0.00032858638,0.0005279899,0.00028747253,0.00033605975],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026009523,0.00038531085,0.00049139245,0.000119526696,0.00021428519,0.000012021057,0.00018067888,0.00015071474,0.0027587854],"category_scores_gemma":[0.00012280907,0.00030650644,0.0001892876,0.00015688605,0.00021620166,0.000084672654,0.000097158336,0.0003503067,0.00023148136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015380735,0.00043553664,0.98485076,0.000055484503,0.00048256296,0.000054548844,0.00064295105,0.00024639774,0.0011315362,0.000006886166,0.009300477,0.0012547811],"study_design_scores_gemma":[0.0033893748,0.0011328305,0.88563305,0.00002140811,0.00072012714,0.00011009371,0.000017238983,0.000034012995,0.00075297395,0.0000038125982,0.107863486,0.00032159785],"about_ca_topic_score_codex":0.00023146864,"about_ca_topic_score_gemma":0.00015306208,"teacher_disagreement_score":0.09921772,"about_ca_system_score_codex":0.00029014493,"about_ca_system_score_gemma":0.00017489394,"threshold_uncertainty_score":0.9999387},"labels":[],"label_agreement":null},{"id":"W2019806232","doi":"10.1016/j.eururo.2005.04.008","title":"Laparoscopic Management of Cryptorchidism in Adults","year":2005,"lang":"en","type":"article","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Laparoscopy; Patient satisfaction; Quality of life (healthcare); Endoscopy; General surgery; Surgery; Nursing","score_opus":0.007692630710145776,"score_gpt":0.2484694563342746,"score_spread":0.24077682562412883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019806232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9534172,0.001023343,0.000021617661,0.00047377398,0.00004309157,0.00015333404,0.0000028585875,0.000024367479,0.044840455],"genre_scores_gemma":[0.99817157,0.000080721344,0.0009858033,0.00037515696,0.00004806976,0.0000032291641,0.000013743372,0.000013691704,0.0003080114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994611,0.000056539564,0.00014755306,0.00014387268,0.00006178984,0.00012912846],"domain_scores_gemma":[0.9997061,0.000010261465,0.000036214096,0.00018087594,0.000009706391,0.000056880395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044343407,0.00006663841,0.00012412565,0.000053142136,0.000008159962,0.0000011404944,0.000047632577,0.000013328649,0.00014177928],"category_scores_gemma":[0.000009412109,0.000057210313,0.00003633197,0.000058624213,0.0000324376,0.000013047589,0.000039188395,0.000048206843,0.00025783372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016229806,0.0036621555,0.7723699,0.0005026745,0.0004699137,0.0060097943,0.0007123333,0.00023177412,0.00037630482,0.008908656,0.0018963779,0.20323712],"study_design_scores_gemma":[0.0038738064,0.0003287751,0.9879539,0.0000535883,0.00007905082,0.000018359968,0.000012880319,0.00006605946,0.000052180803,0.000032812524,0.007486171,0.000042424515],"about_ca_topic_score_codex":0.0000068990144,"about_ca_topic_score_gemma":0.0000033533222,"teacher_disagreement_score":0.21558398,"about_ca_system_score_codex":0.000013084377,"about_ca_system_score_gemma":0.0000064295427,"threshold_uncertainty_score":0.3314017},"labels":[],"label_agreement":null},{"id":"W2020201687","doi":"10.1016/j.eururo.2012.12.062","title":"Screening for Bladder Cancer: Rationale, Limitations, Whom to Target, and Perspectives","year":2013,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Context (archaeology); Bladder cancer; Population; Cancer; Urinary system; Randomized controlled trial; Gynecology; Oncology; Intensive care medicine; Internal medicine; Environmental health","score_opus":0.16120086828201,"score_gpt":0.36172099932560897,"score_spread":0.20052013104359898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020201687","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000070145634,0.986299,0.0016660112,0.0018926306,0.00017900199,0.0025574253,0.00018407051,0.00005776814,0.0071571064],"genre_scores_gemma":[0.000041662843,0.9825134,0.007587569,0.0014443533,0.0009812375,0.00072153326,0.00022392294,0.00012614999,0.006360165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99850726,0.00022805206,0.00033409157,0.0005508874,0.00010376388,0.00027597224],"domain_scores_gemma":[0.99907386,0.00027732202,0.0001340425,0.00023551367,0.00009117348,0.00018807055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013667697,0.00032564282,0.0008689194,0.0001938185,0.00015729695,0.00004279126,0.00010336322,0.0000962229,0.00021365542],"category_scores_gemma":[0.00016784489,0.00025859533,0.0001987192,0.00012500766,0.00009662254,0.00004782344,0.000065947635,0.00020679417,0.00013838799],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050336548,0.000058776386,0.000020988247,0.0009190285,0.0007088138,0.000030931427,0.0006955149,0.0000027820288,0.0000014830732,0.00040968822,0.017457709,0.97964394],"study_design_scores_gemma":[0.0006962208,0.0006006546,0.0003469929,0.0003912037,0.0013475224,0.00011643045,0.00007295095,0.000006429041,3.7178708e-7,0.000022518032,0.9961958,0.00020292385],"about_ca_topic_score_codex":0.000019542324,"about_ca_topic_score_gemma":0.0000071553204,"teacher_disagreement_score":0.97944105,"about_ca_system_score_codex":0.00005428524,"about_ca_system_score_gemma":0.00024112343,"threshold_uncertainty_score":0.99998665},"labels":[],"label_agreement":null},{"id":"W2020780443","doi":"10.1016/j.eururo.2006.08.037","title":"Concomitant Carcinoma In Situ Is a Feature of Aggressive Disease in Patients With Organ-Confined TCC at Radical Cystectomy","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Concomitant; Medicine; Bladder cancer; Carcinoma in situ; Transitional cell carcinoma; Urology; Carcinoma; Urethra; Surgery; Cancer; Internal medicine","score_opus":0.004920991018149207,"score_gpt":0.20763285885152905,"score_spread":0.20271186783337983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020780443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899808,0.00073858286,0.0000022795862,0.0009582192,0.000056643665,0.00048268627,0.000056299257,0.000018595172,0.007705886],"genre_scores_gemma":[0.9982953,0.000005942486,0.000030392965,0.0010112652,0.00006822182,0.000008639479,0.00009324804,0.00004068896,0.00044630878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874,0.00021167699,0.00025696668,0.00033818607,0.00017647717,0.00027669873],"domain_scores_gemma":[0.9993148,0.000042139323,0.0001847427,0.0002786694,0.000054488006,0.00012516712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059999104,0.00018743248,0.00037631983,0.00014406443,0.000021188807,0.0000030888036,0.00009139115,0.00005747593,0.00015424007],"category_scores_gemma":[0.000050344446,0.00013891596,0.000048874062,0.00019233547,0.00016253344,0.000023220153,0.000055691857,0.00019840793,0.000039920895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006033155,0.00046840595,0.98825556,0.00003066637,0.000032878677,0.0029110431,0.0003102272,0.0000064574656,0.0004392955,0.000015292557,0.0012557182,0.00024130305],"study_design_scores_gemma":[0.018281097,0.0012254834,0.9777884,0.00005156131,0.00009840148,0.00002244626,0.0000069549355,0.000009859109,0.0005808681,0.000010522117,0.0018104288,0.00011401681],"about_ca_topic_score_codex":0.00015092289,"about_ca_topic_score_gemma":0.00017507693,"teacher_disagreement_score":0.012247942,"about_ca_system_score_codex":0.00009604344,"about_ca_system_score_gemma":0.000097261836,"threshold_uncertainty_score":0.56648284},"labels":[],"label_agreement":null},{"id":"W2021307785","doi":"10.1016/j.eururo.2014.05.021","title":"Re: Modeling Grade Progression in an Active Surveillance Study","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Statistical Methods and Inference","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine","score_opus":0.17409380555863455,"score_gpt":0.41380521737721465,"score_spread":0.2397114118185801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021307785","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23612791,0.00018697581,0.36885336,0.329221,0.002898467,0.0051152315,0.00016301357,0.0010449416,0.05638906],"genre_scores_gemma":[0.7047442,0.000010539911,0.05851053,0.2325607,0.0034695258,0.00007078905,0.00010478175,0.00034669304,0.00018220957],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99076134,0.007196849,0.0005629507,0.00073462346,0.00026267843,0.00048158754],"domain_scores_gemma":[0.9970463,0.0018214433,0.00025389844,0.0007317103,0.00008453641,0.000062117106],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017103022,0.00034451153,0.00065240223,0.00014684394,0.000060149945,0.00003620396,0.0005248678,0.00026849683,0.00008307732],"category_scores_gemma":[0.002054393,0.00028610934,0.00005022913,0.000114834846,0.000081710146,0.000037445956,0.00018358741,0.0020583963,0.00007052325],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092594884,0.0039920597,0.019061206,0.0010303872,0.0003760709,0.019398883,0.012452605,0.0004736579,0.00014624548,0.008021613,0.7984923,0.13562903],"study_design_scores_gemma":[0.008153171,0.019682812,0.023494164,0.0005158429,0.00046667017,0.00017214342,0.00091631425,0.21248353,0.000027957243,0.49633095,0.23183712,0.005919337],"about_ca_topic_score_codex":0.000009735585,"about_ca_topic_score_gemma":0.000039783314,"teacher_disagreement_score":0.56665516,"about_ca_system_score_codex":0.000029103661,"about_ca_system_score_gemma":0.000022129687,"threshold_uncertainty_score":0.9999591},"labels":[],"label_agreement":null},{"id":"W2024892961","doi":"10.1016/j.eururo.2011.07.066","title":"External Validation of Postoperative Nomograms for Prediction of All-Cause Mortality, Cancer-Specific Mortality, and Recurrence in Patients With Urothelial Carcinoma of the Bladder","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Bladder cancer; Receiver operating characteristic; Urology; Cystectomy; Cohort; Area under the curve; Retrospective cohort study; Surgery; Cancer; Oncology; Internal medicine","score_opus":0.08385544484308506,"score_gpt":0.2941928179687829,"score_spread":0.21033737312569784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024892961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735886,0.00013952874,0.000138166,0.00003753523,0.0001696392,0.0008519724,0.00039684988,0.0000053840745,0.00090204057],"genre_scores_gemma":[0.9996412,0.000049120074,0.00011535735,0.00007129408,0.00003474644,0.000023443956,0.00002832378,0.000019850608,0.000016691445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989339,0.00018009575,0.00035679358,0.000226848,0.00017083132,0.00013152494],"domain_scores_gemma":[0.9992701,0.00002387587,0.00023087037,0.00025085118,0.0001846961,0.000039607454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001599836,0.00012280895,0.00024910117,0.00006105918,0.000019872403,0.0000021261044,0.000097603865,0.000037436253,0.00004403778],"category_scores_gemma":[0.000019684961,0.00008235116,0.000046149387,0.00009850845,0.00024658142,0.000055739176,0.000048809008,0.000088112865,4.6140252e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011478029,0.0004036825,0.9940274,0.000037771744,0.00024053972,0.000003226165,0.0017107162,0.0000064671494,0.001344002,0.000113918846,0.000021604199,0.0009429001],"study_design_scores_gemma":[0.0038367512,0.0026411423,0.9820273,0.00004519885,0.0003568662,0.0000037134414,0.00002825938,0.000013801661,0.0108933095,0.00004997323,0.000050326344,0.000053363197],"about_ca_topic_score_codex":0.00045507585,"about_ca_topic_score_gemma":0.00009130984,"teacher_disagreement_score":0.012000074,"about_ca_system_score_codex":0.00001979087,"about_ca_system_score_gemma":0.00005851187,"threshold_uncertainty_score":0.3358183},"labels":[],"label_agreement":null},{"id":"W2025071626","doi":"10.1016/j.eururo.2008.03.037","title":"Preservation of Renal Function Following Partial or Radical Nephrectomy Using 24-Hour Creatinine Clearance","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Nephrectomy; Renal function; Urology; Creatinine; Renal cell carcinoma; Kidney disease; Kidney; Surgery; Internal medicine","score_opus":0.07664359660321447,"score_gpt":0.2792353980431245,"score_spread":0.20259180143991007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025071626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99082565,0.0002906664,0.0030514777,0.00024019778,0.00027355485,0.00024982152,0.000001437348,0.000071381284,0.004995792],"genre_scores_gemma":[0.9951873,0.00002125788,0.00293871,0.00042159148,0.0004712532,0.0000040914856,0.0000236389,0.00004530895,0.0008868502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984239,0.0003844954,0.0003967054,0.00030000551,0.00024374183,0.00025119656],"domain_scores_gemma":[0.9993043,0.00009290644,0.0001521104,0.00028715978,0.000053154625,0.000110398825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002627694,0.00015392368,0.000330857,0.00010078312,0.00009450396,0.000003898246,0.00007564012,0.00006081967,0.00022166192],"category_scores_gemma":[0.00021791045,0.00012107213,0.00013865942,0.00019495125,0.000120317694,0.00009717026,0.000050847797,0.00019595838,0.000058733058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04731348,0.0015442251,0.5702542,0.00018089586,0.0013556564,0.013361209,0.0021257591,0.004751713,0.34163067,0.00028258012,0.0072382097,0.0099613825],"study_design_scores_gemma":[0.010237603,0.007651558,0.8627211,0.00008234397,0.0008930261,0.0019932638,0.000027919285,0.008460967,0.015380614,0.000016420907,0.09223219,0.00030302998],"about_ca_topic_score_codex":0.000039694536,"about_ca_topic_score_gemma":0.0000031225786,"teacher_disagreement_score":0.32625005,"about_ca_system_score_codex":0.000041221523,"about_ca_system_score_gemma":0.00008708957,"threshold_uncertainty_score":0.49371782},"labels":[],"label_agreement":null},{"id":"W2025897548","doi":"10.1016/j.eururo.2014.08.012","title":"Toward Predictive Signatures of Enzalutamide Response and Resistance","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Enzalutamide; Internal medicine; Prostate cancer; Androgen receptor","score_opus":0.026024943631652444,"score_gpt":0.2793693159428512,"score_spread":0.2533443723111988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025897548","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023354886,0.013396364,0.000085214844,0.9067846,0.00028018665,0.0007508348,0.00014845004,0.00010332858,0.055096146],"genre_scores_gemma":[0.3494153,0.0010428247,0.00032552375,0.6091199,0.0028041292,0.000026089216,0.00034193054,0.00019189218,0.036732405],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99704194,0.0015036955,0.0002869146,0.00050147466,0.00028906832,0.00037687883],"domain_scores_gemma":[0.99848026,0.00068842154,0.00016612868,0.00044061072,0.00013811151,0.00008649495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006742896,0.00025585858,0.00053762767,0.00024735177,0.000042339416,0.000008968897,0.00017370383,0.00034268678,0.0000709395],"category_scores_gemma":[0.00043248705,0.00019547786,0.00009414671,0.00009321489,0.00055788935,0.000019803409,0.00012486741,0.001491713,0.00004280659],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012316971,0.000026527912,0.00032773684,0.00040389874,0.00026894466,0.005717501,0.0004234578,8.4047997e-7,0.0017805515,0.000020715652,0.97846586,0.00024697062],"study_design_scores_gemma":[0.0017311483,0.001880776,0.013663358,0.00010789135,0.00021012417,0.000100341575,0.000009517737,0.000004608868,0.00031351324,0.00013617022,0.9816964,0.0001461025],"about_ca_topic_score_codex":0.0000036619422,"about_ca_topic_score_gemma":8.155256e-7,"teacher_disagreement_score":0.3260604,"about_ca_system_score_codex":0.00004762449,"about_ca_system_score_gemma":0.00012922256,"threshold_uncertainty_score":0.7971356},"labels":[],"label_agreement":null},{"id":"W2026246384","doi":"10.1016/j.eururo.2015.02.007","title":"Corrigendum to “Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort” [Eur Urol 2010;57:300–9]","year":2015,"lang":"en","type":"erratum","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University; Université Laval; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Urothelial carcinoma; Urology; Cohort; Carcinoma; Oncology; Internal medicine; Bladder cancer; Cancer","score_opus":0.03272047341148435,"score_gpt":0.294395894857815,"score_spread":0.2616754214463306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026246384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9596305,0.000098909426,0.000046849942,0.00076918694,0.014873244,0.0017894121,0.010027997,0.00013663103,0.012627283],"genre_scores_gemma":[0.94980115,0.000073950505,0.00042195196,0.0027282515,0.0028618504,0.00003414855,0.012707191,0.0003264249,0.031045068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953102,0.00085180195,0.0012279026,0.0013238561,0.0007938871,0.00049239444],"domain_scores_gemma":[0.9967599,0.00013067853,0.0007499922,0.0010272601,0.0005324804,0.00079972646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041856692,0.0007268616,0.0016743832,0.00028778802,0.00006726362,0.00003623167,0.0004733167,0.000434577,0.000114567425],"category_scores_gemma":[0.00040901016,0.000500975,0.00013605777,0.00014691391,0.0005000508,0.000090138354,0.00019309993,0.0011438653,0.00007175803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0176754,0.0009136229,0.83878267,0.000017751192,0.0011814999,0.00090811664,0.0002473832,3.979309e-7,0.0000034025388,0.0000023654454,0.1391018,0.0011655755],"study_design_scores_gemma":[0.016531125,0.009691127,0.8244328,0.00005355467,0.0013544661,0.0000391356,0.000010681405,0.000028813412,0.0000035607056,0.0000024952562,0.14748214,0.00037008894],"about_ca_topic_score_codex":0.0009164457,"about_ca_topic_score_gemma":0.00025954432,"teacher_disagreement_score":0.018417787,"about_ca_system_score_codex":0.00010189977,"about_ca_system_score_gemma":0.00051153277,"threshold_uncertainty_score":0.9997442},"labels":[],"label_agreement":null},{"id":"W2026724100","doi":"10.1016/j.eururo.2006.11.018","title":"Prospective Evaluation of Quality of Life in Prostate Cancer Patients Receiving Combined Treatment of Postoperative Radiotherapy Plus Androgen Suppression for PT3 or Positive Resection Margin after Radical Prostatectomy","year":2006,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Medical Research Council","keywords":"Medicine; Prostatectomy; Prostate cancer; Quality of life (healthcare); Prospective cohort study; Radiation therapy; Urology; Erectile dysfunction; Androgen deprivation therapy; Sexual function; Prostate; Surgery; Cancer; Internal medicine","score_opus":0.022587241528012166,"score_gpt":0.3393584340488708,"score_spread":0.3167711925208586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026724100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9535324,0.0033617849,0.000011507641,0.0002530609,0.028665217,0.010558608,0.0034140178,0.000017996752,0.00018540533],"genre_scores_gemma":[0.98297626,0.0017894483,0.00016977383,0.00004497584,0.009607048,0.0024768976,0.0026448953,0.0001178334,0.00017285436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951512,0.0017144716,0.00128899,0.000734771,0.0007699771,0.00034055684],"domain_scores_gemma":[0.9959255,0.00075159123,0.0011287824,0.00032569093,0.0017710584,0.00009737266],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001023486,0.00043711238,0.0015084603,0.0003071906,0.000043216674,0.000008221133,0.00008895432,0.00025951787,0.000057648977],"category_scores_gemma":[0.0007791192,0.00031618532,0.00020751375,0.00024176716,0.0002531013,0.00007946188,0.000038748574,0.00023714782,5.5639697e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41896385,0.011457462,0.48016474,0.0018643589,0.0028558078,0.00007987902,0.01226746,0.0007457686,0.0021511528,0.000014851081,0.05523319,0.014201482],"study_design_scores_gemma":[0.10734896,0.06225312,0.80444205,0.0013239386,0.0011751975,0.0000020150314,0.00007998494,0.00033460316,0.014147842,0.000051779345,0.008356398,0.0004840844],"about_ca_topic_score_codex":0.00097457605,"about_ca_topic_score_gemma":0.0006715187,"teacher_disagreement_score":0.32427734,"about_ca_system_score_codex":0.0017941144,"about_ca_system_score_gemma":0.0014055687,"threshold_uncertainty_score":0.999929},"labels":[],"label_agreement":null},{"id":"W2027130044","doi":"10.1016/j.eururo.2012.05.007","title":"Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic Acid","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bone health and treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Zoledronic acid; Nomogram; Placebo; Urology; Prostate-specific antigen; Internal medicine; Clinical endpoint; Oncology; Cancer; Randomized controlled trial; Pathology","score_opus":0.019149799200020967,"score_gpt":0.26646182306731503,"score_spread":0.24731202386729406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027130044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962383,0.0017775963,0.0000040686978,0.00030933318,0.000049717757,0.0011176766,0.0002246677,0.000050274735,0.0002283741],"genre_scores_gemma":[0.9979298,0.00019846548,0.00068056077,0.00041076777,0.000028833108,0.000045728502,0.0003154279,0.000070559916,0.00031983503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834,0.00021577986,0.00035024015,0.0003608434,0.0001895514,0.00054358126],"domain_scores_gemma":[0.9991712,0.000042670556,0.00016286244,0.00026894695,0.00007743948,0.00027689425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010773013,0.00028568352,0.000506922,0.00011606427,0.000066296896,0.000016845053,0.000041074665,0.000040515657,0.000079338766],"category_scores_gemma":[0.000013523395,0.00016344535,0.000018562485,0.00016148866,0.0001434625,0.00011401798,0.000027521255,0.00017627666,0.000030047295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011290538,0.0006497496,0.9839097,0.000024977493,0.00016298408,0.00025975253,0.0006374161,0.0000030864348,0.0004289317,0.0000032481223,0.000043214844,0.0025863573],"study_design_scores_gemma":[0.011990707,0.0044163577,0.98004156,0.000039621762,0.0001986837,0.000019185089,0.00004461608,0.000004539399,0.00027494814,8.925449e-7,0.0027987235,0.00017014235],"about_ca_topic_score_codex":0.0005256968,"about_ca_topic_score_gemma":0.0012273553,"teacher_disagreement_score":0.0038681615,"about_ca_system_score_codex":0.00006167136,"about_ca_system_score_gemma":0.000080840844,"threshold_uncertainty_score":0.6665108},"labels":[],"label_agreement":null},{"id":"W2027142966","doi":"10.1016/j.eururo.2007.08.006","title":"Extended and Saturation Prostatic Biopsy in the Diagnosis and Characterisation of Prostate Cancer: A Critical Analysis of the Literature","year":2007,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":348,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Biopsy; Prostate cancer; Prostate biopsy; Prostate; Radiology; Local anesthesia; Cancer; Internal medicine","score_opus":0.03952540476826056,"score_gpt":0.3592309837332452,"score_spread":0.31970557896498464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027142966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045743164,0.9515587,0.0000011413831,0.001066944,0.00006936485,0.0012353075,0.00025290635,0.000004863026,0.0000676302],"genre_scores_gemma":[0.12288134,0.8764207,0.000022694634,0.00027155443,0.00003753885,0.00017215672,0.00016654326,0.000018254004,0.000009233991],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99811655,0.0006990489,0.00056859304,0.00031213896,0.00014418627,0.00015946655],"domain_scores_gemma":[0.99870235,0.00052434584,0.00034814925,0.0002986044,0.000088107154,0.000038472237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005245445,0.00021282851,0.00095375243,0.00031113022,0.00003530793,0.000020016367,0.000083024155,0.00008977568,0.000008802823],"category_scores_gemma":[0.00021656582,0.00010580755,0.00016543483,0.00086970744,0.00024552457,0.000038201382,0.0000523639,0.00027952663,4.0313057e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105138206,0.000287622,0.032217033,0.008291714,0.0009030859,0.00013813887,0.0046106684,4.4519103e-7,0.000007841784,0.00027599293,0.000044782773,0.95311755],"study_design_scores_gemma":[0.00081436714,0.00084183365,0.8679621,0.006756501,0.015794655,0.00017721562,0.000086669126,0.00002088922,0.000012704476,0.000038392074,0.107295156,0.00019949654],"about_ca_topic_score_codex":0.000021908121,"about_ca_topic_score_gemma":0.000021547754,"teacher_disagreement_score":0.95291805,"about_ca_system_score_codex":0.000036870602,"about_ca_system_score_gemma":0.000064318556,"threshold_uncertainty_score":0.43147066},"labels":[],"label_agreement":null},{"id":"W2027576789","doi":"10.1016/j.eururo.2014.11.025","title":"Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Clinical Reasoning and Diagnostic Skills","field":"Medicine","cited_by":444,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; University of North Carolina at Chapel Hill; Cleveland Clinic; University College London; Albert-Ludwigs-Universität Freiburg; Universiteit Maastricht; ZonMw; University of Oxford; National Institute for Health and Care Research; Cancer Research UK; University of Ottawa; Vanderbilt University; Memorial Sloan-Kettering Cancer Center","keywords":"Tripod (photography); Medicine; Checklist; Statement (logic); Psychology","score_opus":0.239752564895561,"score_gpt":0.38943571751661027,"score_spread":0.14968315262104928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027576789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92975444,0.00070047914,0.050397266,0.011279725,0.0008219432,0.0032775851,0.00042210947,0.00023229091,0.0031141725],"genre_scores_gemma":[0.9930025,0.000087272085,0.004869513,0.0009989733,0.00021897328,0.0002709874,0.0001358691,0.000040453488,0.00037548144],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9968627,0.00027258348,0.0018772117,0.00035926406,0.0003083103,0.00031994662],"domain_scores_gemma":[0.9938812,0.0042268354,0.0010951804,0.00032716096,0.00025548023,0.00021410546],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004277196,0.00015748647,0.00045489575,0.00006593817,0.000069183814,0.000012573366,0.0001516535,0.00007238132,0.00003044008],"category_scores_gemma":[0.079502285,0.00009480972,0.00014771734,0.0001491529,0.000119673125,0.000035526857,0.000062669125,0.00020592373,0.000007935475],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011738452,0.007667954,0.58969903,0.00032006874,0.0016658999,0.00048387793,0.017102703,0.0501877,0.00025706712,0.0005838615,0.17589226,0.14440113],"study_design_scores_gemma":[0.048403192,0.029015174,0.35035825,0.0017164784,0.0070146364,0.00048186097,0.0016548993,0.46932995,0.0027878413,0.0014026146,0.086890504,0.00094460667],"about_ca_topic_score_codex":0.00003063783,"about_ca_topic_score_gemma":0.000008196785,"teacher_disagreement_score":0.41914225,"about_ca_system_score_codex":0.00003368757,"about_ca_system_score_gemma":0.00024845902,"threshold_uncertainty_score":0.92825145},"labels":[],"label_agreement":null},{"id":"W2027932599","doi":"10.1016/j.eururo.2014.03.036","title":"Re: Architectural Heterogeneity and Cribriform Pattern Predict Adverse Clinical Outcome for Gleason Grade 4 Prostatic Adenocarcinoma","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Cribriform; Prostatic adenocarcinoma; Adenocarcinoma; Prostate cancer; Outcome (game theory); Oncology; Urology; Internal medicine; Carcinoma; Cancer","score_opus":0.07359705570210139,"score_gpt":0.33549443023646475,"score_spread":0.26189737453436335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027932599","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3531859,0.0022095689,0.00058029185,0.63743883,0.0014254703,0.003716386,0.0005731159,0.00022612495,0.00064432435],"genre_scores_gemma":[0.4912109,0.0001304764,0.00024960685,0.5031995,0.0034588506,0.00015148788,0.0011958615,0.00016547569,0.00023779253],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99616134,0.00069666625,0.001008063,0.0011211432,0.0002511353,0.0007616255],"domain_scores_gemma":[0.9977201,0.0007086569,0.00043966863,0.00078420347,0.00007760288,0.0002697365],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059704046,0.00058990787,0.0012094455,0.00013723178,0.00010334301,0.0000281874,0.00022391223,0.0003898904,0.000039570576],"category_scores_gemma":[0.0002793025,0.00045700878,0.00045954017,0.0000485711,0.0003617154,0.00003604073,0.00018409116,0.0014429648,0.00011247242],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032558967,0.000111286325,0.59832656,0.0007504795,0.00045617676,0.0021981555,0.00010010529,0.0000013544179,0.000002032663,0.0000016597215,0.38894594,0.008780649],"study_design_scores_gemma":[0.0046887407,0.0062394748,0.48012176,0.00009020785,0.0011498693,0.0005396052,0.000005484949,0.00012981256,0.0000126250025,0.00003054948,0.50664365,0.0003482474],"about_ca_topic_score_codex":0.000027422015,"about_ca_topic_score_gemma":0.000026948574,"teacher_disagreement_score":0.138025,"about_ca_system_score_codex":0.0000846919,"about_ca_system_score_gemma":0.00006205755,"threshold_uncertainty_score":0.99978817},"labels":[],"label_agreement":null},{"id":"W2028039306","doi":"10.1016/j.eururo.2010.11.026","title":"A Panel of TMPRSS2:ERG Fusion Transcript Markers for Urine-Based Prostate Cancer Detection with High Specificity and Sensitivity","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Prostate cancer; TMPRSS2; Internal medicine; Prostate; Urine; PCA3; Fusion gene; Erg; Biopsy; Urology; Cancer; Oncology; Disease; Ophthalmology; Biology","score_opus":0.019534251122526505,"score_gpt":0.2542456640168484,"score_spread":0.2347114128943219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028039306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99592113,0.000107313754,0.0006513792,0.0017674835,0.00016899858,0.00077676785,0.00006694844,0.00003931318,0.0005006509],"genre_scores_gemma":[0.9987092,0.000090144225,0.00035318252,0.00016085364,0.00012144338,0.000028191434,0.000029715407,0.00003386124,0.0004734086],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990518,0.00014981828,0.00014362653,0.0002921982,0.0001173969,0.0002451733],"domain_scores_gemma":[0.99942726,0.00009145924,0.000066668756,0.00017356563,0.00013565869,0.00010541606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036954964,0.00013167788,0.00021998117,0.0000951521,0.000076473785,0.000006712268,0.00002541645,0.00004810342,0.00004127613],"category_scores_gemma":[0.00003317587,0.00009233755,0.000041598374,0.00009596633,0.0002584365,0.000030964835,0.000015777905,0.00023841609,0.0000022754639],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01866239,0.00018307957,0.018491546,0.00020618168,0.000090909125,0.0002523936,0.00023427444,0.00002898713,0.9372023,0.000018059429,0.000115288276,0.024514593],"study_design_scores_gemma":[0.014610807,0.0056451214,0.7081212,0.00005081345,0.00030370918,0.00018048499,0.000058195692,0.002081268,0.25289813,0.000028538045,0.015770048,0.00025168768],"about_ca_topic_score_codex":0.00018562957,"about_ca_topic_score_gemma":0.0005881487,"teacher_disagreement_score":0.6896297,"about_ca_system_score_codex":0.000020083238,"about_ca_system_score_gemma":0.000083397565,"threshold_uncertainty_score":0.37654158},"labels":[],"label_agreement":null},{"id":"W2028525468","doi":"10.1016/j.eururo.2007.11.037","title":"Toxicities Associated with the Administration of Sorafenib, Sunitinib, and Temsirolimus and Their Management in Patients with Metastatic Renal Cell Carcinoma","year":2007,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Sorafenib; Sunitinib; Temsirolimus; Medicine; Renal cell carcinoma; Oncology; Side effect (computer science); Internal medicine; Pharmacology; Dosing; Hepatocellular carcinoma; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway","score_opus":0.03891092092891279,"score_gpt":0.25909736985387083,"score_spread":0.22018644892495803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028525468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50520766,0.48466724,0.000010686916,0.000036140304,0.000018680492,0.0015923963,0.000047030953,0.000015876652,0.008404314],"genre_scores_gemma":[0.85386074,0.14519419,0.000071167844,0.00010978688,0.00002341296,0.000026673883,0.00031086867,0.00008252364,0.00032061918],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978228,0.0007794419,0.0004971102,0.00040208604,0.00020542245,0.0002930978],"domain_scores_gemma":[0.9986958,0.00034092445,0.00047342817,0.00033164662,0.000071553215,0.00008665732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005025783,0.0004228744,0.0010764446,0.00027839662,0.00004933191,0.000015255647,0.00010542665,0.00006596239,0.000008737891],"category_scores_gemma":[0.000016997414,0.00021140103,0.00006874591,0.00022011489,0.00030977905,0.000027296159,0.00008030848,0.0003265822,0.000002618021],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008861819,0.0035698456,0.02009339,0.025838511,0.0049902205,0.010453703,0.0040405933,0.000008285382,0.0000070609876,0.00030729306,0.00034148243,0.9214878],"study_design_scores_gemma":[0.020016432,0.038221702,0.7340764,0.0046296273,0.013306881,0.000917322,0.0010461739,0.000010441038,0.00005902573,0.00001703948,0.18641195,0.0012870071],"about_ca_topic_score_codex":0.000007324032,"about_ca_topic_score_gemma":0.000039004135,"teacher_disagreement_score":0.92020077,"about_ca_system_score_codex":0.000059683698,"about_ca_system_score_gemma":0.00007376834,"threshold_uncertainty_score":0.86206836},"labels":[],"label_agreement":null},{"id":"W2028724485","doi":"10.1016/j.eururo.2006.05.045","title":"A Nomogram for Staging of Exclusive Nonobturator Lymph Node Metastases in Men with Localized Prostate Cancer","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Prostate cancer; Lymph node; Logistic regression; Dissection (medical); Stage (stratigraphy); Prostate; Lymph; Cancer; Radiology; Urology; Oncology; Internal medicine; Pathology","score_opus":0.011251005333552885,"score_gpt":0.2660012317747539,"score_spread":0.254750226441201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028724485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850666,0.0036958754,0.00064797845,0.0024765427,0.00007072026,0.0016113985,0.0003108847,0.000054490618,0.006065546],"genre_scores_gemma":[0.9965494,0.00023370271,0.0015942932,0.0008255938,0.00008140557,0.000288717,0.00011760548,0.000052310457,0.00025695655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988216,0.00011671072,0.00031626,0.00032705854,0.000095315634,0.00032302283],"domain_scores_gemma":[0.99939567,0.00009462256,0.0001603533,0.00020339282,0.00008123195,0.00006475094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015237911,0.00017873064,0.00040971197,0.000118433665,0.000032292963,0.000008076891,0.000064142965,0.000022433162,0.00003831638],"category_scores_gemma":[0.000016885188,0.00012870214,0.000061319544,0.00016003048,0.000118345015,0.000040550436,0.000038718652,0.00006417676,0.0000041637813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00817744,0.0014271652,0.94850594,0.00039891916,0.0005706271,0.0012708624,0.0010601208,0.0032564234,0.0043762033,0.0006814214,0.002731713,0.027543146],"study_design_scores_gemma":[0.06851624,0.0067955707,0.7143431,0.00051840895,0.0016932443,0.00013275494,0.0005683525,0.0025251673,0.03482914,0.0002907879,0.16889189,0.0008953407],"about_ca_topic_score_codex":0.00036004733,"about_ca_topic_score_gemma":0.000058557634,"teacher_disagreement_score":0.23416287,"about_ca_system_score_codex":0.000077683944,"about_ca_system_score_gemma":0.00011459445,"threshold_uncertainty_score":0.52483207},"labels":[],"label_agreement":null},{"id":"W2028807911","doi":"10.1016/j.eururo.2012.11.039","title":"Impact of Smoking and Smoking Cessation on Outcomes in Bladder Cancer Patients Treated with Radical Cystectomy","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Smoking cessation; Internal medicine; Cumulative incidence; Cancer; Disease; Risk factor; Logistic regression; Incidence (geometry); Oncology; Surgery; Cohort; Pathology","score_opus":0.01815115193923157,"score_gpt":0.29360139824940223,"score_spread":0.2754502463101707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028807911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994565,0.00019369445,0.000004510333,0.000080748825,0.00006072855,0.00022342373,0.0000151720415,0.000021774593,0.004834915],"genre_scores_gemma":[0.99950707,0.000021086376,0.000010584484,0.00029008134,0.000063802516,0.000009096651,0.000018387356,0.00003266668,0.000047240253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990806,0.00016499846,0.00018775693,0.00017445187,0.0001396392,0.00025255527],"domain_scores_gemma":[0.99960077,0.00005339373,0.000089508496,0.00012681428,0.000032263026,0.00009722727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011184029,0.00014908706,0.00027644745,0.00014263099,0.000025088675,0.0000039366005,0.000036143567,0.000046014156,0.00011114536],"category_scores_gemma":[0.000029703584,0.00009503232,0.000040506377,0.00011096706,0.00007412624,0.000060743932,0.000019724837,0.00014718513,0.0000036806225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006426524,0.0003747191,0.99471074,0.000009928283,0.00026651155,0.000020477704,0.00050523377,0.000013114586,0.00008604109,0.000007920578,0.00003165446,0.0033309867],"study_design_scores_gemma":[0.0063034096,0.0020067631,0.9911025,0.000029118304,0.00017293119,0.000011987046,0.00000774672,0.000008478561,0.00013959885,0.0000014585778,0.00013690237,0.00007911247],"about_ca_topic_score_codex":0.00040586176,"about_ca_topic_score_gemma":0.000017560627,"teacher_disagreement_score":0.005660757,"about_ca_system_score_codex":0.00008352301,"about_ca_system_score_gemma":0.000027717015,"threshold_uncertainty_score":0.38753057},"labels":[],"label_agreement":null},{"id":"W2029355551","doi":"10.1016/s0302-2838(02)00257-9","title":"Acute Toxicity of Conventional Radiation Therapy for High-Risk Prostate Cancer in EORTC Trial 22863","year":2002,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Fondation ARC pour la Recherche sur le Cancer; Fondation Cancer","keywords":"Medicine; Toxicity; Prostate cancer; Acute toxicity; Radiation therapy; Cancer; Internal medicine; Prostate; Univariate analysis; Clinical trial; Oncology; Urology; Surgery; Multivariate analysis","score_opus":0.021937752698849747,"score_gpt":0.28269429737276475,"score_spread":0.260756544673915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029355551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928742,0.0020730137,0.000043955246,0.0023632678,0.0004035109,0.0013824782,0.00028180482,0.000020030593,0.00055770844],"genre_scores_gemma":[0.9888909,0.0094577065,0.00008418371,0.0006934476,0.00023725019,0.00020648872,0.00007776894,0.000023700832,0.00032856048],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989859,0.00016473915,0.000339318,0.00023552695,0.00009054581,0.00018400844],"domain_scores_gemma":[0.99944353,0.00010841801,0.00020168684,0.00014075455,0.00005572546,0.000049890445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024142403,0.00010798905,0.00025966932,0.00007912985,0.000029624238,0.000004118032,0.000048473707,0.000035275887,0.00044138942],"category_scores_gemma":[0.000051657567,0.00008887807,0.00008270257,0.00008441668,0.00005968251,0.000034639004,0.000013120972,0.00009110808,0.000017588114],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11081064,0.004631429,0.30522197,0.00008614992,0.0016400444,0.00026713737,0.002022417,0.00029115495,0.0042999955,0.002424548,0.017703725,0.55060077],"study_design_scores_gemma":[0.30859765,0.018902153,0.597488,0.00003840747,0.0004459578,0.000015705118,0.0000129804885,0.0007411898,0.01232721,0.0005936128,0.06055387,0.00028330137],"about_ca_topic_score_codex":0.000039940955,"about_ca_topic_score_gemma":0.000018566641,"teacher_disagreement_score":0.55031747,"about_ca_system_score_codex":0.000060416158,"about_ca_system_score_gemma":0.000031261232,"threshold_uncertainty_score":0.48329046},"labels":[],"label_agreement":null},{"id":"W2029459237","doi":"10.1016/j.eururo.2013.12.039","title":"Re: Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Phospholipid; Prostate; Cancer; Internal medicine; Oncology; Biochemistry","score_opus":0.009964041133385063,"score_gpt":0.2332314889784965,"score_spread":0.22326744784511143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029459237","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47129154,0.023698932,0.00014977965,0.42028916,0.051292803,0.0041144583,0.000824969,0.00012187789,0.028216464],"genre_scores_gemma":[0.055467356,0.014467047,0.00006957918,0.7372296,0.18796143,0.00023858462,0.00079287513,0.00024064045,0.003532886],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99601156,0.0019238875,0.00041539833,0.00086276256,0.00017597021,0.0006104234],"domain_scores_gemma":[0.99878997,0.00008837798,0.00030210413,0.0007109256,0.000052938376,0.000055691908],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009744028,0.00042828688,0.0004613203,0.00008303392,0.00011396536,0.00005373108,0.0005520065,0.0005176015,0.000038800965],"category_scores_gemma":[0.00020848829,0.0003251718,0.00014604341,0.000105442065,0.0002673704,0.0000031336847,0.00018918951,0.001496549,0.00003547246],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031612737,0.000021208425,0.0007176391,0.000026725895,0.000078975485,0.000009315232,0.00027965553,0.000015218185,0.0007203947,0.0000034121904,0.9910563,0.003909836],"study_design_scores_gemma":[0.010060329,0.00071442453,0.001561572,0.000006729215,0.00012781427,0.000043425007,0.00001212347,0.000008637019,0.00016526341,0.000016352871,0.98692423,0.00035907817],"about_ca_topic_score_codex":0.00015939193,"about_ca_topic_score_gemma":0.0003171306,"teacher_disagreement_score":0.4158242,"about_ca_system_score_codex":0.000013827859,"about_ca_system_score_gemma":0.000114748145,"threshold_uncertainty_score":0.99992},"labels":[],"label_agreement":null},{"id":"W2030363926","doi":"10.1016/j.eururo.2012.10.053","title":"Reply from Authors re: Brian R. Matlaga. How Do We Manage Infected, Obstructed Hydronephrosis? Eur Urol 2013;64:93–4","year":2012,"lang":"en","type":"letter","venue":"European Urology","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Hydronephrosis; General surgery; Urology; Gynecology; Internal medicine; Urinary system","score_opus":0.020301271598136456,"score_gpt":0.23626420837407297,"score_spread":0.2159629367759365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030363926","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038972404,0.0079222005,0.000045564026,0.92692363,0.004504783,0.0014777011,0.000603097,0.00095350324,0.018597096],"genre_scores_gemma":[0.09279842,0.002113272,0.00083264033,0.83929586,0.01630981,0.00006665587,0.0059556426,0.0010538485,0.04157382],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9920429,0.0021645005,0.0010748481,0.0020554017,0.0008015622,0.0018607933],"domain_scores_gemma":[0.99469507,0.00033979653,0.0009817037,0.0030296536,0.00017586758,0.00077789056],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.00048781006,0.0014713239,0.0018347194,0.00066480617,0.00026376895,0.00019327985,0.0008631672,0.0013848861,0.0022447696],"category_scores_gemma":[0.00039317438,0.0013121245,0.0006601148,0.00046041206,0.00041430793,0.00022953014,0.00063875905,0.0042721634,0.006137593],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031708516,0.00021298676,0.009883432,0.0001507406,0.0013789106,0.0074051605,0.00046277014,0.0000010868702,0.00033399428,0.000016842985,0.97652507,0.0033118988],"study_design_scores_gemma":[0.0034417987,0.00063333474,0.11429768,0.0001354851,0.0024861984,0.00072413817,0.000014928393,0.000015915053,0.000020004642,0.000097938086,0.87726223,0.00087034283],"about_ca_topic_score_codex":0.0003707254,"about_ca_topic_score_gemma":0.000007564716,"teacher_disagreement_score":0.10441425,"about_ca_system_score_codex":0.0001823254,"about_ca_system_score_gemma":0.000100762074,"threshold_uncertainty_score":0.99991155},"labels":[],"label_agreement":null},{"id":"W2030521036","doi":"10.1016/j.eururo.2014.07.010","title":"Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them","year":2014,"lang":"en","type":"review","venue":"European Urology","topic":"Bone health and treatments","field":"Medicine","cited_by":815,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Androgen deprivation therapy; Gynecomastia; Prostate cancer; Adverse effect; Internal medicine; Sexual dysfunction; Enzalutamide; Osteoporosis; Oncology; Tamoxifen; Endocrinology; Breast cancer; Cancer; Androgen receptor","score_opus":0.04408661940243325,"score_gpt":0.32263100403410644,"score_spread":0.2785443846316732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030521036","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0069792597,0.9857341,0.000028217397,0.00007462939,0.00012369473,0.0011333213,0.000005252913,0.00003681107,0.0058846916],"genre_scores_gemma":[0.0079280045,0.9909634,0.00012841789,0.00063331163,0.00006954243,0.000024718123,0.000051712344,0.000054671673,0.00014619756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99863774,0.0004827927,0.0003329451,0.00027948257,0.00007049683,0.00019656245],"domain_scores_gemma":[0.9991482,0.00018416952,0.00019159375,0.00028657613,0.000029359646,0.00016011928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018338473,0.00022470484,0.0009601948,0.00009925423,0.000028535434,0.0000038195344,0.00006643097,0.00009744574,0.000013616579],"category_scores_gemma":[0.000062359475,0.00015614125,0.00010868752,0.00009057243,0.00005646739,0.00001802299,0.000039944982,0.00015462589,0.00022175377],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006570406,0.000054009353,0.00025141583,0.007013656,0.0001887122,0.00013654755,0.000088708366,1.0529176e-7,0.0000023585926,0.00020662784,0.00015865252,0.9918335],"study_design_scores_gemma":[0.0011062123,0.0011587811,0.0031831977,0.0010383321,0.00045527844,0.00016741182,0.000001989913,5.4806e-7,0.0000047482304,0.00003067352,0.9927526,0.00010024041],"about_ca_topic_score_codex":0.0000092458,"about_ca_topic_score_gemma":0.0000014173065,"teacher_disagreement_score":0.99259394,"about_ca_system_score_codex":0.000011901194,"about_ca_system_score_gemma":0.0001091523,"threshold_uncertainty_score":0.63672554},"labels":[],"label_agreement":null},{"id":"W2030602028","doi":"10.1016/j.eururo.2014.06.052","title":"Efficacy of the β3-adrenoceptor Agonist Mirabegron for the Treatment of Overactive Bladder by Severity of Incontinence at Baseline: A Post Hoc Analysis of Pooled Data from Three Randomised Phase 3 Trials","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mirabegron; Medicine; Overactive bladder; Post-hoc analysis; Urology; Agonist; Post hoc; Nocturia; Placebo; Internal medicine; Urinary system; Receptor; Alternative medicine","score_opus":0.0797696875776314,"score_gpt":0.36172148129836623,"score_spread":0.2819517937207348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030602028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7801869,0.009139837,0.0016905697,0.13466331,0.0004699654,0.009516643,0.06353628,0.00002814734,0.0007683635],"genre_scores_gemma":[0.92464197,0.0029531687,0.0003338973,0.028620288,0.0021809053,0.00012261717,0.039068364,0.00023280173,0.0018460045],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923064,0.004387083,0.0016330563,0.0007459344,0.00055425474,0.00037325727],"domain_scores_gemma":[0.97954535,0.015415442,0.00197881,0.0025076098,0.0004796521,0.000073151474],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003134167,0.0004365249,0.002788319,0.00023764705,0.000094944146,0.000009002476,0.0010768845,0.00025065243,0.0014269357],"category_scores_gemma":[0.0026908312,0.0002340462,0.0010998043,0.00036909373,0.000764976,0.000039123166,0.0003503224,0.0005123189,0.000006463063],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31714737,0.004254475,0.0015603793,0.0004206084,0.046301574,0.000094708914,0.0013380984,0.000023125476,0.052518506,0.0000012128037,0.5649171,0.011422815],"study_design_scores_gemma":[0.23607387,0.02236799,0.016141227,0.00014756434,0.083220266,0.000022315537,0.00007930551,0.0045892866,0.01997996,0.000016081232,0.6167617,0.00060043845],"about_ca_topic_score_codex":0.00060889975,"about_ca_topic_score_gemma":0.00008725166,"teacher_disagreement_score":0.14445508,"about_ca_system_score_codex":0.000044108914,"about_ca_system_score_gemma":0.00023704134,"threshold_uncertainty_score":0.9994859},"labels":[],"label_agreement":null},{"id":"W2030720027","doi":"10.1016/j.eururo.2013.09.050","title":"Conditional Survival After Radical Cystectomy for Bladder Cancer: Evidence for a Patient Changing Risk Profile over Time","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Western University; Dalhousie University; Université Laval; University of Alberta; University of British Columbia; McGill University","funders":"","keywords":"Medicine; Cystectomy; Lymphovascular invasion; Bladder cancer; Proportional hazards model; Urology; Lymph node; Stage (stratigraphy); Hazard ratio; Surgery; Cancer; Internal medicine; Gynecology; Oncology; Confidence interval; Metastasis","score_opus":0.022408714139041122,"score_gpt":0.2921674649161132,"score_spread":0.26975875077707206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030720027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788342,0.0023954886,0.0048736106,0.0031475886,0.0008548144,0.0052995,0.0011858111,0.00016774242,0.0032412126],"genre_scores_gemma":[0.99040496,0.000038484817,0.0008334442,0.0034215744,0.0009447591,0.0020775641,0.00013543334,0.000074712,0.002069067],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9985487,0.00017987231,0.00025018613,0.00040333773,0.00016297933,0.00045495006],"domain_scores_gemma":[0.99907166,0.00032226788,0.00010402663,0.00020916811,0.00013964457,0.00015321733],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019769001,0.00019098244,0.0002813286,0.00009549676,0.00010960735,0.000017685901,0.0000819549,0.000060076534,0.0041977162],"category_scores_gemma":[0.00016442678,0.0001544685,0.00015418821,0.00007785552,0.00011023454,0.000090972375,0.000054406515,0.00012849225,0.000538568],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04134901,0.0033649304,0.25767595,0.0014652979,0.0076210625,0.0007973786,0.009856744,0.00021852335,0.023653883,0.0011368117,0.46324784,0.18961258],"study_design_scores_gemma":[0.027298924,0.01287016,0.58132446,0.0002752492,0.0023399703,0.00020848468,0.000088303386,0.006985491,0.0022080715,0.0008837691,0.3643955,0.0011216499],"about_ca_topic_score_codex":0.000057185538,"about_ca_topic_score_gemma":0.000004747829,"teacher_disagreement_score":0.3236485,"about_ca_system_score_codex":0.000063026084,"about_ca_system_score_gemma":0.00009550724,"threshold_uncertainty_score":0.99671257},"labels":[],"label_agreement":null},{"id":"W2030746964","doi":"10.1016/j.eururo.2012.01.040","title":"Reply from Authors re: Joshua J. Meeks, James A. Eastham. Robotic Prostatectomy: The Rise of the Machines or Judgment Day. Eur Urol 2012;61:686–7","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; General surgery; Urology; Internal medicine; Prostate","score_opus":0.024335493818586906,"score_gpt":0.2633874981179133,"score_spread":0.23905200429932638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030746964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88018703,0.028673328,0.00013611902,0.07631428,0.002936731,0.0027874843,0.00020422546,0.00020235615,0.008558458],"genre_scores_gemma":[0.9880117,0.00057408627,0.00018804471,0.007284931,0.00058313383,0.0000830739,0.00003679985,0.0000963211,0.003141877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964561,0.0015527606,0.00057740236,0.0004800774,0.0003290046,0.00060467725],"domain_scores_gemma":[0.9976307,0.00042380358,0.0003784218,0.0012422794,0.000090500944,0.0002342695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011274713,0.00035469644,0.00050829153,0.000068519046,0.00025496824,0.000029426215,0.00040382447,0.00006462453,0.0006453179],"category_scores_gemma":[0.0004378551,0.00016874028,0.00020315795,0.00024824857,0.00041437047,0.00010915049,0.0003395538,0.0005020175,0.0002572054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002914272,0.0023760293,0.65220314,0.00014361004,0.0015858518,0.00050815707,0.013617861,0.00038068154,0.0015890159,0.00046755563,0.2842636,0.039950248],"study_design_scores_gemma":[0.002292838,0.001036146,0.56165296,0.000067910754,0.00074045605,0.00008549601,0.00013381458,0.00014901823,0.0011781061,0.00007930391,0.43238217,0.00020179368],"about_ca_topic_score_codex":0.00029687674,"about_ca_topic_score_gemma":0.00004768047,"teacher_disagreement_score":0.14811857,"about_ca_system_score_codex":0.00007364319,"about_ca_system_score_gemma":0.000121803714,"threshold_uncertainty_score":0.70657784},"labels":[],"label_agreement":null},{"id":"W2031924887","doi":"10.1016/j.eururo.2010.05.017","title":"Re: Effect of Dutasteride on the Risk of Prostate Cancer","year":2010,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Dutasteride; Medicine; Prostate cancer; Placebo; Urology; Prostate; Biopsy; Internal medicine; Prostate biopsy; Prostate-specific antigen; Cancer; Gynecology; Pathology","score_opus":0.016672015792672863,"score_gpt":0.2910840502042073,"score_spread":0.27441203441153444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031924887","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40120906,0.0013297044,6.513601e-7,0.5713972,0.00068024884,0.0013760932,0.00038356122,0.000031940457,0.023591569],"genre_scores_gemma":[0.58635765,0.003799083,0.000021257643,0.3797952,0.004574402,0.00017212844,0.0004727704,0.00033678245,0.02447076],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971809,0.0014689058,0.00032705613,0.00035027118,0.00031071622,0.0003621675],"domain_scores_gemma":[0.99791044,0.0008407792,0.0003688844,0.0007342816,0.00009891632,0.000046675545],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00081414054,0.0002724055,0.0006026777,0.00014571028,0.000047349084,0.000005358894,0.0002677305,0.0003136798,0.00055522297],"category_scores_gemma":[0.00028178756,0.00013432925,0.00019595421,0.0001154104,0.00050551246,0.000010776691,0.000120659504,0.003623515,0.00012682372],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033265508,0.000047456964,0.01787744,0.0006183036,0.0007296001,0.0015165723,0.0003308496,0.0000037290877,0.0026039341,0.0000029582416,0.9666396,0.0063030217],"study_design_scores_gemma":[0.002362272,0.0061305356,0.009365074,0.0001554909,0.00067696866,0.000024692863,0.0000049761097,0.0000064048854,0.011416758,0.000013831327,0.9697038,0.00013920119],"about_ca_topic_score_codex":0.00008587345,"about_ca_topic_score_gemma":0.000010226271,"teacher_disagreement_score":0.19160199,"about_ca_system_score_codex":0.000026714319,"about_ca_system_score_gemma":0.00009376224,"threshold_uncertainty_score":0.99867517},"labels":[],"label_agreement":null},{"id":"W2031934435","doi":"10.1016/j.eururo.2011.05.053","title":"Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer","year":2011,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Cystoscopy; Medicine; Bladder cancer; Urine cytology; Cytology; Urine; Urology; Urinary system; Cancer; Pathology; Internal medicine","score_opus":0.038766942888470185,"score_gpt":0.31326516179748,"score_spread":0.27449821890900983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031934435","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021955787,0.98972374,0.00013816879,0.000031968015,0.00048521513,0.001369747,0.0001987498,0.000034304703,0.0077985562],"genre_scores_gemma":[0.004127335,0.9939302,0.000092011636,0.00019224931,0.00042249853,0.00014760744,0.00005402165,0.00012679347,0.00090724864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99846506,0.00025334794,0.0004461324,0.00048700557,0.00007224575,0.00027619046],"domain_scores_gemma":[0.99892354,0.00018415268,0.0003366123,0.00033984554,0.00010303749,0.00011282059],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022788228,0.00034663884,0.0012544707,0.00015179547,0.00004296922,0.0000043350833,0.000108443484,0.0001491913,0.00017026984],"category_scores_gemma":[0.000086512984,0.00027072834,0.0002766589,0.00011338172,0.00014140793,0.00002098585,0.00006705308,0.00021220847,0.000028286158],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025891233,0.000058941816,0.00015411846,0.005916298,0.0007809303,0.000035729543,0.000057801688,1.02401124e-7,0.000020374686,0.000004538525,0.00052895845,0.99218327],"study_design_scores_gemma":[0.0014902925,0.0016068771,0.0055538304,0.0006288706,0.001663369,0.00012699676,0.000003887348,0.0000017589981,0.000013701057,0.000006758043,0.988695,0.00020862363],"about_ca_topic_score_codex":0.00008482416,"about_ca_topic_score_gemma":0.00009127423,"teacher_disagreement_score":0.99197465,"about_ca_system_score_codex":0.00004340005,"about_ca_system_score_gemma":0.00018320557,"threshold_uncertainty_score":0.9999745},"labels":[],"label_agreement":null},{"id":"W2032005128","doi":"10.1016/j.eururo.2010.05.043","title":"Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Interquartile range; Oncology; Internal medicine; Bladder cancer; Population; Biomarker; Cancer; Pathology","score_opus":0.00811141273050086,"score_gpt":0.24415827334260845,"score_spread":0.23604686061210758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032005128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807242,0.0014304876,0.00006413245,0.0011194664,0.00041659878,0.00057198404,0.00010141742,0.00007004422,0.015501633],"genre_scores_gemma":[0.99467516,0.00078967056,0.00015193733,0.003662737,0.0003532151,0.000056384164,0.000028353777,0.000082243845,0.00020028875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982986,0.0002446787,0.00027581205,0.0005886378,0.0001813801,0.00041088177],"domain_scores_gemma":[0.9990781,0.000094312025,0.00014928363,0.00039601515,0.000069650836,0.00021265796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018828218,0.00027734737,0.00039574326,0.00016826186,0.00007481856,0.000015331038,0.00013445177,0.00011877521,0.00015663648],"category_scores_gemma":[0.00013119123,0.0002390326,0.00007707677,0.00015546022,0.00029573622,0.00006902738,0.00012661579,0.00072682765,0.00005678886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007921593,0.00044123834,0.9408237,0.00008108449,0.00042924704,0.0032061683,0.0015642938,0.000068118796,0.039728943,0.00005194705,0.0015768268,0.011236286],"study_design_scores_gemma":[0.0036997157,0.00083879667,0.9897249,0.00003610331,0.00033269593,0.000104549086,0.000051442898,0.00005113181,0.0018415359,0.00012806126,0.0029959418,0.00019516694],"about_ca_topic_score_codex":0.0003333693,"about_ca_topic_score_gemma":0.0005324473,"teacher_disagreement_score":0.048901174,"about_ca_system_score_codex":0.000045134,"about_ca_system_score_gemma":0.00015387972,"threshold_uncertainty_score":0.97474664},"labels":[],"label_agreement":null},{"id":"W2033992620","doi":"10.1016/j.eururo.2008.04.083","title":"Carcinoma in situ of the Upper Urinary Tract Treated with Radical Nephroureterectomy – Results from a Multicenter Study","year":2008,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Upper urinary tract; Urology; Carcinoma in situ; Multicenter study; Urinary system; Urothelial carcinoma; Carcinoma; Surgery; Internal medicine; Cancer; Randomized controlled trial; Bladder cancer","score_opus":0.0216286178633254,"score_gpt":0.2465053683037416,"score_spread":0.2248767504404162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033992620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9335928,0.00030398445,5.8424024e-7,0.052700542,0.00017955712,0.0013351694,0.00020423507,0.00004093121,0.011642171],"genre_scores_gemma":[0.88767135,0.000020391903,0.000030928055,0.109849855,0.0010466126,0.000021182697,0.00027656424,0.00012119331,0.0009619468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99634564,0.0014884018,0.00060401525,0.00076783885,0.00036285465,0.00043126766],"domain_scores_gemma":[0.9984093,0.00022627314,0.0002623577,0.000972981,0.000053441086,0.00007567603],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000121555226,0.00046441174,0.0008091904,0.00018202157,0.000051337298,0.000007330071,0.00034475597,0.00027903393,0.000097430304],"category_scores_gemma":[0.00005098862,0.00027236206,0.00019227424,0.0001861854,0.0003035174,0.000030733296,0.00011689306,0.001766723,0.00006381847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010759851,0.0032186147,0.7831773,0.000032305375,0.00076607446,0.06352252,0.0037127228,0.0000028965349,0.00015820777,5.884746e-8,0.1343511,0.0002983409],"study_design_scores_gemma":[0.01895786,0.005324126,0.8555168,0.0000638939,0.0007793944,0.0006653233,0.000036725294,0.000005110096,0.00007346956,5.0364065e-7,0.11837716,0.00019962613],"about_ca_topic_score_codex":0.0009870991,"about_ca_topic_score_gemma":0.00004117466,"teacher_disagreement_score":0.072339505,"about_ca_system_score_codex":0.00007697086,"about_ca_system_score_gemma":0.00013389946,"threshold_uncertainty_score":0.9999729},"labels":[],"label_agreement":null},{"id":"W2034141668","doi":"10.1159/000020188","title":"Impact of Noninvasive Imaging on Increased Incidental Detection of Renal Cell Carcinoma","year":2000,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northeast Cancer Centre","funders":"Health Canada","keywords":"Medicine; Renal cell carcinoma; Radiology; Ultrasound; Stage (stratigraphy); Presentation (obstetrics); Carcinoma; Proportional hazards model; Nuclear medicine; Pathology; Surgery","score_opus":0.009684491040837039,"score_gpt":0.2335699977020117,"score_spread":0.22388550666117465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034141668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93446845,0.00019252182,0.000014625362,0.000022137323,0.000035035046,0.00019836238,0.0000118879325,0.000022426631,0.06503454],"genre_scores_gemma":[0.9994813,0.000009614095,0.000038677725,0.00011553499,0.00009602059,0.0000021615815,0.000026045982,0.000039763385,0.00019088683],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986675,0.0003360759,0.00033556705,0.00026392628,0.00017423027,0.00022270215],"domain_scores_gemma":[0.99921334,0.00008910234,0.00016134854,0.00034452477,0.00006941191,0.00012225968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017028759,0.00017550735,0.00031477975,0.00018957055,0.000029071685,0.0000027967826,0.00008934966,0.000033195236,0.0005711151],"category_scores_gemma":[0.00003566664,0.00014278905,0.0002252941,0.0001291038,0.00012251461,0.000031371175,0.000030607964,0.00017274347,0.00019021393],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033538716,0.00050867157,0.20158523,0.000033507582,0.00008669137,0.0019356372,0.00037679606,0.00016975806,0.7785482,0.0000022206539,0.00012135931,0.013278081],"study_design_scores_gemma":[0.0021111579,0.004600543,0.7586407,0.000009734893,0.00012943996,0.00054890424,0.000012226149,0.000091732705,0.2337207,0.0000031818104,0.00006031778,0.000071327355],"about_ca_topic_score_codex":0.00049349066,"about_ca_topic_score_gemma":0.0000061257474,"teacher_disagreement_score":0.55705553,"about_ca_system_score_codex":0.00011591783,"about_ca_system_score_gemma":0.0000678965,"threshold_uncertainty_score":0.625331},"labels":[],"label_agreement":null},{"id":"W2034644833","doi":"10.1016/j.eururo.2005.11.005","title":"Tumour Features in the Control and Screening Arm of A Randomized Trial of Prostate Cancer","year":2005,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Randomized controlled trial; Prostate cancer; Prostate; Oncology; Cancer; Gynecology; Internal medicine; Surgery","score_opus":0.011829197565720161,"score_gpt":0.27050483280483656,"score_spread":0.2586756352391164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034644833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757401,0.008866944,0.000015056545,0.010453049,0.000052274725,0.0015567495,0.000020163408,0.000007377816,0.0032883189],"genre_scores_gemma":[0.9966081,0.0014338602,0.00009916001,0.0015694423,0.00013651687,0.00008692124,0.0000042304255,0.000011421407,0.000050352006],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987544,0.00056533207,0.00031964146,0.00013614839,0.00009404692,0.00013046863],"domain_scores_gemma":[0.9992783,0.00037393937,0.00016498473,0.00011735856,0.00003654384,0.000028852304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008994677,0.00008835609,0.00054106384,0.00006412494,0.000014323786,0.0000034993375,0.000051877872,0.000018773202,0.000018967341],"category_scores_gemma":[0.00016603046,0.000049877264,0.00008188323,0.00005812724,0.00016158079,0.000017270313,0.000016872584,0.00011256134,0.0000010565841],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9512646,0.0005292499,0.009312411,0.000045622844,0.00028252532,0.00010058753,0.0028248439,0.00013286016,0.00084732287,0.00041865304,0.00064855115,0.03359278],"study_design_scores_gemma":[0.9334925,0.0016045142,0.061238054,0.000053227628,0.00032812965,0.000025374566,0.000052883446,0.00009107959,0.00054038916,0.000033115542,0.0024905587,0.00005019055],"about_ca_topic_score_codex":0.000089088426,"about_ca_topic_score_gemma":0.000038035778,"teacher_disagreement_score":0.051925644,"about_ca_system_score_codex":0.00000864949,"about_ca_system_score_gemma":0.000026592963,"threshold_uncertainty_score":0.20339358},"labels":[],"label_agreement":null},{"id":"W2034674240","doi":"10.1016/j.eururo.2007.03.050","title":"Preserved Postoperative Penile Size Correlates Well with Maintained Erectile Function after Bilateral Nerve-Sparing Radical Retropubic Prostatectomy","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Radical retropubic prostatectomy; Erectile dysfunction; Urology; Erectile function; Prostatectomy; Surgery; Penis; Prostate; Internal medicine","score_opus":0.010575291235731832,"score_gpt":0.23233716405780233,"score_spread":0.2217618728220705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034674240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94821954,0.00021620168,0.0027577218,0.0013375102,0.0009743926,0.0005920282,0.0000031808015,0.00038258263,0.045516822],"genre_scores_gemma":[0.97566444,0.0000072929747,0.00030406308,0.0042740395,0.00042624856,0.000027482743,0.000037918322,0.00008047122,0.01917802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978033,0.00031318783,0.00044770614,0.00060461235,0.00026574655,0.00056547415],"domain_scores_gemma":[0.9987614,0.00029136834,0.00012391781,0.00034194847,0.00023603838,0.00024532908],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00065302657,0.00031710192,0.0003996002,0.00018035948,0.00024322442,0.000036476187,0.00007845808,0.000106925014,0.0026241632],"category_scores_gemma":[0.0003087271,0.0002286828,0.000089930465,0.0003550693,0.00035308395,0.00014491152,0.000118068914,0.00061222137,0.000944681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0783791,0.00059633947,0.88366956,0.000079979116,0.00060636905,0.0037427864,0.0020597684,0.00018228545,0.010728267,0.00032339618,0.018184327,0.0014478099],"study_design_scores_gemma":[0.005610697,0.0065754843,0.8654998,0.000018962062,0.00022677727,0.0007845008,0.00058328034,0.00015736673,0.0005132047,0.000020453675,0.11970392,0.00030554252],"about_ca_topic_score_codex":0.000035876896,"about_ca_topic_score_gemma":0.000055721954,"teacher_disagreement_score":0.10151959,"about_ca_system_score_codex":0.0000805268,"about_ca_system_score_gemma":0.000045034503,"threshold_uncertainty_score":0.9998332},"labels":[],"label_agreement":null},{"id":"W2035032608","doi":"10.1016/j.eururo.2008.02.044","title":"Lower Plasma Adiponectin Levels Are Associated with Larger Tumor Size and Metastasis in Clear-Cell Carcinoma of the Kidney","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; Juravinski Cancer Centre; McMaster University; McMaster University Medical Centre","funders":"McMaster University","keywords":"Medicine; Adiponectin; Renal cell carcinoma; Metastasis; Internal medicine; Oncology; Distant metastasis; Carcinoma; Kidney cancer; Kidney; Urology; Cancer research; Cancer; Obesity","score_opus":0.016311238623342585,"score_gpt":0.2109752012259475,"score_spread":0.19466396260260493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035032608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904675,0.00026757104,0.0000032738,0.0005939972,0.00010635565,0.00023559401,0.00005571687,0.000025952271,0.008244047],"genre_scores_gemma":[0.996191,0.000014524197,0.00005242167,0.002058231,0.000072641196,0.0000039940483,0.000007562312,0.00003770757,0.001561885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860084,0.0004626729,0.00028786392,0.00024062282,0.00016601908,0.00024200213],"domain_scores_gemma":[0.99906325,0.0001849265,0.00022292694,0.0002741221,0.00010437699,0.00015036624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003008378,0.00015502988,0.00035198254,0.00007734018,0.00007236826,0.0000037092348,0.000102683865,0.000034886893,0.00017440483],"category_scores_gemma":[0.0015585457,0.00010161365,0.00006534987,0.00023040338,0.00023830534,0.000044262673,0.000057122223,0.00018349315,0.000019512201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001081629,0.0005327741,0.98986745,0.000062754465,0.00013499246,0.0011139754,0.0011083778,0.00003291817,0.0025518322,0.000057547528,0.0032644619,0.00019126893],"study_design_scores_gemma":[0.003164017,0.00028798555,0.9821295,0.000024091132,0.00021901478,0.0001707216,0.000050880077,0.000029225967,0.0009748627,0.0000039269303,0.012846047,0.000099730845],"about_ca_topic_score_codex":0.000023594364,"about_ca_topic_score_gemma":0.00003292095,"teacher_disagreement_score":0.009581585,"about_ca_system_score_codex":0.000013658775,"about_ca_system_score_gemma":0.00013154309,"threshold_uncertainty_score":0.41436845},"labels":[],"label_agreement":null},{"id":"W2035062922","doi":"10.1016/j.eururo.2006.05.021","title":"Discrepancy between Clinical and Pathologic Stage: Impact on Prognosis after Radical Cystectomy","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":367,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cystectomy; Medicine; Stage (stratigraphy); Bladder cancer; Lymphadenectomy; Carcinoma in situ; Transitional cell carcinoma; Surgery; Radical surgery; Carcinoma; Urology; Cancer; Pathology; Internal medicine","score_opus":0.02579578882443177,"score_gpt":0.3319970850088622,"score_spread":0.3062012961844304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035062922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97929907,0.00054863037,0.000047543093,0.0011660368,0.000102356425,0.00038329125,0.00006428293,0.00010897899,0.018279787],"genre_scores_gemma":[0.9966124,0.000036978618,0.00021083246,0.001312782,0.00088028307,0.000020724727,0.000040654882,0.000046271263,0.0008390441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981211,0.00056467496,0.00037451737,0.000471437,0.00013431883,0.000333982],"domain_scores_gemma":[0.9993061,0.00013363718,0.00007083307,0.00028206012,0.000022784798,0.0001845877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003416643,0.00021877697,0.00041960855,0.000072368566,0.000048651284,0.00001560054,0.00007229935,0.00010009745,0.00025185975],"category_scores_gemma":[0.000060087823,0.00014067495,0.00015956178,0.00007877657,0.00032178953,0.000029316938,0.00006764868,0.000342237,0.0002559627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009536234,0.0002788555,0.98793405,0.00001253489,0.00008397271,0.0022426425,0.000030408039,5.122267e-7,0.00001835804,0.00004513822,0.0007899353,0.0076099746],"study_design_scores_gemma":[0.003222468,0.0044924812,0.97593576,0.000011538585,0.00021257435,0.00013954661,0.0000027557844,0.0000037711695,0.000025866364,0.00008819659,0.015745295,0.000119760836],"about_ca_topic_score_codex":0.00003730296,"about_ca_topic_score_gemma":0.000003160315,"teacher_disagreement_score":0.017440744,"about_ca_system_score_codex":0.00001984676,"about_ca_system_score_gemma":0.00003665133,"threshold_uncertainty_score":0.5736558},"labels":[],"label_agreement":null},{"id":"W2035203051","doi":"10.1016/j.eururo.2012.09.035","title":"Temporal Trends, Practice Patterns, and Treatment Outcomes for Infected Upper Urinary Tract Stones in the United States","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Incidence (geometry); Propensity score matching; Sepsis; Odds ratio; Confidence interval; Internal medicine; Urinary system; Percutaneous nephrostomy; Adverse effect; Surgery; Percutaneous","score_opus":0.03458040663389006,"score_gpt":0.32456163635364554,"score_spread":0.2899812297197555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035203051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839507,0.00044530886,0.000016436648,0.013558033,0.00012301601,0.00041707655,0.00005221215,0.000046815658,0.0013904516],"genre_scores_gemma":[0.99123645,0.0002716009,0.00019601436,0.00694357,0.00013009323,0.000044579312,0.0005825446,0.000040617088,0.0005545338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984292,0.0006107442,0.0002536614,0.00022535115,0.00009672967,0.00038430846],"domain_scores_gemma":[0.9988562,0.0005940665,0.000107613945,0.00026961073,0.00003427694,0.00013821654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039360035,0.0002275385,0.00029187193,0.00022697252,0.00008039162,0.00001542457,0.00006621925,0.000050125713,0.00003715472],"category_scores_gemma":[0.0001769492,0.00012913434,0.000079651996,0.00014455036,0.00005780837,0.00012277302,0.000030527986,0.00013103057,0.00002369024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048117567,0.0030189315,0.98814315,0.000011338443,0.00015915891,0.00024086678,0.002828557,0.0000019038291,0.0000067633987,0.00007501929,0.00031633087,0.0047168136],"study_design_scores_gemma":[0.003266532,0.0025628505,0.77535546,0.0000038968974,0.00029281183,0.0011372388,0.00044197222,0.000030138544,0.0000025472027,0.0000033748618,0.21681473,0.000088451256],"about_ca_topic_score_codex":0.0003449577,"about_ca_topic_score_gemma":0.0000039032934,"teacher_disagreement_score":0.2164984,"about_ca_system_score_codex":0.00003462571,"about_ca_system_score_gemma":0.000015099946,"threshold_uncertainty_score":0.5265945},"labels":[],"label_agreement":null},{"id":"W2036288386","doi":"10.1016/j.eururo.2013.08.016","title":"Re: Günter Niegisch, Anja Lorch, Michael J. Droller, Hugh J. Lavery, Kristian D. Stensland, Peter Albers. Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Which Patients Benefit? Eur Urol 2013;64:355–7","year":2013,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Regimen; Cystectomy; Oncology; Internal medicine; Immunotherapy; Radiation therapy; Chemotherapy; Cisplatin; Cancer; Urology","score_opus":0.007929733551989795,"score_gpt":0.2160725467014248,"score_spread":0.208142813149435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036288386","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5825831,0.0029311457,0.000024520381,0.3619845,0.0046305857,0.009408445,0.0022855338,0.00046370542,0.03568842],"genre_scores_gemma":[0.33782497,0.0014301183,0.00017132582,0.640751,0.003927012,0.00027462718,0.004421999,0.0011275557,0.010071401],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927293,0.00073813414,0.0012945508,0.0022736427,0.0010927152,0.001871665],"domain_scores_gemma":[0.9958504,0.00022366292,0.000855634,0.0017734715,0.0008618062,0.0004350167],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0001996345,0.0016912089,0.0019769804,0.0006851174,0.0001920655,0.000105587445,0.00083462807,0.0009889755,0.0025688906],"category_scores_gemma":[0.00007874843,0.0013364619,0.00037950237,0.00048010895,0.0003510539,0.00025947054,0.0003092029,0.0030420145,0.0013521026],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023506875,0.00084114494,0.19565175,0.00017721986,0.0013262229,0.0011120422,0.0013356146,0.000023243583,0.0000075947605,4.0197756e-7,0.7918825,0.0052915826],"study_design_scores_gemma":[0.026486857,0.0047578523,0.4001264,0.00026503598,0.00079855503,0.000025296864,0.000024988169,0.0000138222495,0.000015516072,0.000011561376,0.56635123,0.0011229056],"about_ca_topic_score_codex":0.0020372355,"about_ca_topic_score_gemma":0.0017220333,"teacher_disagreement_score":0.27876648,"about_ca_system_score_codex":0.00033424332,"about_ca_system_score_gemma":0.0003029907,"threshold_uncertainty_score":0.9995834},"labels":[],"label_agreement":null},{"id":"W2036289447","doi":"10.1016/j.eururo.2014.08.078","title":"Amsterdam Patient Charter for Global Kidney Cancer Care","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kidney Foundation of Canada","funders":"","keywords":"Medicine; Kidney cancer; Cancer; Charter; General surgery; Intensive care medicine; Family medicine; Internal medicine; Law","score_opus":0.023659693152349823,"score_gpt":0.22640976017244674,"score_spread":0.2027500670200969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036289447","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010892471,0.008351407,0.003029422,0.57749134,0.009665694,0.0010816089,0.008149915,0.00016082382,0.39098054],"genre_scores_gemma":[0.029466169,0.00021620526,0.00014057723,0.9559705,0.01015608,0.00013850066,0.00077267125,0.00018780546,0.0029514804],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99696964,0.00007582868,0.00096770865,0.0010525614,0.000036064903,0.0008982085],"domain_scores_gemma":[0.99804795,0.000054843767,0.0009106288,0.0007110999,0.000091131704,0.00018433592],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002225083,0.00050828926,0.000994621,0.0001479629,0.00013175818,0.00009925856,0.00062747695,0.00057295244,0.0006790717],"category_scores_gemma":[0.0001513523,0.00059741666,0.00040090526,0.0000721013,0.00014423559,0.00011767995,0.00014715832,0.0007121505,0.0025640551],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003634807,0.000011347198,0.0018181374,0.00013278662,0.00010338681,0.0000425665,0.00028520182,0.0000158356,2.6222997e-7,0.0039031296,0.98783076,0.005820232],"study_design_scores_gemma":[0.00076947885,0.00042815745,0.0012813953,0.000020235519,0.0000368637,0.000012795032,0.000006016571,0.00004282175,0.000001278676,0.0026624298,0.99410504,0.0006335157],"about_ca_topic_score_codex":0.00011960645,"about_ca_topic_score_gemma":0.000022514698,"teacher_disagreement_score":0.38802907,"about_ca_system_score_codex":0.0003466049,"about_ca_system_score_gemma":0.00008840176,"threshold_uncertainty_score":0.99964774},"labels":[],"label_agreement":null},{"id":"W2036310262","doi":"10.1016/j.eururo.2012.09.031","title":"Oncologic Outcomes and Survival in pT0 Tumors After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Results from of a Large Multicenter International Collaborative Study","year":2012,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Urothelial carcinoma; Urology; Multicenter study; Carcinoma; Oncology; Internal medicine; Cancer; Bladder cancer; Randomized controlled trial","score_opus":0.022847343265809523,"score_gpt":0.3045794465530424,"score_spread":0.2817321032872329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036310262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90826374,0.00040698992,0.000018211627,0.07794814,0.0020348292,0.0027263411,0.0056890035,0.000036877092,0.0028758796],"genre_scores_gemma":[0.90317446,0.000014417496,0.00024944995,0.092362456,0.0025776548,0.0001537198,0.0009250385,0.00009954166,0.00044325355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964672,0.0011167254,0.0008181952,0.00074315805,0.00032799513,0.0005267365],"domain_scores_gemma":[0.99826,0.00079200993,0.00032714766,0.00037170688,0.00014076286,0.00010837063],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053040363,0.0004722912,0.0010664705,0.0002771933,0.000035339872,0.000019121067,0.00023221858,0.00032408902,0.0002137159],"category_scores_gemma":[0.00032016364,0.0003612394,0.00018940319,0.000087500805,0.00018399947,0.00007279927,0.00016001696,0.0009782831,0.000027269047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012709188,0.0020417767,0.94398594,0.000041867028,0.00077297253,0.0036060691,0.0050938674,2.4645018e-7,0.00003958902,0.0000019705872,0.031336516,0.0003700207],"study_design_scores_gemma":[0.027016928,0.0020373676,0.73310614,0.000025730245,0.0004486719,0.000021584146,0.00016827685,0.0000070879682,0.0000108582735,0.000004966656,0.23694032,0.0002120674],"about_ca_topic_score_codex":0.00020913479,"about_ca_topic_score_gemma":0.000113563394,"teacher_disagreement_score":0.21087977,"about_ca_system_score_codex":0.00011793003,"about_ca_system_score_gemma":0.00014777738,"threshold_uncertainty_score":0.99988395},"labels":[],"label_agreement":null},{"id":"W2036449946","doi":"10.1016/j.eururo.2013.08.007","title":"Initial Biopsy Gleason Score as a Predictive Marker for Survival Benefit in Patients with Castration-resistant Prostate Cancer Treated with Docetaxel: Data from the TAX327 Study","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Docetaxel; Medicine; Prostate cancer; Mitoxantrone; Oncology; Internal medicine; Cabazitaxel; Prednisone; Cancer; Androgen deprivation therapy; Urology; Chemotherapy","score_opus":0.042908328178824236,"score_gpt":0.30756362990908587,"score_spread":0.26465530173026164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036449946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917955,0.00025831434,0.000006690773,0.0009681831,0.000065432585,0.004685041,0.0012328349,0.000038127142,0.00094990496],"genre_scores_gemma":[0.9969375,0.000027300628,0.0000501678,0.00016862324,0.00013765354,0.00037828548,0.0017877085,0.00006526992,0.00044749898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981384,0.00025713723,0.00025181362,0.0006191933,0.0003261501,0.00040729754],"domain_scores_gemma":[0.9986623,0.00017692056,0.00012006401,0.0006260623,0.00029773422,0.0001169512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024513763,0.0002408661,0.00030086059,0.000071683404,0.0001247307,0.00005371568,0.00027386248,0.000037250025,0.00022053512],"category_scores_gemma":[0.00006488798,0.00012325327,0.00002109918,0.00023129518,0.00020123489,0.0001733504,0.00013137417,0.00024171753,0.00003905099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03219991,0.00077935535,0.9635478,0.000014334342,0.0004983615,0.00021794619,0.0008250923,0.000019243047,0.000115155075,0.0000036286503,0.00043550407,0.0013436342],"study_design_scores_gemma":[0.01581347,0.00933032,0.9733714,0.0000675134,0.00025324392,0.0000042132956,0.00047154547,0.0001485616,0.000028188455,0.000008902635,0.00036846634,0.00013418104],"about_ca_topic_score_codex":0.0038540475,"about_ca_topic_score_gemma":0.0025842797,"teacher_disagreement_score":0.016386444,"about_ca_system_score_codex":0.000073891184,"about_ca_system_score_gemma":0.00019118443,"threshold_uncertainty_score":0.58261925},"labels":[],"label_agreement":null},{"id":"W2036577347","doi":"10.1016/j.eururo.2014.01.040","title":"Dissecting the Association Between Metabolic Syndrome and Prostate Cancer Risk: Analysis of a Large Clinical Cohort","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of British Columbia; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Metabolic syndrome; Internal medicine; Odds ratio; Prostate biopsy; Cohort; Confidence interval; Biopsy; Oncology; Cancer; Obesity","score_opus":0.015318343996291233,"score_gpt":0.3183997650797802,"score_spread":0.30308142108348896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036577347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594325,0.0013461396,0.00003422078,0.0010606812,0.00011430461,0.00026753754,0.00009731897,0.000020945583,0.0011155775],"genre_scores_gemma":[0.9970481,0.0020641936,0.000019401135,0.000459203,0.00014190916,0.00002077605,0.000044779197,0.000017153821,0.0001844956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830365,0.0007124977,0.00038510034,0.0002627319,0.00012638411,0.00020964621],"domain_scores_gemma":[0.99853474,0.00067094644,0.0003883806,0.00022818973,0.00010098422,0.00007673563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023659004,0.000099421566,0.0005601332,0.00008452868,0.00008181308,0.000008551128,0.000056630615,0.00003972971,0.00003102276],"category_scores_gemma":[0.0006614568,0.00006302715,0.00013886216,0.00027947925,0.000056337733,0.000021307806,0.00006194467,0.00020338409,0.000009095773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030298335,0.00006402774,0.98968047,0.000006265113,0.004638208,0.000009293107,0.00023486506,0.000015463753,0.0000044143712,0.000084904736,0.00007770587,0.005154095],"study_design_scores_gemma":[0.00089189585,0.0003767334,0.9755692,0.0000060071316,0.0107075665,0.000002502256,0.000013421342,0.00021968098,0.000015476728,0.000017024888,0.012129001,0.0000515201],"about_ca_topic_score_codex":0.00013065603,"about_ca_topic_score_gemma":0.00008961083,"teacher_disagreement_score":0.01411129,"about_ca_system_score_codex":0.00002636813,"about_ca_system_score_gemma":0.00001636841,"threshold_uncertainty_score":0.25701728},"labels":[],"label_agreement":null},{"id":"W2037073425","doi":"10.1016/j.eururo.2006.01.043","title":"Validation of a Nomogram Predicting the Probability of Lymph Node Invasion among Patients Undergoing Radical Prostatectomy and an Extended Pelvic Lymphadenectomy","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":237,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Prostatectomy; Prostate cancer; Stage (stratigraphy); Lymphadenectomy; Logistic regression; Lymph node; Biopsy; Urology; T-stage; Radiology; Oncology; Cancer; Internal medicine","score_opus":0.01203616406232184,"score_gpt":0.23846734935047578,"score_spread":0.22643118528815395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037073425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973625,0.00022043781,0.000059579586,0.00017458122,0.000056804176,0.00080084574,0.000015514115,0.000040396382,0.0012693447],"genre_scores_gemma":[0.99933994,0.000048709095,0.0003058706,0.000080675745,0.00005901991,0.000028683939,0.000103479164,0.000026121956,0.000007518846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983826,0.00044382006,0.0004450654,0.0003357237,0.0001874344,0.00020532547],"domain_scores_gemma":[0.9990347,0.00019286126,0.0002822165,0.00029980866,0.0001192625,0.0000711516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043998705,0.0001443978,0.0002633669,0.00006976638,0.00007524213,0.0000107845,0.0000796018,0.00004456869,0.000010983929],"category_scores_gemma":[0.00016790559,0.00009905045,0.000054108194,0.00013392148,0.00033814233,0.00008979252,0.000081547856,0.000078061494,0.0000014269583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025592343,0.0008145083,0.993215,0.00014802658,0.00004267148,0.0000136298595,0.00032717476,0.00010565962,0.0009650803,0.000103639715,0.000014186926,0.003994479],"study_design_scores_gemma":[0.004289016,0.0013170142,0.9878635,0.0000724194,0.00014901327,0.000015520462,0.0000311336,0.00029587653,0.0055110473,0.00034254044,0.000041148196,0.00007181327],"about_ca_topic_score_codex":0.00013253157,"about_ca_topic_score_gemma":0.000013441262,"teacher_disagreement_score":0.005351563,"about_ca_system_score_codex":0.00006170898,"about_ca_system_score_gemma":0.00007528233,"threshold_uncertainty_score":0.403916},"labels":[],"label_agreement":null},{"id":"W2037171825","doi":"10.1016/j.eururo.2014.01.019","title":"What Is the Most Bothersome Lower Urinary Tract Symptom? Individual- and Population-level Perspectives for Both Men and Women","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Pelvic floor disorders treatments","field":"Medicine","cited_by":260,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute for Health and Care Research","keywords":"Medicine; Lower urinary tract symptoms; Nocturia; Urinary incontinence; Population; Overactive bladder; Danish; Physical therapy; Gynecology; Urinary system; Internal medicine; Urology; Alternative medicine; Prostate; Environmental health","score_opus":0.01620733573302674,"score_gpt":0.2575446626883023,"score_spread":0.24133732695527554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037171825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854474,0.0025424333,0.000051614938,0.005913916,0.000107390304,0.0004977669,0.000023914698,0.000044358327,0.0053711957],"genre_scores_gemma":[0.99345285,0.0003690598,0.0001410819,0.0040345313,0.00012424885,0.00002677504,0.000022666489,0.00005225733,0.0017765604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988756,0.00020156088,0.00015591712,0.0003707614,0.00010901191,0.00028714704],"domain_scores_gemma":[0.99930197,0.0002149221,0.000075289376,0.00027611078,0.000025945013,0.00010579049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038894764,0.00017533399,0.00022821625,0.000076694254,0.00014287404,0.000051774434,0.000091115486,0.00005040242,0.000089050925],"category_scores_gemma":[0.00009393034,0.0001239903,0.000034435256,0.000059862366,0.00017686859,0.00015053856,0.00007390488,0.00011663086,0.00001974207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003628614,0.0043057892,0.603727,0.0002519129,0.0027479478,0.00035347755,0.24731517,0.000014967765,0.0005419327,0.0028272872,0.015592383,0.118693545],"study_design_scores_gemma":[0.0038508768,0.002592497,0.9738331,0.00001435658,0.00015639699,0.00021343367,0.004857114,0.00020084374,0.0000022727063,0.0006044962,0.0135290325,0.00014558429],"about_ca_topic_score_codex":0.000014732997,"about_ca_topic_score_gemma":0.0000015923721,"teacher_disagreement_score":0.37010613,"about_ca_system_score_codex":0.00003052688,"about_ca_system_score_gemma":0.000013300426,"threshold_uncertainty_score":0.5056178},"labels":[],"label_agreement":null},{"id":"W2037353977","doi":"10.1016/j.eururo.2013.05.052","title":"Prime Time for Intermittent Androgen Suppression","year":2013,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Androgen deprivation therapy; Enzalutamide; Prostate cancer; Oncology; Androgen; Internal medicine; Androgen suppression; Radiation therapy; Androgen receptor; Cancer; Hormone","score_opus":0.026163918867318173,"score_gpt":0.28912788412625606,"score_spread":0.2629639652589379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037353977","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004274426,0.0018786427,0.000077956305,0.9458087,0.00078422844,0.0025231964,0.00013585734,0.00018521085,0.044331804],"genre_scores_gemma":[0.0027544056,0.00018684824,0.0002749852,0.6850959,0.007507146,0.000178458,0.0044965185,0.00028736002,0.2992184],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981568,0.00029229955,0.0002668288,0.00052468217,0.00019121508,0.0005682127],"domain_scores_gemma":[0.9990091,0.00013645933,0.000109586304,0.000509969,0.00012388342,0.00011104645],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00018276241,0.00028616918,0.00046086486,0.00017401346,0.00006522505,0.000025034096,0.0002390236,0.00031491768,0.0014528243],"category_scores_gemma":[0.00006432863,0.00019827999,0.00020568361,0.000046602534,0.000142928,0.000030893392,0.0001902437,0.00096608576,0.0044743097],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026241178,0.000042535183,0.00009519854,0.00011805176,0.00020172713,0.0015569929,0.00005033492,7.880736e-8,0.001716007,8.735283e-7,0.9874813,0.008474483],"study_design_scores_gemma":[0.0019851464,0.0014126606,0.00056815706,0.000050745046,0.0001964035,0.00021561793,0.0000012492858,0.000055233002,0.0006827488,0.000024723793,0.99463683,0.00017050744],"about_ca_topic_score_codex":0.0000035165629,"about_ca_topic_score_gemma":6.592143e-8,"teacher_disagreement_score":0.2607128,"about_ca_system_score_codex":0.00006604309,"about_ca_system_score_gemma":0.00008443906,"threshold_uncertainty_score":0.99946},"labels":[],"label_agreement":null},{"id":"W2037473701","doi":"10.1016/j.eururo.2010.11.024","title":"Phase 1 and 2 Studies Demonstrate the Safety and Efficacy of Intraprostatic Injection of PRX302 for the Targeted Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Huntington Society of Canada","funders":"National Institute on Minority Health and Health Disparities","keywords":"Medicine; Lower urinary tract symptoms; Urology; Hyperplasia; Urinary system; Prostate; Gynecology; Internal medicine; Cancer","score_opus":0.02433445432554206,"score_gpt":0.32992070126255435,"score_spread":0.3055862469370123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037473701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939403,0.00236306,0.00006369833,0.0013199849,0.000094931704,0.0017566277,0.000106932195,0.000009739212,0.00034472372],"genre_scores_gemma":[0.9988692,0.00063545763,0.00019858961,0.0000792683,0.00004348597,0.000028310216,0.000016206872,0.000022517333,0.00010698236],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988516,0.0002516259,0.00038048343,0.00021478444,0.0001061406,0.00019534274],"domain_scores_gemma":[0.99814075,0.0012830837,0.00012839159,0.00024232206,0.00013310155,0.00007235013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057489914,0.00014426027,0.00035432275,0.000093358736,0.00010738758,0.0000048651004,0.00006712571,0.00003216373,0.000027392738],"category_scores_gemma":[0.00023557723,0.00007671707,0.000053989774,0.00012274005,0.00062809425,0.000033959743,0.000047013444,0.00017539217,0.000001050151],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06576802,0.012901465,0.01645876,0.0017437297,0.0032004954,0.0004429467,0.046995316,0.00009044302,0.23752281,0.00082266197,0.00046007638,0.6135933],"study_design_scores_gemma":[0.038419522,0.35113588,0.5580869,0.00011243914,0.0019434887,0.005822819,0.0037333104,0.0012458807,0.022145899,0.00033501614,0.016619338,0.00039951506],"about_ca_topic_score_codex":0.000008644889,"about_ca_topic_score_gemma":0.000004903843,"teacher_disagreement_score":0.61319375,"about_ca_system_score_codex":0.000007859242,"about_ca_system_score_gemma":0.00007739456,"threshold_uncertainty_score":0.31284314},"labels":[],"label_agreement":null},{"id":"W2037907483","doi":"10.1016/j.eururo.2006.05.046","title":"Delay in the Surgical Treatment of Bladder Cancer and Survival: Systematic Review of the Literature","year":2006,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; McGill University","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Occult; Stage (stratigraphy); Surgery; Cancer; Internal medicine; Pathology","score_opus":0.034311922410683336,"score_gpt":0.3364971222671261,"score_spread":0.30218519985644277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037907483","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039014667,0.9901233,1.68923e-7,0.00030930614,0.00014970632,0.0025083604,0.0001244833,0.0000067096707,0.0067389854],"genre_scores_gemma":[0.0003252161,0.9981715,0.0000026288155,0.00035428326,0.00013976179,0.00014824771,0.000056284345,0.000045508994,0.00075653475],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960946,0.0023324022,0.00088895386,0.00029000329,0.0002104037,0.0001836409],"domain_scores_gemma":[0.9984059,0.000336333,0.00048117625,0.0006822529,0.000059731385,0.00003465164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047264626,0.00034479017,0.0025062084,0.00007511851,0.000023617007,0.000006047379,0.00022621691,0.0001109652,0.00004209187],"category_scores_gemma":[0.000047882317,0.00013372181,0.00047988165,0.00035441038,0.00013767468,0.000010940393,0.000044644235,0.00022730714,0.000007680352],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028194358,0.0003171979,0.00015546687,0.9719909,0.00073542295,0.0005364164,0.00030661834,1.6191456e-7,7.041858e-8,0.000078507546,0.0007820219,0.025069062],"study_design_scores_gemma":[0.0008674484,0.0004742484,0.00025130002,0.29819804,0.008383409,0.0008734468,0.000005102703,1.9394214e-7,1.96243e-7,0.0000030050633,0.6908385,0.0001051085],"about_ca_topic_score_codex":0.00007026199,"about_ca_topic_score_gemma":0.00002971079,"teacher_disagreement_score":0.69005644,"about_ca_system_score_codex":0.000050497936,"about_ca_system_score_gemma":0.00013714773,"threshold_uncertainty_score":0.54530174},"labels":[],"label_agreement":null},{"id":"W2038111129","doi":"10.1016/j.eururo.2012.01.021","title":"Predicting Clinical Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Medicine; Lymphovascular invasion; Hazard ratio; Concomitant; Stage (stratigraphy); Internal medicine; Oncology; Cancer; Proportional hazards model; Lymph node; Urology; Carcinoma; Cohort; Metastasis; Confidence interval","score_opus":0.0390510178101316,"score_gpt":0.3309146278737073,"score_spread":0.2918636100635757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038111129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98309106,0.00058842957,0.0003935475,0.0016028787,0.0020483087,0.00072936894,0.000058650552,0.000132528,0.011355207],"genre_scores_gemma":[0.9833607,0.000014831173,0.0010472643,0.009721356,0.0046881684,0.000068606736,0.000034696728,0.00010240937,0.0009619586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978621,0.0004222312,0.00051720795,0.0003795777,0.0001638542,0.0006550378],"domain_scores_gemma":[0.99872893,0.00037648797,0.00009502154,0.0003630384,0.000043901833,0.00039263858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065452117,0.00025608967,0.0004882771,0.00007920298,0.000078998746,0.000012982715,0.00012413025,0.00013626332,0.0004952096],"category_scores_gemma":[0.00031254513,0.00019299581,0.00042575318,0.00005385447,0.00017552928,0.000095487696,0.00006461755,0.00036445312,0.00032743995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015136998,0.0004726448,0.99017644,0.000018230636,0.00017099219,0.00010685172,0.00033197337,1.2669084e-7,0.00004651142,0.00003570491,0.0020984926,0.0050283205],"study_design_scores_gemma":[0.0049615023,0.0011199134,0.8176385,0.0000054221186,0.00039417803,0.00023953756,0.0000124754715,0.000015903324,0.000034862947,0.000009785745,0.17543244,0.00013543134],"about_ca_topic_score_codex":0.000014348475,"about_ca_topic_score_gemma":0.0000018066738,"teacher_disagreement_score":0.17333394,"about_ca_system_score_codex":0.000033744094,"about_ca_system_score_gemma":0.00007055076,"threshold_uncertainty_score":0.78701407},"labels":[],"label_agreement":null},{"id":"W2038313713","doi":"10.1016/j.eururo.2007.09.033","title":"When and How to Treat Superficial and Muscle-Invasive Bladder Cancer","year":2007,"lang":"en","type":"editorial","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bladder cancer; Urology; Cancer; Internal medicine","score_opus":0.015955093815904476,"score_gpt":0.2783630909787044,"score_spread":0.2624079971627999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038313713","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.103724085,0.012232386,0.000079237376,0.0128784105,0.8170825,0.0021203612,0.0013429816,0.00030432656,0.050235685],"genre_scores_gemma":[0.035538208,0.0033559757,0.00019993143,0.0043785376,0.9421614,0.00004690228,0.00028457315,0.00029220394,0.013742278],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976952,0.000225499,0.00023187796,0.00090502953,0.0003968313,0.0005455795],"domain_scores_gemma":[0.9984538,0.00043414359,0.000090372494,0.00037809534,0.0002036508,0.00043993333],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002683356,0.00050144974,0.00071062206,0.00025117563,0.00010902946,0.000054291882,0.00013537228,0.00044201815,0.00026515676],"category_scores_gemma":[0.00047600278,0.00042765768,0.00008296526,0.00008975605,0.00020742824,0.000046680947,0.0001906989,0.00073816156,0.00008418351],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007278015,0.00006020317,0.00053079246,0.00010237464,0.00023625,0.0009940206,0.0012669233,2.626506e-7,0.00030078867,0.0000045637016,0.97467273,0.021103293],"study_design_scores_gemma":[0.0030391354,0.002211202,0.007108264,0.00005693309,0.0009922425,0.000049827788,0.00006454033,5.3966585e-7,0.00008727021,0.000013520227,0.98603225,0.00034425818],"about_ca_topic_score_codex":0.00035776428,"about_ca_topic_score_gemma":0.00043974695,"teacher_disagreement_score":0.12507886,"about_ca_system_score_codex":0.0000906888,"about_ca_system_score_gemma":0.00031245916,"threshold_uncertainty_score":0.99981755},"labels":[],"label_agreement":null},{"id":"W2039529553","doi":"10.1016/j.eururo.2007.11.057","title":"Validation of the Contemporary Epstein Criteria for Insignificant Prostate Cancer in European Men","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Prostate; Cancer; Cohort; Disease; Localized disease; Urology; Gynecology; Internal medicine","score_opus":0.03946040924932154,"score_gpt":0.31070950713743845,"score_spread":0.2712490978881169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039529553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95090616,0.0010599811,0.000081427446,0.003383056,0.00028521725,0.0013055548,0.000078163495,0.000026522643,0.04287393],"genre_scores_gemma":[0.9982477,0.00009228851,0.00007890933,0.0009912485,0.00011746594,0.000031119325,0.000034458808,0.000041523883,0.00036528843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998693,0.0003425544,0.000409824,0.0002449241,0.00009119365,0.00021852415],"domain_scores_gemma":[0.9993279,0.00009638965,0.00017407285,0.00026142495,0.00008097167,0.000059253296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010320512,0.00012097334,0.00021778597,0.00007958456,0.000042319072,0.000008406886,0.00010406102,0.000021044842,0.000033821892],"category_scores_gemma":[0.000082499726,0.000082414,0.00006680641,0.00012900024,0.00012012165,0.000036772617,0.000060857255,0.00009849399,0.0000107971555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048537515,0.0012577465,0.7218953,0.00037590374,0.00035959782,0.00083820545,0.009938782,0.00013271303,0.17342894,0.0009541104,0.020385265,0.065579705],"study_design_scores_gemma":[0.0044230362,0.0011172418,0.8844741,0.00009499737,0.000072491726,0.000013481562,0.0001312027,0.00003562879,0.05418721,0.00006396412,0.055265978,0.00012068429],"about_ca_topic_score_codex":0.00006531838,"about_ca_topic_score_gemma":0.000017301985,"teacher_disagreement_score":0.1625788,"about_ca_system_score_codex":0.00006066213,"about_ca_system_score_gemma":0.00008723033,"threshold_uncertainty_score":0.33607453},"labels":[],"label_agreement":null},{"id":"W2039651067","doi":"10.1016/j.eururo.2014.05.039","title":"Combined Value of Validated Clinical and Genomic Risk Stratification Tools for Predicting Prostate Cancer Mortality in a High-risk Prostatectomy Cohort","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Prostatectomy; Prostate cancer; Cohort; Capra; Confidence interval; Receiver operating characteristic; Concordance; Oncology; Internal medicine; Nomogram; Prostate-specific antigen; Cancer","score_opus":0.02874660183480585,"score_gpt":0.31592149741854897,"score_spread":0.2871748955837431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039651067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960569,0.00021882809,0.00024524247,0.0003641794,0.00017585422,0.0023464279,0.0003421294,0.000048352416,0.00020205729],"genre_scores_gemma":[0.99699455,0.0016654471,0.00052005536,0.00017364614,0.00009957512,0.00026406327,0.0002239316,0.000040631057,0.000018109087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745864,0.000852655,0.00080249086,0.0005195682,0.00010241856,0.0002642174],"domain_scores_gemma":[0.99842054,0.00049995986,0.00050504296,0.00034432585,0.00011945815,0.000110666944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020216962,0.0001741481,0.000517545,0.00006979341,0.0000615787,0.000020274636,0.00007219889,0.000066324275,0.000008460164],"category_scores_gemma":[0.00067908864,0.00014767403,0.00006686752,0.00009923683,0.0001994577,0.00006945262,0.000049178056,0.00024307985,0.0000037980612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009105992,0.00028286708,0.97974825,0.00008348028,0.00025459312,0.000009173448,0.00025400685,0.00024502547,0.00050138065,0.00028357017,0.000054596876,0.017372463],"study_design_scores_gemma":[0.0072845183,0.0026946606,0.98451906,0.000037912534,0.00056166016,0.0000028303314,0.000017774466,0.003146659,0.0007932704,0.0004024794,0.00042780457,0.00011136001],"about_ca_topic_score_codex":0.0006507793,"about_ca_topic_score_gemma":0.0001017715,"teacher_disagreement_score":0.017261103,"about_ca_system_score_codex":0.000044232893,"about_ca_system_score_gemma":0.00008895531,"threshold_uncertainty_score":0.6021972},"labels":[],"label_agreement":null},{"id":"W2040618631","doi":"10.1016/j.eururo.2003.10.003","title":"Role of Bisphosphonates in Prostate Cancer","year":2003,"lang":"en","type":"review","venue":"European Urology","topic":"Bone health and treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Zoledronic acid; Medicine; Prostate cancer; Androgen deprivation therapy; Bisphosphonate; Cancer; Oncology; Internal medicine; Bone Density Conservation Agents; Bone disease; Prostate; Bone mineral; Osteoporosis","score_opus":0.02838987581916445,"score_gpt":0.33902441904253233,"score_spread":0.31063454322336786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040618631","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021427513,0.9799324,5.427435e-8,0.000050980318,0.00015195501,0.0007207537,0.0000342841,0.000018123606,0.018877154],"genre_scores_gemma":[0.000357758,0.99652475,0.000041432013,0.00037546633,0.000019457682,0.000053197215,0.0000680234,0.000074636606,0.002485248],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99833536,0.00039498997,0.0005602517,0.00031094375,0.00007897331,0.00031948579],"domain_scores_gemma":[0.9992642,0.000058184327,0.0002585871,0.0002727775,0.00003053958,0.00011573711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019952767,0.0002395496,0.0012575726,0.00018080731,0.000013743006,0.0000016491468,0.00007604894,0.0000926298,0.00017471769],"category_scores_gemma":[0.000039346793,0.00017737599,0.00014442482,0.00023545821,0.00006143124,0.0000105092995,0.00003432998,0.00035627492,0.00028583733],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050217765,0.00014550521,0.0020412747,0.004149414,0.000097407275,0.00035621217,0.00005690824,2.2378725e-7,3.519636e-7,0.000040776766,0.00029119066,0.9927705],"study_design_scores_gemma":[0.0007231765,0.00028733746,0.0014217946,0.0012054187,0.00039309353,0.00013438782,0.0000020801879,4.1478492e-7,8.9404307e-7,0.000013132721,0.9957237,0.0000945573],"about_ca_topic_score_codex":0.00020037271,"about_ca_topic_score_gemma":0.00004920079,"teacher_disagreement_score":0.9954325,"about_ca_system_score_codex":0.00005720276,"about_ca_system_score_gemma":0.00033948885,"threshold_uncertainty_score":0.7233183},"labels":[],"label_agreement":null},{"id":"W2041317081","doi":"10.1016/j.eururo.2006.04.019","title":"Management and Survival of Screen-Detected Prostate Cancer Patients who Might Have Been Suitable for Active Surveillance","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Watchful waiting; Prostate cancer; Rectal examination; Prostate; Prostatectomy; Prostate-specific antigen; Gynecology; Urology; Stage (stratigraphy); Cancer; Prostate cancer screening; Incidence (geometry); Internal medicine","score_opus":0.009241486591561389,"score_gpt":0.2394734812461326,"score_spread":0.23023199465457123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041317081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876229,0.0011955011,0.000043556975,0.00054607465,0.00013587897,0.0012921875,0.00058048556,0.000032312066,0.008551075],"genre_scores_gemma":[0.9968088,0.00051073584,0.00015358289,0.00015466042,0.0000928582,0.00009926687,0.00022464868,0.00004233368,0.0019130891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883854,0.00012409019,0.00025648286,0.00035355656,0.000119084456,0.0003082555],"domain_scores_gemma":[0.99935514,0.000088986184,0.00014788572,0.00017920065,0.00016260316,0.00006617183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015224672,0.00016379944,0.0003268994,0.000074079755,0.000056234407,0.000007981484,0.00005901807,0.000032018488,0.00002567096],"category_scores_gemma":[0.000019103649,0.00013752577,0.000050697152,0.00007475359,0.00009617664,0.000037313923,0.00007423043,0.00006979635,0.000004287015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015175927,0.00040326134,0.97767466,0.00013761866,0.00030386695,0.000058644753,0.00017447466,0.000025360225,0.00015046206,0.00020567563,0.0034395105,0.015908886],"study_design_scores_gemma":[0.0051064417,0.0013600736,0.9679505,0.0000297865,0.00011578897,0.0000013710198,0.000019118912,0.000032403095,0.0013564018,0.000049931372,0.023863647,0.00011452677],"about_ca_topic_score_codex":0.0002691202,"about_ca_topic_score_gemma":0.00024355947,"teacher_disagreement_score":0.020424137,"about_ca_system_score_codex":0.0000549747,"about_ca_system_score_gemma":0.000017595992,"threshold_uncertainty_score":0.5608138},"labels":[],"label_agreement":null},{"id":"W2041505181","doi":"10.1016/j.eururo.2009.03.041","title":"Reply to Fabio Campodonico, Giacomo Capponi and Massimo Maffezzini’s Letter to the Editor re: Vincent Cloutier, Umberto Capitanio, Laurent Zini, et al. Thirty-Day Mortality after Nephrectomy: Clinical Implications for Informed Consent. Eur Urol 2009;56:998–1005","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Gerontology; Internal medicine","score_opus":0.05270007896978147,"score_gpt":0.3911648154204567,"score_spread":0.33846473645067526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041505181","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39328673,0.0005904142,0.0018545266,0.59296805,0.0022184108,0.0035981226,0.00028574988,0.00015403493,0.005043966],"genre_scores_gemma":[0.53296345,0.00035968886,0.0013003015,0.4599226,0.0036001157,0.00024951086,0.00009181692,0.000061524355,0.00145096],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948086,0.0016961801,0.001169811,0.0009714313,0.00035646523,0.0009974969],"domain_scores_gemma":[0.99479693,0.0024499039,0.00023781243,0.0014147975,0.0002869751,0.00081358076],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038345647,0.00042422564,0.00090018805,0.0001576463,0.00027358948,0.00006687559,0.00047970397,0.00021141971,0.00019076746],"category_scores_gemma":[0.003359637,0.0003033988,0.00027226412,0.00024102675,0.0004225336,0.00008028561,0.00032920146,0.0009268111,0.00046109172],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014566175,0.00031491215,0.12886132,0.000022575652,0.00022142018,0.000084311105,0.00073347986,0.0000033002,0.00015699374,0.0003398226,0.8654536,0.0023516223],"study_design_scores_gemma":[0.0016029452,0.0020375876,0.42519057,0.000018645145,0.00021411706,0.000039886763,0.000032554482,0.00004655416,0.000005142566,0.00004896695,0.57058465,0.0001783591],"about_ca_topic_score_codex":0.00011468106,"about_ca_topic_score_gemma":0.00064113917,"teacher_disagreement_score":0.29632926,"about_ca_system_score_codex":0.0001842681,"about_ca_system_score_gemma":0.0006391697,"threshold_uncertainty_score":0.9999418},"labels":[],"label_agreement":null},{"id":"W2042565581","doi":"10.1016/j.eururo.2004.05.008","title":"Efficacy and Safety of Long-Term Treatment with the Dual 5α-Reductase Inhibitor Dutasteride in Men with Symptomatic Benign Prostatic Hyperplasia","year":2004,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Dutasteride; Hyperplasia; Finasteride; Urology; 5 Alpha-Reductase Inhibitor; Benign prostatic hyperplasia (BPH); Internal medicine; Prostate","score_opus":0.013313876261955142,"score_gpt":0.26249703362994853,"score_spread":0.24918315736799337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042565581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923481,0.0003259061,0.000020783122,0.0028725574,0.00001077509,0.0011661038,0.000013491925,0.000022369724,0.0032199656],"genre_scores_gemma":[0.99925643,0.00010022619,0.00015327247,0.00012243824,0.000050112318,0.000021861035,0.000036103895,0.000041565472,0.0002179677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986127,0.0003296614,0.00025377845,0.00029498822,0.00018637445,0.00032247606],"domain_scores_gemma":[0.9993149,0.00014646318,0.00007318071,0.00030413936,0.000036884376,0.00012442702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026050964,0.0001943141,0.00031642764,0.000114651055,0.000064196756,0.00001324823,0.00006826152,0.00002508886,0.000028877945],"category_scores_gemma":[0.000018153809,0.000101693775,0.000021073638,0.00017031816,0.00039438508,0.000046851183,0.000057017824,0.00018057734,0.000021675087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15223268,0.010388933,0.5564659,0.0020861572,0.0029004267,0.0670655,0.07389487,0.0015676286,0.05973964,0.0006785834,0.00040633412,0.07257333],"study_design_scores_gemma":[0.030019416,0.038832016,0.91925704,0.00022549344,0.0003127358,0.0077135633,0.0004863357,0.00003259159,0.0024967773,0.000012388025,0.00038137662,0.00023027745],"about_ca_topic_score_codex":0.000023615567,"about_ca_topic_score_gemma":0.000039130977,"teacher_disagreement_score":0.36279112,"about_ca_system_score_codex":0.000049984425,"about_ca_system_score_gemma":0.00014773745,"threshold_uncertainty_score":0.41469517},"labels":[],"label_agreement":null},{"id":"W2042838793","doi":"10.1016/j.eururo.2012.02.002","title":"Radical Prostatectomy for Low-Risk Prostate Cancer Following Initial Active Surveillance: Results From a Prospective Observational Study","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Observational study; Urology; Prospective cohort study; Watchful waiting; Prostate; Oncology; Internal medicine; Gynecology; Cancer","score_opus":0.05086673555660886,"score_gpt":0.33923987522737936,"score_spread":0.2883731396707705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042838793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98930573,0.0007957221,0.00005448571,0.0010087946,0.0009013257,0.0042869514,0.002224029,0.0001238468,0.0012991122],"genre_scores_gemma":[0.9954755,0.00011806481,0.00038388622,0.00072465185,0.001183034,0.0011647176,0.00073129917,0.00008803629,0.00013081149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973129,0.00050801795,0.00056951784,0.00067621924,0.00028642605,0.0006468952],"domain_scores_gemma":[0.9981643,0.0007494127,0.00030711887,0.0003376127,0.00018392575,0.00025762414],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00080767885,0.00031249603,0.0005213739,0.0000794468,0.00020770113,0.000025860632,0.0001102272,0.00006441326,0.000050900348],"category_scores_gemma":[0.0008830505,0.00025522587,0.00017421742,0.00018443742,0.00011088369,0.0001803763,0.00009675238,0.00033518992,0.000052187886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010461623,0.0018803829,0.96913725,0.000016278113,0.001075264,0.00018646629,0.0071199047,0.000028095401,0.00016831052,0.000034765693,0.001108574,0.008783089],"study_design_scores_gemma":[0.020089084,0.0026783047,0.966141,0.000032538457,0.00036034637,0.0000073112997,0.00029183275,0.000049803686,0.000753498,0.00010424712,0.009248083,0.00024396271],"about_ca_topic_score_codex":0.00024412334,"about_ca_topic_score_gemma":0.00006469034,"teacher_disagreement_score":0.009627461,"about_ca_system_score_codex":0.0002703633,"about_ca_system_score_gemma":0.00020687532,"threshold_uncertainty_score":0.99999},"labels":[],"label_agreement":null},{"id":"W2044486674","doi":"10.1016/j.eururo.2014.05.011","title":"More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":245,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Interquartile range; Prostatectomy; Lymph node; Prostate cancer; Dissection (medical); Proportional hazards model; Urology; Hazard ratio; Retrospective cohort study; Lymph; Cancer; Surgery; Internal medicine; Pathology","score_opus":0.005610809363363975,"score_gpt":0.2303192703485509,"score_spread":0.22470846098518693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044486674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993942,0.00021747369,0.000034028857,0.0017832166,0.00030342827,0.0005467719,0.000040819257,0.00004779256,0.003084449],"genre_scores_gemma":[0.9969355,0.00010095826,0.000056619778,0.002341156,0.00012954,0.00006514614,0.00014197503,0.000060265425,0.00016884328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860203,0.00021909777,0.00021471112,0.00046152354,0.00015476257,0.00034786682],"domain_scores_gemma":[0.9992641,0.000065395216,0.00011510477,0.0002513565,0.00019014259,0.000113871756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012618188,0.00021709416,0.00031460854,0.00009543794,0.000057790483,0.000013123705,0.000058256508,0.000037701397,0.000025605932],"category_scores_gemma":[0.000050547682,0.0001586725,0.000041806306,0.0001348611,0.000115199175,0.000066637134,0.00004890406,0.00014970572,0.0000464658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017150659,0.00039556317,0.9810422,0.000030229956,0.00010129049,0.0001387722,0.0009155947,0.000129832,0.00025528687,0.00003140266,0.00010048572,0.015144257],"study_design_scores_gemma":[0.006164536,0.0015394097,0.9907669,0.00006359034,0.00011496183,0.000009056743,0.000054752036,0.0001229039,0.00025380135,0.000009116037,0.00074340415,0.00015755746],"about_ca_topic_score_codex":0.00019381207,"about_ca_topic_score_gemma":0.00005432063,"teacher_disagreement_score":0.014986699,"about_ca_system_score_codex":0.0001530397,"about_ca_system_score_gemma":0.000049108457,"threshold_uncertainty_score":0.6470477},"labels":[],"label_agreement":null},{"id":"W2045294456","doi":"10.1016/j.eururo.2014.01.030","title":"Outcomes with Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Who Have Poor Performance Status","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Abiraterone acetate; Prostate cancer; Docetaxel; Internal medicine; Proportional hazards model; Prostate-specific antigen; Oncology; Urology; Log-rank test; Exact test; Progression-free survival; Cancer; Androgen deprivation therapy; Overall survival","score_opus":0.019178178618573894,"score_gpt":0.28189704072956195,"score_spread":0.26271886211098805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045294456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921833,0.00021704023,0.000009663552,0.0015119269,0.00007428836,0.00070681993,0.00003840044,0.000035484176,0.0052230353],"genre_scores_gemma":[0.994109,0.00026142967,0.00015169213,0.0008433168,0.0000334961,0.00006837115,0.000101737074,0.000057964186,0.004372991],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998028,0.00032514537,0.00033604418,0.00039364013,0.00027818175,0.0006390302],"domain_scores_gemma":[0.99924964,0.00005868473,0.00011780022,0.00024692563,0.00014418302,0.00018275122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002986789,0.00023788046,0.00039958404,0.00018064979,0.00008348489,0.00002696411,0.000095360374,0.000024491601,0.000090123634],"category_scores_gemma":[0.00004681548,0.00015306314,0.00003479239,0.00015748042,0.00018044727,0.00012533907,0.000051018636,0.00026164248,0.00009541812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002828324,0.00023854134,0.98646575,0.00011089831,0.00013081315,0.00017713262,0.001104354,0.00021232282,0.000601472,0.000015039308,0.00023312966,0.007882209],"study_design_scores_gemma":[0.009172108,0.0030330645,0.98094445,0.0000469733,0.00008065559,0.0000071783134,0.000051448373,0.00062700367,0.00051447476,0.0000061192814,0.005354006,0.00016250476],"about_ca_topic_score_codex":0.00016707978,"about_ca_topic_score_gemma":0.00040520748,"teacher_disagreement_score":0.007719704,"about_ca_system_score_codex":0.000110375004,"about_ca_system_score_gemma":0.00012738086,"threshold_uncertainty_score":0.6241734},"labels":[],"label_agreement":null},{"id":"W2045589622","doi":"10.1016/j.eururo.2014.06.045","title":"Efficacy of Enzalutamide Following Abiraterone Acetate in Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer Patients","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Enzalutamide; Abiraterone acetate; Prostate cancer; Abiraterone; Oncology; Chemotherapy; Urology; Internal medicine; Cancer; Androgen deprivation therapy; Androgen receptor","score_opus":0.02039178408978887,"score_gpt":0.3027230015513336,"score_spread":0.2823312174615447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045589622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954703,0.000459828,0.00001695437,0.0008892536,0.0001331896,0.00066830183,0.000015519641,0.000026896301,0.0023197967],"genre_scores_gemma":[0.99843794,0.00012607766,0.0001756821,0.0004385525,0.000044805973,0.000026394475,0.000059272,0.000048613132,0.0006426483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825233,0.00041613827,0.0004084006,0.00032308165,0.00022171736,0.0003783285],"domain_scores_gemma":[0.9993337,0.00011700445,0.00013548028,0.00022774268,0.000084205894,0.00010190152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043863806,0.00017633817,0.0003839877,0.0001708244,0.000042520987,0.000010561821,0.000104374936,0.000026874855,0.000070596565],"category_scores_gemma":[0.00011590677,0.000136867,0.000087846776,0.00020962789,0.000114183145,0.00006172981,0.000040737756,0.00018305022,0.000042269556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017314129,0.0027039195,0.6373843,0.0005029529,0.0013272237,0.0009174214,0.011619772,0.00080113625,0.25148416,0.00017758644,0.00071300426,0.075054415],"study_design_scores_gemma":[0.021657094,0.0023379794,0.96380216,0.00009327165,0.00015649188,0.0000043901177,0.000051156665,0.00019137532,0.008752958,0.000058155198,0.0027155185,0.00017947357],"about_ca_topic_score_codex":0.00010284395,"about_ca_topic_score_gemma":0.00004386784,"teacher_disagreement_score":0.32641783,"about_ca_system_score_codex":0.00007373722,"about_ca_system_score_gemma":0.00008379202,"threshold_uncertainty_score":0.55812746},"labels":[],"label_agreement":null},{"id":"W2046660139","doi":"10.1159/000020189","title":"Urinary Retention in Patients with BPH Treated with Finasteride or Placebo over 4 Years","year":2000,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; Finasteride; Urinary retention; Urology; Placebo; Urinary system; Erectile dysfunction; Internal medicine; Prostate","score_opus":0.015298462713256434,"score_gpt":0.24564002590441936,"score_spread":0.23034156319116292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046660139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587818,0.000029935078,0.0000025385432,0.00014234021,0.000011253002,0.00039866532,0.000007880758,0.000043694385,0.040581897],"genre_scores_gemma":[0.98699117,0.000030307752,0.000077356155,0.00032647786,0.000037633272,0.0000069991297,0.00009655771,0.000046537953,0.012386981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987418,0.00030575378,0.00015692093,0.0002953365,0.00017962328,0.00032053405],"domain_scores_gemma":[0.99955827,0.000033986213,0.000028880666,0.00025113692,0.00003099613,0.00009675627],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016214102,0.0001291007,0.00018049408,0.00013666513,0.000029941953,0.000009834137,0.000072420924,0.000035502508,0.0027124595],"category_scores_gemma":[0.000010961738,0.00008524514,0.000019716725,0.0002224987,0.000098542805,0.00007049276,0.000030773474,0.00024630886,0.00038797356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.090439595,0.0008264486,0.878827,0.000040145085,0.00007515169,0.008281469,0.0004070413,0.000033783384,0.000058288017,0.0000025411623,0.0012209158,0.019787636],"study_design_scores_gemma":[0.009000224,0.015476054,0.9603632,0.00003131628,0.00003119523,0.00021113544,0.000010918201,0.000030513891,0.00000876032,0.0000014988826,0.014729883,0.000105316016],"about_ca_topic_score_codex":0.00002778945,"about_ca_topic_score_gemma":0.000009607501,"teacher_disagreement_score":0.081536196,"about_ca_system_score_codex":0.000024914258,"about_ca_system_score_gemma":0.000040265237,"threshold_uncertainty_score":0.9981992},"labels":[],"label_agreement":null},{"id":"W2046799168","doi":"10.1016/j.eururo.2011.06.019","title":"Long-Term Survival After Treatment with Gemcitabine and Oxaliplatin With and Without Paclitaxel Plus Secondary Surgery in Patients with Cisplatin-Refractory and/or Multiply Relapsed Germ Cell Tumors","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Oxaliplatin; Gemcitabine; Chemotherapy; Cisplatin; Paclitaxel; Surgery; Germ cell tumors; Internal medicine; Refractory (planetary science); Oncology; Cancer; Colorectal cancer","score_opus":0.015725287895855936,"score_gpt":0.21440521380228444,"score_spread":0.19867992590642852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046799168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973719,0.0007598001,0.000015300955,0.000025065363,0.00002898681,0.0007149739,0.000053550604,0.000048946218,0.0009814563],"genre_scores_gemma":[0.9986004,0.00005363794,0.00050414586,0.00018999448,0.000026763044,0.000036078018,0.0001036395,0.000095840434,0.0003894947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982869,0.00023775788,0.00030114295,0.0006185737,0.0001718246,0.00038382085],"domain_scores_gemma":[0.99892855,0.00016445982,0.00019513097,0.0003250485,0.000056926638,0.00032990688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011667683,0.00041577002,0.00060134166,0.00016127752,0.000062256746,0.000018966317,0.000033635475,0.000056372057,0.00010353023],"category_scores_gemma":[0.000021539434,0.00023596929,0.00003085684,0.00009464988,0.00031495243,0.000113855975,0.000055818124,0.00018133184,0.000006750188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02019846,0.00089495064,0.96999717,0.00008701851,0.00021561723,0.003800408,0.0008264691,7.501127e-7,0.000007337467,0.0000010085698,0.0000042030615,0.0039665936],"study_design_scores_gemma":[0.020485599,0.009830034,0.96850485,0.00010637204,0.00048219872,0.00020574794,0.00004576998,0.00001247963,0.00000713496,0.0000010038189,0.00004236488,0.0002764399],"about_ca_topic_score_codex":0.00010438127,"about_ca_topic_score_gemma":0.00037753608,"teacher_disagreement_score":0.008935084,"about_ca_system_score_codex":0.000046573437,"about_ca_system_score_gemma":0.00012352206,"threshold_uncertainty_score":0.9622548},"labels":[],"label_agreement":null},{"id":"W2047384599","doi":"10.1016/j.eururo.2008.11.038","title":"The Motion: Nomograms Should Become a Routine Tool in Determining Prostate Cancer Prognosis","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nomogram; Prostate cancer; Prostate; Oncology; Cancer; Medical physics; General surgery; Internal medicine","score_opus":0.04468587313196514,"score_gpt":0.28781365130745173,"score_spread":0.2431277781754866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047384599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981959,0.002365042,0.000011597109,0.012110991,0.00026000428,0.00071288197,0.000010346377,0.00007865631,0.0024914818],"genre_scores_gemma":[0.99362344,0.002501221,0.00010039105,0.0026358024,0.0001907921,0.0002987428,0.000018643908,0.000044370783,0.0005866065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985136,0.00018629518,0.00035148257,0.0003517501,0.00014059759,0.0004563149],"domain_scores_gemma":[0.9993782,0.00010943985,0.000099936384,0.00028141445,0.000057180867,0.000073851574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003208194,0.00017995718,0.00025156664,0.00006599709,0.00018381161,0.000017756618,0.00011289718,0.000037238442,0.00005855898],"category_scores_gemma":[0.00007473799,0.0001195028,0.00007692683,0.00019798605,0.00017402397,0.000050597224,0.000084339044,0.00024400868,0.00007558718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019844648,0.00021485459,0.9048027,0.00001567168,0.000060436698,0.0014765143,0.00090065395,0.00004221456,0.000048427173,0.000048352205,0.0007782485,0.09141349],"study_design_scores_gemma":[0.0024454545,0.0009946706,0.9442747,0.00004027196,0.00006236647,0.00028594997,0.00003281468,0.00021070938,0.0002289147,0.000017185632,0.051269606,0.00013735585],"about_ca_topic_score_codex":0.000057842444,"about_ca_topic_score_gemma":0.00010013083,"teacher_disagreement_score":0.09127613,"about_ca_system_score_codex":0.000099259865,"about_ca_system_score_gemma":0.000066944,"threshold_uncertainty_score":0.48731828},"labels":[],"label_agreement":null},{"id":"W2047905289","doi":"10.1016/j.eururo.2014.01.014","title":"The Effect of Neoadjuvant Chemotherapy on Perioperative Outcomes in Patients Who Have Bladder Cancer Treated with Radical Cystectomy: A Population-based Study","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Perioperative; Propensity score matching; Chemotherapy; Neoadjuvant therapy; Internal medicine; Complication; Oncology; Confounding; Population; Surgery; Cancer; Breast cancer","score_opus":0.0062215926033548224,"score_gpt":0.2635213291937909,"score_spread":0.2572997365904361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047905289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574316,0.00003832465,0.000008194317,0.000563859,0.000051709085,0.0013299674,0.000009733813,0.000025230627,0.0022298237],"genre_scores_gemma":[0.9984285,0.0000026812163,0.0000059088497,0.0009903274,0.000043965778,0.0000770992,0.000016798502,0.000050948114,0.0003837652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793214,0.0010253093,0.00027208525,0.00031385894,0.000225513,0.00023110326],"domain_scores_gemma":[0.99916804,0.00028142595,0.000103876584,0.00032686393,0.00005189367,0.00006788091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002466301,0.00023731965,0.0005163862,0.000088077526,0.00008500447,0.000009892228,0.000099910656,0.000038568778,0.000056202218],"category_scores_gemma":[0.00007663851,0.00011701372,0.00006258084,0.00010461182,0.00009036305,0.00001760141,0.000013279251,0.00018312964,0.000011272089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064124777,0.00047138293,0.9853565,0.0000069796897,0.00024149437,0.000022528482,0.0004965724,0.00015674155,0.000012603714,0.000004029268,0.000025767848,0.006792925],"study_design_scores_gemma":[0.025701527,0.025502145,0.94751465,0.000024346087,0.00013359239,9.3093087e-7,0.000018814024,0.00026225677,0.00027926583,4.2214637e-7,0.00046522784,0.00009682686],"about_ca_topic_score_codex":0.00049829483,"about_ca_topic_score_gemma":0.00030499545,"teacher_disagreement_score":0.037841853,"about_ca_system_score_codex":0.00007427588,"about_ca_system_score_gemma":0.000034030407,"threshold_uncertainty_score":0.4771681},"labels":[],"label_agreement":null},{"id":"W2048274452","doi":"10.1016/j.eururo.2009.04.036","title":"ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice","year":2009,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":386,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"TMPRSS2; Prostate cancer; Medicine; Fusion gene; Cancer; Population; Prostate; Prostatectomy; Oncology; Cancer research; Internal medicine; Bioinformatics; Gene; Disease; Genetics; Biology","score_opus":0.10478676234238236,"score_gpt":0.46481463941728624,"score_spread":0.36002787707490386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048274452","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006749687,0.9793391,0.0000071905615,0.0054635415,0.00065544585,0.0019158131,0.0003131653,0.000059524373,0.011571227],"genre_scores_gemma":[0.00008112177,0.98839766,0.00051477365,0.0035687687,0.0012082737,0.00010437484,0.00077017874,0.00011954941,0.00523528],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946867,0.00220661,0.0011132722,0.0010366086,0.0003045021,0.00065228017],"domain_scores_gemma":[0.99748147,0.0009171289,0.0003217775,0.0007832715,0.00010076197,0.00039558744],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001097892,0.00045211392,0.0018706862,0.000328694,0.00006662219,0.000046961464,0.0003566107,0.00020267622,0.00012509066],"category_scores_gemma":[0.0009869077,0.00031954097,0.0003555371,0.00048651712,0.00012904688,0.00011799534,0.0003586104,0.001488373,0.00118457],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007516732,0.00044927147,0.0003016594,0.0004000935,0.00030362108,0.008432874,0.0001510151,0.0000016514991,0.000003868464,0.0000090096655,0.0096422285,0.97955304],"study_design_scores_gemma":[0.0015664164,0.0012423042,0.0028798531,0.0017087423,0.0011140199,0.00014394274,0.000011204512,0.0000010680665,6.1287267e-7,0.000008179699,0.9910625,0.00026114032],"about_ca_topic_score_codex":0.0002019428,"about_ca_topic_score_gemma":0.00006505607,"teacher_disagreement_score":0.9814203,"about_ca_system_score_codex":0.00023022525,"about_ca_system_score_gemma":0.0010311602,"threshold_uncertainty_score":0.9999257},"labels":[],"label_agreement":null},{"id":"W2048275270","doi":"10.1016/j.eururo.2013.08.034","title":"Long-term Cancer-specific Outcomes of TaG1 Urothelial Carcinoma of the Bladder","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Interquartile range; Proportional hazards model; Bladder cancer; Internal medicine; Urology; Cancer; Cystectomy; Carcinoma; Retrospective cohort study; Oncology; Surgery; Gastroenterology","score_opus":0.02164739504468382,"score_gpt":0.2634388568208737,"score_spread":0.24179146177618988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048275270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760054,0.0013464299,0.000023141045,0.0017955574,0.0005678576,0.0005371182,0.000036775855,0.000023290944,0.019664468],"genre_scores_gemma":[0.99649495,0.00009793887,0.000035390807,0.0012623279,0.00020775545,0.000020893596,0.0000045888346,0.000048042955,0.0018280911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873346,0.00020158813,0.00036597357,0.00025155034,0.00019499758,0.00025245477],"domain_scores_gemma":[0.9989969,0.000053381882,0.00017431923,0.00057511684,0.00011801536,0.00008225104],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000084396066,0.00017985418,0.000391096,0.00006409844,0.000041569478,0.0000050131885,0.00025821093,0.00005125523,0.002013481],"category_scores_gemma":[0.00002532574,0.00010934112,0.00018447111,0.00011751516,0.00028832696,0.00003596204,0.000111278976,0.00016386934,0.00017144869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012342012,0.00018305205,0.9817637,0.000029238288,0.00028324046,0.000027157366,0.00036295448,0.0000031673046,0.008252336,0.0000987928,0.0021793721,0.006693557],"study_design_scores_gemma":[0.0020691312,0.0004374591,0.9896882,0.000010685139,0.00020092425,0.000030634186,0.000013043528,0.0000027266515,0.004817393,0.000023496345,0.0026242742,0.00008201941],"about_ca_topic_score_codex":0.00029487195,"about_ca_topic_score_gemma":0.000022173353,"teacher_disagreement_score":0.020489609,"about_ca_system_score_codex":0.000022045853,"about_ca_system_score_gemma":0.00008268312,"threshold_uncertainty_score":0.9988988},"labels":[],"label_agreement":null},{"id":"W2048611239","doi":"10.1016/j.eururo.2009.02.001","title":"Nonoperative Management of Grade 5 Renal Injury in Children: Does It Have a Place?","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Abdominal Trauma and Injuries","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Medicine; Urinoma; Nephrectomy; Surgery; Blunt; Renal function; Injury Severity Score; Embolization; Radiology; Kidney; Poison control; Internal medicine; Injury prevention","score_opus":0.01033529046572534,"score_gpt":0.271424105967582,"score_spread":0.26108881550185664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048611239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9140433,0.00009798006,0.00004565929,0.00401616,0.000045903565,0.0002701802,0.0000067407946,0.000023523415,0.081450544],"genre_scores_gemma":[0.9943496,0.00009617996,0.000653589,0.0030060129,0.000106003674,0.0000024973651,0.000012986176,0.00001476078,0.001758374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989363,0.00019146412,0.00031020504,0.0002438532,0.00010417378,0.00021402905],"domain_scores_gemma":[0.99961096,0.000017864571,0.000071057184,0.00021948223,0.000023080049,0.00005755911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023907042,0.00013544696,0.00026915662,0.0001348033,0.000027516762,0.000004643217,0.00011036558,0.000036489444,0.00012226115],"category_scores_gemma":[0.000018698773,0.00009640138,0.000055739856,0.000092810566,0.0001404002,0.00004277056,0.000047821686,0.00021230966,0.00006734702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037475698,0.008362811,0.48116222,0.00040314923,0.0026620643,0.009616614,0.03474067,0.0003491433,0.061113045,0.049905192,0.07341157,0.24079782],"study_design_scores_gemma":[0.0027900003,0.003923191,0.97366667,0.000071616945,0.00012060627,0.00011762268,0.00036798164,0.000036413392,0.004479771,0.00022995297,0.014013695,0.00018248949],"about_ca_topic_score_codex":0.0000048453435,"about_ca_topic_score_gemma":0.0000035016924,"teacher_disagreement_score":0.49250445,"about_ca_system_score_codex":0.000015363845,"about_ca_system_score_gemma":0.000011942549,"threshold_uncertainty_score":0.39311343},"labels":[],"label_agreement":null},{"id":"W2049136550","doi":"10.1016/j.eururo.2014.08.056","title":"Identifying Optimal Candidates for Local Treatment of the Primary Tumor Among Patients Diagnosed with Metastatic Prostate Cancer: A SEER-based Study","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; Androgen deprivation therapy; Primary tumor; Proportional hazards model; Oncology; Internal medicine; Cancer; Prostate; Radiation therapy; Lymph node; Epidemiology; Dissection (medical); Metastasis; Surgery","score_opus":0.026586483389811177,"score_gpt":0.29047562621983997,"score_spread":0.2638891428300288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049136550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9500138,0.00067868095,0.00021874702,0.038480774,0.00034151945,0.009441632,0.00053924153,0.0000653114,0.00022028944],"genre_scores_gemma":[0.94467413,0.000044615586,0.00019159334,0.04888732,0.00048410983,0.0016256585,0.0015497655,0.0002561504,0.0022866519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967279,0.0008473372,0.00051187986,0.0007179008,0.00052214164,0.00067283475],"domain_scores_gemma":[0.9980882,0.00039216655,0.00047331522,0.0006671032,0.00027164014,0.00010758632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025223507,0.0005152845,0.0009775871,0.00021195726,0.00016031477,0.000031610183,0.00028878285,0.00007577015,0.000037165006],"category_scores_gemma":[0.000039719413,0.00027472482,0.00023259399,0.0001905635,0.00048231723,0.000039135433,0.00008444217,0.00050549844,0.000009640089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075687566,0.002935836,0.8851946,0.0016452197,0.0032256488,0.004885508,0.0024409557,0.00062034343,0.00003634982,4.7026987e-7,0.08713813,0.00430819],"study_design_scores_gemma":[0.07561965,0.05971338,0.62917364,0.00055994344,0.008186244,0.000046032244,0.00025833832,0.00080290774,0.0006660398,0.0000046168734,0.22399758,0.0009716064],"about_ca_topic_score_codex":0.0003498828,"about_ca_topic_score_gemma":0.0001393789,"teacher_disagreement_score":0.25602093,"about_ca_system_score_codex":0.00038998906,"about_ca_system_score_gemma":0.00048724597,"threshold_uncertainty_score":0.9999705},"labels":[],"label_agreement":null},{"id":"W2049604173","doi":"10.1016/j.eururo.2007.10.038","title":"Poor Overall Survival in Septa- and Octogenarian Patients after Radical Prostatectomy and Radiotherapy for Prostate Cancer: A Population-Based Study of 6183 Men","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; External beam radiotherapy; Urology; Proportional hazards model; Radiation therapy; Population; Internal medicine; Cohort; Relative survival; Prostate; Cancer; Surgery; Oncology; Gynecology; Cancer registry","score_opus":0.010618792667754218,"score_gpt":0.2746347529941948,"score_spread":0.2640159603264406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049604173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567235,0.0010194232,0.000025715493,0.0005318808,0.000078056015,0.00248912,0.000066602894,0.000017277785,0.00009955107],"genre_scores_gemma":[0.9986612,0.00012101935,0.000189879,0.0007027748,0.000048005506,0.0001513232,0.000054177675,0.000041105737,0.000030509445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987119,0.00015859655,0.0003660106,0.00036063278,0.00012569447,0.0002771878],"domain_scores_gemma":[0.9994498,0.00012291355,0.00011132918,0.00013829954,0.00005782315,0.00011984702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038797184,0.00016709988,0.0003557965,0.00013769021,0.00003340474,0.000009022853,0.00003486257,0.000036234534,0.000019529882],"category_scores_gemma":[0.000031132415,0.00013566819,0.00003212254,0.000080863974,0.000055346052,0.000034743814,0.000023684417,0.00008986535,3.9023016e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054981397,0.0009944045,0.979273,0.00006607348,0.00011227515,0.00009546047,0.0012704377,0.000020540538,0.0000734706,0.000011364354,0.000038599712,0.012546191],"study_design_scores_gemma":[0.020901015,0.0053731664,0.97151655,0.000025201345,0.00008464569,0.0000018661106,0.000044837503,0.00014551703,0.00006360813,0.000013620058,0.0017200242,0.00010994081],"about_ca_topic_score_codex":0.00038107362,"about_ca_topic_score_gemma":0.0003649491,"teacher_disagreement_score":0.015402876,"about_ca_system_score_codex":0.00008474324,"about_ca_system_score_gemma":0.00003733627,"threshold_uncertainty_score":0.55323887},"labels":[],"label_agreement":null},{"id":"W2049643177","doi":"10.1016/j.eururo.2010.03.006","title":"Real-Time Magnetic Resonance Imaging–Guided Focal Laser Therapy in Patients with Low-Risk Prostate Cancer","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Magnetic resonance imaging; Prostate cancer; Ablation; Radiology; Prostate; Nuclear medicine; Cancer; Internal medicine","score_opus":0.004589202942530836,"score_gpt":0.2265849338443849,"score_spread":0.22199573090185407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049643177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99221194,0.0010221248,4.445429e-7,0.0013029128,0.00018311487,0.0007695708,0.000060624385,0.00006728479,0.004381982],"genre_scores_gemma":[0.995316,0.0018600043,0.0002053219,0.001594629,0.000118750475,0.000098055905,0.00005252492,0.00008102726,0.000673663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848676,0.00017937981,0.00028830502,0.00047074526,0.00016066687,0.00041413127],"domain_scores_gemma":[0.99916047,0.00006218688,0.00011442799,0.00041302195,0.00011397797,0.00013589536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020182862,0.00022346356,0.00028219612,0.000087335684,0.00004940716,0.00001486098,0.000105106694,0.00003513559,0.0004726977],"category_scores_gemma":[0.000045711506,0.00015898472,0.00004056547,0.00014570335,0.00017547743,0.000054324308,0.0000437341,0.00033812545,0.000195316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013506528,0.00044921483,0.90875274,0.0000060058724,0.000016532167,0.00029277985,0.00026531686,0.000008946064,0.00040832502,0.000006813251,0.0023784041,0.08606429],"study_design_scores_gemma":[0.00947823,0.0021394698,0.9558241,0.000029507648,0.000038000464,0.000009156586,0.000002563655,0.00005873466,0.00036956396,0.00001580358,0.031879485,0.00015542109],"about_ca_topic_score_codex":0.00028434856,"about_ca_topic_score_gemma":0.00010512499,"teacher_disagreement_score":0.08590887,"about_ca_system_score_codex":0.000050833398,"about_ca_system_score_gemma":0.00008471218,"threshold_uncertainty_score":0.6483209},"labels":[],"label_agreement":null},{"id":"W2049831707","doi":"10.1016/j.eururo.2011.02.023","title":"Growth Kinetics of Renal Masses: Analysis of a Prospective Cohort of Patients Undergoing Active Surveillance","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Cohort; Renal cell carcinoma; Prospective cohort study; Kidney disease; Urology; Surgery; Internal medicine; Radiology","score_opus":0.017046274446073952,"score_gpt":0.22625285601337922,"score_spread":0.20920658156730526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049831707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9495366,0.00005960926,0.0003072146,0.000010270327,0.00003315279,0.00029356306,0.000038976646,0.000010835239,0.049709786],"genre_scores_gemma":[0.99914825,0.00003064869,0.0006534211,0.000026007976,0.000013038967,0.000003266387,0.000052211817,0.000023356084,0.00004982092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985904,0.00031207886,0.00045929506,0.0002698495,0.00020896655,0.00015941018],"domain_scores_gemma":[0.9985551,0.00015406868,0.00047017378,0.00033168998,0.0004289194,0.00005999925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017442623,0.00013736245,0.0006191777,0.0003127597,0.000009218045,7.400777e-7,0.00010702827,0.000038570586,0.000105993284],"category_scores_gemma":[0.00023535428,0.000114838185,0.00017496162,0.0005025124,0.0002028334,0.000021694052,0.00007713425,0.00009299227,0.000004986135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011508967,0.00062211993,0.99016917,0.0000495829,0.0026410497,0.000043415002,0.0008819438,0.000019442,0.00413129,0.00016056329,0.000014300504,0.000116223106],"study_design_scores_gemma":[0.0012498607,0.003564874,0.9579157,0.000009543774,0.0016227557,0.0000032526887,0.00003725493,0.000024604493,0.035456378,0.00003736105,0.000012537901,0.00006584343],"about_ca_topic_score_codex":0.00006013435,"about_ca_topic_score_gemma":0.000040836574,"teacher_disagreement_score":0.049659964,"about_ca_system_score_codex":0.000046168403,"about_ca_system_score_gemma":0.00003202597,"threshold_uncertainty_score":0.46829653},"labels":[],"label_agreement":null},{"id":"W2049980881","doi":"10.1016/j.eururo.2013.06.031","title":"Re: Genome Sequencing Identifies a Basis for Everolimus Sensitivity","year":2013,"lang":"en","type":"letter","venue":"European Urology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Everolimus; Computational biology; Genome; Whole genome sequencing; DNA sequencing; Sensitivity (control systems); Bioinformatics; Oncology; Genetics; Gene","score_opus":0.023730600884903523,"score_gpt":0.24148941905317242,"score_spread":0.2177588181682689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049980881","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27262428,0.012078914,0.036085326,0.6082812,0.014644196,0.0054230043,0.0031797655,0.0007551556,0.046928175],"genre_scores_gemma":[0.22384204,0.00016504593,0.0008821868,0.74310946,0.0185213,0.00012497905,0.0020357298,0.00044801846,0.010871244],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99632794,0.0010215009,0.00046166737,0.0011826908,0.00019701768,0.00080919405],"domain_scores_gemma":[0.99804693,0.00020168796,0.00035596924,0.0010634483,0.00024658898,0.00008534121],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00081929105,0.0005260919,0.00048795363,0.00012840227,0.0001545167,0.00007867076,0.0005137439,0.0007874494,0.00015455301],"category_scores_gemma":[0.00050804956,0.0005586246,0.0003423829,0.00007272055,0.00024391152,0.000006267458,0.00038379309,0.000873082,0.00038103637],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049872495,0.0000075110593,0.0000208024,0.00009058198,0.00022180568,0.0003605548,0.000059091868,0.00011656412,0.2766321,0.0000016653664,0.72221196,0.0002274585],"study_design_scores_gemma":[0.00036223175,0.00043365598,0.0001993936,0.000016089267,0.0001472028,0.00013331068,0.000012558669,0.00004441638,0.008440308,0.000043212767,0.9895653,0.00060228974],"about_ca_topic_score_codex":0.000038853617,"about_ca_topic_score_gemma":0.000031263084,"teacher_disagreement_score":0.26819178,"about_ca_system_score_codex":0.0000937153,"about_ca_system_score_gemma":0.00016789022,"threshold_uncertainty_score":0.99968654},"labels":[],"label_agreement":null},{"id":"W2050099732","doi":"10.1016/j.eururo.2014.07.045","title":"Next-generation RNA Sequencing of Archival Formalin-fixed Paraffin-embedded Urothelial Bladder Cancer","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Lunenfeld-Tanenbaum Research Institute; University Health Network; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Transcriptome; Bladder cancer; Concordance; Medicine; RNA; Computational biology; RNA-Seq; Gene; Biology; Cancer; Gene expression; Genetics; Internal medicine","score_opus":0.0750362743545373,"score_gpt":0.293023078256618,"score_spread":0.2179868039020807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050099732","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.089494534,0.003252108,0.0059548533,0.6849866,0.008771548,0.004415215,0.0008164618,0.0008080643,0.20150062],"genre_scores_gemma":[0.35157084,0.00025513113,0.0007727675,0.6224156,0.019360833,0.0000783928,0.000987799,0.0003281863,0.0042304588],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962632,0.0008574874,0.0008485161,0.00080270076,0.00048524907,0.000742817],"domain_scores_gemma":[0.9982159,0.00012456666,0.0005154042,0.0008160907,0.000176656,0.00015138216],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033559516,0.000620919,0.0010335175,0.00029878132,0.00011095477,0.000033827644,0.00035140343,0.00039075036,0.0006606531],"category_scores_gemma":[0.000079713,0.000538362,0.0003709432,0.00013791438,0.00025924406,0.00008774775,0.0001123006,0.0015185914,0.00033253137],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007350176,0.00011472419,0.00021401429,0.00039073257,0.0013685278,0.0018656737,0.0010535938,0.00022475958,0.08204008,0.00014219274,0.9008707,0.010979975],"study_design_scores_gemma":[0.006339519,0.0028027263,0.0008039519,0.00015157215,0.0023732816,0.0006115577,0.000015223148,0.0013643388,0.016171763,0.00013846505,0.9682838,0.00094383623],"about_ca_topic_score_codex":0.00020722458,"about_ca_topic_score_gemma":0.000020433215,"teacher_disagreement_score":0.2620763,"about_ca_system_score_codex":0.00014386234,"about_ca_system_score_gemma":0.0005087325,"threshold_uncertainty_score":0.9997068},"labels":[],"label_agreement":null},{"id":"W2050858827","doi":"10.1016/j.eururo.2009.12.001","title":"Should Bladder Cuff Excision Remain the Standard of Care at Nephroureterectomy in Patients with Urothelial Carcinoma of the Renal Pelvis? A Population-based Study","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal pelvis; Cuff; Urothelial carcinoma; Urology; Pelvis; Standard of care; Urothelium; Carcinoma; Population; Urinary bladder; Surgery; Ureter; Bladder cancer; Internal medicine; Cancer","score_opus":0.012353235833613765,"score_gpt":0.2539879939506797,"score_spread":0.24163475811706597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050858827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963221,0.00011303241,0.0000127376115,0.0005551892,0.00007758798,0.0012560665,0.000049281432,0.0000134279135,0.0016005563],"genre_scores_gemma":[0.9988777,8.8419625e-7,0.00003892525,0.00090375316,0.00006331653,0.0000063418424,0.000024872603,0.00003113068,0.000053050433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799883,0.00068514055,0.0003790383,0.0002854766,0.00044125112,0.00021028332],"domain_scores_gemma":[0.99896073,0.00007647339,0.00019403484,0.00057402404,0.00014715125,0.00004756409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021272815,0.00018839417,0.00035929662,0.00009235807,0.00008068431,0.0000049335677,0.00019554007,0.0000443655,0.00007834386],"category_scores_gemma":[0.000060733393,0.00009641699,0.000092624396,0.00022575326,0.00008123692,0.000024431305,0.00005608855,0.00020724405,0.0000034043087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008891835,0.00037050704,0.9864666,0.00001141373,0.00004834395,0.000030269004,0.0019694518,0.00015760321,0.00008881563,0.000010691279,0.000104387946,0.001850088],"study_design_scores_gemma":[0.010016137,0.010370316,0.9785148,0.0000308425,0.00018880708,0.0000034190566,0.000120608354,0.0000127519415,0.00028138884,0.000014961855,0.00036382998,0.00008217224],"about_ca_topic_score_codex":0.00011760237,"about_ca_topic_score_gemma":0.0002907034,"teacher_disagreement_score":0.009999809,"about_ca_system_score_codex":0.00009979778,"about_ca_system_score_gemma":0.00010367013,"threshold_uncertainty_score":0.3931771},"labels":[],"label_agreement":null},{"id":"W2050877010","doi":"10.1016/j.eururo.2014.05.027","title":"International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia","year":2014,"lang":"en","type":"editorial","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Grading (engineering); Consensus conference; Malignancy; Renal pathology; Pathology; Nephrology; Anatomical pathology; General surgery; Internal medicine; Kidney; Immunohistochemistry","score_opus":0.02407704273938394,"score_gpt":0.26686912081388026,"score_spread":0.24279207807449632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050877010","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4231481,0.0008502787,0.0022157836,0.0012276602,0.55323774,0.001800754,0.0005260893,0.00018462859,0.016808987],"genre_scores_gemma":[0.4265448,0.00016909812,0.0032101804,0.00090131164,0.5659148,0.00006182381,0.0015046688,0.00024077794,0.0014525857],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99795216,0.0003012004,0.0004810499,0.00064720714,0.00027552713,0.00034284842],"domain_scores_gemma":[0.99707884,0.0019730537,0.00036478828,0.00028088762,0.0001741946,0.000128237],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005303019,0.0003577804,0.0007271993,0.00011390615,0.00005006711,0.000012295675,0.00021127611,0.00051536405,0.00005394007],"category_scores_gemma":[0.001351001,0.00027018684,0.0003114378,0.00004243381,0.00034707575,0.000016190777,0.00016086687,0.00060057995,0.000015470667],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089573103,0.00017203426,0.023419108,0.00019426298,0.0005431475,0.00018634406,0.0003984228,0.00000442709,0.0015784038,0.00009780308,0.9717381,0.00077221025],"study_design_scores_gemma":[0.0023038464,0.0038742505,0.0145346625,0.000027064825,0.0005298537,0.00016065761,0.000012307964,0.00009023492,0.00007640315,0.000062388324,0.9781439,0.00018446258],"about_ca_topic_score_codex":0.0000042801785,"about_ca_topic_score_gemma":8.8314283e-7,"teacher_disagreement_score":0.0153564,"about_ca_system_score_codex":0.000052057443,"about_ca_system_score_gemma":0.00008223749,"threshold_uncertainty_score":0.999975},"labels":[],"label_agreement":null},{"id":"W2050902486","doi":"10.1016/j.eururo.2006.02.066","title":"High Radical Prostatectomy Surgical Volume is Related to Lower Radical Prostatectomy Total Hospital Charges","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Canadian Urological Association","keywords":"Medicine; Prostatectomy; Prostate cancer; Multivariate analysis; Urology; Multivariate statistics; Comorbidity; Bayesian multivariate linear regression; Univariate; Surgery; Linear regression; Internal medicine; Cancer; Statistics","score_opus":0.004131105704722687,"score_gpt":0.21928412294030905,"score_spread":0.21515301723558636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050902486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9657977,0.000997166,0.000024879584,0.02181562,0.0008697005,0.0016637469,0.00012282608,0.00037549922,0.00833284],"genre_scores_gemma":[0.99101603,0.00010813516,0.00042161284,0.0019401005,0.0005908434,0.00014290914,0.00028906213,0.00014931428,0.0053420207],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964629,0.00031527173,0.0007503058,0.0010717494,0.00039203808,0.0010077325],"domain_scores_gemma":[0.99848646,0.00009380757,0.00014639119,0.0005707151,0.0001277311,0.0005748979],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00036058054,0.0004955602,0.0007349752,0.00020275557,0.00015129676,0.00005360074,0.0001929234,0.00018662977,0.0019020898],"category_scores_gemma":[0.00007768392,0.00040709416,0.00025963195,0.00039920406,0.00044116832,0.00009612289,0.00019334274,0.0006085756,0.0030598824],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012016694,0.015886476,0.34847602,0.00033025027,0.0018741951,0.12071455,0.0023843877,0.00027125687,0.0031450489,0.015928835,0.44418162,0.034790635],"study_design_scores_gemma":[0.014868129,0.011611742,0.4025832,0.000080594284,0.00029080643,0.0017293076,0.000016540358,0.000092299866,0.0021825354,0.0004385622,0.56533027,0.00077599374],"about_ca_topic_score_codex":0.00007632437,"about_ca_topic_score_gemma":0.0000014699337,"teacher_disagreement_score":0.12114863,"about_ca_system_score_codex":0.0001896851,"about_ca_system_score_gemma":0.00012330276,"threshold_uncertainty_score":0.9998381},"labels":[],"label_agreement":null},{"id":"W2051044115","doi":"10.1016/j.eururo.2008.04.082","title":"Clinicians are Most Familiar with Nomograms and Rate their Clinical Usefulness Highest, Look-up Tables are Second Best","year":2008,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nomogram; MEDLINE; General surgery; Medical physics; Internal medicine","score_opus":0.05304819604357426,"score_gpt":0.27478450106431496,"score_spread":0.2217363050207407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051044115","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52692586,0.0072900048,0.000045889945,0.45126337,0.002375462,0.0019998983,0.0020988213,0.0002982545,0.00770244],"genre_scores_gemma":[0.13346839,0.0138061475,0.00009443533,0.8353829,0.0060684932,0.00013815638,0.0017909111,0.0004923258,0.00875828],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995118,0.0013641437,0.0009761789,0.0014904534,0.00021871162,0.00083247817],"domain_scores_gemma":[0.99654436,0.0009963351,0.0008613958,0.0010902211,0.00021506325,0.0002926462],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005897234,0.0008509051,0.0017710986,0.00016829383,0.00020093864,0.00005353706,0.00029974888,0.0006529969,0.00018515863],"category_scores_gemma":[0.00012308062,0.0005934858,0.00024526677,0.00017760374,0.0012663389,0.00006906933,0.00020694884,0.0025433842,0.00031444742],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004660323,0.00038748514,0.16824418,0.00023887081,0.0008154663,0.029793063,0.00013669554,0.00000270651,0.0000013982699,0.0000029854205,0.7924955,0.007415635],"study_design_scores_gemma":[0.003789318,0.0027822168,0.15547715,0.0003044603,0.0006494352,0.00081414013,0.00009783047,0.000005274866,0.000016160802,0.000008193691,0.8355751,0.00048072517],"about_ca_topic_score_codex":0.000049374547,"about_ca_topic_score_gemma":0.00023871807,"teacher_disagreement_score":0.39345747,"about_ca_system_score_codex":0.00006688851,"about_ca_system_score_gemma":0.00018020898,"threshold_uncertainty_score":0.99975777},"labels":[],"label_agreement":null},{"id":"W2052163549","doi":"10.1016/j.eururo.2010.12.018","title":"Impact of 5α-Reductase Inhibitors on Men Followed by Active Surveillance for Prostate Cancer","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prostate cancer; Hazard ratio; Interquartile range; Proportional hazards model; Internal medicine; Watchful waiting; Retrospective cohort study; Prostate; Confidence interval; Cancer; Cohort; Oncology; Gynecology; Urology","score_opus":0.009337285474684502,"score_gpt":0.2980401976340826,"score_spread":0.28870291215939814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052163549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99045855,0.00033393237,0.0000026468558,0.0018119895,0.0003855933,0.00087953615,0.0009961765,0.000034371726,0.0050972058],"genre_scores_gemma":[0.99845976,0.0002101955,0.000039240582,0.00034672156,0.0002086217,0.00011842827,0.00018346417,0.000053033003,0.00038051078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893385,0.00009316845,0.00022912525,0.00034003332,0.00009800363,0.00030583597],"domain_scores_gemma":[0.9991564,0.00013252272,0.0001668418,0.00028423284,0.000113219336,0.00014679064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018172542,0.00018808145,0.00033230925,0.00006306743,0.000042865788,0.000005770205,0.000075383185,0.000046038098,0.00011909466],"category_scores_gemma":[0.00011619203,0.00013701018,0.00016062311,0.00008641546,0.00011193335,0.000030724674,0.00002809768,0.00018824267,0.000018142022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00863616,0.001617397,0.3514518,0.00007150923,0.0010395885,0.00013503458,0.00118259,0.00005192427,0.3142402,0.000104014405,0.26988396,0.05158581],"study_design_scores_gemma":[0.012656188,0.01599779,0.7810581,0.000042114527,0.00023440644,0.000031078805,0.000037908834,0.000055131317,0.10172241,0.000053147425,0.08772229,0.00038943702],"about_ca_topic_score_codex":0.00015599928,"about_ca_topic_score_gemma":0.000032379947,"teacher_disagreement_score":0.4296063,"about_ca_system_score_codex":0.000077014505,"about_ca_system_score_gemma":0.00011892459,"threshold_uncertainty_score":0.5587113},"labels":[],"label_agreement":null},{"id":"W2052629101","doi":"10.1016/j.eururo.2012.10.047","title":"Reply from Authors re: Martin Spahn, Steven Joniau. Positive Surgical Margin at Radical Prostatectomy: Futile or Surgeon-dependent Predictor of Prostate Cancer Death? Eur Urol 2013;64:26–8","year":2012,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Biochemical recurrence; Hazard ratio; Urology; Odds ratio; Confidence interval; Androgen deprivation therapy; Poisson regression; Cancer; Proportional hazards model; Internal medicine; Gynecology; Oncology; Population","score_opus":0.02170997781793302,"score_gpt":0.26414463299013813,"score_spread":0.2424346551722051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052629101","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44741672,0.016680242,0.00000829037,0.5079984,0.0037414494,0.0065996456,0.01331576,0.00058779144,0.0036516867],"genre_scores_gemma":[0.48599806,0.013766914,0.0004474758,0.39852172,0.017407086,0.002294672,0.015390608,0.0022476558,0.0639258],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99061394,0.0025110268,0.0018093777,0.0020396686,0.0011291944,0.0018967905],"domain_scores_gemma":[0.99533254,0.0007564799,0.0012808498,0.0015225227,0.00035565087,0.00075196754],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001094746,0.0012641324,0.0022872086,0.00036027227,0.0001911904,0.00005146454,0.00053154165,0.00082121143,0.006072438],"category_scores_gemma":[0.00019845707,0.00095973234,0.00055001845,0.00029197248,0.0006038796,0.00014148642,0.0007474585,0.0027443545,0.0008108789],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009508056,0.00067497493,0.10997547,0.0003898198,0.0017006986,0.0351066,0.000970405,0.000009708366,0.00008284399,0.000005992579,0.83924365,0.0023317619],"study_design_scores_gemma":[0.007723992,0.002812367,0.10843317,0.0004441488,0.0017388869,0.0006520477,0.00001569219,0.000024286757,0.0006678124,0.000023357092,0.87670034,0.00076391],"about_ca_topic_score_codex":0.0017336182,"about_ca_topic_score_gemma":0.00013340896,"teacher_disagreement_score":0.10947671,"about_ca_system_score_codex":0.0008575111,"about_ca_system_score_gemma":0.000712651,"threshold_uncertainty_score":0.9999671},"labels":[],"label_agreement":null},{"id":"W2053046644","doi":"10.1016/j.eururo.2007.01.031","title":"Tamoxifen as Prophylaxis for Prevention of Gynaecomastia and Breast Pain Associated with Bicalutamide 150mg Monotherapy in Patients with Prostate Cancer: A Randomised, Placebo-Controlled, Dose–Response Study","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Male Breast Health Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Hôtel-Dieu de Québec","funders":"AstraZeneca","keywords":"Medicine; Bicalutamide; Tamoxifen; Breast cancer; Placebo; Prostate-specific antigen; Adverse effect; Internal medicine; Prostate cancer; Urology; Breast pain; Oncology; Gynecology; Cancer; Androgen receptor; Pathology","score_opus":0.006783794174382149,"score_gpt":0.2614233710534174,"score_spread":0.25463957687903527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053046644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884758,0.00020573009,0.0002471345,0.00040603086,0.000041183233,0.010399071,0.000029699604,0.000044594544,0.00015076],"genre_scores_gemma":[0.99870056,0.000012228854,0.00015832993,0.0003185693,0.000033374534,0.00037741027,0.000016714006,0.00007019186,0.00031264257],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9959747,0.002129895,0.0006961455,0.000457317,0.00026486543,0.00047704906],"domain_scores_gemma":[0.99742204,0.0014440091,0.000490579,0.00021813437,0.00028290492,0.00014234512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005444201,0.00027742414,0.0008953409,0.00028558838,0.00008288385,0.000007763218,0.00008148904,0.000061028306,0.000024453266],"category_scores_gemma":[0.0010476523,0.00018786889,0.000054964436,0.00026900673,0.00017910506,0.000045485496,0.000029871151,0.00022254359,0.0000016278849],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52591556,0.0010762092,0.45600316,0.000052422944,0.00032867581,0.000054988457,0.001263865,0.000020428464,0.00004328339,0.0000010327907,0.000010847501,0.015229553],"study_design_scores_gemma":[0.2778394,0.021156685,0.70039976,0.000059566744,0.0001497797,0.0000116154615,0.00014200032,0.00006810636,0.0000050947283,0.0000052641885,0.000043784432,0.00011895719],"about_ca_topic_score_codex":0.00009211133,"about_ca_topic_score_gemma":0.0005068895,"teacher_disagreement_score":0.24807616,"about_ca_system_score_codex":0.00009838085,"about_ca_system_score_gemma":0.00014328863,"threshold_uncertainty_score":0.7661071},"labels":[],"label_agreement":null},{"id":"W2053203696","doi":"10.1016/j.eururo.2007.04.014","title":"Re: Sorafenib in Advanced Clear-Cell Renal Cell Carcinoma","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Sorafenib; Renal cell carcinoma; Oncology; Internal medicine; Urology; Carcinoma; Clear cell renal cell carcinoma; Cancer research; Hepatocellular carcinoma","score_opus":0.015568587513944986,"score_gpt":0.24088874921630618,"score_spread":0.2253201617023612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053203696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7108092,0.0008102051,0.000099738645,0.00041877315,0.00014872556,0.000270282,0.0000016143496,0.00006095506,0.28738052],"genre_scores_gemma":[0.99189764,0.000023984841,0.0010446482,0.0017049026,0.00023415552,0.0000037399734,0.000030394016,0.000089241796,0.0049712686],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977794,0.00029666422,0.00048991863,0.00055999204,0.00021224447,0.0006617319],"domain_scores_gemma":[0.998829,0.0001451281,0.00012703675,0.0005876815,0.00005433537,0.00025679392],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007245407,0.00026268692,0.0003630513,0.0002642575,0.000047768408,0.000007943544,0.00017607039,0.000092713344,0.00026449407],"category_scores_gemma":[0.000054990396,0.00023907554,0.000119418764,0.00025776777,0.00010564431,0.000045188695,0.00011543228,0.0004848999,0.0013254936],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015397714,0.002923394,0.30020043,0.000279622,0.00006694791,0.08854046,0.0034236184,0.0004693836,0.55268186,0.0002034385,0.010893206,0.02491989],"study_design_scores_gemma":[0.00891783,0.004792042,0.85402054,0.000011898609,0.00010348063,0.0002705172,0.00023016654,0.0000443251,0.072367325,0.000028127983,0.05887725,0.00033652593],"about_ca_topic_score_codex":0.000027840053,"about_ca_topic_score_gemma":0.000052012398,"teacher_disagreement_score":0.5538201,"about_ca_system_score_codex":0.00013140056,"about_ca_system_score_gemma":0.000053708543,"threshold_uncertainty_score":0.9994521},"labels":[],"label_agreement":null},{"id":"W2053355955","doi":"10.1016/j.eururo.2010.04.017","title":"Re: Lower Testosterone Levels Predict Incident Stroke and Transient Ischemic Attack in Older Men","year":2010,"lang":"en","type":"letter","venue":"European Urology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Testosterone (patch); Stroke (engine); Transient (computer programming); Cardiology; Internal medicine; Ischemic stroke; Ischemia","score_opus":0.0256552697732904,"score_gpt":0.258021272043762,"score_spread":0.2323660022704716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053355955","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36634126,0.0020540017,0.000012362956,0.49747258,0.00064245734,0.0006693508,0.00007249607,0.000066812754,0.13266869],"genre_scores_gemma":[0.7023782,0.00018182884,0.000089727335,0.25607103,0.0055319173,0.000024968736,0.00011341433,0.00015509684,0.035453826],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99746984,0.0002901893,0.00047916116,0.0009464967,0.00029490303,0.0005194098],"domain_scores_gemma":[0.99900985,0.000114276416,0.0001435835,0.00054502796,0.000093728246,0.000093526294],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00046069827,0.0004221547,0.0007445272,0.00021366564,0.000057011788,0.000011036049,0.00017629279,0.0005314158,0.00023525376],"category_scores_gemma":[0.00017132773,0.00032058172,0.0001009005,0.000085527514,0.00048397086,0.000038313716,0.0002395715,0.004186004,0.00019858427],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016382454,0.000098412536,0.0042340793,0.00013066457,0.00017543735,0.004232088,0.0009899295,6.9203924e-7,0.0068606464,2.2768046e-7,0.9820713,0.0010427359],"study_design_scores_gemma":[0.0012791593,0.00069274864,0.24354966,0.000042999953,0.0001626312,0.00023776108,0.00003793954,0.0000020661234,0.00008100521,0.0000010395632,0.7536957,0.0002172431],"about_ca_topic_score_codex":0.000013482787,"about_ca_topic_score_gemma":0.000022954673,"teacher_disagreement_score":0.33603695,"about_ca_system_score_codex":0.0000367571,"about_ca_system_score_gemma":0.00004599749,"threshold_uncertainty_score":0.9999246},"labels":[],"label_agreement":null},{"id":"W2054367364","doi":"10.1016/j.eururo.2012.04.049","title":"A Review of Integrated Staging Systems for Renal Cell Carcinoma","year":2012,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Carcinoma; Kidney cancer; Urology; Oncology; Internal medicine","score_opus":0.08266134731898771,"score_gpt":0.3110269158727544,"score_spread":0.22836556855376666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054367364","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021796342,0.97925663,0.00012631522,0.000030749965,0.00048022266,0.0032400936,0.00016175522,0.00005354569,0.016628869],"genre_scores_gemma":[0.00036918346,0.99538076,0.00018730642,0.00032670467,0.0005165923,0.00015880079,0.001167293,0.00021645642,0.0016769171],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959523,0.0013740712,0.0013753896,0.0005642152,0.00019097503,0.0005430494],"domain_scores_gemma":[0.9972784,0.00030582258,0.0010057526,0.00091980153,0.00024335326,0.00024688296],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012215702,0.00060902303,0.0032823812,0.00028841142,0.00003616685,0.0000078346375,0.00029855772,0.0001691733,0.0001085385],"category_scores_gemma":[0.0001332597,0.00041822044,0.00091823074,0.00026829893,0.0000963552,0.000025836924,0.00012519986,0.00049361144,0.0002740735],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006822658,0.00020118366,0.000044248438,0.67432016,0.0003574468,0.00036419995,0.000037628688,2.4613388e-7,0.000010387192,0.00005293134,0.010932871,0.3136105],"study_design_scores_gemma":[0.0005671472,0.00097535824,0.00002331766,0.03978251,0.008471948,0.00070079,0.000004297366,0.000002755977,0.0000048943452,3.050885e-7,0.9492225,0.00024416202],"about_ca_topic_score_codex":0.000021218091,"about_ca_topic_score_gemma":1.9957272e-7,"teacher_disagreement_score":0.93828964,"about_ca_system_score_codex":0.00020145992,"about_ca_system_score_gemma":0.0003721865,"threshold_uncertainty_score":0.99982697},"labels":[],"label_agreement":null},{"id":"W2054397342","doi":"10.1016/j.eururo.2008.02.034","title":"Endothelial Rehabilitation: The Impact of Chronic PDE5 Inhibitors on Erectile Function and Protein Alterations in Cavernous Tissue of Diabetic Rats","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; St Joseph's Health Care; Lawson Health Research Institute","funders":"","keywords":"Vardenafil; Medicine; Erectile dysfunction; Erectile tissue; Endocrinology; Diabetes mellitus; Internal medicine; Tadalafil; Urology; Andrology","score_opus":0.01687975269365841,"score_gpt":0.26796735526023074,"score_spread":0.2510876025665723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054397342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99061275,0.00028439544,0.00008183008,0.0005636321,0.00025990306,0.00046276682,0.000006293962,0.000022735874,0.007705702],"genre_scores_gemma":[0.9985958,0.000019345547,0.000017422819,0.00013002474,0.000230891,0.000019551237,0.000005477494,0.000014645151,0.00096689543],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989703,0.00032371588,0.00029958974,0.00017781244,0.000110167384,0.0001184002],"domain_scores_gemma":[0.9993305,0.0002552472,0.000106374806,0.00018445059,0.00008719663,0.000036184476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022670199,0.00010292777,0.00021506436,0.00014711394,0.00008414086,0.0000022653833,0.000027465832,0.000032207183,0.00019237596],"category_scores_gemma":[0.00036861637,0.000068770954,0.000048740367,0.00018907108,0.00025218484,0.000031841813,0.000023101831,0.00015372442,0.000040852887],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0117739625,0.0032703278,0.33471557,0.00031966946,0.00064846367,0.00013751155,0.01683701,0.005374721,0.56656665,0.0019845183,0.03211331,0.026258282],"study_design_scores_gemma":[0.0027483094,0.020621752,0.9657375,0.00003389758,0.000048195972,0.000097202275,0.00022985549,0.00015620852,0.003928275,0.00007748768,0.00621848,0.0001028027],"about_ca_topic_score_codex":0.00012255245,"about_ca_topic_score_gemma":0.000023083898,"teacher_disagreement_score":0.631022,"about_ca_system_score_codex":0.000047982852,"about_ca_system_score_gemma":0.00006340919,"threshold_uncertainty_score":0.28043982},"labels":[],"label_agreement":null},{"id":"W2055453759","doi":"10.1016/j.eururo.2011.08.045","title":"Reply from Authors re: Simon P. Kim, R. Houston Thompson. Competing-Risks Analysis for Renal Cell Carcinoma: How Do We Accurately Communicate the Risks and Benefits of Treatment to Patients? Eur Urol 2011;60:1160–2","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Urology; Intensive care medicine; General surgery; Oncology","score_opus":0.1506185232062442,"score_gpt":0.2915797787935549,"score_spread":0.1409612555873107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055453759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863234,0.005202157,0.0001518527,0.0029652887,0.00014634998,0.0015073019,0.00029288683,0.000069845235,0.0033409123],"genre_scores_gemma":[0.9961242,0.00069511496,0.0016198044,0.00064288295,0.00013057781,0.00006744099,0.00023965398,0.00011580308,0.0003645197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960433,0.0014282204,0.0007423125,0.00091973017,0.00027597861,0.00059040694],"domain_scores_gemma":[0.9961074,0.0006759306,0.0006834511,0.0018718049,0.0002834021,0.0003779965],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007129586,0.0005521113,0.0010587022,0.0003346972,0.00025962628,0.000040095798,0.0005498211,0.00013264592,0.00013285334],"category_scores_gemma":[0.00013687389,0.00037322965,0.0004204049,0.0003461876,0.0002544522,0.00006449037,0.00040370552,0.0003657463,0.00006228657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007740884,0.001711634,0.9521262,0.000067303175,0.0020434954,0.00027165705,0.012203233,0.0010250598,0.001995493,0.000039599865,0.0033857522,0.017389676],"study_design_scores_gemma":[0.004450331,0.0100587215,0.96328807,0.000018893743,0.0048521245,0.000009722728,0.0003400035,0.0003521737,0.0063183024,0.000021155418,0.0099653695,0.00032512465],"about_ca_topic_score_codex":0.0025045662,"about_ca_topic_score_gemma":0.00029505364,"teacher_disagreement_score":0.01706455,"about_ca_system_score_codex":0.00012880085,"about_ca_system_score_gemma":0.00005094045,"threshold_uncertainty_score":0.99987197},"labels":[],"label_agreement":null},{"id":"W2055636200","doi":"10.1016/j.eururo.2014.08.003","title":"Conditional Survival After Radical Nephroureterectomy for Upper Tract Carcinoma","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Dalhousie University; McMaster University; University of British Columbia; St. Joseph’s Healthcare Hamilton; McGill University Health Centre; Université Laval; University of Alberta; Université de Montréal; McGill University","funders":"","keywords":"Medicine; Proportional hazards model; Urology; Hazard ratio; Stage (stratigraphy); Bladder cancer; Carcinoma in situ; Survivorship curve; Retrospective cohort study; Survival analysis; Cancer; Internal medicine; Oncology; Surgery; Confidence interval","score_opus":0.01702750205646411,"score_gpt":0.2646262123393232,"score_spread":0.2475987102828591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055636200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9314439,0.0002579173,0.0050647985,0.0040178094,0.0009409565,0.00051425706,0.000111826455,0.00010382875,0.05754467],"genre_scores_gemma":[0.9888499,0.0000032579385,0.00047979326,0.007676673,0.0017521608,0.00004170426,0.00018586511,0.000051597333,0.00095909525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888355,0.00023984176,0.00017889278,0.0002941722,0.00011884299,0.00028470668],"domain_scores_gemma":[0.99940896,0.00015388137,0.000036044952,0.00020511865,0.0000440944,0.00015187095],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020135424,0.00015027195,0.00023997114,0.00005887225,0.000052667623,0.000009677508,0.00007311821,0.000057641402,0.00092675776],"category_scores_gemma":[0.000071309914,0.00012348873,0.00014638426,0.000035924168,0.00012592824,0.000031744887,0.000023277484,0.00014583916,0.0003149066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010819701,0.0014725485,0.9017688,0.00016050659,0.00067354174,0.0012215715,0.00087216916,0.000008308622,0.0030948971,0.0064130104,0.050062306,0.023432642],"study_design_scores_gemma":[0.0036604465,0.0012251247,0.5904016,0.000002691535,0.00013309035,0.00019736258,0.0000033560787,0.000043226493,0.000095501084,0.0001897589,0.40395635,0.00009151251],"about_ca_topic_score_codex":0.000005735243,"about_ca_topic_score_gemma":0.0000018111165,"teacher_disagreement_score":0.35389403,"about_ca_system_score_codex":0.000022049338,"about_ca_system_score_gemma":0.00004246496,"threshold_uncertainty_score":0.9999865},"labels":[],"label_agreement":null},{"id":"W2057691584","doi":"10.1016/j.eururo.2007.12.026","title":"Prediction of Progression of Non–Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective Study","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"World Health Organization","keywords":"Medicine; Grading (engineering); Prospective cohort study; Oncology; Internal medicine; Bladder cancer; Immunohistochemistry; Pathology; Gastroenterology; Cancer","score_opus":0.016608149045817963,"score_gpt":0.2775340917394621,"score_spread":0.2609259426936441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057691584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99379086,0.0035466019,0.0000804614,0.000095708536,0.00006656716,0.000976471,0.0001571758,0.000024370473,0.001261782],"genre_scores_gemma":[0.9986459,0.00086050294,0.00005502044,0.00009429545,0.00005314656,0.00004057596,0.00003423183,0.000030260973,0.00018605172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892634,0.00015542483,0.0002588763,0.00031971364,0.00016161143,0.00017806159],"domain_scores_gemma":[0.9994665,0.00004181095,0.00016946794,0.0001223286,0.000107575084,0.00009234018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103213555,0.00014395482,0.00029009042,0.00007729487,0.0000748875,0.0000033751212,0.00003062978,0.000040609575,0.000025394953],"category_scores_gemma":[0.000042704793,0.00011854976,0.00002343092,0.000112657515,0.00021461872,0.00007289884,0.000034410874,0.00011615825,0.0000011955026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000825959,0.0008223348,0.9426626,0.000086817265,0.00037938182,0.00010204028,0.013061048,0.000004771584,0.028067047,0.0000026012922,0.0039494415,0.010035956],"study_design_scores_gemma":[0.006460605,0.008469303,0.9776369,0.00006104379,0.00034386857,0.00007062976,0.000577952,0.00005875814,0.0057629133,0.000012237845,0.00045450858,0.00009130041],"about_ca_topic_score_codex":0.00021991383,"about_ca_topic_score_gemma":0.000017960696,"teacher_disagreement_score":0.03497428,"about_ca_system_score_codex":0.000034854795,"about_ca_system_score_gemma":0.00006693544,"threshold_uncertainty_score":0.4834319},"labels":[],"label_agreement":null},{"id":"W2057734107","doi":"10.1016/j.eururo.2009.06.027","title":"Castration-resistant Prostate Cancer: From New Pathophysiology to New Treatment Targets","year":2009,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":255,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"Cancer Research UK","keywords":"Medicine; Prostate cancer; Clinical trial; Oncology; Androgen receptor; Immunotherapy; Internal medicine; Bevacizumab; Bioinformatics; Cancer; Chemotherapy","score_opus":0.06359432475833031,"score_gpt":0.3659656362270145,"score_spread":0.3023713114686842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057734107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001367063,0.99121547,0.000015432926,0.002550098,0.00045718113,0.0023716732,0.00035112677,0.00012076862,0.002781522],"genre_scores_gemma":[0.000019080999,0.9596655,0.00062006107,0.0011601622,0.0022203855,0.000089334426,0.0016421808,0.00014222357,0.0344411],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965424,0.0006148561,0.0007164662,0.0011047736,0.00022438138,0.0007971553],"domain_scores_gemma":[0.99788105,0.00013518379,0.00025905194,0.00075330527,0.00006948267,0.00090192124],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011136601,0.0007364047,0.002107923,0.0002858573,0.00009780464,0.00003574409,0.00027860573,0.00021944042,0.0006792674],"category_scores_gemma":[0.000051464136,0.00049767195,0.00045600143,0.0003221809,0.00007217913,0.0000366516,0.00010419634,0.00044522213,0.0017982833],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006834059,0.00014544623,0.000008414123,0.00030035523,0.00054604356,0.0022542996,0.0004035507,0.0000044036838,0.00013691971,0.000009760258,0.029307434,0.9662],"study_design_scores_gemma":[0.0020536769,0.0047678975,0.00033325056,0.00087227963,0.0014770526,0.000038369923,0.000005243756,6.3646456e-7,0.000011244446,0.00013004988,0.9899594,0.00035087718],"about_ca_topic_score_codex":0.0021076924,"about_ca_topic_score_gemma":0.00022694007,"teacher_disagreement_score":0.9658491,"about_ca_system_score_codex":0.0005461594,"about_ca_system_score_gemma":0.0026262987,"threshold_uncertainty_score":0.9997475},"labels":[],"label_agreement":null},{"id":"W2058048513","doi":"10.1016/j.eururo.2007.11.026","title":"The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":419,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston General Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Lower urinary tract symptoms; Prostatitis; International Prostate Symptom Score; Nocturia; Urology; Prostate; Prostate cancer; Internal medicine; Body mass index; Inflammation; Placebo; Urinary system; Prostate biopsy; Gastroenterology; Pathology; Cancer","score_opus":0.07196573485195082,"score_gpt":0.3195070900175342,"score_spread":0.24754135516558337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058048513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919655,0.0011251984,0.00013087588,0.004548864,0.00017293684,0.00066323695,0.000082805724,0.000020161691,0.0012904513],"genre_scores_gemma":[0.99818844,0.00020482233,0.000054381268,0.00011475842,0.0006591411,0.000007658109,0.0006436311,0.000017119988,0.000110046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859774,0.0005306771,0.00037224716,0.00023146783,0.0001309519,0.00013690251],"domain_scores_gemma":[0.9955986,0.0035661706,0.00019627418,0.0005381431,0.00005441454,0.000046412217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002690114,0.000092244874,0.00013156206,0.000032558128,0.00012705143,0.000014069973,0.00013463602,0.00003425936,0.000011684996],"category_scores_gemma":[0.0011612445,0.000052896885,0.00002248708,0.00008655288,0.00014830001,0.000086986256,0.00009694077,0.00016319819,0.000016521672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015267703,0.0005972619,0.70713884,0.000027072843,0.00024775162,0.00025061384,0.0019168021,0.0000060281445,0.00035215632,0.0006124401,0.0018915874,0.27169174],"study_design_scores_gemma":[0.0076612546,0.001591938,0.97481537,0.000019704075,0.00019241309,0.000017303,0.000044375352,0.000042036885,0.0001173418,0.00009962773,0.0153530575,0.00004557986],"about_ca_topic_score_codex":0.000014914459,"about_ca_topic_score_gemma":0.0000070030706,"teacher_disagreement_score":0.27164617,"about_ca_system_score_codex":0.00002255445,"about_ca_system_score_gemma":0.0000319773,"threshold_uncertainty_score":0.21570724},"labels":[],"label_agreement":null},{"id":"W2059112550","doi":"10.1016/j.eururo.2009.12.003","title":"Head-to-Head Comparison of the Three Most Commonly Used Preoperative Models for Prediction of Biochemical Recurrence After Radical Prostatectomy","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Prostatectomy; Concordance; Prostate cancer; Capra; Brier score; Biochemical recurrence; Urology; Cohort; Nuclear medicine; Oncology; Internal medicine; Cancer; Statistics; Mathematics","score_opus":0.04507055887753371,"score_gpt":0.3177926053212229,"score_spread":0.2727220464436892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059112550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99036914,0.0006833225,0.002467185,0.0037013283,0.00011693792,0.001706427,0.00032300822,0.000025447407,0.00060721766],"genre_scores_gemma":[0.99824655,0.000019643689,0.00069067243,0.0008100164,0.000059633338,0.00008527293,0.000057265344,0.000017615515,0.000013352528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877214,0.00014447821,0.00041996557,0.00029376,0.00015567733,0.00021396583],"domain_scores_gemma":[0.9991963,0.000096977936,0.00012658918,0.0003410333,0.00013955246,0.00009957764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016449018,0.00015032485,0.00038576688,0.000049010072,0.000039726307,0.000004582989,0.000129535,0.00005300303,0.000010244672],"category_scores_gemma":[0.000078518315,0.000099583856,0.00009296045,0.00015729299,0.00018887587,0.000035993435,0.0000525669,0.0001712225,0.00000359746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015018376,0.006051532,0.8815777,0.0003313579,0.0004565894,0.000051757896,0.00731834,0.0023880033,0.039689895,0.0017354559,0.011410563,0.033970468],"study_design_scores_gemma":[0.00566756,0.011870034,0.9179042,0.00025191705,0.00028494265,0.000025613019,0.000027470322,0.008540751,0.05242163,0.0006164728,0.0022405821,0.00014881192],"about_ca_topic_score_codex":0.000007491972,"about_ca_topic_score_gemma":0.000015673702,"teacher_disagreement_score":0.03632655,"about_ca_system_score_codex":0.000043901993,"about_ca_system_score_gemma":0.00007110888,"threshold_uncertainty_score":0.40609118},"labels":[],"label_agreement":null},{"id":"W2059619755","doi":"10.1016/j.eururo.2014.10.010","title":"Active Surveillance for Prostate Cancer: A Systematic Review of Clinicopathologic Variables and Biomarkers for Risk Stratification","year":2014,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Institutes of Health; National Cancer Institute; KWF Kankerbestrijding; AFA Försäkring","keywords":"Medicine; Risk stratification; Prostate cancer; Oncology; Stratification (seeds); Risk assessment; Prostate; Internal medicine; Cancer; Gynecology","score_opus":0.04080801348440438,"score_gpt":0.3572019564968445,"score_spread":0.3163939430124401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059619755","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000080840055,0.98469234,0.00028660445,0.00018291076,0.00017870955,0.012595972,0.0018445214,0.000028017104,0.00018285148],"genre_scores_gemma":[0.0001001015,0.99395806,0.0004539315,0.0002931299,0.00009016518,0.0042409794,0.0007347136,0.000072068666,0.000056837667],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9965319,0.0013127292,0.0012353798,0.00059720076,0.00008076396,0.00024199359],"domain_scores_gemma":[0.99525076,0.0018121576,0.0021170867,0.00049471715,0.00024425716,0.000081025646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002277017,0.00035158516,0.0033500202,0.000088857836,0.00005737322,0.000009173727,0.00012386378,0.00010769682,0.0000065990557],"category_scores_gemma":[0.0016820678,0.00023247967,0.00038699867,0.00011815745,0.0001183666,0.000019464107,0.00003538756,0.00013192478,0.00000483284],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009001164,0.00006035585,0.000054173055,0.77969956,0.00062650855,0.0000041965986,0.000020696265,1.19036585e-7,2.9866567e-7,0.000062227664,0.00050969096,0.21887213],"study_design_scores_gemma":[0.0016877229,0.003375934,0.00020327303,0.49978274,0.017115805,0.00007726757,0.000008071425,0.000022093955,0.0000019054411,0.00007791965,0.47731557,0.0003316642],"about_ca_topic_score_codex":0.0000071984223,"about_ca_topic_score_gemma":0.000004393938,"teacher_disagreement_score":0.4768059,"about_ca_system_score_codex":0.000073909454,"about_ca_system_score_gemma":0.00020491522,"threshold_uncertainty_score":0.9480246},"labels":[],"label_agreement":null},{"id":"W2059857203","doi":"10.1016/j.eururo.2006.03.041","title":"For the motion: Surgery is the best choice for Peyronie’s disease","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Peter's Hospital","funders":"","keywords":"Medicine; Peyronie's disease; Acoustic shadow; Surgery; Lesion; Erectile dysfunction; Ultrasound; Ultrasonography; Radiology","score_opus":0.059787485120588374,"score_gpt":0.28892757631053334,"score_spread":0.22914009118994497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059857203","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11389809,0.022615233,0.1437665,0.6144995,0.015446276,0.0057858974,0.0002661233,0.00074550544,0.08297688],"genre_scores_gemma":[0.87568057,0.000103866245,0.00005284058,0.055900138,0.0055921115,0.00019958767,0.0000826029,0.00006345009,0.06232481],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991858,0.000094321906,0.00019901275,0.00022036456,0.0000923298,0.00020817383],"domain_scores_gemma":[0.9974175,0.0020270795,0.00006589522,0.00030033573,0.00013610312,0.000053103333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041863215,0.00011028973,0.00014562678,0.00003854002,0.00041335396,0.00001666982,0.00006840378,0.000020221989,0.00014877591],"category_scores_gemma":[0.00064383406,0.000058734215,0.00016742005,0.000086277694,0.00013749243,0.000022347527,0.000031943615,0.00008710278,0.0002483598],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006886565,0.00013392894,0.042106934,0.00003096866,0.00010338309,0.0000071273507,0.00007049962,0.00005808171,0.000027276079,0.0018075759,0.947162,0.0078035654],"study_design_scores_gemma":[0.00060909864,0.00014415414,0.1761971,0.000001765734,0.00021520791,0.000012712376,0.00008267606,0.00019728107,0.000005055789,0.00009634284,0.82239074,0.000047908965],"about_ca_topic_score_codex":0.000019672976,"about_ca_topic_score_gemma":0.000009045269,"teacher_disagreement_score":0.7617825,"about_ca_system_score_codex":0.000011034761,"about_ca_system_score_gemma":0.000026064548,"threshold_uncertainty_score":0.31922457},"labels":[],"label_agreement":null},{"id":"W2060041521","doi":"10.1016/j.eururo.2007.06.012","title":"Re: Detection of Circulating Urothelial Cancer Cells in the Blood Using the CellSearch System","year":2007,"lang":"en","type":"letter","venue":"European Urology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Urothelial cancer; Cancer; Circulating tumor cell; Urothelial carcinoma; Internal medicine; Oncology; Bladder cancer; Metastasis","score_opus":0.04843496586176764,"score_gpt":0.29673919537512694,"score_spread":0.2483042295133593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060041521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6950919,0.008866611,0.0028389506,0.21134709,0.007955485,0.005416651,0.0002740044,0.00019873181,0.06801058],"genre_scores_gemma":[0.8165389,0.00012212191,0.00006830855,0.17626399,0.006566715,0.000013292218,0.000014046253,0.00012232161,0.00029032675],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99672425,0.0013736538,0.0005653424,0.0004083422,0.00044056744,0.00048781728],"domain_scores_gemma":[0.99856013,0.00031440984,0.00034850356,0.00065095373,0.00009369512,0.00003230555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001895583,0.00025103457,0.00046127362,0.00023403946,0.00010387897,0.00001818514,0.00033875238,0.00023391175,0.00007119246],"category_scores_gemma":[0.0000372713,0.00015389951,0.00019690019,0.00036342684,0.00018586038,0.000015172482,0.000085415566,0.0020864804,0.000020751444],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070704956,0.00022442586,0.0007485806,0.004129938,0.0008701097,0.01466787,0.006347542,0.0012396416,0.888416,0.00001790846,0.060026634,0.022604322],"study_design_scores_gemma":[0.0019419388,0.00050397613,0.00062918646,0.0002667608,0.0017283588,0.00088865083,0.000633567,0.00042588983,0.029788943,0.000001646565,0.96286243,0.00032867503],"about_ca_topic_score_codex":0.001108447,"about_ca_topic_score_gemma":0.00012726257,"teacher_disagreement_score":0.9028358,"about_ca_system_score_codex":0.00010180906,"about_ca_system_score_gemma":0.000111144494,"threshold_uncertainty_score":0.90648353},"labels":[],"label_agreement":null},{"id":"W2060402126","doi":"10.1016/j.eururo.2007.02.054","title":"Systematic Assessment of the Ability of the Number and Percentage of Positive Biopsy Cores to Predict Pathologic Stage and Biochemical Recurrence after Radical Prostatectomy","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Prostatectomy; Medicine; Biochemical recurrence; Stage (stratigraphy); breakpoint cluster region; Logistic regression; Receiver operating characteristic; Radical retropubic prostatectomy; Biopsy; Urology; Perineural invasion; Generalizability theory; Statistical significance; Prostate cancer; Oncology; Cancer; Internal medicine; Statistics","score_opus":0.008460704910021823,"score_gpt":0.2802338269565788,"score_spread":0.27177312204655696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060402126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972326,0.0005003937,0.000048708334,0.000322429,0.000062897394,0.0012200078,0.00013096674,0.000005533304,0.00047643317],"genre_scores_gemma":[0.99946815,0.00006527824,0.00019837599,0.0002142122,0.000010656061,0.000021910066,0.0000028312406,0.000008864145,0.000009718173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986643,0.00040241168,0.00039524754,0.00023258415,0.00015827626,0.00014713834],"domain_scores_gemma":[0.9991474,0.00023047873,0.00017249955,0.0003141271,0.00006382283,0.000071657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068777084,0.00011226396,0.00034242947,0.00002303238,0.000022861908,0.000002738713,0.000088084795,0.00003562413,0.00001837586],"category_scores_gemma":[0.0001726855,0.00005570322,0.00006014894,0.00008673061,0.00064475497,0.0000124557755,0.0001987586,0.00012683656,6.2117783e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003175504,0.00028239877,0.97228026,0.0019436027,0.00006388124,0.00006531956,0.0007184161,5.0422284e-7,0.024051271,0.00010165057,0.000018539891,0.00015657309],"study_design_scores_gemma":[0.000739551,0.0006155825,0.9885989,0.00086434535,0.0001443848,0.00011256962,0.00009035927,0.0000094336365,0.008754933,0.000015992915,0.000011333464,0.000042639127],"about_ca_topic_score_codex":0.000009686132,"about_ca_topic_score_gemma":0.0000011952112,"teacher_disagreement_score":0.016318582,"about_ca_system_score_codex":0.00003372218,"about_ca_system_score_gemma":0.00003312505,"threshold_uncertainty_score":0.23756266},"labels":[],"label_agreement":null},{"id":"W2060609594","doi":"10.1016/j.eururo.2010.10.003","title":"A Competing-Risks Analysis of Survival After Alternative Treatment Modalities for Prostate Cancer Patients: 1988–2006","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; Internal medicine; Epidemiology; Proportional hazards model; Urology; Radiation therapy; Surgery; Cancer","score_opus":0.025632996200397974,"score_gpt":0.3067853224082635,"score_spread":0.2811523262078655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060609594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936439,0.00039232054,0.00003249437,0.0007344127,0.00042195793,0.00075593067,0.001423645,0.000027998192,0.0025673697],"genre_scores_gemma":[0.99777347,0.00027592244,0.00017579045,0.00045794537,0.0001561291,0.0003782607,0.0003195122,0.000038694237,0.0004243048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875087,0.0001316384,0.0003427713,0.0003618928,0.00012627509,0.00028656574],"domain_scores_gemma":[0.99901366,0.00016274092,0.00019904399,0.0002780412,0.0002413949,0.00010512251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014864952,0.00020605791,0.00054922514,0.00019674972,0.000042966825,0.0000099325935,0.00007087999,0.00003537038,0.00020962168],"category_scores_gemma":[0.000047129834,0.00015282535,0.00024049428,0.00017121127,0.00014740745,0.000031031752,0.0000392631,0.00009484388,0.000010350944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014750133,0.0010199918,0.97943336,0.000035599107,0.0033831252,0.000049084534,0.0031757546,0.00022675697,0.00019344412,0.00018750939,0.00007191838,0.010748445],"study_design_scores_gemma":[0.0052847834,0.0035804415,0.9652268,0.000015308131,0.0037289534,0.0000013534118,0.00008987909,0.00048011955,0.0012248639,0.0000382165,0.020160094,0.00016914279],"about_ca_topic_score_codex":0.0008560079,"about_ca_topic_score_gemma":0.0009730422,"teacher_disagreement_score":0.020088175,"about_ca_system_score_codex":0.00007696124,"about_ca_system_score_gemma":0.000052107676,"threshold_uncertainty_score":0.6232037},"labels":[],"label_agreement":null},{"id":"W2061263587","doi":"10.1016/j.eururo.2014.12.048","title":"Re: Salvage Focal Prostate Cryoablation for Locally Recurrent Prostate Cancer After Radiotherapy: Initial Results from the Cryo On-line Data Registry","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Centre; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Cryoablation; Prostate cancer; Prostate; Salvage therapy; Cryosurgery; Radiation therapy; Radiology; Urology; Cancer; Surgery; Internal medicine; Ablation; Chemotherapy","score_opus":0.08089610013500098,"score_gpt":0.33977037546608374,"score_spread":0.25887427533108276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061263587","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026269152,0.0139465295,0.00032933362,0.9368302,0.0028893165,0.004580965,0.037093695,0.00017296088,0.0015300785],"genre_scores_gemma":[0.019513028,0.0055476152,0.0006887986,0.8815066,0.023997176,0.0010899447,0.064279586,0.0004942346,0.002882968],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949597,0.0008766954,0.0010126726,0.0017858462,0.0005679527,0.00079713296],"domain_scores_gemma":[0.99513346,0.0008831065,0.0007226986,0.0027271463,0.0003422541,0.00019132947],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010547986,0.00073313515,0.00086029334,0.000103837,0.00013764505,0.0001078733,0.0007399794,0.00041408793,0.000116914016],"category_scores_gemma":[0.00056499045,0.0004929755,0.00018330461,0.00014516727,0.00036120112,0.00011181845,0.0003154834,0.0018412393,0.00009718882],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016964724,0.00019498453,0.0003537781,0.00009610335,0.0006206546,0.0025193964,0.0008992815,0.00007374838,0.0000053682948,0.0000020967054,0.9374466,0.04082328],"study_design_scores_gemma":[0.009804355,0.0046405923,0.0022582246,0.00043590498,0.0007385683,0.000026232972,0.000018149567,0.0005642774,0.00002199959,0.00009327138,0.98094463,0.00045381868],"about_ca_topic_score_codex":0.00020219349,"about_ca_topic_score_gemma":0.00019496462,"teacher_disagreement_score":0.055323556,"about_ca_system_score_codex":0.0004075463,"about_ca_system_score_gemma":0.000683917,"threshold_uncertainty_score":0.99975216},"labels":[],"label_agreement":null},{"id":"W2061414864","doi":"10.1016/j.eururo.2008.11.023","title":"Thirty-Day Mortality After Nephrectomy: Clinical Implications for Informed Consent","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Informed consent; Nephrectomy; Surgery; General surgery; Intensive care medicine; Internal medicine; Family medicine; Kidney; Alternative medicine; Pathology","score_opus":0.14654189914218513,"score_gpt":0.37632787221128716,"score_spread":0.22978597306910203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061414864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9593588,0.00038106597,0.0005879511,0.004949448,0.00026869684,0.0007894476,0.000030885567,0.00011618452,0.0335175],"genre_scores_gemma":[0.9896295,0.00019001818,0.0009114304,0.0071807397,0.0004051074,0.00009164596,0.0000895935,0.000039830655,0.0014621188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834543,0.00032707947,0.00055651343,0.0003606795,0.00008827942,0.00032203709],"domain_scores_gemma":[0.998024,0.0008775593,0.00012204185,0.0006239134,0.00011424763,0.00023827855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045963275,0.00017152428,0.000349572,0.00006761499,0.000093182396,0.0000055147143,0.00010856437,0.00007585878,0.00010216667],"category_scores_gemma":[0.00072468026,0.0001363737,0.00025108238,0.00008031784,0.00032474674,0.0000321248,0.000074580326,0.0001963823,0.0005018429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060822297,0.0003154494,0.97365963,0.000032145686,0.00023088577,0.00045283444,0.00023196886,0.000001941449,0.0001606368,0.00032519412,0.02153659,0.0024444705],"study_design_scores_gemma":[0.0018642587,0.0008942588,0.8537991,0.0000042719766,0.00018231022,0.00035881804,0.0000034441669,0.000012007272,0.000046475052,0.00007059636,0.14266741,0.0000970631],"about_ca_topic_score_codex":0.000007537663,"about_ca_topic_score_gemma":0.000029081899,"teacher_disagreement_score":0.121130824,"about_ca_system_score_codex":0.00004886003,"about_ca_system_score_gemma":0.00033772987,"threshold_uncertainty_score":0.6450342},"labels":[],"label_agreement":null},{"id":"W2061565388","doi":"10.1016/j.eururo.2013.10.010","title":"Optimizing the Management of Pathologic, Possible, and Putative N1 Prostate Cancer","year":2013,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Prostate cancer; Prostate; Prostate disease; Cancer; Management of prostate cancer; Gynecology; General surgery; Pathology; Internal medicine","score_opus":0.020041954041981166,"score_gpt":0.2620382111342898,"score_spread":0.24199625709230865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061565388","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03311823,0.027409105,0.00003418189,0.8976087,0.0005773388,0.0028642192,0.00024096784,0.00008622368,0.038061023],"genre_scores_gemma":[0.05606299,0.040598955,0.0021747353,0.8877665,0.0011586609,0.000767746,0.0004062434,0.0002089216,0.010855275],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830884,0.00031901826,0.0003343807,0.000500627,0.0001638918,0.0003732356],"domain_scores_gemma":[0.9990646,0.00009967994,0.0002970943,0.0003928774,0.00009404425,0.00005168584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020152824,0.00030919292,0.0004748834,0.00008399355,0.00007264027,0.00002301206,0.00015042079,0.000119071585,0.00011862847],"category_scores_gemma":[0.0000069935763,0.00018083668,0.000089041336,0.00009007841,0.00033374116,0.000030930383,0.00023568317,0.0006937391,0.00006256038],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023454751,0.00015428713,0.0045309355,0.001330406,0.0024857232,0.02153006,0.0033184248,0.00008592126,0.000042337848,0.00014027717,0.89079344,0.07535362],"study_design_scores_gemma":[0.0026710455,0.00197451,0.06100755,0.0003478386,0.0017589831,0.0002932611,0.00017636381,0.000031856995,0.00011214974,0.00021323089,0.93105704,0.00035616226],"about_ca_topic_score_codex":0.00003683509,"about_ca_topic_score_gemma":6.217062e-7,"teacher_disagreement_score":0.074997455,"about_ca_system_score_codex":0.000053764023,"about_ca_system_score_gemma":0.00003107095,"threshold_uncertainty_score":0.7374306},"labels":[],"label_agreement":null},{"id":"W2061623831","doi":"10.1016/j.eururo.2011.01.004","title":"Accurate Molecular Classification of Kidney Cancer Subtypes Using MicroRNA Signature","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":220,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; St. Michael's Hospital; York University; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Chromophobe cell; Oncocytoma; Medicine; Papillary renal cell carcinomas; Clear cell renal cell carcinoma; Clear cell; Pathology; Carcinogenesis; microRNA; Renal cell carcinoma; Computational biology; Biology; Cancer; Gene; Internal medicine; Genetics","score_opus":0.06107287388755651,"score_gpt":0.28105026548148543,"score_spread":0.21997739159392893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061623831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96912473,0.0012873181,0.00038279092,0.0005302019,0.00015138731,0.00018839267,0.000009159135,0.000031827887,0.028294193],"genre_scores_gemma":[0.99698025,0.000038651462,0.0009535791,0.0017160107,0.00006487564,0.000002746533,0.00002043511,0.000038437283,0.00018502152],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990694,0.00020801186,0.00021707847,0.00024210429,0.000088553934,0.00017484163],"domain_scores_gemma":[0.99926835,0.000014140418,0.00015554401,0.000302892,0.00010318028,0.00015590234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000120538236,0.00012645389,0.00019855145,0.000087504595,0.00002227798,0.000002469798,0.00009831513,0.00006037816,0.00026778193],"category_scores_gemma":[0.00008437477,0.00010463562,0.00007216819,0.0001089512,0.00009358557,0.00002627202,0.000039944644,0.00015529401,0.00006491067],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034288436,0.00010506316,0.015002937,0.000038748534,0.000117093354,0.0004788734,0.0003937714,0.000013879132,0.98192304,0.00028195078,0.00070018246,0.00060156826],"study_design_scores_gemma":[0.0017626303,0.0009031653,0.6194259,0.0000487003,0.0006909289,0.00024995787,0.0000368737,0.0004937224,0.3656815,0.00007287515,0.010404465,0.0002292655],"about_ca_topic_score_codex":0.000050551094,"about_ca_topic_score_gemma":0.0000016337499,"teacher_disagreement_score":0.6162416,"about_ca_system_score_codex":0.00003744883,"about_ca_system_score_gemma":0.000108821834,"threshold_uncertainty_score":0.42669168},"labels":[],"label_agreement":null},{"id":"W2062070169","doi":"10.1016/j.eururo.2013.12.063","title":"Disease Control Outcomes from Analysis of Pooled Individual Patient Data from Five Comparative Randomised Clinical Trials of Degarelix Versus Luteinising Hormone-releasing Hormone Agonists","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Goserelin; Prostate cancer; Androgen deprivation therapy; Adverse effect; Hazard ratio; Hormone antagonist; Internal medicine; Urology; Proportional hazards model; Gynecology; Hormone; Cancer; Confidence interval; Endocrine system","score_opus":0.1776010312981112,"score_gpt":0.4037994191575199,"score_spread":0.22619838785940868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062070169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848434,0.0053659547,0.0011745133,0.0006454874,0.00033194257,0.0008755354,0.006358427,0.000031122727,0.0003736704],"genre_scores_gemma":[0.9932009,0.0004202076,0.00048010328,0.0007416754,0.00016961218,0.000015759624,0.0049374313,0.000030621784,0.000003686053],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99144524,0.0050119744,0.0021640589,0.00072952744,0.00037220062,0.0002770243],"domain_scores_gemma":[0.9859339,0.010817098,0.0015739657,0.0011735731,0.00016812682,0.0003333119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020285256,0.0003092765,0.003017121,0.00021065588,0.000064324566,0.000021888185,0.00035274363,0.00008105627,0.00008779301],"category_scores_gemma":[0.0052066753,0.00023280502,0.0006626953,0.00021367369,0.000309789,0.00007300155,0.0002485662,0.00023150576,0.000020785708],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44617444,0.005428887,0.34263057,0.000027023976,0.12808922,0.0005338056,0.004461952,0.0015433582,0.0026865143,0.00009801239,0.0072784685,0.061047748],"study_design_scores_gemma":[0.10536203,0.0025380393,0.8507391,0.000023488623,0.034797452,2.300088e-7,0.00009978368,0.0055351383,0.000079992824,0.00002241534,0.0006320276,0.00017031096],"about_ca_topic_score_codex":0.00032156732,"about_ca_topic_score_gemma":0.000023330802,"teacher_disagreement_score":0.50810856,"about_ca_system_score_codex":0.000036247948,"about_ca_system_score_gemma":0.000112061934,"threshold_uncertainty_score":0.9493513},"labels":[],"label_agreement":null},{"id":"W2062146824","doi":"10.1016/j.eururo.2008.05.001","title":"Microsatellite Analysis of Voided-Urine Samples for Surveillance of Low-Grade Non-Muscle-Invasive Urothelial Carcinoma: Feasibility and Clinical Utility in a Prospective Multicenter Study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer Trial [CEFUB])","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Urology; Urothelial carcinoma; Urine; Urinary system; Multicenter study; Prospective cohort study; Carcinoma; Bladder cancer; Internal medicine; Oncology; Cancer; Randomized controlled trial","score_opus":0.08350172055388473,"score_gpt":0.3657386511952072,"score_spread":0.2822369306413225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062146824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920518,0.00062074384,0.000094038915,0.000017901675,0.00024232597,0.0059499475,0.0009478045,0.0000100369125,0.000065416134],"genre_scores_gemma":[0.9993363,0.00023780137,0.00009630802,0.000025026597,0.00007988593,0.00012808619,0.00004241055,0.00003816845,0.000016031216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955137,0.0017877815,0.0013724135,0.00078258,0.00023539444,0.0003081551],"domain_scores_gemma":[0.9966555,0.0015553862,0.0006138596,0.00060595846,0.00046311095,0.00010614166],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016616383,0.00029909686,0.001910993,0.0003016625,0.000037978563,0.000001892807,0.00017324147,0.00010712933,0.000029127077],"category_scores_gemma":[0.0006326477,0.00025469312,0.0005163135,0.00050827826,0.0007491319,0.000046955374,0.00013454854,0.0002166864,4.027224e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12922925,0.0066563487,0.85524344,0.00040200414,0.0021729986,0.000051251012,0.0018529656,0.000021211898,0.0039915037,0.00000136215,0.0000030295973,0.00037465096],"study_design_scores_gemma":[0.0965779,0.009514365,0.8866361,0.000040479386,0.0015219917,0.0000040550003,0.00013274726,0.000087351924,0.005338486,0.000009245987,0.0000071123995,0.00013016471],"about_ca_topic_score_codex":0.0019758265,"about_ca_topic_score_gemma":0.0016383217,"teacher_disagreement_score":0.032651342,"about_ca_system_score_codex":0.00007259899,"about_ca_system_score_gemma":0.00027741707,"threshold_uncertainty_score":0.9999905},"labels":[],"label_agreement":null},{"id":"W2062383779","doi":"10.1016/j.eururo.2007.10.070","title":"High Provider Volume is Associated with Lower Rate of Secondary Therapies after Definitive Radiotherapy for Localized Prostate Cancer","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Radiation therapy; Prostate cancer; External beam radiotherapy; Hormonal therapy; Cumulative dose; Proportional hazards model; Internal medicine; Cancer; Cohort; Surgery; Urology","score_opus":0.010363425079540575,"score_gpt":0.2510346968363343,"score_spread":0.2406712717567937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062383779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852177,0.0069674356,0.0006304197,0.0041441987,0.00026098877,0.0014436707,0.00035249954,0.00006161598,0.0009214915],"genre_scores_gemma":[0.9840871,0.0007916479,0.0005441685,0.012245383,0.00012138299,0.00021638414,0.000074574215,0.00009867241,0.0018206792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986078,0.00016260025,0.0003396205,0.0003779289,0.00010188084,0.0004101707],"domain_scores_gemma":[0.9990104,0.00017732196,0.00022581175,0.00022223059,0.0002648228,0.00009944344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046327035,0.00023759741,0.00047914812,0.00008608996,0.000046139357,0.000010613311,0.000062301,0.00006589355,0.0007335304],"category_scores_gemma":[0.00003807212,0.00016707265,0.000105500854,0.00012679861,0.00024711806,0.00005547757,0.000018291348,0.00015582613,0.000011876745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.117036164,0.0035842215,0.6653959,0.00047455294,0.01202459,0.0039707045,0.020407917,0.00008010908,0.004493056,0.00049730536,0.03655258,0.13548288],"study_design_scores_gemma":[0.03034561,0.016769059,0.72139925,0.00022829247,0.00076108356,0.000038767434,0.00014375093,0.000057967714,0.0074537583,0.00022078317,0.22207302,0.00050864165],"about_ca_topic_score_codex":0.000068176116,"about_ca_topic_score_gemma":0.00007966058,"teacher_disagreement_score":0.18552044,"about_ca_system_score_codex":0.00011746093,"about_ca_system_score_gemma":0.00014857651,"threshold_uncertainty_score":0.8031643},"labels":[],"label_agreement":null},{"id":"W2063205071","doi":"10.1016/j.eururo.2011.06.027","title":"Predictors of Unfavourable Repeat Biopsy Results in Men Participating in a Prospective Active Surveillance Program","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Biopsy; Prostate cancer; Prostate-specific antigen; Odds ratio; Prostate biopsy; Prospective cohort study; Internal medicine; Urology; Cancer; Gynecology","score_opus":0.03090927692069698,"score_gpt":0.2801062529128179,"score_spread":0.2491969759921209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063205071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9258449,0.000177841,0.0000011147147,0.00022393312,0.000065422304,0.0008822105,0.000028923683,0.000051414187,0.07272426],"genre_scores_gemma":[0.99907625,0.00009009088,0.00029924346,0.000049694252,0.000033916756,0.0003250469,0.000019926954,0.000026093112,0.00007973516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837005,0.00033320946,0.00046132362,0.00039719735,0.00009679076,0.00034140496],"domain_scores_gemma":[0.99930155,0.00009350302,0.0001842964,0.00027769126,0.00006715688,0.00007582604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005183686,0.00014126279,0.0003474843,0.00013340818,0.000016814824,0.0000029207135,0.000074905336,0.000041356714,0.00003126309],"category_scores_gemma":[0.00033417728,0.000117099604,0.00004148473,0.00030018814,0.00011931012,0.000048193047,0.000058811067,0.00018601624,0.00001377387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025350093,0.0010616871,0.98076606,0.000024891231,0.00007688231,0.0006834597,0.006849918,0.000014198025,0.00018414398,0.0000493894,0.000105745785,0.0076486133],"study_design_scores_gemma":[0.0041142674,0.0026307579,0.989524,0.000059153746,0.00002408635,0.000021279246,0.00018306395,0.00006799397,0.002868601,0.00004608725,0.00037521514,0.00008550057],"about_ca_topic_score_codex":0.00037173068,"about_ca_topic_score_gemma":0.00018561317,"teacher_disagreement_score":0.07323137,"about_ca_system_score_codex":0.000109488006,"about_ca_system_score_gemma":0.000051802454,"threshold_uncertainty_score":0.47751832},"labels":[],"label_agreement":null},{"id":"W2063646746","doi":"10.1016/j.eururo.2011.07.002","title":"Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":471,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Placebo; Overactive bladder; Spinal cord injury; Trigone of urinary bladder; Urinary incontinence; Quality of life (healthcare); Urology; Adverse effect; Urinary system; Clinical endpoint; Randomized controlled trial; Internal medicine; Spinal cord","score_opus":0.027482686209277695,"score_gpt":0.2744573629386346,"score_spread":0.2469746767293569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063646746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98305315,0.000095341224,0.00004118364,0.00023795193,0.00009410684,0.0064308275,0.0000062511704,0.000028451348,0.010012738],"genre_scores_gemma":[0.99914706,0.000033910048,0.00015992654,0.00023704083,0.00007676778,0.00009172847,0.000011934185,0.000050165647,0.00019144254],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972721,0.00095346477,0.00056280044,0.0004990173,0.0002776553,0.00043496903],"domain_scores_gemma":[0.9985201,0.00055318186,0.00016567497,0.00039232412,0.000112373404,0.0002563431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010561844,0.00024151179,0.0008141733,0.00035542302,0.00005529138,0.000008661083,0.0001669964,0.000065383974,0.00014656113],"category_scores_gemma":[0.00035244806,0.00018435682,0.00008211201,0.00029153825,0.00014625338,0.00009893044,0.00021087115,0.000446962,0.000043149434],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9743335,0.0020761243,0.019158067,0.000028394492,0.00017333611,0.0010849723,0.0007631674,0.0000052470236,0.0001390924,0.000015899835,0.000018997553,0.0022031744],"study_design_scores_gemma":[0.73381954,0.016262656,0.24917921,0.000015747675,0.00010632831,0.00011333794,0.000008437607,0.000012788869,0.00007935119,0.000005116488,0.0002753268,0.0001221467],"about_ca_topic_score_codex":0.000032718483,"about_ca_topic_score_gemma":0.000009453744,"teacher_disagreement_score":0.24051398,"about_ca_system_score_codex":0.00002007554,"about_ca_system_score_gemma":0.00011608062,"threshold_uncertainty_score":0.7517853},"labels":[],"label_agreement":null},{"id":"W2063677232","doi":"10.1016/j.eururo.2015.09.007","title":"Cardiovascular Safety of β3-adrenoceptor Agonists for the Treatment of Patients with Overactive Bladder Syndrome","year":2015,"lang":"en","type":"review","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Astellas Pharma US; Society for Cultural Anthropology; Pfizer","keywords":"Mirabegron; Medicine; Overactive bladder; Agonist; Urology; Internal medicine; Pharmacology; Intensive care medicine; Receptor; Alternative medicine","score_opus":0.051114844130965245,"score_gpt":0.32386972284196536,"score_spread":0.2727548787110001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063677232","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030747816,0.99195206,0.00007113288,0.000031611326,0.00014203742,0.0035693005,0.0007268696,0.000014387999,0.0031851456],"genre_scores_gemma":[0.0015729949,0.99652195,0.00008063213,0.00001621041,0.00013816169,0.000089663044,0.00071548694,0.00012463558,0.0007402868],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973775,0.0008374237,0.0005582246,0.0004442817,0.00042986125,0.00035271712],"domain_scores_gemma":[0.997646,0.0005587911,0.00032335124,0.00091751217,0.0004189487,0.00013540375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059327943,0.00038133797,0.0022081858,0.00014615043,0.00006274348,0.000005424157,0.00022900118,0.00011350971,0.00014956795],"category_scores_gemma":[0.00006686871,0.00019553045,0.0009276344,0.00019038413,0.00029636166,0.0000264064,0.00007176689,0.00023586344,0.000045961344],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023678618,0.0011531175,0.0001944694,0.004461393,0.015463815,0.0002725737,0.00047830344,0.000009895894,1.0190043e-7,0.000013023712,0.00072314346,0.9748623],"study_design_scores_gemma":[0.0031485425,0.014464916,0.002312053,0.00027459287,0.006572262,0.00019805788,0.00001286558,0.0000012333453,8.4845493e-7,0.0000022629663,0.972861,0.00015138363],"about_ca_topic_score_codex":0.000016690758,"about_ca_topic_score_gemma":8.406878e-7,"teacher_disagreement_score":0.97471094,"about_ca_system_score_codex":0.00011719149,"about_ca_system_score_gemma":0.00043019277,"threshold_uncertainty_score":0.79735},"labels":[],"label_agreement":null},{"id":"W2063698832","doi":"10.1016/j.eururo.2014.05.010","title":"Systemic Therapy for Non–clear Cell Renal Cell Carcinomas: A Systematic Review and Meta-analysis","year":2014,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Clear cell renal cell carcinoma; Oncology; Internal medicine; Clear cell; Renal cell carcinoma; Targeted therapy; Odds ratio; Meta-analysis; Confidence interval; Cancer","score_opus":0.07410049256108052,"score_gpt":0.30740602801999656,"score_spread":0.23330553545891602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063698832","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000122408865,0.9843452,0.00021042817,0.00010433658,0.000057288296,0.010629559,0.00008830804,0.00007194544,0.0044807205],"genre_scores_gemma":[0.0010836913,0.98749584,0.00021923169,0.0017480252,0.0001449777,0.0010906511,0.0003270802,0.0002884002,0.0076021007],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.991666,0.003817003,0.0022341441,0.001355333,0.00032677164,0.00060075754],"domain_scores_gemma":[0.994783,0.00083903223,0.001770768,0.002054658,0.0002034474,0.00034912812],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.002307382,0.0011458019,0.01664718,0.00058297167,0.00009902854,0.000040997216,0.0004910637,0.0002616204,0.0001711813],"category_scores_gemma":[0.00011523015,0.00067556027,0.005871534,0.00052035006,0.00010377667,0.00002711334,0.00014770318,0.00051281706,0.00057201524],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032204545,0.00009543096,0.0000012058061,0.919176,0.078924984,0.00028423322,0.00003925955,6.307542e-7,0.000003948675,0.000004688742,0.001006928,0.00043050502],"study_design_scores_gemma":[0.00065796834,0.0015460956,0.0000022294505,0.0072917473,0.8341841,0.0007144141,0.0000036083738,0.000008282751,0.0000020022817,6.122353e-7,0.15518358,0.00040534706],"about_ca_topic_score_codex":0.000007793803,"about_ca_topic_score_gemma":0.0000010734929,"teacher_disagreement_score":0.91188425,"about_ca_system_score_codex":0.00011470794,"about_ca_system_score_gemma":0.00013307045,"threshold_uncertainty_score":0.99956954},"labels":[],"label_agreement":null},{"id":"W2063908487","doi":"10.1016/j.eururo.2006.07.042","title":"Prostate Cancer Nomograms: An Update","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Prostate cancer; Prostate-specific antigen; Oncology; Cancer; Urology; Internal medicine","score_opus":0.011112871507759178,"score_gpt":0.26214314738675626,"score_spread":0.25103027587899707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063908487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95840985,0.0031625442,0.000025081185,0.0062244968,0.0002828312,0.00038090165,0.000045470664,0.00017716797,0.031291634],"genre_scores_gemma":[0.9927394,0.0006120349,0.00022311095,0.0045452104,0.0004523473,0.000050419636,0.00018433861,0.00005113853,0.0011419957],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894416,0.00011722351,0.0001967363,0.00033734008,0.000087141256,0.00031741493],"domain_scores_gemma":[0.99945456,0.000013054573,0.00006385507,0.000296146,0.000053017953,0.00011936353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012014198,0.00014682661,0.00019150639,0.00005626863,0.000056735415,0.000017455424,0.00007139715,0.000026822949,0.0003269615],"category_scores_gemma":[0.0000061980454,0.000117897245,0.000053027306,0.000093124676,0.00008790676,0.000056434586,0.00003767586,0.000114867085,0.0004049046],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088183844,0.0018571387,0.74325794,0.00006318609,0.00023878236,0.0040148706,0.00044350754,0.0003544719,0.0029588668,0.0029585233,0.048040774,0.19493009],"study_design_scores_gemma":[0.0019723417,0.0011888703,0.435747,0.0000115101375,0.00012945117,0.000076615775,0.000009403154,0.00005338806,0.00072896475,0.00018107424,0.55975944,0.00014191755],"about_ca_topic_score_codex":0.00021994798,"about_ca_topic_score_gemma":0.0000977909,"teacher_disagreement_score":0.5117187,"about_ca_system_score_codex":0.000048924394,"about_ca_system_score_gemma":0.00004197235,"threshold_uncertainty_score":0.5204364},"labels":[],"label_agreement":null},{"id":"W2064932201","doi":"10.1016/j.eururo.2004.09.010","title":"Active Surveillance with Selective Delayed Intervention Using PSA Doubling Time for Good Risk Prostate Cancer","year":2004,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Watchful waiting; Prostate cancer; Prostatectomy; Prostate; Prostate-specific antigen; Cancer; Internal medicine; Urology; Oncology; Surgery","score_opus":0.030977774467025272,"score_gpt":0.33536392129595416,"score_spread":0.3043861468289289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064932201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013032613,0.9923171,0.0005238496,0.000069731825,0.00023923903,0.0037688983,0.0010683682,0.0001019068,0.0006076639],"genre_scores_gemma":[0.002776128,0.9943927,0.0006092661,0.0000811182,0.00032957149,0.0005359309,0.0007613105,0.00023109949,0.00028290844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973352,0.0005811245,0.00061039015,0.00084085535,0.0001223416,0.000510078],"domain_scores_gemma":[0.998017,0.0002473492,0.0009981157,0.0003301216,0.00027080174,0.00013660874],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043462723,0.0005491221,0.0015449544,0.00019437748,0.00014102178,0.000030328842,0.00012746891,0.00013499119,0.000045019173],"category_scores_gemma":[0.000070110116,0.00039438956,0.00044239516,0.00030549915,0.00010021963,0.00006963632,0.00006901517,0.00050485524,0.000057802583],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019805375,0.00042931837,0.0005586304,0.0054604346,0.004302383,0.00027988906,0.00031647584,0.0002666583,0.0000022269876,0.000021348062,0.0001568723,0.98622525],"study_design_scores_gemma":[0.009751406,0.008725555,0.00084126706,0.013423691,0.009372526,0.00049650326,0.000016086413,0.0001218638,0.000029029417,0.000045638193,0.9563162,0.0008602494],"about_ca_topic_score_codex":0.000208439,"about_ca_topic_score_gemma":0.0000807342,"teacher_disagreement_score":0.985365,"about_ca_system_score_codex":0.00091999874,"about_ca_system_score_gemma":0.0005585102,"threshold_uncertainty_score":0.9998508},"labels":[],"label_agreement":null},{"id":"W2064988955","doi":"10.1016/j.eururo.2012.10.008","title":"A Contemporary Update on Pathology Standards for Bladder Cancer: Transurethral Resection and Radical Cystectomy Specimens","year":2012,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Center for Advancing Translational Sciences; National Institutes of Health","keywords":"Medicine; Cystectomy; Bladder cancer; Surgical pathology; Dissection (medical); General surgery; Lymph node; Anatomical pathology; Cancer; Pathology; Surgery; Immunohistochemistry; Internal medicine","score_opus":0.08446840903479175,"score_gpt":0.37118038104542417,"score_spread":0.2867119720106324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064988955","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012129728,0.98144335,0.00012430413,0.0006267353,0.0010245828,0.0020182866,0.0014033664,0.00009854222,0.013139537],"genre_scores_gemma":[0.0046420726,0.9905416,0.00008016776,0.0013025652,0.001995531,0.00025892677,0.00039003335,0.000215318,0.0005738084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99684894,0.0010291896,0.0006000956,0.00074046984,0.00024383003,0.00053749396],"domain_scores_gemma":[0.9987796,0.00018985664,0.00023717819,0.00041889635,0.00009052623,0.00028395408],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077512517,0.00054636126,0.0017832128,0.00024115285,0.000116105555,0.000015381464,0.00012987135,0.0003619074,0.000322182],"category_scores_gemma":[0.000052361404,0.0004076537,0.00038413514,0.000121304845,0.00030228533,0.00004145079,0.000047006848,0.0007086273,0.00007183275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003314936,0.0002811315,0.00006291045,0.00540792,0.0015341707,0.000999353,0.00022879578,2.3120586e-7,0.000006191834,0.00016560328,0.020374889,0.9676239],"study_design_scores_gemma":[0.004456548,0.003382451,0.0001437699,0.00067828153,0.002818093,0.0008348874,0.0000049568152,9.355379e-7,0.0000032916441,0.000013735672,0.9873741,0.00028892932],"about_ca_topic_score_codex":0.000016019285,"about_ca_topic_score_gemma":0.000012475396,"teacher_disagreement_score":0.9673349,"about_ca_system_score_codex":0.000171625,"about_ca_system_score_gemma":0.00056962133,"threshold_uncertainty_score":0.9998375},"labels":[],"label_agreement":null},{"id":"W2065153594","doi":"10.1016/j.eururo.2006.06.010","title":"Precystectomy Nomogram for Prediction of Advanced Bladder Cancer Stage","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Cystectomy; Stage (stratigraphy); Lymphadenectomy; Bladder cancer; Multivariate analysis; Multivariate statistics; Urology; T-stage; Logistic regression; Lymph node; Oncology; Surgery; Cancer; Internal medicine; Statistics; Mathematics","score_opus":0.01630425556545365,"score_gpt":0.27568795261437345,"score_spread":0.2593836970489198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065153594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8776273,0.0026190716,0.004209361,0.000936825,0.0009901596,0.002062286,0.00104864,0.00026896782,0.1102374],"genre_scores_gemma":[0.99175435,0.000041756037,0.00058891537,0.00036508733,0.00043468858,0.00009130294,0.00011448204,0.000048774727,0.0065606222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991089,0.00006857188,0.0002558384,0.0002519812,0.00009435988,0.00022033072],"domain_scores_gemma":[0.999498,0.000037804693,0.00010251751,0.00021564026,0.00009529107,0.000050728217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009692398,0.00012681494,0.00022670852,0.000069784684,0.000037661266,0.000003406616,0.00006169947,0.000043688906,0.00021850946],"category_scores_gemma":[0.000019846348,0.000108773434,0.0000924291,0.00008639941,0.00007080637,0.00003635169,0.000020011032,0.00007945772,0.000017327015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016396932,0.004178258,0.44915405,0.0013290878,0.0024593852,0.0003468518,0.0015464288,0.004840436,0.23973134,0.0038183841,0.055147056,0.2210518],"study_design_scores_gemma":[0.012992617,0.00390921,0.5049829,0.000025874546,0.0005259524,0.000036971367,0.00003340002,0.0002481729,0.010371378,0.00014011901,0.46656314,0.00017029696],"about_ca_topic_score_codex":0.00009242263,"about_ca_topic_score_gemma":0.00003458275,"teacher_disagreement_score":0.41141605,"about_ca_system_score_codex":0.000029942417,"about_ca_system_score_gemma":0.000052320513,"threshold_uncertainty_score":0.4435652},"labels":[],"label_agreement":null},{"id":"W2066555332","doi":"10.1016/j.eururo.2011.03.027","title":"Select Screening in a Specific High-Risk Population of Patients Suggests a Stage Migration Toward Detection of Non–Muscle-Invasive Bladder Cancer","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Nephrotoxicity and Medicinal Plants","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bladder cancer; Stage (stratigraphy); Population; Internal medicine; Cancer; Incidence (geometry); Risk factor; Gynecology; Surgery","score_opus":0.026399971953939994,"score_gpt":0.24335706076064056,"score_spread":0.21695708880670056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066555332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977218,0.00007149023,0.0011541401,0.000030360497,0.0001526,0.00046001995,0.000032477903,0.000018188306,0.00035891155],"genre_scores_gemma":[0.9991381,0.00017913929,0.00033954828,0.00012654842,0.00008832566,0.000007757208,0.000062827436,0.000023259965,0.00003449723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869823,0.00028623972,0.00041685082,0.0002313415,0.00017879593,0.00018852024],"domain_scores_gemma":[0.9992559,0.00005754501,0.00034711894,0.00015624845,0.000121011624,0.00006219568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031110237,0.00012284794,0.00029710322,0.0002875705,0.000022980448,0.0000014654041,0.000062621504,0.00007023734,0.00008482456],"category_scores_gemma":[0.00017051473,0.00011354558,0.000047519046,0.00024103238,0.00005120652,0.00007230715,0.000025202145,0.00022900672,0.000008968832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002163044,0.00032415084,0.857736,0.0001133258,0.00007899854,0.000065093016,0.0037082573,0.000081581704,0.10674073,0.00000974001,0.000058641876,0.028920436],"study_design_scores_gemma":[0.0019161465,0.0016656216,0.96039605,0.00006488031,0.00007963692,0.000004003179,0.000090958834,0.0001224409,0.035401363,0.0000088702245,0.00017235553,0.00007766648],"about_ca_topic_score_codex":0.0034071847,"about_ca_topic_score_gemma":0.0023506812,"teacher_disagreement_score":0.10266005,"about_ca_system_score_codex":0.000026101126,"about_ca_system_score_gemma":0.000027112581,"threshold_uncertainty_score":0.5150667},"labels":[],"label_agreement":null},{"id":"W2067573216","doi":"10.1016/j.eururo.2012.09.007","title":"A Phase 3, Double-blind, Randomised, Parallel-group, Placebo-controlled Study of Oral Weekly Alendronate for the Prevention of Androgen Deprivation Bone Loss in Nonmetastatic Prostate Cancer: The Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) Study","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bone health and treatments","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Prostate cancer; Osteoporosis; Placebo; Androgen deprivation therapy; Cancer; Oncology; Internal medicine; Randomized controlled trial; Urology; Prostate; Gynecology; Alternative medicine","score_opus":0.08995542459046717,"score_gpt":0.3921568895774073,"score_spread":0.3022014649869401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067573216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764776,0.004848921,0.000030929084,0.001072173,0.000047702415,0.01745923,0.00002645786,0.000009450581,0.00002750454],"genre_scores_gemma":[0.9956388,0.00080528867,0.000089523564,0.00006910861,0.000024497325,0.00312529,0.000015474752,0.000041469983,0.000190587],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968942,0.001283565,0.0006751451,0.00036892542,0.00030399545,0.00047416033],"domain_scores_gemma":[0.9984441,0.0005527553,0.0003949509,0.0003308833,0.00015432488,0.0001230048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00407648,0.00020882342,0.0007049186,0.00018733853,0.00018041361,0.000011385288,0.000105539664,0.000033759414,0.000008971951],"category_scores_gemma":[0.000073856936,0.0001121125,0.000045433135,0.0002541211,0.00024089574,0.000113580645,0.00008761008,0.00025788127,9.4438786e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6062294,0.0051898947,0.36347672,0.00014547257,0.00084789563,0.00003831557,0.009323133,0.00010414458,0.00010540978,0.000011104589,0.000020032723,0.014508466],"study_design_scores_gemma":[0.8319497,0.016583055,0.14654185,0.000045904926,0.0014575844,0.000052090047,0.0025832758,0.00043291625,0.000056786725,0.000022569215,0.00016184447,0.00011243644],"about_ca_topic_score_codex":0.0019976671,"about_ca_topic_score_gemma":0.0045972494,"teacher_disagreement_score":0.22572027,"about_ca_system_score_codex":0.000042011954,"about_ca_system_score_gemma":0.00011118441,"threshold_uncertainty_score":0.4571815},"labels":[],"label_agreement":null},{"id":"W2068287946","doi":"10.1016/j.eururo.2007.01.070","title":"Collecting Duct Renal Cell Carcinoma: A Matched Analysis of 41 Cases","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Stage (stratigraphy); Internal medicine; Cohort; Clear cell; Clear cell renal cell carcinoma; Kidney cancer; Kidney disease; Surgery; Urology; Oncology; Kidney","score_opus":0.03327093450918067,"score_gpt":0.26999642904469967,"score_spread":0.236725494535519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068287946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91890424,0.00064413546,0.00019292042,0.00012601857,0.00007870998,0.00018017723,0.000006953493,0.000044043976,0.07982277],"genre_scores_gemma":[0.99697816,0.000006468667,0.00062414154,0.0003264165,0.00013669104,0.0000016882265,0.00004243667,0.000041112427,0.0018428544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824774,0.0002683378,0.00050806,0.00038190908,0.00020337147,0.0003905728],"domain_scores_gemma":[0.9986475,0.00037323838,0.00022269397,0.0004621416,0.00012199684,0.0001724446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073895365,0.00019294553,0.00060917187,0.00066001376,0.00006390405,0.000005599781,0.00011032729,0.000055091834,0.00028304875],"category_scores_gemma":[0.00015773327,0.00016609622,0.0002830714,0.0010405824,0.00010995496,0.000019529847,0.00008048803,0.00019093438,0.000078320314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027987831,0.00095687684,0.6212446,0.00012663187,0.00219136,0.035624262,0.0026735626,0.00035877022,0.33008358,0.000069139445,0.002077923,0.0017945197],"study_design_scores_gemma":[0.0016812808,0.0018394231,0.94900197,0.000003899005,0.00403033,0.00071297644,0.00018975098,0.00013976176,0.040816467,0.0000032294724,0.0014341186,0.00014678133],"about_ca_topic_score_codex":0.00016550878,"about_ca_topic_score_gemma":0.00006845118,"teacher_disagreement_score":0.3277574,"about_ca_system_score_codex":0.00008086179,"about_ca_system_score_gemma":0.000056530967,"threshold_uncertainty_score":0.6773207},"labels":[],"label_agreement":null},{"id":"W2068943694","doi":"10.1016/j.eururo.2008.06.035","title":"Corrigendum to: “The Influence of Baseline Parameters on Changes in IPSS with Dutasteride, Tamsulosin, and Combination Therapy: Two-Year Data from the Combination of Avodart® and Tamsulosin (CombAT) Study” [Eur Urol Suppl 2008;7:171 (Abstract no. 403)]","year":2008,"lang":"en","type":"erratum","venue":"European Urology","topic":"Urinary Tract Infections Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Tamsulosin; Medicine; Dutasteride; Urology; Combination therapy; Baseline (sea); Internal medicine; Prostate; Hyperplasia","score_opus":0.04246769685384892,"score_gpt":0.27223243051016704,"score_spread":0.2297647336563181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068943694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98674834,0.0005896251,0.000020219111,0.004627367,0.0022093728,0.0029557452,0.00051102164,0.00004580643,0.002292484],"genre_scores_gemma":[0.9921358,0.001793083,0.000080763464,0.0022414955,0.00022586402,0.000046521323,0.0013820598,0.00010968905,0.0019847266],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99619305,0.0013488417,0.0007317709,0.00086111506,0.00053042994,0.00033477947],"domain_scores_gemma":[0.9967268,0.0005118776,0.00071591017,0.0016617245,0.00028625602,0.00009743986],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014807958,0.0004803441,0.0007376744,0.00044525045,0.00014164948,0.000035560995,0.0006260428,0.00012723602,0.00005310095],"category_scores_gemma":[0.00052327674,0.00032580955,0.000038435956,0.0004299957,0.00044219146,0.00014304993,0.00045529022,0.0010655009,0.000041214098],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013476758,0.022964323,0.20347463,0.000541057,0.0020949666,0.0015060795,0.006162521,0.0013667443,0.001043252,0.00017094512,0.73709977,0.010098938],"study_design_scores_gemma":[0.005902353,0.017443197,0.8768643,0.00022546764,0.00030190594,0.00007817205,0.00025514478,0.0004180315,0.000026143114,0.000010010115,0.09817676,0.00029846857],"about_ca_topic_score_codex":0.00088311214,"about_ca_topic_score_gemma":0.0011114653,"teacher_disagreement_score":0.67338973,"about_ca_system_score_codex":0.000044955013,"about_ca_system_score_gemma":0.00008283557,"threshold_uncertainty_score":0.9999194},"labels":[],"label_agreement":null},{"id":"W2069638934","doi":"10.1016/j.eururo.2010.12.005","title":"The Prognostic Significance of Capsular Incision Into Tumor During Radical Prostatectomy","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Prostatectomy; Biochemical recurrence; Prostate cancer; Hazard ratio; Urology; Confidence interval; Proportional hazards model; Prostate-specific antigen; Lymph node; Retrospective cohort study; Prostate; Surgical margin; Surgery; Cancer; Internal medicine","score_opus":0.006291288103818469,"score_gpt":0.23723200473599404,"score_spread":0.23094071663217558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069638934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492896,0.00074617995,0.00002100242,0.001597495,0.00026865036,0.0006981353,0.0000045657653,0.000048057245,0.0016869786],"genre_scores_gemma":[0.9989322,0.00011705487,0.0003421118,0.00027069513,0.00015004052,0.00006045882,0.000008027379,0.000034104392,0.00008529652],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99881995,0.00016851678,0.00030139793,0.0002796329,0.00016221519,0.0002683061],"domain_scores_gemma":[0.99906,0.00021302646,0.00012427632,0.0003924453,0.00008520848,0.00012508528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037726967,0.0001331647,0.0002097204,0.000046176654,0.00014016684,0.000011719268,0.00014494472,0.000029085693,0.000042322856],"category_scores_gemma":[0.00047409924,0.00008274407,0.00006283868,0.00011044511,0.00038162692,0.000026703136,0.0000927726,0.00033636484,0.00007998973],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020002925,0.00097523566,0.3831986,0.00028812824,0.00025100948,0.0035226382,0.0012770077,0.000023042245,0.57074386,0.0017909254,0.0007593173,0.035169967],"study_design_scores_gemma":[0.0029373295,0.0016773301,0.8746273,0.000039691644,0.00012219632,0.00029502346,0.00003266114,0.00005397409,0.06576419,0.00031143354,0.053995065,0.00014378871],"about_ca_topic_score_codex":0.000015579095,"about_ca_topic_score_gemma":0.0000148113895,"teacher_disagreement_score":0.50497967,"about_ca_system_score_codex":0.000025996465,"about_ca_system_score_gemma":0.00008157473,"threshold_uncertainty_score":0.33742052},"labels":[],"label_agreement":null},{"id":"W2069672800","doi":"10.1016/j.eururo.2010.10.029","title":"Age-Adjusted Incidence, Mortality, and Survival Rates of Stage-Specific Renal Cell Carcinoma in North America: A Trend Analysis","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":311,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Incidence (geometry); Renal cell carcinoma; Stage (stratigraphy); Epidemiology; Mortality rate; Survival rate; Demography; Internal medicine","score_opus":0.04569799973891559,"score_gpt":0.27548371824312046,"score_spread":0.22978571850420487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069672800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856921,0.00045977984,0.000024393488,0.00008129072,0.000102693964,0.00020815966,0.00003543882,0.000025181469,0.013370978],"genre_scores_gemma":[0.998841,0.00007406368,0.0002547004,0.00010188786,0.00009245292,0.0000052873656,0.00017609914,0.000035491157,0.00041901646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779356,0.00051741296,0.0005516543,0.000544345,0.0002472988,0.00034570447],"domain_scores_gemma":[0.99869996,0.00017797099,0.00023440065,0.00062685943,0.00006505662,0.00019574008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003661923,0.00025255635,0.00072199723,0.0006157793,0.000035422094,0.000013359326,0.00016723934,0.00006469923,0.00025625963],"category_scores_gemma":[0.000054741085,0.00021478566,0.00015291339,0.0010634623,0.00040593883,0.0000445542,0.00015545767,0.00044350236,0.000028620783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026889087,0.00022360464,0.9779467,0.000030226149,0.00017838698,0.003710892,0.0005776136,0.0001291317,0.016127883,0.00002007435,0.000064401596,0.00072222244],"study_design_scores_gemma":[0.0015555611,0.00078776316,0.9937273,0.0000018743547,0.000601067,0.00003326379,0.00009067946,0.00021255019,0.0012725756,0.0000028947973,0.0015659712,0.00014845349],"about_ca_topic_score_codex":0.0006257818,"about_ca_topic_score_gemma":0.007596382,"teacher_disagreement_score":0.015780672,"about_ca_system_score_codex":0.00002561409,"about_ca_system_score_gemma":0.000041343803,"threshold_uncertainty_score":0.8758705},"labels":[],"label_agreement":null},{"id":"W2069701490","doi":"10.1016/j.eururo.2013.08.012","title":"Impact of Bone and Liver Metastases on Patients with Renal Cell Carcinoma Treated with Targeted Therapy","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":253,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Toronto; Western University; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Calgary","funders":"National Cancer Institute; Bayer Korea; Genentech; GlaxoSmithKline; Pfizer","keywords":"Medicine; Renal cell carcinoma; Targeted therapy; Oncology; Carcinoma; Internal medicine; Cancer","score_opus":0.0117646008524895,"score_gpt":0.20782902668480147,"score_spread":0.19606442583231196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069701490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99403757,0.0006603418,0.0000045260576,0.00003617843,0.0000071632817,0.0006178232,0.00002304541,0.000028196122,0.0045851576],"genre_scores_gemma":[0.9991627,0.000026727177,0.00021682674,0.0001731126,0.000024116767,0.000009385546,0.00011014237,0.00005632565,0.00022069919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987527,0.0002930047,0.00020301495,0.00032114994,0.00017315609,0.00025696895],"domain_scores_gemma":[0.9991317,0.000065668675,0.00015110592,0.0003282661,0.00015433443,0.00016896939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068631125,0.00025400534,0.0003957396,0.00015201027,0.000032759668,0.000008085859,0.00004411832,0.000030769625,0.00034239207],"category_scores_gemma":[0.000009699707,0.00013188603,0.000067527384,0.000118869284,0.00015954391,0.000046247256,0.00002302018,0.0001271135,0.00007249201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057995077,0.0009814675,0.9781978,0.000017198225,0.00029531086,0.00071620115,0.00023507483,0.000025316516,0.010582219,0.000002580095,0.0007115335,0.0024357808],"study_design_scores_gemma":[0.007431738,0.03850069,0.9461411,0.00000844933,0.00016414153,0.00007182547,0.0000067043684,0.000016154509,0.0074405186,6.8053566e-7,0.00010154223,0.00011642114],"about_ca_topic_score_codex":0.00031596638,"about_ca_topic_score_gemma":0.0000028513093,"teacher_disagreement_score":0.03751922,"about_ca_system_score_codex":0.000032735214,"about_ca_system_score_gemma":0.00003282798,"threshold_uncertainty_score":0.53781563},"labels":[],"label_agreement":null},{"id":"W2069717010","doi":"10.1016/j.eururo.2007.04.015","title":"Re: Cytoreductive Nephrectomy in the Elderly Patient: The M.D. Anderson Cancer Center Experience","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Cancer; Center (category theory); General surgery; Urology; Surgery; Internal medicine; Kidney","score_opus":0.026934407015303093,"score_gpt":0.2824254768634989,"score_spread":0.2554910698481958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069717010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94376785,0.0009871746,0.00003070537,0.0044183214,0.00024782628,0.00041599546,0.0000018676777,0.000021382413,0.05010888],"genre_scores_gemma":[0.9939394,0.000045650908,0.00003439846,0.0055360575,0.00024267897,0.000024541583,0.000005703791,0.000022610604,0.00014898804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856955,0.00040920614,0.0002113676,0.000276456,0.00018790008,0.00034554125],"domain_scores_gemma":[0.9992991,0.00015457199,0.000072403396,0.00038139045,0.00003521143,0.00005731574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037900277,0.00014318677,0.00014132868,0.00006239482,0.00008227987,0.000012095889,0.00018437848,0.000031546286,0.00011794549],"category_scores_gemma":[0.000046919202,0.000072902236,0.000059085363,0.00018847386,0.00019814867,0.000036808593,0.000047544694,0.00028856474,0.00006470112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00470457,0.001312571,0.5241331,0.00003324129,0.00023987527,0.010141774,0.26228634,0.00004510021,0.006411244,0.00041933826,0.018668467,0.17160441],"study_design_scores_gemma":[0.002185463,0.0026379733,0.8164768,0.000017236796,0.00006775819,0.00043282346,0.010494788,0.000011481154,0.0023370825,0.000025547848,0.16515666,0.00015633133],"about_ca_topic_score_codex":0.00011283773,"about_ca_topic_score_gemma":0.00014804384,"teacher_disagreement_score":0.29234377,"about_ca_system_score_codex":0.00007589618,"about_ca_system_score_gemma":0.000022945656,"threshold_uncertainty_score":0.2972867},"labels":[],"label_agreement":null},{"id":"W2070261070","doi":"10.1016/j.eururo.2010.03.026","title":"Re: Comparative Effectiveness of Minimally Invasive Versus Open Radical Prostatectomy","year":2010,"lang":"en","type":"letter","venue":"European Urology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Prostatectomy; Urology; Surgery; Prostate cancer; Internal medicine; Cancer","score_opus":0.35461949243154944,"score_gpt":0.42754140962925963,"score_spread":0.07292191719771018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070261070","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.076609366,0.0012138163,0.00027974474,0.68196875,0.005766498,0.0054126442,0.0018938786,0.00011862345,0.22673665],"genre_scores_gemma":[0.2079726,0.00008586907,0.0023530181,0.78211105,0.003991478,0.0003492088,0.0015176248,0.00031103703,0.0013081387],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98696154,0.006669317,0.004204136,0.0013439514,0.00012819888,0.0006928509],"domain_scores_gemma":[0.98335433,0.010690885,0.004481743,0.0011609519,0.00015582559,0.00015628112],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.02057137,0.0005072417,0.0028928088,0.0004856024,0.00015896512,0.000113765906,0.0018740781,0.0010396362,0.0009773761],"category_scores_gemma":[0.0059622456,0.00063051254,0.00023883472,0.00020091486,0.0006291766,0.00029446892,0.00063730695,0.003241838,0.0055156113],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007959478,0.0001135757,0.0017009026,0.0011935971,0.0004812416,0.00014901021,0.0012368127,0.000023918667,0.000025132202,0.0057130107,0.9885438,0.000023051782],"study_design_scores_gemma":[0.0041803755,0.0010749468,0.009569339,0.00011509573,0.000041427335,0.000013501516,0.00009955917,0.00004052118,0.00004002563,0.002195635,0.9819823,0.00064726744],"about_ca_topic_score_codex":0.00027035867,"about_ca_topic_score_gemma":0.00015094812,"teacher_disagreement_score":0.22542852,"about_ca_system_score_codex":0.00026608765,"about_ca_system_score_gemma":0.00046620716,"threshold_uncertainty_score":0.99993587},"labels":[],"label_agreement":null},{"id":"W2070349594","doi":"10.1016/j.eururo.2014.10.050","title":"Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: A Systematic Review","year":2014,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":308,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Magnetic resonance imaging; Watchful waiting; Radiology; Prostate; Biopsy; Cancer; Internal medicine","score_opus":0.018192031398286835,"score_gpt":0.30738247428802445,"score_spread":0.2891904428897376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070349594","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007256475,0.992712,6.929657e-7,0.00034770902,0.00015759267,0.004359817,0.00013933622,0.000031981417,0.0022435738],"genre_scores_gemma":[0.00020165935,0.9974141,0.00001573819,0.00094129646,0.000070764974,0.00089197094,0.00008695561,0.00011002646,0.00026750498],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955483,0.0018238613,0.001397314,0.00063697883,0.00018837838,0.00040516845],"domain_scores_gemma":[0.99770033,0.00036856887,0.00094145106,0.00077375944,0.00011501564,0.00010086495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009047644,0.00047092157,0.004653419,0.0001940171,0.000020211848,0.0000064881765,0.000245281,0.000059176797,0.000060969833],"category_scores_gemma":[0.0003877532,0.00033794946,0.0003619148,0.00037187574,0.00012630226,0.000025263047,0.00011288454,0.00036637625,0.00011315034],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018757946,0.000060675797,0.00042847687,0.58771026,0.000042819123,0.00031459646,0.000037124133,1.2426266e-7,5.8712107e-8,0.00001138013,0.00039038958,0.41098532],"study_design_scores_gemma":[0.00052315876,0.00030525247,0.0007298039,0.478047,0.0014700631,0.00015166716,0.000001745818,0.0000020903583,2.134481e-7,0.0000022673667,0.51858646,0.00018024827],"about_ca_topic_score_codex":0.000041105588,"about_ca_topic_score_gemma":0.00002287203,"teacher_disagreement_score":0.5181961,"about_ca_system_score_codex":0.00022710876,"about_ca_system_score_gemma":0.00025128646,"threshold_uncertainty_score":0.99990726},"labels":[],"label_agreement":null},{"id":"W2070492470","doi":"10.1016/j.eururo.2006.07.008","title":"Zonal Origin of Localized Prostate Cancer Does not Affect the Rate of Biochemical Recurrence after Radical Prostatectomy","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Prostatectomy; Medicine; Prostate cancer; Biochemical recurrence; Urology; Prostate; Concordance; Prostate-specific antigen; Proportional hazards model; Multivariate analysis; Internal medicine; Oncology; Cancer","score_opus":0.010850598252755233,"score_gpt":0.2683802346990641,"score_spread":0.25752963644630883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070492470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99179024,0.002418773,0.000032650853,0.0038293472,0.00020789588,0.00078580703,0.00018849577,0.000029638974,0.000717176],"genre_scores_gemma":[0.9978625,0.0005632441,0.00012661764,0.00083124905,0.0001595805,0.0001562064,0.00004187005,0.00003288596,0.00022584399],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983163,0.0003869717,0.0004467249,0.0003621386,0.0001678747,0.00031998262],"domain_scores_gemma":[0.9990808,0.0002021921,0.00020488094,0.00032017365,0.00011258049,0.00007936759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040882002,0.00020384995,0.00041167144,0.00006147215,0.000030629173,0.0000067291235,0.00012888692,0.0000481935,0.00019157624],"category_scores_gemma":[0.0000662518,0.00010759524,0.0001258843,0.00017027734,0.0006982416,0.00002763242,0.0000779837,0.00021510507,0.00002106712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024911,0.002566877,0.7569655,0.0010718135,0.0008037442,0.0015383404,0.0010636629,0.0001360323,0.17093937,0.0020896904,0.01646902,0.021444917],"study_design_scores_gemma":[0.00853556,0.0023808663,0.5065154,0.00028338534,0.00050123147,0.00007191003,0.00001646827,0.00011644797,0.41181654,0.00037616995,0.069076024,0.00031002975],"about_ca_topic_score_codex":0.0001495162,"about_ca_topic_score_gemma":0.000016896956,"teacher_disagreement_score":0.25045016,"about_ca_system_score_codex":0.000046706074,"about_ca_system_score_gemma":0.0001279587,"threshold_uncertainty_score":0.43876067},"labels":[],"label_agreement":null},{"id":"W2071275751","doi":"10.1016/j.eururo.2011.07.064","title":"A Stage-for-Stage and Grade-for-Grade Analysis of Cancer-Specific Mortality Rates in Renal Cell Carcinoma According to Age: A Competing-Risks Regression Analysis","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Stage (stratigraphy); Kidney cancer; Internal medicine; Cancer; Epidemiology; Population; Cohort; Cancer stage; Carcinoma; Oncology","score_opus":0.138070243098142,"score_gpt":0.3530760132821776,"score_spread":0.21500577018403558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071275751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493444,0.0015191701,0.0010245845,0.00011759718,0.000060224746,0.0008038435,0.00016534417,0.000031867537,0.0013429511],"genre_scores_gemma":[0.99699706,0.00010613021,0.0020144952,0.0001563139,0.000064209074,0.00006754177,0.00019480984,0.000051462448,0.0003479597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971678,0.00052696874,0.0007688338,0.0008286652,0.00021403124,0.00049367524],"domain_scores_gemma":[0.99826133,0.00027597143,0.00041378854,0.00066249643,0.00013256008,0.0002538792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009250846,0.00033893227,0.001215232,0.0011667322,0.000088459856,0.00001725538,0.00020951692,0.00008728875,0.00009606382],"category_scores_gemma":[0.00007917587,0.00028021517,0.0004484342,0.0016500632,0.00015175276,0.000043828637,0.0001463352,0.00021960611,0.0000028163797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010964606,0.00024248683,0.97158337,0.00011327476,0.0016218661,0.00051228906,0.0021610763,0.0009630591,0.02099427,0.00006380823,0.000041707553,0.0006063304],"study_design_scores_gemma":[0.002188633,0.0010262373,0.97383064,0.000017136283,0.006436138,0.0000029491107,0.00055366097,0.0021272372,0.012970962,0.000008241633,0.00061262475,0.00022555653],"about_ca_topic_score_codex":0.0020852303,"about_ca_topic_score_gemma":0.0012010512,"teacher_disagreement_score":0.008023308,"about_ca_system_score_codex":0.0001032129,"about_ca_system_score_gemma":0.000043394026,"threshold_uncertainty_score":0.999965},"labels":[],"label_agreement":null},{"id":"W2072047104","doi":"10.1016/j.eururo.2007.01.075","title":"The Immediate and 6-mo Reproducibility of Pressure–Flow Studies in Men with Benign Prostatic Enlargement","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Reproducibility; Bladder outlet obstruction; Placebo; Urology; Surgery; Internal medicine; Pathology; Prostate; Statistics","score_opus":0.04254506515509549,"score_gpt":0.3361634998905858,"score_spread":0.2936184347354903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072047104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96911573,0.011735915,0.00004747504,0.0028984598,0.000047812053,0.0010529237,0.000005690562,0.000021640762,0.015074364],"genre_scores_gemma":[0.99754035,0.0009920469,0.0002141404,0.0001230751,0.000055141572,0.00000873347,0.000003574798,0.000017262353,0.0010456775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981606,0.00048373244,0.0003205288,0.0005060596,0.00019489127,0.00033418022],"domain_scores_gemma":[0.99875134,0.0004117469,0.00006823531,0.0005824114,0.00011689565,0.0000693399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072226594,0.000101898426,0.0002321329,0.00007213942,0.00006738513,0.0000049831347,0.0000838412,0.000017954007,0.000008858162],"category_scores_gemma":[0.00071868405,0.000057797788,0.00001725022,0.00013740848,0.0005065293,0.000027130909,0.00015151253,0.00022650958,0.0000063521607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02059929,0.0012071774,0.83207774,0.0014673844,0.001472733,0.0027372746,0.037893068,0.00011057556,0.006368496,0.0004883156,0.004758101,0.09081982],"study_design_scores_gemma":[0.0033590752,0.005551981,0.96525097,0.000037139875,0.00013452668,0.00016135904,0.0016859998,0.0002332595,0.0016326689,0.00035545192,0.021472853,0.00012473513],"about_ca_topic_score_codex":0.000013280671,"about_ca_topic_score_gemma":0.000026061653,"teacher_disagreement_score":0.13317318,"about_ca_system_score_codex":0.000011703099,"about_ca_system_score_gemma":0.000032609387,"threshold_uncertainty_score":0.2503244},"labels":[],"label_agreement":null},{"id":"W2072300037","doi":"10.1016/j.eururo.2011.06.048","title":"Basic Research in Kidney Cancer","year":2011,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute","keywords":"Medicine; Kidney cancer; Cancer; Kidney; Internal medicine","score_opus":0.286109948887339,"score_gpt":0.4244793886500025,"score_spread":0.13836943976266353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072300037","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038458395,0.80363524,3.4308837e-7,0.0001817805,0.00028210308,0.0007823372,0.000018255274,0.000034646437,0.19502686],"genre_scores_gemma":[0.00019164951,0.9924236,0.00003119735,0.0005210903,0.0005838876,0.00012651652,0.00011999257,0.00017081689,0.0058312365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949604,0.0028434994,0.00056776754,0.000736603,0.00022327583,0.0006684335],"domain_scores_gemma":[0.9983521,0.00020844882,0.00013424626,0.00085319043,0.00008200158,0.00037000384],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001334405,0.00036818619,0.0014527935,0.00080046634,0.000039391576,0.0000087775825,0.00034268678,0.00020503947,0.0011807879],"category_scores_gemma":[0.00018294917,0.00026906046,0.00029172105,0.0005277017,0.00020605627,0.000017761302,0.00027692664,0.0015048764,0.005658676],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069725975,0.00016618881,0.00020388693,0.0073877005,0.00016557676,0.007011269,0.00010492458,4.55849e-8,7.6921214e-7,0.00017377794,0.014153929,0.9705622],"study_design_scores_gemma":[0.0005135117,0.00057464873,0.00058425806,0.0037335749,0.00048600178,0.00048222518,0.0000019592428,2.6237228e-7,6.5679023e-7,0.000014375075,0.99344385,0.00016465361],"about_ca_topic_score_codex":0.00015127238,"about_ca_topic_score_gemma":0.000018267514,"teacher_disagreement_score":0.97928995,"about_ca_system_score_codex":0.0003246823,"about_ca_system_score_gemma":0.0007565385,"threshold_uncertainty_score":0.99997616},"labels":[],"label_agreement":null},{"id":"W2072478300","doi":"10.1016/j.eururo.2014.05.034","title":"Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":474,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; BC Cancer Agency; Sunnybrook Health Science Centre; Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Carcinoma; Kidney; Urology; Internal medicine; Oncology; Database","score_opus":0.014312277349316473,"score_gpt":0.21491309446702786,"score_spread":0.20060081711771138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072478300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850228,0.0004889218,0.00026970572,0.0006725984,0.00037749155,0.0007824811,0.0020783055,0.000051598377,0.010256126],"genre_scores_gemma":[0.98936266,0.0000062437025,0.0029938167,0.0011474452,0.0004942547,0.00002856522,0.0056785233,0.00010197791,0.00018650625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951842,0.0016425558,0.00081520405,0.0011594204,0.0006172173,0.0005813986],"domain_scores_gemma":[0.99664265,0.0011802573,0.00048150937,0.0012087771,0.00021236899,0.00027444193],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006215674,0.0005324767,0.00066788844,0.00021397015,0.000117901785,0.00005090553,0.0005739932,0.000058334666,0.00028092155],"category_scores_gemma":[0.00030944197,0.00035498128,0.00014474454,0.00021720142,0.0003642251,0.00015461321,0.00033277972,0.00062664907,0.00030679486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03463608,0.0044509214,0.90497375,0.000051466373,0.0010225556,0.0066202004,0.0045849625,0.0007623097,0.021028962,0.00007088562,0.019119427,0.0026784965],"study_design_scores_gemma":[0.021910615,0.0028380698,0.950881,0.000026987373,0.0010400994,0.00004096611,0.00018255455,0.00029066828,0.014074959,0.0000255569,0.008297089,0.0003914439],"about_ca_topic_score_codex":0.0025630386,"about_ca_topic_score_gemma":0.00024306997,"teacher_disagreement_score":0.045907255,"about_ca_system_score_codex":0.00022502548,"about_ca_system_score_gemma":0.00020278606,"threshold_uncertainty_score":0.9998902},"labels":[],"label_agreement":null},{"id":"W2073428880","doi":"10.1016/j.eururo.2015.04.004","title":"Renal Tumor Biopsy for Small Renal Masses: A Single-center 13-year Experience","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":310,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Toronto General Hospital; University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Concordance; Biopsy; Single Center; Radiology; Retrospective cohort study; Renal biopsy; Surgery; Internal medicine","score_opus":0.0789498930544846,"score_gpt":0.27202023566142497,"score_spread":0.19307034260694036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073428880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94454116,0.00020775569,0.001437297,0.0008378185,0.00034097524,0.0005774623,0.000015907905,0.00012004718,0.05192159],"genre_scores_gemma":[0.98719543,0.00000226225,0.008085317,0.0017810477,0.00057378475,0.000051701238,0.00006283359,0.00007992401,0.0021676982],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99821955,0.00023840099,0.00034647394,0.0005261802,0.00018610981,0.00048329352],"domain_scores_gemma":[0.9987868,0.00007879138,0.0001238227,0.0004833435,0.00015123215,0.0003760239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003297781,0.00024049454,0.0003224391,0.00012352047,0.0000525394,0.000025259355,0.00019880808,0.000047054546,0.00010743208],"category_scores_gemma":[0.00027692525,0.00019540857,0.00013682162,0.00011544701,0.00016949224,0.000046163063,0.00012726204,0.00016492911,0.0005037892],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03107578,0.0067937775,0.34120235,0.00033274756,0.0010366644,0.041404612,0.017553005,0.00014447384,0.45779032,0.0017975057,0.09103233,0.00983646],"study_design_scores_gemma":[0.02157895,0.01719539,0.039866634,0.00008438977,0.00039240677,0.010506588,0.0007206711,0.0002998187,0.016171489,0.00015488602,0.8922688,0.0007599889],"about_ca_topic_score_codex":0.000010829952,"about_ca_topic_score_gemma":0.0000064512537,"teacher_disagreement_score":0.80123645,"about_ca_system_score_codex":0.00010743018,"about_ca_system_score_gemma":0.00008506154,"threshold_uncertainty_score":0.79685307},"labels":[],"label_agreement":null},{"id":"W2073596856","doi":"10.1016/j.eururo.2012.08.041","title":"Re: Combined Androgen Deprivation Therapy and Radiation Therapy for Locally Advanced Prostate Cancer: A Randomised, Phase 3 Trial","year":2012,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Radiation therapy; Oncology; Prostate; Internal medicine; Cancer; Gynecology","score_opus":0.027582999991273723,"score_gpt":0.2972546359218929,"score_spread":0.26967163593061916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073596856","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31731394,0.07417115,0.00021919573,0.5815714,0.0021819165,0.02325969,0.00048396157,0.00022236735,0.00057637785],"genre_scores_gemma":[0.11372144,0.12789358,0.00028614217,0.736937,0.0084980475,0.005758241,0.0057313354,0.00039746962,0.0007767447],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977058,0.000452664,0.00054173364,0.0006185079,0.0001844896,0.0004967675],"domain_scores_gemma":[0.9985217,0.00035470817,0.00046789026,0.0003933543,0.00013981498,0.00012252796],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046175258,0.00043525998,0.00078533695,0.0001418171,0.000114789,0.000034098826,0.00010536259,0.0002528407,0.00009289286],"category_scores_gemma":[0.00007626958,0.00033981897,0.00018932289,0.00009094719,0.00010542669,0.00008914556,0.000019641135,0.00046195555,0.000012224378],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37621304,0.0004508352,0.00057798455,0.00006765189,0.0006235175,0.00012533319,0.00039902935,0.0000030998365,0.00024173682,0.000004892181,0.20555395,0.4157389],"study_design_scores_gemma":[0.41774932,0.008268547,0.00037414487,0.000023744276,0.00018598478,0.000008700898,0.000002776255,0.000018623838,0.00044328105,0.000029506287,0.5727085,0.0001868924],"about_ca_topic_score_codex":0.00001128422,"about_ca_topic_score_gemma":0.0000022552229,"teacher_disagreement_score":0.41555202,"about_ca_system_score_codex":0.00011209539,"about_ca_system_score_gemma":0.00016151843,"threshold_uncertainty_score":0.9999054},"labels":[],"label_agreement":null},{"id":"W2074014907","doi":"10.1016/j.eururo.2011.06.040","title":"Treatment of Localised Renal Cell Carcinoma","year":2011,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":235,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Cryoablation; Watchful waiting; Laparoscopy; Surgery; Kidney cancer; Radiofrequency ablation; Cryotherapy; General surgery; Kidney; Ablation; Internal medicine; Cancer","score_opus":0.07577986124350544,"score_gpt":0.2886587940130707,"score_spread":0.21287893276956527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074014907","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005528571,0.8566267,0.000011648868,0.000012599391,0.00019206801,0.00096947304,0.000038396964,0.00004960046,0.14154668],"genre_scores_gemma":[0.0079328045,0.98600113,0.00019856707,0.000051101117,0.0003786513,0.000041947616,0.0003312906,0.00020332291,0.0048611853],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99677587,0.0009400157,0.0009463679,0.00071983656,0.0001605636,0.00045737784],"domain_scores_gemma":[0.9977575,0.00013842167,0.00057437865,0.0011734165,0.000076620025,0.0002796748],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013500554,0.0007051732,0.002702941,0.00034531488,0.000033340457,0.000004828518,0.00024286106,0.00023370085,0.000505799],"category_scores_gemma":[0.000018593573,0.0004743613,0.0010893544,0.00018843816,0.00020718807,0.000015032245,0.00009631239,0.00025058896,0.0015302823],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028126803,0.0012897777,0.00014262297,0.006756418,0.00055625814,0.007848795,0.00026093723,2.988101e-7,0.000021317634,0.00008352255,0.0010271443,0.98173165],"study_design_scores_gemma":[0.0017316646,0.008287822,0.00041255134,0.00028141084,0.005624805,0.001400772,0.0000028961829,8.0462326e-7,0.00009972921,0.0000024853928,0.98189145,0.00026361347],"about_ca_topic_score_codex":0.00004238603,"about_ca_topic_score_gemma":0.0000012947556,"teacher_disagreement_score":0.981468,"about_ca_system_score_codex":0.00022377528,"about_ca_system_score_gemma":0.00030635583,"threshold_uncertainty_score":0.9997708},"labels":[],"label_agreement":null},{"id":"W2074145847","doi":"10.1016/j.eururo.2013.02.029","title":"Reply from Authors re: Jean-Nicolas Cornu. Overactive Bladder Medical Management in the Elderly: It Is Time to Go Beyond the Tip of the Iceberg. Eur Urol 2013;64:82–3","year":2013,"lang":"en","type":"letter","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Overactive bladder; Iceberg; Urology; Gynecology; General surgery; Alternative medicine; Pathology","score_opus":0.021942929898743076,"score_gpt":0.28396732270247177,"score_spread":0.2620243928037287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074145847","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026984594,0.0005594678,0.000015142416,0.8317008,0.00050670264,0.0025056307,0.00014128102,0.000037363894,0.16183513],"genre_scores_gemma":[0.004271214,0.0005023364,0.00004788375,0.8827329,0.002318866,0.00012255636,0.00022664574,0.00018151022,0.10959605],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98930925,0.005601939,0.0009761849,0.0011560492,0.0019229876,0.0010335898],"domain_scores_gemma":[0.9935627,0.0029451076,0.0003933012,0.00268631,0.00019149984,0.00022110362],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0028864914,0.00061330985,0.00080092973,0.00028094888,0.00021886022,0.00008136257,0.0024535137,0.000505496,0.021063568],"category_scores_gemma":[0.000721051,0.000321483,0.00034532935,0.0005879699,0.0006332104,0.000083245475,0.0013690728,0.005894407,0.011268119],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004822711,0.00017217225,0.000109467466,0.00005728024,0.00074585347,0.003177299,0.0026594603,0.0000048663533,0.000034673794,0.000010420886,0.98799604,0.0045501716],"study_design_scores_gemma":[0.0013570263,0.0016247614,0.007113955,0.000073786716,0.00044956722,0.00016659343,0.00015660957,0.00012125699,0.000012896279,0.00023140557,0.9883969,0.00029523976],"about_ca_topic_score_codex":0.00039198555,"about_ca_topic_score_gemma":0.000041018066,"teacher_disagreement_score":0.052239083,"about_ca_system_score_codex":0.00007361947,"about_ca_system_score_gemma":0.00021542174,"threshold_uncertainty_score":0.9999237},"labels":[],"label_agreement":null},{"id":"W2074942653","doi":"10.1016/j.eururo.2008.01.090","title":"Editorial Comment on: Prostate Growth and Prevalence of Prostate Diseases in Early Onset Spinal Cord Injuries","year":2008,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate; Spinal cord injury; Spinal cord; Internal medicine; Psychiatry","score_opus":0.009759635915672159,"score_gpt":0.26888045514130693,"score_spread":0.2591208192256348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074942653","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13525367,0.0037258225,3.826706e-7,0.0018106571,0.85434276,0.0016251691,0.0027288618,0.00006561584,0.0004470524],"genre_scores_gemma":[0.23223454,0.019352598,0.000028051762,0.000612323,0.7467462,0.00017072028,0.00055846845,0.00011932219,0.00017781425],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99681956,0.00049728935,0.00070257694,0.00082141446,0.0006661497,0.0004930272],"domain_scores_gemma":[0.99813503,0.00048711928,0.00043292367,0.00046929548,0.00023444902,0.00024118075],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026025024,0.00051082147,0.0009049702,0.00025709844,0.00007693768,0.000024623067,0.00020166399,0.00023313319,0.000011415283],"category_scores_gemma":[0.0006829508,0.0004345039,0.00011615442,0.0001401011,0.00060116686,0.00007098069,0.00022538338,0.0008511038,0.000025247171],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017732281,0.0007596039,0.0831107,0.0010617592,0.00013442764,0.0007227824,0.0003634578,6.451534e-7,0.000003828148,0.0000143600255,0.8951743,0.0009218405],"study_design_scores_gemma":[0.00534427,0.037049737,0.16928387,0.00068480027,0.0003693822,0.000013779626,0.000007818024,4.4363279e-7,0.00007338635,0.000051094437,0.7867908,0.00033066366],"about_ca_topic_score_codex":0.000110881,"about_ca_topic_score_gemma":0.000004294555,"teacher_disagreement_score":0.10838356,"about_ca_system_score_codex":0.000121379,"about_ca_system_score_gemma":0.00040230106,"threshold_uncertainty_score":0.9998107},"labels":[],"label_agreement":null},{"id":"W2075265368","doi":"10.1016/j.eururo.2011.05.037","title":"Additional Evidence for Improved Functional Outcomes Following Robot-Assisted Radical Prostatectomy","year":2011,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Prostatectomy; Urology; General surgery; Prostate cancer; Internal medicine; Cancer","score_opus":0.08181543910509723,"score_gpt":0.2964721356248631,"score_spread":0.21465669651976585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075265368","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060505175,0.0022660226,0.0016747008,0.9621592,0.004419722,0.0051065404,0.015284467,0.0005717357,0.007912537],"genre_scores_gemma":[0.00463686,0.000084225365,0.004266693,0.924407,0.004776082,0.0022247534,0.048498888,0.00031948095,0.010786012],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972207,0.0002849132,0.0005727658,0.0009748839,0.00027751838,0.0006692026],"domain_scores_gemma":[0.9971224,0.0017251071,0.00030374565,0.00052310136,0.00016126128,0.00016439849],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002583612,0.00052345614,0.00082300545,0.00019819762,0.00016041014,0.000032783133,0.00019981833,0.00036523066,0.01097936],"category_scores_gemma":[0.00080887426,0.00041739427,0.0007541882,0.0000973559,0.00019138098,0.000090853944,0.00010949284,0.0011097528,0.00046655786],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042174238,0.00015760967,0.0013915453,0.000121572055,0.0009864182,0.0017484125,0.000018606062,5.2089223e-7,0.000038242968,0.000015042195,0.9900915,0.0050088074],"study_design_scores_gemma":[0.0030397768,0.0013366017,0.13282293,0.00019730486,0.0008485291,0.0001684568,0.0000012658726,0.000009850963,0.000011936558,0.00008789607,0.8611635,0.0003119486],"about_ca_topic_score_codex":0.0000072324,"about_ca_topic_score_gemma":0.0000025156962,"teacher_disagreement_score":0.13143139,"about_ca_system_score_codex":0.000216445,"about_ca_system_score_gemma":0.00036686804,"threshold_uncertainty_score":0.9998278},"labels":[],"label_agreement":null},{"id":"W2075361673","doi":"10.1016/j.eururo.2012.07.026","title":"Extranodal Extension Is a Powerful Prognostic Factor in Bladder Cancer Patients with Lymph Node Metastasis","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Hazard ratio; Cystectomy; Bladder cancer; Lymphovascular invasion; Lymphadenectomy; Proportional hazards model; Lymph node; Urology; Stage (stratigraphy); Metastasis; Cancer; Retrospective cohort study; Confidence interval; Internal medicine; Oncology; Surgery","score_opus":0.01974532135692254,"score_gpt":0.2669175957561475,"score_spread":0.24717227439922496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075361673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99091357,0.0013770998,0.00007810961,0.0006238947,0.00030113154,0.0004991362,0.000087498454,0.00005713852,0.006062442],"genre_scores_gemma":[0.9945863,0.000047506473,0.000209919,0.0044629257,0.00018288521,0.000020905067,0.000035661124,0.00008198902,0.00037189035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836725,0.00020834735,0.00024993616,0.00037342325,0.00023871746,0.0005623422],"domain_scores_gemma":[0.9992646,0.000046107933,0.00007910563,0.0002947456,0.00009163702,0.00022381944],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010375606,0.0002574064,0.00033319264,0.00013743056,0.00004080661,0.000008859461,0.000087496286,0.000056996018,0.00152403],"category_scores_gemma":[0.000043466,0.00018202279,0.00006467109,0.0001809926,0.00008154634,0.00011245577,0.000048818598,0.00017335873,0.00040832936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000764843,0.0008360927,0.99064046,0.000020095404,0.00018599506,0.000096693686,0.001034796,0.0000031920852,0.00024587428,0.0000043833065,0.00061890663,0.0055486374],"study_design_scores_gemma":[0.004982115,0.00061752636,0.9841906,0.000028319673,0.00031365524,0.000034016073,0.000018648887,0.000007737511,0.00022031678,0.0000024137487,0.009407791,0.00017689198],"about_ca_topic_score_codex":0.00010201823,"about_ca_topic_score_gemma":0.000012920462,"teacher_disagreement_score":0.008788885,"about_ca_system_score_codex":0.00007365911,"about_ca_system_score_gemma":0.0000725026,"threshold_uncertainty_score":0.9993887},"labels":[],"label_agreement":null},{"id":"W2075627892","doi":"10.1016/j.eururo.2011.02.035","title":"Renal Cell Carcinoma (RCC) in Patients With End-Stage Renal Disease Exhibits Many Favourable Clinical, Pathologic, and Outcome Features Compared With RCC in the General Population","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Univariate analysis; Renal cell carcinoma; End stage renal disease; Population; Context (archaeology); Asymptomatic; Internal medicine; Stage (stratigraphy); Urology; Disease; Multivariate analysis","score_opus":0.047260411543950734,"score_gpt":0.26756811840260314,"score_spread":0.22030770685865242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075627892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939423,0.0002478753,0.000012172547,0.00017959968,0.00005282359,0.00080242136,0.000022706234,0.00002990196,0.004710159],"genre_scores_gemma":[0.9974541,0.000008408963,0.00064100506,0.0010903397,0.000072263065,0.0000185987,0.00022274005,0.000045960092,0.00044655125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690104,0.0012371853,0.00055650546,0.0006062045,0.00027552116,0.00042354522],"domain_scores_gemma":[0.99887997,0.00009495866,0.00023005177,0.00053865905,0.00005302745,0.00020334448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059609953,0.00030667946,0.00048181185,0.00017003294,0.000073860625,0.000019281895,0.00017960869,0.00006927667,0.00006332466],"category_scores_gemma":[0.00004575532,0.00017210234,0.0000622405,0.0001592468,0.00020303934,0.00007415179,0.00008943597,0.0004949352,0.000019861172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052531743,0.00067132834,0.9864636,0.000024837462,0.00001627227,0.006485846,0.00056204566,0.000060165905,0.000035923687,0.000050524108,0.00012975866,0.00024653802],"study_design_scores_gemma":[0.007526892,0.003762225,0.9880027,0.000015246063,0.00013118285,0.00007695193,0.00004696366,0.000045372264,0.000026237629,0.000012969743,0.00016732278,0.00018590798],"about_ca_topic_score_codex":0.00024428352,"about_ca_topic_score_gemma":0.00019049467,"teacher_disagreement_score":0.006408894,"about_ca_system_score_codex":0.000049508988,"about_ca_system_score_gemma":0.000035779896,"threshold_uncertainty_score":0.701813},"labels":[],"label_agreement":null},{"id":"W2075849635","doi":"10.1016/j.eururo.2009.03.048","title":"Positive Surgical Margin Appears to Have Negligible Impact on Survival of Renal Cell Carcinomas Treated by Nephron-Sparing Surgery","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":271,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Proportional hazards model; Surgery; Retrospective cohort study; Renal cell carcinoma; Natural history; Surgical margin; Cohort; Cancer; Kidney cancer; Internal medicine; Kidney","score_opus":0.018482975515621097,"score_gpt":0.2562083614132526,"score_spread":0.2377253858976315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075849635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92275494,0.00046156917,0.0000247897,0.0007777423,0.00007861953,0.0004257964,0.00004354668,0.00007206802,0.07536093],"genre_scores_gemma":[0.99746335,0.000029939414,0.00004021132,0.0006201604,0.0001892535,0.0000036568867,0.00019353603,0.00006980368,0.0013900725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99700695,0.00076321216,0.00054454734,0.0006428497,0.00034484937,0.0006975858],"domain_scores_gemma":[0.9982608,0.0004281299,0.00017129003,0.0005575683,0.00009983656,0.00048238967],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004905348,0.000421521,0.00086919445,0.0003619779,0.00006118394,0.000016497339,0.00015483286,0.00010454118,0.00012434386],"category_scores_gemma":[0.000051005816,0.00033355533,0.0003674039,0.000280241,0.00009334942,0.000040895186,0.00007043294,0.00033527764,0.00028900465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032607038,0.0037427999,0.605265,0.0000881349,0.0007992476,0.032991804,0.0012359243,0.0020804312,0.25704518,0.00013435583,0.051309377,0.012700667],"study_design_scores_gemma":[0.0029075334,0.009113169,0.9164045,0.000053151092,0.00022540282,0.0003860758,0.000031000633,0.00008487455,0.06697557,0.0000063084067,0.0034540915,0.00035834816],"about_ca_topic_score_codex":0.00018437425,"about_ca_topic_score_gemma":0.0000041604817,"teacher_disagreement_score":0.31113943,"about_ca_system_score_codex":0.00019324786,"about_ca_system_score_gemma":0.00008322762,"threshold_uncertainty_score":0.99991167},"labels":[],"label_agreement":null},{"id":"W2075983453","doi":"10.1016/j.eururo.2014.01.034","title":"International Urology Journal Club via Twitter: 12-Month Experience","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":164,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen's University","funders":"","keywords":"Medicine; Journal club; Urology; Club; Medical education","score_opus":0.06730660964335718,"score_gpt":0.36868823728297473,"score_spread":0.30138162763961757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075983453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53158975,0.00014371662,0.0072285384,0.05440199,0.046736237,0.00042262737,0.0000010299059,0.00018129643,0.3592948],"genre_scores_gemma":[0.9841969,0.00011539241,0.00043776474,0.006722955,0.008214667,0.000033098964,0.0000037359916,0.000024374733,0.00025109536],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959834,0.002564583,0.0003546244,0.0002754578,0.00031862795,0.0005033124],"domain_scores_gemma":[0.99806607,0.001074862,0.00024762424,0.00018926835,0.00014979568,0.000272389],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021298367,0.00011071876,0.00015128567,0.00013457713,0.00058034743,0.00006288759,0.00072787044,0.000100250254,0.0010610076],"category_scores_gemma":[0.005086462,0.00011647646,0.000054485026,0.0001280855,0.00055044435,0.00016497693,0.00008397201,0.00041465022,0.00069988694],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023086224,0.0003223556,0.21553405,0.000008103988,0.00005920969,0.00010781577,0.35037562,0.00007298906,0.00057472603,0.019127337,0.028167997,0.38541892],"study_design_scores_gemma":[0.00023948224,0.00018785468,0.071468085,0.0000011353164,0.0000076480255,0.000033603934,0.00074274786,0.00008068812,0.00000374146,0.00090213394,0.92623043,0.0001024671],"about_ca_topic_score_codex":0.00026538447,"about_ca_topic_score_gemma":0.00018653533,"teacher_disagreement_score":0.8980624,"about_ca_system_score_codex":0.00010566615,"about_ca_system_score_gemma":0.000119851844,"threshold_uncertainty_score":0.9998522},"labels":[],"label_agreement":null},{"id":"W2076872027","doi":"10.1016/j.eururo.2013.07.031","title":"Survival Outcome and Treatment Response of Patients with Late Relapse from Renal Cell Carcinoma in the Era of Targeted Therapy","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Alberta; Queen Elizabeth II Health Sciences Centre; London Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre; University of Toronto; Western University; Sunnybrook Health Science Centre; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Internal medicine; Proportional hazards model; Exact test; Retrospective cohort study; Carcinoma; Oncology; Surgery; Urology; Kidney","score_opus":0.018819540177126618,"score_gpt":0.21995767785616618,"score_spread":0.20113813767903957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076872027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731773,0.00049508,0.0000014653173,0.00046716587,0.000037524555,0.0006570303,0.00002834107,0.0000088422785,0.0009868185],"genre_scores_gemma":[0.99934095,0.000031623324,0.00015615491,0.00022620388,0.000020201258,0.000012615845,0.000054526972,0.000030624422,0.00012711776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770164,0.001296217,0.00037422337,0.00025996324,0.00017761353,0.00019036407],"domain_scores_gemma":[0.99886805,0.0003799654,0.00017354774,0.00043951644,0.00007335462,0.00006555343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029706015,0.00018792285,0.00038937473,0.000082073384,0.00002101796,0.0000044589856,0.00010159913,0.000040614505,0.000103794424],"category_scores_gemma":[0.000032008447,0.00009880594,0.00005734806,0.000103548264,0.00014642136,0.000029576551,0.000031310778,0.00015428229,0.000023303111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0082010245,0.0005863197,0.976781,0.000005256615,0.000060539427,0.00019949212,0.0020095392,0.000011914774,0.0112370225,0.000002614718,0.000031567033,0.0008736731],"study_design_scores_gemma":[0.008361517,0.008286794,0.98003477,0.0000047013036,0.00007015764,0.00000441579,0.000058849117,0.000014299801,0.0028816129,0.000005304011,0.00020430109,0.00007329822],"about_ca_topic_score_codex":0.00054127554,"about_ca_topic_score_gemma":0.000020624422,"teacher_disagreement_score":0.00835541,"about_ca_system_score_codex":0.000032700962,"about_ca_system_score_gemma":0.00003183143,"threshold_uncertainty_score":0.40291893},"labels":[],"label_agreement":null},{"id":"W2077895617","doi":"10.1016/j.eururo.2011.06.034","title":"Evaluating the Value of Number of Cycles of Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; Ontario Clinical Oncology Group","funders":"National Cancer Institute","keywords":"Medicine; Docetaxel; Prostate cancer; Prednisone; Internal medicine; Confidence interval; Urology; Oncology; Cancer","score_opus":0.0831548646736861,"score_gpt":0.3774955184049625,"score_spread":0.2943406537312764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077895617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887422,0.001039119,0.0000054289285,0.00025142598,0.00000910195,0.00045261794,0.000021298718,0.0000038128337,0.009475011],"genre_scores_gemma":[0.99844646,0.00021286937,0.0009917696,0.000023149674,0.000007952227,0.000018023851,0.0000044206304,0.000015030613,0.00028033712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989147,0.0003416554,0.00028897423,0.00014292185,0.00016880286,0.00014290828],"domain_scores_gemma":[0.999429,0.00009041455,0.00017566573,0.00016182208,0.00011103287,0.000032104093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059293734,0.00008159271,0.00024182374,0.00005223859,0.00001930583,0.000001651156,0.000061979204,0.000011791474,0.00007616546],"category_scores_gemma":[0.00004999142,0.000044892207,0.000020036052,0.00012479983,0.00034099302,0.000030130133,0.000037775662,0.0000897862,0.0000012612488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017872872,0.0008208182,0.751903,0.0009748345,0.0009435356,0.00024464977,0.03298608,0.00031719447,0.18021475,0.0017205279,0.0000736178,0.011928127],"study_design_scores_gemma":[0.006064899,0.0032365732,0.9707841,0.00013114553,0.000333291,0.000047824928,0.0008361252,0.00072100747,0.017483672,0.00026208945,0.00002566601,0.000073588766],"about_ca_topic_score_codex":0.00058982766,"about_ca_topic_score_gemma":0.00007087882,"teacher_disagreement_score":0.21888112,"about_ca_system_score_codex":0.000011936934,"about_ca_system_score_gemma":0.0001248705,"threshold_uncertainty_score":0.1830651},"labels":[],"label_agreement":null},{"id":"W2077936479","doi":"10.1016/j.eururo.2013.03.059","title":"Photodynamic Diagnosis of Non–muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data","year":2013,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":450,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Cystoscopy; Bladder cancer; Carcinoma in situ; Confidence interval; Odds ratio; Urology; Relative risk; Meta-analysis; Carcinoma; Prospective cohort study; Cancer; Internal medicine; Surgery; Urinary system","score_opus":0.11765074424705113,"score_gpt":0.3583073433956708,"score_spread":0.24065659914861964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077936479","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013574001,0.9938762,0.00026622982,0.00007147532,0.00011599352,0.0017201202,0.001498072,0.000026058045,0.001068418],"genre_scores_gemma":[0.07401942,0.92433006,0.00016544183,0.000315423,0.00005434153,0.0003839929,0.0005217536,0.00010651421,0.00010305022],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9968039,0.000840688,0.00075215346,0.0010225895,0.00029652563,0.00028414713],"domain_scores_gemma":[0.99661314,0.0005687601,0.0009425955,0.0015664592,0.00017461836,0.00013443541],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034432262,0.0005641264,0.0038611894,0.00071724283,0.000043757853,0.000010560069,0.00039424654,0.00015724059,0.0006008014],"category_scores_gemma":[0.000106678875,0.0003607323,0.00063458324,0.0008154623,0.000269416,0.000058000966,0.00015514162,0.0003913505,0.000021734468],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039877545,0.00064118486,0.00033500197,0.008077653,0.22223106,0.00022556238,0.00013477099,0.00015393937,0.000050945822,0.0000018302477,0.00019160735,0.7675577],"study_design_scores_gemma":[0.001477236,0.003765653,0.0028392978,0.00097032945,0.91975814,0.000028209564,0.000008099067,0.00093503017,0.00010716685,8.8040986e-7,0.06968186,0.00042811886],"about_ca_topic_score_codex":0.00058396946,"about_ca_topic_score_gemma":0.00042823932,"teacher_disagreement_score":0.76712954,"about_ca_system_score_codex":0.000053935604,"about_ca_system_score_gemma":0.00030601877,"threshold_uncertainty_score":0.9998845},"labels":[],"label_agreement":null},{"id":"W2078191606","doi":"10.1159/000020162","title":"Risk Factors for Lower Urinary Tract Symptoms in Elderly Men","year":2000,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Merck Sharp and Dohme; Kaiser Permanente","keywords":"Medicine; Lower urinary tract symptoms; International Prostate Symptom Score; Body mass index; Quality of life (healthcare); Risk factor; Internal medicine; Urinary system; Urology; Medical history; Prostate; Renal function; Physical examination","score_opus":0.019596103191321924,"score_gpt":0.2894729638532748,"score_spread":0.2698768606619529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078191606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86042196,0.00031189775,0.000019533614,0.00057426037,0.00006297816,0.00044794256,0.000027399221,0.000058095382,0.13807593],"genre_scores_gemma":[0.98952174,0.0003154712,0.00005362724,0.00026034017,0.00016677819,0.000012294162,0.000053582688,0.000055361746,0.009560781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837947,0.00040078195,0.00025021576,0.00034974853,0.00012814361,0.00049162656],"domain_scores_gemma":[0.9991991,0.0002801544,0.0000331902,0.00030095837,0.000028309221,0.00015831349],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047986073,0.00015875266,0.00024391008,0.00015191505,0.00006939051,0.000011225866,0.00013797796,0.000065830456,0.0023879753],"category_scores_gemma":[0.00008368703,0.00013114724,0.00010021201,0.0001322157,0.00009055695,0.0000617268,0.000031567553,0.00041364363,0.00054133777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016622812,0.008124204,0.5514758,0.00020013905,0.00048978475,0.014779855,0.007956321,0.00027029458,0.0011962127,0.00013015745,0.021553686,0.3772007],"study_design_scores_gemma":[0.0037248707,0.019133668,0.69073683,0.00000912287,0.000067303874,0.0005397846,0.000069918424,0.00028764858,0.000049752914,0.00012925001,0.2850538,0.00019805782],"about_ca_topic_score_codex":0.000034671102,"about_ca_topic_score_gemma":0.0000014151132,"teacher_disagreement_score":0.37700263,"about_ca_system_score_codex":0.000023324556,"about_ca_system_score_gemma":0.00004072751,"threshold_uncertainty_score":0.99852395},"labels":[],"label_agreement":null},{"id":"W2078543659","doi":"10.1016/j.eururo.2012.01.055","title":"To Biopsy or Not to Biopsy—Thou Shall Think Twice","year":2012,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Sunnybrook Health Science Centre; Health Sciences Centre; Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Biopsy; Prostate cancer; Rectal examination; Population; Incidence (geometry); Prostate; Prostate biopsy; Cancer; Surgery; Internal medicine","score_opus":0.04377876225718281,"score_gpt":0.2997819299378592,"score_spread":0.2560031676806764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078543659","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026499916,0.0008370401,0.00007941134,0.94321567,0.0025865615,0.0015548187,0.0003368541,0.00030476236,0.024584945],"genre_scores_gemma":[0.023395615,0.00010923199,0.0014239652,0.9509491,0.009625145,0.000095850985,0.0005176989,0.00030915916,0.013574261],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965886,0.00032451042,0.0005421483,0.0010727856,0.0003573261,0.0011146511],"domain_scores_gemma":[0.9976646,0.0002385765,0.00017949351,0.0012367239,0.0001332221,0.0005474275],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00039768722,0.00065579725,0.0008952725,0.00038420525,0.00008666592,0.000041864285,0.00045682283,0.00039565188,0.0014965889],"category_scores_gemma":[0.00019765233,0.00047923744,0.00021598072,0.00030267672,0.00008817889,0.00004508673,0.0004145608,0.0012451548,0.015790116],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009098315,0.00017192803,0.0008730253,0.00011595851,0.00031475176,0.019267188,0.00081445,0.0000014307457,0.00048043806,0.000024037097,0.9728634,0.004163568],"study_design_scores_gemma":[0.0010627891,0.0027884764,0.025979986,0.00008812886,0.00052414875,0.0014799009,0.000009511295,7.2127034e-7,0.00016304677,0.000004628225,0.96744144,0.0004572192],"about_ca_topic_score_codex":0.00005961634,"about_ca_topic_score_gemma":0.000005424799,"teacher_disagreement_score":0.02510696,"about_ca_system_score_codex":0.00020135955,"about_ca_system_score_gemma":0.00011813297,"threshold_uncertainty_score":0.99976593},"labels":[],"label_agreement":null},{"id":"W2078703793","doi":"10.1016/j.eururo.2015.04.005","title":"A Brief Survey of Active Surveillance","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Overdiagnosis; Prostate cancer; Incidence (geometry); Prostate-specific antigen; Watchful waiting; Prostate cancer screening; Risk stratification; Erectile dysfunction; Prostate; Gynecology; Urinary system; Cancer; Internal medicine; Intensive care medicine","score_opus":0.044555828133994044,"score_gpt":0.28084552367599,"score_spread":0.23628969554199597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078703793","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038145334,0.007118592,0.000025871619,0.7559015,0.0019419058,0.0014586906,0.003296085,0.00018106388,0.19193093],"genre_scores_gemma":[0.31600544,0.0005789521,0.000041702708,0.67494226,0.0017746231,0.000023004988,0.004341094,0.00017842812,0.0021145234],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974394,0.0011493398,0.00034892446,0.00048280423,0.0002374504,0.0003420791],"domain_scores_gemma":[0.9983475,0.0003445754,0.00030476818,0.0006062984,0.00030507214,0.00009177954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047736694,0.00027938024,0.00078094465,0.000109086825,0.000017278486,0.000005744472,0.00016465121,0.00022176559,0.00012908083],"category_scores_gemma":[0.0003774027,0.00023334718,0.00010763631,0.0001356055,0.00018300752,0.00001696846,0.0001059673,0.00083261315,0.0001839922],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031188264,0.000086129345,0.02523898,0.000069536116,0.00033357806,0.002725982,0.000082569655,9.74868e-7,0.0000122051315,0.0000019596666,0.9664338,0.0047023892],"study_design_scores_gemma":[0.0010744667,0.0010759799,0.3688855,0.000018215516,0.00007529942,0.000077879806,9.868652e-7,0.0000011788402,0.000040766186,0.0000056342456,0.62862957,0.00011451881],"about_ca_topic_score_codex":0.00047266603,"about_ca_topic_score_gemma":0.000054572974,"teacher_disagreement_score":0.34364653,"about_ca_system_score_codex":0.00007268399,"about_ca_system_score_gemma":0.00024705753,"threshold_uncertainty_score":0.9515622},"labels":[],"label_agreement":null},{"id":"W2078843021","doi":"10.1016/j.eururo.2006.02.034","title":"Tumor Size Improves the Accuracy of TNM Predictions in Patients with Renal Cancer","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Multivariate analysis; Univariate; Nephrectomy; Multivariate statistics; Renal cell carcinoma; Cancer; Internal medicine; Oncology; Renal tumor; Kidney cancer; Univariate analysis; Urology; Kidney; Statistics","score_opus":0.007029511871624475,"score_gpt":0.21556016880366738,"score_spread":0.2085306569320429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078843021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851997,0.00021429153,0.000010983537,0.0007610213,0.00006853718,0.0003641266,0.000014064529,0.000021479947,0.0133458115],"genre_scores_gemma":[0.9988539,0.000005659863,0.00006432471,0.0004184269,0.00012195176,0.000017679757,0.000015303396,0.000024296223,0.00047841735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911004,0.00015862778,0.00023119258,0.00018504042,0.00013427039,0.00018080465],"domain_scores_gemma":[0.99933684,0.00016712773,0.00012459958,0.00026885924,0.00006736158,0.000035233796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010206912,0.00010746899,0.00016682583,0.0000497804,0.000032608154,0.0000035786152,0.000085054526,0.000015816771,0.000078096666],"category_scores_gemma":[0.00009031379,0.000060181566,0.000037531205,0.00012851109,0.00013364661,0.000027772528,0.00003960472,0.00015116569,0.000017599094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014613481,0.00061208016,0.9890658,0.000023581722,0.00008810937,0.0001999068,0.00020070946,0.0005099957,0.00362444,0.000090061665,0.0022352054,0.0018887606],"study_design_scores_gemma":[0.0024218757,0.0012578403,0.9919931,0.000012859405,0.000097426375,0.000017018232,0.0000077144805,0.000033093984,0.0005226434,0.000011765726,0.0035765283,0.000048122944],"about_ca_topic_score_codex":0.0002841857,"about_ca_topic_score_gemma":0.000100700905,"teacher_disagreement_score":0.013654256,"about_ca_system_score_codex":0.000040811283,"about_ca_system_score_gemma":0.000053802352,"threshold_uncertainty_score":0.2454133},"labels":[],"label_agreement":null},{"id":"W2080849036","doi":"10.1016/j.eururo.2015.01.007","title":"Active Surveillance for Prostate Cancer: Debate over the Application, Not the Concept","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Gynecology; Cancer; Internal medicine","score_opus":0.022442451219351636,"score_gpt":0.28571553870025856,"score_spread":0.26327308748090694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080849036","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018392616,0.0055291443,0.00009357195,0.98275554,0.0006888582,0.0037674878,0.0015418283,0.00008569231,0.0036985993],"genre_scores_gemma":[0.07501172,0.0011399252,0.000016737027,0.9111793,0.005127081,0.002016203,0.0012666791,0.00016127955,0.0040810914],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978853,0.00047228823,0.00031878788,0.00060312724,0.00023830883,0.0004822272],"domain_scores_gemma":[0.9978449,0.0005782435,0.00036684633,0.00084376597,0.00029826592,0.000068012254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004213987,0.00035051463,0.00046346488,0.0000360133,0.0001789261,0.000031411517,0.00037236226,0.00015191371,0.000058432233],"category_scores_gemma":[0.000088730274,0.000179798,0.00015756997,0.000105956184,0.00039144742,0.000022146272,0.00010465478,0.0008568108,0.00010731322],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031616297,0.000028582746,0.0008352845,0.000030210247,0.0003532551,0.00009869408,0.0006343177,0.00002129359,0.000010603582,0.000059773465,0.98064226,0.016969545],"study_design_scores_gemma":[0.0017074739,0.0005363889,0.0130348485,0.000014483245,0.00026898115,0.000041681546,0.000016681437,0.000036196194,0.000073261566,0.000083094565,0.9840073,0.00017963584],"about_ca_topic_score_codex":0.00016781087,"about_ca_topic_score_gemma":0.000052648917,"teacher_disagreement_score":0.07317246,"about_ca_system_score_codex":0.0001875331,"about_ca_system_score_gemma":0.0002689762,"threshold_uncertainty_score":0.73319495},"labels":[],"label_agreement":null},{"id":"W2080928007","doi":"10.1016/j.eururo.2013.09.025","title":"Predicting Survival of Patients with Node-positive Prostate Cancer Following Multimodal Treatment","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Nomogram; Prostatectomy; Prostate cancer; Lymph node; Stage (stratigraphy); Adjuvant therapy; Proportional hazards model; Radiation therapy; Oncology; Biochemical recurrence; Internal medicine; Population; Cancer; Surgical margin; Cohort; Hormonal therapy; Urology","score_opus":0.009149752220555692,"score_gpt":0.23807736374030908,"score_spread":0.22892761151975338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080928007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99443394,0.00032048477,0.000012629804,0.00056517095,0.00020844303,0.0010544679,0.00009268983,0.000045274526,0.0032669024],"genre_scores_gemma":[0.9988389,0.00008194969,0.00023287602,0.0002881837,0.00007272662,0.00013767935,0.00011514384,0.00004956078,0.0001829722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988297,0.00013708245,0.0002461641,0.0003248206,0.00015844271,0.00030374588],"domain_scores_gemma":[0.99931115,0.000078451274,0.0001368762,0.00020969313,0.00014015925,0.00012364419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000664237,0.00019951667,0.00034626506,0.0000563135,0.000058371097,0.000009241644,0.000049991824,0.00002719221,0.00010492749],"category_scores_gemma":[0.000019966643,0.00013183671,0.0000888948,0.00008201285,0.000071171904,0.00007366637,0.000038640865,0.000081120575,0.00004665485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038542945,0.0005881824,0.98272175,0.000015346162,0.0005080343,0.00008962038,0.001247727,0.0000881732,0.00017600799,0.000004696103,0.00004871407,0.014126341],"study_design_scores_gemma":[0.0066091963,0.003994578,0.9875161,0.00005263455,0.0003160113,0.0000021452458,0.000050117185,0.0001247464,0.00076982315,0.0000024592762,0.00045407383,0.00010808932],"about_ca_topic_score_codex":0.0006856321,"about_ca_topic_score_gemma":0.00003945459,"teacher_disagreement_score":0.014018252,"about_ca_system_score_codex":0.00012817567,"about_ca_system_score_gemma":0.000059515125,"threshold_uncertainty_score":0.5376145},"labels":[],"label_agreement":null},{"id":"W2081011440","doi":"10.1016/j.eururo.2014.12.001","title":"Corrigendum to “Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study” [Eur Urol 2014;66:489–99]","year":2014,"lang":"en","type":"erratum","venue":"European Urology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Gynecology; Prostate; Oncology; Prostate cancer; Cancer; Internal medicine; Urology","score_opus":0.22472055274744476,"score_gpt":0.4026001681863392,"score_spread":0.17787961543889444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081011440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.864545,0.015660975,0.002296411,0.04172989,0.035223387,0.0089286305,0.017093848,0.00015820109,0.014363686],"genre_scores_gemma":[0.9800729,0.00021612854,0.00023620352,0.010499108,0.0031102358,0.00011994703,0.00071211054,0.00021699564,0.0048163855],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.98794997,0.004831327,0.0048532677,0.0013887443,0.00021727817,0.0007594282],"domain_scores_gemma":[0.9922824,0.0013589219,0.004683555,0.0012825032,0.00015817102,0.00023445439],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.017788965,0.0005590408,0.0016408613,0.00048757624,0.00038374393,0.00017198929,0.0010317728,0.00032240528,0.00016066829],"category_scores_gemma":[0.0071270205,0.0004915076,0.00020650108,0.0003919058,0.00022922765,0.00026241332,0.00044343586,0.0013658433,0.0002216549],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064589694,0.0001077081,0.10652881,0.00008378188,0.00056534325,0.000023603945,0.028829638,0.0063321698,0.0000034512193,0.00014050986,0.85524625,0.0014928586],"study_design_scores_gemma":[0.003358045,0.0006512881,0.7951189,0.00019161508,0.00006925016,0.0000104574165,0.0020168098,0.00685173,9.0410225e-7,0.0003091726,0.19080397,0.0006178485],"about_ca_topic_score_codex":0.033360735,"about_ca_topic_score_gemma":0.0084128,"teacher_disagreement_score":0.6885901,"about_ca_system_score_codex":0.00025807566,"about_ca_system_score_gemma":0.0003735743,"threshold_uncertainty_score":0.99975365},"labels":[],"label_agreement":null},{"id":"W2081597080","doi":"10.1016/j.eururo.2009.09.035","title":"The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":788,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Tamsulosin; Dutasteride; Tolerability; Urology; Combination therapy; Lower urinary tract symptoms; Prostate; International Prostate Symptom Score; Urinary retention; Hyperplasia; Benign prostatic hyperplasia (BPH); Prostate-specific antigen; Internal medicine; Adverse effect; Cancer","score_opus":0.01997649446066495,"score_gpt":0.3126527257230526,"score_spread":0.2926762312623876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081597080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905919,0.0001231783,0.0000027778274,0.0049511967,0.000026462445,0.001828796,0.0000061116557,0.000019128865,0.002450446],"genre_scores_gemma":[0.9989624,0.00018179843,0.000032438424,0.00060410926,0.00002213081,0.0000128625725,0.000012698235,0.000021740243,0.00014982381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99683714,0.00198635,0.0003953805,0.00028615468,0.00027779158,0.0002171934],"domain_scores_gemma":[0.9955932,0.0037407638,0.00012732243,0.0004279224,0.000050480226,0.000060341852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012599374,0.00015298513,0.00034658465,0.00005354625,0.00009712734,0.000024397883,0.00014986476,0.000027572878,0.0000020734449],"category_scores_gemma":[0.00036571207,0.00006525192,0.000024372051,0.00013209916,0.00025218268,0.000032787473,0.000037299058,0.00036709543,0.000008801072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020879738,0.002454469,0.958147,0.000018922552,0.00030414434,0.0005944516,0.0051220185,0.0000050428525,0.00015393796,0.00015378336,0.00026304516,0.011903446],"study_design_scores_gemma":[0.016574359,0.056332212,0.9261267,0.00004903155,0.00005479767,0.000025658836,0.00047981797,0.00006199573,0.00003582298,0.000079846264,0.000116120886,0.00006364388],"about_ca_topic_score_codex":0.000035851044,"about_ca_topic_score_gemma":0.000035869478,"teacher_disagreement_score":0.053877745,"about_ca_system_score_codex":0.000009692456,"about_ca_system_score_gemma":0.000035826786,"threshold_uncertainty_score":0.26608962},"labels":[],"label_agreement":null},{"id":"W2081830150","doi":"10.1016/j.eururo.2012.06.004","title":"Image-Guided Prostate Biopsy Using Magnetic Resonance Imaging–Derived Targets: A Systematic Review","year":2012,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":537,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Institute for Health and Care Research","keywords":"Medicine; Biopsy; Prostate cancer; Magnetic resonance imaging; Prostate biopsy; Prostate; Radiology; Cancer; Gold standard (test); Population; Internal medicine","score_opus":0.05123164031093032,"score_gpt":0.32635406671542344,"score_spread":0.27512242640449314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081830150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000029377416,0.9901826,0.000018992769,0.00033925063,0.0004532951,0.006838662,0.00016140801,0.00015684021,0.0018460402],"genre_scores_gemma":[0.000006303351,0.9941925,0.0013933657,0.0023094905,0.00030222948,0.0005896126,0.00035842918,0.00031617872,0.0005319262],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99404573,0.001931077,0.001846966,0.00095220865,0.00029737508,0.0009266569],"domain_scores_gemma":[0.9967897,0.00018393983,0.0010728927,0.0013860149,0.00020816927,0.00035931752],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010760791,0.00094917783,0.0046391464,0.0002337971,0.00011137267,0.000043334352,0.0003626413,0.000108027336,0.0002982321],"category_scores_gemma":[0.00037199815,0.00067149755,0.0007551633,0.0004159455,0.00024735613,0.000099721394,0.0002725975,0.00054890383,0.0017771068],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000132905725,0.00018959328,0.000027003092,0.89333826,0.00020776148,0.0026493396,0.000055792465,2.1579496e-8,0.000006324346,0.000010402619,0.002275744,0.101226486],"study_design_scores_gemma":[0.00056189013,0.00022413612,0.00002680006,0.3218681,0.015519862,0.0049806223,0.0000026178993,0.0000074161308,5.966712e-7,0.0000020151822,0.656384,0.0004219299],"about_ca_topic_score_codex":0.0000106488815,"about_ca_topic_score_gemma":3.043775e-7,"teacher_disagreement_score":0.6541083,"about_ca_system_score_codex":0.00034741728,"about_ca_system_score_gemma":0.0002905474,"threshold_uncertainty_score":0.99957365},"labels":[],"label_agreement":null},{"id":"W2082805725","doi":"10.1016/j.eururo.2012.11.025","title":"Cost Effectiveness of Treatment Options for Early Prostate Cancer: Can We Put the Puzzle Pieces Together?","year":2012,"lang":"en","type":"letter","venue":"European Urology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Prostate cancer; Cost effectiveness; Prostate; Oncology; Intensive care medicine; Urology; Internal medicine; Cancer; Risk analysis (engineering)","score_opus":0.3186672580451469,"score_gpt":0.40751884644451336,"score_spread":0.08885158839936647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082805725","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015830075,0.014697322,0.0008254911,0.9482598,0.0031256576,0.0052617122,0.008428513,0.00007254105,0.0034988965],"genre_scores_gemma":[0.25296405,0.006445235,0.00080291706,0.697863,0.017575871,0.007293559,0.002243776,0.00075980043,0.01405178],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99307626,0.0029901,0.0024127301,0.00072507234,0.000062990344,0.00073286385],"domain_scores_gemma":[0.99316996,0.0031397492,0.0026302827,0.0008579804,0.00009925941,0.000102764105],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010429676,0.00040157838,0.0013863633,0.0002817115,0.0002952729,0.000055816796,0.0005763073,0.00030562456,0.00019200043],"category_scores_gemma":[0.0005617523,0.00037073894,0.00030066588,0.00012008422,0.00021463248,0.00012247065,0.00008133873,0.0005002429,0.0009038985],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022591681,0.00026114722,0.04336519,0.0026412671,0.0016130864,0.000015042928,0.010861988,0.0016528408,0.0000061447167,0.009908234,0.9262362,0.0032129139],"study_design_scores_gemma":[0.0009261674,0.00047476744,0.010343367,0.000055518478,0.00007529464,0.0000071488207,0.000051896615,0.000092322865,0.00000393222,0.001017893,0.98663586,0.00031581792],"about_ca_topic_score_codex":0.002121686,"about_ca_topic_score_gemma":0.00041176434,"teacher_disagreement_score":0.2503968,"about_ca_system_score_codex":0.00074120454,"about_ca_system_score_gemma":0.00019773375,"threshold_uncertainty_score":0.9998745},"labels":[],"label_agreement":null},{"id":"W2082922220","doi":"10.1016/j.eururo.2012.01.006","title":"Reply to Maximilian Burger, Wolfgang Otto, and Arndt Hartmann's Letter to the Editor re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage. Eur Urol 2012;61:378–84","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Hyperfractionation; Hazard ratio; Cumulative incidence; Confidence interval; Nuclear medicine; Urology; Surgery; Radiation therapy; Internal medicine; Dose fractionation; Transplantation","score_opus":0.014764921136303752,"score_gpt":0.2612066068535865,"score_spread":0.24644168571728273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082922220","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3926452,0.010348163,0.0017395113,0.564549,0.009521995,0.006859913,0.00037838897,0.0006670397,0.013290757],"genre_scores_gemma":[0.769118,0.00012734965,0.0003109051,0.21174543,0.008617728,0.00019901199,0.00003536499,0.0002508295,0.009595351],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959581,0.0007598877,0.00057631737,0.0010756865,0.00044673996,0.0011832805],"domain_scores_gemma":[0.99711096,0.0002425191,0.00015597047,0.0009976588,0.00014044261,0.0013524588],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008850951,0.00063169864,0.0006594469,0.00023401435,0.00028777364,0.0001465081,0.0003385591,0.00010764977,0.00043588996],"category_scores_gemma":[0.00024997775,0.00044011482,0.00010831205,0.00036811086,0.00013973845,0.00024038041,0.00035987148,0.0004990009,0.00089839275],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010563248,0.00015374989,0.022654295,0.000059857735,0.0003776569,0.00028369576,0.0055455137,0.000030977848,0.0011682482,0.00008580934,0.96054995,0.008033918],"study_design_scores_gemma":[0.0017783082,0.0009972722,0.10181353,0.000103046186,0.0004990978,0.00015023988,0.0001841999,0.000013004297,0.00022496714,0.000005313575,0.8938075,0.00042356344],"about_ca_topic_score_codex":0.00068531575,"about_ca_topic_score_gemma":0.00039016487,"teacher_disagreement_score":0.37647283,"about_ca_system_score_codex":0.000101835525,"about_ca_system_score_gemma":0.00012862064,"threshold_uncertainty_score":0.99987954},"labels":[],"label_agreement":null},{"id":"W2084061419","doi":"10.1016/s0302-2838(02)00053-2","title":"Assessment of Clinical Reasoning Competence in Urology with the Script Concordance Test: an Exploratory Study Across Two Sites from Different Countries","year":2002,"lang":"en","type":"article","venue":"European Urology","topic":"Clinical Reasoning and Diagnostic Skills","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Université de Montréal","funders":"McGill University","keywords":"Concordance; Cronbach's alpha; Medicine; Competence (human resources); Test (biology); Urology; Significant difference; Internal medicine; Clinical psychology; Psychometrics; Psychology; Social psychology","score_opus":0.06177579569147867,"score_gpt":0.3867001813956141,"score_spread":0.3249243857041354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084061419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955992,0.0005438664,0.00017372041,0.0013643196,0.00023998019,0.0004156495,0.000029882165,0.00006245307,0.0015709109],"genre_scores_gemma":[0.9949452,0.00011661919,0.00027703386,0.004228508,0.0002916084,0.000020499781,0.00002197104,0.0000404912,0.00005804709],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99564844,0.0020350842,0.00092203857,0.0006570435,0.0003090222,0.00042838117],"domain_scores_gemma":[0.97871614,0.01975074,0.0003969394,0.0007943914,0.00014231874,0.00019945584],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0019271037,0.00024918263,0.00088023423,0.00004232002,0.00010063907,0.000023507058,0.0003553602,0.00006983899,0.00016664308],"category_scores_gemma":[0.0112066595,0.0001544871,0.00007629158,0.00014341103,0.0009933464,0.000060322855,0.0001936273,0.00081027555,0.000049808164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031453895,0.0022215273,0.9926072,0.0000035263154,0.00006758892,0.00076624274,0.0022129312,0.000075658645,0.000073104435,0.00011784165,0.00028970098,0.0012501357],"study_design_scores_gemma":[0.0057456386,0.008749871,0.9802637,0.00008023161,0.00014066359,0.000032946908,0.0013512657,0.002649249,0.0000068842896,0.000015857388,0.0008183074,0.00014536726],"about_ca_topic_score_codex":0.00008368436,"about_ca_topic_score_gemma":0.0012022783,"teacher_disagreement_score":0.017715657,"about_ca_system_score_codex":0.000019901594,"about_ca_system_score_gemma":0.000058959413,"threshold_uncertainty_score":0.99712235},"labels":[],"label_agreement":null},{"id":"W2084990199","doi":"10.1016/j.eururo.2003.11.005","title":"Spermatocytic Seminoma: A Review","year":2003,"lang":"en","type":"review","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Seminoma; Urology; Radiology; Gynecology; General surgery; Surgery; Chemotherapy","score_opus":0.05686903846565462,"score_gpt":0.35949662944306715,"score_spread":0.30262759097741254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084990199","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.956797e-7,0.95239943,0.0000052876317,0.000075335505,0.00017212742,0.0011091434,0.00002859667,0.000086461536,0.046123244],"genre_scores_gemma":[0.000003469035,0.99357575,0.00010568607,0.003433768,0.00014750806,0.000037839563,0.0003661754,0.0001326266,0.002197191],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978456,0.00068946084,0.00053463626,0.0004818343,0.00012896546,0.00031950985],"domain_scores_gemma":[0.998613,0.00007621995,0.00026340742,0.0007509252,0.000034339206,0.00026213625],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016080234,0.00042948543,0.0018465994,0.00009425232,0.000035062232,0.000007647198,0.00014644393,0.00009319351,0.0008980864],"category_scores_gemma":[0.00020505318,0.0003032496,0.00074032973,0.00018791718,0.000062778534,0.000013130631,0.00007465696,0.0003215508,0.008331215],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000035962955,0.00018825087,0.000020035654,0.061308447,0.00044866707,0.009095907,0.0000021963524,9.901435e-9,1.0117547e-8,0.00009526045,0.026428822,0.9024088],"study_design_scores_gemma":[0.0003808213,0.00018807192,0.00005201785,0.016428076,0.011633741,0.007867117,1.6510837e-7,1.7666139e-7,4.503997e-9,0.0000033403196,0.963254,0.00019247096],"about_ca_topic_score_codex":8.020537e-7,"about_ca_topic_score_gemma":6.556583e-8,"teacher_disagreement_score":0.93682516,"about_ca_system_score_codex":0.00006872624,"about_ca_system_score_gemma":0.00023820055,"threshold_uncertainty_score":0.99994195},"labels":[],"label_agreement":null},{"id":"W2085308874","doi":"10.1016/j.eururo.2014.02.015","title":"Comparative Effectiveness of Robot-assisted Versus Open Radical Prostatectomy Cancer Control","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Androgen deprivation therapy; Odds ratio; Retrospective cohort study; Confidence interval; Urology; Surgical margin; Population; Surveillance, Epidemiology, and End Results; Hazard ratio; Cancer; Surgery; Internal medicine; Gynecology; Cancer registry","score_opus":0.041346536597648455,"score_gpt":0.34059813196417643,"score_spread":0.29925159536652796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085308874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94184506,0.0011681495,0.0010327125,0.0011870746,0.0006285636,0.0022879222,0.00006195665,0.00006743172,0.05172112],"genre_scores_gemma":[0.99895096,0.000051555253,0.00012812835,0.0004972896,0.00008646257,0.00016589047,0.000038936876,0.00002843762,0.000052332387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977983,0.0012302755,0.00025841047,0.0003507067,0.00011412851,0.00024817747],"domain_scores_gemma":[0.9986752,0.0006480437,0.00014458274,0.00028216324,0.00011354173,0.0001364712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005727099,0.0001712211,0.000698624,0.000054177475,0.000050851268,0.000013689663,0.0001790579,0.00003899831,0.00013435741],"category_scores_gemma":[0.00009290353,0.00013136605,0.00007560106,0.00011287456,0.0002310679,0.000044249195,0.00010217685,0.0001532216,0.00006277477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20141275,0.00893926,0.4743487,0.0016902932,0.0104613695,0.0016505334,0.0025403937,0.0037904067,0.0996035,0.018012315,0.009252346,0.16829816],"study_design_scores_gemma":[0.034974948,0.0061683734,0.9281197,0.00011239402,0.00042486005,0.0000231335,0.000011537978,0.00023168282,0.007030739,0.0000404885,0.022708533,0.00015360345],"about_ca_topic_score_codex":0.00008556074,"about_ca_topic_score_gemma":0.000015012876,"teacher_disagreement_score":0.45377102,"about_ca_system_score_codex":0.000085943655,"about_ca_system_score_gemma":0.00009809789,"threshold_uncertainty_score":0.5356952},"labels":[],"label_agreement":null},{"id":"W2085370706","doi":"10.1016/j.eururo.2013.03.006","title":"Survival Following Biochemical Recurrence After Radical Prostatectomy and Adjuvant Radiotherapy in Patients With Prostate Cancer: The Impact of Competing Causes of Mortality and Patient Stratification","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Nomogram; Prostatectomy; Biochemical recurrence; Prostate cancer; Radiation therapy; Urology; Proportional hazards model; Lymph node; Internal medicine; Cancer; Oncology; Surgery","score_opus":0.012061659936978558,"score_gpt":0.27370745380683525,"score_spread":0.2616457938698567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085370706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630016,0.002440494,0.0000024492997,0.00019642015,0.00003164808,0.0009623891,0.000031782143,0.0000060942916,0.00002855437],"genre_scores_gemma":[0.9993781,0.00039199743,0.00006646349,0.000047148238,0.000009392144,0.00007394799,0.000018297294,0.000014103293,5.6866594e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902445,0.00019034055,0.0002849995,0.00022493565,0.000118106014,0.00015714297],"domain_scores_gemma":[0.9994876,0.000078050165,0.0001498109,0.00015495079,0.00006669723,0.00006293508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013602884,0.00012356685,0.00027186918,0.000036606147,0.000019732011,0.000008245484,0.000033784945,0.000020647281,0.0000135227265],"category_scores_gemma":[0.000028535202,0.00006864924,0.000032097843,0.00008481789,0.0002389576,0.000047199148,0.000026059288,0.00010213374,2.5742654e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006453069,0.00023125231,0.98887414,0.000034730867,0.000118838616,0.000009827543,0.0012464978,0.000011381811,0.0011059542,0.0000032547227,0.000013130658,0.0077056815],"study_design_scores_gemma":[0.0022913152,0.00189064,0.99466014,0.00009731826,0.000045375495,0.0000018253077,0.00004855276,0.0000638694,0.0008166927,0.000007995164,0.000012750663,0.00006350316],"about_ca_topic_score_codex":0.00047948028,"about_ca_topic_score_gemma":0.000017105129,"teacher_disagreement_score":0.0076421783,"about_ca_system_score_codex":0.000040207065,"about_ca_system_score_gemma":0.00004930692,"threshold_uncertainty_score":0.2799435},"labels":[],"label_agreement":null},{"id":"W2085420626","doi":"10.1016/j.eururo.2008.01.004","title":"Nomograms for Bladder Cancer","year":2008,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Generalizability theory; Bladder cancer; Clinical trial; Predictive modelling; MEDLINE; Clinical study design; Medical physics; Intensive care medicine; Cancer; Oncology; Machine learning; Internal medicine; Statistics; Computer science","score_opus":0.08507779769368708,"score_gpt":0.3759497747433012,"score_spread":0.29087197704961415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085420626","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000013686783,0.96519744,0.00007809267,0.00016554617,0.0007987312,0.0015216318,0.00019046136,0.00011717263,0.031929567],"genre_scores_gemma":[0.000009669412,0.9879075,0.00018030862,0.0016007703,0.0018695602,0.0003549173,0.00033875485,0.00024107737,0.0074974247],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99814314,0.00022074052,0.00046299794,0.00059888995,0.00011832831,0.00045591898],"domain_scores_gemma":[0.9989459,0.00011508573,0.00019886633,0.0004913417,0.000068479494,0.00018031285],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008140876,0.00046666965,0.0015468935,0.00014319835,0.000089041314,0.00000934027,0.00019925891,0.0001956903,0.00044090292],"category_scores_gemma":[0.000041592553,0.00034363102,0.000752595,0.00014727635,0.0001265204,0.00001829113,0.00006541614,0.00035289486,0.00073205156],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054529068,0.00010636346,0.000012472323,0.0017085935,0.0008523959,0.00031647307,0.000039462248,1.5293442e-7,1.3255125e-7,0.000022142085,0.03452644,0.96236086],"study_design_scores_gemma":[0.001171785,0.00073386345,0.000034757817,0.000523525,0.0027420355,0.00089079275,0.0000010395669,8.366384e-7,2.4774835e-7,0.000005362079,0.99364513,0.00025061917],"about_ca_topic_score_codex":0.000021322896,"about_ca_topic_score_gemma":0.000005663835,"teacher_disagreement_score":0.9621102,"about_ca_system_score_codex":0.000081940525,"about_ca_system_score_gemma":0.00038036847,"threshold_uncertainty_score":0.9999016},"labels":[],"label_agreement":null},{"id":"W2085714273","doi":"10.1016/j.eururo.2004.12.015","title":"Insulin-Like Growth Factor Binding Protein 2: An Androgen-Dependent Predictor of Prostate Cancer Survival","year":2005,"lang":"en","type":"article","venue":"European Urology","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; Urology; Internal medicine; Insulin-like growth factor-binding protein; Oncology; Stage (stratigraphy); Prostate-specific antigen; Proportional hazards model; Prostate; Multivariate analysis; Cancer; Gynecology; Insulin-like growth factor; Growth factor","score_opus":0.026341853579182898,"score_gpt":0.2617992558007724,"score_spread":0.2354574022215895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085714273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911085,0.00070539647,0.000038016795,0.0007934699,0.00051258894,0.0009321382,0.00021058899,0.00021702815,0.0054822667],"genre_scores_gemma":[0.9965993,0.00025220806,0.00028229918,0.00056417676,0.0006686879,0.000033573797,0.000095679694,0.0001360382,0.001367993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99681103,0.00052218064,0.0008111866,0.0006818812,0.00048300606,0.0006907061],"domain_scores_gemma":[0.99836075,0.00005495071,0.00033284348,0.0005417847,0.00026275683,0.00044689584],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000516637,0.00040184232,0.0006356656,0.0003324706,0.00011028675,0.000022018648,0.0003338551,0.00015739685,0.00038694163],"category_scores_gemma":[0.00018059736,0.0003481668,0.00014799292,0.00031204373,0.00021586931,0.00028756945,0.00016531632,0.0005484152,0.00023469463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040500285,0.0019376632,0.48284236,0.00037514596,0.00070376013,0.00073084846,0.005468077,0.00003612223,0.48077554,0.0007591878,0.0011278222,0.021193445],"study_design_scores_gemma":[0.020068772,0.011665633,0.7128856,0.00018926649,0.00067245436,0.00043610102,0.00043515675,0.0005101967,0.18394203,0.00009639165,0.06730458,0.0017937735],"about_ca_topic_score_codex":0.00007604798,"about_ca_topic_score_gemma":0.000029053073,"teacher_disagreement_score":0.29683352,"about_ca_system_score_codex":0.0000930837,"about_ca_system_score_gemma":0.00018383618,"threshold_uncertainty_score":0.99989706},"labels":[],"label_agreement":null},{"id":"W2085849248","doi":"10.1016/j.eururo.2012.04.022","title":"Comparison of Three Different Tools for Prediction of Seminal Vesicle Invasion at Radical Prostatectomy","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"National Cancer Institute","keywords":"Brier score; Nomogram; Prostatectomy; Medicine; Receiver operating characteristic; Prostate cancer; Statistics; Urology; Oncology; Internal medicine; Cancer; Mathematics","score_opus":0.07771387704735205,"score_gpt":0.3134551053098417,"score_spread":0.23574122826248967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085849248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960533,0.001137966,0.00049881736,0.00027042377,0.00019367442,0.00068502966,0.00010275701,0.000023482375,0.0010345972],"genre_scores_gemma":[0.99920326,0.00006279594,0.00024091496,0.0000912141,0.00014374581,0.00004068669,0.00016146476,0.000021946082,0.000033985285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907416,0.000082479964,0.00034588823,0.00015657523,0.000119385695,0.00022152525],"domain_scores_gemma":[0.99930716,0.00018072748,0.00016513586,0.00018859483,0.000049706094,0.000108656204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019358165,0.00010718651,0.00033599904,0.000046256482,0.00003408586,0.0000023785483,0.00004915658,0.00003826634,0.00006206996],"category_scores_gemma":[0.00008783677,0.0000795185,0.000082653685,0.000042728658,0.00011276046,0.00005158211,0.00006367719,0.00007454774,0.00001197161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013182956,0.0011125739,0.9269992,0.00015345472,0.00009650739,0.000004374851,0.00044840647,0.0000056445892,0.05235283,0.00020609351,0.002057158,0.015245442],"study_design_scores_gemma":[0.0027531143,0.0037110967,0.83487725,0.000039637584,0.00019752236,0.000018881849,0.000018803436,0.00011672011,0.1501463,0.000021089216,0.008053041,0.000046545385],"about_ca_topic_score_codex":0.000002012459,"about_ca_topic_score_gemma":0.0000023597197,"teacher_disagreement_score":0.09779348,"about_ca_system_score_codex":0.00006124887,"about_ca_system_score_gemma":0.00001540328,"threshold_uncertainty_score":0.32426703},"labels":[],"label_agreement":null},{"id":"W2086224953","doi":"10.1016/j.eururo.2009.05.004","title":"Classification of Male Lower Urinary Tract Symptoms Using Mathematical Modelling and a Regression Tree Algorithm of Noninvasive Near-Infrared Spectroscopy Parameters","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Medicine; Nomogram; Lower urinary tract symptoms; Prospective cohort study; Urology; Hemodynamics; International Prostate Symptom Score; Internal medicine; Prostate","score_opus":0.04511831173831689,"score_gpt":0.3118526062202249,"score_spread":0.26673429448190805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086224953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9638552,0.0003967178,0.022539234,0.00028427097,0.000027680493,0.0002823462,0.000007494561,0.000020163545,0.012586864],"genre_scores_gemma":[0.9564004,0.00012857564,0.04311242,0.00006422061,0.000036493646,0.0000011383206,0.000013478501,0.000024176992,0.00021909951],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99863005,0.00026424218,0.00037183837,0.0002748572,0.00020280691,0.00025620466],"domain_scores_gemma":[0.9992077,0.00014586112,0.0001495368,0.00030058602,0.00007910682,0.00011725466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035442843,0.00014236392,0.0003499521,0.00013159859,0.00005261887,0.000009592271,0.00008534701,0.00006890695,0.00007025257],"category_scores_gemma":[0.00004720434,0.00011619029,0.000074582065,0.00013438478,0.000251711,0.00006894224,0.000040832118,0.0002528435,0.000010608434],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016601719,0.016182158,0.022039667,0.0017408752,0.0008261864,0.01655367,0.0140552325,0.004014289,0.7335859,0.0013517006,0.0008925172,0.17215608],"study_design_scores_gemma":[0.00571477,0.033913698,0.09804341,0.0005310285,0.0005122821,0.01221662,0.0003291201,0.8258019,0.018729923,0.0032225917,0.00047395626,0.00051070104],"about_ca_topic_score_codex":0.0000026426446,"about_ca_topic_score_gemma":2.6217117e-8,"teacher_disagreement_score":0.8217876,"about_ca_system_score_codex":0.0000185676,"about_ca_system_score_gemma":0.000060153518,"threshold_uncertainty_score":0.47381026},"labels":[],"label_agreement":null},{"id":"W2088852716","doi":"10.1016/j.eururo.2014.06.005","title":"Obesity Is Associated with Risk of Progression for Low-risk Prostate Cancers Managed Expectantly","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University Health Network; University of Toronto","funders":"Janssen Canada; Canadian Cancer Society Research Institute; Amgen Canada; Prostate Cancer Canada","keywords":"Medicine; Prostate cancer; Hazard ratio; Proportional hazards model; Biopsy; Body mass index; Internal medicine; Population; Oncology; Tumor progression; Prostate biopsy; Cancer; Cohort; Confidence interval","score_opus":0.007996629647518502,"score_gpt":0.24383333618956488,"score_spread":0.23583670654204636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088852716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99432117,0.00047406607,0.00038335292,0.00042221893,0.000100008634,0.0010560872,0.00015991608,0.000073219744,0.0030099917],"genre_scores_gemma":[0.9979618,0.0005124676,0.0004623825,0.00054345303,0.00006938253,0.00008495826,0.000072309944,0.00005260647,0.00024062971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848115,0.00039197746,0.00028204772,0.00038209418,0.00014792543,0.00031479157],"domain_scores_gemma":[0.99871427,0.0002194918,0.00046164796,0.00031833025,0.00017507176,0.00011116287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000543677,0.00018142865,0.0003898349,0.00006388127,0.00010999519,0.000007283878,0.00008345154,0.00004408164,0.000030601605],"category_scores_gemma":[0.00041397728,0.00012576097,0.00008009118,0.0001422542,0.00013527754,0.000031269366,0.000039666218,0.00016336328,0.000014953418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029413814,0.00072591734,0.94536203,0.00013778704,0.0009556181,0.00013543345,0.0020526345,0.00011681323,0.00036811686,0.00006787988,0.005212063,0.041924305],"study_design_scores_gemma":[0.012479049,0.01368437,0.94670695,0.00026422297,0.0013205182,0.000014788092,0.00008112222,0.0011837658,0.007867187,0.00015149656,0.015953323,0.00029318436],"about_ca_topic_score_codex":0.0000560746,"about_ca_topic_score_gemma":0.000051051135,"teacher_disagreement_score":0.04163112,"about_ca_system_score_codex":0.000105322564,"about_ca_system_score_gemma":0.00006616437,"threshold_uncertainty_score":0.5128383},"labels":[],"label_agreement":null},{"id":"W2089569703","doi":"10.1016/j.eururo.2013.01.023","title":"Active Surveillance, Quality of Life, and Cancer-related Anxiety","year":2013,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Quality of life (healthcare); Anxiety; Prostate cancer; Confidence interval; Cohort; Prostatectomy; Population; Cancer; Cohort study; Internal medicine; Physical therapy; Psychiatry","score_opus":0.024158539378616645,"score_gpt":0.2786227353565421,"score_spread":0.25446419597792547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089569703","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31466517,0.013176257,0.0000026558832,0.63073325,0.0009214422,0.0012748824,0.0006393134,0.00016246527,0.03842458],"genre_scores_gemma":[0.43316,0.017230105,0.000063387124,0.54492605,0.0015073845,0.00009983579,0.00073094736,0.00015419078,0.0021280926],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977068,0.0007123981,0.0005224221,0.0005473823,0.00017353034,0.00033749576],"domain_scores_gemma":[0.99857855,0.0002371457,0.00045704792,0.0004460396,0.00016133388,0.00011991191],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024394003,0.00031101806,0.0008917461,0.000095577656,0.000034926088,0.000008236121,0.00010743142,0.00030649465,0.0004677639],"category_scores_gemma":[0.000099686884,0.00025014783,0.00013188695,0.000098913115,0.00021749007,0.000029149305,0.000107208376,0.0009191123,0.000091206195],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017973818,0.000119904915,0.09662076,0.0003727401,0.0011238665,0.00021811947,0.00025244185,0.0000012530448,0.0000708094,0.000021709257,0.88750935,0.013509286],"study_design_scores_gemma":[0.0015231519,0.00042759176,0.3782867,0.000023274042,0.00012033778,0.000020351183,0.0000039299944,0.0000032406767,0.000023628805,0.000018290826,0.6193976,0.00015191184],"about_ca_topic_score_codex":0.00037775218,"about_ca_topic_score_gemma":0.000013349324,"teacher_disagreement_score":0.28166592,"about_ca_system_score_codex":0.00007562181,"about_ca_system_score_gemma":0.0001427684,"threshold_uncertainty_score":0.99999505},"labels":[],"label_agreement":null},{"id":"W2090482383","doi":"10.1016/j.eururo.2008.08.042","title":"Re: Hypothalamic-Pituitary-Testicular Axis Disruptions in Older Men Are Differentially Linked to Age and Modifiable Risk Factors: The European Male Aging Study","year":2008,"lang":"en","type":"letter","venue":"European Urology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Hypothalamic–pituitary–gonadal axis; Internal medicine; Physiology; Endocrinology; Hormone; Luteinizing hormone","score_opus":0.02919824600382681,"score_gpt":0.24968164112504102,"score_spread":0.2204833951212142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090482383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8761947,0.0010916162,0.00006686897,0.10283756,0.00031881017,0.0018062681,0.000078053505,0.000115374576,0.017490737],"genre_scores_gemma":[0.9652758,0.00045073367,0.000051958996,0.024487194,0.0030471077,0.000033496548,0.00013918894,0.00019049882,0.006323973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940996,0.0029874877,0.00059551734,0.0012674903,0.00036220983,0.0006877018],"domain_scores_gemma":[0.9981898,0.00032646485,0.00024970795,0.0009938113,0.00011462634,0.00012559223],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00074209285,0.00062002975,0.00092227804,0.00031922173,0.00043075366,0.00004263126,0.00038655434,0.0001310467,0.000050563285],"category_scores_gemma":[0.0005796088,0.00039243413,0.00016030822,0.00026139908,0.00040316215,0.000044518532,0.00075412577,0.002430771,0.00017547756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001922499,0.0015796896,0.45293003,0.00029160536,0.002118613,0.10451733,0.037732176,0.0005100917,0.0005706796,0.0000034170328,0.39836565,0.001188451],"study_design_scores_gemma":[0.0011376244,0.00065110554,0.9301288,0.00006203073,0.00050080987,0.00017657809,0.0013187412,0.000019519966,0.000001645406,0.000013497917,0.065602735,0.00038688479],"about_ca_topic_score_codex":0.00036299363,"about_ca_topic_score_gemma":0.00006584606,"teacher_disagreement_score":0.47719878,"about_ca_system_score_codex":0.00005379487,"about_ca_system_score_gemma":0.000022550208,"threshold_uncertainty_score":0.99987066},"labels":[],"label_agreement":null},{"id":"W2091005397","doi":"10.1016/j.eururo.2007.03.018","title":"Prostate-Specific Antigen Improves the Ability of Clinical Stage and Biopsy Gleason Sum to Predict the Pathologic Stage at Radical Prostatectomy in the New Millennium","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Stage (stratigraphy); Prostate cancer; Quartile; Urology; Biopsy; Prostate-specific antigen; Prostate; Logistic regression; Internal medicine; Cancer; Confidence interval","score_opus":0.03563617577069187,"score_gpt":0.318645700564126,"score_spread":0.2830095247934341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091005397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794594,0.0052559585,0.000053080945,0.010632691,0.00023860109,0.0026176313,0.000078420955,0.000037027752,0.001627168],"genre_scores_gemma":[0.99414414,0.0024673007,0.00015941236,0.0026765976,0.00022309217,0.000038791786,0.00002419746,0.000033605866,0.00023285412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996504,0.0011771478,0.0008648893,0.0006282095,0.00028329648,0.0005424338],"domain_scores_gemma":[0.99752223,0.001100386,0.00024140868,0.00087173405,0.0000610499,0.00020318014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005061435,0.00025676537,0.00047064913,0.00006471015,0.00014436018,0.000024451161,0.00034614382,0.00009093927,0.000054874425],"category_scores_gemma":[0.00039939268,0.000112342546,0.00012864615,0.00027398934,0.00092612405,0.000035552173,0.00028402187,0.0005346316,0.000028473341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007658487,0.0010673873,0.9135291,0.00009800444,0.0001260644,0.002111133,0.0070780055,0.000013260046,0.012326687,0.00049768545,0.00835988,0.04713431],"study_design_scores_gemma":[0.0022040897,0.0030198821,0.7887487,0.000014778733,0.000036739402,0.00007266514,0.000415054,0.000009386579,0.0005074872,0.000019983489,0.20486389,0.00008737688],"about_ca_topic_score_codex":0.00007898194,"about_ca_topic_score_gemma":0.000059910682,"teacher_disagreement_score":0.196504,"about_ca_system_score_codex":0.000056215977,"about_ca_system_score_gemma":0.00009646546,"threshold_uncertainty_score":0.45811963},"labels":[],"label_agreement":null},{"id":"W2091172403","doi":"10.1016/j.eururo.2009.06.004","title":"The Extent of Lymphadenectomy Seems to Be Associated with Better Survival in Patients with Nonmetastatic Upper-Tract Urothelial Carcinoma: How Many Lymph Nodes Should Be Removed?","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lymphadenectomy; Urology; Hazard ratio; Proportional hazards model; Lymphovascular invasion; Lymph; Stage (stratigraphy); Lymph node; Population; Carcinoma; Cancer; Oncology; Internal medicine; Surgery; Metastasis; Pathology; Confidence interval","score_opus":0.01975750519065544,"score_gpt":0.24438450789171723,"score_spread":0.22462700270106178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091172403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850398,0.00010375356,0.00007925954,0.010256009,0.00012996506,0.00073035393,0.000076368764,0.00004247204,0.0035420433],"genre_scores_gemma":[0.9908415,0.000009539646,0.00018829308,0.008212207,0.00009030443,0.000015055738,0.000071795315,0.000079756646,0.0004915401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997498,0.00053103897,0.00035616657,0.000496191,0.0005339163,0.00058469805],"domain_scores_gemma":[0.99879444,0.00018000795,0.00018537593,0.0005101389,0.0001512412,0.00017878471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037699283,0.00035477956,0.0005523874,0.00015256679,0.000103645565,0.00003090635,0.00024605248,0.00006753272,0.000033155364],"category_scores_gemma":[0.00012068647,0.00021296051,0.00008823417,0.00030205716,0.00015605743,0.000073501345,0.00005033223,0.00020377494,0.00001229914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033667043,0.001045464,0.9898933,0.000011348268,0.0002291213,0.0004143086,0.00067326747,0.000036669142,0.0003992659,0.00003498235,0.00018038218,0.0037151626],"study_design_scores_gemma":[0.010765905,0.0036613985,0.9834112,0.000034141154,0.00027248065,0.000028114795,0.00006893463,0.000025777148,0.00017921458,0.000009435243,0.0013296164,0.00021376183],"about_ca_topic_score_codex":0.0000898184,"about_ca_topic_score_gemma":0.000055149514,"teacher_disagreement_score":0.0073992005,"about_ca_system_score_codex":0.00014532595,"about_ca_system_score_gemma":0.000119504315,"threshold_uncertainty_score":0.86842775},"labels":[],"label_agreement":null},{"id":"W2091430003","doi":"10.1016/j.eururo.2007.10.010","title":"Urogenital Pain – Time to Accept a New Approach to Phenotyping and, as a Consequence, Management","year":2007,"lang":"en","type":"letter","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Queen (butterfly); University hospital; Reproductive medicine; Family medicine; Kingdom; Library science; Gerontology","score_opus":0.029696068085559534,"score_gpt":0.28533006514908427,"score_spread":0.25563399706352474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091430003","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049651857,0.00035285266,0.0040021613,0.3444234,0.00006953729,0.0017106554,0.000018440085,0.00013732542,0.6487891],"genre_scores_gemma":[0.0011054645,0.00003097206,0.0036425442,0.83665055,0.0020101478,0.00002564204,0.0002844189,0.00016385909,0.15608642],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962743,0.000982393,0.0003699582,0.000989601,0.00041578678,0.00096795894],"domain_scores_gemma":[0.9984376,0.0002219981,0.000056972243,0.0006480413,0.00006550872,0.00056991086],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0016019866,0.00040514092,0.00051042164,0.0007569327,0.00009379054,0.00006291022,0.00039217283,0.00023416537,0.0017928823],"category_scores_gemma":[0.0001921617,0.0003849388,0.00010474299,0.00038818858,0.00013465276,0.000031335505,0.00064212386,0.0014519852,0.01815655],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053822837,0.000054692377,0.000018525283,0.00018264812,0.00025169045,0.023599572,0.00038469295,0.0000036074673,0.00010683887,0.000019603292,0.9305463,0.044293597],"study_design_scores_gemma":[0.00078213046,0.0012295301,0.00023168625,0.00003169805,0.00014613025,0.0027169262,0.000025871388,0.000024927624,0.0000072450957,0.00003231789,0.99443835,0.00033319174],"about_ca_topic_score_codex":0.000024546824,"about_ca_topic_score_gemma":3.950144e-7,"teacher_disagreement_score":0.4927027,"about_ca_system_score_codex":0.00006063672,"about_ca_system_score_gemma":0.00011824638,"threshold_uncertainty_score":0.9998602},"labels":[],"label_agreement":null},{"id":"W2092085969","doi":"10.1016/j.eururo.2006.05.009","title":"Outcomes Research: A Methodologic Review","year":2006,"lang":"en","type":"review","venue":"European Urology","topic":"Health Policy Implementation Science","field":"Health Professions","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Outcomes research; Ethnic group; Health care; Conceptual framework; Macro; Data sharing; Data science; Alternative medicine; Pathology; Economic growth; Social science","score_opus":0.978520447293236,"score_gpt":0.8416202488544301,"score_spread":0.13690019843880585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092085969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.9797397e-7,0.81918305,0.000112456415,0.0068191504,0.0009046334,0.0033215263,0.00010214186,0.0001811768,0.16937567],"genre_scores_gemma":[2.1263696e-7,0.91656023,0.0011110241,0.06856997,0.0007194066,0.0005845263,0.0000856223,0.00012579013,0.012243195],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8575601,0.13598394,0.00295863,0.00093217735,0.00063592714,0.0019291961],"domain_scores_gemma":[0.96066403,0.035725255,0.0014380993,0.0014187135,0.0003828142,0.00037109296],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","insufficient_payload"],"category_scores_codex":[0.05924402,0.00049512635,0.002997813,0.0007554416,0.0011468974,0.000011728649,0.0016623549,0.0003456583,0.0028343846],"category_scores_gemma":[0.029311333,0.00034381717,0.0004004108,0.0015621698,0.0004125817,0.00007177753,0.001104501,0.004078704,0.04523493],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000001073767,0.000010493338,0.000042852054,0.047482625,0.00002110785,0.00006600388,0.00017717727,2.1838304e-8,1.6834614e-8,0.00081789284,0.5102861,0.44109464],"study_design_scores_gemma":[0.00015595264,0.00009281555,0.00020923714,0.0067907893,0.0001697447,0.000021877937,0.000018391569,9.144091e-8,1.2128679e-9,0.00013942998,0.9921655,0.00023618746],"about_ca_topic_score_codex":0.00010496019,"about_ca_topic_score_gemma":0.000046475427,"teacher_disagreement_score":0.48187938,"about_ca_system_score_codex":0.00031767666,"about_ca_system_score_gemma":0.0018090422,"threshold_uncertainty_score":0.99990135},"labels":[],"label_agreement":null},{"id":"W2092222339","doi":"10.1016/j.eururo.2013.09.007","title":"Surgical Management of Node-positive Prostate Cancer: Perspectives from Breast Oncology","year":2013,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Oncology; Prostate cancer; Prostate; Internal medicine; General surgery; Cancer; Management of prostate cancer; Gynecology","score_opus":0.016949416555269506,"score_gpt":0.2998620626426468,"score_spread":0.2829126460873773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092222339","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028688243,0.011721493,0.000004685326,0.80813205,0.0005543779,0.001655604,0.001559165,0.000102207574,0.14758217],"genre_scores_gemma":[0.23927628,0.06075938,0.0014012322,0.47290817,0.021080242,0.0009498283,0.013601311,0.0010788208,0.18894474],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99684197,0.00082450313,0.0004341295,0.000854274,0.0003742832,0.0006708339],"domain_scores_gemma":[0.9985843,0.00020157515,0.00026371898,0.00052328274,0.00028897895,0.00013819999],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018657155,0.0004119047,0.00088708365,0.0002237076,0.00006553362,0.000015768148,0.00029670063,0.00036039838,0.0021797337],"category_scores_gemma":[0.000006123689,0.0003134193,0.00022267345,0.00015595845,0.00066373165,0.000042401127,0.0003203895,0.0016593834,0.0006204744],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026306673,0.00044970246,0.0025668298,0.00037116662,0.0036920689,0.062262543,0.0024827635,0.000003654067,0.00015716415,0.00006611608,0.8993698,0.025947541],"study_design_scores_gemma":[0.005297111,0.0014720238,0.025138972,0.0002178076,0.0008573495,0.00051552756,0.0003409117,0.000010820028,0.000051887768,0.000045721066,0.9657378,0.00031401956],"about_ca_topic_score_codex":0.00048422124,"about_ca_topic_score_gemma":0.000003597879,"teacher_disagreement_score":0.33522388,"about_ca_system_score_codex":0.00036166832,"about_ca_system_score_gemma":0.00019403653,"threshold_uncertainty_score":0.9999318},"labels":[],"label_agreement":null},{"id":"W2092798324","doi":"10.1016/j.eururo.2009.03.063","title":"Systematic Review and Meta-Analysis of Robotic-Assisted versus Conventional Laparoscopic Pyeloplasty for Patients with Ureteropelvic Junction Obstruction: Effect on Operative Time, Length of Hospital Stay, Postoperative Complications, and Success Rate","year":2009,"lang":"en","type":"review","venue":"European Urology","topic":"Pediatric Urology and Nephrology Studies","field":"Medicine","cited_by":207,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Medicine; Meta-analysis; Pyeloplasty; Odds ratio; Laparoscopy; Ureteropelvic junction; Surgery; Complication; Internal medicine; Hydronephrosis; Urinary system","score_opus":0.02845991043705447,"score_gpt":0.3098541691684673,"score_spread":0.2813942587314128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092798324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047615813,0.98991024,0.000030437008,0.00036907755,0.00011174845,0.0043850183,0.00024323093,0.00002065263,0.0001680012],"genre_scores_gemma":[0.0073890714,0.98899865,0.0002115276,0.0010171455,0.000031372536,0.0004417681,0.0016620834,0.00005867936,0.00018972768],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99587953,0.002238869,0.0009676302,0.00059187965,0.00014002995,0.00018207887],"domain_scores_gemma":[0.99652,0.0015069736,0.0011190324,0.00035278636,0.00043468506,0.00006653138],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000594477,0.00046174356,0.0056258207,0.000334356,0.00013295581,0.0000066597545,0.0001106157,0.00015119213,0.00002958347],"category_scores_gemma":[0.00045277673,0.00027938705,0.00051816006,0.00038418578,0.00044063234,0.000052696145,0.000058526,0.00027878172,0.0000072067314],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024543828,0.0009770016,0.00070993137,0.17408761,0.8178307,0.000023751614,0.00015715788,0.000012369883,8.3229685e-7,0.00033137432,0.0006517033,0.0027632287],"study_design_scores_gemma":[0.0027293528,0.016416488,0.020200633,0.0010618566,0.9576447,0.00002039803,0.0000029707637,0.000008878904,2.7008198e-7,9.872621e-7,0.0016817326,0.00023172236],"about_ca_topic_score_codex":0.000001031489,"about_ca_topic_score_gemma":0.0000025080124,"teacher_disagreement_score":0.17302576,"about_ca_system_score_codex":0.000028556646,"about_ca_system_score_gemma":0.000052109466,"threshold_uncertainty_score":0.99996585},"labels":[],"label_agreement":null},{"id":"W2093305355","doi":"10.1016/j.eururo.2008.02.029","title":"Rebuttal from Authors re: James W.F. Catto. More Nomograms or Better Evidence of Efficacy: What Do We Need in Urologic Oncology? Eur Urol 2008;54:11–12","year":2008,"lang":"en","type":"letter","venue":"European Urology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Rebuttal; Nomogram; Urology; Oncology","score_opus":0.05393908734455041,"score_gpt":0.3014044325163688,"score_spread":0.24746534517181837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093305355","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3922467,0.020274255,0.00007584764,0.5820754,0.0027698688,0.0011525218,0.000046382436,0.00036547598,0.0009935639],"genre_scores_gemma":[0.45390412,0.0106356675,0.001068228,0.52220434,0.008522399,0.00010116191,0.00044114472,0.00042368117,0.0026992357],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923085,0.0026730273,0.001444187,0.0017520353,0.0007000951,0.0011221796],"domain_scores_gemma":[0.9952838,0.0019158658,0.00093823066,0.0014108868,0.00019701417,0.00025424254],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00096188276,0.00091061037,0.0018987422,0.0008781624,0.00012837007,0.00006319813,0.00082222826,0.0016750707,0.0005883467],"category_scores_gemma":[0.0012616827,0.00075983116,0.00049005315,0.00076209963,0.00090798887,0.0002568444,0.00043849566,0.005176718,0.00029570257],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019513413,0.00032133528,0.010843404,0.00021322124,0.00033378004,0.029447157,0.0038320448,0.00012528323,0.0003642016,3.8873088e-7,0.85858446,0.07642133],"study_design_scores_gemma":[0.0035012115,0.013517295,0.030403025,0.0007731949,0.00054590596,0.0016055312,0.00017574162,0.00016201726,0.00008967132,0.000014989589,0.9485065,0.00070493063],"about_ca_topic_score_codex":0.0007520927,"about_ca_topic_score_gemma":0.00033353773,"teacher_disagreement_score":0.08992204,"about_ca_system_score_codex":0.0002612193,"about_ca_system_score_gemma":0.00037853897,"threshold_uncertainty_score":0.999621},"labels":[],"label_agreement":null},{"id":"W2093425856","doi":"10.1016/j.eururo.2014.01.026","title":"Gonadotropin-releasing Hormone Agonists and Acute Kidney Injury in Patients with Prostate Cancer","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Androgen deprivation therapy; Hazard ratio; Prostate cancer; Acute kidney injury; Internal medicine; Urology; Orchiectomy; Retrospective cohort study; Cohort; Proportional hazards model; Confidence interval; Oncology; Cancer","score_opus":0.006215485402694604,"score_gpt":0.2543343339433628,"score_spread":0.2481188485406682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093425856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928713,0.00030302737,0.0000089621235,0.0029507498,0.000068246234,0.00039538438,0.000036028716,0.000036470265,0.0033298426],"genre_scores_gemma":[0.99627924,0.00071245024,0.000104222265,0.0018624016,0.000080596146,0.000015266407,0.00007723294,0.000044122753,0.0008244676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988441,0.00018587195,0.00015266599,0.00031465408,0.00014044918,0.00036226102],"domain_scores_gemma":[0.9994681,0.0000144974865,0.000051229297,0.00018411112,0.00006515908,0.00021689947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104468636,0.00014720108,0.00022418717,0.00012130999,0.000062927735,0.000016542226,0.000060266066,0.00003319622,0.00002285704],"category_scores_gemma":[0.000040125808,0.00010259344,0.000017345636,0.00013197176,0.00018452035,0.0000534478,0.00007464798,0.00023506915,0.00003449939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009329169,0.00021311431,0.9411814,0.000047610498,0.0001595724,0.00020532384,0.00047687296,0.0000017797329,0.0019210764,0.00004572251,0.0030821266,0.043336194],"study_design_scores_gemma":[0.0063086804,0.0025236188,0.9628909,0.00003199095,0.00005949183,0.0000086799455,0.0000023717262,0.000036403246,0.00007097057,0.000013455608,0.027944194,0.00010922708],"about_ca_topic_score_codex":0.00004560625,"about_ca_topic_score_gemma":0.0000026324753,"teacher_disagreement_score":0.04322697,"about_ca_system_score_codex":0.000056591496,"about_ca_system_score_gemma":0.000079481055,"threshold_uncertainty_score":0.4183639},"labels":[],"label_agreement":null},{"id":"W2095183081","doi":"10.1016/j.eururo.2013.03.057","title":"Pelvic Lymph Node Dissection During Robot-assisted Radical Prostatectomy: Efficacy, Limitations, and Complications—A Systematic Review of the Literature","year":2013,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":247,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital; Jewish General Hospital","funders":"","keywords":"Medicine; Prostatectomy; Dissection (medical); Lymph node; Prostate cancer; Lymphocele; Surgery; Stage (stratigraphy); Urology; Cancer; Complication; Internal medicine","score_opus":0.03771454683541852,"score_gpt":0.2976116280914866,"score_spread":0.2598970812560681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095183081","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020725834,0.99306345,0.0000046087935,0.0008399356,0.0001360455,0.0050994353,0.000048110127,0.000052383544,0.0005487891],"genre_scores_gemma":[0.0013301971,0.99671537,0.00010556805,0.00049887714,0.00006479777,0.0006823181,0.00033567415,0.0000750583,0.00019215261],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99678063,0.0013388034,0.0010178756,0.00047127315,0.0001751762,0.00021624044],"domain_scores_gemma":[0.9976796,0.00041280958,0.00079120405,0.00083526573,0.00016374956,0.00011739442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029616323,0.00037621232,0.0018321266,0.00013104056,0.00012913265,0.000033693967,0.00019551582,0.00011316656,0.000014414061],"category_scores_gemma":[0.00056695286,0.0002091142,0.00037976462,0.0004312983,0.00014842497,0.00003809465,0.00012567006,0.00035547648,0.00007395988],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009000212,0.00020531184,0.000045466022,0.9647483,0.00041116762,0.000042250962,0.00008085215,2.556499e-7,0.0000042642064,0.000067025554,0.00018888328,0.034197222],"study_design_scores_gemma":[0.0010289609,0.00017095947,0.029023295,0.9061281,0.0074175075,0.0024089275,0.0000057384605,0.000002287104,0.0000020836712,0.000004272282,0.05356861,0.00023925018],"about_ca_topic_score_codex":0.0000016619267,"about_ca_topic_score_gemma":3.2314108e-7,"teacher_disagreement_score":0.058620192,"about_ca_system_score_codex":0.00014624569,"about_ca_system_score_gemma":0.00012539682,"threshold_uncertainty_score":0.8527429},"labels":[],"label_agreement":null},{"id":"W2096395073","doi":"10.1016/j.eururo.2011.05.055","title":"Sequelae of Treatment in Long-term Survivors of Testis Cancer","year":2011,"lang":"en","type":"review","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Testicular cancer; Malignancy; Disease; Cancer; Radiation therapy; Retrospective cohort study; Life expectancy; Pediatrics; Intensive care medicine; Internal medicine; Population","score_opus":0.06892250296069206,"score_gpt":0.34867543588995864,"score_spread":0.27975293292926656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096395073","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006020719,0.9902828,0.0000022007778,0.0000060152015,0.00013425884,0.00070346467,0.00016820036,0.00001976736,0.0026626203],"genre_scores_gemma":[0.009699544,0.9895325,0.00004034599,0.000019808234,0.000056968136,0.00004093712,0.00019616807,0.00007856897,0.00033520767],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983552,0.00040833687,0.00059735,0.00034675052,0.00006851053,0.00022381893],"domain_scores_gemma":[0.9988057,0.000112499525,0.00044144518,0.00048046804,0.00004480411,0.00011510734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083983956,0.00032808466,0.0016074559,0.00022085944,0.000008551424,0.0000013423742,0.00012511843,0.000101582256,0.00038626185],"category_scores_gemma":[0.00006330181,0.00022807214,0.0003840485,0.00017298666,0.0001278405,0.000011395817,0.000061854385,0.00012054188,0.000071675284],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043699714,0.0007089275,0.09689486,0.0050788904,0.0007103083,0.0014785198,0.00005990184,5.486197e-7,5.951863e-7,0.00002909901,0.00001476828,0.8949799],"study_design_scores_gemma":[0.0032275543,0.0052736057,0.51041734,0.00804624,0.01360348,0.00049467507,0.0000030578037,0.0000012434692,0.00000342315,0.000011592778,0.4584847,0.0004331132],"about_ca_topic_score_codex":0.0013951523,"about_ca_topic_score_gemma":0.00033532808,"teacher_disagreement_score":0.89454675,"about_ca_system_score_codex":0.00012561299,"about_ca_system_score_gemma":0.000349349,"threshold_uncertainty_score":0.9300512},"labels":[],"label_agreement":null},{"id":"W2096835959","doi":"10.1016/j.eururo.2013.10.011","title":"Enhanced Recovery After Surgery: Are We Ready, and Can We Afford Not to Implement These Pathways for Patients Undergoing Radical Cystectomy?","year":2013,"lang":"en","type":"editorial","venue":"European Urology","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cystectomy; Medicine; General surgery; Surgery; Intensive care medicine; Bladder cancer; Internal medicine; Cancer","score_opus":0.020483586249521797,"score_gpt":0.2580426601444266,"score_spread":0.23755907389490483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096835959","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2841148,0.0010055926,0.0013182553,0.0056484854,0.7000188,0.00403424,0.0024439138,0.00037362584,0.0010422744],"genre_scores_gemma":[0.46018153,0.0060581467,0.0011004423,0.0063148923,0.51741916,0.0011749419,0.0029057756,0.0009901194,0.0038549653],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941821,0.0008515047,0.0012937291,0.0016331892,0.00072866865,0.0013107994],"domain_scores_gemma":[0.98926103,0.0078569995,0.000719703,0.0010645845,0.00044308687,0.0006545985],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011866055,0.00091185427,0.0018174043,0.00065384404,0.00012091772,0.00009365066,0.00031736013,0.0007096237,0.00016634399],"category_scores_gemma":[0.004823595,0.000819316,0.0004279981,0.0002062359,0.00013649827,0.00013620887,0.0005212328,0.0010516702,0.00021395076],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006724042,0.00021328019,0.00052132836,0.0009751478,0.00035799213,0.00033716895,0.0005033157,0.0000021851417,0.0003399497,0.0000060143457,0.9663948,0.02362479],"study_design_scores_gemma":[0.0025311287,0.0036596553,0.0017670061,0.0009130784,0.00029898016,0.00001925021,0.000046498993,0.0000031050977,0.00050438254,0.00007716668,0.98933184,0.00084791944],"about_ca_topic_score_codex":0.000022765353,"about_ca_topic_score_gemma":0.00023468574,"teacher_disagreement_score":0.18259963,"about_ca_system_score_codex":0.0003249304,"about_ca_system_score_gemma":0.0005551107,"threshold_uncertainty_score":0.99942577},"labels":[],"label_agreement":null},{"id":"W2098762575","doi":"10.1016/j.eururo.2011.12.027","title":"Perioperative Outcomes of Robot-Assisted Radical Prostatectomy Compared With Open Radical Prostatectomy: Results From the Nationwide Inpatient Sample","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":421,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Prostatectomy; Medicine; Perioperative; Odds ratio; Confidence interval; Complication; Propensity score matching; Urology; Population; Logistic regression; Surgery; Prostate cancer; Internal medicine; Cancer","score_opus":0.056108898472691356,"score_gpt":0.28311485138081394,"score_spread":0.2270059529081226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098762575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772729,0.0002498763,0.00037986872,0.004782447,0.00016475056,0.0031577705,0.0008100616,0.00008782651,0.013094477],"genre_scores_gemma":[0.99101454,0.000051820873,0.0056770863,0.0021400806,0.000047310965,0.0001679542,0.0007361874,0.00005534161,0.00010966662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973723,0.0006979149,0.00067227747,0.0006024415,0.00030169307,0.00035334475],"domain_scores_gemma":[0.9980028,0.0006291309,0.0003309006,0.00063100783,0.00021602571,0.00019012419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043384483,0.00029711594,0.0006597398,0.00006715625,0.00016809849,0.000040153365,0.00040597096,0.00005335107,0.00019322295],"category_scores_gemma":[0.00047007695,0.0001624729,0.00008532363,0.00021755895,0.0006610499,0.000102531834,0.00028131568,0.0003084972,0.000052497664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03336789,0.0047985306,0.90456885,0.00005092211,0.002580205,0.0012574033,0.032369245,0.000106643165,0.0007501427,0.0026170437,0.0029041984,0.014628903],"study_design_scores_gemma":[0.016039245,0.0036062514,0.96296346,0.00006436754,0.00024652053,0.000034269444,0.0002488008,0.00006765671,0.0017703502,0.000076709,0.014696387,0.00018598356],"about_ca_topic_score_codex":0.001096422,"about_ca_topic_score_gemma":0.00019956476,"teacher_disagreement_score":0.05839459,"about_ca_system_score_codex":0.00008763538,"about_ca_system_score_gemma":0.00025453983,"threshold_uncertainty_score":0.66254526},"labels":[],"label_agreement":null},{"id":"W2099037568","doi":"10.1016/j.eururo.2013.10.032","title":"Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":338,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Myocardial infarction; Prostate cancer; Vitamin K antagonist; Heart failure; Cardiology; Sudden cardiac death; Heart disease; Endocrinology; Confidence interval; Cancer; Atrial fibrillation","score_opus":0.023439555135874323,"score_gpt":0.26627709641805025,"score_spread":0.24283754128217594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099037568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98513746,0.0037439626,0.00005666894,0.0011470373,0.000044177166,0.0003945878,0.0000073654774,0.0001037405,0.00936498],"genre_scores_gemma":[0.9976406,0.00079605513,0.00014790252,0.00038318298,0.00016171066,0.000011659076,0.00010644384,0.00005007766,0.00070235034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998479,0.00042793454,0.0001392863,0.00037247874,0.00020299871,0.00037827904],"domain_scores_gemma":[0.99921066,0.000034864403,0.000042869484,0.00036114093,0.00011531345,0.00023516086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020793009,0.00015893579,0.000310251,0.00006824774,0.00016406081,0.00004783316,0.00007668969,0.00005225028,0.000045110097],"category_scores_gemma":[0.00007147101,0.00011393026,0.00006329558,0.00011823563,0.00030930413,0.000100100006,0.00006338661,0.00026242636,0.00010011237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070209783,0.0033975765,0.5207221,0.00032194098,0.012896793,0.025796343,0.003970265,0.00016483793,0.15566467,0.00069402356,0.02439983,0.24495062],"study_design_scores_gemma":[0.003367471,0.0021073432,0.9834037,0.000013020218,0.00019721033,0.00025157406,0.000035579942,0.00018422128,0.00016833287,0.000027160333,0.010094058,0.00015033378],"about_ca_topic_score_codex":0.00025532706,"about_ca_topic_score_gemma":0.000008941052,"teacher_disagreement_score":0.4626816,"about_ca_system_score_codex":0.000060230712,"about_ca_system_score_gemma":0.000056926336,"threshold_uncertainty_score":0.46459413},"labels":[],"label_agreement":null},{"id":"W2099815527","doi":"10.1016/j.eururo.2009.08.024","title":"An Updated Critical Analysis of the Treatment Strategy for Newly Diagnosed High-grade T1 (Previously T1G3) Bladder Cancer","year":2009,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":225,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; McGill University Health Centre; Montreal General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Disease; Cancer; Urology; Intensive care medicine; Internal medicine","score_opus":0.059345227700210224,"score_gpt":0.3838745589587246,"score_spread":0.32452933125851435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099815527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00067397964,0.9933697,0.000093073875,0.00048230807,0.000429033,0.0024597463,0.0011267709,0.00008959359,0.0012757786],"genre_scores_gemma":[0.013027201,0.9823023,0.0001249722,0.0012524129,0.00064730836,0.0002617494,0.0015221753,0.00015948158,0.00070236326],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996061,0.0011588488,0.00094545004,0.00090260466,0.00024204486,0.0006900282],"domain_scores_gemma":[0.9976375,0.00031048874,0.00037496668,0.001234633,0.0001548073,0.00028758394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022934905,0.0007103647,0.0029958144,0.0003583982,0.00012968286,0.000027888987,0.0004582899,0.0002780347,0.0007868653],"category_scores_gemma":[0.00005744228,0.00041832085,0.0014953441,0.0008144891,0.0002458316,0.00004287072,0.000039062717,0.00032504436,0.00003135465],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023373765,0.0021372684,0.00020999632,0.00072727725,0.013398917,0.00029229128,0.00020753274,0.00011316161,0.0000056199437,0.00035624593,0.0033454017,0.97897255],"study_design_scores_gemma":[0.0027355622,0.0053095724,0.004064652,0.0002938083,0.100030296,0.00003545194,0.000010605117,0.000043921507,0.0000065155937,0.000031289437,0.88708717,0.0003511834],"about_ca_topic_score_codex":0.00044586242,"about_ca_topic_score_gemma":0.00032502128,"teacher_disagreement_score":0.97862136,"about_ca_system_score_codex":0.00022713104,"about_ca_system_score_gemma":0.0005717045,"threshold_uncertainty_score":0.99982685},"labels":[],"label_agreement":null},{"id":"W2100762183","doi":"10.1016/j.eururo.2011.05.006","title":"The Contemporary Concept of Significant Versus Insignificant Prostate Cancer","year":2011,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":314,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Nomogram; Prostatectomy; Prostate cancer; Prostate; Disease; MEDLINE; Biochemical recurrence; Cancer; Oncology; Gynecology; Internal medicine","score_opus":0.11705608710954567,"score_gpt":0.3412844884386875,"score_spread":0.22422840132914185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100762183","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039275754,0.9733472,0.0000012098767,0.00016448337,0.0010010818,0.0019184116,0.0002861835,0.000051751915,0.023190437],"genre_scores_gemma":[0.004375981,0.9937934,0.000011569894,0.0001243173,0.00025616688,0.000323871,0.0001707337,0.00013225869,0.0008116607],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99708813,0.0008159342,0.00094254606,0.0005804273,0.00015378301,0.00041915698],"domain_scores_gemma":[0.9974991,0.00053648325,0.00083795004,0.00079144316,0.00014798074,0.0001870344],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036623492,0.00048907555,0.0016702886,0.00009948812,0.00009980298,0.000014535048,0.00033401392,0.00012335558,0.00012021825],"category_scores_gemma":[0.000103495375,0.00027015866,0.0005811799,0.00018892193,0.0006552078,0.000026333255,0.00015677039,0.00048257475,0.00014855195],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066577713,0.00019901173,0.0000871922,0.0014240248,0.0018103492,0.0005368587,0.00034839674,4.1745167e-7,0.0000011120349,0.0005413078,0.012661465,0.9817241],"study_design_scores_gemma":[0.0017531033,0.002772595,0.00020872155,0.0012654009,0.0015654116,0.000022738903,0.000020898688,3.8992755e-7,0.0000088159295,0.0000064388532,0.9921567,0.00021877968],"about_ca_topic_score_codex":0.00014283672,"about_ca_topic_score_gemma":0.0000057344514,"teacher_disagreement_score":0.98150533,"about_ca_system_score_codex":0.00015483158,"about_ca_system_score_gemma":0.0011572259,"threshold_uncertainty_score":0.9999751},"labels":[],"label_agreement":null},{"id":"W2101000894","doi":"10.1016/j.eururo.2012.04.056","title":"Early Salvage Radiation Therapy Does Not Compromise Cancer Control in Patients with pT3N0 Prostate Cancer After Radical Prostatectomy: Results of a Match-controlled Multi-institutional Analysis","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Cancer; Urology; Radiation therapy; Oncology; Internal medicine","score_opus":0.00890387247190538,"score_gpt":0.24895984802716642,"score_spread":0.24005597555526104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101000894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992559,0.0024669063,0.00006878964,0.0011435581,0.00017754857,0.0025700748,0.00090569846,0.0000372775,0.00007113897],"genre_scores_gemma":[0.99650615,0.00064414385,0.00012645335,0.001368964,0.00012403149,0.0009020659,0.00019406165,0.000042111173,0.00009201689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767584,0.0004258994,0.0006571365,0.00043838358,0.0003085129,0.00049421395],"domain_scores_gemma":[0.9988619,0.000112001,0.00036346872,0.0002953998,0.00016742629,0.00019976615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004358929,0.00030598466,0.00089849235,0.0003087418,0.00005271424,0.000014871371,0.00008364663,0.000066001,0.00009218815],"category_scores_gemma":[0.00004726433,0.00017323738,0.00017060067,0.0003518747,0.00024177982,0.00015282538,0.000024480558,0.00021601368,0.000014150773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.064390026,0.0016348949,0.9247677,0.000026847812,0.0018030261,0.00006290739,0.0016111106,0.00068282674,0.00024339407,0.000006174636,0.000032891032,0.004738241],"study_design_scores_gemma":[0.106136926,0.001028467,0.8899589,0.000040384693,0.00083284517,9.2221313e-7,0.0000061262385,0.00040932588,0.00027708444,7.531954e-7,0.0011418095,0.00016644844],"about_ca_topic_score_codex":0.0005002997,"about_ca_topic_score_gemma":0.00018263585,"teacher_disagreement_score":0.041746903,"about_ca_system_score_codex":0.00021473212,"about_ca_system_score_gemma":0.00013997081,"threshold_uncertainty_score":0.7064415},"labels":[],"label_agreement":null},{"id":"W2101506484","doi":"10.1016/j.eururo.2015.08.027","title":"Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hôpital Notre-Dame; Alberta Cancer Foundation","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Androgen; Prostate; Oncology; Internal medicine; Term (time); Urology; Prostate disease; Cancer; Gynecology; Hormone","score_opus":0.07159375603985815,"score_gpt":0.372412872666056,"score_spread":0.30081911662619787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101506484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99477106,0.002821171,0.0002017481,0.00017022983,0.00012197456,0.00046063855,0.000016686534,0.000040636143,0.0013958242],"genre_scores_gemma":[0.9987562,0.00050116953,0.00011497678,0.00015813977,0.0000719027,0.000024328689,0.00026748527,0.000030249039,0.0000755807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973882,0.00082943897,0.00058805593,0.00047088208,0.00039528144,0.00032816397],"domain_scores_gemma":[0.9988524,0.000045650806,0.000083064835,0.0006275453,0.00015385813,0.00023750655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021391402,0.00015321889,0.00075946574,0.00033050354,0.000028813478,0.000010340278,0.00015650148,0.00007138794,0.00002560972],"category_scores_gemma":[0.00017264379,0.00012598638,0.00041786506,0.0007064623,0.00012685903,0.00008589404,0.00009532954,0.00020505565,0.000010045214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008579932,0.00019328819,0.9816895,0.000020596968,0.003944434,0.00086607394,0.0007388131,0.002012723,0.00042276015,0.0000056667222,0.000022101745,0.009226061],"study_design_scores_gemma":[0.00483963,0.0008799113,0.9857655,0.000016329977,0.0035766978,0.000007083512,0.00008840737,0.0029330663,0.0002671086,0.00002012838,0.0014639029,0.00014222269],"about_ca_topic_score_codex":0.000389656,"about_ca_topic_score_gemma":0.00022013756,"teacher_disagreement_score":0.009083839,"about_ca_system_score_codex":0.00010778844,"about_ca_system_score_gemma":0.00019780341,"threshold_uncertainty_score":0.5137576},"labels":[],"label_agreement":null},{"id":"W2102942754","doi":"10.1016/j.eururo.2013.10.013","title":"The Impact of Low Serum Sodium on Treatment Outcome of Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Cancer Database Consortium","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Electrolyte and hormonal disorders","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Dalhousie University; BC Cancer Agency","funders":"National Cancer Institute; Bayer Korea; Genentech; GlaxoSmithKline; Pfizer","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Kidney cancer; Cancer; Targeted therapy","score_opus":0.03140875065545458,"score_gpt":0.29455226573080784,"score_spread":0.2631435150753533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102942754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899007,0.001645194,0.000011120014,0.003145907,0.000073887546,0.0005672072,0.00067109894,0.000010109878,0.0039747464],"genre_scores_gemma":[0.99753225,0.0005829721,0.00006012281,0.0008464677,0.00006405651,0.000026100222,0.00028247654,0.000033887154,0.0005716516],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99778783,0.0006073484,0.00069988257,0.00031548468,0.00025246915,0.0003369679],"domain_scores_gemma":[0.99809265,0.0008274698,0.00038206764,0.00050239137,0.00011544899,0.00007997706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044959201,0.0002474659,0.0004180754,0.00010349908,0.000057312594,0.000013113826,0.00033356066,0.000023227445,0.00033170093],"category_scores_gemma":[0.00011300297,0.00011999919,0.00020296834,0.00013525868,0.00019278219,0.000050040795,0.00005339063,0.00027300758,0.000053573072],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02199465,0.0038834626,0.14876692,0.000042451346,0.0022557802,0.00047361353,0.0040038433,0.002741207,0.7845036,0.00011023169,0.022180038,0.009044198],"study_design_scores_gemma":[0.0117587745,0.0047458364,0.94661915,0.000013928322,0.00021005473,0.000008518334,0.0001667335,0.0013957375,0.0339988,0.00009044208,0.00084002665,0.00015197536],"about_ca_topic_score_codex":0.0063588596,"about_ca_topic_score_gemma":0.0005286747,"teacher_disagreement_score":0.7978522,"about_ca_system_score_codex":0.000078303325,"about_ca_system_score_gemma":0.00017882009,"threshold_uncertainty_score":0.9612736},"labels":[],"label_agreement":null},{"id":"W2103725052","doi":"10.1016/j.eururo.2014.09.007","title":"Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":297,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia Hospital; Alberta Cancer Foundation; McGill University Health Centre; University of Alberta; McGill University; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Bladder cancer; Cystectomy; Tolerability; Regimen; Neoadjuvant therapy; Internal medicine; Urology; Vinblastine; Gemcitabine; Oncology; Chemotherapy; Odds ratio; Surgery; Cancer; Adverse effect; Breast cancer","score_opus":0.018837636679873423,"score_gpt":0.3187905982001069,"score_spread":0.2999529615202335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103725052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87624764,0.00081055897,0.016411293,0.010882348,0.0014759526,0.0023024492,0.00014200073,0.00016718035,0.09156059],"genre_scores_gemma":[0.988596,0.00015187036,0.001985189,0.007866424,0.00044946605,0.00005195293,0.000024782472,0.00006442976,0.0008098931],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989232,0.00013950736,0.0002589301,0.00029979242,0.00011605505,0.00026252543],"domain_scores_gemma":[0.99923515,0.00012816812,0.00012112414,0.0002998128,0.000118231386,0.000097520904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018789209,0.00016269673,0.0003263835,0.00006134728,0.0000392449,0.000004857849,0.00010167769,0.00004487598,0.00044469733],"category_scores_gemma":[0.000049484788,0.00012916834,0.00013113009,0.000050050072,0.00008712525,0.000024871288,0.000029234721,0.000102673104,0.000025343783],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042080637,0.0035875647,0.25120133,0.0007594566,0.0035668109,0.00015232564,0.004074922,0.00034619603,0.20057069,0.0024463919,0.03585874,0.4932275],"study_design_scores_gemma":[0.018036166,0.0041072974,0.73441637,0.000051707684,0.0005355315,0.000017594146,0.000046972,0.0012938963,0.006929862,0.00009351726,0.23421988,0.0002512002],"about_ca_topic_score_codex":0.00003984337,"about_ca_topic_score_gemma":0.00002043035,"teacher_disagreement_score":0.4929763,"about_ca_system_score_codex":0.000034575343,"about_ca_system_score_gemma":0.00008319724,"threshold_uncertainty_score":0.5267332},"labels":[],"label_agreement":null},{"id":"W2105398102","doi":"10.1016/j.eururo.2009.12.029","title":"Prognostic Role of Lymphovascular Invasion in Patients with Urothelial Carcinoma of the Upper Urinary Tract: An International Validation Study","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Lymphovascular invasion; Medicine; Hazard ratio; Urothelial carcinoma; Proportional hazards model; Urology; Upper urinary tract; Internal medicine; Cohort; Urinary system; Stage (stratigraphy); Oncology; Cancer; Metastasis; Bladder cancer; Confidence interval","score_opus":0.008469725238063056,"score_gpt":0.22965426993734156,"score_spread":0.2211845446992785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105398102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968935,0.000011154821,0.0000020648188,0.000051926338,0.00019092848,0.00072916475,0.000012202473,0.000008729113,0.0021003173],"genre_scores_gemma":[0.9997302,0.0000010148269,0.00004387661,0.000074927724,0.00006720679,0.000010241521,0.0000267617,0.000024899875,0.000020868398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989883,0.00022410719,0.00023094003,0.00020870155,0.0002416536,0.000106320374],"domain_scores_gemma":[0.9993775,0.000022893648,0.0001094375,0.0003485412,0.00010326357,0.000038395996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018009228,0.00010188433,0.00016324458,0.00009427035,0.000022087856,0.00000340757,0.00017467533,0.000032038948,0.00008475404],"category_scores_gemma":[0.00006353368,0.00006497964,0.000044695797,0.000094902665,0.00007490419,0.00007332627,0.00005881367,0.0001435598,0.0000067048163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007778095,0.004315638,0.9900719,0.000006339814,0.000047561225,0.00002006393,0.0008770211,0.000010143654,0.0022010568,0.000015973319,0.0000012652026,0.0016552209],"study_design_scores_gemma":[0.005587764,0.0044678994,0.9881927,0.000008605075,0.000116933195,0.000026774665,0.000062217,0.000018826515,0.0013443548,0.00001125116,0.000111137146,0.000051557134],"about_ca_topic_score_codex":0.000091160124,"about_ca_topic_score_gemma":0.000013045655,"teacher_disagreement_score":0.0048099547,"about_ca_system_score_codex":0.000015014081,"about_ca_system_score_gemma":0.0000661908,"threshold_uncertainty_score":0.26497927},"labels":[],"label_agreement":null},{"id":"W2105737543","doi":"10.1016/j.eururo.2012.11.042","title":"Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; McMaster University; Ontario Clinical Oncology Group","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Proportional hazards model; Retrospective cohort study; Context (archaeology); Carboplatin; Metastatic Urothelial Carcinoma; Oncology; Performance status; Prospective cohort study; Chemotherapy; Cancer; Cisplatin; Urothelial carcinoma; Bladder cancer","score_opus":0.01676099696267899,"score_gpt":0.3059331095521803,"score_spread":0.2891721125895013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105737543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99401903,0.0013254449,0.00020539954,0.00017941056,0.000112975584,0.0014111259,0.00043941473,0.000027653348,0.0022795203],"genre_scores_gemma":[0.998562,0.000046664874,0.0003906751,0.00036093075,0.00040173202,0.000050257102,0.00006740751,0.000042834417,0.0000774903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99659073,0.0015361634,0.0008528547,0.0004032693,0.0002527284,0.0003642706],"domain_scores_gemma":[0.99781066,0.00080784,0.00078314374,0.00040501787,0.00011925517,0.00007405998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019512499,0.00025595824,0.001270551,0.0002906596,0.000058563684,0.0000066471166,0.00018846287,0.00006727656,0.00061642536],"category_scores_gemma":[0.0008862851,0.00017470725,0.00032435267,0.00075416715,0.00017048272,0.000098613586,0.000039464052,0.0003002366,0.000018717146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005807206,0.0019301302,0.8814492,0.0000368333,0.0037521422,0.00003730762,0.02027042,0.000026119089,0.078246236,0.000029257362,0.000030294214,0.008384811],"study_design_scores_gemma":[0.011973701,0.0024040516,0.96152437,0.00002343396,0.0041093486,0.000008377588,0.0003694735,0.00022919282,0.01902885,0.0000733674,0.000113128524,0.00014272724],"about_ca_topic_score_codex":0.00011673182,"about_ca_topic_score_gemma":0.0000625175,"teacher_disagreement_score":0.08007511,"about_ca_system_score_codex":0.000068506706,"about_ca_system_score_gemma":0.00006426004,"threshold_uncertainty_score":0.7124355},"labels":[],"label_agreement":null},{"id":"W2106187131","doi":"10.1016/j.eururo.2013.05.025","title":"Management of Biochemical Recurrence After Primary Treatment of Prostate Cancer: A Systematic Review of the Literature","year":2013,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Salvage therapy; Cryotherapy; Brachytherapy; Biochemical recurrence; Radiation therapy; Systematic review; Prostate-specific antigen; Randomized controlled trial; Cryoablation; Management of prostate cancer; Surgery; Oncology; Cancer; Internal medicine; MEDLINE; Chemotherapy","score_opus":0.019410449488987624,"score_gpt":0.2954136844253047,"score_spread":0.27600323493631707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106187131","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001117602,0.9915724,2.0792608e-7,0.0001841494,0.00015930997,0.0067340015,0.0003472909,0.000008459019,0.0008824547],"genre_scores_gemma":[0.00018323172,0.9971193,0.000063246975,0.00018841487,0.000035529025,0.0017590984,0.00014366923,0.000048077534,0.00045940705],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99724054,0.0006341256,0.001298695,0.00039690206,0.00022274659,0.0002070141],"domain_scores_gemma":[0.99741334,0.000087584915,0.0012696836,0.0010012668,0.00016031692,0.00006783339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020609969,0.00040659655,0.0031587775,0.00007987431,0.000011145991,0.0000037283119,0.00024138708,0.000080825695,0.00005642183],"category_scores_gemma":[0.000024518848,0.00019569803,0.00072617637,0.00033368636,0.00016095159,0.00001636431,0.00014790296,0.00014386859,0.00001730258],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028251823,0.00034632694,0.000037931644,0.88332313,0.0011710544,0.00011639726,0.00011153033,2.2932877e-8,7.101766e-7,0.000013027565,0.0005198751,0.11433176],"study_design_scores_gemma":[0.0004423614,0.00075600157,0.00011846892,0.8335973,0.0113730235,0.00006892817,0.000002232681,6.3448866e-8,0.000022856342,0.0000019504166,0.15350415,0.00011266948],"about_ca_topic_score_codex":0.000004437378,"about_ca_topic_score_gemma":1.3412867e-7,"teacher_disagreement_score":0.15298428,"about_ca_system_score_codex":0.00018141189,"about_ca_system_score_gemma":0.00013679331,"threshold_uncertainty_score":0.7980334},"labels":[],"label_agreement":null},{"id":"W2106421364","doi":"10.1016/j.eururo.2007.01.004","title":"Urethral Reconstruction Using the Radial Forearm Free Flap: Experience in Oncologic Cases and Gender Reassignment","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Reconstructive Surgery and Microvascular Techniques","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Air (Canada)","funders":"","keywords":"Medicine; Surgery; Urethra; Urethral stricture; Stenosis; Phalloplasty; Urethroplasty; Free flap; Penectomy; Fistula; Reconstructive surgery; Urinary incontinence; Forearm; Reconstructive Surgeon; Penis; Penile cancer; Radiology","score_opus":0.07413267121674576,"score_gpt":0.320338886559442,"score_spread":0.2462062153426962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106421364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98859954,0.00064062484,0.002302592,0.00011439325,0.00028586856,0.0002613599,0.0000014364261,0.00004643875,0.0077477302],"genre_scores_gemma":[0.99652815,0.000075019016,0.002606202,0.0005686997,0.00017757273,0.0000035787673,0.0000021209316,0.00001527109,0.000023365752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881595,0.0003309308,0.00025645038,0.00026471968,0.000074948475,0.00025699238],"domain_scores_gemma":[0.99936825,0.00020452988,0.000078349316,0.00025826803,0.000027492224,0.00006309313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010390452,0.00011660672,0.00019098318,0.00011920637,0.000088055785,0.000009035778,0.00008054061,0.000069356836,0.000059632624],"category_scores_gemma":[0.0003055654,0.00008330384,0.000057535195,0.000103280705,0.00048145375,0.000060532282,0.00008027085,0.0002536808,0.0000027315102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011030645,0.00014311778,0.6107527,0.000030108416,0.0001360867,0.0044188374,0.004002738,0.000012576838,0.0974635,0.0012929178,0.00037468964,0.28026965],"study_design_scores_gemma":[0.0027310394,0.0010371084,0.89483243,0.000038957794,0.00017640341,0.060725253,0.0020532168,0.00014410188,0.022309963,0.0016426013,0.013904267,0.00040465337],"about_ca_topic_score_codex":0.000039794497,"about_ca_topic_score_gemma":0.000026284826,"teacher_disagreement_score":0.28407973,"about_ca_system_score_codex":0.00006312295,"about_ca_system_score_gemma":0.000030406509,"threshold_uncertainty_score":0.3397032},"labels":[],"label_agreement":null},{"id":"W2107806473","doi":"10.1016/j.eururo.2012.10.048","title":"Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":356,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Astellas Pharma Canada; Pfizer; Eli Lilly and Company","keywords":"Mirabegron; Tolterodine; Medicine; Overactive bladder; Tolerability; Placebo; Urology; Adverse effect; Internal medicine; Discontinuation; Agonist; Randomized controlled trial","score_opus":0.06821404398549276,"score_gpt":0.3772788177020855,"score_spread":0.30906477371659274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107806473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96363264,0.000534655,0.00016042388,0.0007937064,0.0001569094,0.0061910423,0.000020845993,0.000035562665,0.028474225],"genre_scores_gemma":[0.99798125,0.000076330194,0.00011088942,0.00028366075,0.00027283834,0.00009403141,0.000038726655,0.000064759115,0.0010774956],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99454683,0.003131364,0.00078983087,0.00049986644,0.00034662746,0.0006855022],"domain_scores_gemma":[0.997025,0.0017587552,0.00021168466,0.00043159164,0.00014803548,0.00042492105],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035554871,0.00032056245,0.001558904,0.00044102466,0.00009083352,0.000020962334,0.00017270881,0.00006722623,0.0006348677],"category_scores_gemma":[0.0007179491,0.0002465233,0.000171054,0.00027318503,0.00023556646,0.00017619706,0.00023021118,0.00059749343,0.00008679165],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97199184,0.007738949,0.0038546612,0.00002531293,0.00090070587,0.00023653884,0.009753956,0.000009114066,0.0018078453,0.000050295366,0.0001527787,0.0034780032],"study_design_scores_gemma":[0.9276455,0.006234762,0.06104391,0.000013455166,0.00048332225,0.00006768805,0.00072715664,0.00005497987,0.00052000425,0.000004768671,0.0029905709,0.00021390263],"about_ca_topic_score_codex":0.00008729498,"about_ca_topic_score_gemma":0.000028020637,"teacher_disagreement_score":0.05718925,"about_ca_system_score_codex":0.00005650143,"about_ca_system_score_gemma":0.00011204699,"threshold_uncertainty_score":0.9999987},"labels":[],"label_agreement":null},{"id":"W2108539565","doi":"10.1016/j.eururo.2010.03.008","title":"Focal Laser Ablation for Prostate Cancer Followed by Radical Prostatectomy: Validation of Focal Therapy and Imaging Accuracy","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Ablation; Magnetic resonance imaging; Coagulative necrosis; Prostate; Radiology; Histopathology; Nuclear medicine; Urology; Cancer; Pathology; Internal medicine","score_opus":0.013548492531635639,"score_gpt":0.28445356039926706,"score_spread":0.2709050678676314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108539565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916196,0.0010641823,0.00033139132,0.00499001,0.00025193833,0.0012331802,0.00009687321,0.000051883762,0.0003609294],"genre_scores_gemma":[0.9973281,0.0006318826,0.00044930715,0.0009584035,0.00013524236,0.00016962612,0.0001860159,0.000045768462,0.00009568114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896806,0.000092469774,0.00027380616,0.00032136962,0.00010436344,0.00023992462],"domain_scores_gemma":[0.99929625,0.00017479411,0.00014770802,0.00017085082,0.00010422645,0.00010615698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002868514,0.00015180474,0.00024148622,0.000059514095,0.000064629014,0.000017336346,0.00004968776,0.000041620595,0.00005717359],"category_scores_gemma":[0.00011928111,0.000120091056,0.000059322247,0.00006815537,0.00016206868,0.00009449743,0.000027055166,0.00016291828,0.0000044561184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045580906,0.00072335877,0.39835057,0.00013515132,0.0002720837,0.00006880075,0.0012352912,0.00002092214,0.22130565,0.00033948058,0.014733789,0.35825682],"study_design_scores_gemma":[0.028580429,0.0045967475,0.3481497,0.0000709748,0.00039534128,0.00009794047,0.0000487875,0.001992296,0.32561558,0.00061911275,0.2893414,0.00049172057],"about_ca_topic_score_codex":0.000031186242,"about_ca_topic_score_gemma":0.000006167536,"teacher_disagreement_score":0.3577651,"about_ca_system_score_codex":0.000024056302,"about_ca_system_score_gemma":0.0000707526,"threshold_uncertainty_score":0.48971713},"labels":[],"label_agreement":null},{"id":"W2108648584","doi":"10.1016/j.eururo.2005.08.015","title":"Holmium Laser Enucleation of the Prostate (HoLEP): The Endourologic Alternative to Open Prostatectomy","year":2005,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Enucleation; Urology; Prostate; Prostatectomy; Open Prostatectomy; Surgery; Internal medicine","score_opus":0.031903620840623106,"score_gpt":0.31480065522352896,"score_spread":0.28289703438290587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108648584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8480779,0.00009355684,0.000042357024,0.05037791,0.00012537927,0.0023374655,0.000029810757,0.000036394027,0.098879226],"genre_scores_gemma":[0.98573524,0.000045382996,0.00015999703,0.007071223,0.00021641632,0.000044437045,0.000011319939,0.000039244343,0.006676733],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977769,0.0009708732,0.00029174404,0.0003282702,0.0002575982,0.00037461828],"domain_scores_gemma":[0.9988966,0.00014259014,0.00011606314,0.00058738835,0.00015133094,0.00010600207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010464913,0.00015035763,0.00020809156,0.00007919758,0.00016482236,0.00003985909,0.0007443671,0.000031637963,0.00025143757],"category_scores_gemma":[0.00022214152,0.0000784453,0.000069794616,0.00029410544,0.00024131595,0.0000960694,0.0008877556,0.00042328372,0.000536747],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033195876,0.0042035813,0.23115142,0.00036490473,0.0015144068,0.0018437505,0.07212162,0.009865666,0.11634104,0.0056634014,0.13378975,0.38994458],"study_design_scores_gemma":[0.0031634888,0.0038860512,0.29591092,0.000020331603,0.000078105644,0.00028653943,0.00016103985,0.00028874222,0.017838443,0.00026662642,0.6779274,0.00017229872],"about_ca_topic_score_codex":0.000038027498,"about_ca_topic_score_gemma":0.00002115022,"teacher_disagreement_score":0.54413766,"about_ca_system_score_codex":0.000027355312,"about_ca_system_score_gemma":0.00007750044,"threshold_uncertainty_score":0.6898976},"labels":[],"label_agreement":null},{"id":"W2108660403","doi":"10.1016/j.eururo.2011.12.013","title":"Does the Imprecise Definition of Overactive Bladder Serve Commercial Rather than Patient Interests?","year":2012,"lang":"en","type":"editorial","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Overactive bladder; Urology; General surgery; Alternative medicine; Pathology","score_opus":0.025158421417074348,"score_gpt":0.29748867963417464,"score_spread":0.2723302582171003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108660403","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07757975,0.0016058286,0.000033910233,0.002246736,0.80518353,0.0016571648,0.001027119,0.0000945093,0.110571474],"genre_scores_gemma":[0.5120329,0.00072521204,0.00004706288,0.00043233926,0.48433194,0.000034607063,0.0010347539,0.0001823221,0.001178841],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960866,0.0018959565,0.0005023134,0.00040599314,0.00059454545,0.0005145678],"domain_scores_gemma":[0.9968086,0.0016018365,0.00034350797,0.00069316244,0.00039551832,0.00015739237],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00081495673,0.00034490108,0.0005418378,0.0001561328,0.00010760756,0.000022618162,0.0003339655,0.00033659552,0.0009663661],"category_scores_gemma":[0.0006702656,0.0001765312,0.00023506797,0.000114690265,0.00034850303,0.000082761915,0.00044560293,0.0018768684,0.00039576477],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004300591,0.00056942896,0.00089713227,0.00012520351,0.00054439146,0.00021433992,0.0037037751,3.8986772e-7,0.00022976185,0.00004649317,0.98014677,0.009221732],"study_design_scores_gemma":[0.0013458771,0.0032967234,0.010261892,0.000056439872,0.00038925526,0.00003835872,0.0001622707,0.0000020927362,0.00016610754,0.0001892616,0.983872,0.00021970127],"about_ca_topic_score_codex":0.000106129235,"about_ca_topic_score_gemma":0.000048146245,"teacher_disagreement_score":0.43445316,"about_ca_system_score_codex":0.00005330322,"about_ca_system_score_gemma":0.00019606003,"threshold_uncertainty_score":0.9999469},"labels":[],"label_agreement":null},{"id":"W2108830038","doi":"10.1016/j.eururo.2013.06.038","title":"Intermittent Androgen Deprivation Therapy: Clarity from Confusion","year":2013,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"","keywords":"Medicine; Androgen deprivation therapy; Gynecomastia; Libido; Prostate cancer; Adverse effect; Androgen; Internal medicine; Erectile dysfunction; Sexual dysfunction; Endocrinology; Testosterone (patch); Estrogen; Antiandrogens; Hormone; Antiandrogen; Cancer","score_opus":0.045858137463887436,"score_gpt":0.28477856026545945,"score_spread":0.238920422801572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108830038","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21343084,0.0034729596,0.000052403782,0.7583541,0.0007286754,0.0010915293,0.00007434244,0.00015842421,0.02263668],"genre_scores_gemma":[0.060946405,0.0021589773,0.00009784074,0.91415584,0.005551352,0.000042088093,0.0054827104,0.00015283132,0.011411963],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997948,0.00057244144,0.00028257127,0.00054687436,0.0002613624,0.00038873183],"domain_scores_gemma":[0.9989827,0.000107248576,0.00013034334,0.00056707923,0.00012471518,0.000087886365],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00016523944,0.00028036063,0.0004040292,0.00015062385,0.00007052824,0.000035181652,0.00022681787,0.0004097861,0.002048232],"category_scores_gemma":[0.000041199153,0.00020193057,0.00013869237,0.0000669356,0.00015667947,0.00003947764,0.00018057531,0.0017199883,0.0020807125],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026432282,0.00006410408,0.00534769,0.000023961273,0.00028599094,0.002661611,0.0001616002,9.467242e-8,0.001622781,0.0000023437947,0.9549418,0.034623712],"study_design_scores_gemma":[0.0021468513,0.00063530245,0.04793067,0.00002713776,0.000083202256,0.00005652142,0.000003838217,0.000020743923,0.00027085,0.00009942105,0.9485641,0.00016135057],"about_ca_topic_score_codex":0.00013807371,"about_ca_topic_score_gemma":0.0000018848905,"teacher_disagreement_score":0.15580168,"about_ca_system_score_codex":0.00007692574,"about_ca_system_score_gemma":0.00007704113,"threshold_uncertainty_score":0.99886405},"labels":[],"label_agreement":null},{"id":"W2109783350","doi":"10.1016/j.eururo.2014.08.025","title":"Efficacy Outcomes by Baseline Prostate-specific Antigen Quartile in the AFFIRM Trial","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate-specific antigen; Quartile; Baseline (sea); Prostate; Internal medicine; Prostatectomy; Oncology; Urology; Confidence interval; Cancer","score_opus":0.028676018643462732,"score_gpt":0.30663772382565424,"score_spread":0.2779617051821915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109783350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9620094,0.0008029576,0.00005943281,0.019196372,0.00025906373,0.0011213993,0.0000120264895,0.000063926134,0.01647543],"genre_scores_gemma":[0.9951292,0.00019846763,0.00003500812,0.0024624125,0.00029987705,0.000026031745,0.00013760236,0.00003514868,0.0016762336],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99755585,0.0011752043,0.00030078937,0.000328703,0.00022739655,0.00041202552],"domain_scores_gemma":[0.9989265,0.00045643456,0.00005654873,0.00043597785,0.00003466505,0.00008985877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015979173,0.00015805756,0.00028116239,0.00009816703,0.00007756768,0.000024120807,0.00021313364,0.00004253311,0.00019127519],"category_scores_gemma":[0.00024560583,0.00008935892,0.00008233524,0.00018345029,0.00015191559,0.000030378562,0.000049600574,0.00031939472,0.0006305654],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19441542,0.0061456016,0.10169838,0.00006712272,0.00028944464,0.0018966391,0.0078768395,0.00004436721,0.013048129,0.00084384414,0.5008081,0.1728661],"study_design_scores_gemma":[0.066288434,0.003770998,0.1023289,0.0000065331524,0.000022678334,0.000016283615,0.00007873915,0.000082003535,0.00020567792,0.000023851795,0.82705146,0.00012444644],"about_ca_topic_score_codex":0.000016241669,"about_ca_topic_score_gemma":0.0000066787834,"teacher_disagreement_score":0.32624337,"about_ca_system_score_codex":0.000022831327,"about_ca_system_score_gemma":0.00003095015,"threshold_uncertainty_score":0.8104853},"labels":[],"label_agreement":null},{"id":"W2110096771","doi":"10.1016/j.eururo.2013.11.009","title":"Effects of Nonlinear Aerobic Training on Erectile Dysfunction and Cardiovascular Function Following Radical Prostatectomy for Clinically Localized Prostate Cancer","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Prostatectomy; Prostate cancer; Erectile dysfunction; Aerobic exercise; Internal medicine; Urology; Randomized controlled trial; Cancer","score_opus":0.022324895476756725,"score_gpt":0.2747068414022283,"score_spread":0.2523819459254716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110096771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788321,0.0015856783,0.010811039,0.00081477454,0.002551875,0.0026035088,0.0000047294006,0.00023895802,0.0025573012],"genre_scores_gemma":[0.9935204,0.00023277133,0.00080363004,0.0034728518,0.0005760805,0.00035010377,0.000029206354,0.000077532204,0.0009374331],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980604,0.00033977965,0.0005145874,0.0005368466,0.00022825488,0.00032014225],"domain_scores_gemma":[0.99874353,0.00055023347,0.00013791886,0.00023085307,0.00018460545,0.00015285876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069132965,0.000232111,0.0006570805,0.00015702785,0.00015117868,0.000016631619,0.000040807932,0.00013038008,0.00008001811],"category_scores_gemma":[0.0007766875,0.00018701283,0.00032415797,0.0001811613,0.0001575502,0.00007633918,0.000039470215,0.00034598954,0.000068260444],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03729164,0.0015044736,0.034466986,0.0020804207,0.0115267495,0.0002149266,0.004153189,0.0014253046,0.060355123,0.0004485541,0.024361134,0.8221715],"study_design_scores_gemma":[0.052260425,0.025905285,0.23603486,0.00030628688,0.004202218,0.00014795469,0.0010931523,0.0032804082,0.0020451127,0.00016176436,0.6737104,0.00085213926],"about_ca_topic_score_codex":0.000033412616,"about_ca_topic_score_gemma":0.0000013128148,"teacher_disagreement_score":0.82131934,"about_ca_system_score_codex":0.000025962803,"about_ca_system_score_gemma":0.00005416719,"threshold_uncertainty_score":0.76261616},"labels":[],"label_agreement":null},{"id":"W2110508454","doi":"10.1016/j.eururo.2010.05.023","title":"A Critical Analysis of Orthotopic Bladder Substitutes in Adult Patients with Bladder Cancer: Is There a Perfect Solution?","year":2010,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urinary diversion; Surgery; Quality of life (healthcare); Cancer; Urology; General surgery; Internal medicine","score_opus":0.02114202816562201,"score_gpt":0.32098729133185927,"score_spread":0.2998452631662373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110508454","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010941385,0.9790252,0.000025705353,0.00022537472,0.0002856055,0.0011305927,0.0004700813,0.00004815365,0.007847917],"genre_scores_gemma":[0.0465027,0.9512876,0.00011710774,0.00085086015,0.00021972111,0.00014287006,0.00035171956,0.00013582963,0.0003915727],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99724513,0.00050633634,0.0007211508,0.0007453364,0.00030650446,0.00047553485],"domain_scores_gemma":[0.99835503,0.00019880723,0.00026490702,0.0006918439,0.00032233458,0.00016709203],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015616283,0.0005228682,0.002239899,0.0006562206,0.0000562607,0.00001390354,0.00023819246,0.00028894184,0.0017044925],"category_scores_gemma":[0.00014719361,0.00035256756,0.00056663656,0.00095120084,0.00035437665,0.00005282559,0.00007913028,0.0008131246,0.00007996139],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060417916,0.0022610563,0.23912735,0.005149317,0.017496914,0.0008039478,0.0008931463,0.00000457808,0.0000018607666,0.00026010576,0.0008191508,0.7325784],"study_design_scores_gemma":[0.0037050575,0.0017244502,0.1541741,0.0016997167,0.056157626,0.000043626034,0.00001041144,0.000028621023,0.0000019695624,0.0000062277227,0.7818069,0.0006412826],"about_ca_topic_score_codex":0.00033811587,"about_ca_topic_score_gemma":0.0008036087,"teacher_disagreement_score":0.78098774,"about_ca_system_score_codex":0.00007479586,"about_ca_system_score_gemma":0.00040489444,"threshold_uncertainty_score":0.99989265},"labels":[],"label_agreement":null},{"id":"W2110568962","doi":"10.1016/j.eururo.2013.09.003","title":"Prediction of Intravesical Recurrence After Radical Nephroureterectomy: Development of a Clinical Decision-making Tool","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nomogram; Proportional hazards model; Concordance; Urology; Surgery; Cohort; Retrospective cohort study; Prospective cohort study; Bladder cancer; Internal medicine; Cancer","score_opus":0.03562128064193753,"score_gpt":0.31931701469133467,"score_spread":0.28369573404939713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110568962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903008,0.00016377884,0.0051089968,0.00013786931,0.00037226794,0.00033529542,0.000009448893,0.000028739127,0.0035428551],"genre_scores_gemma":[0.9826256,0.000023641993,0.01644947,0.00058936665,0.00023493219,0.000017920012,0.000006645522,0.000021372072,0.000031066593],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981185,0.00026945557,0.00091618014,0.0002879604,0.0002101507,0.00019772889],"domain_scores_gemma":[0.99907976,0.0002744002,0.00016973782,0.00026513144,0.00010794502,0.000103023456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044880348,0.00012995831,0.00041215142,0.0000800058,0.000022986855,0.000004474426,0.00010933977,0.000088347486,0.00089852],"category_scores_gemma":[0.00044719674,0.00009983073,0.00010902716,0.00009816335,0.00021468704,0.000050434715,0.000087641674,0.00024445922,0.00017578334],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023977528,0.0005557488,0.19437674,0.00005048313,0.0002131201,0.000095699346,0.0008527545,0.0000010710667,0.00066608115,0.000036517475,0.0016321457,0.79912186],"study_design_scores_gemma":[0.0017935395,0.0012440266,0.9850276,0.000112387075,0.000091442,0.00006702239,0.000010473529,0.00011842583,0.00025226083,0.00013120232,0.011080345,0.00007124265],"about_ca_topic_score_codex":0.0000030830186,"about_ca_topic_score_gemma":0.0000011589987,"teacher_disagreement_score":0.7990506,"about_ca_system_score_codex":0.000019626536,"about_ca_system_score_gemma":0.00017897469,"threshold_uncertainty_score":0.9838164},"labels":[],"label_agreement":null},{"id":"W2110643529","doi":"10.1016/j.eururo.2007.11.006","title":"Neoadjuvant Sutent Induction Therapy May Effectively Down-Stage Renal Cell Carcinoma Atrial Thrombi","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Thrombus; Sunitinib; Stage (stratigraphy); Renal cell carcinoma; Urology; Median sternotomy; Internal medicine; Surgery","score_opus":0.029572603943497824,"score_gpt":0.26359032866365856,"score_spread":0.23401772472016075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110643529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9553383,0.0014165359,0.0002626339,0.00056511717,0.00097107637,0.00085171,0.000007546075,0.00013876724,0.040448338],"genre_scores_gemma":[0.99475604,0.000060283874,0.00028143826,0.0008313081,0.0016249034,0.0000051266175,0.00004839312,0.000097726814,0.0022947842],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971646,0.0006820732,0.00048986723,0.0006719595,0.0003354675,0.00065602746],"domain_scores_gemma":[0.998639,0.000184868,0.00021088982,0.00056913786,0.00010827735,0.00028783092],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011903081,0.0003713376,0.00047432954,0.0002530643,0.00012932105,0.000018447621,0.0001679895,0.00014100641,0.00028833057],"category_scores_gemma":[0.0000520897,0.00028929734,0.00033303647,0.00021494896,0.00017582689,0.000047458845,0.00009603334,0.00053080614,0.0007627186],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019911423,0.0015675467,0.13926227,0.000102662096,0.00060293864,0.020894693,0.0026737163,0.00025149723,0.7159943,0.00050379254,0.0046989378,0.093536235],"study_design_scores_gemma":[0.008099077,0.0076702693,0.88399017,0.000006288446,0.00017298841,0.00060635014,0.000058661368,0.000019605024,0.0642913,0.000012886211,0.034809794,0.00026260084],"about_ca_topic_score_codex":0.00012588178,"about_ca_topic_score_gemma":0.000010767199,"teacher_disagreement_score":0.7447279,"about_ca_system_score_codex":0.00019964745,"about_ca_system_score_gemma":0.00007373001,"threshold_uncertainty_score":0.9999559},"labels":[],"label_agreement":null},{"id":"W2112412554","doi":"10.1016/j.eururo.2009.02.021","title":"Lymphadenectomy in the Surgical Management of Penile Cancer","year":2009,"lang":"en","type":"review","venue":"European Urology","topic":"Genital Health and Disease","field":"Medicine","cited_by":245,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Penile cancer; Lymphadenectomy; Lymph node; Dissection (medical); Lymph; Surgery; Penile Carcinoma; Inguinal canal; Cancer; Radiology; General surgery; Penis; Pathology; Inguinal hernia; Internal medicine; Hernia","score_opus":0.0561211195513133,"score_gpt":0.38977679426320644,"score_spread":0.33365567471189317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112412554","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016517942,0.8811362,2.6952515e-7,0.00025047667,0.00008965729,0.0006227103,0.000012153207,0.000012691499,0.117710665],"genre_scores_gemma":[0.015009682,0.9826987,0.0000132760415,0.001032608,0.00021176992,0.00003402189,0.000059946746,0.000026824315,0.0009131831],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99810475,0.00072004943,0.00047798688,0.00026066022,0.00015218751,0.0002843868],"domain_scores_gemma":[0.9992539,0.00008952786,0.00014017093,0.00037612926,0.00001674727,0.00012347818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000401948,0.00018950595,0.000776825,0.00012184023,0.000018826018,0.000003007108,0.00024377771,0.000068192516,0.00022783512],"category_scores_gemma":[0.000012138342,0.00011338705,0.00022554105,0.00023520703,0.00005275565,0.000007692973,0.000055062003,0.00022446366,0.00026482838],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010463414,0.00021601544,0.00007079993,0.016576061,0.000021152657,0.007386383,0.000036342044,6.1607625e-7,4.74331e-9,0.00034179835,0.0025699472,0.9726762],"study_design_scores_gemma":[0.00079428125,0.00020699084,0.0028047794,0.00041009285,0.0007552304,0.0003466998,0.000006886234,5.522923e-7,7.104917e-9,0.000008457775,0.9945875,0.00007854966],"about_ca_topic_score_codex":0.000013841235,"about_ca_topic_score_gemma":0.0000023263335,"teacher_disagreement_score":0.9920175,"about_ca_system_score_codex":0.000032769825,"about_ca_system_score_gemma":0.00014152238,"threshold_uncertainty_score":0.46237898},"labels":[],"label_agreement":null},{"id":"W2112441848","doi":"10.1016/j.eururo.2014.03.028","title":"Next-generation Sequencing of Urologic Cancers: Next Is Now","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Medicine; Exome sequencing; DNA sequencing; Exome; Prostate cancer; Genome; Computational biology; Bioinformatics; Gene; Internal medicine; Mutation; Cancer; Genetics; Biology","score_opus":0.09248761131502344,"score_gpt":0.2618621397794102,"score_spread":0.16937452846438678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112441848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.940145,0.0006905222,0.0006832817,0.0014191319,0.00022463026,0.0001821067,0.000002203339,0.00005362608,0.056599505],"genre_scores_gemma":[0.99251544,0.00007242314,0.0007852856,0.005393611,0.00051182887,0.0000046499313,0.00002781978,0.00003504184,0.0006538869],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99858904,0.00038595908,0.00029852818,0.00033342256,0.0001428405,0.00025019472],"domain_scores_gemma":[0.99919116,0.00006463882,0.00014327599,0.0004145619,0.000082787585,0.0001035767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034848746,0.00015724507,0.00029073155,0.00009909354,0.00004414277,0.00001079781,0.0001063681,0.00005851607,0.00032219704],"category_scores_gemma":[0.000103261445,0.00012920861,0.000089539855,0.000103524646,0.00010421237,0.0000755841,0.00005271773,0.00015884051,0.00044370248],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003766541,0.000110122935,0.019604037,0.00008559163,0.00018334319,0.0004698527,0.0012758615,0.0008835847,0.9424809,0.0007059448,0.009531313,0.024292747],"study_design_scores_gemma":[0.012342457,0.030069338,0.21260256,0.00008746725,0.0018809222,0.002340577,0.0003048386,0.07113653,0.25804666,0.00059791387,0.4092246,0.0013661218],"about_ca_topic_score_codex":0.000062991356,"about_ca_topic_score_gemma":0.000021061362,"teacher_disagreement_score":0.6844343,"about_ca_system_score_codex":0.00011822099,"about_ca_system_score_gemma":0.000075359916,"threshold_uncertainty_score":0.5703046},"labels":[],"label_agreement":null},{"id":"W2112640474","doi":"10.1016/j.eururo.2012.12.061","title":"Radical Locoregional Therapy for Bladder Cancer: Underutilized, or Unsuitable in Many?","year":2013,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Cancer; General surgery; Urology; Surgery; Internal medicine","score_opus":0.056047969735519114,"score_gpt":0.3122638391787825,"score_spread":0.25621586944326336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112640474","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028280907,0.0082707945,0.00045598103,0.95845103,0.0015781983,0.0039060079,0.00025739043,0.00018863601,0.024063839],"genre_scores_gemma":[0.005055738,0.002603904,0.00030347172,0.92957413,0.0069216467,0.00067354814,0.000676676,0.0003228845,0.053868007],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970933,0.00036887455,0.0005027965,0.0008645196,0.0002915686,0.0008789106],"domain_scores_gemma":[0.99882025,0.0002938612,0.00016190071,0.0004908866,0.00009429,0.00013881653],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019401938,0.0005306347,0.00085967034,0.0002646584,0.000074778916,0.000027134787,0.00031120284,0.00055613625,0.007720182],"category_scores_gemma":[0.000036440648,0.00038068093,0.0002481017,0.000120834906,0.0002925015,0.000049033595,0.00007046896,0.0013431361,0.0007478359],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020423755,0.00017947948,0.001025681,0.000093715396,0.00048541118,0.0019899087,0.00007161961,0.000002353477,0.000027577576,0.000034313205,0.9821769,0.01187064],"study_design_scores_gemma":[0.010663626,0.001704134,0.004297786,0.000041425043,0.00021640975,0.0002827387,0.000006494888,0.000054420216,0.00001881131,0.00021611704,0.9821628,0.00033527313],"about_ca_topic_score_codex":0.0003078289,"about_ca_topic_score_gemma":0.000041655327,"teacher_disagreement_score":0.029804168,"about_ca_system_score_codex":0.00016785976,"about_ca_system_score_gemma":0.00052669464,"threshold_uncertainty_score":0.9998645},"labels":[],"label_agreement":null},{"id":"W2113194416","doi":"10.1016/j.eururo.2011.04.038","title":"New Therapies for Castration-Resistant Prostate Cancer: Efficacy and Safety","year":2011,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; Université de Montréal; Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Castration; Oncology; Prostate; Cancer; Gynecology; Internal medicine; Urology; Hormone","score_opus":0.08461366801589301,"score_gpt":0.3722958268717825,"score_spread":0.28768215885588944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113194416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019089315,0.9914083,0.000024714696,0.00054934237,0.00019342598,0.0024054216,0.00013020642,0.00005562484,0.005213867],"genre_scores_gemma":[0.00003961632,0.9867718,0.00030715193,0.00012159067,0.00047328442,0.00010219055,0.0002651374,0.00010766876,0.011811522],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983688,0.00026429837,0.00040763456,0.00048534496,0.00008790352,0.00038599322],"domain_scores_gemma":[0.99905705,0.00018660676,0.00017608782,0.0003007513,0.00006893537,0.00021058664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027097607,0.0003355813,0.00097567233,0.00013482681,0.000114087205,0.000023651857,0.00012809821,0.00010741282,0.0001952043],"category_scores_gemma":[0.000044385626,0.00021877889,0.00017167845,0.000108428685,0.00013727274,0.000028616772,0.0000671611,0.0002965237,0.00006175727],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011718312,0.00003979853,0.000018949086,0.0031894743,0.0005204303,0.00010323193,0.00038738482,5.559079e-8,0.0000056053136,0.00024286952,0.0032453784,0.991075],"study_design_scores_gemma":[0.0025219114,0.0013005079,0.00048048256,0.0009279345,0.0010556537,0.00007608141,0.0000060229704,3.1495432e-7,0.0000010797146,0.000024408448,0.9934302,0.00017538754],"about_ca_topic_score_codex":0.000047978592,"about_ca_topic_score_gemma":0.000019401528,"teacher_disagreement_score":0.9908996,"about_ca_system_score_codex":0.000064690714,"about_ca_system_score_gemma":0.00063672394,"threshold_uncertainty_score":0.8921544},"labels":[],"label_agreement":null},{"id":"W2113518167","doi":"10.1016/j.eururo.2006.12.015","title":"Renal Cell Carcinoma with Nodal Metastases in the Absence of Distant Metastatic Disease: Prognostic Indicators of Disease-Specific Survival","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Clear cell; Oncology; Cohort; Carcinoma; Clear cell renal cell carcinoma; Disease; Kidney cancer; Stage (stratigraphy); Nephrectomy; Adjuvant therapy; Kidney; Cancer","score_opus":0.018816999113465294,"score_gpt":0.22500989613217784,"score_spread":0.20619289701871255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113518167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924125,0.003232692,0.00016301606,0.0002609883,0.00004722009,0.000694773,0.00012748035,0.000017127128,0.003044194],"genre_scores_gemma":[0.99932003,0.000019783862,0.00023423429,0.000060151877,0.000056287732,0.000023107625,0.00017161286,0.000045265304,0.00006952806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99717605,0.0009819033,0.00056005426,0.00042093592,0.00051395583,0.00034710998],"domain_scores_gemma":[0.9983995,0.00041581958,0.00030261517,0.0006405582,0.00006525202,0.00017624511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049301336,0.00026319304,0.00046865208,0.00026035687,0.00003887246,0.000008504673,0.00026342005,0.000013227869,0.000060908817],"category_scores_gemma":[0.000065294545,0.00015693906,0.00013232767,0.0004807616,0.0005138667,0.000037235048,0.00006269402,0.00019016926,0.00001757125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004219822,0.001990116,0.9763998,0.00035272026,0.00007952117,0.011279609,0.00034224827,0.00038189263,0.0028227186,0.0015722959,0.00033261953,0.00022664164],"study_design_scores_gemma":[0.0018826919,0.001400645,0.99395216,0.000030582254,0.00048569174,0.000040720228,0.00011079008,0.000022965007,0.00087073166,0.00006231256,0.0010065776,0.00013411256],"about_ca_topic_score_codex":0.000050030314,"about_ca_topic_score_gemma":0.000020027826,"teacher_disagreement_score":0.017552383,"about_ca_system_score_codex":0.000033686585,"about_ca_system_score_gemma":0.00014674784,"threshold_uncertainty_score":0.6399789},"labels":[],"label_agreement":null},{"id":"W2114417162","doi":"10.1016/j.eururo.2006.08.039","title":"Development and External Validation of an Extended 10-Core Biopsy Nomogram","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Biopsy; Prostate biopsy; Prostate cancer; Logistic regression; Radiology; Urology; Cancer; Internal medicine","score_opus":0.022330094026095634,"score_gpt":0.267319752371696,"score_spread":0.24498965834560033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114417162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927846,0.00041277762,0.000117787604,0.00013133847,0.000053127194,0.0001388052,0.0000043491,0.000030107487,0.006327096],"genre_scores_gemma":[0.99305326,0.000020353047,0.0062921974,0.00014172256,0.00008939779,0.000008124815,0.00008367267,0.000017092167,0.00029418655],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99933934,0.000050369963,0.00020480885,0.00019946974,0.00007554686,0.00013048142],"domain_scores_gemma":[0.9996651,0.000014989759,0.00007834167,0.00014046929,0.000040076564,0.00006104904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011135074,0.00009075785,0.00014127245,0.000059133763,0.00002991513,0.00000624521,0.000036190027,0.000021484944,0.00010974021],"category_scores_gemma":[0.0000087947865,0.0000750024,0.000020900086,0.000045920453,0.000059961112,0.000029778284,0.00002916152,0.000042892592,0.00003791098],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015048687,0.003652715,0.26219496,0.00017529858,0.00026523572,0.002814613,0.001556311,0.00006714942,0.11166427,0.003371766,0.0013133792,0.61141944],"study_design_scores_gemma":[0.0017035244,0.00096276443,0.9461169,0.000017100008,0.000066835164,0.00021988172,0.000014292409,0.00003323596,0.028120779,0.00012609645,0.022530736,0.000087812805],"about_ca_topic_score_codex":0.000013919668,"about_ca_topic_score_gemma":0.0000035862954,"teacher_disagreement_score":0.683922,"about_ca_system_score_codex":0.000019762234,"about_ca_system_score_gemma":0.00002508405,"threshold_uncertainty_score":0.3058509},"labels":[],"label_agreement":null},{"id":"W2114868523","doi":"10.1016/j.eururo.2013.04.038","title":"A Negative Confirmatory Biopsy Among Men on Active Surveillance for Prostate Cancer Does Not Protect Them from Histologic Grade Progression","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prostate cancer; Interquartile range; Hazard ratio; Cancer; Internal medicine; Proportional hazards model; Confidence interval; Perineural invasion; Oncology; Tumor progression; Biopsy; Prostate-specific antigen; Urology","score_opus":0.024713384736662167,"score_gpt":0.2782676481357407,"score_spread":0.2535542633990785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114868523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832269,0.00034744115,0.000017013817,0.0068444745,0.00027884706,0.0045006056,0.00036152374,0.00014658291,0.0042765867],"genre_scores_gemma":[0.99435425,0.00021767907,0.00026436592,0.0013882457,0.00018199267,0.002899262,0.0000892466,0.00006138748,0.00054360036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820787,0.00036884632,0.00027536845,0.00059630023,0.00014617384,0.00040543877],"domain_scores_gemma":[0.9987992,0.00031418542,0.0002831382,0.0003129126,0.000142886,0.00014768775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001535848,0.00028461247,0.000427162,0.000055262466,0.00012396272,0.000021676713,0.00012207961,0.00007256009,0.00027006833],"category_scores_gemma":[0.00011879806,0.0001673255,0.00009668759,0.00007036566,0.00028128078,0.000074191455,0.000059551538,0.00023270957,0.00014723836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012560089,0.002406989,0.6535366,0.00031647386,0.0018976599,0.0010091141,0.010499322,0.00003695215,0.05107236,0.0004413551,0.01789687,0.2483262],"study_design_scores_gemma":[0.005218654,0.0026969023,0.9220283,0.0001218313,0.00010382584,0.000013954061,0.0001776281,0.00017434178,0.05712545,0.00050052564,0.011524016,0.00031455158],"about_ca_topic_score_codex":0.00050604873,"about_ca_topic_score_gemma":0.0000348215,"teacher_disagreement_score":0.26849172,"about_ca_system_score_codex":0.00017620284,"about_ca_system_score_gemma":0.00006626066,"threshold_uncertainty_score":0.6823336},"labels":[],"label_agreement":null},{"id":"W2115095086","doi":"10.1016/j.eururo.2013.08.015","title":"A New Era of Testosterone and Prostate Cancer: From Physiology to Clinical Implications","year":2013,"lang":"en","type":"review","venue":"European Urology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Testosterone (patch); Prostate cancer; Prostatectomy; Internal medicine; Prostate-specific antigen; Prostate; Urology; Oncology; Gynecology; Endocrinology; Cancer","score_opus":0.0960314767337262,"score_gpt":0.3980814669088046,"score_spread":0.3020499901750784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115095086","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022302885,0.99104357,0.000008984582,0.0043422733,0.00024751737,0.0009745079,0.00010005078,0.00002693819,0.0010258739],"genre_scores_gemma":[0.00048116886,0.99572986,0.00065588026,0.00053930824,0.0013601187,0.000056171197,0.00006283784,0.000048867874,0.0010657776],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99797064,0.00042726944,0.00067034154,0.0006732047,0.000051730098,0.00020678686],"domain_scores_gemma":[0.99869317,0.00025935174,0.0002845901,0.0004680559,0.000107570784,0.00018729092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016993593,0.00024975085,0.0017560237,0.000061002473,0.000035708166,0.0000030191895,0.00013504663,0.00009556676,0.000067823545],"category_scores_gemma":[0.000248552,0.00016051144,0.0001619756,0.000124003,0.00023844658,0.000012659102,0.00033834242,0.0004967711,0.0003339861],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003901489,0.000050141767,0.0005189757,0.0005144269,0.00040404464,0.000006589906,0.00012232464,6.776462e-8,0.00007906948,0.000024615514,0.006703963,0.99153674],"study_design_scores_gemma":[0.00027317734,0.0007956752,0.09282008,0.00043343275,0.00080794527,0.000027270426,0.000004215552,6.007029e-8,5.632565e-7,0.000062358384,0.90465736,0.000117852294],"about_ca_topic_score_codex":0.0001614808,"about_ca_topic_score_gemma":0.000009746471,"teacher_disagreement_score":0.9914189,"about_ca_system_score_codex":0.0000118894095,"about_ca_system_score_gemma":0.00016253041,"threshold_uncertainty_score":0.6545467},"labels":[],"label_agreement":null},{"id":"W2115408881","doi":"10.1016/j.eururo.2012.08.002","title":"The Impact of Solitary and Multiple Positive Surgical Margins on Hard Clinical End Points in 1712 Adjuvant Treatment–Naive pT2–4 N0 Radical Prostatectomy Patients","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Medicine; Prostatectomy; Biochemical recurrence; Prostate cancer; Proportional hazards model; Urology; Surgical margin; Adjuvant; Androgen deprivation therapy; Adjuvant therapy; Internal medicine; Radiation therapy; Surgery; Hazard ratio; Oncology; Cancer; Confidence interval","score_opus":0.026230593128294746,"score_gpt":0.3229165909808464,"score_spread":0.2966859978525517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115408881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940596,0.0016920851,8.594048e-7,0.00065476185,0.00017285098,0.0008893495,0.0001992448,0.000016193437,0.0023150311],"genre_scores_gemma":[0.9976433,0.0016828349,0.000034553563,0.00023952601,0.00015881548,0.000017031269,0.00014851581,0.000031827563,0.000043629545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997577,0.00088735064,0.0005059824,0.00034989647,0.00014894907,0.0005308171],"domain_scores_gemma":[0.99807465,0.0011149094,0.00014618358,0.00027892532,0.00005167422,0.0003336435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048254756,0.00025106416,0.0005233041,0.00008090733,0.00006904317,0.000007234476,0.00007025436,0.000073480245,0.00005632172],"category_scores_gemma":[0.00021275374,0.00013946388,0.00019610408,0.000079257064,0.00042822276,0.00005625972,0.00006573111,0.000258562,0.00005958871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045483722,0.0023997573,0.95616394,0.000006018393,0.00028775836,0.00041163096,0.00058010925,0.0000045008483,0.000008727751,0.00004301646,0.00029598043,0.035250187],"study_design_scores_gemma":[0.013064415,0.012114417,0.97200406,0.000033321132,0.000099456,0.0000629587,0.000026315509,0.000055829074,0.00012257668,0.000016958758,0.0022932417,0.00010644054],"about_ca_topic_score_codex":0.00016104312,"about_ca_topic_score_gemma":0.0000135990285,"teacher_disagreement_score":0.035143744,"about_ca_system_score_codex":0.00017097189,"about_ca_system_score_gemma":0.000068887064,"threshold_uncertainty_score":0.5687172},"labels":[],"label_agreement":null},{"id":"W2115702569","doi":"10.1016/j.eururo.2005.11.007","title":"Development and Internal Validation of a Nomogram Predicting the Probability of Prostate Cancer Gleason Sum Upgrading Between Biopsy and Radical Prostatectomy Pathology","year":2005,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Prostatectomy; Prostate cancer; Biopsy; Urology; Prostate; Cancer; Pathology; Oncology; Internal medicine","score_opus":0.02162149779947089,"score_gpt":0.26958470779204247,"score_spread":0.24796320999257157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115702569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957828,0.0014755025,0.00005120476,0.0016148527,0.000044993893,0.000720788,0.000026226073,0.000023435705,0.00026017908],"genre_scores_gemma":[0.9974985,0.0002535473,0.0019571045,0.000090468326,0.0000875261,0.000055743683,0.000021343374,0.000018459627,0.000017274764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987326,0.00021728255,0.00043016032,0.00029979492,0.000108936234,0.00021118385],"domain_scores_gemma":[0.9993745,0.00009819458,0.00023018735,0.00014649934,0.000068528105,0.0000820615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062086683,0.00013608935,0.0002978573,0.00006287491,0.00005931854,0.000008040469,0.00005917561,0.000038595434,0.000009770083],"category_scores_gemma":[0.00008808151,0.00009107122,0.000029897781,0.00008515093,0.00037124395,0.00004303647,0.00010805597,0.00015945695,0.0000010203239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019869664,0.000118928976,0.89272803,0.00014183117,0.00011602787,0.000025681004,0.0036102724,0.0000075531148,0.0015775342,0.000055353074,0.00001779674,0.10140231],"study_design_scores_gemma":[0.00209313,0.0008107559,0.97199726,0.000114791765,0.000175888,0.00014408934,0.000069628164,0.000069436246,0.019329527,0.000046442256,0.005060613,0.000088417844],"about_ca_topic_score_codex":0.000032113487,"about_ca_topic_score_gemma":0.000008534385,"teacher_disagreement_score":0.10131389,"about_ca_system_score_codex":0.000053012354,"about_ca_system_score_gemma":0.000070606606,"threshold_uncertainty_score":0.37137765},"labels":[],"label_agreement":null},{"id":"W2115726304","doi":"10.1016/j.eururo.2013.03.030","title":"Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group","year":2013,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":451,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"National Cancer Institute; National Institute for Health and Care Research","keywords":"Medicine; Checklist; Biopsy; Prostate cancer; Medical physics; Magnetic resonance imaging; Prostate biopsy; Radiology; Cancer; Internal medicine","score_opus":0.12764005176450444,"score_gpt":0.41313361581350316,"score_spread":0.2854935640489987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115726304","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009364261,0.9926818,0.000070271584,0.00091580016,0.001532076,0.0018406777,0.0012760792,0.000027872971,0.0007189705],"genre_scores_gemma":[0.0022390366,0.99370754,0.0018852267,0.00015168749,0.0003373014,0.0002277602,0.0012959507,0.000068768575,0.00008670887],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99716544,0.00038256025,0.0016588252,0.00040841682,0.00019541068,0.00018936483],"domain_scores_gemma":[0.99557364,0.00035044004,0.0030950855,0.00050519436,0.00042314685,0.00005246994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009216423,0.00025199432,0.0012343613,0.00010628221,0.00006974301,0.000010896997,0.00022096722,0.000066908004,0.000103674],"category_scores_gemma":[0.0010026786,0.00015348382,0.0003512458,0.0001256728,0.00014968327,0.000048577323,0.00017986004,0.00020566666,0.000003327019],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091625414,0.00029947615,0.0041466868,0.0023860228,0.002700483,0.00003791546,0.0007379826,0.0000019636013,0.000013644267,0.0001504698,0.005954042,0.9834797],"study_design_scores_gemma":[0.0006604218,0.0005518926,0.0011681573,0.0038753443,0.0013050231,0.000028057204,0.00009014203,0.0000053028157,0.000016096203,0.00006268486,0.9921247,0.000112180474],"about_ca_topic_score_codex":0.000023367047,"about_ca_topic_score_gemma":0.000010057285,"teacher_disagreement_score":0.98617065,"about_ca_system_score_codex":0.00016463004,"about_ca_system_score_gemma":0.00018301902,"threshold_uncertainty_score":0.6258889},"labels":[],"label_agreement":null},{"id":"W2116692142","doi":"10.1016/j.eururo.2012.10.015","title":"Contemporary Grading for Prostate Cancer: Implications for Patient Care","year":2012,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University Health Centre","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Grading (engineering); Radiation therapy; Disease; Biochemical recurrence; Prostate; Cancer; Radiology; Oncology; Internal medicine","score_opus":0.11322808577090465,"score_gpt":0.370851795451536,"score_spread":0.25762370968063136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116692142","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014153416,0.98584396,0.000059175647,0.00071380084,0.0005910149,0.0072121904,0.0029864553,0.00007481683,0.002504465],"genre_scores_gemma":[0.0025167295,0.9843879,0.00025763188,0.00070087047,0.00060341536,0.0077416208,0.0034348532,0.00018373235,0.00017325288],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983118,0.00014181405,0.00055267254,0.00051109557,0.000050602717,0.00043198548],"domain_scores_gemma":[0.9985322,0.00025651685,0.0004127694,0.0004319026,0.00017217662,0.00019444904],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013229369,0.00037031583,0.0011613095,0.00011661943,0.00013204449,0.000013879095,0.00011908589,0.00009832121,0.000011578117],"category_scores_gemma":[0.00003811234,0.00028104056,0.00050674914,0.000088452,0.000057090594,0.00003232684,0.0000649146,0.0001570301,0.000029003062],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005453309,0.00009865691,0.0004367148,0.009277501,0.0003683599,0.000008123736,0.00033587826,2.3780552e-7,3.5912257e-7,0.00017777314,0.013877868,0.97536397],"study_design_scores_gemma":[0.0009820559,0.0017962836,0.00017627447,0.0011186316,0.0025566185,0.000037714057,0.000018866796,3.3186865e-7,0.0000016600284,0.000014628465,0.99307543,0.00022151213],"about_ca_topic_score_codex":0.000009935313,"about_ca_topic_score_gemma":0.000002852478,"teacher_disagreement_score":0.97919756,"about_ca_system_score_codex":0.00025852767,"about_ca_system_score_gemma":0.00037474706,"threshold_uncertainty_score":0.9999642},"labels":[],"label_agreement":null},{"id":"W2116692433","doi":"10.1016/j.eururo.2011.10.044","title":"Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":787,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Nomogram; Medicine; Prostate cancer; Lymph node; Prostatectomy; Dissection (medical); Stage (stratigraphy); Logistic regression; Urology; Lymph; T-stage; Biopsy; Radiology; Cancer; Oncology; Internal medicine; Pathology","score_opus":0.010527261666475014,"score_gpt":0.23483864879275515,"score_spread":0.22431138712628013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116692433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968089,0.00033948952,0.000016569684,0.00017674902,0.00015461029,0.00061139214,0.00007262502,0.000029113122,0.0017905824],"genre_scores_gemma":[0.9990695,0.00024630973,0.00009412529,0.000296487,0.000040135,0.00003353047,0.00014929188,0.000045110784,0.000025469106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984911,0.0002133895,0.00044190063,0.00037364702,0.0001939859,0.00028597907],"domain_scores_gemma":[0.9990408,0.00006626154,0.0003736828,0.0003072256,0.00014270554,0.000069312424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017078627,0.00019789519,0.00032203048,0.00009620407,0.00007073382,0.0000057958387,0.00011288872,0.00003896835,0.00011283902],"category_scores_gemma":[0.000029883413,0.00013024779,0.00005852804,0.00018818911,0.00022965646,0.000082515224,0.00008777297,0.00012178748,0.0000032861024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031978232,0.00078231416,0.99175805,0.00007462274,0.000179211,0.00009513609,0.0024371275,0.00007842706,0.0005913197,0.000027058282,0.000018212193,0.00076067867],"study_design_scores_gemma":[0.0054979967,0.0008184007,0.99052405,0.00022743127,0.00020691725,0.000017917317,0.00028780717,0.0000839131,0.0022077854,0.000011040493,0.000009831596,0.000106892156],"about_ca_topic_score_codex":0.00041780932,"about_ca_topic_score_gemma":0.00026542402,"teacher_disagreement_score":0.0023001735,"about_ca_system_score_codex":0.00012003554,"about_ca_system_score_gemma":0.00012415877,"threshold_uncertainty_score":0.5311351},"labels":[],"label_agreement":null},{"id":"W2118521074","doi":"10.1016/j.eururo.2013.09.005","title":"Efficacy and Safety of Abiraterone Acetate in an Elderly Patient Subgroup (Aged 75 and Older) with Metastatic Castration-resistant Prostate Cancer After Docetaxel-based Chemotherapy","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Université de Montréal","funders":"","keywords":"Medicine; Abiraterone acetate; Docetaxel; Prostate cancer; Hazard ratio; Internal medicine; Clinical endpoint; Proportional hazards model; Urology; Prednisone; Placebo; Post-hoc analysis; Confidence interval; Androgen deprivation therapy; Chemotherapy; Oncology; Cancer; Randomized controlled trial; Pathology","score_opus":0.012385192065177481,"score_gpt":0.2647034834322848,"score_spread":0.2523182913671073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118521074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448067,0.002062715,0.000017866034,0.0019181127,0.000018136325,0.0013551059,0.000023000892,0.000019436315,0.000104933904],"genre_scores_gemma":[0.99843425,0.00040247463,0.00034720852,0.00047214664,0.000015739124,0.00011351924,0.000035577017,0.000042531683,0.00013656379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852604,0.0003323035,0.00031283085,0.0003626216,0.00015259607,0.00031362651],"domain_scores_gemma":[0.99937785,0.00005403407,0.00010205854,0.00021758223,0.00009620076,0.00015228668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001914276,0.00019607352,0.0003357079,0.00013097718,0.000043567168,0.000028334562,0.00004725933,0.000026584843,0.00015501786],"category_scores_gemma":[0.000009228487,0.00013095832,0.00001817814,0.00013345035,0.00030250562,0.00011596723,0.000017565571,0.00016974048,0.0000052268347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07809543,0.002181243,0.48742634,0.0010209227,0.0006807555,0.0020730863,0.019512586,0.0002890798,0.2463989,0.00002377796,0.00017964734,0.16211824],"study_design_scores_gemma":[0.016975787,0.006190412,0.9732723,0.000082888466,0.0000750399,0.000020493664,0.000099851255,0.00012208585,0.002815109,0.0000109894845,0.00019375783,0.00014127417],"about_ca_topic_score_codex":0.0002129288,"about_ca_topic_score_gemma":0.00023003753,"teacher_disagreement_score":0.48584598,"about_ca_system_score_codex":0.00003080071,"about_ca_system_score_gemma":0.00007184084,"threshold_uncertainty_score":0.5340325},"labels":[],"label_agreement":null},{"id":"W2118534671","doi":"10.1016/j.eururo.2012.04.044","title":"Increasing Risk of Infectious Complications After Transrectal Ultrasound–Guided Prostate Biopsies: Time to Reassess Antimicrobial Prophylaxis?","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":285,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Bacteremia; Odds ratio; Prostate biopsy; Ciprofloxacin; Internal medicine; Incidence (geometry); Urinary system; Sepsis; Surgery; Antibiotics; Prostate; Microbiology","score_opus":0.009470955632014994,"score_gpt":0.24670015826880876,"score_spread":0.23722920263679376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118534671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883775,0.0002537676,0.000119121185,0.0004957394,0.00012576007,0.00086290645,0.00017543226,0.00009800821,0.009491748],"genre_scores_gemma":[0.9977521,0.00008784598,0.0007849428,0.000885183,0.000167504,0.00006837638,0.00007848505,0.000057615183,0.00011797627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836135,0.00047349266,0.00036705303,0.00029612725,0.0001049893,0.00039698707],"domain_scores_gemma":[0.99894035,0.00019065145,0.00014589213,0.0003597824,0.00013384658,0.00022946789],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043047813,0.00020070594,0.00033337073,0.00015182466,0.00008167963,0.00001489395,0.00007980682,0.00004854056,0.00019447574],"category_scores_gemma":[0.00021905352,0.00017084352,0.000106480344,0.00023866541,0.00014476282,0.00008451351,0.000045601115,0.00017484715,0.0008852311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010720283,0.0014601576,0.8976911,0.000106342646,0.00036766264,0.00008292659,0.0026434273,0.000042216965,0.0895279,0.000024218129,0.0021744322,0.0048076445],"study_design_scores_gemma":[0.0016260089,0.0015319801,0.9799379,0.000053435706,0.00031071375,0.0012513003,0.000011885613,0.000005370702,0.0063261837,0.000006661799,0.008749812,0.0001887198],"about_ca_topic_score_codex":0.0001005987,"about_ca_topic_score_gemma":0.0000050434164,"teacher_disagreement_score":0.083201714,"about_ca_system_score_codex":0.00007385056,"about_ca_system_score_gemma":0.00004887425,"threshold_uncertainty_score":0.9998927},"labels":[],"label_agreement":null},{"id":"W2119144996","doi":"10.1016/j.eururo.2012.03.051","title":"Chronic Kidney Disease After Nephrectomy in Patients with Small Renal Masses: A Retrospective Observational Analysis","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Kidney disease; Nephrectomy; Renal cell carcinoma; Retrospective cohort study; Renal function; Internal medicine; Nephrology; Anemia; Proportional hazards model; Renal replacement therapy; Urology; Surgery; Kidney","score_opus":0.01872499190374968,"score_gpt":0.2239723813713477,"score_spread":0.20524738946759802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119144996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947085,0.00037056045,0.00015472871,0.00056869787,0.00006080792,0.00036866195,0.00003457595,0.000037154536,0.0036963073],"genre_scores_gemma":[0.99637157,0.0000039957304,0.0008484441,0.0015807254,0.00030284916,0.00004041792,0.00043273767,0.00004188427,0.00037737892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839085,0.00030726384,0.00025417196,0.00037474034,0.00024132158,0.00043162645],"domain_scores_gemma":[0.9988926,0.000038414964,0.00009827745,0.00039534213,0.00009697101,0.00047839983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020282662,0.00021087879,0.0003281351,0.0003000968,0.000030223575,0.000009981946,0.00008251883,0.000034727946,0.0005862672],"category_scores_gemma":[0.0001068182,0.00015957541,0.00012453992,0.00055753515,0.00008308162,0.000093372844,0.0000689212,0.00021433512,0.00017227771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019498394,0.00037688404,0.99632823,0.000014464222,0.00048407656,0.0003059978,0.00013830284,0.00004075053,0.000018215625,0.000035968347,0.00015669655,0.00015057491],"study_design_scores_gemma":[0.0032142915,0.00084688177,0.9847179,0.000012887645,0.0011799291,0.0000045360543,0.0000025050542,0.000039532842,0.000009987494,0.0000073026895,0.009821189,0.0001430322],"about_ca_topic_score_codex":0.00001786357,"about_ca_topic_score_gemma":0.000032488788,"teacher_disagreement_score":0.011610304,"about_ca_system_score_codex":0.00036654953,"about_ca_system_score_gemma":0.00013529845,"threshold_uncertainty_score":0.65072966},"labels":[],"label_agreement":null},{"id":"W2119995188","doi":"10.1016/j.eururo.2013.06.041","title":"Pathologic Nodal Staging Scores in Patients Treated with Radical Prostatectomy: A Postoperative Decision Tool","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Lymph node; Dissection (medical); Prostate cancer; Cohort; NODAL; Retrospective cohort study; Metastasis; Urology; Surgery; Radiology; Cancer; Internal medicine","score_opus":0.00811839672290022,"score_gpt":0.22777736914883742,"score_spread":0.2196589724259372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119995188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956688,0.00012670038,0.000044002318,0.0006392385,0.000044325192,0.0012225289,0.000012790244,0.00006653987,0.002175061],"genre_scores_gemma":[0.99690914,0.000046488316,0.0006241836,0.002101863,0.00002547974,0.00010329781,0.00008118643,0.000039138773,0.000069205875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985213,0.00024630097,0.0002783323,0.0004379335,0.00015463299,0.00036148838],"domain_scores_gemma":[0.9993709,0.00009140096,0.00006925874,0.00024181405,0.00011428802,0.00011238005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001316845,0.00020904075,0.00031249187,0.00014091628,0.00005462258,0.00002748362,0.00007447745,0.00004252669,0.0002117785],"category_scores_gemma":[0.000100011726,0.00013039827,0.000036415848,0.00017560736,0.00014612632,0.00009922392,0.00006772585,0.00021772736,0.00030987835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011674364,0.00058097835,0.958991,0.0000074072004,0.00003387409,0.0015289348,0.00044718248,0.000015727395,0.00016937127,0.000025955456,0.00041342486,0.03661871],"study_design_scores_gemma":[0.007978089,0.006565859,0.98399705,0.00005994369,0.000034946308,0.00004525028,0.000024808538,0.00005748648,0.00027385648,0.0000295882,0.0007944742,0.00013864803],"about_ca_topic_score_codex":0.000052793344,"about_ca_topic_score_gemma":0.00000574394,"teacher_disagreement_score":0.03648006,"about_ca_system_score_codex":0.0001121356,"about_ca_system_score_gemma":0.000048566344,"threshold_uncertainty_score":0.5317488},"labels":[],"label_agreement":null},{"id":"W2120696911","doi":"10.1016/j.eururo.2013.09.028","title":"Determining the Role of Testosterone Deficiency in Sexual Function: The Beginning of the End or the End of the Beginning?","year":2013,"lang":"en","type":"letter","venue":"European Urology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Sexual function; Testosterone (patch); Erectile dysfunction; Terminology; Function (biology); Task (project management); Internal medicine","score_opus":0.021627587466126974,"score_gpt":0.2279817721477766,"score_spread":0.20635418468164962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120696911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60617393,0.0037092392,0.0000058698474,0.36311063,0.0009801765,0.0010878018,0.00002262197,0.000018487388,0.024891218],"genre_scores_gemma":[0.9500657,0.00002960472,0.000008736586,0.0453639,0.0016266893,0.0000226676,0.0000049125315,0.00005642525,0.0028214194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965931,0.0013855705,0.00066002633,0.0004587868,0.0005001359,0.000402373],"domain_scores_gemma":[0.9966259,0.0010530151,0.00076503295,0.0013203329,0.00021854504,0.000017164819],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0011786718,0.00033277858,0.0005781554,0.0000812665,0.00032932137,0.000009468178,0.0010459675,0.00014123904,0.00008006443],"category_scores_gemma":[0.0007582156,0.00009544394,0.00017871855,0.0003967731,0.0033116213,0.000030797346,0.00088949426,0.0019061936,0.00001489672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013060283,0.00074015325,0.45877263,0.0008279828,0.002170862,0.00021370572,0.061656065,0.00038891984,0.022498343,0.000575797,0.33443815,0.11641137],"study_design_scores_gemma":[0.0005598232,0.0011054244,0.6001515,0.00008611562,0.00047749665,0.00016822232,0.0025455232,0.000020417467,0.00027320298,0.00009377522,0.39436784,0.00015064803],"about_ca_topic_score_codex":0.00009545827,"about_ca_topic_score_gemma":0.000037593654,"teacher_disagreement_score":0.34389168,"about_ca_system_score_codex":0.000020579362,"about_ca_system_score_gemma":0.00011734105,"threshold_uncertainty_score":0.9994008},"labels":[],"label_agreement":null},{"id":"W2121167328","doi":"10.1016/j.eururo.2013.05.026","title":"The Role of Robot-assisted Radical Prostatectomy and Pelvic Lymph Node Dissection in the Management of High-risk Prostate Cancer: A Systematic Review","year":2013,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Dissection (medical); Perioperative; Lymph node; Prostate; Lymphocele; Urology; Biochemical recurrence; Surgery; Cancer; Internal medicine; Complication","score_opus":0.01484147743862256,"score_gpt":0.28239218186264003,"score_spread":0.26755070442401746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121167328","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005628857,0.9902582,0.0000021800918,0.00034989245,0.00009423762,0.0081313215,0.000054764107,0.00001716557,0.000529341],"genre_scores_gemma":[0.0065022777,0.99053,0.000044164524,0.00012701373,0.000030331179,0.002554682,0.000066276814,0.0000601187,0.000085095504],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9955245,0.0020509432,0.0014139469,0.00043789175,0.00026481587,0.0003079035],"domain_scores_gemma":[0.99738485,0.00042508772,0.001301129,0.0007443399,0.00007628705,0.00006833644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013029709,0.00038416186,0.002181807,0.00010221124,0.00007960545,0.000019531079,0.0002796003,0.000068476824,0.000012665684],"category_scores_gemma":[0.00008454777,0.00017627024,0.00024711058,0.0003581696,0.00022830725,0.000026733407,0.00012872608,0.00030883378,0.000018972225],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003861045,0.00016353566,0.00024207548,0.5369979,0.00089698413,0.00010639185,0.000114473565,9.94723e-7,2.617713e-7,0.00017998395,0.000059377104,0.4611994],"study_design_scores_gemma":[0.0030271308,0.0011404055,0.0150183225,0.70571333,0.029237688,0.0007184107,0.0001850574,0.000017161521,0.0000029684381,0.000100156816,0.24441186,0.00042749045],"about_ca_topic_score_codex":0.00016331853,"about_ca_topic_score_gemma":0.000011076171,"teacher_disagreement_score":0.46077192,"about_ca_system_score_codex":0.00013023871,"about_ca_system_score_gemma":0.00009087931,"threshold_uncertainty_score":0.71880925},"labels":[],"label_agreement":null},{"id":"W2121606020","doi":"10.1016/j.eururo.2009.03.088","title":"Testosterone and Prostate Cancer: Revisiting Old Paradigms","year":2009,"lang":"en","type":"review","venue":"European Urology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McMaster University","funders":"","keywords":"Medicine; Prostate cancer; Testosterone (patch); Prostate; Androgen; Natural history; Disease; Urology; Cancer; Oncology; Internal medicine; Gynecology; Endocrinology; Hormone","score_opus":0.046069615104002176,"score_gpt":0.3273869289522771,"score_spread":0.28131731384827496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121606020","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012428271,0.9720334,6.0992994e-7,0.0013780183,0.0001314783,0.0006205759,0.000015480531,0.00007142684,0.025624769],"genre_scores_gemma":[0.00017507773,0.99251,0.000049270882,0.00058512005,0.0017123251,0.000017582757,0.00003226662,0.00006790944,0.004850427],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99805087,0.0003754085,0.000453269,0.0006841911,0.0001015072,0.00033475112],"domain_scores_gemma":[0.99918216,0.000083789295,0.00024723183,0.00032064316,0.000053503736,0.00011265902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038806006,0.00036612462,0.0016212506,0.00011080111,0.000100065954,0.00001160069,0.00009008549,0.00007396045,0.000016631875],"category_scores_gemma":[0.00016428804,0.00023930318,0.00014981083,0.00014200427,0.00020157479,0.000021391277,0.00014807862,0.0005306064,0.00014517104],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019906702,0.000018565583,0.00011164038,0.0035699278,0.00018662924,0.00048231045,0.00012332799,7.720596e-8,0.0000018668744,0.000059119095,0.00060393667,0.9948227],"study_design_scores_gemma":[0.00023917695,0.0005041237,0.0022409605,0.0025778958,0.001136834,0.00077271526,0.000006651584,2.1917563e-7,1.645652e-7,0.000009851347,0.9923042,0.0002071832],"about_ca_topic_score_codex":0.0000057351162,"about_ca_topic_score_gemma":6.796887e-7,"teacher_disagreement_score":0.9946155,"about_ca_system_score_codex":0.000028574299,"about_ca_system_score_gemma":0.000054357675,"threshold_uncertainty_score":0.97585},"labels":[],"label_agreement":null},{"id":"W2121655616","doi":"10.1016/j.eururo.2012.05.072","title":"Active Surveillance for Prostate Cancer: A Systematic Review of the Literature","year":2012,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":603,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Watchful waiting; Medicine; Prostate cancer; Psychological intervention; Malignancy; Prostate; Cancer; Stage (stratigraphy); MEDLINE; Prostate-specific antigen; Gynecology; Intensive care medicine; Internal medicine","score_opus":0.03125465905776508,"score_gpt":0.3248775677124963,"score_spread":0.29362290865473123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121655616","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000012272699,0.9882454,9.093606e-7,0.0005905938,0.00047218855,0.008847978,0.0010474025,0.000020948428,0.00077330583],"genre_scores_gemma":[0.00004729371,0.995474,0.000012364711,0.0013416193,0.00023561358,0.0018768907,0.0002597849,0.00009206579,0.00066039135],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972985,0.0011008515,0.0007931188,0.0003526348,0.00014129879,0.000313639],"domain_scores_gemma":[0.997495,0.000344891,0.0010854936,0.0007732794,0.00021425911,0.000087104345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006152365,0.00038162823,0.0029792737,0.000056165878,0.00004404389,0.0000075964385,0.00024920344,0.00009158407,0.000026119544],"category_scores_gemma":[0.00029688646,0.00018600629,0.0007772972,0.0002801961,0.00007747849,0.000023511706,0.000100209574,0.00030451064,0.000027181457],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020205645,0.000065360044,0.000019374991,0.8964215,0.0006253352,0.000015162187,0.00011204468,2.196714e-8,6.414655e-8,0.000028912762,0.0012553583,0.101436645],"study_design_scores_gemma":[0.00020738198,0.00016297484,0.000035114856,0.45927614,0.004780644,0.000088855566,9.7283e-7,5.9199394e-8,5.447869e-7,0.0000014258713,0.53536016,0.000085763655],"about_ca_topic_score_codex":0.0000025614538,"about_ca_topic_score_gemma":0.000002364409,"teacher_disagreement_score":0.53410476,"about_ca_system_score_codex":0.00013491746,"about_ca_system_score_gemma":0.00022422406,"threshold_uncertainty_score":0.75851166},"labels":[],"label_agreement":null},{"id":"W2121743907","doi":"10.1016/j.eururo.2012.02.057","title":"Prediction of Functional Outcomes After Nerve-Sparing Radical Prostatectomy: Results of Conditional Survival Analyses","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Prostatectomy; Urology; Prostate cancer; Proportional hazards model; Nerve sparing; Erectile dysfunction; Biochemical recurrence; Erectile function; Confidence interval; Confounding; Sexual function; Surgery; Internal medicine; Cancer","score_opus":0.07809875477435343,"score_gpt":0.3072959866242164,"score_spread":0.229197231849863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121743907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99286324,0.0006702577,0.00031756965,0.000547007,0.00040564715,0.00020738933,0.00042073964,0.00003315586,0.00453498],"genre_scores_gemma":[0.9986717,0.00003751614,0.00013494292,0.00019171958,0.00022480966,0.000021543305,0.0005532797,0.000019134604,0.00014533085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987392,0.00019130073,0.0004452074,0.00018898457,0.00022017951,0.00021513099],"domain_scores_gemma":[0.9992582,0.00016459085,0.00017160538,0.00018880377,0.00010066891,0.00011613009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036538226,0.00012309085,0.0003236068,0.000115658804,0.000024946665,0.0000024414596,0.000037660557,0.000039531365,0.00018321512],"category_scores_gemma":[0.00014165702,0.00009368869,0.0001236145,0.00009797201,0.00018773097,0.00007429163,0.00004713553,0.00011475733,0.000037236794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020765052,0.0006389435,0.9929119,0.000045293793,0.00038873457,0.00004722701,0.00016446077,0.00011784552,0.0018281013,0.000380147,0.0010359118,0.00036492493],"study_design_scores_gemma":[0.003674311,0.0005523211,0.98946196,0.000016290696,0.0002510463,0.000033314445,0.000014482392,0.000029215755,0.0017207658,0.000033012937,0.004159539,0.000053725373],"about_ca_topic_score_codex":0.000013415304,"about_ca_topic_score_gemma":0.0000016394423,"teacher_disagreement_score":0.0058084694,"about_ca_system_score_codex":0.0000371897,"about_ca_system_score_gemma":0.00004412227,"threshold_uncertainty_score":0.3820514},"labels":[],"label_agreement":null},{"id":"W2124017956","doi":"10.1016/j.eururo.2010.02.024","title":"Prevention and Management of Complications Following Radical Cystectomy for Bladder Cancer","year":2010,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Quality of life (healthcare); MEDLINE; Sexual function; Intensive care medicine; General surgery; Surgery; Cancer; Internal medicine","score_opus":0.05861563086777336,"score_gpt":0.3833460492484744,"score_spread":0.324730418380701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124017956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047346985,0.9860961,0.0006478359,0.0001658411,0.0003038429,0.0020463178,0.00006516169,0.00003367873,0.0105938725],"genre_scores_gemma":[0.00028264354,0.9960852,0.0013779133,0.0001456524,0.00017766414,0.00039286725,0.00015797216,0.00007540358,0.001304649],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988426,0.00013905119,0.00039180237,0.0003587635,0.000087972265,0.00017982788],"domain_scores_gemma":[0.99931914,0.00006439218,0.00018900073,0.000316492,0.000028259581,0.00008271397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016661927,0.00021466339,0.00081077294,0.000098921795,0.000054140277,0.000005730379,0.000108196116,0.00011400007,0.000048690148],"category_scores_gemma":[0.000009962302,0.00017064887,0.00035006204,0.000084696716,0.00008553049,0.000015478272,0.000067389716,0.00020732527,0.00001980739],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029211664,0.00011146376,0.00002735349,0.0061112996,0.0012383288,0.000032643533,0.000022058297,6.707748e-8,0.0000032379023,0.00039705716,0.00054257247,0.9914847],"study_design_scores_gemma":[0.0015061819,0.00032113653,0.00049005944,0.0015315681,0.0061403653,0.00007272609,0.0000022781257,0.0000017197088,7.945061e-7,0.00003405781,0.9897885,0.00011065239],"about_ca_topic_score_codex":0.000005474005,"about_ca_topic_score_gemma":0.0000039048705,"teacher_disagreement_score":0.9913741,"about_ca_system_score_codex":0.000024813655,"about_ca_system_score_gemma":0.000076510914,"threshold_uncertainty_score":0.6958859},"labels":[],"label_agreement":null},{"id":"W2124161420","doi":"10.1016/j.eururo.2008.02.013","title":"Outcomes in Urinary Incontinence: Reconciling Clinical Relevance with Scientific Rigour","year":2008,"lang":"en","type":"review","venue":"European Urology","topic":"Pelvic floor disorders treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Université de Montréal","funders":"","keywords":"Rigour; Medicine; Urinary incontinence; Relevance (law); Urology; MEDLINE; Epistemology","score_opus":0.07291964209972289,"score_gpt":0.3687251610699989,"score_spread":0.295805518970276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124161420","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009287869,0.9764067,0.0000063579305,0.00017648304,0.00083230145,0.0009780895,0.000015064339,0.00012377792,0.012173382],"genre_scores_gemma":[0.000648998,0.99083394,0.0007473225,0.0003887886,0.00018742321,0.000032530716,0.00014480205,0.00015197339,0.0068642446],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994982,0.0014036127,0.0014152211,0.0012962945,0.00029446458,0.00060842757],"domain_scores_gemma":[0.99734455,0.0006734737,0.0005569691,0.0011352355,0.000083958555,0.00020580106],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009781066,0.0005906043,0.0027987491,0.0004857704,0.00011081311,0.000020199192,0.0004450152,0.00027011544,0.00007065249],"category_scores_gemma":[0.0010593509,0.00041217412,0.00045850422,0.00053107884,0.00073149346,0.00006947931,0.00021555046,0.0013453502,0.0017436326],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022739709,0.0013195451,0.0764604,0.001723359,0.00047687153,0.018828956,0.00011174582,0.0000014884114,9.37016e-8,0.00000825217,0.0023903137,0.89845157],"study_design_scores_gemma":[0.002664108,0.0012519981,0.017392335,0.0020140877,0.00048133289,0.0030664762,0.0000049344862,0.000004449498,1.9792342e-8,0.000005289506,0.9727899,0.00032507448],"about_ca_topic_score_codex":0.000008634915,"about_ca_topic_score_gemma":0.000023457635,"teacher_disagreement_score":0.97039956,"about_ca_system_score_codex":0.000119078395,"about_ca_system_score_gemma":0.0006276071,"threshold_uncertainty_score":0.999833},"labels":[],"label_agreement":null},{"id":"W2124163052","doi":"10.1016/j.eururo.2012.04.052","title":"Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Medicine; Cuff; Urology; Ureter; Concomitant; Bladder cancer; Stage (stratigraphy); Retrospective cohort study; Upper urinary tract; Surgery; Carcinoma; Urinary system; Cancer; Internal medicine","score_opus":0.02826661581038656,"score_gpt":0.32752612508702833,"score_spread":0.2992595092766418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124163052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698067,0.00016833625,0.0002515597,0.00035959325,0.00074545183,0.00084692176,0.000060881324,0.00005441082,0.027706191],"genre_scores_gemma":[0.99658173,0.0000050253393,0.000572536,0.0015270018,0.00050127757,0.000039825434,0.000052542404,0.00006991009,0.00065017195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841654,0.00022052044,0.0003246997,0.0002979814,0.0001877969,0.0005524806],"domain_scores_gemma":[0.9991815,0.00015742773,0.00009657694,0.00032970187,0.00002017226,0.00021463147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027820445,0.00027509846,0.00049585785,0.00013215646,0.000062295665,0.000008016792,0.00013521925,0.00007917406,0.00025951926],"category_scores_gemma":[0.000051956755,0.00018460238,0.00071982923,0.0000676397,0.000086135304,0.00006213874,0.000052902495,0.00017757635,0.00008896252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001782741,0.0010475313,0.9871894,0.000034749744,0.0008200936,0.0002217257,0.00038713336,0.000003073128,0.00083843066,0.00020576971,0.0017696931,0.005699651],"study_design_scores_gemma":[0.0070121065,0.005546499,0.97016346,0.000009623789,0.0006087033,0.00006024961,0.000016664935,0.000006641253,0.00016648289,0.000019696769,0.016233603,0.00015629237],"about_ca_topic_score_codex":0.00001608955,"about_ca_topic_score_gemma":4.0537373e-7,"teacher_disagreement_score":0.02705602,"about_ca_system_score_codex":0.000118828684,"about_ca_system_score_gemma":0.000038273305,"threshold_uncertainty_score":0.75278664},"labels":[],"label_agreement":null},{"id":"W2124745089","doi":"10.1016/j.eururo.2012.05.009","title":"Rationale for Percutaneous Biopsy and Histologic Characterisation of Renal Tumours","year":2012,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":246,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Biopsy; Renal cell carcinoma; Percutaneous; Radiology; Pathology","score_opus":0.08501986248181878,"score_gpt":0.29973086918757563,"score_spread":0.21471100670575685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124745089","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031228324,0.9927739,0.000060685215,0.00010035964,0.00018032297,0.0011455237,0.000052036718,0.000025771486,0.002538556],"genre_scores_gemma":[0.009063405,0.9874559,0.0007215446,0.00010656649,0.00046191068,0.00004652554,0.0009714841,0.0000785408,0.0010940947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99857,0.00034188488,0.0004766096,0.000312936,0.00009161002,0.00020691162],"domain_scores_gemma":[0.99894947,0.00022536011,0.00041103878,0.0002513225,0.0000654983,0.00009733683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002846141,0.00025754998,0.0010280043,0.0001644445,0.000035910914,0.000004234935,0.0000756236,0.00012233233,0.000086620144],"category_scores_gemma":[0.00008785375,0.00019058364,0.00022930847,0.000053357347,0.0001249579,0.000020078003,0.000045010944,0.00016361142,0.00007623224],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002935831,0.00024023064,0.00015650541,0.010480552,0.0003616311,0.0009251169,0.00029567294,3.1837922e-7,0.0006288033,0.00033876474,0.0004554518,0.9858234],"study_design_scores_gemma":[0.00030904217,0.00094535283,0.0012886364,0.000247095,0.0027081145,0.016899262,0.0000035071782,0.00000254996,0.0000039124516,0.0000074291,0.9774412,0.00014388509],"about_ca_topic_score_codex":0.0000014116263,"about_ca_topic_score_gemma":3.101402e-7,"teacher_disagreement_score":0.9856795,"about_ca_system_score_codex":0.00007398731,"about_ca_system_score_gemma":0.00007883372,"threshold_uncertainty_score":0.7771776},"labels":[],"label_agreement":null},{"id":"W2125344257","doi":"10.1016/j.eururo.2005.11.032","title":"Pre-Treatment Nomogram for Disease-Specific Survival of Patients with Chemotherapy-Naive Androgen Independent Prostate Cancer","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nomogram; Prostate cancer; Oncology; Chemotherapy; Internal medicine; Disease; Prostate; Androgen; Cancer; Urology; Hormone","score_opus":0.012437255829143009,"score_gpt":0.242683488092199,"score_spread":0.230246232263056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125344257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993923,0.0018604575,0.00006739579,0.0007026524,0.00014793388,0.0020533847,0.0005916424,0.000043188244,0.0006103588],"genre_scores_gemma":[0.99760425,0.00061672396,0.000130104,0.00019919174,0.00015749189,0.00030668452,0.00050710567,0.000068281115,0.00041017888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987777,0.00007264203,0.0002658611,0.00040552104,0.00016900887,0.00030930404],"domain_scores_gemma":[0.99921346,0.00004525857,0.00016525706,0.0002870654,0.00015845994,0.0001305271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006890355,0.000227141,0.00034088505,0.00006121233,0.000049846876,0.000009759115,0.0000644815,0.000027115673,0.00007288977],"category_scores_gemma":[0.000003052911,0.0001550123,0.00010330221,0.00007965112,0.0001058114,0.000031129668,0.000021865151,0.000049115777,0.000007947678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053223376,0.0018979345,0.9644877,0.000043689546,0.00030080153,0.00006957614,0.00020596033,0.00010021914,0.000041817613,0.00007937935,0.00059235416,0.026858242],"study_design_scores_gemma":[0.010258122,0.004431566,0.91677785,0.000022821996,0.00023703674,0.0000016471735,0.000007789241,0.000016542566,0.00053534535,0.000034232973,0.0675419,0.0001351645],"about_ca_topic_score_codex":0.00006148426,"about_ca_topic_score_gemma":0.00004367046,"teacher_disagreement_score":0.06694955,"about_ca_system_score_codex":0.00014393973,"about_ca_system_score_gemma":0.0000828568,"threshold_uncertainty_score":0.6321218},"labels":[],"label_agreement":null},{"id":"W2126431730","doi":"10.1016/j.eururo.2004.06.004","title":"DD3 RNA Analysis in Urine ? A New Perspective for Detecting Prostate Cancer","year":2004,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":284,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"DiagnoCure (Canada)","funders":"","keywords":"Prostate cancer; Medicine; Prostate; Urine; PCA3; Rectal examination; Prostate biopsy; Urology; Urinalysis; Cancer; Internal medicine","score_opus":0.018664141807931255,"score_gpt":0.2993525700378679,"score_spread":0.28068842822993667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126431730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755972,0.0038721105,0.0007086234,0.013392857,0.00012980482,0.00085864135,0.00002668559,0.0000689621,0.005345092],"genre_scores_gemma":[0.9966303,0.00040031844,0.00075049256,0.0014529597,0.00020740804,0.00008332226,0.000014827469,0.000035324247,0.0004250384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893886,0.000055517798,0.00021682514,0.00039764386,0.00007156578,0.00031961864],"domain_scores_gemma":[0.99946314,0.000052034815,0.00008396875,0.00019539718,0.00008042422,0.00012505833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016277915,0.00014430885,0.00032253744,0.00024530612,0.000044047458,0.000010090472,0.0000578426,0.000026180516,0.000065704065],"category_scores_gemma":[0.00010415156,0.00012301482,0.0001390492,0.000446947,0.000037794467,0.00003377535,0.00003593202,0.00013471473,0.000023921097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008503716,0.0028847281,0.6628991,0.00023922326,0.010564613,0.008850405,0.042712253,0.051590618,0.0077503035,0.00690179,0.0020593372,0.19504395],"study_design_scores_gemma":[0.027944839,0.0061402763,0.92715424,0.00010330704,0.0040123276,0.00012517895,0.0010051753,0.00033743173,0.0066303085,0.0026711544,0.023305582,0.0005701687],"about_ca_topic_score_codex":0.0013876265,"about_ca_topic_score_gemma":0.0013737034,"teacher_disagreement_score":0.2642552,"about_ca_system_score_codex":0.00038446387,"about_ca_system_score_gemma":0.0001531664,"threshold_uncertainty_score":0.50163984},"labels":[],"label_agreement":null},{"id":"W2126763861","doi":"10.1016/j.eururo.2011.09.027","title":"Functional Outcomes and Complications Following Radiation Therapy for Prostate Cancer: A Critical Analysis of the Literature","year":2011,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":287,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Tomotherapy; Prostate cancer; Radiation therapy; Brachytherapy; External beam radiotherapy; Medical physics; Radiation treatment planning; MEDLINE; Cancer; Intensive care medicine; Surgery; Internal medicine","score_opus":0.05646863405540974,"score_gpt":0.35781056825467544,"score_spread":0.3013419341992657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126763861","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003253482,0.9962335,0.000031109612,0.001288531,0.00024404883,0.0011116811,0.00050858734,0.0000147461315,0.00024243147],"genre_scores_gemma":[0.0042891856,0.99370027,0.00004996355,0.00076911633,0.000064741165,0.0004487828,0.00051230734,0.000033050324,0.00013255802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989084,0.00022086813,0.00034772346,0.0003121368,0.00006914531,0.00014172297],"domain_scores_gemma":[0.9989854,0.00037639434,0.00018914584,0.0003066208,0.00008787714,0.00005455935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015661835,0.00019485303,0.00091671624,0.00017625456,0.00008648162,0.000013218624,0.00007598217,0.00006759454,0.000024215438],"category_scores_gemma":[0.000091626855,0.00010818183,0.00070541253,0.00035192005,0.00008477924,0.000022124965,0.000034196863,0.0001459277,0.0000021996993],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005675334,0.00019240717,0.023029594,0.0012134553,0.0064820894,0.0000068544186,0.00038299282,0.0000015840183,5.831839e-7,0.0013438063,0.0008587941,0.9664311],"study_design_scores_gemma":[0.000655635,0.00020278525,0.16185725,0.00047861028,0.011499919,0.000008489544,0.0000019533118,0.000005755451,3.9974896e-7,0.000036815687,0.82516617,0.00008620301],"about_ca_topic_score_codex":0.000007847619,"about_ca_topic_score_gemma":0.000004199151,"teacher_disagreement_score":0.9663449,"about_ca_system_score_codex":0.000040667503,"about_ca_system_score_gemma":0.00009823179,"threshold_uncertainty_score":0.4411527},"labels":[],"label_agreement":null},{"id":"W2127655297","doi":"10.1016/j.eururo.2012.08.014","title":"Contemporary Management of Postchemotherapy Testis Cancer","year":2012,"lang":"en","type":"review","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of British Columbia","funders":"","keywords":"Medicine; Retroperitoneal lymph node dissection; Testicular cancer; Germ cell tumors; Chemotherapy; Teratoma; Seminoma; Dissection (medical); Cancer; Lymph node; Radiology; Surgery; Internal medicine","score_opus":0.0995855550325417,"score_gpt":0.3653091844080068,"score_spread":0.2657236293754651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127655297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022259046,0.9670822,0.000008548936,0.000058717153,0.00019105064,0.0006872587,0.00008901195,0.000050115435,0.031810824],"genre_scores_gemma":[0.00194198,0.9957873,0.00020617354,0.00027832724,0.00017445572,0.00003291548,0.00020930075,0.00010816609,0.0012613365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987957,0.00021180304,0.00038374253,0.00028087865,0.00011167843,0.00021620201],"domain_scores_gemma":[0.99901617,0.000046591827,0.000309733,0.00044319624,0.00003129284,0.00015299102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009304815,0.00028682608,0.0010219594,0.0000903402,0.000017337496,0.0000030196395,0.0001268785,0.00007123293,0.00042656285],"category_scores_gemma":[0.000006992135,0.00020708912,0.0003374507,0.000116460316,0.000073354495,0.000015078911,0.00007894081,0.00013804543,0.00031724863],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028956512,0.00031440656,0.00076237554,0.008153918,0.0016488687,0.0011139847,0.00000987768,4.5833097e-8,2.1822655e-7,0.000043857584,0.00171039,0.9862131],"study_design_scores_gemma":[0.0007604284,0.00024735386,0.0043120915,0.0020641105,0.005154307,0.00015167843,0.0000014981531,1.9153207e-7,1.8182261e-7,0.0000021745655,0.98717433,0.0001316541],"about_ca_topic_score_codex":0.00001908636,"about_ca_topic_score_gemma":1.5450273e-7,"teacher_disagreement_score":0.9860814,"about_ca_system_score_codex":0.000033843226,"about_ca_system_score_gemma":0.000092483395,"threshold_uncertainty_score":0.8444849},"labels":[],"label_agreement":null},{"id":"W2127782155","doi":"10.1016/j.eururo.2012.10.007","title":"New and Emerging Therapies for Bone Metastases in Genitourinary Cancers","year":2012,"lang":"en","type":"review","venue":"European Urology","topic":"Bone health and treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Institutes of Health; Bayer; Amgen; National Cancer Institute; Prostate Cancer Foundation","keywords":"Medicine; Denosumab; Zoledronic acid; Prostate cancer; Bone pain; Spinal cord compression; Oncology; Genitourinary system; Bone metastasis; Clinical trial; Bone disease; Radiation therapy; Internal medicine; Cabozantinib; Cancer; Osteoporosis","score_opus":0.08145922075533021,"score_gpt":0.3688841827296056,"score_spread":0.28742496197427536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127782155","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008545679,0.997074,0.0000227582,0.00028430793,0.00027787228,0.0008864667,0.000031356387,0.00003001701,0.0013077604],"genre_scores_gemma":[0.00027388326,0.9964135,0.0010504277,0.0004849453,0.0003752449,0.000049642673,0.00012234299,0.00008586795,0.001144091],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985175,0.00032663488,0.00038793165,0.0002986124,0.000055606117,0.00041372253],"domain_scores_gemma":[0.9992259,0.00015380682,0.00016351935,0.00021234708,0.000012307053,0.0002320853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028583792,0.00027183635,0.0011076718,0.0002165323,0.000045243927,0.0000046172386,0.000052473988,0.00008165919,0.000072436225],"category_scores_gemma":[0.000031838335,0.00020337196,0.00013783584,0.00009619061,0.000038750837,0.000027312093,0.000048184218,0.00024133883,0.000056544395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008158391,0.00003395061,0.0001706635,0.003090132,0.00019464754,0.0002690875,0.00010819459,4.8467072e-8,1.1181381e-7,0.000030018684,0.0007908035,0.99523073],"study_design_scores_gemma":[0.0011074867,0.00044557772,0.0006422793,0.00039179603,0.0014739955,0.0005490839,0.0000067236806,3.9047637e-7,4.545248e-8,0.00000830891,0.99525124,0.000123084],"about_ca_topic_score_codex":0.00016514494,"about_ca_topic_score_gemma":0.000052961477,"teacher_disagreement_score":0.99510765,"about_ca_system_score_codex":0.00006422156,"about_ca_system_score_gemma":0.00024942373,"threshold_uncertainty_score":0.8293268},"labels":[],"label_agreement":null},{"id":"W2128353247","doi":"10.1016/j.eururo.2007.01.060","title":"Development and Split-Sample Validation of a Nomogram Predicting the Probability of Seminal Vesicle Invasion at Radical Prostatectomy","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Prostatectomy; Medicine; Urology; Logistic regression; Cutoff; Cohort; Prostate cancer; Surgery; Internal medicine; Cancer","score_opus":0.025732789800987085,"score_gpt":0.25992477391893054,"score_spread":0.23419198411794345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128353247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784636,0.0002421975,0.000230542,0.00029690797,0.00003665333,0.0005725612,0.000007876974,0.000018613948,0.00074829836],"genre_scores_gemma":[0.9954197,0.000029770852,0.0043477155,0.000101534235,0.000031275275,0.000011943191,0.00003363677,0.000011821479,0.00001260676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990097,0.00011189132,0.00036620602,0.00020744388,0.00013414862,0.00017058493],"domain_scores_gemma":[0.99926144,0.00027755377,0.0001566039,0.00017513773,0.000059873557,0.00006939402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010964064,0.00008819162,0.0001737621,0.00003753772,0.000063830106,0.0000029757748,0.00004756345,0.000026388858,0.000019641306],"category_scores_gemma":[0.00021029275,0.000058192472,0.000029588664,0.00009025816,0.0002090599,0.000021190746,0.00010546313,0.0000852572,0.0000028561303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009564264,0.00045516118,0.9220376,0.00021596291,0.000083494626,0.00004427078,0.0036379243,0.000009834791,0.013111539,0.00019854601,0.000057897203,0.059191335],"study_design_scores_gemma":[0.0014522208,0.0010165588,0.8038218,0.000046619127,0.00007739351,0.00005818856,0.000074768985,0.000028841592,0.18606023,0.000071250084,0.0072368444,0.00005527225],"about_ca_topic_score_codex":0.000016915734,"about_ca_topic_score_gemma":0.000011647317,"teacher_disagreement_score":0.17294869,"about_ca_system_score_codex":0.000061451574,"about_ca_system_score_gemma":0.000050986542,"threshold_uncertainty_score":0.237302},"labels":[],"label_agreement":null},{"id":"W2128495482","doi":"10.1016/j.eururo.2008.07.037","title":"A Preoperative Prognostic Model for Patients Treated with Nephrectomy for Renal Cell Carcinoma","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Nomogram; Medicine; Nephrectomy; Renal cell carcinoma; Proportional hazards model; Cohort; Kidney cancer; Urology; Internal medicine; Surgery; Oncology; Kidney","score_opus":0.026652199894483124,"score_gpt":0.22610928892225746,"score_spread":0.19945708902777434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128495482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832968,0.0001268882,0.0040352955,0.00012295805,0.00003609742,0.0030990245,0.000059462764,0.000081019454,0.009142464],"genre_scores_gemma":[0.988546,0.0000036744984,0.0061782263,0.00044059474,0.00011752949,0.00036266906,0.00033854146,0.00010574166,0.0039070314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852026,0.00012748147,0.00026882548,0.0005116785,0.00014172093,0.0004300173],"domain_scores_gemma":[0.9989572,0.00017312834,0.000109171895,0.0002979574,0.00028447498,0.0001780298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008424155,0.00028338569,0.00037449668,0.000103477316,0.00015529185,0.000007269475,0.00009788545,0.00005461543,0.000012559705],"category_scores_gemma":[0.000071436545,0.00020048223,0.00012168634,0.00009635343,0.00012535206,0.00004046832,0.000031314987,0.00011684345,0.000035762318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016825816,0.0024867803,0.962677,0.00020409147,0.00031051278,0.0007895891,0.0034517366,0.0013618324,0.0028539503,0.00007953578,0.008283657,0.000675515],"study_design_scores_gemma":[0.042993322,0.05806875,0.8286016,0.000030083904,0.0015695062,0.00041558998,0.000038282422,0.051977184,0.008546141,0.000022899023,0.0070203147,0.0007163114],"about_ca_topic_score_codex":0.000006219651,"about_ca_topic_score_gemma":0.0000041320923,"teacher_disagreement_score":0.13407537,"about_ca_system_score_codex":0.00006774095,"about_ca_system_score_gemma":0.00012663251,"threshold_uncertainty_score":0.8175428},"labels":[],"label_agreement":null},{"id":"W2128659368","doi":"10.1016/j.eururo.2014.01.003","title":"Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":251,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Institute of Cancer Research","funders":"National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Prostate cancer; Internal medicine; Oncology; Cancer; Germline mutation; Prostate; Prostate-specific antigen; Breast cancer; Genetic testing; Prostate biopsy; Gynecology; Incidence (geometry); Germline; Mutation; Genetics; Gene; Biology","score_opus":0.030528795153351548,"score_gpt":0.3126138810895187,"score_spread":0.28208508593616716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128659368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995446,0.0009088258,0.000051518295,0.002025402,0.000101988466,0.00077134254,0.00015346245,0.000017257156,0.0005241517],"genre_scores_gemma":[0.9989303,0.000057703495,0.000068350215,0.00065509236,0.00016378527,0.00002435935,0.000054823642,0.000027895934,0.000017716788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981381,0.00082447665,0.0003505959,0.00031897397,0.00014790053,0.00021994408],"domain_scores_gemma":[0.9989911,0.00035645615,0.000205171,0.00032135847,0.00006299345,0.000062919105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066407357,0.00015186197,0.00025339882,0.000047341888,0.000099756224,0.000021931115,0.0001106153,0.000028327137,0.000016778957],"category_scores_gemma":[0.00035487005,0.0000834594,0.00005148413,0.00016459491,0.00013896184,0.00005882045,0.00010494628,0.00022639519,0.0000018293355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002062686,0.00017568776,0.93296003,0.000005816235,0.00033050322,0.00011443698,0.014768667,0.0018579939,0.00030484414,0.0000069231464,0.000323386,0.047089048],"study_design_scores_gemma":[0.0070149195,0.0013005739,0.9888489,0.000058653583,0.00013883051,0.00001039526,0.0007835574,0.0008925506,0.00026100888,0.000026180087,0.00058937975,0.000075016345],"about_ca_topic_score_codex":0.0057919025,"about_ca_topic_score_gemma":0.00085992157,"teacher_disagreement_score":0.05588893,"about_ca_system_score_codex":0.00003530532,"about_ca_system_score_gemma":0.00005071252,"threshold_uncertainty_score":0.8755663},"labels":[],"label_agreement":null},{"id":"W2128714524","doi":"10.1016/j.eururo.2014.11.004","title":"Active Surveillance for Low-risk Prostate Cancer: Developments to Date","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Watchful waiting; Gynecology; Oncology; Cancer; Internal medicine","score_opus":0.017737339180031664,"score_gpt":0.273688203441349,"score_spread":0.2559508642613173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128714524","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02763598,0.0012933945,0.0003345356,0.949482,0.0024260627,0.0052739684,0.0027424134,0.00025352632,0.010558099],"genre_scores_gemma":[0.025243815,0.0021532846,0.0008202971,0.95906824,0.0036549305,0.0011313355,0.0027933877,0.00030977503,0.004824923],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99703807,0.00040603135,0.00049904286,0.0010325057,0.00021821946,0.0008061443],"domain_scores_gemma":[0.9982267,0.00033562505,0.00040391448,0.0006058345,0.00023647315,0.00019144907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037849828,0.0005118735,0.0008335022,0.00017128221,0.00012304554,0.000027802893,0.00026071983,0.00021472733,0.0000905575],"category_scores_gemma":[0.00023629422,0.00043263606,0.00015556514,0.0001267321,0.00008033848,0.000027912229,0.00015196243,0.00082102505,0.00060599664],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006796915,0.00005802722,0.010672425,0.0002189526,0.0005818011,0.00074997067,0.00033211734,0.0000204618,0.000021028687,0.0000023542693,0.94092965,0.045733545],"study_design_scores_gemma":[0.0023331097,0.0012881554,0.03279163,0.000105445724,0.0002180643,0.00003247547,0.0000028806116,0.000007003092,0.00024500655,0.000013025718,0.9625842,0.00037899773],"about_ca_topic_score_codex":0.00006448816,"about_ca_topic_score_gemma":0.000029716799,"teacher_disagreement_score":0.04535455,"about_ca_system_score_codex":0.00020321732,"about_ca_system_score_gemma":0.00023111122,"threshold_uncertainty_score":0.99981254},"labels":[],"label_agreement":null},{"id":"W2129501383","doi":"10.1016/j.eururo.2015.05.030","title":"Re: Comparative Effectiveness of Shock Wave Lithotripsy and Ureteroscopy for Treating Patients With Kidney Stones","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Ureteroscopy; Shock wave lithotripsy; Lithotripsy; Kidney stones; Urology; Extracorporeal shock wave lithotripsy; Surgery; Ureter","score_opus":0.03407792188377025,"score_gpt":0.2876250529195674,"score_spread":0.2535471310357972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129501383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94110054,0.00081342657,0.0002789972,0.03591464,0.000713196,0.0049340874,0.0014454992,0.00013732334,0.0146623105],"genre_scores_gemma":[0.82554233,0.000022889732,0.0026206512,0.1633255,0.001231368,0.00014956888,0.0053097606,0.00033264677,0.0014652835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970954,0.001010925,0.0004342569,0.00073008274,0.00028919848,0.00044012547],"domain_scores_gemma":[0.9978141,0.0005749578,0.00042964926,0.00048132407,0.00043744632,0.0002625184],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040607728,0.00053308863,0.0013345705,0.00019308383,0.00008117676,0.000015723836,0.000113947746,0.0003061649,0.000014055652],"category_scores_gemma":[0.00029178578,0.0003776974,0.00012693672,0.000112418245,0.0002925682,0.0000521334,0.000088394445,0.00062494597,0.000010667054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01473126,0.00073265104,0.5752104,0.002839665,0.0026042713,0.00069054926,0.0021989828,0.0000037543377,0.00014671589,0.000017339084,0.40014043,0.0006839538],"study_design_scores_gemma":[0.02818576,0.022388961,0.53028536,0.000881795,0.002844773,0.00017649303,0.00006804665,0.00007203097,0.00032665767,0.000055836383,0.41391093,0.0008033325],"about_ca_topic_score_codex":0.000014420713,"about_ca_topic_score_gemma":2.9698785e-7,"teacher_disagreement_score":0.12741086,"about_ca_system_score_codex":0.00007015568,"about_ca_system_score_gemma":0.0001505909,"threshold_uncertainty_score":0.9998675},"labels":[],"label_agreement":null},{"id":"W2129819340","doi":"10.1016/j.eururo.2013.12.057","title":"Metformin in Chemotherapy-naive Castration-resistant Prostate Cancer: A Multicenter Phase 2 Trial (SAKK 08/09)","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Oncology; Prostate cancer; Internal medicine; Metformin; Chemotherapy; Urology; Cancer; Prostate; Gynecology","score_opus":0.010418181554749476,"score_gpt":0.27459869739687515,"score_spread":0.26418051584212565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129819340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97801167,0.01771268,0.00014124379,0.00014503213,0.0005968898,0.0005020739,0.000045860717,0.000018194012,0.002826337],"genre_scores_gemma":[0.9891586,0.0063893795,0.00018120518,0.0024365429,0.0010772498,0.00007878347,0.000106606014,0.0000585563,0.0005131106],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981424,0.0004805369,0.0003791608,0.00048457386,0.000105443236,0.0004078395],"domain_scores_gemma":[0.99930555,0.000021362055,0.00015581414,0.00035596153,0.00006254997,0.000098751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005580129,0.00021686208,0.00026116072,0.00006806029,0.00005321312,0.000025057738,0.00022811453,0.00008873303,0.0001543142],"category_scores_gemma":[0.00010819601,0.00019899209,0.00009233019,0.00008425453,0.00010511608,0.000007116576,0.000060357015,0.00014736912,0.00005099194],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056150183,0.0007423255,0.0006713314,0.000041354917,0.00018303892,0.000047078025,0.0009384296,0.0001477999,0.31633723,0.00019840206,0.005197638,0.6193452],"study_design_scores_gemma":[0.0525252,0.0019596997,0.00081545254,0.000006605678,0.000038482187,0.0000037706156,0.000037243262,0.00015817302,0.027201869,0.000034315857,0.91693634,0.00028282875],"about_ca_topic_score_codex":0.000041781925,"about_ca_topic_score_gemma":0.00017042486,"teacher_disagreement_score":0.9117387,"about_ca_system_score_codex":0.000015981257,"about_ca_system_score_gemma":0.00006880169,"threshold_uncertainty_score":0.81146616},"labels":[],"label_agreement":null},{"id":"W2130039728","doi":"10.1016/j.eururo.2009.01.037","title":"Pharmacological Approaches to Reducing the Risk of Prostate Cancer","year":2009,"lang":"en","type":"review","venue":"European Urology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Prostate cancer; Finasteride; Dutasteride; Prostate; Cancer; Oncology; Gynecology; Prostate-specific antigen; Prostate biopsy; Internal medicine; Management of prostate cancer","score_opus":0.07487265699197224,"score_gpt":0.311657135339084,"score_spread":0.23678447834711178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130039728","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037580048,0.99099094,0.000038028793,0.00018206348,0.0033835492,0.00076393655,0.00013426911,0.000015621914,0.004115811],"genre_scores_gemma":[0.00028783293,0.98415935,0.000095705655,0.0005953341,0.0134124635,0.00008492888,0.00008055355,0.00006323019,0.0012205864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99694574,0.0014271382,0.0005061095,0.0006414194,0.000100075886,0.00037951674],"domain_scores_gemma":[0.9988807,0.000043641317,0.0004138232,0.0005131434,0.000039148086,0.00010955492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073875196,0.0003596055,0.00082607067,0.000067704204,0.00008673686,0.000013396997,0.0006159921,0.00017572354,0.00003680106],"category_scores_gemma":[0.00013278784,0.0002239675,0.00039729747,0.00015868571,0.00016929752,0.0000014085778,0.0002913808,0.00041865543,0.000039018283],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006475947,0.00004801083,0.000008004977,0.0002840659,0.00029924678,7.3199374e-7,0.0000952348,0.00015632118,0.00025943166,0.00003094268,0.044404685,0.95434856],"study_design_scores_gemma":[0.00019029537,0.000279372,0.000091848684,0.000093028604,0.0010305623,0.000029000166,0.0000058136693,0.000001665912,0.000040929244,0.0000048102725,0.9979982,0.00023447342],"about_ca_topic_score_codex":0.000021188342,"about_ca_topic_score_gemma":0.000009490725,"teacher_disagreement_score":0.9541141,"about_ca_system_score_codex":0.000013500774,"about_ca_system_score_gemma":0.00017393129,"threshold_uncertainty_score":0.9133129},"labels":[],"label_agreement":null},{"id":"W2130456918","doi":"10.1016/j.eururo.2014.04.008","title":"All Bacillus Calmette-Guérin (BCG) Strains Are Equal, but Some BCG Strains Are More Equal Than Others","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bacillus (shape); BCG vaccine; Microbiology; Virology; Vaccination","score_opus":0.055396853291983475,"score_gpt":0.29031367116690987,"score_spread":0.2349168178749264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130456918","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044272657,0.0024424852,0.0011202635,0.86840874,0.0038636005,0.0027433645,0.0047010104,0.0011891728,0.07125869],"genre_scores_gemma":[0.27222174,0.0001111338,0.0000824888,0.70245165,0.012570302,0.000050219936,0.0016216886,0.00061979296,0.010271016],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931632,0.0014091484,0.0009802113,0.0018052056,0.00085780304,0.0017843837],"domain_scores_gemma":[0.99657655,0.0001922323,0.0007893016,0.0017746086,0.00015917409,0.00050810754],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0004938838,0.0013622844,0.001805417,0.00046966915,0.00019077152,0.00008202139,0.0009185276,0.0011001652,0.0014416055],"category_scores_gemma":[0.00017413218,0.0011942633,0.00066455035,0.0001821164,0.00066353724,0.00011096819,0.00027794173,0.0035677443,0.0024378311],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034243992,0.00034047713,0.002260411,0.0005046133,0.00212536,0.024228875,0.0010666996,0.0000414384,0.0005162926,0.00012475549,0.9657771,0.0026715102],"study_design_scores_gemma":[0.0062094736,0.002697655,0.021350073,0.00017098086,0.0013906949,0.0008620479,0.00023009675,0.000034478788,0.000050896746,0.00015130483,0.96564585,0.0012064334],"about_ca_topic_score_codex":0.00029250543,"about_ca_topic_score_gemma":0.00007173231,"teacher_disagreement_score":0.22794908,"about_ca_system_score_codex":0.00026105667,"about_ca_system_score_gemma":0.0002603811,"threshold_uncertainty_score":0.9999128},"labels":[],"label_agreement":null},{"id":"W2131125612","doi":"10.1016/j.eururo.2007.10.052","title":"Type 1 and Type 2 5α-Reductase Expression in the Development and Progression of Prostate Cancer","year":2007,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"GlaxoSmithKline","keywords":"Dutasteride; Finasteride; Medicine; Prostate cancer; Prostate; Dihydrotestosterone; Testosterone (patch); Management of prostate cancer; 5 Alpha-Reductase Inhibitor; Androgen; Hyperplasia; Internal medicine; Oncology; Antiandrogen; Intraepithelial neoplasia; PCA3; Cancer; Urology; Cancer research; Hormone","score_opus":0.10370436565663399,"score_gpt":0.42925141271675027,"score_spread":0.3255470470601163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131125612","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011481389,0.9857366,2.3280951e-7,0.00012690572,0.000104029976,0.0009453924,0.000006017448,0.000009331715,0.001590115],"genre_scores_gemma":[0.0013560428,0.9976292,0.00019285892,0.000065828484,0.00007865144,0.000026783535,0.00010041781,0.00003463457,0.000515549],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985818,0.00038550887,0.00034108516,0.00029587818,0.00015579502,0.00023989682],"domain_scores_gemma":[0.99943167,0.00009590241,0.00013791346,0.00018743514,0.00007497028,0.00007211767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006677513,0.00019465071,0.00053864636,0.00017666759,0.00004534637,0.000008018199,0.00009341629,0.000087035565,0.00002525108],"category_scores_gemma":[0.00006519477,0.000097452976,0.000024291987,0.0002981785,0.00017321014,0.000017575321,0.00013197625,0.00035444688,0.000011903229],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034121005,0.00007776118,0.0009323009,0.003625655,0.000044884793,0.00034670046,0.001111623,3.7678745e-8,0.00003301232,0.000004164438,0.0005916411,0.992891],"study_design_scores_gemma":[0.00060830713,0.00053570705,0.001473268,0.0029266782,0.00013299547,0.00010745433,0.0000347233,3.5230357e-7,0.00005025961,0.0000019563333,0.99403596,0.00009231738],"about_ca_topic_score_codex":0.0000032703726,"about_ca_topic_score_gemma":0.0000037946388,"teacher_disagreement_score":0.9934443,"about_ca_system_score_codex":0.000033619926,"about_ca_system_score_gemma":0.0003229393,"threshold_uncertainty_score":0.3974017},"labels":[],"label_agreement":null},{"id":"W2132024289","doi":"10.1016/j.eururo.2006.11.027","title":"Prostate Cancer-Specific Survival in Men Treated with Hormonal Therapy after Failure of Radical Prostatectomy","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nomogram; Prostatectomy; Prostate cancer; Hormonal therapy; Urology; Proportional hazards model; Prostate-specific antigen; Stage (stratigraphy); Radiation therapy; Surgical margin; Biochemical recurrence; Internal medicine; Surgery; Oncology; Cancer","score_opus":0.009292938395441269,"score_gpt":0.2245566970867081,"score_spread":0.21526375869126685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132024289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867536,0.0042635263,0.000006381365,0.001844169,0.000034622113,0.00087493676,0.00006814974,0.000049729504,0.006104895],"genre_scores_gemma":[0.9975206,0.0013943628,0.00011900833,0.00020147079,0.00012290022,0.00019842963,0.00009703653,0.000062115985,0.00028402626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984042,0.00022824173,0.00035785534,0.0004207993,0.00020179138,0.00038711797],"domain_scores_gemma":[0.999419,0.000046143727,0.00011360041,0.00025313586,0.00007916288,0.00008897072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017375762,0.00024164145,0.00042880827,0.00013752258,0.000024750432,0.000010572753,0.00007765281,0.000049562273,0.00019154893],"category_scores_gemma":[0.0000033094423,0.00016342766,0.000060714512,0.000256851,0.00025394085,0.000046255936,0.000027440212,0.0002044475,0.000021460553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008638326,0.00083250366,0.9750185,0.000030150337,0.00013329105,0.0023018944,0.00029643613,0.00006565482,0.00332525,0.00013886947,0.0015727789,0.0076463367],"study_design_scores_gemma":[0.0098369215,0.0026915248,0.94008833,0.00004562166,0.00004162753,0.000050144794,0.000023920738,0.0000111112495,0.0034046536,0.000029455952,0.043617535,0.00015916284],"about_ca_topic_score_codex":0.00022133626,"about_ca_topic_score_gemma":0.00015619896,"teacher_disagreement_score":0.042044755,"about_ca_system_score_codex":0.00009189012,"about_ca_system_score_gemma":0.0000861626,"threshold_uncertainty_score":0.66643864},"labels":[],"label_agreement":null},{"id":"W2132527468","doi":"10.1016/j.eururo.2008.08.033","title":"Investigation, Treatment, and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":344,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Pediatrics; Testosterone (patch); Internal medicine; Intensive care medicine","score_opus":0.06517704574217491,"score_gpt":0.2765946022648315,"score_spread":0.2114175565226566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132527468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99007404,0.0020647072,0.0000030823392,0.0041162777,0.00007418763,0.00011210821,0.000008210026,0.000014657407,0.0035327342],"genre_scores_gemma":[0.9955753,0.0025535813,0.00038876684,0.00012204498,0.000116430165,0.000004187813,0.000011844773,0.000012054162,0.0012158006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992965,0.00014347858,0.0001853848,0.00022365131,0.000034774872,0.000116243784],"domain_scores_gemma":[0.9996569,0.00007868369,0.00005089568,0.00011303243,0.000038302845,0.000062148916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012942823,0.00009421722,0.00020108095,0.000100182544,0.00008084319,0.00000169369,0.000022605971,0.000023081857,0.00000985903],"category_scores_gemma":[0.00012132549,0.00007434017,0.000017156193,0.000087924054,0.00034475257,0.000034967965,0.000039941013,0.000084321626,0.000011949947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051418592,0.00004066792,0.9925212,0.000010527177,0.000049409027,0.000065802335,0.0032391038,0.0000016320798,0.0017660444,0.00003027671,0.00020973023,0.002014156],"study_design_scores_gemma":[0.0008796875,0.0004261802,0.9922712,0.0000121583535,0.000030835654,0.00016935113,0.0002402854,0.0000047183407,0.00048815715,0.00010677765,0.005313999,0.000056654033],"about_ca_topic_score_codex":0.000075985925,"about_ca_topic_score_gemma":0.000014034642,"teacher_disagreement_score":0.0055012545,"about_ca_system_score_codex":0.000013024905,"about_ca_system_score_gemma":0.000018356497,"threshold_uncertainty_score":0.30315042},"labels":[],"label_agreement":null},{"id":"W2133621280","doi":"10.1016/j.eururo.2015.10.021","title":"Prior Endocrine Therapy Impact on Abiraterone Acetate Clinical Efficacy in Metastatic Castration-resistant Prostate Cancer: Post-hoc Analysis of Randomised Phase 3 Studies","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Abiraterone acetate; Prostate cancer; Post-hoc analysis; Oncology; Abiraterone; Post hoc; Internal medicine; Urology; Clinical trial; Androgen deprivation therapy; Cancer","score_opus":0.1580192024020125,"score_gpt":0.4869502137233973,"score_spread":0.3289310113213848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133621280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876391,0.008379897,0.000002227377,0.0021033734,0.00011909505,0.0013305274,0.000117200754,0.000031251795,0.00027731012],"genre_scores_gemma":[0.9930139,0.0058347587,0.00007250276,0.00037565277,0.00006754124,0.000045999186,0.00015202654,0.000038304614,0.00039927234],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964405,0.0014655786,0.00090428704,0.00044875438,0.00030688397,0.00043401995],"domain_scores_gemma":[0.9981109,0.0005696424,0.00028732093,0.0003859042,0.00039306917,0.00025318944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016088581,0.0002708364,0.0012159203,0.0005505737,0.000041274347,0.00001362102,0.00013082183,0.00002631696,0.000097120974],"category_scores_gemma":[0.00043994442,0.00016316616,0.00030689838,0.000691148,0.00032025488,0.00005813087,0.00004713788,0.0002854891,0.000028362707],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81004995,0.006740496,0.03075674,0.00009672347,0.022678392,0.0048124865,0.008639703,0.0033830332,0.027252972,0.000015997546,0.0009062174,0.08466732],"study_design_scores_gemma":[0.5046405,0.061212786,0.4224978,0.00008017701,0.004183478,0.000032729542,0.00075285375,0.0010853395,0.0030777105,0.000019661788,0.0020020776,0.00041484452],"about_ca_topic_score_codex":0.000109849374,"about_ca_topic_score_gemma":0.00010014984,"teacher_disagreement_score":0.39174107,"about_ca_system_score_codex":0.00013449724,"about_ca_system_score_gemma":0.00037177512,"threshold_uncertainty_score":0.66537225},"labels":[],"label_agreement":null},{"id":"W2133646931","doi":"10.1016/j.eururo.2012.09.057","title":"ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers","year":2012,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":267,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystoscopy; Bladder cancer; Urine cytology; MEDLINE; Cancer; Gold standard (test); Urinary system; Oncology; Internal medicine; Urology","score_opus":0.05054170174184221,"score_gpt":0.3471694749275516,"score_spread":0.29662777318570943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133646931","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003915518,0.9602073,0.0000723605,0.000655247,0.00082978373,0.0007622252,0.0001585709,0.00005831218,0.037217088],"genre_scores_gemma":[0.00064982177,0.99327666,0.00012838034,0.0027608944,0.0007327651,0.00019758151,0.00039384872,0.00013262453,0.0017274484],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980769,0.00046462717,0.00039152298,0.0005123401,0.00022014447,0.00033444058],"domain_scores_gemma":[0.99899936,0.00018210705,0.0002468018,0.00028944385,0.00007250325,0.00020976638],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021181689,0.00041696662,0.0007866465,0.000217928,0.00005405679,0.000022499287,0.0001541877,0.0001686344,0.0014275257],"category_scores_gemma":[0.00006841095,0.0003327841,0.00019976428,0.000102445214,0.00013501414,0.000058961337,0.000096105236,0.000428203,0.0004053151],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013652793,0.00012530938,0.0004693055,0.0005480767,0.0013116504,0.00026301248,0.00006469769,7.6308226e-7,8.4881043e-7,0.00011629823,0.008589018,0.9883745],"study_design_scores_gemma":[0.0012765534,0.00035668802,0.0015496674,0.00083216926,0.0029760718,0.00017492668,0.0000044670105,0.0000017749214,0.000002072869,0.000003016872,0.99258274,0.00023983583],"about_ca_topic_score_codex":0.000044372053,"about_ca_topic_score_gemma":0.000006967998,"teacher_disagreement_score":0.9881347,"about_ca_system_score_codex":0.0000741055,"about_ca_system_score_gemma":0.00009739156,"threshold_uncertainty_score":0.99991244},"labels":[],"label_agreement":null},{"id":"W2134868034","doi":"10.1016/j.eururo.2015.09.051","title":"The Impact of Adding Taxanes to Gemcitabine and Platinum Chemotherapy for the First-Line Therapy of Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis","year":2015,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Gemcitabine; Taxane; Docetaxel; Oncology; Internal medicine; Paclitaxel; Chemotherapy; Regimen; Cancer; Urology; Breast cancer","score_opus":0.12192699752079104,"score_gpt":0.4142933770080399,"score_spread":0.29236637948724886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134868034","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020288837,0.9892367,0.00009385053,0.0010153324,0.00003654409,0.008695421,0.00083000545,0.000014244194,0.000057613666],"genre_scores_gemma":[0.000347334,0.99644506,0.00017665968,0.0009343887,0.00006343669,0.0013120705,0.000029166216,0.00010334769,0.00058852276],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99703985,0.0007168789,0.0012705484,0.0004498321,0.00022626194,0.00029665275],"domain_scores_gemma":[0.9959728,0.0016292919,0.0012073915,0.0007974419,0.0002618361,0.00013123255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014944297,0.0005664659,0.0069602737,0.00016684101,0.000108921085,0.000017598575,0.00032334586,0.00005544634,0.0001335888],"category_scores_gemma":[0.0004276112,0.00020470598,0.0015493341,0.00057245267,0.00017458982,0.000028340386,0.00006984646,0.00017075497,0.00000247033],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001815957,0.00018603234,0.000008874474,0.31881517,0.5112947,0.000020114445,0.000639682,0.000050006096,0.0000034596276,0.000020255742,0.0010211854,0.16612455],"study_design_scores_gemma":[0.0022194337,0.003534458,0.000024867768,0.0041306815,0.77607024,0.00012028157,0.000019876647,0.000020848189,0.0000016804657,0.000010053801,0.21360074,0.0002468476],"about_ca_topic_score_codex":0.00008263333,"about_ca_topic_score_gemma":0.000047130674,"teacher_disagreement_score":0.3146845,"about_ca_system_score_codex":0.000047006142,"about_ca_system_score_gemma":0.00023905886,"threshold_uncertainty_score":0.8347668},"labels":[],"label_agreement":null},{"id":"W2135564723","doi":"10.1016/j.eururo.2011.05.044","title":"Contemporary Management of Small Renal Masses","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Nephrectomy; Watchful waiting; Observational study; Randomized controlled trial; MEDLINE; Ablative case; Surgery; Renal mass; General surgery; Kidney; Radiation therapy; Internal medicine; Cancer","score_opus":0.09378567032500179,"score_gpt":0.243701965537001,"score_spread":0.1499162952119992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135564723","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4496325,0.0005363086,0.00016796205,0.000090591144,0.000060827682,0.00014907916,0.0000013911152,0.000033563792,0.5493278],"genre_scores_gemma":[0.9915188,0.000038018283,0.0051017473,0.0003983494,0.000044843975,0.0000041358476,0.000013045098,0.000029437644,0.0028516105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991272,0.00016356893,0.00024963354,0.00021787015,0.00008423077,0.00015747736],"domain_scores_gemma":[0.9994179,0.00001904693,0.00009239888,0.00035156688,0.0000337114,0.00008538671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018482775,0.00011517085,0.00020798668,0.00007905366,0.000015156205,0.0000015114874,0.00010547311,0.00002413175,0.00029442422],"category_scores_gemma":[0.000006839393,0.00009239469,0.000078360914,0.00006364363,0.00009493486,0.000015015206,0.000098453864,0.00008630475,0.00030973516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012226816,0.0048228814,0.70389515,0.0014690876,0.00509156,0.12089937,0.0050615766,0.000013650416,0.03238433,0.017466942,0.04684357,0.049825095],"study_design_scores_gemma":[0.002558282,0.002912386,0.9244605,0.00003753928,0.00028650137,0.00033090223,0.00009528848,0.000007808445,0.009454652,0.00011226494,0.059607215,0.00013666303],"about_ca_topic_score_codex":0.000016477054,"about_ca_topic_score_gemma":5.974318e-7,"teacher_disagreement_score":0.5464762,"about_ca_system_score_codex":0.000012539499,"about_ca_system_score_gemma":0.000016798893,"threshold_uncertainty_score":0.3981122},"labels":[],"label_agreement":null},{"id":"W2136098219","doi":"10.1016/j.eururo.2012.01.019","title":"Subclassification of pT3 Urothelial Carcinoma of the Renal Pelvicalyceal System is Associated With Recurrence-Free and Cancer-Specific Survival: Proposal for a Revision of the Current TNM Classification","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Urology","score_opus":0.04862427174382285,"score_gpt":0.28588005207882544,"score_spread":0.2372557803350026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136098219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98919046,0.003560718,0.00040905742,0.0020828885,0.00083486,0.0018911902,0.00041417644,0.000022540416,0.0015941123],"genre_scores_gemma":[0.9994322,0.00014555787,0.000072231094,0.000029277775,0.00019038738,0.000023209737,0.000017845523,0.00003054679,0.000058750007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981899,0.00057306536,0.00047004607,0.0002476073,0.00030793188,0.00021143342],"domain_scores_gemma":[0.99829876,0.0001157922,0.0006325241,0.0005844852,0.00030390502,0.00006453157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055592356,0.00015510916,0.00035846254,0.000050017963,0.00007990921,0.0000040870755,0.00024636072,0.000055494,0.000011412927],"category_scores_gemma":[0.00013626531,0.00008316878,0.00010948383,0.00023264042,0.00033384,0.000040853894,0.00007782279,0.00017747318,0.0000010814917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00403213,0.0010209123,0.8881443,0.0009860813,0.00035145748,0.0000013226291,0.003948307,0.0000038835806,0.02132302,0.008121006,0.0032261782,0.06884141],"study_design_scores_gemma":[0.0032197176,0.0008295065,0.9817961,0.0003220588,0.00047184824,0.000012433826,0.000089133806,0.00016326582,0.0055935397,0.000029107892,0.007379642,0.00009363826],"about_ca_topic_score_codex":0.000029373372,"about_ca_topic_score_gemma":0.000012719788,"teacher_disagreement_score":0.093651816,"about_ca_system_score_codex":0.00008053311,"about_ca_system_score_gemma":0.00022666,"threshold_uncertainty_score":0.33915246},"labels":[],"label_agreement":null},{"id":"W2136122972","doi":"10.1016/j.eururo.2012.10.036","title":"Selecting the Optimal Candidate for Adjuvant Radiotherapy After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Proportional hazards model; Lymph node; Oncology; Internal medicine; Biochemical recurrence; Cohort; Stage (stratigraphy); Radiation therapy; Dissection (medical); Urology; Cancer; Gynecology; Surgery","score_opus":0.016228670200731262,"score_gpt":0.3027822279966144,"score_spread":0.28655355779588315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136122972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97403955,0.013244724,0.0049650143,0.0037670764,0.00046794853,0.0030235704,0.0002884165,0.00008490951,0.00011876052],"genre_scores_gemma":[0.9925331,0.0011554266,0.00092571654,0.0018884445,0.0008919609,0.001964626,0.00019249144,0.00009915893,0.00034909244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789196,0.0002513491,0.00037799435,0.00045897363,0.00015109303,0.00086860824],"domain_scores_gemma":[0.9988189,0.00029231652,0.00017317614,0.00035291526,0.00012168478,0.0002410351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007903122,0.00028898634,0.0005653207,0.00013356359,0.00021304784,0.0000379794,0.0001310327,0.000053216063,0.00011677008],"category_scores_gemma":[0.000059247886,0.00018473662,0.00033044617,0.000304171,0.00015908657,0.00007862922,0.00004421947,0.00018556563,0.000008205293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061572157,0.00040480806,0.95236075,0.00013040032,0.0038188766,0.00007935607,0.0023378981,0.00019808326,0.00048955815,0.000051197785,0.00069560297,0.033276238],"study_design_scores_gemma":[0.008522758,0.002429296,0.9266096,0.000031032,0.0040793736,0.00007119271,0.000038292066,0.0009394269,0.0010234814,0.000006187837,0.055909425,0.00033993446],"about_ca_topic_score_codex":0.000049196373,"about_ca_topic_score_gemma":0.00008060072,"teacher_disagreement_score":0.055213824,"about_ca_system_score_codex":0.00016567936,"about_ca_system_score_gemma":0.00010940856,"threshold_uncertainty_score":0.7533341},"labels":[],"label_agreement":null},{"id":"W2136476240","doi":"10.1016/j.eururo.2012.01.022","title":"Cancer Control and Functional Outcomes of Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer: A Systematic Review of the Literature","year":2012,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":286,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Radiation therapy; Biochemical recurrence; Watchful waiting; Systematic review; MEDLINE; Prostate-specific antigen; Cancer; Internal medicine; General surgery; Oncology; Surgery","score_opus":0.025130209962894917,"score_gpt":0.31556264071433304,"score_spread":0.2904324307514381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136476240","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033892306,0.9860578,0.0000051902593,0.0010714466,0.00061634113,0.009997545,0.0021588546,0.000015123637,0.000043802964],"genre_scores_gemma":[0.00086904666,0.9938281,0.000012105802,0.0011452775,0.00017937085,0.0034874761,0.00024605053,0.00006914871,0.00016340247],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99715215,0.00077208626,0.0011747936,0.0003696695,0.00023843569,0.00029284362],"domain_scores_gemma":[0.9973806,0.0005016497,0.0013369138,0.00043488073,0.0002235798,0.00012237763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063263683,0.00041424143,0.0031238648,0.000100539335,0.000051367057,0.000009214075,0.00013156787,0.0001018987,0.000040448227],"category_scores_gemma":[0.0002788408,0.00020898302,0.0006203796,0.00021246905,0.00017422147,0.00003633977,0.000060313356,0.0003021064,0.0000033403128],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007126372,0.00014810235,0.0014597985,0.9072094,0.0015965778,0.0000064234155,0.00012115904,2.6214278e-7,4.4186473e-7,0.00010744495,0.000965441,0.08831368],"study_design_scores_gemma":[0.0024542345,0.0003974866,0.0028689252,0.46779618,0.020106182,0.00007265987,0.0000020726143,0.0000020055486,0.000001272971,0.0000053602535,0.5060997,0.00019392947],"about_ca_topic_score_codex":0.0000059534564,"about_ca_topic_score_gemma":0.0000022699417,"teacher_disagreement_score":0.5051342,"about_ca_system_score_codex":0.00013405803,"about_ca_system_score_gemma":0.00037326888,"threshold_uncertainty_score":0.8522081},"labels":[],"label_agreement":null},{"id":"W2139287380","doi":"10.1016/j.eururo.2013.05.015","title":"Toxicities Following Treatment with Bisphosphonates and Receptor Activator of Nuclear Factor-κB Ligand Inhibitors in Patients with Advanced Prostate Cancer","year":2013,"lang":"en","type":"review","venue":"European Urology","topic":"Bone health and treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Denosumab; Zoledronic acid; Osteonecrosis of the jaw; Prostate cancer; Adverse effect; Oncology; Internal medicine; Osteoclast; Androgen deprivation therapy; Cancer; Osteoporosis; Bisphosphonate","score_opus":0.01486733800395289,"score_gpt":0.27054112805454456,"score_spread":0.25567379005059165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139287380","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48918718,0.5088288,3.152119e-8,0.000037259197,0.000098203636,0.0015954715,0.00006762217,0.000025012245,0.00016041021],"genre_scores_gemma":[0.093932234,0.9049051,0.00016981096,0.00010390812,0.00002360885,0.0001345654,0.000118316486,0.00017878292,0.00043366864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99825376,0.00018205703,0.00049274846,0.0005045851,0.00016557757,0.000401255],"domain_scores_gemma":[0.99900115,0.000083254505,0.00040357863,0.00025656167,0.000053185475,0.00020225492],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00004776625,0.000500978,0.001571032,0.00018544856,0.00005342324,0.000010540117,0.000059749855,0.00011724508,0.000039332197],"category_scores_gemma":[0.000016295837,0.0002848521,0.0000996393,0.00018193926,0.000120068806,0.000087970075,0.000042251657,0.00024597967,0.000023882858],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011150393,0.00041562074,0.059973396,0.0025362733,0.00066932396,0.0000910645,0.00080001756,3.239482e-7,0.000004702294,0.0000019245726,0.000051169107,0.93434113],"study_design_scores_gemma":[0.010673578,0.014721415,0.026518766,0.007530532,0.0010065133,0.000014545813,0.000060462153,3.3850554e-7,0.000046791774,6.614453e-7,0.9389574,0.00046901923],"about_ca_topic_score_codex":0.0002660091,"about_ca_topic_score_gemma":0.00003920722,"teacher_disagreement_score":0.9389062,"about_ca_system_score_codex":0.00019352604,"about_ca_system_score_gemma":0.00023490906,"threshold_uncertainty_score":0.99996036},"labels":[],"label_agreement":null},{"id":"W2140294274","doi":"10.1159/000049858","title":"Antisense Bcl–2 Oligonucleotide Uptake in Human Transitional Cell Carcinoma","year":2001,"lang":"en","type":"article","venue":"European Urology","topic":"DNA and Nucleic Acid Chemistry","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Urothelium; Flow cytometry; Molecular biology; Staining; Cell culture; Intracellular; Fluorescence microscope; Cell; Urothelial Cell; Biology; Ex vivo; In vivo; Pathology; Medicine; Urinary bladder; Fluorescence; Cell biology; Internal medicine; Biochemistry","score_opus":0.01067207808188652,"score_gpt":0.22409427272671023,"score_spread":0.2134221946448237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140294274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9052346,0.00029897635,0.00015237479,0.0002653684,0.000100986326,0.00006645657,0.000016384269,0.000024488565,0.09384041],"genre_scores_gemma":[0.995151,0.00007214874,0.00021829043,0.001228767,0.00040660327,0.0000027057956,0.00027699946,0.000056256715,0.002587251],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998563,0.00016260105,0.0002960622,0.00048470532,0.000092935494,0.0004007264],"domain_scores_gemma":[0.9993712,0.000009049212,0.00006607685,0.0004052628,0.000034042525,0.00011439824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020121885,0.0002071459,0.00016713506,0.000056592653,0.00008537996,0.000014045344,0.00026822,0.0001247381,0.00026194254],"category_scores_gemma":[0.000021724609,0.00022885996,0.000101666854,0.0000870431,0.0001488672,0.0000037226334,0.0001018946,0.0002000869,0.00018220587],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010706041,0.00013180489,0.009950333,0.000009473067,0.000009553888,0.00035813198,0.00006937673,0.000052010844,0.98464364,0.000035495712,0.004178422,0.0004546975],"study_design_scores_gemma":[0.00255835,0.00035865162,0.16964233,0.000004961942,0.000030948722,0.00058837206,0.000046711844,0.000020340474,0.14900535,0.0000724025,0.67712003,0.0005515622],"about_ca_topic_score_codex":0.000009938108,"about_ca_topic_score_gemma":0.000028769047,"teacher_disagreement_score":0.8356383,"about_ca_system_score_codex":0.000010004058,"about_ca_system_score_gemma":0.000025427711,"threshold_uncertainty_score":0.93326384},"labels":[],"label_agreement":null},{"id":"W2140757158","doi":"10.1016/j.eururo.2013.01.002","title":"Randomised, Multicentre, Placebo-controlled, Double-blind Crossover Study Investigating the Effect of Solifenacin and Oxybutynin in Elderly People with Mild Cognitive Impairment: The SENIOR Study","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Oxybutynin; Solifenacin; Placebo; Crossover study; Overactive bladder; Tolerability; Adverse effect; Cognition; Urology; Internal medicine; Psychiatry","score_opus":0.018926730379371665,"score_gpt":0.298226531393148,"score_spread":0.2792998010137763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140757158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778001,0.00034010666,0.0000034728246,0.00071475253,0.00003595246,0.019431325,0.000003972011,0.00002300235,0.0016473351],"genre_scores_gemma":[0.9987012,0.000017941582,0.000006719479,0.00019874674,0.00007604027,0.00065396394,0.0000055735054,0.000047299513,0.0002925141],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99392956,0.0042416644,0.0005184818,0.00043715315,0.0003716778,0.00050143595],"domain_scores_gemma":[0.99590975,0.003254165,0.00018777476,0.0003654115,0.00013314236,0.00014978065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033008463,0.0002944585,0.0007303778,0.00014086113,0.00022889802,0.000070874215,0.00019667979,0.000039440507,0.00009404448],"category_scores_gemma":[0.00040163207,0.00013367983,0.00007109229,0.0002941834,0.00038164845,0.000092073096,0.00021088115,0.00067562493,0.00005253089],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38008028,0.00086417433,0.586756,0.000055574073,0.0005980671,0.00020235627,0.030515438,0.0000417089,0.000119919045,8.060689e-7,0.00008659082,0.0006790821],"study_design_scores_gemma":[0.6051404,0.02434263,0.3578317,0.00003219868,0.0005152414,0.000079813835,0.011227184,0.0005683249,0.00012344572,0.0000021508733,0.0000113147435,0.00012563771],"about_ca_topic_score_codex":0.0005989501,"about_ca_topic_score_gemma":0.00042267362,"teacher_disagreement_score":0.22892432,"about_ca_system_score_codex":0.000014911262,"about_ca_system_score_gemma":0.000060281818,"threshold_uncertainty_score":0.5451305},"labels":[],"label_agreement":null},{"id":"W2141561215","doi":"10.1016/j.eururo.2011.11.047","title":"A Non–Cancer-Related Survival Benefit Is Associated With Partial Nephrectomy","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Propensity score matching; Nephrectomy; Hazard ratio; Renal cell carcinoma; Confidence interval; Internal medicine; Cancer; Proportional hazards model; Population; Epidemiology; Surgery; Urology; Kidney","score_opus":0.0351994027784501,"score_gpt":0.2380875145360995,"score_spread":0.2028881117576494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141561215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8798609,0.00022242374,0.000013767413,0.0003730381,0.00023117627,0.00036291085,0.000008268371,0.00019285847,0.11873466],"genre_scores_gemma":[0.9959658,0.00003182706,0.00015803578,0.0009897138,0.00012191919,0.000028158096,0.000033851422,0.00008556019,0.0025851405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844027,0.00018691525,0.00029193563,0.0004399675,0.00019242486,0.00044851602],"domain_scores_gemma":[0.99909604,0.00004938631,0.0001537032,0.00038954642,0.00010438051,0.00020696723],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024327717,0.00025075767,0.00040692274,0.00009544946,0.00006554272,0.00000765167,0.00013377683,0.000088174915,0.0016302993],"category_scores_gemma":[0.000028649798,0.00018907958,0.00010402854,0.0002228707,0.000110749825,0.000039007897,0.00006683575,0.0002892817,0.00074587215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036258008,0.0016065725,0.964976,0.000028964841,0.0028967299,0.009715027,0.006117153,0.000018460374,0.0025710731,0.00039958846,0.0027870105,0.0052576205],"study_design_scores_gemma":[0.0060299602,0.00395634,0.9707587,0.000028879238,0.0008810712,0.00020960796,0.000020197329,0.00013649534,0.0033049565,0.000036530408,0.0143635925,0.000273682],"about_ca_topic_score_codex":0.00010198485,"about_ca_topic_score_gemma":0.000031953714,"teacher_disagreement_score":0.11614952,"about_ca_system_score_codex":0.00007968921,"about_ca_system_score_gemma":0.000064202766,"threshold_uncertainty_score":0.99928236},"labels":[],"label_agreement":null},{"id":"W2142294849","doi":"10.1016/j.eururo.2013.03.034","title":"Management of Localized Kidney Cancer: Calculating Cancer-specific Mortality and Competing Risks of Death for Surgery and Nonsurgical Management","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Hazard ratio; Kidney cancer; Confidence interval; Confounding; Proportional hazards model; Cancer; Surgery; Cohort; Urology; Internal medicine; Kidney","score_opus":0.11561826740946685,"score_gpt":0.33747665171932817,"score_spread":0.22185838430986132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142294849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891506,0.0029336265,0.00043924808,0.0003745707,0.00009996502,0.0009051134,0.000024606088,0.000022040002,0.0060502365],"genre_scores_gemma":[0.9951972,0.0022556153,0.0020778154,0.00017016812,0.000053426927,0.000084458195,0.000022673783,0.00003193607,0.000106746695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998486,0.000202871,0.00051348575,0.00037345072,0.00015529782,0.00026889006],"domain_scores_gemma":[0.999055,0.00020030074,0.00023419053,0.00025622928,0.00007837568,0.00017584924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048766893,0.00017688108,0.0005291259,0.00009452164,0.000051326508,0.000007804769,0.00005769937,0.000034316363,0.00010778186],"category_scores_gemma":[0.000017236505,0.00014837255,0.00009119876,0.00008316488,0.00016132514,0.000024578076,0.00015126818,0.00008098859,0.0000027708509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005483566,0.00022228585,0.93000054,0.002295837,0.0011971411,0.00050156494,0.00023903024,0.00013062969,0.0010344791,0.0014734779,0.0007734764,0.06158315],"study_design_scores_gemma":[0.0024496128,0.00019795024,0.98948175,0.00020690598,0.00053685816,0.000027348342,0.0001103313,0.0010130971,0.00046169304,0.00003594218,0.00534786,0.00013065645],"about_ca_topic_score_codex":0.0006086184,"about_ca_topic_score_gemma":0.000005516502,"teacher_disagreement_score":0.061452493,"about_ca_system_score_codex":0.00004189284,"about_ca_system_score_gemma":0.000015769374,"threshold_uncertainty_score":0.6050457},"labels":[],"label_agreement":null},{"id":"W2145567935","doi":"10.1016/j.eururo.2012.11.005","title":"Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":542,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Overdiagnosis; Prostate cancer; Biopsy; Proportional hazards model; Prostatectomy; Internal medicine; Prostate-specific antigen; Watchful waiting; Prospective cohort study; Gynecology; Cancer; Hazard ratio; Prostate; Cohort; Prostate biopsy; Oncology; Confidence interval","score_opus":0.01954647276093407,"score_gpt":0.29696657979658564,"score_spread":0.27742010703565156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145567935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863396,0.0033892037,0.000026922875,0.003939345,0.0007348677,0.0025756345,0.00012879552,0.0000636763,0.0028019121],"genre_scores_gemma":[0.995399,0.00069189846,0.000036535384,0.0017970899,0.000636691,0.0005457109,0.000023356173,0.000055221273,0.0008144788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998438,0.00045182835,0.00024010998,0.00029175758,0.00011231868,0.00046596827],"domain_scores_gemma":[0.99882627,0.00040015616,0.00017195422,0.00038118966,0.00009355534,0.00012688285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072664156,0.00017880293,0.00026611306,0.000037674203,0.00015278233,0.000012609584,0.00010963704,0.000020978203,0.00008767955],"category_scores_gemma":[0.00021445981,0.00010733843,0.000079977945,0.00011538644,0.00008685108,0.000053147305,0.00007317536,0.0001877882,0.00010551684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011349914,0.0009427808,0.9337489,0.000018713841,0.00042601465,0.000032888827,0.004654844,0.000027249036,0.000053216707,0.000049005386,0.0059293015,0.052982118],"study_design_scores_gemma":[0.002837956,0.0012825654,0.85332215,0.00000735824,0.00019623632,0.000009858779,0.00022453305,0.000012146496,0.00021681924,0.000014652523,0.14177333,0.000102364116],"about_ca_topic_score_codex":0.000062307845,"about_ca_topic_score_gemma":0.00010313223,"teacher_disagreement_score":0.13584404,"about_ca_system_score_codex":0.00008126684,"about_ca_system_score_gemma":0.000048997023,"threshold_uncertainty_score":0.43771338},"labels":[],"label_agreement":null},{"id":"W2146646572","doi":"10.1016/j.eururo.2009.09.024","title":"Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":200,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University; Université Laval; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urothelial carcinoma; Urology; Cohort; Stage (stratigraphy); Chemotherapy; Lymph node; Oncology; Internal medicine; Surgery; Cancer","score_opus":0.017163952590407035,"score_gpt":0.2848521973894684,"score_spread":0.26768824479906134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146646572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957946,0.000011388737,0.000030032503,0.00055148,0.00014461379,0.00036161765,0.00051358703,0.000047754937,0.00254494],"genre_scores_gemma":[0.99718326,0.000018284805,0.00033426067,0.001450735,0.00022763034,0.0000025658417,0.00063346926,0.00003288604,0.00011692179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983948,0.00026329173,0.00047500926,0.0004469998,0.00023478703,0.00018512677],"domain_scores_gemma":[0.9990735,0.00009421773,0.00019574755,0.00033809306,0.000106062434,0.00019238281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015100853,0.00020286412,0.00049347256,0.00007201461,0.000033714055,0.0000104307155,0.00012364957,0.00006857412,0.00003781751],"category_scores_gemma":[0.00009074209,0.00013029986,0.000045442375,0.000056235644,0.00023998664,0.00006128071,0.000025467927,0.00020574822,0.000009008326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010796547,0.00077604305,0.98404753,0.0000020912744,0.00028586076,0.00029136767,0.00012529505,3.0827354e-7,0.00002388598,0.000012129182,0.000067831774,0.0035711005],"study_design_scores_gemma":[0.017162554,0.007518518,0.9729897,0.000010277359,0.00038602843,0.000019110366,0.0000043863624,0.000025680552,0.000037529207,0.00000520757,0.0017223028,0.00011871206],"about_ca_topic_score_codex":0.00009806899,"about_ca_topic_score_gemma":0.000015361342,"teacher_disagreement_score":0.011057846,"about_ca_system_score_codex":0.000020127236,"about_ca_system_score_gemma":0.000053938842,"threshold_uncertainty_score":0.5313474},"labels":[],"label_agreement":null},{"id":"W2146900559","doi":"10.1016/j.eururo.2011.07.069","title":"Contemporary Management of the Painful Bladder: A Systematic Review","year":2011,"lang":"en","type":"review","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Interstitial cystitis; Randomized controlled trial; Placebo; Meta-analysis; Bladder Pain Syndrome; MEDLINE; Pelvic pain; Systematic review; English language; Surgery; Internal medicine; Urinary system; Alternative medicine; Pathology","score_opus":0.11184234724019684,"score_gpt":0.3487257098177548,"score_spread":0.23688336257755796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146900559","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.2672717e-7,0.7880389,0.0000047569256,0.00014792391,0.000109346,0.004570862,0.00001767126,0.000032439086,0.20707798],"genre_scores_gemma":[0.00003615423,0.9907126,0.000020962225,0.00087103347,0.000057836474,0.00013063724,0.00005161242,0.000101702375,0.008017504],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935593,0.0041403114,0.0012716877,0.0004178096,0.00028133122,0.00032955906],"domain_scores_gemma":[0.9973518,0.00019300455,0.0006421895,0.0016054229,0.000084263236,0.00012331783],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022354126,0.0003848639,0.002803606,0.00013312587,0.00005048028,0.000005883432,0.00074523344,0.0000967156,0.00031455237],"category_scores_gemma":[0.00012954194,0.00020289468,0.00083262083,0.00036568654,0.00020861448,0.000020303782,0.0005954597,0.0006534535,0.0009398678],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013863748,0.00008897157,0.0000019608485,0.9536978,0.0013020633,0.00074061146,0.000035525318,2.4085032e-9,1.621099e-8,0.00015937464,0.014761784,0.029198002],"study_design_scores_gemma":[0.00016201871,0.00028459184,0.000008160345,0.32940182,0.0046811947,0.00060409436,0.0000059155623,1.1786644e-7,3.7406053e-8,0.0000049821624,0.66474193,0.000105159765],"about_ca_topic_score_codex":0.0000032640792,"about_ca_topic_score_gemma":1.1144299e-7,"teacher_disagreement_score":0.6499801,"about_ca_system_score_codex":0.000025346908,"about_ca_system_score_gemma":0.00018839404,"threshold_uncertainty_score":0.999838},"labels":[],"label_agreement":null},{"id":"W2147520841","doi":"10.1016/j.eururo.2008.11.005","title":"Risk-Adjusted Hazard Rates of Biochemical Recurrence for Prostate Cancer Patients after Radical Prostatectomy","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Biochemical recurrence; Prostatectomy; Prostate cancer; Cohort; Urology; Proportional hazards model; Prostate-specific antigen; Hazard ratio; Internal medicine; Pathological; Prostate; Stage (stratigraphy); Cancer; Oncology; Confidence interval","score_opus":0.019809463452436435,"score_gpt":0.2730286041682744,"score_spread":0.25321914071583795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147520841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946284,0.0023265562,0.000029710163,0.000636302,0.00022664733,0.0013788795,0.00043072665,0.00004397616,0.00029880225],"genre_scores_gemma":[0.996043,0.002124367,0.00040606796,0.0005550234,0.00010949385,0.0004233925,0.00016400625,0.00004882667,0.00012578849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984761,0.00015598466,0.0004026727,0.00043987168,0.00015338656,0.00037199582],"domain_scores_gemma":[0.9990211,0.00011442028,0.00020920295,0.00024414257,0.00024360987,0.00016753348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000139776,0.00020939393,0.0003811101,0.00007894181,0.00006298089,0.0000041662215,0.00008934839,0.000059017595,0.00007872175],"category_scores_gemma":[0.00021740375,0.000162683,0.00012008389,0.0001383848,0.0003598335,0.000038714526,0.00006248196,0.0001881458,0.000034304037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035634146,0.000786184,0.9791318,0.0001303824,0.00015302219,0.00013179005,0.0005531151,0.0000045607626,0.0004486613,0.0000080626805,0.0076912497,0.0073977425],"study_design_scores_gemma":[0.006972877,0.003276942,0.94996154,0.00007978881,0.00021793212,0.0000210527,0.00000631876,0.00005302089,0.018236998,0.000027171434,0.020965979,0.00018037966],"about_ca_topic_score_codex":0.00002157872,"about_ca_topic_score_gemma":0.0000041627422,"teacher_disagreement_score":0.029170275,"about_ca_system_score_codex":0.00006074846,"about_ca_system_score_gemma":0.00011302914,"threshold_uncertainty_score":0.663402},"labels":[],"label_agreement":null},{"id":"W2147728603","doi":"10.1016/j.eururo.2013.04.028","title":"Following Radical Prostatectomy, To Beam or Not To Beam?","year":2013,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Prostatectomy; Medicine; Radiation therapy; Salvage therapy; External beam radiotherapy; Adjuvant radiotherapy; Adjuvant; Urology; Surgery; Prostate cancer; Brachytherapy; Oncology; Internal medicine; Cancer; Chemotherapy","score_opus":0.025161340381227578,"score_gpt":0.2833118565392803,"score_spread":0.25815051615805273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147728603","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.084316604,0.0003694769,0.00007691991,0.9011545,0.0019186476,0.0034362471,0.00012815309,0.00029293806,0.0083065275],"genre_scores_gemma":[0.034601975,0.00008165033,0.00072040036,0.94576037,0.0045435224,0.0003886811,0.0004689192,0.00030875168,0.01312573],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964236,0.00026958762,0.0005974763,0.0011890989,0.0004609695,0.0010592466],"domain_scores_gemma":[0.99803305,0.00025672858,0.00012991046,0.0009444346,0.000094750714,0.0005411213],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030795316,0.0006241078,0.0010581928,0.000359626,0.00010403288,0.000064906235,0.00037957288,0.0003469119,0.00091224705],"category_scores_gemma":[0.0003245181,0.00045877113,0.00031928642,0.00026196233,0.000085953,0.000045527875,0.00036302215,0.0014119756,0.0094792545],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005166357,0.00012017382,0.00034288756,0.000092268965,0.00039247714,0.021066029,0.000317598,0.0000066580515,0.000332367,0.0000031886277,0.9711188,0.00569089],"study_design_scores_gemma":[0.0021271987,0.0051741083,0.006282989,0.00015084974,0.00042969827,0.00026463848,0.000006809954,0.0000011377045,0.00068702677,0.0000056918457,0.98442894,0.0004409093],"about_ca_topic_score_codex":0.000048634574,"about_ca_topic_score_gemma":0.0000034083423,"teacher_disagreement_score":0.049714625,"about_ca_system_score_codex":0.00024911933,"about_ca_system_score_gemma":0.00019344348,"threshold_uncertainty_score":0.9997864},"labels":[],"label_agreement":null},{"id":"W2149476294","doi":"10.1016/j.eururo.2014.01.011","title":"Differences in Ureteroscopic Stone Treatment and Outcomes for Distal, Mid-, Proximal, or Multiple Ureteral Locations: The Clinical Research Office of the Endourological Society Ureteroscopy Global Study","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Ureteroscopy; Urology; Renal stone; Endoscopy; Ureter; Surgery; General surgery; Internal medicine; Urinary system","score_opus":0.15372289980996653,"score_gpt":0.42684055548534794,"score_spread":0.2731176556753814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149476294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99262685,0.00016931824,0.00007689365,0.004458397,0.00021689136,0.0022494902,0.000046074874,0.000023330254,0.00013274753],"genre_scores_gemma":[0.9980061,0.000050627314,0.00031523005,0.0010429046,0.00010421513,0.00015330334,0.000011221296,0.000020566096,0.0002958463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959919,0.0022150003,0.00059844356,0.0005396177,0.00023739887,0.00041762867],"domain_scores_gemma":[0.9974892,0.0015332472,0.00015591842,0.00060791627,0.00009100666,0.00012270374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001444892,0.00023666886,0.00058492296,0.000037733393,0.00024888688,0.000027493152,0.00030522072,0.00009733983,0.000010298496],"category_scores_gemma":[0.0013556852,0.00009981739,0.0001975971,0.00020427689,0.0008442629,0.000030330993,0.00022302209,0.00030380912,0.0000050654485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014652114,0.001782372,0.9945565,0.000020907382,0.00019894434,0.0000051831994,0.0007555839,0.0000011493491,0.000092417824,0.00007068914,0.00013775245,0.0009132785],"study_design_scores_gemma":[0.007828604,0.01049925,0.97878873,0.000011887752,0.00018257176,0.00001947352,0.00029691416,0.00032687437,0.000021673239,0.000038659837,0.0019058932,0.00007943625],"about_ca_topic_score_codex":0.00007546538,"about_ca_topic_score_gemma":0.00010355496,"teacher_disagreement_score":0.01576775,"about_ca_system_score_codex":0.000055009303,"about_ca_system_score_gemma":0.00009085322,"threshold_uncertainty_score":0.40704352},"labels":[],"label_agreement":null},{"id":"W2150195966","doi":"10.1016/j.eururo.2012.03.042","title":"Insights of Modern Pathology Reports Originating from Prostate Biopsy and Radical Prostatectomy Specimens","year":2012,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Malignancy; Disease; Localized disease; TMPRSS2; Oncology; Internal medicine; Radiation therapy; Cancer","score_opus":0.015463193895149635,"score_gpt":0.24213095805798035,"score_spread":0.22666776416283071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150195966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.826197,0.024610344,0.00009440234,0.13195713,0.0014918104,0.0021334249,0.00033023537,0.00020692946,0.0129787205],"genre_scores_gemma":[0.84589994,0.0010227268,0.0016170527,0.14457776,0.0036137283,0.000106671934,0.0021178059,0.00028510377,0.00075922144],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968193,0.00051841285,0.0008266084,0.00096083473,0.00027419202,0.0006006154],"domain_scores_gemma":[0.9980429,0.00021536667,0.0007042358,0.0007353084,0.000120547586,0.00018166668],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002270878,0.00050127105,0.0010431069,0.00022908555,0.00006584552,0.000016890099,0.000101534206,0.00039721842,0.00011960071],"category_scores_gemma":[0.00009393089,0.00039645037,0.00013268254,0.00010353963,0.00053203653,0.00006258717,0.00020391076,0.0013052067,0.000050941682],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010190879,0.0012443395,0.09768015,0.0013729281,0.002385494,0.45933318,0.006524244,0.0000074416125,0.014727088,0.00020905466,0.37392473,0.04157227],"study_design_scores_gemma":[0.0026982476,0.0017683085,0.04702875,0.00019694275,0.00095600536,0.00496263,0.000009128238,0.000024815623,0.0011383933,0.0014554411,0.9392592,0.0005021605],"about_ca_topic_score_codex":0.0000288234,"about_ca_topic_score_gemma":0.0000013291565,"teacher_disagreement_score":0.56533444,"about_ca_system_score_codex":0.00008708513,"about_ca_system_score_gemma":0.000114552924,"threshold_uncertainty_score":0.9998487},"labels":[],"label_agreement":null},{"id":"W2150267964","doi":"10.1016/j.eururo.2014.10.040","title":"Diagnosis and Management of Urothelial Carcinoma In Situ of the Lower Urinary Tract: A Systematic Review","year":2014,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Urothelial carcinoma; Carcinoma in situ; Urology; Urinary system; Carcinoma; General surgery; Gynecology; Oncology; Internal medicine; Bladder cancer; Cancer","score_opus":0.03233820772248965,"score_gpt":0.3026795715473506,"score_spread":0.27034136382486096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150267964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021575863,0.98521686,9.879327e-7,0.000116699506,0.00016442011,0.0037521254,0.000024408831,0.000008697432,0.010500039],"genre_scores_gemma":[0.015338519,0.98351663,0.000012378979,0.00047222135,0.000053162556,0.00023489291,0.000008693638,0.00006355541,0.00029991977],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99702567,0.0011956572,0.0010525929,0.00034796025,0.0001848276,0.00019330892],"domain_scores_gemma":[0.9983862,0.00016099283,0.00059088547,0.0007733704,0.00003005425,0.000058464273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005597716,0.00032304603,0.0027085277,0.00011593553,0.000017091812,0.0000025253996,0.00026826398,0.00008213024,0.000044607044],"category_scores_gemma":[0.000067830806,0.0001864111,0.00042699324,0.00020098683,0.00012527964,0.000013052658,0.00018959325,0.00024272494,0.000035440273],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022491147,0.00054252933,0.0001932603,0.9738638,0.0003062896,0.0005467816,0.000038165326,3.5770203e-8,1.2843495e-7,0.00004868078,0.00015428117,0.024283558],"study_design_scores_gemma":[0.0012975666,0.001717612,0.0039223963,0.6739287,0.017708408,0.0011807962,0.0000047222916,2.7962346e-7,9.507179e-7,0.00000596528,0.30001187,0.00022077805],"about_ca_topic_score_codex":0.0000100357265,"about_ca_topic_score_gemma":0.0000014457247,"teacher_disagreement_score":0.29993513,"about_ca_system_score_codex":0.000035509827,"about_ca_system_score_gemma":0.00005517138,"threshold_uncertainty_score":0.7601624},"labels":[],"label_agreement":null},{"id":"W2151747843","doi":"10.1016/j.eururo.2011.06.039","title":"Cancer-Specific and Other-Cause Mortality After Radical Prostatectomy Versus Observation in Patients with Prostate Cancer: Competing-Risks Analysis of a Large North American Population-Based Cohort","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; Cohort; Urology; Oncology; Cohort study; Cancer; Population; Proportional hazards model; Internal medicine; Gynecology","score_opus":0.04101202024053809,"score_gpt":0.29242454881969654,"score_spread":0.25141252857915847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151747843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815524,0.00025041145,0.0000114045815,0.0000800628,0.000052518197,0.00089115254,0.00046127784,0.00002907608,0.0000688587],"genre_scores_gemma":[0.9985505,0.00018861257,0.00015789994,0.00046613044,0.000018553552,0.00021269506,0.00036718775,0.00003605526,0.000002392512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843204,0.00022904306,0.0003979161,0.0004456878,0.00020450256,0.00029083306],"domain_scores_gemma":[0.99911124,0.00005478522,0.000311564,0.00028895846,0.00011751039,0.00011592026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001793005,0.00019701039,0.0005183701,0.00022160415,0.000036739006,0.00000690192,0.00005577525,0.000022925566,0.000089564935],"category_scores_gemma":[0.000017163304,0.00015609285,0.000054758344,0.0007227372,0.00018274058,0.000044950495,0.000027922903,0.00013672542,0.0000015491486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007104759,0.0005968691,0.9883221,0.000031245585,0.0012375091,0.000056298217,0.0005941196,0.00022726571,0.0000012595438,0.000007711092,0.000005112892,0.001815791],"study_design_scores_gemma":[0.006118232,0.0014086216,0.99018383,0.000027773942,0.0015083983,1.684258e-7,0.000014499758,0.0002759809,0.000015849699,5.558172e-7,0.00030550928,0.00014055143],"about_ca_topic_score_codex":0.0053288355,"about_ca_topic_score_gemma":0.009540869,"teacher_disagreement_score":0.004212033,"about_ca_system_score_codex":0.00013737624,"about_ca_system_score_gemma":0.00006114244,"threshold_uncertainty_score":0.80556405},"labels":[],"label_agreement":null},{"id":"W2152104760","doi":"10.1016/j.eururo.2004.01.020","title":"Stage II Testicular Seminoma: Patterns of Recurrence and Outcome of Treatment","year":2004,"lang":"en","type":"article","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Seminoma; Radiation therapy; Chemotherapy; Stage (stratigraphy); Lymphovascular invasion; Mediastinum; Surgery; Internal medicine; Metastasis; Cancer","score_opus":0.026006558812642362,"score_gpt":0.28144182977447285,"score_spread":0.2554352709618305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152104760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973364,0.001220749,0.00013530944,0.00014754472,0.000039527735,0.00018142046,0.00007633447,0.000018976156,0.00084374135],"genre_scores_gemma":[0.99920756,0.00006572472,0.00039426237,0.00009123876,0.000018951203,0.0000025752079,0.000026834921,0.000015284699,0.0001775703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993475,0.000049077156,0.00022633348,0.00018591544,0.00006474089,0.00012645384],"domain_scores_gemma":[0.99948007,0.000035365785,0.00011148569,0.00023893706,0.000034685094,0.000099430996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047064477,0.000114515155,0.00025324564,0.000038245504,0.00002374557,0.0000013812772,0.000039267015,0.000020921827,0.000045387373],"category_scores_gemma":[0.00009617675,0.000085442356,0.000063727784,0.00004157448,0.000077033685,0.000013934628,0.00005359799,0.000039094874,0.000010297488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006794666,0.0006677193,0.99308145,0.000066711706,0.0001111948,0.00067780796,0.00019710367,0.000038015478,0.0008113422,0.00033168952,0.0000034366433,0.003945567],"study_design_scores_gemma":[0.003227466,0.004561546,0.99022895,0.00002885071,0.00036578023,0.000114289156,0.000018349341,0.000010126125,0.0005965035,0.0000301578,0.0007557323,0.00006222999],"about_ca_topic_score_codex":0.00010614071,"about_ca_topic_score_gemma":0.0000039659917,"teacher_disagreement_score":0.0038938266,"about_ca_system_score_codex":0.000027808019,"about_ca_system_score_gemma":0.00003120698,"threshold_uncertainty_score":0.3484238},"labels":[],"label_agreement":null},{"id":"W2152288672","doi":"10.1016/j.eururo.2010.05.024","title":"Rosuvastatin, Identified From a Zebrafish Chemical Genetic Screen for Antiangiogenic Compounds, Suppresses the Growth of Prostate Cancer","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":127,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Rosuvastatin; Medicine; Angiogenesis; Cancer research; Apoptosis; Zebrafish; Statin; Pharmacology; Prostate cancer; Cancer; Internal medicine; Biology; Biochemistry","score_opus":0.007216606658039912,"score_gpt":0.22955772075023112,"score_spread":0.2223411140921912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152288672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911601,0.0024675464,0.00047583823,0.0005101301,0.0038009689,0.00038171757,0.0007128802,0.000017856493,0.00047296114],"genre_scores_gemma":[0.98981017,0.00031070216,0.00083060237,0.0008696757,0.007477608,0.000043014006,0.00035378308,0.00006112099,0.00024329763],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869215,0.0001500618,0.00031414523,0.00042913793,0.000099040764,0.00031543942],"domain_scores_gemma":[0.99905866,0.00006478846,0.00017144856,0.00046220174,0.00016667489,0.000076195305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020361331,0.00017982366,0.00022568602,0.000031373966,0.000074621115,0.000026542959,0.00047434782,0.00009061185,0.000057117544],"category_scores_gemma":[0.00015711162,0.0001456464,0.00016508883,0.00006578283,0.00033429504,0.000004253011,0.0001882017,0.00014935549,0.000008582365],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026854928,0.00004061513,0.0032594637,0.000013046736,0.00011960726,3.402078e-7,0.00013933232,0.000006741049,0.92889756,0.000067155204,0.066114806,0.001072761],"study_design_scores_gemma":[0.0019955854,0.00019323365,0.06097697,0.0000053001822,0.00021013201,0.000021822136,0.000030716972,0.000042193533,0.3752011,0.0002863007,0.56073403,0.00030257588],"about_ca_topic_score_codex":0.00028166143,"about_ca_topic_score_gemma":0.00036758487,"teacher_disagreement_score":0.55369645,"about_ca_system_score_codex":0.0000023291457,"about_ca_system_score_gemma":0.00007490746,"threshold_uncertainty_score":0.59392875},"labels":[],"label_agreement":null},{"id":"W2152455106","doi":"10.1016/j.eururo.2009.06.028","title":"Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy","year":2009,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":760,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Carcinoma in situ; Cystoscopy; Epidemiology; Disease; Stage (stratigraphy); Oncology; Internal medicine; Urology; Cancer; Urinary system","score_opus":0.08428718980636966,"score_gpt":0.40038776636539947,"score_spread":0.3161005765590298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152455106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026146928,0.9931884,0.000009341431,0.00041415816,0.00018735614,0.0018080797,0.0004013676,0.000024464154,0.0013521342],"genre_scores_gemma":[0.008456618,0.9897869,0.0001646376,0.0005795264,0.00032560152,0.00018563739,0.00028943058,0.00006570969,0.0001459385],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99650747,0.0011605329,0.00083909807,0.0009065885,0.0001015262,0.00048478256],"domain_scores_gemma":[0.99815255,0.00046731872,0.00037430628,0.0005254538,0.00004614955,0.00043419143],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024316917,0.00053168926,0.0023044206,0.00024857593,0.000033699816,0.0000046464575,0.00016599482,0.00017370547,0.00011866576],"category_scores_gemma":[0.0002030786,0.00036962703,0.00023477932,0.00020915183,0.00013999436,0.000025910389,0.0000945165,0.00029489433,0.00006610254],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002936481,0.00031036913,0.0026187703,0.00081162044,0.00021960515,0.00051809003,0.00012949234,0.0000056239337,0.0000016199024,0.000010926835,0.00022186355,0.9948584],"study_design_scores_gemma":[0.0028398614,0.009380648,0.10657619,0.009484064,0.0038739878,0.00003328402,0.000010943295,0.000006779561,0.0000031639836,0.0001388128,0.86712396,0.0005282907],"about_ca_topic_score_codex":0.00042650182,"about_ca_topic_score_gemma":0.00013274167,"teacher_disagreement_score":0.9943301,"about_ca_system_score_codex":0.00015770101,"about_ca_system_score_gemma":0.00056408596,"threshold_uncertainty_score":0.99987555},"labels":[],"label_agreement":null},{"id":"W2153481935","doi":"10.1016/j.eururo.2015.07.034","title":"Fine-tuning Risk Stratification for Non–Muscle-invasive Bladder Cancer","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Trapping; Positron; Doping; Positron annihilation; Spectroscopy; Chalcogenide; Chalcogen; Medicine; Atomic physics; Molecular physics; Condensed matter physics; Crystallography; Materials science; Physics; Optoelectronics; Nuclear physics; Chemistry; Electron","score_opus":0.041971260394933596,"score_gpt":0.2991049233562622,"score_spread":0.2571336629613286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153481935","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0077658994,0.0041668075,0.0029406345,0.8502679,0.0049484917,0.0050315703,0.0027835586,0.0004904932,0.12160463],"genre_scores_gemma":[0.07546584,0.000631397,0.0010857955,0.8541718,0.02914241,0.0006416549,0.0050137495,0.00066740403,0.03317995],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976002,0.00035663668,0.0004366202,0.00078735204,0.00027096362,0.00054823153],"domain_scores_gemma":[0.9981833,0.00022840734,0.00039021042,0.00069422903,0.00035957695,0.00014426638],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002987247,0.00045410733,0.00059770443,0.00017327265,0.00012589461,0.000030783856,0.00024563173,0.0004226095,0.00041168506],"category_scores_gemma":[0.00022708983,0.0003959642,0.0002171186,0.00011079806,0.0001290458,0.000049882074,0.000057244746,0.0012666121,0.00042189012],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017480188,0.00004895168,0.00060663314,0.000116906405,0.0005411017,0.00045592303,0.0003612237,0.0000144661635,0.0002846931,0.000004433002,0.986746,0.0106448345],"study_design_scores_gemma":[0.0028709979,0.0013640587,0.0049544456,0.000052497002,0.0017080584,0.000052754815,0.000016765085,0.000061290026,0.000105822975,0.00014726509,0.9883211,0.00034491424],"about_ca_topic_score_codex":0.00015210471,"about_ca_topic_score_gemma":0.00010848862,"teacher_disagreement_score":0.088424675,"about_ca_system_score_codex":0.00013829317,"about_ca_system_score_gemma":0.0005836464,"threshold_uncertainty_score":0.9998492},"labels":[],"label_agreement":null},{"id":"W2153515948","doi":"10.1016/j.eururo.2011.03.011","title":"Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer: A Multi-institutional Collaboration","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Prostatectomy; Biochemical recurrence; Metastasis; Urology; Internal medicine; Oncology; Cancer; Prostate-specific antigen; breakpoint cluster region","score_opus":0.03593865251642982,"score_gpt":0.2990693934191239,"score_spread":0.2631307409026941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153515948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9438379,0.015851507,0.0061472342,0.00979633,0.0032005124,0.009729967,0.0014504942,0.00054592994,0.009440147],"genre_scores_gemma":[0.9917506,0.0011226095,0.0036383276,0.0015725374,0.00028888122,0.0008733443,0.000418117,0.000047276742,0.00028828628],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871594,0.00012000763,0.00031549582,0.00040318054,0.00012496412,0.00032042325],"domain_scores_gemma":[0.99928224,0.000047429075,0.00013014142,0.00018947774,0.00017559373,0.00017513205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021228596,0.0001977401,0.00025554287,0.00009890675,0.00014615578,0.000016304464,0.00007268647,0.000046715613,0.00015073257],"category_scores_gemma":[0.00010631786,0.00015598522,0.0000850404,0.00015799273,0.00016784867,0.000090912756,0.000030516327,0.00012451918,0.00009269284],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0144762285,0.007466652,0.28253147,0.0007473196,0.0017076194,0.0016258102,0.016652813,0.00028515595,0.0053134044,0.02147587,0.03778293,0.6099347],"study_design_scores_gemma":[0.017351247,0.004595112,0.37981418,0.000071111186,0.00042847323,0.00008194806,0.00006995982,0.0013437698,0.005343808,0.0001717348,0.5903451,0.0003835525],"about_ca_topic_score_codex":0.000026777794,"about_ca_topic_score_gemma":0.00003330348,"teacher_disagreement_score":0.60955113,"about_ca_system_score_codex":0.00017594261,"about_ca_system_score_gemma":0.00034145144,"threshold_uncertainty_score":0.63608927},"labels":[],"label_agreement":null},{"id":"W2154765924","doi":"10.1016/j.eururo.2015.08.061","title":"Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome","year":2015,"lang":"en","type":"review","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":300,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Prostatitis; Pelvic pain; Chronic prostatitis/chronic pelvic pain syndrome; Randomized controlled trial; Intensive care medicine; Clinical trial; Etiology; Chronic bacterial prostatitis; MEDLINE; Systematic review; Sexual function; Physical therapy; Internal medicine; Surgery; Prostate","score_opus":0.09315393003013837,"score_gpt":0.3640373507221375,"score_spread":0.2708834206919991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154765924","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008861287,0.8783526,0.000052422285,0.0001243995,0.00019682873,0.0023049635,0.000084997744,0.00008433653,0.118790634],"genre_scores_gemma":[0.0011357282,0.9858523,0.000073558,0.000087295266,0.00026343844,0.00008575406,0.0008606563,0.00020856543,0.011432686],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938871,0.0032372123,0.0010145903,0.00072886527,0.00046949537,0.00066272606],"domain_scores_gemma":[0.99797726,0.00020455249,0.00038680542,0.0009827119,0.00012978591,0.0003189051],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032719944,0.00051995803,0.0021122287,0.00041873148,0.000050481383,0.000015736136,0.0004781452,0.00018135962,0.00054675335],"category_scores_gemma":[0.00004709432,0.0004233145,0.00040040142,0.0004225555,0.00033349794,0.000052131345,0.00049685134,0.0009304455,0.0016780668],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006587028,0.0002259569,0.000012580712,0.077522956,0.0009563064,0.020491665,0.000048477512,5.9385644e-7,3.428776e-7,0.000078098055,0.033008344,0.8675888],"study_design_scores_gemma":[0.0013160117,0.008321203,0.00007550048,0.0054208543,0.00078430056,0.0027339188,0.000013316359,0.000011497166,1.1141978e-7,0.000018349845,0.9810103,0.00029459852],"about_ca_topic_score_codex":0.000008886509,"about_ca_topic_score_gemma":9.68611e-7,"teacher_disagreement_score":0.948002,"about_ca_system_score_codex":0.00034837358,"about_ca_system_score_gemma":0.0015696152,"threshold_uncertainty_score":0.99982184},"labels":[],"label_agreement":null},{"id":"W2154997696","doi":"10.1016/j.eururo.2010.01.015","title":"Validation of the AJCC TNM Substaging of pT2 Bladder Cancer: Deep Muscle Invasion Is Associated with Significantly Worse Outcome","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Cancer; Lymph node; Lymph; Internal medicine; Carcinoma; Cohort; Urology; Oncology; Surgery; Pathology","score_opus":0.02384119592272884,"score_gpt":0.26682718451557796,"score_spread":0.24298598859284912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154997696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926295,0.00007323238,0.00004599787,0.000969175,0.00029766336,0.00030879205,0.00002993811,0.000031274012,0.005614391],"genre_scores_gemma":[0.9982507,0.000017513803,0.00006000787,0.0011143453,0.00006635083,0.000006835299,0.000015860693,0.000042878837,0.000425496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998763,0.00022130359,0.00033492723,0.00024363058,0.00022726199,0.00020982794],"domain_scores_gemma":[0.9989919,0.00008529985,0.0002948108,0.0004063134,0.00015516995,0.00006650552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028916728,0.0001480745,0.00029800643,0.000071852875,0.00006160981,0.0000049152027,0.00016386701,0.00006239203,0.00048356314],"category_scores_gemma":[0.00012864708,0.00009410192,0.000085588166,0.00023691666,0.0001848389,0.000042385116,0.000053371252,0.00028879326,0.000016389993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036305943,0.0003441255,0.857183,0.000034407596,0.00034985342,0.000044583394,0.0024453658,0.000050639177,0.13409194,0.000052751893,0.0003810563,0.0046592243],"study_design_scores_gemma":[0.002664013,0.00048686308,0.9558396,0.00003094989,0.00048408753,0.000013544192,0.00008203098,0.00005815849,0.039116625,0.000029033046,0.001080872,0.00011424408],"about_ca_topic_score_codex":0.00018842898,"about_ca_topic_score_gemma":0.00020383364,"teacher_disagreement_score":0.09865659,"about_ca_system_score_codex":0.000023531322,"about_ca_system_score_gemma":0.00008693819,"threshold_uncertainty_score":0.52946776},"labels":[],"label_agreement":null},{"id":"W2155418842","doi":"10.1016/j.eururo.2014.01.013","title":"Metformin for Castrate-resistant Prostate Cancer: Learning More About an Old Dog's New Tricks","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Enzalutamide; Medicine; Cabazitaxel; Prostate cancer; Abiraterone; Metformin; Oncology; Internal medicine; Cancer; Androgen deprivation therapy; Androgen receptor","score_opus":0.015344758423552849,"score_gpt":0.27234526734265285,"score_spread":0.2570005089191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155418842","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20110233,0.6971875,0.0033073542,0.06996051,0.007428803,0.0045491955,0.0015093586,0.00045750418,0.014497442],"genre_scores_gemma":[0.010294846,0.046438064,0.0009073188,0.8420249,0.039490044,0.00032802342,0.0074958955,0.00085343403,0.052167434],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963256,0.0006986644,0.0005697476,0.0011950715,0.00020705478,0.0010038383],"domain_scores_gemma":[0.9982984,0.00004520657,0.00048997335,0.0007804731,0.0001677148,0.00021823439],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005936436,0.00062343915,0.0006891396,0.00013241827,0.00017310945,0.0000859122,0.00069579197,0.0006619105,0.00015327017],"category_scores_gemma":[0.00013288137,0.00058322604,0.00029620505,0.00009678142,0.00017225234,0.0000080049895,0.00014329128,0.0010801873,0.000044771026],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030440334,0.000021928185,0.00012903706,0.00015692903,0.00023206965,0.00012715,0.00017344674,0.00018931774,0.0054087266,0.00001699389,0.8467072,0.14653277],"study_design_scores_gemma":[0.0013879741,0.001187174,0.00015883002,0.000016973288,0.00024858618,0.00002816846,0.000014164816,0.000048484264,0.0019584296,0.000031751333,0.99427193,0.0006475265],"about_ca_topic_score_codex":0.00017536178,"about_ca_topic_score_gemma":0.000064490196,"teacher_disagreement_score":0.77206445,"about_ca_system_score_codex":0.000026155412,"about_ca_system_score_gemma":0.0002942624,"threshold_uncertainty_score":0.9996619},"labels":[],"label_agreement":null},{"id":"W2156399381","doi":"10.1016/j.eururo.2013.11.045","title":"Prediction of Outcome Following Early Salvage Radiotherapy Among Patients with Biochemical Recurrence After Radical Prostatectomy","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Prostatectomy; Medicine; Nomogram; Biochemical recurrence; Prostate cancer; Proportional hazards model; Concordance; Retrospective cohort study; T-stage; Stage (stratigraphy); Prostate-specific antigen; Radiation therapy; Oncology; Cancer; Urology; Internal medicine","score_opus":0.009794564572334104,"score_gpt":0.22326473841264444,"score_spread":0.21347017384031033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156399381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762356,0.00036919833,0.00012452953,0.0002425542,0.00015762464,0.0008825473,0.000025521389,0.00005424773,0.00052022404],"genre_scores_gemma":[0.9987812,0.000032755426,0.00046039541,0.00041467184,0.000064684886,0.0001090813,0.000053150034,0.000040910785,0.000043117197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879485,0.000120236364,0.00032073824,0.00031982566,0.00018709728,0.00025726986],"domain_scores_gemma":[0.99938655,0.00004171004,0.000104193736,0.0002562151,0.00006801735,0.00014332838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010347149,0.00016448859,0.00029295945,0.00007331158,0.00002490185,0.000011349991,0.0000702942,0.000049564875,0.00013227385],"category_scores_gemma":[0.000035389283,0.00011453468,0.00008785114,0.000109044544,0.00018565544,0.000096370044,0.000030128389,0.00017700977,0.00004110005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036211824,0.00031462504,0.9956118,0.000024753102,0.00013507814,0.00007762352,0.00023853705,7.6810335e-7,0.00043741136,0.000003433378,0.0003869119,0.0024069247],"study_design_scores_gemma":[0.0039549475,0.0026887974,0.9916512,0.000054539018,0.00009656025,0.0000050379545,0.0000036451688,0.000015887415,0.00061364373,0.0000051109446,0.0008245934,0.000086049324],"about_ca_topic_score_codex":0.000028993567,"about_ca_topic_score_gemma":6.371901e-7,"teacher_disagreement_score":0.0039606276,"about_ca_system_score_codex":0.000053455326,"about_ca_system_score_gemma":0.000017234319,"threshold_uncertainty_score":0.46705887},"labels":[],"label_agreement":null},{"id":"W2156992415","doi":"10.1016/j.eururo.2013.05.049","title":"Systematic Review of Complications of Prostate Biopsy","year":2013,"lang":"en","type":"review","venue":"European Urology","topic":"Urologic and reproductive health conditions","field":"Medicine","cited_by":1057,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Prostate biopsy; Biopsy; Prostate cancer; Urinary retention; Lower urinary tract symptoms; Prostate; Urinary system; Surgery; Urology; Cancer; Radiology; Internal medicine","score_opus":0.06782895445484331,"score_gpt":0.36303339853298694,"score_spread":0.2952044440781436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156992415","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000011613372,0.97585964,0.00004043846,0.00062627357,0.00011552886,0.004964306,0.000089785004,0.000038386697,0.018264476],"genre_scores_gemma":[0.000013259484,0.9972605,0.00024368023,0.0008305311,0.00006610777,0.00025100008,0.00029622295,0.000049984286,0.0009886858],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960232,0.0014603114,0.0017809246,0.00039588555,0.00013761324,0.0002020881],"domain_scores_gemma":[0.99640304,0.00028073954,0.001683256,0.0011395034,0.00039476017,0.000098698576],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00086265727,0.00025419367,0.003182074,0.00020598539,0.000037046822,0.000001384827,0.00023503361,0.00009875075,0.00019483054],"category_scores_gemma":[0.001082561,0.00015945113,0.00043205096,0.00032969742,0.00033715682,0.000015651032,0.00009486673,0.00036124224,0.0008427677],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000001611383,0.000112939924,0.0000026754637,0.9910929,0.00026165956,0.000013680452,0.000016929864,1.8175328e-8,0.0000012122524,0.00063609245,0.0020783425,0.0057819053],"study_design_scores_gemma":[0.00011016898,0.0003800207,0.00008243674,0.4441495,0.005624238,0.0008989126,0.0000030886858,2.954648e-7,1.3632561e-7,0.000019505274,0.5486185,0.00011321982],"about_ca_topic_score_codex":0.0000026361824,"about_ca_topic_score_gemma":3.5157967e-8,"teacher_disagreement_score":0.5469434,"about_ca_system_score_codex":0.000020110549,"about_ca_system_score_gemma":0.00021059319,"threshold_uncertainty_score":0.9999352},"labels":[],"label_agreement":null},{"id":"W2157071879","doi":"10.1016/j.eururo.2010.12.011","title":"Prediction of Progression-Free Survival Rates After Bevacizumab Plus Interferon Versus Interferon Alone in Patients with Metastatic Renal Cell Carcinoma: Comparison of a Nomogram to the Motzer Criteria","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Nomogram; Bevacizumab; Oncology; Proportional hazards model; Interferon; Urology; Gastroenterology; Chemotherapy; Immunology","score_opus":0.028079955276174014,"score_gpt":0.2827781620400433,"score_spread":0.2546982067638693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157071879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996802,0.00014041463,0.00010840324,0.0002530069,0.00051003596,0.0010048491,0.000060490875,0.000021510248,0.0010993269],"genre_scores_gemma":[0.99877596,9.103599e-7,0.0008634272,0.00004437326,0.00007043685,0.00004912954,0.00010130022,0.00005283892,0.000041611438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977525,0.0005339588,0.00063842797,0.00040168897,0.00035545524,0.00031797073],"domain_scores_gemma":[0.9984942,0.00015247217,0.00025258935,0.00076940097,0.00020229665,0.00012905872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004091437,0.0002691434,0.00058212015,0.00023152771,0.000028763383,0.0000110420515,0.00029115062,0.000054834392,0.0001163452],"category_scores_gemma":[0.00011086135,0.00016708986,0.00008131578,0.00021260425,0.00021231566,0.000056602414,0.00027355686,0.00042825862,0.000023916835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12787312,0.0029267068,0.8420127,0.00025310047,0.00024742767,0.00021486629,0.0065893056,0.00012839992,0.015122944,0.000008369842,0.0008813901,0.0037416301],"study_design_scores_gemma":[0.015430368,0.029187838,0.9445915,0.0000583813,0.00035121242,0.000011391508,0.00015675926,0.00037917573,0.009434415,0.0000024675214,0.000268128,0.00012835598],"about_ca_topic_score_codex":0.00006706593,"about_ca_topic_score_gemma":0.0002853854,"teacher_disagreement_score":0.11244276,"about_ca_system_score_codex":0.00006859158,"about_ca_system_score_gemma":0.00005374573,"threshold_uncertainty_score":0.6813727},"labels":[],"label_agreement":null},{"id":"W2158408464","doi":"10.1016/j.eururo.2013.04.012","title":"A Systematic Review of the Volume–Outcome Relationship for Radical Prostatectomy","year":2013,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Prostatectomy; Urology; Outcome (game theory); MEDLINE; Surgery; General surgery; Prostate cancer; Internal medicine; Cancer","score_opus":0.07121097535452811,"score_gpt":0.3501639611464847,"score_spread":0.2789529857919566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158408464","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000001980851,0.98388016,0.000027062035,0.0008075649,0.00023974931,0.013460377,0.000085937754,0.000033289987,0.0014638948],"genre_scores_gemma":[0.000028658436,0.99397033,0.00017786367,0.0013868398,0.000081214,0.0021818783,0.0001393589,0.000095230826,0.0019385999],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.996426,0.0012295508,0.0015430031,0.00036487923,0.00017701583,0.00025958204],"domain_scores_gemma":[0.99707377,0.0007281033,0.0010533951,0.0009177371,0.00012653095,0.000100466335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090481865,0.0003390338,0.0028762808,0.000079456986,0.00006190774,0.000008584886,0.00028926774,0.00010792954,0.000093089606],"category_scores_gemma":[0.0021138883,0.00016928992,0.0009917511,0.00021842221,0.00014899512,0.00001993633,0.00010653287,0.00035929517,0.00038347745],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000043987798,0.00007184854,0.00018507999,0.98480755,0.00034513554,0.00001725437,0.000011488332,2.9448914e-8,1.4627567e-8,0.00035449053,0.004775291,0.009427427],"study_design_scores_gemma":[0.00035871693,0.00028482015,0.00015979928,0.3864877,0.008020555,0.00017379483,7.009541e-7,0.0000010675266,6.403066e-8,0.000012938077,0.60440177,0.00009809228],"about_ca_topic_score_codex":0.0000014690356,"about_ca_topic_score_gemma":2.16129e-7,"teacher_disagreement_score":0.5996265,"about_ca_system_score_codex":0.00011926766,"about_ca_system_score_gemma":0.0002089843,"threshold_uncertainty_score":0.6903443},"labels":[],"label_agreement":null},{"id":"W2160046662","doi":"10.1016/j.eururo.2011.03.030","title":"Active Surveillance of Small Renal Masses: Progression Patterns of Early Stage Kidney Cancer","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":497,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; London Health Sciences Centre; University of Manitoba; Princess Margaret Cancer Centre; St Joseph's Health Care; Vancouver General Hospital; Queen Elizabeth II Health Sciences Centre; University of Ottawa; McGill University Health Centre; Queen's University; University of Toronto; Western University; Dalhousie University; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Biopsy; Histology; Stage (stratigraphy); Renal cell carcinoma; Prospective cohort study; Cancer; Metastasis; Kidney cancer; Tumor progression; Radiology; Kidney; Pathology; Internal medicine","score_opus":0.04709776680148336,"score_gpt":0.27873696765583417,"score_spread":0.2316392008543508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160046662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97731113,0.00018511877,0.00012141012,0.000100098194,0.00011068836,0.00029006513,0.00009296393,0.000026165555,0.021762365],"genre_scores_gemma":[0.99829364,0.00007165073,0.00058689143,0.00017342898,0.000065610715,0.000010153787,0.000025449839,0.00003851156,0.00073468615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986927,0.00035762548,0.0003091763,0.000274791,0.00014381653,0.00022190793],"domain_scores_gemma":[0.9990286,0.000041792755,0.0002907703,0.0003595505,0.00012679082,0.00015245404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002008495,0.0001493246,0.0003397327,0.0000910107,0.000015718339,0.0000015576044,0.00013080305,0.00004648974,0.00053929747],"category_scores_gemma":[0.00006226337,0.00011334209,0.00008544493,0.000077084034,0.00010717236,0.000024829367,0.00009101198,0.00015222913,0.00002412525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020181823,0.00028219612,0.9680894,0.00012735087,0.00016839596,0.0005323179,0.0015610602,0.0000018190286,0.021887874,0.000046346497,0.00009957741,0.0051855016],"study_design_scores_gemma":[0.0012821985,0.002718163,0.94193786,0.0000594136,0.000067114066,0.000022010281,0.000030428622,0.000006034038,0.051022183,0.0000045535758,0.0027696972,0.000080312166],"about_ca_topic_score_codex":0.00047789438,"about_ca_topic_score_gemma":0.000046880723,"teacher_disagreement_score":0.029134309,"about_ca_system_score_codex":0.000029160565,"about_ca_system_score_gemma":0.000091724236,"threshold_uncertainty_score":0.5904929},"labels":[],"label_agreement":null},{"id":"W2160324169","doi":"10.1016/j.eururo.2009.01.018","title":"Complications of Laparoscopic Surgery for Renal Masses: Prevention, Management, and Comparison with the Open Experience","year":2009,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Surgery; Laparoscopy; Open surgery; General surgery","score_opus":0.12919350648513242,"score_gpt":0.3799376335403153,"score_spread":0.2507441270551829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160324169","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032809007,0.9712917,0.0009862409,0.00030534223,0.000040845127,0.0034966627,0.000015155708,0.000021771686,0.02351415],"genre_scores_gemma":[0.004465518,0.9887837,0.0026491927,0.0002978427,0.000070465896,0.00048587826,0.00032852212,0.000066872046,0.0028519675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99833703,0.00043934467,0.0005144439,0.0004173862,0.00010309554,0.00018867507],"domain_scores_gemma":[0.9984305,0.00033774594,0.0004927212,0.00061894406,0.000055439068,0.00006466116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034709388,0.00024056353,0.0011877577,0.00010984544,0.0000943976,0.000027926402,0.00034296472,0.00004352741,0.000013372495],"category_scores_gemma":[0.000020311485,0.00013931787,0.00014838668,0.00016348036,0.00019151838,0.000030849176,0.00017371826,0.00013620027,0.000011392161],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026125982,0.00056501565,0.0012147871,0.00796437,0.0009948001,0.000115060924,0.00030971383,0.0000024641163,0.0000020031264,0.0017619985,0.019957142,0.9668514],"study_design_scores_gemma":[0.0005313816,0.00070714473,0.005451408,0.0013040607,0.0016209813,0.0001639984,0.000029799348,0.0000022194836,0.0000016792637,0.000016462247,0.9900623,0.00010854163],"about_ca_topic_score_codex":0.0000030972387,"about_ca_topic_score_gemma":0.00000404652,"teacher_disagreement_score":0.9701052,"about_ca_system_score_codex":0.000025932739,"about_ca_system_score_gemma":0.000071054405,"threshold_uncertainty_score":0.5681218},"labels":[],"label_agreement":null},{"id":"W2160507464","doi":"10.1016/j.eururo.2004.09.015","title":"The Current Status of Therapy for Symptomatic Late-Onset Hypogonadism with Transdermal Testosterone Gel","year":2004,"lang":"en","type":"review","venue":"European Urology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Testosterone (patch); Transdermal; Prostate cancer; Libido; Transdermal patch; Internal medicine; Urology; Endocrinology; Cancer; Pharmacology","score_opus":0.047425321595151546,"score_gpt":0.3211065239729628,"score_spread":0.27368120237781124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160507464","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010527215,0.995259,0.00006218721,0.0003358876,0.00024437768,0.0018164811,0.00009617754,0.00003685264,0.0010963164],"genre_scores_gemma":[0.0026590659,0.9964022,0.00008115111,0.000056295346,0.00026274167,0.00009682133,0.00009097314,0.00009646689,0.00025428872],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99795306,0.0003572897,0.0005688205,0.00044696598,0.00016295057,0.0005109259],"domain_scores_gemma":[0.99860764,0.0003935975,0.00031696152,0.00045004842,0.00012342921,0.00010830712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003472933,0.0003908711,0.0013543449,0.00008613281,0.00014828972,0.0000069846737,0.00018998438,0.000053010346,0.000006141301],"category_scores_gemma":[0.00009831178,0.00017809309,0.0003117082,0.00012258878,0.0005574081,0.000015693206,0.000043462438,0.00042829418,0.000036869897],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027596927,0.00016833965,0.000049273654,0.0053500757,0.00075259607,0.000032968892,0.00033322818,0.000001436875,0.0000011023197,0.000060253693,0.00012635461,0.9928484],"study_design_scores_gemma":[0.0013562912,0.0023418632,0.0038738379,0.001559546,0.001066559,0.00017784651,0.000011865651,5.539518e-7,9.281966e-7,0.000046313387,0.9893806,0.00018377867],"about_ca_topic_score_codex":0.0000027272094,"about_ca_topic_score_gemma":0.0000023862528,"teacher_disagreement_score":0.99266464,"about_ca_system_score_codex":0.000041651012,"about_ca_system_score_gemma":0.00035446728,"threshold_uncertainty_score":0.72624254},"labels":[],"label_agreement":null},{"id":"W2162130153","doi":"10.1016/j.eururo.2012.07.033","title":"Epidemiology and Risk Factors of Urothelial Bladder Cancer","year":2012,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2187,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Epidemiology; Incidence (geometry); Risk factor; Disease; Bladder cancer; Cancer; Genetic predisposition; Malignancy; Environmental health; Internal medicine; Gynecology","score_opus":0.11074265965547934,"score_gpt":0.37335568263733554,"score_spread":0.2626130229818562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162130153","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005014281,0.9902901,0.000023207383,0.00004738738,0.0006893605,0.0006836279,0.0004182755,0.000049024202,0.007297582],"genre_scores_gemma":[0.0013545459,0.99620414,0.00008217635,0.00026893735,0.00090782,0.00003470973,0.00009381623,0.00015115544,0.0009026935],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960065,0.0019563176,0.00084342103,0.0005487619,0.000098836965,0.0005461659],"domain_scores_gemma":[0.9978179,0.0006545225,0.0006901147,0.0005040463,0.00004716702,0.0002862677],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006228058,0.00052819424,0.002701691,0.00020171407,0.00005831893,0.0000018836909,0.00016755646,0.00031006188,0.0007997957],"category_scores_gemma":[0.00027054566,0.0003533897,0.00044399756,0.00012286838,0.00037153144,0.000028502905,0.00014613052,0.00065288186,0.00017254951],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086141335,0.00015142631,0.034772325,0.0029020957,0.0022615714,0.00004308092,0.00019452878,3.7953384e-7,6.5743814e-7,0.00010172383,0.00066875474,0.9588173],"study_design_scores_gemma":[0.0006658593,0.0005873602,0.010723487,0.00033698976,0.010188911,0.00015608348,0.0000041180933,5.191037e-7,9.707328e-7,0.000017288832,0.9770913,0.00022709637],"about_ca_topic_score_codex":0.00035117418,"about_ca_topic_score_gemma":0.000013568782,"teacher_disagreement_score":0.97642255,"about_ca_system_score_codex":0.00004660506,"about_ca_system_score_gemma":0.00018443119,"threshold_uncertainty_score":0.9998918},"labels":[],"label_agreement":null},{"id":"W2162259512","doi":"10.1016/j.eururo.2012.07.030","title":"Initial Prostate Biopsy: Development and Internal Validation of a Biopsy-specific Nomogram Based on the Prostate Cancer Antigen 3 Assay","year":2012,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Nomogram; Prostate cancer; Prostate-specific antigen; Biopsy; Prostate; Prostate biopsy; Urology; PCA3; Oncology; Cancer; Internal medicine","score_opus":0.03339335961939396,"score_gpt":0.282983096303543,"score_spread":0.24958973668414905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162259512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99171287,0.0009499907,0.00012401723,0.0024738982,0.00032211287,0.00063482503,0.00004355825,0.00003409565,0.0037046175],"genre_scores_gemma":[0.9979488,0.00026867806,0.0004596691,0.0008742726,0.000163643,0.00009081881,0.000058387963,0.000036807745,0.00009890227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998654,0.00029191878,0.0003110101,0.00025466963,0.00016560002,0.0003228083],"domain_scores_gemma":[0.99930984,0.00009417186,0.00017322497,0.00022135793,0.00007942517,0.00012195642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064387283,0.00018237905,0.00021784088,0.0001056533,0.00007958616,0.00001844093,0.000074140655,0.000032178796,0.00013234129],"category_scores_gemma":[0.00003668748,0.000116338444,0.000044030145,0.0001221425,0.00016175529,0.00004924862,0.00005849443,0.00014933266,0.00005032625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013120149,0.00086005736,0.8879531,0.000080136706,0.00026315465,0.00019284419,0.004082542,0.00003533905,0.0055854195,0.00030640143,0.0013253848,0.0980036],"study_design_scores_gemma":[0.0024012132,0.00090790814,0.8687742,0.00011549429,0.00007773164,0.00007617632,0.00006280828,0.00008276575,0.044020604,0.000010076758,0.0832863,0.00018472361],"about_ca_topic_score_codex":0.000017932442,"about_ca_topic_score_gemma":0.0000013115791,"teacher_disagreement_score":0.097818874,"about_ca_system_score_codex":0.000062092004,"about_ca_system_score_gemma":0.00007607599,"threshold_uncertainty_score":0.47441438},"labels":[],"label_agreement":null},{"id":"W2162661850","doi":"10.1016/j.eururo.2011.11.053","title":"A Critical Analysis of the Long-Term Impact of Radical Prostatectomy on Cancer Control and Function Outcomes","year":2011,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":236,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Term (time); Urology; Oncology; Cancer; Internal medicine","score_opus":0.0412497851399375,"score_gpt":0.3678839978677342,"score_spread":0.3266342127277967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162661850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014755133,0.9831102,0.000014632697,0.00013248979,0.00016659779,0.0008949867,0.00034151564,0.000013020652,0.0005714412],"genre_scores_gemma":[0.28516707,0.71442837,0.0000019108952,0.0002047353,0.000041321382,0.000057639343,0.000034099536,0.000032651136,0.000032185562],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981778,0.0005913833,0.0005374289,0.00035111586,0.00012630109,0.00021595809],"domain_scores_gemma":[0.9986345,0.0003985782,0.00033134117,0.00043930786,0.00008415283,0.00011211156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002118242,0.00029231256,0.0020094444,0.00025557162,0.000027886124,0.0000048559277,0.00010460888,0.00009973255,0.00023291423],"category_scores_gemma":[0.00016583144,0.00014146842,0.0009897364,0.00028433537,0.00037389208,0.000015362983,0.00005463782,0.00027842526,0.0000071563427],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055212947,0.00063510635,0.4025606,0.0032749544,0.018429326,0.000114706796,0.00007478842,0.0000029063472,0.0000016141352,0.00030003727,0.00014607687,0.5739078],"study_design_scores_gemma":[0.0015292008,0.0025638053,0.92255825,0.0010647058,0.046458248,0.000027183367,5.4041817e-7,0.0000037852521,9.686653e-7,0.000005266029,0.025669858,0.000118168566],"about_ca_topic_score_codex":0.000050426963,"about_ca_topic_score_gemma":0.0000098526825,"teacher_disagreement_score":0.5737896,"about_ca_system_score_codex":0.000089110974,"about_ca_system_score_gemma":0.0001737512,"threshold_uncertainty_score":0.5768915},"labels":[],"label_agreement":null},{"id":"W2163764479","doi":"10.1016/j.eururo.2008.09.051","title":"Positive Surgical Margins in Radical Prostatectomy: Outlining the Problem and Its Long-Term Consequences","year":2008,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Biochemical recurrence; Prostate cancer; Surgical margin; Hazard ratio; Radiation therapy; Incidence (geometry); Surgery; Urology; Cancer; Internal medicine","score_opus":0.04702651701724552,"score_gpt":0.32750840718952445,"score_spread":0.2804818901722789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163764479","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003237314,0.9873263,6.546502e-7,0.0010623352,0.000095772426,0.002150172,0.00006376874,0.000043478747,0.0060201786],"genre_scores_gemma":[0.009032343,0.9897313,0.000025122394,0.00040511688,0.00019439167,0.00017750423,0.00017078659,0.000075024385,0.00018837817],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99685854,0.0012311258,0.0006290985,0.0006622032,0.00015887857,0.00046013796],"domain_scores_gemma":[0.99869066,0.0006009226,0.00024957463,0.00024378097,0.000042835938,0.00017220296],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037188313,0.0004338096,0.0014126275,0.00015606575,0.000104388026,0.000025201854,0.00016404245,0.00014993131,0.000047932594],"category_scores_gemma":[0.000056800814,0.00024782654,0.00019950418,0.00020163934,0.00061039056,0.000033510296,0.0001664532,0.0008082819,0.000119963806],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026787273,0.00035692155,0.006854583,0.0035255235,0.0006585634,0.075852074,0.00078281795,9.599188e-7,4.035699e-7,0.000885154,0.00035166723,0.91046345],"study_design_scores_gemma":[0.0026341814,0.0017313287,0.011777503,0.0054073045,0.00078945444,0.017518582,0.000007681046,0.0000023406403,0.0000017521336,0.00001824404,0.9597505,0.00036114687],"about_ca_topic_score_codex":0.000010096583,"about_ca_topic_score_gemma":0.000008249464,"teacher_disagreement_score":0.9593988,"about_ca_system_score_codex":0.00016375096,"about_ca_system_score_gemma":0.00044463528,"threshold_uncertainty_score":0.9999974},"labels":[],"label_agreement":null},{"id":"W2164455762","doi":"10.1016/j.eururo.2008.09.037","title":"Re: Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma","year":2008,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Temsirolimus; Medicine; Renal cell carcinoma; Interferon alfa; Oncology; Internal medicine; Interferon; Alpha interferon; Discovery and development of mTOR inhibitors; Virology; PI3K/AKT/mTOR pathway; Apoptosis","score_opus":0.03724392434054155,"score_gpt":0.2547802718044395,"score_spread":0.21753634746389797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164455762","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11705142,0.009815884,0.00076314755,0.63722175,0.0044414336,0.0074108224,0.0005859063,0.0008526911,0.22185694],"genre_scores_gemma":[0.20951429,0.00033733333,0.0017101646,0.65988195,0.00850244,0.00019825579,0.0033763498,0.0007769558,0.11570227],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99540526,0.0006694917,0.0009049314,0.0014592316,0.00039601058,0.0011650769],"domain_scores_gemma":[0.9970257,0.00049441843,0.0004959493,0.0015921246,0.00014224926,0.00024954425],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026578104,0.0009424539,0.0013437327,0.00041224988,0.00015122292,0.000022901138,0.0005185113,0.00065342075,0.00042787794],"category_scores_gemma":[0.00013725036,0.00072705303,0.0005655261,0.00016319384,0.0002688397,0.000055226476,0.00023717435,0.0020395264,0.0007683404],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035873968,0.00015193867,0.00019713237,0.00038858398,0.00016340362,0.03047165,0.00022397238,0.00000675337,0.0014001111,0.0000011575236,0.9616856,0.0017223053],"study_design_scores_gemma":[0.006021385,0.012404888,0.0012682417,0.000054055094,0.0006784112,0.0019327968,0.000015547092,0.000017727256,0.00150467,0.000006989946,0.9755094,0.0005858764],"about_ca_topic_score_codex":0.000022192691,"about_ca_topic_score_gemma":0.000011988641,"teacher_disagreement_score":0.10615466,"about_ca_system_score_codex":0.00029769551,"about_ca_system_score_gemma":0.00024658794,"threshold_uncertainty_score":0.99951804},"labels":[],"label_agreement":null},{"id":"W2164545683","doi":"10.1016/j.eururo.2005.04.020","title":"Multi-Centre Study of Intraurethral Valve-Pump Catheter in Women with a Hypocontractile or Acontractile Bladder","year":2005,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Tract Infections Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Fleurimont; Université de Sherbrooke","funders":"","keywords":"Medicine; Tolerability; Clean Intermittent Catheterization; Adverse effect; Catheter; Quality of life (healthcare); Urinary catheterization; Surgery; Prospective cohort study; Urinary system; Urology; Internal medicine","score_opus":0.01810951973309864,"score_gpt":0.26484177904894923,"score_spread":0.2467322593158506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164545683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901687,0.000037405964,0.00008777465,0.0010026791,0.000116283285,0.0011350828,0.0000032231305,0.00009369412,0.007355153],"genre_scores_gemma":[0.99633205,0.000014669056,0.0008427212,0.0012218645,0.00017191935,0.00004926033,0.0000036560316,0.00006734771,0.0012965052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979863,0.0004317385,0.00047131142,0.0004296874,0.00018675072,0.0004942189],"domain_scores_gemma":[0.99893606,0.00014437053,0.00019079853,0.00051984587,0.00007405716,0.00013485826],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004467807,0.00024096882,0.00044011296,0.00030862493,0.000044426368,0.000012017241,0.00015648945,0.000055161465,0.001163052],"category_scores_gemma":[0.00010623589,0.00017971979,0.00005548267,0.00023688056,0.00008875431,0.00016301859,0.00008323835,0.00048396733,0.00023691202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043425415,0.33114398,0.40423748,0.0002612456,0.006227797,0.012418238,0.08600351,0.005327348,0.00540567,0.000078701785,0.0043892176,0.10108139],"study_design_scores_gemma":[0.019213323,0.018799635,0.9061065,0.00002431429,0.00038229066,0.00044465114,0.0036748284,0.00039339115,0.00009382709,0.0000021651365,0.050558444,0.0003066596],"about_ca_topic_score_codex":0.00005040458,"about_ca_topic_score_gemma":0.00033082947,"teacher_disagreement_score":0.501869,"about_ca_system_score_codex":0.00012018251,"about_ca_system_score_gemma":0.000048189682,"threshold_uncertainty_score":0.99975},"labels":[],"label_agreement":null},{"id":"W2164741834","doi":"10.1016/j.eururo.2008.05.024","title":"Prostate Cancer Diagnosis: Importance of Individualized Risk Stratification Models over PSA Alone","year":2008,"lang":"en","type":"letter","venue":"European Urology","topic":"AI in cancer detection","field":"Computer Science","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Artificial intelligence; Pattern recognition (psychology); Feature selection; Segmentation; Support vector machine; Feature extraction; Medicine; Preprocessor; Naive Bayes classifier; Computer science","score_opus":0.025994762095703273,"score_gpt":0.25124793399435535,"score_spread":0.22525317189865207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164741834","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05617639,0.020559687,0.27332973,0.5995329,0.012363708,0.0054381727,0.002476609,0.0025094221,0.027613409],"genre_scores_gemma":[0.26718006,0.026955754,0.017082881,0.67675,0.006916284,0.0018558707,0.0005781667,0.0005435043,0.0021374838],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99568176,0.0012431142,0.00084737357,0.0011565465,0.0005450109,0.0005262088],"domain_scores_gemma":[0.9964898,0.00021478164,0.0015471213,0.0014959185,0.00018981774,0.00006256568],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052214175,0.0004262008,0.00055014575,0.0002821686,0.00014079176,0.000059892114,0.0015608981,0.0003672877,0.0000832648],"category_scores_gemma":[0.000059075155,0.00043324885,0.00015476604,0.00043752772,0.00024167712,0.00046519304,0.00033324055,0.001602614,0.00006206822],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029779325,0.00004556308,0.0074954126,0.00006541462,0.00016820089,0.00032970522,0.001274685,0.0026922356,0.000029537106,0.00017642467,0.9765333,0.011159741],"study_design_scores_gemma":[0.0014868423,0.00054123276,0.020057553,0.000060723945,0.00018953475,0.00010463406,0.0000036008996,0.012426,0.00042284562,0.0043314365,0.95938426,0.0009913219],"about_ca_topic_score_codex":0.00023354581,"about_ca_topic_score_gemma":0.000045316167,"teacher_disagreement_score":0.25624683,"about_ca_system_score_codex":0.00011627855,"about_ca_system_score_gemma":0.00019983281,"threshold_uncertainty_score":0.99981195},"labels":[],"label_agreement":null},{"id":"W2165216406","doi":"10.1016/j.eururo.2009.07.027","title":"Should Pathologists Routinely Report Prostate Tumour Volume? The Prognostic Value of Tumour Volume in Prostate Cancer","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; Univariate analysis; Prostate; Proportional hazards model; Stage (stratigraphy); Prostate-specific antigen; Oncology; Cancer; Surgical margin; Urology; Internal medicine; Pathology; Multivariate analysis","score_opus":0.0231535063592045,"score_gpt":0.2857580381858074,"score_spread":0.2626045318266029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165216406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96465534,0.0028094181,0.000021207206,0.025453199,0.00028890322,0.0017780821,0.000057867182,0.000107918626,0.004828062],"genre_scores_gemma":[0.99342114,0.0006199347,0.00015091084,0.0031845844,0.00018331467,0.00015317215,0.00007584871,0.000064217194,0.002146857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968346,0.00051636517,0.00093215087,0.00071286876,0.00031030914,0.0006937385],"domain_scores_gemma":[0.99846774,0.00008366342,0.00049347716,0.00059269246,0.00020257891,0.00015983573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010850707,0.0003595206,0.00063159387,0.0001447296,0.000086170665,0.000024744417,0.00024322621,0.00006574003,0.0000787071],"category_scores_gemma":[0.0005066934,0.00024388653,0.00014852635,0.00036340565,0.00028277698,0.00007767483,0.000113488,0.00051430706,0.000088835695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059890846,0.00071961107,0.96473163,0.000064849126,0.00007073369,0.016264424,0.0012799883,0.0006315318,0.0030220638,0.00015079133,0.0043641753,0.008101309],"study_design_scores_gemma":[0.0019882072,0.0025612144,0.9823232,0.00011240132,0.00020667685,0.0011472341,0.00005603812,0.0003556386,0.0007230378,0.00017922884,0.0101325475,0.00021457118],"about_ca_topic_score_codex":0.00020391178,"about_ca_topic_score_gemma":0.00004452661,"teacher_disagreement_score":0.028765816,"about_ca_system_score_codex":0.00014039199,"about_ca_system_score_gemma":0.00025599272,"threshold_uncertainty_score":0.9945404},"labels":[],"label_agreement":null},{"id":"W2165246410","doi":"10.1016/j.eururo.2015.06.007","title":"Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Agency for Healthcare Research and Quality; Movember Foundation","keywords":"Medicine; Prostate cancer; Delphi method; Multidisciplinary approach; Quality of life (healthcare); Patient-reported outcome; Health care; Family medicine; Cancer; Intensive care medicine; Internal medicine; Nursing","score_opus":0.05172890715524608,"score_gpt":0.32798311303659317,"score_spread":0.2762542058813471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165246410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455744,0.00013396736,0.0015152936,0.00033395915,0.000309595,0.0016795225,0.0006145241,0.000024445017,0.0008312792],"genre_scores_gemma":[0.9583321,0.000034649514,0.04018079,0.00023421975,0.00004393191,0.00038940166,0.0006744122,0.00003478442,0.00007566436],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988907,0.000043270993,0.0004521562,0.00026789607,0.00015398012,0.00019197827],"domain_scores_gemma":[0.9989654,0.000035066372,0.00026431502,0.00019080112,0.00043233283,0.00011208217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002866878,0.00013664081,0.00038289715,0.00008012568,0.000025090318,0.0000039752995,0.00010273692,0.000024459923,0.000008199247],"category_scores_gemma":[0.000082654275,0.00010666208,0.00008000788,0.00004831324,0.000065652355,0.000050237708,0.000049138864,0.000034417513,9.3510744e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06224884,0.0035934185,0.6476581,0.00085703336,0.003534567,0.000034088815,0.03638422,0.0006516595,0.0050827838,0.0012522053,0.003130749,0.23557234],"study_design_scores_gemma":[0.108345054,0.023299374,0.17473215,0.00020529461,0.00076494523,0.000028081828,0.0024486817,0.001342833,0.0580415,0.0002699012,0.629834,0.0006881781],"about_ca_topic_score_codex":0.0000039104166,"about_ca_topic_score_gemma":0.000007984088,"teacher_disagreement_score":0.62670326,"about_ca_system_score_codex":0.00010195863,"about_ca_system_score_gemma":0.00024310275,"threshold_uncertainty_score":0.43495536},"labels":[],"label_agreement":null},{"id":"W2166339241","doi":"10.1016/j.eururo.2014.07.020","title":"Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer","year":2014,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":336,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Prostate cancer; Internal medicine; Oncology; Cancer; Proportional hazards model; Lymph node; Epidemiology; Prostate","score_opus":0.01796808666336216,"score_gpt":0.3020701490429054,"score_spread":0.2841020623795433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166339241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969934,0.00010370612,0.000002710273,0.00022745962,0.000045142686,0.00038186,0.000116821575,0.0000054703796,0.0021234083],"genre_scores_gemma":[0.99960786,0.000023091046,0.000020036445,0.000082883795,0.000013480073,0.0000058980463,0.000026487736,0.000020918538,0.00019934028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987027,0.0005549802,0.00018532154,0.00015422213,0.0002053342,0.00019741734],"domain_scores_gemma":[0.9993786,0.00010280244,0.000116208765,0.00025782478,0.000096868316,0.000047695463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030173495,0.00010531895,0.0002774545,0.00009745525,0.000016867154,0.0000020307211,0.000070448936,0.000009948977,0.000068430876],"category_scores_gemma":[0.00008627484,0.00004869792,0.000066967485,0.00020089853,0.00016913828,0.000020478636,0.000044326665,0.00012950914,0.00000917983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032519593,0.00037244972,0.9923068,0.000037754384,0.00018440919,0.00001087001,0.00027835433,0.00034429345,0.00041454093,0.000026457144,0.000096910524,0.00267517],"study_design_scores_gemma":[0.00499262,0.0043155816,0.989747,0.00003419868,0.00009125277,8.932292e-7,0.00000584013,0.00002674793,0.00042047517,0.0000079029705,0.00031487236,0.00004263115],"about_ca_topic_score_codex":0.00015234928,"about_ca_topic_score_gemma":0.000058140384,"teacher_disagreement_score":0.003943132,"about_ca_system_score_codex":0.00003405974,"about_ca_system_score_gemma":0.00007788629,"threshold_uncertainty_score":0.19858435},"labels":[],"label_agreement":null},{"id":"W2166597765","doi":"10.1016/j.eururo.2011.06.021","title":"Outcomes of Small Renal Mass Needle Core Biopsy, Nondiagnostic Percutaneous Biopsy, and the Role of Repeat Biopsy","year":2011,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":404,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network; Queen's University","funders":"","keywords":"Medicine; Biopsy; Radiology; Grading (engineering); Renal cell carcinoma; Percutaneous; Renal biopsy; Pathology","score_opus":0.0275736788116021,"score_gpt":0.22403570965798925,"score_spread":0.19646203084638714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166597765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95428604,0.0017132157,0.000033777796,0.00027371425,0.00011678817,0.0004008414,0.000022856171,0.0000397245,0.043113057],"genre_scores_gemma":[0.9970139,0.00009529128,0.0020371545,0.00020953527,0.000057237394,0.000005792721,0.000018654164,0.000054148633,0.00050828303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982617,0.00033069283,0.00054132903,0.00038134566,0.00017042943,0.0003145261],"domain_scores_gemma":[0.9983087,0.00044006566,0.00028520604,0.0007148411,0.00011054289,0.00014062545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039728024,0.00026739377,0.00065462483,0.00016937987,0.000050387254,0.0000047776884,0.00023334914,0.00008185141,0.00018448324],"category_scores_gemma":[0.0003047247,0.00016294194,0.00018204273,0.000146067,0.0008661475,0.000018680485,0.00016191135,0.00021205175,0.00007320363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004411801,0.00057975866,0.79576117,0.00012765947,0.0008655176,0.009346471,0.005892202,0.0000087918925,0.17655016,0.0025656028,0.000087223925,0.0038036352],"study_design_scores_gemma":[0.004068703,0.0023082334,0.9623763,0.000038336362,0.0010697206,0.019817676,0.00050243107,0.00011515326,0.008205595,0.0008042583,0.0004502331,0.00024335897],"about_ca_topic_score_codex":0.0002700143,"about_ca_topic_score_gemma":0.00000507734,"teacher_disagreement_score":0.16834457,"about_ca_system_score_codex":0.00001888147,"about_ca_system_score_gemma":0.00003438435,"threshold_uncertainty_score":0.664458},"labels":[],"label_agreement":null},{"id":"W2166692714","doi":"10.1016/j.eururo.2010.07.034","title":"Predictive and Prognostic Models in Radical Prostatectomy Candidates: A Critical Analysis of the Literature","year":2010,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"National Cancer Institute","keywords":"Prostatectomy; Medicine; Nomogram; Prostate cancer; Biochemical recurrence; MEDLINE; Intensive care medicine; Oncology; Internal medicine; Cancer","score_opus":0.019457875987320315,"score_gpt":0.308326673874696,"score_spread":0.2888687978873757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166692714","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015598914,0.9950459,0.000013293471,0.000294924,0.000112325644,0.0014045647,0.0004253546,0.0000188151,0.0011249558],"genre_scores_gemma":[0.041908786,0.9572904,0.00005140244,0.00020400491,0.00006987382,0.00016622285,0.00022716142,0.000047693928,0.00003442205],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776465,0.00068686024,0.00055573054,0.0005403821,0.00015898226,0.00029341594],"domain_scores_gemma":[0.99860334,0.00053979846,0.00017464826,0.00046150232,0.00008116261,0.00013951905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029570377,0.00032144913,0.0016195748,0.00041117996,0.000035163608,0.000019904666,0.00015610244,0.00022234434,0.00001991666],"category_scores_gemma":[0.0004463081,0.00017792711,0.00035665356,0.0009333012,0.00048055217,0.000036605947,0.0001603394,0.0010002967,0.000003709535],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006706191,0.002328078,0.033576354,0.027188083,0.009633943,0.004933482,0.004288597,0.000048470018,0.0000027135889,0.0035974835,0.00056814036,0.913164],"study_design_scores_gemma":[0.0026636655,0.002600755,0.033842478,0.01727442,0.058394503,0.0007699818,0.000017539005,0.001246467,0.0000022308416,0.00042207842,0.8821908,0.0005750293],"about_ca_topic_score_codex":0.000008740921,"about_ca_topic_score_gemma":0.00001912619,"teacher_disagreement_score":0.912589,"about_ca_system_score_codex":0.000055462573,"about_ca_system_score_gemma":0.0002166025,"threshold_uncertainty_score":0.7255657},"labels":[],"label_agreement":null},{"id":"W2166824729","doi":"10.1016/j.eururo.2007.04.074","title":"Holmium Laser Enucleation of the Prostate (HoLEP): Long-Term Results, Reoperation Rate, and Possible Impact of the Learning Curve","year":2007,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":256,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Enucleation; Prostate; International Prostate Symptom Score; Surgery; Prostatectomy; Urology; Urethral stricture; Lower urinary tract symptoms; Urethra; Internal medicine","score_opus":0.019473219402081316,"score_gpt":0.31218533861484205,"score_spread":0.29271211921276075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166824729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860174,0.0001471957,0.000024144683,0.00072779285,0.00006213173,0.00038939036,0.000014580952,0.000013220864,0.012604166],"genre_scores_gemma":[0.9965019,0.00010410411,0.00001020491,0.000100171885,0.0000660336,8.4338143e-7,0.000027659133,0.0000220747,0.0031669764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983259,0.0008214341,0.00030596563,0.00018013173,0.0001507075,0.0002158551],"domain_scores_gemma":[0.9992123,0.00013769389,0.00015596107,0.0002944877,0.00014577286,0.00005374083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017029905,0.00009492568,0.00014349677,0.000071830036,0.000115845985,0.000011694157,0.00010988658,0.000039632738,0.000033034787],"category_scores_gemma":[0.00037760026,0.00005137401,0.000069950765,0.00022880686,0.00023235286,0.00006338985,0.0001356058,0.0003583292,0.000010424664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029769538,0.0001208187,0.9156377,0.00007414911,0.00007381225,0.000053575986,0.0026696478,0.00036372163,0.07226503,0.00002330944,0.00044202924,0.005299311],"study_design_scores_gemma":[0.0013424549,0.0015872025,0.98643994,0.000027047503,0.000032245913,0.000083954445,0.000035450474,0.00010038338,0.009737087,0.000007902842,0.0005603044,0.00004603332],"about_ca_topic_score_codex":0.000037644128,"about_ca_topic_score_gemma":0.000015522124,"teacher_disagreement_score":0.07080229,"about_ca_system_score_codex":0.000018809493,"about_ca_system_score_gemma":0.000073266674,"threshold_uncertainty_score":0.20949712},"labels":[],"label_agreement":null},{"id":"W2167395328","doi":"10.1016/j.eururo.2010.12.010","title":"Non–Risk-Adapted Surveillance in Clinical Stage I Nonseminomatous Germ Cell Tumors: The Princess Margaret Hospital’s Experience","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Cohort; Lymphovascular invasion; Internal medicine; Stage (stratigraphy); Germ cell tumors; Surgery; Oncology; Chemotherapy; Cancer; Metastasis","score_opus":0.010597242985795568,"score_gpt":0.279463006734114,"score_spread":0.26886576374831844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167395328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909783,0.00024761938,0.000034444234,0.0004442386,0.0004381696,0.0004617764,0.000025241845,0.00007359332,0.007296624],"genre_scores_gemma":[0.99850684,0.000060786726,0.00017335816,0.0006369039,0.00017086767,0.000019149336,0.000024102908,0.000044820554,0.00036318277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980967,0.0004126468,0.00047636926,0.0004835096,0.0001614803,0.00036929446],"domain_scores_gemma":[0.9983813,0.00032193155,0.0002620986,0.0007782066,0.000052830426,0.00020361198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005923763,0.00020412373,0.00032342004,0.00004747727,0.000081104445,0.00002106002,0.00031024608,0.00006923551,0.0001937908],"category_scores_gemma":[0.0005743438,0.0001374887,0.000121021505,0.00013614245,0.00032277158,0.000035433022,0.00015185622,0.00060305174,0.00027472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013247259,0.00060010486,0.99392664,0.000010416967,0.000020375286,0.0026027102,0.00039712,0.0000045272404,0.000116548705,0.000030732404,0.0002189345,0.0019393974],"study_design_scores_gemma":[0.0017552524,0.00059464795,0.98813444,0.000006819101,0.000032632935,0.00006506178,0.000074215845,0.0002657238,0.00004565225,0.000006026057,0.008882504,0.00013702615],"about_ca_topic_score_codex":0.00010590055,"about_ca_topic_score_gemma":0.000094988965,"teacher_disagreement_score":0.00866357,"about_ca_system_score_codex":0.000012474695,"about_ca_system_score_gemma":0.000086732405,"threshold_uncertainty_score":0.5606626},"labels":[],"label_agreement":null},{"id":"W2167545922","doi":"10.1016/j.eururo.2006.11.013","title":"A Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1044,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; Vlaamse Liga Tegen Kanker","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Kidney cancer; Perioperative; Surgery; Asymptomatic; Kidney; Dissection (medical); Stage (stratigraphy); Kidney disease; Urology; Lymph node; Prospective cohort study; Internal medicine","score_opus":0.02324272183046309,"score_gpt":0.2679309512522843,"score_spread":0.2446882294218212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167545922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843193,0.00060157495,0.0035105157,0.00022689236,0.00006325783,0.0035340223,0.000009939841,0.000050950388,0.007683536],"genre_scores_gemma":[0.9988086,0.0000055731057,0.0003208946,0.0001382178,0.00016442106,0.00027127133,0.000047626425,0.000052666277,0.00019073121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738884,0.00092493615,0.00067933556,0.00049982744,0.00016412664,0.0003429297],"domain_scores_gemma":[0.9973733,0.0016573698,0.000325514,0.0004100482,0.0001376475,0.000096160176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010626599,0.0002635219,0.0009649751,0.00018287917,0.0001709559,0.000021434356,0.00013371318,0.000038180937,0.000013708464],"category_scores_gemma":[0.00014853242,0.00018378356,0.00024267579,0.00017677851,0.000500489,0.00004196756,0.00012113523,0.00027142165,0.000006549304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17710426,0.0074780607,0.7776612,0.00022883275,0.0010111099,0.00052925065,0.004374033,0.00021288908,0.027148964,0.0017308709,0.0014748365,0.0010456839],"study_design_scores_gemma":[0.21290879,0.0026186523,0.77163094,0.000025823969,0.0010215327,0.00017740205,0.00030010688,0.00326347,0.006706107,0.00012061981,0.0009718323,0.0002547298],"about_ca_topic_score_codex":0.00021928333,"about_ca_topic_score_gemma":0.00004768724,"teacher_disagreement_score":0.035804536,"about_ca_system_score_codex":0.00008860106,"about_ca_system_score_gemma":0.00006866168,"threshold_uncertainty_score":0.7494476},"labels":[],"label_agreement":null},{"id":"W2168020987","doi":"10.1016/j.eururo.2012.08.055","title":"Treatment Options Available for Bacillus Calmette-Guérin Failure in Non–muscle-invasive Bladder Cancer","year":2012,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Gemcitabine; Salvage therapy; Taxane; Prostatectomy; Intensive care medicine; Regimen; Chemotherapy; Oncology; Internal medicine; Surgery; Cancer; Prostate cancer","score_opus":0.07887159433563308,"score_gpt":0.33870304126964607,"score_spread":0.259831446934013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168020987","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040336286,0.9784505,0.000035901296,0.00052632845,0.0007239699,0.0033900915,0.0007258985,0.000079779624,0.016027218],"genre_scores_gemma":[0.0003423403,0.97860634,0.00038323578,0.0006045438,0.0015361976,0.0016650687,0.0006739842,0.00027542893,0.015912855],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99681115,0.00046821593,0.0007494562,0.0008963589,0.00016083171,0.0009140108],"domain_scores_gemma":[0.99825895,0.00027696035,0.00028762597,0.0007656467,0.00008849556,0.00032232748],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00021489146,0.00079743407,0.0020990693,0.00037998616,0.00011056654,0.000021164302,0.00023977523,0.00033863165,0.0021708414],"category_scores_gemma":[0.000050814295,0.0005939423,0.00069977995,0.0003052941,0.000120963465,0.00006796429,0.00009635442,0.0004457881,0.002688709],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011572959,0.0007577788,0.00018393858,0.0033632035,0.001624988,0.0005460187,0.00029517387,0.0000052105274,0.000008170209,0.00004639551,0.013686117,0.97936726],"study_design_scores_gemma":[0.0034922413,0.0015471742,0.00022790508,0.0006752229,0.0057078553,0.00022278316,0.000012782531,0.000002783968,0.0000027456908,0.0000036741096,0.9876869,0.00041798133],"about_ca_topic_score_codex":0.00028816442,"about_ca_topic_score_gemma":0.00068883953,"teacher_disagreement_score":0.9789493,"about_ca_system_score_codex":0.0006493343,"about_ca_system_score_gemma":0.0007343296,"threshold_uncertainty_score":0.9996512},"labels":[],"label_agreement":null},{"id":"W2168241437","doi":"10.1016/j.eururo.2010.01.043","title":"Should Urologists Always Perform a Bladder Cuff Resection During Nephroureterectomy, and Which Method Should They Use?","year":2010,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Cuff; Urology; Resection; Surgery","score_opus":0.06077078477150742,"score_gpt":0.31643928395628323,"score_spread":0.2556684991847758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168241437","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39215448,0.0011042529,0.00040932582,0.54139,0.0035481246,0.0024618045,0.00023104016,0.0009528781,0.057748083],"genre_scores_gemma":[0.38433903,0.000696827,0.0018979638,0.5935515,0.011568244,0.00009292887,0.0004891734,0.0005872613,0.0067770896],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995134,0.0012240161,0.000620402,0.0014597474,0.000524625,0.001037234],"domain_scores_gemma":[0.99764013,0.00039816857,0.00030102578,0.0011723317,0.00024558636,0.0002427435],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00071854074,0.000869873,0.0010258695,0.00046437065,0.00030787216,0.00012951132,0.0003485749,0.0021299266,0.00069679733],"category_scores_gemma":[0.00036672252,0.0007072834,0.0002488522,0.00020193623,0.00023648668,0.00017371382,0.0003632964,0.009003166,0.00023603912],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006620102,0.0003854761,0.033645663,0.00080353813,0.003707429,0.014609418,0.0025903666,0.00001892478,0.01118429,0.0000531497,0.9142949,0.012086749],"study_design_scores_gemma":[0.003926907,0.0026097326,0.07227245,0.000042657866,0.0015115151,0.0049727852,0.000012173935,0.000102076854,0.00075649563,0.00012025704,0.9129563,0.0007166766],"about_ca_topic_score_codex":0.00039673116,"about_ca_topic_score_gemma":0.00036259711,"teacher_disagreement_score":0.05216149,"about_ca_system_score_codex":0.000097927084,"about_ca_system_score_gemma":0.00014901359,"threshold_uncertainty_score":0.9995378},"labels":[],"label_agreement":null},{"id":"W2168267238","doi":"10.1016/j.eururo.2014.09.020","title":"A Genome-wide Pleiotropy Scan for Prostate Cancer Risk","year":2014,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Cancer Research UK; National Institutes of Health; National Institute for Health and Care Research; Canadian Institutes of Health Research; European Commission","keywords":"Medicine; Prostate cancer; Pleiotropy; Prostate; Gynecology; Cancer; Oncology; Internal medicine; Genetics; Gene; Phenotype","score_opus":0.030938898984178585,"score_gpt":0.32206485165152643,"score_spread":0.29112595266734786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168267238","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009521941,0.99112266,0.00010440242,0.00046411884,0.00055380235,0.0034338566,0.0007849736,0.000113928814,0.0033270237],"genre_scores_gemma":[0.0001413851,0.9927933,0.00022002887,0.0012283104,0.0011289262,0.0013771501,0.00083954434,0.00029256876,0.0019787585],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969752,0.0005890792,0.00073905155,0.00089754874,0.0001358475,0.0006632713],"domain_scores_gemma":[0.9978039,0.00040978438,0.0006732046,0.00071686646,0.00011259584,0.00028360778],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048222675,0.00060601224,0.0022437032,0.0001997531,0.00012500767,0.000027445196,0.00023889089,0.00015119523,0.00018536735],"category_scores_gemma":[0.00021536218,0.00043739128,0.00071103085,0.0001537332,0.00013281377,0.000021338454,0.0001236986,0.0004711946,0.000517513],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012712862,0.00012913469,0.0012604304,0.007615575,0.0010310232,0.00018029168,0.00008158512,0.00000419031,2.7783653e-7,0.00003409543,0.0070645614,0.9824717],"study_design_scores_gemma":[0.0015793046,0.001803422,0.0019612068,0.0013786217,0.0049671954,0.0000631537,0.0000015609245,0.0000038114574,5.5274126e-7,0.000020780955,0.987879,0.00034138656],"about_ca_topic_score_codex":0.00004429846,"about_ca_topic_score_gemma":0.000025083698,"teacher_disagreement_score":0.98213035,"about_ca_system_score_codex":0.00030283383,"about_ca_system_score_gemma":0.00038810424,"threshold_uncertainty_score":0.9998078},"labels":[],"label_agreement":null},{"id":"W2168500832","doi":"10.1016/j.eururo.2014.05.038","title":"Combining Enzalutamide with Abiraterone, Prednisone, and Androgen Deprivation Therapy in the STAMPEDE Trial","year":2014,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pfizer UK; Institute of Cancer Research; Prostate Cancer UK; Cancer Research UK; Novartis; National Institute for Health and Care Research; Medical Research Council; Sanofi; Janssen Biotech; Astellas European Foundation","keywords":"Enzalutamide; Medicine; Abiraterone; Prednisone; Prostate cancer; Androgen deprivation therapy; Internal medicine; Oncology; Androgen; Urology; Androgen receptor; Cancer; Hormone","score_opus":0.02257539387822483,"score_gpt":0.29324291389917534,"score_spread":0.2706675200209505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168500832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84527165,0.003278652,0.00006629992,0.0017883731,0.13505314,0.0032832294,0.00004682572,0.000101449856,0.011110398],"genre_scores_gemma":[0.5304876,0.0035261556,0.00009429724,0.0010223164,0.46167213,0.00018829892,0.0013172673,0.00021530467,0.0014766644],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972224,0.0011682223,0.00030587337,0.00048080456,0.00045247521,0.00037021388],"domain_scores_gemma":[0.9985625,0.0007038274,0.00015610688,0.00041315978,0.00009038528,0.000073982585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001295138,0.0002766346,0.0004531542,0.0001637136,0.00009764307,0.00006178783,0.00021909046,0.00022675178,0.000019100571],"category_scores_gemma":[0.000239992,0.00015397907,0.000042002583,0.00013184494,0.00022445763,0.00004217643,0.00006781046,0.00089196616,0.000021449994],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26852664,0.0006895026,0.009129638,0.00018748907,0.00061848626,0.0015330395,0.0046233516,0.000011377771,0.0004617858,0.000095145784,0.69655436,0.017569197],"study_design_scores_gemma":[0.104152106,0.013638068,0.0034604163,0.000060721133,0.00011019501,0.000038243757,0.00005926649,0.000017745779,0.00005045479,0.00004847534,0.87815493,0.00020936354],"about_ca_topic_score_codex":0.0000466661,"about_ca_topic_score_gemma":0.00003733361,"teacher_disagreement_score":0.32661897,"about_ca_system_score_codex":0.000045412336,"about_ca_system_score_gemma":0.00021081707,"threshold_uncertainty_score":0.6279084},"labels":[],"label_agreement":null},{"id":"W2170235048","doi":"10.1016/j.eururo.2009.11.035","title":"Tumour Necrosis Is an Indicator of Aggressive Biology in Patients with Urothelial Carcinoma of the Upper Urinary Tract","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Lymphovascular invasion; Necrosis; Stage (stratigraphy); Urology; Pathology; Cancer; Carcinoma; Metastasis; T-stage; Ureteral neoplasm; Lymph node; Oncology; Transitional cell carcinoma; Internal medicine; Bladder cancer; Biology","score_opus":0.010936577657274984,"score_gpt":0.24459689892668932,"score_spread":0.23366032126941433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170235048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957799,0.00016319232,0.0000024898645,0.0005343171,0.00007550895,0.00037217847,0.000078466015,0.000010497598,0.0029834574],"genre_scores_gemma":[0.99793524,0.00000922119,0.000053111762,0.0018566959,0.00005753727,0.0000033723431,0.000017556195,0.000025362837,0.00004192431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987546,0.00031654027,0.00029389298,0.00028383176,0.00012313502,0.00022796303],"domain_scores_gemma":[0.99911696,0.000024117964,0.00035749015,0.00037156238,0.000055178392,0.00007471189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093708324,0.00015932489,0.00033334477,0.0001263066,0.000029476698,0.0000018781443,0.0002013328,0.000062892264,0.00012775532],"category_scores_gemma":[0.000036322494,0.00009692469,0.000074801435,0.00014601699,0.00020433504,0.00003694792,0.00003913698,0.00018776009,0.000012808393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015816621,0.0016639632,0.9915064,0.000010256802,0.000034032633,0.000055161217,0.0009750871,0.0000013102008,0.0018604177,0.000027998154,0.000053231954,0.0022305055],"study_design_scores_gemma":[0.0047264155,0.011756677,0.979921,0.000025089825,0.0000932736,0.000040880084,0.000016895276,0.0000023219657,0.0030864412,0.000046113357,0.00020636233,0.000078526384],"about_ca_topic_score_codex":0.000054249573,"about_ca_topic_score_gemma":0.0000016850539,"teacher_disagreement_score":0.01158537,"about_ca_system_score_codex":0.000020708632,"about_ca_system_score_gemma":0.00009039233,"threshold_uncertainty_score":0.3952474},"labels":[],"label_agreement":null},{"id":"W2170774448","doi":"10.1016/j.eururo.2003.11.010","title":"Long-Term Safety and Tolerability of Tadalafil in the Treatment of Erectile Dysfunction","year":2003,"lang":"en","type":"article","venue":"European Urology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Eli Lilly and Company","keywords":"Medicine; Tadalafil; Tolerability; Erectile dysfunction; Safety profile; Urology; Adverse effect; Intensive care medicine; Internal medicine","score_opus":0.029665841190868306,"score_gpt":0.27323166281170425,"score_spread":0.24356582162083595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170774448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95285636,0.0006215435,0.0002708379,0.00031437606,0.00028953503,0.00021327048,0.0000024688686,0.000013950301,0.045417637],"genre_scores_gemma":[0.9984693,0.0003126323,0.000021492038,0.00038502712,0.000042031563,0.0000036581123,0.0000054118127,0.0000074860154,0.00075294427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989258,0.00044015737,0.0002879987,0.00016902132,0.000079572805,0.000097440214],"domain_scores_gemma":[0.99944043,0.00019244594,0.00007757926,0.00021030709,0.000051766045,0.000027482025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036321126,0.00008759626,0.0002541012,0.00006694802,0.00003566737,0.0000017514575,0.000021888465,0.000027050266,0.00022539272],"category_scores_gemma":[0.00014978841,0.0000550652,0.000041755316,0.00013120178,0.00013879484,0.000016766418,0.0000073238784,0.00006341078,0.00001337305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014855639,0.00086344226,0.97830397,0.000034817956,0.00007800166,0.000027158188,0.0018658004,0.000017150021,0.0008174535,0.0006778848,0.00027342807,0.015555355],"study_design_scores_gemma":[0.0020120442,0.0028945045,0.94726443,0.000002967309,0.00006131089,0.000090011985,0.00024401119,0.0000045742822,0.00020897477,0.0000104013,0.04717005,0.00003672453],"about_ca_topic_score_codex":0.000018694016,"about_ca_topic_score_gemma":0.000026943811,"teacher_disagreement_score":0.04689662,"about_ca_system_score_codex":0.000020708401,"about_ca_system_score_gemma":0.000014901085,"threshold_uncertainty_score":0.24678923},"labels":[],"label_agreement":null},{"id":"W2171081137","doi":"10.1016/j.eururo.2013.09.051","title":"Effects of Tadalafil Treatment on Erectile Function Recovery Following Bilateral Nerve-sparing Radical Prostatectomy: A Randomised Placebo-controlled Study (REACTT)","year":2013,"lang":"en","type":"article","venue":"European Urology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":245,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); Western University","funders":"","keywords":"Tadalafil; Medicine; Placebo; Urology; Prostatectomy; Erectile dysfunction; cGMP-specific phosphodiesterase type 5; Prostate cancer; Surgery; Internal medicine","score_opus":0.013664956627118315,"score_gpt":0.2425126347768844,"score_spread":0.2288476781497661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171081137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97928965,0.00024539125,0.00023362154,0.00018580162,0.0018375232,0.004673728,8.100031e-7,0.00022522097,0.013308244],"genre_scores_gemma":[0.9933049,0.000018490267,0.000026769461,0.00081790733,0.00030173597,0.0005247128,0.000012674797,0.000061021678,0.004931752],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99723136,0.0010163076,0.0006113786,0.0005246938,0.00025218184,0.00036406892],"domain_scores_gemma":[0.9980868,0.0011334704,0.00021450651,0.0003124376,0.00008539826,0.00016736674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005316557,0.000343058,0.0010230687,0.00030532802,0.00015387396,0.000026930726,0.00005887067,0.00007281289,0.00028222444],"category_scores_gemma":[0.0006862684,0.00023561598,0.00035797263,0.00019328223,0.000060003393,0.00009704404,0.00004654566,0.00024532236,0.0005335886],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80041593,0.008897277,0.05081203,0.0001843804,0.009708789,0.0014716192,0.0033728075,0.00059948396,0.07461356,0.000035235847,0.0077076433,0.042181212],"study_design_scores_gemma":[0.64771855,0.050611883,0.2867973,0.000063237254,0.0025602272,0.000091220834,0.0006138358,0.00048639285,0.002301948,0.00002988292,0.008267456,0.00045807785],"about_ca_topic_score_codex":0.00009088335,"about_ca_topic_score_gemma":0.000004570141,"teacher_disagreement_score":0.23598528,"about_ca_system_score_codex":0.0001067344,"about_ca_system_score_gemma":0.00004703995,"threshold_uncertainty_score":0.9608141},"labels":[],"label_agreement":null},{"id":"W2171117253","doi":"10.1016/j.eururo.2009.06.008","title":"A Proposal for Reclassification of the Fuhrman Grading System in Patients with Clear Cell Renal Cell Carcinoma","year":2009,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Grading (engineering); Kidney cancer; Clear cell renal cell carcinoma; Internal medicine; Oncology; Urology","score_opus":0.012197935261030466,"score_gpt":0.2012686175175145,"score_spread":0.18907068225648402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171117253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97950155,0.00005621273,0.000067422625,0.00039795667,0.00006614785,0.0010518093,0.000004962227,0.000023513594,0.01883042],"genre_scores_gemma":[0.99881124,5.7550767e-7,0.00067263294,0.00012647168,0.00005941363,0.000008031893,0.000025089297,0.000030203524,0.00026631536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987715,0.00027942273,0.00029871982,0.000272401,0.00015789333,0.00022009751],"domain_scores_gemma":[0.9992438,0.000034244535,0.00020105169,0.0003779607,0.000084723906,0.000058237423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002263473,0.00013617879,0.00022050277,0.00009606135,0.000046921436,0.000004913947,0.00012946078,0.000039165498,0.0000030738545],"category_scores_gemma":[0.000014528356,0.000084357,0.00006620566,0.00014200009,0.00005451975,0.000025968326,0.000023088849,0.000141517,0.000014205547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009011946,0.0018895756,0.9313913,0.0005935519,0.00004240076,0.00016893807,0.0018348665,0.00011432838,0.048717465,0.0017053836,0.0012544515,0.0032757784],"study_design_scores_gemma":[0.0041292137,0.005688144,0.9785611,0.000028699815,0.00010682947,0.00001563913,0.000048213584,0.00018673693,0.01066218,0.000010336359,0.00048149485,0.00008139189],"about_ca_topic_score_codex":0.0000060978123,"about_ca_topic_score_gemma":0.0000023186517,"teacher_disagreement_score":0.04716981,"about_ca_system_score_codex":0.00010294128,"about_ca_system_score_gemma":0.000065642416,"threshold_uncertainty_score":0.3439979},"labels":[],"label_agreement":null},{"id":"W2171174421","doi":"10.1016/j.eururo.2010.11.013","title":"Adverse Renal Outcomes in Subjects Undergoing Nephrectomy for Renal Tumors: A Population-Based Analysis","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Nephrectomy; Hazard ratio; Renal function; Kidney disease; Proteinuria; Population; Urology; Internal medicine; Proportional hazards model; Dialysis; Confidence interval; Surgery; Kidney","score_opus":0.016265435466603955,"score_gpt":0.2635935778235525,"score_spread":0.24732814235694858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171174421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941053,0.000025819543,0.000749925,0.00090729626,0.000120796045,0.0004768606,0.00000939964,0.00008119073,0.0035234469],"genre_scores_gemma":[0.99419665,8.2865586e-7,0.0038843432,0.0010668299,0.00014669105,0.000028026125,0.00023117688,0.00004925429,0.00039617493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982769,0.00024960772,0.0004442939,0.00046630568,0.0001747034,0.00038817123],"domain_scores_gemma":[0.9985812,0.00056869455,0.00015888487,0.00047223087,0.000062351464,0.00015665032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046080962,0.0002276864,0.0005249238,0.0006858512,0.00006545626,0.0000112400985,0.000121836005,0.000071097245,0.00016933914],"category_scores_gemma":[0.00050542946,0.00019101238,0.00033032196,0.00046902464,0.00005222871,0.00004517189,0.000035921566,0.00031033403,0.00006529675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006266252,0.00018312506,0.991251,0.000021437809,0.0003217147,0.0006404417,0.00008265284,0.0015140986,0.004799928,0.00013437506,0.00006686489,0.000357756],"study_design_scores_gemma":[0.0040677707,0.0006171558,0.99097383,0.000009773818,0.0007526351,0.000036029178,0.000010732517,0.0018353442,0.0005365102,0.000051725492,0.0009497363,0.00015875038],"about_ca_topic_score_codex":0.0001705907,"about_ca_topic_score_gemma":0.0022674126,"teacher_disagreement_score":0.004263418,"about_ca_system_score_codex":0.00007740255,"about_ca_system_score_gemma":0.00011851875,"threshold_uncertainty_score":0.77892584},"labels":[],"label_agreement":null},{"id":"W2174770546","doi":"10.1016/j.eururo.2015.11.008","title":"Utility of Reporting the Percentage of High-grade Prostate Cancer","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Prostate cancer; Grading (engineering); Biopsy; Prostate; Prostatectomy; Cribriform; Cancer; Pathology; Internal medicine; Carcinoma","score_opus":0.05167887689007766,"score_gpt":0.3072000822864656,"score_spread":0.25552120539638795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174770546","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36433086,0.008083546,0.0000030887331,0.6151593,0.000989828,0.0012606328,0.00047728277,0.000054225868,0.009641276],"genre_scores_gemma":[0.8169094,0.0012270823,0.000046505676,0.17868595,0.001181088,0.000040427767,0.00036266263,0.00008900785,0.0014579262],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997241,0.0004696684,0.0011914396,0.00044414023,0.00031590863,0.00033783828],"domain_scores_gemma":[0.9967709,0.00012045963,0.0020334024,0.0008050347,0.00020839694,0.000061798135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007812816,0.000262782,0.000814484,0.000070962975,0.000033606644,0.000004921746,0.0001888537,0.0001466016,0.00024208058],"category_scores_gemma":[0.00023781475,0.00016217802,0.00018698961,0.000082035265,0.0003632234,0.000018279976,0.00014926345,0.0008782474,0.000017262599],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015723043,0.0001342396,0.072890036,0.00047764616,0.00039557213,0.0021763074,0.0006790349,0.0000046905725,0.00012990594,0.0000072111443,0.91908,0.003868098],"study_design_scores_gemma":[0.0011273094,0.0006631075,0.14816836,0.00013042935,0.00063686434,0.0001117625,0.000029721617,0.0000074172603,0.0005540535,0.0000431747,0.8484042,0.0001235792],"about_ca_topic_score_codex":0.0005906457,"about_ca_topic_score_gemma":0.000025670577,"teacher_disagreement_score":0.45257849,"about_ca_system_score_codex":0.000053830412,"about_ca_system_score_gemma":0.0002545222,"threshold_uncertainty_score":0.6613428},"labels":[],"label_agreement":null},{"id":"W2183117764","doi":"10.1016/j.eururo.2015.10.053","title":"The Proteome of Primary Prostate Cancer","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":187,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Novo Nordisk Fonden","keywords":"Medicine; Prostate cancer; Proteome; Primary (astronomy); Prostate; Oncology; Gynecology; Internal medicine; Cancer; Bioinformatics","score_opus":0.019486643359062618,"score_gpt":0.2646833325421228,"score_spread":0.24519668918306017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2183117764","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4514858,0.00203868,0.004122439,0.004991284,0.00009443532,0.00061957235,0.00006687398,0.00035569785,0.5362252],"genre_scores_gemma":[0.9858183,0.0003296962,0.0061283032,0.0004278403,0.00017985552,0.00025228527,0.000015769352,0.00005177978,0.006796146],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994542,0.0000350394,0.0001666405,0.00013626987,0.00006279873,0.00014507279],"domain_scores_gemma":[0.999417,0.000031965392,0.00012326306,0.00031466119,0.000066822315,0.00004628866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019563561,0.00006796927,0.00008264796,0.000009450008,0.000058820333,0.0000062221,0.0002526614,0.000022946302,0.000027018754],"category_scores_gemma":[0.00003924707,0.000048474543,0.000023746505,0.000049008537,0.00014044723,0.000021426371,0.00012020574,0.00014022611,0.000027891361],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005612487,0.00018009904,0.0071681053,0.00011465593,0.00008079605,0.00003148833,0.0011203856,0.00051345973,0.8433727,0.019093018,0.018188678,0.10957537],"study_design_scores_gemma":[0.00036843892,0.000066210574,0.00052733556,0.0000058445657,0.000011940336,0.000012884401,0.000026340884,0.000050402683,0.07694472,0.006472432,0.9153928,0.000120661614],"about_ca_topic_score_codex":0.000009088203,"about_ca_topic_score_gemma":0.0000020027162,"teacher_disagreement_score":0.8972041,"about_ca_system_score_codex":0.000022446096,"about_ca_system_score_gemma":0.000043265354,"threshold_uncertainty_score":0.19767345},"labels":[],"label_agreement":null},{"id":"W2184945069","doi":"10.1016/j.eururo.2013.11.015","title":"Reply from Authors re: Arthur L. Burnett. Erection Rehabilitation After Radical Prostatectomy: Definite Purpose, Indefinite Strategy. Eur Urol 2014;65:597–8","year":2013,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Prostatectomy; Urology; General surgery; Rehabilitation; Physical therapy; Internal medicine; Prostate cancer","score_opus":0.015403699003679163,"score_gpt":0.23777982568707176,"score_spread":0.2223761266833926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2184945069","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2310078,0.0094990935,0.00013534896,0.72599316,0.003988633,0.006569088,0.0011854448,0.0010088247,0.020612627],"genre_scores_gemma":[0.22183552,0.0016552455,0.0011804958,0.7538769,0.006796386,0.0017085935,0.0076752524,0.0006819736,0.004589604],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924198,0.0022802257,0.001400626,0.0020970213,0.00067945,0.0011228718],"domain_scores_gemma":[0.9959516,0.0009666011,0.00074937975,0.0015914729,0.00034950365,0.00039145513],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007536618,0.0010452936,0.0012860314,0.00057290454,0.00015821781,0.00017695276,0.0003153968,0.0009655104,0.002419429],"category_scores_gemma":[0.00051024696,0.0009124832,0.00046970852,0.00034775448,0.0005054527,0.00023030391,0.00019081925,0.0038117184,0.0061521595],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012014159,0.0003095984,0.014459789,0.0002057782,0.0004569477,0.005620704,0.00051851943,0.000017490293,0.000054597775,0.000033796747,0.9682052,0.008916161],"study_design_scores_gemma":[0.0033272184,0.004625329,0.13571472,0.00019651944,0.0007753762,0.00017805099,0.000020815878,0.00003493551,0.000028382277,0.0010939476,0.8533367,0.0006680003],"about_ca_topic_score_codex":0.00029484488,"about_ca_topic_score_gemma":0.000021823002,"teacher_disagreement_score":0.12125494,"about_ca_system_score_codex":0.0003500438,"about_ca_system_score_gemma":0.0003039855,"threshold_uncertainty_score":0.9993326},"labels":[],"label_agreement":null},{"id":"W2190126170","doi":"10.1016/j.eururo.2015.11.025","title":"It Is Time to Harmonize the Design and Conduct of Clinical Trials in Metastatic Hormone-sensitive Prostate Cancer","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Docetaxel; Clinical trial; Prostate cancer; Oncology; Internal medicine; Population; Androgen deprivation therapy; Medical physics; Family medicine; Cancer","score_opus":0.36813012458798644,"score_gpt":0.47041072013199176,"score_spread":0.10228059554400531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2190126170","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007612138,0.004900318,0.000030481744,0.9804936,0.00020321083,0.0032502061,0.00027461312,0.000019970948,0.0032154263],"genre_scores_gemma":[0.0050528822,0.0030919195,0.0005510067,0.9596221,0.0015145437,0.0001314554,0.0001844872,0.000152179,0.02969944],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98587966,0.011398487,0.0012785341,0.0006073205,0.00036156454,0.00047440824],"domain_scores_gemma":[0.9950296,0.0036043264,0.00046232116,0.00043123518,0.00030251316,0.0001699645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013049669,0.00031748775,0.0019008504,0.0002274326,0.000034358276,0.000019336396,0.00019055262,0.00018800578,0.00027112194],"category_scores_gemma":[0.00286734,0.0001779646,0.00017917638,0.0002102934,0.00049612735,0.00003054599,0.00017812333,0.0015468458,0.00044986533],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039152247,0.000049361883,0.00009156864,0.000053673633,0.0006395708,0.0031429597,0.001602522,0.000005292506,0.00053392776,2.5540646e-7,0.9854238,0.0045418227],"study_design_scores_gemma":[0.0060113496,0.0029798287,0.0014812908,0.00008151925,0.0008378385,0.00009125586,0.000049846283,0.000110940746,0.00023427026,0.000033080658,0.98788774,0.00020102767],"about_ca_topic_score_codex":0.00005050964,"about_ca_topic_score_gemma":0.000002373542,"teacher_disagreement_score":0.026484013,"about_ca_system_score_codex":0.000057915786,"about_ca_system_score_gemma":0.0006060622,"threshold_uncertainty_score":0.72571856},"labels":[],"label_agreement":null},{"id":"W2194123948","doi":"10.1016/j.eururo.2015.10.043","title":"New Rates of Interventions to Manage Complications of Modern Prostate Cancer Treatment in Older Men","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Relative risk; Confidence interval; Urinary incontinence; Surgery; Population; Radiation therapy; Cohort; Retrospective cohort study; Epidemiology; Cancer; Internal medicine","score_opus":0.06615099610038339,"score_gpt":0.35426174713662756,"score_spread":0.2881107510362442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2194123948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94359356,0.0053620525,0.00092752883,0.012121104,0.00011268121,0.0017527797,0.00012015824,0.00003285067,0.035977308],"genre_scores_gemma":[0.9967049,0.00027189907,0.000626732,0.00025307914,0.000023067874,0.000102781894,0.000036128506,0.000019120384,0.001962317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923337,0.0000872479,0.00029675302,0.00018765529,0.000061404346,0.00013356983],"domain_scores_gemma":[0.9994342,0.00002505323,0.000092335715,0.00024096444,0.00007170651,0.00013578242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009179243,0.00009430072,0.00024469494,0.00012122366,0.000009093025,0.0000025063707,0.000062513354,0.000014143552,0.000062721956],"category_scores_gemma":[0.000016670729,0.00007576074,0.00006682797,0.00012353783,0.00003333359,0.000017586697,0.00004778873,0.000035970268,0.000033691114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001056992,0.0040193964,0.7349515,0.00032711503,0.00048822424,0.00019667244,0.021002475,0.0037948263,0.0029515114,0.0014511405,0.024037147,0.20572299],"study_design_scores_gemma":[0.0055626896,0.0029915292,0.9736696,0.00018404766,0.00021660727,0.000009068419,0.0001202998,0.00012761775,0.0027647875,0.00041027044,0.0138433045,0.00010017502],"about_ca_topic_score_codex":0.00069283205,"about_ca_topic_score_gemma":0.0003391952,"teacher_disagreement_score":0.23871809,"about_ca_system_score_codex":0.00010556769,"about_ca_system_score_gemma":0.000067306544,"threshold_uncertainty_score":0.30894336},"labels":[],"label_agreement":null},{"id":"W2201237979","doi":"10.1016/j.eururo.2006.03.034","title":"Plasmacytoid Urothelial Carcinoma of the Urinary Bladder","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Curriculum; Medicine; Obstetrics and gynaecology; Specialty; Competence (human resources); Gynecology; Medical education; Sociology; Management; Pedagogy; Family medicine; Pregnancy","score_opus":0.010933734831924918,"score_gpt":0.22706489558853937,"score_spread":0.21613116075661445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2201237979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7881257,0.0003557951,0.000021771004,0.0011595947,0.00031660014,0.00023131093,0.00002110668,0.000036190733,0.20973194],"genre_scores_gemma":[0.9926661,0.000006738394,0.00006552921,0.0014105837,0.00050329714,0.000005015253,0.00000871939,0.000043260632,0.005290707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998938,0.00020626998,0.00024216707,0.00022865554,0.00015244324,0.00023244038],"domain_scores_gemma":[0.99937105,0.000036013706,0.00008285835,0.00041999953,0.00004067488,0.00004938226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094991614,0.00014353984,0.00020423606,0.000050709255,0.00006586807,0.000003912141,0.0001670403,0.000041564475,0.00033325367],"category_scores_gemma":[0.000021073763,0.00009430368,0.00013551756,0.00011177237,0.0001974134,0.000020277783,0.00009767888,0.0001647199,0.00019733736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022743254,0.0018094,0.90992594,0.00008013489,0.0003202557,0.0013970111,0.00055052777,0.00007864492,0.038115844,0.0027795432,0.038475648,0.0041927295],"study_design_scores_gemma":[0.0027835574,0.0010131495,0.92199403,0.000005849789,0.00017279063,0.0005548448,0.0000102830545,0.00001742613,0.007078368,0.00015489076,0.066121615,0.00009320397],"about_ca_topic_score_codex":0.0001101657,"about_ca_topic_score_gemma":0.0000075111584,"teacher_disagreement_score":0.20454046,"about_ca_system_score_codex":0.00002010706,"about_ca_system_score_gemma":0.000079565434,"threshold_uncertainty_score":0.38455924},"labels":[],"label_agreement":null},{"id":"W2215495878","doi":"10.1016/j.eururo.2015.12.011","title":"Re: Yvonne Vergouwe, Ewout W. Steyerberg, Richard S. Foster, et al. Predicting Retroperitoneal Histology in Postchemotherapy Testicular Germ Cell Cancer: A Model Update and Multicentre Validation with More Than 1000 Patients. Eur Urol 2007;51:424–32","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Testicular cancer; Histology; Germ cell; Germ cell tumors; Testicular Germ Cell Tumor; Cancer; Gynecology; Pathology; Surgery; Internal medicine; Chemotherapy","score_opus":0.012429715185723214,"score_gpt":0.250741231882948,"score_spread":0.23831151669722478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2215495878","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.764603,0.009231628,0.00018760991,0.21992092,0.0006799784,0.0025316807,0.00085039623,0.00030498943,0.0016897571],"genre_scores_gemma":[0.4779936,0.0012440525,0.0010857689,0.51309407,0.0006126895,0.00009349465,0.0046275477,0.00048977433,0.00075901404],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.995586,0.0008914014,0.00071323046,0.0013619442,0.0005816197,0.00086579926],"domain_scores_gemma":[0.9976416,0.00013589744,0.00067981094,0.0008257146,0.00037976383,0.0003372064],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002917126,0.0008267937,0.001020229,0.0003029809,0.00009851219,0.000046217363,0.00027130326,0.000414993,0.000084629486],"category_scores_gemma":[0.00016627512,0.0006867422,0.00013173005,0.00019725128,0.00022589667,0.00013337079,0.00020635873,0.0014875435,0.00005852216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032625268,0.0009962753,0.5072902,0.0003791191,0.0006682492,0.011976844,0.0013688622,0.0016029637,0.00011856079,0.0000017905114,0.4699407,0.0023939544],"study_design_scores_gemma":[0.05786476,0.008966951,0.15204227,0.00072737085,0.005438694,0.0007741758,0.00014402783,0.034328118,0.000119479104,0.000026131294,0.7368607,0.0027073526],"about_ca_topic_score_codex":0.00030734297,"about_ca_topic_score_gemma":0.000062019426,"teacher_disagreement_score":0.35524788,"about_ca_system_score_codex":0.000330367,"about_ca_system_score_gemma":0.0003522262,"threshold_uncertainty_score":0.9995584},"labels":[],"label_agreement":null},{"id":"W2218810808","doi":"10.1016/j.eururo.2015.11.010","title":"Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis","year":2015,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":281,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; Radiation therapy; Brachytherapy; Hazard ratio; External beam radiotherapy; Meta-analysis; Relative risk; Cochrane Library; Regimen; Confidence interval; Internal medicine; Oncology; Surgery; Cancer","score_opus":0.21258764514917944,"score_gpt":0.43281030546248844,"score_spread":0.220222660313309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2218810808","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.8341168e-7,0.9890635,0.000029086703,0.0015945937,0.0001976906,0.008324516,0.0005542886,0.00006548426,0.00017054297],"genre_scores_gemma":[0.0000014318289,0.9896094,0.00021523109,0.0039324686,0.00011738342,0.0046208054,0.00052896247,0.00015076189,0.00082352554],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99402106,0.0022723514,0.0021384126,0.0009220877,0.00021795419,0.00042815236],"domain_scores_gemma":[0.99466926,0.0023424826,0.0014311348,0.00097398966,0.00024396373,0.00033918727],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.003316369,0.00068072317,0.017252058,0.00028394882,0.00005236833,0.000029400055,0.00018017396,0.00014630955,0.00020045832],"category_scores_gemma":[0.00069585175,0.00039860667,0.0044117905,0.00050381303,0.00012947472,0.00002831579,0.00006744529,0.00026951218,0.00004092535],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019436065,0.000100000645,0.0000058684386,0.60512465,0.3621239,0.00014379834,0.000024309644,4.3762674e-7,2.3197573e-9,0.000009083237,0.0077164923,0.024557088],"study_design_scores_gemma":[0.0006581764,0.00047905193,4.2716255e-7,0.0048248763,0.51514906,0.000029284976,7.2000654e-7,0.0000014434303,5.3805858e-9,0.0000010853724,0.47869635,0.00015950362],"about_ca_topic_score_codex":0.000012737937,"about_ca_topic_score_gemma":0.000005844997,"teacher_disagreement_score":0.6002998,"about_ca_system_score_codex":0.00019038818,"about_ca_system_score_gemma":0.00044916215,"threshold_uncertainty_score":0.9998466},"labels":[],"label_agreement":null},{"id":"W2223657219","doi":"10.1016/j.eururo.2015.12.029","title":"Magnetic Resonance Imaging–Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Profound Medical (Canada); London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Prostate cancer; Prostate; Common Terminology Criteria for Adverse Events; Dysuria; Magnetic resonance imaging; Prostate biopsy; Urology; Interquartile range; Ablation; Prostatectomy; Adverse effect; Radiology; Cancer; Urinary system; Surgery; Internal medicine","score_opus":0.018145323153024275,"score_gpt":0.3209241133738259,"score_spread":0.3027787902208017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2223657219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919251,0.0020672772,0.000046792244,0.0012449471,0.00022967276,0.003476275,0.00019693971,0.00004666029,0.00076631404],"genre_scores_gemma":[0.9980474,0.0007491667,0.00021055921,0.0003115675,0.000108892345,0.00021900208,0.00004808417,0.00006001707,0.00024532282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974057,0.0005068716,0.0008350947,0.00061156345,0.0002464486,0.00039429328],"domain_scores_gemma":[0.99879175,0.00022154897,0.00028461442,0.0003309018,0.00023532851,0.00013587209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052064116,0.00024876936,0.00058669114,0.00010890273,0.00003345406,0.000009051319,0.00009203052,0.00004818606,0.00012289245],"category_scores_gemma":[0.00020535251,0.00015543908,0.00007153812,0.00021230945,0.00042113196,0.00010227725,0.000021947799,0.00017528798,0.00001977037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10275213,0.0016733845,0.74664575,0.00002238604,0.000037901,0.00012642036,0.00052410655,0.0000030799758,0.00015070642,0.000024552724,0.00023380367,0.14780577],"study_design_scores_gemma":[0.26531765,0.018574888,0.7037569,0.00015351019,0.00014695522,0.00000863938,0.0000068630643,0.000008311152,0.0005990546,0.00006318312,0.011200121,0.000163909],"about_ca_topic_score_codex":0.000060407856,"about_ca_topic_score_gemma":0.000042993506,"teacher_disagreement_score":0.16256553,"about_ca_system_score_codex":0.00014081257,"about_ca_system_score_gemma":0.00017739004,"threshold_uncertainty_score":0.63386214},"labels":[],"label_agreement":null},{"id":"W2224015183","doi":"10.1016/j.eururo.2015.12.032","title":"Physical Activity and Survival After Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":237,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary; Alberta Health Services","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Hazard ratio; Confidence interval; Prostate cancer; Proportional hazards model; Metabolic equivalent; Prospective cohort study; Relative risk; Cohort study; Internal medicine; Lower risk; Physical activity; Cancer; Physical therapy","score_opus":0.011962277062764396,"score_gpt":0.2655640136313793,"score_spread":0.25360173656861495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2224015183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839947,0.00024253274,0.00004052282,0.005131425,0.00035497494,0.00009214721,0.00002083027,0.000050187988,0.010072659],"genre_scores_gemma":[0.9955851,0.00011167693,0.0000028207005,0.0007949523,0.00048667172,0.000013506504,7.6259164e-7,0.000026447024,0.0029780888],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992715,0.00016413406,0.000052147887,0.00024060777,0.00007967729,0.00019191019],"domain_scores_gemma":[0.9996234,0.000055116263,0.000024127427,0.00016895877,0.00003056558,0.00009780953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096329204,0.00009577675,0.00015728426,0.000026428734,0.000020413816,0.0000051772004,0.0000346466,0.000020916703,0.00015460067],"category_scores_gemma":[0.000023006072,0.00005930226,0.000037884824,0.00004214182,0.00013073493,0.000038235303,0.00006668671,0.00009500096,0.00010817966],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040423544,0.00021839094,0.3702831,0.00007225002,0.00012423517,0.0007202222,0.002753464,3.1644322e-7,0.0601325,0.00028703045,0.0011555719,0.5602106],"study_design_scores_gemma":[0.0011047616,0.00033602852,0.91132736,0.000014708099,0.0000584082,0.000027578812,0.000013985738,0.000004758019,0.0009669999,0.000035998855,0.08599704,0.00011235166],"about_ca_topic_score_codex":0.00008006761,"about_ca_topic_score_gemma":0.00025619418,"teacher_disagreement_score":0.56009823,"about_ca_system_score_codex":0.000016476257,"about_ca_system_score_gemma":0.000022870565,"threshold_uncertainty_score":0.24182759},"labels":[],"label_agreement":null},{"id":"W2250188469","doi":"10.1016/j.eururo.2016.01.008","title":"Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Radiation therapy; Salvage therapy; Classifier (UML); Metastasis; Urology; Oncology; Internal medicine; Artificial intelligence; Cancer; Chemotherapy","score_opus":0.03908358716419629,"score_gpt":0.27991602738458454,"score_spread":0.24083244022038824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2250188469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99038416,0.0018565053,0.0053217607,0.00069925084,0.000191644,0.0009096032,0.00021161066,0.00002947426,0.00039600267],"genre_scores_gemma":[0.99813914,0.0009111266,0.0003665052,0.000236318,0.00008188366,0.000109724926,0.000067150766,0.000032879198,0.000055264958],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99906415,0.00015122161,0.00032577186,0.00021557066,0.00009468625,0.00014857527],"domain_scores_gemma":[0.9994543,0.0001058807,0.00015024083,0.00018055986,0.0000584552,0.000050530343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027641363,0.0001028357,0.0002460347,0.00010244559,0.000019447505,0.0000024377316,0.000038976523,0.00003873075,0.00007071002],"category_scores_gemma":[0.000062925596,0.00006644773,0.00014415839,0.00006462249,0.00007289204,0.000053881548,0.000014616048,0.000033070144,0.000007726492],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052797194,0.00069034204,0.30037913,0.00012675762,0.0009959042,0.000051416326,0.000740123,0.0000069970292,0.18156284,0.0003990287,0.00097621436,0.5087915],"study_design_scores_gemma":[0.009480447,0.00325812,0.90052515,0.000045670262,0.0003080536,0.000009065404,0.000009360961,0.00005839206,0.04779989,0.000110268214,0.038320772,0.00007481504],"about_ca_topic_score_codex":0.0000017942674,"about_ca_topic_score_gemma":6.10009e-7,"teacher_disagreement_score":0.600146,"about_ca_system_score_codex":0.000051805644,"about_ca_system_score_gemma":0.000046307687,"threshold_uncertainty_score":0.27096596},"labels":[],"label_agreement":null},{"id":"W2252992087","doi":"10.1016/j.eururo.2013.12.042","title":"Re: Pazopanib Versus Sunitinib in Metastatic Renal-cell Carcinoma","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pazopanib; Sunitinib; Renal cell carcinoma; Oncology; Internal medicine; Urology","score_opus":0.057886416794818006,"score_gpt":0.2659248840158177,"score_spread":0.2080384672209997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2252992087","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17845295,0.0018325007,0.000034290642,0.39057207,0.0013398847,0.0012593913,0.000042792355,0.00019638674,0.4262697],"genre_scores_gemma":[0.580832,0.000036994763,0.00029004808,0.4075616,0.0025976566,0.000033305925,0.0012173944,0.0003061499,0.007124872],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940719,0.0024746682,0.0008530631,0.0011094474,0.00047609262,0.0010148073],"domain_scores_gemma":[0.9970093,0.0008626808,0.00038225634,0.0014382361,0.00010560838,0.00020194368],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007183524,0.00075622933,0.0012377943,0.0006368319,0.00005814301,0.000028087712,0.0004432004,0.00037411976,0.00078584603],"category_scores_gemma":[0.0002248281,0.0006720451,0.00034455804,0.0002707435,0.00022497032,0.000035087756,0.0002058171,0.0029588614,0.0032714093],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010761573,0.00014955329,0.0009454117,0.00032877224,0.00015600357,0.101277545,0.00021509052,0.000009707603,0.00029241032,0.000010647445,0.89498395,0.0005547605],"study_design_scores_gemma":[0.008571446,0.0042266417,0.00806792,0.00003986071,0.0010738445,0.0006565129,0.000026340978,0.000023890865,0.00036603076,0.000018069293,0.9763964,0.0005330719],"about_ca_topic_score_codex":0.000098943885,"about_ca_topic_score_gemma":0.0000370128,"teacher_disagreement_score":0.41914484,"about_ca_system_score_codex":0.00023286787,"about_ca_system_score_gemma":0.00016420966,"threshold_uncertainty_score":0.99957305},"labels":[],"label_agreement":null},{"id":"W2253620301","doi":"10.1016/j.eururo.2016.01.037","title":"Long-term Impact of Mode of Delivery on Stress Urinary Incontinence and Urgency Urinary Incontinence: A Systematic Review and Meta-analysis","year":2016,"lang":"en","type":"review","venue":"European Urology","topic":"Pelvic floor disorders treatments","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Urinary incontinence; Vaginal delivery; Odds ratio; Meta-analysis; Confidence interval; Obstetrics; Gynecology; Relative risk; Randomized controlled trial; CINAHL; Pregnancy; Urology; Internal medicine; Psychological intervention","score_opus":0.041955649017037334,"score_gpt":0.3472881142983133,"score_spread":0.30533246528127594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2253620301","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049174572,0.9913923,0.000010986403,0.00006511148,0.000023545208,0.0023985042,0.00044060237,0.000026784972,0.0007246883],"genre_scores_gemma":[0.02703519,0.97195196,0.000035974157,0.00012367565,0.00002008652,0.00009116054,0.00012675661,0.00008126613,0.00053393014],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9942209,0.0021864977,0.002060161,0.0008515011,0.0003158808,0.00036504466],"domain_scores_gemma":[0.99556017,0.000580641,0.002068575,0.0013842551,0.00018446443,0.00022190079],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071262923,0.0007943218,0.010572826,0.00073116843,0.00003683238,0.0000068612676,0.00039126002,0.00017520443,0.00028828872],"category_scores_gemma":[0.00044016555,0.0004452402,0.0023725897,0.000492493,0.00031352945,0.00007584147,0.00037514948,0.00031436668,0.000040299718],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011787421,0.0008533429,0.0029553503,0.8174394,0.17283624,0.0009908216,0.00006208819,6.749589e-7,0.000001908264,0.000009167802,0.000057221172,0.0046759136],"study_design_scores_gemma":[0.0008934881,0.002880667,0.007289969,0.05236998,0.9350784,0.00087128,0.0000020241973,0.0000028986067,2.9993873e-7,0.000004524006,0.00020092129,0.0004055759],"about_ca_topic_score_codex":0.0000375807,"about_ca_topic_score_gemma":0.0000029298685,"teacher_disagreement_score":0.7650694,"about_ca_system_score_codex":0.000051001185,"about_ca_system_score_gemma":0.00013951275,"threshold_uncertainty_score":0.9997999},"labels":[],"label_agreement":null},{"id":"W2258966579","doi":"10.1016/j.eururo.2016.01.047","title":"Percutaneous Nephrolithotomy: Update, Trends, and Future Directions","year":2016,"lang":"en","type":"review","venue":"European Urology","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":241,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Percutaneous nephrolithotomy; Percutaneous; MEDLINE; General surgery; Urology; Surgery","score_opus":0.01870164597179039,"score_gpt":0.2993182433885797,"score_spread":0.2806165974167893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2258966579","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014953588,0.94057024,0.0000014237553,0.0022481503,0.0006932802,0.00032665898,0.00016434761,0.00019009355,0.055790838],"genre_scores_gemma":[0.000015999834,0.9852532,0.00012812242,0.0014795274,0.0023008701,0.00001599297,0.0002539846,0.00017826306,0.010374047],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99758154,0.0005963349,0.0004886919,0.0007463348,0.00012507368,0.0004620049],"domain_scores_gemma":[0.9985829,0.00009362222,0.00021812502,0.0006658856,0.00004116402,0.00039828024],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015259346,0.000572306,0.0015743758,0.00041156003,0.00014393879,0.000023148601,0.00015287493,0.0002854422,0.00086731993],"category_scores_gemma":[0.000036936257,0.00035060765,0.00041822254,0.00024528388,0.00016060892,0.000034543995,0.00013903304,0.0004709824,0.0014254533],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032488424,0.00008089167,0.000031044507,0.00061983516,0.0004671168,0.0020291542,0.000038367893,1.30918e-9,3.15708e-7,0.00015202253,0.005155902,0.99139285],"study_design_scores_gemma":[0.0004751537,0.00036284208,0.0007365275,0.0004128952,0.002389661,0.03296651,0.0000026997104,1.9504512e-7,1.5485655e-8,0.000006382975,0.96237713,0.0002699999],"about_ca_topic_score_codex":0.0000039478464,"about_ca_topic_score_gemma":7.8500045e-7,"teacher_disagreement_score":0.99112284,"about_ca_system_score_codex":0.00006688145,"about_ca_system_score_gemma":0.00011144955,"threshold_uncertainty_score":0.9998946},"labels":[],"label_agreement":null},{"id":"W2259186924","doi":"10.1016/j.eururo.2016.01.048","title":"Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4 cm Can Be Offered Active Surveillance as an Initial Management Strategy","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Tuberous Sclerosis Complex Research","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Natural history; Angiomyolipoma; Urology; Management strategy; Watchful waiting; Radiology; Kidney; Internal medicine; Cancer","score_opus":0.02730242014387337,"score_gpt":0.26651119465640916,"score_spread":0.23920877451253578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2259186924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97611207,0.000081205995,0.000052453266,0.0006612809,0.00020692735,0.0005202322,0.00015468721,0.00007623216,0.022134924],"genre_scores_gemma":[0.9954477,0.000011155335,0.000082496386,0.0009259468,0.00014705717,0.000010197021,0.00018848229,0.000075999444,0.0031109995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970862,0.00087818544,0.0003377438,0.0005524871,0.00050928816,0.00063605444],"domain_scores_gemma":[0.9984856,0.00011594505,0.00018204532,0.00065819605,0.00032186694,0.00023634847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003434054,0.00025015927,0.00039542382,0.00024030733,0.000054324693,0.0000074189215,0.0003437446,0.00005776267,0.0005376104],"category_scores_gemma":[0.000097707845,0.00017354522,0.00006145932,0.00016612007,0.0004064829,0.00010183856,0.00022675678,0.00026997505,0.000073642106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07927255,0.010030173,0.35819325,0.0005528423,0.004860644,0.008198113,0.008174965,0.000041226533,0.19529338,0.015382761,0.08666084,0.23333925],"study_design_scores_gemma":[0.007691911,0.0044367844,0.97095466,0.000034407767,0.00004900983,0.00004064619,0.000039957074,0.000024471887,0.00036003644,0.000019237717,0.016123863,0.00022503902],"about_ca_topic_score_codex":0.00009268649,"about_ca_topic_score_gemma":0.00035825765,"teacher_disagreement_score":0.6127614,"about_ca_system_score_codex":0.00030619613,"about_ca_system_score_gemma":0.00016594936,"threshold_uncertainty_score":0.7076969},"labels":[],"label_agreement":null},{"id":"W2261727231","doi":"10.1016/j.eururo.2016.02.007","title":"Prospective Pilot Study of Mirabegron in Pediatric Patients with Overactive Bladder","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Mirabegron; Overactive bladder; Tolerability; Urology; Placebo; Prospective cohort study; Population; Urinary incontinence; Internal medicine; Adverse effect","score_opus":0.018468520417732268,"score_gpt":0.2640945466383219,"score_spread":0.2456260262205896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2261727231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787476,0.000042098298,0.0000094426305,0.0001747157,0.000036240413,0.0009568788,0.0000070751794,0.00001964585,0.020006306],"genre_scores_gemma":[0.99930006,0.000023627199,0.000017519256,0.00006125315,0.0000802539,0.00001446516,0.0000036154722,0.000034694793,0.0004644968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984685,0.00045960996,0.00021750132,0.00033024568,0.00024796868,0.00027615088],"domain_scores_gemma":[0.99925953,0.00016944374,0.000080238904,0.00025363357,0.0001578341,0.00007933297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024988607,0.000125632,0.0002301105,0.00023208144,0.000024422236,0.0000028503546,0.000090262816,0.000015946101,0.00015991287],"category_scores_gemma":[0.00010607157,0.00007268634,0.000015351217,0.00024345722,0.00007520756,0.00007763194,0.00008948604,0.00020499104,0.00011321551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006964391,0.0049784617,0.98525316,0.000014212133,0.000067559704,0.0002455864,0.0010318365,0.0000011180363,0.0002112996,0.000011157987,0.00013538395,0.0010858619],"study_design_scores_gemma":[0.010477796,0.05842348,0.93068373,0.000005811849,0.000054104774,0.000007122191,0.00007556292,6.897435e-7,0.000039881077,0.000018284793,0.00013426368,0.00007929833],"about_ca_topic_score_codex":0.000025436688,"about_ca_topic_score_gemma":0.00003048272,"teacher_disagreement_score":0.054569427,"about_ca_system_score_codex":0.000036861748,"about_ca_system_score_gemma":0.00005221664,"threshold_uncertainty_score":0.29640633},"labels":[],"label_agreement":null},{"id":"W2262066536","doi":"10.1016/j.eururo.2016.01.050","title":"Complete Responses with Targeted Therapy in Metastatic Renal Cell Carcinoma: Balancing Efficacy and Toxicity","year":2016,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sunitinib; Pazopanib; Sorafenib; Bevacizumab; Renal cell carcinoma; Oncology; Internal medicine; Angiogenesis; Vascular endothelial growth factor; Temsirolimus; Toxicity; Surgery; Chemotherapy; VEGF receptors; Hepatocellular carcinoma","score_opus":0.03138310968950889,"score_gpt":0.24227991991917194,"score_spread":0.21089681022966306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2262066536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88109356,0.0025566574,0.000050913008,0.10868947,0.000104479084,0.0009091754,0.00008429457,0.00007346522,0.0064379913],"genre_scores_gemma":[0.8156681,0.0000944208,0.0004759633,0.18049479,0.0008577566,0.000019177436,0.00022304378,0.00017504075,0.0019917372],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99540275,0.0021092005,0.00051065255,0.00091560784,0.0003273281,0.00073444896],"domain_scores_gemma":[0.997919,0.0008689438,0.0002721984,0.0007153833,0.00007752523,0.00014695464],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005047285,0.00059903343,0.000990476,0.0004528865,0.00006831158,0.000022544762,0.00020421534,0.00017751145,0.0001602533],"category_scores_gemma":[0.00007671558,0.000377477,0.00010086374,0.00015816648,0.00031339008,0.000037273854,0.00010732757,0.0012632543,0.00014666525],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025180057,0.00064920954,0.057945244,0.0007246468,0.0009903442,0.27523023,0.0019737284,0.000014049084,0.22760534,0.000009287597,0.4042787,0.0053991703],"study_design_scores_gemma":[0.019247996,0.012563652,0.46639702,0.00014156965,0.0004966947,0.00272304,0.00001168093,0.000015550097,0.0043735923,0.000014927982,0.49323598,0.00077828777],"about_ca_topic_score_codex":0.000043862045,"about_ca_topic_score_gemma":0.000007432446,"teacher_disagreement_score":0.4084518,"about_ca_system_score_codex":0.000122059086,"about_ca_system_score_gemma":0.0001500271,"threshold_uncertainty_score":0.99986774},"labels":[],"label_agreement":null},{"id":"W2281395530","doi":"10.1016/j.eururo.2016.02.033","title":"Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"Dana-Farber/Harvard Cancer Center; Swiss Cancer Research Foundation; Pfizer","keywords":"Medicine; Hazard ratio; Internal medicine; Renal cell carcinoma; Confidence interval; Odds ratio; Proportional hazards model; Biomarker; Neutrophil to lymphocyte ratio; Prospective cohort study; Oncology; Gastroenterology; Progression-free survival; Urology; Lymphocyte; Overall survival","score_opus":0.03129581762172239,"score_gpt":0.2896932412071104,"score_spread":0.258397423585388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2281395530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918101,0.0007431344,0.00009579722,0.0041588387,0.00007802601,0.0028902853,0.00004384958,0.000030199042,0.00014979842],"genre_scores_gemma":[0.9958504,0.000026469024,0.0013181583,0.0023043724,0.00005289457,0.0003205148,0.000008282814,0.000065982764,0.000052940286],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99741864,0.0010345634,0.00049764616,0.00049776747,0.00013666201,0.0004147136],"domain_scores_gemma":[0.998419,0.00075356534,0.00011060633,0.00036697974,0.00008990975,0.00025995745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011748526,0.00021916411,0.00039307517,0.00069153216,0.00002510635,0.0000069773705,0.00015824116,0.00005076218,0.000054984528],"category_scores_gemma":[0.0011687159,0.00016387511,0.00006889972,0.000371488,0.00013275085,0.00004766818,0.000106164465,0.00006299384,0.000062747466],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10658427,0.0006318583,0.142903,0.00010493377,0.00007592806,0.0010042327,0.0021400142,0.0000012074122,0.71957606,0.00004773155,0.00039409034,0.026536688],"study_design_scores_gemma":[0.012299684,0.003090348,0.96038234,0.000059140148,0.000052389856,0.000030874027,0.0000188296,0.000056195957,0.019114906,0.000013284861,0.0047056563,0.00017633323],"about_ca_topic_score_codex":0.000013754132,"about_ca_topic_score_gemma":0.000006343921,"teacher_disagreement_score":0.8174794,"about_ca_system_score_codex":0.00006442661,"about_ca_system_score_gemma":0.0001431639,"threshold_uncertainty_score":0.6682633},"labels":[],"label_agreement":null},{"id":"W2283097513","doi":"10.1016/j.eururo.2014.07.025","title":"RETRACTED: Narrowing the Cystoscopy Gap","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cystoscopy; General surgery; MEDLINE; Pathology; Alternative medicine; Law","score_opus":0.03444900414761905,"score_gpt":0.27487068114346896,"score_spread":0.24042167699584993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283097513","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006843654,0.0007520874,0.00006427202,0.70137125,0.001331232,0.00037239355,0.00001579626,0.0001601542,0.29524848],"genre_scores_gemma":[0.05014233,0.000052697702,0.00006392415,0.9200354,0.014822768,0.00001526436,0.0002588977,0.00019919446,0.014409515],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973293,0.00091201003,0.00034153895,0.00055918295,0.00032191945,0.0005360557],"domain_scores_gemma":[0.9985162,0.00019921825,0.00016938632,0.0009699975,0.00006528667,0.00007992431],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039733565,0.0003876051,0.00051300036,0.000111047964,0.00014918284,0.000029292065,0.00037319597,0.0004869069,0.0007661725],"category_scores_gemma":[0.00010747194,0.0002477641,0.00023022637,0.00010578981,0.00020493931,0.00002437266,0.00008637062,0.0032634824,0.0029414622],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009223712,0.00002095141,0.00029389496,0.000049748734,0.00022353492,0.0037769822,0.00014815935,5.4169226e-7,0.00011570141,0.000011567171,0.9941817,0.0010849638],"study_design_scores_gemma":[0.00094262214,0.000777455,0.0020464885,0.000034261415,0.0005331545,0.001188068,0.000004422673,0.0000049464365,0.000027008877,0.00004277975,0.9942031,0.00019567377],"about_ca_topic_score_codex":0.000026900741,"about_ca_topic_score_gemma":0.0000014616594,"teacher_disagreement_score":0.28083897,"about_ca_system_score_codex":0.000051271312,"about_ca_system_score_gemma":0.00008802147,"threshold_uncertainty_score":0.99999744},"labels":[],"label_agreement":null},{"id":"W2284331415","doi":"10.1016/j.eururo.2016.02.014","title":"Incidence and Remission of Nocturia: A Systematic Review and Meta-analysis","year":2016,"lang":"en","type":"review","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"Medical Research Council; Jane ja Aatos Erkon Säätiö; U.S. Department of Veterans Affairs","keywords":"Nocturia; Medicine; Incidence (geometry); Natural history; Meta-analysis; Population; Cumulative incidence; Epidemiology; Systematic review; Demography; MEDLINE; Gerontology; Pediatrics; Internal medicine; Urinary system; Environmental health","score_opus":0.10793799911370353,"score_gpt":0.3974458647517101,"score_spread":0.28950786563800657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2284331415","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[6.645717e-7,0.99518114,0.00002242737,0.00052112626,0.000008933655,0.0015691082,0.00003621901,0.000014899174,0.0026455056],"genre_scores_gemma":[0.0000476522,0.9963188,0.00005108281,0.00036272116,0.000022565295,0.00003749838,0.000023737219,0.000039383583,0.0030965426],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9952283,0.0028761083,0.0009668087,0.0004931157,0.00021673455,0.0002189513],"domain_scores_gemma":[0.99779564,0.0006734254,0.0005039201,0.0007318105,0.000106074105,0.00018913281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00225989,0.0003157119,0.007055156,0.00035006338,0.000034821485,0.000008097685,0.00017701792,0.00010112814,0.0004484588],"category_scores_gemma":[0.0007447708,0.00015133848,0.00086820615,0.00037550594,0.00017246859,0.000028366492,0.00030203795,0.0003258441,0.00007892296],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009059981,0.000016158985,0.0000019665404,0.9389116,0.054229993,0.00026975002,0.000022108581,3.036729e-9,5.0781824e-7,0.000013225192,0.0002735484,0.006252045],"study_design_scores_gemma":[0.00009612691,0.00030871612,0.000005440708,0.021969026,0.77937245,0.0010883432,8.7210566e-7,2.425297e-7,1.1730162e-7,0.0000065749377,0.19703764,0.00011446321],"about_ca_topic_score_codex":0.000002078421,"about_ca_topic_score_gemma":4.8875205e-7,"teacher_disagreement_score":0.9169426,"about_ca_system_score_codex":0.000011304321,"about_ca_system_score_gemma":0.000075574724,"threshold_uncertainty_score":0.6171404},"labels":[],"label_agreement":null},{"id":"W2290563936","doi":"10.1016/j.eururo.2016.02.036","title":"Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Tadalafil; Medicine; Prostatectomy; Placebo; Erectile dysfunction; Randomization; International Prostate Symptom Score; Population; Sexual function; Randomized controlled trial; Urology; Prostate; Surgery; Internal medicine; Lower urinary tract symptoms","score_opus":0.07418585838898836,"score_gpt":0.28971291690512224,"score_spread":0.21552705851613388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290563936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9560021,0.0002967309,0.037006833,0.0003981368,0.0028087616,0.0010160035,0.0000946056,0.000056307825,0.0023204852],"genre_scores_gemma":[0.99829084,0.000099809855,0.00045862893,0.00028167723,0.00054928515,0.000044425396,0.000043804346,0.00003712732,0.00019442198],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971774,0.00087630114,0.0009286218,0.00046733805,0.00034963465,0.00020067173],"domain_scores_gemma":[0.9953826,0.0031442272,0.0002951768,0.0008755419,0.0002024017,0.00010005366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019344671,0.00018813986,0.0007638101,0.0001637084,0.000045994617,0.000006305288,0.0002167619,0.000075584205,0.00031130246],"category_scores_gemma":[0.003774798,0.00010269822,0.00015048313,0.00018170408,0.00023705672,0.0001766618,0.00035781067,0.00017662394,0.00006189863],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98243284,0.00013785301,0.0008218815,0.000011733065,0.00046028206,0.000012043253,0.00027834074,0.00025149464,0.0024713345,0.000010817421,0.0035330777,0.009578318],"study_design_scores_gemma":[0.97046965,0.0060507185,0.005134203,0.0002139132,0.0010872933,0.000013488819,0.00036003726,0.0036449789,0.0004903587,0.00015086752,0.012144887,0.00023962847],"about_ca_topic_score_codex":0.000057167024,"about_ca_topic_score_gemma":0.000027510976,"teacher_disagreement_score":0.042288687,"about_ca_system_score_codex":0.000023773415,"about_ca_system_score_gemma":0.00008283078,"threshold_uncertainty_score":0.45190585},"labels":[],"label_agreement":null},{"id":"W2291059315","doi":"10.1016/j.eururo.2016.02.057","title":"Assessment of the Rate of Adherence to International Guidelines for Androgen Deprivation Therapy with External-beam Radiation Therapy: A Population-based Study","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Internal medicine; Radiation therapy; Guideline; Epidemiology; Population; Logistic regression; Comorbidity; Stage (stratigraphy); Cancer; Urology; Pathology","score_opus":0.05940771529193162,"score_gpt":0.3620704972705168,"score_spread":0.3026627819785852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2291059315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990816,0.00011615535,0.0044882195,0.0031244727,0.000121151876,0.0012348774,0.000024431074,0.000009824931,0.00006488884],"genre_scores_gemma":[0.9974561,0.00007931362,0.0007792542,0.0014369978,0.00007194759,0.00011083628,0.000014066521,0.000016164257,0.000035365112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992141,0.00012921347,0.0002838799,0.00017409092,0.00012229927,0.0000763768],"domain_scores_gemma":[0.99905324,0.0001233471,0.00022636124,0.00022229184,0.0003476717,0.000027078513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032074,0.00008404382,0.00014712341,0.00005658909,0.000023708217,0.00000397155,0.00010378397,0.000012110449,0.000035651978],"category_scores_gemma":[0.00009591594,0.000040298284,0.000044366487,0.00007339875,0.000017174718,0.000028095285,0.000015224604,0.000020883115,0.0000010321605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063301105,0.00034594245,0.9403654,0.0000031796487,0.00011059943,0.0000016101712,0.00008321101,0.000287625,0.0110922605,0.000061371626,0.00007968322,0.046936132],"study_design_scores_gemma":[0.0054597706,0.0046437327,0.9782769,0.000036437912,0.000027660913,0.0000010971319,0.000008976658,0.000114722265,0.010282227,0.00003438296,0.0010714025,0.00004270749],"about_ca_topic_score_codex":0.000049021863,"about_ca_topic_score_gemma":0.000015998989,"teacher_disagreement_score":0.046893425,"about_ca_system_score_codex":0.000043391687,"about_ca_system_score_gemma":0.000069851594,"threshold_uncertainty_score":0.16433163},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2293202443","doi":"10.1016/j.eururo.2016.02.030","title":"Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Solifenacin; Medicine; Mirabegron; Overactive bladder; Urology; Tolterodine; Urinary urgency","score_opus":0.047778341306366594,"score_gpt":0.3576508429871424,"score_spread":0.3098725016807758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293202443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99005085,0.000041732026,0.00009433173,0.002223199,0.000053506137,0.0069961385,0.00005176741,0.00003630097,0.00045216037],"genre_scores_gemma":[0.9981983,0.000050132865,0.00008650361,0.0011889873,0.00010301329,0.00009500097,0.000022244676,0.000097995835,0.00015785516],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99450535,0.0029757624,0.0006737986,0.00077960145,0.00044739738,0.00061807345],"domain_scores_gemma":[0.99745935,0.0010608027,0.00016657719,0.00057469675,0.00023155604,0.0005070145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016575995,0.00038486984,0.0007112714,0.0006494721,0.00008582329,0.000021830625,0.00019617756,0.000071343384,0.00014272661],"category_scores_gemma":[0.00034209056,0.0002446969,0.000054007283,0.00033393307,0.00012868235,0.00015167826,0.000115821495,0.00033495875,0.000062671104],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.912305,0.009901506,0.010048623,0.000009641216,0.000292932,0.0005290903,0.014005801,0.000035313198,0.008633033,0.0000024530516,0.000075707336,0.044160895],"study_design_scores_gemma":[0.6053461,0.08414785,0.3058228,0.00007491816,0.00005788842,0.000012258284,0.00035635507,0.000018336625,0.0023097042,0.0000031771963,0.0015712632,0.00027940967],"about_ca_topic_score_codex":0.000084921725,"about_ca_topic_score_gemma":0.000091295675,"teacher_disagreement_score":0.30695894,"about_ca_system_score_codex":0.000075817836,"about_ca_system_score_gemma":0.00014612923,"threshold_uncertainty_score":0.99784493},"labels":[],"label_agreement":null},{"id":"W2293619070","doi":"10.1016/j.eururo.2015.09.015","title":"Reply from Authors re: Tracy L. Rose, Matthew I. Milowsky. A Small Step Toward Improving Salvage Treatment for Metastatic Bladder Cancer — At What Cost? Eur Urol 2016;69:642–44","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Urology; Salvage therapy; Bladder cancer; Surgery; General surgery; Cancer; Internal medicine; Chemotherapy","score_opus":0.08441656718375008,"score_gpt":0.31338070184851446,"score_spread":0.2289641346647644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293619070","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0131254075,0.08931156,0.0016856871,0.82584935,0.02626319,0.01953876,0.010783232,0.0013851105,0.012057707],"genre_scores_gemma":[0.0032054116,0.004044941,0.0026734006,0.8750121,0.020590654,0.0020764265,0.0064655556,0.0014478731,0.08448363],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925605,0.0013535278,0.0013409393,0.0023865374,0.0006997566,0.0016587529],"domain_scores_gemma":[0.99559957,0.00060959964,0.00089409715,0.0019034512,0.00036780056,0.0006254907],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.00068161666,0.0015763643,0.002228216,0.00037324827,0.00024341645,0.00021738463,0.0006638833,0.00064569485,0.0014895541],"category_scores_gemma":[0.00020862454,0.0012618231,0.0008430843,0.0002109253,0.00028319043,0.0002537307,0.00029500568,0.0015741062,0.0011061698],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026062857,0.00033973184,0.00013308553,0.00026141232,0.0031770454,0.00430966,0.0021297554,0.000013024018,0.0003040989,0.0000011125742,0.9321318,0.054592974],"study_design_scores_gemma":[0.012574931,0.004369186,0.00042126788,0.00019235275,0.007500354,0.00019513932,0.00012595452,0.000118042524,0.00020407727,0.000070591996,0.97326946,0.00095861935],"about_ca_topic_score_codex":0.0025358049,"about_ca_topic_score_gemma":0.0003339375,"teacher_disagreement_score":0.08526662,"about_ca_system_score_codex":0.001215205,"about_ca_system_score_gemma":0.0009818122,"threshold_uncertainty_score":0.99969846},"labels":[],"label_agreement":null},{"id":"W2294289462","doi":"10.1016/j.eururo.2015.11.035","title":"Reply from Authors re: Matthew C. Hayes, David J. Breen. Excision Versus Ablation in Renal Cancer: Optimising Outcome and Minimising Risk. Eur Urol 2016;69:683–4","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Outcome (game theory); Ablation; Kidney cancer; General surgery; Surgery; Cancer; Internal medicine","score_opus":0.07443297247606305,"score_gpt":0.3080245612372155,"score_spread":0.23359158876115244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2294289462","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47968033,0.023726314,0.0005191449,0.46608716,0.0046348344,0.002267872,0.00045300453,0.00045932896,0.022172002],"genre_scores_gemma":[0.3550897,0.004205882,0.0127987005,0.5755748,0.021992167,0.000106130545,0.00712748,0.0018608468,0.02124424],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932731,0.0021744496,0.0013312708,0.001661557,0.00071876304,0.0008408884],"domain_scores_gemma":[0.99642664,0.0008186501,0.00094416563,0.0013066991,0.00017361662,0.00033022414],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001437663,0.00082996587,0.0013002247,0.000607906,0.00014709773,0.00009216383,0.0003597646,0.00067901704,0.00028578535],"category_scores_gemma":[0.0006463605,0.0007428166,0.00021012277,0.00025631345,0.00022769881,0.00014021168,0.00034336813,0.0029721067,0.0003087589],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050991247,0.00009240999,0.020085262,0.00012753304,0.00042867943,0.018848842,0.0010070715,0.0006661759,0.00033038517,0.0000011025337,0.93625546,0.017057931],"study_design_scores_gemma":[0.009797125,0.0019046625,0.08822193,0.00040184986,0.0016557013,0.00031369738,0.000039190163,0.001240241,0.00004791403,0.00006141685,0.8954698,0.00084646966],"about_ca_topic_score_codex":0.00209334,"about_ca_topic_score_gemma":0.00008706949,"teacher_disagreement_score":0.12459062,"about_ca_system_score_codex":0.0006222186,"about_ca_system_score_gemma":0.0002524798,"threshold_uncertainty_score":0.9995023},"labels":[],"label_agreement":null},{"id":"W2295669653","doi":"10.1016/j.eururo.2016.02.035","title":"Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Abiraterone acetate; Prednisone; Prostate cancer; Incidence (geometry); Corticosteroid; Urology; Adverse effect; Castration; Abiraterone; Prostate; Internal medicine; Oncology; Cancer; Androgen deprivation therapy; Hormone","score_opus":0.015879586920593606,"score_gpt":0.274688650856204,"score_spread":0.2588090639356104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295669653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960549,0.000042009902,0.00007006746,0.0012845106,0.00007978123,0.0020814412,0.00025147968,0.000042346583,0.00009349212],"genre_scores_gemma":[0.9973061,0.00004336043,0.00012186479,0.00053108315,0.00002420431,0.00012866552,0.00007122262,0.00007680229,0.0016966593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975553,0.0003577264,0.00042715666,0.000559243,0.00053941883,0.0005611535],"domain_scores_gemma":[0.9984155,0.00008227554,0.00024350274,0.00043180652,0.00045807217,0.00036882615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022331227,0.00030331098,0.00046874263,0.00019485006,0.00007534954,0.000008697923,0.0001758069,0.000033139706,0.00011529384],"category_scores_gemma":[0.00010351224,0.0001692342,0.000043612356,0.00031609178,0.0001403526,0.00012531076,0.0000921507,0.00013934949,0.00014569942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039387975,0.001340567,0.89140314,0.00016619009,0.00064821204,0.0011160655,0.0016580701,0.00036210183,0.057747506,0.0000015816948,0.00012185497,0.0060467203],"study_design_scores_gemma":[0.01327274,0.01894536,0.95955986,0.00077816093,0.00019104093,0.000007760912,0.00001870199,0.0000025048444,0.0069990647,0.0000015038476,0.000024989564,0.00019830617],"about_ca_topic_score_codex":0.0000441059,"about_ca_topic_score_gemma":0.00043856123,"teacher_disagreement_score":0.06815671,"about_ca_system_score_codex":0.00023256255,"about_ca_system_score_gemma":0.00021137114,"threshold_uncertainty_score":0.69011706},"labels":[],"label_agreement":null},{"id":"W2298315650","doi":"10.1016/j.eururo.2016.03.017","title":"The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Enzalutamide; Medicine; Prostate cancer; Placebo; Hazard ratio; Internal medicine; Androgen deprivation therapy; Oncology; Clinical endpoint; Gastroenterology; Urology; Cancer; Surgery; Confidence interval; Randomized controlled trial; Pathology; Androgen receptor","score_opus":0.016546739678843146,"score_gpt":0.29596243410123,"score_spread":0.2794156944223869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2298315650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97979975,0.0040201955,0.00008756819,0.0125563005,0.00002157716,0.002689154,0.0005465776,0.000032272073,0.00024659192],"genre_scores_gemma":[0.9876058,0.0013823969,0.00007852274,0.000438984,0.000026736807,0.0002555525,0.00007880606,0.000052174677,0.010080991],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847305,0.000397786,0.00029299883,0.00033522327,0.00020811136,0.00029280843],"domain_scores_gemma":[0.99878305,0.00046079687,0.0001360746,0.0002951033,0.00016702151,0.00015792374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006230505,0.0001857484,0.0003054876,0.000047857036,0.0001336202,0.000015711881,0.00007920948,0.000011938839,0.000029993995],"category_scores_gemma":[0.00009162608,0.000078330246,0.000046031648,0.00007766482,0.00026641344,0.000049681756,0.000037469727,0.000072191135,0.0000039026154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047606397,0.0015469403,0.78494585,0.00034025378,0.0023160672,0.00038903437,0.001733309,0.000008126299,0.08018005,0.000029823743,0.009886056,0.0710181],"study_design_scores_gemma":[0.023982598,0.006107528,0.94598866,0.00007927236,0.00096253125,0.000010008952,0.00022683735,0.00008415475,0.002183969,0.000033309978,0.020114198,0.00022694604],"about_ca_topic_score_codex":0.000048372032,"about_ca_topic_score_gemma":0.00004969273,"teacher_disagreement_score":0.16104281,"about_ca_system_score_codex":0.00005523368,"about_ca_system_score_gemma":0.00014027547,"threshold_uncertainty_score":0.31942147},"labels":[],"label_agreement":null},{"id":"W2313546112","doi":"10.1016/j.eururo.2020.12.031","title":"The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of British Columbia, Okanagan Campus; Princess Margaret Cancer Centre; BC Cancer Agency; Kelowna General Hospital; University of British Columbia; Queen's University","funders":"National Institute for Health and Care Research; Cancer Research UK; Canadian Urological Association Scholarship Fund","keywords":"Medicine; Androgen deprivation therapy; Hazard ratio; Clinical endpoint; Statin; Prostate cancer; Internal medicine; Confidence interval; Post-hoc analysis; Statistical significance; Randomized controlled trial; Proportional hazards model; Urology; Oncology; Cancer","score_opus":0.01916286191612419,"score_gpt":0.23642679365351277,"score_spread":0.2172639317373886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313546112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819434,0.00023818052,0.00008991044,0.0006923786,0.00038778665,0.00012976873,0.000019451716,0.000008744373,0.00023942655],"genre_scores_gemma":[0.99582326,0.00040310292,0.000054081836,0.00233123,0.0012487295,0.0000035065996,0.00008491687,0.00001732882,0.00003382175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990542,0.0003531054,0.00018291982,0.00018801152,0.000068898735,0.0001528985],"domain_scores_gemma":[0.9996112,0.00008991675,0.00011620309,0.00009857349,0.00004406296,0.000040023362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002657798,0.00008155111,0.00010400308,0.000015044514,0.00006977886,0.00003178884,0.00008503373,0.000045651643,0.0000015940917],"category_scores_gemma":[0.00066583185,0.000064895896,0.000024416435,0.000044768967,0.000023701406,0.0000068136906,0.000072887124,0.000085439955,0.0000051282186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052145602,0.000009668422,0.9856927,0.0000010324867,0.000034066852,5.8106174e-8,0.00022540249,0.0000061243936,0.0019157823,0.00001799157,0.001032836,0.011012229],"study_design_scores_gemma":[0.00089206145,0.00015590976,0.79890245,3.7148172e-7,0.0000062187582,9.274532e-8,0.000011629271,0.0000063639723,0.00024338746,0.000009016707,0.19971499,0.000057506266],"about_ca_topic_score_codex":0.000009819577,"about_ca_topic_score_gemma":0.000019134817,"teacher_disagreement_score":0.19868214,"about_ca_system_score_codex":0.0000070996043,"about_ca_system_score_gemma":0.000012990748,"threshold_uncertainty_score":0.26463777},"labels":[],"label_agreement":null},{"id":"W2321561417","doi":"10.1016/j.eururo.2016.03.014","title":"Corrigendum re: “Suppression of Heat Shock Protein 27 Using OGX-427 Induces Endoplasmic Reticulum Stress and Potentiates Heat Shock Protein 90 Inhibitors to Delay Castrate-resistant Prostate Cancer” [Eur Urol 2014;66:145–55]","year":2016,"lang":"en","type":"erratum","venue":"European Urology","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Endoplasmic reticulum; Heat shock protein; Shock (circulatory); Prostate; Internal medicine; Endocrinology; Cancer research; Cancer; Cell biology; Biochemistry; Biology","score_opus":0.01666061293201372,"score_gpt":0.2645816625572847,"score_spread":0.247921049625271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321561417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737109,0.01088348,0.00016379196,0.0010781649,0.004554303,0.005483892,0.0017582144,0.000081856524,0.0022853864],"genre_scores_gemma":[0.95864713,0.0015235479,0.0003757455,0.00023085257,0.0023227546,0.00043594366,0.00080345245,0.00057329313,0.03508726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9904485,0.0026357407,0.0015558938,0.0025140545,0.0009194627,0.0019263782],"domain_scores_gemma":[0.9963942,0.000038662587,0.00047361376,0.0016231558,0.0006733032,0.0007970559],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0010741642,0.001310281,0.0012747449,0.0005719706,0.0003984436,0.00014597957,0.0012058931,0.0012198966,0.00020300961],"category_scores_gemma":[0.00052042265,0.0011079562,0.00029188764,0.00035824554,0.0007337619,0.000039984374,0.001910211,0.0017147852,0.000089342684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017164409,0.00017268975,0.0002179344,0.00073104986,0.00023791882,0.0005061558,0.0001645642,0.00022634049,0.9095111,0.000004526515,0.08585973,0.0006515395],"study_design_scores_gemma":[0.0016787313,0.0034070106,0.000245516,0.0015050906,0.00014446057,0.00016075693,0.000105359715,0.00020973339,0.8798738,0.000018205877,0.11129954,0.0013517935],"about_ca_topic_score_codex":0.0010001071,"about_ca_topic_score_gemma":0.0005532195,"teacher_disagreement_score":0.032801874,"about_ca_system_score_codex":0.00015110424,"about_ca_system_score_gemma":0.0010932275,"threshold_uncertainty_score":0.9999649},"labels":[],"label_agreement":null},{"id":"W2340210533","doi":"10.1016/j.eururo.2016.03.053","title":"The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging–Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging–Assisted TURBT in Primary Non–Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Narrow-band imaging; Urology; Prospective cohort study; Surgery; Endoscopy; Internal medicine; Cancer","score_opus":0.04879894981340178,"score_gpt":0.35394337775457774,"score_spread":0.30514442794117597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340210533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9469961,0.0001693776,0.000007068993,0.0060092406,0.0012439045,0.04069893,0.00022028394,0.000027637812,0.004627464],"genre_scores_gemma":[0.9963106,0.000089770976,0.000045609395,0.00018069106,0.0004940659,0.0025307268,0.000024614335,0.00004961742,0.00027429924],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9924762,0.0037436872,0.0017010415,0.0007194483,0.00082000816,0.000539591],"domain_scores_gemma":[0.9951169,0.0025621874,0.0008062356,0.0005304846,0.00083537115,0.0001488114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033907066,0.0003097969,0.0007946247,0.00011936984,0.0001912672,0.000018446532,0.00036251414,0.0001749716,0.0001116727],"category_scores_gemma":[0.0021231202,0.00016187855,0.0005428434,0.0003500598,0.0015622289,0.00009652663,0.00014667657,0.00073451,0.0000043774726],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9571465,0.0020201425,0.024472533,0.00008714432,0.00047047288,0.000024058012,0.0005770685,0.0000022817019,0.008343466,0.0000052296077,0.004212175,0.0026388771],"study_design_scores_gemma":[0.62151575,0.0047849454,0.36979574,0.000098112374,0.00027325365,0.0000055801015,0.00008171016,0.000015335241,0.0013375101,0.000008873009,0.001972151,0.000111032874],"about_ca_topic_score_codex":0.00006447976,"about_ca_topic_score_gemma":0.000113064474,"teacher_disagreement_score":0.3453232,"about_ca_system_score_codex":0.000119033524,"about_ca_system_score_gemma":0.00065249973,"threshold_uncertainty_score":0.66012156},"labels":[],"label_agreement":null},{"id":"W2344211686","doi":"10.1016/j.eururo.2016.02.038","title":"Reply from Authors re: Martin Spahn, Alan Dal Pra, Daniel Aebersold, Bertrand Tombal. Radiation Therapy Versus Radical Prostatectomy: A Never-ending Discussion. Eur Urol 2016;70:31–2","year":2016,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostatectomy; General surgery; Radiation therapy; Urology; Prostate cancer; Surgery; Internal medicine","score_opus":0.023819179430264528,"score_gpt":0.2664925882828171,"score_spread":0.24267340885255256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344211686","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012926696,0.0038792319,0.00011058111,0.9640562,0.0046124333,0.002742668,0.00085066096,0.00043411466,0.010387399],"genre_scores_gemma":[0.04346173,0.007186842,0.00041876567,0.8817846,0.022641074,0.0005371161,0.008963055,0.00097508775,0.03403168],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936943,0.0015097117,0.0010298511,0.0018576335,0.00065496145,0.0012535531],"domain_scores_gemma":[0.9967701,0.0006119575,0.0007210253,0.0013567578,0.0001011487,0.00043902555],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071726757,0.00096283894,0.0011967598,0.00033030284,0.00024247226,0.00010257184,0.00045415873,0.0006383236,0.0008723936],"category_scores_gemma":[0.0003115895,0.00058579334,0.000415126,0.0002196432,0.00035141208,0.00024374378,0.0001929666,0.0020367487,0.0005774941],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004937759,0.00018296219,0.0030690779,0.000041793177,0.00086912804,0.0063081565,0.00067177985,0.0000016519491,0.00036988017,0.000012079876,0.95985216,0.023683587],"study_design_scores_gemma":[0.01801717,0.0033860034,0.01023729,0.00021841712,0.0006021754,0.00007705118,0.000015417074,0.000023442059,0.0002364566,0.00007703181,0.96645105,0.000658493],"about_ca_topic_score_codex":0.00015844344,"about_ca_topic_score_gemma":0.000009427907,"teacher_disagreement_score":0.08227157,"about_ca_system_score_codex":0.00043984017,"about_ca_system_score_gemma":0.00040211988,"threshold_uncertainty_score":0.99965936},"labels":[],"label_agreement":null},{"id":"W2345204866","doi":"10.1016/j.eururo.2016.04.016","title":"Reply to Erik Rud and Eduard Baco's Letter to the Editor re: Re: Jeffrey C. Weinreb, Jelle O. Barentsz, Peter L. Choyke, et al. PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2. Eur Urol 2016;69:16–40","year":2016,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"National Institutes of Health","keywords":"Medicine; Protocol (science); Standardization; Guideline; Medical physics; Prostate; Nuclear medicine; Computer science; Internal medicine; Pathology; Alternative medicine","score_opus":0.020921243720357172,"score_gpt":0.2823011488877211,"score_spread":0.2613799051673639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345204866","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016724557,0.0037346464,0.00013585268,0.9787494,0.0075708777,0.0024394046,0.000774039,0.00019801487,0.004725291],"genre_scores_gemma":[0.007568442,0.0011473721,0.00031173145,0.9572818,0.024898855,0.00016541484,0.0013869812,0.00035817435,0.0068812096],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99299335,0.0011584709,0.001507414,0.0025540388,0.00064785517,0.0011388473],"domain_scores_gemma":[0.9945472,0.0003851679,0.001182431,0.0031904157,0.00024803347,0.0004467884],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029023984,0.0008587277,0.0010933427,0.00030600047,0.00032558764,0.00022543798,0.00071488845,0.0001950343,0.00013389612],"category_scores_gemma":[0.0008886827,0.0005606383,0.00013657256,0.0001700026,0.00019932739,0.00028033066,0.0021251328,0.0014792057,0.00077154493],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048357475,0.00003592634,0.0027528247,0.000275194,0.00023118767,0.004790412,0.000312038,0.0000011496757,0.0002377411,7.698056e-7,0.987802,0.0030771832],"study_design_scores_gemma":[0.0020348725,0.00093313225,0.0050041834,0.0010197617,0.00052446325,0.0006542646,0.000036245885,0.00001776421,0.000043809974,0.0000018235286,0.9891722,0.00055744854],"about_ca_topic_score_codex":0.00013042752,"about_ca_topic_score_gemma":0.000010484412,"teacher_disagreement_score":0.021467598,"about_ca_system_score_codex":0.00024598802,"about_ca_system_score_gemma":0.00015763333,"threshold_uncertainty_score":0.9996845},"labels":[],"label_agreement":null},{"id":"W2345642268","doi":"10.1016/j.eururo.2015.09.036","title":"Reply from Authors re: Julia Verne, Luke Hounsome, Roger Kockelbergh, Jem Rashbass. Improving Outcomes from Prostate Cancer: Unlocking the Treasure Trove of Information in Cancer Registries. Eur Urol 2016;69:1013–4","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"World Health Organization","keywords":"Treasure; Medicine; Prostate cancer; Miller; Art history; Cancer; Archaeology; Art; History; Internal medicine","score_opus":0.023632388457321508,"score_gpt":0.25560234340262145,"score_spread":0.23196995494529993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345642268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49390274,0.0135814585,0.00021452659,0.4706725,0.007304566,0.0028205598,0.0025055401,0.00058329577,0.0084148105],"genre_scores_gemma":[0.708156,0.0008076045,0.00014150291,0.27811217,0.0048868484,0.00026921477,0.0017526095,0.00031855845,0.005555489],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950116,0.0011034389,0.0014048504,0.00089199154,0.00085319637,0.0007349221],"domain_scores_gemma":[0.99594116,0.00051994505,0.0016871558,0.0011990502,0.0004900712,0.00016263779],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010850126,0.0007067,0.0012597833,0.00042874232,0.00014026335,0.000098550765,0.0005538487,0.00057259365,0.00019921806],"category_scores_gemma":[0.0011878235,0.00054240925,0.0002968593,0.0005254422,0.00027673255,0.00035386602,0.00024882957,0.003331765,0.00007228001],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061329566,0.00004404768,0.065023504,0.00016201231,0.00062778103,0.00039991617,0.004433446,0.00075588364,0.00016687717,0.0000012264942,0.8768619,0.045390483],"study_design_scores_gemma":[0.0043606805,0.0012834625,0.09830067,0.0002868498,0.00080807426,0.000027047636,0.00015442599,0.00084050646,0.00027143798,0.000070694165,0.89298844,0.0006077273],"about_ca_topic_score_codex":0.059361964,"about_ca_topic_score_gemma":0.0032621003,"teacher_disagreement_score":0.21425323,"about_ca_system_score_codex":0.0006551084,"about_ca_system_score_gemma":0.0009126782,"threshold_uncertainty_score":0.99970275},"labels":[],"label_agreement":null},{"id":"W2356434884","doi":"10.1016/j.eururo.2016.04.028","title":"SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; BC Cancer Agency; Simon Fraser University; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Cancer research; Medicine; Androgen receptor; Adenocarcinoma; Prostate; RNA splicing; Biology; LNCaP; Bioinformatics; Cancer; RNA; Gene; Internal medicine; Genetics","score_opus":0.02049081329495721,"score_gpt":0.2548148578924346,"score_spread":0.23432404459747735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2356434884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893963,0.00061079045,0.00036035062,0.0072636483,0.00012743348,0.00040677717,0.000050052393,0.000063857646,0.0017208377],"genre_scores_gemma":[0.99715155,0.00047830667,0.0000381144,0.00025182782,0.000112704685,0.0000118796015,0.000092959715,0.00003987013,0.0018227804],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986789,0.00030665137,0.0002633582,0.00029658194,0.00016576485,0.0002887439],"domain_scores_gemma":[0.9994331,0.000060048158,0.00008701784,0.00022203957,0.00008771556,0.00011009403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010820872,0.0001376185,0.00021455988,0.00014211916,0.00004321398,0.0000054208485,0.000057988127,0.0000227979,0.0003747721],"category_scores_gemma":[0.00003435274,0.0000848479,0.00007895927,0.00011165232,0.00017857188,0.000073386575,0.000040496037,0.000103385464,0.00016423689],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024002374,0.0003668584,0.08536275,0.00010488082,0.0001647896,0.00044957534,0.0005714186,0.0000021839683,0.8802516,0.000734068,0.0009933435,0.028598314],"study_design_scores_gemma":[0.011793715,0.0046047643,0.5632751,0.000092940325,0.00013919611,0.00025539967,0.000062591775,0.000016275206,0.4058028,0.00046633085,0.013263934,0.00022695493],"about_ca_topic_score_codex":0.0000029130024,"about_ca_topic_score_gemma":0.0000021041237,"teacher_disagreement_score":0.47791237,"about_ca_system_score_codex":0.00003373429,"about_ca_system_score_gemma":0.000051445608,"threshold_uncertainty_score":0.41034916},"labels":[],"label_agreement":null},{"id":"W2362741058","doi":"10.1016/j.eururo.2016.04.035","title":"Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Skin cancer; Hazard ratio; Internal medicine; Melanoma; Basal cell carcinoma; Proportional hazards model; Cohort; Cancer; Cohort study; Pill; Confidence interval; Oncology; Basal cell; Pharmacology","score_opus":0.004820583826353902,"score_gpt":0.2061890983445643,"score_spread":0.20136851451821042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2362741058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99438894,0.0020542478,0.000301055,0.0008578201,0.00042141372,0.00008541948,0.000012790295,0.0000076167835,0.0018706796],"genre_scores_gemma":[0.996529,0.0015050645,0.00002573627,0.00047655843,0.00019324821,0.0000034212298,0.0000058411742,0.0000142057515,0.0012469128],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.999185,0.00033959083,0.00015020235,0.00017714013,0.000043673048,0.00010435471],"domain_scores_gemma":[0.99955493,0.000047703157,0.000114463204,0.00019911818,0.000051731036,0.00003202857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028314308,0.00008537808,0.000097124524,0.000018312601,0.000054054675,0.0000045678967,0.00007534354,0.000042047057,0.000043233922],"category_scores_gemma":[0.000125549,0.000042874915,0.00004176517,0.000037183123,0.000323572,0.0000024301073,0.00009137003,0.00004021276,0.00001490283],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007150252,0.00011366107,0.19226862,0.00002718799,0.0005829627,0.000015332142,0.0009010902,0.00012740343,0.6107588,0.0016346049,0.028094066,0.15832601],"study_design_scores_gemma":[0.006602013,0.0008531809,0.25751242,0.000018504794,0.00014397368,0.000049496415,0.000046937865,0.00004623334,0.18829344,0.00022953072,0.5459078,0.0002964693],"about_ca_topic_score_codex":0.000026481674,"about_ca_topic_score_gemma":0.000032241023,"teacher_disagreement_score":0.51781374,"about_ca_system_score_codex":0.000003101812,"about_ca_system_score_gemma":0.000014691351,"threshold_uncertainty_score":0.17483883},"labels":[],"label_agreement":null},{"id":"W2400611717","doi":"10.1016/j.eururo.2016.05.018","title":"Reply to Dino Papeš, Ana Jerončić's Letter to the Editor re: Giuseppe Magistro, Florian M.E. Wagenlehner, Magnus Grabe, Wolfgang Weidner, Christian G. Stief, J. Curtis Nickel. Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Eur Urol 2016;69:286–97","year":2016,"lang":"en","type":"letter","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Humanities; Theology; Philosophy","score_opus":0.020122680059797986,"score_gpt":0.25651453561633125,"score_spread":0.23639185555653328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400611717","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060703635,0.016051952,0.00107126,0.94182444,0.0100749945,0.0073632817,0.0012485615,0.00038033436,0.021378137],"genre_scores_gemma":[0.025078515,0.0031586518,0.00037143685,0.7099864,0.08428354,0.00084464304,0.0023488905,0.0011740925,0.17275383],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98572516,0.004868921,0.0020475772,0.0027279835,0.0017649521,0.002865421],"domain_scores_gemma":[0.9932528,0.00070282223,0.0007426349,0.004011968,0.00041065126,0.00087912445],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.003965987,0.0015102781,0.0018203931,0.0009771375,0.00040186188,0.00016100428,0.0022288712,0.0005975642,0.003212726],"category_scores_gemma":[0.0003503849,0.0011206953,0.0005799385,0.00088944373,0.00077697035,0.00022619714,0.0016072338,0.003927076,0.0072774976],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008355607,0.00016521272,0.00018818915,0.0020832466,0.00096551597,0.036654808,0.0003042073,0.000009329019,0.00023052782,0.000009843612,0.9361215,0.022432024],"study_design_scores_gemma":[0.0036076072,0.011944077,0.002454198,0.0010351667,0.0004781567,0.00055893033,0.000044288783,0.000023208442,0.000042283336,0.000021472299,0.9786872,0.0011034037],"about_ca_topic_score_codex":0.00037467096,"about_ca_topic_score_gemma":0.000052582025,"teacher_disagreement_score":0.23183803,"about_ca_system_score_codex":0.00068175944,"about_ca_system_score_gemma":0.00092295883,"threshold_uncertainty_score":0.9997646},"labels":[],"label_agreement":null},{"id":"W2408205930","doi":"10.1016/j.eururo.2006.01.044","title":"The Motion: There is a Role for Chronic Treatment with PDE5-Inhibitors","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Medicine; Pharmacology","score_opus":0.008684280269422022,"score_gpt":0.24481935697594795,"score_spread":0.23613507670652592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408205930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90518236,0.0078024804,0.00032385066,0.018210068,0.00029098496,0.0011768446,0.000018925082,0.00015220854,0.06684225],"genre_scores_gemma":[0.98688084,0.000112570815,0.00007635901,0.0011358284,0.0007735193,0.000060020764,0.000023466184,0.000030597952,0.010906795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999152,0.00013139487,0.00013537203,0.00023593366,0.000060457405,0.00028483526],"domain_scores_gemma":[0.99952537,0.0001023846,0.000056793946,0.00022594187,0.00003480581,0.000054726806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011500595,0.00014918522,0.00015578662,0.000026212538,0.0002569535,0.000008557027,0.00006733446,0.000038940707,0.00013108873],"category_scores_gemma":[0.000003833628,0.00007957526,0.00008533015,0.000047708698,0.00013544454,0.000017628974,0.000017303802,0.00008021363,0.00023366477],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018064113,0.0098455455,0.22891992,0.00016531395,0.0055985353,0.0053095557,0.0034228533,0.0007856518,0.029986376,0.010214835,0.27819562,0.4094917],"study_design_scores_gemma":[0.0069629312,0.00875104,0.06302031,0.00000589651,0.00053230254,0.00023830953,0.000031904674,0.00022693069,0.0068962486,0.00020456093,0.9130079,0.00012166139],"about_ca_topic_score_codex":0.000018946956,"about_ca_topic_score_gemma":0.00006257687,"teacher_disagreement_score":0.6348123,"about_ca_system_score_codex":0.00011512725,"about_ca_system_score_gemma":0.00005852856,"threshold_uncertainty_score":0.32449847},"labels":[],"label_agreement":null},{"id":"W2412608229","doi":"10.1016/j.eururo.2016.05.044","title":"Re: Jennifer R. Rider, Kathryn M. Wilson, Jennifer A. Sinnott, Rachel S. Kelly, Lorelei A. Muccia, Edward L. Giovannucci. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. Eur Urol 2016;70:974–82","year":2016,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Prostate cancer; Ejaculation; Gynecology; Gerontology; Cancer; Internal medicine","score_opus":0.012769768834632291,"score_gpt":0.24349143834912323,"score_spread":0.23072166951449094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412608229","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41644335,0.024892937,0.0002163145,0.43374765,0.002350257,0.0076156203,0.10234369,0.00058603496,0.011804152],"genre_scores_gemma":[0.52859837,0.06502482,0.0042933426,0.25581992,0.013820459,0.0012825661,0.110381745,0.00217049,0.018608293],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937566,0.0011771342,0.001645207,0.0016866536,0.000783583,0.0009508052],"domain_scores_gemma":[0.9948258,0.00046999854,0.0020429865,0.0012655287,0.001077541,0.00031818255],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000724197,0.0009872328,0.0015588062,0.00050015305,0.00016372291,0.000033110766,0.00036726717,0.00062717946,0.001041453],"category_scores_gemma":[0.00030156437,0.0007179822,0.00027988854,0.0003672287,0.00079140445,0.0003006157,0.00016226937,0.0014437697,0.00009400103],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005551411,0.00033065802,0.033615667,0.00028358307,0.0019558303,0.0024791323,0.00054648536,0.000028201583,0.0002511662,0.000017472461,0.94307405,0.011866351],"study_design_scores_gemma":[0.017236432,0.006967092,0.10794393,0.0008652945,0.0029123605,0.0002727342,0.000025359876,0.000040687082,0.00061128836,0.00028470514,0.8618821,0.0009580063],"about_ca_topic_score_codex":0.0005333901,"about_ca_topic_score_gemma":0.0002338302,"teacher_disagreement_score":0.17792772,"about_ca_system_score_codex":0.00020417065,"about_ca_system_score_gemma":0.0006058092,"threshold_uncertainty_score":0.99987173},"labels":[],"label_agreement":null},{"id":"W2419284359","doi":"10.1016/j.eururo.2016.03.001","title":"Retraction notice to “Narrowing the Cystoscopy Gap”","year":2016,"lang":"en","type":"retraction","venue":"European Urology","topic":"Ureteral procedures and complications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cystoscopy; Notice; Urology; General surgery; Internal medicine; Urinary system","score_opus":0.03930216344939112,"score_gpt":0.31165839255588645,"score_spread":0.2723562291064953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419284359","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030687805,0.0024191232,0.004201758,0.105135925,0.009476666,0.0012840845,0.000054626824,0.000380481,0.87397856],"genre_scores_gemma":[0.65693915,0.0019592403,0.0008078365,0.05508489,0.026408244,0.00009989359,0.0004083873,0.00046879204,0.25782356],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982967,0.0003206508,0.0003340901,0.00048168417,0.000245518,0.00032135227],"domain_scores_gemma":[0.9985915,0.0002098103,0.00019303658,0.0007076584,0.00015018013,0.0001478453],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045935521,0.00023944941,0.00029367342,0.00016548637,0.00021931365,0.000030867297,0.0002617605,0.0003004646,0.00048693153],"category_scores_gemma":[0.000414061,0.00014868072,0.00015113341,0.00017625041,0.000064801796,0.00005493178,0.00008989273,0.0012507098,0.0049386728],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003610377,0.000076705175,0.000088194116,0.0001069834,0.00016491977,0.00010673521,0.00021066243,0.000009034155,0.0064352304,0.00038133006,0.9681805,0.023878686],"study_design_scores_gemma":[0.00023967044,0.00055438565,0.006870478,0.00008992014,0.00026929358,0.0006421943,0.00000989817,0.000015459544,0.000029190738,0.0000465924,0.9910757,0.00015721492],"about_ca_topic_score_codex":0.000014234245,"about_ca_topic_score_gemma":0.0000054617312,"teacher_disagreement_score":0.6538704,"about_ca_system_score_codex":0.000090226466,"about_ca_system_score_gemma":0.000089318244,"threshold_uncertainty_score":0.9958361},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2433976232","doi":"10.1016/j.eururo.2016.05.049","title":"Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; University Health Network; University of Toronto; Sunnybrook Health Science Centre; Queen's University","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Carcinoma; Internal medicine; Targeted therapy; Database; Cancer","score_opus":0.04153451134003557,"score_gpt":0.25925405271735386,"score_spread":0.21771954137731828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2433976232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739584,0.0025295636,0.00039978832,0.0073353876,0.0005182772,0.00085294177,0.0011173398,0.00007955722,0.013208792],"genre_scores_gemma":[0.99081796,0.00017808311,0.0017392647,0.0030475357,0.00045330203,0.000037237183,0.0011356456,0.00011706276,0.0024738808],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.994448,0.0018336604,0.0012294846,0.0011279248,0.0006299338,0.000731011],"domain_scores_gemma":[0.9959467,0.0016603463,0.000506257,0.0013866947,0.00020136804,0.0002986534],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014383366,0.0005620149,0.000704049,0.00028985922,0.00010912473,0.00003888206,0.0007570499,0.00006342695,0.00071984757],"category_scores_gemma":[0.00048760526,0.0003167608,0.00024779706,0.00028300597,0.00036499175,0.00015129788,0.00032550207,0.00057288184,0.00080518675],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019641312,0.002588569,0.06913877,0.000050552644,0.0006618357,0.024831139,0.0031413047,0.00015243008,0.8303594,0.00015052644,0.044348277,0.004935864],"study_design_scores_gemma":[0.056999132,0.0055840313,0.6350083,0.000073543335,0.0010001307,0.00059952785,0.0003318479,0.0007234147,0.2539233,0.0002194406,0.044598795,0.0009385978],"about_ca_topic_score_codex":0.0006911764,"about_ca_topic_score_gemma":0.00014728316,"teacher_disagreement_score":0.5764361,"about_ca_system_score_codex":0.00018392847,"about_ca_system_score_gemma":0.00028284173,"threshold_uncertainty_score":0.9999728},"labels":[],"label_agreement":null},{"id":"W2439583849","doi":"10.1016/j.eururo.2016.06.007","title":"A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":397,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Prostate cancer; Discontinuation; Watchful waiting; Prostatectomy; Biopsy; Internal medicine; Gynecology; Concordance; Proportional hazards model; Prostate-specific antigen; Oncology; Cancer","score_opus":0.07614278233931378,"score_gpt":0.3741801575520668,"score_spread":0.29803737521275303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2439583849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854991,0.000053831016,0.000006226267,0.012178766,0.00006382851,0.0018415058,0.00005289063,0.0000045679967,0.00029931252],"genre_scores_gemma":[0.9990113,0.00004408486,0.000026465368,0.0007334135,0.000029147322,0.0001314452,0.000003841382,0.000012986736,0.000007357161],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976907,0.0015646239,0.00019976536,0.0002552375,0.00015763895,0.00013205469],"domain_scores_gemma":[0.9991686,0.00020476758,0.00009779278,0.00037096944,0.000105440035,0.000052449737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085279485,0.00010716413,0.00023287274,0.00006108192,0.000024681953,0.0000037499383,0.00009932663,0.000015814558,0.000033983473],"category_scores_gemma":[0.00015942767,0.000047990867,0.000026238107,0.00013583618,0.000036880057,0.000031125368,0.00005803036,0.00003784637,0.0000057249513],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037078045,0.0027366048,0.4005049,0.000009420817,0.0003633069,0.000034631783,0.05507815,0.000015368143,0.0147575205,0.00005447924,0.00025506175,0.52248275],"study_design_scores_gemma":[0.004206673,0.0053519895,0.9832558,0.000020134861,0.00011643006,0.000006491651,0.00065877987,0.000006322893,0.005015173,0.000043419288,0.0012721556,0.000046641977],"about_ca_topic_score_codex":0.00008850086,"about_ca_topic_score_gemma":0.0008632883,"teacher_disagreement_score":0.5827509,"about_ca_system_score_codex":0.00011844058,"about_ca_system_score_gemma":0.00005279458,"threshold_uncertainty_score":0.19570108},"labels":[],"label_agreement":null},{"id":"W2472429093","doi":"10.1016/j.eururo.2016.06.033","title":"Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Astellas Pharma; National Cancer Institute; Celgene","keywords":"Medicine; Abiraterone acetate; Docetaxel; Prostate cancer; Discontinuation; Prednisone; Post-hoc analysis; Internal medicine; Chemotherapy; Oncology; Enzalutamide; Placebo; Cancer; Prostate-specific antigen; Surgery; Urology; Androgen deprivation therapy; Pathology; Androgen receptor","score_opus":0.01391030899297009,"score_gpt":0.26569581402143905,"score_spread":0.25178550502846897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472429093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641484,0.00055403804,0.000011284689,0.0017797876,0.000021606964,0.0007237484,0.00041632177,0.000014141099,0.000064207044],"genre_scores_gemma":[0.99770635,0.0012991243,0.000051500694,0.00022972452,0.00001325842,0.00008054562,0.000114491006,0.000035713456,0.0004692726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856937,0.00021568152,0.0003184193,0.00037447512,0.00019576875,0.00032628587],"domain_scores_gemma":[0.99930334,0.000045863737,0.00012744154,0.00025835878,0.00014496839,0.000120001925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013846064,0.000211287,0.00046926818,0.00031569626,0.000026243039,0.000011276698,0.00005183157,0.000021925554,0.00023825925],"category_scores_gemma":[0.0000060119924,0.0001102975,0.00005900752,0.0002564505,0.00017524126,0.000066029854,0.000022002696,0.000058048103,0.0000077909635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017954871,0.00048204622,0.9525867,0.000039516424,0.0018968703,0.00038024574,0.0013306192,0.000015001865,0.004598533,0.0000032608161,0.0000064255396,0.020705903],"study_design_scores_gemma":[0.013970571,0.00639363,0.9774876,0.000045048768,0.0007982741,0.000002712408,0.000034850214,0.000015940395,0.00088247634,0.0000017308822,0.00025278993,0.00011436228],"about_ca_topic_score_codex":0.0002801519,"about_ca_topic_score_gemma":0.0013275314,"teacher_disagreement_score":0.024900906,"about_ca_system_score_codex":0.00016792171,"about_ca_system_score_gemma":0.000087284716,"threshold_uncertainty_score":0.44978017},"labels":[],"label_agreement":null},{"id":"W2475267864","doi":"10.1016/j.eururo.2016.06.011","title":"Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations—A Report of a European School of Oncology Task Force","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":260,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Institute for Health and Care Research","keywords":"Medicine; Prostate cancer; Checklist; Magnetic resonance imaging; Medical physics; Cohort; Prostate; Radiology; Cancer; Internal medicine","score_opus":0.02041001119236186,"score_gpt":0.3106884331128319,"score_spread":0.29027842192047004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2475267864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8222546,0.00756975,0.00023807766,0.067592904,0.00061951,0.0045473017,0.00042343079,0.00009056649,0.09666385],"genre_scores_gemma":[0.9954718,0.0017438573,0.00032372406,0.000569085,0.00010794689,0.00020197379,0.000028108292,0.000053793152,0.0014997423],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970902,0.0006564248,0.0013333784,0.00047559044,0.00012404418,0.00032032453],"domain_scores_gemma":[0.9968005,0.0006585863,0.0016897122,0.0005361723,0.00023988448,0.00007513596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021967227,0.00017024617,0.00046399803,0.00010951864,0.000051929324,0.000004300571,0.00014558557,0.000023832481,0.000058386315],"category_scores_gemma":[0.0022875222,0.00010395866,0.00009389446,0.00015707331,0.00017190207,0.000051611303,0.00009300787,0.00013996007,0.000010105155],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021518006,0.00028715728,0.2937127,0.000043515403,0.000042717314,0.0007632091,0.0006526977,0.000015667316,0.0066788956,0.000060188322,0.006689802,0.6889016],"study_design_scores_gemma":[0.004665344,0.0027410272,0.7658758,0.00032549346,0.000065445965,0.00024201721,0.00010232006,0.00003176097,0.0039245547,0.00013129826,0.22175813,0.00013678118],"about_ca_topic_score_codex":0.00008429874,"about_ca_topic_score_gemma":0.00008184275,"teacher_disagreement_score":0.68876487,"about_ca_system_score_codex":0.00020817165,"about_ca_system_score_gemma":0.00020912381,"threshold_uncertainty_score":0.4239311},"labels":[],"label_agreement":null},{"id":"W2478136527","doi":"10.1016/j.eururo.2016.07.014","title":"Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel","year":2016,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":318,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Systematic review; Urology; Urothelial carcinoma; Cochrane Library; Nephrectomy; Kidney cancer; MEDLINE; Bladder cancer; Meta-analysis; Surgery; Cancer; Kidney; Internal medicine","score_opus":0.13376593551474786,"score_gpt":0.3754905467695089,"score_spread":0.24172461125476102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2478136527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000056792167,0.98548895,0.000053379572,0.0038794084,0.0019405059,0.0065970877,0.0008226487,0.00006368429,0.0010975357],"genre_scores_gemma":[0.00048650647,0.9850427,0.0000650998,0.010079563,0.0011769544,0.0016526371,0.00023052197,0.0002423256,0.001023711],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939718,0.0016565467,0.0023575027,0.00086987205,0.0004098335,0.000734408],"domain_scores_gemma":[0.9923939,0.0043185344,0.0014826738,0.0011073678,0.0003083351,0.00038920308],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014536837,0.00092756306,0.0058737807,0.00019259883,0.00013606375,0.000021102172,0.00065316487,0.00032138693,0.0003465321],"category_scores_gemma":[0.0059004687,0.00045561523,0.002021388,0.00023335438,0.0003264897,0.00006054288,0.00017526472,0.0004999134,0.00014535456],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044293917,0.00038452665,0.00041847155,0.6307964,0.0045274957,0.00029625185,0.00011987676,1.4681873e-7,0.000012813775,0.000011139661,0.27843437,0.08455559],"study_design_scores_gemma":[0.0031768973,0.0008117575,0.00015837714,0.09784629,0.02017152,0.0002584273,0.00000951528,0.0000012182269,0.0000038520975,0.0000027425594,0.8770903,0.0004691217],"about_ca_topic_score_codex":0.000113299306,"about_ca_topic_score_gemma":0.0000085341435,"teacher_disagreement_score":0.5986559,"about_ca_system_score_codex":0.00024866618,"about_ca_system_score_gemma":0.0021446864,"threshold_uncertainty_score":0.99978954},"labels":[],"label_agreement":null},{"id":"W2486398733","doi":"10.1016/j.eururo.2016.07.019","title":"Re: Anthony Zietman, Joseph Smith, Eric Klein, Michael Droller, Prokar Dasgupta, James Catto. Describing the Grade of Prostate Cancer: Consistent Use of Contemporary Terminology Is Now Required. Eur Urol 2016;70:1","year":2016,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Terminology; Prostate cancer; Prostate disease; Cancer; Gynecology; Internal medicine; Philosophy; Linguistics","score_opus":0.09253707808052347,"score_gpt":0.27147201117239433,"score_spread":0.17893493309187086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2486398733","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06952102,0.05564259,0.00001562366,0.8625852,0.002130816,0.004715036,0.0027553586,0.00017975934,0.0024545863],"genre_scores_gemma":[0.28640532,0.06173553,0.00028109533,0.6290526,0.0031325894,0.00078434445,0.00069096265,0.00075118826,0.01716639],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99315345,0.0016964211,0.0018897639,0.0015204711,0.0005508287,0.0011890723],"domain_scores_gemma":[0.9942127,0.0008543925,0.0021619117,0.002055104,0.00050793187,0.00020795478],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006309828,0.0010430659,0.002188971,0.00045293072,0.0001758152,0.000036616097,0.0007212025,0.0005673241,0.00017087435],"category_scores_gemma":[0.00018659559,0.00066384,0.00061731576,0.0002514324,0.001999162,0.00017384536,0.00051793735,0.0014862132,0.00013131762],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008610236,0.00030168518,0.021313718,0.00073963864,0.0017319401,0.004578309,0.0013538505,0.0000024330404,0.0013451063,0.000008019375,0.96146584,0.006298447],"study_design_scores_gemma":[0.0049221036,0.003100381,0.0048013683,0.0012728617,0.0012398598,0.0003559704,0.00006820035,0.000011322047,0.004633261,0.000032777665,0.9789756,0.00058629893],"about_ca_topic_score_codex":0.0003984155,"about_ca_topic_score_gemma":0.000030576535,"teacher_disagreement_score":0.23353265,"about_ca_system_score_codex":0.00021184278,"about_ca_system_score_gemma":0.0009990282,"threshold_uncertainty_score":0.9995813},"labels":[],"label_agreement":null},{"id":"W2487276065","doi":"10.1016/j.eururo.2016.07.012","title":"Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Prostate cancer; Medicine; Oncology; Prostatectomy; Proportional hazards model; Internal medicine; Cancer; Prostate; Biochemical recurrence; Clinical endpoint; Clinical significance; Metastasis; Clinical trial","score_opus":0.012250132710306774,"score_gpt":0.2650405619120201,"score_spread":0.2527904292017133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487276065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9714603,0.00073211174,0.02479127,0.0014540901,0.000167024,0.0004010565,0.00016372603,0.000038956714,0.00079145393],"genre_scores_gemma":[0.9957843,0.0002959952,0.00052817405,0.0006174426,0.00006386634,0.000059385166,0.000082898965,0.00004671435,0.002521263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979856,0.00043780488,0.00022009715,0.00063439156,0.00024220534,0.00047988739],"domain_scores_gemma":[0.99925196,0.000033155648,0.00011770392,0.00037762377,0.00010613646,0.00011341655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003664014,0.00023632382,0.00027886636,0.00021700698,0.000086469045,0.000021099388,0.00030122558,0.00011477729,0.00013916675],"category_scores_gemma":[0.00015845938,0.00014662118,0.00013668441,0.00023657229,0.00017176858,0.000009121825,0.00023990675,0.00017569108,0.000047249297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035459702,0.00016006338,0.076334566,0.0000067285764,0.00046217017,0.0001445133,0.00004855636,0.0013924764,0.9190983,0.000011787568,0.00030379745,0.0016824533],"study_design_scores_gemma":[0.008448037,0.0007938935,0.22892997,0.000060206774,0.0002887492,0.00003250205,0.000037414953,0.00042770393,0.7373447,0.000017511515,0.02280306,0.0008162516],"about_ca_topic_score_codex":0.00005704638,"about_ca_topic_score_gemma":0.001027319,"teacher_disagreement_score":0.18175359,"about_ca_system_score_codex":0.00006962559,"about_ca_system_score_gemma":0.00013123233,"threshold_uncertainty_score":0.59790385},"labels":[],"label_agreement":null},{"id":"W2489425084","doi":"10.1016/j.eururo.2016.07.032","title":"Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":419,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Enzalutamide; Prostate cancer; Oncology; Chemotherapy; Internal medicine; Docetaxel; Urology; Gynecology; Cancer; Androgen receptor","score_opus":0.025524197897897706,"score_gpt":0.33593789526287937,"score_spread":0.31041369736498164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2489425084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931764,0.00047145082,0.000017118438,0.0028918115,0.000019593685,0.001207122,0.00005998406,0.000017176832,0.0021393378],"genre_scores_gemma":[0.99655616,0.00020563269,0.000033102406,0.00015780797,0.000019496063,0.000071964765,0.000008721425,0.000027744556,0.0029193852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998184,0.00059373956,0.0003362625,0.0003344332,0.00027146837,0.00028004675],"domain_scores_gemma":[0.99912375,0.000106286345,0.0001569533,0.000433597,0.000107436965,0.000072002236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004982217,0.00015431941,0.0004039917,0.0002481921,0.000045790614,0.000007695868,0.00015073633,0.000014614692,0.00022430018],"category_scores_gemma":[0.000044461158,0.00006808287,0.00007979196,0.000757512,0.0002110637,0.000046387442,0.000042319673,0.00011440485,0.0000069569096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029369986,0.006239229,0.6577779,0.00011446989,0.011840619,0.0016348419,0.013899769,0.00024792395,0.2118217,0.000075497985,0.0005563786,0.06642164],"study_design_scores_gemma":[0.023239616,0.0044839326,0.96317035,0.000044198146,0.0022590314,0.000010286318,0.00058552285,0.00015877481,0.005024325,0.000017760025,0.00087639067,0.00012983516],"about_ca_topic_score_codex":0.00016384576,"about_ca_topic_score_gemma":0.000669256,"teacher_disagreement_score":0.30539238,"about_ca_system_score_codex":0.000091707785,"about_ca_system_score_gemma":0.00018567947,"threshold_uncertainty_score":0.27763388},"labels":[],"label_agreement":null},{"id":"W2495059596","doi":"10.1016/j.eururo.2016.07.027","title":"Impact of Enzalutamide Compared with Bicalutamide on Quality of Life in Men with Metastatic Castration-resistant Prostate Cancer: Additional Analyses from the TERRAIN Randomised Clinical Trial","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Queen's University; Health Sciences Centre","funders":"","keywords":"Medicine; Enzalutamide; Hazard ratio; Prostate cancer; Confidence interval; Bicalutamide; Internal medicine; Quality of life (healthcare); Oncology; Urology; Cancer; Androgen receptor","score_opus":0.16597122953671442,"score_gpt":0.44820777346541885,"score_spread":0.28223654392870445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2495059596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937417,0.00017042967,0.00003393916,0.0017807616,0.000020584072,0.0012158373,0.0021529535,0.000011973765,0.0008718219],"genre_scores_gemma":[0.9990139,0.000097714976,0.00013393108,0.00015404909,0.000108468776,0.00007660749,0.00027192655,0.000023008204,0.00012038929],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99558866,0.0025249189,0.0009121341,0.0003335536,0.00039008097,0.00025067784],"domain_scores_gemma":[0.99515516,0.0037295453,0.000475332,0.00034428766,0.00015323999,0.00014243361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012571111,0.00018208496,0.000808423,0.000101382204,0.00003680685,0.000006844133,0.00013993408,0.00002878556,0.00085967046],"category_scores_gemma":[0.00088698394,0.00007028948,0.00016676683,0.00020026142,0.00068707985,0.000041324998,0.00002680455,0.00019788204,0.0000073919846],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8856599,0.0007946288,0.099255644,0.000017658647,0.001621158,0.00010982045,0.00036542627,0.00017290028,0.009073781,0.000015210922,0.0018999759,0.001013941],"study_design_scores_gemma":[0.26956984,0.0075606117,0.7219595,0.000115323906,0.00021649024,0.0000023694936,0.00007931839,0.000045619126,0.00022582767,0.000029018824,0.000109069326,0.00008702961],"about_ca_topic_score_codex":0.0012630129,"about_ca_topic_score_gemma":0.0007596666,"teacher_disagreement_score":0.62270385,"about_ca_system_score_codex":0.00007797938,"about_ca_system_score_gemma":0.00080799725,"threshold_uncertainty_score":0.9412789},"labels":[],"label_agreement":null},{"id":"W2507534879","doi":"10.1016/j.eururo.2016.08.022","title":"Reply to Mieke Van Hemelrijck, Hans Garmo, Jan Adolfsson, and Pär Stattin's Letter to the Editor re: Adi J. Klil-Drori, Hui Yin, Vicky Tagalakis, Armen Aprikian, Laurent Azoulay. Androgen Deprivation Therapy for Prostate Cancer and Risk of Venous Thromboembolism. Eur Urol 2016;70:56–61","year":2016,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Androgen; Theology; Internal medicine; Philosophy","score_opus":0.01757143683601436,"score_gpt":0.28046108216353627,"score_spread":0.2628896453275219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507534879","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09851811,0.010432523,0.00041404238,0.8759615,0.0030004205,0.008576389,0.0025258258,0.00013758503,0.0004336418],"genre_scores_gemma":[0.024674542,0.026455568,0.0006384389,0.8596018,0.070653774,0.00181689,0.0014572812,0.00083951076,0.013862175],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99495846,0.00091492553,0.00084368343,0.0013762577,0.00063892954,0.0012677457],"domain_scores_gemma":[0.99686885,0.00041572246,0.0005841842,0.0012033286,0.0005521405,0.00037576977],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001284683,0.0007765132,0.0011738569,0.00038322317,0.00039710055,0.000105470164,0.0005016621,0.00036755303,0.00012796688],"category_scores_gemma":[0.00024112071,0.000489456,0.0002169478,0.00025353945,0.00045691596,0.00010924565,0.0003322981,0.0012626232,0.000079050405],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002747914,0.00013518595,0.007418543,0.00025715685,0.0010523765,0.00021506954,0.003740466,0.0000055372707,0.0019929945,0.0000019438673,0.9513934,0.031039396],"study_design_scores_gemma":[0.004966678,0.0041508414,0.013408949,0.00021130493,0.0005351638,0.00003765426,0.000046273217,0.000007603381,0.0010919014,0.000050491344,0.97499466,0.0004984722],"about_ca_topic_score_codex":0.0002858925,"about_ca_topic_score_gemma":0.00008074147,"teacher_disagreement_score":0.07384357,"about_ca_system_score_codex":0.00016477307,"about_ca_system_score_gemma":0.00033959319,"threshold_uncertainty_score":0.9997557},"labels":[],"label_agreement":null},{"id":"W2508667271","doi":"10.1016/j.eururo.2016.08.029","title":"Re: Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma","year":2016,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Stage (stratigraphy); Urothelial carcinoma; Urothelial cancer; Carcinoma; Oncology; Internal medicine; Cancer research; Bladder cancer; Cancer","score_opus":0.03834620235858986,"score_gpt":0.27602998643502996,"score_spread":0.23768378407644009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508667271","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13645893,0.002334697,0.0006968388,0.69614935,0.0021825673,0.001580584,0.0068408404,0.00026629725,0.15348992],"genre_scores_gemma":[0.43760467,0.00010028891,0.000079554404,0.537707,0.0044945595,0.00001844161,0.0010452124,0.00017348281,0.018776817],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971538,0.0006216365,0.000585653,0.000708113,0.00043369993,0.00049705093],"domain_scores_gemma":[0.9984551,0.00016958956,0.00027874397,0.0007719153,0.00021267161,0.00011199405],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000113699905,0.00044214807,0.0011699096,0.0006947686,0.00005359115,0.000009614331,0.00028254476,0.0003731776,0.0035193297],"category_scores_gemma":[0.000018339942,0.0003392839,0.0007794163,0.00033711933,0.00033894982,0.00003389482,0.0000588564,0.00087424665,0.00039954967],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029561599,0.00022865893,0.047029797,0.00036590025,0.018663673,0.012154278,0.0011070571,0.000016751284,0.0044447496,0.0001381344,0.9101708,0.0027240491],"study_design_scores_gemma":[0.0023045624,0.0011670317,0.15820323,0.00001744566,0.0064687207,0.000027917984,0.000006699972,0.0000069521075,0.000060856848,0.0000098300125,0.8314961,0.00023062516],"about_ca_topic_score_codex":0.00014473687,"about_ca_topic_score_gemma":0.00001269451,"teacher_disagreement_score":0.30114576,"about_ca_system_score_codex":0.0000646909,"about_ca_system_score_gemma":0.00015475255,"threshold_uncertainty_score":0.99990594},"labels":[],"label_agreement":null},{"id":"W2513507045","doi":"10.1016/j.eururo.2016.08.004","title":"Complications After Systematic, Random, and Image-guided Prostate Biopsy","year":2016,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":519,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Biopsy; Prostate biopsy; Incidence (geometry); Prostate cancer; Magnetic resonance imaging; Urinary retention; Systematic review; Lower urinary tract symptoms; Prostate; Surgery; Complication; Radiology; MEDLINE; Internal medicine; Cancer","score_opus":0.03609365746889444,"score_gpt":0.32311904810012726,"score_spread":0.28702539063123284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513507045","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013192187,0.9841453,0.00007009689,0.00075107603,0.00016911242,0.003365711,0.00019599887,0.00008497892,0.011204574],"genre_scores_gemma":[0.00019223224,0.9965529,0.00020897183,0.00051678705,0.00014880394,0.0011584178,0.00013297668,0.000113201786,0.0009757426],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99750954,0.0007267759,0.00078135985,0.000566823,0.000104807645,0.0003106862],"domain_scores_gemma":[0.99831086,0.00033473785,0.0003737972,0.00069292553,0.00009726082,0.00019038656],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037170167,0.0004111622,0.0019126936,0.00016113404,0.000058834816,0.000032919535,0.000116301235,0.000085284446,0.00008350417],"category_scores_gemma":[0.00012682994,0.00023184766,0.0002774737,0.000096397904,0.00020340261,0.000034113214,0.0001334587,0.00018136157,0.0017617939],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002662644,0.0004345916,0.00017265652,0.49701446,0.0025250784,0.0037076722,0.0002684595,2.5672884e-8,0.0000069959997,0.0005371493,0.009573781,0.48549286],"study_design_scores_gemma":[0.0022868756,0.0002594549,0.00033755557,0.03704516,0.0028383601,0.0022257827,0.000001794164,5.601066e-7,4.0059666e-7,0.000017459428,0.9547585,0.00022809167],"about_ca_topic_score_codex":0.0000017356135,"about_ca_topic_score_gemma":2.913854e-7,"teacher_disagreement_score":0.9451847,"about_ca_system_score_codex":0.00007660669,"about_ca_system_score_gemma":0.00008689865,"threshold_uncertainty_score":0.99901545},"labels":[],"label_agreement":null},{"id":"W2517160827","doi":"10.1016/j.eururo.2016.07.013","title":"Conditional Risk of Relapse in Surveillance for Clinical Stage I Testicular Cancer","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Testicular cancer; Seminoma; Confidence interval; Orchiectomy; Cancer; Stage (stratigraphy); Oncology; Internal medicine; Testicular Germ Cell Tumor; Gynecology; Chemotherapy","score_opus":0.0393861157938752,"score_gpt":0.3607949338707665,"score_spread":0.3214088180768913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517160827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951604,0.0011683941,0.0011388235,0.00070813065,0.00013352884,0.00028131678,0.000705756,0.000023610335,0.00068001274],"genre_scores_gemma":[0.9984166,0.00036969592,0.0003392662,0.0003084932,0.00010448638,0.000015347223,0.000043941163,0.000020196878,0.00038199773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989925,0.0002798777,0.000290915,0.00021911484,0.000069565496,0.00014800734],"domain_scores_gemma":[0.9988356,0.0006743979,0.00014115291,0.00019078163,0.00007101933,0.000087001325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033791692,0.00007899844,0.00022192008,0.000038837177,0.000015300337,0.0000011274668,0.000048054735,0.000032650703,0.0002103113],"category_scores_gemma":[0.0014736515,0.000050489474,0.00010048115,0.00004340688,0.00013638943,0.000014550572,0.000024165764,0.00006051556,0.000048183738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039636774,0.00029029112,0.99279654,0.000014750246,0.00010478044,0.00021284731,0.0000059451568,0.000014162431,0.00014316347,0.00032332895,0.0008811507,0.0048167016],"study_design_scores_gemma":[0.0052097933,0.00068096287,0.9794739,0.000017054059,0.00009955311,0.000010653989,0.0000014879404,0.00005098238,0.00001565249,0.000157469,0.014230553,0.000051962055],"about_ca_topic_score_codex":0.000022927221,"about_ca_topic_score_gemma":0.000017470782,"teacher_disagreement_score":0.013349403,"about_ca_system_score_codex":0.000016865628,"about_ca_system_score_gemma":0.00006180541,"threshold_uncertainty_score":0.23027611},"labels":[],"label_agreement":null},{"id":"W2526505218","doi":"10.1016/j.eururo.2016.08.061","title":"Solifenacin in Children and Adolescents with Overactive Bladder: Results of a Phase 3 Randomised Clinical Trial","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Solifenacin; Overactive bladder; Urology; Clinical trial; Nocturia; Internal medicine; Urinary system; Alternative medicine","score_opus":0.033243513421402374,"score_gpt":0.3579412419883641,"score_spread":0.3246977285669617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526505218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99401754,0.00008825158,0.000052353415,0.0009362019,0.00004500696,0.0011281589,0.00003929089,0.000016007716,0.00367717],"genre_scores_gemma":[0.9989196,0.00034023274,0.000033288437,0.00022453279,0.00022250658,0.0000054529232,0.000012847981,0.000024677267,0.00021687307],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99740696,0.0012402307,0.00054189353,0.00037330983,0.00016344617,0.00027415046],"domain_scores_gemma":[0.99900955,0.00035829688,0.00014173784,0.0002669243,0.00005861595,0.00016486575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014707858,0.000124996,0.00042448382,0.00013820612,0.000020376869,0.000004114253,0.00008135101,0.000055501572,0.00003173252],"category_scores_gemma":[0.0007657232,0.00007180273,0.000058368656,0.000093159,0.00031500933,0.000050233728,0.00007772972,0.00028237165,0.000032322147],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91677564,0.0013917402,0.05553324,0.000010177395,0.00013702686,0.00032911633,0.00017482486,1.799728e-7,0.00083030784,0.0000031496866,0.0006081141,0.024206456],"study_design_scores_gemma":[0.68880856,0.014434268,0.2954642,0.000059974554,0.000061819665,0.00014690621,0.000006999671,0.0000075160956,0.00019536102,0.0000095144505,0.0007290461,0.00007587441],"about_ca_topic_score_codex":0.000013988489,"about_ca_topic_score_gemma":0.000004022971,"teacher_disagreement_score":0.23993094,"about_ca_system_score_codex":0.000009294159,"about_ca_system_score_gemma":0.00009463468,"threshold_uncertainty_score":0.29280305},"labels":[],"label_agreement":null},{"id":"W2529206793","doi":"10.1016/j.eururo.2016.09.042","title":"Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; St. Thomas Hospital","funders":"National Cancer Institute","keywords":"Medicine; Nomogram; Urothelium; Metastatic Urothelial Carcinoma; Oncology; Chemotherapy; Urothelial carcinoma; Urothelial cancer; Vinblastine; Retrospective cohort study; Internal medicine; Bladder cancer; Urology; Cancer; Urinary bladder","score_opus":0.014713076496097545,"score_gpt":0.24209026157429,"score_spread":0.22737718507819246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529206793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966165,0.000022467771,0.00027469214,0.00047216238,0.00032321006,0.001263775,0.0003975787,0.000017342798,0.0006122624],"genre_scores_gemma":[0.99943864,0.000009445084,0.00011856125,0.00019155329,0.00006073276,0.000041997693,0.00001575301,0.000056603858,0.000066704146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805075,0.00036641755,0.00056329765,0.00036413028,0.00045279955,0.00020259226],"domain_scores_gemma":[0.9985218,0.00019405098,0.0005036687,0.00040591558,0.00032656398,0.000048010283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023604151,0.00022038732,0.0004954314,0.000177502,0.000031593376,0.0000027186745,0.00022097708,0.000035761546,0.00020068952],"category_scores_gemma":[0.00017453318,0.0001289444,0.000094122435,0.00022139934,0.00018568595,0.000058488833,0.000044291395,0.00014056513,0.0000014839835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007074245,0.0019273607,0.9847488,0.00004029764,0.00026666926,0.000008194672,0.000592023,0.00085481536,0.003047177,0.000005383874,0.000011720743,0.0014233607],"study_design_scores_gemma":[0.036278885,0.006659235,0.951113,0.00015164785,0.00016791334,7.7335056e-7,0.000034704593,0.00010167638,0.005341792,0.000011580884,0.000048302016,0.00009051653],"about_ca_topic_score_codex":0.00038204968,"about_ca_topic_score_gemma":0.00065494655,"teacher_disagreement_score":0.033635776,"about_ca_system_score_codex":0.00015288324,"about_ca_system_score_gemma":0.00021252711,"threshold_uncertainty_score":0.52582},"labels":[],"label_agreement":null},{"id":"W2529608586","doi":"10.1016/j.eururo.2016.09.035","title":"Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy","year":2016,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Urothelium; Cystectomy; Urology; Bladder cancer; Prostatic urethra; Carcinoma in situ; Metastasis; Urethra; Upper urinary tract; Radiation therapy; Chemotherapy; Ureter; Carcinoma; Urinary bladder; Urinary system; Oncology; Internal medicine; Prostate; Cancer","score_opus":0.026846812147496613,"score_gpt":0.2948770115014079,"score_spread":0.26803019935391126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529608586","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000022330887,0.9754303,0.000006340515,0.0019566722,0.00043116728,0.0047047106,0.00007753824,0.000035379788,0.017355626],"genre_scores_gemma":[0.0002313762,0.98821396,0.0000033738168,0.0073481416,0.00029731347,0.00037700133,0.0000059840595,0.0001343552,0.0033885061],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99365175,0.004014448,0.001150905,0.00046481565,0.00037216736,0.00034591428],"domain_scores_gemma":[0.9967036,0.0005730948,0.0007106627,0.0018506383,0.00006186636,0.0001001266],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00103587,0.00050878245,0.0027053242,0.00007726932,0.00006361739,0.000007695799,0.00066924695,0.00012864781,0.00052253413],"category_scores_gemma":[0.00062278437,0.00016493889,0.0010871271,0.00021384237,0.00031153773,0.000012049879,0.00019012144,0.00054891343,0.0020533993],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093727474,0.00012663801,0.000003958359,0.9618714,0.0013305583,0.00038905637,0.000047599362,8.132614e-9,0.0000012274143,0.00031915566,0.004698546,0.031118168],"study_design_scores_gemma":[0.00030523146,0.00025074353,0.000014441885,0.3836419,0.0048542954,0.0004964181,6.0332763e-7,4.8042043e-8,9.531472e-7,0.0000062338454,0.6103213,0.00010785076],"about_ca_topic_score_codex":0.0000022055178,"about_ca_topic_score_gemma":5.279975e-7,"teacher_disagreement_score":0.6056227,"about_ca_system_score_codex":0.00007431509,"about_ca_system_score_gemma":0.00020935108,"threshold_uncertainty_score":0.9987236},"labels":[],"label_agreement":null},{"id":"W2529703599","doi":"10.1016/j.eururo.2016.09.041","title":"Setting an Agenda for Assessment of Health-related Quality of Life Among Men with Prostate Cancer on Active Surveillance: A Consensus Paper from a European School of Oncology Task Force","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Delphi method; Quality of life (healthcare); Multidisciplinary approach; Delphi; Prostate cancer; Family medicine; Medical education; Cancer; Nursing; Internal medicine; Artificial intelligence","score_opus":0.03790730484604728,"score_gpt":0.3441781272653911,"score_spread":0.30627082241934384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529703599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780842,0.00027749184,0.00029971826,0.0022779994,0.00017237652,0.0009286512,0.0007859968,0.000042282794,0.017131258],"genre_scores_gemma":[0.9979934,0.00007158553,0.00022295809,0.0011277616,0.0000899282,0.000027313477,0.00008935493,0.00007444869,0.00030326602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940824,0.0037647549,0.0010627556,0.00049717264,0.00023664642,0.00035626604],"domain_scores_gemma":[0.99661326,0.0009038329,0.001400957,0.0004888943,0.00038736634,0.00020568215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022894696,0.00022079119,0.00095851533,0.000098556644,0.000050150116,0.0000027687674,0.00015382486,0.00006780197,0.00016891897],"category_scores_gemma":[0.00048452444,0.00015089232,0.00010799741,0.00013570795,0.000385749,0.000042681662,0.00006728224,0.0002325055,0.0000035185087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02961522,0.00080034096,0.7800466,0.00062007265,0.0016385216,0.00009386163,0.01088357,0.00023167899,0.0799413,0.00024267072,0.0020072497,0.09387891],"study_design_scores_gemma":[0.0077777533,0.0062758913,0.9809556,0.00016186544,0.000076976474,0.0000046561363,0.0011090784,0.0000525216,0.0004368301,0.000024739695,0.0029524195,0.00017165755],"about_ca_topic_score_codex":0.0032148757,"about_ca_topic_score_gemma":0.0034167492,"teacher_disagreement_score":0.20090902,"about_ca_system_score_codex":0.00014618615,"about_ca_system_score_gemma":0.000664573,"threshold_uncertainty_score":0.61532104},"labels":[],"label_agreement":null},{"id":"W2532994291","doi":"10.1016/j.eururo.2016.09.047","title":"Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto; University Health Network; Princess Margaret Cancer Centre; Ottawa Regional Cancer Foundation; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Carcinoma; Oncology; Internal medicine; Baseline (sea); Urology; Database","score_opus":0.05249452266807545,"score_gpt":0.2787321393715898,"score_spread":0.22623761670351436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532994291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906257,0.0016136217,0.0019757492,0.0014704323,0.00038817403,0.0020375869,0.0008869882,0.000047380418,0.0009544004],"genre_scores_gemma":[0.9932774,0.0000353977,0.002800432,0.0014311379,0.0005927887,0.00016126328,0.0011711374,0.00011976183,0.00041071218],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966199,0.00067827443,0.00092487317,0.00088665925,0.00030212317,0.00058817456],"domain_scores_gemma":[0.9970961,0.0012974545,0.00036217936,0.0006890463,0.00024209425,0.000313089],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008071374,0.00042605554,0.00070133945,0.0005287187,0.0000448751,0.000012290353,0.00038609686,0.00006735863,0.0007446965],"category_scores_gemma":[0.00044266332,0.00031126774,0.0001976992,0.00022542116,0.000126532,0.000118604985,0.0002015275,0.0002332155,0.00013092582],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010194939,0.0015568872,0.14465888,0.00011736021,0.00016285386,0.002004451,0.0010423425,0.000032188105,0.8305538,0.000020356172,0.0015376089,0.008118313],"study_design_scores_gemma":[0.026614781,0.0057573556,0.61881566,0.00007230733,0.0003702069,0.00008488063,0.000117099,0.0004991844,0.34113798,0.00002466754,0.0060292133,0.00047664766],"about_ca_topic_score_codex":0.00020291863,"about_ca_topic_score_gemma":0.00007316137,"teacher_disagreement_score":0.48941582,"about_ca_system_score_codex":0.00012827842,"about_ca_system_score_gemma":0.00016061457,"threshold_uncertainty_score":0.99993396},"labels":[],"label_agreement":null},{"id":"W2534471526","doi":"10.1016/j.eururo.2016.10.007","title":"Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":203,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Sunitinib; Everolimus; BAP1; Renal cell carcinoma; Clear cell renal cell carcinoma; PTEN; Oncology; Internal medicine; Kidney cancer; Cancer research; Cancer; PI3K/AKT/mTOR pathway; Biology","score_opus":0.0220491632672999,"score_gpt":0.22366098757125152,"score_spread":0.20161182430395164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534471526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943727,0.00028475033,0.00008969318,0.00018677146,0.00006284189,0.0013865494,0.000009760917,0.00001626744,0.0035906173],"genre_scores_gemma":[0.9993569,0.000021297472,0.00032296346,0.00008687716,0.0000404419,0.000019042925,0.000023298095,0.0000428151,0.00008633723],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99772674,0.00087898795,0.0006057893,0.00033705038,0.00016722428,0.0002842334],"domain_scores_gemma":[0.9986698,0.00057108887,0.00027473035,0.00028757818,0.00006907496,0.00012773991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007035573,0.00021728537,0.00095497305,0.00026323256,0.000026844787,0.000004700238,0.000086627144,0.000028498902,0.00005390792],"category_scores_gemma":[0.00014872318,0.00012565657,0.00010266149,0.00010209267,0.0002994134,0.000033355303,0.00008246788,0.00009824589,0.000021164244],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79155123,0.00038450016,0.20563032,0.000048006375,0.00020966947,0.00027863376,0.0002068078,0.000011120877,0.0009860083,0.000010043746,0.000024388863,0.0006592972],"study_design_scores_gemma":[0.6111659,0.0031715604,0.38468668,0.000023383374,0.0003697807,0.000020282247,0.0000054663406,0.00003604564,0.0003699979,0.000008096518,0.000055782257,0.00008707793],"about_ca_topic_score_codex":0.000057097124,"about_ca_topic_score_gemma":0.000024161047,"teacher_disagreement_score":0.18038535,"about_ca_system_score_codex":0.00005269355,"about_ca_system_score_gemma":0.000042717453,"threshold_uncertainty_score":0.5124126},"labels":[],"label_agreement":null},{"id":"W2546813772","doi":"10.1016/j.eururo.2016.10.013","title":"Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network; Université Laval; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research; Prostate Cancer UK; Academy of Medical Sciences; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Prostate cancer; Prostatectomy; Biochemical recurrence; Hazard ratio; Locus (genetics); Retrospective cohort study; Oncology; Internal medicine; Metastasis; Proportional hazards model; Classifier (UML); Confidence interval; Gene; Cancer; Artificial intelligence; Genetics; Biology","score_opus":0.022306537545539407,"score_gpt":0.27572699053125793,"score_spread":0.2534204529857185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546813772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97430336,0.00044283542,0.00020004646,0.014732194,0.00013975459,0.0011149892,0.000009661733,0.00006790185,0.008989227],"genre_scores_gemma":[0.99745446,0.00019158708,0.00014643365,0.0012240519,0.0001307371,0.00010675795,0.000017721408,0.000049593884,0.0006786397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981252,0.000506773,0.0004588287,0.00044622688,0.00012638308,0.0003365756],"domain_scores_gemma":[0.9991326,0.0002593578,0.00015526883,0.00030851844,0.000060674265,0.00008360288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006908903,0.0001815188,0.0003013309,0.00008674823,0.000075384494,0.000015191137,0.000106104824,0.00004296228,0.00018985376],"category_scores_gemma":[0.00023919296,0.00009785181,0.00008358127,0.00016057953,0.00020070729,0.000058486457,0.000047697813,0.00019807533,0.0003181073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010043111,0.00029213043,0.92744035,0.000027693799,0.00012682339,0.0005765142,0.0057715885,0.000010276829,0.0074519375,0.00024954905,0.0006688187,0.05638002],"study_design_scores_gemma":[0.0057847383,0.0020249756,0.9776892,0.00012723329,0.00013390793,0.000050336523,0.000108891996,0.000060694823,0.0009195534,0.00070149184,0.012232599,0.00016637008],"about_ca_topic_score_codex":0.000021374668,"about_ca_topic_score_gemma":0.000045555338,"teacher_disagreement_score":0.056213647,"about_ca_system_score_codex":0.00020332719,"about_ca_system_score_gemma":0.000096212956,"threshold_uncertainty_score":0.4088732},"labels":[],"label_agreement":null},{"id":"W2549502041","doi":"10.1016/j.eururo.2016.11.017","title":"Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Institute for Prostate Cancer Research; Canary Foundation; National Institute of General Medical Sciences; U.S. Department of Defense","keywords":"Medicine; Prostate cancer; Receiver operating characteristic; Confidence interval; Area under the curve; Prostate-specific antigen; Prostate; Biopsy; Odds ratio; Internal medicine; Prostate biopsy; Urology; Oncology; Cancer","score_opus":0.07706866949235953,"score_gpt":0.3292818871784762,"score_spread":0.25221321768611665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549502041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835586,0.0003712193,0.0000034552186,0.011486813,0.00014545598,0.0037608985,0.00044449116,0.000008740724,0.00022032436],"genre_scores_gemma":[0.998479,0.00033214226,0.000011083008,0.00029893656,0.00006544376,0.0006529006,0.0000098249775,0.000026923512,0.00012372441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975546,0.0012228579,0.00042900685,0.000298096,0.00023098083,0.00026446726],"domain_scores_gemma":[0.99856234,0.00058389455,0.00030303322,0.00041476847,0.000111690286,0.0000242486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014869502,0.00014740608,0.00029121054,0.00005457814,0.000058158894,0.000003915074,0.0002195206,0.000024387942,0.000009575862],"category_scores_gemma":[0.00023989566,0.000059193015,0.000056350756,0.0002180244,0.00015808363,0.000037590155,0.00007820021,0.00014938983,9.197437e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020310609,0.00057180336,0.95280653,0.000053047803,0.00017738104,0.00003718268,0.01028654,0.00071895204,0.0037722485,0.000057318503,0.00032610088,0.02916184],"study_design_scores_gemma":[0.005527869,0.0032819384,0.9890002,0.00008734644,0.00008747419,0.000007742952,0.00069120125,0.00022288391,0.000658065,0.00014220252,0.00024015721,0.000052892054],"about_ca_topic_score_codex":0.0014148778,"about_ca_topic_score_gemma":0.0027028623,"teacher_disagreement_score":0.036193706,"about_ca_system_score_codex":0.00012619475,"about_ca_system_score_gemma":0.00016237839,"threshold_uncertainty_score":0.2413821},"labels":[],"label_agreement":null},{"id":"W2553632813","doi":"10.1016/j.eururo.2016.11.010","title":"Postoperative Radiotherapy in Locally Advanced Prostate Cancer: A Question of Who and When","year":2016,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Prostate cancer; Radiation therapy; Prostate; Prostatectomy; Prostate disease; Urology; Cancer; General surgery; Oncology; Surgery; Internal medicine","score_opus":0.008514942615582223,"score_gpt":0.26282151581602564,"score_spread":0.2543065732004434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553632813","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046124287,0.023627415,0.000048384027,0.9261064,0.00026011595,0.0013283417,0.00019320619,0.00003889766,0.0022729395],"genre_scores_gemma":[0.031245727,0.051413648,0.0005495206,0.9094331,0.0014062687,0.00026311545,0.0001915381,0.0002050615,0.005291984],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982731,0.00043030313,0.00036031468,0.0004967021,0.00012379144,0.0003158285],"domain_scores_gemma":[0.9992659,0.00009922047,0.00020450953,0.00026987135,0.000104290586,0.00005620442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017724345,0.00027958854,0.00063816993,0.00016957939,0.000020114825,0.000007239302,0.00007829483,0.0001597706,0.00010013112],"category_scores_gemma":[0.000028571856,0.00019781137,0.00005484218,0.0000561222,0.00020710721,0.000049073766,0.000040183575,0.000494757,0.000009936662],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029820944,0.0001490689,0.049641352,0.0005092194,0.0006241032,0.006526589,0.0036912707,0.00002420134,0.0025200718,0.000117604715,0.53512496,0.39808944],"study_design_scores_gemma":[0.0054168478,0.0036006474,0.02202153,0.00076396804,0.000093039765,0.00007952759,0.00000494545,0.000011238082,0.00028757384,0.00007589079,0.9674301,0.0002146936],"about_ca_topic_score_codex":0.00009424508,"about_ca_topic_score_gemma":0.000034605935,"teacher_disagreement_score":0.43230513,"about_ca_system_score_codex":0.00017154428,"about_ca_system_score_gemma":0.0001377439,"threshold_uncertainty_score":0.80665135},"labels":[],"label_agreement":null},{"id":"W2554139259","doi":"10.1016/j.eururo.2016.11.004","title":"Reply from Authors re: Peter Albers. Surveillance of Patients with Clinical Stage I Testis Cancer is Safe and Will Remain Unchanged. Eur Urol 2017;71:130–131.","year":2016,"lang":"en","type":"letter","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); General surgery; Gynecology","score_opus":0.0241147645665068,"score_gpt":0.28456225792472356,"score_spread":0.26044749335821676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554139259","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42970937,0.008221717,0.00014464212,0.52927536,0.002257523,0.0028727746,0.019444022,0.00027704053,0.007797534],"genre_scores_gemma":[0.2180169,0.0012690956,0.0008545944,0.7569868,0.004511055,0.00004677334,0.0031598888,0.0005020579,0.014652829],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99544114,0.0012287068,0.00084079936,0.0013620735,0.00048654492,0.00064075657],"domain_scores_gemma":[0.9963108,0.00086762226,0.00089888065,0.0013131073,0.00027539604,0.0003341948],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039067052,0.0006096598,0.0011683081,0.00014197256,0.00007006171,0.000019047622,0.000269186,0.00033070554,0.0011949417],"category_scores_gemma":[0.0006755692,0.00041235355,0.00022071965,0.00009893534,0.00052923034,0.00006722598,0.00022686787,0.0009786129,0.00015048892],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006589516,0.00011301878,0.5046981,0.00007363706,0.00060753914,0.0033290128,0.000048548674,2.1396113e-7,0.0000020528569,6.3686986e-7,0.48781434,0.0026539795],"study_design_scores_gemma":[0.0031707198,0.0012334159,0.4929566,0.00011852727,0.000540622,0.000014736957,9.031023e-7,0.0000030010613,9.27326e-7,0.000009009829,0.5017168,0.00023471938],"about_ca_topic_score_codex":0.0003641402,"about_ca_topic_score_gemma":0.000049907856,"teacher_disagreement_score":0.22771142,"about_ca_system_score_codex":0.00005860922,"about_ca_system_score_gemma":0.00014884707,"threshold_uncertainty_score":0.9998328},"labels":[],"label_agreement":null},{"id":"W2559656152","doi":"10.1016/j.eururo.2016.11.023","title":"Conflict of Evidence: Resolving Discrepancies When Findings from Randomized Controlled Trials and Meta-analyses Disagree","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Randomized controlled trial; Medicine; Guideline; External validity; Evidence-based medicine; Psychological intervention; Systematic review; MEDLINE; Medical physics; Evidence-based practice; Meta-analysis; Alternative medicine; Nursing; Psychology; Surgery; Social psychology; Internal medicine; Pathology","score_opus":0.9253659755559948,"score_gpt":0.5742743429163227,"score_spread":0.351091632639672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559656152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5350621,0.18765713,0.16319387,0.06477625,0.001209856,0.010344442,0.0003827761,0.00006766214,0.037305925],"genre_scores_gemma":[0.976424,0.00052208273,0.0020011724,0.00071547076,0.00012325817,0.00006474501,0.0000024584833,0.000022863325,0.02012395],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.70805585,0.25766945,0.027926747,0.0018331672,0.0040579,0.0004568853],"domain_scores_gemma":[0.6399243,0.33831117,0.01640595,0.0039807386,0.001143338,0.00023449569],"candidate_categories":["metaresearch","metaepi_broad","insufficient_payload"],"consensus_categories":["metaresearch","insufficient_payload"],"category_scores_codex":[0.44031414,0.00048430404,0.033212893,0.0004928579,0.000118703676,0.00042604897,0.0016884925,0.0000798877,0.030080171],"category_scores_gemma":[0.67742413,0.00012504488,0.009617506,0.00032327478,0.0006487297,0.00031947086,0.00038462406,0.00011937525,0.0009904567],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16246642,0.0003256516,0.02771096,0.00014009765,0.3489967,0.00022346042,0.01575793,0.00007277736,0.08153598,0.030420957,0.31345716,0.018891912],"study_design_scores_gemma":[0.29532057,0.0005403998,0.015186675,0.00013759753,0.44223145,0.000042160245,0.00082518824,0.0019047162,0.0009195063,0.049750615,0.19181429,0.0013268633],"about_ca_topic_score_codex":0.000053887856,"about_ca_topic_score_gemma":0.000026080157,"teacher_disagreement_score":0.4413619,"about_ca_system_score_codex":0.000008547649,"about_ca_system_score_gemma":0.000035172146,"threshold_uncertainty_score":0.9997874},"labels":[],"label_agreement":null},{"id":"W2562252195","doi":"10.1016/j.eururo.2016.12.013","title":"Reply to Roberto Iacovelli, Walter Artibani, and Giampaolo Tortora's Letter to the Editor re: Ian D. Davis, Wanling Xie, Carmel Pezaro, et al. Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category. Eur Urol 2017;71:970–8","year":2016,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Classics","score_opus":0.039492417459690815,"score_gpt":0.2783214578204729,"score_spread":0.2388290403607821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562252195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51516825,0.0018358389,0.0025518283,0.4661518,0.0036587017,0.0063119405,0.003984833,0.00007502951,0.00026177877],"genre_scores_gemma":[0.5128816,0.000035478468,0.0019435093,0.46557122,0.014233989,0.00044188992,0.0038509632,0.00029957367,0.00074176904],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9916738,0.0018327018,0.0018340102,0.002441201,0.00084811053,0.0013701281],"domain_scores_gemma":[0.99436736,0.00176665,0.00083160884,0.0019004634,0.00054074835,0.00059317384],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020102798,0.0012420273,0.0016258638,0.0010030189,0.00014352197,0.00010452284,0.0010368937,0.00024692254,0.0004224622],"category_scores_gemma":[0.0007452078,0.0009009254,0.00037712086,0.00033826346,0.00016682051,0.00019543759,0.00070175313,0.0016718847,0.00015384522],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003783718,0.00035685507,0.0045213117,0.00017999057,0.00025866352,0.003777767,0.0016330889,0.000076241035,0.052626874,7.1783705e-7,0.9318025,0.000982245],"study_design_scores_gemma":[0.008024547,0.004650066,0.017562572,0.00019990694,0.000661334,0.00013566818,0.00006569292,0.00023684846,0.019036675,0.0000042855813,0.9484496,0.000972802],"about_ca_topic_score_codex":0.0006747903,"about_ca_topic_score_gemma":0.00018694178,"teacher_disagreement_score":0.033590198,"about_ca_system_score_codex":0.0002713722,"about_ca_system_score_gemma":0.00029729964,"threshold_uncertainty_score":0.9993441},"labels":[],"label_agreement":null},{"id":"W2566816189","doi":"10.1016/j.eururo.2016.12.019","title":"Re: Low Adherence to Guidelines in Nonmuscle-invasive Disease","year":2016,"lang":"en","type":"letter","venue":"European Urology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Disease; MEDLINE; Intensive care medicine; Internal medicine","score_opus":0.36288398636840447,"score_gpt":0.4214847615667759,"score_spread":0.058600775198371424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566816189","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021275284,0.001569009,0.0009924518,0.9693114,0.0023695119,0.0009923861,0.0011343315,0.000099456964,0.021403907],"genre_scores_gemma":[0.0049320674,0.0002342825,0.0006332855,0.97262704,0.009838985,0.00013586206,0.00017608811,0.0001915239,0.011230849],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98947,0.0018523673,0.00586357,0.0016383228,0.00012822793,0.0010474885],"domain_scores_gemma":[0.99353737,0.0020171234,0.0024226366,0.0015101103,0.00014742494,0.00036535098],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.011476684,0.0005184924,0.0015593509,0.00090579106,0.00010312762,0.0000752678,0.0011544611,0.00041085988,0.0019250246],"category_scores_gemma":[0.017644007,0.0005978213,0.00022857866,0.00023000297,0.00012691227,0.0002183315,0.00031933739,0.0009353334,0.060908984],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024086115,0.000016352946,0.0037031528,0.00025845683,0.000031085758,0.00032550696,0.0002681358,0.000061142826,6.777063e-7,0.00073712243,0.99413186,0.0004424025],"study_design_scores_gemma":[0.0005953701,0.00017375356,0.006512614,0.00022802268,0.000008428905,0.0000043014197,0.000022617649,0.00006744781,2.9094593e-7,0.00254544,0.98920953,0.00063215976],"about_ca_topic_score_codex":0.00028928934,"about_ca_topic_score_gemma":0.00030026623,"teacher_disagreement_score":0.05898396,"about_ca_system_score_codex":0.00043016445,"about_ca_system_score_gemma":0.00030722943,"threshold_uncertainty_score":0.9996473},"labels":[],"label_agreement":null},{"id":"W2567658625","doi":"10.1016/j.eururo.2016.07.010","title":"Re: Alexander Kutikov, Marc C. Smaldone, Robert G. Uzzo, Miki Haifler, Gennady Bratslavsky, Bradley C. Leibovich. Renal Mass Biopsy: Always, Sometimes, or Never? Eur Urol 2016;70:403–6","year":2016,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Renal mass; Biopsy; Radiology; Kidney; Internal medicine","score_opus":0.02930264268600588,"score_gpt":0.24451822498229445,"score_spread":0.21521558229628857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567658625","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031568706,0.012453852,0.0011729794,0.77857554,0.0041284813,0.003480611,0.00073506637,0.00123046,0.19506612],"genre_scores_gemma":[0.005072886,0.0016263375,0.00198151,0.5946691,0.01707033,0.00014082337,0.00259785,0.0014816032,0.37535957],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98567915,0.0033736678,0.002266025,0.0037228814,0.0015844207,0.0033738804],"domain_scores_gemma":[0.99198306,0.0010870043,0.0012920174,0.004133184,0.00048867706,0.0010160358],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0013632133,0.0026251753,0.0030936906,0.0014161004,0.00039950907,0.00018155853,0.0018146035,0.0020404821,0.01265485],"category_scores_gemma":[0.00038449024,0.0018653657,0.0011791015,0.00070932053,0.00097486476,0.000347697,0.0009373197,0.004548601,0.013462261],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002794406,0.0002529298,0.00090169307,0.0003161138,0.0017924254,0.07289886,0.00009083792,0.000005320341,0.0058901217,0.000023408711,0.910574,0.00445986],"study_design_scores_gemma":[0.00852924,0.0035199453,0.005231242,0.00028195418,0.0020821423,0.006329619,0.000010142899,0.000036740825,0.0005623154,0.00007997609,0.97150207,0.0018345894],"about_ca_topic_score_codex":0.0002453118,"about_ca_topic_score_gemma":0.000046726527,"teacher_disagreement_score":0.18390647,"about_ca_system_score_codex":0.00063823187,"about_ca_system_score_gemma":0.0010964426,"threshold_uncertainty_score":0.99925506},"labels":[],"label_agreement":null},{"id":"W2576656535","doi":"10.1016/j.eururo.2016.12.025","title":"Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric Oncology","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":207,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Geriatric oncology; Geriatrics; Prostate cancer; Disease; Psychological intervention; Gerontology; Cancer; Physical therapy; Internal medicine; Psychiatry","score_opus":0.04701956794465245,"score_gpt":0.36120582816170593,"score_spread":0.3141862602170535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576656535","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002225672,0.977191,0.0000050314234,0.0016151564,0.0008394311,0.0023762858,0.0010430791,0.0000055641503,0.014698799],"genre_scores_gemma":[0.005820233,0.99302864,0.00016844181,0.000066169574,0.000030985026,0.000118373566,0.00013176052,0.000025868703,0.0006095247],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983481,0.00021279248,0.0009257913,0.00023755692,0.00014014255,0.0001355966],"domain_scores_gemma":[0.9974802,0.00010148739,0.001777431,0.00044418554,0.00017135293,0.000025354717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031418452,0.00016690893,0.0010202307,0.000112193164,0.000018780835,0.0000016813498,0.000358841,0.0000717096,0.000045577435],"category_scores_gemma":[0.000030208019,0.00011197659,0.0003772275,0.00013884931,0.00016944035,0.00002296833,0.00028068302,0.0001714062,0.0000021835533],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006757108,0.0006784845,0.0035335238,0.0061421623,0.0010617155,0.000007866916,0.00032473376,0.0000049355713,0.0000017833665,0.00011892169,0.0034336385,0.9846247],"study_design_scores_gemma":[0.0019040278,0.0009971176,0.009011996,0.0035476612,0.0011390037,0.0000031013192,0.000022789582,0.0000024907567,0.000009713339,0.000017259019,0.9832758,0.00006904584],"about_ca_topic_score_codex":0.00005933622,"about_ca_topic_score_gemma":0.000015485539,"teacher_disagreement_score":0.9845556,"about_ca_system_score_codex":0.00018338703,"about_ca_system_score_gemma":0.00026134716,"threshold_uncertainty_score":0.45662728},"labels":[],"label_agreement":null},{"id":"W2580264005","doi":"10.1016/j.eururo.2017.01.025","title":"The Evolving Narrative of DNA Repair Gene Defects: Distinguishing Indolent from Lethal Prostate Cancer","year":2017,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prostate cancer; DNA repair; Gene; Prostate; Cancer research; Cancer; Internal medicine; Genetics; Biology","score_opus":0.03053900874751399,"score_gpt":0.3087893932639272,"score_spread":0.2782503845164132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580264005","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43161663,0.042432535,0.000008640978,0.48402762,0.0029891948,0.0021661238,0.0006377033,0.0002727464,0.0358488],"genre_scores_gemma":[0.8280517,0.0038883712,0.0002345747,0.116444096,0.019120501,0.00024510178,0.0018958051,0.00048701128,0.02963285],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99667656,0.0009852594,0.00048289826,0.0007070931,0.00045602536,0.0006921858],"domain_scores_gemma":[0.9972964,0.00058866385,0.0006253034,0.0010626031,0.0003283068,0.00009875217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006702673,0.00038843512,0.0006486427,0.00010206146,0.00055577804,0.00007305656,0.0005261494,0.0002516378,0.00011284327],"category_scores_gemma":[0.001005285,0.00024336658,0.00028130182,0.00006948728,0.0007363076,0.00005606576,0.0004015272,0.0021799156,0.000045412828],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010021059,0.000059814403,0.016526945,0.00025146978,0.0015023339,0.014629763,0.009429442,0.000004162906,0.0022904926,0.0000029970035,0.9507903,0.0035101993],"study_design_scores_gemma":[0.0027711492,0.001046167,0.037866395,0.00049425935,0.0005812104,0.00009348964,0.00019115108,0.00006172711,0.0011738767,0.00007852275,0.9552548,0.0003872657],"about_ca_topic_score_codex":0.00052958255,"about_ca_topic_score_gemma":0.00005182567,"teacher_disagreement_score":0.39643505,"about_ca_system_score_codex":0.00018772704,"about_ca_system_score_gemma":0.00037620487,"threshold_uncertainty_score":0.9924201},"labels":[],"label_agreement":null},{"id":"W2580862866","doi":"10.1016/j.eururo.2016.12.003","title":"The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":533,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Cochrane; Health Sciences Centre","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Dissection (medical); Lymph node; Urology; Prostate; Cancer; Oncology; Surgery; Internal medicine","score_opus":0.049364341406844765,"score_gpt":0.3375003198449971,"score_spread":0.28813597843815236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580862866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013368775,0.990335,0.0000018740614,0.00020724749,0.00021821678,0.007561959,0.00026551218,0.000018001358,0.00005530773],"genre_scores_gemma":[0.002823665,0.99462956,0.000008259242,0.00004776642,0.00007020201,0.0021032072,0.00008212992,0.00008325902,0.00015193078],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99748355,0.00042179547,0.0011633879,0.0004459828,0.0001771671,0.00030810208],"domain_scores_gemma":[0.9972101,0.00028574196,0.0015681842,0.0006902926,0.00012956618,0.00011611242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049070327,0.0003921054,0.0029141658,0.00007896739,0.00016474191,0.000018618226,0.00021885236,0.00007087195,0.0000040723403],"category_scores_gemma":[0.00033513262,0.00020185449,0.0004073426,0.0000599846,0.00022152458,0.00002662741,0.00013272675,0.00016127538,0.0000028470902],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011012224,0.00011592357,0.00029060303,0.80045146,0.0007265879,0.000027704953,0.000040409832,1.7324405e-7,0.0000017283745,0.0000304884,0.000028801807,0.19817601],"study_design_scores_gemma":[0.0028204361,0.0009404337,0.0037411372,0.918957,0.014994343,0.00041466346,0.0000054110037,0.0000055993455,0.000030021796,0.000009970553,0.05778549,0.0002954818],"about_ca_topic_score_codex":0.000008977178,"about_ca_topic_score_gemma":0.000002598012,"teacher_disagreement_score":0.19788052,"about_ca_system_score_codex":0.0001090123,"about_ca_system_score_gemma":0.0001099111,"threshold_uncertainty_score":0.8231387},"labels":[],"label_agreement":null},{"id":"W2583552964","doi":"10.1016/j.eururo.2017.01.035","title":"Active Surveillance Discussion for Low-risk Prostate Cancer: Patients’ Preferences and Counseling Techniques","year":2017,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prostate cancer; Watchful waiting; Gynecology; Prostate; Oncology; Cancer; Medical physics; Internal medicine","score_opus":0.013734351008319661,"score_gpt":0.26856487866827816,"score_spread":0.2548305276599585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583552964","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28309247,0.008457094,0.00008235626,0.6824461,0.0022434744,0.009189136,0.008587861,0.00049377995,0.005407717],"genre_scores_gemma":[0.60970896,0.07719246,0.000662862,0.29070473,0.007624032,0.0025098685,0.0065209414,0.000544826,0.004531359],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980068,0.0002804078,0.00034341615,0.0007639552,0.000172515,0.00043288246],"domain_scores_gemma":[0.9983548,0.00022531139,0.0006597118,0.0004479504,0.0002297074,0.00008254258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026230977,0.00038862316,0.0006271174,0.00009124669,0.00025736148,0.000056177185,0.00017216781,0.0002303816,0.000019718525],"category_scores_gemma":[0.00020446331,0.00023414005,0.000103408645,0.000026988519,0.00022427537,0.00006635063,0.000101439226,0.0007572248,0.000009493603],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086799194,0.00015081445,0.10882986,0.0005572749,0.0003896635,0.00027745854,0.00079719897,7.348979e-7,0.000019606636,0.0000013647204,0.6182904,0.2698176],"study_design_scores_gemma":[0.0015734561,0.0023148614,0.05546213,0.00030573478,0.0002741817,0.000009135819,0.0000074274726,0.000007732115,0.0002346954,0.00009561812,0.9394198,0.0002952487],"about_ca_topic_score_codex":0.00008203173,"about_ca_topic_score_gemma":0.00003386567,"teacher_disagreement_score":0.39174142,"about_ca_system_score_codex":0.00009476083,"about_ca_system_score_gemma":0.000102723825,"threshold_uncertainty_score":0.9547954},"labels":[],"label_agreement":null},{"id":"W2587228972","doi":"10.1016/j.eururo.2017.01.044","title":"Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians’ Health Study","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Joseph Brant Hospital","funders":"","keywords":"Medicine; Aspirin; Hazard ratio; Cohort; Prospective cohort study; Prostate cancer; Internal medicine; Cohort study; Confidence interval; Proportional hazards model; Relative risk; Surgery; Cancer","score_opus":0.018933774471752336,"score_gpt":0.2918611676602422,"score_spread":0.2729273931884899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587228972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933338,0.00057832175,0.0000021808187,0.0043859337,0.00016740624,0.000930556,0.0000070774745,0.000008198951,0.00058652926],"genre_scores_gemma":[0.9979379,0.00023829605,0.000006731731,0.0014908127,0.0002007006,0.000018137107,0.0000010733276,0.000017511975,0.00008881629],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724114,0.0020571395,0.00020848551,0.00017436835,0.00012584131,0.00019303369],"domain_scores_gemma":[0.998818,0.00021639102,0.00028825147,0.0006155792,0.000029656301,0.000032156295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002762678,0.000098011944,0.0002799916,0.000032674856,0.0001948952,0.000020348643,0.00018577573,0.00001692159,0.000004266778],"category_scores_gemma":[0.00035049242,0.000049441227,0.000037703605,0.000034744397,0.00041970142,0.000046130695,0.000082361184,0.00030074466,0.000007126884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011713502,0.00018033788,0.95438504,0.00005446263,0.000088910354,0.00033739582,0.019716058,0.000020628118,0.00012002723,0.00023279118,0.0006685067,0.023024479],"study_design_scores_gemma":[0.004176555,0.0008239725,0.9913059,0.0000245103,0.00007013557,0.000015227623,0.00029498115,0.0001062952,0.000022751814,0.00002781127,0.003088499,0.000043363667],"about_ca_topic_score_codex":0.00076184556,"about_ca_topic_score_gemma":0.00038604683,"teacher_disagreement_score":0.036920846,"about_ca_system_score_codex":0.000008244461,"about_ca_system_score_gemma":0.000036486705,"threshold_uncertainty_score":0.20161548},"labels":[],"label_agreement":null},{"id":"W2587662747","doi":"10.1016/j.eururo.2017.01.037","title":"Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Tolterodine; Overactive bladder; Medicine; Mirabegron; Solifenacin; Oxybutynin; Hazard ratio; Discontinuation; Internal medicine; Urology; Interquartile range; Population; Confidence interval","score_opus":0.2135035870599135,"score_gpt":0.4217277642492797,"score_spread":0.2082241771893662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587662747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976015,0.000035309848,0.0000023386797,0.0006054173,0.00008506541,0.00089762243,0.0000064563615,0.0000103107495,0.022342533],"genre_scores_gemma":[0.99924815,0.000051363815,0.00025553975,0.00023741364,0.00004717584,0.000012252174,0.000015676767,0.000024583396,0.00010786407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976376,0.0007514423,0.00029992257,0.00060667156,0.00038871448,0.00031562807],"domain_scores_gemma":[0.99853057,0.00047271562,0.00022534376,0.00048699326,0.0001649003,0.000119461125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085878075,0.00016639139,0.00032321594,0.00010408619,0.00014448752,0.000045757635,0.00019581635,0.000048205322,0.000043346765],"category_scores_gemma":[0.0014107039,0.00012888048,0.00002313009,0.00012303896,0.000344865,0.00032934002,0.00020937993,0.0007473212,0.00002311785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027817212,0.0016203733,0.9666031,0.0000065571385,0.00016758728,0.0013668763,0.0011932983,0.0000026411528,0.00000233175,0.00000827309,0.00004041524,0.0011713228],"study_design_scores_gemma":[0.018927231,0.029079016,0.95095503,0.000026174666,0.000084868036,0.000022907321,0.00053895253,0.000049342994,6.748853e-7,0.000004136198,0.00018522935,0.00012640575],"about_ca_topic_score_codex":0.00016652863,"about_ca_topic_score_gemma":0.00025489405,"teacher_disagreement_score":0.027458642,"about_ca_system_score_codex":0.000054228058,"about_ca_system_score_gemma":0.00014902714,"threshold_uncertainty_score":0.52555937},"labels":[],"label_agreement":null},{"id":"W2590670834","doi":"10.1016/j.eururo.2017.01.046","title":"Tract Sizes in Miniaturized Percutaneous Nephrolithotomy: A Systematic Review from the European Association of Urology Urolithiasis Guidelines Panel","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"European Association of Urology","keywords":"Medicine; Percutaneous nephrolithotomy; Urology; General surgery; MEDLINE; Gynecology; Surgery; Percutaneous","score_opus":0.11187758105824297,"score_gpt":0.36609697721063894,"score_spread":0.25421939615239597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590670834","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016207543,0.9819856,0.0000016627363,0.0037048336,0.00053366605,0.0043275957,0.00039484474,0.000106930944,0.008782757],"genre_scores_gemma":[0.0006598526,0.9879467,0.00023395281,0.007822937,0.0007379661,0.000110764966,0.0005751083,0.00029979626,0.0016129497],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9794704,0.013899848,0.0039890027,0.0011868117,0.0006119942,0.00084194663],"domain_scores_gemma":[0.9887298,0.0029598007,0.004811741,0.0028210848,0.0004002412,0.00027738477],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0058387504,0.0011325366,0.0077510853,0.00029849168,0.00018303581,0.000057060493,0.0014718783,0.00050036627,0.00012442507],"category_scores_gemma":[0.015759397,0.000688621,0.0016740733,0.00030960163,0.0002179927,0.00007470986,0.0003861001,0.0013893837,0.00079385715],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039648745,0.001704019,0.0014538829,0.7824673,0.008350881,0.015158334,0.0012820815,0.0000010765618,0.0000131795705,0.00005407206,0.014707575,0.17441109],"study_design_scores_gemma":[0.0014355064,0.00047114355,0.0030509576,0.095316194,0.027223721,0.0041994196,0.00001511141,0.0000052133187,5.9005064e-8,0.00001658416,0.86777073,0.00049534114],"about_ca_topic_score_codex":0.00016070354,"about_ca_topic_score_gemma":0.00001497531,"teacher_disagreement_score":0.85306317,"about_ca_system_score_codex":0.00024969413,"about_ca_system_score_gemma":0.00043712405,"threshold_uncertainty_score":0.99998415},"labels":[],"label_agreement":null},{"id":"W2592942889","doi":"10.1016/j.eururo.2017.02.025","title":"Procedure-specific Risks of Thrombosis and Bleeding in Urological Non-cancer Surgery: Systematic Review and Meta-analysis","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Toronto; McMaster University; Impact","funders":"","keywords":"Medicine; Interquartile range; Surgery; Nephrectomy; Observational study; Percutaneous nephrolithotomy; Transplantation; Percutaneous; Kidney; Internal medicine","score_opus":0.4217875255756352,"score_gpt":0.4418219874885708,"score_spread":0.02003446191293562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592942889","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000037457856,0.99421597,0.0000066430043,0.0008887884,0.000054661337,0.0030130222,0.00003038072,0.000022075603,0.0017309815],"genre_scores_gemma":[0.0037488763,0.994483,0.000028673128,0.0010597848,0.000054744665,0.00042557679,0.00003082156,0.00007018198,0.00009833832],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99558234,0.0011736465,0.0017206828,0.0008991612,0.00023335667,0.0003908064],"domain_scores_gemma":[0.9966019,0.00056248455,0.0016640098,0.0009446952,0.00008120896,0.00014574124],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0031067382,0.0005832812,0.017343419,0.00068392575,0.000081122205,0.000037395406,0.00031107778,0.00019199942,0.00029995697],"category_scores_gemma":[0.0004165067,0.00036631178,0.0016161689,0.00044811165,0.00024925426,0.000051353796,0.000364162,0.00046868972,0.000028521941],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004090449,0.00019043597,0.00026553226,0.8970825,0.097136825,0.000097409815,0.0000551823,6.406652e-7,1.0789227e-7,0.000092024944,0.0019312764,0.0031439718],"study_design_scores_gemma":[0.000120512435,0.000117636264,0.0043528234,0.017297586,0.853639,0.00003970238,0.0000046592154,0.00000248293,2.7792519e-8,0.0000038934354,0.12414996,0.0002717129],"about_ca_topic_score_codex":0.000032809745,"about_ca_topic_score_gemma":0.00001164878,"teacher_disagreement_score":0.87978494,"about_ca_system_score_codex":0.000029430204,"about_ca_system_score_gemma":0.000054665088,"threshold_uncertainty_score":0.9998789},"labels":[],"label_agreement":null},{"id":"W2593176248","doi":"10.1016/j.eururo.2017.02.023","title":"Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair–deficient Prostate Cancer","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":218,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Loss of heterozygosity; Germline; Prostate cancer; Prostate; Oncology; DNA repair; Internal medicine; Cancer; Cancer research; Gynecology; DNA; Genetics; Allele; Gene","score_opus":0.03292710841914352,"score_gpt":0.33842346555120995,"score_spread":0.3054963571320664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593176248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991202,0.0010841701,7.712796e-7,0.0038566547,0.00011407449,0.0004672377,0.000038028305,0.00003086993,0.0032062002],"genre_scores_gemma":[0.9963362,0.0008604215,0.00004333674,0.00020684469,0.000043649157,0.000024226425,0.000011032581,0.000022400518,0.0024518718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988856,0.00012850775,0.00024544826,0.0003254714,0.000117031705,0.0002979606],"domain_scores_gemma":[0.99918103,0.000038062874,0.00013108901,0.00049520604,0.000049847626,0.00010476563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021058807,0.00015153261,0.0003791815,0.00009915604,0.00010529227,0.000012733424,0.00009631498,0.000024500985,0.00003962565],"category_scores_gemma":[0.00006997169,0.000100145415,0.00007859298,0.000035063793,0.00035041006,0.00004196112,0.00013948769,0.00010946563,0.000016658874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085466687,0.00034418996,0.99102294,0.000054276716,0.000098685705,0.0018511988,0.00053741253,0.000004768204,0.0013138434,0.000028850856,0.00006410421,0.0038250638],"study_design_scores_gemma":[0.005134805,0.001449525,0.9875618,0.000022536786,0.00006478121,0.00006449331,0.000016746184,0.000077591714,0.0009781471,0.000011897647,0.0045386897,0.00007898916],"about_ca_topic_score_codex":0.0003579088,"about_ca_topic_score_gemma":0.00013828615,"teacher_disagreement_score":0.005134223,"about_ca_system_score_codex":0.00008380966,"about_ca_system_score_gemma":0.000065646804,"threshold_uncertainty_score":0.40838113},"labels":[],"label_agreement":null},{"id":"W2596327728","doi":"10.1016/j.eururo.2017.02.038","title":"Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; BC Cancer Agency; Genome British Columbia; University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Prostate cancer; Nomogram; Prostatectomy; Oncology; Proportional hazards model; Stromal cell; Biochemical recurrence; Receiver operating characteristic; Gene signature; Metastasis; Internal medicine; Prostate; Cancer; Gene expression; Gene; Biology","score_opus":0.043962014356619505,"score_gpt":0.34487937536754326,"score_spread":0.30091736101092376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596327728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9571143,0.0034242317,0.00076479744,0.010191814,0.0005505006,0.00219811,0.0006032101,0.00010690762,0.025046166],"genre_scores_gemma":[0.98268574,0.00067946425,0.001766818,0.0014193607,0.0004300696,0.0002034631,0.00014429085,0.0000696102,0.01260116],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987689,0.00011473813,0.00017513445,0.000383516,0.00016556677,0.00039210165],"domain_scores_gemma":[0.9990287,0.000052998268,0.00013910994,0.0005015857,0.00012423257,0.00015341066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025378892,0.00015287085,0.0002619718,0.000063723004,0.00033608562,0.000035605743,0.00019887817,0.000030221272,0.00015094459],"category_scores_gemma":[0.000085525964,0.00010957778,0.0000858527,0.00002379864,0.00022681116,0.000104161234,0.0001688689,0.00016785778,0.00005796577],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03220403,0.0012238992,0.18845846,0.00092669314,0.0019024356,0.0028810522,0.0060402206,0.00005203991,0.562228,0.00009957855,0.112498336,0.09148526],"study_design_scores_gemma":[0.022924462,0.007672727,0.7141925,0.00014373359,0.00082072924,0.0001339918,0.00009452123,0.00057221233,0.10509503,0.000352803,0.14755067,0.00044658082],"about_ca_topic_score_codex":0.000015177949,"about_ca_topic_score_gemma":0.0000017443132,"teacher_disagreement_score":0.52573407,"about_ca_system_score_codex":0.00006355742,"about_ca_system_score_gemma":0.00014764305,"threshold_uncertainty_score":0.4468452},"labels":[],"label_agreement":null},{"id":"W2598081978","doi":"10.1016/j.eururo.2017.03.007","title":"Clinical Outcomes from Androgen Signaling–directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Abiraterone acetate; Enzalutamide; Prednisone; Medicine; Prostate cancer; Internal medicine; Oncology; Urology; Pharmacology; Androgen deprivation therapy; Cancer; Androgen receptor","score_opus":0.03572552789192894,"score_gpt":0.32709393763645467,"score_spread":0.2913684097445257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598081978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964684,0.001348748,0.0000027551832,0.00055351533,0.000028091528,0.00096218614,0.00054353883,0.000023089695,0.00006964684],"genre_scores_gemma":[0.9977985,0.0010839676,0.0003360509,0.00013758664,0.00001682948,0.00007438883,0.00030961304,0.000040038958,0.00020304066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980996,0.00039698376,0.0004598304,0.00049883116,0.00024060019,0.0003041508],"domain_scores_gemma":[0.9986828,0.00012188239,0.00033110008,0.0004980789,0.0002177748,0.00014838894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023076683,0.00026230185,0.0008466858,0.00019804017,0.00009614278,0.000043649205,0.000098324206,0.000036690257,0.00011246045],"category_scores_gemma":[0.000021110658,0.00014541217,0.00008424357,0.00015272529,0.00041585133,0.00009435942,0.000038409875,0.00012668887,0.0000037542463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042205103,0.00071030407,0.9400357,0.000013496977,0.005455952,0.0004718309,0.0010379425,0.000028208033,0.0004693707,4.1028156e-7,0.000003186307,0.009568485],"study_design_scores_gemma":[0.024397967,0.011432461,0.96176094,0.00003171013,0.0018031668,0.0000012594114,0.00003981458,0.000080986705,0.00021581023,0.0000018867555,0.00009795785,0.00013602054],"about_ca_topic_score_codex":0.0009254462,"about_ca_topic_score_gemma":0.001944853,"teacher_disagreement_score":0.021725249,"about_ca_system_score_codex":0.00005845024,"about_ca_system_score_gemma":0.00014185849,"threshold_uncertainty_score":0.5929736},"labels":[],"label_agreement":null},{"id":"W2602353650","doi":"10.1016/j.eururo.2017.02.026","title":"What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":390,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Cochrane; Health Sciences Centre","funders":"","keywords":"Medicine; Prostate cancer; Meta-analysis; Interquartile range; Prostate; Biopsy; Magnetic resonance imaging; Cancer; Urology; Radiology; Internal medicine","score_opus":0.13420610987620205,"score_gpt":0.3789047417646195,"score_spread":0.24469863188841748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602353650","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018098652,0.9845444,0.0000026357932,0.0067386418,0.00018382692,0.006330855,0.0018693829,0.000018754372,0.00013053435],"genre_scores_gemma":[0.0029752997,0.9920294,0.00004412157,0.0024988297,0.00008338935,0.0014379667,0.00010273837,0.000110648594,0.00071760645],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9885738,0.0069084866,0.0024979275,0.0010665414,0.00045302438,0.0005002451],"domain_scores_gemma":[0.9903026,0.0026108301,0.0049348376,0.0013785706,0.00067792437,0.000095221025],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0041876244,0.00072388694,0.006355432,0.00035594715,0.00017700777,0.00006366949,0.0006144921,0.00010209411,0.00008185536],"category_scores_gemma":[0.002298928,0.000366415,0.001216781,0.0009833073,0.00042281082,0.00014639046,0.00051987503,0.0005315938,0.000013397775],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004466515,0.0005323393,0.039430376,0.33223453,0.19326767,0.00077243993,0.014079105,0.00024353641,0.000005058436,0.00002430254,0.0035978104,0.41536617],"study_design_scores_gemma":[0.0013076749,0.00035337557,0.017282875,0.030068735,0.88034403,0.000046708974,0.00011562792,0.00022589216,0.000002271038,0.00002423236,0.069797345,0.0004312007],"about_ca_topic_score_codex":0.001335886,"about_ca_topic_score_gemma":0.00025899406,"teacher_disagreement_score":0.6870764,"about_ca_system_score_codex":0.0004104092,"about_ca_system_score_gemma":0.00019168243,"threshold_uncertainty_score":0.99987876},"labels":[],"label_agreement":null},{"id":"W2604203648","doi":"10.1016/j.eururo.2017.03.020","title":"Local Therapy Improves Survival in Metastatic Prostate Cancer","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Propensity score matching; Prostatectomy; Confidence interval; Confounding; Retrospective cohort study; Urology; Hazard ratio; Prostate; Radiation therapy; Internal medicine; Proportional hazards model; Oncology; Cancer","score_opus":0.05171756802889916,"score_gpt":0.3560259746240684,"score_spread":0.3043084065951692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604203648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604815,0.003424713,0.00004112783,0.008927686,0.00036104943,0.0005337354,0.000013115454,0.00003991609,0.026177134],"genre_scores_gemma":[0.992253,0.0023350213,0.000037249294,0.00059919007,0.00011068286,0.000032926513,0.0000134052225,0.000038079936,0.0045804507],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987856,0.00022934165,0.00017062237,0.00029100198,0.00013874599,0.00038466166],"domain_scores_gemma":[0.99928665,0.000038091977,0.00007692,0.00044090694,0.00005023399,0.00010717095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004146622,0.00013445922,0.00025278627,0.000085846885,0.00012802299,0.000034193366,0.00019447961,0.000023472427,0.0001454051],"category_scores_gemma":[0.00006119954,0.000093329334,0.000049845723,0.000046898404,0.00036442096,0.00007275348,0.00009720289,0.00025009701,0.00013689537],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006017869,0.00055242196,0.29228008,0.000084655934,0.00039037896,0.005161681,0.0017817349,0.00002764527,0.020438118,0.0002481676,0.0014120291,0.6716052],"study_design_scores_gemma":[0.00862885,0.0012043095,0.9469226,0.00001931605,0.00003499565,0.000029041152,0.000068612244,0.00027024405,0.0017115849,0.00012704042,0.04083742,0.0001459815],"about_ca_topic_score_codex":0.00032978767,"about_ca_topic_score_gemma":0.00014376451,"teacher_disagreement_score":0.67145926,"about_ca_system_score_codex":0.00005228793,"about_ca_system_score_gemma":0.00012423351,"threshold_uncertainty_score":0.38058597},"labels":[],"label_agreement":null},{"id":"W2604535399","doi":"10.1016/j.eururo.2017.03.030","title":"Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":792,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Genome British Columbia; University of British Columbia","funders":"National Cancer Institute","keywords":"Subtyping; Medicine; Bladder cancer; Concordance; Oncology; Proportional hazards model; Internal medicine; Hazard ratio; Surgical oncology; Context (archaeology); Cancer; Confidence interval; Biology","score_opus":0.016112525959410505,"score_gpt":0.31020482395376325,"score_spread":0.29409229799435277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604535399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99372655,0.0007050905,0.000008553063,0.0010051578,0.00012674216,0.00023662864,0.000027594773,0.000017430984,0.004146243],"genre_scores_gemma":[0.998743,0.0002524493,0.000020785927,0.0006887685,0.000106424326,0.000012402211,0.000002656019,0.000048387894,0.00012510108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988329,0.00030368636,0.00019353983,0.00030711913,0.000116976065,0.00024580606],"domain_scores_gemma":[0.9991834,0.00010320167,0.00012388844,0.00044857257,0.00004572299,0.00009519245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002834296,0.00017276892,0.0003046775,0.000100001795,0.000050120398,0.000013611242,0.00010676163,0.000054953307,0.00018037471],"category_scores_gemma":[0.00020809568,0.00013406108,0.000085130065,0.00003579228,0.0001648934,0.000041695068,0.000055557546,0.00016930651,0.000012700231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016840471,0.00021295833,0.9342785,0.00001981527,0.00030847767,0.0013705561,0.0013805991,0.000038811268,0.029712358,0.000006099725,0.000038939008,0.015792426],"study_design_scores_gemma":[0.00423003,0.0024154545,0.9911926,0.000045634493,0.00006984334,0.000021144371,0.000015274098,0.000019134766,0.001679801,0.00001927857,0.00019713701,0.000094712035],"about_ca_topic_score_codex":0.00039891363,"about_ca_topic_score_gemma":0.00011891011,"teacher_disagreement_score":0.05691407,"about_ca_system_score_codex":0.00004545351,"about_ca_system_score_gemma":0.00010524421,"threshold_uncertainty_score":0.54668516},"labels":[],"label_agreement":null},{"id":"W2604768144","doi":"10.1016/j.eururo.2017.03.036","title":"Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Prostatectomy; Odds ratio; Receiver operating characteristic; Confidence interval; Logistic regression; Internal medicine; Gynecology; Prostate-specific antigen; Oncology; Cancer","score_opus":0.026792226797258668,"score_gpt":0.2820921176976257,"score_spread":0.25529989090036703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604768144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853067,0.0004958848,0.000012264179,0.0009783041,0.00009771718,0.00082272856,0.00012876473,0.000025992695,0.01213167],"genre_scores_gemma":[0.997495,0.0016270508,0.00015851151,0.00022413343,0.00008452771,0.00009239861,0.000034458866,0.000028197775,0.0002557408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987637,0.00021989607,0.00025033602,0.00040060328,0.00012123714,0.00024425893],"domain_scores_gemma":[0.9988849,0.000027163385,0.00028893462,0.00063062337,0.00006384361,0.00010451524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003589295,0.00015702879,0.00030829315,0.00008601982,0.00008765628,0.000013203794,0.00014981045,0.000040059575,0.00005768551],"category_scores_gemma":[0.00005096531,0.00011263608,0.000044540328,0.000049928633,0.00015538876,0.000057221972,0.00009474003,0.00017904196,0.000036242163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010589004,0.00017717661,0.9863206,0.000022322009,0.00008747561,0.00077113934,0.0008854638,0.00041072513,0.0024164093,0.000032929504,0.0010645954,0.006752273],"study_design_scores_gemma":[0.0026598584,0.001473491,0.9892498,0.000035852285,0.00012317249,0.000022359633,0.000048461254,0.00001204729,0.0017940534,0.000029109875,0.0044553746,0.00009637476],"about_ca_topic_score_codex":0.0002723587,"about_ca_topic_score_gemma":0.00013774204,"teacher_disagreement_score":0.012188306,"about_ca_system_score_codex":0.000100427314,"about_ca_system_score_gemma":0.00006288733,"threshold_uncertainty_score":0.4593166},"labels":[],"label_agreement":null},{"id":"W2606159587","doi":"10.1016/j.eururo.2017.03.049","title":"Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":238,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Prostate cancer; Prostatectomy; Logistic regression; Receiver operating characteristic; Lymph node; Cutoff; Stage (stratigraphy); Dissection (medical); Biopsy; Urology; Prostate-specific antigen; Cancer; Radiology; Oncology; Internal medicine","score_opus":0.041799217128731525,"score_gpt":0.3441445441825115,"score_spread":0.30234532705378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606159587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99519366,0.00016483544,0.0012152414,0.0023692218,0.00012027195,0.00050741504,0.000026104186,0.000007315806,0.00039593954],"genre_scores_gemma":[0.99816114,0.000107438376,0.00091974396,0.0003501404,0.000034728993,0.00016421551,0.000016857346,0.00001654964,0.00022916253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993803,0.000023026012,0.00019541696,0.0002010755,0.000061972285,0.00013822544],"domain_scores_gemma":[0.9995733,0.00002165786,0.00012279961,0.00018268445,0.00005409944,0.000045481334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022970223,0.000085902015,0.0001388886,0.000055497385,0.00009663969,0.000024950188,0.0000801407,0.000013417792,0.0000040273912],"category_scores_gemma":[0.000065219385,0.00005920515,0.000020572528,0.000022345563,0.00004717865,0.00004833159,0.00007633642,0.000042601365,0.0000022327008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037944182,0.0009920744,0.7955675,0.00033475534,0.00040781393,0.0000866596,0.0175924,0.0041906927,0.0682254,0.0005971129,0.00067080924,0.10754033],"study_design_scores_gemma":[0.0030312317,0.00016306566,0.9769547,0.00008354253,0.000059764254,0.00001917113,0.00004924506,0.0041519646,0.014440804,0.000044639666,0.00093055994,0.00007132146],"about_ca_topic_score_codex":0.00015037712,"about_ca_topic_score_gemma":0.00019054198,"teacher_disagreement_score":0.18138716,"about_ca_system_score_codex":0.00007229063,"about_ca_system_score_gemma":0.00006286353,"threshold_uncertainty_score":0.2414316},"labels":[],"label_agreement":null},{"id":"W2606357130","doi":"10.1016/j.eururo.2017.04.008","title":"Reply to Philipp Dahm, Vikram Narayan, and Jae Hung Jung's Letter to the Editor re: Richard J. Sylvester, Steven E. Canfield, Thomas B.L. Lam, et al. Conflict of Evidence: Resolving Discrepancies When Findings from Randomized Controlled Trials and Meta-analyses Disagree. Eur Urol 2017;71:811–9","year":2017,"lang":"en","type":"letter","venue":"European Urology","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Theology; Psychoanalysis; Philosophy; Psychology","score_opus":0.7440317960310794,"score_gpt":0.5520674210308707,"score_spread":0.1919643750002087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606357130","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029839275,0.0164696,0.00042268587,0.9590963,0.0060564256,0.011363979,0.00093128026,0.00014522021,0.0025305827],"genre_scores_gemma":[0.006312969,0.0022585473,0.00048329047,0.953185,0.019477518,0.001351428,0.00016451151,0.00026629632,0.016500419],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8577267,0.13105057,0.0058800573,0.0023568834,0.0014695652,0.0015162296],"domain_scores_gemma":[0.8659159,0.12129318,0.007870768,0.0035119553,0.0008765234,0.00053170626],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaresearch","metaepi_narrow"],"category_scores_codex":[0.081072554,0.0013940688,0.012432508,0.0006242787,0.0015920909,0.0004300383,0.0022075283,0.00092892523,0.00058657536],"category_scores_gemma":[0.19995677,0.0007645524,0.0014564574,0.00017546352,0.00084115996,0.000703095,0.00222971,0.006361257,0.00022360377],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029677428,0.00002821998,0.00031858817,0.0003107234,0.0073088673,0.00035334536,0.0102243805,0.0000023813166,0.00027499915,0.000021896489,0.9513999,0.00007927294],"study_design_scores_gemma":[0.031419,0.0004082137,0.0008593822,0.00037559198,0.01803606,0.000018047274,0.00033374538,0.000015183972,0.000009375608,0.00008294213,0.9477484,0.00069405633],"about_ca_topic_score_codex":0.009975288,"about_ca_topic_score_gemma":0.0013494832,"teacher_disagreement_score":0.11888423,"about_ca_system_score_codex":0.000103842314,"about_ca_system_score_gemma":0.0005624453,"threshold_uncertainty_score":0.99988097},"labels":[],"label_agreement":null},{"id":"W2606976048","doi":"10.1016/j.eururo.2017.03.037","title":"Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham; Lakeridge Health","funders":"","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Internal medicine; Carcinoma; Oncology; Kidney cancer; Urology; Immunotherapy; Cancer","score_opus":0.009601757548408387,"score_gpt":0.23328043273228824,"score_spread":0.22367867518387985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606976048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9574478,0.00016783767,0.000002033373,0.00020389727,0.00003384957,0.0010977959,0.0000109787925,0.00004122451,0.040994544],"genre_scores_gemma":[0.9981943,0.00001212746,0.00048939226,0.00006275868,0.000036043955,0.000053914147,0.000139424,0.00008189665,0.0009301453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980472,0.00024036814,0.00032437936,0.0006418992,0.00022924165,0.00051694806],"domain_scores_gemma":[0.9985604,0.00002530985,0.00026952455,0.00090199756,0.00007193418,0.00017081005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102766986,0.0003730972,0.0005127859,0.0002207622,0.00011885685,0.000026097921,0.00018084949,0.00006768015,0.00003682925],"category_scores_gemma":[0.00001531243,0.00023261008,0.000049789225,0.00009575843,0.00018330355,0.000110087014,0.000079555015,0.00021202097,0.000089812784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00894799,0.0013265677,0.97007954,0.000023993696,0.00003281411,0.0049982504,0.0002996069,0.0000394977,0.00076807814,0.0000031797517,0.000016902746,0.013463591],"study_design_scores_gemma":[0.029745055,0.020703483,0.94356614,0.000050968873,0.000110145615,0.00005292867,0.000015360081,0.000034647022,0.004949009,0.0000018292163,0.0005661006,0.00020431956],"about_ca_topic_score_codex":0.000117419506,"about_ca_topic_score_gemma":0.00020475867,"teacher_disagreement_score":0.040746458,"about_ca_system_score_codex":0.00029927513,"about_ca_system_score_gemma":0.00008063563,"threshold_uncertainty_score":0.9485564},"labels":[],"label_agreement":null},{"id":"W2607115439","doi":"10.1016/j.eururo.2017.03.021","title":"An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; Zymeworks (Canada); University of British Columbia","funders":"H. Lundbeck A/S; Lundbeckfonden; Prostate Cancer Canada","keywords":"Medicine; Cisplatin; Oncofetal antigen; Bladder cancer; Oncology; Internal medicine; Cancer research; Cancer; Chemotherapy; Immunotherapy","score_opus":0.06121569020570082,"score_gpt":0.3822384388406729,"score_spread":0.32102274863497204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607115439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790151,0.00048040797,0.004173565,0.003420139,0.0003342253,0.0007766092,0.00010061892,0.000047420053,0.0116518885],"genre_scores_gemma":[0.9953061,0.0001162584,0.00028349174,0.0019488878,0.00074362673,0.00013479008,0.000114225484,0.000089172194,0.0012634844],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99743015,0.00043245478,0.00032262347,0.00090921926,0.00025637663,0.00064919714],"domain_scores_gemma":[0.99744076,0.000017641942,0.00020989004,0.0018095177,0.00019054269,0.00033162738],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052791706,0.00030381195,0.00023458981,0.000116143194,0.0006447888,0.00042730992,0.002033983,0.00013589165,0.000119997356],"category_scores_gemma":[0.00018346534,0.0002772286,0.00009342729,0.00007703207,0.00030413008,0.000041428353,0.00056977686,0.00023573377,0.000100375335],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012156811,0.00017373156,0.0066337143,0.00001826685,0.00012894638,0.00006246759,0.00013200825,0.00038628996,0.8974299,0.00034743335,0.0018797088,0.09159187],"study_design_scores_gemma":[0.0020905102,0.0038082385,0.5681288,0.000018637395,0.000096550655,0.00004580191,0.000058160003,0.001523602,0.10837324,0.00021246624,0.3146068,0.0010372249],"about_ca_topic_score_codex":0.00042718515,"about_ca_topic_score_gemma":0.0009705567,"teacher_disagreement_score":0.78905666,"about_ca_system_score_codex":0.000032857224,"about_ca_system_score_gemma":0.0001869383,"threshold_uncertainty_score":0.999968},"labels":[],"label_agreement":null},{"id":"W2607199659","doi":"10.1016/j.eururo.2017.04.006","title":"Seeking the Molecular Truth in Bladder Cancer: Biology = Genome × (Transcriptome) 2","year":2017,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Transcriptome; Genome; Bladder cancer; Computational biology; Cancer; Genetics; Gene; Internal medicine; Gene expression; Biology","score_opus":0.024545535611393256,"score_gpt":0.289450091162787,"score_spread":0.26490455555139375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607199659","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010539301,0.017030368,0.00018222403,0.8380989,0.0029466497,0.0012151536,0.0002612865,0.00015319123,0.12957293],"genre_scores_gemma":[0.33860925,0.00073695765,0.000027965487,0.6520848,0.0047628386,0.00008580432,0.0003593988,0.00022543788,0.0031074914],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967931,0.0008629076,0.0004484122,0.00086175045,0.00019762135,0.0008362378],"domain_scores_gemma":[0.9982095,0.00011380581,0.00025329247,0.0012771675,0.00006228985,0.0000839857],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00032873335,0.0005279078,0.0007910334,0.00025350027,0.00016196031,0.000040862324,0.000763538,0.0005093162,0.00065389846],"category_scores_gemma":[0.00007009866,0.00036918258,0.00026718315,0.000103756,0.00044894253,0.000033830947,0.00014360563,0.0024611582,0.00037163432],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013162993,0.00044840912,0.015310103,0.0006253218,0.005948874,0.10148396,0.0036015161,0.000058577712,0.023733128,0.00057425135,0.82076246,0.026137117],"study_design_scores_gemma":[0.002108089,0.00048335423,0.011544766,0.000035205143,0.00057158055,0.00034306443,0.000006347299,0.000008013401,0.000030832154,0.00016779265,0.98438716,0.0003138115],"about_ca_topic_score_codex":0.00035872243,"about_ca_topic_score_gemma":0.000026546038,"teacher_disagreement_score":0.32806996,"about_ca_system_score_codex":0.0001174873,"about_ca_system_score_gemma":0.00022132833,"threshold_uncertainty_score":0.999876},"labels":[],"label_agreement":null},{"id":"W2607459795","doi":"10.1016/j.eururo.2017.04.004","title":"Intraductal Carcinoma of the Prostate: Anonymous to Ominous","year":2017,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Carcinoma; Prostate; Prostate disease; Prostate carcinoma; General surgery; Urology; Gynecology; Oncology; Internal medicine; Cancer","score_opus":0.017611321929255287,"score_gpt":0.24502531327714697,"score_spread":0.22741399134789167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607459795","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22933699,0.0011220359,0.0000021219055,0.73697466,0.0015105121,0.0013487906,0.00021120354,0.000037642,0.029456027],"genre_scores_gemma":[0.58959526,0.00006467603,0.000040318915,0.4024003,0.0024551882,0.000041174542,0.00011715594,0.00010435585,0.005181581],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99818784,0.00026415676,0.0003456099,0.0005302788,0.0002280009,0.0004441327],"domain_scores_gemma":[0.99821264,0.00006327501,0.00031767107,0.0012055662,0.0001060618,0.000094775714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014592717,0.0003219636,0.00057689246,0.00009674772,0.00010695758,0.000019934909,0.0004432071,0.00018143722,0.00008759909],"category_scores_gemma":[0.00012447605,0.00020732229,0.00020938722,0.00005871585,0.0002692477,0.000018767323,0.00029864174,0.0009215848,0.00024853792],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013587417,0.00008594796,0.015382171,0.00013122738,0.0001523117,0.008402405,0.00035545375,9.391913e-7,0.00016390285,0.0000063134985,0.96884996,0.0063335015],"study_design_scores_gemma":[0.0009448535,0.0017348295,0.13787654,0.00005752786,0.00030646988,0.0007921779,0.0000032125722,8.371477e-7,0.0006580207,0.000012417683,0.85745114,0.00016195551],"about_ca_topic_score_codex":0.000058843078,"about_ca_topic_score_gemma":0.000005156559,"teacher_disagreement_score":0.36025825,"about_ca_system_score_codex":0.00008943717,"about_ca_system_score_gemma":0.00019137262,"threshold_uncertainty_score":0.84543574},"labels":[],"label_agreement":null},{"id":"W2609464379","doi":"10.1016/j.eururo.2017.04.015","title":"Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":286,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Grading (engineering); Bladder cancer; Reproducibility; Disease; Repeatability; Oncology; Cancer; Internal medicine; Pathology","score_opus":0.10392295709868216,"score_gpt":0.35299454891618864,"score_spread":0.2490715918175065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609464379","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002993034,0.98654157,0.00001055379,0.0018034705,0.00072602974,0.0072647114,0.0001528869,0.000032497646,0.00047526392],"genre_scores_gemma":[0.09967034,0.89810616,0.000013815809,0.0007531421,0.00030745947,0.00026903895,0.00009762163,0.00013341327,0.00064899545],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9917424,0.003399722,0.0026002848,0.0014221148,0.00037100847,0.00046448718],"domain_scores_gemma":[0.99150735,0.00058036664,0.0049331877,0.0019531128,0.0008826048,0.00014339789],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0047558085,0.00058101554,0.0032222068,0.00030488727,0.00020723295,0.00003157157,0.00044730754,0.00017194057,0.00001854879],"category_scores_gemma":[0.0067149,0.00039835667,0.00018641975,0.00064717466,0.00024443856,0.00012509558,0.0002491734,0.00053912256,0.0000139394715],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042150114,0.00026300873,0.047687788,0.85917354,0.001384418,0.00003108751,0.0011254254,0.000023053553,0.000056178465,0.000013658678,0.004355131,0.08584456],"study_design_scores_gemma":[0.0031747988,0.0013670839,0.3854506,0.5405928,0.017550632,0.00026232545,0.000113120965,0.00015592876,0.000009184219,0.000007890683,0.050313476,0.0010021994],"about_ca_topic_score_codex":0.000667624,"about_ca_topic_score_gemma":0.0005759871,"teacher_disagreement_score":0.3377628,"about_ca_system_score_codex":0.00045372924,"about_ca_system_score_gemma":0.0013256724,"threshold_uncertainty_score":0.9998468},"labels":[],"label_agreement":null},{"id":"W2609878739","doi":"10.1016/j.eururo.2017.04.016","title":"What are the Benefits and Harms of Ureteroscopy Compared with Shock-wave Lithotripsy in the Treatment of Upper Ureteral Stones? A Systematic Review","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Cochrane; Health Sciences Centre","funders":"","keywords":"Medicine; Ureteroscopy; Shock wave lithotripsy; Lithotripsy; Surgery; Urology; Ureter","score_opus":0.11652105910030887,"score_gpt":0.3523281918539673,"score_spread":0.23580713275365844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609878739","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028719932,0.9910037,5.815334e-7,0.0005850317,0.00015934306,0.005020905,0.00008044443,0.0000108518825,0.0002671463],"genre_scores_gemma":[0.0053316895,0.9933238,0.000031898646,0.0006806094,0.00006759004,0.00021883156,0.00009727149,0.00007501563,0.00017330823],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99571353,0.0019819492,0.0011812844,0.00050612685,0.000296337,0.00032074572],"domain_scores_gemma":[0.9960072,0.000380086,0.0017070434,0.0017072319,0.00009192241,0.00010653574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007119422,0.0006139526,0.0044441316,0.00014305243,0.00009251546,0.00004720229,0.000412171,0.0001170559,0.000012239036],"category_scores_gemma":[0.00012708787,0.00023711153,0.0004698703,0.0001499162,0.00033340618,0.000069922084,0.000069089656,0.0002797615,0.000013891129],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004231573,0.0013327723,0.006065306,0.914806,0.0033253243,0.0008017532,0.004120638,6.2858936e-7,3.6979452e-7,0.00006664395,0.00014527736,0.06891214],"study_design_scores_gemma":[0.0037255962,0.0055805445,0.015156602,0.7412766,0.028551029,0.0055906987,0.00029866162,0.000008427892,7.2129654e-7,0.0000025531078,0.19936727,0.00044129137],"about_ca_topic_score_codex":0.000015870708,"about_ca_topic_score_gemma":0.0000042724464,"teacher_disagreement_score":0.19922198,"about_ca_system_score_codex":0.00005071597,"about_ca_system_score_gemma":0.00008644835,"threshold_uncertainty_score":0.96691275},"labels":[],"label_agreement":null},{"id":"W2610791421","doi":"10.1016/j.eururo.2017.03.019","title":"Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Life expectancy; Radiation therapy; Incidence (geometry); Quality of life (healthcare); MEDLINE; Geriatric oncology; Cancer; Internal medicine; Intensive care medicine; Population","score_opus":0.1060390419798309,"score_gpt":0.3951790412339981,"score_spread":0.2891399992541672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610791421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000031340821,0.97974753,0.0000050386975,0.00024256937,0.00039451572,0.012739849,0.0005165268,0.000039262548,0.006311548],"genre_scores_gemma":[0.000046954035,0.9912623,0.00002160213,0.0014548047,0.00022979826,0.004232797,0.00040695598,0.00016871197,0.0021760298],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964487,0.0009900853,0.0011419257,0.00077516027,0.00016947153,0.00047464506],"domain_scores_gemma":[0.9972899,0.00035919898,0.0010007446,0.0010144416,0.00017477784,0.0001609588],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027794827,0.0007120241,0.0043898723,0.00019876618,0.000107192325,0.000025308449,0.00032938473,0.00016764163,0.00017358371],"category_scores_gemma":[0.00060855655,0.00045820232,0.00079283497,0.000120333745,0.00009537648,0.00006669581,0.00007046074,0.00026538954,0.0003263091],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044971257,0.00043175532,0.000017875578,0.5960979,0.0016050523,0.00023851276,0.00022493598,8.351602e-8,4.3896474e-8,0.000012140299,0.0017037189,0.399623],"study_design_scores_gemma":[0.0024047538,0.0028167202,0.000055260134,0.27301937,0.0125869615,0.0000352591,0.0000055919068,3.0929385e-7,1.2573405e-7,0.000005329331,0.70877916,0.00029117716],"about_ca_topic_score_codex":0.00007261735,"about_ca_topic_score_gemma":0.0001763494,"teacher_disagreement_score":0.7070754,"about_ca_system_score_codex":0.00048609174,"about_ca_system_score_gemma":0.0006840566,"threshold_uncertainty_score":0.999787},"labels":[],"label_agreement":null},{"id":"W2611553464","doi":"10.1016/j.eururo.2017.04.028","title":"Trimodal Therapy is Inferior to Radical Cystectomy for Muscle-invasive Bladder Cancer using Population-level Data: Is There Evidence in the (Lack of) Details?","year":2017,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; Population; Surgery; Cancer; Internal medicine; Environmental health","score_opus":0.3241282466932805,"score_gpt":0.41843067829454245,"score_spread":0.09430243160126195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611553464","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29238817,0.0135881305,0.00056413043,0.6810338,0.0014746537,0.006197762,0.0029790283,0.00006310276,0.0017112376],"genre_scores_gemma":[0.36651346,0.0009673864,0.0005312199,0.6256458,0.0047047627,0.00014323591,0.00033687163,0.00019575455,0.0009614949],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967641,0.0006609983,0.00062871556,0.0009701787,0.00042810207,0.00054789364],"domain_scores_gemma":[0.9966248,0.00062334136,0.00045257615,0.002053556,0.00016545353,0.000080262434],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059450144,0.00047964556,0.0008804422,0.00020934473,0.00016419918,0.00006141789,0.0012798198,0.00037528825,0.00049402134],"category_scores_gemma":[0.0003941714,0.000326643,0.00021462856,0.00014510484,0.00021558607,0.00017232478,0.00021627716,0.0009274888,0.00006821499],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018325242,0.00020085108,0.03715026,0.00046701846,0.0011749575,0.0014497357,0.0037782267,0.000010154306,0.0007544064,0.0000045929887,0.93367606,0.01950121],"study_design_scores_gemma":[0.0056838416,0.0014840532,0.18966998,0.00057115435,0.0009291568,0.00015146863,0.000035157143,0.00009089573,0.00017420216,0.000050679115,0.8006604,0.00049903215],"about_ca_topic_score_codex":0.0021501987,"about_ca_topic_score_gemma":0.00021010154,"teacher_disagreement_score":0.15251972,"about_ca_system_score_codex":0.000102720995,"about_ca_system_score_gemma":0.00058185105,"threshold_uncertainty_score":0.9999186},"labels":[],"label_agreement":null},{"id":"W2612811682","doi":"10.1016/j.eururo.2017.04.011","title":"Setting Research Priorities for Kidney Cancer","year":2017,"lang":"en","type":"editorial","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia; Princess Margaret Cancer Centre; University of Calgary; Alberta Kidney Disease Network; Memorial University of Newfoundland; University of Alberta; St. Michael's Hospital; University of Ottawa; University Health Network; Ottawa Hospital; Dalhousie University; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; General partnership; Kidney cancer; Context (archaeology); Cancer; Kidney disease; Intensive care medicine; Internal medicine","score_opus":0.07535470973050647,"score_gpt":0.3987827583344235,"score_spread":0.32342804860391705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612811682","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010641642,0.004095463,0.000011310323,0.0040418445,0.86982936,0.001376534,0.00057020737,0.00011785697,0.11889326],"genre_scores_gemma":[0.0031033684,0.0006674065,0.0002998492,0.00035442345,0.93043536,0.00018062489,0.00071855844,0.000248659,0.06399176],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964745,0.0007345104,0.00038523253,0.0008297463,0.0007362942,0.00083974056],"domain_scores_gemma":[0.99570954,0.0016679225,0.00026098732,0.0011234457,0.0008838331,0.00035428166],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021841275,0.0003576096,0.00068106386,0.0002794325,0.00044487006,0.000084417596,0.00052415335,0.00046366226,0.00013163377],"category_scores_gemma":[0.008952051,0.0003082956,0.00023009612,0.000048791724,0.00039702072,0.00003917135,0.00034332077,0.001666472,0.0003432694],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006589951,0.00003463369,0.00025409812,0.0004980862,0.00021718405,0.0008860383,0.00017542487,4.4673328e-7,0.0002110759,0.000020416794,0.99322504,0.0038185802],"study_design_scores_gemma":[0.0020854434,0.0016178057,0.0009533589,0.00018953285,0.00033839158,0.000024515026,0.000010074576,0.000006234147,0.00011313978,0.000050431754,0.9944009,0.00021013593],"about_ca_topic_score_codex":0.00014305887,"about_ca_topic_score_gemma":0.000023761128,"teacher_disagreement_score":0.060605988,"about_ca_system_score_codex":0.0002941492,"about_ca_system_score_gemma":0.001993329,"threshold_uncertainty_score":0.99993694},"labels":[],"label_agreement":null},{"id":"W2613052489","doi":"10.1016/j.eururo.2017.04.033","title":"The Impact of Quality Variations on Patients Undergoing Surgery for Renal Cell Carcinoma: A National Cancer Database Study","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; University of Ottawa; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Cancer; Kidney cancer; National database; Carcinoma; Database; Surgery; Internal medicine; Oncology; General surgery; Urology","score_opus":0.12604353412197047,"score_gpt":0.4340858199076101,"score_spread":0.30804228578563964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613052489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848508,0.000036000485,0.0001611735,0.0007335627,0.00013149234,0.0005682813,0.00015762584,0.0000073293213,0.013353721],"genre_scores_gemma":[0.998965,0.000020989986,0.000050976578,0.00012576803,0.00018459401,0.000039070786,0.000058180023,0.000015640144,0.00053976226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983787,0.00063364394,0.00031935005,0.00020417271,0.00023483165,0.0002293153],"domain_scores_gemma":[0.9951155,0.0036959066,0.0003040718,0.00046983437,0.00033733805,0.000077305005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020453748,0.000091767935,0.00028055834,0.00007001456,0.00052285637,0.000015550157,0.00018493386,0.000027461854,0.00005192042],"category_scores_gemma":[0.0049681207,0.000058224643,0.00010829813,0.00003508648,0.00015822293,0.00003927995,0.00009841227,0.00014704034,0.000017317298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011384235,0.00087496307,0.99088764,0.000020937228,0.00014278595,0.000010075672,0.00021008919,0.000012719345,0.00011297427,0.00026357133,0.0059601045,0.00036568544],"study_design_scores_gemma":[0.0027497776,0.0017027355,0.9948139,0.000006715059,0.00008392736,0.0000013186165,0.000024680146,0.0002705331,0.000011623438,0.000076771015,0.00020988479,0.000048086615],"about_ca_topic_score_codex":0.00047338102,"about_ca_topic_score_gemma":0.00023059,"teacher_disagreement_score":0.014114205,"about_ca_system_score_codex":0.00009009625,"about_ca_system_score_gemma":0.0008200635,"threshold_uncertainty_score":0.5947664},"labels":[],"label_agreement":null},{"id":"W2613476616","doi":"10.1016/j.eururo.2017.04.034","title":"A Prostate Cancer “ Nimbosus ”: Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Université Laval; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Prostate cancer; Metastasis; Cancer; Oncology; Biochemical recurrence; Cancer research; Pathological; Internal medicine; Pathology","score_opus":0.024017560087857916,"score_gpt":0.2913931653293357,"score_spread":0.26737560524147774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613476616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883431,0.006885936,0.000008674736,0.0033019725,0.000116402116,0.0003533159,0.000034115743,0.00002587839,0.0009305829],"genre_scores_gemma":[0.9928019,0.0067247264,0.00019425454,0.00013929572,0.00005496665,0.000014391134,0.000013937021,0.000018310782,0.000038185633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991987,0.00008937482,0.00020729538,0.00026864803,0.0000626389,0.00017337009],"domain_scores_gemma":[0.9992856,0.000036297148,0.00021861872,0.0003339593,0.00005100933,0.00007453581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021245873,0.00012652209,0.00025114327,0.000062181185,0.00015072478,0.000023496186,0.0000621953,0.000040802945,0.000015845037],"category_scores_gemma":[0.00011610988,0.000097753,0.000025498202,0.00002302413,0.00053823227,0.00009192916,0.00017704294,0.0000997365,0.0000027099304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006881463,0.00008005977,0.8334512,0.000117411255,0.000055709887,0.000088633096,0.0010499345,0.0000046965233,0.014199698,0.00025300632,0.00006209318,0.14994937],"study_design_scores_gemma":[0.0017946535,0.0008160616,0.99340814,0.00008629151,0.000082701226,0.00008275477,0.000057985766,0.00003903445,0.0023220426,0.0004068662,0.0008234769,0.000079992926],"about_ca_topic_score_codex":0.00007634208,"about_ca_topic_score_gemma":0.00004644113,"teacher_disagreement_score":0.1599569,"about_ca_system_score_codex":0.00004269488,"about_ca_system_score_gemma":0.000044723198,"threshold_uncertainty_score":0.39862517},"labels":[],"label_agreement":null},{"id":"W2615697870","doi":"10.1016/j.eururo.2017.05.009","title":"Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Metastasis; Biopsy; Hazard ratio; Oncology; Cancer; Internal medicine; Prostate; Prostate biopsy; Radiation therapy; Biochemical recurrence; Confidence interval","score_opus":0.050108025248086864,"score_gpt":0.29780099335761,"score_spread":0.24769296810952315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615697870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932733,0.00066181377,0.000022025346,0.0031522566,0.00029883752,0.00072450354,0.00041183335,0.000026596541,0.0014288053],"genre_scores_gemma":[0.99788606,0.0006201274,0.0001294749,0.00090687803,0.00016016146,0.00011632421,0.000034197492,0.000035699144,0.00011104765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984892,0.00022135804,0.0003695233,0.0004986485,0.00014803694,0.00027324702],"domain_scores_gemma":[0.9985194,0.00015768412,0.00023122093,0.000819903,0.000069495305,0.0002022931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005166431,0.00019604432,0.0004502375,0.00012175372,0.00009721157,0.000032608612,0.00008719644,0.000038980692,0.0003793408],"category_scores_gemma":[0.00012074966,0.00014589129,0.00009816663,0.000058452184,0.00021056764,0.000058899055,0.000071200964,0.00010748118,0.000038097234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037812034,0.00035892354,0.9611225,0.00008687505,0.00018049848,0.00037110824,0.00031980278,0.00005257311,0.0024310506,0.000010485593,0.002103538,0.029181406],"study_design_scores_gemma":[0.001331801,0.00086785684,0.973458,0.000034436536,0.00017648697,0.000007640106,0.000010371873,0.00009453913,0.0010675037,0.0000069353327,0.02283038,0.0001140298],"about_ca_topic_score_codex":0.00016680967,"about_ca_topic_score_gemma":0.000045407574,"teacher_disagreement_score":0.029067377,"about_ca_system_score_codex":0.00011971452,"about_ca_system_score_gemma":0.00011485428,"threshold_uncertainty_score":0.5949274},"labels":[],"label_agreement":null},{"id":"W2620846984","doi":"10.1016/j.eururo.2017.05.049","title":"Re: Clonal Evolution of Chemotherapy-resistant Urothelial Carcinoma","year":2017,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Urothelial carcinoma; Chemotherapy; Carcinoma; Oncology; Urothelial cancer; Internal medicine; Cancer research; Cancer; Bladder cancer","score_opus":0.020412164458466706,"score_gpt":0.2620784331030494,"score_spread":0.24166626864458268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620846984","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027614893,0.0035244448,0.00015333603,0.680781,0.0024459728,0.0013544726,0.0006586281,0.00018905854,0.28327817],"genre_scores_gemma":[0.6768454,0.000060459453,0.00014052069,0.30092174,0.009363784,0.000017117192,0.00028411386,0.00023525096,0.012131619],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976611,0.00037567364,0.00047639123,0.0006319747,0.00037615682,0.00047867268],"domain_scores_gemma":[0.99806696,0.00006377687,0.00045752112,0.0011829329,0.00013764751,0.000091145645],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022645434,0.0004223614,0.0007669155,0.0001964101,0.00011585536,0.000016544867,0.00042301326,0.0004440417,0.00073726964],"category_scores_gemma":[0.00007571666,0.00036557118,0.00033395662,0.000055862332,0.00037652545,0.000035173598,0.000093380215,0.0011395122,0.00033484717],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017148799,0.00012176554,0.005459665,0.00021557494,0.00041891463,0.004481247,0.00017075145,3.8725508e-7,0.0016132551,0.000027344347,0.98420835,0.0015678626],"study_design_scores_gemma":[0.0037935874,0.0019836666,0.060925484,0.0000511236,0.0005421884,0.00019980442,0.000007812624,0.0000041633666,0.00033635416,0.000098685196,0.9317919,0.00026522463],"about_ca_topic_score_codex":0.00023743931,"about_ca_topic_score_gemma":0.000012579467,"teacher_disagreement_score":0.6492305,"about_ca_system_score_codex":0.00017075874,"about_ca_system_score_gemma":0.00040858824,"threshold_uncertainty_score":0.9998796},"labels":[],"label_agreement":null},{"id":"W2621328536","doi":"10.1016/j.eururo.2017.05.044","title":"Robotic-assisted Radical Prostatectomy for High-risk Cancer: Time for “Sexta-fecta”","year":2017,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; St Joseph's Health Centre; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Urology; Cancer; Manduca sexta; Internal medicine","score_opus":0.022369681529650076,"score_gpt":0.2810895093106328,"score_spread":0.25871982778098274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621328536","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005789899,0.0057568755,0.0011190297,0.9637728,0.0035958514,0.010606654,0.0042964136,0.00045256887,0.004609908],"genre_scores_gemma":[0.030825762,0.0028510806,0.005115025,0.8637234,0.030430023,0.0077384524,0.0151816765,0.0014145982,0.042719983],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965954,0.00035386684,0.00058816874,0.0012190414,0.00023730248,0.0010062668],"domain_scores_gemma":[0.99700564,0.0006821741,0.00073522434,0.0011304492,0.00024156897,0.00020495275],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042872792,0.0006618077,0.0013689368,0.00018117468,0.0003688218,0.00007895061,0.00042646663,0.0005267985,0.0002604804],"category_scores_gemma":[0.0004015715,0.00053806446,0.0004857162,0.00005403317,0.00035357574,0.000050126506,0.00012260299,0.0011513128,0.00033032836],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094489305,0.00017454343,0.0006388398,0.00048256188,0.001212281,0.0017591139,0.000045185967,0.00001317157,0.00006599092,0.000024821433,0.96853334,0.026105285],"study_design_scores_gemma":[0.00920769,0.0047398927,0.0074617025,0.0001534082,0.002912919,0.00015226145,7.0765054e-7,0.000107298445,0.0001601797,0.00017993001,0.9744509,0.0004731113],"about_ca_topic_score_codex":0.000096767755,"about_ca_topic_score_gemma":0.000009903059,"teacher_disagreement_score":0.1000494,"about_ca_system_score_codex":0.00028516367,"about_ca_system_score_gemma":0.00033937406,"threshold_uncertainty_score":0.9997071},"labels":[],"label_agreement":null},{"id":"W2622587024","doi":"10.1016/j.eururo.2017.05.055","title":"Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Randomized controlled trial; Prostate cancer; Prostatectomy; Observational study; Quality of life (healthcare); Radiation therapy; Erectile dysfunction; Surgery; Internal medicine; Cancer","score_opus":0.10795839623399713,"score_gpt":0.41751997583182093,"score_spread":0.3095615795978238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622587024","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003706952,0.9930987,0.000018967443,0.0022107093,0.0005683396,0.0024629876,0.0006076291,0.00003078986,0.0009648595],"genre_scores_gemma":[0.00009875304,0.99592507,0.00010936294,0.0006321209,0.00022396324,0.0008503879,0.0019851716,0.000060349197,0.0001148436],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983307,0.00040485733,0.00047377814,0.00051405985,0.000093075716,0.00018348987],"domain_scores_gemma":[0.99844646,0.00040850553,0.00051409466,0.00035084828,0.00013832451,0.00014174315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060032273,0.00026756735,0.0013757728,0.00010309839,0.00016241289,0.000051842217,0.000102659666,0.00006101682,0.000011564824],"category_scores_gemma":[0.00030032048,0.00021428375,0.0001803978,0.00006800791,0.00010130694,0.00010302217,0.00006283457,0.00012618865,0.000006487902],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031943415,0.00005257057,0.0012107654,0.0056444425,0.00051520794,0.000040777468,0.00003885066,9.0956945e-8,9.6006104e-8,0.00012588502,0.0020722528,0.9902671],"study_design_scores_gemma":[0.0007653327,0.00022186512,0.0022646063,0.007010047,0.0018962172,0.000038879756,0.0000035407118,0.000006557083,1.1661336e-7,0.000009890803,0.9876212,0.00016174793],"about_ca_topic_score_codex":0.000014074369,"about_ca_topic_score_gemma":0.000012099167,"teacher_disagreement_score":0.9901054,"about_ca_system_score_codex":0.000087555985,"about_ca_system_score_gemma":0.00030377318,"threshold_uncertainty_score":0.87382376},"labels":[],"label_agreement":null},{"id":"W2626140211","doi":"10.1016/j.eururo.2017.06.006","title":"Re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol. 2017;71:606–17","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Nephrectomy; Meta-analysis; Urology; Renal cell carcinoma; Oncology; Internal medicine; Kidney","score_opus":0.41490675997856413,"score_gpt":0.4694977684829215,"score_spread":0.054591008504357386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626140211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003331472,0.9866798,0.000033185013,0.00031145322,0.00044583983,0.009953984,0.0005506408,0.00008266716,0.0016092914],"genre_scores_gemma":[0.0011363736,0.9935179,0.0008751543,0.0005454519,0.0005122957,0.0013384027,0.0005086264,0.00018128358,0.0013845556],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9851096,0.0063617094,0.0045562363,0.0022558002,0.0007710453,0.0009455531],"domain_scores_gemma":[0.98770046,0.0039565805,0.0045205536,0.0024904588,0.00060975464,0.0007221701],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004784347,0.0016608306,0.025384327,0.0006265743,0.00033039798,0.0000875677,0.00083427894,0.00043145014,0.00014675804],"category_scores_gemma":[0.002153057,0.0011237799,0.0045943977,0.00054722716,0.0014203504,0.00013570537,0.000615699,0.0012408482,0.000059997456],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018384375,0.000604802,0.00023158547,0.36528495,0.596541,0.003301912,0.0004023611,0.000002404768,6.302578e-7,0.000050821684,0.028834732,0.0029063383],"study_design_scores_gemma":[0.003161673,0.0021201705,0.00018855318,0.004948683,0.57343996,0.0003413048,0.000020996185,0.000019959463,5.886211e-7,0.000002986346,0.41524482,0.000510312],"about_ca_topic_score_codex":0.000030545998,"about_ca_topic_score_gemma":0.000031488482,"teacher_disagreement_score":0.3864101,"about_ca_system_score_codex":0.00016656857,"about_ca_system_score_gemma":0.00047668122,"threshold_uncertainty_score":0.9996139},"labels":[],"label_agreement":null},{"id":"W2664930764","doi":"10.1016/j.eururo.2017.06.002","title":"Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":643,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of British Columbia; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Medical Research Council; Sanofi Genzyme; Astellas Pharma; National Institute for Health and Care Research; Prostate Cancer Foundation; Movember Foundation; AstraZeneca; Bristol-Myers Squibb; Swiss Cancer Research Foundation; Sanofi; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Amgen; European School of Oncology; National Health and Medical Research Council; Cancer Research UK","keywords":"Medicine; Prostate cancer; Prostate; Cancer; Management of prostate cancer; Consensus conference; Prostate disease; Oncology; Gynecology; General surgery; Internal medicine","score_opus":0.023431968039114393,"score_gpt":0.31425055469832053,"score_spread":0.2908185866592061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2664930764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97179514,0.0014694331,0.000002900492,0.007928038,0.00038145029,0.0021662745,0.00016048692,0.000022112761,0.01607417],"genre_scores_gemma":[0.9868783,0.002189267,0.00011610387,0.00015208924,0.00003156881,0.00013580908,0.000025903246,0.000040985225,0.010429984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981556,0.00018538634,0.00041728292,0.0004261102,0.0004031782,0.00041247075],"domain_scores_gemma":[0.997105,0.000042614018,0.0008664835,0.0013756014,0.0005226653,0.00008760652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032256107,0.0002212055,0.00037776324,0.000041464362,0.0003250057,0.000018402661,0.0005014164,0.000031293133,0.00005321945],"category_scores_gemma":[0.000066544824,0.00010850685,0.00007576819,0.00009587656,0.0012274326,0.00005865966,0.00035032257,0.000263358,0.0000063324123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012456044,0.00048015817,0.8637376,0.0006392959,0.001151465,0.0018572382,0.0019573206,0.00039209862,0.00196452,0.00032455887,0.002071234,0.11296845],"study_design_scores_gemma":[0.0071398905,0.0008862444,0.96029115,0.0003083692,0.00026931913,0.000029603765,0.00014980513,0.000022370543,0.0023085175,0.00004286021,0.02840417,0.00014772933],"about_ca_topic_score_codex":0.00012761795,"about_ca_topic_score_gemma":0.00007352907,"teacher_disagreement_score":0.11282072,"about_ca_system_score_codex":0.000056116085,"about_ca_system_score_gemma":0.0002552041,"threshold_uncertainty_score":0.45225266},"labels":[],"label_agreement":null},{"id":"W2735520635","doi":"10.1016/j.eururo.2017.06.040","title":"Recommendations for the Management of Rare Kidney Cancers","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Sunitinib; MEDLINE; Guideline; Druggability; Systematic review; Renal cell carcinoma; Narrative review; Intensive care medicine; Internal medicine; Bioinformatics; Oncology; Pathology","score_opus":0.1797549126628778,"score_gpt":0.382251211013476,"score_spread":0.20249629835059818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735520635","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.7110726e-7,0.9307055,0.00008912208,0.0019093562,0.00057169975,0.0017997589,0.00014123258,0.000019832665,0.064763136],"genre_scores_gemma":[0.000027480666,0.9890008,0.0006307062,0.00046947424,0.00024124849,0.00018725255,0.0004587832,0.00007664138,0.008907621],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987114,0.00022778593,0.0004391161,0.0003196628,0.00008926008,0.00021275028],"domain_scores_gemma":[0.9980994,0.00018050689,0.0004952778,0.0010675733,0.000053066353,0.00010418129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035964086,0.0002460597,0.00088287634,0.000086826614,0.00013362755,0.000009991809,0.00039901581,0.000061104714,0.00016282001],"category_scores_gemma":[0.000055352717,0.00014520502,0.00047240139,0.000051666197,0.00011505417,0.000012258893,0.00015673377,0.00019658027,0.00013550221],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002943925,0.000025825915,0.0000018638193,0.007372827,0.0013703364,0.00013184786,0.000026125606,3.7259997e-7,4.9035194e-8,0.00026170234,0.05349195,0.9372877],"study_design_scores_gemma":[0.00053151854,0.00029521043,0.00006142675,0.001959418,0.0061099115,0.000103772174,0.000008626057,0.0000017851587,3.1142395e-7,0.0000061363617,0.99082786,0.00009404883],"about_ca_topic_score_codex":0.000011305843,"about_ca_topic_score_gemma":0.000001480801,"teacher_disagreement_score":0.9373359,"about_ca_system_score_codex":0.00012717892,"about_ca_system_score_gemma":0.00018474711,"threshold_uncertainty_score":0.5921289},"labels":[],"label_agreement":null},{"id":"W2736033387","doi":"10.1016/j.eururo.2005.12.047","title":"Plasmacytoid Urothelial Carcinoma of the Urinary Bladder","year":2006,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Urothelial carcinoma; Pathology; Pathological; Urinary bladder; Cystoscopy; Carcinoma; Transitional cell carcinoma; Urinary system; Urology; Internal medicine; Bladder cancer; Cancer","score_opus":0.010933734831924918,"score_gpt":0.22706489558853937,"score_spread":0.21613116075661445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736033387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7881257,0.0003557951,0.000021771004,0.0011595947,0.00031660014,0.00023131093,0.00002110668,0.000036190733,0.20973194],"genre_scores_gemma":[0.9926661,0.000006738394,0.00006552921,0.0014105837,0.00050329714,0.000005015253,0.00000871939,0.000043260632,0.005290707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998938,0.00020626998,0.00024216707,0.00022865554,0.00015244324,0.00023244038],"domain_scores_gemma":[0.99937105,0.000036013706,0.00008285835,0.00041999953,0.00004067488,0.00004938226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094991614,0.00014353984,0.00020423606,0.000050709255,0.00006586807,0.000003912141,0.0001670403,0.000041564475,0.00033325367],"category_scores_gemma":[0.000021073763,0.00009430368,0.00013551756,0.00011177237,0.0001974134,0.000020277783,0.00009767888,0.0001647199,0.00019733736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022743254,0.0018094,0.90992594,0.00008013489,0.0003202557,0.0013970111,0.00055052777,0.00007864492,0.038115844,0.0027795432,0.038475648,0.0041927295],"study_design_scores_gemma":[0.0027835574,0.0010131495,0.92199403,0.000005849789,0.00017279063,0.0005548448,0.0000102830545,0.00001742613,0.007078368,0.00015489076,0.066121615,0.00009320397],"about_ca_topic_score_codex":0.0001101657,"about_ca_topic_score_gemma":0.0000075111584,"teacher_disagreement_score":0.20454046,"about_ca_system_score_codex":0.00002010706,"about_ca_system_score_gemma":0.000079565434,"threshold_uncertainty_score":0.38455924},"labels":[],"label_agreement":null},{"id":"W2737346747","doi":"10.1016/j.eururo.2017.07.011","title":"Optimal Radiotherapy for Unfavorable-risk Prostate Cancer","year":2017,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia; Interior Health","funders":"","keywords":"Medicine; Prostate cancer; Radiation therapy; Prostate; Oncology; Gynecology; Internal medicine; Urology; Cancer","score_opus":0.022245445407475552,"score_gpt":0.2948369476120114,"score_spread":0.2725915022045359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737346747","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0055906554,0.025010468,0.00025465153,0.95469975,0.00227064,0.0030889171,0.001799751,0.00019071897,0.007094415],"genre_scores_gemma":[0.0023150623,0.028956005,0.0024215842,0.91154814,0.015825218,0.0010895182,0.0016951248,0.0005600078,0.035589334],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975056,0.0002712353,0.0004137457,0.0008796986,0.00018162347,0.00074807886],"domain_scores_gemma":[0.9978751,0.00022101692,0.0006069505,0.001022745,0.00014727123,0.00012694646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034346312,0.00050481723,0.0008366778,0.00013222419,0.00025593312,0.000069069545,0.0003243761,0.00031804238,0.00028952333],"category_scores_gemma":[0.0001152636,0.0004057446,0.00032135163,0.000037324244,0.00023683727,0.000047899102,0.000066565415,0.0011987957,0.00012111993],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054850976,0.00007377674,0.003496146,0.00018072076,0.0009828084,0.0030000187,0.00018500179,0.00006932556,0.00002196178,0.000004225564,0.9683142,0.02312333],"study_design_scores_gemma":[0.004429273,0.0025467237,0.0026169505,0.00008782573,0.0008688886,0.00012451761,0.0000019462282,0.00006639278,0.000062072446,0.000019924928,0.9888345,0.00034097212],"about_ca_topic_score_codex":0.00010260227,"about_ca_topic_score_gemma":0.000006160715,"teacher_disagreement_score":0.043151636,"about_ca_system_score_codex":0.00021411107,"about_ca_system_score_gemma":0.00026446398,"threshold_uncertainty_score":0.9998394},"labels":[],"label_agreement":null},{"id":"W2737405214","doi":"10.1016/j.eururo.2017.07.005","title":"Emerging Minimally Invasive Treatment Options for Male Lower Urinary Tract Symptoms","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Royal Victoria Regional Health Centre; McGill University Health Centre","funders":"","keywords":"Medicine; Lower urinary tract symptoms; Cochrane Library; Clinical trial; Randomized controlled trial; Adverse effect; Surgery; Prostate; Internal medicine","score_opus":0.13236560479858095,"score_gpt":0.41049008678938537,"score_spread":0.2781244819908044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737405214","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017027154,0.93431586,0.000011898157,0.0004358124,0.0004056623,0.0023415764,0.0002272065,0.0000708643,0.06202083],"genre_scores_gemma":[0.00027801617,0.9576228,0.00021311836,0.00010882185,0.0009932758,0.00027921132,0.0007828484,0.00020074149,0.039521154],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99704593,0.00065984577,0.000608456,0.0007923388,0.00017217183,0.0007212589],"domain_scores_gemma":[0.9975969,0.0005774088,0.0003247754,0.0010866692,0.00010934541,0.0003048653],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005122753,0.0005591677,0.0016431819,0.00037307848,0.00033744104,0.000051310006,0.0004200952,0.00020930731,0.0007097504],"category_scores_gemma":[0.00022430807,0.00042583418,0.00093144475,0.00008674188,0.00021421329,0.00007196939,0.00020542313,0.00050467905,0.0013952784],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032454592,0.0014627362,0.00004240463,0.0053838184,0.0009449177,0.01293762,0.00014384776,5.503659e-7,0.0000028718498,0.000043278436,0.0029556649,0.9757577],"study_design_scores_gemma":[0.0012345487,0.014662504,0.00016217574,0.0009820368,0.0019617162,0.00964605,0.0000072417693,0.000002879879,3.7489642e-7,0.0000070683377,0.97102296,0.00031042055],"about_ca_topic_score_codex":0.0000053504236,"about_ca_topic_score_gemma":0.0000015690614,"teacher_disagreement_score":0.9754473,"about_ca_system_score_codex":0.00013675426,"about_ca_system_score_gemma":0.0006868188,"threshold_uncertainty_score":0.99981934},"labels":[],"label_agreement":null},{"id":"W2738724631","doi":"10.1016/j.eururo.2017.07.014","title":"Benefits and Harms of Treatment of Asymptomatic Bacteriuria: A Systematic Review and Meta-analysis by the European Association of Urology Urological Infection Guidelines Panel","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Urinary Tract Infections Management","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; McMaster University Medical Centre","funders":"","keywords":"Medicine; Bacteriuria; Urinary system; Antibiotics; Antibiotic prophylaxis; Cochrane Library; Asymptomatic; Intensive care medicine; Watchful waiting; MEDLINE; Adverse effect; Surgery; Internal medicine; Randomized controlled trial","score_opus":0.20868917574601675,"score_gpt":0.37091088481192236,"score_spread":0.1622217090659056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738724631","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027467997,0.9945974,0.00004837039,0.0008408887,0.000058910446,0.0025341287,0.00012452855,0.000031336724,0.0014898061],"genre_scores_gemma":[0.005189996,0.99354136,0.000043661104,0.00028898512,0.00004356644,0.0001090786,0.00012683134,0.000054273904,0.00060223736],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.990581,0.0060419356,0.0024207444,0.0005140545,0.00021171382,0.0002305462],"domain_scores_gemma":[0.9928804,0.0008312367,0.004748443,0.0011520353,0.00031142056,0.000076433265],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037647053,0.0005101311,0.0071710492,0.00040832403,0.00008663201,0.000015925478,0.00023818691,0.00015860675,0.00007810668],"category_scores_gemma":[0.0015507933,0.00027771952,0.001428603,0.0003035108,0.00021301574,0.000050391438,0.00020889522,0.0002236858,0.000019317467],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036647594,0.0018415549,0.0007490777,0.5727325,0.3816472,0.000049010752,0.00013708258,0.000026813621,0.0000037102911,0.00011568677,0.0007002687,0.04196045],"study_design_scores_gemma":[0.00037210356,0.0037774101,0.0017799584,0.0015047889,0.9001411,0.0003100313,0.0000015491886,0.000009545516,2.533485e-7,0.0000033514157,0.091937415,0.00016248095],"about_ca_topic_score_codex":0.00004076252,"about_ca_topic_score_gemma":0.000006412196,"teacher_disagreement_score":0.5712277,"about_ca_system_score_codex":0.00006694083,"about_ca_system_score_gemma":0.00003365212,"threshold_uncertainty_score":0.9999675},"labels":[],"label_agreement":null},{"id":"W2740573178","doi":"10.1016/j.eururo.2017.06.035","title":"Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":259,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Ipsen; Astellas Pharma; Intuitive Surgical; European Association of Urology; Sanofi; Genentech; Les Laboratories Pierre Fabre; AstraZeneca; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Prostate cancer; Brachytherapy; Randomized controlled trial; Quality of life (healthcare); Sexual function; Cochrane Library; Radiation therapy; External beam radiotherapy; Observational study; Systematic review; MEDLINE; Cancer; Internal medicine; Surgery","score_opus":0.16806906658825294,"score_gpt":0.4516779117454975,"score_spread":0.28360884515724455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740573178","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012117225,0.98285913,0.000007896172,0.0009240551,0.000332003,0.013712236,0.0011145615,0.000048861493,0.0009891092],"genre_scores_gemma":[0.000068592315,0.9860694,0.000111526366,0.0041474956,0.00015602636,0.007491933,0.0004916135,0.00014927637,0.0013141369],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935066,0.0016444075,0.0033582423,0.00081217516,0.00024307086,0.0004354722],"domain_scores_gemma":[0.9932731,0.0011500543,0.0032392833,0.0018137166,0.00022618372,0.00029770957],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016997101,0.0007299738,0.010253335,0.000103124636,0.00006387361,0.000018602304,0.00034209897,0.00016392117,0.000057214198],"category_scores_gemma":[0.0014267395,0.00042039345,0.0021106864,0.0000680395,0.00020333784,0.000034231394,0.0001311343,0.00021441201,0.000100015845],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029928295,0.00047592213,0.0012112912,0.81184024,0.002674007,0.0001221364,0.000035487472,5.8093477e-8,1.6737886e-8,0.000009315866,0.0007069624,0.18262525],"study_design_scores_gemma":[0.0028457607,0.0020337673,0.0012632022,0.2899818,0.018430362,0.00001980148,0.0000011849254,2.2084444e-7,4.6404967e-8,0.000003653489,0.6851122,0.0003079754],"about_ca_topic_score_codex":0.000030859897,"about_ca_topic_score_gemma":0.000010572313,"teacher_disagreement_score":0.68440527,"about_ca_system_score_codex":0.00036421855,"about_ca_system_score_gemma":0.0011055783,"threshold_uncertainty_score":0.99982476},"labels":[],"label_agreement":null},{"id":"W2742438219","doi":"10.1016/j.eururo.2017.07.017","title":"The Risk of Tumour Recurrence in Patients Undergoing Renal Transplantation for End-stage Renal Disease after Previous Treatment for a Urological Cancer: A Systematic Review","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Nephrotoxicity and Medicinal Plants","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); End stage renal disease; Transplantation; Disease; Cancer; Urology; Surgery; Oncology; Internal medicine","score_opus":0.05983251973760696,"score_gpt":0.3484760618904653,"score_spread":0.28864354215285837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742438219","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036283224,0.9839975,0.00017992004,0.00011983142,0.00017138173,0.013508162,0.0015911629,0.000015989577,0.000053168354],"genre_scores_gemma":[0.0017345385,0.9936018,0.00005488244,0.00027382834,0.00014486014,0.00340118,0.00050476956,0.000048456604,0.00023568932],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99598444,0.0015802229,0.0012906113,0.0005186226,0.00021978712,0.00040630487],"domain_scores_gemma":[0.996018,0.0016684025,0.0014787834,0.0005584689,0.00009626338,0.00018008043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014764003,0.0004260205,0.0025025392,0.000115869414,0.00014071407,0.000013291593,0.0003139281,0.00010566747,0.000010852061],"category_scores_gemma":[0.002132972,0.00022935003,0.00065146224,0.0000723878,0.00013176759,0.000035889567,0.000031158488,0.00030586697,0.00000873871],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032486997,0.00028710195,0.00021918981,0.86463284,0.0005245608,0.00027426973,0.00008909246,0.0000013751205,3.0692428e-7,0.000018584818,0.00014571803,0.13055824],"study_design_scores_gemma":[0.0050872182,0.006386462,0.0020973692,0.5996858,0.03194202,0.00008967759,0.0000036722665,0.000028721517,6.703693e-7,0.000018540013,0.35428503,0.00037486228],"about_ca_topic_score_codex":0.000009344511,"about_ca_topic_score_gemma":0.00007121424,"teacher_disagreement_score":0.3541393,"about_ca_system_score_codex":0.000118068885,"about_ca_system_score_gemma":0.00041427062,"threshold_uncertainty_score":0.93526226},"labels":[],"label_agreement":null},{"id":"W2744156886","doi":"10.1016/j.eururo.2017.07.015","title":"Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"National Heart, Lung, and Blood Institute; Medical Research Council; National Institute for Health and Care Research; National Cancer Institute; Cancer Research UK; National Institutes of Health; Francis Crick Institute; World Health Organization","keywords":"Telomere; Mendelian randomization; Genome-wide association study; Medicine; Odds ratio; Renal cell carcinoma; Oncology; Internal medicine; Confidence interval; Single-nucleotide polymorphism; Genotype; Genetics; Biology; Genetic variants; Gene","score_opus":0.03571342217877427,"score_gpt":0.276009987736049,"score_spread":0.24029656555727474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744156886","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.082625076,0.9020455,0.000015177192,0.00004441611,0.00032319137,0.0014666936,0.0003620344,0.00014233218,0.012975615],"genre_scores_gemma":[0.21995254,0.77625436,0.00022506154,0.00024502704,0.00026192045,0.0000241616,0.0002773126,0.0003634949,0.0023961258],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938059,0.0025180732,0.001290671,0.0011528388,0.00044459166,0.0007879316],"domain_scores_gemma":[0.9945159,0.00044485243,0.00229171,0.0018988795,0.00030735365,0.0005412893],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009512889,0.0008437858,0.0032537698,0.000590361,0.00020800644,0.000028877814,0.000822585,0.0004978616,0.00025064425],"category_scores_gemma":[0.0015387681,0.00063754147,0.0004658286,0.00048835494,0.00034272467,0.00004570139,0.0002648392,0.001383229,0.0006428239],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001233799,0.0018054226,0.07406865,0.011890468,0.0041435384,0.028686468,0.0012503895,0.000022579705,0.00010799467,0.000021073698,0.008385223,0.8683844],"study_design_scores_gemma":[0.0028432643,0.0024570494,0.4587211,0.0044391975,0.007131477,0.0008449674,0.000018969102,0.000011906555,0.000008446528,0.0000040505765,0.5225861,0.00093344133],"about_ca_topic_score_codex":0.00011269779,"about_ca_topic_score_gemma":0.000045171426,"teacher_disagreement_score":0.86745095,"about_ca_system_score_codex":0.00010738594,"about_ca_system_score_gemma":0.0005382522,"threshold_uncertainty_score":0.99960756},"labels":[],"label_agreement":null},{"id":"W2746932121","doi":"10.1016/j.eururo.2017.08.012","title":"Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201)","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia","funders":"","keywords":"Enzalutamide; Prostate cancer; Androgen receptor; Medicine; Bicalutamide; Cancer research; Pharmacology; Cancer; TMPRSS2; Internal medicine; Oncology","score_opus":0.040856426086149006,"score_gpt":0.32843672203740637,"score_spread":0.28758029595125734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2746932121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98609024,0.002831077,0.000032153926,0.007229606,0.00047078572,0.0010305712,0.00008787298,0.000037912316,0.0021897664],"genre_scores_gemma":[0.9974765,0.0006744429,0.000431848,0.00052634464,0.00023993204,0.000025334548,0.0000143908765,0.000056031095,0.00055512827],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977918,0.00038045386,0.00047698463,0.0004779233,0.00031627083,0.00055651384],"domain_scores_gemma":[0.99828696,0.00016569147,0.0005386129,0.0006798865,0.00019638013,0.00013244625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014822341,0.0002543046,0.00042778577,0.00008267552,0.00088464713,0.000062814725,0.00046936554,0.000118176096,0.00004469538],"category_scores_gemma":[0.00079540076,0.0001255886,0.00011540812,0.00012441096,0.00099802,0.00013588717,0.0008016191,0.0005242047,0.000006646385],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005744864,0.0002753656,0.07092478,0.00014874857,0.00042237985,0.00019069584,0.0033986329,0.00023591761,0.8761346,0.00007384068,0.0008667025,0.041583467],"study_design_scores_gemma":[0.02605048,0.007730105,0.5319996,0.00067763403,0.0015154044,0.0005846259,0.0016744006,0.008934859,0.21815224,0.0006347373,0.2008863,0.0011596591],"about_ca_topic_score_codex":0.00023707337,"about_ca_topic_score_gemma":0.000049954553,"teacher_disagreement_score":0.65798235,"about_ca_system_score_codex":0.00016249102,"about_ca_system_score_gemma":0.00036652107,"threshold_uncertainty_score":0.680408},"labels":[],"label_agreement":null},{"id":"W2748149325","doi":"10.1016/j.eururo.2017.07.038","title":"Intravenous Mannitol Versus Placebo During Partial Nephrectomy in Patients with Normal Kidney Function: A Double-blind, Clinically-integrated, Randomized Trial","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Medicine; Placebo; Nephrectomy; Renal function; Randomized controlled trial; Urology; Mannitol; Double blind; Kidney; Surgery; Anesthesia; Internal medicine; Pathology","score_opus":0.03052373154215624,"score_gpt":0.2763420271572101,"score_spread":0.2458182956150539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748149325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9653155,0.00002565316,0.000050985338,0.0004103058,0.0016462858,0.0035025347,0.0000054329266,0.00008171046,0.028961556],"genre_scores_gemma":[0.9975247,0.000012177315,0.0001529016,0.00035696218,0.0009750305,0.00019589766,0.00012098856,0.000072665665,0.0005886769],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968561,0.0008475449,0.0008196934,0.00060297834,0.00033379826,0.0005398959],"domain_scores_gemma":[0.9979217,0.0002358551,0.0004696076,0.00086049474,0.00013367785,0.00037863298],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009469522,0.00035693703,0.00095875293,0.00018379495,0.00024109535,0.00007469998,0.0002529925,0.00013588653,0.00031672925],"category_scores_gemma":[0.00058862806,0.00025483288,0.00021839318,0.00007673896,0.00037583636,0.00012634946,0.00014873194,0.00065327616,0.00039502775],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96935177,0.000751021,0.026672421,0.000016270558,0.00043432252,0.0013200366,0.00011947689,0.000021857,0.000013830755,0.00002220787,0.00011400925,0.0011627713],"study_design_scores_gemma":[0.9281849,0.00934687,0.057714943,0.000028080243,0.00063253444,0.000038801667,0.0000119780525,0.000035999874,0.000079429374,0.0000014878674,0.0037132686,0.00021168706],"about_ca_topic_score_codex":0.00008578701,"about_ca_topic_score_gemma":0.000024370393,"teacher_disagreement_score":0.041166857,"about_ca_system_score_codex":0.00009695906,"about_ca_system_score_gemma":0.00018580737,"threshold_uncertainty_score":0.9999904},"labels":[],"label_agreement":null},{"id":"W2754374178","doi":"10.1016/j.eururo.2017.08.027","title":"Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":200,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Transcriptome; Prostate cancer; Disease; Genome; Whole genome sequencing; DNA sequencing; Cancer; Computational biology; Bioinformatics; Gene; Genetics; Internal medicine; Gene expression; Biology","score_opus":0.03928653072164747,"score_gpt":0.35225984655746123,"score_spread":0.3129733158358138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754374178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98654026,0.0058563324,0.00009039899,0.005750479,0.00013235112,0.00048740554,0.00003374396,0.000028460727,0.0010805875],"genre_scores_gemma":[0.9953636,0.0009546016,0.00022360205,0.00013451146,0.00019181526,0.000017081446,0.000034080138,0.0000307371,0.003050007],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990261,0.00010467634,0.00019647315,0.000278049,0.00014193973,0.00025275908],"domain_scores_gemma":[0.9991669,0.000014639283,0.00011077146,0.0003613725,0.00006459188,0.00028170508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014055033,0.00011512,0.00017966182,0.0000863552,0.00025531062,0.000056690267,0.00012618583,0.000022321241,0.000060903636],"category_scores_gemma":[0.000060610022,0.000089539084,0.000043224405,0.000038061582,0.00023933493,0.00010815068,0.000087489076,0.00013791196,0.000017128368],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005634858,0.00007942859,0.4734006,0.00023293297,0.0001329426,0.000977182,0.0025683397,0.00005091621,0.49138606,0.000029577352,0.00029441016,0.03028414],"study_design_scores_gemma":[0.0019070483,0.00033900217,0.9900495,0.00011200144,0.00014271606,0.000023733448,0.000020934112,0.0001751762,0.0006566433,0.00007080388,0.0064119115,0.00009052853],"about_ca_topic_score_codex":0.000043048818,"about_ca_topic_score_gemma":0.000018310218,"teacher_disagreement_score":0.5166489,"about_ca_system_score_codex":0.000037757633,"about_ca_system_score_gemma":0.00022299601,"threshold_uncertainty_score":0.3651298},"labels":[],"label_agreement":null},{"id":"W2754940790","doi":"10.1016/j.eururo.2017.08.018","title":"Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS)","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Prostate Cancer UK; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Prostate cancer; Prostate; Magnetic resonance imaging; Biopsy; Cost effectiveness; Radiology; Cancer; Prostate biopsy; Confidence interval; Cost-effectiveness analysis; Internal medicine","score_opus":0.02937559107658512,"score_gpt":0.3182774270838818,"score_spread":0.2889018360072967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754940790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777364,0.0065243654,0.000015484648,0.010478953,0.00009755853,0.0043833,0.00008272747,0.000014947193,0.0006662322],"genre_scores_gemma":[0.9967563,0.00071104406,0.000033848126,0.0011080834,0.000033099062,0.0012956691,0.0000068870813,0.000040641822,0.0000143971165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961977,0.0019512445,0.00049353595,0.00053913443,0.00038886387,0.00042953403],"domain_scores_gemma":[0.995806,0.0019300715,0.0005135717,0.001487736,0.0002095712,0.000053084816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029758252,0.0002758544,0.00056485477,0.00026446005,0.00033685856,0.00007974044,0.0006245856,0.000018681714,0.00004434181],"category_scores_gemma":[0.0008384889,0.00013639058,0.00019248032,0.00085894216,0.00052915455,0.00006980548,0.00016477694,0.0004359692,0.00000429612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087759097,0.0011002675,0.9152592,0.000033467495,0.0001504,0.0002646018,0.002437887,0.004157334,0.000044471497,0.000016062577,0.000058989175,0.07559973],"study_design_scores_gemma":[0.0039777556,0.0010576665,0.97964656,0.0001434832,0.0010582618,0.000004967771,0.00039451403,0.012418523,0.0005394379,0.000013389812,0.0006256141,0.00011980719],"about_ca_topic_score_codex":0.0011861678,"about_ca_topic_score_gemma":0.00014028339,"teacher_disagreement_score":0.075479925,"about_ca_system_score_codex":0.00009903462,"about_ca_system_score_gemma":0.00009878174,"threshold_uncertainty_score":0.55618465},"labels":[],"label_agreement":null},{"id":"W2755459284","doi":"10.1016/j.eururo.2017.08.016","title":"Key Steps in Conducting Systematic Reviews for Underpinning Clinical Practice Guidelines: Methodology of the European Association of Urology","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":226,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Systematic review; Underpinning; MEDLINE; Evidence-based medicine; Randomized controlled trial; Alternative medicine; Surgery; Pathology","score_opus":0.9521809000821818,"score_gpt":0.6588957970890883,"score_spread":0.2932851029930935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755459284","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14231521,0.019275153,0.38964933,0.08860287,0.013859649,0.018588146,0.00006535548,0.000041256128,0.32760304],"genre_scores_gemma":[0.9150135,0.0003236597,0.073278084,0.006783285,0.0005861978,0.00004554577,0.000004130637,0.00006836074,0.0038972537],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.43031225,0.52426946,0.04060735,0.001750968,0.0024075848,0.00065235724],"domain_scores_gemma":[0.8444568,0.084344946,0.060238175,0.0065960106,0.0042718346,0.00009222008],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6717261,0.00029609932,0.005834237,0.00025634715,0.00024215288,0.00015344803,0.0042169224,0.00014261711,0.00014899373],"category_scores_gemma":[0.90356666,0.0001434251,0.0018481037,0.00039024363,0.0002476892,0.00024293516,0.0007245134,0.00044166466,0.00043352766],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058345456,0.0013111201,0.35633263,0.019629648,0.0062590144,0.00016278755,0.016335951,0.004127553,0.004501165,0.06396305,0.38425088,0.14254275],"study_design_scores_gemma":[0.0027924345,0.00083228416,0.075919546,0.0010153939,0.004266668,0.00018116568,0.0026570961,0.0063306666,0.000028136023,0.0064421906,0.8989248,0.0006096168],"about_ca_topic_score_codex":0.000014882138,"about_ca_topic_score_gemma":0.000054132168,"teacher_disagreement_score":0.7726983,"about_ca_system_score_codex":0.000029925654,"about_ca_system_score_gemma":0.00007532155,"threshold_uncertainty_score":0.7836161},"labels":[],"label_agreement":null},{"id":"W2762652685","doi":"10.1016/j.eururo.2017.10.002","title":"Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naïve Prostate Cancer: A Systematic Review and Network Meta-analysis","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Docetaxel; Abiraterone acetate; Internal medicine; Oncology; Hazard ratio; Randomized controlled trial; Meta-analysis; Subgroup analysis; Confidence interval; Cancer","score_opus":0.16600679951125935,"score_gpt":0.41055575600573463,"score_spread":0.24454895649447528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762652685","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027364814,0.9921299,0.000015347297,0.00024211979,0.000011838595,0.004702384,0.00011275791,0.000015018749,0.000034116092],"genre_scores_gemma":[0.010307049,0.98853844,0.00017160451,0.000097545766,0.00001851583,0.00045217946,0.00015856477,0.0000673652,0.0001887419],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99520147,0.0023528563,0.0011626849,0.0006812094,0.00023154433,0.00037024138],"domain_scores_gemma":[0.997156,0.000270105,0.001623456,0.00067850837,0.00012305568,0.00014888003],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018396934,0.0005268092,0.008948863,0.00034419954,0.00011305979,0.000050278508,0.0001667561,0.00007425981,0.000014065461],"category_scores_gemma":[0.000086935346,0.00028090196,0.00030549965,0.00045810852,0.00034956788,0.00008054548,0.00013151679,0.0004295415,0.0000029508224],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005857454,0.0001963135,0.009428541,0.63953054,0.2514142,0.00037220737,0.00069162645,0.000024847726,0.0000011082311,0.000017170145,0.00011443334,0.097623274],"study_design_scores_gemma":[0.003641138,0.0024339354,0.0035740808,0.017064743,0.9607448,0.000174351,0.000016858929,0.00005478421,9.22151e-7,0.000022087072,0.01181936,0.00045293284],"about_ca_topic_score_codex":0.00015320885,"about_ca_topic_score_gemma":0.00011310627,"teacher_disagreement_score":0.7093306,"about_ca_system_score_codex":0.000034616936,"about_ca_system_score_gemma":0.00010579021,"threshold_uncertainty_score":0.9999643},"labels":[],"label_agreement":null},{"id":"W2762702051","doi":"10.1016/j.eururo.2017.09.032","title":"Re: Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient-specific Molds to Correlate Images with Whole-mount Pathology","year":2017,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Magnetic resonance imaging; Prostate; Prostate cancer; Pathology; Cancer; Radiology; Internal medicine","score_opus":0.01924574377708664,"score_gpt":0.2548417450267798,"score_spread":0.23559600124969315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762702051","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37025303,0.06423143,0.00018164203,0.55400044,0.0016312886,0.0041033747,0.0027796729,0.00015197556,0.0026671616],"genre_scores_gemma":[0.76656604,0.007728035,0.0029159386,0.21621777,0.00093523244,0.00040185743,0.0014506807,0.0005273562,0.0032570648],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971839,0.00036431284,0.00069445424,0.0008519682,0.00034612394,0.00055922737],"domain_scores_gemma":[0.9972074,0.00019449412,0.00089198904,0.0012100083,0.00038729215,0.00010881742],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018606447,0.00047224396,0.0009335875,0.00040232812,0.000083697436,0.000038040223,0.0002535621,0.00017339052,0.000103852566],"category_scores_gemma":[0.00011848821,0.00038072572,0.000111921385,0.00018833594,0.00053698424,0.00011310182,0.00019718158,0.0007764604,0.00006042297],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017784372,0.00029309315,0.06875937,0.0005350585,0.00017941868,0.018667117,0.0011722462,0.00047326996,0.0010181137,0.000027433738,0.8000974,0.106999055],"study_design_scores_gemma":[0.0019810721,0.003694183,0.19101658,0.00067511894,0.00037912477,0.0002026879,0.000021852644,0.00003004069,0.0003450528,0.000017825974,0.8013123,0.0003241522],"about_ca_topic_score_codex":0.0001922609,"about_ca_topic_score_gemma":0.000017922008,"teacher_disagreement_score":0.39631304,"about_ca_system_score_codex":0.00020374949,"about_ca_system_score_gemma":0.00014198544,"threshold_uncertainty_score":0.99986446},"labels":[],"label_agreement":null},{"id":"W2766194852","doi":"10.1016/j.eururo.2017.10.003","title":"Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Immunotherapy; Urology; Internal medicine; Immunology; Immune system","score_opus":0.04937522301427826,"score_gpt":0.33522190961141674,"score_spread":0.28584668659713847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766194852","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002654431,0.98839545,0.000044795717,0.0017585449,0.0005521345,0.005311879,0.0001247118,0.00020524542,0.0035807197],"genre_scores_gemma":[0.000060838032,0.9880681,0.00009271385,0.0067836684,0.0007047448,0.0003612576,0.000048147136,0.00032490326,0.003555641],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908825,0.0055374173,0.0015623479,0.0009657725,0.00039299997,0.00065895944],"domain_scores_gemma":[0.99641365,0.00069036626,0.0007447395,0.0016426423,0.00013808631,0.0003705084],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002074852,0.00085227535,0.004536403,0.00028326872,0.00012238506,0.000034721674,0.00061651063,0.0002622748,0.0005085128],"category_scores_gemma":[0.00130593,0.00056830625,0.0008056947,0.00048234142,0.00014691138,0.000033924203,0.00022821367,0.0008005882,0.004395811],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089421833,0.0002132552,0.000014824934,0.8923045,0.0021672486,0.002532539,0.00031282858,7.0829046e-8,0.000003265876,0.000008756403,0.012088509,0.089460015],"study_design_scores_gemma":[0.0006442742,0.0016671359,0.000033692886,0.3160846,0.004572955,0.0013761212,0.000009547931,6.1669596e-7,2.9836158e-7,0.000001952034,0.675308,0.0003008399],"about_ca_topic_score_codex":0.000009287724,"about_ca_topic_score_gemma":0.0000045299894,"teacher_disagreement_score":0.66321945,"about_ca_system_score_codex":0.0002524391,"about_ca_system_score_gemma":0.00035225274,"threshold_uncertainty_score":0.9996768},"labels":[],"label_agreement":null},{"id":"W2766558944","doi":"10.1016/j.eururo.2017.09.025","title":"Testicular Tumour Size and Rete Testis Invasion as Prognostic Factors for the Risk of Relapse of Clinical Stage I Seminoma Testis Patients Under Surveillance: a Systematic Review by the Testicular Cancer Guidelines Panel","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Health Sciences Centre; Cochrane","funders":"","keywords":"Medicine; Seminoma; Hazard ratio; Rete testis; Internal medicine; Meta-analysis; Testicular cancer; Oncology; Cochrane Library; Stage (stratigraphy); Cancer; Gynecology; Confidence interval; Chemotherapy","score_opus":0.16566539577623546,"score_gpt":0.4109850447261051,"score_spread":0.24531964894986963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766558944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038467902,0.98466325,0.00003917401,0.00019021281,0.0002611388,0.008752206,0.0021670524,0.00004166852,0.000038496975],"genre_scores_gemma":[0.024691118,0.973553,0.00015879836,0.0003372479,0.00011306651,0.00038794326,0.0003433179,0.00016090734,0.00025460182],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9927354,0.0025165663,0.002977467,0.0008417272,0.0005091048,0.0004197433],"domain_scores_gemma":[0.9715704,0.020458205,0.005019492,0.0017490401,0.0009316756,0.00027121528],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024682686,0.0007743568,0.0043072575,0.000061975355,0.00025786727,0.000032370972,0.0006654683,0.00022560042,0.000026384456],"category_scores_gemma":[0.16326766,0.00035772688,0.0009869572,0.0002009727,0.0006440309,0.000039895272,0.0003265312,0.0005395242,0.000014372866],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107447195,0.0008128159,0.2198396,0.7181783,0.0046937033,0.00028550613,0.00003695003,0.0000096445565,0.0000015784461,0.000014975201,0.004328303,0.051691182],"study_design_scores_gemma":[0.004800783,0.0048618615,0.36545977,0.4269402,0.124663815,0.00053305464,0.000031347216,0.00016889711,8.7304596e-7,0.0000399217,0.07146763,0.001031838],"about_ca_topic_score_codex":0.00025612942,"about_ca_topic_score_gemma":0.000009028885,"teacher_disagreement_score":0.2912381,"about_ca_system_score_codex":0.00004458038,"about_ca_system_score_gemma":0.00049795426,"threshold_uncertainty_score":0.99988747},"labels":[],"label_agreement":null},{"id":"W2767459057","doi":"10.1016/j.eururo.2017.09.030","title":"The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Cystectomy; Metastasectomy; Lymphadenectomy; Bladder cancer; Metastasis; Lymph node; Surgery; General surgery; Cancer; Internal medicine","score_opus":0.11183418547563065,"score_gpt":0.38515343788039763,"score_spread":0.27331925240476695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767459057","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[7.006367e-7,0.9876082,5.421008e-7,0.00017183952,0.0002497459,0.0024455378,0.000045786168,0.000018397888,0.009459261],"genre_scores_gemma":[0.000063705265,0.997877,0.0000047986905,0.00042257333,0.00010456082,0.00041921833,0.000034162003,0.00009585897,0.0009781435],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99557394,0.0020982476,0.0014021237,0.00036383444,0.00021431333,0.0003475674],"domain_scores_gemma":[0.9964618,0.0009048336,0.0012281465,0.0012471883,0.00006981718,0.00008822076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015584152,0.0003897043,0.0046114004,0.0001547984,0.00007866482,0.000014835859,0.00042860257,0.00006528918,0.00008642824],"category_scores_gemma":[0.0008894429,0.00020873909,0.00073747244,0.00016015724,0.00016358118,0.000024710587,0.00010261948,0.00038286287,0.0002289894],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014745465,0.000059145157,0.000027074926,0.6655391,0.0011363369,0.0002739384,0.00002417615,2.7538468e-8,4.6337384e-8,0.000028281165,0.00079466,0.33210248],"study_design_scores_gemma":[0.0001630161,0.00006804954,0.000021494787,0.26789254,0.010277055,0.00024551054,0.0000037156278,4.5490606e-7,1.03179616e-7,0.000012297107,0.7211997,0.00011606185],"about_ca_topic_score_codex":0.00007753432,"about_ca_topic_score_gemma":0.00003317216,"teacher_disagreement_score":0.72040504,"about_ca_system_score_codex":0.00006812026,"about_ca_system_score_gemma":0.00060209056,"threshold_uncertainty_score":0.8512133},"labels":[],"label_agreement":null},{"id":"W2769954611","doi":"10.1016/j.eururo.2007.02.056","title":"Editorial Comment on: Systematic Assessment of the Ability of the Number and Percentage of Positive Biopsy Cores to Predict Pathologic Stage and Biochemical Recurrence after Radical Prostatectomy","year":2007,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Medicine; Prostatectomy; Stage (stratigraphy); Biochemical recurrence; Urology; Biopsy; Prostate cancer; Pathology; Internal medicine; Cancer","score_opus":0.0077235235156977305,"score_gpt":0.2888909115899899,"score_spread":0.2811673880742922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769954611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.610327,0.00044668035,0.000009425708,0.00066391134,0.38284135,0.0033591972,0.002016078,0.000011937517,0.00032443463],"genre_scores_gemma":[0.8915912,0.00023128497,0.00007548665,0.000296693,0.1075942,0.00010953835,0.000056779227,0.000032921573,0.000011908156],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.996601,0.0010768998,0.0007771922,0.0005221344,0.0007705567,0.0002522541],"domain_scores_gemma":[0.9972123,0.0012378468,0.0005192271,0.00065426715,0.00024966506,0.00012670567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012520348,0.0003181221,0.0009346267,0.00005122651,0.00004453575,0.000008796708,0.0002334992,0.0002523512,0.000019145706],"category_scores_gemma":[0.0008217241,0.0001660446,0.00015336463,0.00010482112,0.0009785834,0.00001421069,0.0004592209,0.00070603075,0.0000011298265],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005269922,0.0025070794,0.16117881,0.02024127,0.0007299823,0.00023791322,0.0018898811,0.0000026622438,0.0028226299,0.000088507615,0.8048413,0.00019008778],"study_design_scores_gemma":[0.009054618,0.010764962,0.89640504,0.017176896,0.00232787,0.000096656215,0.00024480527,0.000012365531,0.0037216612,0.000043334367,0.059581134,0.0005706828],"about_ca_topic_score_codex":0.000026829384,"about_ca_topic_score_gemma":0.0000010692605,"teacher_disagreement_score":0.7452601,"about_ca_system_score_codex":0.0001510291,"about_ca_system_score_gemma":0.00018201517,"threshold_uncertainty_score":0.67711025},"labels":[],"label_agreement":null},{"id":"W2774748297","doi":"10.1016/j.eururo.2017.11.038","title":"Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health; Prostate Cancer UK; U.S. Department of Veterans Affairs","keywords":"Prostate cancer; Androgen receptor; Medicine; Androgen; Cancer; Oncology; Cancer research; Internal medicine","score_opus":0.08094570057224588,"score_gpt":0.3730374993675895,"score_spread":0.29209179879534364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774748297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015511679,0.9804785,4.552167e-7,0.0007594993,0.0006450278,0.002057083,0.0006213944,0.00004342522,0.013843444],"genre_scores_gemma":[0.0004293699,0.9930162,0.00010988676,0.000075863514,0.00077129435,0.00008213507,0.0012728517,0.0001579384,0.004084476],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949623,0.0016363839,0.0012456183,0.0010392262,0.00040981156,0.0007067069],"domain_scores_gemma":[0.9962516,0.00033236464,0.0014265096,0.0015637145,0.00017191138,0.00025391873],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019745845,0.00055775244,0.002070753,0.00020901598,0.00024671934,0.000049046746,0.00081156514,0.0002771624,0.00045466056],"category_scores_gemma":[0.0008200073,0.000338733,0.0003572639,0.00022505359,0.0003026203,0.000088068344,0.00049999775,0.00093549275,0.00028921742],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008460468,0.00025257986,0.0054244744,0.0017256996,0.001126648,0.0037144164,0.0007610947,0.0000012266696,0.0004073121,0.0000038258586,0.02062666,0.96511],"study_design_scores_gemma":[0.0016152503,0.00029535592,0.001072007,0.005900182,0.0007532626,0.00036138282,0.000028552346,0.000006974171,0.000053591728,0.000017944982,0.98961437,0.00028110467],"about_ca_topic_score_codex":0.0007571899,"about_ca_topic_score_gemma":0.00003361811,"teacher_disagreement_score":0.9689877,"about_ca_system_score_codex":0.00018244449,"about_ca_system_score_gemma":0.0013056482,"threshold_uncertainty_score":0.9999065},"labels":[],"label_agreement":null},{"id":"W2775397021","doi":"10.1016/j.eururo.2017.11.024","title":"Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence Postprostatectomy","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Prostatectomy; Hazard ratio; Prostate-specific antigen; Metastasis; Oncology; Proportional hazards model; Internal medicine; Biochemical recurrence; Urology; Confidence interval; Cancer","score_opus":0.03127422189968705,"score_gpt":0.2570332387415931,"score_spread":0.22575901684190608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775397021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98504966,0.0020790629,7.637352e-7,0.0013069916,0.00007921764,0.0012280258,0.00006871364,0.000029337312,0.010158214],"genre_scores_gemma":[0.9938065,0.00529883,0.0002306376,0.0001467036,0.00004757091,0.0001492768,0.00002480851,0.00006764073,0.0002280374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978888,0.00016866931,0.000527381,0.0006301541,0.00020787395,0.00057712325],"domain_scores_gemma":[0.99860984,0.000043497534,0.0004233307,0.000684266,0.000116368756,0.00012270435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053191336,0.00028829457,0.00057013624,0.00024574128,0.00014383963,0.00003758604,0.00026832338,0.000048545433,0.000051019808],"category_scores_gemma":[0.00003606563,0.0002232082,0.00006417703,0.00017105952,0.0003763841,0.00021094918,0.00015927639,0.0003312613,0.000020854068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044491137,0.00024291503,0.97389066,0.0001316268,0.00011453459,0.0007440007,0.002975384,0.00029841266,0.004522069,0.0000067140327,0.00006637636,0.012558173],"study_design_scores_gemma":[0.0056786123,0.0027194067,0.9846466,0.0002943462,0.00007178809,0.000054349708,0.00028654124,0.00064990384,0.002531929,0.0000026415444,0.0028619878,0.00020184836],"about_ca_topic_score_codex":0.00033907156,"about_ca_topic_score_gemma":0.0002520028,"teacher_disagreement_score":0.012356325,"about_ca_system_score_codex":0.0002067624,"about_ca_system_score_gemma":0.00018769802,"threshold_uncertainty_score":0.9102166},"labels":[],"label_agreement":null},{"id":"W2776118692","doi":"10.1016/j.eururo.2017.11.029","title":"A Partner in Crime: Tumor-associated Stroma and Metastatic Prostate Cancer","year":2017,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Stroma; Prostate; Prostate cancer; Cancer; Oncology; Pathology; Gynecology; Internal medicine; Immunohistochemistry","score_opus":0.04801246166563941,"score_gpt":0.3424569798413135,"score_spread":0.2944445181756741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2776118692","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22567548,0.011253341,6.9273113e-7,0.7294346,0.00056437793,0.0018008361,0.00035406015,0.00012424165,0.030792385],"genre_scores_gemma":[0.34591493,0.0028380752,0.000065118285,0.5355781,0.0022288081,0.00032263764,0.0015453089,0.00042276786,0.11108429],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971843,0.00073821377,0.00034500804,0.00066490617,0.00027796734,0.00078960054],"domain_scores_gemma":[0.9988891,0.00012603536,0.00025152112,0.00051167543,0.00009805053,0.00012364406],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045391734,0.0003695655,0.0007450987,0.00027853326,0.000113905095,0.000059779857,0.00021574627,0.00014839305,0.00022730592],"category_scores_gemma":[0.00021452837,0.00028280116,0.00008713648,0.0000882269,0.00039175941,0.000057219826,0.00018606093,0.0018908607,0.00013479449],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004796116,0.00012126605,0.028812315,0.00031922548,0.0005906628,0.07192761,0.0004873616,8.629348e-7,0.00015526077,0.00000465446,0.8950907,0.002010456],"study_design_scores_gemma":[0.005705359,0.001073496,0.14818974,0.00019704491,0.0004840517,0.00028410574,0.000012178902,0.00003189067,0.000025105952,0.00007443083,0.84359896,0.00032366134],"about_ca_topic_score_codex":0.00022984791,"about_ca_topic_score_gemma":0.000050150058,"teacher_disagreement_score":0.19385652,"about_ca_system_score_codex":0.00014112702,"about_ca_system_score_gemma":0.0002875188,"threshold_uncertainty_score":0.9999624},"labels":[],"label_agreement":null},{"id":"W2777583152","doi":"10.1016/j.eururo.2017.12.013","title":"Re: Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy","year":2017,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Centre; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Prostatectomy; Prostate-specific antigen; Urology; Salvage therapy; Radiation therapy; Prostate; Prostate cancer; Surgery; Internal medicine; Chemotherapy; Cancer","score_opus":0.018829409644827357,"score_gpt":0.2602459843929012,"score_spread":0.24141657474807385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2777583152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810583,0.0012641576,0.000001867704,0.014203244,0.0001707115,0.0024700128,0.00025890997,0.000050701765,0.00052207237],"genre_scores_gemma":[0.978532,0.0011651624,0.000056968558,0.017915776,0.00047716,0.00009191249,0.0013449941,0.00020596347,0.00021005349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969591,0.00053996115,0.00061226217,0.0008048818,0.0004150997,0.00066873396],"domain_scores_gemma":[0.99805206,0.000093184535,0.0006538313,0.0008794394,0.00019857363,0.00012291253],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026671687,0.00055170833,0.00091746886,0.00037982874,0.00007849689,0.00006440297,0.00023109569,0.00029886694,0.00023788128],"category_scores_gemma":[0.000045926707,0.00034781737,0.00023734651,0.0001833318,0.0003259155,0.00013363462,0.000058601254,0.0010997147,0.000053153366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02125143,0.0005501336,0.90806156,0.00010096358,0.0006982207,0.006703258,0.0010148683,0.0000047205826,0.00004711291,1.733269e-7,0.0531051,0.008462474],"study_design_scores_gemma":[0.011751069,0.017430203,0.88934845,0.00022348913,0.00010656806,0.000014813059,0.0000040919335,0.0000020009354,0.000054289045,0.0000019784243,0.080758624,0.00030444772],"about_ca_topic_score_codex":0.00009749054,"about_ca_topic_score_gemma":0.0000059301847,"teacher_disagreement_score":0.027653527,"about_ca_system_score_codex":0.00034616946,"about_ca_system_score_gemma":0.00026401787,"threshold_uncertainty_score":0.99989736},"labels":[],"label_agreement":null},{"id":"W2778812317","doi":"10.1016/j.eururo.2017.12.014","title":"Re: Brachytherapy for Patients with Prostate Cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update","year":2017,"lang":"en","type":"letter","venue":"European Urology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prostate cancer; Brachytherapy; Guideline; Clinical Oncology; Internal medicine; Oncology; Cancer; General surgery; Medical physics; Gynecology; Radiation therapy; Pathology","score_opus":0.1042131896865912,"score_gpt":0.35257741536709636,"score_spread":0.24836422568050515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2778812317","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3709226,0.0026308422,0.000047077196,0.6169064,0.0012887255,0.004070365,0.0012122156,0.0001092965,0.002812493],"genre_scores_gemma":[0.15135987,0.0030633009,0.008450808,0.8138491,0.0070385835,0.0005361797,0.009054957,0.00045642437,0.0061907917],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99617654,0.0005332824,0.0013415327,0.0009845332,0.00032956136,0.00063453184],"domain_scores_gemma":[0.9957164,0.00015006693,0.0021072482,0.0009832385,0.0008813597,0.00016170311],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005854689,0.0005605183,0.0019711629,0.00008455991,0.00015704814,0.000018798037,0.00033221033,0.0004551497,0.0002953016],"category_scores_gemma":[0.000056929286,0.0004085435,0.0007815987,0.000069948976,0.00074839883,0.00004738405,0.00012162082,0.001673794,0.000024613706],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016272019,0.0001434344,0.44453165,0.00012844487,0.0009189143,0.00027622492,0.00061438454,6.586899e-7,0.0000019838747,1.4400644e-7,0.4856322,0.066124745],"study_design_scores_gemma":[0.0073412615,0.0093616005,0.088082045,0.000088171284,0.0014379473,0.00000550395,0.000023091981,0.000028515788,0.0000139894255,0.0000022429736,0.89328444,0.00033117554],"about_ca_topic_score_codex":0.0049004927,"about_ca_topic_score_gemma":0.004340001,"teacher_disagreement_score":0.40765226,"about_ca_system_score_codex":0.00032144203,"about_ca_system_score_gemma":0.0014605619,"threshold_uncertainty_score":0.9998366},"labels":[],"label_agreement":null},{"id":"W2783195757","doi":"10.1016/j.eururo.2017.12.030","title":"Non–risk-adapted Surveillance for Stage I Testicular Cancer: Critical Review and Summary","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Testicular cancer; Neuroblastoma RAS viral oncogene homolog; Stage (stratigraphy); Watchful waiting; Radiation therapy; Cancer; Intensive care medicine; Surgery; Internal medicine; Prostate cancer; Colorectal cancer","score_opus":0.05136394443355194,"score_gpt":0.36562014891888234,"score_spread":0.3142562044853304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783195757","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006031594,0.994981,0.000111491434,0.00030588516,0.00022190754,0.0019849846,0.0012838262,0.00008477938,0.0010201324],"genre_scores_gemma":[0.000042603468,0.99624676,0.00043842598,0.0012873313,0.00042960374,0.00016686125,0.0006085335,0.00015351841,0.00062635605],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99756956,0.0005299747,0.0005641307,0.00077059574,0.00012570483,0.0004400615],"domain_scores_gemma":[0.99787784,0.00066738843,0.00029705119,0.0006278461,0.00018238113,0.00034747485],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042246305,0.0004895453,0.002033949,0.00007879491,0.00010672417,0.000016301743,0.00015737372,0.00013120324,0.00019096409],"category_scores_gemma":[0.0021105264,0.00036084163,0.00042216165,0.0001431562,0.00026534812,0.000021519498,0.00012763737,0.0002964416,0.00015493266],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000880668,0.00038631033,0.0019698583,0.17475587,0.0016032376,0.0020680223,0.0000083197165,1.3962155e-7,1.6811498e-7,0.000107111315,0.03656944,0.78244346],"study_design_scores_gemma":[0.0006860758,0.0008243991,0.0016525306,0.008700351,0.01247966,0.0002521879,3.9080865e-7,0.000011023428,2.1361995e-8,0.000006277355,0.97510695,0.0002801329],"about_ca_topic_score_codex":0.000022190872,"about_ca_topic_score_gemma":0.0000059845734,"teacher_disagreement_score":0.93853754,"about_ca_system_score_codex":0.000045491255,"about_ca_system_score_gemma":0.00023279164,"threshold_uncertainty_score":0.99988437},"labels":[],"label_agreement":null},{"id":"W2785897485","doi":"10.1016/j.eururo.2018.01.034","title":"Re: Propensity Score Analysis of Radical Cystectomy Versus Bladder-sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Propensity score matching; Multidisciplinary approach; Urology; Urothelial cancer; Cancer; Surgery; Internal medicine","score_opus":0.08947373137303824,"score_gpt":0.3400682012875923,"score_spread":0.25059446991455403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785897485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90456533,0.0018417147,0.00001901959,0.08085795,0.0007348442,0.0015501751,0.00014439427,0.00005197514,0.010234615],"genre_scores_gemma":[0.9386252,0.00044241548,0.000076121905,0.057736903,0.0023103382,0.000061524006,0.00029176948,0.00012462083,0.0003311151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99533594,0.0015891752,0.0010746171,0.0008583482,0.0005618005,0.0005800943],"domain_scores_gemma":[0.9972848,0.0006068982,0.0007429742,0.0011053496,0.00018941736,0.00007054781],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011518579,0.0004943257,0.0016304888,0.00063158787,0.000093805655,0.000012729575,0.0006082518,0.0004592023,0.0007265161],"category_scores_gemma":[0.00014208972,0.00032858385,0.0006077155,0.0010416406,0.00062719063,0.000043760494,0.0002274309,0.001770646,0.00003339361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027758505,0.0016920095,0.61831164,0.0007145357,0.034155034,0.0059035593,0.014424714,0.0001385985,0.00071046443,0.0000035971577,0.28553724,0.010650118],"study_design_scores_gemma":[0.022630703,0.0079356115,0.9017762,0.00022972516,0.015357056,0.000063545565,0.00020447245,0.0003621711,0.0002891332,0.000012705051,0.05046567,0.00067298464],"about_ca_topic_score_codex":0.0006617057,"about_ca_topic_score_gemma":0.00046924592,"teacher_disagreement_score":0.2834646,"about_ca_system_score_codex":0.00008482396,"about_ca_system_score_gemma":0.0003380075,"threshold_uncertainty_score":0.9999166},"labels":[],"label_agreement":null},{"id":"W2786027037","doi":"10.1016/j.eururo.2018.02.003","title":"Re: Jochen Walz. The “PROMIS” of Magnetic Resonance Imaging Cost Effectiveness in Prostate Cancer Diagnosis? Eur Urol 2018;73:31–2","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Prostate Cancer UK; National Institute for Health and Care Research","keywords":"Medicine; Prostate cancer; Magnetic resonance imaging; Gynecology; Medical physics; Urology; Cancer; Radiology; Internal medicine","score_opus":0.01871335276519269,"score_gpt":0.27323487210582825,"score_spread":0.25452151934063555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786027037","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09183748,0.13692549,0.0000058000555,0.74761313,0.002323879,0.007965973,0.0009995803,0.00015679715,0.0121718915],"genre_scores_gemma":[0.33012646,0.019378427,0.000085093976,0.63403434,0.0052330857,0.006936526,0.0006212213,0.0006283826,0.0029564507],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950449,0.0016668186,0.0007892918,0.0011673413,0.0003964959,0.000935152],"domain_scores_gemma":[0.9970458,0.00092926127,0.00047398126,0.0012083882,0.00023129255,0.00011124043],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001015287,0.000666066,0.0010792492,0.00025477578,0.00010703123,0.000037094727,0.00054775213,0.00020505775,0.0003965183],"category_scores_gemma":[0.00025171644,0.00047618823,0.0002230599,0.00036196405,0.0007743423,0.00006932624,0.00031376927,0.0016313314,0.00022414693],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007340585,0.00022690417,0.1968192,0.00044935773,0.00011747821,0.0047735223,0.0005687539,0.000007742502,0.000063861,0.0000047042377,0.7698572,0.026377182],"study_design_scores_gemma":[0.003386329,0.0011288122,0.26834086,0.00063827675,0.0003846931,0.000066806366,0.000012125729,0.000021923595,0.000355979,0.00005204831,0.7253039,0.00030823686],"about_ca_topic_score_codex":0.00040723098,"about_ca_topic_score_gemma":0.00009536904,"teacher_disagreement_score":0.238289,"about_ca_system_score_codex":0.00036514347,"about_ca_system_score_gemma":0.00027375802,"threshold_uncertainty_score":0.999769},"labels":[],"label_agreement":null},{"id":"W2786229152","doi":"10.1016/j.eururo.2018.01.017","title":"Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes","year":2018,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Medicine; Prostate cancer; Hazard ratio; Proportional hazards model; Prostate-specific antigen; Confidence interval; Prostate biopsy; Internal medicine; Prostate; Urology; Oncology; Cancer","score_opus":0.020522214795747968,"score_gpt":0.2893583488221263,"score_spread":0.26883613402637835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786229152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98854035,0.0006706467,0.000036156718,0.004320909,0.00030360257,0.00074798806,0.00055970735,0.00007500517,0.004745625],"genre_scores_gemma":[0.9958985,0.0010549597,0.00028139458,0.0017487097,0.00015295805,0.00005960058,0.00015092299,0.000053461612,0.0005994978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981062,0.00021160452,0.0004706575,0.0005644701,0.0002268428,0.00042024167],"domain_scores_gemma":[0.9985038,0.000101195496,0.00022332108,0.00058234535,0.00038685222,0.00020249744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021213962,0.00024974102,0.0007262513,0.00035533076,0.000055061588,0.000011868221,0.00014938001,0.000044281376,0.00032499072],"category_scores_gemma":[0.000092314265,0.0001930495,0.00016338206,0.00089355407,0.00023258195,0.000034987002,0.00011691788,0.00011657025,0.00010238508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018597038,0.00037426353,0.9652681,0.00002099145,0.0022634412,0.00012219309,0.0016423339,0.00015625452,0.0049405093,0.00003903307,0.004546394,0.018766822],"study_design_scores_gemma":[0.0013384569,0.003391731,0.88994646,0.000015213587,0.0004645409,0.0000027608266,0.000030188698,0.00004242353,0.0040580505,0.0000049352816,0.100562066,0.00014317561],"about_ca_topic_score_codex":0.00008653269,"about_ca_topic_score_gemma":0.0002288034,"teacher_disagreement_score":0.09601567,"about_ca_system_score_codex":0.00010268884,"about_ca_system_score_gemma":0.000057409277,"threshold_uncertainty_score":0.78723305},"labels":[],"label_agreement":null},{"id":"W2786824211","doi":"10.1016/j.eururo.2018.01.016","title":"Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study","year":2018,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Medicine; Prostate cancer; Cancer; Hazard ratio; Biopsy; Internal medicine; Oncology; Proportional hazards model; Prostate; Prostate-specific antigen; Gynecology; Confidence interval","score_opus":0.018303774450277633,"score_gpt":0.2731411092001277,"score_spread":0.25483733474985004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786824211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839169,0.00071342575,0.000007982868,0.0050267465,0.00019976287,0.0025239093,0.0011425713,0.000044461533,0.0064242766],"genre_scores_gemma":[0.99769944,0.00016532536,0.0001350809,0.0005767343,0.00040281905,0.00036672887,0.00020125408,0.000050659968,0.00040194037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981635,0.00045435625,0.0003483252,0.0005689874,0.00016973255,0.0002951013],"domain_scores_gemma":[0.9977184,0.0007194303,0.00031259272,0.0005884759,0.0005732353,0.00008789528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000480603,0.00020367741,0.00033798668,0.000033369266,0.00012129644,0.000012537477,0.00016338917,0.000031371073,0.000058230624],"category_scores_gemma":[0.0004324205,0.00012231753,0.00004548924,0.00019486493,0.00030252486,0.000034274788,0.000054952237,0.000120945115,0.000054065113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019071674,0.0006478548,0.9614734,0.000015854599,0.0006523938,0.00007615467,0.0029368615,0.000005882712,0.0009548331,0.000017988392,0.0029457207,0.011201378],"study_design_scores_gemma":[0.004397151,0.0062107933,0.95903814,0.00003736637,0.00010605187,0.000017924194,0.00033819056,0.00007221429,0.00030787263,0.00002192945,0.029326553,0.0001258046],"about_ca_topic_score_codex":0.0017708127,"about_ca_topic_score_gemma":0.0025146923,"teacher_disagreement_score":0.026380833,"about_ca_system_score_codex":0.00007109942,"about_ca_system_score_gemma":0.00023311342,"threshold_uncertainty_score":0.49879643},"labels":[],"label_agreement":null},{"id":"W2787384626","doi":"10.1016/j.eururo.2018.01.019","title":"You Can Trust a Crystal Ball About as Far as You Can Throw It","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Crystal Ball; Ball (mathematics); Geometry","score_opus":0.02177698420659383,"score_gpt":0.2484371381695119,"score_spread":0.22666015396291808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787384626","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0809287,0.0012339947,0.000006239178,0.49578932,0.0014274528,0.00088999665,0.00018761517,0.00024136448,0.41929534],"genre_scores_gemma":[0.15930471,0.00018747122,0.00009643602,0.72129935,0.011748031,0.000033058623,0.0017354878,0.00046527767,0.10513019],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99442726,0.0010960373,0.0008122685,0.0015827985,0.0007064786,0.0013751558],"domain_scores_gemma":[0.9969293,0.00013066508,0.00044686295,0.0018211037,0.000238856,0.000433203],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00040366952,0.0010468478,0.0012741361,0.00041311348,0.0001808299,0.00006712824,0.0007226962,0.00078554376,0.003815838],"category_scores_gemma":[0.00025166865,0.00089476886,0.00048774204,0.00019972505,0.0007071834,0.000033953627,0.00039050347,0.0026106797,0.0074495384],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034442183,0.000106441155,0.0014604157,0.00011952289,0.00065375573,0.059931256,0.0012497776,0.0000012167118,0.00046979415,0.000033834072,0.93483883,0.00079072465],"study_design_scores_gemma":[0.0022936065,0.0052670464,0.0073374757,0.000057890247,0.0011230181,0.0054251365,0.000045031917,0.000005293438,0.00014538442,0.000044603625,0.97761,0.0006455386],"about_ca_topic_score_codex":0.0013824983,"about_ca_topic_score_gemma":0.00026045,"teacher_disagreement_score":0.31416515,"about_ca_system_score_codex":0.00039407826,"about_ca_system_score_gemma":0.0005250576,"threshold_uncertainty_score":0.99969035},"labels":[],"label_agreement":null},{"id":"W2788459110","doi":"10.1016/j.eururo.2018.01.043","title":"Clinical and Genomic Characterization of Low–Prostate-specific Antigen, High-grade Prostate Cancer","year":2018,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"EMD Serono; Astellas Pharma; Myriad Genetics; Sanofi; National Cancer Institute; Prostate Cancer Foundation","keywords":"Medicine; Prostate cancer; Prostate-specific antigen; Hazard ratio; Prostate; Urology; Internal medicine; Prostatectomy; Proportional hazards model; Oncology; Gynecology; Cancer; Confidence interval","score_opus":0.02531279295167289,"score_gpt":0.2912840659696812,"score_spread":0.2659712730180083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788459110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99537677,0.0011879242,0.000023935301,0.0018201553,0.0005781644,0.00048364734,0.00010236033,0.00004208116,0.0003849569],"genre_scores_gemma":[0.9832037,0.014397437,0.00013770099,0.001302584,0.00057364634,0.000017780678,0.00012127191,0.000048637838,0.00019722142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985523,0.00020078513,0.00047568374,0.000425322,0.00008833568,0.00025756485],"domain_scores_gemma":[0.999218,0.00003810837,0.00020468388,0.00028410327,0.00012038729,0.00013471233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027254008,0.00016066048,0.0003637407,0.00007607139,0.000058977806,0.000011480752,0.00006684371,0.000051083352,0.00016238286],"category_scores_gemma":[0.00001783725,0.00013291679,0.000052986048,0.000099355595,0.000519878,0.000047489113,0.00008000628,0.00013078994,0.00011173435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013214935,0.00044164824,0.75650114,0.000073320065,0.00018485796,0.00018072435,0.00093587907,0.0000017825867,0.18041754,0.0002183329,0.00095069065,0.058772575],"study_design_scores_gemma":[0.0024522888,0.002275914,0.9266007,0.00003813339,0.000057783298,0.000017780289,0.000008356468,0.000021197213,0.005898783,0.000021879088,0.06250202,0.00010517318],"about_ca_topic_score_codex":0.000020681964,"about_ca_topic_score_gemma":0.0000060086377,"teacher_disagreement_score":0.17451875,"about_ca_system_score_codex":0.000025075442,"about_ca_system_score_gemma":0.000055685614,"threshold_uncertainty_score":0.54201895},"labels":[],"label_agreement":null},{"id":"W2788936567","doi":"10.1016/j.eururo.2018.01.029","title":"Is 68 Ga-Prostate-specific Membrane Antigen–ligand Positron Emission Tomography/Computed Tomography Ready To Simplify the Conundrum of Biochemically Recurrent Prostate Cancer?","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Glutamate carboxypeptidase II; Prostate cancer; Positron emission tomography; Prostate; Positron Emission Tomography-Computed Tomography; Tomography; Computed tomography; Nuclear medicine; Prostate-specific antigen; Ligand (biochemistry); Cancer; Radiology; Internal medicine; Receptor","score_opus":0.0271435183773459,"score_gpt":0.296689163182916,"score_spread":0.2695456448055701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788936567","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4123736,0.021629678,0.00002196425,0.55343205,0.0018405565,0.0044502844,0.0016178322,0.00026506436,0.0043690023],"genre_scores_gemma":[0.37522116,0.025832336,0.0006112388,0.5648473,0.011862529,0.00040561424,0.008344146,0.0010387608,0.0118369125],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99451077,0.00074186677,0.0010224953,0.001499498,0.00086181716,0.0013635253],"domain_scores_gemma":[0.99660414,0.00023235199,0.00053160486,0.0014531406,0.0007803049,0.0003984347],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00065396045,0.00084666506,0.0011594009,0.00082467525,0.00026759037,0.00007775781,0.00085622433,0.00050568726,0.00028328274],"category_scores_gemma":[0.00004489305,0.00055990525,0.00047506488,0.0011619303,0.0010038982,0.00005112386,0.00047947015,0.0020887314,0.0002031112],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033830418,0.00019192051,0.004406628,0.0004792555,0.0007519527,0.0009064846,0.0011934587,0.000001424289,0.08315943,0.0000024664816,0.9012093,0.0043146284],"study_design_scores_gemma":[0.0025106254,0.0036908118,0.0074144225,0.00048168385,0.00031168724,0.0001038966,0.000029341763,0.000011577463,0.070363656,0.000026148216,0.9145176,0.00053855416],"about_ca_topic_score_codex":0.00007972609,"about_ca_topic_score_gemma":0.000003344102,"teacher_disagreement_score":0.037152447,"about_ca_system_score_codex":0.00011486066,"about_ca_system_score_gemma":0.00026095659,"threshold_uncertainty_score":0.9996852},"labels":[],"label_agreement":null},{"id":"W2792663325","doi":"10.1016/j.eururo.2018.03.001","title":"Active Surveillance for Stage I Testicular Cancer: A Four-decade–old Experiment Proven Correct","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Testicular cancer; Stage (stratigraphy); Gynecology; Cancer; Internal medicine","score_opus":0.034178912861080046,"score_gpt":0.3015697377736466,"score_spread":0.26739082491256655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792663325","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0985689,0.021779453,0.0021901727,0.80990833,0.010003885,0.01893599,0.009854179,0.001766411,0.026992686],"genre_scores_gemma":[0.13824205,0.0002657877,0.0011933799,0.80450124,0.016411195,0.001262846,0.0037578838,0.0007946967,0.033570945],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99727714,0.00037790087,0.0003645719,0.000978374,0.00028847173,0.0007135482],"domain_scores_gemma":[0.99809784,0.00032509092,0.00036837783,0.0007768511,0.0002412762,0.0001905751],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014813157,0.00054894097,0.0007615627,0.00012528055,0.00011472714,0.000027662845,0.00025323368,0.00029414016,0.00042849395],"category_scores_gemma":[0.00046142418,0.00045846752,0.00033126018,0.00009568383,0.00020337228,0.000028877723,0.00013451197,0.00064819265,0.00026734473],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082182337,0.0002621081,0.00455511,0.0002813883,0.0012127402,0.007943931,0.00015342976,0.0000070479864,0.00027832997,0.0000073285973,0.9794386,0.0050381483],"study_design_scores_gemma":[0.0031064346,0.0027049584,0.014612759,0.00007674586,0.0007340357,0.00017662076,0.000008474301,0.00009519345,0.00021484891,0.00001307719,0.9778475,0.00040936435],"about_ca_topic_score_codex":0.00011321568,"about_ca_topic_score_gemma":0.000008828813,"teacher_disagreement_score":0.039673146,"about_ca_system_score_codex":0.00020099174,"about_ca_system_score_gemma":0.00022870008,"threshold_uncertainty_score":0.99978673},"labels":[],"label_agreement":null},{"id":"W2792717752","doi":"10.1016/j.eururo.2018.03.006","title":"Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder Cancer","year":2018,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Canadian Centre for Applied Research in Cancer Control; Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Pembrolizumab; Medicine; Willingness to pay; Bladder cancer; Cost effectiveness; Cancer; Internal medicine; Oncology; Immunotherapy","score_opus":0.041437149618426775,"score_gpt":0.3442876869679283,"score_spread":0.3028505373495015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792717752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93180853,0.0008212118,0.0001607993,0.00023339465,0.00041811683,0.0006439944,0.000033030326,0.000042089876,0.06583885],"genre_scores_gemma":[0.9975405,0.00006919399,0.00007042497,0.0011806906,0.00025605585,0.000046770532,0.00001635225,0.00004716494,0.0007728716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986616,0.00038157214,0.0002524494,0.00032148417,0.00010024508,0.0002826704],"domain_scores_gemma":[0.9993435,0.00008886067,0.00007665,0.00029102236,0.00011599396,0.00008393359],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024776874,0.00015830762,0.00036016817,0.00012464299,0.00002620719,0.0000025771376,0.0001019211,0.000051478823,0.0016018278],"category_scores_gemma":[0.000052382147,0.00013596923,0.0000606348,0.00018506621,0.00020842731,0.000043541324,0.000054288328,0.00016254814,0.00015748345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.068220526,0.0037125724,0.33678064,0.0011209621,0.0018670389,0.002277828,0.0045978315,0.00046894836,0.2963464,0.0017340856,0.004182488,0.27869067],"study_design_scores_gemma":[0.017252332,0.004555269,0.891931,0.00007830231,0.00016233446,0.00010861194,0.00003068532,0.000076573575,0.03506841,0.0001540627,0.0503679,0.00021454145],"about_ca_topic_score_codex":0.00005666424,"about_ca_topic_score_gemma":0.00015311607,"teacher_disagreement_score":0.55515033,"about_ca_system_score_codex":0.000062006824,"about_ca_system_score_gemma":0.00010469217,"threshold_uncertainty_score":0.99931085},"labels":[],"label_agreement":null},{"id":"W2792782785","doi":"10.1016/j.eururo.2018.02.014","title":"Repeat Transurethral Resection in Non–muscle-invasive Bladder Cancer: A Systematic Review","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":332,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute for Health and Care Research","keywords":"Medicine; Bladder cancer; Resection; Detrusor muscle; Cancer; Urology; Surgery; Internal medicine; Urinary bladder","score_opus":0.04492470978304158,"score_gpt":0.34777947095349376,"score_spread":0.3028547611704522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792782785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007690418,0.98049366,0.000009362908,0.00028527266,0.00070246484,0.0051608994,0.000065072534,0.0000864484,0.013189148],"genre_scores_gemma":[0.000104883096,0.99389905,0.000020778409,0.0021683048,0.00081490306,0.00073371246,0.0001444723,0.00021380131,0.0019000896],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9944118,0.0022605993,0.0014958311,0.0009664828,0.00030660446,0.00055866194],"domain_scores_gemma":[0.997815,0.00021870446,0.0005700687,0.0010675953,0.00013549323,0.00019312804],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009972526,0.0006885412,0.00421777,0.00034927676,0.00006821739,0.000016321192,0.00033771733,0.00028778627,0.0004391895],"category_scores_gemma":[0.0003698531,0.0004957563,0.00077985105,0.00056674797,0.00014828006,0.000052589712,0.00007198392,0.00081256597,0.0010478129],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000625479,0.00012123017,0.000008774674,0.9580708,0.00088242115,0.0011491402,0.00019747634,1.057068e-7,6.6397007e-7,0.000003565503,0.0052945064,0.034208782],"study_design_scores_gemma":[0.0011555966,0.0013486702,0.00005993427,0.5694992,0.014052591,0.0008651285,0.0000068895324,7.6584195e-7,6.630504e-7,0.0000046084187,0.41261694,0.0003889826],"about_ca_topic_score_codex":0.00009852867,"about_ca_topic_score_gemma":0.00022096792,"teacher_disagreement_score":0.40732244,"about_ca_system_score_codex":0.0003028531,"about_ca_system_score_gemma":0.00049647846,"threshold_uncertainty_score":0.9997494},"labels":[],"label_agreement":null},{"id":"W2793652009","doi":"10.1016/j.eururo.2018.02.019","title":"Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer","year":2018,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Androgen deprivation therapy; Medicine; Androgen receptor; Gene knockdown; Cancer research; Downregulation and upregulation; Oncology; Cancer; Internal medicine; Biology; Gene","score_opus":0.03172585020511681,"score_gpt":0.2926756746891043,"score_spread":0.2609498244839875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793652009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99242425,0.001688921,0.00002765671,0.0014820357,0.00019322705,0.002863813,0.00023547045,0.000091323054,0.000993278],"genre_scores_gemma":[0.9948871,0.00043385103,0.0011780016,0.00019700534,0.0002904963,0.0005539854,0.00023708059,0.000116057294,0.002106424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964439,0.00066993525,0.0007656869,0.0007890286,0.00054604426,0.00078538415],"domain_scores_gemma":[0.9977642,0.000051117266,0.00042501767,0.0005380191,0.0008915713,0.0003300688],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046750685,0.00040896385,0.0004698128,0.00015642094,0.0005050375,0.00006761944,0.0002972531,0.00010148957,0.00059361086],"category_scores_gemma":[0.00008978002,0.00027860256,0.0000908445,0.00032628598,0.00064546487,0.00026120257,0.00020576411,0.00034196483,0.00009366556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006022996,0.0002697928,0.003818035,0.000080814396,0.0004763546,0.0000492137,0.023574272,0.000020913429,0.953429,0.00001650207,0.0012625825,0.01097952],"study_design_scores_gemma":[0.006135446,0.007305848,0.048083093,0.00022086756,0.00018889729,0.000020525475,0.000913675,0.00019280254,0.9208654,0.00014898044,0.01521245,0.0007119764],"about_ca_topic_score_codex":0.00042538054,"about_ca_topic_score_gemma":0.00026982182,"teacher_disagreement_score":0.044265058,"about_ca_system_score_codex":0.00025822743,"about_ca_system_score_gemma":0.0011139374,"threshold_uncertainty_score":0.9999666},"labels":[],"label_agreement":null},{"id":"W2797935388","doi":"10.1016/j.eururo.2018.03.036","title":"First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Sunnybrook Health Science Centre; Health Sciences Centre; Mount Sinai Hospital; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Cabozantinib; Meta-analysis; Internal medicine; Oncology; Renal cell carcinoma; MEDLINE; Adverse effect; Randomized controlled trial; Clinical trial; Systematic review; Intensive care medicine; Immunotherapy; Cancer","score_opus":0.139009630443,"score_gpt":0.3312376492555004,"score_spread":0.19222801881250043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797935388","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000051479933,0.98632777,0.0006596646,0.00014662913,0.00010594521,0.011827216,0.00012950027,0.00007199895,0.0007261446],"genre_scores_gemma":[0.00072545314,0.9918006,0.00074718666,0.0013745046,0.00037967335,0.0016943213,0.0005321393,0.00025767682,0.0024884588],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99082273,0.004222507,0.0025715318,0.0013430119,0.00032862733,0.00071160734],"domain_scores_gemma":[0.9940697,0.0014230423,0.0019604233,0.0019307671,0.00028365906,0.00033243964],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.003234458,0.0011894733,0.016897986,0.0004454989,0.00015794758,0.000039784583,0.0004533954,0.00016666813,0.00021311358],"category_scores_gemma":[0.00024265292,0.0006833099,0.0057856753,0.0008752364,0.0001568806,0.0000320046,0.00016385432,0.00040928298,0.00032394417],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003885814,0.00010095239,0.0000015598126,0.85931325,0.13784634,0.0004666397,0.000028779185,0.0000066765406,7.946758e-8,0.000012448285,0.0018693377,0.0003150864],"study_design_scores_gemma":[0.000703837,0.0017711645,0.0000025787936,0.0148263415,0.84052974,0.0017919787,0.0000015873069,0.000018623574,1.7143631e-7,0.000005623342,0.13996136,0.00038695923],"about_ca_topic_score_codex":0.00000758332,"about_ca_topic_score_gemma":0.0000060745488,"teacher_disagreement_score":0.8444869,"about_ca_system_score_codex":0.00012116321,"about_ca_system_score_gemma":0.00015316857,"threshold_uncertainty_score":0.9995618},"labels":[],"label_agreement":null},{"id":"W2799460967","doi":"10.1016/j.eururo.2018.03.017","title":"Are There Extended Benefits with Extended Lymph Node Dissection During Radical Prostatectomy?","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Prostatectomy; Dissection (medical); Lymph node; Urology; Surgery; General surgery; Prostate cancer; Cancer; Internal medicine","score_opus":0.01507638196279241,"score_gpt":0.23791039549873585,"score_spread":0.22283401353594345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799460967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6865773,0.0035263086,0.00003093568,0.29296502,0.0010126216,0.0017760933,0.00022775408,0.00061807234,0.013265905],"genre_scores_gemma":[0.62212956,0.00094946264,0.00024371553,0.36157086,0.009123923,0.00030102904,0.0010068909,0.0006140815,0.004060494],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9967161,0.00040549794,0.0004503468,0.0011913481,0.00040499642,0.0008317474],"domain_scores_gemma":[0.9981439,0.000077175195,0.000511852,0.00089180237,0.00017756078,0.00019770223],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015706453,0.0006689428,0.0008153251,0.00022589615,0.00020185219,0.00005020364,0.0002254932,0.00039123764,0.00043469417],"category_scores_gemma":[0.000060626437,0.00047960508,0.00018558351,0.00018280509,0.00038511129,0.0000641791,0.00012924474,0.0011865637,0.0005101985],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008700442,0.0018819735,0.092143856,0.0023841697,0.003812575,0.20552048,0.0006046989,0.000042213065,0.00051377155,0.00005903164,0.67047393,0.013862835],"study_design_scores_gemma":[0.0061177397,0.0019834049,0.7257275,0.00056785415,0.0007417356,0.0034368043,0.000020185242,0.000008298802,0.0005773665,0.000029517736,0.26021758,0.00057200884],"about_ca_topic_score_codex":0.0000122552265,"about_ca_topic_score_gemma":0.00001004889,"teacher_disagreement_score":0.63358366,"about_ca_system_score_codex":0.00028345254,"about_ca_system_score_gemma":0.00010644849,"threshold_uncertainty_score":0.9997656},"labels":[],"label_agreement":null},{"id":"W2803049809","doi":"10.1016/j.eururo.2018.04.003","title":"Risks and Benefits of Adjuvant Radiotherapy After Inguinal Lymphadenectomy in Node-positive Penile Cancer: A Systematic Review by the European Association of Urology Penile Cancer Guidelines Panel","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Genital Health and Disease","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Penile cancer; Lymphadenectomy; Radiation therapy; Prostatectomy; Lymph node; Retrospective cohort study; Oncology; Urology; Cancer; Gynecology; Internal medicine; Prostate cancer","score_opus":0.06818715704310588,"score_gpt":0.36921223942957854,"score_spread":0.30102508238647263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803049809","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019132134,0.992701,0.0000040410537,0.00082952715,0.0002490681,0.002670977,0.0006726086,0.00002110299,0.0009384836],"genre_scores_gemma":[0.032336276,0.96161085,0.000024518471,0.004761504,0.00044385577,0.00027888722,0.00012527872,0.00011763819,0.00030120523],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913315,0.005064265,0.0021768778,0.0006059412,0.00032141653,0.0004999742],"domain_scores_gemma":[0.9960796,0.0005230033,0.0020695925,0.00058682816,0.00052259606,0.00021836165],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027385151,0.0005044832,0.0032042859,0.00020504589,0.000055131517,0.000008910395,0.00035758707,0.00017347818,0.00013972737],"category_scores_gemma":[0.0011952084,0.000331787,0.0003385241,0.00033045633,0.00018697945,0.00003605013,0.00014066712,0.00037896476,0.00003735456],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051715627,0.0002546611,0.0036288209,0.91197264,0.00039027553,0.00020479069,0.0006001414,0.00000653827,0.0000035942303,0.000007813272,0.011298353,0.071115226],"study_design_scores_gemma":[0.008451926,0.003543081,0.033239726,0.26105353,0.03613123,0.0012641335,0.000055129276,0.00009830064,0.0000031462162,0.000011405613,0.6545443,0.0016040929],"about_ca_topic_score_codex":0.000516329,"about_ca_topic_score_gemma":0.00011634104,"teacher_disagreement_score":0.6509191,"about_ca_system_score_codex":0.00020638654,"about_ca_system_score_gemma":0.00045419083,"threshold_uncertainty_score":0.9999134},"labels":[],"label_agreement":null},{"id":"W2804413706","doi":"10.1016/j.eururo.2018.05.003","title":"A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts","year":2018,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Prostate biopsy; Biopsy; Prostate; Confidence interval; Logistic regression; Rectal examination; Prostate-specific antigen; Receiver operating characteristic; Prostatectomy; Risk assessment; Oncology; Internal medicine; Radiology; Cancer","score_opus":0.01932548774936438,"score_gpt":0.2539121307040133,"score_spread":0.23458664295464893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804413706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98059314,0.0005105437,0.00010974473,0.00095273677,0.00038764635,0.00077943876,0.00012353554,0.00016805678,0.016375156],"genre_scores_gemma":[0.99357086,0.00003804252,0.0002266053,0.0054859575,0.00030847784,0.000041812735,0.00009254547,0.00007019656,0.00016549244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844056,0.0003181576,0.00027051911,0.00049978227,0.00014337394,0.00032761222],"domain_scores_gemma":[0.9989119,0.00012601908,0.00013528678,0.00051329326,0.00008918823,0.00022430008],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022990735,0.00022209978,0.00030966222,0.00009766201,0.000112766334,0.000013877649,0.00007750551,0.000048269267,0.0001675796],"category_scores_gemma":[0.00017466322,0.00017267503,0.000109494176,0.000097432574,0.00022813879,0.00002177375,0.000046323246,0.000161216,0.0008315209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002993213,0.00094384066,0.967573,0.00002983334,0.00026172755,0.0077296575,0.00028002285,0.00013947969,0.0008634783,0.000016265827,0.013435096,0.005734379],"study_design_scores_gemma":[0.012592025,0.017791262,0.6934547,0.00008428533,0.00028810237,0.0005271633,0.000012585191,0.0097434735,0.00997793,0.000020530224,0.25502977,0.00047816103],"about_ca_topic_score_codex":0.000051258805,"about_ca_topic_score_gemma":0.000005618152,"teacher_disagreement_score":0.2741183,"about_ca_system_score_codex":0.000057390665,"about_ca_system_score_gemma":0.000079798745,"threshold_uncertainty_score":0.9999465},"labels":[],"label_agreement":null},{"id":"W2805086678","doi":"10.1016/j.eururo.2018.05.005","title":"Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II)","year":2018,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"Astellas Pharma Europe; Astellas Pharma","keywords":"Mirabegron; Solifenacin; Medicine; Overactive bladder; Urology; Safety profile; Tolterodine; Combination therapy; Extended release; Internal medicine; Adverse effect; Pharmacology","score_opus":0.012193138886827087,"score_gpt":0.2894866163821063,"score_spread":0.2772934774952792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805086678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971382,0.000102479615,0.00003325875,0.00014275605,0.000014153782,0.001834153,0.0000064647497,0.000011533103,0.0007169792],"genre_scores_gemma":[0.99966854,0.00006680264,0.00003467959,0.0000849549,0.000019652247,0.000007566707,0.000039353974,0.000029134644,0.000049296115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998258,0.0006857891,0.00029773708,0.00033809547,0.0001767788,0.0002436141],"domain_scores_gemma":[0.9992878,0.0002092722,0.00011094964,0.000185153,0.000114077266,0.000092778646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035289399,0.00016285627,0.0004035784,0.00022959943,0.000059575144,0.000008094103,0.000055840246,0.00002911018,0.00003448686],"category_scores_gemma":[0.00004642182,0.000118139964,0.00001262108,0.00017087084,0.00026724837,0.00008338624,0.000061155915,0.00020696638,0.000002148622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26852965,0.0062682126,0.7090079,0.000022527294,0.00014634784,0.00018310154,0.008903326,0.0000101938995,0.00014642917,0.0000032790583,0.0000058792943,0.0067731226],"study_design_scores_gemma":[0.26401728,0.02136466,0.71396685,0.000030067044,0.000042230346,0.000010485491,0.00015149919,0.00024280531,0.00004802406,0.0000010377289,0.000042503325,0.00008254092],"about_ca_topic_score_codex":0.00006470348,"about_ca_topic_score_gemma":0.0001951408,"teacher_disagreement_score":0.015096447,"about_ca_system_score_codex":0.00002728375,"about_ca_system_score_gemma":0.00003647587,"threshold_uncertainty_score":0.4817608},"labels":[],"label_agreement":null},{"id":"W2807028128","doi":"10.1016/j.eururo.2018.05.017","title":"Corrigendum re “Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma” [Eur Urol 2017;72:747–54]","year":2018,"lang":"en","type":"erratum","venue":"European Urology","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"National Institutes of Health; National Institute for Health and Care Research; Cancer Research UK; World Health Organization","keywords":"Medicine; Telomere; Renal cell carcinoma; Nothing; Internal medicine; Genetics; DNA; Biology; Epistemology; Philosophy","score_opus":0.01332422423011003,"score_gpt":0.2076303586893473,"score_spread":0.19430613445923725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807028128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7697871,0.0004024352,0.00020821774,0.00019691612,0.004076307,0.001854194,0.0008608394,0.0001704266,0.22244361],"genre_scores_gemma":[0.9456123,0.00020726713,0.00025440688,0.0020430442,0.00039285846,0.000042814554,0.000496688,0.00041017513,0.050540447],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.98907113,0.004866026,0.0011926747,0.002334988,0.0009368198,0.0015983636],"domain_scores_gemma":[0.9951152,0.00026188648,0.0020671345,0.0017526234,0.000075841155,0.0007272678],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002151846,0.0009780732,0.0011050741,0.00031156477,0.00044403964,0.000035221314,0.0013093784,0.0006511746,0.005212193],"category_scores_gemma":[0.00091811875,0.0009300243,0.00018430082,0.0006138999,0.0008788491,0.00013028456,0.0010761159,0.0025130743,0.00676412],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033683836,0.00053855305,0.17496327,0.00006306727,0.00028594784,0.0028600527,0.0013910951,0.00046202008,0.000971882,8.887815e-7,0.81687385,0.0012525524],"study_design_scores_gemma":[0.0014728565,0.001931913,0.89500064,0.00010355279,0.00053832505,0.00006970739,0.00005963778,0.00037488004,0.00010416641,0.000022183342,0.09940977,0.0009124005],"about_ca_topic_score_codex":0.0007347438,"about_ca_topic_score_gemma":0.0006734005,"teacher_disagreement_score":0.72003734,"about_ca_system_score_codex":0.00044882778,"about_ca_system_score_gemma":0.00016372847,"threshold_uncertainty_score":0.99978817},"labels":[],"label_agreement":null},{"id":"W2809172769","doi":"10.1016/j.eururo.2018.06.007","title":"Somatic Bi-allelic Loss of TSC Genes in Eosinophilic Solid and Cystic Renal Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"European Urology","topic":"Tuberous Sclerosis Complex Research","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"National Cancer Institute; Howard Hughes Medical Institute","keywords":"Tuberous sclerosis; Renal cell carcinoma; TSC2; TSC1; Medicine; Clear cell; Somatic cell; Cancer research; Loss of heterozygosity; Kidney cancer; Pathology; Germline; PI3K/AKT/mTOR pathway; Biology; Gene; Allele; Genetics","score_opus":0.03196774528037082,"score_gpt":0.2802978180835013,"score_spread":0.24833007280313046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809172769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900055,0.0009028633,0.00007498163,0.00072392967,0.00007466313,0.00026283172,0.0000039790084,0.00003218744,0.007919044],"genre_scores_gemma":[0.998551,0.00004053265,0.00036031223,0.0004129241,0.00027275944,0.0000042723077,0.0000064600636,0.000049748967,0.00030196656],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99799514,0.00056017557,0.0004156386,0.0003718616,0.00020398064,0.0004532172],"domain_scores_gemma":[0.99899495,0.00017847617,0.00009116002,0.0004746933,0.00010638536,0.00015434457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005123557,0.00016266212,0.0003789124,0.00031757465,0.000053507843,0.000009455672,0.00020832143,0.000057500813,0.00019472337],"category_scores_gemma":[0.00016809783,0.00014604475,0.00004392135,0.00023010523,0.0006379822,0.00003129302,0.0002614113,0.00024174234,0.00034624024],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006530533,0.00049898087,0.27854165,0.00038674625,0.000045393754,0.0010847633,0.0020538578,0.000024401941,0.7106129,0.0002535282,0.00074539677,0.0050993264],"study_design_scores_gemma":[0.0023392793,0.0026553979,0.9830215,0.000030715593,0.000044202057,0.0004240232,0.000032626212,0.0012641428,0.008828704,0.00014225386,0.0010797858,0.00013735135],"about_ca_topic_score_codex":0.000055565873,"about_ca_topic_score_gemma":0.000048095208,"teacher_disagreement_score":0.7044799,"about_ca_system_score_codex":0.00002486514,"about_ca_system_score_gemma":0.00006253643,"threshold_uncertainty_score":0.5955532},"labels":[],"label_agreement":null},{"id":"W2811472135","doi":"10.1016/j.eururo.2018.06.018","title":"Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial","year":2018,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Rimouski; Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec; Centre hospitalier universitaire de Québec; Centre de Santé et de Services Sociaux de Chicoutimi; Centre Hospitalier de l’Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University Health Centre; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Randomized controlled trial; Quality of life (healthcare); Radiation therapy; Confidence interval; Urology; Proportional hazards model; Androgen; Internal medicine; Surgery; Cancer; Hormone","score_opus":0.01774937550346184,"score_gpt":0.29462709137230664,"score_spread":0.2768777158688448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811472135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99479353,0.0010433879,0.0001131453,0.0010363081,0.00027661788,0.0020070383,0.000022023347,0.000026757942,0.0006812145],"genre_scores_gemma":[0.9930071,0.0057949703,0.00010283564,0.00046358482,0.00030948772,0.0001811629,0.000068364,0.000021871001,0.00005059904],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983898,0.0005880023,0.00053530524,0.00023590354,0.000093523086,0.00015749346],"domain_scores_gemma":[0.9991913,0.0001411593,0.00033034573,0.00019113376,0.0000997474,0.000046307247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007585708,0.00011569953,0.00046576836,0.00010953257,0.00003459116,0.0000055434657,0.000046750818,0.00003329905,0.000116978554],"category_scores_gemma":[0.00019512603,0.00008480475,0.000071302034,0.00013850219,0.00016427615,0.000043758988,0.000018064666,0.0000846099,0.000017753746],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8925202,0.00071598485,0.010902022,0.0000074385503,0.0002083479,0.000046970392,0.0015011398,0.000009628084,0.0013882226,0.00013142184,0.00029088726,0.092277765],"study_design_scores_gemma":[0.97163826,0.0066498835,0.007437392,0.000017668805,0.00014126915,0.0000051572597,0.000009503181,0.0001961434,0.009988559,0.00018115282,0.0036597238,0.00007528971],"about_ca_topic_score_codex":0.00035412068,"about_ca_topic_score_gemma":0.00005355588,"teacher_disagreement_score":0.09220247,"about_ca_system_score_codex":0.000042115542,"about_ca_system_score_gemma":0.00008177446,"threshold_uncertainty_score":0.34582373},"labels":[],"label_agreement":null},{"id":"W2884302925","doi":"10.1016/j.eururo.2018.06.025","title":"Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective Trial","year":2018,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; McMaster University; Queen's University; Health Sciences Centre; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Biopsy; Magnetic resonance imaging; Population; Randomized controlled trial; Clinical endpoint; Prostate cancer; Prospective cohort study; Radiology; Cancer; Internal medicine","score_opus":0.011591686422356171,"score_gpt":0.2761211319492402,"score_spread":0.264529445526884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884302925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95896447,0.0023027838,0.000018754445,0.0011379622,0.00056937704,0.0048223394,0.00006935912,0.00006552377,0.03204944],"genre_scores_gemma":[0.99840957,0.00010835958,0.0001276168,0.00038661042,0.00040724856,0.00014772148,0.000012793876,0.000036819616,0.0003632417],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971565,0.0012267025,0.0006072575,0.00053555024,0.00018823083,0.00028572927],"domain_scores_gemma":[0.99841225,0.00047720075,0.0002773374,0.0004448914,0.00030627998,0.000082037266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001108768,0.00019884373,0.0008013006,0.00009240848,0.000060543676,0.000009772891,0.00011096822,0.00002195221,0.00007529318],"category_scores_gemma":[0.0010951727,0.00014898584,0.00015066906,0.00014613176,0.0004979648,0.00003902033,0.00009464922,0.00014548787,0.00008296652],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92701304,0.001651102,0.05098718,0.000007375429,0.00015331835,0.0003190524,0.0029949467,3.7374008e-7,0.00008600892,0.000023667902,0.00064200966,0.016121933],"study_design_scores_gemma":[0.6296284,0.007147082,0.35890937,0.000019652218,0.00017481814,0.000012789517,0.000107470485,0.00005382437,0.00037548982,0.00001593279,0.0034638622,0.00009129363],"about_ca_topic_score_codex":0.000072121715,"about_ca_topic_score_gemma":0.000043914657,"teacher_disagreement_score":0.30792218,"about_ca_system_score_codex":0.000064559266,"about_ca_system_score_gemma":0.000049471713,"threshold_uncertainty_score":0.6075466},"labels":[],"label_agreement":null},{"id":"W2884458916","doi":"10.1016/j.eururo.2018.06.024","title":"Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Disease; Clinical trial; Oncology; Surgery; Internal medicine; Cancer","score_opus":0.0744495674123909,"score_gpt":0.33871565536885617,"score_spread":0.2642660879564653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884458916","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021674114,0.9868748,0.00018960517,0.0010259864,0.0009960114,0.0035448004,0.00058636954,0.00017346155,0.006392191],"genre_scores_gemma":[0.0014753895,0.9819373,0.00066121796,0.00078094186,0.0029133218,0.00024607655,0.0032727444,0.00029371463,0.0084192995],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967697,0.00061608077,0.00079116906,0.0010616197,0.00013424162,0.0006271513],"domain_scores_gemma":[0.9981106,0.00028233824,0.00034506855,0.00070876686,0.00008995907,0.00046327952],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010935277,0.0008344147,0.0018333928,0.00030705184,0.0002259564,0.000056780384,0.0002177397,0.0003123764,0.0004929935],"category_scores_gemma":[0.000050019105,0.000604991,0.00043053756,0.0002363072,0.0001855514,0.00006752047,0.00009720142,0.0002994871,0.00043876134],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003140289,0.0006127152,0.000025745603,0.00071858574,0.0019315504,0.0005556346,0.00035271543,4.7375778e-7,0.0000030808137,0.0004799389,0.067497835,0.9275077],"study_design_scores_gemma":[0.008330926,0.00596365,0.00021791764,0.00020894712,0.005796412,0.0003511724,0.000012521964,0.0000045400993,0.0000050299263,0.000112188536,0.97857666,0.00042001304],"about_ca_topic_score_codex":0.00032581945,"about_ca_topic_score_gemma":0.00010722617,"teacher_disagreement_score":0.92708766,"about_ca_system_score_codex":0.00018982739,"about_ca_system_score_gemma":0.0008536767,"threshold_uncertainty_score":0.99964017},"labels":[],"label_agreement":null},{"id":"W2884521443","doi":"10.1016/j.eururo.2018.07.006","title":"Comparison of Perioperative Outcomes Between Cytoreductive Radical Prostatectomy and Radical Prostatectomy for Nonmetastatic Prostate Cancer","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Propensity score matching; Perioperative; Urology; Retrospective cohort study; Odds ratio; Logistic regression; Surgery; Cancer; Internal medicine","score_opus":0.040786361982918365,"score_gpt":0.35432602557843634,"score_spread":0.313539663595518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884521443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5681825,0.0068194736,0.00030200486,0.40087727,0.0011261154,0.014841985,0.005986475,0.00023813009,0.0016259995],"genre_scores_gemma":[0.8087885,0.0011692026,0.005770895,0.16503502,0.006032577,0.0037565709,0.005068929,0.00084716536,0.003531178],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952459,0.0007174902,0.0012176813,0.0013553834,0.00048369946,0.0009798601],"domain_scores_gemma":[0.9972657,0.00069174776,0.0007559016,0.0005749597,0.00042111613,0.0002906062],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046574176,0.00088673714,0.002543369,0.00032861155,0.00020322278,0.000054450633,0.00025519496,0.0003975209,0.00014032949],"category_scores_gemma":[0.00025518803,0.0006635314,0.00032136586,0.00019621917,0.002172179,0.000099977166,0.00020645902,0.0014688108,0.000038006387],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039142994,0.0011391396,0.5084876,0.0041226996,0.007492475,0.0017352859,0.01250973,0.000009598226,0.00046293827,0.00012434949,0.44082397,0.019177942],"study_design_scores_gemma":[0.012281952,0.011442415,0.10149513,0.00039680966,0.0030485461,0.00009923057,0.00015735043,0.000052252202,0.0026402357,0.000106175255,0.8674498,0.00083004887],"about_ca_topic_score_codex":0.000047472895,"about_ca_topic_score_gemma":0.000004917763,"teacher_disagreement_score":0.42662588,"about_ca_system_score_codex":0.00025768424,"about_ca_system_score_gemma":0.00047922012,"threshold_uncertainty_score":0.9995816},"labels":[],"label_agreement":null},{"id":"W2884928681","doi":"10.1016/j.eururo.2018.07.004","title":"Re: Fabio Conforti, Laura Pala, Vincenzo Bagnardi, et al. Cancer Immunotherapy Efficacy and Patients’ Sex: A Systematic Review and Meta-analysis. Lancet Oncol 2018;19:737–46","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Meta-analysis; Immunotherapy; Gynecology; Oncology; Internal medicine; Cancer","score_opus":0.07941094937152471,"score_gpt":0.3713891982163465,"score_spread":0.2919782488448218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884928681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011611071,0.98883593,0.000024977422,0.0039128233,0.00019879639,0.0053093336,0.00034526337,0.00013488778,0.0012263726],"genre_scores_gemma":[0.000031990996,0.92684233,0.000077141034,0.07055781,0.00012704752,0.00041473398,0.00030948195,0.00020870115,0.0014307799],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921935,0.0033911876,0.0021904863,0.0012113509,0.0004035993,0.00060987426],"domain_scores_gemma":[0.995534,0.0005830928,0.0018152044,0.001614542,0.00019066563,0.0002624713],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031526883,0.001011436,0.010692002,0.00036725064,0.00013199984,0.00008539542,0.00047630313,0.00025196135,0.0009349318],"category_scores_gemma":[0.0002762701,0.00064667466,0.0018973514,0.00067141326,0.0004754163,0.00007990875,0.00019364861,0.00071997364,0.00007808099],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006203824,0.00031474908,0.000129694,0.44189763,0.3486933,0.00014265382,0.0003446618,2.2390537e-7,0.0000018875077,0.000014221852,0.18200321,0.025837373],"study_design_scores_gemma":[0.0015381818,0.00065188855,0.00009875888,0.0066280463,0.31341255,0.000073457864,0.000005174228,7.097593e-7,8.363309e-8,6.178229e-7,0.6771938,0.0003967198],"about_ca_topic_score_codex":0.00009756973,"about_ca_topic_score_gemma":0.00006345939,"teacher_disagreement_score":0.4951906,"about_ca_system_score_codex":0.00015965274,"about_ca_system_score_gemma":0.00025183934,"threshold_uncertainty_score":0.99997836},"labels":[],"label_agreement":null},{"id":"W2885763638","doi":"10.1016/j.eururo.2018.07.023","title":"Adjuvant Therapy for Resected Renal Cell Carcinoma—Still Searching","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Adjuvant; Adjuvant therapy; Oncology; Carcinoma; Internal medicine; Cancer","score_opus":0.042511222484433224,"score_gpt":0.27189746761657263,"score_spread":0.2293862451321394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885763638","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46897417,0.0057411944,0.00046908658,0.40236214,0.0017906448,0.004459589,0.0003004121,0.00047130094,0.11543145],"genre_scores_gemma":[0.37951443,0.00013254822,0.0014272148,0.5694236,0.020181319,0.000107087566,0.0027398507,0.0006386064,0.025835326],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99525154,0.0012641788,0.0006168613,0.0012414355,0.0004822312,0.0011437853],"domain_scores_gemma":[0.99727196,0.0005369716,0.00031882976,0.0013095171,0.0003378155,0.00022493927],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000662512,0.0006923037,0.0009485382,0.00045412718,0.00014849856,0.00004121268,0.00050706626,0.00052062067,0.00045436603],"category_scores_gemma":[0.00015079373,0.0005450572,0.00047849905,0.00015879843,0.0003257762,0.00003425234,0.00020266291,0.0021696675,0.00096324785],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015686885,0.000106794105,0.0004309672,0.00019567455,0.00018755297,0.009893283,0.00036703958,0.000001588219,0.008359844,0.000002143393,0.97684604,0.0020403767],"study_design_scores_gemma":[0.004589538,0.009150726,0.011937765,0.000032189277,0.00032006804,0.00062342896,0.0000050244084,0.000047837762,0.0042380914,0.000033955737,0.9685984,0.00042296527],"about_ca_topic_score_codex":0.000037162692,"about_ca_topic_score_gemma":0.0000029149714,"teacher_disagreement_score":0.1670615,"about_ca_system_score_codex":0.00016484396,"about_ca_system_score_gemma":0.0002450074,"threshold_uncertainty_score":0.9998146},"labels":[],"label_agreement":null},{"id":"W2887873865","doi":"10.1016/j.eururo.2018.07.028","title":"The Promise and Perils of Sequencing Individual Prostate Cancer Nuclei","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Prostate; Cancer; Gynecology; Internal medicine","score_opus":0.04036587580997668,"score_gpt":0.3008160201691731,"score_spread":0.2604501443591964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887873865","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23723961,0.01701939,7.926368e-7,0.7242833,0.0005987621,0.0015744166,0.00023542422,0.00007390101,0.018974438],"genre_scores_gemma":[0.15061757,0.02302786,0.00023922282,0.7203642,0.016311992,0.00028069908,0.00084100134,0.0006289237,0.087688506],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980982,0.00041573666,0.00029236535,0.00040375927,0.00029072785,0.00049924216],"domain_scores_gemma":[0.9990494,0.00014121231,0.0001851381,0.0003896848,0.00015735453,0.00007719236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050237565,0.00023524824,0.00036140427,0.00010240372,0.00016958559,0.000035675224,0.00022081756,0.00017233608,0.0001278922],"category_scores_gemma":[0.00008523031,0.00013704512,0.00006881931,0.000091758935,0.0009987457,0.00002811384,0.00022835433,0.0010369443,0.000050842948],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060876954,0.000017176493,0.0035160861,0.00034557638,0.00054879545,0.0018359325,0.002320421,2.3379967e-7,0.0009793795,0.0000064449314,0.97594947,0.013871701],"study_design_scores_gemma":[0.0013175752,0.0010707903,0.0058508953,0.000081419115,0.00025746145,0.00014243292,0.000043118813,0.0000061409432,0.0002715534,0.00003083092,0.9907965,0.00013127028],"about_ca_topic_score_codex":0.000030781146,"about_ca_topic_score_gemma":0.000006814502,"teacher_disagreement_score":0.08662204,"about_ca_system_score_codex":0.00007175611,"about_ca_system_score_gemma":0.00033229237,"threshold_uncertainty_score":0.55885375},"labels":[],"label_agreement":null},{"id":"W2889839167","doi":"10.1016/j.eururo.2018.08.035","title":"Variation and Trends in Antidepressant Prescribing for Men Undergoing Treatment for Nonmetastatic Prostate Cancer: A Population-based Cohort Study","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University Health Network; Health Sciences Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Odds ratio; Prostate cancer; Population; Confidence interval; Internal medicine; Retrospective cohort study; Medical prescription; Antidepressant; Radiation therapy; Cancer; Environmental health","score_opus":0.029040420040184506,"score_gpt":0.29858400747287756,"score_spread":0.269543587432693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889839167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7396267,0.0015468869,0.004027367,0.2284032,0.0024585642,0.019788615,0.0016390263,0.000286909,0.002222738],"genre_scores_gemma":[0.94819134,0.00006117964,0.00030178254,0.04273431,0.0021599093,0.0015019311,0.002907727,0.00018748964,0.001954314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788254,0.00041135523,0.00044769037,0.0007196987,0.00015808616,0.00038059516],"domain_scores_gemma":[0.9988443,0.00043377493,0.00025417816,0.00033283146,0.00008554364,0.000049322014],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047647307,0.00031724572,0.0006295588,0.00039189664,0.000093107665,0.00003486741,0.00007532783,0.00011928954,0.000033218195],"category_scores_gemma":[0.00007391888,0.00027929674,0.00010492605,0.00012283579,0.000033835222,0.000039233022,0.000027109305,0.00021965023,0.0000015111361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022256882,0.00034553575,0.91705066,0.0007222244,0.00095615425,0.0003272923,0.0063199755,0.000316784,0.000029843242,0.0000048731813,0.056023043,0.01567791],"study_design_scores_gemma":[0.009228059,0.0053123324,0.9075971,0.00011023332,0.0017821592,0.00001119855,0.00008633221,0.0035431327,0.0000045461225,0.000028766484,0.0719352,0.00036093933],"about_ca_topic_score_codex":0.0030803906,"about_ca_topic_score_gemma":0.005162243,"teacher_disagreement_score":0.20856465,"about_ca_system_score_codex":0.00024099188,"about_ca_system_score_gemma":0.00009426459,"threshold_uncertainty_score":0.9999659},"labels":[],"label_agreement":null},{"id":"W2891643837","doi":"10.1016/j.eururo.2018.08.024","title":"Low Testosterone and Prostate Cancer: Is the Protection Real?","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Mount Sinai Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Testosterone (patch); Prostate; Urology; Gynecology; Cancer; Oncology; Internal medicine","score_opus":0.022492534520646472,"score_gpt":0.24890834413406326,"score_spread":0.22641580961341679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891643837","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031751167,0.0020233258,0.0000025440943,0.94861245,0.00050861243,0.0008786093,0.000027336833,0.000069801186,0.016126169],"genre_scores_gemma":[0.04277697,0.0041982965,0.000024051878,0.8743096,0.024071189,0.000121505545,0.000045399553,0.00014566821,0.054307308],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99849486,0.0003088801,0.00019405819,0.0005705672,0.00014617793,0.0002854644],"domain_scores_gemma":[0.9992612,0.000035768284,0.00013726082,0.00038558975,0.00014906224,0.00003109464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026481977,0.00023437542,0.00032726076,0.00006282532,0.00018340844,0.00001203111,0.00009231939,0.00012808165,0.000055362114],"category_scores_gemma":[0.00007654844,0.00012702221,0.000051533312,0.0000796617,0.0006906926,0.000017717202,0.00016799393,0.0010779907,0.00023175571],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016424802,0.000017384276,0.00057239324,0.00016538742,0.00022502804,0.0003960513,0.0014156515,8.630328e-8,0.00080475496,9.38677e-7,0.97832656,0.017911507],"study_design_scores_gemma":[0.00032288133,0.0010148395,0.03914804,0.000039684233,0.0001822661,0.000240195,0.000019788242,0.0000018023635,0.00013518179,0.000033715245,0.9587321,0.00012947817],"about_ca_topic_score_codex":0.000096010706,"about_ca_topic_score_gemma":0.000008990294,"teacher_disagreement_score":0.07430282,"about_ca_system_score_codex":0.00002244955,"about_ca_system_score_gemma":0.000033479304,"threshold_uncertainty_score":0.5179815},"labels":[],"label_agreement":null},{"id":"W2892390072","doi":"10.1016/j.eururo.2018.09.035","title":"Lessons Learned from the Global Epidemiology of Kidney Cancer: A Refresher in Epidemiology 101","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Epidemiology; Kidney cancer; Epidemiology of cancer; Cancer; Oncology; Internal medicine; Breast cancer","score_opus":0.17016779293750467,"score_gpt":0.3698195794372992,"score_spread":0.19965178649979454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892390072","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02309278,0.009715365,0.00004744003,0.94015473,0.0012180628,0.00061768544,0.0006546107,0.0000672579,0.024432065],"genre_scores_gemma":[0.024091091,0.0014897492,0.000609233,0.96278983,0.0072876923,0.00006305666,0.001320892,0.00014475685,0.0022036778],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9824254,0.012969449,0.0016805441,0.0014637947,0.0001887842,0.0012720387],"domain_scores_gemma":[0.9909394,0.0056024976,0.0010837744,0.0019055691,0.0001482624,0.0003205013],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.003147618,0.00068182795,0.0025787395,0.0001567848,0.00006706099,0.0000024650283,0.00087862415,0.0011425876,0.0012143012],"category_scores_gemma":[0.012522108,0.0004497334,0.00048672815,0.00027974433,0.0014957347,0.00002222754,0.00047359313,0.0027339053,0.0008166199],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047047556,0.000053697557,0.27428925,0.000048560854,0.00041515715,0.0019326229,0.000087594155,0.000009384117,0.000020341471,0.000104074716,0.72064173,0.0019271398],"study_design_scores_gemma":[0.0014519966,0.00088600145,0.25059438,0.000106318745,0.0004929187,0.00020195275,0.000006345227,0.000021489333,0.0000062427616,0.0027174796,0.74329144,0.00022340742],"about_ca_topic_score_codex":0.0046079294,"about_ca_topic_score_gemma":0.0004547693,"teacher_disagreement_score":0.02369485,"about_ca_system_score_codex":0.00041921373,"about_ca_system_score_gemma":0.0005744321,"threshold_uncertainty_score":0.9999614},"labels":[],"label_agreement":null},{"id":"W2892569486","doi":"10.1016/j.eururo.2018.09.001","title":"Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":840,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute for Health and Care Research; World Health Organization","keywords":"Medicine; Epidemiology; Bladder cancer; Population; Environmental health; Risk factor; MEDLINE; Systematic review; Incidence (geometry); Disease; Cancer; Demography; Gerontology; Pathology; Internal medicine","score_opus":0.08891836199494443,"score_gpt":0.3647492421572954,"score_spread":0.2758308801623509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892569486","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008083455,0.9952965,0.000004376513,0.000063859465,0.0001859246,0.0022342317,0.00042060253,0.000017516435,0.001696171],"genre_scores_gemma":[0.0015777677,0.99725527,0.000030315066,0.00066924747,0.000083167935,0.000069297814,0.000109396424,0.00008144873,0.00012407509],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9929042,0.0040921317,0.0020991485,0.0005271871,0.000093933,0.0002833979],"domain_scores_gemma":[0.99632335,0.00085635093,0.0019233772,0.0006929389,0.00008232366,0.00012167847],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014547876,0.00045771073,0.007033738,0.00025745624,0.000018276069,6.907414e-7,0.00022694288,0.00019877583,0.00018540885],"category_scores_gemma":[0.0011283858,0.00029326862,0.00039622842,0.00022859877,0.00040776684,0.000025393689,0.00013015069,0.00038980506,0.00007064636],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048114725,0.00011843042,0.0075674253,0.9839785,0.0018190193,0.00006434486,0.00011448031,6.994573e-8,5.6789087e-8,0.000025565765,0.0033811498,0.0028828513],"study_design_scores_gemma":[0.0023550363,0.0023317214,0.0050587426,0.5622261,0.046000786,0.0002777197,0.00002156457,0.0000019560362,0.0000011059467,0.000058297,0.3810152,0.00065172295],"about_ca_topic_score_codex":0.0003321059,"about_ca_topic_score_gemma":0.000021449328,"teacher_disagreement_score":0.42175236,"about_ca_system_score_codex":0.000044709628,"about_ca_system_score_gemma":0.00027457552,"threshold_uncertainty_score":0.99995196},"labels":[],"label_agreement":null},{"id":"W2894713544","doi":"10.1016/j.eururo.2018.09.034","title":"External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis","year":2018,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; Urology; External beam radiotherapy; Population; Incidence (geometry); Confidence interval; Radiation therapy; Prostate; Bladder cancer; Proportional hazards model; Cumulative incidence; Cancer; Internal medicine; Gynecology; Surgery; Cohort","score_opus":0.0058585482027211,"score_gpt":0.24521128239789755,"score_spread":0.23935273419517644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894713544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955391,0.002161427,0.0001372446,0.00049228244,0.000050811803,0.0011340932,0.00039110312,0.00003690313,0.000056987996],"genre_scores_gemma":[0.997685,0.00042080772,0.0002254488,0.0010563601,0.00008452684,0.00019283002,0.0002555638,0.000045701287,0.000033764973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802446,0.0005861557,0.00038458686,0.00041480432,0.00026461977,0.00032538275],"domain_scores_gemma":[0.99887896,0.00013114096,0.00034321033,0.00035433675,0.00017327008,0.00011908433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002252745,0.00023389234,0.0005222792,0.00019393816,0.00008805146,0.000015242661,0.00013200007,0.000037058213,0.0004301729],"category_scores_gemma":[0.0000387429,0.00013973746,0.00009827416,0.00050612644,0.00032754723,0.00004086044,0.000024043973,0.00018256821,0.0000042371157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032525847,0.0008773722,0.98895675,0.000017887627,0.0013618566,0.000021229154,0.0004780801,0.0010530689,0.00015486055,0.0000012249369,0.00095421384,0.0028708589],"study_design_scores_gemma":[0.009212718,0.0024181476,0.983714,0.000059644975,0.0012471913,0.00000145048,0.000008104065,0.0014978686,0.0006748163,0.00000473956,0.0010232456,0.00013806662],"about_ca_topic_score_codex":0.009508359,"about_ca_topic_score_gemma":0.001515089,"teacher_disagreement_score":0.007993271,"about_ca_system_score_codex":0.00017146557,"about_ca_system_score_gemma":0.00012498088,"threshold_uncertainty_score":0.9970874},"labels":[],"label_agreement":null},{"id":"W2895262488","doi":"10.1016/j.eururo.2018.07.027","title":"Systematic Review of Systemic Therapies and Therapeutic Combinations with Local Treatments for High-risk Localized Prostate Cancer","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"Janssen Biotech; Astellas Pharma; Bayer","keywords":"Medicine; Prostate cancer; Prostatectomy; Oncology; Androgen deprivation therapy; Internal medicine; Docetaxel; Clinical trial; Radiation therapy; External beam radiotherapy; Randomized controlled trial; Systematic review; Cochrane Library; Cancer; MEDLINE","score_opus":0.02506403940741644,"score_gpt":0.3124699479015766,"score_spread":0.2874059084941602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895262488","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007695524,0.98911434,0.00014960508,0.00015916479,0.00011468993,0.00983228,0.00043993152,0.0000426411,0.000070398884],"genre_scores_gemma":[0.0019362367,0.99364316,0.00006837734,0.00042354295,0.0000483154,0.0032583578,0.00023452022,0.00013316839,0.0002542871],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9970164,0.0010350818,0.0009849519,0.00051886804,0.00016471246,0.00028002477],"domain_scores_gemma":[0.99749726,0.00040455943,0.0011857752,0.0005564517,0.0002547606,0.0001011684],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048113815,0.0005024979,0.003344516,0.00012768958,0.000087646615,0.0000115219145,0.00012992126,0.00008721043,0.000020706277],"category_scores_gemma":[0.00005076061,0.00027246535,0.00026508296,0.00017691248,0.00032083428,0.000023561845,0.000039059407,0.0001454929,0.000021735923],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009024914,0.0002542819,0.000056302484,0.90319496,0.0063841236,0.00003746739,0.00023746295,2.0819147e-7,7.6497514e-8,0.00020669754,0.00012597989,0.08941221],"study_design_scores_gemma":[0.0042665615,0.005937434,0.000048009642,0.867969,0.06099103,0.00036843403,0.00004015788,0.0000042696674,9.813759e-7,0.000028630924,0.060047694,0.0002978487],"about_ca_topic_score_codex":0.00003867854,"about_ca_topic_score_gemma":0.000006208471,"teacher_disagreement_score":0.08911436,"about_ca_system_score_codex":0.00017850076,"about_ca_system_score_gemma":0.00025021896,"threshold_uncertainty_score":0.99997276},"labels":[],"label_agreement":null},{"id":"W2896809746","doi":"10.1016/j.eururo.2018.10.010","title":"Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":251,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"Eisai; Pfizer Pharmaceuticals; Ipsen Biopharmaceuticals","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Cabozantinib; Immunotherapy; Oncology; Internal medicine; Kidney cancer; Bevacizumab; Systemic therapy; Systematic review; Intensive care medicine; MEDLINE; Cancer; Chemotherapy; Breast cancer","score_opus":0.06739911552993089,"score_gpt":0.29867236533035735,"score_spread":0.23127324980042646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896809746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035863917,0.9608501,0.0000039231404,0.00001554425,0.00044504035,0.0015139466,0.00012857566,0.000021625641,0.0011573156],"genre_scores_gemma":[0.016281592,0.9824777,0.00017740206,0.000010872423,0.000330159,0.000050511728,0.00016662522,0.00013735321,0.00036778892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958175,0.0016800516,0.0012801572,0.00066191517,0.0001912785,0.00036910217],"domain_scores_gemma":[0.9977275,0.00027955818,0.00088093546,0.00088592886,0.00007609077,0.00015000078],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025896277,0.0006222289,0.002567063,0.0005673671,0.00003816684,0.000010071897,0.00015052724,0.00013499374,0.00005804312],"category_scores_gemma":[0.0000113024835,0.00043976182,0.0005320423,0.0002979469,0.0002361237,0.000037076104,0.00006510957,0.0002923964,0.00007349238],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001063875,0.0036483873,0.0014985815,0.031887032,0.0010935082,0.0015134003,0.0021232376,0.000003723798,0.000233789,0.000031635824,0.001152168,0.95575064],"study_design_scores_gemma":[0.0021134904,0.0061225006,0.0016214725,0.001222822,0.0029138622,0.0008744783,0.00002003409,0.0000050435433,0.00005879468,0.0000010943447,0.98480326,0.00024315873],"about_ca_topic_score_codex":0.00010762693,"about_ca_topic_score_gemma":0.000009166989,"teacher_disagreement_score":0.9836511,"about_ca_system_score_codex":0.00024949538,"about_ca_system_score_gemma":0.00022771975,"threshold_uncertainty_score":0.9998054},"labels":[],"label_agreement":null},{"id":"W2897445406","doi":"10.1016/j.eururo.2018.10.011","title":"Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":517,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Biochemical recurrence; Confounding; Meta-analysis; MEDLINE; Internal medicine; Population; Watchful waiting; Radiation therapy; Oncology; Cancer","score_opus":0.0494296569429105,"score_gpt":0.35337345651289703,"score_spread":0.3039437995699865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897445406","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044800374,0.98293555,0.000034415498,0.00030940704,0.00022253748,0.015936002,0.0002792068,0.00004197383,0.00019612319],"genre_scores_gemma":[0.00022322849,0.9910155,0.0002467332,0.0002970508,0.00010814601,0.007429746,0.00041377562,0.000118358854,0.00014749111],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9967942,0.0006246367,0.0011868122,0.0007790948,0.00019764343,0.00041761622],"domain_scores_gemma":[0.9973768,0.0004990332,0.0010833107,0.0006233968,0.00024804738,0.00016944099],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041221062,0.00064694503,0.0041974727,0.00011510153,0.000050482875,0.000010738653,0.00019495437,0.00008549121,0.000011418833],"category_scores_gemma":[0.00040049016,0.00035157733,0.000805192,0.00026519282,0.00017406595,0.000027919323,0.000068211724,0.0001696208,0.000039174694],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011414275,0.00044189297,0.00006204443,0.939577,0.0034141864,0.00024906715,0.00021511824,9.295021e-8,5.1399337e-7,0.00003089843,0.0011840577,0.054710984],"study_design_scores_gemma":[0.001115462,0.0105686905,0.0000037907223,0.7134679,0.033778418,0.00019993201,0.000008360841,0.0000040692125,0.0000109958855,0.0000034617499,0.2405596,0.00027934072],"about_ca_topic_score_codex":0.000011392992,"about_ca_topic_score_gemma":0.0000024499304,"teacher_disagreement_score":0.23937553,"about_ca_system_score_codex":0.00041134245,"about_ca_system_score_gemma":0.0005861849,"threshold_uncertainty_score":0.9998936},"labels":[],"label_agreement":null},{"id":"W2897636829","doi":"10.1016/j.eururo.2018.09.048","title":"Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency","year":2018,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Academy of Medical Sciences; Medical Research Council; National Institute for Health and Care Research; Cancer Research UK","keywords":"Carboplatin; Medicine; Prostate cancer; Poly ADP ribose polymerase; DNA repair; Prostate; Cancer; Oncology; Internal medicine; Cancer research; PARP inhibitor; Homologous recombination; Chemotherapy; DNA; Polymerase; Cisplatin; Genetics; Biology","score_opus":0.0261167313762709,"score_gpt":0.29900115618391065,"score_spread":0.27288442480763975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897636829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981022,0.00028043985,0.000057459925,0.00018201082,0.00003281997,0.00040466676,0.0001177181,0.000021975206,0.000800704],"genre_scores_gemma":[0.999106,0.000020141286,0.00041860246,0.00010314568,0.000029970148,0.00001835614,0.000062135405,0.000021687794,0.00021997723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998703,0.00021390022,0.0003158879,0.00027985958,0.00025919426,0.00022816502],"domain_scores_gemma":[0.99911076,0.00010698902,0.00018647245,0.00025385956,0.00025204025,0.00008987975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002469537,0.00012133831,0.0003583742,0.00045386108,0.00005177732,0.000003110933,0.00009818412,0.000016181515,0.00024042386],"category_scores_gemma":[0.000107672306,0.00007815646,0.00007935596,0.0005548364,0.0002777442,0.000018441526,0.00008572447,0.0000822223,0.000015657037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029428427,0.00023690348,0.9851228,0.000039878436,0.0009896349,0.000012472398,0.0012948432,0.000067899644,0.0076149222,0.000019325142,0.000035823534,0.0016226256],"study_design_scores_gemma":[0.0011766655,0.0030420737,0.9934914,0.000019957455,0.0010771841,0.0000011418291,0.000027715278,0.00018610568,0.00083115796,0.0000071119416,0.0000707113,0.00006879157],"about_ca_topic_score_codex":0.000060879243,"about_ca_topic_score_gemma":0.00014178143,"teacher_disagreement_score":0.0083685545,"about_ca_system_score_codex":0.00005174278,"about_ca_system_score_gemma":0.00010933388,"threshold_uncertainty_score":0.3187128},"labels":[],"label_agreement":null},{"id":"W2898364126","doi":"10.1016/j.eururo.2018.10.026","title":"Evolving Changes in the Delivery of Health Services: A Place for Urological Homecare?","year":2018,"lang":"en","type":"editorial","venue":"European Urology","topic":"Patient Satisfaction in Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Patient satisfaction; Medical emergency; Intensive care medicine; Nursing","score_opus":0.06318866514366168,"score_gpt":0.3958923444225734,"score_spread":0.3327036792789117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898364126","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027236063,0.0032318097,0.00010433736,0.0052595506,0.9540401,0.0044269515,0.001729737,0.00018224705,0.0037891867],"genre_scores_gemma":[0.1684345,0.00086556096,0.0003551321,0.015914446,0.8106084,0.00080586097,0.002344854,0.00024731705,0.00042391132],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98275816,0.013418374,0.0014372764,0.00076605217,0.0005443382,0.0010758237],"domain_scores_gemma":[0.984775,0.011792283,0.0017832855,0.00083174865,0.00070514786,0.000112511036],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0066991146,0.00038905026,0.00095332053,0.00034991672,0.00068105536,0.000007677851,0.0010263886,0.0009580666,0.0002621979],"category_scores_gemma":[0.0016535523,0.0002927906,0.00011482656,0.00027203266,0.00018705358,0.00005651415,0.00035374242,0.0019398167,0.00023944654],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038448858,0.000032432705,0.02022387,0.002642878,0.000026425274,0.000009045528,0.011223148,0.0000053190092,0.0000017216752,0.000044680655,0.9647596,0.00064637366],"study_design_scores_gemma":[0.0011484994,0.0021494527,0.040971775,0.00038954473,0.000029724059,0.0000015503388,0.001742315,0.00006511423,1.2457147e-7,0.00009398835,0.953205,0.00020292639],"about_ca_topic_score_codex":0.0012349662,"about_ca_topic_score_gemma":0.0045891283,"teacher_disagreement_score":0.14343171,"about_ca_system_score_codex":0.00025426102,"about_ca_system_score_gemma":0.00085157464,"threshold_uncertainty_score":0.99995244},"labels":[],"label_agreement":null},{"id":"W2898365270","doi":"10.1016/j.eururo.2018.10.029","title":"Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432–31","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Androgen; Gynecology; Oncology; Internal medicine; Gerontology; Cancer; Hormone","score_opus":0.020146190849544623,"score_gpt":0.30497478271557166,"score_spread":0.28482859186602705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898365270","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28004557,0.0030699754,0.00007131468,0.70452833,0.0027841048,0.008721222,0.00037152725,0.000066787434,0.00034116447],"genre_scores_gemma":[0.033918332,0.009119022,0.00016782165,0.92770535,0.021925231,0.0015557962,0.0009045078,0.0002747201,0.00442922],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99217725,0.0038214864,0.0013676044,0.0011718916,0.00069957395,0.0007622063],"domain_scores_gemma":[0.9968734,0.0006796663,0.0008224472,0.0010068851,0.00040745814,0.00021016052],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004485517,0.000604544,0.001453671,0.0005499333,0.00019089914,0.00009164673,0.0003915188,0.00031286204,0.00008966777],"category_scores_gemma":[0.0011623093,0.00039316874,0.00020869901,0.00043773506,0.00040114395,0.00014002435,0.0002200014,0.001497106,0.000050433653],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28949687,0.00012233669,0.0003238325,0.000038914503,0.00035536222,0.00044506925,0.0016731756,0.000005928189,0.0007718686,0.0000012038101,0.70457333,0.0021920844],"study_design_scores_gemma":[0.28719747,0.003749447,0.00015053546,0.00006619845,0.00020707627,0.000025145775,0.000014771979,0.00002165473,0.000621257,0.00002096137,0.70767134,0.00025412417],"about_ca_topic_score_codex":0.0010067857,"about_ca_topic_score_gemma":0.00010723768,"teacher_disagreement_score":0.24612725,"about_ca_system_score_codex":0.00015401634,"about_ca_system_score_gemma":0.00041051416,"threshold_uncertainty_score":0.999852},"labels":[],"label_agreement":null},{"id":"W2898746949","doi":"10.1016/j.eururo.2018.10.025","title":"Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium","year":2018,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Winship Cancer Institute; University of Texas MD Anderson Cancer Center; Centre hospitalier régional universitaire de Lille; Sahlgrenska Universitetssjukhuset; Monash University; Erasmus Medisch Centrum; University College Dublin; Cambridge University Hospitals; Skånes universitetssjukhus; Università degli Studi di Milano; Singapore General Hospital; National Cancer Institute; University of Toronto; Cleveland Clinic; University College London; Yonsei University; University of Cambridge; BC Cancer Agency; Movember Foundation; King's College London","keywords":"Medicine; Discontinuation; Watchful waiting; Cumulative incidence; Incidence (geometry); Prostate cancer; Confidence interval; Internal medicine; Demography; Pediatrics; Gynecology; Cancer","score_opus":0.017261520575253174,"score_gpt":0.30837022787917684,"score_spread":0.2911087073039237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898746949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747996,0.00034441645,0.00005001155,0.0042215516,0.00015705709,0.0006872111,0.0000880845,0.0000106209,0.019641452],"genre_scores_gemma":[0.9981655,0.000224194,0.00010493692,0.0011864437,0.00012423284,0.00005395067,0.000034742523,0.00001722798,0.00008876215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988475,0.0003212161,0.00025595614,0.00022405572,0.00009591619,0.0002553953],"domain_scores_gemma":[0.99911207,0.00044511812,0.00011789036,0.00022578092,0.00006818484,0.000030938925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051691796,0.00011011681,0.0002724784,0.00006255334,0.00002963884,0.000008444242,0.000086141634,0.00002626722,0.0000620208],"category_scores_gemma":[0.00013385304,0.000073047835,0.00004662343,0.0000793874,0.00022240069,0.000032168686,0.00003733264,0.00010503172,0.0000063816346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052485586,0.00029609443,0.99042445,0.000028740165,0.00006277568,0.000098318356,0.0019974376,0.000007905644,0.00016406001,0.0024543996,0.0018393595,0.0021015855],"study_design_scores_gemma":[0.0023928047,0.0008927899,0.95950943,0.000036977395,0.000029909304,0.000011018608,0.00035160754,0.000056477442,0.0003352574,0.00006256034,0.036259416,0.0000617343],"about_ca_topic_score_codex":0.00009725594,"about_ca_topic_score_gemma":0.0010109618,"teacher_disagreement_score":0.034420058,"about_ca_system_score_codex":0.0000792868,"about_ca_system_score_gemma":0.00006605561,"threshold_uncertainty_score":0.2978804},"labels":[],"label_agreement":null},{"id":"W2900349954","doi":"10.1016/j.eururo.2018.10.053","title":"Results of Prostate Cancer Screening in a Unique Cohort at 19 yr of Follow-up","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Prostate cancer; Cohort; Internal medicine; Prostate cancer screening; Prostate-specific antigen; Cancer; Confidence interval; Prostate; Randomization; Oncology; Randomized controlled trial; Gynecology; Cohort study; Overdiagnosis","score_opus":0.02549328231492005,"score_gpt":0.2779491483131166,"score_spread":0.2524558659981966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900349954","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55664504,0.005075561,0.000010946226,0.39900807,0.0011740568,0.0029187256,0.0018548527,0.000085900414,0.033226892],"genre_scores_gemma":[0.47265887,0.0070283744,0.0005421799,0.48848277,0.0027622497,0.00032941208,0.0033933278,0.00041021168,0.0243926],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972559,0.00050665543,0.0008567929,0.0006623705,0.0002628206,0.00045546124],"domain_scores_gemma":[0.9982182,0.00019180213,0.0006448373,0.0006616872,0.00019701333,0.00008648025],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005487834,0.00034032698,0.0009522949,0.00029260016,0.000027212576,0.0000036887857,0.00019214222,0.00025885028,0.00014126905],"category_scores_gemma":[0.00016734222,0.00028666906,0.0001703884,0.00020101042,0.00032346105,0.000023761359,0.00021290725,0.0006949393,0.0000341301],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024660137,0.00008535311,0.18292531,0.00031079885,0.0004918556,0.0028147402,0.0006919599,0.000014463752,0.00012274226,0.0000030865062,0.80838543,0.0016882494],"study_design_scores_gemma":[0.0066239275,0.0020092227,0.11697837,0.00047157498,0.0004083858,0.00005542202,0.000005819239,0.000010283994,0.0010577901,0.000010462462,0.8721607,0.00020806128],"about_ca_topic_score_codex":0.0010319968,"about_ca_topic_score_gemma":0.00029415995,"teacher_disagreement_score":0.08947472,"about_ca_system_score_codex":0.00016186618,"about_ca_system_score_gemma":0.00019617591,"threshold_uncertainty_score":0.9999586},"labels":[],"label_agreement":null},{"id":"W2900801955","doi":"10.1016/j.eururo.2018.11.001","title":"Serum Free Methylated Glutathione S-transferase 1 DNA Levels, Survival, and Response to Docetaxel in Metastatic, Castration-resistant Prostate Cancer: Post Hoc Analyses of Data from a Phase 3 Trial","year":2018,"lang":"en","type":"article","venue":"European Urology","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Docetaxel; Medicine; Prostate cancer; Hazard ratio; Oncology; Internal medicine; Proportional hazards model; Prostate-specific antigen; GSTP1; Progression-free survival; Chemotherapy; Confidence interval; Cancer; Urology; Glutathione","score_opus":0.09195892776510856,"score_gpt":0.37203019571598134,"score_spread":0.2800712679508728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900801955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830486,0.001711115,0.000765182,0.0016201397,0.00020713119,0.00053630426,0.012022043,0.00001564794,0.000073840776],"genre_scores_gemma":[0.99705905,0.0003027232,0.0010354719,0.0004951977,0.00018093557,0.00001297417,0.0008029441,0.0000500788,0.00006061917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964392,0.0015895127,0.0006541554,0.0007777926,0.00017491601,0.00036440225],"domain_scores_gemma":[0.9984108,0.00015274939,0.00011579404,0.0009758876,0.00016281474,0.00018193547],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011580703,0.0002857242,0.00043423133,0.00017024827,0.00008715617,0.00003183473,0.00054382405,0.00008039816,0.00016506854],"category_scores_gemma":[0.00031160086,0.00026570432,0.00006610155,0.00025797225,0.00024972134,0.00002117428,0.00018497343,0.00014641843,0.000013144243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12817393,0.00025426378,0.000052416286,0.00000937238,0.00020696688,0.00012167789,0.0005367106,0.000028859713,0.86882174,0.000012685461,0.00020805259,0.0015733391],"study_design_scores_gemma":[0.21528772,0.043278784,0.041528422,0.000078920566,0.001264475,0.00006506517,0.00077488413,0.00055365736,0.6617542,0.00017133394,0.033528406,0.001714146],"about_ca_topic_score_codex":0.0012036444,"about_ca_topic_score_gemma":0.0054301415,"teacher_disagreement_score":0.20706753,"about_ca_system_score_codex":0.000009682009,"about_ca_system_score_gemma":0.00024804627,"threshold_uncertainty_score":0.9999795},"labels":[],"label_agreement":null},{"id":"W2901039471","doi":"10.1016/j.eururo.2018.11.017","title":"Aging in Place: Implications for Continence Care for Older People","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Geriatric Care and Nursing Homes","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Older people; Urinary continence; Gerontology; Prostatectomy; Internal medicine; Prostate cancer","score_opus":0.03397424008764142,"score_gpt":0.3754522862375726,"score_spread":0.34147804614993116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901039471","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004811033,0.0011124933,0.003738591,0.9711473,0.0050641857,0.00393201,0.00070023816,0.00019349452,0.00930065],"genre_scores_gemma":[0.03916152,0.000086052394,0.0017625357,0.9030957,0.029153517,0.0019513048,0.0053554946,0.00043697737,0.018996887],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99731636,0.0006637539,0.00053605397,0.00060007756,0.0000618252,0.00082192785],"domain_scores_gemma":[0.996994,0.0017226193,0.0003251875,0.0005384199,0.00037250476,0.000047223028],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048565585,0.00024787875,0.00047282202,0.00024333531,0.0005034534,0.000011002517,0.00040357013,0.00047552446,0.000100887926],"category_scores_gemma":[0.00034872408,0.0002470387,0.00013855592,0.00015074767,0.00006582035,0.000030382544,0.000114320035,0.0010821752,0.00020936868],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038279675,0.0000073597967,0.002004712,0.0004718923,0.000012235646,0.0000050163685,0.0076894695,8.492641e-7,0.000007689335,0.00005113223,0.98872364,0.00098771],"study_design_scores_gemma":[0.0011762562,0.00015813508,0.032674324,0.0000638216,0.00007253614,0.0000041122994,0.0005511398,0.0000054076754,5.966876e-7,0.000120377175,0.9649537,0.00021959457],"about_ca_topic_score_codex":0.00006294579,"about_ca_topic_score_gemma":0.0003534883,"teacher_disagreement_score":0.06805159,"about_ca_system_score_codex":0.000100762074,"about_ca_system_score_gemma":0.00020565282,"threshold_uncertainty_score":0.9999982},"labels":[],"label_agreement":null},{"id":"W2902779309","doi":"10.1016/j.eururo.2018.11.042","title":"Reply to Nicholas G. Zaorsky, Daniel E. Spratt, and Pierre Blanchard's Letter to the Editor re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319–28","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; External beam radiotherapy; Radiation therapy; Surgery; Brachytherapy","score_opus":0.006389850569856406,"score_gpt":0.24910172564670077,"score_spread":0.24271187507684436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902779309","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5997156,0.006241731,0.00015689766,0.38170514,0.0011022902,0.006215381,0.0047167833,0.00009504406,0.000051109993],"genre_scores_gemma":[0.1228689,0.0016574626,0.0003889626,0.8648492,0.004822687,0.0018042681,0.0026212824,0.00032614186,0.00066110137],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932124,0.002343866,0.0010352173,0.0015860723,0.00091321225,0.0009092044],"domain_scores_gemma":[0.9963898,0.00051061617,0.0010097988,0.0014236558,0.00035122767,0.00031491404],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009346114,0.0009340954,0.0015578374,0.0004921693,0.00023644204,0.00012963507,0.00059873983,0.00022169457,0.00028441157],"category_scores_gemma":[0.0001790139,0.0005528224,0.00024914538,0.0007677459,0.00038090278,0.00011609474,0.00019223869,0.0018033,0.000015788783],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023869495,0.00033192095,0.35113356,0.000045533492,0.001650036,0.00012944009,0.0005831006,0.00053423987,0.000033133907,8.966695e-8,0.64264196,0.0005300696],"study_design_scores_gemma":[0.0047127786,0.0021145467,0.44694316,0.00020359599,0.0014066849,0.000006726628,0.0000050156355,0.00018792051,0.000035576108,0.0000013604315,0.54402965,0.00035298508],"about_ca_topic_score_codex":0.009251218,"about_ca_topic_score_gemma":0.0013477376,"teacher_disagreement_score":0.48314404,"about_ca_system_score_codex":0.00032163836,"about_ca_system_score_gemma":0.00027987076,"threshold_uncertainty_score":0.9996923},"labels":[],"label_agreement":null},{"id":"W2903076913","doi":"10.1016/j.eururo.2018.11.043","title":"Reply to Alba Fiorentino, Angelo Errico, and Marcello Scarcia's Letter to the Editor re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319–28","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Letter to the editor","score_opus":0.005673161200026091,"score_gpt":0.24111544641140198,"score_spread":0.2354422852113759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903076913","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68670183,0.004661618,0.000116082105,0.29819492,0.0008119115,0.0053914613,0.0040023425,0.000076907665,0.000042900672],"genre_scores_gemma":[0.21858716,0.0011712154,0.00046282716,0.76993257,0.0039714877,0.0018148549,0.003284746,0.00030726905,0.00046787784],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9934385,0.002322175,0.0009628812,0.0014807795,0.0008985676,0.0008971397],"domain_scores_gemma":[0.9967253,0.00047020867,0.00093003054,0.0012535576,0.00033016244,0.00029069372],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000818024,0.00086334295,0.0014233132,0.00053792883,0.00021963024,0.00011618414,0.0005573074,0.00018992244,0.0003875495],"category_scores_gemma":[0.0001290599,0.0005110751,0.0002559749,0.00079683174,0.00040400232,0.00008848646,0.00019836894,0.001435592,0.000013616521],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001800219,0.0003029057,0.41239446,0.00004688989,0.0012547161,0.00008703457,0.00046267762,0.0005127795,0.000020851303,4.9826557e-8,0.5822566,0.00086080073],"study_design_scores_gemma":[0.0039311307,0.0016563582,0.527525,0.0001704972,0.0014776622,0.000004359593,0.000004107712,0.00020718925,0.000030999516,0.0000011570054,0.46467263,0.00031887804],"about_ca_topic_score_codex":0.014078687,"about_ca_topic_score_gemma":0.0015582262,"teacher_disagreement_score":0.47173762,"about_ca_system_score_codex":0.00030158777,"about_ca_system_score_gemma":0.00021336414,"threshold_uncertainty_score":0.9997341},"labels":[],"label_agreement":null},{"id":"W2903241832","doi":"10.1016/j.eururo.2018.11.033","title":"Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint","year":2018,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Mitoxantrone; Cabozantinib; Prostate cancer; Clinical endpoint; Prednisone; Enzalutamide; Oncology; Randomized controlled trial; Internal medicine; Cancer; Anesthesia; Surgery; Chemotherapy","score_opus":0.030470491173510597,"score_gpt":0.3315535634413619,"score_spread":0.3010830722678513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903241832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853759,0.001520944,0.00021902325,0.0028715278,0.00035857302,0.00424635,0.000059110724,0.000098679266,0.0052499054],"genre_scores_gemma":[0.9964858,0.00029529745,0.00081233744,0.0004907088,0.00038927657,0.00043444848,0.00016209441,0.000071733026,0.0008582495],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953036,0.002501067,0.0006710032,0.00052149105,0.0003666197,0.00063623925],"domain_scores_gemma":[0.9982566,0.0007821307,0.00023139676,0.00038282492,0.00014690019,0.0002000948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025225715,0.0003049091,0.00095850416,0.0002803045,0.000111575544,0.000038453323,0.00013825267,0.000040622417,0.0002760426],"category_scores_gemma":[0.0004952807,0.00020271359,0.00012017322,0.0003519559,0.00070659444,0.000088444285,0.0000557205,0.00029278998,0.000075082346],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98405266,0.0008340876,0.00014345066,0.00012705076,0.000595421,0.001801385,0.0016209998,0.000006897294,0.0043231524,0.00005708259,0.00042114806,0.0060166703],"study_design_scores_gemma":[0.978439,0.015582904,0.0009045389,0.0000995421,0.00055952085,0.00004179314,0.00015846595,0.0008930241,0.0004885916,0.000022470253,0.0025916642,0.00021853147],"about_ca_topic_score_codex":0.00016337773,"about_ca_topic_score_gemma":0.00027707958,"teacher_disagreement_score":0.014748816,"about_ca_system_score_codex":0.00014964583,"about_ca_system_score_gemma":0.0006120424,"threshold_uncertainty_score":0.82664204},"labels":[],"label_agreement":null},{"id":"W2903577385","doi":"10.1016/j.eururo.2018.12.004","title":"Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: What We See and What We Miss","year":2018,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Toronto; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Medicine; Magnetic resonance imaging; Prostate cancer; Prostate; Radiology; Cancer; Medical physics; Internal medicine","score_opus":0.019117491536421113,"score_gpt":0.2647635996030252,"score_spread":0.24564610806660409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903577385","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003020596,0.5097182,0.000026623711,0.48320013,0.002013753,0.001646565,0.00007494442,0.0000952325,0.00020399164],"genre_scores_gemma":[0.009663304,0.473322,0.00042214576,0.50208217,0.00679463,0.000865362,0.00016958569,0.00034265142,0.0063381195],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970977,0.0002828947,0.00045617443,0.001167631,0.00022141435,0.00077421125],"domain_scores_gemma":[0.9984829,0.0003576082,0.0002597449,0.0005169127,0.00022469644,0.00015816368],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024998706,0.00055035565,0.00068776915,0.00034901872,0.00016772351,0.00034767648,0.00017410121,0.00021922372,0.00017483451],"category_scores_gemma":[0.00008220078,0.00047426342,0.00015718071,0.00025912534,0.00036051255,0.00038874263,0.00013751874,0.0007990826,0.00014295705],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034294438,0.000048566035,0.00071400194,0.00038892543,0.00007574532,0.0015941698,0.0004745301,0.000001012673,0.00005662317,4.6836007e-7,0.30985868,0.68644434],"study_design_scores_gemma":[0.0033632978,0.0020156496,0.003544807,0.00079952937,0.00053141464,0.00048318133,0.00008621255,0.00018067248,0.0002637901,0.000047185094,0.98828644,0.0003978083],"about_ca_topic_score_codex":0.00003559303,"about_ca_topic_score_gemma":0.000019995297,"teacher_disagreement_score":0.68604654,"about_ca_system_score_codex":0.0001876725,"about_ca_system_score_gemma":0.00009189322,"threshold_uncertainty_score":0.9997709},"labels":[],"label_agreement":null},{"id":"W2904555583","doi":"10.1016/j.eururo.2018.11.052","title":"Micropapillary Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-analysis of Disease Characteristics and Treatment Outcomes","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Hazard ratio; Internal medicine; Meta-analysis; Systematic review; Confidence interval; Cochrane Library; Oncology; Lymph node; Urology; Gynecology; Surgery; Cancer; MEDLINE","score_opus":0.06669638066961328,"score_gpt":0.32100160023820185,"score_spread":0.25430521956858854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904555583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021484825,0.9950957,0.0000012586971,0.00024152298,0.00005323162,0.002788418,0.0013508132,0.000010289903,0.00024395074],"genre_scores_gemma":[0.0027547504,0.99502593,0.000014430581,0.0009741402,0.00003938007,0.00010288215,0.000084915795,0.00006682308,0.0009367237],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9964468,0.0014770142,0.0012205873,0.0004837721,0.00017762765,0.00019418982],"domain_scores_gemma":[0.9973721,0.00022576803,0.0010405774,0.0011024401,0.00009832062,0.00016082622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031752515,0.0005335374,0.008269059,0.00020453657,0.000047957223,0.0000076071965,0.00019674201,0.0000749699,0.0001347607],"category_scores_gemma":[0.00017794459,0.00024568415,0.002194504,0.00028534426,0.0003437115,0.000013451167,0.00015936609,0.000118904594,0.0000129204345],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005643645,0.00028304014,0.0013068317,0.62378603,0.37223455,0.0001198303,0.00013281275,1.2055981e-8,5.807669e-7,0.000021710179,0.00011276688,0.001945416],"study_design_scores_gemma":[0.00033606743,0.0005124317,0.003705645,0.0030609316,0.9656212,0.00006678821,0.0000017497624,4.637898e-7,3.462337e-7,9.900749e-7,0.026547274,0.00014611788],"about_ca_topic_score_codex":0.000021153939,"about_ca_topic_score_gemma":0.0000040883633,"teacher_disagreement_score":0.6207251,"about_ca_system_score_codex":0.00003344488,"about_ca_system_score_gemma":0.0001672965,"threshold_uncertainty_score":0.9999995},"labels":[],"label_agreement":null},{"id":"W2904575729","doi":"10.1016/j.eururo.2018.12.003","title":"Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"Janssen Pharmaceuticals; Pharmaceuticals Bayer; Allergan; Medtronic; Astellas Pharma US; Janssen Scientific Affairs; Pfizer","keywords":"Medicine; Prostate cancer; Radiation therapy; Narrative review; General surgery; Management of prostate cancer; Prostate; Cancer; Gynecology; Radiology; Internal medicine; Intensive care medicine","score_opus":0.03919217132898125,"score_gpt":0.35579589858778604,"score_spread":0.3166037272588048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904575729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000100253994,0.9867496,0.0000031757177,0.0018015523,0.00026840836,0.0030535725,0.00046901908,0.00004617403,0.007508226],"genre_scores_gemma":[0.00017351242,0.9919436,0.00008573905,0.004005939,0.00029387922,0.0018209527,0.0012253093,0.00007173709,0.00037932396],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979913,0.0006038012,0.00044760262,0.00065280736,0.000101533115,0.00020292275],"domain_scores_gemma":[0.9987888,0.000057377805,0.00036988303,0.0004442758,0.00021740035,0.00012228853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022856743,0.0003848376,0.00085862825,0.00014125761,0.00009088405,0.000034281224,0.00015948343,0.000058160254,0.00025603088],"category_scores_gemma":[0.000014210978,0.00025618522,0.00012331436,0.00023741947,0.00017366528,0.000105030005,0.000082481,0.00018521564,0.000108795226],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007130237,0.00015884425,0.00013067627,0.0034477855,0.0010022006,0.00005977151,0.00146358,6.3291125e-8,8.977856e-8,0.00011813317,0.004538909,0.98900867],"study_design_scores_gemma":[0.0007296297,0.0006247401,0.004223977,0.0064936504,0.0005999847,0.000047120895,0.000033783585,0.0000018111635,3.2207944e-7,0.000016528269,0.9870346,0.00019382914],"about_ca_topic_score_codex":0.0000033331842,"about_ca_topic_score_gemma":0.0000059825506,"teacher_disagreement_score":0.98881483,"about_ca_system_score_codex":0.0001438715,"about_ca_system_score_gemma":0.00011536459,"threshold_uncertainty_score":0.99998903},"labels":[],"label_agreement":null},{"id":"W2905135402","doi":"10.1016/j.eururo.2018.11.015","title":"Homeobox B13 G84E Mutation and Prostate Cancer Risk","year":2018,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Prostate Cancer UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; National Institute for Health and Care Research; National Cancer Research Institute; Cancer Research Institute","keywords":"Medicine; Mutation; Prostate; Prostate cancer; Homeobox; Oncology; Cancer; Internal medicine; Gynecology; Genetics; Gene","score_opus":0.031234531576420636,"score_gpt":0.32702882869730937,"score_spread":0.2957942971208887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905135402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00064024946,0.9936283,0.000004409305,0.00020067082,0.00045643694,0.0011426182,0.00023063227,0.000075035205,0.003621597],"genre_scores_gemma":[0.00035210844,0.99695307,0.00007320126,0.0004403489,0.0006483657,0.00020205889,0.00028230905,0.00012275908,0.00092578353],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99791247,0.0005612979,0.00044410277,0.0006406767,0.00011111563,0.00033034157],"domain_scores_gemma":[0.9988327,0.00013276609,0.00041362774,0.0003687256,0.000078835146,0.00017336597],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031723408,0.0003848789,0.0010983568,0.00015173969,0.000088203844,0.000024894154,0.000085830376,0.0001266469,0.00016362434],"category_scores_gemma":[0.00008707447,0.00027451027,0.00017733622,0.00014351023,0.00019652642,0.000033992103,0.000103970284,0.00038432647,0.00058088993],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003787695,0.00006417526,0.0005579867,0.0026400145,0.0004315436,0.0007528481,0.00019664346,2.8428988e-7,5.973351e-8,0.000014401889,0.0056282706,0.9896759],"study_design_scores_gemma":[0.0008232008,0.0015229711,0.0016735047,0.0015855579,0.0030454174,0.00037508158,0.0000044503236,0.0000020445423,6.560685e-7,0.00001922526,0.99073666,0.00021122079],"about_ca_topic_score_codex":0.000043414813,"about_ca_topic_score_gemma":0.000014493078,"teacher_disagreement_score":0.9894647,"about_ca_system_score_codex":0.00011054365,"about_ca_system_score_gemma":0.00016842101,"threshold_uncertainty_score":0.99997073},"labels":[],"label_agreement":null},{"id":"W2905845365","doi":"10.1016/j.eururo.2018.12.015","title":"Health-related Quality of Life for Abiraterone Plus Prednisone Versus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer: Results from a Phase II Randomized Trial","year":2018,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Abbotsford Veterinary Clinic; Fraser Health; BC Cancer Agency","funders":"","keywords":"Medicine; Enzalutamide; Prostate cancer; Prednisone; Abiraterone; Randomized controlled trial; Quality of life (healthcare); Oncology; Internal medicine; Abiraterone acetate; Androgen deprivation therapy; Urology; Cancer; Androgen receptor; Nursing","score_opus":0.07043159014875042,"score_gpt":0.3704435745394552,"score_spread":0.30001198439070476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905845365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892812,0.0006777603,0.000053897453,0.0022552959,0.00036808767,0.0054836837,0.001575006,0.0000355288,0.00026959047],"genre_scores_gemma":[0.9973588,0.00007453486,0.0004429901,0.00017045262,0.000120416276,0.00019802661,0.0012887677,0.000043384982,0.00030263053],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956998,0.0016418964,0.001409595,0.0004954408,0.00031227325,0.00044097615],"domain_scores_gemma":[0.9976885,0.0007510814,0.00070601335,0.00033992605,0.00031194984,0.00020255528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001951731,0.00022289976,0.0012331101,0.00015499924,0.00012401954,0.000011017023,0.00010676434,0.00004482401,0.00006143992],"category_scores_gemma":[0.0011244939,0.00015376882,0.00009790566,0.00022087047,0.00049172953,0.00006775144,0.000049074864,0.00018288592,0.000008537301],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9919632,0.0012103994,0.00018732795,0.000065229964,0.00065285154,0.00001885157,0.0034641847,0.000033998273,0.00043680877,0.000029563054,0.00023240139,0.0017051661],"study_design_scores_gemma":[0.9558589,0.03808064,0.0049423403,0.00005789827,0.00020054939,2.967517e-7,0.00005802194,0.00023539821,0.00017062965,0.000040221534,0.00023234017,0.00012276795],"about_ca_topic_score_codex":0.0025445616,"about_ca_topic_score_gemma":0.000933298,"teacher_disagreement_score":0.03687024,"about_ca_system_score_codex":0.00017876722,"about_ca_system_score_gemma":0.0008143166,"threshold_uncertainty_score":0.62705106},"labels":[],"label_agreement":null},{"id":"W2907828838","doi":"10.1016/j.eururo.2018.12.035","title":"Re: Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE)","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Radiation therapy; Oncology; Prostate; Internal medicine; Gynecology; Cancer","score_opus":0.03232727007621445,"score_gpt":0.3181438679428259,"score_spread":0.28581659786661145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907828838","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019540307,0.01307964,0.00025493524,0.9717229,0.0012624407,0.0061243204,0.00054442266,0.00010594126,0.0049513597],"genre_scores_gemma":[0.0008061413,0.003935249,0.0006194585,0.90620774,0.0063251485,0.0008540997,0.0011842668,0.0003544827,0.079713404],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99641633,0.0007732389,0.00045504814,0.00088424433,0.00043831143,0.001032808],"domain_scores_gemma":[0.99767876,0.00087822025,0.00020941126,0.0008986057,0.00019383938,0.0001411419],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000723872,0.0005175573,0.0008595465,0.00024926857,0.00015635211,0.00006672456,0.0005420198,0.00016666476,0.00036746473],"category_scores_gemma":[0.00014902717,0.0003119991,0.00029613235,0.00023568995,0.00017387261,0.000045495544,0.0001467278,0.0014852412,0.0005608204],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015926801,0.00005559198,0.0004500095,0.0004744646,0.00066970714,0.0024063315,0.00085478195,0.000041278647,0.00033068738,0.0000030634938,0.98273,0.010391437],"study_design_scores_gemma":[0.00512922,0.00217512,0.0018257782,0.00007886477,0.00043410892,0.00006127185,0.00002784481,0.000025359213,0.000045010314,0.00001401187,0.98987335,0.00031004072],"about_ca_topic_score_codex":0.00008530103,"about_ca_topic_score_gemma":0.000028477,"teacher_disagreement_score":0.07476205,"about_ca_system_score_codex":0.0003025919,"about_ca_system_score_gemma":0.000572669,"threshold_uncertainty_score":0.9999332},"labels":[],"label_agreement":null},{"id":"W2907983605","doi":"10.1016/j.eururo.2018.12.027","title":"Renal Function Outcomes Following Radical or Partial Nephrectomy for Localized Renal Cell Carcinoma: Should Urologists Rely on Preoperative Variables to Predict Renal Function in the Long Term?","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Urology; Renal function; Nephrology; Kidney; Surgery; Internal medicine","score_opus":0.04548489675109446,"score_gpt":0.27557481163972963,"score_spread":0.23008991488863517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907983605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7600403,0.0007786625,0.017319743,0.18994273,0.005141338,0.014830049,0.00021605717,0.0004543284,0.011276822],"genre_scores_gemma":[0.659514,0.000008135557,0.00041042225,0.32833385,0.004154685,0.00079110276,0.0016512786,0.00026534672,0.004871199],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99105644,0.0033438492,0.0013068974,0.0019106012,0.0010451126,0.0013370871],"domain_scores_gemma":[0.99585676,0.0019655812,0.0004621153,0.0013642198,0.00013537909,0.0002159381],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018103091,0.001144697,0.0016166427,0.0006452836,0.00025786195,0.00011551256,0.00062740926,0.0010105622,0.0002123113],"category_scores_gemma":[0.0006129214,0.000701728,0.0007827553,0.00040359976,0.00022019309,0.00012302707,0.00021292701,0.0032324938,0.00033603067],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048666988,0.00086538144,0.10748617,0.00036970817,0.0013680586,0.019427577,0.0007695336,0.0013543667,0.001939778,0.000037578473,0.8163774,0.0013374372],"study_design_scores_gemma":[0.018186094,0.035445347,0.2600997,0.00016849671,0.004040594,0.00045077805,0.000022409911,0.00031056587,0.0007079782,0.000019744199,0.6795769,0.0009713988],"about_ca_topic_score_codex":0.00006622707,"about_ca_topic_score_gemma":0.000039607115,"teacher_disagreement_score":0.15261355,"about_ca_system_score_codex":0.0004035239,"about_ca_system_score_gemma":0.0004131352,"threshold_uncertainty_score":0.99954337},"labels":[],"label_agreement":null},{"id":"W2908530606","doi":"10.1016/j.eururo.2019.01.006","title":"Needle Tract Seeding Following Renal Tumor Biopsy: Scarcely a Concern or a Concern to Scare?","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Seeding; Biopsy; Urology; Renal biopsy; Radiology; Intensive care medicine; Surgery","score_opus":0.062470460440980535,"score_gpt":0.28593494384486473,"score_spread":0.2234644834038842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908530606","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5366004,0.0015384383,0.0001269534,0.35951877,0.0038095044,0.0031217462,0.00016731829,0.0006147598,0.0945021],"genre_scores_gemma":[0.47728696,0.0000093436065,0.00040636578,0.49366862,0.006885322,0.0000414893,0.00039063927,0.00045547154,0.020855771],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945994,0.0007580757,0.0009065285,0.0015991516,0.0007712837,0.0013655538],"domain_scores_gemma":[0.9972659,0.0005412151,0.0004234545,0.0012434394,0.00016000654,0.00036603367],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005702586,0.0009909701,0.001690036,0.00060746743,0.00013873448,0.00010085713,0.0006586116,0.0004653211,0.0006474688],"category_scores_gemma":[0.0003272196,0.00078119413,0.00078931305,0.00040924142,0.00017996076,0.00008510812,0.00040728558,0.0024902455,0.0059214584],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011641234,0.00011175069,0.0068921107,0.00028867947,0.0008616145,0.17398013,0.0010491265,0.0000137399475,0.012580017,0.000003099328,0.8020902,0.00096534623],"study_design_scores_gemma":[0.0041181734,0.004305421,0.011841879,0.00037428192,0.0012136569,0.00928009,0.000085840955,0.0000446765,0.00025833386,0.0000031697864,0.9675998,0.0008746731],"about_ca_topic_score_codex":0.0001040759,"about_ca_topic_score_gemma":0.0000031279096,"teacher_disagreement_score":0.16550955,"about_ca_system_score_codex":0.00044909064,"about_ca_system_score_gemma":0.00043028253,"threshold_uncertainty_score":0.99981105},"labels":[],"label_agreement":null},{"id":"W2908900580","doi":"10.1016/j.eururo.2018.12.022","title":"Benefits of Empiric Nutritional and Medical Therapy for Semen Parameters and Pregnancy and Live Birth Rates in Couples with Idiopathic Infertility: A Systematic Review and Meta-analysis","year":2019,"lang":"en","type":"review","venue":"European Urology","topic":"Ovarian function and disorders","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cochrane; McMaster University; Health Sciences Centre","funders":"","keywords":"Medicine; Meta-analysis; Infertility; Obstetrics; Pregnancy; Live birth; Gynecology; Semen; Andrology; Internal medicine","score_opus":0.10048167687758239,"score_gpt":0.3330850576577957,"score_spread":0.23260338078021334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908900580","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006520352,0.9955964,0.00003074564,0.00048938335,0.000009287083,0.003118578,0.000059150698,0.000010938766,0.000033484237],"genre_scores_gemma":[0.0026308196,0.99558073,0.00007157426,0.001381634,0.000005818022,0.00019929334,0.00005366032,0.00003304515,0.000043447326],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9973809,0.00093548506,0.00082190847,0.0005186145,0.00017953147,0.00016353297],"domain_scores_gemma":[0.9984839,0.00059247774,0.0004321183,0.000271788,0.00008985279,0.00012984642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011865245,0.0003269095,0.0045898003,0.0003290207,0.00002808479,0.000014982484,0.0000655809,0.00012811307,0.00004942708],"category_scores_gemma":[0.00050818425,0.00019213502,0.00026091663,0.00029096758,0.00023526663,0.00003444827,0.000053062755,0.00021422203,0.0000019366482],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012195827,0.0001462193,0.0016882193,0.9559318,0.03338038,0.000020872621,0.00015052516,7.1872535e-7,3.931687e-8,0.000112255446,0.00001666974,0.008430373],"study_design_scores_gemma":[0.0053750533,0.003726072,0.005239728,0.11597973,0.8611273,0.0005919701,0.00007440005,0.00008871958,5.809772e-8,0.000051583775,0.0071621463,0.00058320153],"about_ca_topic_score_codex":0.000006176102,"about_ca_topic_score_gemma":0.00001962616,"teacher_disagreement_score":0.83995205,"about_ca_system_score_codex":0.0000062941554,"about_ca_system_score_gemma":0.0000992264,"threshold_uncertainty_score":0.7835039},"labels":[],"label_agreement":null},{"id":"W2909007662","doi":"10.1016/j.eururo.2018.12.043","title":"The Microbiome and Genitourinary Cancer: A Collaborative Review","year":2019,"lang":"en","type":"review","venue":"European Urology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"National Cancer Institute","keywords":"Microbiome; Genitourinary system; Medicine; Prostate cancer; Cancer; Kidney cancer; Bladder cancer; Dysbiosis; Bioinformatics; Internal medicine; Biology","score_opus":0.025035611788224374,"score_gpt":0.33862922687205327,"score_spread":0.3135936150838289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909007662","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016586562,0.9955584,0.0000018603868,0.0005452474,0.0004580765,0.0009686455,0.00017710675,0.000010737838,0.0022633823],"genre_scores_gemma":[0.0000037528741,0.99371547,0.000024801853,0.0021260937,0.00045531415,0.00004204154,0.00028602002,0.00008359755,0.0032628947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972417,0.0012876457,0.00045065317,0.0005920447,0.000044494096,0.00038350813],"domain_scores_gemma":[0.9988051,0.000059714454,0.00035845334,0.00061017013,0.0000806543,0.000085903215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005013528,0.00036795717,0.0008323037,0.000041063147,0.00018923596,0.000027004038,0.00043929124,0.00018546931,0.000021252576],"category_scores_gemma":[0.000053385036,0.00024180415,0.00018574986,0.00015104312,0.00020621235,0.0000013438714,0.00043745732,0.00032520047,0.00026089264],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025306867,0.000025171064,0.0000037290238,0.021874571,0.00033003543,0.000040904546,0.000018443501,7.919258e-8,0.00076911267,0.000037240996,0.18272895,0.7941465],"study_design_scores_gemma":[0.00012881722,0.0002888983,0.000012805846,0.0018142313,0.00041930747,0.00030972666,0.0000024070653,4.1710567e-8,0.0000020155671,7.667808e-7,0.9967798,0.00024119383],"about_ca_topic_score_codex":0.0000039141923,"about_ca_topic_score_gemma":0.000013014919,"teacher_disagreement_score":0.81405085,"about_ca_system_score_codex":0.000018268054,"about_ca_system_score_gemma":0.00042203636,"threshold_uncertainty_score":0.98604876},"labels":[],"label_agreement":null},{"id":"W2909533581","doi":"10.1016/j.eururo.2019.01.009","title":"Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Concomitant; Pembrolizumab; Radiation therapy; Adverse effect; Oncology; Common Terminology Criteria for Adverse Events; Internal medicine; Tolerability; Cancer; Immunotherapy","score_opus":0.039707263629051734,"score_gpt":0.31667370917701404,"score_spread":0.2769664455479623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909533581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77709955,0.0037401682,0.0004711619,0.14048669,0.009362997,0.020695865,0.00081256055,0.00022191797,0.047109075],"genre_scores_gemma":[0.8529542,0.00023106816,0.00018792735,0.13813484,0.0047901017,0.00019356958,0.00061230507,0.00044088045,0.0024550846],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934053,0.0034326045,0.0011218246,0.000834945,0.00054417556,0.0006611903],"domain_scores_gemma":[0.99711204,0.0010629843,0.0007068337,0.0009107045,0.00010989997,0.00009754858],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006950473,0.0007098994,0.0029650456,0.00050344714,0.000033578515,0.000024613222,0.0003235195,0.00028033744,0.00072187855],"category_scores_gemma":[0.00015917818,0.00051699043,0.0005355025,0.00018417058,0.00049346243,0.00006566199,0.000052001837,0.0015234948,0.00010235087],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9642394,0.00058797095,0.00005866185,0.00020834112,0.002629426,0.0094280215,0.00032854162,0.000003629252,0.00022484334,0.000012671521,0.02202243,0.00025606985],"study_design_scores_gemma":[0.87684536,0.019921945,0.00005051715,0.00005289863,0.0031514254,0.0004155323,0.0000074079935,0.00007666104,0.0000750019,0.0000062410327,0.09904454,0.00035248615],"about_ca_topic_score_codex":0.00020628859,"about_ca_topic_score_gemma":0.00000948486,"teacher_disagreement_score":0.08739405,"about_ca_system_score_codex":0.00021022839,"about_ca_system_score_gemma":0.00082135457,"threshold_uncertainty_score":0.99972814},"labels":[],"label_agreement":null},{"id":"W2909626878","doi":"10.1016/j.eururo.2018.12.042","title":"Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Canadian Institutes of Health Research; Business Finland; Prostate Cancer Canada; Academy of Finland; Prostate Cancer Foundation","keywords":"Prostate cancer; Medicine; Liquid biopsy; Prostate; Biopsy; Prostate biopsy; Concordance; Oncology; Cell-free fetal DNA; PCA3; Internal medicine; Androgen deprivation therapy; Cancer; Pathology; Biology","score_opus":0.020518337142015078,"score_gpt":0.30058030883879766,"score_spread":0.2800619716967826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909626878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918868,0.0014264993,0.000021504698,0.0012261753,0.000104405066,0.00048088774,0.000012128022,0.000030511452,0.004811094],"genre_scores_gemma":[0.9979087,0.00014097914,0.00014536349,0.00070282415,0.00005433071,0.000014678385,0.000011743521,0.000027763668,0.0009936092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869335,0.0002714412,0.00019268633,0.00032630813,0.000115438386,0.00040079403],"domain_scores_gemma":[0.9995784,0.000045480054,0.00005158035,0.00018025709,0.000038401413,0.00010586122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045779758,0.00011687394,0.00022930246,0.00008757534,0.000038244547,0.000014228312,0.00006221224,0.000016844162,0.00024355164],"category_scores_gemma":[0.000043580745,0.00009550206,0.0000315003,0.00012489327,0.00011971852,0.000051578947,0.00007669578,0.00024202604,0.000076664175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015670988,0.00019048921,0.9237333,0.0003365924,0.00012087214,0.0063982503,0.0020909663,0.00013763612,0.04920756,0.00006273253,0.00010771338,0.016046802],"study_design_scores_gemma":[0.0053717936,0.00047786543,0.98705214,0.00005013779,0.00006338277,0.0006204518,0.00012736143,0.0027566245,0.0006417708,0.00012641924,0.0025749134,0.0001371609],"about_ca_topic_score_codex":0.00009103246,"about_ca_topic_score_gemma":0.000026293912,"teacher_disagreement_score":0.06331883,"about_ca_system_score_codex":0.000060356404,"about_ca_system_score_gemma":0.00013373418,"threshold_uncertainty_score":0.3894461},"labels":[],"label_agreement":null},{"id":"W2910889145","doi":"10.1016/j.eururo.2018.12.038","title":"Further Evidence of Differences in Prostate Cancer Biomarkers Between Caucasian and Asian Men","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Sinai Health System","funders":"","keywords":"Medicine; Prostate cancer; Oncology; Internal medicine; Prostate; Prostate disease; Gynecology; Cancer","score_opus":0.051123529249238346,"score_gpt":0.3203399666767041,"score_spread":0.26921643742746576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910889145","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20276642,0.012166869,9.789896e-7,0.7674071,0.00019922796,0.0012648387,0.00010796414,0.000031687352,0.016054872],"genre_scores_gemma":[0.9413108,0.0050327918,0.000026022082,0.04240071,0.000980266,0.00004296315,0.0001335137,0.00011463119,0.0099582635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755836,0.0006640426,0.00038566813,0.0005920089,0.00027761448,0.000522331],"domain_scores_gemma":[0.9989515,0.00032235094,0.00019392847,0.0003912111,0.00006424258,0.00007679776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037032654,0.0003063265,0.00073937903,0.0003818821,0.000024805337,0.000015647713,0.00021510385,0.00021612918,0.00017425841],"category_scores_gemma":[0.00007848103,0.00022147936,0.00007307201,0.00018901254,0.00041425627,0.000054231205,0.00015825461,0.0010082255,0.000056847133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005690255,0.000024529301,0.8545742,0.0010255498,0.0004866482,0.0022005646,0.0016093769,9.84792e-8,0.0001904298,6.368549e-7,0.12922032,0.010098627],"study_design_scores_gemma":[0.0026253122,0.0018669592,0.87937665,0.0010688348,0.0003279558,0.000050971925,0.00011871057,0.0000063439084,0.000062344065,0.000023303537,0.11415237,0.0003202224],"about_ca_topic_score_codex":0.00030926577,"about_ca_topic_score_gemma":0.000044993085,"teacher_disagreement_score":0.7385444,"about_ca_system_score_codex":0.000080214355,"about_ca_system_score_gemma":0.0002579759,"threshold_uncertainty_score":0.9031666},"labels":[],"label_agreement":null},{"id":"W2911652114","doi":"10.1016/j.eururo.2018.12.036","title":"Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; Canadian Cancer Society","keywords":"Medicine; Prostate cancer; Magnetic resonance imaging; Visibility; Multiparametric MRI; Prostate; Nuclear magnetic resonance; Cancer; Radiology; Internal medicine; Optics","score_opus":0.010268782711774994,"score_gpt":0.2895967742992548,"score_spread":0.2793279915874798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911652114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9537701,0.03109602,0.0000045360016,0.0009843239,0.00010616802,0.0006917884,0.000010604285,0.000022786668,0.013313679],"genre_scores_gemma":[0.9976096,0.0006116231,0.00012160497,0.00042069337,0.000019895018,0.000017139759,0.000010764764,0.00003211882,0.0011565182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845153,0.00030104414,0.0002983636,0.0004046753,0.00017925975,0.00036511038],"domain_scores_gemma":[0.99928254,0.000083416264,0.00006513287,0.000397265,0.00009282481,0.00007881108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046718717,0.00012888684,0.0002954543,0.0002754202,0.000013021333,0.0000054685606,0.00012426994,0.000025088839,0.00026168517],"category_scores_gemma":[0.00012933747,0.000106587766,0.000059932954,0.00046065662,0.00014608029,0.000038810038,0.000103690116,0.00026404866,0.00010384521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010293126,0.00017737839,0.91487145,0.00009762429,0.0000107270025,0.00070326333,0.0002579073,0.000094117844,0.017789304,0.00002655791,0.00009027905,0.064852096],"study_design_scores_gemma":[0.004413952,0.00063131977,0.9833377,0.000052096224,0.000023210512,0.00002377097,0.000027221975,0.0018552557,0.0024835123,0.000033690867,0.0070116436,0.0001066436],"about_ca_topic_score_codex":0.0001706419,"about_ca_topic_score_gemma":0.000011335451,"teacher_disagreement_score":0.06846625,"about_ca_system_score_codex":0.00007434588,"about_ca_system_score_gemma":0.00009653817,"threshold_uncertainty_score":0.43465227},"labels":[],"label_agreement":null},{"id":"W2911761868","doi":"10.1016/j.eururo.2019.02.001","title":"Effective Technology-based Behaviour Change Interventions in Prostate Cancer Supportive Care: Are We There Yet?","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Behavioral Health and Interventions","field":"Psychology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Psychological intervention; Prostate; Intensive care medicine; Cancer; Oncology; Gynecology; Internal medicine; Nursing","score_opus":0.07482283392994313,"score_gpt":0.38430918737116626,"score_spread":0.3094863534412231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911761868","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13156319,0.029641453,0.000023635237,0.80552465,0.011817291,0.007845062,0.004120866,0.0006707351,0.008793143],"genre_scores_gemma":[0.6611542,0.00022700643,0.000037794794,0.31450686,0.0018429114,0.006128663,0.0018676079,0.00050569646,0.013729255],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943055,0.0019966569,0.00096264284,0.0012957288,0.00018775235,0.0012517438],"domain_scores_gemma":[0.99756014,0.00013471025,0.0009146338,0.0010684127,0.00022971125,0.000092364906],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00037100873,0.0006577356,0.0008835703,0.0013559689,0.00011822063,0.000028174016,0.00079402386,0.0010774699,0.003563693],"category_scores_gemma":[0.00003908885,0.00065149966,0.00064513664,0.00056533155,0.00035562445,0.000084390005,0.0002396008,0.0047622393,0.0032220948],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022490375,0.00050725264,0.16186742,0.00069118757,0.00012740523,0.0064410637,0.0023043358,0.000002215117,0.0000040049713,0.000055103366,0.79491127,0.032863867],"study_design_scores_gemma":[0.0019143306,0.0021313801,0.33814996,0.001147887,0.00028396686,0.00004482099,0.00057290314,0.0000014442354,0.000005958213,0.000028703436,0.6551283,0.0005903406],"about_ca_topic_score_codex":0.0008035772,"about_ca_topic_score_gemma":0.0012408805,"teacher_disagreement_score":0.529591,"about_ca_system_score_codex":0.0003239265,"about_ca_system_score_gemma":0.000099196295,"threshold_uncertainty_score":0.9995936},"labels":[],"label_agreement":null},{"id":"W2912528055","doi":"10.1016/j.eururo.2019.01.046","title":"Management of Urinary Retention in Patients with Benign Prostatic Obstruction: A Systematic Review and Meta-analysis","year":2019,"lang":"en","type":"review","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Cochrane; McMaster University","funders":"Sigrid Juséliuksen Säätiö; Academy of Finland","keywords":"Medicine; Alfuzosin; Tamsulosin; Randomized controlled trial; Odds ratio; Lower urinary tract symptoms; Cochrane Library; Meta-analysis; Urology; Placebo; Confidence interval; MEDLINE; Adverse effect; Systematic review; Internal medicine; Prostate; Alternative medicine","score_opus":0.08490185411973572,"score_gpt":0.33408646504306616,"score_spread":0.24918461092333044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912528055","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002978966,0.99158704,0.000009267296,0.000058644666,0.000014988534,0.0063462947,0.000041536925,0.000012779148,0.0018996331],"genre_scores_gemma":[0.00042358,0.996671,0.00015944126,0.000068906804,0.0000051483066,0.00016968008,0.00036381368,0.000053035063,0.0020853763],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99581647,0.001959776,0.0010895064,0.00054664933,0.00034346172,0.00024415096],"domain_scores_gemma":[0.9983541,0.000098255856,0.00057838677,0.00077848864,0.00011348887,0.000077283774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010491908,0.00033722748,0.0053537143,0.0005556863,0.000022517017,0.0000090529475,0.0001546194,0.000063090345,0.0001887717],"category_scores_gemma":[0.000027485099,0.00020146898,0.00067520613,0.0008781689,0.00007973994,0.000045339755,0.0001589153,0.00034088801,0.000064178064],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048156748,0.000152002,0.00008212853,0.91561675,0.0817163,0.00031520534,0.000024191699,5.2012723e-7,1.461359e-9,0.000020515237,0.00001666233,0.0020075608],"study_design_scores_gemma":[0.0005463341,0.0018950062,0.001289125,0.022966519,0.9664966,0.00015417412,0.0000086810405,0.0000013559763,3.5312584e-9,0.0000027018389,0.006462615,0.00017686967],"about_ca_topic_score_codex":0.0000020606608,"about_ca_topic_score_gemma":3.0762334e-7,"teacher_disagreement_score":0.89265025,"about_ca_system_score_codex":0.000035113917,"about_ca_system_score_gemma":0.000034588105,"threshold_uncertainty_score":0.8215667},"labels":[],"label_agreement":null},{"id":"W2913237306","doi":"10.1016/j.eururo.2019.01.026","title":"Higher Risk of Fragility Fractures in Prostate Cancer Patients Treated with Combined Radium-223 and Abiraterone: Prednisone May Be the Culprit","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Abiraterone; Prednisone; Prostate cancer; Radium-223; Urology; Abiraterone acetate; Oncology; Internal medicine; Culprit; Cancer; Bone metastasis; Androgen deprivation therapy","score_opus":0.013504451037174944,"score_gpt":0.26671526150621866,"score_spread":0.2532108104690437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913237306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83034253,0.0021538546,3.3129544e-7,0.16291131,0.00016372869,0.0018475497,0.0003671588,0.000035019464,0.002178512],"genre_scores_gemma":[0.8993489,0.0016259725,0.000010150961,0.08351862,0.0003254759,0.00008814445,0.00091289566,0.00013323179,0.01403657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969077,0.0011274318,0.00041872333,0.0006501823,0.00036130653,0.00053461816],"domain_scores_gemma":[0.9986244,0.00022169453,0.00032522003,0.0005973904,0.00016579103,0.00006550113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031780303,0.000415404,0.000750012,0.0001697659,0.00007064575,0.000021169704,0.0002182294,0.0002474073,0.00027948763],"category_scores_gemma":[0.00003820029,0.00021802734,0.00007175561,0.00018329886,0.0005983803,0.000045718512,0.00013716439,0.001759191,0.000028942244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044619283,0.00028874679,0.8476908,0.00029792608,0.00054470997,0.0006055691,0.00060234644,0.000008040263,0.000046740908,7.6833743e-7,0.14445007,0.001002365],"study_design_scores_gemma":[0.009645587,0.002677446,0.7252854,0.000079257035,0.00033183888,0.000006517387,0.00000624434,0.000009408075,0.0001447176,0.000005580444,0.26162583,0.00018219119],"about_ca_topic_score_codex":0.000869792,"about_ca_topic_score_gemma":0.00004509934,"teacher_disagreement_score":0.1224054,"about_ca_system_score_codex":0.0001011635,"about_ca_system_score_gemma":0.00011437278,"threshold_uncertainty_score":0.8890897},"labels":[],"label_agreement":null},{"id":"W2913857335","doi":"10.1016/j.eururo.2019.01.011","title":"Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Genome British Columbia","funders":"National Cancer Institute; Bladder Cancer Advocacy Network; Burroughs Wellcome Fund","keywords":"Medicine; Bladder cancer; Cystectomy; Stromal cell; Interquartile range; Oncology; Hazard ratio; Cohort; Internal medicine; Urology; Cancer; Confidence interval","score_opus":0.027204802501490773,"score_gpt":0.32716684181275496,"score_spread":0.2999620393112642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913857335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99389696,0.00050990126,0.000068940106,0.0002996091,0.0002779349,0.0008809165,0.00004713225,0.000037057933,0.0039815474],"genre_scores_gemma":[0.9988251,0.0001058248,0.0000607073,0.00056069583,0.00009977938,0.000026901942,0.000031486084,0.00004939243,0.00024014844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881554,0.0001407147,0.0003162979,0.00033179938,0.00012774643,0.00026790737],"domain_scores_gemma":[0.999215,0.00020222804,0.0001492357,0.0002986549,0.000056805748,0.00007808667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020941184,0.0002130616,0.00045907625,0.00008739938,0.0000525332,0.000011336802,0.00007652786,0.00006130428,0.00014978102],"category_scores_gemma":[0.00006810307,0.00015683085,0.00029772992,0.0000661546,0.0000467835,0.00007105835,0.000027416065,0.00013294838,0.000014788763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015960478,0.0002940748,0.93193465,0.00003131396,0.0016309432,0.0000182419,0.0007431349,0.00009974658,0.052668676,0.00011663324,0.000081597675,0.010784917],"study_design_scores_gemma":[0.007833792,0.004997985,0.9842735,0.000017116827,0.00019421714,0.000003945908,0.000032896536,0.000034306307,0.0022840279,0.000038903174,0.00016662008,0.00012269845],"about_ca_topic_score_codex":0.00025659965,"about_ca_topic_score_gemma":0.000016328824,"teacher_disagreement_score":0.052338816,"about_ca_system_score_codex":0.000048328224,"about_ca_system_score_gemma":0.00013731077,"threshold_uncertainty_score":0.63953763},"labels":[],"label_agreement":null},{"id":"W2916380532","doi":"10.1016/j.eururo.2019.02.019","title":"Re: Prostate Cancer-specific Mortality Across Gleason Scores in Black vs Nonblack Men","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Prostate; Gynecology; Oncology; Cancer; Urology; Internal medicine","score_opus":0.0356745146151478,"score_gpt":0.3067836043743799,"score_spread":0.2711090897592321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916380532","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32957777,0.008226236,0.0000022078236,0.62881285,0.0014425572,0.0028862832,0.00094597554,0.00017212382,0.027933983],"genre_scores_gemma":[0.28709164,0.016060283,0.000032242093,0.68099326,0.004818198,0.00025360167,0.0019881923,0.00040607684,0.008356468],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954333,0.0006602555,0.0007870535,0.0014498609,0.00044142507,0.0012281197],"domain_scores_gemma":[0.99777156,0.00020299669,0.000425348,0.0013349908,0.00013194025,0.00013316856],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005319227,0.00071325566,0.0012526554,0.00016166482,0.00006619569,0.00006781381,0.00039240564,0.00044997665,0.0005487076],"category_scores_gemma":[0.000054495085,0.000612171,0.00025014742,0.00026047992,0.00044456494,0.00007896284,0.00028980692,0.0021602928,0.0020206396],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005023701,0.00014837751,0.19455983,0.0003827762,0.00026402844,0.008747253,0.0010794647,0.00004813181,0.000022404129,0.0000042933434,0.79256636,0.0016746897],"study_design_scores_gemma":[0.0029268553,0.0010073808,0.27653542,0.0002306245,0.00015167694,0.000022611082,0.000033213448,0.00001780652,0.00006831613,0.000016279115,0.7186126,0.00037722653],"about_ca_topic_score_codex":0.0005737075,"about_ca_topic_score_gemma":0.00024431996,"teacher_disagreement_score":0.081975594,"about_ca_system_score_codex":0.0005222801,"about_ca_system_score_gemma":0.00020652328,"threshold_uncertainty_score":0.99963295},"labels":[],"label_agreement":null},{"id":"W2916798133","doi":"10.1016/j.eururo.2019.02.009","title":"A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":698,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Cancer Institute; European Association of Urology","keywords":"Medicine; Prostate cancer; Hazard ratio; Confidence interval; Population; Internal medicine; Prostate; Prostate cancer screening; Gynecology; Prostate-specific antigen; Randomized controlled trial; Cancer; Urology","score_opus":0.021426063505889457,"score_gpt":0.2771761350273339,"score_spread":0.25575007152144447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916798133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807425,0.001215694,0.00007748276,0.0007933303,0.0004632546,0.0041126553,0.000040837458,0.000024216279,0.012530012],"genre_scores_gemma":[0.99743944,0.00012796852,0.000068155685,0.0005049364,0.000081437785,0.00010969731,0.000011368926,0.000059760132,0.0015972395],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977202,0.0010961968,0.0004949838,0.0003051365,0.00015586986,0.0002276399],"domain_scores_gemma":[0.9986761,0.00028376994,0.0003649467,0.0004665453,0.00015409503,0.00005450162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001167598,0.00016430793,0.00072658143,0.000063262654,0.00004223888,0.000004782841,0.00017068839,0.000017503042,0.00007620446],"category_scores_gemma":[0.0001710073,0.00009811578,0.0002540502,0.00012074489,0.00011696248,0.000024282353,0.0001352351,0.00011244684,0.000015503285],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15541558,0.0029682303,0.72720635,0.0004504012,0.0042213355,0.00010105507,0.016580883,0.0007396345,0.004073284,0.0005989685,0.007126016,0.08051823],"study_design_scores_gemma":[0.71542305,0.007890136,0.2499494,0.00028659427,0.00221762,0.000019176165,0.00084286695,0.000168848,0.0023788062,0.00005319836,0.020491049,0.00027929017],"about_ca_topic_score_codex":0.00013039877,"about_ca_topic_score_gemma":0.000035079687,"teacher_disagreement_score":0.56000745,"about_ca_system_score_codex":0.000025404312,"about_ca_system_score_gemma":0.000043421896,"threshold_uncertainty_score":0.40010455},"labels":[],"label_agreement":null},{"id":"W2917264624","doi":"10.1016/j.eururo.2019.02.010","title":"The Impact of Lifestyle-related Factors on Survival After a Prostate Cancer Diagnosis","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Health and Wellbeing Research","field":"Health Professions","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research; Healthway","keywords":"Medicine; Prostate cancer; Oncology; Prostate; Internal medicine; Cancer; Gynecology","score_opus":0.04422026759483922,"score_gpt":0.4167607165778291,"score_spread":0.3725404489829899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917264624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51822674,0.0010137989,4.6185275e-7,0.44816005,0.0038463902,0.0022997968,0.0008665932,0.00010139006,0.02548476],"genre_scores_gemma":[0.6152408,0.0026837043,0.0000011164681,0.33940554,0.0039688824,0.00077049853,0.00033269465,0.00039184035,0.03720492],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9849495,0.011045102,0.0010406084,0.00062587735,0.00048733922,0.0018515515],"domain_scores_gemma":[0.9876583,0.010214473,0.000651089,0.0010179097,0.0002576063,0.00020059236],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0023950413,0.0004704873,0.00074026186,0.00025303647,0.0005396775,0.000015577312,0.0007225789,0.00083680695,0.0022905224],"category_scores_gemma":[0.0013596885,0.00026516704,0.00032274713,0.0002545574,0.0002854065,0.000034490833,0.0003255782,0.008133246,0.004311672],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002855019,0.000021865584,0.35528168,0.00019756395,0.0001410274,0.00016833292,0.001054991,0.0000148461695,0.0000011844884,0.000004645205,0.64229137,0.000536985],"study_design_scores_gemma":[0.0005188442,0.00070435024,0.32765132,0.00012704884,0.000026584767,6.9454205e-7,0.000018578361,0.000007164704,5.535585e-7,0.00001788582,0.6707564,0.00017058963],"about_ca_topic_score_codex":0.0024128724,"about_ca_topic_score_gemma":0.0000970458,"teacher_disagreement_score":0.10875453,"about_ca_system_score_codex":0.00025698976,"about_ca_system_score_gemma":0.0012803625,"threshold_uncertainty_score":0.99998003},"labels":[],"label_agreement":null},{"id":"W2921451618","doi":"10.1016/j.eururo.2019.03.004","title":"Androgen Deprivation Therapy with Postprostatectomy Radiotherapy: For Whom and for How Long?","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; National Institute for Health and Care Research; Royal Marsden NHS Foundation Trust","keywords":"Medicine; Androgen deprivation therapy; Radiation therapy; Prostatectomy; Prostate cancer; Urology; General surgery; Internal medicine; Cancer","score_opus":0.03161862020509741,"score_gpt":0.28897821149286584,"score_spread":0.2573595912877684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921451618","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051461596,0.009457536,0.0040523345,0.9271808,0.00024669504,0.0068210703,0.00023500307,0.00010609992,0.00043885672],"genre_scores_gemma":[0.018445069,0.004334166,0.0026779673,0.9225289,0.0065075723,0.0006983346,0.006197699,0.00073342735,0.03787682],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99842626,0.00015834322,0.00015389764,0.0006060691,0.00016011142,0.0004953324],"domain_scores_gemma":[0.9989493,0.00029726993,0.00013328642,0.00037994297,0.00018349937,0.000056726214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002497424,0.00032146793,0.00049040024,0.00018457137,0.000116473224,0.00008073062,0.00012553917,0.00023834982,0.000021417607],"category_scores_gemma":[0.000029678646,0.00021150598,0.000100153135,0.0000738232,0.00021203615,0.000050485098,0.000025177458,0.00048525605,0.000008096349],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011645566,0.00007752707,0.01635971,0.0006758608,0.001429889,0.00066200516,0.00045356926,0.0000014127248,0.0013175773,0.000007778055,0.94342405,0.023945076],"study_design_scores_gemma":[0.012830268,0.008552038,0.0044194427,0.000033939068,0.00013360225,0.00020481762,0.0000051711863,0.000046412108,0.000336834,0.000019791089,0.9731881,0.00022958958],"about_ca_topic_score_codex":0.000003260259,"about_ca_topic_score_gemma":0.0000016755783,"teacher_disagreement_score":0.037437964,"about_ca_system_score_codex":0.000056813744,"about_ca_system_score_gemma":0.00016183766,"threshold_uncertainty_score":0.8624963},"labels":[],"label_agreement":null},{"id":"W2922071185","doi":"10.1016/j.eururo.2019.02.033","title":"Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2","year":2019,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2407,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Medicine; Prostate; Medical physics; Magnetic resonance imaging; Process (computing); Value (mathematics); Data mining; Radiology; Computer science; Machine learning; Internal medicine","score_opus":0.07317183706669592,"score_gpt":0.3529039087838561,"score_spread":0.2797320717171602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922071185","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022483054,0.9897008,0.000025715412,0.00028961425,0.0009483729,0.002772367,0.0016421967,0.0001985877,0.00217403],"genre_scores_gemma":[0.016768351,0.96962047,0.00046078913,0.0001072605,0.00026791953,0.000020100244,0.012290406,0.0002516987,0.0002130269],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910569,0.00080780505,0.00453133,0.0024958006,0.00040661494,0.00070155633],"domain_scores_gemma":[0.98291206,0.00025263548,0.012409447,0.0039610085,0.00020590154,0.00025894493],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0060897535,0.000742394,0.0030951954,0.00034556913,0.00021155774,0.00011004865,0.00067935465,0.000107692395,0.000007724415],"category_scores_gemma":[0.0010482746,0.00058918865,0.00015836065,0.0002469658,0.00020345625,0.00045522896,0.0042249737,0.00062537135,0.00010898383],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029155234,0.00011968002,0.036235034,0.13169906,0.00092982576,0.016233822,0.000269455,0.0000034809652,0.000032803262,0.000033543052,0.01633301,0.7978187],"study_design_scores_gemma":[0.0019525886,0.00027669893,0.0009713079,0.035665855,0.0058206823,0.0099582095,0.00034859136,0.0017527635,0.000007136032,6.850844e-7,0.9426763,0.0005691488],"about_ca_topic_score_codex":0.00011906855,"about_ca_topic_score_gemma":0.0000014410024,"teacher_disagreement_score":0.9263433,"about_ca_system_score_codex":0.0002683001,"about_ca_system_score_gemma":0.00038774364,"threshold_uncertainty_score":0.99965596},"labels":[],"label_agreement":null},{"id":"W2926592082","doi":"10.1016/j.eururo.2019.03.020","title":"Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Prostate Cancer Foundation; American Association for Cancer Research; U.S. National Library of Medicine; U.S. Department of Defense","keywords":"Enzalutamide; Prostate cancer; Medicine; Oncology; Wnt signaling pathway; Cancer research; Internal medicine; Cancer; Gene; Genetics; Biology; Androgen receptor","score_opus":0.020228257927322236,"score_gpt":0.28447764855202234,"score_spread":0.2642493906247001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2926592082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881995,0.0037687633,0.0000012432696,0.0018551607,0.00005658087,0.00077778974,0.00003703942,0.000015665806,0.005288301],"genre_scores_gemma":[0.9957686,0.0007775855,0.00035980283,0.00020657555,0.000018835368,0.000027196187,0.000017781338,0.000027062153,0.0027965347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881345,0.00020127972,0.00027158603,0.00030370403,0.00013706763,0.0002729076],"domain_scores_gemma":[0.99953926,0.000070202725,0.000096235286,0.0001505532,0.000064286905,0.00007943905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028187415,0.00012260712,0.00027937483,0.00015700469,0.000025310766,0.000008256802,0.000068826106,0.00002187024,0.00011309006],"category_scores_gemma":[0.00003136312,0.00009936416,0.00003447136,0.0001616046,0.00015811871,0.00004934667,0.000047577552,0.00015115613,0.000038042257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004110553,0.00020386213,0.68805504,0.00054642215,0.00023630414,0.0007243932,0.0027409373,0.000058478847,0.29993507,0.000439757,0.00043173012,0.0025174601],"study_design_scores_gemma":[0.0052874805,0.0009251169,0.9819148,0.00009720827,0.00011705649,0.000015899637,0.000237334,0.000065478176,0.0042604096,0.00008721761,0.0068506706,0.00014130933],"about_ca_topic_score_codex":0.000089109606,"about_ca_topic_score_gemma":0.00030186708,"teacher_disagreement_score":0.29567465,"about_ca_system_score_codex":0.00007072935,"about_ca_system_score_gemma":0.00014962933,"threshold_uncertainty_score":0.40519527},"labels":[],"label_agreement":null},{"id":"W2937762300","doi":"10.1016/j.eururo.2019.04.005","title":"Separating the Dreadful from the Merely Bad: Towards Prognostic and Predictive Biomarkers in Metastatic Castration-resistant Prostate Cancer","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Prostate cancer; Oncology; Castration; Internal medicine; Prostate; Cancer; Gynecology; Hormone","score_opus":0.03304992946873519,"score_gpt":0.3061657694597973,"score_spread":0.2731158399910621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937762300","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17581499,0.01932717,0.000010893796,0.7929369,0.00053688383,0.004368325,0.0012635647,0.00005559498,0.0056856633],"genre_scores_gemma":[0.69414634,0.0018932747,0.00010198709,0.29380277,0.0018377108,0.0006523326,0.00244368,0.00024770646,0.004874191],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963328,0.0015367911,0.00044918928,0.000680225,0.00041181612,0.0005891341],"domain_scores_gemma":[0.99786896,0.0012274091,0.00023527576,0.00049929734,0.00011846471,0.000050621347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068237464,0.0003924049,0.000501262,0.000117633135,0.00016465699,0.000085654596,0.0002824412,0.00013841923,0.00012211512],"category_scores_gemma":[0.00027298517,0.00019851419,0.00009130277,0.00023451919,0.00053387956,0.000060608014,0.0001669269,0.0016614292,0.000066300076],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00490949,0.0001487442,0.061868608,0.00047383123,0.005502652,0.0103239985,0.012069893,0.000098475444,0.0012124382,0.000009682735,0.88971454,0.013667646],"study_design_scores_gemma":[0.0053377273,0.0020919065,0.44316265,0.00045743777,0.0020376435,0.00015688551,0.00062091526,0.0009458517,0.000074749645,0.000114191185,0.5444994,0.00050064066],"about_ca_topic_score_codex":0.0011099908,"about_ca_topic_score_gemma":0.00020475191,"teacher_disagreement_score":0.51833135,"about_ca_system_score_codex":0.00012506847,"about_ca_system_score_gemma":0.0005303706,"threshold_uncertainty_score":0.8095173},"labels":[],"label_agreement":null},{"id":"W2939558853","doi":"10.1016/j.eururo.2019.03.011","title":"RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Prostate Cancer UK; Prostate Cancer Canada","keywords":"RNA splicing; Cancer research; Biology; Transcriptome; Alternative splicing; Demethylase; Prostate cancer; Epigenetics; Long non-coding RNA; RNA; Gene; Cell biology; Cancer; Gene expression; Exon; Genetics","score_opus":0.013445044681499988,"score_gpt":0.30973899801847266,"score_spread":0.29629395333697267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939558853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716717,0.0013417416,0.000007995673,0.019298706,0.0003878401,0.0011861426,0.000016439735,0.000033652574,0.0060558096],"genre_scores_gemma":[0.9906847,0.00026862414,0.00003980367,0.0020104372,0.00009257051,0.000025284151,0.000009078645,0.00003507094,0.0068344567],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99880224,0.00019570872,0.00020900652,0.00027265417,0.00017320618,0.0003472029],"domain_scores_gemma":[0.9992928,0.000046987574,0.000079376194,0.00037940973,0.00011139188,0.000090027286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015923497,0.00012070063,0.00023640518,0.000082271064,0.000052827538,0.000007541485,0.0001659236,0.00001369935,0.00010963209],"category_scores_gemma":[0.000060566363,0.00006791964,0.000064235384,0.00024177486,0.00009152919,0.000022420973,0.00024043846,0.00019956604,0.00014136438],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018892704,0.00013666002,0.35028857,0.000103896986,0.00012091929,0.00024535117,0.00029492663,0.00013039233,0.62065876,0.00009729721,0.0029493598,0.023084624],"study_design_scores_gemma":[0.005852574,0.0021020502,0.5694937,0.00016906369,0.00013013414,0.00009724649,0.000030035948,0.0001727201,0.31220698,0.00003984417,0.10955602,0.00014961435],"about_ca_topic_score_codex":0.00002767665,"about_ca_topic_score_gemma":0.0000045957877,"teacher_disagreement_score":0.30845177,"about_ca_system_score_codex":0.000039565464,"about_ca_system_score_gemma":0.00008123211,"threshold_uncertainty_score":0.27696824},"labels":[],"label_agreement":null},{"id":"W2941797036","doi":"10.1016/j.eururo.2019.04.006","title":"Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"DOD Prostate Cancer Research Program; National Cancer Institute; Medical Research Council; Imperial Experimental Cancer Medicine Centre; Stand Up To Cancer; Cancer Research UK; Academy of Medical Sciences; U.S. Department of Veterans Affairs; Patrick C. Walsh Prostate Cancer Research Fund; Institute for Prostate Cancer Research; Prostate Cancer Foundation; Movember Foundation; National Institutes of Health; Prostate Cancer UK; National Institute for Health and Care Research; U.S. Department of Defense","keywords":"Medicine; Prostate cancer; Interquartile range; Circulating tumor cell; Androgen receptor; Biopsy; Internal medicine; Hazard ratio; Oncology; Liquid biopsy; Pathology; Cancer; Confidence interval; Metastasis","score_opus":0.04920556836931989,"score_gpt":0.3493108338620497,"score_spread":0.3001052654927298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941797036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855595,0.0015334169,0.000009252164,0.00039009054,0.00020284677,0.0008444202,0.00009108905,0.000023272773,0.011346082],"genre_scores_gemma":[0.99784434,0.00047574722,0.00044871963,0.00016740459,0.000062504434,0.000014499417,0.00007425278,0.000035667654,0.000876892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973782,0.00080047536,0.0006858972,0.0004510855,0.00022014616,0.00046422196],"domain_scores_gemma":[0.998946,0.00022588548,0.00021095725,0.00031876258,0.00012982017,0.00016858599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011686962,0.00015842283,0.00045923342,0.00011384835,0.000032151624,0.0000073508295,0.00010040516,0.00004430956,0.00081853993],"category_scores_gemma":[0.00012406286,0.00012842145,0.00009130851,0.00023643629,0.0001327975,0.00005880482,0.00007266928,0.0003620373,0.00015636998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034264561,0.0006603275,0.90596426,0.00042793245,0.00017297454,0.0008947669,0.0012939699,0.00008225044,0.07872262,0.000035549685,0.00041486946,0.007904031],"study_design_scores_gemma":[0.0091616465,0.0018253969,0.9766158,0.0000772901,0.00015585961,0.000036743786,0.00036493785,0.0013221261,0.0027952557,0.000036131023,0.0074037206,0.00020511595],"about_ca_topic_score_codex":0.0003212167,"about_ca_topic_score_gemma":0.00007039588,"teacher_disagreement_score":0.07592736,"about_ca_system_score_codex":0.000053823598,"about_ca_system_score_gemma":0.00040176837,"threshold_uncertainty_score":0.8962438},"labels":[],"label_agreement":null},{"id":"W2944471807","doi":"10.1016/j.eururo.2019.05.001","title":"Grading Noninvasive Bladder Cancer: World Health Organisation 1973 or 2004 May Be the Wrong Question","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Grading (engineering); Bladder cancer; Risk stratification; Medical physics; Cancer; Internal medicine","score_opus":0.029982643837709613,"score_gpt":0.3119230620012545,"score_spread":0.2819404181635449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944471807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68503743,0.0071158996,0.0008501654,0.1838959,0.004646252,0.0040117414,0.00014130477,0.00061937695,0.113681905],"genre_scores_gemma":[0.9620766,0.00030953172,0.00010419513,0.02139556,0.0005151403,0.000018087809,0.00006111086,0.00006687406,0.015452873],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984234,0.0004533813,0.00025501547,0.00034499486,0.0001738365,0.00034937606],"domain_scores_gemma":[0.99922997,0.00010528718,0.00014732414,0.00034778292,0.00005095415,0.00011869704],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035479607,0.00018013704,0.00025698,0.00009725317,0.00014707343,0.000019615803,0.00012338335,0.00003508132,0.0021039664],"category_scores_gemma":[0.000038526483,0.00011467715,0.00005634188,0.0002071782,0.0000774521,0.00006207613,0.00004581458,0.00026697098,0.0007557963],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005530894,0.0010648597,0.5330494,0.00046517837,0.0022143594,0.0012343491,0.020573309,0.0008952581,0.006815476,0.008449237,0.3117933,0.10791439],"study_design_scores_gemma":[0.0076215276,0.0044214544,0.27130383,0.00014404357,0.00053588365,0.0006198158,0.0005773803,0.00018407585,0.0019882359,0.00017334898,0.7119402,0.0004901693],"about_ca_topic_score_codex":0.0004563658,"about_ca_topic_score_gemma":0.0006129198,"teacher_disagreement_score":0.40014693,"about_ca_system_score_codex":0.00019263834,"about_ca_system_score_gemma":0.00033385254,"threshold_uncertainty_score":0.99880826},"labels":[],"label_agreement":null},{"id":"W2944489822","doi":"10.1016/j.eururo.2019.04.036","title":"Molecular Subtyping of Clinically Localized Urothelial Carcinoma Reveals Lower Rates of Pathological Upstaging at Radical Cystectomy Among Luminal Tumors","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Medicine; Cystectomy; Pathological; Urology; Logistic regression; Subtyping; Bladder cancer; Stage (stratigraphy); Oncology; Internal medicine; Retrospective cohort study; Cancer","score_opus":0.01567969441747168,"score_gpt":0.2775872557985292,"score_spread":0.26190756138105753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944489822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826011,0.00036842606,0.00024024483,0.00020400647,0.0002623181,0.00060536904,0.000023901279,0.00004834279,0.015646305],"genre_scores_gemma":[0.99771076,0.00001477712,0.00036453176,0.0011430677,0.00014673603,0.000007832128,0.000023583127,0.0000676568,0.00052102236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968454,0.00083407486,0.0010315102,0.00055673317,0.00029880196,0.00043346075],"domain_scores_gemma":[0.9985033,0.0002205915,0.00040099933,0.0005611797,0.000119669225,0.00019421498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008114111,0.00027708174,0.00091078074,0.00012910826,0.000038231432,0.000005147285,0.00024509963,0.00013550335,0.0007006714],"category_scores_gemma":[0.0002725909,0.00022186195,0.00031523238,0.00016213363,0.0006162407,0.000034958415,0.00021037017,0.00034115746,0.00013058913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049178605,0.0003393695,0.9070775,0.0001295096,0.00014098658,0.0023230584,0.00026364662,0.00004102337,0.08409132,0.00009498717,0.00018996595,0.00039076383],"study_design_scores_gemma":[0.014481267,0.008760265,0.9533703,0.00019693945,0.0005009258,0.00083186285,0.00006774825,0.00024656922,0.018508183,0.00009514635,0.0025281443,0.0004126915],"about_ca_topic_score_codex":0.000032408792,"about_ca_topic_score_gemma":0.0000012920381,"teacher_disagreement_score":0.06558313,"about_ca_system_score_codex":0.00004481773,"about_ca_system_score_gemma":0.00009411661,"threshold_uncertainty_score":0.90472674},"labels":[],"label_agreement":null},{"id":"W2946970690","doi":"10.1016/j.eururo.2019.05.036","title":"Reply to Rodolfo Montironi, Liang Cheng, Marina Scarpelli, Alessia Cimadamore, Francesco Montorsi, and Antonio Lopez-Beltran's Letter to the Editor re: Gillian Vandekerkhove, Werner J. Struss, Matti Annala, et al. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. Eur Urol 2019;75:667–75: How Does Circulating DNA Reach the Blood Stream?","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Art history; Humanities; Gerontology; Art","score_opus":0.0072516703696241715,"score_gpt":0.22280908465704524,"score_spread":0.21555741428742106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946970690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74246687,0.004648645,0.00029582682,0.24732174,0.0020944818,0.0017512448,0.0011206542,0.00003264865,0.00026789546],"genre_scores_gemma":[0.6164712,0.0011917272,0.0003270787,0.37477028,0.005793981,0.000103036444,0.00034695622,0.00023496173,0.0007607977],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994362,0.0011708217,0.0008090939,0.001971359,0.00043180468,0.0012549434],"domain_scores_gemma":[0.99729043,0.00025854542,0.0006180898,0.0014575233,0.00016442625,0.00021098883],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015100079,0.0008862418,0.0008161978,0.0001361332,0.00032224503,0.0003992096,0.0008801624,0.00025723167,0.000023864004],"category_scores_gemma":[0.0003477467,0.00065753976,0.00019685876,0.00022708082,0.00035825287,0.00003698569,0.00075301155,0.0016406698,0.000010048534],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043624328,0.00011487501,0.03068881,0.00034967845,0.0005105204,0.0016185158,0.001310828,0.0035137865,0.020963583,0.0000046385817,0.93725437,0.0032341452],"study_design_scores_gemma":[0.0016324666,0.0004694714,0.055813666,0.00015946693,0.0003420636,0.0002865214,0.00011235755,0.0005154459,0.0007616299,0.00002742529,0.93884027,0.0010391867],"about_ca_topic_score_codex":0.0011914847,"about_ca_topic_score_gemma":0.0015398541,"teacher_disagreement_score":0.12744853,"about_ca_system_score_codex":0.000070875285,"about_ca_system_score_gemma":0.0002124064,"threshold_uncertainty_score":0.9995876},"labels":[],"label_agreement":null},{"id":"W2947107330","doi":"10.1016/j.eururo.2019.05.033","title":"Reply to Takeshi Takahashi's Letter to the Editor re: Bimal Bhindi, Christine M. Lohse, Phillip J. Schulte, et al. Predicting functional outcomes after partial and radical nephrectomy. Eur Urol 2019;75:766–72. Partial Nephrectomy: “Geocentrism” of the 21st century in the Church of Urology?","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Calgary","funders":"","keywords":"Medicine; Nephrectomy; Internal medicine; Kidney","score_opus":0.015809895396502717,"score_gpt":0.23703209143736773,"score_spread":0.22122219604086502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947107330","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1930192,0.0020589074,0.000061848485,0.7915882,0.007805074,0.0035318334,0.00044560968,0.00007854855,0.0014107719],"genre_scores_gemma":[0.32411838,0.0001090226,0.00007244701,0.6571191,0.017466104,0.0002064276,0.0003158387,0.00017063525,0.0004220541],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98950815,0.004476111,0.0016123096,0.0015859654,0.0014607584,0.0013567101],"domain_scores_gemma":[0.99444246,0.0024361988,0.0006953905,0.001993487,0.00021273312,0.00021971196],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0029443384,0.0009746563,0.0014327898,0.0004991459,0.0001891789,0.00008465857,0.0010677679,0.00057792244,0.00043374716],"category_scores_gemma":[0.001431304,0.0005367398,0.00055123353,0.0006581138,0.0007662109,0.00011942518,0.00074476574,0.0044691865,0.00016637173],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002869276,0.00020797036,0.104417086,0.00009868791,0.0003960318,0.0010622047,0.0009766577,0.000095782154,0.0002587865,0.000008539389,0.88910776,0.00050123065],"study_design_scores_gemma":[0.002348502,0.0011611328,0.24633817,0.000071434944,0.00045497314,0.00035640717,0.000030181249,0.000039428298,0.000048269878,0.0000013550831,0.74884284,0.00030731127],"about_ca_topic_score_codex":0.00014926256,"about_ca_topic_score_gemma":0.00002285738,"teacher_disagreement_score":0.14192109,"about_ca_system_score_codex":0.00011597668,"about_ca_system_score_gemma":0.000299444,"threshold_uncertainty_score":0.9997084},"labels":[],"label_agreement":null},{"id":"W2951459521","doi":"10.1016/j.eururo.2019.06.006","title":"Surgical Safety of Cytoreductive Nephrectomy Following Sunitinib: Results from the Multicentre, Randomised Controlled Trial of Immediate Versus Deferred Nephrectomy (SURTIME)","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre","funders":"Ipsen; European Society for Medical Oncology; Astellas Pharma; Eisai; GlaxoSmithKline; Pfizer; AstraZeneca; European Organisation for Research and Treatment of Cancer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Adverse effect; Common Terminology Criteria for Adverse Events; Nephrectomy; Kidney cancer; Surgery; Randomized controlled trial; Internal medicine; Kidney","score_opus":0.021642751848621408,"score_gpt":0.25962897743649965,"score_spread":0.23798622558787824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951459521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9462288,0.00052952307,0.000005868108,0.0005507917,0.001663867,0.004498967,0.000073724244,0.00004845986,0.046399996],"genre_scores_gemma":[0.99848044,0.00006770229,0.0001881199,0.00008446662,0.00053766434,0.00003141272,0.00023517697,0.00006488959,0.0003101338],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99454486,0.0026973728,0.0013281225,0.0005435181,0.00044858587,0.00043753028],"domain_scores_gemma":[0.9897145,0.008423694,0.0007120988,0.0008059688,0.00017542375,0.0001683302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014952992,0.00035084417,0.001542039,0.00011425912,0.00006167662,0.000009145593,0.0002882538,0.00011982148,0.00021458241],"category_scores_gemma":[0.0018760643,0.00022401252,0.00085803244,0.00020795286,0.0002145243,0.000053995933,0.00012793018,0.00037909314,0.00017436214],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9898946,0.0004435242,0.0010541935,0.0000077607,0.0018644308,0.0004414722,0.0011825751,0.00006919099,0.004186624,0.000029886383,0.0001615847,0.0006641515],"study_design_scores_gemma":[0.9745874,0.0031435888,0.0121546965,0.00003014037,0.0016308869,0.000017168117,0.00031479428,0.00017857703,0.0019809583,0.000007055182,0.005784394,0.00017034097],"about_ca_topic_score_codex":0.00016376826,"about_ca_topic_score_gemma":0.000008811044,"teacher_disagreement_score":0.05225163,"about_ca_system_score_codex":0.00007697958,"about_ca_system_score_gemma":0.00018416079,"threshold_uncertainty_score":0.91349655},"labels":[],"label_agreement":null},{"id":"W2959688418","doi":"10.1016/j.eururo.2019.06.032","title":"Incremental Utility of Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Quantifying the Relapse Risk Associated with Therapeutic Effect","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Nomogram; Bladder cancer; Cystectomy; Chemotherapy; Internal medicine; Oncology; Adjuvant; Proportional hazards model; Urology; Stage (stratigraphy); Cancer","score_opus":0.02131265361603766,"score_gpt":0.27833898707411386,"score_spread":0.2570263334580762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2959688418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906822,0.0015096356,0.000010339225,0.00050647603,0.000163977,0.0009453232,0.000032659835,0.00004083916,0.006108586],"genre_scores_gemma":[0.9978241,0.000402214,0.000008652876,0.0015020509,0.000049091825,0.000021748785,0.000016034599,0.000057622605,0.000118486154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771935,0.0010909993,0.00029382878,0.0003652215,0.00021392058,0.00031670855],"domain_scores_gemma":[0.99883455,0.00040980862,0.0002259589,0.0004227479,0.000053201085,0.00005375148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007369909,0.00022439488,0.00045989075,0.000072788374,0.00005516898,0.0000064042947,0.00015818278,0.00006432931,0.0005287322],"category_scores_gemma":[0.00007741354,0.000131346,0.00009849661,0.000224219,0.00016900367,0.000038885693,0.000042390224,0.00039057768,0.000054468743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019484687,0.00026068193,0.9737897,0.000031214164,0.000637534,0.00006173179,0.0012667985,0.000020448115,0.0052368217,0.00000810264,0.00009635109,0.016642166],"study_design_scores_gemma":[0.00845728,0.002783711,0.98479766,0.000070904855,0.00032559564,0.000013435334,0.000104691,0.00015910402,0.0025651017,0.000012499915,0.000591497,0.000118535994],"about_ca_topic_score_codex":0.0006195787,"about_ca_topic_score_gemma":0.0005271562,"teacher_disagreement_score":0.01652363,"about_ca_system_score_codex":0.000065652974,"about_ca_system_score_gemma":0.00010811612,"threshold_uncertainty_score":0.57892466},"labels":[],"label_agreement":null},{"id":"W2961268067","doi":"10.1016/j.eururo.2019.06.026","title":"Re: Joaquin Mateo, Karim Fizazi, Silke Gillessen, et al. Managing Nonmetastatic Castration-resistant Prostate Cancer. Eur Urol 2019:75:285–93","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Prostate cancer; Gynecology; San Joaquin; Cancer; Urology; Oncology; Internal medicine","score_opus":0.027174212522934563,"score_gpt":0.31210722580766087,"score_spread":0.2849330132847263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961268067","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00464461,0.007581656,0.00004890586,0.9495801,0.0016391088,0.0027900923,0.00095662207,0.00027707338,0.03248186],"genre_scores_gemma":[0.019522185,0.0061691385,0.0002612048,0.85658985,0.0016763464,0.00019059582,0.0049936944,0.0006382095,0.10995875],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99312663,0.0016567319,0.0010100909,0.0016491836,0.0009537599,0.0016036035],"domain_scores_gemma":[0.9970337,0.0004651146,0.0005793944,0.0014126891,0.0002604712,0.00024860364],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010386452,0.000979438,0.0012831731,0.0006161214,0.00023998739,0.00017337706,0.0005255431,0.00034677229,0.0012741077],"category_scores_gemma":[0.00012523108,0.0008129549,0.00032252824,0.00041299418,0.00038953742,0.00017181473,0.00037338448,0.0034236468,0.002711735],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010591008,0.00011058492,0.00065088645,0.0007687101,0.00075342524,0.023070164,0.0004801862,0.00014450017,0.0019586834,0.000022688548,0.9699461,0.0010349686],"study_design_scores_gemma":[0.0043537808,0.0016022959,0.0028105527,0.00028107717,0.0006385377,0.00028814975,0.00006157041,0.00013980671,0.00015560907,0.000044428503,0.9889082,0.0007160468],"about_ca_topic_score_codex":0.00033308732,"about_ca_topic_score_gemma":0.000076178316,"teacher_disagreement_score":0.0929902,"about_ca_system_score_codex":0.00030861585,"about_ca_system_score_gemma":0.00063500076,"threshold_uncertainty_score":0.99963886},"labels":[],"label_agreement":null},{"id":"W2961305810","doi":"10.1016/j.eururo.2019.06.027","title":"Hypospadias Prevalence and Trends in International Birth Defect Surveillance Systems, 1980–2010","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Urological Disorders and Treatments","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; Alberta Children's Hospital","funders":"Centers for Disease Control and Prevention; National Institutes of Health","keywords":"Medicine; Hypospadias; Obstetrics; Gynecology; Demography; Surgery","score_opus":0.014518457231062999,"score_gpt":0.2432105785498612,"score_spread":0.2286921213187982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961305810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9434995,0.0017825122,0.0000063488837,0.0006954484,0.00041098878,0.00013490045,0.000014483443,0.00003952004,0.053416323],"genre_scores_gemma":[0.9926792,0.0002518816,0.000023481893,0.0005789317,0.000048716975,0.0000038703747,0.000029156115,0.00001703564,0.006367758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998988,0.00022910726,0.00017160908,0.00032492942,0.00009104372,0.00019535041],"domain_scores_gemma":[0.9995881,0.00008300189,0.000052983607,0.00018740528,0.00002061624,0.00006792533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021149377,0.000116015726,0.00020532837,0.00014013087,0.000015000094,0.00001145914,0.00009158087,0.0000459829,0.00031799852],"category_scores_gemma":[0.00006084613,0.00008941493,0.00004240274,0.00010290576,0.00005683382,0.00003069919,0.00006813472,0.00015026929,0.00041104603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018506467,0.00011149982,0.9948146,0.000021814434,0.000046484074,0.00022089295,0.000050039027,0.0000182612,0.00008578616,0.00028469067,0.00021805023,0.0039428393],"study_design_scores_gemma":[0.0017724412,0.00071675814,0.9837725,0.000006096259,0.000016120166,0.000119543794,0.0000048621364,0.00032114558,7.4407563e-7,0.00001296921,0.013185534,0.00007128833],"about_ca_topic_score_codex":0.00003476867,"about_ca_topic_score_gemma":0.000016296804,"teacher_disagreement_score":0.04917969,"about_ca_system_score_codex":0.0000135600585,"about_ca_system_score_gemma":0.0000056823264,"threshold_uncertainty_score":0.5283302},"labels":[],"label_agreement":null},{"id":"W2962244197","doi":"10.1016/j.eururo.2019.06.018","title":"Treatment of Bladder Stones in Adults and Children: A Systematic Review and Meta-analysis on Behalf of the European Association of Urology Urolithiasis Guideline Panel","year":2019,"lang":"en","type":"review","venue":"European Urology","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cochrane; Health Sciences Centre; McMaster University","funders":"","keywords":"Medicine; Guideline; Meta-analysis; Urology; MEDLINE; Systematic review; Gynecology; Internal medicine; Pathology","score_opus":0.059223839941292364,"score_gpt":0.3223887929987649,"score_spread":0.2631649530574725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962244197","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009127528,0.9931056,0.000001425842,0.00080691715,0.000042895837,0.003403039,0.0004031782,0.000011718483,0.0013124826],"genre_scores_gemma":[0.021629177,0.9765649,0.00003301847,0.00075548055,0.00002890747,0.000050456445,0.00019527797,0.000087985216,0.0006548193],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98982483,0.006124178,0.0027022192,0.00072019536,0.0003299471,0.00029862957],"domain_scores_gemma":[0.9945586,0.00055772584,0.003330368,0.0012480736,0.00019785177,0.000107382104],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016088743,0.00063925143,0.009234636,0.0005282072,0.000029298837,0.000004383017,0.0002608505,0.0001940522,0.00006111578],"category_scores_gemma":[0.00068680017,0.00034110917,0.0019111597,0.00060780154,0.00015182176,0.000023011333,0.00015969746,0.00025771704,0.000021153135],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002538893,0.0028026525,0.013966336,0.5095312,0.45559183,0.00013113738,0.00090368465,0.000014449341,0.0000011689717,0.00013209126,0.00025061137,0.016420953],"study_design_scores_gemma":[0.0016903257,0.0020307666,0.021522889,0.0035819118,0.96297616,0.0002684769,0.000008582083,0.000005159267,4.014194e-7,0.0000019914855,0.0076936157,0.00021975],"about_ca_topic_score_codex":0.000093338924,"about_ca_topic_score_gemma":0.000008655009,"teacher_disagreement_score":0.5073843,"about_ca_system_score_codex":0.0000706028,"about_ca_system_score_gemma":0.00008069965,"threshold_uncertainty_score":0.9999041},"labels":[],"label_agreement":null},{"id":"W2963018021","doi":"10.1016/j.eururo.2019.07.013","title":"Re: Scientists Rise up Against Statistical Significance","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine","score_opus":0.3932360839177287,"score_gpt":0.49253349210319597,"score_spread":0.09929740818546728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963018021","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013223475,0.00018381282,0.33312854,0.3997219,0.02601019,0.0024088137,0.0033828653,0.0007883676,0.23424329],"genre_scores_gemma":[0.00033753418,0.00004229684,0.3340459,0.63576424,0.00898049,0.00003015929,0.00013082317,0.00044075237,0.020227818],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9819237,0.012231279,0.0019171941,0.0017969887,0.00089358713,0.0012372767],"domain_scores_gemma":[0.8958558,0.10099368,0.00086763053,0.0019000284,0.0002050883,0.00017779345],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.006754387,0.0007268542,0.0017515906,0.00022054296,0.00013798337,0.0001284957,0.0015970251,0.00094574934,0.0025639697],"category_scores_gemma":[0.14154164,0.00066375104,0.00030156737,0.00027278508,0.0012804965,0.00004573666,0.00063425326,0.0046031233,0.009470441],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008014771,0.000059140562,0.000024525487,0.0003031227,0.00010877028,0.0034365107,0.000040125993,0.0000015131387,0.000018390592,0.008436389,0.98243356,0.0050578183],"study_design_scores_gemma":[0.00083960884,0.00028096227,0.00012105609,0.000046284942,0.00022786978,0.000016757187,0.0000034230827,0.00007934285,0.000007847356,0.17119525,0.8265862,0.00059542037],"about_ca_topic_score_codex":0.0000028591724,"about_ca_topic_score_gemma":0.0000015237837,"teacher_disagreement_score":0.23604235,"about_ca_system_score_codex":0.00007213112,"about_ca_system_score_gemma":0.00017307106,"threshold_uncertainty_score":0.9995814},"labels":[],"label_agreement":null},{"id":"W2964161328","doi":"10.1016/j.eururo.2019.07.024","title":"Re: Comparison of Population-based Observational Studies with Randomized Trials in Oncology","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Observational study; Randomized controlled trial; Oncology; Internal medicine; Population; Environmental health","score_opus":0.12302848087532112,"score_gpt":0.3692032353075951,"score_spread":0.24617475443227396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964161328","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.188092,0.013581394,0.0015988698,0.7805834,0.0031598934,0.0037603755,0.0005581448,0.00003600178,0.008629979],"genre_scores_gemma":[0.48407406,0.000493356,0.0014251657,0.5042119,0.0027609915,0.00007683678,0.0063895034,0.00012233313,0.00044585022],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99404293,0.0037007392,0.001330592,0.0005091805,0.00015635096,0.00026019546],"domain_scores_gemma":[0.9914169,0.006673998,0.0012316045,0.0004586444,0.000197955,0.00002093001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028510974,0.0002933976,0.0022625858,0.00016115,0.00002600371,0.000008881969,0.000273973,0.00042172693,0.00003052489],"category_scores_gemma":[0.007578731,0.00023838942,0.00027818637,0.00008453882,0.0002116978,0.0000015082247,0.00011087372,0.0005057271,0.000013860178],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02362577,0.000117593605,0.016114293,0.00015939017,0.0006802845,0.00008945568,0.000118800985,0.01153887,0.00058103516,0.00008078046,0.9464102,0.0004835468],"study_design_scores_gemma":[0.05168562,0.0014121153,0.00255856,0.000043458214,0.00035838198,0.0000041598264,0.000029309911,0.00024347236,0.0002549821,0.00010866634,0.94291764,0.0003836579],"about_ca_topic_score_codex":0.000050888797,"about_ca_topic_score_gemma":0.00023419,"teacher_disagreement_score":0.29598206,"about_ca_system_score_codex":0.00005059979,"about_ca_system_score_gemma":0.00028179775,"threshold_uncertainty_score":0.97212386},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"methods","study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2967754426","doi":"10.1016/j.eururo.2019.07.053","title":"Medical Expulsive Therapy for Urinary Stones: Future Trends and Knowledge Gaps","year":2019,"lang":"en","type":"review","venue":"European Urology","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Boston Scientific Corporation","keywords":"Medicine; MEDLINE; Cochrane Library; Placebo; Meta-analysis; Clinical trial; Evidence-based medicine; Randomized controlled trial; Intensive care medicine; Surgery; Alternative medicine; Internal medicine; Pathology","score_opus":0.050685840031242525,"score_gpt":0.37391713460482595,"score_spread":0.3232312945735834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967754426","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000091223075,0.9789595,0.000005752761,0.001184524,0.001221229,0.0010120771,0.00009892868,0.00008299385,0.017343778],"genre_scores_gemma":[0.00007534865,0.9838388,0.00007209743,0.001465329,0.002662803,0.00010469305,0.0007082779,0.00021786743,0.010854777],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971074,0.0007055454,0.0006097781,0.00087454217,0.00020341466,0.0004993356],"domain_scores_gemma":[0.99818027,0.000327582,0.0002778602,0.00066442456,0.00007271094,0.00047716207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004347068,0.0006548178,0.0022380555,0.0003775415,0.00009501023,0.000014256921,0.00028842455,0.0005222793,0.00044859236],"category_scores_gemma":[0.00011024242,0.00043205154,0.0006389798,0.00020330983,0.00017198604,0.000030619773,0.00018639093,0.0006335603,0.00045277498],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002225557,0.0005010896,0.000081606995,0.0037295327,0.0006862836,0.00052649603,0.00021892918,4.5871236e-9,1.1616229e-7,0.00014142947,0.01183641,0.98205554],"study_design_scores_gemma":[0.0035108044,0.0033626002,0.0014700177,0.0009110138,0.00165152,0.0043618516,0.000017409882,0.0000023523792,5.4046332e-8,0.0000049159903,0.9843949,0.00031256923],"about_ca_topic_score_codex":0.000001350858,"about_ca_topic_score_gemma":2.9259982e-7,"teacher_disagreement_score":0.981743,"about_ca_system_score_codex":0.000045272525,"about_ca_system_score_gemma":0.00038480308,"threshold_uncertainty_score":0.99981314},"labels":[],"label_agreement":null},{"id":"W2969494022","doi":"10.1016/j.eururo.2019.07.051","title":"Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Prostate cancer; Biopsy; Interquartile range; Internal medicine; Prostatectomy; Carcinoma; Grading (engineering); Cribriform; Perineural invasion; Confidence interval; Urology; Oncology; Cancer","score_opus":0.010415142038790676,"score_gpt":0.23145273512258277,"score_spread":0.2210375930837921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969494022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929326,0.0021929955,0.0000036266003,0.003345298,0.00013686318,0.0007139534,0.00004158011,0.000011178281,0.00062190613],"genre_scores_gemma":[0.99801195,0.00085819484,0.000030489236,0.0008631951,0.000059771373,0.000038638493,0.000082231694,0.000021646309,0.000033907083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908096,0.00014855979,0.00023974787,0.00025800962,0.00008132875,0.00019138874],"domain_scores_gemma":[0.99950486,0.00007841896,0.00014544734,0.00019079873,0.00003321313,0.00004726812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023630363,0.0001288596,0.00022097609,0.00007196962,0.000026264432,0.0000105724575,0.00007244774,0.00003020646,0.000020587544],"category_scores_gemma":[0.000022927534,0.00008699418,0.00003031558,0.000104296574,0.00010328497,0.000073300514,0.000041729858,0.00014520738,0.000010606368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028449457,0.00017198847,0.927576,0.00010815254,0.00005229326,0.000116651645,0.0031666716,0.000004582153,0.06289585,0.00044227263,0.0017937997,0.003387262],"study_design_scores_gemma":[0.0039575095,0.0026294428,0.980181,0.000040449933,0.00010684677,0.00019498605,0.00040513952,0.00021793916,0.010329557,0.00024076189,0.0015385284,0.00015784262],"about_ca_topic_score_codex":0.00030225058,"about_ca_topic_score_gemma":0.000060563514,"teacher_disagreement_score":0.052605014,"about_ca_system_score_codex":0.000045456225,"about_ca_system_score_gemma":0.000046979934,"threshold_uncertainty_score":0.35475197},"labels":[],"label_agreement":null},{"id":"W2969650566","doi":"10.1016/j.eururo.2019.07.040","title":"The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management","year":2019,"lang":"en","type":"review","venue":"European Urology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prevention of Organ Failure; BC Cancer Agency; Decipher Biosciences (Canada); University of British Columbia","funders":"U.S. Food and Drug Administration; Mitacs; Terry Fox Foundation; Prostate Cancer Canada","keywords":"Medicine; Prostate cancer; Disease; Prostate; Long non-coding RNA; Cancer; Non-coding RNA; Prostate disease; Tumor progression; Bioinformatics; Oncology; RNA; Pathology; Internal medicine; Gene; Genetics","score_opus":0.04539148258551831,"score_gpt":0.3938536142493695,"score_spread":0.3484621316638512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969650566","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019835287,0.99478704,0.0002304864,0.00006419289,0.00028828255,0.0015916894,0.00003402462,0.0000059267136,0.0010148344],"genre_scores_gemma":[0.097539246,0.9018914,0.00001547462,0.000036526977,0.00008838879,0.0001265941,0.00006976887,0.00004638953,0.00018621616],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99615747,0.0017921529,0.0008182776,0.0006929252,0.00017811997,0.00036106617],"domain_scores_gemma":[0.9988665,0.00006838763,0.00038531452,0.0004995841,0.00009179331,0.00008839611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001697734,0.00023736872,0.0004996167,0.00013998813,0.000051750765,0.000017911487,0.0003961007,0.0001584665,0.000009420044],"category_scores_gemma":[0.00025280952,0.00018684569,0.00013552062,0.00026524035,0.00013876271,0.000005715766,0.00060485624,0.00048688543,0.000010293626],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034208465,0.00009531072,0.00085456274,0.0032718868,0.0001073227,0.00015168979,0.00002478851,0.000040219307,0.000041150226,0.00020293606,0.00010636183,0.9947617],"study_design_scores_gemma":[0.0017004359,0.0004028208,0.020588476,0.0030142455,0.00030326794,0.000016935765,0.000023399023,0.00036471742,0.000038703038,0.00005220453,0.97298735,0.0005074582],"about_ca_topic_score_codex":0.0000060166467,"about_ca_topic_score_gemma":0.00010705733,"teacher_disagreement_score":0.99425423,"about_ca_system_score_codex":0.00008914284,"about_ca_system_score_gemma":0.00034763623,"threshold_uncertainty_score":0.7619346},"labels":[],"label_agreement":null},{"id":"W2969712092","doi":"10.1016/j.eururo.2019.07.048","title":"First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Hospital; Queen Elizabeth II Health Sciences Centre; CancerCare Manitoba; University of Calgary","funders":"National Cancer Institute; Foundation Medicine; Pfizer Japan; Novartis Pharma; EMD Serono; Genentech; Ipsen; Alexion Pharmaceuticals; Eisai; National Comprehensive Cancer Network; Sanofi; Exelixis; GlaxoSmithKline; Astellas Pharma; Celldex Therapeutics; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Metastasis; Carcinoma; Cancer","score_opus":0.03263677506092706,"score_gpt":0.26286220185634424,"score_spread":0.2302254267954172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969712092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96069854,0.0032947443,0.00014815934,0.008544776,0.0008177896,0.0013482947,0.0003738864,0.000065577915,0.02470824],"genre_scores_gemma":[0.9909528,0.0001987306,0.0010960199,0.0024738899,0.00018359479,0.000052341973,0.0023278943,0.00010971587,0.0026050233],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99457407,0.0018953362,0.0013021632,0.0010426297,0.00055077055,0.00063502026],"domain_scores_gemma":[0.9953083,0.0021807905,0.00066799845,0.0014292648,0.00023727851,0.00017640146],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017331628,0.00053176004,0.00084552425,0.0003597005,0.00012517394,0.000050211715,0.00071863475,0.0000857349,0.0006929453],"category_scores_gemma":[0.00037330997,0.00038773502,0.00023395865,0.0003323891,0.00029256035,0.0001723119,0.00042454287,0.00073148194,0.001125038],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044422325,0.016746003,0.2973049,0.00061731547,0.002975732,0.037891604,0.03154795,0.0047378517,0.5061282,0.0017709917,0.047770947,0.008086187],"study_design_scores_gemma":[0.081935294,0.011349012,0.7313468,0.00011100681,0.0021874823,0.0010290392,0.0018625802,0.007039044,0.035877828,0.0005740468,0.12543544,0.0012524588],"about_ca_topic_score_codex":0.0011030366,"about_ca_topic_score_gemma":0.0003859098,"teacher_disagreement_score":0.47025037,"about_ca_system_score_codex":0.00035224896,"about_ca_system_score_gemma":0.0002683061,"threshold_uncertainty_score":0.9998574},"labels":[],"label_agreement":null},{"id":"W2972160710","doi":"10.1016/j.eururo.2019.08.021","title":"Do Not Learn a Technique, Learn the Biology Underlying the Disease: Techniques Evolve, Biology Prevails","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Disease; Bladder cancer; Cancer; Pathology; Internal medicine","score_opus":0.03733691755352884,"score_gpt":0.3213158959399568,"score_spread":0.28397897838642794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972160710","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3053805,0.018550279,0.009906806,0.08802186,0.002396486,0.014471482,0.00021553566,0.0026907844,0.5583663],"genre_scores_gemma":[0.98570025,0.0003631718,0.00026530167,0.008731695,0.0002659167,0.00016090293,0.000039644317,0.00008535308,0.0043877824],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99717015,0.0012170662,0.00033940256,0.00061114953,0.00012007255,0.0005421743],"domain_scores_gemma":[0.99824363,0.00031547484,0.00014880116,0.0010823697,0.000081690654,0.00012805744],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007892446,0.00030389428,0.0003768999,0.0001159616,0.00021707088,0.000028176184,0.00052185624,0.00013560322,0.00076895347],"category_scores_gemma":[0.00016285735,0.00016024499,0.00018364406,0.0002123465,0.00052259595,0.00004508739,0.0002735062,0.0006631303,0.0009217437],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061727325,0.0010935845,0.33163226,0.0003028916,0.0018338766,0.0005672071,0.0019381086,0.000022318354,0.22489646,0.05221688,0.025562463,0.35376123],"study_design_scores_gemma":[0.0015027398,0.0031143248,0.099525794,0.00004300539,0.0004033865,0.00028258676,0.00008664161,0.000033240463,0.0013949919,0.0030228992,0.8902498,0.00034062026],"about_ca_topic_score_codex":0.000050011007,"about_ca_topic_score_gemma":0.0000043771734,"teacher_disagreement_score":0.8646873,"about_ca_system_score_codex":0.00005008549,"about_ca_system_score_gemma":0.00012687652,"threshold_uncertainty_score":0.9998562},"labels":[],"label_agreement":null},{"id":"W2972166775","doi":"10.1016/j.eururo.2019.08.025","title":"Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":246,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research; Cancer Research UK; Royal Marsden NHS Foundation Trust","keywords":"Medicine; Hazard ratio; Relative risk; Confidence interval; Internal medicine; Prospective cohort study; Cohort; Population; Cohort study; Incidence (geometry); Family history; Prostate cancer; Gynecology; Cancer; Demography","score_opus":0.011422687126125505,"score_gpt":0.2845935823316915,"score_spread":0.27317089520556603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972166775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925968,0.0008083163,0.000296898,0.0001754617,0.00036938384,0.0021505118,0.00006882811,0.000019994339,0.0035137807],"genre_scores_gemma":[0.99638534,0.00006455996,0.00025689727,0.00041691845,0.00022117356,0.0003523843,0.00007185803,0.000054530203,0.0021763586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998709,0.0001899418,0.00018493886,0.00060641626,0.00007773794,0.00023194117],"domain_scores_gemma":[0.99936956,0.00002068161,0.000104890896,0.00030832647,0.00014412406,0.00005239733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035483798,0.00015221848,0.0001523023,0.000045075445,0.00008407784,0.000025153291,0.00012466313,0.00005797052,0.000062552266],"category_scores_gemma":[0.000073316136,0.00015347169,0.000038357448,0.000067526715,0.00009007216,0.0000058232595,0.00010431459,0.00009064767,0.000033179735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037587906,0.0000789829,0.9723112,0.000019614774,0.00030038194,0.000012197804,0.0013723968,0.00080175855,0.019570677,0.000032317137,0.0015835635,0.0035410437],"study_design_scores_gemma":[0.002959317,0.0022410506,0.9548022,0.0000033391866,0.000129296,0.000063415355,0.000592494,0.00019832153,0.0040574335,0.000072738825,0.03457914,0.0003012169],"about_ca_topic_score_codex":0.000045422832,"about_ca_topic_score_gemma":0.0001029219,"teacher_disagreement_score":0.032995574,"about_ca_system_score_codex":0.000045001303,"about_ca_system_score_gemma":0.000093870905,"threshold_uncertainty_score":0.6258394},"labels":[],"label_agreement":null},{"id":"W2973334574","doi":"10.1016/j.eururo.2019.09.005","title":"The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging–targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Magnetic resonance imaging; Prostatectomy; Prostate cancer; Concomitant; Biopsy; Radiology; Prostate; Urology; Cancer; Internal medicine","score_opus":0.006468932185677394,"score_gpt":0.22292059511162648,"score_spread":0.21645166292594908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973334574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84621376,0.14913116,0.0000030756853,0.000800877,0.00017835558,0.0034657218,0.00012972543,0.000019985988,0.00005732076],"genre_scores_gemma":[0.9922849,0.0068997554,0.00014369751,0.00024026968,0.00001484942,0.00029028393,0.000014655004,0.00003085132,0.000080725964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980256,0.0004503699,0.0005977396,0.00040610507,0.00019298568,0.00032720942],"domain_scores_gemma":[0.99770945,0.0014966362,0.0002838337,0.0002992669,0.00014742336,0.000063411106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005688378,0.0002154301,0.00049208483,0.00011455121,0.000094212664,0.000013581246,0.00011972978,0.000034151628,0.0000045082975],"category_scores_gemma":[0.00068099005,0.00012061919,0.00005783628,0.00023372445,0.0006209271,0.000049921033,0.00010427386,0.00019003848,0.0000011814459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016110896,0.0002003911,0.98779064,0.001387232,0.000020728992,0.000041325136,0.000909667,0.000021518592,0.00033123037,0.00019996142,0.00010230126,0.007383921],"study_design_scores_gemma":[0.009414422,0.0029097975,0.98111117,0.00087189255,0.00017879902,0.000037481208,0.00021190285,0.0043143416,0.0001656876,0.00006700477,0.00061971723,0.000097758966],"about_ca_topic_score_codex":0.000047915808,"about_ca_topic_score_gemma":0.000018003271,"teacher_disagreement_score":0.14607114,"about_ca_system_score_codex":0.000061692495,"about_ca_system_score_gemma":0.00006243463,"threshold_uncertainty_score":0.49187076},"labels":[],"label_agreement":null},{"id":"W2973483382","doi":"10.1016/j.eururo.2019.08.031","title":"An Opioid Prescription for Men Undergoing Minor Urologic Surgery Is Associated with an Increased Risk of New Persistent Opioid Use","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Western University","keywords":"Medicine; Opioid; Medical prescription; Opioid use disorder; Opioid abuse; Anesthesia; Internal medicine; Pharmacology","score_opus":0.025772559957018923,"score_gpt":0.24190331301961912,"score_spread":0.2161307530626002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973483382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99670416,0.00028328729,0.0001567534,0.00026375894,0.00014927247,0.0011580485,0.000097417695,0.00013747509,0.0010498345],"genre_scores_gemma":[0.9957527,0.00010583904,0.00093922694,0.001359754,0.00009746286,0.000016863702,0.00071817863,0.000098538614,0.00091142213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749535,0.0007594382,0.00042722843,0.00063970353,0.00022667457,0.00045160315],"domain_scores_gemma":[0.99788797,0.000540745,0.00040072252,0.00073456415,0.00016266208,0.00027334678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005548192,0.0002997073,0.00060017843,0.00020587567,0.00007748968,0.00002728557,0.00016447727,0.0001205318,0.00017066661],"category_scores_gemma":[0.0004490691,0.0002449826,0.00022202801,0.00014964482,0.00007631559,0.00021193501,0.000044404234,0.00018447322,0.00005652908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005831967,0.0015805745,0.9805442,0.00011443162,0.0010859699,0.000070155475,0.0029870537,0.00024700628,0.0031658825,0.00004119713,0.0031861125,0.0011454691],"study_design_scores_gemma":[0.006024946,0.013539828,0.9729379,0.000047524987,0.0013640318,0.000034706867,0.00045511525,0.002486008,0.00032481586,0.000057302022,0.0024377839,0.00029006714],"about_ca_topic_score_codex":0.0005040232,"about_ca_topic_score_gemma":0.00006146826,"teacher_disagreement_score":0.011959254,"about_ca_system_score_codex":0.00008417205,"about_ca_system_score_gemma":0.00028197552,"threshold_uncertainty_score":0.9990101},"labels":[],"label_agreement":null},{"id":"W2974215038","doi":"10.1016/j.eururo.2019.08.019","title":"Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Jewish General Hospital; Institute of Cancer Research","funders":"National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Prostate-specific antigen; Interim; Mutation; Oncology; Prostate; Internal medicine; Gynecology; Cancer; Genetics","score_opus":0.0811281474935512,"score_gpt":0.3533391881580847,"score_spread":0.2722110406645335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974215038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935387,0.0015481892,0.00009446846,0.0018733363,0.00020749739,0.0021236253,0.0000934195,0.00003171629,0.0004890746],"genre_scores_gemma":[0.998739,0.00020100446,0.000121590754,0.0005150102,0.00013388444,0.000048241232,0.00014674422,0.00003537038,0.000059154987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985228,0.0003300841,0.00033405292,0.00044459233,0.00010731543,0.00026111148],"domain_scores_gemma":[0.9986671,0.0006632516,0.00012937517,0.00041138675,0.00006294963,0.000065932974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006569739,0.00015089886,0.00024432671,0.00006029789,0.00004972183,0.000029324547,0.0001318498,0.000025227042,0.000044046363],"category_scores_gemma":[0.00027318142,0.0000967911,0.00007586656,0.00012465446,0.00004870458,0.00008276703,0.000062253945,0.00015504808,0.000086490225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010736678,0.00029668945,0.9322708,0.000009207174,0.0002429192,0.00044157528,0.013818096,0.0009999264,0.0017450998,0.0000069065777,0.0031636772,0.036268387],"study_design_scores_gemma":[0.006165849,0.0051374524,0.98222065,0.0000923032,0.000040744293,0.000008783389,0.00095733546,0.00033819818,0.00020373853,0.000016466416,0.0047263107,0.00009219809],"about_ca_topic_score_codex":0.00065877504,"about_ca_topic_score_gemma":0.00007940781,"teacher_disagreement_score":0.04994978,"about_ca_system_score_codex":0.00007760711,"about_ca_system_score_gemma":0.000050246133,"threshold_uncertainty_score":0.3947026},"labels":[],"label_agreement":null},{"id":"W2974579064","doi":"10.1016/j.eururo.2019.08.034","title":"Androgen Receptor Modulation Optimized for Response—Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor Splice Variant-7–expressing Metastatic Castration-resistant Prostate Cancer","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Enzalutamide; Prostate cancer; Medicine; Androgen receptor; Androgen deprivation therapy; Internal medicine; Oncology; Clinical endpoint; Circulating tumor cell; Androgen; Docetaxel; Urology; Randomized controlled trial; Cancer research; Cancer; Metastasis; Hormone","score_opus":0.04215919260931933,"score_gpt":0.3414474701722842,"score_spread":0.2992882775629649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974579064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871427,0.0014714727,0.0007708204,0.0012799172,0.0006803672,0.0076480852,0.00038543862,0.000055560235,0.00056564726],"genre_scores_gemma":[0.98995245,0.0006152641,0.0066108503,0.000120943005,0.00023605456,0.00068588834,0.00051478785,0.00011756626,0.001146191],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947075,0.0025676389,0.0010630741,0.00070700137,0.00036630806,0.0005884265],"domain_scores_gemma":[0.99680823,0.0017404116,0.0005182299,0.0004929658,0.00025812932,0.00018202585],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034302557,0.00034629626,0.0012254495,0.00037115568,0.00010046211,0.000027645952,0.00018217172,0.000103704144,0.00042733544],"category_scores_gemma":[0.0009067261,0.0002846009,0.00024321265,0.00033638102,0.00020699874,0.00018914731,0.000069351794,0.00027548714,0.000045587174],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7759287,0.0005080666,0.000017545808,0.000130064,0.0005157098,0.00010647445,0.0013715561,0.00068938674,0.21886395,0.000025800515,0.00014747406,0.0016952956],"study_design_scores_gemma":[0.97160506,0.00586003,0.000064668544,0.00013220732,0.0005641953,0.000025118848,0.00013929361,0.008070175,0.009915848,0.000025624246,0.003326315,0.00027147497],"about_ca_topic_score_codex":0.00012416493,"about_ca_topic_score_gemma":0.00001819841,"teacher_disagreement_score":0.20894809,"about_ca_system_score_codex":0.00020096872,"about_ca_system_score_gemma":0.00046522697,"threshold_uncertainty_score":0.9999606},"labels":[],"label_agreement":null},{"id":"W2975497362","doi":"10.1016/j.eururo.2019.09.006","title":"A Consensus Molecular Classification of Muscle-invasive Bladder Cancer","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1360,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; University Health Network; Mount Sinai Hospital; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Human Genome Research Institute; Novo Nordisk Fonden; Cancerfonden","keywords":"Medicine; Bladder cancer; Clinical trial; Disease; Bioinformatics; Computational biology; Oncology; Internal medicine; Cancer; Biology","score_opus":0.022014076230808866,"score_gpt":0.280815197036909,"score_spread":0.2588011208061001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975497362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9022064,0.0006806442,0.0000396698,0.0016964416,0.00023777803,0.0003376396,0.000020431322,0.00003880691,0.09474218],"genre_scores_gemma":[0.99644965,0.00006580104,0.000111224006,0.0020860755,0.0000782611,0.000009726361,0.00001684604,0.000038685917,0.0011437592],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990623,0.00016348893,0.00020921932,0.00026642237,0.000119595265,0.00017897731],"domain_scores_gemma":[0.9993189,0.000057420646,0.000105491796,0.00034083994,0.00010397584,0.00007334693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087894885,0.00011783193,0.00022655289,0.00007085686,0.000015503874,0.0000027905166,0.000074386466,0.0000463076,0.00080870034],"category_scores_gemma":[0.000045886576,0.000101983605,0.00007819097,0.00009683522,0.00009269811,0.000011695435,0.000030354038,0.00011410576,0.0005130194],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075248274,0.00036860284,0.09786865,0.00012867477,0.00065630017,0.0004553102,0.00078614673,0.00006997757,0.8785426,0.0016643186,0.0036145893,0.0150923515],"study_design_scores_gemma":[0.004995829,0.0016891382,0.9413806,0.00003937604,0.00047783705,0.00010399923,0.00011845236,0.00009971888,0.019218504,0.00010609704,0.0315642,0.00020620285],"about_ca_topic_score_codex":0.00004946866,"about_ca_topic_score_gemma":0.000008447407,"teacher_disagreement_score":0.8593241,"about_ca_system_score_codex":0.000026031967,"about_ca_system_score_gemma":0.00012525746,"threshold_uncertainty_score":0.8854702},"labels":[],"label_agreement":null},{"id":"W2978125439","doi":"10.1016/j.eururo.2019.09.025","title":"Effect of Renal Mass Biopsy on Subsequent Nephrectomy Outcomes: A Population-based Assessment","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Renal mass; Nephrectomy; Urology; Biopsy; Renal biopsy; Population; Nephrology; Kidney; Surgery; Internal medicine","score_opus":0.012767852949447194,"score_gpt":0.28373416983982674,"score_spread":0.27096631689037953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978125439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705397,0.000038305963,0.00013064506,0.0005506557,0.0002504266,0.00074064336,0.0000069944826,0.000066032735,0.027676623],"genre_scores_gemma":[0.99793065,0.0000011513795,0.00055112696,0.0007539592,0.000056846944,0.000013841756,0.0001230195,0.000052666834,0.000516733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779004,0.00089084986,0.00036415568,0.00038071047,0.00030357038,0.00027068463],"domain_scores_gemma":[0.99859697,0.00045919413,0.00017799098,0.00060499774,0.000042416672,0.00011845467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005883935,0.00024612105,0.00053276616,0.0002056219,0.000024404717,0.000006468606,0.000113335875,0.000056177814,0.00039841523],"category_scores_gemma":[0.00006820175,0.00016960164,0.00021312796,0.00012486268,0.000037310485,0.00001846846,0.000028467031,0.00021831375,0.0005858977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011842275,0.00016619502,0.97242,0.000104721206,0.00014932781,0.00053866755,0.000016626325,0.0007708232,0.023409834,0.00016257662,0.00006897232,0.0010080589],"study_design_scores_gemma":[0.005063053,0.009567821,0.97777355,0.00003213495,0.00021168223,0.000048129186,0.0000018284126,0.0005076295,0.005678259,0.0000070099645,0.0009810595,0.00012785941],"about_ca_topic_score_codex":0.00003783918,"about_ca_topic_score_gemma":0.0000010136492,"teacher_disagreement_score":0.027390981,"about_ca_system_score_codex":0.00015323712,"about_ca_system_score_gemma":0.00005286716,"threshold_uncertainty_score":0.7530725},"labels":[],"label_agreement":null},{"id":"W2978420585","doi":"10.1016/j.eururo.2019.08.035","title":"Response of Primary Renal Cell Carcinoma to Systemic Therapy","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; University of Ottawa","funders":"Dana-Farber/Harvard Cancer Center; Pfizer","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Response Evaluation Criteria in Solid Tumors; Systemic therapy; Primary tumor; Internal medicine; Targeted therapy; Oncology; Population; Kidney cancer; Clinical trial; Surgery; Urology; Phases of clinical research; Cancer; Kidney; Metastasis","score_opus":0.01792994027894139,"score_gpt":0.22405420465918482,"score_spread":0.20612426438024345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978420585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93708587,0.0012260121,0.000022310362,0.0004923001,0.00016653787,0.00063332636,0.000005215486,0.000040374314,0.06032808],"genre_scores_gemma":[0.99177074,0.000016040382,0.00023926723,0.0022629779,0.000080805155,0.0000060472776,0.000012889211,0.000057917296,0.005553339],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99797106,0.0008715573,0.0003342322,0.00035979334,0.00019415257,0.00026922862],"domain_scores_gemma":[0.9987777,0.00018155495,0.00011114621,0.00069029874,0.00008235732,0.00015693769],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00064387463,0.00017425246,0.00040847473,0.00018954276,0.000017337208,0.000003843173,0.00016268394,0.000048616002,0.00021149774],"category_scores_gemma":[0.000035271223,0.00013773091,0.00011565061,0.00013993806,0.000043454304,0.000018563629,0.00008825409,0.00014379238,0.0019798968],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012191878,0.00015191617,0.0626434,0.00006850017,0.00003494206,0.00066056196,0.0005850307,0.000034670713,0.9209707,0.000014431135,0.0017188312,0.0009251352],"study_design_scores_gemma":[0.0036980254,0.008621403,0.89298475,0.000021298856,0.00004928978,0.00053316454,0.00003158526,0.0000063099183,0.07702592,0.0000018786963,0.01688996,0.00013644704],"about_ca_topic_score_codex":0.000010062165,"about_ca_topic_score_gemma":1.8771263e-7,"teacher_disagreement_score":0.8439448,"about_ca_system_score_codex":0.00008750698,"about_ca_system_score_gemma":0.00010445569,"threshold_uncertainty_score":0.9987972},"labels":[],"label_agreement":null},{"id":"W2979747184","doi":"10.1016/j.eururo.2019.08.039","title":"Re: Jack R. Andrews, Thomas Atwell, Grant Schmit, et al. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2019;76:244–51","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Nephrectomy; Percutaneous; Urology; Renal mass; Ablation; General surgery; Surgery; Kidney; Internal medicine","score_opus":0.03850725037447998,"score_gpt":0.28208693566071097,"score_spread":0.24357968528623097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979747184","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19801585,0.005028055,0.0005785415,0.76327515,0.0032956756,0.0061722137,0.00021045234,0.0004897787,0.022934262],"genre_scores_gemma":[0.13535178,0.0004062273,0.0028765758,0.84328544,0.0021447674,0.00012817288,0.0024132996,0.0004912844,0.012902432],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940418,0.0015988004,0.00099644,0.0016409726,0.00061211747,0.0011098661],"domain_scores_gemma":[0.9965746,0.0014521987,0.00057179085,0.0010546489,0.0001356788,0.00021112281],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010950953,0.001003926,0.0017026645,0.00038150305,0.00020674529,0.00010927525,0.00035682245,0.0007124003,0.00012557274],"category_scores_gemma":[0.00041529632,0.0007984968,0.00073393167,0.00015043408,0.00019714853,0.00013118803,0.00026745375,0.0021003508,0.00049891346],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009427788,0.00013114119,0.014918239,0.00016423038,0.00087434566,0.024889328,0.00019808233,0.000050661776,0.0014747037,0.00001547017,0.9555644,0.0007766466],"study_design_scores_gemma":[0.004681479,0.0042198463,0.012748507,0.0000621688,0.0016886942,0.0023118893,0.000014948716,0.00020854527,0.000058813912,0.000046314326,0.9732779,0.0006808936],"about_ca_topic_score_codex":0.000049382117,"about_ca_topic_score_gemma":0.000018378782,"teacher_disagreement_score":0.080010295,"about_ca_system_score_codex":0.00021213848,"about_ca_system_score_gemma":0.00021731661,"threshold_uncertainty_score":0.9994466},"labels":[],"label_agreement":null},{"id":"W2980951417","doi":"10.1016/j.eururo.2019.08.001","title":"Re: Adam C. Calaway, Lawrence H. Einhorn, Timothy A. Masterson, Richard S. Foster, Clint Cary. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer. Eur Urol 2019;76:607–9","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Retroperitoneal lymph node dissection; Dissection (medical); Testicular cancer; Lymph node; General surgery; Cancer; Surgery; Pathology; Internal medicine","score_opus":0.010848384422667052,"score_gpt":0.2280631505010881,"score_spread":0.21721476607842105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980951417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9475372,0.0012511987,0.00012054297,0.041901328,0.0019107601,0.0031041056,0.00095665787,0.0006021005,0.002616096],"genre_scores_gemma":[0.90777,0.000073828225,0.00016910477,0.07874399,0.001066004,0.00010000496,0.006397711,0.0005790316,0.0051003215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941809,0.001056993,0.000822916,0.0016773419,0.0010588346,0.0012029691],"domain_scores_gemma":[0.9966123,0.00035768506,0.00090468687,0.0012192416,0.0005053578,0.00040069618],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002023351,0.0011765226,0.0016516637,0.00025787373,0.00020075293,0.000062941595,0.00039863552,0.00059882406,0.00025971272],"category_scores_gemma":[0.00029871077,0.0008184066,0.00037765608,0.00037433446,0.00045539407,0.00015798293,0.0002377464,0.0015730312,0.00035843355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010158899,0.0006847388,0.91190135,0.00015351902,0.001699121,0.022618104,0.00008125325,0.0007726683,0.0000020580765,4.2019855e-7,0.06088144,0.0001894409],"study_design_scores_gemma":[0.011373318,0.0032852916,0.9640901,0.00050540175,0.0046086907,0.00020775829,0.000014887527,0.00034575938,0.0000012558909,8.450889e-7,0.0146674,0.0008992954],"about_ca_topic_score_codex":0.00039708082,"about_ca_topic_score_gemma":0.00009351147,"teacher_disagreement_score":0.05218875,"about_ca_system_score_codex":0.00048010747,"about_ca_system_score_gemma":0.00028834643,"threshold_uncertainty_score":0.99942666},"labels":[],"label_agreement":null},{"id":"W2980955535","doi":"10.1016/j.eururo.2019.09.036","title":"Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Prostate Cancer Foundation","keywords":"Medicine; Prostate cancer; Oncology; Internal medicine; Metastasis; Cancer; Prostate; Androgen deprivation therapy; Androgen receptor; Cancer research","score_opus":0.030672605083990775,"score_gpt":0.3691256600384133,"score_spread":0.3384530549544225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980955535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97514355,0.0009681207,0.0000021876258,0.003748956,0.0007500962,0.00091202796,0.000022119046,0.00006561846,0.018387336],"genre_scores_gemma":[0.97685957,0.0019176601,0.000068065216,0.0020324616,0.00012522847,0.000033631062,0.000028483348,0.000054093576,0.018880809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782103,0.00041379154,0.0004963433,0.0005295843,0.00021887799,0.00052037],"domain_scores_gemma":[0.99905974,0.00016847801,0.000096669544,0.00043112732,0.00005460241,0.00018940595],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00051441614,0.00018986347,0.0004927054,0.00014035894,0.00002964287,0.000009934954,0.00015329952,0.000068488705,0.00057740323],"category_scores_gemma":[0.00011793413,0.00013493339,0.00012179209,0.00010876053,0.00012671841,0.00005711003,0.0001492042,0.0005385665,0.0012566785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00197083,0.00036529827,0.96469736,0.00003238622,0.00009433065,0.0018713626,0.0001936797,0.000044230303,0.0026823522,0.000028530625,0.00015508535,0.027864529],"study_design_scores_gemma":[0.010813367,0.0015694146,0.94751966,0.000032688138,0.000045421166,0.000026948623,0.000052553096,0.000061807455,0.00033325565,0.00003162886,0.039350394,0.00016284094],"about_ca_topic_score_codex":0.000049883598,"about_ca_topic_score_gemma":0.000086013366,"teacher_disagreement_score":0.03919531,"about_ca_system_score_codex":0.00008015681,"about_ca_system_score_gemma":0.00014067031,"threshold_uncertainty_score":0.99952096},"labels":[],"label_agreement":null},{"id":"W2981212934","doi":"10.1016/j.eururo.2019.09.024","title":"Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma Europe; Astellas Pharma","keywords":"Mirabegron; Medicine; Overactive bladder; Tolterodine; Nocturia; Solifenacin; Urology; Placebo; Adverse effect; Internal medicine; Urination; Clinical trial; Urinary system","score_opus":0.033552578589041475,"score_gpt":0.35026656042758064,"score_spread":0.31671398183853916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981212934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99570185,0.00009713581,0.00015250852,0.00007947135,0.00009679369,0.0010109374,0.00040788372,0.000013406697,0.0024400088],"genre_scores_gemma":[0.99839234,0.00023536384,0.0003018655,0.00009172231,0.000039117982,0.0000015506434,0.0005719764,0.000035452882,0.0003305786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99638194,0.0014610799,0.0010053349,0.0004990299,0.00033931097,0.0003133225],"domain_scores_gemma":[0.99661946,0.0017071362,0.00050461,0.00063557585,0.0003890151,0.00014419248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018916945,0.00019729407,0.0011144854,0.0003972533,0.000028609309,0.0000043906375,0.00016854165,0.000091639624,0.0009050617],"category_scores_gemma":[0.0010697502,0.00013317389,0.00016861464,0.0007098047,0.0003085143,0.000090026246,0.0002385187,0.0005001949,0.000012604883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46542904,0.0024548594,0.5240641,0.00012023081,0.0036827875,0.00005695796,0.0007658651,0.00001545239,0.00021758105,0.00002095283,0.00018756682,0.0029845568],"study_design_scores_gemma":[0.09098237,0.014909818,0.88858473,0.000054947806,0.001755131,0.000004602717,0.00011988922,0.0005511538,0.00007207049,5.89729e-7,0.0028371504,0.00012752239],"about_ca_topic_score_codex":0.000054900884,"about_ca_topic_score_gemma":0.00003568018,"teacher_disagreement_score":0.37444666,"about_ca_system_score_codex":0.000013963681,"about_ca_system_score_gemma":0.0001834119,"threshold_uncertainty_score":0.99097914},"labels":[],"label_agreement":null},{"id":"W2984399591","doi":"10.1016/j.eururo.2019.10.007","title":"Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Queen's University; McMaster University; Health Sciences Centre; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Biopsy; Magnetic resonance imaging; Prostate cancer; Randomized controlled trial; Radiology; Clinical trial; Cancer; Surgery; Internal medicine","score_opus":0.011888437334971885,"score_gpt":0.24776489213826794,"score_spread":0.23587645480329605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984399591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977229,0.014310399,0.0000011500575,0.00020123443,0.0002901743,0.0052796206,0.000020505055,0.000033807348,0.0026341144],"genre_scores_gemma":[0.9992113,0.00029439531,0.00003319072,0.00007238765,0.000019186835,0.00016747297,0.000010282522,0.00004635646,0.0001454403],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99624974,0.0018983958,0.0007707299,0.0005583662,0.00022286134,0.00029991195],"domain_scores_gemma":[0.99775165,0.0011834304,0.00035886068,0.0005162392,0.00009116115,0.000098661236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001223422,0.00029451968,0.0017129722,0.0002365638,0.00003686051,0.000020088977,0.00010892726,0.00003988906,0.000021246451],"category_scores_gemma":[0.00057523843,0.0002151052,0.00007975603,0.00021856063,0.00013812508,0.00004698242,0.00009061928,0.00015623882,0.000040998548],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42537937,0.002786885,0.44773722,0.09743794,0.0016577364,0.0029175752,0.017344462,0.000017914814,0.0030296969,0.0008022235,0.000102215265,0.0007867784],"study_design_scores_gemma":[0.51788914,0.006017028,0.46104428,0.008339948,0.0009203795,0.0002441044,0.004423645,0.00061493786,0.000095459545,0.00001792173,0.00000713736,0.0003860307],"about_ca_topic_score_codex":0.00008958225,"about_ca_topic_score_gemma":0.000013700539,"teacher_disagreement_score":0.09250977,"about_ca_system_score_codex":0.00007277578,"about_ca_system_score_gemma":0.000024843881,"threshold_uncertainty_score":0.87717354},"labels":[],"label_agreement":null},{"id":"W2984818885","doi":"10.1016/j.eururo.2019.11.005","title":"Adjuvant Versus Salvage Radiotherapy Following Radical Prostatectomy: Meta-analysis of the Effect of Comparator Salvage Approach on Study Conclusions","year":2019,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Prostatectomy; Salvage therapy; Adjuvant; Adjuvant radiotherapy; Meta-analysis; Salvage surgery; Radiation therapy; Urology; Surgery; Oncology; Prostate cancer; Internal medicine; Cancer; Chemotherapy","score_opus":0.12294269478234367,"score_gpt":0.39153810747690687,"score_spread":0.2685954126945632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984818885","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0075719217,0.9825852,0.000013563728,0.000064413776,0.0004266368,0.0065910467,0.00027645304,0.00003846806,0.0024322995],"genre_scores_gemma":[0.2553016,0.742644,0.000083252824,0.0003332434,0.0001359191,0.0005603474,0.00046255873,0.0002667171,0.0002123613],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9916892,0.005267226,0.001213183,0.00089593057,0.0005444409,0.00038999482],"domain_scores_gemma":[0.9952138,0.0019128796,0.0009781969,0.0017068428,0.000045536315,0.00014276395],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014373467,0.0007365707,0.009163052,0.00046235707,0.00009092631,0.0000114740815,0.00054420327,0.00014837095,0.00012213142],"category_scores_gemma":[0.00015112347,0.00036097085,0.0059445854,0.0010321483,0.00023005731,0.000019961048,0.00025419687,0.0006604121,0.000030914172],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021240625,0.0029241024,0.0025702808,0.0049469573,0.9322121,0.00054519257,0.0006591234,0.0002199409,0.000010235715,0.000096325784,0.00088429986,0.052807346],"study_design_scores_gemma":[0.006965664,0.01394498,0.0011572018,0.00020656304,0.754227,0.000012100725,0.000018750708,0.000030058682,0.000012768956,1.5329762e-7,0.22315826,0.0002665462],"about_ca_topic_score_codex":0.000014190891,"about_ca_topic_score_gemma":0.0000021789406,"teacher_disagreement_score":0.24772969,"about_ca_system_score_codex":0.00018147171,"about_ca_system_score_gemma":0.00018661217,"threshold_uncertainty_score":0.99988425},"labels":[],"label_agreement":null},{"id":"W2984884245","doi":"10.1016/j.eururo.2019.10.002","title":"Efficacy, safety, and tolerability of mirabegron in patients aged ≥65 yr with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (PILLAR)","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Alberta","funders":"Pfizer Canada; Astellas Pharma Global Development; Astellas Pharma; Astellas Pharma Canada","keywords":"Medicine; Tolerability; Overactive bladder; Mirabegron; Placebo; Urology; Pillar; Double blind; Safety profile; Adverse effect; Surgery; Internal medicine; Pathology","score_opus":0.020216187693184753,"score_gpt":0.30404079106119114,"score_spread":0.2838246033680064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984884245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766693,0.00013197279,0.000010725923,0.00024402104,0.00006872814,0.009039233,0.000014681893,0.000027405984,0.013793947],"genre_scores_gemma":[0.9991518,0.00004062702,0.000019678471,0.00012956894,0.000044383796,0.000045822708,0.000049911534,0.000053897507,0.0004643085],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958778,0.0019073331,0.0007103947,0.0006412979,0.00040712085,0.0004560324],"domain_scores_gemma":[0.9980388,0.00082927593,0.00022361557,0.00054990733,0.00017152645,0.00018686295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018805825,0.00029515353,0.001142322,0.00027496603,0.00006264364,0.000016746339,0.00015072225,0.00007327188,0.00040019586],"category_scores_gemma":[0.00019900696,0.00021268622,0.00009400766,0.00023993051,0.0001849413,0.000101651334,0.00016228823,0.0006154466,0.00006748015],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7783766,0.0054309657,0.21121399,0.0000462165,0.00044785027,0.00019357818,0.0025542497,0.000039502924,0.0003593423,0.0000031364052,0.000028690021,0.0013058743],"study_design_scores_gemma":[0.6352484,0.0175437,0.3462695,0.000014819203,0.00016471282,0.000017666756,0.00018966402,0.000082182065,0.000046528487,0.000002355314,0.0002827917,0.00013767423],"about_ca_topic_score_codex":0.000051945455,"about_ca_topic_score_gemma":0.00003278795,"teacher_disagreement_score":0.14312817,"about_ca_system_score_codex":0.00004545716,"about_ca_system_score_gemma":0.00010655311,"threshold_uncertainty_score":0.8673093},"labels":[],"label_agreement":null},{"id":"W2990415936","doi":"10.1016/j.eururo.2019.11.013","title":"Local Failure in High-grade Prostate Cancer: An Elusive but Important Outcome and Target for Clinical Trials","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Prostate cancer; Clinical trial; Prostate; Oncology; Outcome (game theory); Cancer; Internal medicine; Gynecology","score_opus":0.1164952402966855,"score_gpt":0.43139707213675804,"score_spread":0.31490183184007253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990415936","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12673692,0.0059824423,0.00008499746,0.857842,0.0017140432,0.005675111,0.001649298,0.00009530182,0.00021983968],"genre_scores_gemma":[0.10551973,0.010858261,0.0010599401,0.8345828,0.015888901,0.00065721356,0.0088632135,0.00066586834,0.021904074],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99291736,0.0028841537,0.0018175658,0.0011670515,0.00029925306,0.0009146216],"domain_scores_gemma":[0.997047,0.001360008,0.0006247395,0.0006101189,0.00014478833,0.00021332159],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004371593,0.0005079654,0.0021916032,0.00032136135,0.000063305495,0.000036607962,0.0002692956,0.00071185775,0.0001451817],"category_scores_gemma":[0.00079820736,0.00035625257,0.00030358238,0.00011581383,0.00047408303,0.00006658302,0.0001751369,0.0026066005,0.000061152256],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042929756,0.00020932588,0.19064742,0.00060700363,0.0006094448,0.009230997,0.00019902967,0.000009881338,0.000105415944,0.000016867756,0.7885737,0.005497937],"study_design_scores_gemma":[0.015010446,0.0051203817,0.018581217,0.00006304895,0.00043740115,0.00010250771,0.000040136718,0.0001300237,0.000022785996,0.00010107709,0.96000636,0.0003846097],"about_ca_topic_score_codex":0.00012781782,"about_ca_topic_score_gemma":0.00007909897,"teacher_disagreement_score":0.1720662,"about_ca_system_score_codex":0.00013738242,"about_ca_system_score_gemma":0.00047343172,"threshold_uncertainty_score":0.99988896},"labels":[],"label_agreement":null},{"id":"W2995928704","doi":"10.1016/j.eururo.2019.11.021","title":"Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen Deprivation Therapy: Post Hoc Analysis of Phase 3 LATITUDE Study","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Janssen Research and Development","keywords":"Medicine; Abiraterone acetate; Prostate cancer; Androgen deprivation therapy; Urology; Hazard ratio; Internal medicine; Prostate-specific antigen; Proportional hazards model; Prednisone; Oncology; Prostatectomy; Progression-free survival; Cancer; Overall survival; Confidence interval","score_opus":0.03699912934729221,"score_gpt":0.31919868235556953,"score_spread":0.2821995530082773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995928704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945906,0.00032953336,0.00013709968,0.00022699418,0.000027586626,0.0043468964,0.0002164289,0.000027360566,0.00009749401],"genre_scores_gemma":[0.9981792,0.0005020991,0.00054706505,0.000027569346,0.000014558168,0.000078339326,0.0004694449,0.00004259831,0.00013909908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973063,0.00086429133,0.0005277217,0.0005573393,0.0004183669,0.00032596968],"domain_scores_gemma":[0.9985674,0.00020552028,0.0003169988,0.00036687756,0.00042013178,0.00012309793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000551525,0.00028395542,0.0008831477,0.00044511928,0.00004258221,0.000020403711,0.0001024518,0.000046549972,0.000059077774],"category_scores_gemma":[0.000037364473,0.0001657874,0.00003947469,0.0008958677,0.00020044361,0.00010325685,0.0000662341,0.00017773046,0.0000025527409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18216346,0.0017788897,0.7442912,0.000060159455,0.0026042184,0.0005967256,0.008483168,0.012968669,0.042469524,0.00000935691,0.000006191657,0.004568471],"study_design_scores_gemma":[0.042667918,0.047273647,0.90225875,0.00007353904,0.0006582743,0.00002045545,0.001117957,0.003203828,0.0024670623,0.0000014547508,0.00003732566,0.00021978108],"about_ca_topic_score_codex":0.00015323945,"about_ca_topic_score_gemma":0.0007578989,"teacher_disagreement_score":0.1579676,"about_ca_system_score_codex":0.00008259537,"about_ca_system_score_gemma":0.00016085403,"threshold_uncertainty_score":0.6760614},"labels":[],"label_agreement":null},{"id":"W2995993425","doi":"10.1016/j.eururo.2019.08.026","title":"Reply to Eva Compérat, Mahul Amin, Victor Reuter’s Editorial Reply re: Murali Varma, Brett Delahunt, Theodorus van der Kwast. Grading Noninvasive Bladder Cancer: World Health Organisation 1973 or 2004 May Be the Wrong Question. Eur Urol 2019;76:413–5","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Grading (engineering)","score_opus":0.028121047620976378,"score_gpt":0.3045412718670938,"score_spread":0.2764202242461174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995993425","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006457441,0.002646456,0.0004033702,0.9297228,0.054530703,0.0044058273,0.0011890199,0.0005029479,0.0059531704],"genre_scores_gemma":[0.003800529,0.0005428343,0.0004608783,0.8180294,0.13004664,0.00018499263,0.0016950466,0.0006564109,0.044583272],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9895069,0.0035344807,0.0016654417,0.0022588277,0.0012869356,0.0017474404],"domain_scores_gemma":[0.994079,0.000982121,0.0013041879,0.0025575454,0.00059944077,0.00047772028],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0015418374,0.0013778731,0.0016926627,0.0006052758,0.000636551,0.00020283295,0.0011300162,0.0005387645,0.0027593586],"category_scores_gemma":[0.0004429347,0.0010073133,0.00039785943,0.0007415486,0.0003351272,0.00023430292,0.00043773177,0.0037133612,0.0019463828],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001872641,0.000121631034,0.00089066866,0.00016416582,0.0011116633,0.0014248774,0.0019554659,0.000062827676,0.000113042144,0.000023653514,0.99125975,0.0009996054],"study_design_scores_gemma":[0.0041656336,0.002834838,0.0016259571,0.00027676404,0.0013031665,0.0006641897,0.000073472824,0.00001567763,0.00011293221,0.00004354504,0.9879939,0.00088994665],"about_ca_topic_score_codex":0.0026114997,"about_ca_topic_score_gemma":0.00078893115,"teacher_disagreement_score":0.11169337,"about_ca_system_score_codex":0.0011539813,"about_ca_system_score_gemma":0.0018228786,"threshold_uncertainty_score":0.9998972},"labels":[],"label_agreement":null},{"id":"W2999224037","doi":"10.1016/j.eururo.2019.12.006","title":"The Singularity is Near(ish): Emerging Applications of Artificial Intelligence in Prostate Cancer Management","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Prostate cancer; Management of prostate cancer; Cancer; Gynecology; Artificial intelligence; Internal medicine","score_opus":0.09671608893635084,"score_gpt":0.3928840965899413,"score_spread":0.2961680076535904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999224037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6921138,0.0030354487,0.026910836,0.25916386,0.0007998527,0.0028734785,0.000016952406,0.00013446355,0.014951253],"genre_scores_gemma":[0.99448824,0.00052445085,0.0005847388,0.0040363134,0.00020944951,0.000048647857,0.000005662899,0.000015692644,0.00008679598],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988516,0.00012968374,0.00046355356,0.00023225923,0.00010902139,0.00021388684],"domain_scores_gemma":[0.99943894,0.00007215608,0.00010602415,0.00021228672,0.00009161718,0.00007897744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037393364,0.0000775094,0.00012392148,0.000042118165,0.00013816378,0.000015292228,0.00013979666,0.000022941042,0.000088446504],"category_scores_gemma":[0.00008482854,0.00006423844,0.00003582573,0.00037791964,0.00021009763,0.000025534924,0.00006248465,0.00021436012,0.00012889052],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002100634,0.00008667695,0.008480336,0.00009367839,0.0000229401,0.000022167618,0.01062435,0.00025297632,0.00021822662,0.0045462376,0.00043615568,0.97500616],"study_design_scores_gemma":[0.00016797117,0.0014203725,0.05204487,0.0001350357,0.00027468053,0.00003132431,0.015625516,0.04584228,0.013328855,0.022233833,0.8482877,0.00060759234],"about_ca_topic_score_codex":0.00020379585,"about_ca_topic_score_gemma":0.000081402744,"teacher_disagreement_score":0.9743986,"about_ca_system_score_codex":0.000026066673,"about_ca_system_score_gemma":0.00006486736,"threshold_uncertainty_score":0.26195675},"labels":[],"label_agreement":null},{"id":"W3003349858","doi":"10.1016/j.eururo.2020.01.019","title":"Re: Clinical Efficacy and Biomarker Analysis of Neoadjuvant Atezolizumab in Operable Urothelial Carcinoma in the ABACUS Trial","year":2020,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Atezolizumab; Oncology; Urothelial carcinoma; Biomarker; Bladder cancer; Internal medicine; Clinical trial; Cancer; Immunotherapy","score_opus":0.07430930771093772,"score_gpt":0.34230889060095676,"score_spread":0.267999582890019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003349858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57148904,0.0017796877,0.000007756038,0.4062392,0.00079506653,0.0022170062,0.00018562053,0.000038841987,0.017247759],"genre_scores_gemma":[0.7018285,0.0002649983,0.000023622772,0.2959174,0.0014572116,0.00001952812,0.00024889436,0.00006817851,0.00017168217],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99434865,0.0028667627,0.0011976918,0.0008306634,0.00031299592,0.00044321833],"domain_scores_gemma":[0.9981814,0.0007230452,0.00026345134,0.00070479943,0.00004020047,0.00008711906],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085717026,0.00038890756,0.0015751048,0.0005582336,0.000036378762,0.000020325382,0.00038657835,0.0003622953,0.00021167481],"category_scores_gemma":[0.0003368096,0.00026287363,0.00037979684,0.0008202978,0.0003463928,0.000026285545,0.00014439685,0.0017687922,0.00005348359],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15663706,0.0020267386,0.13604346,0.00027796294,0.0068940576,0.06918358,0.0047407458,0.00003256252,0.00009153325,0.000017098495,0.5949587,0.029096462],"study_design_scores_gemma":[0.10793027,0.006520469,0.45949173,0.000039882812,0.005760133,0.000080443366,0.000051357303,0.00033038342,0.000003856607,0.000011823483,0.41941583,0.00036379535],"about_ca_topic_score_codex":0.00046290108,"about_ca_topic_score_gemma":0.00011759078,"teacher_disagreement_score":0.32344827,"about_ca_system_score_codex":0.00004175431,"about_ca_system_score_gemma":0.0001956518,"threshold_uncertainty_score":0.99998236},"labels":[],"label_agreement":null},{"id":"W3004941033","doi":"10.1016/j.eururo.2019.12.014","title":"Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434–5","year":2020,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; University of British Columbia; University of Toronto; University Health Network; Mount Sinai Hospital; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"Novo Nordisk Fonden","keywords":"Medicine; Bladder cancer; Urothelial cancer; Cancer; Internal medicine","score_opus":0.015225321649509477,"score_gpt":0.25063531271796263,"score_spread":0.23540999106845314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004941033","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13428795,0.008033522,0.00012996176,0.82254964,0.0024081476,0.004989732,0.0011140013,0.00026729304,0.026219761],"genre_scores_gemma":[0.19021031,0.0007901728,0.00025169918,0.7972032,0.004605273,0.0002250257,0.000278799,0.0003309223,0.0061046174],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942772,0.0017720651,0.0010256871,0.0014860075,0.00052300585,0.0009160296],"domain_scores_gemma":[0.9972287,0.0006457712,0.0004893259,0.0011166504,0.00023054505,0.00028903017],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005003453,0.00078808627,0.0012945448,0.0004249543,0.000119639015,0.000043872406,0.0006876661,0.00031466523,0.00072123605],"category_scores_gemma":[0.00047513703,0.00060993124,0.00036968666,0.0005977445,0.00023692336,0.000033036988,0.00029089427,0.0017992109,0.00096720416],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014587715,0.00011869054,0.0037032363,0.00033059818,0.0007234824,0.017825983,0.0025559196,0.000051050116,0.0011081279,0.0000024828132,0.9680652,0.0040564598],"study_design_scores_gemma":[0.002364651,0.0025915343,0.1032115,0.00020491095,0.0011829747,0.00046693813,0.000064908665,0.000012502111,0.00022348533,0.0000085670645,0.8891629,0.0005051292],"about_ca_topic_score_codex":0.002138361,"about_ca_topic_score_gemma":0.0009690179,"teacher_disagreement_score":0.09950826,"about_ca_system_score_codex":0.00025561202,"about_ca_system_score_gemma":0.00036972685,"threshold_uncertainty_score":0.99981064},"labels":[],"label_agreement":null},{"id":"W3009063567","doi":"10.1016/j.eururo.2020.01.033","title":"Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review","year":2020,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Medicine; Prostate cancer; Multidisciplinary approach; Risk assessment; Gynecology; Oncology; Cancer; Medical physics; Internal medicine","score_opus":0.05613167901764782,"score_gpt":0.35907400086712676,"score_spread":0.30294232184947895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009063567","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00059614255,0.98949957,0.000015396345,0.0003355876,0.00017443123,0.007624069,0.0016346136,0.000040888543,0.00007928908],"genre_scores_gemma":[0.0002815017,0.99580556,0.00068322214,0.0003684098,0.000081982296,0.0014825718,0.0011320758,0.00011315489,0.000051490617],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9972172,0.00055442215,0.0010583899,0.0007645909,0.00016396743,0.00024147051],"domain_scores_gemma":[0.9979021,0.0002737958,0.0010580161,0.0004035475,0.000134268,0.0002282898],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032548435,0.00049920107,0.003297912,0.000103348764,0.00006525202,0.000012903839,0.00016315404,0.00009006897,0.000010041965],"category_scores_gemma":[0.00015367629,0.00034409965,0.00021720867,0.00010296728,0.00012608615,0.00007428201,0.00019544124,0.00020232424,0.000006769872],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022447709,0.0001703556,0.00032596197,0.3649413,0.0014627217,0.00009193732,0.000075512326,0.0000023733305,2.342152e-7,0.000028309902,0.000026030928,0.6326508],"study_design_scores_gemma":[0.013608703,0.011952124,0.005064699,0.72972775,0.065640576,0.00047792704,0.000020704983,0.00006223811,0.000003182771,0.000041415205,0.17252737,0.00087330566],"about_ca_topic_score_codex":0.00003157494,"about_ca_topic_score_gemma":0.0000063133684,"teacher_disagreement_score":0.63177747,"about_ca_system_score_codex":0.00016566546,"about_ca_system_score_gemma":0.00018985778,"threshold_uncertainty_score":0.9999011},"labels":[],"label_agreement":null},{"id":"W3009271488","doi":"10.1016/j.eururo.2020.02.028","title":"Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Decipher Biosciences (Canada)","funders":"","keywords":"Medicine; Pembrolizumab; Bladder cancer; Pathological; Neoadjuvant therapy; Oncology; Complete response; Infiltration (HVAC); Subtyping; Immune system; Pathology; Internal medicine; Immunotherapy; Urology; Cancer; Chemotherapy; Immunology","score_opus":0.03256325318126531,"score_gpt":0.32039077979070874,"score_spread":0.28782752660944344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009271488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957488,0.0013027361,0.000031494714,0.0016560337,0.00004646742,0.00027032325,0.0000130203325,0.000025416575,0.00090570434],"genre_scores_gemma":[0.997897,0.00010781741,0.000048001613,0.0018557253,0.00003880657,0.0000073327724,0.0000072226962,0.00002807045,0.000010007671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986206,0.000461684,0.00030356174,0.0003144484,0.000097281896,0.00020237287],"domain_scores_gemma":[0.9995063,0.00013245438,0.00008138096,0.00014040372,0.000023085231,0.000116397714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021447575,0.00016609504,0.00036930738,0.00009003198,0.000028869319,0.000007752485,0.000047890644,0.000059844897,0.000047291836],"category_scores_gemma":[0.0003733322,0.00012916578,0.00009761216,0.000110809124,0.000075244505,0.000039144677,0.000055526358,0.00021035434,0.0000063729335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011594017,0.00016138016,0.52534825,0.000043897864,0.00023994602,0.0039558164,0.003024062,0.00021129145,0.44800174,0.00005329501,0.00002041067,0.007345894],"study_design_scores_gemma":[0.0044543887,0.0040735356,0.9898869,0.000026757441,0.00010665053,0.000057764613,0.000042800464,0.00006887431,0.0011262217,0.000018162877,0.0000372723,0.000100671954],"about_ca_topic_score_codex":0.000073886215,"about_ca_topic_score_gemma":0.000005786684,"teacher_disagreement_score":0.46453863,"about_ca_system_score_codex":0.000036758418,"about_ca_system_score_gemma":0.00007068415,"threshold_uncertainty_score":0.5267228},"labels":[],"label_agreement":null},{"id":"W3009410127","doi":"10.1016/j.eururo.2020.02.012","title":"Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non–muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-Guérin","year":2020,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Bladder cancer; Urology; Urinary bladder; Cancer; Oncology; Surgery; Internal medicine","score_opus":0.045430518186591745,"score_gpt":0.34184871876276784,"score_spread":0.29641820057617607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009410127","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047605998,0.98759264,0.00005900502,0.000549473,0.000500899,0.008634137,0.00025301616,0.0000386787,0.002324535],"genre_scores_gemma":[0.0012698031,0.9946877,0.00006262469,0.0021518266,0.00033384832,0.0006209341,0.00008950113,0.00023545288,0.0005483082],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.994763,0.0015450512,0.0019161886,0.00078593334,0.00046852487,0.00052129553],"domain_scores_gemma":[0.9957772,0.0012378492,0.0013181012,0.0013077422,0.00016093283,0.00019815986],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004983199,0.0007968829,0.0051489486,0.0001347815,0.00009717348,0.00001132602,0.0008503332,0.00021540925,0.00019738737],"category_scores_gemma":[0.00096914615,0.0004626907,0.0025047234,0.00049485045,0.00017162417,0.000039418017,0.0003040883,0.0004995363,0.00006578494],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085106934,0.00035034659,0.000015089887,0.87766653,0.01567316,0.00017525282,0.00031602898,8.1974844e-7,0.000033071447,0.00002044618,0.00091771694,0.1047464],"study_design_scores_gemma":[0.0055770003,0.002562177,0.000348414,0.6713171,0.14404091,0.00018646909,0.000033694785,0.000016574508,0.000058747297,0.00001588363,0.17514212,0.0007009256],"about_ca_topic_score_codex":0.000035033754,"about_ca_topic_score_gemma":0.0000066934763,"teacher_disagreement_score":0.20634949,"about_ca_system_score_codex":0.00018405364,"about_ca_system_score_gemma":0.0008089602,"threshold_uncertainty_score":0.9997825},"labels":[],"label_agreement":null},{"id":"W3010820367","doi":"10.1016/j.eururo.2020.02.031","title":"Converging Roads to Early Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada)","funders":"Novo Nordisk Fonden","keywords":"Medicine; Bladder cancer; Urothelial cancer; Urology; General surgery; Cancer; Internal medicine","score_opus":0.030506977357041894,"score_gpt":0.28321182134739903,"score_spread":0.25270484399035714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010820367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8172153,0.00074554933,0.00064334663,0.048704594,0.00051418203,0.0004435408,0.000022994936,0.00025354038,0.13145696],"genre_scores_gemma":[0.9322641,0.000028165767,0.00013222062,0.06530185,0.0007496615,0.000011485314,0.000005256655,0.000051116833,0.0014561316],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99904335,0.00009818643,0.00015336473,0.00032392537,0.000111808564,0.00026936847],"domain_scores_gemma":[0.9994022,0.000016732773,0.00002919072,0.00017414376,0.000040546638,0.00033718933],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000054658496,0.00013613624,0.00020850608,0.00004072583,0.000042600757,0.0000106832695,0.000101868514,0.000029237035,0.0015023843],"category_scores_gemma":[0.000040484458,0.00011869509,0.00005935971,0.00014393867,0.000037683174,0.000028563762,0.0000736828,0.00015678961,0.0026649446],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059634973,0.00047986026,0.50622284,0.0001359173,0.0020336316,0.006174069,0.026721418,0.00038982308,0.056576002,0.00088900124,0.25583798,0.13857596],"study_design_scores_gemma":[0.0033138117,0.0025547135,0.37290168,0.000011251216,0.00027737577,0.000051813888,0.000049681712,0.000090446556,0.001667137,0.0000126189625,0.6188296,0.00023985791],"about_ca_topic_score_codex":0.000077703095,"about_ca_topic_score_gemma":0.0000049810105,"teacher_disagreement_score":0.3629916,"about_ca_system_score_codex":0.00002135235,"about_ca_system_score_gemma":0.000052399082,"threshold_uncertainty_score":0.9994104},"labels":[],"label_agreement":null},{"id":"W3010943001","doi":"10.1016/j.eururo.2020.03.006","title":"A Plea for the Evaluation of the Carbon Footprint of New Mini-invasive Surgical Technologies in Urology","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Climate Change and Health Impacts","field":"Environmental Science","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Plea; Carbon footprint; Footprint; Urology; General surgery; Medical physics; Surgery; Archaeology","score_opus":0.1449663573850662,"score_gpt":0.32540428670023885,"score_spread":0.18043792931517266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010943001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9415431,0.00030057752,0.000011696964,0.053689044,0.00008704921,0.0005539443,0.000004467518,0.0000168721,0.00379322],"genre_scores_gemma":[0.99915296,0.00007457665,0.000025680676,0.0006757741,0.00003935958,0.000010771726,0.0000010369362,0.000009230228,0.000010626643],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99886966,0.00033909394,0.00024842093,0.000181024,0.00015440244,0.00020743046],"domain_scores_gemma":[0.9991968,0.0003746868,0.00015461579,0.00022700003,0.00001295518,0.000033910692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008356965,0.00007371411,0.00014469058,0.000020058957,0.000029606652,0.0000017099422,0.00035837106,0.000052810792,0.000075430966],"category_scores_gemma":[0.0011210309,0.000040328145,0.000043111748,0.0001755081,0.00026354057,0.000008575407,0.00033262302,0.00013326171,0.00001017951],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002089948,0.0003608251,0.43146765,0.00016496678,0.00007521213,0.00005421211,0.033572316,0.030125951,0.044089988,0.0012479688,0.0055618803,0.45118907],"study_design_scores_gemma":[0.0046397476,0.0028940893,0.9131969,0.000015273186,0.00020407852,0.000042311294,0.0019798796,0.015546233,0.008522011,0.0038838857,0.0488266,0.00024895862],"about_ca_topic_score_codex":0.00010967232,"about_ca_topic_score_gemma":0.0004023235,"teacher_disagreement_score":0.48172927,"about_ca_system_score_codex":0.000026129068,"about_ca_system_score_gemma":0.00003219158,"threshold_uncertainty_score":0.1644534},"labels":[],"label_agreement":null},{"id":"W3011222032","doi":"10.1016/j.eururo.2020.03.005","title":"Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Resection; Bladder cancer; Urology; Diligence; Cystoscopy; Cancer; Surgery; Urinary system; Internal medicine","score_opus":0.022359662781911573,"score_gpt":0.2784904849868241,"score_spread":0.2561308222049125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011222032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8810346,0.0026809145,0.000047236652,0.10586715,0.00011411717,0.0008458427,0.000011067061,0.00006162645,0.009337444],"genre_scores_gemma":[0.9925682,0.00020822928,0.000018039298,0.00682562,0.00018768212,0.00005702241,0.000006152638,0.00003420354,0.000094857576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984295,0.00049748085,0.00031233334,0.00031079075,0.00016106103,0.00028883826],"domain_scores_gemma":[0.99951255,0.0000749602,0.00007861167,0.00023903127,0.000054880657,0.000039979383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019123404,0.00015841727,0.00027435762,0.00013388135,0.00004410141,0.000005571669,0.00026019372,0.00009749003,0.00021913798],"category_scores_gemma":[0.00015393848,0.000092375376,0.000057559148,0.00093638845,0.00021440275,0.000031731746,0.00003407111,0.0006685448,0.000032413678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021414323,0.0026136772,0.5257542,0.0005609175,0.0015364664,0.0032741583,0.102991685,0.0017942279,0.2543805,0.0016950647,0.044474613,0.03951014],"study_design_scores_gemma":[0.010803087,0.005261738,0.94301337,0.00006584578,0.00041774163,0.0003620855,0.0019371622,0.00067045056,0.0059776357,0.00032154296,0.030871436,0.00029788903],"about_ca_topic_score_codex":0.00012165838,"about_ca_topic_score_gemma":0.00059639965,"teacher_disagreement_score":0.41725916,"about_ca_system_score_codex":0.000026363328,"about_ca_system_score_gemma":0.00012521031,"threshold_uncertainty_score":0.37669587},"labels":[],"label_agreement":null},{"id":"W3011470625","doi":"10.1016/j.eururo.2019.09.035","title":"EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†","year":2019,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Cilag; Sanofi Pasteur; Pharmacyclics; Chugai Pharmaceutical; Genentech; European Association of Urology; European Society for Medical Oncology; Astellas Pharma; Eisai; Bayer; Universitat Autònoma de Barcelona; Cancer Research UK; GlaxoSmithKline; UroGen Pharma; MSD Australia; EMD Serono; Radboud Universitair Medisch Centrum; Pfizer; Incyte; Medac; Ipsen; Clovis Oncology; Alere; Bayer HealthCare; Sanofi; Amgen; Radboud Universiteit; Novartis; Les Laboratories Pierre Fabre; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Consensus conference; Bladder cancer; MEDLINE; Family medicine; Urology; General surgery; Oncology; Cancer; Internal medicine","score_opus":0.02578443331298604,"score_gpt":0.3183087991993905,"score_spread":0.29252436588640446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011470625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9338018,0.00015066729,0.000020598278,0.0018026716,0.00051020493,0.00082538987,0.000120482284,0.000022811399,0.062745415],"genre_scores_gemma":[0.9949311,0.00026251876,0.00035483434,0.0020815267,0.000048571314,0.00002751169,0.000030060224,0.000029713687,0.0022341548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898064,0.00013814797,0.00022270616,0.00030876687,0.00017796237,0.00017175305],"domain_scores_gemma":[0.9993789,0.000047457143,0.00011903973,0.00029195668,0.00009638399,0.000066219334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015844846,0.00014641657,0.0001881691,0.00005014357,0.000042321015,0.000009601731,0.000112855094,0.00002358587,0.00059402356],"category_scores_gemma":[0.0000070176816,0.00009897742,0.000026446864,0.00007764274,0.00010686178,0.000039782746,0.00006243196,0.0001068777,0.00006944224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049232185,0.007932373,0.41520512,0.0009871966,0.03466279,0.008618267,0.024854276,0.0058864276,0.025492225,0.121882915,0.016716687,0.28852955],"study_design_scores_gemma":[0.014844882,0.0038447601,0.8768343,0.0001154082,0.0004855803,0.000059398983,0.0013548016,0.00044601425,0.0010754657,0.00013931254,0.10052146,0.0002786672],"about_ca_topic_score_codex":0.000042188447,"about_ca_topic_score_gemma":0.000013526025,"teacher_disagreement_score":0.46162912,"about_ca_system_score_codex":0.00003412668,"about_ca_system_score_gemma":0.000034053523,"threshold_uncertainty_score":0.6504141},"labels":[],"label_agreement":null},{"id":"W3011518560","doi":"10.1016/j.eururo.2020.01.012","title":"Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":395,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"Medical Research Council; National Institute for Health and Care Research; Cancer Research UK","keywords":"Prostate cancer; Medicine; Management of prostate cancer; Prostate; Voting; Delphi method; Consensus conference; Cancer; Oncology; Gynecology; Internal medicine","score_opus":0.017205193418965557,"score_gpt":0.2828804490915681,"score_spread":0.2656752556726026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011518560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809373,0.0018863126,0.0000066870375,0.009572878,0.00018385137,0.0019457408,0.00023952314,0.000038473667,0.0051892465],"genre_scores_gemma":[0.9937338,0.0016606514,0.0002676164,0.000468304,0.000026494496,0.00007300971,0.000065739485,0.00004791098,0.0036564292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819374,0.00016560075,0.00045384816,0.00045376463,0.00037084884,0.0003622147],"domain_scores_gemma":[0.9985145,0.00002968502,0.0004359524,0.00043494217,0.00044386508,0.00014105497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013248634,0.00020878058,0.0004079702,0.000042996315,0.00005703863,0.000004844095,0.0001985977,0.000028182907,0.00009992679],"category_scores_gemma":[0.00003404218,0.00012540216,0.0000662003,0.00029962434,0.00043630062,0.000036809735,0.00019519553,0.0002269708,0.00000912715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027683001,0.0006315987,0.8508348,0.0015822642,0.0014180327,0.0028105832,0.0038197048,0.0017355338,0.007836719,0.00021541982,0.003921473,0.09751087],"study_design_scores_gemma":[0.016637247,0.0036475782,0.91567487,0.00043961065,0.00046077705,0.000027247826,0.0003069686,0.000078821475,0.0087408405,0.000022497226,0.053653333,0.00031020708],"about_ca_topic_score_codex":0.000041155978,"about_ca_topic_score_gemma":0.000010701188,"teacher_disagreement_score":0.09720066,"about_ca_system_score_codex":0.0000500304,"about_ca_system_score_gemma":0.00025311517,"threshold_uncertainty_score":0.5113752},"labels":[],"label_agreement":null},{"id":"W3011534960","doi":"10.1016/j.eururo.2019.11.011","title":"Re: Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol 2020;77:420–33","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Novo Nordisk Fonden","keywords":"Medicine; Gynecology; Bladder cancer; Urology; Cancer; Internal medicine","score_opus":0.027457939979029553,"score_gpt":0.29489693889459145,"score_spread":0.2674389989155619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011534960","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023994211,0.0047324146,0.00019083482,0.89316285,0.0016608714,0.0022376105,0.00116851,0.0002814798,0.07257123],"genre_scores_gemma":[0.17332602,0.0016594359,0.00026762998,0.8152398,0.0013125595,0.000107241365,0.0011819045,0.00044778184,0.0064576734],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937885,0.0020055487,0.0010190757,0.001498468,0.00067979965,0.0010086128],"domain_scores_gemma":[0.9962294,0.00057772716,0.0008982782,0.0016699948,0.00041231824,0.00021224697],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00063316704,0.00086699333,0.0013059974,0.00032487782,0.000090518384,0.000036797435,0.00061050017,0.0006942954,0.0008647692],"category_scores_gemma":[0.00047992697,0.000826334,0.00047204646,0.0002898283,0.0005203525,0.000053109037,0.00020832251,0.002308845,0.0006707225],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005099281,0.0001878399,0.0012982981,0.0002640508,0.0012814327,0.0053638835,0.00055788015,0.00005247477,0.015195355,0.000037961647,0.9739237,0.0013271879],"study_design_scores_gemma":[0.003908346,0.0017021102,0.018961258,0.00017191062,0.0016793654,0.0003166188,0.000055996305,0.000055901965,0.0007617789,0.00006367864,0.9716897,0.00063332176],"about_ca_topic_score_codex":0.00046537485,"about_ca_topic_score_gemma":0.00011932472,"teacher_disagreement_score":0.14933181,"about_ca_system_score_codex":0.0002609681,"about_ca_system_score_gemma":0.0013144475,"threshold_uncertainty_score":0.99999285},"labels":[],"label_agreement":null},{"id":"W3014348002","doi":"10.1016/j.eururo.2020.03.001","title":"The Oral Gonadotropin-releasing Hormone Receptor Antagonist Relugolix as Neoadjuvant/Adjuvant Androgen Deprivation Therapy to External Beam Radiotherapy in Patients with Localised Intermediate-risk Prostate Cancer: A Randomised, Open-label, Parallel-group Phase 2 Trial","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Myovant Sciences; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Urology; External beam radiotherapy; Castration; Clinical endpoint; Goserelin; Radiation therapy; Internal medicine; Oncology; Randomized controlled trial; Cancer; Hormone","score_opus":0.02050125745166244,"score_gpt":0.29176730926772587,"score_spread":0.27126605181606345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014348002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98146427,0.0062472797,0.00042286527,0.0043217526,0.000338088,0.006978744,0.000113514056,0.00006693131,0.00004652822],"genre_scores_gemma":[0.9654314,0.02507793,0.00070133136,0.007299499,0.00041253297,0.00068214914,0.00023246625,0.00013708997,0.000025630092],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966373,0.0007958793,0.00082448585,0.0007956627,0.00033224197,0.000614461],"domain_scores_gemma":[0.9983981,0.00017974032,0.00045847072,0.00042566087,0.0001226285,0.00041534603],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042937094,0.00043365872,0.00078950444,0.00008955496,0.00026063845,0.00016785189,0.0004356546,0.000066550565,0.000055713303],"category_scores_gemma":[0.00017685322,0.00027738456,0.00008070884,0.0003247726,0.00020335839,0.0001633403,0.000111569214,0.0004048571,0.00004430697],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7501712,0.0017729364,0.037426814,0.000008206385,0.00036616286,0.00021496342,0.0013757198,0.0001252755,0.0028080384,0.000011109565,0.0013541906,0.20436539],"study_design_scores_gemma":[0.8320434,0.05128161,0.064793415,0.000083813844,0.00013596375,0.0000094010065,0.00004782451,0.00030767688,0.0005314228,0.000011480869,0.05036315,0.0003908055],"about_ca_topic_score_codex":0.00035305647,"about_ca_topic_score_gemma":0.00003775587,"teacher_disagreement_score":0.20397459,"about_ca_system_score_codex":0.00024770852,"about_ca_system_score_gemma":0.00019760306,"threshold_uncertainty_score":0.9999678},"labels":[],"label_agreement":null},{"id":"W3016451403","doi":"10.1016/j.eururo.2020.03.021","title":"Immune Signatures Dominate Molecular Subtyping to Predict Response to Neoadjuvant Immunotherapy","year":2020,"lang":"en","type":"letter","venue":"European Urology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Subtyping; Immunotherapy; Immune system; Neoadjuvant therapy; Immunology; Internal medicine; Cancer","score_opus":0.00769869526836274,"score_gpt":0.21914398084457892,"score_spread":0.21144528557621617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016451403","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.062256657,0.043279767,0.0019770763,0.88056946,0.0055195787,0.0023528044,0.00033484504,0.00089484465,0.002814962],"genre_scores_gemma":[0.10388379,0.00031380716,0.00021235803,0.87905854,0.00078551995,0.00011899051,0.00065099454,0.00061118795,0.014364818],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.984372,0.010483434,0.00138599,0.0017132537,0.00018456562,0.0018607546],"domain_scores_gemma":[0.9958771,0.0013222583,0.0004947054,0.0019967793,0.00020034233,0.0001088132],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0015982277,0.0013321135,0.001670226,0.0010526968,0.0004953568,0.000115883005,0.0026033064,0.0013655281,0.0014916973],"category_scores_gemma":[0.0011200684,0.0012930776,0.0007050678,0.000655772,0.0004439575,0.00009835243,0.00086015486,0.0050927512,0.012756751],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017925346,0.00004398511,0.000003415233,0.000020889602,0.00072144833,0.00306282,0.0011212828,0.000042477644,0.5615356,0.0000121955545,0.41046953,0.005041002],"study_design_scores_gemma":[0.0026708492,0.003740944,0.0010901184,0.00010337657,0.000121357334,0.00041484358,0.000036141984,0.0000016227477,0.04833958,0.000029352504,0.9422425,0.0012093184],"about_ca_topic_score_codex":0.000043467975,"about_ca_topic_score_gemma":7.9476695e-7,"teacher_disagreement_score":0.531773,"about_ca_system_score_codex":0.0001418217,"about_ca_system_score_gemma":0.00025474487,"threshold_uncertainty_score":0.999943},"labels":[],"label_agreement":null},{"id":"W3019962442","doi":"10.1016/j.eururo.2020.03.019","title":"Effect of Enzalutamide plus Androgen Deprivation Therapy on Health-related Quality of Life in Patients with Metastatic Hormone-sensitive Prostate Cancer: An Analysis of the ARCHES Randomised, Placebo-controlled, Phase 3 Study","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma; Pfizer","keywords":"Medicine; Enzalutamide; Placebo; Prostate cancer; Androgen deprivation therapy; Quality of life (healthcare); Internal medicine; Visual analogue scale; Oncology; Urology; Cancer; Physical therapy; Androgen receptor; Pathology","score_opus":0.0378007804806476,"score_gpt":0.34450563072495666,"score_spread":0.30670485024430905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019962442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331045,0.000649687,0.000009810856,0.0006220759,0.00001284453,0.005253341,0.00008976365,0.0000106637,0.000041361283],"genre_scores_gemma":[0.9994337,0.00013329256,0.0000064032083,0.00024243853,0.0000068248814,0.00006657472,0.00008234243,0.000022303613,0.0000061224287],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9922708,0.006032855,0.0008172764,0.00030854286,0.00036951984,0.00020094965],"domain_scores_gemma":[0.99802446,0.00073323067,0.00068209367,0.00028647092,0.00015403732,0.0001196894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020555141,0.00017669397,0.0014564416,0.00023367608,0.000036705813,0.000002837482,0.000111755784,0.00002116043,0.000009080412],"category_scores_gemma":[0.00049674214,0.00009285835,0.00015283238,0.0007217696,0.0001787608,0.00003356677,0.00003417504,0.00019806263,6.3569325e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6476379,0.0011640163,0.32997242,0.00006325176,0.0037454043,0.0000135200635,0.009580915,0.003181521,0.0009101248,0.0000018603994,0.000002816681,0.0037262745],"study_design_scores_gemma":[0.42136782,0.031869967,0.54237366,0.00001710373,0.0008984303,1.8504957e-7,0.0002392758,0.0016370107,0.0015286267,0.0000010752451,0.000001249221,0.000065623266],"about_ca_topic_score_codex":0.0006595613,"about_ca_topic_score_gemma":0.0001049575,"teacher_disagreement_score":0.22627006,"about_ca_system_score_codex":0.00006603735,"about_ca_system_score_gemma":0.00019665353,"threshold_uncertainty_score":0.37866536},"labels":[],"label_agreement":null},{"id":"W3021403359","doi":"10.1016/j.eururo.2020.04.059","title":"An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting","year":2020,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Research Grants Council, University Grants Committee","keywords":"Medicine; Delphi method; Delphi; Confidence interval; Systematic review; Randomized controlled trial; Statement (logic); MEDLINE; Perforation; Evidence-based medicine; Medical physics; Surgery; Internal medicine; Alternative medicine; Statistics; Pathology","score_opus":0.08279533778653005,"score_gpt":0.3928676001667775,"score_spread":0.3100722623802475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021403359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022419577,0.984251,0.0000280923,0.0002742549,0.00059977197,0.0053794114,0.00055891834,0.00007327076,0.0065932795],"genre_scores_gemma":[0.058576163,0.9382993,0.0008830325,0.00048740982,0.0006428819,0.00019984468,0.0005842138,0.00019101563,0.00013612256],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9858958,0.010749389,0.0019416355,0.000782027,0.00035669567,0.00027445328],"domain_scores_gemma":[0.99542993,0.0015868426,0.0019219011,0.00043838617,0.00040961808,0.00021331382],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033475473,0.0005799518,0.0027721608,0.00028077507,0.00009855084,0.000046043035,0.00021758069,0.00010275589,0.00003812648],"category_scores_gemma":[0.0022330778,0.00044157606,0.00018251823,0.0003915717,0.00019864259,0.000030234218,0.0001313106,0.00053700927,0.000086799875],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011283974,0.0036560828,0.0040170783,0.55466497,0.029358279,0.015802337,0.010638363,0.00023958497,0.00075322785,0.0015144831,0.010338666,0.35773295],"study_design_scores_gemma":[0.022437863,0.030131495,0.0010263979,0.14580002,0.019456925,0.006086879,0.0014697294,0.0011912462,0.00004521994,0.00011002822,0.76953965,0.002704561],"about_ca_topic_score_codex":0.00015986509,"about_ca_topic_score_gemma":0.00019105442,"teacher_disagreement_score":0.759201,"about_ca_system_score_codex":0.00022373175,"about_ca_system_score_gemma":0.0005027363,"threshold_uncertainty_score":0.9998036},"labels":[],"label_agreement":null},{"id":"W3021579311","doi":"10.1016/j.eururo.2020.04.044","title":"Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":377,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Labex Immuno-Oncology; European Research Council; European Society for Medical Oncology; Novo Nordisk Fonden; Cancéropôle Ile de France; Institut Universitaire de France; Fondation de France; Ligue Contre le Cancer; Fondation pour la Recherche Médicale; Institut National Du Cancer; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche; Institut Gustave-Roussy; Fondation Leducq; Breast Cancer Research Foundation; European Commission; Association pour la Recherche sur le Cancer; Fondation Philanthropia","keywords":"Medicine; Renal cell carcinoma; Immunotherapy; Carcinoma; Cancer; Bacteria; Primary (astronomy); Kidney cancer; Internal medicine; Oncology; Cancer research","score_opus":0.0067173410544776845,"score_gpt":0.2149751329187804,"score_spread":0.2082577918643027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021579311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99458814,0.00054852356,0.00011101965,0.0016766373,0.0001195375,0.00018568235,0.00003768195,0.000015060496,0.0027176973],"genre_scores_gemma":[0.984514,0.00010734574,0.00043621083,0.01436454,0.00018909476,0.0000059886133,0.00019990031,0.000041756215,0.00014115596],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998891,0.0002686866,0.00020788485,0.0003511207,0.000042507705,0.00023881014],"domain_scores_gemma":[0.9996274,0.000004954927,0.000066579494,0.00017389355,0.000035958437,0.000091173795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007191598,0.00012357182,0.00013554536,0.00003178912,0.000037277743,0.0000096726235,0.0001805905,0.00005416672,0.000029493714],"category_scores_gemma":[0.000005917849,0.00012968329,0.00003472975,0.00006970869,0.000034313736,0.000002696917,0.00009625356,0.00010379263,0.00004265092],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062702585,0.000053515272,0.01978342,0.00001899532,0.00000520246,0.000009828576,0.00031896672,0.000019519757,0.9718783,0.000004110319,0.006860405,0.0004207269],"study_design_scores_gemma":[0.0010596954,0.0005482311,0.8154732,0.000004165992,0.0000035122641,8.770515e-7,0.0000042124625,0.0000012424355,0.021706706,0.0000011098826,0.16105826,0.00013881513],"about_ca_topic_score_codex":0.000009919699,"about_ca_topic_score_gemma":0.00003543013,"teacher_disagreement_score":0.9501716,"about_ca_system_score_codex":0.000020679085,"about_ca_system_score_gemma":0.000044629738,"threshold_uncertainty_score":0.52883315},"labels":[],"label_agreement":null},{"id":"W3022776782","doi":"10.1016/j.eururo.2020.04.038","title":"Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; BC Cancer Agency; Calgary Laboratory Services; Princess Margaret Cancer Centre; CancerCare Manitoba; University of Alberta; University of Calgary","funders":"","keywords":"Sunitinib; Medicine; Renal cell carcinoma; Hazard ratio; Internal medicine; Proportional hazards model; Confidence interval; Urology; Oncology; Nephrectomy; Sunitinib malate; Surgery; Kidney","score_opus":0.019212219728380962,"score_gpt":0.2148306997747429,"score_spread":0.19561848004636193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022776782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846029,0.00022343348,0.000088553505,0.0008385014,0.000061427185,0.0007251156,0.000012522829,0.000060606275,0.013386885],"genre_scores_gemma":[0.99592006,0.0000028369502,0.0014431925,0.0022085577,0.00012025574,0.000018051513,0.000114101626,0.00008177001,0.00009115762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979236,0.0005301618,0.00032907148,0.0005618773,0.00024609666,0.0004091978],"domain_scores_gemma":[0.9990549,0.000107339714,0.00012521366,0.00031185988,0.00008282727,0.00031785952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105769905,0.00028726706,0.0004534682,0.0001368835,0.000035460107,0.000011863909,0.00014224912,0.000033129843,0.00013010038],"category_scores_gemma":[0.00009328941,0.00022113662,0.00008211073,0.00030831722,0.000112091366,0.00006254836,0.00008387928,0.00032730016,0.00036106963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006512982,0.0009242109,0.9750054,0.00006589694,0.00014774752,0.00842132,0.0031638576,0.00030004673,0.0018528242,0.000021097616,0.0018034326,0.0017812222],"study_design_scores_gemma":[0.014334971,0.0065981834,0.97455394,0.000007340518,0.0002658554,0.00003199262,0.00008216347,0.000060132912,0.0011706955,0.0000052138703,0.0026914147,0.00019810861],"about_ca_topic_score_codex":0.000036371403,"about_ca_topic_score_gemma":0.000007818482,"teacher_disagreement_score":0.013295727,"about_ca_system_score_codex":0.00008696421,"about_ca_system_score_gemma":0.000089821435,"threshold_uncertainty_score":0.901769},"labels":[],"label_agreement":null},{"id":"W3023010843","doi":"10.1016/j.eururo.2020.04.010","title":"Re: Artificial Intelligence for Diagnosis and Grading of Prostate Cancer in Biopsies: A Population-based, Diagnostic Study","year":2020,"lang":"en","type":"letter","venue":"European Urology","topic":"AI in cancer detection","field":"Computer Science","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sinai Health System; Princess Margaret Cancer Centre; Toronto Metropolitan University; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Prostate cancer; Grading (engineering); Prostate; Gynecology; Cancer; Oncology; Radiology; Internal medicine","score_opus":0.045175037710329616,"score_gpt":0.2888313898830617,"score_spread":0.24365635217273207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023010843","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06270206,0.001336283,0.094459645,0.8324597,0.0036226015,0.0048253625,0.00020247349,0.00032076286,0.00007111365],"genre_scores_gemma":[0.90610653,0.00011546497,0.0010079135,0.09124051,0.0009067593,0.00052907947,0.00002093451,0.00006472165,0.000008095562],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9974129,0.00061345403,0.0006201783,0.00083519187,0.0001925516,0.00032570295],"domain_scores_gemma":[0.9968594,0.002259467,0.00037279603,0.0004039604,0.000063234074,0.00004116909],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038352713,0.0002577718,0.0003976582,0.0003201693,0.00007865558,0.00006409655,0.00061808474,0.00010899063,0.000009837965],"category_scores_gemma":[0.0007004167,0.0002713893,0.000060175025,0.0004152547,0.00008213144,0.0001095011,0.00022578405,0.0006274815,0.0000066886137],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003143575,0.0005712253,0.39419726,0.001358051,0.00025634078,0.0027073512,0.01413713,0.020280255,0.000024266465,0.00030997867,0.11591087,0.44993293],"study_design_scores_gemma":[0.0038567977,0.025430128,0.2462553,0.0013628597,0.0010681782,0.00005666831,0.00097115757,0.3461294,0.0024871628,0.03182447,0.3342142,0.0063437093],"about_ca_topic_score_codex":0.0003196868,"about_ca_topic_score_gemma":0.00049680925,"teacher_disagreement_score":0.8434045,"about_ca_system_score_codex":0.00008724771,"about_ca_system_score_gemma":0.00006675689,"threshold_uncertainty_score":0.99997383},"labels":[],"label_agreement":null},{"id":"W3023171487","doi":"10.1016/j.eururo.2020.05.005","title":"Prostate Cancer Risk by BRCA2 Genomic Regions","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research; Cancer Research UK; Royal Marsden NHS Foundation Trust","keywords":"Medicine; Prostate cancer; Hazard ratio; Internal medicine; Prospective cohort study; Oncology; Confidence interval; Cancer; Incidence (geometry); Population; Proportional hazards model; Cohort; Gynecology","score_opus":0.010425501354199972,"score_gpt":0.2359871049903855,"score_spread":0.22556160363618552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023171487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9646859,0.010334819,0.0028672428,0.012340703,0.0004008305,0.0002744564,0.00032884625,0.00007296276,0.008694201],"genre_scores_gemma":[0.98302037,0.0016415735,0.0003646294,0.0131787835,0.0006297952,0.000024520636,0.00014325361,0.00007031873,0.0009267736],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99873775,0.00028962395,0.0001826585,0.00047796872,0.0000577087,0.00025427906],"domain_scores_gemma":[0.999413,0.000010117547,0.00011086282,0.00030067115,0.00004548303,0.00011986831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011508465,0.00014461282,0.00010860199,0.000018155515,0.00009833383,0.000015223965,0.00028012518,0.00006117332,0.0001571845],"category_scores_gemma":[0.000092056674,0.0001507022,0.000060203045,0.00008591319,0.00013109398,0.0000021723754,0.00018192116,0.00016616537,0.0002743495],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017940484,0.000031455656,0.007827958,0.000008774541,0.00015026348,0.000020395706,0.0005202259,0.0015708293,0.5104709,0.000052734205,0.46944386,0.009723162],"study_design_scores_gemma":[0.0005275469,0.00029883417,0.004740776,8.072809e-7,0.00003812272,0.000011477603,0.000022657845,0.000108317516,0.008334753,0.000035462235,0.9856942,0.00018700752],"about_ca_topic_score_codex":0.000015278298,"about_ca_topic_score_gemma":0.000014362417,"teacher_disagreement_score":0.5162504,"about_ca_system_score_codex":0.000021077298,"about_ca_system_score_gemma":0.000090552145,"threshold_uncertainty_score":0.6145457},"labels":[],"label_agreement":null},{"id":"W3023665721","doi":"10.1016/j.eururo.2020.04.060","title":"A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; Achievement Rewards for College Scientists Foundation","keywords":"Medicine; Germline; Prostate cancer; Germline mutation; Cancer; Prostate disease; Oncology; Prostate; Gynecology; Genetics; Internal medicine; Mutation; Gene","score_opus":0.015706495001730335,"score_gpt":0.2688839871800143,"score_spread":0.253177492178284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023665721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722467,0.0021576588,0.015444249,0.0036940626,0.00018541096,0.00076156884,0.00027988246,0.000017903678,0.005212537],"genre_scores_gemma":[0.9984213,0.0002461802,0.00023467887,0.0007527874,0.000100801924,0.00001959989,0.000029265184,0.000037054695,0.00015832874],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998548,0.00026668847,0.00035627588,0.00039821575,0.00011956649,0.00031127987],"domain_scores_gemma":[0.99941975,0.000015556183,0.000114584676,0.00024358631,0.000095528776,0.00011101523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025989447,0.0001345276,0.00025746605,0.00007460999,0.000019954205,0.0000040887535,0.00027958569,0.0000779399,0.000040802803],"category_scores_gemma":[0.00019533731,0.00013875656,0.000057765683,0.0002375106,0.000093536466,0.000001992241,0.00057991507,0.00014399385,0.000008456183],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016556288,0.000034800152,0.00052044215,0.000043611726,0.00006437173,0.000078119534,0.00029575353,0.009847398,0.98518384,0.000024064173,0.000567049,0.0016849113],"study_design_scores_gemma":[0.004928267,0.0038474172,0.0106018605,0.000053232216,0.000058266294,0.00003098298,0.00014987458,0.007881454,0.9174182,0.000026531394,0.05456781,0.00043614258],"about_ca_topic_score_codex":0.000093829905,"about_ca_topic_score_gemma":0.00017806554,"teacher_disagreement_score":0.06776569,"about_ca_system_score_codex":0.000027751408,"about_ca_system_score_gemma":0.000096016185,"threshold_uncertainty_score":0.5658328},"labels":[],"label_agreement":null},{"id":"W3028042488","doi":"10.1016/j.eururo.2020.04.058","title":"Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Hôpital Saint-Luc; Juravinski Cancer Centre; University of Calgary; BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"AKT1; Prostate cancer; PTEN; Cancer research; Medicine; Mutation; Germline mutation; Cancer; Internal medicine; Oncology; PI3K/AKT/mTOR pathway; Biology; Gene; Genetics; Signal transduction","score_opus":0.05629279256817002,"score_gpt":0.33272519908053744,"score_spread":0.27643240651236745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028042488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97329646,0.0012227065,0.000024049401,0.019984925,0.000031422464,0.0004198631,0.000023179267,0.000037483318,0.0049599037],"genre_scores_gemma":[0.99770236,0.00018564776,0.0003526502,0.0012904151,0.00006419811,0.00002872023,0.000036811038,0.000023431176,0.0003157646],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999089,0.00016661268,0.0001863673,0.00024133167,0.00009890094,0.0002177625],"domain_scores_gemma":[0.99963236,0.00007169783,0.00004696439,0.0000766258,0.000041703748,0.00013063176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013310337,0.00009628573,0.0001625049,0.00007038365,0.00006122541,0.00001674968,0.000038189773,0.000013517644,0.000101152466],"category_scores_gemma":[0.00013049807,0.00007783374,0.00001952046,0.00019924752,0.00009302657,0.00006024083,0.000037748363,0.00019601278,0.000030081284],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009002497,0.000669589,0.24100044,0.0010901382,0.0008347759,0.012027337,0.051990274,0.0013432594,0.5301835,0.0011954097,0.0032398796,0.14742288],"study_design_scores_gemma":[0.015151323,0.0038401594,0.93026906,0.00011308014,0.00027015872,0.00014630896,0.002210921,0.004309711,0.0059578796,0.00024405433,0.037015557,0.0004717696],"about_ca_topic_score_codex":0.00006337344,"about_ca_topic_score_gemma":0.000046566187,"teacher_disagreement_score":0.68926865,"about_ca_system_score_codex":0.00003115809,"about_ca_system_score_gemma":0.000112796755,"threshold_uncertainty_score":0.3173968},"labels":[],"label_agreement":null},{"id":"W3028210810","doi":"10.1016/j.eururo.2020.03.017","title":"Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ [European Urology 77 (2020) 223–250]","year":2020,"lang":"en","type":"erratum","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Regret; Urology; Bladder cancer; Consensus conference; General surgery; Gynecology; Cancer; Internal medicine","score_opus":0.05825446353727916,"score_gpt":0.3427683230842654,"score_spread":0.28451385954698627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028210810","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14076048,0.008346729,0.0006514023,0.2825548,0.103528954,0.015535124,0.0066114487,0.00036358344,0.44164747],"genre_scores_gemma":[0.83074886,0.004703751,0.00080045935,0.068137765,0.0026120166,0.00026414904,0.0007450253,0.0004985818,0.09148939],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99500734,0.0015685449,0.0011980211,0.0010023513,0.0006970246,0.0005267366],"domain_scores_gemma":[0.9966943,0.00017101357,0.0009874387,0.0012808705,0.0006545884,0.00021173574],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007486125,0.00070225156,0.0008587224,0.00013292584,0.00029469182,0.000041427204,0.0012273286,0.00016249054,0.00040851292],"category_scores_gemma":[0.00011846064,0.00039466625,0.00017842358,0.00040861586,0.0007897294,0.000054687825,0.0007780017,0.000991171,0.000049689483],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038843963,0.0007541705,0.0019619125,0.00024833818,0.008234844,0.0011727869,0.0037600321,0.0014737496,0.00022087226,0.0039209817,0.967849,0.0065189213],"study_design_scores_gemma":[0.0044064033,0.0024063203,0.106040694,0.00020650485,0.0016682904,0.00007577665,0.0017143487,0.0002804135,0.000056421697,0.00009065412,0.8826649,0.00038925256],"about_ca_topic_score_codex":0.00036907964,"about_ca_topic_score_gemma":0.00052222435,"teacher_disagreement_score":0.6899884,"about_ca_system_score_codex":0.00010856203,"about_ca_system_score_gemma":0.00029706015,"threshold_uncertainty_score":0.9998505},"labels":[],"label_agreement":null},{"id":"W3033018685","doi":"10.1016/j.eururo.2020.04.067","title":"Hunner Lesion Interstitial Cystitis: The Bad, The Good, and The Unknown","year":2020,"lang":"en","type":"letter","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Urological Association Scholarship Fund","keywords":"Medicine; Interstitial cystitis; Lesion; Urology; Dermatology; Surgery; Urinary system; Internal medicine","score_opus":0.02929533968706674,"score_gpt":0.2713594700115161,"score_spread":0.24206413032444937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033018685","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034496782,0.0035294825,0.00006089924,0.8917859,0.0005380339,0.0007406942,0.000025433434,0.000056276705,0.102918305],"genre_scores_gemma":[0.091910504,0.0013389665,0.000010280088,0.88420385,0.008979113,0.000027313163,0.00015520427,0.0001114646,0.013263277],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952111,0.003161083,0.00030772068,0.00048064726,0.00035677664,0.00048263106],"domain_scores_gemma":[0.99785686,0.0011802522,0.00010173667,0.00071597856,0.00006579517,0.00007940283],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009281556,0.00030280097,0.0003900177,0.000060440274,0.0004029185,0.00008913104,0.00065465405,0.00016323348,0.0004110268],"category_scores_gemma":[0.00027911697,0.00012087996,0.00016678339,0.00013388826,0.0017716326,0.00002714064,0.0007370266,0.004108698,0.0008388436],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008629009,0.000011533953,0.000046353318,0.00006075438,0.00018452211,0.0049918955,0.0009285885,8.8369626e-7,0.000017831022,0.00027648028,0.9871145,0.00550377],"study_design_scores_gemma":[0.0016976735,0.0011563494,0.00069522666,0.00002620813,0.00028122467,0.0017629106,0.000052567455,0.000094304625,0.0000028719066,0.00016015825,0.993943,0.00012754544],"about_ca_topic_score_codex":0.000043202683,"about_ca_topic_score_gemma":0.000006093404,"teacher_disagreement_score":0.091565534,"about_ca_system_score_codex":0.000016332518,"about_ca_system_score_gemma":0.00008393759,"threshold_uncertainty_score":0.99993914},"labels":[],"label_agreement":null},{"id":"W3034344253","doi":"10.1016/j.eururo.2020.05.032","title":"Baseline Risks of Venous Thromboembolism and Major Bleeding are Crucial in Decision-making on Thromboprophylaxis","year":2020,"lang":"en","type":"letter","venue":"European Urology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Sigrid Juséliuksen Säätiö; Academy of Finland; Helsingin ja Uudenmaan Sairaanhoitopiiri","keywords":"Medicine; Venous thromboembolism; Baseline (sea); Intensive care medicine; Major bleeding; MEDLINE; Surgery; Thrombosis; Internal medicine; Myocardial infarction","score_opus":0.042523353778677754,"score_gpt":0.3055841308516221,"score_spread":0.26306077707294434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034344253","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39598197,0.0036553699,0.00047856075,0.55842173,0.0033743118,0.0030969633,0.00023905562,0.00033664977,0.03441541],"genre_scores_gemma":[0.61424106,0.00055326096,0.0005190775,0.3810569,0.003346692,0.000014009189,0.000058734207,0.00018030065,0.000029977333],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99605185,0.0005791474,0.0009949058,0.0011487396,0.00054715585,0.0006782331],"domain_scores_gemma":[0.9977065,0.0007482399,0.00062068366,0.000691789,0.00010671732,0.00012611623],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00065174885,0.00060531026,0.0023046685,0.0006953952,0.00011224604,0.000035990884,0.00040077273,0.00042002482,0.0002874539],"category_scores_gemma":[0.0009054989,0.00056148844,0.0002275938,0.0003518213,0.00026763932,0.000050158953,0.0005233688,0.0022915679,0.00019264437],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006273365,0.0011482307,0.0016621324,0.0014772105,0.0007994181,0.0278877,0.0014861539,0.00009862205,0.00033564318,0.00026131407,0.9089577,0.055258505],"study_design_scores_gemma":[0.004688084,0.00820482,0.32047454,0.0030315742,0.0017719683,0.000274432,0.00017844677,0.0003420987,0.00006847434,0.0017433959,0.6578941,0.0013280907],"about_ca_topic_score_codex":0.00007112324,"about_ca_topic_score_gemma":0.000020443942,"teacher_disagreement_score":0.3188124,"about_ca_system_score_codex":0.000081276405,"about_ca_system_score_gemma":0.000067434965,"threshold_uncertainty_score":0.9996837},"labels":[],"label_agreement":null},{"id":"W3034586552","doi":"10.1016/j.eururo.2020.05.018","title":"Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Guideline; Prostate cancer; Medical physics; Prostate; MEDLINE; Biopsy; Prostate-specific antigen; Radiology; Cancer; Pathology; Internal medicine","score_opus":0.058421188360434376,"score_gpt":0.34579229957424346,"score_spread":0.2873711112138091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034586552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761928,0.004413944,0.0016827167,0.01619483,0.00018565968,0.0007664988,0.0004030235,0.0000672351,0.00009331981],"genre_scores_gemma":[0.98993117,0.003648156,0.0042989063,0.0016134664,0.00024657574,0.0001166575,0.00009937882,0.000027027696,0.000018667182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988479,0.00029645432,0.00020942175,0.0003910131,0.00007941112,0.00017580653],"domain_scores_gemma":[0.99938595,0.00021442589,0.00008556878,0.00010030111,0.00008201405,0.000131726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032323107,0.00014891473,0.00028695067,0.000028358745,0.000059447768,0.000025007485,0.000039177794,0.00004564517,0.000025092808],"category_scores_gemma":[0.0001099958,0.00011156128,0.000034758843,0.000037254365,0.00016790305,0.000044665263,0.00005732906,0.00009967499,9.936206e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058908153,0.00013399486,0.7774807,0.0000932782,0.0005296789,0.00038932447,0.0048029707,0.0001329999,0.00318581,0.0001905301,0.00055979,0.15359275],"study_design_scores_gemma":[0.017558869,0.005218385,0.9147045,0.000014979663,0.000078739606,0.00005520071,0.00009043572,0.0048412764,0.00084985874,0.00026112038,0.056100532,0.00022611636],"about_ca_topic_score_codex":0.00000817545,"about_ca_topic_score_gemma":0.000009257113,"teacher_disagreement_score":0.15336664,"about_ca_system_score_codex":0.000023282619,"about_ca_system_score_gemma":0.00003920218,"threshold_uncertainty_score":0.4549337},"labels":[],"label_agreement":null},{"id":"W3035356494","doi":"10.1016/j.eururo.2020.04.061","title":"Five-year Survival Prediction and Safety Outcomes with Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer from the PREVAIL Trial","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Pfizer","keywords":"Enzalutamide; Medicine; Hazard ratio; Prostate cancer; Placebo; Internal medicine; Docetaxel; Adverse effect; Confidence interval; Chemotherapy; Oncology; Cabazitaxel; Proportional hazards model; Survival analysis; Incidence (geometry); Urology; Surgery; Cancer; Androgen deprivation therapy; Pathology; Androgen receptor","score_opus":0.027991985900491928,"score_gpt":0.2827059940051615,"score_spread":0.2547140081046696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035356494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722863,0.0005781579,0.000029140405,0.022979636,0.00004430836,0.0016055446,0.00018954524,0.000041913674,0.0022454422],"genre_scores_gemma":[0.9972901,0.00056607655,0.0001408206,0.0009974575,0.00017051256,0.000063262385,0.0000938172,0.00004312353,0.0006348417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845827,0.0004494301,0.00024291813,0.00036281772,0.00024272368,0.00024387125],"domain_scores_gemma":[0.99937075,0.00020267526,0.000085758955,0.00017407381,0.0000535555,0.00011318952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029599632,0.00017443886,0.00031526366,0.000032775006,0.000078339865,0.000026873327,0.00008160801,0.000022854045,0.00010339135],"category_scores_gemma":[0.0000512945,0.00008855024,0.000026811655,0.00015627831,0.00019456638,0.00006536054,0.000033015644,0.00025998708,0.000009842676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45372996,0.00025927203,0.5216626,0.000080902784,0.0013125006,0.0007790957,0.013551542,0.00027261095,0.002483151,0.000069586866,0.0010179725,0.0047808303],"study_design_scores_gemma":[0.09582329,0.0044413814,0.89423245,0.00003833585,0.000283745,0.000009238256,0.00091526366,0.00029537844,0.00014609478,0.000014944833,0.0036636228,0.00013625447],"about_ca_topic_score_codex":0.00039634714,"about_ca_topic_score_gemma":0.00044413874,"teacher_disagreement_score":0.3725699,"about_ca_system_score_codex":0.000049255847,"about_ca_system_score_gemma":0.00017346263,"threshold_uncertainty_score":0.3610974},"labels":[],"label_agreement":null},{"id":"W3037221203","doi":"10.1016/j.eururo.2020.06.002","title":"Differential Impact of Gonadotropin-releasing Hormone Antagonist Versus Agonist on Clinical Safety and Oncologic Outcomes on Patients with Metastatic Prostate Cancer: A Meta-analysis of Randomized Controlled Trials","year":2020,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Internal medicine; Agonist; Oncology; Randomized controlled trial; Gonadotropin-releasing hormone; Relative risk; Meta-analysis; Gonadotropin-releasing hormone antagonist; Adverse effect; Confidence interval; Cancer; Hormone; Luteinizing hormone; Receptor","score_opus":0.20110476670321595,"score_gpt":0.4695688075371052,"score_spread":0.2684640408338893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037221203","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011118641,0.9750405,0.00001627717,0.0004641677,0.00023089824,0.010108074,0.0024546562,0.000032728658,0.00053407426],"genre_scores_gemma":[0.043427713,0.9548184,0.000046907124,0.000086068605,0.00007459371,0.00022964178,0.0010529839,0.00009206862,0.00017158416],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97739774,0.016224692,0.0043694526,0.0008846183,0.0006661313,0.00045739248],"domain_scores_gemma":[0.980405,0.01398463,0.0044501103,0.0005603777,0.00028910505,0.00031077897],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0031872408,0.00091292674,0.04322656,0.0007464694,0.00009833502,0.00003330036,0.00023815998,0.0001558255,0.00026756144],"category_scores_gemma":[0.0046277624,0.0003733748,0.012409347,0.00057610753,0.00093750935,0.000024986693,0.00012528637,0.0007810056,0.000008935119],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5068603,0.00064815773,0.0002197146,0.0005002666,0.45212594,0.0001316181,0.000033563825,0.00001294316,5.347116e-7,0.000018166606,0.000026535385,0.039422262],"study_design_scores_gemma":[0.3505426,0.014818838,0.003665473,0.00013157305,0.62501454,0.000001760176,0.0000029966554,0.000025150403,1.7412154e-7,0.0000011166228,0.0055905688,0.00020521536],"about_ca_topic_score_codex":0.00008518351,"about_ca_topic_score_gemma":0.000007080939,"teacher_disagreement_score":0.17288859,"about_ca_system_score_codex":0.00023224679,"about_ca_system_score_gemma":0.00075513416,"threshold_uncertainty_score":0.9998718},"labels":[],"label_agreement":null},{"id":"W3038031098","doi":"10.1016/j.eururo.2020.06.016","title":"Re: Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review","year":2020,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; St Joseph's Health Centre; Western University","funders":"","keywords":"Medicine; Prostate cancer; Multidisciplinary approach; Risk assessment; Intensive care medicine; Oncology; Gynecology; Internal medicine; Cancer","score_opus":0.050697400324201794,"score_gpt":0.3438884402095829,"score_spread":0.29319103988538114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038031098","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036419768,0.37243995,0.00006942562,0.5697286,0.00063755625,0.015923453,0.0038266578,0.00016693155,0.0007876262],"genre_scores_gemma":[0.019333964,0.732419,0.0018601419,0.2330861,0.0011739216,0.0015208063,0.0076611703,0.00036138968,0.0025835189],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99728084,0.00061599433,0.0006977657,0.0007592464,0.00030244267,0.0003436921],"domain_scores_gemma":[0.9983721,0.00025539307,0.00057036954,0.00041895502,0.00022205224,0.00016117493],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003146976,0.0004000649,0.0014211762,0.00013472895,0.00009431712,0.00001646975,0.00020858359,0.00015021351,0.000021389213],"category_scores_gemma":[0.00017912092,0.00028680012,0.00010882131,0.00009471642,0.0002498506,0.0000871644,0.00022510697,0.00060912356,0.0000069698376],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013470105,0.0006865367,0.018494619,0.7715684,0.00930513,0.0060641947,0.0018547487,0.000034968518,0.0002733353,0.000025037132,0.09612584,0.082097046],"study_design_scores_gemma":[0.16331978,0.07854848,0.093488164,0.3961823,0.077072114,0.0012619412,0.00038508148,0.002447984,0.0004777648,0.00081447256,0.18085724,0.005144682],"about_ca_topic_score_codex":0.00006071826,"about_ca_topic_score_gemma":0.000008466403,"teacher_disagreement_score":0.37538615,"about_ca_system_score_codex":0.00011962206,"about_ca_system_score_gemma":0.00014787258,"threshold_uncertainty_score":0.9999584},"labels":[],"label_agreement":null},{"id":"W3038542852","doi":"10.1016/j.eururo.2020.06.047","title":"Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Prostatectomy; Lymph node; Prostate cancer; Biochemical recurrence; Dissection (medical); Positron emission tomography; Radiology; Prostate; Urology; Cancer; Internal medicine","score_opus":0.051462145216867684,"score_gpt":0.3303954642954508,"score_spread":0.2789333190785831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038542852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97622365,0.00073652685,0.0001695922,0.019848656,0.00040395293,0.0010796434,0.0012213282,0.000078505574,0.0002381193],"genre_scores_gemma":[0.99655664,0.0002573654,0.00038617177,0.0004892033,0.00050464435,0.00017990678,0.00095825247,0.00005221685,0.00061558775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976539,0.00040753064,0.0005237672,0.0006608271,0.00029075454,0.0004632198],"domain_scores_gemma":[0.99896276,0.00021262979,0.00018796754,0.00024187569,0.00017193203,0.00022284663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003334685,0.0002837893,0.0003875698,0.00007905551,0.0003372194,0.00006449859,0.00014289346,0.00009523706,0.00008021715],"category_scores_gemma":[0.00021452723,0.00017666533,0.00014221479,0.00020676055,0.00064008543,0.00021206182,0.00015017754,0.00035416507,0.000013593655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14170572,0.0012540556,0.738815,0.0008637021,0.0011830898,0.005494257,0.028915921,0.0008600541,0.062329207,0.000060499522,0.0015834996,0.016934987],"study_design_scores_gemma":[0.038533784,0.0032128547,0.8740001,0.00051616743,0.0007321296,0.0009380597,0.00076096394,0.009108244,0.016543638,0.00007495832,0.054747246,0.0008318833],"about_ca_topic_score_codex":0.0003250998,"about_ca_topic_score_gemma":0.00016552956,"teacher_disagreement_score":0.13518506,"about_ca_system_score_codex":0.00021970973,"about_ca_system_score_gemma":0.00030343968,"threshold_uncertainty_score":0.7204203},"labels":[],"label_agreement":null},{"id":"W3038750967","doi":"10.1016/j.eururo.2020.06.043","title":"Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"National Cancer Institute","keywords":"Medicine; Biochemical recurrence; Prostate cancer; Prostatectomy; Interquartile range; Androgen deprivation therapy; Lymph node; Urology; Salvage therapy; Dissection (medical); Proportional hazards model; Prostate-specific antigen; Positron emission tomography; Lymphadenectomy; Surgery; Cancer; Internal medicine; Radiology; Chemotherapy","score_opus":0.022522269793311882,"score_gpt":0.30338785393834733,"score_spread":0.28086558414503543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038750967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881158,0.0021590402,0.00010977201,0.006593748,0.00028535517,0.001679903,0.00023337566,0.000063962805,0.00075905485],"genre_scores_gemma":[0.9944912,0.0010054386,0.00023479943,0.003309097,0.00016467573,0.0003623717,0.00008544885,0.00007292418,0.0002740247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980914,0.00018211658,0.000572963,0.0005473796,0.0002170052,0.00038914502],"domain_scores_gemma":[0.998883,0.0001365724,0.000303967,0.0003030601,0.00014733506,0.0002260289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001983618,0.0002748635,0.0006679443,0.00006817355,0.00003964591,0.000010440809,0.00013900016,0.00006569023,0.00015348732],"category_scores_gemma":[0.00023763155,0.00021293758,0.00020183329,0.00016265111,0.00021972861,0.00007306161,0.000097566975,0.00016321674,0.00004508746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006401772,0.00052229816,0.97190344,0.0008092023,0.0003818025,0.0004055011,0.0017075586,0.000015015163,0.0023102025,0.0001454736,0.0002016169,0.0151961],"study_design_scores_gemma":[0.005751152,0.0038938303,0.9662311,0.00017505868,0.0004971338,0.00005976143,0.000017014549,0.000029283778,0.019875502,0.000024873965,0.0032402365,0.00020505628],"about_ca_topic_score_codex":0.000034752433,"about_ca_topic_score_gemma":0.000008957328,"teacher_disagreement_score":0.0175653,"about_ca_system_score_codex":0.00007678139,"about_ca_system_score_gemma":0.00020511034,"threshold_uncertainty_score":0.86833423},"labels":[],"label_agreement":null},{"id":"W3040294580","doi":"10.1016/j.eururo.2020.06.026","title":"Re: Reconsidering Prostate Cancer Mortality - The Future of PSA Screening","year":2020,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University Health Network","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Prostate cancer; Prostate; Prostate disease; Cancer; Prostate cancer screening; Prostate-specific antigen; Gynecology; Oncology; Urology; Internal medicine","score_opus":0.05442791017858508,"score_gpt":0.28600609557359363,"score_spread":0.23157818539500855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040294580","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007789048,0.01327756,0.000009799567,0.9723238,0.00090950954,0.0007473863,0.00023385182,0.00008295675,0.0046260925],"genre_scores_gemma":[0.050833527,0.005157119,0.00015444821,0.9348622,0.007861532,0.00009151134,0.00032408646,0.00014550173,0.0005700639],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99789274,0.00044816383,0.00047698274,0.00056402007,0.0002340142,0.0003840786],"domain_scores_gemma":[0.9986618,0.00014099007,0.00038886967,0.0006348803,0.000092491406,0.00008094797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020969399,0.00033518544,0.00063671987,0.00005729178,0.000085104446,0.000016577342,0.00020744166,0.00015417073,0.00032670252],"category_scores_gemma":[0.00004618552,0.00022126615,0.00021082697,0.0001334787,0.00020786283,0.000028560977,0.0001641293,0.0015503338,0.00004493175],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105771636,0.000023209435,0.019899322,0.0002849186,0.00074961537,0.0050976295,0.0006629174,0.000014491924,0.00002608631,0.0000048451407,0.9561243,0.017006887],"study_design_scores_gemma":[0.00075519126,0.00047659216,0.019790228,0.000117387244,0.00071742595,0.00005278919,0.00005727999,0.000011832634,0.00013402663,0.00003426257,0.9776796,0.00017339281],"about_ca_topic_score_codex":0.00006452167,"about_ca_topic_score_gemma":0.000049354705,"teacher_disagreement_score":0.04304448,"about_ca_system_score_codex":0.00005006334,"about_ca_system_score_gemma":0.00012664824,"threshold_uncertainty_score":0.90229714},"labels":[],"label_agreement":null},{"id":"W3040296184","doi":"10.1016/j.eururo.2020.06.039","title":"Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysis","year":2020,"lang":"en","type":"review","venue":"European Urology","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University Health Centre","funders":"National Institute for Health and Care Research; U.S. Department of Defense","keywords":"Medicine; Cystectomy; Confidence interval; Perioperative; Meta-analysis; Complication; Comorbidity; Surgery; Internal medicine; Bladder cancer; Cancer","score_opus":0.19987396724655943,"score_gpt":0.41317563257038903,"score_spread":0.2133016653238296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040296184","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000747822,0.9757712,0.00029513607,0.00014241338,0.00013121811,0.023135902,0.00030685554,0.000074707765,0.00006777724],"genre_scores_gemma":[0.0011160738,0.98120195,0.00073031295,0.002203192,0.00006931783,0.012617374,0.0018130601,0.0001991829,0.000049534727],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9841333,0.004960751,0.00833992,0.0014334265,0.000672631,0.0004599515],"domain_scores_gemma":[0.9855795,0.0021813542,0.009682888,0.002241692,0.00008897357,0.00022558172],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.007222517,0.0007831134,0.018239679,0.0007098352,0.000047832815,0.000043556593,0.00044624053,0.00017920262,0.0002112212],"category_scores_gemma":[0.007207477,0.0005339255,0.0051862746,0.0010892475,0.00007950541,0.00021069184,0.0009201308,0.0006222299,0.00003169757],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026368401,0.00006176347,0.0002942346,0.71183395,0.24533235,0.0016507708,0.00008567868,1.1883067e-7,5.597839e-7,2.9166182e-7,0.0002545431,0.04045938],"study_design_scores_gemma":[0.0001904043,0.00024942763,0.0001792787,0.037733335,0.9174516,0.00027977795,0.000016241074,4.314844e-7,0.0000025010966,7.8899376e-7,0.043450605,0.00044559958],"about_ca_topic_score_codex":0.000006200062,"about_ca_topic_score_gemma":0.000008345379,"teacher_disagreement_score":0.67410064,"about_ca_system_score_codex":0.000052912404,"about_ca_system_score_gemma":0.00039156227,"threshold_uncertainty_score":0.9997112},"labels":[],"label_agreement":null},{"id":"W3042323140","doi":"10.1016/j.eururo.2020.07.002","title":"FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"KWF Kankerbestrijding; University of Toronto","keywords":"Fibroblast growth factor receptor 3; Cystectomy; Medicine; Bladder cancer; Cancer research; Fibroblast growth factor receptor 4; Cancer; Fibroblast growth factor receptor; Oncology; Mutant; Mutation; Internal medicine; Pathology; Fibroblast growth factor; Receptor; Biology; Gene; Genetics","score_opus":0.02178128534591488,"score_gpt":0.3026336147215789,"score_spread":0.280852329375664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042323140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98353744,0.0031729592,0.0009758404,0.0071927854,0.00008315352,0.0018290383,0.00079350115,0.00015816478,0.0022570956],"genre_scores_gemma":[0.99472594,0.000764784,0.0001697627,0.0027907256,0.00017885088,0.00030903454,0.0006625911,0.0000766977,0.00032161758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982522,0.00023328503,0.000337563,0.0006110987,0.00009217334,0.00047364054],"domain_scores_gemma":[0.99921507,0.00009527672,0.00010004497,0.00022091446,0.00005501498,0.00031368723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009295762,0.00026265238,0.00044095996,0.00009250274,0.0001149037,0.000018213772,0.00006900975,0.00009742899,0.00018909917],"category_scores_gemma":[0.000068814006,0.00021493914,0.00007598259,0.0002016276,0.00009185165,0.00007021192,0.00003790343,0.0001389174,0.000029904575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017859713,0.000798677,0.9248952,0.00006246425,0.0004160091,0.0001622013,0.0020712768,0.000013116979,0.046696097,0.000059787704,0.008392559,0.014646634],"study_design_scores_gemma":[0.019015182,0.00323502,0.8473148,0.000022098762,0.00059027976,0.000054895223,0.000063442974,0.00035687638,0.0035049708,0.000028398934,0.12554087,0.00027318788],"about_ca_topic_score_codex":0.0001706561,"about_ca_topic_score_gemma":0.000051629944,"teacher_disagreement_score":0.11714831,"about_ca_system_score_codex":0.000115119394,"about_ca_system_score_gemma":0.00010936165,"threshold_uncertainty_score":0.8764963},"labels":[],"label_agreement":null},{"id":"W3042541691","doi":"10.1016/j.eururo.2020.06.053","title":"Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of British Columbia; Queen Elizabeth II Health Sciences Centre; University of Ottawa; McGill University Health Centre; Queen's University; University of Toronto; Western University; University of Manitoba; Princess Margaret Cancer Centre; Dalhousie University; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Interquartile range; Biopsy; Renal cell carcinoma; Cohort; Clear cell; Histology; Doubling time; Pathology; Radiology; Urology; Internal medicine; Cell","score_opus":0.0377270233563232,"score_gpt":0.22892915566113434,"score_spread":0.19120213230481115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042541691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655065,0.0009120151,0.00021866069,0.010014444,0.00021910883,0.00045688648,0.000011630361,0.00014372566,0.022517012],"genre_scores_gemma":[0.99506664,0.00018753398,0.0007692299,0.0030639335,0.00032016594,0.000016863165,0.0001541189,0.00007132734,0.00035015595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747175,0.0007801486,0.00049182447,0.00067065016,0.0001357921,0.0004498387],"domain_scores_gemma":[0.99905396,0.00012879551,0.00014107625,0.00034261288,0.00007682267,0.00025675938],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040582885,0.00027941077,0.00062855886,0.00014967169,0.000037679576,0.000012754388,0.00018992416,0.000091073336,0.00035967832],"category_scores_gemma":[0.00016567938,0.00024429764,0.000118815464,0.0002642731,0.0001784176,0.000027133045,0.000090513364,0.0004120278,0.0010519009],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026820428,0.00013640383,0.737594,0.000041815158,0.00011784148,0.014046634,0.00034499954,0.0000033727779,0.24206075,0.00017474612,0.0023271958,0.00047019066],"study_design_scores_gemma":[0.0034291467,0.000904953,0.96479684,0.0000070692677,0.000042950258,0.0006110107,0.000011888352,0.000061590625,0.001386144,0.000024027433,0.028524214,0.00020019304],"about_ca_topic_score_codex":0.000014726993,"about_ca_topic_score_gemma":0.0000053204603,"teacher_disagreement_score":0.2406746,"about_ca_system_score_codex":0.000092179806,"about_ca_system_score_gemma":0.000049850238,"threshold_uncertainty_score":0.9997259},"labels":[],"label_agreement":null},{"id":"W3081138644","doi":"10.1016/j.eururo.2020.08.004","title":"The 2019 International Society of Urological Pathology Consensus Conference on Prostate Cancer Grading","year":2020,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Grading (engineering); Prostate cancer; Prostate; Consensus conference; Carcinoma; Magnetic resonance imaging; Pathology; Cribriform; Cancer; General surgery; Radiology; Internal medicine","score_opus":0.02733613318987957,"score_gpt":0.2988687388141064,"score_spread":0.2715326056242269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081138644","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012065553,0.005808832,0.000010222989,0.10473668,0.8550429,0.0012801808,0.002507694,0.00014810852,0.018399842],"genre_scores_gemma":[0.18120669,0.071996115,0.00029244335,0.010737758,0.7273414,0.00025997244,0.002615329,0.0002593391,0.005290924],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977922,0.00036388653,0.00048804824,0.00062804244,0.0003675482,0.00036026424],"domain_scores_gemma":[0.9976725,0.0010961369,0.0004372779,0.00034102722,0.00032854965,0.00012448133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038547567,0.00032110952,0.000582059,0.000036884812,0.00010276026,0.000022917366,0.00032425183,0.0002726939,0.000074979485],"category_scores_gemma":[0.0004927591,0.00020550964,0.00024681032,0.00006831394,0.00057640846,0.000009592116,0.00021271787,0.0010855572,0.00009651037],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001226719,0.00011848157,0.0011895007,0.00003301347,0.00048481798,0.0005852662,0.00027359382,0.000009868937,0.00021307437,0.00036512822,0.9920388,0.0034617283],"study_design_scores_gemma":[0.0019611693,0.0026705351,0.003640684,0.00005393415,0.00023585047,0.00002613074,0.00001979685,0.000056756966,0.00007140977,0.00010925377,0.9910032,0.00015124539],"about_ca_topic_score_codex":0.000021237309,"about_ca_topic_score_gemma":0.0000043259793,"teacher_disagreement_score":0.16914114,"about_ca_system_score_codex":0.00012096627,"about_ca_system_score_gemma":0.00042126613,"threshold_uncertainty_score":0.838044},"labels":[],"label_agreement":null},{"id":"W3081748145","doi":"10.1016/j.eururo.2020.08.030","title":"The Impact of the COVID-19 Pandemic on Genitourinary Cancer Care: Re-envisioning the Future","year":2020,"lang":"en","type":"review","venue":"European Urology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Bayer Fund; Janssen Pharmaceuticals; Genentech; AstraZeneca; Blavatnik Family Foundation; National Institute on Handicapped Research; Astellas Pharma US; Sanofi; National Cancer Institute; Prostate Cancer Foundation","keywords":"Medicine; Pandemic; Telemedicine; Triage; Health care; Telehealth; Multidisciplinary approach; Socioeconomic status; Medical emergency; Intensive care medicine; Coronavirus disease 2019 (COVID-19); Family medicine; Disease; Population; Environmental health; Pathology; Infectious disease (medical specialty)","score_opus":0.1398211783527255,"score_gpt":0.4683102474665392,"score_spread":0.3284890691138137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081748145","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013715068,0.95925456,0.000002721364,0.03583734,0.0010546301,0.0013384303,0.00012550592,0.000068748595,0.0021808918],"genre_scores_gemma":[0.006090027,0.969299,0.0000018679486,0.02037868,0.0038215653,0.000026842295,0.000025118052,0.00012404207,0.00023286384],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944789,0.0033522143,0.00072267035,0.0005299406,0.0003605682,0.00055572065],"domain_scores_gemma":[0.9952329,0.0021602472,0.00071014406,0.0013832484,0.00009012394,0.00042335957],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0009971661,0.00050969806,0.0012592574,0.00009286025,0.0006383711,0.000025703028,0.0010039244,0.0002588465,0.00015263152],"category_scores_gemma":[0.0016519004,0.00018964437,0.0010419067,0.00047548572,0.00033738848,0.000016583597,0.00043830927,0.0023458914,0.00010583852],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003323727,0.00002458922,0.0011168317,0.0043508816,0.00037855608,0.00034828557,0.0016242424,0.0000403279,0.0000010523911,0.000047807713,0.036302503,0.95543253],"study_design_scores_gemma":[0.00039927143,0.0010936195,0.0044118813,0.00071655784,0.00074176164,0.000527234,0.00011739434,0.000002724477,4.514036e-8,0.000009016648,0.9918233,0.00015718144],"about_ca_topic_score_codex":0.0003536254,"about_ca_topic_score_gemma":0.00015929365,"teacher_disagreement_score":0.9555208,"about_ca_system_score_codex":0.00075404515,"about_ca_system_score_gemma":0.0042051366,"threshold_uncertainty_score":0.9999557},"labels":[],"label_agreement":null},{"id":"W3083310601","doi":"10.1016/j.eururo.2020.08.011","title":"Apalutamide and Overall Survival in Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":290,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Janssen Research and Development","keywords":"Medicine; Prostate; Prostate cancer; Oncology; Cancer; Urology; Gynecology; Internal medicine","score_opus":0.036342933274420584,"score_gpt":0.3024633613023374,"score_spread":0.26612042802791686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083310601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9510084,0.0023922836,0.0000036926729,0.028511675,0.00007291042,0.0002502436,0.000009909929,0.0000398422,0.017711058],"genre_scores_gemma":[0.99348974,0.0013021753,0.000027247774,0.0039203935,0.0001533325,0.000008051903,0.000012585536,0.000024027571,0.0010624676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991541,0.00015549916,0.00011989028,0.00024453984,0.00008662314,0.0002393645],"domain_scores_gemma":[0.9996961,0.000031010582,0.000020712294,0.00008224224,0.000020571411,0.00014941231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013244957,0.00008762539,0.00016899953,0.000044113553,0.000021607384,0.000008010077,0.00004557958,0.000017637072,0.00012160524],"category_scores_gemma":[0.000051084276,0.00006828765,0.0000192804,0.00009041612,0.0000891412,0.000028156106,0.000078884164,0.0002020595,0.00007864277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035136498,0.00010524752,0.9504241,0.0001439221,0.00010310172,0.0045307255,0.0035460019,0.000047727666,0.011516694,0.00029734548,0.0032715008,0.022499986],"study_design_scores_gemma":[0.0064198705,0.001094419,0.8987105,0.00001673463,0.000035160287,0.00003451815,0.00005970936,0.0004558199,0.0002940404,0.0000571877,0.092690066,0.00013197804],"about_ca_topic_score_codex":0.00004893629,"about_ca_topic_score_gemma":0.000018836106,"teacher_disagreement_score":0.08941857,"about_ca_system_score_codex":0.000021622334,"about_ca_system_score_gemma":0.00004837299,"threshold_uncertainty_score":0.27846897},"labels":[],"label_agreement":null},{"id":"W3087662097","doi":"10.1016/j.eururo.2020.09.001","title":"The Link Between the Gut Microbiome and Response to Immune Checkpoint Inhibitors in Renal Cell Carcinoma","year":2020,"lang":"en","type":"letter","venue":"European Urology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Renal cell carcinoma; Gut microbiome; Immune system; Microbiome; Immune checkpoint; Immunology; Cancer research; Gut flora; Oncology; Bioinformatics; Immunotherapy","score_opus":0.02378723311206998,"score_gpt":0.27441792397639664,"score_spread":0.25063069086432666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087662097","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3254351,0.0011522545,0.000006062726,0.6680947,0.00013622966,0.00064400607,0.000020085947,0.00002197676,0.004489582],"genre_scores_gemma":[0.5358992,0.00017207226,0.0001440062,0.44268298,0.010274549,0.00004624663,0.00013076159,0.00015878878,0.010491356],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99392617,0.0037865886,0.0007395217,0.00058637897,0.00024139704,0.0007199521],"domain_scores_gemma":[0.9963997,0.002428569,0.00017834449,0.00075982354,0.000069608184,0.00016392628],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0025864486,0.00033084894,0.0007736899,0.00024118004,0.00023109936,0.00003760736,0.0005535182,0.0003474682,0.00004928306],"category_scores_gemma":[0.0009373894,0.00019236657,0.0001348713,0.00029470812,0.00071429665,0.000013602983,0.00068411365,0.0035677648,0.0006531341],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003914934,0.000021707292,0.028917884,0.0001329931,0.00018641297,0.013166592,0.0028052956,3.7509398e-7,0.04679037,0.0000020762714,0.89938563,0.0046757185],"study_design_scores_gemma":[0.0011286096,0.0014909182,0.20855561,0.00002391313,0.00015431581,0.00016555854,0.000032010863,0.00000554076,0.00019451049,0.000015815598,0.78809017,0.00014301148],"about_ca_topic_score_codex":0.00006603718,"about_ca_topic_score_gemma":0.000006350017,"teacher_disagreement_score":0.2254117,"about_ca_system_score_codex":0.000102115286,"about_ca_system_score_gemma":0.00031141075,"threshold_uncertainty_score":0.998731},"labels":[],"label_agreement":null},{"id":"W3088359032","doi":"10.1016/j.eururo.2020.09.006","title":"Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":262,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Gross domestic product; Per capita; Incidence (geometry); Demography; Mortality rate; Cancer; Environmental health; Population; Surgery; Internal medicine","score_opus":0.04096937007477142,"score_gpt":0.30562649293941185,"score_spread":0.26465712286464044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088359032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928119,0.0024421148,0.000020617375,0.003089173,0.000038088234,0.00014547013,0.00018098706,0.000026030166,0.0012455881],"genre_scores_gemma":[0.9976347,0.0003005045,0.000059833783,0.0017569633,0.00012393737,0.0000056119025,0.000012481086,0.00001775384,0.00008818561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915403,0.00011613492,0.00014581194,0.00032577087,0.000087913075,0.00017033554],"domain_scores_gemma":[0.99953175,0.00005156787,0.00007377381,0.00013915468,0.00006556121,0.00013817466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008564318,0.00014153088,0.00026268876,0.000026751186,0.00005502623,0.00001994102,0.000041306113,0.000025843454,0.000063737425],"category_scores_gemma":[0.00007570139,0.00009810641,0.000017812099,0.00010087295,0.00023170718,0.00008682484,0.00008860195,0.0000847348,0.0000031517563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015518608,0.000042750726,0.9940126,0.000019622736,0.00025857406,0.00006288038,0.0014177687,0.000005255554,0.0002996362,0.00007146509,0.0003626392,0.0032915997],"study_design_scores_gemma":[0.0013408569,0.00075628737,0.9966049,0.0000070599144,0.00030550876,0.00011759356,0.00005156685,0.00002192065,0.000027368309,0.00002366954,0.0006574695,0.000085791246],"about_ca_topic_score_codex":0.00050208153,"about_ca_topic_score_gemma":0.0004352118,"teacher_disagreement_score":0.004822797,"about_ca_system_score_codex":0.000019602927,"about_ca_system_score_gemma":0.000058053574,"threshold_uncertainty_score":0.40006632},"labels":[],"label_agreement":null},{"id":"W3088645697","doi":"10.1016/j.eururo.2020.09.019","title":"Are We Moving Closer to Accurate Restaging after Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer?","year":2020,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Bladder cancer; Chemotherapy; Neoadjuvant therapy; Cancer; Urology; Oncology; Radiology; Surgery; Internal medicine; Breast cancer","score_opus":0.04181905133073745,"score_gpt":0.30261550186579694,"score_spread":0.2607964505350595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088645697","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040957117,0.0023497154,0.0005143557,0.98582304,0.0013847222,0.002066125,0.000636984,0.00026099608,0.0028683278],"genre_scores_gemma":[0.023398029,0.0008240022,0.00047346085,0.95692796,0.012312994,0.00047982438,0.0002012009,0.0005236609,0.004858873],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99655795,0.00031575857,0.00055299676,0.0013073494,0.0003146335,0.00095130247],"domain_scores_gemma":[0.9981524,0.00022472825,0.00039872475,0.0007430261,0.00018673265,0.0002944357],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000116250565,0.0007499343,0.0010240893,0.00023711151,0.0001255733,0.000059970585,0.00038312477,0.00033052772,0.0007181647],"category_scores_gemma":[0.00013670932,0.0006617771,0.00037791813,0.00020584089,0.00010226008,0.00006346718,0.00017684266,0.0013707939,0.00042337776],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001255983,0.00004537472,0.00074946566,0.000380523,0.00071112544,0.009716913,0.0012610934,0.000015546988,0.00041361235,0.0000011210799,0.9754999,0.00994934],"study_design_scores_gemma":[0.0032293138,0.00096551393,0.0077968314,0.0002901404,0.00068735564,0.00006386704,0.00004983259,0.000018702993,0.000217639,0.00004922743,0.98606247,0.0005691079],"about_ca_topic_score_codex":0.00004804871,"about_ca_topic_score_gemma":0.00004578064,"teacher_disagreement_score":0.028895108,"about_ca_system_score_codex":0.00017486059,"about_ca_system_score_gemma":0.00025570567,"threshold_uncertainty_score":0.99958336},"labels":[],"label_agreement":null},{"id":"W3090562759","doi":"10.1016/j.eururo.2020.08.025","title":"Prostate-specific Antigen Progression in Enzalutamide-treated Men with Nonmetastatic Castration-resistant Prostate Cancer: Any Rise in Prostate-specific Antigen May Require Closer Monitoring","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Astellas Pharma US; Pfizer","keywords":"Medicine; Prostate cancer; Enzalutamide; Prostate-specific antigen; Urology; Prostate; Antigen; Oncology; Castration; Internal medicine; Cancer; Immunology; Hormone; Androgen receptor","score_opus":0.04052337154656442,"score_gpt":0.312660925060009,"score_spread":0.27213755351344454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090562759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779157,0.010238314,0.0000064077653,0.004876248,0.0001289843,0.004093051,0.00014114844,0.00019589023,0.0024042728],"genre_scores_gemma":[0.988243,0.009139092,0.00061429973,0.0001290465,0.0002731109,0.00033138692,0.0002636555,0.00021414922,0.00079225993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99449813,0.0009152744,0.0010678953,0.0014177446,0.0007161183,0.0013848137],"domain_scores_gemma":[0.9981978,0.00010073826,0.00034825905,0.0005884658,0.0002493625,0.00051540957],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007812257,0.00066756917,0.00090207875,0.000497504,0.00021436658,0.0001296702,0.00032786006,0.000118204625,0.00013719016],"category_scores_gemma":[0.00005275069,0.0005052456,0.00009644281,0.0014208711,0.00043552433,0.0004485513,0.00018457387,0.00093142426,0.00015935884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02700464,0.00060477655,0.7652503,0.0003704002,0.00018325158,0.016940268,0.009713298,0.00046446102,0.16386853,0.000022800525,0.00078054453,0.014796679],"study_design_scores_gemma":[0.01750737,0.0078052664,0.9038752,0.00089860155,0.000083933104,0.00008536867,0.0017589045,0.00046009483,0.02611324,0.000025753887,0.04048288,0.00090340304],"about_ca_topic_score_codex":0.00025438162,"about_ca_topic_score_gemma":0.00010041765,"teacher_disagreement_score":0.13862485,"about_ca_system_score_codex":0.00040389766,"about_ca_system_score_gemma":0.0004055079,"threshold_uncertainty_score":0.99973994},"labels":[],"label_agreement":null},{"id":"W3093951006","doi":"10.1016/j.eururo.2020.09.048","title":"Significantly Minimizing Drug Wastage and the Cost of Cabazitaxel Used to Treat Metastatic Castration-Resistant Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cabazitaxel; Medicine; Vial; Prostate cancer; Docetaxel; Drug; Oncology; Chemotherapy; Internal medicine; Urology; Androgen deprivation therapy; Surgery; Cancer; Pharmacology","score_opus":0.059502030270270755,"score_gpt":0.31639045980587904,"score_spread":0.2568884295356083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093951006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95233756,0.0018655825,0.000060594677,0.04075007,0.000051535662,0.0015981698,0.00015800967,0.000034480345,0.0031439746],"genre_scores_gemma":[0.9963269,0.00025157677,0.00017317095,0.0016733706,0.00007378314,0.000059514474,0.000025104673,0.000035614634,0.0013809286],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99846834,0.00043633918,0.00030105657,0.00031378688,0.00019375776,0.00028671222],"domain_scores_gemma":[0.99915516,0.00024024211,0.000093174574,0.00018922899,0.000089225556,0.00023298684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035851746,0.00015799371,0.0003634274,0.00006454475,0.000088726156,0.000021210848,0.000105982814,0.000013476465,0.00008797951],"category_scores_gemma":[0.00015044134,0.000094187555,0.00005741194,0.00020925996,0.00031117574,0.00003788934,0.00007767349,0.00016866998,0.000030860254],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.062165875,0.00053642975,0.020064445,0.001472771,0.0014220455,0.004649926,0.13899346,0.0009489548,0.7175909,0.0013526694,0.020408286,0.030394232],"study_design_scores_gemma":[0.23899044,0.024687963,0.24845767,0.00074669335,0.008228853,0.00049038365,0.039746676,0.00795681,0.21998335,0.00030585125,0.2073519,0.0030534088],"about_ca_topic_score_codex":0.0001548956,"about_ca_topic_score_gemma":0.00007924047,"teacher_disagreement_score":0.49760756,"about_ca_system_score_codex":0.000027105256,"about_ca_system_score_gemma":0.00012386969,"threshold_uncertainty_score":0.38408569},"labels":[],"label_agreement":null},{"id":"W3097074307","doi":"10.1016/j.eururo.2020.10.006","title":"The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis","year":2020,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Nivolumab; Internal medicine; Hazard ratio; Ipilimumab; Oncology; Odds ratio; Confidence interval; Response Evaluation Criteria in Solid Tumors; Meta-analysis; Cancer; Immunotherapy; Progressive disease; Disease","score_opus":0.033800532151267354,"score_gpt":0.25898902668824697,"score_spread":0.22518849453697962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097074307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023223262,0.9871256,0.000013254268,0.000095502524,0.0000072972184,0.009935651,0.000079727055,0.000030592066,0.00039005044],"genre_scores_gemma":[0.09224271,0.90533954,0.00027810858,0.00013241435,0.00001984532,0.0011011099,0.00046777618,0.00021434062,0.00020413313],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9917574,0.0040991222,0.002229224,0.0009136379,0.00054636283,0.00045428876],"domain_scores_gemma":[0.9957482,0.00055596454,0.0020856534,0.0011043452,0.00026472047,0.0002410755],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011762492,0.0009291168,0.010039037,0.0003884892,0.000068463145,0.000029531733,0.00029992757,0.00008717502,0.000010318788],"category_scores_gemma":[0.00020517275,0.00039309353,0.0014468388,0.0013212749,0.00026267656,0.000040326846,0.0001599455,0.00060059194,0.000013737324],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008252773,0.00079516426,0.0016858502,0.730765,0.26234284,0.0021642454,0.00037175207,0.0000063170833,5.735037e-7,0.000009067394,0.000016539418,0.0010173831],"study_design_scores_gemma":[0.0018073963,0.0073191924,0.001922488,0.009288907,0.97758704,0.00017513603,0.00001832482,0.0000070789533,0.000009563108,6.47252e-7,0.0015529017,0.00031130825],"about_ca_topic_score_codex":0.000057302346,"about_ca_topic_score_gemma":0.000010399769,"teacher_disagreement_score":0.7214761,"about_ca_system_score_codex":0.00014598745,"about_ca_system_score_gemma":0.00022351321,"threshold_uncertainty_score":0.9998521},"labels":[],"label_agreement":null},{"id":"W3097849656","doi":"10.1016/j.eururo.2020.10.024","title":"Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Surrey Place Centre; Princess Margaret Cancer Centre; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Teratoma; Malignancy; Germ cell tumors; Germ cell; Cohort; Oncology; Pathology; Internal medicine; Chemotherapy; Gastroenterology; Biology","score_opus":0.025530493978185152,"score_gpt":0.26091140805753443,"score_spread":0.23538091407934927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097849656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974714,0.00071431854,0.000034494624,0.00024392884,0.000033993452,0.00041931515,0.00003430124,0.000034372522,0.0010138877],"genre_scores_gemma":[0.99880636,0.000018079712,0.00033030883,0.0006814282,0.000026150768,0.0000063482667,0.000054101598,0.000039279654,0.000037971247],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99855727,0.00027657332,0.00035524648,0.00044701726,0.00012359649,0.00024031257],"domain_scores_gemma":[0.99922884,0.00008765392,0.00017450846,0.00016915129,0.000045398734,0.00029445416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084515836,0.0002048687,0.00036848662,0.00010959897,0.000039007202,0.000014701328,0.000072014096,0.000042744497,0.00004510462],"category_scores_gemma":[0.0001159918,0.00016990182,0.000048746453,0.00015072433,0.00006004173,0.000046534333,0.00016821116,0.0001453759,0.000023500017],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005270528,0.00035227442,0.37663037,0.00016762054,0.000026414747,0.0037892,0.0018158542,0.000011743875,0.61460584,0.000005047671,0.00011766139,0.0019508918],"study_design_scores_gemma":[0.0028211032,0.0006974358,0.97006464,0.00016934914,0.000100921956,0.000089233254,0.0001699746,0.00034308634,0.025172206,0.000007685272,0.00021958437,0.00014477457],"about_ca_topic_score_codex":0.00004557852,"about_ca_topic_score_gemma":0.0000021040578,"teacher_disagreement_score":0.5934343,"about_ca_system_score_codex":0.000016877766,"about_ca_system_score_gemma":0.00002610398,"threshold_uncertainty_score":0.6928395},"labels":[],"label_agreement":null},{"id":"W3104397273","doi":"10.1016/j.eururo.2020.10.019","title":"European Association of Urology Position Paper on the Prevention of Infectious Complications Following Prostate Biopsy","year":2020,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"European Association of Urology","keywords":"Medicine; Prostate biopsy; Antibiotic prophylaxis; Urology; Biopsy; Prostate cancer; Prostate; European union; Antibiotics; Surgery; Internal medicine; Cancer","score_opus":0.011072518167959683,"score_gpt":0.26295651539104997,"score_spread":0.2518839972230903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104397273","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13567722,0.0027938064,0.00044006383,0.06428079,0.57875395,0.0070804493,0.0017806184,0.00056729175,0.20862584],"genre_scores_gemma":[0.93243814,0.00058181817,0.00004208576,0.0016948046,0.062470816,0.00007535413,0.0021286537,0.00013758648,0.00043075363],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966166,0.0016085887,0.0006760901,0.00046736334,0.00038361666,0.00024774912],"domain_scores_gemma":[0.9972193,0.00092966214,0.0010266055,0.00046554732,0.0002859288,0.00007293893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085044955,0.00027307303,0.00055765605,0.00013089317,0.00009679863,0.0000127428575,0.0001751926,0.00018595351,0.00004555522],"category_scores_gemma":[0.0011066588,0.00021154866,0.00032802628,0.00020428012,0.00008387862,0.000040442716,0.0001042217,0.00063280284,0.00016069452],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080595975,0.0013159208,0.0076307673,0.0002759356,0.0021400067,0.0002463561,0.0010318906,0.00006941126,0.0068806373,0.0010620228,0.97391415,0.0046269167],"study_design_scores_gemma":[0.0037526602,0.008500831,0.061922017,0.00021177632,0.0020466633,0.00001891741,0.000021715086,0.000013695961,0.00031880286,0.00037643098,0.92254704,0.00026943177],"about_ca_topic_score_codex":0.00001616046,"about_ca_topic_score_gemma":0.000005548786,"teacher_disagreement_score":0.7967609,"about_ca_system_score_codex":0.00018897177,"about_ca_system_score_gemma":0.00013627693,"threshold_uncertainty_score":0.86267036},"labels":[],"label_agreement":null},{"id":"W3105418148","doi":"10.1016/j.eururo.2020.11.017","title":"Female Authorship Trends in Urology During the COVID-19 Pandemic","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital","funders":"","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Pandemic; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Urology; MEDLINE; Betacoronavirus; Gynecology; Internal medicine; Virology; Infectious disease (medical specialty); Disease","score_opus":0.12464784028055832,"score_gpt":0.3309365854804793,"score_spread":0.20628874519992096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105418148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75314814,0.00023062054,0.00007067592,0.09452026,0.00036012492,0.000077320954,0.0000042514353,0.0001524994,0.1514361],"genre_scores_gemma":[0.94846123,0.000046637666,0.0000049485675,0.04928457,0.00051202223,0.0000013470545,0.000004274134,0.000009036608,0.0016759102],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965788,0.0023771583,0.00015390906,0.00027765572,0.00022830932,0.00038413386],"domain_scores_gemma":[0.9992374,0.00025697335,0.000057225025,0.00014446814,0.000015161963,0.00028875683],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023237683,0.00008603123,0.00014008756,0.00008893177,0.00037278177,0.00002348781,0.00079375185,0.0000798813,0.0012795023],"category_scores_gemma":[0.0012240759,0.00007144697,0.00004788379,0.00043569444,0.0006545348,0.000048526737,0.00020775475,0.00044839407,0.0003321175],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034398917,0.000044438264,0.714861,0.000016294027,0.000030436313,0.0014111609,0.24934234,0.00048881286,0.00016442184,0.01213824,0.014797976,0.006360924],"study_design_scores_gemma":[0.0007537345,0.00017288416,0.1170859,5.253239e-7,0.000023170935,0.00001853277,0.0070967884,0.000019001813,7.0280095e-7,0.00020951056,0.87451005,0.00010922289],"about_ca_topic_score_codex":0.00025519857,"about_ca_topic_score_gemma":0.0010940832,"teacher_disagreement_score":0.85971206,"about_ca_system_score_codex":0.00004650839,"about_ca_system_score_gemma":0.000057430727,"threshold_uncertainty_score":0.9996335},"labels":[],"label_agreement":null},{"id":"W3110773361","doi":"10.1016/j.eururo.2020.11.038","title":"Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada)","funders":"National Cancer Institute; U.S. Department of Defense","keywords":"Prostate cancer; Medicine; Hazard ratio; Oncology; Transcriptome; Internal medicine; Prostatectomy; Immune system; Confidence interval; Prostate; Cancer; Immunology; Biology; Gene; Genetics","score_opus":0.09134125043236942,"score_gpt":0.3142924554285957,"score_spread":0.22295120499622628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110773361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95252264,0.0013424649,0.000065989574,0.044424,0.00020102125,0.0005825461,0.00014553491,0.0000580372,0.00065774814],"genre_scores_gemma":[0.99649733,0.00043370266,0.00007745394,0.0013249804,0.00019997048,0.00003733135,0.00007609515,0.00004753657,0.0013055905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998648,0.00016038824,0.00034515766,0.00038005522,0.00011136065,0.00035506932],"domain_scores_gemma":[0.99947476,0.00007976076,0.00006270078,0.00014922292,0.000032493725,0.00020105632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014702333,0.00018163111,0.0004199101,0.00011854832,0.000054390213,0.000016637101,0.00010349998,0.000042864558,0.00009480199],"category_scores_gemma":[0.000037421312,0.00013963712,0.00006982372,0.000109092325,0.00018504474,0.0000683169,0.00007795959,0.00051053683,0.000048182075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011130816,0.00016366686,0.7907404,0.000058886657,0.00036645014,0.00031915779,0.002289358,0.000018012928,0.20092177,0.000031401676,0.00031252546,0.0036653029],"study_design_scores_gemma":[0.0075227576,0.00068049633,0.9810867,0.000019203464,0.00013013849,0.000029823055,0.000119058685,0.0001315798,0.00078660063,0.0000054971056,0.009370586,0.000117595475],"about_ca_topic_score_codex":0.00026080172,"about_ca_topic_score_gemma":0.000054375963,"teacher_disagreement_score":0.20013517,"about_ca_system_score_codex":0.00008969427,"about_ca_system_score_gemma":0.000078670484,"threshold_uncertainty_score":0.5694236},"labels":[],"label_agreement":null},{"id":"W3112634939","doi":"10.1016/j.eururo.2020.08.012","title":"Re: Hiten D. Patel, Farzana A. Faisal, Bruce J. Trock, et al. Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial. Eur Urol 2020;78:360–368","year":2020,"lang":"en","type":"letter","venue":"European Urology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Randomized controlled trial; Venous thromboembolism; Clinical trial; Gynecology; Urology; Prostate cancer; Surgery; Internal medicine; Thrombosis; Cancer","score_opus":0.024046358236424998,"score_gpt":0.3300087308400573,"score_spread":0.3059623726036323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112634939","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11427574,0.0027696625,0.00006943322,0.8470743,0.0052185426,0.021927997,0.0001674019,0.0004797654,0.0080172],"genre_scores_gemma":[0.29869303,0.0024647068,0.000045563724,0.6921215,0.004148206,0.0011843164,0.0003632283,0.0003809412,0.00059852866],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9646866,0.027558988,0.0029489216,0.0022445947,0.001234401,0.0013265392],"domain_scores_gemma":[0.98994625,0.0057584587,0.002018486,0.0017391914,0.00017561138,0.0003619854],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.007901054,0.0014705557,0.0069053676,0.00032600152,0.00019346963,0.00009982579,0.0013308851,0.00080898276,0.0010490753],"category_scores_gemma":[0.0035327682,0.0008900177,0.0022089197,0.000434789,0.0015110578,0.00008243287,0.00092017703,0.007207204,0.0010891376],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25919876,0.0015130455,0.000052107174,0.00048096653,0.0027100418,0.008294434,0.00031334764,0.0000073925544,0.00004697865,0.000009234328,0.72352386,0.0038498198],"study_design_scores_gemma":[0.26532578,0.031420335,0.0013722108,0.00016301264,0.004226227,0.000064993365,0.0000067959786,0.00004210974,0.000044296103,0.000040476185,0.6967117,0.0005820604],"about_ca_topic_score_codex":0.0000244771,"about_ca_topic_score_gemma":0.0000025264912,"teacher_disagreement_score":0.18441729,"about_ca_system_score_codex":0.000100334335,"about_ca_system_score_gemma":0.00025962395,"threshold_uncertainty_score":0.9998641},"labels":[],"label_agreement":null},{"id":"W3113153998","doi":"10.1016/j.eururo.2020.11.021","title":"A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer","year":2020,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Prostate Cancer Foundation","keywords":"Medicine; Prostatectomy; Prostate cancer; Meta-analysis; Internal medicine; Systematic review; Disease; Prospective cohort study; DECIPHER; Oncology; Cancer; Evidence-based medicine; MEDLINE; Gynecology; Pathology; Bioinformatics; Alternative medicine","score_opus":0.11323069971148107,"score_gpt":0.3818952679292196,"score_spread":0.2686645682177385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113153998","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000030969222,0.9839722,0.0000042880697,0.004620831,0.00029982638,0.010765394,0.00007415609,0.00001131309,0.00024889113],"genre_scores_gemma":[0.000050187322,0.99156725,0.000013555042,0.004820139,0.00013299151,0.002969647,0.000010554525,0.000081028134,0.0003546609],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969689,0.001092554,0.0011088321,0.00042267496,0.00015225285,0.00025474353],"domain_scores_gemma":[0.99690807,0.0013182741,0.0008322574,0.0008018638,0.00007923596,0.00006031004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089108176,0.00032265254,0.0022899932,0.000039869265,0.00004588615,0.000008751458,0.00045908158,0.000049743023,0.00005373544],"category_scores_gemma":[0.0010581053,0.00013630366,0.00064697047,0.0002848467,0.00011864472,0.00001765809,0.00018135546,0.00033822266,0.000058993788],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003067118,0.00003438288,0.00005619802,0.91679764,0.00052539294,0.00006129476,0.00009551722,6.1592e-7,2.8220305e-7,0.000033077347,0.0027374881,0.07962747],"study_design_scores_gemma":[0.00022177852,0.00014759412,0.00013201938,0.46541303,0.005721062,0.000045939843,0.000002812208,0.0000033819474,1.719553e-7,0.0000021160272,0.5282388,0.000071332295],"about_ca_topic_score_codex":0.000013417112,"about_ca_topic_score_gemma":0.000015371475,"teacher_disagreement_score":0.52550125,"about_ca_system_score_codex":0.00023286276,"about_ca_system_score_gemma":0.0005452162,"threshold_uncertainty_score":0.5558302},"labels":[],"label_agreement":null},{"id":"W3115075529","doi":"10.1016/j.eururo.2020.12.017","title":"A Modified Newcastle-Ottawa Scale for Assessment of Study Quality in Genetic Urological Research","year":2020,"lang":"en","type":"editorial","venue":"European Urology","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council; Rosetrees Trust","keywords":"Medicine; Scale (ratio); Quality (philosophy); Quality assessment; Family medicine; Medical physics; Gynecology; Pathology; External quality assessment","score_opus":0.4458743064051375,"score_gpt":0.576956866046544,"score_spread":0.13108255964140647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115075529","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38651386,0.0012238439,0.002157542,0.053475637,0.45778972,0.022671409,0.0008274974,0.00027153766,0.07506894],"genre_scores_gemma":[0.6325688,0.00018785549,0.0009838748,0.0022094366,0.36264303,0.00025446864,0.00031015056,0.00014567543,0.0006967066],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98372716,0.00896939,0.0015720403,0.0011248902,0.0026726867,0.0019338314],"domain_scores_gemma":[0.985122,0.009286515,0.00028127202,0.00086521154,0.00094473246,0.003500244],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.020931896,0.0003291969,0.0014775879,0.0005187234,0.00008764293,0.000018587694,0.0006358585,0.00063798676,0.00012294266],"category_scores_gemma":[0.17045587,0.000266077,0.00017844136,0.00054061,0.0005054467,0.000021905158,0.00046638274,0.0046575535,0.00006096345],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032930882,0.0019910596,0.0064931647,0.0009203533,0.000069208945,0.0010863108,0.00043349175,0.000012565073,0.00018820676,0.000025329693,0.9814098,0.004077432],"study_design_scores_gemma":[0.008203375,0.02613333,0.112724274,0.00005006912,0.000059506307,0.0000058546775,0.00010704761,0.00034418478,0.0000020774828,0.00007013635,0.85212755,0.00017256875],"about_ca_topic_score_codex":0.0002464924,"about_ca_topic_score_gemma":0.00009951417,"teacher_disagreement_score":0.24605492,"about_ca_system_score_codex":0.0002596332,"about_ca_system_score_gemma":0.008114647,"threshold_uncertainty_score":0.99997914},"labels":[],"label_agreement":null},{"id":"W3115918502","doi":"10.1016/j.eururo.2020.12.012","title":"Re: Umang Swami, Pedro Isaacsson Velho, Roberto Nussenzveig, et al. Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer. Eur Urol 2020;78:652–6","year":2020,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Foundation; National Cancer Institute; Prostate Cancer Foundation","keywords":"Medicine; Prostate cancer; Swami; Gynecology; Oncology; Internal medicine; Cancer; Theology","score_opus":0.019905035738930103,"score_gpt":0.3054813802605399,"score_spread":0.2855763445216098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115918502","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.099044174,0.00039450778,0.00010169652,0.8910572,0.000109068664,0.0022415088,0.0005878885,0.00010136038,0.006362576],"genre_scores_gemma":[0.41316828,0.0008062084,0.0010333954,0.5676807,0.0005147211,0.00031974964,0.0036396948,0.00039808403,0.012439164],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956072,0.0014367767,0.0006459567,0.0008125451,0.00073291746,0.0007645779],"domain_scores_gemma":[0.99776375,0.0006114565,0.000672875,0.00037503333,0.0004242967,0.00015256862],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005839419,0.00053228834,0.0010764985,0.00033564976,0.00009904141,0.000044541437,0.00018291955,0.00015045764,0.000090115725],"category_scores_gemma":[0.000269614,0.00039668186,0.00011654597,0.00054641475,0.00019656385,0.00014049861,0.000073857285,0.0019416943,0.000056136967],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057094246,0.00055146025,0.20488772,0.00071170134,0.004507973,0.06717982,0.017940735,0.0018656959,0.001744079,0.00001655849,0.6940002,0.00088467303],"study_design_scores_gemma":[0.053332582,0.020206895,0.42848057,0.0013430526,0.0063188407,0.0016546272,0.0048207166,0.0025408233,0.0020409652,0.000104715145,0.476113,0.003043219],"about_ca_topic_score_codex":0.000540563,"about_ca_topic_score_gemma":0.001345079,"teacher_disagreement_score":0.32337654,"about_ca_system_score_codex":0.00058057345,"about_ca_system_score_gemma":0.0009475348,"threshold_uncertainty_score":0.9998485},"labels":[],"label_agreement":null},{"id":"W3116004252","doi":"10.1016/j.eururo.2020.11.022","title":"Evidence for Focal Grade Group Progression in Low-risk Prostate Cancer","year":2020,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prostate cancer; Prostate; Oncology; Internal medicine; Prostate disease; Gynecology; Urology; Cancer","score_opus":0.055359257924435516,"score_gpt":0.3323087619557301,"score_spread":0.2769495040312946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116004252","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009759221,0.022718864,0.000074256655,0.9619884,0.00096340646,0.0037045442,0.0003049423,0.00014844425,0.00033794646],"genre_scores_gemma":[0.07136559,0.018568838,0.0005789705,0.9000386,0.005735935,0.0019633675,0.00093927496,0.0003005947,0.0005088096],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969532,0.00053296186,0.0005714454,0.001016926,0.00025392446,0.0006715351],"domain_scores_gemma":[0.998492,0.0005065327,0.0003705119,0.000418133,0.00006833957,0.0001444889],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027896982,0.00044466672,0.000712998,0.00014576428,0.00007192608,0.000026888685,0.00021920791,0.00023285608,0.00006934001],"category_scores_gemma":[0.000360683,0.00034845728,0.00020979834,0.00016984402,0.00015982088,0.00006144902,0.000145807,0.0015755587,0.00010756053],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011943507,0.00019392293,0.04057459,0.0010148915,0.00018960558,0.010180989,0.0004316145,0.00001172731,0.000057881745,0.0000056074646,0.8979043,0.04824052],"study_design_scores_gemma":[0.0034881139,0.004283067,0.02262468,0.001651739,0.00050337345,0.00005018604,0.000004825523,0.00013811175,0.00009501846,0.000097464464,0.9667141,0.0003493566],"about_ca_topic_score_codex":0.000061135295,"about_ca_topic_score_gemma":0.000030565876,"teacher_disagreement_score":0.06880976,"about_ca_system_score_codex":0.00023000465,"about_ca_system_score_gemma":0.00016008192,"threshold_uncertainty_score":0.99989676},"labels":[],"label_agreement":null},{"id":"W3118911040","doi":"10.1016/j.eururo.2020.12.019","title":"A Systematic Review of Patients’ Values, Preferences, and Expectations for the Diagnosis and Treatment of Male Lower Urinary Tract Symptoms","year":2021,"lang":"en","type":"review","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Sigrid Juséliuksen Säätiö; Academy of Finland; Helsingin ja Uudenmaan Sairaanhoitopiiri","keywords":"Medicine; Lower urinary tract symptoms; Urinary system; MEDLINE; Intensive care medicine; Urology; General surgery; Gynecology; Internal medicine","score_opus":0.0734674109536698,"score_gpt":0.3547806004941835,"score_spread":0.28131318954051365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118911040","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027593246,0.99422437,0.0000044171607,0.00007869124,0.00005099005,0.004525274,0.00020444609,0.0000064938336,0.0006293617],"genre_scores_gemma":[0.0007736911,0.9976729,0.00003646338,0.000039703067,0.00003924606,0.0007577001,0.00024535472,0.00003876766,0.00039617962],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99745214,0.0011584691,0.00075601286,0.00030988015,0.0001505358,0.00017296785],"domain_scores_gemma":[0.9970213,0.001953371,0.00036412582,0.0004313881,0.00015373438,0.00007608832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003721122,0.00024027587,0.0019021953,0.00009899001,0.000053030133,0.000007150718,0.000103425235,0.00005891572,0.00010268283],"category_scores_gemma":[0.0003698058,0.00012999831,0.0002895169,0.00013423922,0.00016140702,0.000020183972,0.000074703596,0.00011429943,0.00000485271],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003052576,0.0011508691,0.00029032098,0.87471807,0.0009156051,0.00010122597,0.00030971933,1.6037642e-8,2.2098634e-8,0.000017244118,0.0002645744,0.12220181],"study_design_scores_gemma":[0.0015817209,0.025137218,0.0013228906,0.44500113,0.021840058,0.001588004,0.0001012519,0.0000041776625,4.0765562e-7,0.000006121507,0.5031229,0.00029411973],"about_ca_topic_score_codex":0.0000032971716,"about_ca_topic_score_gemma":2.7863283e-7,"teacher_disagreement_score":0.50285834,"about_ca_system_score_codex":0.000021188926,"about_ca_system_score_gemma":0.00011522964,"threshold_uncertainty_score":0.53011775},"labels":[],"label_agreement":null},{"id":"W3119166731","doi":"10.1016/j.eururo.2020.12.037","title":"Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer","year":2021,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health; Fundación Científica Asociación Española Contra el Cáncer; National Cancer Institute; Fundación Fero; “la Caixa” Foundation","keywords":"Liquid biopsy; Prostate cancer; Medicine; Circulating tumor cell; Precision medicine; Context (archaeology); Biopsy; Biomarker; Personalized medicine; Microvesicles; Prostate; Oncology; Cancer; Pathology; Bioinformatics; Internal medicine; microRNA; Metastasis; Biology; Gene","score_opus":0.15599802804801202,"score_gpt":0.5461625296701861,"score_spread":0.3901645016221741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119166731","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026180618,0.97158056,0.000034165907,0.00031963032,0.00010021889,0.0009126852,0.00025369338,0.000016792555,0.0006016381],"genre_scores_gemma":[0.00475491,0.99318296,0.0011658686,0.0003414624,0.000039643117,0.00008043056,0.00021659114,0.000053456308,0.00016468647],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954815,0.0018525224,0.0013635672,0.0006514925,0.00028296135,0.00036797448],"domain_scores_gemma":[0.99480474,0.0038724053,0.00044535258,0.0003864994,0.00032049758,0.00017048875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021159744,0.00033714948,0.002930083,0.0015319152,0.000045879005,0.000016621672,0.00016405927,0.00013063656,0.00012358784],"category_scores_gemma":[0.002012796,0.00023879501,0.0005013262,0.0026167491,0.0003652009,0.000036447014,0.0002351709,0.00054953655,0.00002076264],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004127459,0.0005561775,0.002582442,0.005285074,0.012192263,0.002529299,0.010324932,0.00009439975,0.000003568307,0.00022048251,0.00021853964,0.96186537],"study_design_scores_gemma":[0.004886423,0.01388542,0.00573845,0.024574356,0.036189664,0.000043107506,0.0019761547,0.00019337938,0.0000060296093,0.000017978457,0.91158056,0.0009084616],"about_ca_topic_score_codex":0.0000416165,"about_ca_topic_score_gemma":0.00015072235,"teacher_disagreement_score":0.96095693,"about_ca_system_score_codex":0.00006765683,"about_ca_system_score_gemma":0.0007464545,"threshold_uncertainty_score":0.97377783},"labels":[],"label_agreement":null},{"id":"W3119708965","doi":"10.1016/j.eururo.2020.12.029","title":"Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"National Cancer Institute; Novartis Pharmaceuticals Corporation; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Pazopanib; Nephrectomy; Renal cell carcinoma; Placebo; Adjuvant; Oncology; Urology; Internal medicine; Kidney cancer; Surgery; Kidney; Sunitinib; Pathology","score_opus":0.022189224509967465,"score_gpt":0.2557066031132377,"score_spread":0.2335173786032702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119708965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954976,0.00017785693,0.00012732882,0.00013360883,0.0002608938,0.0015349836,0.00004584966,0.000022144148,0.002199775],"genre_scores_gemma":[0.99858826,0.0000041445223,0.00039434686,0.00022695764,0.000077315315,0.0000691779,0.00013932561,0.000054317505,0.0004461246],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9963778,0.0014269756,0.0006210766,0.00063804135,0.0004925302,0.00044358007],"domain_scores_gemma":[0.99836844,0.00024197965,0.00027157622,0.0007676221,0.00020385154,0.00014654241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033576845,0.00033645518,0.00088637054,0.00023449954,0.00004349272,0.000011767487,0.00019245117,0.0000764915,0.00044405262],"category_scores_gemma":[0.00019959718,0.00020146476,0.00029991547,0.0008755999,0.00016368693,0.00004720415,0.00016620733,0.00039218218,0.000017704864],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9134257,0.0022191864,0.076501526,0.000047873837,0.0006587947,0.0033163698,0.00025043348,0.0009346304,0.0009633961,0.000003913864,0.0000411156,0.0016370796],"study_design_scores_gemma":[0.4678216,0.016170083,0.50787735,0.000028307126,0.0028373552,0.000014257163,0.000028951386,0.00031572778,0.0028496026,0.0000012616271,0.0018010485,0.0002544654],"about_ca_topic_score_codex":0.000038086277,"about_ca_topic_score_gemma":0.00028794652,"teacher_disagreement_score":0.4456041,"about_ca_system_score_codex":0.00014430136,"about_ca_system_score_gemma":0.00037671,"threshold_uncertainty_score":0.8215495},"labels":[],"label_agreement":null},{"id":"W3119850026","doi":"10.1016/j.eururo.2020.12.040","title":"The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institutes of Health; McMaster University; Movember Foundation; National Cancer Institute; Prostate Cancer Foundation","keywords":"Medicine; Prostate cancer; Castration; Oncology; Prostate; Cancer; Internal medicine; Gynecology; Hormone","score_opus":0.017893513775631104,"score_gpt":0.2964395411881939,"score_spread":0.2785460274125628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119850026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82495517,0.023584938,0.00023084677,0.084262505,0.000391593,0.0012374313,0.00020555555,0.00006188453,0.06507008],"genre_scores_gemma":[0.9926698,0.0012761065,0.000041696396,0.00083153084,0.0001292472,0.000014625291,0.000108514825,0.000018640489,0.004909828],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99829483,0.00092640467,0.00020542482,0.00018034595,0.00018234603,0.0002106316],"domain_scores_gemma":[0.9988136,0.00060987065,0.00009006101,0.00023258822,0.00020705812,0.000046808484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006599082,0.000091024536,0.00015796069,0.00003291211,0.00018077769,0.00001916986,0.00007506124,0.000012316327,0.00021048504],"category_scores_gemma":[0.00019936488,0.00004544273,0.00006358124,0.00021395556,0.00027299035,0.00002372658,0.000049106155,0.0001924722,0.00004851767],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035427358,0.0021645138,0.12024746,0.0010280537,0.0155845145,0.04056655,0.046772826,0.0023811345,0.08679106,0.32557523,0.064959206,0.2585021],"study_design_scores_gemma":[0.012227848,0.0027775175,0.8192722,0.00016093146,0.0017610763,0.0032708435,0.0065950816,0.0015613538,0.037595328,0.010552868,0.103724524,0.0005003927],"about_ca_topic_score_codex":0.000007664074,"about_ca_topic_score_gemma":0.000025736283,"teacher_disagreement_score":0.6990248,"about_ca_system_score_codex":0.00001938691,"about_ca_system_score_gemma":0.00026777203,"threshold_uncertainty_score":0.23046637},"labels":[],"label_agreement":null},{"id":"W3120445389","doi":"10.1016/j.eururo.2020.12.033","title":"European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":463,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Grading (engineering); Proportional hazards model; Risk factor; Cystectomy; Concomitant; Internal medicine; Oncology; Carcinoma in situ; Clinical endpoint; Urology; Cancer; Randomized controlled trial","score_opus":0.06401271365823098,"score_gpt":0.3034778241472664,"score_spread":0.2394651104890354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120445389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94645256,0.0101078395,0.011761485,0.021017902,0.0018189236,0.0043379846,0.003449979,0.00014034637,0.0009130024],"genre_scores_gemma":[0.9912383,0.0017206314,0.00040586555,0.0033138336,0.001901529,0.00022824331,0.00059117994,0.00012975956,0.00047063982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960289,0.001774676,0.000826798,0.0007029789,0.00023847239,0.00042817442],"domain_scores_gemma":[0.9957908,0.0016085152,0.0010101561,0.00060651073,0.00085890765,0.00012510654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001090114,0.0003353915,0.0005564073,0.000058935417,0.00036620945,0.00007058985,0.00028201437,0.00013355375,0.0000256367],"category_scores_gemma":[0.001969505,0.00021462647,0.0001486049,0.0001686227,0.00017393658,0.000120767676,0.00010646818,0.00030556644,0.000016633463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022946012,0.0010416671,0.77145404,0.00051872944,0.0052464097,0.00016396002,0.011161741,0.00095722795,0.031703804,0.001651075,0.08892422,0.08488251],"study_design_scores_gemma":[0.006265527,0.0021377087,0.9295159,0.00013327488,0.0025468862,0.000038860377,0.0009518487,0.008791386,0.00034342328,0.0005955556,0.04827842,0.0004012235],"about_ca_topic_score_codex":0.0005364874,"about_ca_topic_score_gemma":0.00063176,"teacher_disagreement_score":0.15806183,"about_ca_system_score_codex":0.00008137871,"about_ca_system_score_gemma":0.0002668107,"threshold_uncertainty_score":0.8752214},"labels":[],"label_agreement":null},{"id":"W3125592099","doi":"10.1016/j.eururo.2021.01.004","title":"Male Overactive Bladder: Underappreciated, Under-researched. More Please?","year":2021,"lang":"en","type":"letter","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Overactive bladder; Urology; Pathology; Alternative medicine","score_opus":0.06230964238701663,"score_gpt":0.3300033568674475,"score_spread":0.26769371448043083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125592099","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038092039,0.0030259774,0.00014574673,0.76757085,0.00042755954,0.00078772724,0.00020231861,0.00017168133,0.22385894],"genre_scores_gemma":[0.018202405,0.0017121456,0.00015344705,0.8176349,0.0070501897,0.000041267125,0.0052060084,0.00045556523,0.1495441],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925865,0.0028379988,0.00054873945,0.0013884353,0.0010774627,0.001560845],"domain_scores_gemma":[0.99667794,0.0009572901,0.00017467272,0.0013631893,0.0004424219,0.00038449137],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00073507015,0.00064953614,0.00093599333,0.0005654605,0.0002327903,0.00011652202,0.0005526005,0.0007782085,0.01128768],"category_scores_gemma":[0.00037095658,0.000613738,0.00041556908,0.00047855463,0.0005713809,0.00010364894,0.00072558975,0.007821355,0.0031584578],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048868766,0.00022355298,0.00042465102,0.00022758417,0.001006143,0.07468091,0.0002501216,0.000012437742,0.00030492898,0.000022198727,0.9208354,0.0015234196],"study_design_scores_gemma":[0.0018740738,0.0014353705,0.004353213,0.000060431805,0.00028032227,0.007743271,0.00016389448,0.000059079346,0.00007174261,0.00014888665,0.9833092,0.0005004802],"about_ca_topic_score_codex":0.000071844916,"about_ca_topic_score_gemma":0.000007716276,"teacher_disagreement_score":0.074314825,"about_ca_system_score_codex":0.00020365386,"about_ca_system_score_gemma":0.00087718887,"threshold_uncertainty_score":0.9996314},"labels":[],"label_agreement":null},{"id":"W3131622597","doi":"10.1016/j.eururo.2020.12.015","title":"Reply to John T. Lafin, Aditya Bagrodia’s Letter to the Editor re: Lucia Nappi, Marisa Thi, Nabil Adra, et al. Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors. Eur Urol 2021;79:16–9","year":2020,"lang":"en","type":"letter","venue":"European Urology","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Gynecology","score_opus":0.011716619856882868,"score_gpt":0.23902017125791766,"score_spread":0.2273035514010348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131622597","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8061146,0.0011734981,0.0001805461,0.18725695,0.0018097499,0.001906306,0.0005794299,0.000042862415,0.00093605864],"genre_scores_gemma":[0.47477338,0.000085701504,0.00020486314,0.52001315,0.003538046,0.00009269528,0.00080958393,0.00020129207,0.0002812653],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99263126,0.0027554128,0.0010999879,0.0021658072,0.0004989762,0.0008485805],"domain_scores_gemma":[0.9970836,0.00025535468,0.00064704,0.001395121,0.00023850461,0.00038039836],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007579398,0.0008753141,0.0008898036,0.00033649063,0.0001550854,0.00015485792,0.0010564544,0.0004360779,0.00007892952],"category_scores_gemma":[0.0008519991,0.0007698922,0.0002335449,0.0003534639,0.00019606359,0.00002254223,0.0015864742,0.0015059144,0.000093189665],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028395737,0.00007227081,0.0015515969,0.00010785269,0.000045974768,0.0011550311,0.000550599,0.000020526186,0.37113333,2.8004524e-7,0.6248305,0.00024813545],"study_design_scores_gemma":[0.00090056646,0.0005876887,0.018971931,0.00023301701,0.00009767842,0.00007822188,0.00007461888,0.00001236998,0.051984075,0.00000708517,0.92624336,0.000809385],"about_ca_topic_score_codex":0.00016782526,"about_ca_topic_score_gemma":0.00004811039,"teacher_disagreement_score":0.33275622,"about_ca_system_score_codex":0.00006729829,"about_ca_system_score_gemma":0.00013620393,"threshold_uncertainty_score":0.9994752},"labels":[],"label_agreement":null},{"id":"W3133949928","doi":"10.1016/j.eururo.2021.02.031","title":"Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital; McMaster University; Centre for Probe Development and Commercialization; Women's College Hospital","funders":"Terry Fox Research Institute; University of Toronto; Princess Margaret Cancer Foundation; AbbVie","keywords":"Medicine; Prostatectomy; Prostate cancer; Clinical endpoint; SABR volatility model; Urology; Radiation therapy; Biochemical recurrence; Metastasis; Prostate-specific antigen; Prostate; Stage (stratigraphy); Androgen deprivation therapy; Phases of clinical research; Oncology; Cancer; Surgery; Internal medicine; Clinical trial; Randomized controlled trial","score_opus":0.0954410268437023,"score_gpt":0.35168373391626456,"score_spread":0.25624270707256225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133949928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9077313,0.032621052,0.0010912088,0.036631767,0.0011620169,0.00924213,0.00073975284,0.00057968625,0.010201095],"genre_scores_gemma":[0.9914792,0.0011315465,0.0024485542,0.0013232902,0.00041491297,0.0014899004,0.00013187023,0.00010875693,0.001471967],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967089,0.0009636202,0.0005034418,0.0007555665,0.00034959917,0.00071885984],"domain_scores_gemma":[0.99745256,0.0007371699,0.00022771122,0.00049874396,0.0009005414,0.00018327507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068599655,0.00038471445,0.0006401657,0.00016200836,0.00055037695,0.00007496954,0.00021747088,0.00005074223,0.00015438035],"category_scores_gemma":[0.0018541615,0.0002384447,0.00031086674,0.0007524201,0.00032265318,0.00007715954,0.00020046296,0.00038915063,0.0000245954],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15056376,0.007333718,0.002039251,0.0002605146,0.008781518,0.0018953189,0.012156109,0.000038785423,0.072172455,0.0010676761,0.0060873786,0.7376035],"study_design_scores_gemma":[0.48723924,0.065487,0.011332121,0.00034962912,0.0067082206,0.00071300205,0.0031333528,0.0024875014,0.13070609,0.0028713874,0.28710446,0.0018680221],"about_ca_topic_score_codex":0.0000370833,"about_ca_topic_score_gemma":0.00002192512,"teacher_disagreement_score":0.7357355,"about_ca_system_score_codex":0.0001574167,"about_ca_system_score_gemma":0.00048964785,"threshold_uncertainty_score":0.9723493},"labels":[],"label_agreement":null},{"id":"W3135619295","doi":"10.1016/j.eururo.2021.02.025","title":"Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Canadian Cancer Society","keywords":"Medicine; Renal cell carcinoma; Disease; Surgical resection; Resection; Kidney disease; Carcinoma; Clear cell renal cell carcinoma; Surgery; Oncology; Internal medicine","score_opus":0.013090911233855031,"score_gpt":0.2559281251699412,"score_spread":0.24283721393608615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135619295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99207115,0.004209053,0.00045659085,0.00035719216,0.0004371625,0.0006310287,0.00002826471,0.00007427372,0.0017352711],"genre_scores_gemma":[0.99742764,0.00015466641,0.0013074771,0.00008546056,0.00030460925,0.00003595843,0.00013565754,0.00006001027,0.00048854563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743265,0.0007738512,0.00038017292,0.00075191475,0.0002506004,0.0004107914],"domain_scores_gemma":[0.9986157,0.0003558869,0.00014951208,0.00031256667,0.00014071191,0.0004256173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005170457,0.0002533112,0.00040969736,0.000084168765,0.0002202944,0.000039485207,0.0000606079,0.00007438448,0.000014649365],"category_scores_gemma":[0.00036593303,0.0002158206,0.0001221605,0.00012317782,0.00011871744,0.0000862228,0.00015849307,0.00030536845,0.000005574787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017123062,0.00039098688,0.943167,0.0002856452,0.00016370382,0.011862847,0.00039899902,0.000055021537,0.0031309822,0.00026790134,0.00015824096,0.022995615],"study_design_scores_gemma":[0.017477315,0.0060297293,0.96684086,0.00011169914,0.00067617296,0.00023931969,0.000044769982,0.0009533487,0.0018600903,0.00021048082,0.005250548,0.0003056855],"about_ca_topic_score_codex":0.000023381512,"about_ca_topic_score_gemma":0.000012194177,"teacher_disagreement_score":0.023673847,"about_ca_system_score_codex":0.00004240072,"about_ca_system_score_gemma":0.00011295726,"threshold_uncertainty_score":0.8800909},"labels":[],"label_agreement":null},{"id":"W3137566103","doi":"10.1016/j.eururo.2021.02.041","title":"Untangling the PROfound Trial for Advanced Prostate Cancer: Is There Really a Role for Olaparib?","year":2021,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Arnold Ventures","keywords":"Olaparib; Medicine; PARP inhibitor; Prostate cancer; Homologous recombination; Oncology; Clinical endpoint; Internal medicine; Prostate; Gene; Cancer; Randomized controlled trial; Poly ADP ribose polymerase; Genetics","score_opus":0.022213001699800724,"score_gpt":0.3445303999727195,"score_spread":0.3223173982729188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137566103","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008654294,0.051174603,0.00009594277,0.01732115,0.88947594,0.019921541,0.0038553267,0.00023622607,0.009265001],"genre_scores_gemma":[0.0018220871,0.008146956,0.00030668237,0.0010136148,0.92476225,0.004066827,0.003885001,0.00041672098,0.055579852],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967882,0.00037961558,0.0005388463,0.0009552965,0.000478848,0.0008591973],"domain_scores_gemma":[0.9965224,0.0014113613,0.0003417842,0.0006963119,0.0008736397,0.00015450199],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010283745,0.00045683072,0.00081918994,0.00009874948,0.00036433685,0.00009139173,0.00041251074,0.00037385675,0.00009445205],"category_scores_gemma":[0.0011592882,0.0002934665,0.00039755742,0.00016936602,0.00020378586,0.000051353265,0.00017215498,0.00097528164,0.000022600681],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.121155724,0.00016263145,0.000025045612,0.00043638685,0.0007378626,0.00013513798,0.0010231278,0.000006057773,0.00020628393,0.000027919055,0.8576482,0.01843565],"study_design_scores_gemma":[0.07769495,0.0047338903,0.000016377413,0.00013444552,0.0006444109,0.0000050821127,0.00015175407,0.000039394636,0.00018691133,0.0001519943,0.9159912,0.00024959448],"about_ca_topic_score_codex":0.000045436926,"about_ca_topic_score_gemma":0.00009603818,"teacher_disagreement_score":0.05834302,"about_ca_system_score_codex":0.00023436947,"about_ca_system_score_gemma":0.0018926006,"threshold_uncertainty_score":0.9999517},"labels":[],"label_agreement":null},{"id":"W3139707937","doi":"10.1016/j.eururo.2021.03.017","title":"Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada)","funders":"National Center for Advancing Translational Sciences; National Institutes of Health; National Cancer Institute; Vetenskapsrådet","keywords":"Medicine; Prostate cancer; Glutamate carboxypeptidase II; Biochemical recurrence; Positron emission tomography; Prostate; Prostatectomy; Oncology; Cancer research; Cancer; Lymph node; Internal medicine; Nuclear medicine","score_opus":0.020741619947131414,"score_gpt":0.2755894216283982,"score_spread":0.2548478016812668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139707937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9568578,0.038655043,0.000012537004,0.0020536869,0.0000655521,0.0004139636,0.000100025034,0.000036152713,0.0018052676],"genre_scores_gemma":[0.9738345,0.02241194,0.00036480112,0.0008320853,0.00007163248,0.000013563703,0.00026417937,0.00006130885,0.002145997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982974,0.00035725633,0.00032196357,0.0005032573,0.0001934161,0.00032673654],"domain_scores_gemma":[0.99912465,0.00009602618,0.00013403599,0.0002371922,0.00025092842,0.00015714398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040793113,0.0001911553,0.00052735675,0.00006838805,0.000060304574,0.000018010947,0.000057230725,0.00008338882,0.0000777323],"category_scores_gemma":[0.00004287066,0.00013600508,0.000045247907,0.00020979445,0.000396728,0.00004915125,0.000057664307,0.0002823889,0.0000020954428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004130341,0.00043143358,0.88125,0.00031745477,0.0008074659,0.0051979665,0.00058186945,0.000016822427,0.09869431,0.000046804365,0.0008227829,0.0077027483],"study_design_scores_gemma":[0.0053339805,0.0010979337,0.968658,0.00012435051,0.00022000678,0.00015843865,0.00005289863,0.000008707581,0.012243158,0.000017107022,0.01192523,0.00016024425],"about_ca_topic_score_codex":0.000015336875,"about_ca_topic_score_gemma":0.00002690976,"teacher_disagreement_score":0.08740794,"about_ca_system_score_codex":0.000021675713,"about_ca_system_score_gemma":0.00019939289,"threshold_uncertainty_score":0.5546126},"labels":[],"label_agreement":null},{"id":"W3140838881","doi":"10.1016/j.eururo.2021.03.014","title":"Molecular Characterization of Residual Bladder Cancer after Neoadjuvant Pembrolizumab","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Decipher Biosciences (Canada); University of British Columbia","funders":"","keywords":"Pembrolizumab; Medicine; Cystectomy; Bladder cancer; Oncology; Internal medicine; Cohort; Neoadjuvant therapy; Pathology; Immunotherapy; Cancer","score_opus":0.010779881652693762,"score_gpt":0.2584130071316301,"score_spread":0.24763312547893637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3140838881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810293,0.0013412518,0.00018389986,0.0019707128,0.0002530439,0.00014143177,0.000061861734,0.00003687382,0.014981662],"genre_scores_gemma":[0.993864,0.00021369675,0.00006559682,0.0040432857,0.0002371509,0.000017013253,0.00010913642,0.000048833135,0.0014012746],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99892145,0.00020486322,0.00023557457,0.00028636502,0.00014495439,0.00020681258],"domain_scores_gemma":[0.9993896,0.000011463877,0.00007219377,0.0003046465,0.0001390637,0.00008306054],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005895509,0.0001337489,0.00024725308,0.000057144316,0.000021007583,0.0000062606937,0.000055510227,0.000048728172,0.0013739517],"category_scores_gemma":[0.000027330783,0.000120918674,0.00007525972,0.0001191055,0.0000670304,0.000033955854,0.00006191277,0.00012094825,0.00009448893],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002278719,0.00042614935,0.02489083,0.00008436762,0.0005616986,0.0057763383,0.00081470463,0.00001421676,0.9494976,0.00023953633,0.0005344533,0.014881403],"study_design_scores_gemma":[0.0034145552,0.0005823086,0.8736057,0.0000317,0.000441896,0.00028216632,0.000013912631,0.000020200816,0.09275233,0.000025608508,0.028671656,0.0001579463],"about_ca_topic_score_codex":0.000015739264,"about_ca_topic_score_gemma":0.0000060310413,"teacher_disagreement_score":0.85674524,"about_ca_system_score_codex":0.00002176179,"about_ca_system_score_gemma":0.00014880419,"threshold_uncertainty_score":0.9995389},"labels":[],"label_agreement":null},{"id":"W3147725646","doi":"10.1016/j.eururo.2013.08.008","title":"Castration-Resistant Prostate Cancer: From New Pathophysiology to New Treatment","year":2013,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; BC Cancer Agency","funders":"Janssen Pharmaceuticals; Astellas Pharma Canada; Novartis; Bayer; Amgen","keywords":"Cabazitaxel; Medicine; Enzalutamide; Docetaxel; Clinical trial; Prostate cancer; Taxane; Abiraterone acetate; Oncology; Cancer; Internal medicine; Androgen receptor; Breast cancer; Androgen deprivation therapy","score_opus":0.0855193134577789,"score_gpt":0.3721937028405051,"score_spread":0.2866743893827262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3147725646","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003763487,0.9910244,0.00001119314,0.001959285,0.000546359,0.0030948408,0.00031406534,0.00010927931,0.0025642656],"genre_scores_gemma":[0.000012009479,0.9327141,0.0005481884,0.00069788354,0.002050708,0.00023963396,0.0012250376,0.00016655936,0.06234585],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99675715,0.0005956163,0.00068178785,0.0010273458,0.0002031214,0.0007349779],"domain_scores_gemma":[0.99780864,0.0001657091,0.00024978325,0.0007844632,0.00007757831,0.00091380166],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000088172834,0.0006916556,0.0019537557,0.00025882208,0.00008557299,0.00004503577,0.00027671718,0.00020952003,0.0016767739],"category_scores_gemma":[0.000047216367,0.0004469418,0.00040895905,0.00028622325,0.00008602869,0.00004201001,0.00015222668,0.00041269223,0.00529473],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003380693,0.00009996855,0.000012444897,0.00042891785,0.0006576608,0.0009631411,0.00038586103,0.0000021467938,0.00019074246,0.0000095081605,0.039917625,0.95699394],"study_design_scores_gemma":[0.0017911913,0.0031885214,0.00017856101,0.0008059222,0.0014020023,0.000031653926,0.000008195097,7.3778705e-7,0.000010182737,0.00007855975,0.9921832,0.00032125553],"about_ca_topic_score_codex":0.0055172266,"about_ca_topic_score_gemma":0.00020896916,"teacher_disagreement_score":0.95667267,"about_ca_system_score_codex":0.00048762432,"about_ca_system_score_gemma":0.0024702826,"threshold_uncertainty_score":0.99979824},"labels":[],"label_agreement":null},{"id":"W3151414537","doi":"10.1016/j.eururo.2021.03.001","title":"Treatment and Patient Selection for Patients with Metastatic Castration-resistant Prostate After Progression on Docetaxel and Abiraterone/Enzalutamide: When to Play Your CARD and When to Do Your PARP","year":2021,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Enzalutamide; Docetaxel; Cabazitaxel; Medicine; Prostate cancer; Oncology; PARP inhibitor; Internal medicine; Chemotherapy; Abiraterone; Poly ADP ribose polymerase; Androgen receptor; Olaparib; Pharmacology; Cancer research; Cancer; Androgen deprivation therapy; Polymerase","score_opus":0.018068637499209773,"score_gpt":0.303282293205035,"score_spread":0.28521365570582524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3151414537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744583,0.002228718,0.000024477911,0.0012693874,0.015236597,0.005567539,0.001056005,0.000046324967,0.0001126784],"genre_scores_gemma":[0.9305339,0.0011904989,0.006211017,0.00080649415,0.049566444,0.0033457354,0.0037296487,0.00052893447,0.0040873587],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99721736,0.00034444366,0.00040843608,0.0010561959,0.0004447429,0.0005288509],"domain_scores_gemma":[0.9985497,0.00016926412,0.00016729944,0.0002671632,0.0004196571,0.000426923],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018329086,0.00052254664,0.0006721382,0.00026062442,0.0001784065,0.0001592329,0.000054427517,0.00013661383,0.0000146519715],"category_scores_gemma":[0.00015290463,0.00034121846,0.00005011845,0.00009438719,0.000095104624,0.000073506635,0.000108496744,0.00028794562,0.0000082858805],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20728855,0.0040963506,0.06276714,0.0024853337,0.0044362475,0.0027735366,0.05296104,0.00006908258,0.002722563,0.000017113058,0.43431106,0.226072],"study_design_scores_gemma":[0.021729972,0.10830853,0.033908315,0.0007090451,0.0013140335,0.000050590545,0.00033517138,0.0000182741,0.00047901826,0.000033999928,0.8322716,0.00084146624],"about_ca_topic_score_codex":0.00005096087,"about_ca_topic_score_gemma":0.00009295043,"teacher_disagreement_score":0.39796054,"about_ca_system_score_codex":0.00024160555,"about_ca_system_score_gemma":0.00024101425,"threshold_uncertainty_score":0.999904},"labels":[],"label_agreement":null},{"id":"W3152013950","doi":"10.1016/j.eururo.2015.03.054","title":"Re: AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Enzalutamide; Medicine; Abiraterone; Prostate cancer; Oncology; Internal medicine; Cancer; Androgen receptor","score_opus":0.034510154443889926,"score_gpt":0.30761034225910344,"score_spread":0.2731001878152135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152013950","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11711613,0.02032427,0.0000012474916,0.8438607,0.00024201645,0.0010561965,0.0001087305,0.00005668261,0.017234067],"genre_scores_gemma":[0.06443712,0.0066760965,0.00028656327,0.8224486,0.0024340786,0.00018568212,0.00029955278,0.00026305323,0.102969214],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99767375,0.0004282111,0.00031398103,0.0007309167,0.00024644745,0.0006066772],"domain_scores_gemma":[0.9991523,0.00007855696,0.00008466516,0.00036984615,0.000102705715,0.00021195276],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050463877,0.00031117327,0.00054822204,0.00030093352,0.00004523516,0.000033893928,0.00011794679,0.00017539969,0.000053945645],"category_scores_gemma":[0.00009712285,0.00024834252,0.000025921478,0.00017804414,0.00025176178,0.000041489973,0.00020628561,0.0012072759,0.00008588295],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014545671,0.000023545545,0.010642131,0.000335302,0.00007599766,0.0114893755,0.0011072902,9.566173e-7,0.00030367752,0.000003841778,0.9724279,0.0021354195],"study_design_scores_gemma":[0.0025753323,0.00063860114,0.019050704,0.00016307613,0.00006859563,0.000054035765,0.000025995467,0.0000018468356,0.000043811004,0.00009247507,0.9770581,0.00022742581],"about_ca_topic_score_codex":0.000086230764,"about_ca_topic_score_gemma":0.00034320971,"teacher_disagreement_score":0.08573514,"about_ca_system_score_codex":0.00014949644,"about_ca_system_score_gemma":0.0001676379,"threshold_uncertainty_score":0.9999969},"labels":[],"label_agreement":null},{"id":"W3153039798","doi":"10.1016/j.eururo.2021.03.028","title":"Re: Ming Yuen Teo, Jose Mauricio Mota, Karissa A. Whiting, et al. Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma. Eur Urol 2020;78:907–15","year":2021,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Chemotherapy; Differential (mechanical device); Oncology; Internal medicine","score_opus":0.013593204480486192,"score_gpt":0.24739706178803206,"score_spread":0.23380385730754585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153039798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7633285,0.00027955865,0.0034332038,0.22658542,0.00043893344,0.0027390302,0.0021733353,0.00020497583,0.00081702805],"genre_scores_gemma":[0.5832321,0.000048374695,0.00094501855,0.41204423,0.00051894214,0.000056629266,0.0021249317,0.00032001553,0.00070972514],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9934931,0.002404261,0.00081772014,0.0015672295,0.00066570786,0.0010519869],"domain_scores_gemma":[0.99778044,0.0005055469,0.000508318,0.00057469035,0.00031699907,0.00031402998],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035143163,0.0009787093,0.0014225469,0.00035715624,0.00013888249,0.0001292187,0.00015510438,0.00031024762,0.00066235237],"category_scores_gemma":[0.0004119708,0.0008842767,0.00017932539,0.00040419775,0.0001500368,0.00013021371,0.00011538722,0.0018631525,0.00005168697],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016768029,0.0020194973,0.06276583,0.0012675697,0.0036933462,0.029084414,0.012399441,0.00054434384,0.07584407,0.0000039488627,0.7842788,0.011330719],"study_design_scores_gemma":[0.13620183,0.032267347,0.50341046,0.0040977313,0.0037146166,0.0008765276,0.000503741,0.0069896514,0.023512024,0.000034744506,0.28093478,0.007456545],"about_ca_topic_score_codex":0.0002608353,"about_ca_topic_score_gemma":0.00035978152,"teacher_disagreement_score":0.503344,"about_ca_system_score_codex":0.0002968542,"about_ca_system_score_gemma":0.0005238579,"threshold_uncertainty_score":0.9993608},"labels":[],"label_agreement":null},{"id":"W3154163809","doi":"10.1016/j.eururo.2021.03.026","title":"Free Graft Augmentation Urethroplasty for Bulbar Urethral Strictures: Which Technique Is Best? A Systematic Review","year":2021,"lang":"en","type":"review","venue":"European Urology","topic":"Urological Disorders and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; University of Saskatchewan","funders":"","keywords":"Medicine; Urethroplasty; Randomized controlled trial; Surgery; Urethra; Systematic review; Observational study; MEDLINE; Internal medicine","score_opus":0.05247263055785203,"score_gpt":0.35876567128452036,"score_spread":0.30629304072666835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154163809","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.054359e-7,0.9843753,0.0015671145,0.0009467986,0.00023037926,0.01018146,0.00035629142,0.00012565055,0.0022165119],"genre_scores_gemma":[0.000010633179,0.9894664,0.0009645256,0.004968264,0.00016871655,0.0018460093,0.0015172012,0.0001732678,0.00088494417],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99503535,0.0017191382,0.0014055023,0.0009979409,0.0003153186,0.00052677165],"domain_scores_gemma":[0.9969609,0.0004897108,0.00078507833,0.0012745046,0.00028342757,0.0002064003],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007177554,0.0007817782,0.004269917,0.0001922376,0.00012984182,0.00003084202,0.00044957493,0.0004664008,0.00039200523],"category_scores_gemma":[0.0018045355,0.0005174889,0.0010650425,0.000555583,0.00009195034,0.000036855705,0.00023585864,0.00072294165,0.00026661457],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026747251,0.00050279824,0.000005428891,0.9468099,0.0017664761,0.00036371974,0.00004193075,1.3216294e-7,5.6660997e-7,0.0003034657,0.029616954,0.020561874],"study_design_scores_gemma":[0.0011098504,0.002016379,0.0000042848346,0.16583481,0.025371617,0.00071645255,0.0000076258284,0.0000016894836,3.6487734e-7,0.00008846642,0.80444276,0.00040568694],"about_ca_topic_score_codex":0.0000047329904,"about_ca_topic_score_gemma":0.000004210492,"teacher_disagreement_score":0.7809751,"about_ca_system_score_codex":0.000093488845,"about_ca_system_score_gemma":0.00023414126,"threshold_uncertainty_score":0.99972767},"labels":[],"label_agreement":null},{"id":"W3159047986","doi":"10.1016/j.eururo.2021.04.028","title":"A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate Cancer","year":2021,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Perioperative; Interquartile range; Biochemical recurrence; Prostate-specific antigen; Confounding; MEDLINE; Cochrane Library; Meta-analysis; Cancer; Surgery; General surgery; Internal medicine","score_opus":0.024500800973487287,"score_gpt":0.3494514794619429,"score_spread":0.3249506784884556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159047986","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009207899,0.97995585,0.0000016904828,0.00051773887,0.00012712566,0.009265705,0.000851543,0.00001331458,0.000059154794],"genre_scores_gemma":[0.0073765395,0.98955256,0.00006617904,0.0005177242,0.000034369838,0.0021994554,0.00008175378,0.000060029066,0.00011137817],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9959986,0.0014442236,0.0013465263,0.00062444876,0.00021578048,0.00037038713],"domain_scores_gemma":[0.9969714,0.0011684847,0.0010287643,0.000486724,0.00016454772,0.00018004657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008706291,0.00054252945,0.0049522985,0.00008587062,0.00004464775,0.000012767079,0.00013678386,0.00014570718,0.00008345718],"category_scores_gemma":[0.0011635243,0.0002445388,0.0009351637,0.0002083934,0.00045327054,0.000022380415,0.00019418103,0.00036714866,0.0000040373247],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022281618,0.0009610729,0.007773752,0.9380169,0.002359599,0.0008994233,0.00012278609,4.832776e-7,2.19764e-7,0.000020901081,0.0010759318,0.04854612],"study_design_scores_gemma":[0.004620176,0.019492954,0.042375546,0.83092546,0.025300626,0.0011535165,0.00002085318,0.000010715222,0.0000016430739,0.0000134049615,0.075348176,0.00073693355],"about_ca_topic_score_codex":0.000020634647,"about_ca_topic_score_gemma":0.0000024154403,"teacher_disagreement_score":0.107091434,"about_ca_system_score_codex":0.00021054607,"about_ca_system_score_gemma":0.0005181188,"threshold_uncertainty_score":0.99720025},"labels":[],"label_agreement":null},{"id":"W3161251912","doi":"10.1016/j.eururo.2021.04.035","title":"Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Jonsson Comprehensive Cancer Center; Astellas Pharma; AstraZeneca; Amgen; National Cancer Institute; Prostate Cancer Foundation; American Society for Radiation Oncology; Stop Cancer; U.S. Department of Veterans Affairs","keywords":"Medicine; Prostate cancer; Prostate; Oncology; Cancer; Internal medicine; Gynecology","score_opus":0.031664185441761715,"score_gpt":0.3637983551121217,"score_spread":0.33213416967036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161251912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99092937,0.005381637,0.00001189632,0.0020184682,0.00060554006,0.0002974988,0.00007661676,0.000020458709,0.0006585139],"genre_scores_gemma":[0.9850665,0.013792242,0.00018079136,0.0005166138,0.00018571006,0.000038928833,0.00007115967,0.000025871752,0.00012218535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981227,0.00057899946,0.0005996185,0.00036087784,0.00011858476,0.00021925187],"domain_scores_gemma":[0.9991904,0.00012011156,0.00022729186,0.0002692289,0.000085992106,0.00010700368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042254955,0.00011737617,0.00041207077,0.00005009334,0.00001682246,0.0000039682564,0.000054031418,0.00004150712,0.00021097554],"category_scores_gemma":[0.00019249089,0.000089603884,0.00009148102,0.000104006474,0.00005100982,0.00002011543,0.00008366848,0.00026760637,0.00002741915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026125435,0.00059358194,0.7517536,0.000043981287,0.000060571372,0.0010534892,0.00017662751,0.000014282266,0.00005379898,0.00003637584,0.00039987062,0.24555255],"study_design_scores_gemma":[0.0039967187,0.0012370566,0.9655738,0.00015618805,0.00011313234,0.000023195,0.000017658132,0.000027675922,0.001620907,0.000021686914,0.027138483,0.00007351623],"about_ca_topic_score_codex":0.000083024875,"about_ca_topic_score_gemma":0.000085401545,"teacher_disagreement_score":0.24547905,"about_ca_system_score_codex":0.000035186094,"about_ca_system_score_gemma":0.00013747468,"threshold_uncertainty_score":0.36539403},"labels":[],"label_agreement":null},{"id":"W3162018632","doi":"10.1016/j.eururo.2021.02.036","title":"Re: Sachin Malde, Roland Umbach, Jessica R. Wheeler, et al. A Systematic Review of Patients’ Values, Preferences, and Expectations for the Diagnosis and Treatment of Male Lower Urinary Tract Symptoms. Eur Urol 2021;79:796–809","year":2021,"lang":"en","type":"review","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Urinary system; Lower urinary tract symptoms; Gynecology; Urology; Internal medicine","score_opus":0.060795318949810155,"score_gpt":0.3529325206590136,"score_spread":0.29213720170920343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162018632","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004593924,0.9906761,0.000009842756,0.0008709642,0.00009496539,0.0060152183,0.00046419373,0.000011631552,0.0013976627],"genre_scores_gemma":[0.0017465601,0.99513113,0.00007295943,0.00040217963,0.000058080197,0.00107355,0.0006374679,0.000092796254,0.0007852547],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941811,0.003198967,0.0012661811,0.0006739154,0.00032687,0.00035298397],"domain_scores_gemma":[0.9949032,0.003182183,0.00070131355,0.00081496063,0.0002306836,0.00016763734],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009400569,0.00050068024,0.0028396784,0.00018923725,0.000113903414,0.00002600377,0.00023139374,0.000110184315,0.00030683525],"category_scores_gemma":[0.000709001,0.00029677365,0.00045249832,0.00026070053,0.00022426205,0.00006173974,0.00016763755,0.00035180806,0.0000126050145],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023619954,0.004046815,0.0019881702,0.81683487,0.0025140308,0.00044204557,0.0010387326,2.9406922e-7,2.9445744e-7,0.000032890544,0.010611479,0.16225417],"study_design_scores_gemma":[0.00226018,0.01582673,0.0016292422,0.14735161,0.0117335925,0.0008571888,0.00009445529,0.000013445609,4.5184186e-7,0.000005062822,0.8198378,0.00039021837],"about_ca_topic_score_codex":0.000010423003,"about_ca_topic_score_gemma":0.000003071892,"teacher_disagreement_score":0.80922633,"about_ca_system_score_codex":0.000037726484,"about_ca_system_score_gemma":0.00022871302,"threshold_uncertainty_score":0.99994844},"labels":[],"label_agreement":null},{"id":"W3162609200","doi":"10.1016/j.eururo.2021.04.032","title":"Mastering the Landscape of Postradiation Local Prostate Salvage Therapy","year":2021,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia, Okanagan Campus; Kelowna General Hospital","funders":"","keywords":"Medicine; Salvage therapy; Prostate cancer; Prostate; Prostate disease; Surgery; Internal medicine; Chemotherapy; Cancer","score_opus":0.011543622800716852,"score_gpt":0.24887691758247474,"score_spread":0.23733329478175788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162609200","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04440963,0.030990878,0.00012919136,0.0050921477,0.89661306,0.0016202002,0.00055253285,0.00012983503,0.020462546],"genre_scores_gemma":[0.4075468,0.015842358,0.000051837913,0.0011265259,0.5718477,0.000059792706,0.0023108155,0.00018348193,0.0010307201],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841785,0.00033700353,0.00034846968,0.00036807286,0.0002845155,0.0002440813],"domain_scores_gemma":[0.99875706,0.0003264058,0.0002385093,0.00045222827,0.00016060365,0.00006519885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032159776,0.00023453835,0.0004312513,0.00006421575,0.000045434383,0.00001988282,0.00013835069,0.00014902551,0.0001445291],"category_scores_gemma":[0.00010903197,0.0001518775,0.00013733961,0.000097642675,0.00011647154,0.000022098271,0.000079190395,0.0004840018,0.000042978012],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064765004,0.00019674463,0.0012507242,0.00011860357,0.0004263696,0.00081113976,0.00064685073,0.00004020809,0.00024026206,0.000015564372,0.9526009,0.04300498],"study_design_scores_gemma":[0.0021645885,0.002336952,0.009064532,0.00007434213,0.00017206284,0.000022509776,0.00004627744,0.000021064372,0.00030875683,0.0000069421103,0.9856588,0.00012313713],"about_ca_topic_score_codex":0.000018348808,"about_ca_topic_score_gemma":0.000006849982,"teacher_disagreement_score":0.36313716,"about_ca_system_score_codex":0.000044992375,"about_ca_system_score_gemma":0.0002213296,"threshold_uncertainty_score":0.61933845},"labels":[],"label_agreement":null},{"id":"W3163163893","doi":"10.1016/j.eururo.2021.05.004","title":"Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Odds ratio; Confidence interval; Urology; Logistic regression; Biopsy; Retrospective cohort study; Stage (stratigraphy); Kidney disease; Hydronephrosis; T-stage; Internal medicine; Surgery; Cancer; Urinary system","score_opus":0.029307410559832922,"score_gpt":0.3055534652005652,"score_spread":0.27624605464073226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163163893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99079907,0.00017394096,0.00017172738,0.0006088186,0.0006314072,0.001070323,0.0001864824,0.000041491694,0.00631676],"genre_scores_gemma":[0.99773735,0.0000628171,0.00040154738,0.00046558445,0.0003476356,0.00015129765,0.00040991788,0.000043528824,0.00038031366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812526,0.00061088987,0.000359832,0.0005185802,0.00015149254,0.00023394052],"domain_scores_gemma":[0.9990808,0.00016411766,0.00011692637,0.00033365178,0.00016452686,0.00014001361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031445493,0.00018151036,0.00030874915,0.00013963497,0.0000749503,0.000032782285,0.00008696155,0.000043974855,0.00017224289],"category_scores_gemma":[0.00032326422,0.00016740494,0.000074359195,0.00016670354,0.00003628845,0.000120359895,0.000028036455,0.00015375495,0.000026603322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067935605,0.0025136112,0.98858446,0.000011746742,0.00019038233,0.00050121365,0.002104396,0.000022096094,0.0009389695,0.00006535997,0.00019827495,0.004190111],"study_design_scores_gemma":[0.005595848,0.0016824187,0.98599416,0.000010416473,0.00022442592,0.00003675309,0.00054872705,0.00012595746,0.0018285473,0.00003643284,0.003803292,0.00011303597],"about_ca_topic_score_codex":0.00009649703,"about_ca_topic_score_gemma":0.00011611332,"teacher_disagreement_score":0.0069383085,"about_ca_system_score_codex":0.00012214699,"about_ca_system_score_gemma":0.00045655406,"threshold_uncertainty_score":0.68265754},"labels":[],"label_agreement":null},{"id":"W3164345089","doi":"10.1016/j.eururo.2021.05.022","title":"European Association of Urology Guidelines on Urethral Stricture Disease (Part 1): Management of Male Urethral Stricture Disease","year":2021,"lang":"en","type":"review","venue":"European Urology","topic":"Urological Disorders and Treatments","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Urethral stricture; Medicine; Urethroplasty; Urethra; Surgery; Urologic disease; Urology; Intensive care medicine; General surgery; Internal medicine; Urinary system","score_opus":0.06511315115248775,"score_gpt":0.336626321115348,"score_spread":0.27151316996286023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164345089","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005045981,0.9744144,0.00006011437,0.0017567686,0.00067871396,0.0013175965,0.0008097374,0.0000923189,0.020365741],"genre_scores_gemma":[0.0070778793,0.98051125,0.00019273293,0.0025080848,0.0005957464,0.00003216126,0.0030391319,0.00019654786,0.0058464482],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99297833,0.0028320372,0.0016840304,0.001176807,0.00064376264,0.0006850471],"domain_scores_gemma":[0.996213,0.00027467764,0.0014484901,0.0011678006,0.0003493307,0.0005466805],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069895224,0.00087352406,0.0024490068,0.00033379722,0.000087563516,0.00001698451,0.000522058,0.00033950582,0.00093268795],"category_scores_gemma":[0.0008570226,0.0006428752,0.0012426245,0.0005383179,0.00017425446,0.0000364927,0.0004631711,0.0009262896,0.00023511119],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021656007,0.0052886945,0.009956082,0.016505558,0.00904058,0.028157543,0.00009270856,0.0003618659,0.0000012789743,0.004109168,0.10251719,0.82180375],"study_design_scores_gemma":[0.0019714797,0.0013218567,0.015966948,0.0010346702,0.01099854,0.000036678943,0.000007967569,0.000009669145,9.6888975e-8,0.00007265095,0.96818775,0.0003916655],"about_ca_topic_score_codex":0.0000026215496,"about_ca_topic_score_gemma":9.367711e-7,"teacher_disagreement_score":0.86567056,"about_ca_system_score_codex":0.00010838002,"about_ca_system_score_gemma":0.00018142328,"threshold_uncertainty_score":0.99998057},"labels":[],"label_agreement":null},{"id":"W3164510972","doi":"10.1016/j.eururo.2021.05.016","title":"Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; BC Cancer Agency; Queen's University; University of British Columbia","funders":"Astellas Pharma US","keywords":"Medicine; Enzalutamide; Prostate cancer; Hazard ratio; Androgen deprivation therapy; Oncology; Internal medicine; Hormonal therapy; Hormone therapy; Interim analysis; Prostate; Cancer; Confidence interval; Urology; Clinical trial; Breast cancer; Androgen receptor","score_opus":0.024867884516760856,"score_gpt":0.2810322654030481,"score_spread":0.25616438088628724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164510972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882573,0.005314585,0.00006778165,0.0007386274,0.000009204573,0.00048361908,0.00003713624,0.00002994339,0.005061836],"genre_scores_gemma":[0.9937801,0.0046057664,0.00031097507,0.00018063067,0.0000289453,0.000018032784,0.000117259966,0.000046184912,0.00091212423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866414,0.00039008187,0.0001683095,0.0003362318,0.00019054832,0.00025069684],"domain_scores_gemma":[0.99928063,0.0000788252,0.00009576883,0.00020045218,0.00024730864,0.00009700561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018398958,0.00017128036,0.00037906924,0.00007582678,0.00005703198,0.000012106094,0.000036019686,0.000020823436,0.000032060758],"category_scores_gemma":[0.000014236153,0.00010443484,0.000028942548,0.00018402879,0.00020770986,0.000061279105,0.000027705104,0.0001310708,0.000004025208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06311595,0.0013284639,0.46369326,0.0002530155,0.010387388,0.015352245,0.009756546,0.00042448766,0.39484638,0.00047695616,0.00034745247,0.040017843],"study_design_scores_gemma":[0.028328037,0.008249451,0.8263079,0.00006438223,0.0010197612,0.0007664883,0.00053553155,0.00034293171,0.13088207,0.00003835,0.0030906969,0.00037444086],"about_ca_topic_score_codex":0.00015629538,"about_ca_topic_score_gemma":0.00007005556,"teacher_disagreement_score":0.3626146,"about_ca_system_score_codex":0.00003967583,"about_ca_system_score_gemma":0.00022307869,"threshold_uncertainty_score":0.42587292},"labels":[],"label_agreement":null},{"id":"W3167124105","doi":"10.1016/j.eururo.2021.05.032","title":"European Association of Urology Guidelines on Urethral Stricture Disease (Part 2): Diagnosis, Perioperative Management, and Follow-up in Males","year":2021,"lang":"en","type":"review","venue":"European Urology","topic":"Urological Disorders and Treatments","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Urethroplasty; Urethral stricture; Sexual medicine; Perioperative; Surgery; Urethra; Urology","score_opus":0.06949314828717365,"score_gpt":0.3382912198603727,"score_spread":0.268798071573199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167124105","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001748307,0.9801001,0.0000057642865,0.0012364971,0.0003507598,0.0009258488,0.00015390613,0.000043477863,0.015435353],"genre_scores_gemma":[0.0043291007,0.9885254,0.000078878074,0.0024448065,0.00021533176,0.00006448394,0.0008046628,0.00009874379,0.003438592],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948245,0.002688367,0.0009526992,0.00087620574,0.00023141729,0.00042676],"domain_scores_gemma":[0.9984265,0.00031352474,0.000495202,0.00044695823,0.00012529036,0.00019251187],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005587214,0.00055066025,0.0017185021,0.0003006644,0.00006629013,0.000021692116,0.00019866489,0.00021150577,0.00023060053],"category_scores_gemma":[0.0009896469,0.00040641564,0.00038447086,0.0003064637,0.000119040655,0.00003197804,0.00029036344,0.00059188803,0.00011469549],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005540454,0.0016581047,0.08067811,0.0035930835,0.0026619493,0.012644859,0.0002107334,0.000023536179,2.8667654e-7,0.0022647667,0.017215049,0.87849545],"study_design_scores_gemma":[0.0021042554,0.0010079957,0.042695947,0.0006629064,0.0025160748,0.000027099373,0.00001306307,0.0000032484825,4.269197e-8,0.000019475667,0.95070255,0.00024731766],"about_ca_topic_score_codex":0.0000040043265,"about_ca_topic_score_gemma":0.0000112460575,"teacher_disagreement_score":0.93348753,"about_ca_system_score_codex":0.00006949162,"about_ca_system_score_gemma":0.000059439128,"threshold_uncertainty_score":0.99983877},"labels":[],"label_agreement":null},{"id":"W3173352595","doi":"10.1016/j.eururo.2021.06.006","title":"Circulating MicroRNAs, the Next-Generation Serum Biomarkers in Testicular Germ Cell Tumours: A Systematic Review","year":2021,"lang":"en","type":"review","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia","funders":"","keywords":"Medicine; Seminoma; Cochrane Library; Testicular cancer; Germ cell tumors; Stage (stratigraphy); Disease; microRNA; MEDLINE; Oncology; Teratoma; Receiver operating characteristic; Internal medicine; Systematic review; Cancer; Bioinformatics; Pathology; Meta-analysis; Chemotherapy","score_opus":0.0848719034777923,"score_gpt":0.31556531763546075,"score_spread":0.23069341415766845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173352595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008092479,0.99554056,0.000012734518,0.00020130305,0.00018111576,0.0032297727,0.000026544958,0.00005285482,0.0006742062],"genre_scores_gemma":[0.00183882,0.99544245,0.00009942791,0.0014241503,0.00019402734,0.00014969538,0.00062193885,0.00013355064,0.00009593748],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99409664,0.0034033554,0.0012205713,0.00065503694,0.00022986344,0.00039451977],"domain_scores_gemma":[0.99753845,0.0003972217,0.000823575,0.0010014063,0.00008747251,0.00015189034],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00092959974,0.0005290167,0.0024633496,0.00014407311,0.000090558504,0.0000590841,0.00025545852,0.000114251976,0.00008264351],"category_scores_gemma":[0.0016303305,0.00032386425,0.0007489465,0.0005000801,0.00006496512,0.000034344084,0.00014038033,0.00041192118,0.00035314614],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002244312,0.0002994727,0.0001575735,0.94096875,0.0008552024,0.015075266,0.00003431473,0.000002451535,0.0000101312025,0.000013506942,0.00081315637,0.041767903],"study_design_scores_gemma":[0.0011302736,0.00028764276,0.00045725927,0.7993816,0.052364312,0.010556295,0.00002773361,0.0002124658,7.2179455e-7,0.00000192779,0.13482268,0.0007570586],"about_ca_topic_score_codex":0.000010759245,"about_ca_topic_score_gemma":0.000002560958,"teacher_disagreement_score":0.14158715,"about_ca_system_score_codex":0.00013394839,"about_ca_system_score_gemma":0.0003134797,"threshold_uncertainty_score":0.9999213},"labels":[],"label_agreement":null},{"id":"W3174860370","doi":"10.1016/j.eururo.2021.05.034","title":"Re: Radical Cystectomy Against Intravesical BCG for High-risk High-grade Nonmuscle Invasive Bladder Cancer: Results from the Randomized Controlled BRAVO-feasibility Study","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; Randomized controlled trial; Urothelial cancer; Surgery; Cancer; Internal medicine","score_opus":0.022824573759835872,"score_gpt":0.28123271869978494,"score_spread":0.25840814493994907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174860370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97008353,0.0015442623,0.00052567583,0.01585317,0.00119486,0.007510079,0.0009970538,0.00014980612,0.0021415348],"genre_scores_gemma":[0.9884016,0.0005503576,0.0003358352,0.0074583786,0.0017557902,0.00047958156,0.00040540847,0.00010248381,0.000510576],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9904886,0.0059604365,0.0012960883,0.001206204,0.00044382058,0.00060484826],"domain_scores_gemma":[0.99053085,0.007219599,0.00046868637,0.0011995955,0.00028565104,0.0002956043],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022793938,0.00049132516,0.0023117678,0.00006425114,0.00032149325,0.00006080772,0.0003604224,0.00015940306,0.00032646875],"category_scores_gemma":[0.0068687843,0.00029911418,0.0005896289,0.00023091718,0.000547545,0.000055788754,0.00018886112,0.000725426,0.000084200125],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94340885,0.004713633,0.011951554,0.000034219243,0.01046483,0.002421912,0.0057940483,0.000097090735,0.0022596153,0.0004040163,0.01249431,0.005955922],"study_design_scores_gemma":[0.9093533,0.0021082365,0.0787061,0.000034259923,0.004741539,0.000020580468,0.00058386906,0.00016841466,0.0010562501,0.0008664013,0.0020221148,0.0003389148],"about_ca_topic_score_codex":0.0015861845,"about_ca_topic_score_gemma":0.0014280806,"teacher_disagreement_score":0.06675455,"about_ca_system_score_codex":0.00013211396,"about_ca_system_score_gemma":0.0005578267,"threshold_uncertainty_score":0.9999461},"labels":[],"label_agreement":null},{"id":"W3176786146","doi":"10.1016/j.eururo.2021.06.008","title":"Validation of the STAR-CAP Clinical Prognostic System for Predicting Biochemical Recurrence, Metastasis, and Cancer-specific Mortality After Radical Prostatectomy in a European Cohort","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; Stage (stratigraphy); Biochemical recurrence; Receiver operating characteristic; Oncology; Cohort; Internal medicine; Proportional hazards model; Urology; Radiation therapy; Metastasis; Nomogram; Cancer","score_opus":0.038553635457525326,"score_gpt":0.3142131982215876,"score_spread":0.2756595627640623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176786146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99106497,0.005824607,0.00005668274,0.00055754825,0.00036403898,0.0014341759,0.00018868932,0.000033206063,0.0004760926],"genre_scores_gemma":[0.99809533,0.000922301,0.0002723043,0.00017641918,0.00018633639,0.00020734032,0.000091576774,0.000036599675,0.000011772529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970145,0.0012002969,0.0007548553,0.00057402626,0.00018149483,0.00027481353],"domain_scores_gemma":[0.99884367,0.0002913063,0.00022164377,0.00036614967,0.00015493731,0.00012230966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013704627,0.00017356114,0.00044766747,0.00004635875,0.000046153924,0.000017085527,0.00009447423,0.0000494679,0.000018221206],"category_scores_gemma":[0.00042040506,0.00012425869,0.0001264772,0.00020626401,0.00027767703,0.00003439197,0.00014762257,0.00026904192,0.0000034658692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004033282,0.0003258166,0.9935925,0.0003237607,0.00019915664,0.00025997896,0.00014007934,0.0000039025476,0.00065415754,0.000057016674,0.00027532532,0.0037649886],"study_design_scores_gemma":[0.0027267116,0.00046338185,0.9848176,0.00034432413,0.00045735674,0.00007483887,0.000048317714,0.00009559884,0.006191712,0.00001078819,0.004662814,0.000106522726],"about_ca_topic_score_codex":0.0000107903525,"about_ca_topic_score_gemma":0.0000049655187,"teacher_disagreement_score":0.008774855,"about_ca_system_score_codex":0.00007533157,"about_ca_system_score_gemma":0.00014059126,"threshold_uncertainty_score":0.5067122},"labels":[],"label_agreement":null},{"id":"W3177737328","doi":"10.1016/s0302-2838(21)00691-6","title":"Management of women with overactive bladder syndrome: A systematic review with meta-analysis of benefits and potential harms of surgical and non-surgical treatment options by the EAU non-neurogenic female LUTS Guidelines panel","year":2021,"lang":"en","type":"review","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Overactive bladder; Meta-analysis; Urology; Gynecology; Internal medicine; Alternative medicine; Pathology","score_opus":0.1000217500917464,"score_gpt":0.3566261813617142,"score_spread":0.2566044312699678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177737328","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048356373,0.9914521,0.000016016635,0.00027825506,0.000009899762,0.0028227437,0.00028983608,0.000006544848,0.000288983],"genre_scores_gemma":[0.009681591,0.9888905,0.000120911376,0.00003399864,0.000012065021,0.00029866563,0.00019538763,0.000060377635,0.00070646376],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9952341,0.0017735693,0.0014013597,0.00067847443,0.00053343934,0.00037906817],"domain_scores_gemma":[0.9973069,0.00046698877,0.0008445359,0.00084677455,0.0003349402,0.00019989518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013534456,0.0005103381,0.006547255,0.00027573731,0.000059720413,0.000014774307,0.00020995834,0.000078372046,0.00020923813],"category_scores_gemma":[0.000023164603,0.00023534948,0.00084891124,0.00086369325,0.0003349521,0.00003506636,0.00024950536,0.0002703984,0.000003834174],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005240947,0.0010099274,0.00001899636,0.36915815,0.60744625,0.012166202,0.00031981614,0.000064169166,0.0000010586451,0.000040598312,0.000091510265,0.009159212],"study_design_scores_gemma":[0.0019865404,0.0057781953,0.0001721862,0.019422118,0.9393673,0.013057741,0.00016965906,0.000040652896,0.0000013726195,3.7342576e-7,0.019682953,0.00032092957],"about_ca_topic_score_codex":0.000022053628,"about_ca_topic_score_gemma":0.0000013508192,"teacher_disagreement_score":0.34973603,"about_ca_system_score_codex":0.000041724692,"about_ca_system_score_gemma":0.00012424577,"threshold_uncertainty_score":0.95972735},"labels":[],"label_agreement":null},{"id":"W3180312779","doi":"10.1016/s0302-2838(21)01586-4","title":"The effect of lymph node dissection on cancer-specific survival in salvage radical prostatectomy patients","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Prostatectomy; Dissection (medical); Lymph node; Prostate cancer; Urology; Surgery; Salvage therapy; Cancer; Internal medicine; Chemotherapy","score_opus":0.009150513051366162,"score_gpt":0.25478075713631865,"score_spread":0.2456302440849525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180312779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916411,0.0015103876,0.000004703905,0.0010382241,0.0006233912,0.0003460133,0.000020802067,0.00002095229,0.004794405],"genre_scores_gemma":[0.9982794,0.0011764187,0.00000492298,0.00021937037,0.00009953555,0.0000518169,0.00005335006,0.000028898945,0.00008629635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984072,0.0006739053,0.00024387658,0.0002852781,0.00015656144,0.00023321749],"domain_scores_gemma":[0.99920124,0.00035272012,0.00007486597,0.00026094425,0.00004659348,0.00006366739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028128925,0.00013137581,0.00025633085,0.000044657754,0.00005781993,0.000008823002,0.000060981904,0.00003176377,0.00004413166],"category_scores_gemma":[0.000118005584,0.0000828864,0.000068192465,0.00016296553,0.00010443422,0.000015878983,0.00004357198,0.00015529497,0.00003575069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019191464,0.00034413056,0.9526605,0.00004446072,0.00007141355,0.0005307122,0.000113543814,0.000049415048,0.0008007295,0.0001283774,0.00047750285,0.042860083],"study_design_scores_gemma":[0.005438628,0.0018374745,0.9662277,0.000051990333,0.00003801665,0.0000102818985,0.000008026422,0.000012362197,0.008644844,0.0000076108995,0.017657924,0.00006515122],"about_ca_topic_score_codex":0.000018396027,"about_ca_topic_score_gemma":0.000018627918,"teacher_disagreement_score":0.04279493,"about_ca_system_score_codex":0.00012947997,"about_ca_system_score_gemma":0.00004007808,"threshold_uncertainty_score":0.33800092},"labels":[],"label_agreement":null},{"id":"W3182009252","doi":"10.1016/s0302-2838(21)00689-8","title":"What are the different diagnostic tests for female Bladder Outlet Obstruction (fBOO)? A systematic review from the European Association of Urology non-neurogenic female LUTS Guidelines Panel","year":2021,"lang":"en","type":"review","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Bladder outlet obstruction; Urology; Urinary bladder neck obstruction; Gynecology; General surgery; Internal medicine; Prostate","score_opus":0.13478041948522426,"score_gpt":0.37399610038568554,"score_spread":0.23921568090046127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182009252","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035943327,0.9867899,0.000079684236,0.0040493356,0.0012821526,0.0067295255,0.00028776962,0.000060868813,0.00036132996],"genre_scores_gemma":[0.0012857103,0.9908998,0.000027486063,0.0032042975,0.001305762,0.0004543257,0.0010744194,0.00025699753,0.0014911887],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9827151,0.01242874,0.002449771,0.0010154517,0.0006401624,0.00075081474],"domain_scores_gemma":[0.9829257,0.011960714,0.0022107188,0.0018745933,0.00085293927,0.00017533726],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004328915,0.00078075624,0.0037308517,0.0001436593,0.00026149896,0.000111615154,0.0009918824,0.00024057712,0.00011589774],"category_scores_gemma":[0.017148418,0.00042164396,0.0012675673,0.00041783016,0.00020356826,0.000088931265,0.0006016357,0.0011910178,0.0003392382],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012295447,0.00074669364,0.0011002318,0.7735858,0.008693706,0.0017483601,0.0013255228,0.000009241034,0.000017012417,0.00004271279,0.04301308,0.16959469],"study_design_scores_gemma":[0.0017602852,0.0015535859,0.004708718,0.1886275,0.038207494,0.0016761356,0.00049712457,0.000037139765,0.0000026487899,0.000033434902,0.7620594,0.00083656143],"about_ca_topic_score_codex":0.000010156533,"about_ca_topic_score_gemma":0.000020504443,"teacher_disagreement_score":0.7190463,"about_ca_system_score_codex":0.00011814653,"about_ca_system_score_gemma":0.00021599549,"threshold_uncertainty_score":0.9998235},"labels":[],"label_agreement":null},{"id":"W3186357354","doi":"10.1016/j.eururo.2021.07.001","title":"Addressing Equality of Representation in Urology Societies","year":2021,"lang":"en","type":"letter","venue":"European Urology","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Urology; Representation (politics)","score_opus":0.18383020322244872,"score_gpt":0.3662805681614067,"score_spread":0.18245036493895797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186357354","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005146573,0.0012171444,0.000085112675,0.6538361,0.0014231814,0.00012812378,0.000017553464,0.000044899054,0.33810133],"genre_scores_gemma":[0.08248438,0.0005535455,0.00007151702,0.90478516,0.003915097,0.000002459133,0.00029199186,0.000031012503,0.007864829],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928591,0.0055147284,0.00033858285,0.00037852168,0.00053172075,0.00037733943],"domain_scores_gemma":[0.99875575,0.00053415704,0.00026170947,0.00027578813,0.00013760701,0.00003501001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024971322,0.00012650063,0.00037979832,0.0001376476,0.0001363884,0.000020538075,0.00060499704,0.00043582608,0.00071552716],"category_scores_gemma":[0.0008637216,0.00014361509,0.00011110572,0.0002483787,0.0011405481,0.00006464472,0.00025368863,0.001237808,0.000048200956],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001455211,0.000019099398,0.00245428,0.000047361616,0.000029328163,0.00096208905,0.013218543,0.000011972132,0.000021040752,0.0004006523,0.98147535,0.0013457272],"study_design_scores_gemma":[0.00026532807,0.000065805114,0.0029247797,0.00001646224,0.000055907825,0.0000040634395,0.0045382353,0.000002146962,0.0000046171117,0.00060696586,0.99139327,0.00012244312],"about_ca_topic_score_codex":0.000531044,"about_ca_topic_score_gemma":0.00020534424,"teacher_disagreement_score":0.3302365,"about_ca_system_score_codex":0.000043050284,"about_ca_system_score_gemma":0.0001597232,"threshold_uncertainty_score":0.78345203},"labels":[],"label_agreement":null},{"id":"W3189278449","doi":"10.1016/j.eururo.2021.07.019","title":"Adjuvant Immune Checkpoint Inhibition in Muscle-invasive Bladder Cancer: Is It Ready for Prime Time?","year":2021,"lang":"en","type":"editorial","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Queen's University","funders":"","keywords":"Medicine; Atezolizumab; Nivolumab; Bladder cancer; Adjuvant; Oncology; Internal medicine; Chemotherapy; Neoadjuvant therapy; Immunotherapy; Adjuvant chemotherapy; Cancer; Urology; Breast cancer","score_opus":0.02389745304614387,"score_gpt":0.3051402551644497,"score_spread":0.2812428021183058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3189278449","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008121214,0.01977447,0.000102438644,0.013273495,0.8930158,0.0048984624,0.005215325,0.00030740304,0.055291403],"genre_scores_gemma":[0.01162488,0.006427152,0.00027343706,0.005460606,0.9303105,0.000593859,0.011372257,0.0006229725,0.03331432],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99640477,0.00041968536,0.0009145669,0.0011253234,0.0004492845,0.0006863743],"domain_scores_gemma":[0.9977482,0.00045052395,0.0004048019,0.000742953,0.00047262898,0.00018089167],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00049381296,0.00060212123,0.0012307958,0.0002586132,0.00008549168,0.0000312807,0.00016780102,0.0006337646,0.001854341],"category_scores_gemma":[0.0006989262,0.00057416514,0.00035920774,0.00020288526,0.00013670653,0.00006382652,0.00018293438,0.001045817,0.00067106495],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009914925,0.00036236492,0.000025826133,0.00022671059,0.0005131974,0.0014443999,0.0009497831,0.0000036308454,0.006889697,0.0000028165236,0.9848774,0.0037126562],"study_design_scores_gemma":[0.008288651,0.0019825972,0.0009281574,0.00041334814,0.0009569096,0.000038287915,0.000051902396,0.000013698975,0.004790901,0.00002891333,0.9820337,0.0004729218],"about_ca_topic_score_codex":0.00047537923,"about_ca_topic_score_gemma":0.00020399645,"teacher_disagreement_score":0.037294723,"about_ca_system_score_codex":0.0003823079,"about_ca_system_score_gemma":0.001381134,"threshold_uncertainty_score":0.999671},"labels":[],"label_agreement":null},{"id":"W3190656951","doi":"10.1016/j.eururo.2021.07.005","title":"Retrospective Concomitant Nonrandomized Comparison of “Touch” Cautery Versus Athermal Dissection of the Prostatic Vascular Pedicles and Neurovascular Bundles During Robot-assisted Radical Prostatectomy","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Neurovascular bundle; Prostatectomy; Surgery; Concomitant; Body mass index; Retrospective cohort study; Dissection (medical); Prostate; Urology; Erectile dysfunction; Laparoscopic radical prostatectomy; Internal medicine; Cancer","score_opus":0.02386175423654825,"score_gpt":0.2725136037749951,"score_spread":0.24865184953844688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190656951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962132,0.0008511573,0.00041424442,0.00037140975,0.00073631614,0.00043074772,0.0000055196183,0.000050765513,0.00092665444],"genre_scores_gemma":[0.99936336,0.0000990836,0.000113836024,0.00010965158,0.000099561774,0.000010683612,0.000010200501,0.000029249133,0.00016437692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786276,0.00080613134,0.0005127307,0.0003478869,0.00028463677,0.0001858854],"domain_scores_gemma":[0.9989045,0.00022643208,0.00023713434,0.00032120023,0.0002382219,0.00007246633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027369687,0.00017130404,0.00065594155,0.0000746016,0.00015405858,0.000009959755,0.000055500124,0.000052556505,0.00005838772],"category_scores_gemma":[0.0008946191,0.00012127577,0.00019831747,0.00025616345,0.00042786147,0.000039967745,0.0001287724,0.00028444792,0.0000045750867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030934952,0.0014994015,0.6194913,0.0006450767,0.002473365,0.00034365294,0.0046627517,0.00024610778,0.33653936,0.00038166318,0.00022991073,0.002552462],"study_design_scores_gemma":[0.024766695,0.0009771391,0.96327704,0.00003691752,0.00057838496,0.00023609618,0.0008223897,0.00020577821,0.008267543,0.0000069536623,0.00071975956,0.0001052907],"about_ca_topic_score_codex":0.000012433795,"about_ca_topic_score_gemma":0.000013299795,"teacher_disagreement_score":0.34378576,"about_ca_system_score_codex":0.000032510925,"about_ca_system_score_gemma":0.000054910146,"threshold_uncertainty_score":0.49454823},"labels":[],"label_agreement":null},{"id":"W3194097125","doi":"10.1016/j.eururo.2021.06.004","title":"Reply to Wei Liu, Katherine Zukotynski, and Glenn Bauman’s Letter to the Editor re: Rachel M. Glicksman, Ur Metser, Douglass Vines, et al. Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis. Eur Urol 2021;80:374–82","year":2021,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; General surgery","score_opus":0.060725641845245856,"score_gpt":0.328905315257747,"score_spread":0.26817967341250115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194097125","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00812287,0.017461203,0.00035350505,0.9549553,0.004004208,0.013088683,0.0012285947,0.0002589235,0.00052673504],"genre_scores_gemma":[0.007511828,0.002926572,0.0026419808,0.9461078,0.02398005,0.009828712,0.0009805404,0.0006660729,0.0053564543],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98997533,0.0034738071,0.001333021,0.0024448137,0.0011113235,0.0016616797],"domain_scores_gemma":[0.99376315,0.0020947335,0.00073218386,0.0017896456,0.0012265189,0.00039375856],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0026113957,0.0014333342,0.0019185893,0.0005457292,0.00085742044,0.0003775923,0.0009667775,0.0002547731,0.00016605195],"category_scores_gemma":[0.0034548976,0.00083780667,0.00061718264,0.0012721446,0.00046177616,0.00015824291,0.001010995,0.0028492815,0.00005745451],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026739797,0.00074386224,0.000059854236,0.00013996652,0.0037784618,0.0011024667,0.004253721,0.00001027614,0.0023432935,0.000007964213,0.9304137,0.03040663],"study_design_scores_gemma":[0.029471206,0.010637719,0.00025184033,0.00020267421,0.0017349181,0.00010868155,0.00018996281,0.00008391666,0.00096000195,0.000036759535,0.95553905,0.0007832769],"about_ca_topic_score_codex":0.0003622735,"about_ca_topic_score_gemma":0.00012197107,"teacher_disagreement_score":0.029623352,"about_ca_system_score_codex":0.0003769715,"about_ca_system_score_gemma":0.0005719503,"threshold_uncertainty_score":0.99984163},"labels":[],"label_agreement":null},{"id":"W3194210605","doi":"10.1016/j.eururo.2021.06.003","title":"Re: Rachel M. Glicksman, Ur Metser, Douglass Vines, et al. Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis. Eur Urol 2021;80:374–82","year":2021,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; London Health Sciences Centre; Western University","funders":"Ontario Institute for Cancer Research; Canadian Association of Radiation Oncology","keywords":"Medicine; Prostate cancer; Oncology; Metastasis; Prostate; Internal medicine; Clinical trial; Gynecology; Cancer; Urology","score_opus":0.09249571404793779,"score_gpt":0.3496596363935667,"score_spread":0.2571639223456289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194210605","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008293153,0.055781137,0.0004007606,0.9135599,0.0023184041,0.013950076,0.0020050693,0.00052015844,0.003171343],"genre_scores_gemma":[0.053442862,0.019494757,0.0056295083,0.87191385,0.009145272,0.016723577,0.007930022,0.0017757538,0.0139443735],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98805845,0.004759714,0.0015664506,0.0024622746,0.0012308155,0.0019222926],"domain_scores_gemma":[0.99272394,0.0025101965,0.0011999907,0.0016322249,0.0016130937,0.00032053524],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002334631,0.0016216207,0.0024554222,0.0006767752,0.0008491427,0.00030127662,0.00095587055,0.0003842714,0.00032552448],"category_scores_gemma":[0.0035251356,0.0010699028,0.0010971145,0.0014822677,0.0007292259,0.0001969329,0.0006921525,0.0037397959,0.000059455288],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052009247,0.0024770782,0.00014113917,0.0003749913,0.010984118,0.004772747,0.0034900627,0.0000132581235,0.0034424881,0.00003410395,0.8527516,0.06950914],"study_design_scores_gemma":[0.072639704,0.011281125,0.00019010698,0.00023494469,0.0035272646,0.00016364855,0.00025931618,0.00025183574,0.0017488492,0.00013321653,0.90859914,0.000970865],"about_ca_topic_score_codex":0.00021603072,"about_ca_topic_score_gemma":0.00007499203,"teacher_disagreement_score":0.06853828,"about_ca_system_score_codex":0.0005037903,"about_ca_system_score_gemma":0.0013035465,"threshold_uncertainty_score":0.9996531},"labels":[],"label_agreement":null},{"id":"W3194741964","doi":"10.1016/j.eururo.2021.07.026","title":"Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ozmosis Research (Canada); McMaster University; University of Calgary; Princess Margaret Cancer Centre; Juravinski Cancer Centre; University of Manitoba; Ottawa Hospital; CancerCare Manitoba; University of Ottawa; McGill University; Sunnybrook Health Science Centre; Jewish General Hospital; University of Alberta; London Health Sciences Centre; University of Toronto; Western University","funders":"","keywords":"Medicine; Internal medicine; Renal cell carcinoma; Cumulative incidence; Oncology; Prospective cohort study; Tyrosine-kinase inhibitor; Radiation therapy; Incidence (geometry); Confidence interval; Systemic therapy; Cancer; Surgery; Cohort","score_opus":0.027230859123176722,"score_gpt":0.3187360434546051,"score_spread":0.29150518433142836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194741964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99254936,0.003502579,0.000052631935,0.00028461815,0.00031129358,0.002858434,0.00002121696,0.00004103279,0.00037884343],"genre_scores_gemma":[0.997238,0.00016271246,0.0008885211,0.00065672095,0.00020378643,0.0002927629,0.000058503414,0.00010281884,0.00039621018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974353,0.0008106002,0.0004679605,0.00065760355,0.00022124799,0.0004073275],"domain_scores_gemma":[0.99893355,0.00014902958,0.00019387055,0.0003606664,0.00022294135,0.00013992333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030554054,0.00029511764,0.00048703913,0.00016356487,0.00007211886,0.000027883007,0.00008766525,0.000034313973,0.00014025091],"category_scores_gemma":[0.0001025477,0.00022967228,0.00011645022,0.00023459402,0.00005149555,0.0000783313,0.00005680546,0.00024391191,0.000013987194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014610996,0.028166164,0.7936385,0.000118947,0.00063272077,0.004183424,0.007733049,0.000027949398,0.11081601,0.0000016013063,0.00040660234,0.03966398],"study_design_scores_gemma":[0.10146163,0.020441167,0.80647045,0.00012325401,0.00040913664,0.00003585127,0.00029730055,0.00037139282,0.06662132,0.0000055172136,0.0033916263,0.0003713239],"about_ca_topic_score_codex":0.000024281973,"about_ca_topic_score_gemma":0.000044748314,"teacher_disagreement_score":0.08685063,"about_ca_system_score_codex":0.000264556,"about_ca_system_score_gemma":0.000096064265,"threshold_uncertainty_score":0.93657637},"labels":[],"label_agreement":null},{"id":"W3200243008","doi":"10.1016/j.eururo.2021.07.003","title":"Re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of “Manels” in Major Urology Meetings. Eur Urol 2021;80:442–9","year":2021,"lang":"en","type":"letter","venue":"European Urology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Gynecology","score_opus":0.07743136056126249,"score_gpt":0.3574768404797371,"score_spread":0.2800454799184746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200243008","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03957225,0.01033574,0.00012967119,0.9357509,0.00050979335,0.0011334785,0.00016219249,0.000088791094,0.012317172],"genre_scores_gemma":[0.1436146,0.0022403924,0.00056458125,0.84982985,0.0008900375,0.000029860137,0.00037596966,0.00020756414,0.0022471298],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98670495,0.0077580702,0.00178785,0.0017044998,0.0007667145,0.0012779236],"domain_scores_gemma":[0.9921773,0.0040550246,0.0013987034,0.001619922,0.00045207256,0.00029697554],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003353004,0.0008151907,0.0020101678,0.0010561834,0.00014842521,0.00004061957,0.0008432393,0.0007378123,0.0009690813],"category_scores_gemma":[0.007020083,0.0006786791,0.0005391255,0.0019343412,0.0008172677,0.00008702677,0.0005915558,0.0056540268,0.00018513827],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006100822,0.00023994477,0.06418419,0.0039362996,0.0026318985,0.015246621,0.014263397,0.0004925404,0.0021207714,0.00025492636,0.8947645,0.0012548589],"study_design_scores_gemma":[0.001685454,0.0018539745,0.07723187,0.00024503504,0.0035757371,0.00035130253,0.00041895747,0.000730173,0.000060795406,0.000046674726,0.91316396,0.0006360562],"about_ca_topic_score_codex":0.0009322253,"about_ca_topic_score_gemma":0.0013925645,"teacher_disagreement_score":0.10404236,"about_ca_system_score_codex":0.0001400482,"about_ca_system_score_gemma":0.0009501057,"threshold_uncertainty_score":0.99994415},"labels":[],"label_agreement":null},{"id":"W3203212377","doi":"10.1016/j.eururo.2021.09.025","title":"Urinary Extracellular Vesicles in Urology: Current Successes and Challenges Ahead","year":2021,"lang":"en","type":"letter","venue":"European Urology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Extracellular vesicles; Urology; Current (fluid); Urinary system; Internal medicine; Cell biology","score_opus":0.026754753115150538,"score_gpt":0.2503441034795913,"score_spread":0.22358935036444075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203212377","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09789091,0.71139205,0.00007689528,0.18613562,0.0008830482,0.0003331002,0.000062370156,0.000056151977,0.0031698796],"genre_scores_gemma":[0.63847953,0.14256188,0.0003380396,0.20061813,0.011675026,0.00009504078,0.0035545595,0.00068736245,0.0019904254],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948093,0.0020532864,0.00058050564,0.0015647018,0.0002004449,0.0007917102],"domain_scores_gemma":[0.9982791,0.00011450882,0.0002529357,0.0011315559,0.000079024576,0.00014285487],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005421632,0.0006145189,0.0005343403,0.0002078993,0.00008078163,0.000046094465,0.0006989298,0.00074826425,0.00007043313],"category_scores_gemma":[0.00027315065,0.0006839333,0.00017167818,0.00009903968,0.00050027884,0.000007735672,0.00091529166,0.0016172443,0.00008418653],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006378855,0.0016057357,0.00457628,0.0028611997,0.00060731516,0.06951284,0.0005187088,0.00008675024,0.09515951,0.00047002634,0.74975115,0.07421259],"study_design_scores_gemma":[0.00065151195,0.0005126516,0.0033165151,0.000029976749,0.00009959326,0.00053735485,0.000019293399,0.000012181845,0.000797072,0.00013522858,0.993274,0.0006146577],"about_ca_topic_score_codex":0.0000039447805,"about_ca_topic_score_gemma":0.00001486655,"teacher_disagreement_score":0.56883013,"about_ca_system_score_codex":0.000017240669,"about_ca_system_score_gemma":0.0001228785,"threshold_uncertainty_score":0.9995612},"labels":[],"label_agreement":null},{"id":"W3207043292","doi":"10.1016/j.eururo.2021.09.027","title":"Reply to Laurence Klotz’s Letter to the Editor re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of “Manels” in Major Urology Meetings. Eur Urol 2021;80:442–9. Eur Urol 2021;80:e100","year":2021,"lang":"en","type":"letter","venue":"European Urology","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; General surgery","score_opus":0.03503561995421256,"score_gpt":0.28826163366496743,"score_spread":0.25322601371075487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207043292","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008830171,0.0015969404,0.00026277735,0.957775,0.0044584675,0.0013087764,0.00019504945,0.00007328912,0.025499547],"genre_scores_gemma":[0.022024956,0.00040707484,0.00057801453,0.9574743,0.011728063,0.00006122612,0.00012642912,0.00011422534,0.007485702],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9784669,0.014593221,0.0013149008,0.002082116,0.0020486752,0.0014941292],"domain_scores_gemma":[0.99269205,0.003604438,0.0010319994,0.0016724739,0.00066071004,0.00033830613],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009870887,0.00077258406,0.0013163822,0.00068601716,0.0006603842,0.00020801327,0.0042042253,0.00058299507,0.0017690932],"category_scores_gemma":[0.008213252,0.000617176,0.00045228095,0.003241372,0.0017512736,0.00019605765,0.0016309043,0.004464437,0.00066703616],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009295808,0.000047620462,0.0041166693,0.00008463426,0.00044003173,0.0011624772,0.04098155,0.0006334932,0.00020547103,0.00014406197,0.9517676,0.0003234015],"study_design_scores_gemma":[0.00038446567,0.0006142001,0.0037433712,0.00009026797,0.0012281563,0.000016907406,0.0042106146,0.00006561746,0.00002010756,0.000029715775,0.9890156,0.00058098516],"about_ca_topic_score_codex":0.0026254198,"about_ca_topic_score_gemma":0.0042353147,"teacher_disagreement_score":0.03724796,"about_ca_system_score_codex":0.00011968047,"about_ca_system_score_gemma":0.00043996307,"threshold_uncertainty_score":0.99962795},"labels":[],"label_agreement":null},{"id":"W3207279690","doi":"10.1016/j.eururo.2021.09.023","title":"Vesicoureteral Reflux, Renal Scars, and Urinary Tract Infections in Children: A New Way to Think About an Old Problem","year":2021,"lang":"en","type":"letter","venue":"European Urology","topic":"Pediatric Urology and Nephrology Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Vesicoureteral reflux; Urinary system; Scars; Urology; Reflux; Surgery; Internal medicine; Disease","score_opus":0.014680926023922186,"score_gpt":0.2507618964088658,"score_spread":0.23608097038494363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207279690","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6471131,0.0063908985,0.000010875729,0.3400036,0.00038026858,0.0006673401,0.000034797926,0.00018072508,0.005218394],"genre_scores_gemma":[0.07594292,0.0013526779,0.0006959515,0.9059908,0.01101438,0.000035953857,0.00079660135,0.00017187129,0.0039988603],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.995935,0.0012764103,0.0005867745,0.0011954625,0.00017949344,0.00082684145],"domain_scores_gemma":[0.998626,0.00020234744,0.00018404359,0.0006704124,0.00006346071,0.00025375202],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00050236,0.0005642536,0.000928652,0.0006488883,0.00018898693,0.00002513826,0.000254993,0.00092841027,0.000178552],"category_scores_gemma":[0.00012886304,0.00053001766,0.00014897322,0.0003266815,0.00030998114,0.00009675186,0.0003519504,0.0042145234,0.00012358291],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034650406,0.00058426755,0.082860224,0.0000263526,0.0007456548,0.015405815,0.0011587727,0.000007183167,0.000056981935,0.00001978163,0.8962355,0.0025529526],"study_design_scores_gemma":[0.0019872377,0.006746969,0.55269206,0.000018964249,0.0007210754,0.018565333,0.000004738482,0.0000031127977,0.0000016653521,0.00008902273,0.41878507,0.0003847829],"about_ca_topic_score_codex":0.00007619777,"about_ca_topic_score_gemma":0.0000311061,"teacher_disagreement_score":0.57117015,"about_ca_system_score_codex":0.00004226982,"about_ca_system_score_gemma":0.00016632071,"threshold_uncertainty_score":0.99971515},"labels":[],"label_agreement":null},{"id":"W3211141989","doi":"10.1016/j.eururo.2017.03.008","title":"Procedure-specific Risks of Thrombosis and Bleeding in Urological Cancer Surgery: Systematic Review and Meta-analysis","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital; University of Toronto; McMaster University; Impact","funders":"","keywords":"Medicine; Meta-analysis; Thrombosis; Systematic review; Surgery; MEDLINE; General surgery; Internal medicine","score_opus":0.4604082266599825,"score_gpt":0.4476018471127764,"score_spread":0.012806379547206093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211141989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031448908,0.99508435,0.000003958509,0.00088685355,0.000049906994,0.0026701223,0.000035198234,0.000024855808,0.0012133366],"genre_scores_gemma":[0.0020289707,0.9962565,0.000024839086,0.001067163,0.00004762186,0.00038503655,0.000031258434,0.00006399573,0.00009464323],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955511,0.0013936076,0.001625684,0.00084165676,0.00022011295,0.0003678441],"domain_scores_gemma":[0.9967932,0.0005560735,0.0015613714,0.00087410206,0.000076564655,0.0001386835],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0029295841,0.00054230576,0.016603146,0.0006382567,0.00007693168,0.000033830584,0.00028123183,0.00017691261,0.00030087918],"category_scores_gemma":[0.00047293273,0.000338616,0.0014836412,0.0004134383,0.00023784085,0.00004521112,0.00032693124,0.00043692492,0.000019292267],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003436358,0.00016090058,0.0002532219,0.89441895,0.099418506,0.00009832523,0.00005001941,5.951121e-7,6.5502846e-8,0.00014346185,0.0017152313,0.003737253],"study_design_scores_gemma":[0.00009423592,0.00009162687,0.0029654389,0.0145875,0.82399046,0.000040787698,0.0000041168905,0.0000016715782,1.5909752e-8,0.0000033619797,0.15798421,0.00023656133],"about_ca_topic_score_codex":0.000052927964,"about_ca_topic_score_gemma":0.000021754473,"teacher_disagreement_score":0.8798315,"about_ca_system_score_codex":0.00003138567,"about_ca_system_score_gemma":0.000056639572,"threshold_uncertainty_score":0.9999066},"labels":[],"label_agreement":null},{"id":"W3211585399","doi":"10.1016/j.eururo.2021.10.026","title":"Sex and Gender Differences in Cancers of the Genitourinary Tract: The Need to Consider Immune Divergence","year":2021,"lang":"en","type":"editorial","venue":"European Urology","topic":"Sex and Gender in Healthcare","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Genitourinary system; Immune system; Divergence (linguistics); Oncology; Internal medicine; Gynecology; Immunology","score_opus":0.056033880419226266,"score_gpt":0.31437431704807633,"score_spread":0.2583404366288501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211585399","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38934386,0.01666267,0.000004583694,0.0064376853,0.5812219,0.00083635526,0.00010857085,0.000026580099,0.0053578187],"genre_scores_gemma":[0.8458168,0.0009681809,0.000018370469,0.0014584775,0.15041336,0.000013955768,0.000027182581,0.00004371145,0.001239944],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99714965,0.0012027381,0.0004609231,0.00049068447,0.00036831864,0.00032769903],"domain_scores_gemma":[0.9978116,0.0011054869,0.0001629147,0.00067660335,0.00014510061,0.00009825182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006584688,0.00024052897,0.00054323045,0.00008452227,0.00010464064,0.000010278089,0.0003501724,0.00023588988,0.00012775691],"category_scores_gemma":[0.0009952227,0.00014275764,0.000093090704,0.00020555242,0.000281492,0.000013061592,0.00040561397,0.0011535174,0.000008913692],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037060774,0.00010222403,0.0925661,0.0004781743,0.0002361278,0.0009340118,0.015823957,0.000020203393,0.00041925325,0.000026875057,0.88543403,0.003588456],"study_design_scores_gemma":[0.00093107595,0.00052540906,0.5317507,0.0000796565,0.00018504767,0.00012369046,0.0023412632,0.000010278689,0.000055911172,0.00007725017,0.46368966,0.00023005603],"about_ca_topic_score_codex":0.0006458983,"about_ca_topic_score_gemma":0.00014141756,"teacher_disagreement_score":0.45647296,"about_ca_system_score_codex":0.000052092884,"about_ca_system_score_gemma":0.00054409687,"threshold_uncertainty_score":0.58214873},"labels":[],"label_agreement":null},{"id":"W3211938324","doi":"10.1016/j.eururo.2021.10.001","title":"First-line Nivolumab plus Ipilimumab Versus Sunitinib in Patients Without Nephrectomy and With an Evaluable Primary Renal Tumor in the CheckMate 214 Trial","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"University of Texas MD Anderson Cancer Center; Bristol-Myers Squibb; Ono Pharmaceutical; National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center; European Society for Medical Oncology","keywords":"Medicine; Nivolumab; Sunitinib; Ipilimumab; Nephrectomy; Urology; Internal medicine; Second line; Kidney cancer; Renal cell carcinoma; Oncology; First line; Surgery; Kidney; Immunotherapy; Cancer","score_opus":0.03503532779758081,"score_gpt":0.26541876185246216,"score_spread":0.23038343405488135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211938324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980426,0.0002948946,0.0000042069173,0.00045856604,0.00015691099,0.0009246746,0.00000664322,0.000032788612,0.017695291],"genre_scores_gemma":[0.99789494,0.000029780747,0.00034138816,0.0010036625,0.00019659498,0.0000363082,0.00018478534,0.000056216548,0.00025631822],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9970987,0.0012275152,0.0004007543,0.00053022575,0.0003263353,0.00041649892],"domain_scores_gemma":[0.99892545,0.0002011477,0.000121196616,0.0005334275,0.000098064425,0.000120700985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007155209,0.00025476352,0.00047335782,0.00014339441,0.0000739442,0.000029805758,0.00014962017,0.000048627582,0.000085073305],"category_scores_gemma":[0.00017452771,0.00017592472,0.000045250064,0.0002910032,0.00014406846,0.00008714921,0.00011224843,0.0004164506,0.000033352953],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.784222,0.0036704012,0.1830577,0.00018177515,0.0002571683,0.01680667,0.004037666,0.00066228764,0.00034493196,0.00007186512,0.00032635918,0.00636118],"study_design_scores_gemma":[0.31721655,0.019443108,0.6559257,0.00005654362,0.000256594,0.0003802829,0.00016175755,0.00048387394,0.00010946123,0.000015400476,0.0056983936,0.00025234243],"about_ca_topic_score_codex":0.00008494702,"about_ca_topic_score_gemma":0.00054704264,"teacher_disagreement_score":0.472868,"about_ca_system_score_codex":0.00016272512,"about_ca_system_score_gemma":0.00023441331,"threshold_uncertainty_score":0.7174002},"labels":[],"label_agreement":null},{"id":"W3212440910","doi":"10.1016/j.eururo.2021.10.031","title":"Re: Long-term Mental Health Service Utilization Among Survivors of Testicular Cancer: A Population-based Cohort Study","year":2021,"lang":"en","type":"letter","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Testicular cancer; Term (time); Mental health; Cohort; Cohort study; Population; Cancer survivor; Gerontology; Cancer; Environmental health; Psychiatry; Internal medicine","score_opus":0.030282621589069296,"score_gpt":0.30463706462108253,"score_spread":0.27435444303201323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212440910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88593006,0.0031724188,0.00006259078,0.1064561,0.00066788343,0.0029203764,0.00037796164,0.00014727225,0.00026532137],"genre_scores_gemma":[0.801006,0.000065420856,0.00004566008,0.18298754,0.00047092483,0.00004802216,0.015042421,0.00013672056,0.00019725096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966955,0.0011446406,0.0006108113,0.0007134685,0.00047163008,0.00036395204],"domain_scores_gemma":[0.99821246,0.00010710732,0.00057149626,0.0007257464,0.00023005299,0.00015313005],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022708745,0.00037776286,0.0007990986,0.00017308567,0.00010229418,0.000016893393,0.00015122113,0.00015510691,0.00054093386],"category_scores_gemma":[0.000117236974,0.0003544981,0.00016205752,0.00033103823,0.0000532904,0.00002769191,0.000083439816,0.0004780588,0.000027355298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058261066,0.00071653136,0.9752662,0.00046892924,0.00061059545,0.0031937708,0.00010011582,0.00007488051,0.0000014125836,2.6116044e-7,0.019045224,0.0004638081],"study_design_scores_gemma":[0.0019179366,0.0007803786,0.99285495,0.0001968539,0.0012575864,0.000023928817,0.000013562839,0.00022722779,0.0000013774878,4.5841904e-7,0.0025254597,0.00020027753],"about_ca_topic_score_codex":0.005622062,"about_ca_topic_score_gemma":0.0017465712,"teacher_disagreement_score":0.08492403,"about_ca_system_score_codex":0.00018259928,"about_ca_system_score_gemma":0.00032300164,"threshold_uncertainty_score":0.9998907},"labels":[],"label_agreement":null},{"id":"W3214444446","doi":"10.1016/j.eururo.2021.10.030","title":"Effect of Simulation-based Training on Surgical Proficiency and Patient Outcomes: A Randomised Controlled Clinical and Educational Trial","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Surgical Simulation and Training","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dalhousie University","funders":"National Institute for Health and Care Research","keywords":"Medicine; Confidence interval; Randomized controlled trial; Simulation training; Hazard ratio; Trial registration; Physical therapy; Surgery; Internal medicine; Simulation","score_opus":0.044393827245175876,"score_gpt":0.3706711284144489,"score_spread":0.326277301169273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214444446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98668724,0.00011090231,0.00006815982,0.0018873202,0.00023379402,0.0008731446,0.0000021717933,0.000021442707,0.010115795],"genre_scores_gemma":[0.99831796,0.000003726992,0.00004504662,0.0014189009,0.00010801791,0.000015193179,0.000018173334,0.000014462988,0.00005850409],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99684066,0.0018979211,0.00064259715,0.00029909506,0.00017535636,0.00014438345],"domain_scores_gemma":[0.9811776,0.018319236,0.00015211827,0.00012591883,0.00008066664,0.00014443576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014149103,0.00013013619,0.00072739937,0.000071437564,0.000054232467,0.000009166017,0.000024823326,0.000081121296,0.0002368968],"category_scores_gemma":[0.007255513,0.00008849509,0.00017996266,0.00008423232,0.0001828232,0.0000138214955,0.000018361417,0.00023489865,0.000006794259],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8335218,0.0010049798,0.06269186,0.000047215606,0.00025431797,0.0003881447,0.00059441413,0.006634475,0.000027788476,0.0009949252,0.000011657604,0.093828455],"study_design_scores_gemma":[0.91093457,0.0057583456,0.050181996,0.000022237153,0.00017486518,0.000016698848,0.000024633568,0.029790329,0.000013892468,0.000015116737,0.0029672466,0.000100044985],"about_ca_topic_score_codex":3.2819992e-7,"about_ca_topic_score_gemma":1.3285559e-7,"teacher_disagreement_score":0.093728416,"about_ca_system_score_codex":0.000004781478,"about_ca_system_score_gemma":0.00010301088,"threshold_uncertainty_score":0.86860514},"labels":[],"label_agreement":null},{"id":"W3215250616","doi":"10.1016/j.eururo.2021.11.008","title":"Not “If”, but “When” and “How”: Testing Antibody-Drug Conjugates in Patients with Non–muscle-invasive Bladder Cancer","year":2021,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Drug; Cancer; Antibody; Antibody-drug conjugate; Urology; Internal medicine; Oncology; Pathology; Pharmacology; Immunology; Monoclonal antibody","score_opus":0.018863785653275345,"score_gpt":0.244590630052256,"score_spread":0.22572684439898066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215250616","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6988666,0.0016564733,0.000013954867,0.2846671,0.00085671654,0.001452216,0.00045586337,0.00013391927,0.011897144],"genre_scores_gemma":[0.4571002,0.0002503981,0.00034278142,0.53397626,0.002423659,0.00005331799,0.0009911902,0.00030884764,0.004553304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969582,0.00044978122,0.00036353024,0.0011193505,0.00037035753,0.00073877163],"domain_scores_gemma":[0.9983608,0.00035781204,0.0002757188,0.00054833875,0.00030873396,0.00014858604],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014234368,0.0006429725,0.00093828264,0.00024149704,0.00010034784,0.00006479397,0.00019374942,0.00028393147,0.00024237687],"category_scores_gemma":[0.00019216105,0.0005182117,0.00008585892,0.00020179566,0.00029287566,0.00008595896,0.0001965599,0.0016367241,0.000055258566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006361574,0.00031105516,0.65669954,0.0006665568,0.0011123309,0.018023878,0.001279648,0.0000095469495,0.0007007941,0.0000017379729,0.3148058,0.0057529663],"study_design_scores_gemma":[0.010437932,0.0019331962,0.7874196,0.0006710524,0.001101783,0.0001474809,0.000058989095,0.000014155989,0.00021192907,0.000009292512,0.19718874,0.00080583233],"about_ca_topic_score_codex":0.00042025995,"about_ca_topic_score_gemma":0.00010487529,"teacher_disagreement_score":0.24930917,"about_ca_system_score_codex":0.00009210795,"about_ca_system_score_gemma":0.00035681398,"threshold_uncertainty_score":0.99972695},"labels":[],"label_agreement":null},{"id":"W3217344408","doi":"10.1016/j.eururo.2021.11.002","title":"A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Interquartile range; Logistic regression; Nephrectomy; Cohort; Body mass index; Renal function; Internal medicine; Referral; Surgery; Kidney","score_opus":0.10098861138534833,"score_gpt":0.38487766565775544,"score_spread":0.2838890542724071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217344408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711349,0.00005968703,0.025731863,0.0004925027,0.00029426083,0.0008595586,0.00037430608,0.00007944231,0.00097349845],"genre_scores_gemma":[0.8887693,0.00004186582,0.10529704,0.001162531,0.00047110493,0.00003881422,0.0035718181,0.000047283724,0.0006002201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99538684,0.001151335,0.0013535648,0.0013078606,0.0003940476,0.00040635891],"domain_scores_gemma":[0.99642426,0.001659757,0.00033432644,0.0005522546,0.00054345623,0.0004859753],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010233046,0.00035606383,0.0010439554,0.00021933256,0.00017932201,0.00003174001,0.00012333627,0.00014647508,0.0002308941],"category_scores_gemma":[0.0016841108,0.00024877005,0.00073976157,0.0004924613,0.0001821663,0.000043942473,0.000096684016,0.0002725176,0.00023093507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029520558,0.00355106,0.9439931,0.0000047281624,0.0028958058,0.0008273565,0.00020177153,0.00045830038,0.000053169475,0.000013502795,0.00071051857,0.017770126],"study_design_scores_gemma":[0.03801298,0.014033353,0.8585795,0.000023175973,0.0038941912,0.000050596693,0.000027929684,0.0018065367,0.000053738095,0.0000039183305,0.08330227,0.00021179813],"about_ca_topic_score_codex":0.00008413044,"about_ca_topic_score_gemma":0.0003732543,"teacher_disagreement_score":0.08541359,"about_ca_system_score_codex":0.00023156578,"about_ca_system_score_gemma":0.00043386247,"threshold_uncertainty_score":0.9999965},"labels":[],"label_agreement":null},{"id":"W4200180513","doi":"10.1016/j.eururo.2021.12.005","title":"International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin–exposed High-risk Non–muscle-invasive Bladder Cancer","year":2021,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; University of British Columbia; McGill University","funders":"","keywords":"Medicine; Bladder cancer; Clinical trial; Clinical endpoint; Internal medicine; Randomized controlled trial; Carcinoma in situ; Randomization; Clinical study design; Oncology; Gemcitabine; Cohort; Cancer; Surgery","score_opus":0.11399722070787006,"score_gpt":0.3872158354096365,"score_spread":0.27321861470176645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200180513","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008819759,0.93341,0.0017089606,0.0014646662,0.018942293,0.022424592,0.009665738,0.00027045558,0.003293547],"genre_scores_gemma":[0.0020604618,0.9841151,0.0012573055,0.0026860593,0.004063136,0.001885669,0.0022045975,0.00044194845,0.0012856823],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923506,0.0023501753,0.0019744849,0.0017890442,0.00069631264,0.00083938485],"domain_scores_gemma":[0.99486715,0.0018126094,0.0014059898,0.00087924296,0.00060163386,0.00043340033],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008967482,0.0010778735,0.002928786,0.0002897156,0.0001823788,0.000059186994,0.00046068282,0.00041741363,0.0014651718],"category_scores_gemma":[0.0005396734,0.00077115966,0.00088256504,0.0002478067,0.0003177626,0.00004407457,0.0001890576,0.0011191122,0.00016584866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034856062,0.0027006771,0.0005540308,0.000859187,0.013668148,0.0008537451,0.00011676861,0.000063867425,6.6306563e-7,0.00002263249,0.03794607,0.90835816],"study_design_scores_gemma":[0.086470105,0.021419264,0.0010788519,0.0014087007,0.009201718,0.00001659333,0.000011765684,0.000008418476,0.000001913528,0.0000044056796,0.87969685,0.00068139506],"about_ca_topic_score_codex":0.00023681621,"about_ca_topic_score_gemma":0.00013506212,"teacher_disagreement_score":0.90767676,"about_ca_system_score_codex":0.0005625867,"about_ca_system_score_gemma":0.0017235817,"threshold_uncertainty_score":0.9994739},"labels":[],"label_agreement":null},{"id":"W4200257752","doi":"10.1016/j.eururo.2021.11.018","title":"Re: Jeremy Yuen-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of “Manels” in Major Urology Meetings. Euro Urol 2021;80:442–9","year":2021,"lang":"en","type":"letter","venue":"European Urology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; General surgery","score_opus":0.07755340533891836,"score_gpt":0.3569240536812775,"score_spread":0.27937064834235914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200257752","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034800515,0.01046782,0.00013906686,0.93899685,0.0005350455,0.001181271,0.00017035492,0.00009623249,0.0136128655],"genre_scores_gemma":[0.13902275,0.0023553246,0.00056748046,0.85463756,0.00087710295,0.000029493756,0.00037777214,0.00022528412,0.0019072158],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9855389,0.008572595,0.0019048132,0.0018220947,0.000813286,0.0013483067],"domain_scores_gemma":[0.9912408,0.004744314,0.0014940116,0.0017206946,0.0004836275,0.0003165489],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034678078,0.00087028445,0.0020942113,0.0011202496,0.00016063188,0.00004508479,0.0009044716,0.0007364635,0.00096488214],"category_scores_gemma":[0.008385828,0.0007280525,0.0005682004,0.002091879,0.0008885866,0.00009295555,0.00062785443,0.0060088397,0.00018405721],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006430453,0.0002533345,0.055443693,0.0039165677,0.002614513,0.017796883,0.013036777,0.00054379465,0.0023846526,0.00026260366,0.90186656,0.001237596],"study_design_scores_gemma":[0.0016719924,0.0019345563,0.07070611,0.00023789305,0.00362879,0.00038551827,0.00035696666,0.00069211464,0.00006711524,0.000045118595,0.9196228,0.0006510432],"about_ca_topic_score_codex":0.0008482217,"about_ca_topic_score_gemma":0.0011558472,"teacher_disagreement_score":0.104222246,"about_ca_system_score_codex":0.00014363143,"about_ca_system_score_gemma":0.0009813859,"threshold_uncertainty_score":0.999967},"labels":[],"label_agreement":null},{"id":"W4200342108","doi":"10.1016/j.eururo.2021.11.020","title":"Deep Prostate-specific Antigen Response following Addition of Apalutamide to Ongoing Androgen Deprivation Therapy and Long-term Clinical Benefit in SPARTAN","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Prostate-specific antigen; Prostate cancer; Placebo; Antiandrogen; Urology; Hazard ratio; Androgen deprivation therapy; Internal medicine; Confidence interval; Oncology; Cancer; Pathology","score_opus":0.06073126657511658,"score_gpt":0.3453950488027126,"score_spread":0.28466378222759603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200342108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99489194,0.0029153023,0.00008557508,0.0012391151,0.00009947961,0.0004275269,0.0000071914487,0.000022153,0.00031168704],"genre_scores_gemma":[0.9967061,0.0021817565,0.00032273435,0.00042111365,0.000084511266,0.0000099742065,0.00011551253,0.000030470523,0.00012781692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824476,0.0005821003,0.00039552836,0.00037811944,0.00014700966,0.0002524826],"domain_scores_gemma":[0.99921983,0.00025868876,0.0000666061,0.00025265035,0.000080664766,0.000121546705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009770762,0.00011270985,0.0002836779,0.00016855911,0.000047556587,0.000014999291,0.00005966586,0.000054671647,0.000065655455],"category_scores_gemma":[0.00023069639,0.00010018889,0.00007070199,0.00025607727,0.00006947072,0.000054775523,0.00007818295,0.00017446361,0.000025702104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007619139,0.00018471216,0.88761026,0.000015138946,0.00007868564,0.002058772,0.00078732194,0.000018531568,0.0421041,0.00002130765,0.00004243587,0.05945961],"study_design_scores_gemma":[0.003559017,0.0013213636,0.98792326,0.000056136854,0.000014040594,0.000046538782,0.000038863436,0.000035742924,0.0049253595,0.00002510334,0.0019725824,0.00008197229],"about_ca_topic_score_codex":0.0000034336244,"about_ca_topic_score_gemma":0.00003916884,"teacher_disagreement_score":0.10031303,"about_ca_system_score_codex":0.000037570506,"about_ca_system_score_gemma":0.000067437155,"threshold_uncertainty_score":0.40855843},"labels":[],"label_agreement":null},{"id":"W4205339646","doi":"10.1016/j.eururo.2021.12.038","title":"Quality and Quantity: Evaluating Tumor Biology Alongside Novel Imaging on Diagnosis of Metastatic Hormone-sensitive Prostate Cancer","year":2022,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Centre Hospitalier de l’Université de Montréal; University of British Columbia; Nova Scotia Cancer Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Prostate cancer; Biomarker; Hormone; Cancer; Prostate; Oncology; Pathology; Internal medicine; Biology","score_opus":0.07781672848737231,"score_gpt":0.41893051623557426,"score_spread":0.34111378774820195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205339646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6714579,0.026116354,0.000043100747,0.00522498,0.28230798,0.003578148,0.007034627,0.00019399186,0.0040429416],"genre_scores_gemma":[0.7377029,0.013986756,0.0009986229,0.0028889067,0.23540588,0.0011242571,0.0054922123,0.00064816687,0.0017522858],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99517256,0.0018835431,0.00072783,0.0009653975,0.00065041805,0.0006002269],"domain_scores_gemma":[0.9956427,0.002673176,0.00062984554,0.0004523301,0.00043527246,0.000166667],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025997479,0.00042937679,0.001157449,0.00037440268,0.00018290673,0.000020930487,0.00018767983,0.00008296254,0.00014095241],"category_scores_gemma":[0.0030954352,0.00035540425,0.00015674028,0.00023268165,0.0005469257,0.000047358633,0.00045512422,0.001316971,0.000017378388],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027694428,0.002289895,0.077699095,0.002286544,0.0050720223,0.008076068,0.0051146727,0.000120843375,0.022485852,0.00043246994,0.79637533,0.052352756],"study_design_scores_gemma":[0.03272611,0.021889538,0.12070001,0.00054374896,0.003936413,0.00022329153,0.0011321678,0.0005725516,0.0016046056,0.0002726212,0.81455064,0.0018482807],"about_ca_topic_score_codex":0.001284926,"about_ca_topic_score_gemma":0.00004945735,"teacher_disagreement_score":0.066245034,"about_ca_system_score_codex":0.00022312393,"about_ca_system_score_gemma":0.0006369476,"threshold_uncertainty_score":0.9998898},"labels":[],"label_agreement":null},{"id":"W4205586634","doi":"10.1016/j.eururo.2021.12.007","title":"Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy","year":2021,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McMaster University","funders":"","keywords":"Medicine; Biopsy; Prostate cancer; Protocol (science); Systematic review; Disease; MEDLINE; Radiology; Cancer; Internal medicine; Pathology; Alternative medicine","score_opus":0.03269332170641845,"score_gpt":0.3564535952745068,"score_spread":0.32376027356808834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205586634","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0069580865,0.9848358,0.000036422458,0.00040152168,0.0003892386,0.0042094467,0.0031166973,0.000025342057,0.000027451455],"genre_scores_gemma":[0.01036403,0.9870598,0.0002548915,0.00014532657,0.0001249877,0.00052136154,0.0013716167,0.00009561058,0.000062396124],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99473566,0.0016607934,0.0022173412,0.00084039103,0.00023256138,0.00031325],"domain_scores_gemma":[0.9944392,0.0013701966,0.0023776228,0.00062129815,0.00088510255,0.0003065835],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019564335,0.00049572974,0.00361575,0.00017007868,0.00025612683,0.000014034059,0.00019348341,0.00012399147,0.000014746298],"category_scores_gemma":[0.004039226,0.00037267804,0.00023846942,0.00042038722,0.0001564171,0.000041244002,0.0024841598,0.00026159387,0.0000019615],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048775336,0.00015911994,0.0154231815,0.7157626,0.00080873346,0.00015780043,0.00039436307,4.3647307e-7,0.000009279566,0.000005488456,0.00021933891,0.26657188],"study_design_scores_gemma":[0.0022271539,0.0015651501,0.039059322,0.8912292,0.0045412853,0.00021057225,0.000040365943,0.000012668485,0.00001141668,0.000008958974,0.060356036,0.00073787203],"about_ca_topic_score_codex":0.000021946684,"about_ca_topic_score_gemma":0.000008416431,"teacher_disagreement_score":0.265834,"about_ca_system_score_codex":0.00027297065,"about_ca_system_score_gemma":0.0004604726,"threshold_uncertainty_score":0.9998725},"labels":[],"label_agreement":null},{"id":"W4205901546","doi":"10.1016/j.eururo.2021.12.028","title":"Re: Changes in Prostate-specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer Screening","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; National Institutes of Health","keywords":"Task force; Prostate cancer screening; Prostate-specific antigen; Prostate cancer; MEDLINE; Cancer screening","score_opus":0.03651155159653925,"score_gpt":0.2839764172164907,"score_spread":0.24746486561995146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205901546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9322559,0.0018721974,0.00003168208,0.054393854,0.00034269234,0.0034853225,0.00024342327,0.00009725772,0.0072776503],"genre_scores_gemma":[0.98776925,0.00071928644,0.00029523557,0.0092028305,0.00015442233,0.00078290905,0.00024581238,0.00006276292,0.00076750846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997756,0.00083248183,0.0003036727,0.0005514008,0.00017732302,0.00037912178],"domain_scores_gemma":[0.99907416,0.00024584297,0.00023604662,0.0002805163,0.0000820358,0.00008137944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007102525,0.00020430554,0.00026009476,0.00015732156,0.00031770335,0.000024801135,0.00014900092,0.000017160482,0.00024515376],"category_scores_gemma":[0.000067878536,0.00015647312,0.000040945473,0.00054265704,0.000034666195,0.00007030714,0.00024283411,0.00038868145,0.00004243734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068649,0.0007793172,0.5669591,0.00018593657,0.00041962508,0.0009645339,0.037030134,0.010770451,0.0043906583,0.00014569462,0.00979238,0.36169726],"study_design_scores_gemma":[0.0027593065,0.0057885232,0.57797295,0.00027720045,0.000077756435,0.000018134313,0.001295055,0.00050550164,0.0006448456,0.000040561194,0.41036725,0.00025294718],"about_ca_topic_score_codex":0.00014598429,"about_ca_topic_score_gemma":0.0002753958,"teacher_disagreement_score":0.40057486,"about_ca_system_score_codex":0.00023347797,"about_ca_system_score_gemma":0.0000397222,"threshold_uncertainty_score":0.63807887},"labels":[],"label_agreement":null},{"id":"W4205915684","doi":"10.1016/j.eururo.2007.12.025","title":"European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":252,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Consensus conference; Family medicine; Testicular cancer; Radiation therapy; Stage (stratigraphy); Cancer; Clinical trial; Disease; Gynecology; General surgery; Pathology; Surgery; Internal medicine","score_opus":0.03507435618615791,"score_gpt":0.2564519178978619,"score_spread":0.22137756171170403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205915684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9273001,0.0039052535,3.3025432e-7,0.0007850619,0.00028793194,0.0006412555,0.00031349016,0.000029163413,0.06673742],"genre_scores_gemma":[0.9957345,0.0013131823,0.000040107316,0.00036868997,0.0001294495,0.000017317921,0.000013977363,0.00007994972,0.002302842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963425,0.0017218223,0.00080209144,0.000530139,0.00026686248,0.00033661688],"domain_scores_gemma":[0.997239,0.00031693865,0.0012069789,0.0008851843,0.00018144914,0.00017043424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000376421,0.00034774898,0.00060010736,0.00006162359,0.00021463816,0.0000052478904,0.00020648075,0.00003980163,0.00016788252],"category_scores_gemma":[0.00017429289,0.00020886195,0.0002680324,0.00015370958,0.00087756105,0.000009625743,0.00022792771,0.00016488478,0.000008304152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005507641,0.002756585,0.9627685,0.0002739762,0.00062142115,0.0066313674,0.0023838286,0.000117091135,0.012757303,0.00007673284,0.0039728363,0.0070896],"study_design_scores_gemma":[0.0048519475,0.0022423035,0.94711787,0.00021847239,0.0010838947,0.0007593915,0.00008773119,0.000032141077,0.014601657,0.0000071557124,0.02875948,0.00023798087],"about_ca_topic_score_codex":0.0005421598,"about_ca_topic_score_gemma":0.0001533952,"teacher_disagreement_score":0.068434395,"about_ca_system_score_codex":0.00005200018,"about_ca_system_score_gemma":0.00021074865,"threshold_uncertainty_score":0.8517143},"labels":[],"label_agreement":null},{"id":"W4206592801","doi":"10.1016/j.eururo.2021.12.023","title":"A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"National Institute of General Medical Sciences; National Institutes of Health; Cancer Research UK; National Cancer Institute; National Institute for Health and Care Research; Achievement Rewards for College Scientists Foundation","keywords":"Prostate cancer; Medicine; Odds ratio; Germline; Allele; Internal medicine; Germline mutation; Oncology; Prostate cancer screening; Prostate; Cancer; Confidence interval; Gynecology; Demography; Prostate-specific antigen; Genetics; Mutation; Biology; Gene","score_opus":0.008679694621434373,"score_gpt":0.25866498936089133,"score_spread":0.24998529473945696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206592801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863156,0.00402977,0.0025695574,0.0010259592,0.00019711412,0.00073055224,0.0009378793,0.000012415733,0.0041811713],"genre_scores_gemma":[0.998617,0.00039707753,0.00013392903,0.00027167102,0.00004777702,0.00008404888,0.00006212417,0.0000395678,0.00034683768],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978583,0.0008684966,0.00036033467,0.00040530262,0.0001723821,0.00033521224],"domain_scores_gemma":[0.9991999,0.000026940841,0.00019236079,0.00039974172,0.00011012427,0.000070933296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073522725,0.00013219839,0.0002514141,0.00016997782,0.000051766867,0.000004143798,0.00038464315,0.000050413324,0.00013732619],"category_scores_gemma":[0.0002171635,0.00014037044,0.00007042002,0.0003825191,0.00009257256,0.0000017688766,0.00065152324,0.0002851684,0.0000033239232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016817212,0.00015643159,0.002507279,0.000026396634,0.00015568556,0.00014290334,0.00030784545,0.027010795,0.96176356,0.00014096644,0.0017748603,0.0043315543],"study_design_scores_gemma":[0.00891907,0.007866819,0.046512235,0.000043320386,0.00018425906,0.00011887302,0.00073051424,0.0021532094,0.6591933,0.0003957817,0.27303565,0.0008469982],"about_ca_topic_score_codex":0.00023683942,"about_ca_topic_score_gemma":0.00011327958,"teacher_disagreement_score":0.3025703,"about_ca_system_score_codex":0.00003807401,"about_ca_system_score_gemma":0.00017501855,"threshold_uncertainty_score":0.57241404},"labels":[],"label_agreement":null},{"id":"W4206991343","doi":"10.1016/s0302-2838(21)01139-8","title":"Oncological long-term benefit of re--resection in T1 bladder cancer: A population-based cohort study from Ontario","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Cohort; Population; Term (time); Cohort study; Resection; Surgery; Oncology; Cancer; General surgery; Internal medicine; Environmental health","score_opus":0.028064904573314627,"score_gpt":0.3041125760296459,"score_spread":0.2760476714563313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206991343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915066,0.0002335268,0.000019996898,0.00038101876,0.00032291256,0.0005540608,0.000022198878,0.000030537045,0.006929178],"genre_scores_gemma":[0.99762046,0.000019282981,0.0000600715,0.0008826886,0.00016696003,0.000041068193,0.00019931396,0.00002700941,0.0009831623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984366,0.00033287902,0.0003737498,0.00045956916,0.00019636595,0.00020083498],"domain_scores_gemma":[0.99928755,0.00009695545,0.000102258775,0.00034487722,0.0000885514,0.00007984082],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017455337,0.00015188979,0.0004166136,0.00008849039,0.00003784259,0.000007386639,0.00007891545,0.00007348818,0.0045852927],"category_scores_gemma":[0.000054705008,0.00013524349,0.00007704843,0.00016684174,0.00003447835,0.000027520213,0.000049941107,0.00025967357,0.00004739322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009508428,0.0012636945,0.99372643,0.0000072505622,0.00022795144,0.0011417989,0.00046551658,0.00022894138,0.0002511248,0.0000035719327,0.00008232235,0.0016505572],"study_design_scores_gemma":[0.0043966593,0.0014036534,0.9932542,0.000019402063,0.00032503868,0.0000109086795,0.000029841118,0.000023975217,0.00017740719,0.000021734848,0.00024171725,0.00009548504],"about_ca_topic_score_codex":0.057687897,"about_ca_topic_score_gemma":0.38944054,"teacher_disagreement_score":0.33175263,"about_ca_system_score_codex":0.0003137587,"about_ca_system_score_gemma":0.00025579345,"threshold_uncertainty_score":0.99632466},"labels":[],"label_agreement":null},{"id":"W4207040466","doi":"10.1016/j.eururo.2022.01.009","title":"Combination of Tadalafil and Finasteride for the Treatment of Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Commercialization of the Prescribing Cascade","year":2022,"lang":"en","type":"editorial","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"Bayer; Astellas Pharma US; Pfizer","keywords":"Medicine; Finasteride; Tadalafil; Lower urinary tract symptoms; Urology; Polypharmacy; Hyperplasia; Erectile dysfunction; Prostate; Gynecology; Intensive care medicine; Internal medicine","score_opus":0.02051248849257696,"score_gpt":0.29748359951608094,"score_spread":0.27697111102350397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4207040466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8510526,0.0055863005,0.00010420228,0.0036993022,0.12462223,0.010138526,0.0016869105,0.000045000234,0.0030649554],"genre_scores_gemma":[0.986082,0.0012778076,0.00004443504,0.000052430732,0.009361221,0.00015095681,0.000731782,0.0001132743,0.002186098],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976973,0.00084720005,0.00056747824,0.00028664153,0.0003918509,0.00020955503],"domain_scores_gemma":[0.9972459,0.0017097222,0.00035587305,0.0004249425,0.00021272189,0.000050860614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066243927,0.00019461273,0.00049631746,0.00015311004,0.00014009305,0.0000065088775,0.00021304388,0.00012523857,0.00004075133],"category_scores_gemma":[0.00052729587,0.00012445451,0.0001270449,0.00020932597,0.00020871028,0.000029259632,0.0001435106,0.00031579306,7.9477985e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032917816,0.019266948,0.02257779,0.008075889,0.0046273787,0.0005972671,0.08269271,0.0023741026,0.013079098,0.0014950325,0.74609643,0.06619955],"study_design_scores_gemma":[0.0068846834,0.05831413,0.033888724,0.00016065045,0.0012957593,0.00022191806,0.00038902214,0.0006371045,0.0009060569,0.00007410968,0.89701873,0.00020909446],"about_ca_topic_score_codex":0.000059578833,"about_ca_topic_score_gemma":0.0000034650723,"teacher_disagreement_score":0.15092233,"about_ca_system_score_codex":0.00006377583,"about_ca_system_score_gemma":0.00019579592,"threshold_uncertainty_score":0.5075108},"labels":[],"label_agreement":null},{"id":"W4210573911","doi":"10.1016/j.eururo.2022.01.028","title":"Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis","year":2022,"lang":"en","type":"review","venue":"European Urology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Adverse effect; Incidence (geometry); Pneumonitis; Hazard ratio; Meta-analysis; Clinical trial; Confidence interval; Oncology; Lung","score_opus":0.2107031185622853,"score_gpt":0.4523014668649802,"score_spread":0.2415983483026949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210573911","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008473997,0.9875118,0.0000035789824,0.00025006084,0.00023331364,0.011271071,0.0005503806,0.000015952584,0.00007906222],"genre_scores_gemma":[0.00014288862,0.99563265,0.000032132448,0.0015836325,0.00004764734,0.001994598,0.00031709476,0.000072226685,0.00017715326],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9755738,0.016968153,0.0061776363,0.0007366513,0.00026303466,0.0002807609],"domain_scores_gemma":[0.991546,0.0025295187,0.004994863,0.00067455415,0.0001701001,0.00008496533],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.018535977,0.0005498221,0.016098285,0.0005169047,0.000051513685,0.0000036051667,0.00030910186,0.00019881615,0.0009057566],"category_scores_gemma":[0.003292575,0.0003297409,0.006368205,0.0013759644,0.00016448862,0.000030678766,0.0001322444,0.0005302686,0.000004544951],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025163994,0.0010930722,0.0001818277,0.5199816,0.4445981,0.000038822713,0.00021053119,0.0000013456668,6.5272803e-7,0.0000042016427,0.00035669457,0.03101671],"study_design_scores_gemma":[0.0031101936,0.0021684668,0.00020370458,0.0038398246,0.6875584,0.0000070167093,0.000016650087,0.0000012235307,2.2304178e-7,0.0000018912821,0.3028406,0.00025182363],"about_ca_topic_score_codex":0.000039376944,"about_ca_topic_score_gemma":0.000017642966,"teacher_disagreement_score":0.5161418,"about_ca_system_score_codex":0.00010864871,"about_ca_system_score_gemma":0.0003156504,"threshold_uncertainty_score":0.9999155},"labels":[],"label_agreement":null},{"id":"W4211030126","doi":"10.1016/j.eururo.2022.01.041","title":"Optimal Dissemination of Scientific Manuscripts via Social Media: A Prospective Trial Comparing Visual Abstracts Versus Key Figures in Consecutive Original Manuscripts Published in European Urology","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Social media; Confidence interval; Internal medicine; World Wide Web; Computer science","score_opus":0.0812901057274066,"score_gpt":0.3637975165716652,"score_spread":0.2825074108442586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211030126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94751376,0.00009276784,0.000011754398,0.002105552,0.015685698,0.0015175662,0.000018156288,0.000076987526,0.03297777],"genre_scores_gemma":[0.99810165,0.000006178311,0.00007264402,0.000095151874,0.0012556441,0.00024433728,0.000112683665,0.000045145785,0.00006655557],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.98911107,0.007418183,0.0010095364,0.0008022831,0.0007808581,0.0008780842],"domain_scores_gemma":[0.9956693,0.003040042,0.0006892174,0.0002005655,0.0002283277,0.00017253395],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0073598856,0.00023770926,0.000502424,0.0008710901,0.00093846547,0.00011455937,0.0007140787,0.00011522941,0.0004351959],"category_scores_gemma":[0.009669609,0.00029884613,0.00008940575,0.0013454908,0.0013402095,0.00036012518,0.0002898444,0.0010742473,0.00006948775],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06567268,0.004298317,0.10032504,0.00009592439,0.00012345068,0.0010780109,0.7872981,0.0011316343,0.0012790192,0.016800243,0.012347769,0.009549809],"study_design_scores_gemma":[0.017651176,0.0014917841,0.94277066,0.000013505712,0.000055069704,0.000008805921,0.014166599,0.00017685645,0.000042606025,0.00050635205,0.022664284,0.00045231232],"about_ca_topic_score_codex":0.0009950207,"about_ca_topic_score_gemma":0.004632745,"teacher_disagreement_score":0.8424456,"about_ca_system_score_codex":0.00074426987,"about_ca_system_score_gemma":0.0006118172,"threshold_uncertainty_score":0.99994636},"labels":[],"label_agreement":null},{"id":"W4212907613","doi":"10.1016/j.eururo.2022.02.010","title":"What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Centre Hospitalier de l’Université de Montréal; Health Sciences Centre; University of British Columbia","funders":"Medical Research Council; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Prostate cancer; Pandemic; Intensive care medicine; Vaccination; Disease; Radiation therapy; Internal medicine; Oncology; Management of prostate cancer; Cancer; Family medicine; Gynecology; Coronavirus disease 2019 (COVID-19); Immunology; Infectious disease (medical specialty)","score_opus":0.06769575744855937,"score_gpt":0.3752726536151028,"score_spread":0.30757689616654343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212907613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74727786,0.025995225,0.0000116469255,0.22127436,0.0020000709,0.0020565162,0.00016711828,0.00015774595,0.0010594621],"genre_scores_gemma":[0.8699238,0.026985604,0.000025042986,0.09244262,0.0004271303,0.00044686647,0.00008081432,0.00007506624,0.009593092],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99620724,0.0012031877,0.00061104645,0.0007957301,0.0004780916,0.0007047004],"domain_scores_gemma":[0.99757576,0.0005010906,0.00041918043,0.0010300899,0.00013150954,0.00034237283],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011647573,0.00030677652,0.00039324546,0.00007168182,0.0009391271,0.00008673359,0.00040075678,0.00004230909,0.0017943823],"category_scores_gemma":[0.00038506062,0.00019535377,0.000098644996,0.00024793885,0.00032226613,0.00008374988,0.0006434131,0.0007358073,0.000028868913],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012485043,0.00034298358,0.5477539,0.000864139,0.0012817215,0.048325848,0.13768107,0.008567815,0.005389997,0.000349828,0.08948231,0.14747536],"study_design_scores_gemma":[0.0025411942,0.00019553839,0.15345429,0.000060063063,0.00013194024,0.000813309,0.0055498043,0.000069346155,0.000023510202,0.00010323354,0.8368369,0.00022091305],"about_ca_topic_score_codex":0.0034113307,"about_ca_topic_score_gemma":0.0017203029,"teacher_disagreement_score":0.74735457,"about_ca_system_score_codex":0.0005579211,"about_ca_system_score_gemma":0.0010001123,"threshold_uncertainty_score":0.9991181},"labels":[],"label_agreement":null},{"id":"W4223609500","doi":"10.1016/j.eururo.2022.02.023","title":"Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Western University; Sunnybrook Health Science Centre","funders":"Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Docetaxel; Enzalutamide; Prostate cancer; Prednisone; Internal medicine; Oncology; Pembrolizumab; Clinical endpoint; Cohort; Prostate-specific antigen; Cancer; Urology; Surgery; Clinical trial","score_opus":0.022785338373954987,"score_gpt":0.30158755323356945,"score_spread":0.2788022148596145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223609500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929174,0.0010401347,0.000002866585,0.0012992775,0.0000958431,0.0032119642,0.0008509514,0.00003414104,0.0005474267],"genre_scores_gemma":[0.9977778,0.0001155027,0.000018073366,0.00027548234,0.000051456336,0.00027020051,0.0007647299,0.000048164733,0.00067857496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970801,0.0009855952,0.00042170053,0.00061492727,0.0004987772,0.0003988831],"domain_scores_gemma":[0.9989819,0.00017869643,0.00016962033,0.00045540772,0.00008996474,0.00012442078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059228163,0.00022695496,0.00037830757,0.00010841167,0.00029383824,0.000039633,0.00017889243,0.000014532227,0.00009746398],"category_scores_gemma":[0.00006485546,0.0001430914,0.000030256655,0.00026542266,0.00019041273,0.000069411246,0.0002100603,0.00044600663,0.000008708373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.062447637,0.0029666557,0.9217059,0.000020492782,0.0005259125,0.0022455328,0.005991935,0.00018946927,0.00009645131,0.0000030269866,0.0002844511,0.0035225116],"study_design_scores_gemma":[0.08381362,0.0079380255,0.9069525,0.000014357605,0.0003294501,0.000015751039,0.00032296905,0.00009879997,0.000010105567,0.00000409705,0.00037085754,0.00012944413],"about_ca_topic_score_codex":0.00081639306,"about_ca_topic_score_gemma":0.0006865589,"teacher_disagreement_score":0.021365987,"about_ca_system_score_codex":0.0002109645,"about_ca_system_score_gemma":0.0002598671,"threshold_uncertainty_score":0.5835098},"labels":[],"label_agreement":null},{"id":"W4223651460","doi":"10.1016/j.eururo.2022.03.010","title":"Efficacy and Safety of AbobotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results from Two Phase 3 Randomized Studies (CONTENT1 and CONTENT2)","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"","keywords":"Medicine; Clean Intermittent Catheterization; Urology; Urinary incontinence; Randomized controlled trial; Urinary bladder; Surgery","score_opus":0.022541393533478542,"score_gpt":0.2938421268108257,"score_spread":0.27130073327734716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223651460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970939,0.0007494453,0.00004015467,0.00065788504,0.000073507304,0.0011237138,0.00009367927,0.000019718742,0.00014800846],"genre_scores_gemma":[0.99908483,0.00038516553,0.00006275686,0.00020840224,0.000033348333,0.000015238722,0.00011527178,0.000030975738,0.0000640285],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968427,0.001613359,0.00057316455,0.00047776807,0.00024327188,0.0002497436],"domain_scores_gemma":[0.99845487,0.00078908517,0.0002522413,0.00028262392,0.00012115551,0.00010000274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011461722,0.00018854967,0.0006915631,0.0001652871,0.00014047507,0.000010340044,0.000103140745,0.000018077086,0.000023024559],"category_scores_gemma":[0.0007500552,0.00014861653,0.000054086064,0.00015107423,0.00035826612,0.000097277545,0.0004237437,0.00037970766,0.0000011047739],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87428516,0.00097055756,0.07855705,0.000043891232,0.00061732135,0.0005406166,0.004772407,0.0000666,0.0025293836,0.000018272414,0.000013259116,0.03758548],"study_design_scores_gemma":[0.53905946,0.0058240667,0.45231092,0.000048891146,0.00027659052,0.00007153109,0.0004081831,0.0013084657,0.00023003656,0.000014721197,0.00027446458,0.00017268982],"about_ca_topic_score_codex":0.00006463661,"about_ca_topic_score_gemma":0.000011297564,"teacher_disagreement_score":0.37375388,"about_ca_system_score_codex":0.00003287697,"about_ca_system_score_gemma":0.00003433736,"threshold_uncertainty_score":0.6060406},"labels":[],"label_agreement":null},{"id":"W4223903621","doi":"10.1016/j.eururo.2022.04.004","title":"Corrigendum to “What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021” [Eur Urol 82(1):6–11]","year":2022,"lang":"en","type":"erratum","venue":"European Urology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Centre Hospitalier de l’Université de Montréal; Health Sciences Centre; University of British Columbia","funders":"Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Prostate cancer; Coronavirus disease 2019 (COVID-19); Pandemic; Management of prostate cancer; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Consensus conference; Coronavirus Infections; MEDLINE; Cancer; Gynecology; Oncology; Internal medicine; Pathology; Disease","score_opus":0.07716583362439391,"score_gpt":0.3706764261713112,"score_spread":0.29351059254691725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223903621","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08857891,0.1640675,0.00005707023,0.5611127,0.14518838,0.018859737,0.003669487,0.0011350124,0.01733121],"genre_scores_gemma":[0.052955844,0.14718793,0.000054707412,0.25805333,0.0054035815,0.0020636776,0.0016112794,0.0005860166,0.53208363],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.991375,0.0020849174,0.0015089617,0.0021998596,0.0011588032,0.001672433],"domain_scores_gemma":[0.99400747,0.00055495877,0.0012690289,0.002709103,0.00038943734,0.0010699817],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016910383,0.0010686477,0.0013174018,0.0002741888,0.0012392076,0.00023914313,0.0012351674,0.00030309474,0.0038874147],"category_scores_gemma":[0.0012975677,0.0007150371,0.00030243938,0.0005559532,0.00051848363,0.000115388844,0.0014873671,0.0028144263,0.000121061974],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00308529,0.000093450224,0.020187927,0.00075996626,0.0006032723,0.02061278,0.019838149,0.00043527712,0.00014294109,0.000031816122,0.9175512,0.016657913],"study_design_scores_gemma":[0.0023780817,0.00039293448,0.04976089,0.0003770207,0.00050131086,0.0009368332,0.0027498773,0.00004239662,0.0000044547774,0.000040888306,0.9421352,0.000680104],"about_ca_topic_score_codex":0.009675258,"about_ca_topic_score_gemma":0.009776062,"teacher_disagreement_score":0.5147524,"about_ca_system_score_codex":0.0014830475,"about_ca_system_score_gemma":0.0041929143,"threshold_uncertainty_score":0.9995301},"labels":[],"label_agreement":null},{"id":"W4224084882","doi":"10.1016/j.eururo.2022.04.002","title":"Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021","year":2022,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Centre Hospitalier de l’Université de Montréal; Health Sciences Centre; University of British Columbia","funders":"National Health and Medical Research Council; Swiss Cancer Research Foundation; Astellas Pharma; Medical Research Council; Peter MacCallum Foundation; National Institute for Health and Care Research; Advanced Accelerator Applications; European School of Oncology; Prostate Cancer Foundation; Movember Foundation; AstraZeneca; Pfizer; Amgen","keywords":"Medicine; Prostate cancer; Voting; Consensus conference; Delphi method; Family medicine; Disease; Management of prostate cancer; Prostate; Cancer; Medical physics; Intensive care medicine; Gynecology; Internal medicine; Artificial intelligence; Political science","score_opus":0.03961115593197285,"score_gpt":0.33922148657362666,"score_spread":0.2996103306416538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224084882","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004510748,0.9809618,0.0000015632617,0.00089875236,0.0006139722,0.0054314397,0.0020039359,0.000054292028,0.0055235],"genre_scores_gemma":[0.0010698837,0.9855077,0.0001620078,0.00015758234,0.000109479886,0.0013905966,0.0027399063,0.00018114515,0.008681695],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955705,0.0008515835,0.0010143033,0.0011610244,0.0006920544,0.0007105699],"domain_scores_gemma":[0.99685836,0.0002718315,0.0011652949,0.0011952209,0.00032221116,0.00018705906],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004025213,0.0006531235,0.0017256899,0.00012972046,0.00020296511,0.000022832872,0.00048621045,0.000081514096,0.0016832601],"category_scores_gemma":[0.00005091704,0.0003800796,0.00025297262,0.000523614,0.00051708013,0.000042727097,0.0005376426,0.0009215863,0.000037926955],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022950969,0.00023734305,0.0031405466,0.0032957075,0.0019343366,0.005500128,0.0003446196,0.00002805058,0.0000012274735,0.000015190923,0.0013586741,0.9818491],"study_design_scores_gemma":[0.004143434,0.000956301,0.004528433,0.0032153185,0.002171879,0.00004340633,0.00011687728,0.0000018438384,0.0000027097653,0.0000080176205,0.9844489,0.0003628968],"about_ca_topic_score_codex":0.00015746099,"about_ca_topic_score_gemma":0.00003980995,"teacher_disagreement_score":0.9830902,"about_ca_system_score_codex":0.00032148167,"about_ca_system_score_gemma":0.001003517,"threshold_uncertainty_score":0.9998651},"labels":[],"label_agreement":null},{"id":"W4224248442","doi":"10.1016/j.eururo.2022.04.003","title":"High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient–data Network Meta-analysis from the MARCAP Consortium","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Centre Hospitalier Universitaire de Sherbrooke","funders":"Medical Research Council; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Interquartile range; Hazard ratio; Confidence interval; Radiation therapy; Randomized controlled trial; Internal medicine; Clinical endpoint; Oncology; Urology; Cancer","score_opus":0.13012442087845424,"score_gpt":0.3338310833148854,"score_spread":0.20370666243643118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224248442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9366541,0.034274388,0.000595223,0.01911086,0.00036983553,0.004353697,0.004490884,0.0001181106,0.000032884866],"genre_scores_gemma":[0.9598828,0.0067183007,0.0012774853,0.016027259,0.0003074749,0.0021608213,0.0134200845,0.00008572215,0.00012006122],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.99673444,0.0012810824,0.00052090926,0.0008390995,0.00026953136,0.00035491263],"domain_scores_gemma":[0.99772227,0.00043278153,0.00029310127,0.0013151073,0.00011548096,0.000121254154],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059518026,0.00030055136,0.00083650486,0.00008902752,0.0003860595,0.000048723083,0.00036770743,0.000034998524,0.0016410573],"category_scores_gemma":[0.000039869665,0.00017293918,0.00032121,0.00042518057,0.000110898036,0.00008189367,0.0001322461,0.0001368421,0.00000767957],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039923888,0.004056731,0.11217485,0.000012511363,0.44719675,0.00043960876,0.011229737,0.03170721,0.0006005714,0.0004738825,0.02885003,0.32333422],"study_design_scores_gemma":[0.018451398,0.021129023,0.07990699,0.0000030265774,0.14502883,0.000053888674,0.0005861563,0.0047684694,0.000686475,0.00034553956,0.72850615,0.00053402927],"about_ca_topic_score_codex":0.0015560035,"about_ca_topic_score_gemma":0.00033362093,"teacher_disagreement_score":0.6996561,"about_ca_system_score_codex":0.00020202462,"about_ca_system_score_gemma":0.00020180627,"threshold_uncertainty_score":0.9992716},"labels":[],"label_agreement":null},{"id":"W4224301258","doi":"10.1016/j.eururo.2022.03.031","title":"Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysis","year":2022,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"European Association of Urology","keywords":"Medicine; Prostate cancer; Meta-analysis; Systemic therapy; Oncology; Cancer; Internal medicine; Breast cancer","score_opus":0.1232624599005695,"score_gpt":0.3546245118874924,"score_spread":0.2313620519869229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224301258","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051958155,0.98992497,0.000013552817,0.000395098,0.000022577127,0.008750327,0.0007202904,0.0000130201615,0.00010822587],"genre_scores_gemma":[0.0038583456,0.98467886,0.000026835141,0.00083714456,0.0000052563387,0.00972964,0.0007122853,0.000057085996,0.00009455427],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9946125,0.0027752833,0.0015213424,0.00065941707,0.0001741433,0.00025727352],"domain_scores_gemma":[0.9979399,0.000505413,0.0008499514,0.0005276134,0.00008153358,0.00009562838],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009306778,0.00045154843,0.0073411814,0.0007909925,0.000025180445,0.000008069595,0.00010657639,0.000047119145,0.00032771289],"category_scores_gemma":[0.00012282413,0.0002890443,0.00076907425,0.0012162288,0.000057030735,0.000028961653,0.000050685976,0.00020732947,0.000024858586],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013673463,0.0008794346,0.00007503523,0.7486463,0.12896147,0.0008502925,0.0017046132,0.00012339409,3.9253706e-7,0.000056169352,0.00010220546,0.118463956],"study_design_scores_gemma":[0.0011560291,0.0030351318,0.000093275594,0.03335021,0.92865103,0.00023113089,0.00021665651,0.000012356794,8.969211e-7,0.00000489239,0.032917533,0.00033082938],"about_ca_topic_score_codex":0.00035282332,"about_ca_topic_score_gemma":0.00015215788,"teacher_disagreement_score":0.7996896,"about_ca_system_score_codex":0.0007534816,"about_ca_system_score_gemma":0.00020853049,"threshold_uncertainty_score":0.9999562},"labels":[],"label_agreement":null},{"id":"W4225499003","doi":"10.1016/j.eururo.2022.03.027","title":"Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria","year":2022,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cochrane; McMaster University; Impact; McMaster University Medical Centre","funders":"","keywords":"Medicine; Incidence (geometry); Renal cell carcinoma; Bladder cancer; Cochrane Library; Population; Confidence interval; Meta-analysis; Internal medicine; Urology; Gynecology; Cancer","score_opus":0.01854652745967333,"score_gpt":0.2589730960350942,"score_spread":0.24042656857542088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225499003","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013736481,0.9805051,0.0000031123743,0.0000056220406,0.00011625528,0.004548728,0.0005626268,0.0000074630275,0.00051461416],"genre_scores_gemma":[0.015880916,0.9836051,0.000022095886,0.00009085154,0.000031681946,0.00013796307,0.000055012482,0.000072080766,0.00010431297],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9975037,0.0009884108,0.00072912953,0.00036366103,0.00023644172,0.00017866134],"domain_scores_gemma":[0.9977109,0.00039461988,0.0012598402,0.00048391894,0.00007282443,0.00007788654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037318908,0.00032666782,0.0020564238,0.00007660757,0.00007894336,0.0000039684746,0.0002054558,0.000059266964,0.000034563735],"category_scores_gemma":[0.00028992418,0.00016899515,0.00023932272,0.00014141647,0.00024430235,0.00002266146,0.00015029043,0.00028135916,5.9502804e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102719,0.00005444413,0.012016381,0.9835252,0.00047883348,0.000011645455,0.00025127642,2.988304e-7,1.8642022e-7,0.0000043803257,0.00012013158,0.0034345079],"study_design_scores_gemma":[0.008099345,0.011352123,0.061696276,0.6871429,0.09741765,0.00020784499,0.0000872063,0.0000053799336,0.000017667684,0.000012880322,0.1328857,0.0010750422],"about_ca_topic_score_codex":0.00016035332,"about_ca_topic_score_gemma":0.000013341876,"teacher_disagreement_score":0.2963823,"about_ca_system_score_codex":0.000066909575,"about_ca_system_score_gemma":0.00024720782,"threshold_uncertainty_score":0.6891422},"labels":[],"label_agreement":null},{"id":"W4235097351","doi":"10.1016/j.eururo.2014.03.043","title":"Reply to E. David Crawford and Bo-Eric Persson's Letter to the Editor re: Giorgio Gandaglia, Maxine Sun, Jim C. Hu, et al. Gonadotropin-releasing Hormone Agonists and Acute Kidney Injury in Patients with Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.01.026","year":2014,"lang":"en","type":"letter","venue":"European Urology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Psychoanalysis; Internal medicine; Gerontology; Environmental ethics; Philosophy; Psychology","score_opus":0.010568160307238844,"score_gpt":0.2385448844359001,"score_spread":0.22797672412866127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235097351","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15143213,0.0014989639,0.000007800677,0.8407931,0.0012717817,0.0024214275,0.00025711456,0.00009139696,0.0022262947],"genre_scores_gemma":[0.022406373,0.001516164,0.00014940655,0.9409353,0.012778157,0.00022955808,0.0004316014,0.00038763668,0.021165801],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940892,0.001142034,0.0008299596,0.0020969599,0.0006716311,0.0011702403],"domain_scores_gemma":[0.9976922,0.00011636839,0.00040879034,0.0010519462,0.00035338095,0.00037727688],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007584107,0.00097393314,0.0013526613,0.0004291877,0.00023295393,0.000093522285,0.00041894376,0.00024633296,0.00007604179],"category_scores_gemma":[0.0006082059,0.0006412422,0.000101829006,0.00040139642,0.00060232624,0.0001417046,0.00079618214,0.0030792842,0.00031444128],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005793701,0.000110371984,0.008593029,0.00014127792,0.0003081993,0.00096268853,0.0015475651,0.000005845204,0.0003470447,6.1341404e-7,0.98102564,0.0011640544],"study_design_scores_gemma":[0.0023395722,0.0032774126,0.26788518,0.00015097173,0.00021672215,0.0000323921,0.000010411007,0.000003469722,0.000010222776,0.0000019809786,0.7255543,0.00051736995],"about_ca_topic_score_codex":0.00045371844,"about_ca_topic_score_gemma":0.000027583004,"teacher_disagreement_score":0.25929213,"about_ca_system_score_codex":0.00013896807,"about_ca_system_score_gemma":0.00013957795,"threshold_uncertainty_score":0.99960387},"labels":[],"label_agreement":null},{"id":"W4235148313","doi":"10.1016/j.eururo.2017.11.028","title":"Response to Claire Vale, David Fisher, Jayne Tierney, Ian White, Matthew Sydes, and James Carpenter's Letter to the Editor re: Christopher J.D. Wallis, Zachary Klaassen, Bimal Bhindi, et al. Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naïve Prostate Cancer: A Systematic Review and Network Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.10.002","year":2017,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; White (mutation); Gerontology","score_opus":0.08799935074101853,"score_gpt":0.3583162520787868,"score_spread":0.2703169013377683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235148313","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006510136,0.97108996,0.000007388077,0.013883288,0.000067389185,0.008061686,0.00025196272,0.000025578267,0.00010259946],"genre_scores_gemma":[0.0031702484,0.9870375,0.00016224282,0.0026490898,0.0001709466,0.0012315565,0.00023175034,0.00015174458,0.00519497],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98878694,0.00707116,0.0016167857,0.00131463,0.00052334234,0.00068716315],"domain_scores_gemma":[0.99630165,0.0005389973,0.0014043122,0.0012250138,0.00019768513,0.00033232197],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004984451,0.00092382194,0.006241291,0.000505346,0.00018721698,0.00017017625,0.0004610979,0.00014299605,0.00016051257],"category_scores_gemma":[0.00030963754,0.00051565486,0.0002861421,0.00061244366,0.0003870095,0.00020918716,0.00043983056,0.0010983178,0.000038657017],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018572558,0.000830402,0.0129797775,0.19576488,0.09609174,0.0019992986,0.0077311965,0.00020764495,0.000022792156,0.0000028525574,0.6364215,0.029375365],"study_design_scores_gemma":[0.0036500073,0.0030390325,0.0086722765,0.008924268,0.07536118,0.00008095163,0.00003892115,0.000040544594,0.0000013401681,0.000002185753,0.89958924,0.0006000627],"about_ca_topic_score_codex":0.00039600552,"about_ca_topic_score_gemma":0.00031282194,"teacher_disagreement_score":0.26316774,"about_ca_system_score_codex":0.00009054349,"about_ca_system_score_gemma":0.0001562133,"threshold_uncertainty_score":0.9997295},"labels":[],"label_agreement":null},{"id":"W4235546774","doi":"10.1016/j.eururo.2013.07.025","title":"Reply to Hiten D. Patel and Mohamad E. Allaf's Letter to the Editor re: Maxine Sun, Andreas Becker, Zhe Tian, et al. Management of Localized Kidney Cancer: Calculating Cancer-specific Mortality and Competing Risks of Death for Surgery and Nonsurgical Management. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.03.034","year":2013,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cancer; Kidney cancer; Gerontology; Internal medicine","score_opus":0.093052254768827,"score_gpt":0.31450187273621655,"score_spread":0.22144961796738954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235546774","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41770217,0.010279807,0.0001659101,0.554465,0.0013632718,0.0075470572,0.0005320885,0.00010215755,0.007842534],"genre_scores_gemma":[0.13047495,0.015038484,0.0038086595,0.82015455,0.010969689,0.0022553569,0.0015045435,0.00086099707,0.014932743],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943126,0.0012367802,0.0014229572,0.0015397625,0.0006327449,0.0008551608],"domain_scores_gemma":[0.99692565,0.00071218,0.0007070017,0.001048121,0.00023612412,0.00037093792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019333705,0.00078066584,0.0016000356,0.00036649813,0.00011225362,0.00006021597,0.0003232086,0.00024731245,0.00033893783],"category_scores_gemma":[0.00013246035,0.0005949146,0.0002037193,0.0002513635,0.00029363044,0.00006903207,0.000822343,0.0010467076,0.000038706115],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011109493,0.00010997102,0.028064432,0.0014339188,0.0009227389,0.0018931594,0.00027842523,0.000102721206,0.000087625995,0.000012048557,0.9627541,0.0032299145],"study_design_scores_gemma":[0.0026208118,0.00039476357,0.13202935,0.00055087043,0.0007493546,0.0000380816,0.000027832542,0.00023895924,0.00004144894,0.000003883856,0.86289686,0.00040775663],"about_ca_topic_score_codex":0.003319486,"about_ca_topic_score_gemma":0.00006271925,"teacher_disagreement_score":0.2872272,"about_ca_system_score_codex":0.00011929518,"about_ca_system_score_gemma":0.00004707565,"threshold_uncertainty_score":0.99965024},"labels":[],"label_agreement":null},{"id":"W4239598310","doi":"10.1016/s0302-2838(21)01454-8","title":"Circumcision and risk of HIV among males from Ontario, Canada","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Genital Health and Disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Male circumcision; Human immunodeficiency virus (HIV); Family medicine; Gynecology; Surgery; Environmental health; Population; Health services","score_opus":0.008704672452279474,"score_gpt":0.2079228032482559,"score_spread":0.19921813079597644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239598310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97996145,0.0014072035,0.000011943055,0.00030405377,0.00011717291,0.000050219696,0.000054858872,0.00000805562,0.01808504],"genre_scores_gemma":[0.9974311,0.000019772728,0.000102882674,0.0011235595,0.000060134535,4.0121452e-7,0.000073790856,0.000010344886,0.0011780178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992829,0.00016948814,0.00015783492,0.00017373689,0.00008207413,0.00013397672],"domain_scores_gemma":[0.9993849,0.000083513056,0.000052504074,0.00018702447,0.000046541085,0.0002455385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007185285,0.00006199298,0.00014306183,0.000019161476,0.000031307434,0.0000021481874,0.00003086791,0.000021092188,0.0006160606],"category_scores_gemma":[0.00017412407,0.000056908208,0.000022216369,0.00003418008,0.000048337988,0.0000117886775,0.000048250407,0.00012880082,0.00002100497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014951086,0.000029930237,0.99275714,0.000020813726,0.000011839254,0.0012734429,0.00013935659,0.0000035568107,0.00015060141,0.000008778786,0.003710682,0.0017443474],"study_design_scores_gemma":[0.0007427908,0.00009140569,0.98338914,0.0000036738013,0.00009924561,0.000030481624,0.000048856004,0.000024185245,0.00007123682,0.000054646225,0.015403641,0.0000406686],"about_ca_topic_score_codex":0.7337179,"about_ca_topic_score_gemma":0.9123947,"teacher_disagreement_score":0.17867681,"about_ca_system_score_codex":0.00002394216,"about_ca_system_score_gemma":0.0005381177,"threshold_uncertainty_score":0.6745432},"labels":[],"label_agreement":null},{"id":"W4244842137","doi":"10.1016/j.eururo.2020.03.012","title":"Re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. Eur Urol. 2020;77: 508–47 https://doi.org/10.1016/j.eururo.2020.01.012","year":2020,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Prostate cancer; Prostate; Cancer; Management of prostate cancer; Gynecology; Urology; Radiology; Internal medicine","score_opus":0.01632491710633048,"score_gpt":0.2792461981090559,"score_spread":0.2629212810027254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244842137","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07619202,0.013524817,0.000007867124,0.85096115,0.0016823441,0.010928562,0.0030625248,0.00032182087,0.043318905],"genre_scores_gemma":[0.13744797,0.04057839,0.0011118464,0.35147917,0.0017412486,0.002123532,0.00891256,0.0016805758,0.4549247],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913102,0.0012891699,0.0018907507,0.0022335788,0.0017632999,0.0015130184],"domain_scores_gemma":[0.99345046,0.00023545786,0.0023910603,0.0019991938,0.0015512771,0.00037256806],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00058988336,0.0012899452,0.0020623913,0.00022068595,0.0002265894,0.00004077686,0.0009991507,0.00029918272,0.0028118696],"category_scores_gemma":[0.0001900297,0.00089941255,0.0004259018,0.00088343193,0.0013824635,0.00013666114,0.0009840019,0.003446212,0.0003949432],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010258858,0.00037827156,0.011568791,0.0021424773,0.0022814607,0.017740618,0.00063044176,0.00024110581,0.00054283364,0.0000059326317,0.9470367,0.0071725147],"study_design_scores_gemma":[0.010534759,0.0026189066,0.027408127,0.0010987583,0.0011216884,0.000059557668,0.00010143944,0.000024944355,0.0006612902,0.000013518344,0.9555471,0.0008099149],"about_ca_topic_score_codex":0.00012962382,"about_ca_topic_score_gemma":0.000034591794,"teacher_disagreement_score":0.49948198,"about_ca_system_score_codex":0.0003025906,"about_ca_system_score_gemma":0.0011320766,"threshold_uncertainty_score":0.9999852},"labels":[],"label_agreement":null},{"id":"W4245722877","doi":"10.1016/j.eururo.2010.12.013","title":"A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma","year":2010,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1047,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Hazard ratio; Kidney cancer; Urology; Confidence interval; Stage (stratigraphy); Surgery; Cancer; Kidney; Internal medicine","score_opus":0.03468517665407165,"score_gpt":0.29433749929549774,"score_spread":0.25965232264142607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245722877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99149233,0.00018433461,0.0003651603,0.00015153372,0.00026633876,0.0033005723,0.000005949225,0.000059961454,0.004173844],"genre_scores_gemma":[0.99872714,0.000004015378,0.0003071717,0.00024069192,0.00024486674,0.00016885443,0.000014754562,0.00006359179,0.0002289141],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727416,0.0006898073,0.000761309,0.0006063073,0.00020015227,0.00046828543],"domain_scores_gemma":[0.9972916,0.0015456523,0.00036230046,0.0004962276,0.00011881766,0.00018536263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015698771,0.00033605134,0.0010161739,0.00019939862,0.00016382645,0.000024345121,0.00020199282,0.00007844544,0.00004863402],"category_scores_gemma":[0.00043955,0.00022295195,0.00025754006,0.0001677926,0.00041454536,0.000053033124,0.00019456605,0.0006899476,0.000009301226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024525559,0.0021003378,0.92902535,0.000092322225,0.00024971986,0.00065941527,0.0014312707,0.0000106902435,0.040788587,0.000053107746,0.00018241911,0.0008812134],"study_design_scores_gemma":[0.0712373,0.006468796,0.9092866,0.000010315834,0.0006249446,0.00022785952,0.00027974707,0.00078625936,0.009422524,0.000017221206,0.001394844,0.00024358074],"about_ca_topic_score_codex":0.000060846993,"about_ca_topic_score_gemma":0.000077297635,"teacher_disagreement_score":0.046711743,"about_ca_system_score_codex":0.00008110506,"about_ca_system_score_gemma":0.000088697125,"threshold_uncertainty_score":0.90917164},"labels":[],"label_agreement":null},{"id":"W4251314507","doi":"10.1016/s0302-2838(21)00690-4","title":"Benefits and harms of conservative, pharmacological, and surgical management options for women with bladder outlet obstruction: A systematic review from the European Association of Urology non-neurogenic female LUTS guidelines panel","year":2021,"lang":"en","type":"review","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Conservative management; Bladder outlet obstruction; Urology; Surgery; Urinary bladder neck obstruction; Gynecology; Internal medicine; Prostate","score_opus":0.12322710813660427,"score_gpt":0.36533375520839023,"score_spread":0.24210664707178597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251314507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019879804,0.9914738,0.000025608118,0.0013956295,0.00008656257,0.0036068552,0.00032298034,0.000021590708,0.0010789988],"genre_scores_gemma":[0.0007846685,0.99682367,0.00029124273,0.0007709125,0.00014991211,0.00024743544,0.00023512701,0.000070664835,0.0006263955],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932132,0.0042183455,0.001311011,0.0006086611,0.00027562998,0.00037317327],"domain_scores_gemma":[0.9962696,0.001748316,0.0009266243,0.00043371008,0.0004820431,0.0001397126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027816182,0.00037471374,0.0023496638,0.00010638765,0.0001075434,0.000019193076,0.0002547176,0.00010354087,0.0001009971],"category_scores_gemma":[0.00049340486,0.00022188082,0.00020554184,0.0002961123,0.00027593257,0.000033598597,0.00035907966,0.00042364094,0.000011907382],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007530808,0.0006735308,0.00061558996,0.83399403,0.018446876,0.0018526623,0.00092409446,0.000013524873,0.000012964573,0.00031248038,0.0085165845,0.13388455],"study_design_scores_gemma":[0.005982572,0.0046405694,0.003765072,0.06488458,0.03317223,0.003118049,0.00035521542,0.000033097996,0.0000020728291,0.00002450072,0.8833274,0.00069460564],"about_ca_topic_score_codex":0.0000031291895,"about_ca_topic_score_gemma":0.000001099997,"teacher_disagreement_score":0.8748109,"about_ca_system_score_codex":0.000037501788,"about_ca_system_score_gemma":0.00008852617,"threshold_uncertainty_score":0.90480375},"labels":[],"label_agreement":null},{"id":"W4253230002","doi":"10.1016/s0302-2838(04)00071-5","title":"Stage II Testicular Seminoma: Patterns of Recurrence and Outcome of Treatment","year":2004,"lang":"en","type":"article","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Seminoma; Radiation therapy; Chemotherapy; Stage (stratigraphy); Lymphovascular invasion; Mediastinum; Surgery; Internal medicine; Metastasis; Cancer","score_opus":0.026006558812642362,"score_gpt":0.28144182977447285,"score_spread":0.2554352709618305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253230002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973364,0.001220749,0.00013530944,0.00014754472,0.000039527735,0.00018142046,0.00007633447,0.000018976156,0.00084374135],"genre_scores_gemma":[0.99920756,0.00006572472,0.00039426237,0.00009123876,0.000018951203,0.0000025752079,0.000026834921,0.000015284699,0.0001775703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993475,0.000049077156,0.00022633348,0.00018591544,0.00006474089,0.00012645384],"domain_scores_gemma":[0.99948007,0.000035365785,0.00011148569,0.00023893706,0.000034685094,0.000099430996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047064477,0.000114515155,0.00025324564,0.000038245504,0.00002374557,0.0000013812772,0.000039267015,0.000020921827,0.000045387373],"category_scores_gemma":[0.00009617675,0.000085442356,0.000063727784,0.00004157448,0.000077033685,0.000013934628,0.00005359799,0.000039094874,0.000010297488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006794666,0.0006677193,0.99308145,0.000066711706,0.0001111948,0.00067780796,0.00019710367,0.000038015478,0.0008113422,0.00033168952,0.0000034366433,0.003945567],"study_design_scores_gemma":[0.003227466,0.004561546,0.99022895,0.00002885071,0.00036578023,0.000114289156,0.000018349341,0.000010126125,0.0005965035,0.0000301578,0.0007557323,0.00006222999],"about_ca_topic_score_codex":0.00010614071,"about_ca_topic_score_gemma":0.0000039659917,"teacher_disagreement_score":0.0038938266,"about_ca_system_score_codex":0.000027808019,"about_ca_system_score_gemma":0.00003120698,"threshold_uncertainty_score":0.3484238},"labels":[],"label_agreement":null},{"id":"W4280562448","doi":"10.1016/j.eururo.2022.04.019","title":"TNM Staging of Prostate Cancer: Challenges in Securing a Globally Applicable Classification","year":2022,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; Glutamate carboxypeptidase II; Interquartile range; Positron emission tomography; Radiation therapy; Metastasis; Population; Prostate-specific antigen; Prostate; Oncology; Disease; Cancer; Radiology; Internal medicine","score_opus":0.07091666804099069,"score_gpt":0.3162267047172977,"score_spread":0.24531003667630702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280562448","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021019205,0.029751843,0.0000032429232,0.8636356,0.00032100748,0.0015030042,0.00013184521,0.000107720065,0.083526544],"genre_scores_gemma":[0.5099403,0.13254143,0.00021529758,0.3271449,0.004720752,0.0015188339,0.0029416007,0.0006849223,0.020291941],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99751157,0.0005022946,0.00040871155,0.00063563214,0.0003960907,0.0005456934],"domain_scores_gemma":[0.99907386,0.00008202916,0.00023230385,0.00048107925,0.00007389292,0.00005684517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005297493,0.00024840355,0.00051091827,0.00034359854,0.000055249588,0.0000103888515,0.00029456898,0.0001456153,0.0003521697],"category_scores_gemma":[0.000026032454,0.0002267979,0.00008590012,0.00023483316,0.00013290603,0.000033631266,0.00025773156,0.0016336959,0.000033278735],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004147213,0.0007195445,0.05707739,0.0055163587,0.0011026048,0.018744523,0.0072239353,0.00022207547,0.0030040804,0.0004407846,0.77085674,0.13094476],"study_design_scores_gemma":[0.001656725,0.00063107314,0.011786999,0.00008654414,0.000081630846,0.000039502327,0.00013552718,0.0000653438,0.000052233685,0.000051820585,0.98524106,0.00017157377],"about_ca_topic_score_codex":0.00009869265,"about_ca_topic_score_gemma":0.000020951085,"teacher_disagreement_score":0.5364907,"about_ca_system_score_codex":0.0003171297,"about_ca_system_score_gemma":0.0002486461,"threshold_uncertainty_score":0.924855},"labels":[],"label_agreement":null},{"id":"W4280605905","doi":"10.1016/j.eururo.2022.04.022","title":"Can Oncogenic Driver Alterations be Responsible for the Lack of Immunotherapy Efficacy in First-line Advanced Urothelial Carcinoma?","year":2022,"lang":"en","type":"editorial","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Medicine; Biomarker; Immunotherapy; Urothelial carcinoma; Cancer research; First line; Carcinoma; Oncology; Internal medicine; Cancer; Bladder cancer; Biology","score_opus":0.03441785734394094,"score_gpt":0.32475810357648244,"score_spread":0.2903402462325415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280605905","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05594181,0.014599067,0.00028135147,0.024389673,0.879835,0.0100304615,0.0080147665,0.00022099797,0.0066868663],"genre_scores_gemma":[0.4241447,0.005735525,0.0005660911,0.005418948,0.5413085,0.0011484297,0.004007743,0.0008205488,0.016849512],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972618,0.0005849417,0.0006853214,0.00061767973,0.0004091802,0.0004410498],"domain_scores_gemma":[0.99637663,0.002166584,0.00030606732,0.0008921875,0.00017899794,0.00007951334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058893085,0.00039261923,0.0007445142,0.00025907924,0.00022824005,0.000013855004,0.00047031074,0.00019988751,0.00067346107],"category_scores_gemma":[0.00061670266,0.00030935393,0.0003331801,0.0002599132,0.00019324709,0.000029253768,0.00014051553,0.00087097095,0.000015762595],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029888794,0.0015077465,0.0006019111,0.00017793056,0.0011086286,0.00038097124,0.0038703354,0.0016306047,0.0033366438,0.00016015733,0.9479483,0.009388017],"study_design_scores_gemma":[0.015420056,0.004421416,0.0026818078,0.000026838656,0.00039327785,0.000014369862,0.000030128254,0.00003955206,0.0002578769,0.00004012406,0.97645235,0.00022219829],"about_ca_topic_score_codex":0.00033732736,"about_ca_topic_score_gemma":0.000583219,"teacher_disagreement_score":0.3682029,"about_ca_system_score_codex":0.00022175377,"about_ca_system_score_gemma":0.001156397,"threshold_uncertainty_score":0.99993587},"labels":[],"label_agreement":null},{"id":"W4281612438","doi":"10.1016/s0302-2838(22)00726-6","title":"Configuration and validation of the Toronto nomogram of antenatal ultrasound index generated from Bayesian meta-regression analysis in predicting Posterior Urethral Valves (PUV)","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Urological Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nomogram; Meta-analysis; Index (typography); Regression; Ultrasound; Regression analysis; Statistics; Obstetrics; Radiology; Oncology; Internal medicine","score_opus":0.017809945122571287,"score_gpt":0.25509096061692293,"score_spread":0.23728101549435165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281612438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753803,0.0010285387,0.00021925977,0.00024490355,0.00005649042,0.00021643803,0.00007505063,0.000011770629,0.0006094972],"genre_scores_gemma":[0.9994133,0.000021717044,0.000060097384,0.00018498354,0.00001466762,0.000007881473,0.0002561944,0.000009901159,0.00003124112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984141,0.00076567975,0.00032750302,0.0002284007,0.00015503484,0.000109273045],"domain_scores_gemma":[0.99940604,0.00011112661,0.0002290226,0.00018365271,0.000038010498,0.00003215924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023534443,0.000111702044,0.00036376296,0.00007052925,0.000069181886,0.000005655309,0.00008048409,0.000035905352,0.00052226585],"category_scores_gemma":[0.00010953443,0.000066047935,0.00013919656,0.00022937662,0.00008626874,0.000046727437,0.0000877365,0.00012398344,2.7649486e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047074098,0.00025200663,0.96774584,0.0000057162556,0.0017122042,0.00003206682,0.000917945,0.00064763194,0.02727289,0.000013234917,0.000008942362,0.0009207711],"study_design_scores_gemma":[0.0012475005,0.00069324195,0.99165535,0.0000024918488,0.0023973302,0.000017005605,0.00022345303,0.002167544,0.0014797742,0.000038855276,0.000026265516,0.00005115875],"about_ca_topic_score_codex":0.000889669,"about_ca_topic_score_gemma":0.00028498704,"teacher_disagreement_score":0.025793115,"about_ca_system_score_codex":0.000018445247,"about_ca_system_score_gemma":0.000016029548,"threshold_uncertainty_score":0.57184446},"labels":[],"label_agreement":null},{"id":"W4281630379","doi":"10.1016/s0302-2838(22)00327-x","title":"Highly sensitive and specific detection of bladder cancer via targeted ultra-deep sequencing of urinary DNA","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Bladder cancer; Urinary system; DNA sequencing; DNA; Urology; Cancer; Oncology; Internal medicine; Genetics","score_opus":0.014950454072681212,"score_gpt":0.23554432693440144,"score_spread":0.22059387286172022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281630379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895915,0.0016026966,0.0003404472,0.00021119945,0.0003012603,0.00024196212,0.000049497932,0.000034457236,0.0076269982],"genre_scores_gemma":[0.99896747,0.00015650978,0.00005769736,0.00042734962,0.0001268972,0.000009832968,0.000015696896,0.000035812598,0.00020272963],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988592,0.00032918176,0.00023962793,0.0002601221,0.00014217464,0.00016964674],"domain_scores_gemma":[0.9995206,0.000046677895,0.00013258887,0.00017501558,0.00006503499,0.000060067905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015107352,0.00012240064,0.00026313262,0.00011862797,0.00007839931,0.0000015631673,0.00004698542,0.00002522395,0.00031495007],"category_scores_gemma":[0.000011221117,0.0001177056,0.0000552082,0.0001529038,0.00012942367,0.000026601016,0.000054563618,0.00018881455,0.000008383236],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011988358,0.00013791186,0.0021790394,0.000035930843,0.0002518172,0.00044258527,0.0018088345,0.00015438002,0.9858979,0.000016044629,0.000099638404,0.0077770753],"study_design_scores_gemma":[0.0061614583,0.010218885,0.32223147,0.000021568361,0.0006546387,0.0020497174,0.0010978743,0.0004326134,0.6429503,0.000082731094,0.013743871,0.00035486402],"about_ca_topic_score_codex":0.00014238356,"about_ca_topic_score_gemma":0.000008183181,"teacher_disagreement_score":0.3429476,"about_ca_system_score_codex":0.00007877608,"about_ca_system_score_gemma":0.000046261186,"threshold_uncertainty_score":0.4799895},"labels":[],"label_agreement":null},{"id":"W4281640954","doi":"10.1016/s0302-2838(22)00609-1","title":"Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Prostate cancer; Chemotherapy; Ethnic group; Oncology; Race (biology); Prostate; Cancer; Internal medicine; Gynecology","score_opus":0.020136514418924303,"score_gpt":0.3418920798911864,"score_spread":0.32175556547226214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281640954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99220866,0.0012006013,0.000012986826,0.003562847,0.00014032269,0.00094539457,0.000020687345,0.000029079216,0.0018794385],"genre_scores_gemma":[0.99741024,0.00019531482,0.00004404181,0.0011559203,0.000045489207,0.0001522149,0.00001792738,0.0000423457,0.0009365026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790543,0.0010378893,0.00022818074,0.00028760303,0.00020612894,0.0003347672],"domain_scores_gemma":[0.99942696,0.00017118269,0.000065912216,0.00021570858,0.000027809996,0.00009241705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001235794,0.000129855,0.0003711123,0.00023157756,0.00006215769,0.0000040017408,0.00013861926,0.000011046368,0.0003894331],"category_scores_gemma":[0.00007811833,0.00010103198,0.000064074324,0.00043936956,0.000061278675,0.00002607995,0.00018331954,0.00031777943,0.000026795973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036482524,0.0007598461,0.62246466,0.0005443878,0.0005152408,0.002727502,0.008459155,0.0021464168,0.11480303,0.000072200615,0.0028837745,0.20814127],"study_design_scores_gemma":[0.06545082,0.064072676,0.6855875,0.0001586471,0.00061439344,0.0003893628,0.0014110623,0.0014431363,0.082014136,0.00013642525,0.09771785,0.0010039329],"about_ca_topic_score_codex":0.00010945927,"about_ca_topic_score_gemma":0.000010567286,"teacher_disagreement_score":0.20713733,"about_ca_system_score_codex":0.00013603174,"about_ca_system_score_gemma":0.000067355046,"threshold_uncertainty_score":0.4264019},"labels":[],"label_agreement":null},{"id":"W4281651554","doi":"10.1016/j.eururo.2022.05.007","title":"Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; NIHR Cambridge Biomedical Research Centre; Cancer Research UK Cambridge Institute, University of Cambridge; NIHR Oxford Biomedical Research Centre; Canadian Institutes of Health Research; Hutchison Whampoa Limited; Li Ka Shing Foundation; Syöpäjärjestöt; National Institute for Health and Care Research; Weill Cornell Medical College; Centre Léon Bérard; Tampereen Yliopisto; National Health and Medical Research Council; Cancer Research Institute; Institut National Du Cancer; Institut National de la Santé et de la Recherche Médicale; Rosetrees Trust; Prostate Cancer Foundation of Australia; National Cancer Research Institute; Royal Marsden NHS Foundation Trust; Cancer Research UK; Biotechnology and Biological Sciences Research Council; Prostate Cancer Foundation; Johns Hopkins University; Movember Foundation; Novo Nordisk Fonden; Academy of Finland; Masonic Charitable Foundation","keywords":"Medicine; Prostate cancer; Prostate; Biochemical recurrence; Germline; Oncology; Cancer; Prostatectomy; Internal medicine; Gynecology; Urology; Gene; Genetics","score_opus":0.017173823923271783,"score_gpt":0.2629722313961336,"score_spread":0.24579840747286186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281651554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815127,0.009680193,0.0000016461062,0.0038415561,0.0003573127,0.002759195,0.001422849,0.00016438679,0.0002601647],"genre_scores_gemma":[0.99025416,0.0019211153,0.000020141459,0.0018263452,0.00021180297,0.0044357865,0.0004598201,0.00013276986,0.0007380294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961999,0.00096150476,0.0005027672,0.0011101662,0.0004425611,0.00078307174],"domain_scores_gemma":[0.9985782,0.00010723395,0.00034639591,0.0005274205,0.0001252591,0.0003154912],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003455705,0.0005063346,0.0007418213,0.0001475363,0.00027838364,0.000033761316,0.00019099472,0.000054026143,0.0012652096],"category_scores_gemma":[0.000061006966,0.00037405058,0.00012685201,0.00049419684,0.00023189171,0.00007309926,0.00023410842,0.00051621464,0.000028330505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009354247,0.009517714,0.9332202,0.000049568396,0.0016501098,0.012303233,0.0051862854,0.000058532114,0.0004221379,0.0000054931484,0.0037749177,0.024457566],"study_design_scores_gemma":[0.017962659,0.020698573,0.9320852,0.00015126013,0.0012128339,0.00015879155,0.00034711068,0.00006879089,0.00019687088,0.0000072386515,0.026585026,0.00052565313],"about_ca_topic_score_codex":0.0002372942,"about_ca_topic_score_gemma":0.00022129004,"teacher_disagreement_score":0.023931913,"about_ca_system_score_codex":0.00082716614,"about_ca_system_score_gemma":0.00027757097,"threshold_uncertainty_score":0.99987113},"labels":[],"label_agreement":null},{"id":"W4283258055","doi":"10.1016/j.eururo.2022.05.030","title":"Patient-reported Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Harboring DNA Damage Response Alterations Treated with Talazoparib: Results from TALAPRO-1","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre Hospitalier de l’Université de Montréal","funders":"Medical Research Council; National Institute for Health and Care Research; Pfizer","keywords":"Medicine; Prostate cancer; Internal medicine; Quality of life (healthcare); Population; Oncology; Taxane; Visual analogue scale; Cancer; Hormonal therapy; Breast cancer; Surgery","score_opus":0.026208309276524597,"score_gpt":0.28873884592051924,"score_spread":0.2625305366439946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283258055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916274,0.00016159278,0.000004844093,0.003933024,0.00004171833,0.0013290395,0.000690332,0.00009052567,0.0021215368],"genre_scores_gemma":[0.99519116,0.000018626335,0.0002214479,0.00025679116,0.000021379285,0.00038943804,0.0008726444,0.000072193616,0.002956341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99683946,0.0011110939,0.0005492063,0.0006205084,0.0004279183,0.000451821],"domain_scores_gemma":[0.9987471,0.0002478442,0.00024932227,0.00048014347,0.0001207997,0.00015477827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052622607,0.00026432335,0.00040376245,0.0002943323,0.00027464365,0.00004254582,0.00010550862,0.000018224222,0.00015288567],"category_scores_gemma":[0.0001230099,0.00018178733,0.00004062221,0.0005049994,0.00014980578,0.00011878369,0.000100053265,0.00040984876,0.000010511438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35069475,0.0020629908,0.4166637,0.000045408575,0.0021691183,0.054247778,0.016232446,0.008553184,0.14657348,0.000034968485,0.001309546,0.0014126085],"study_design_scores_gemma":[0.024160229,0.0075435247,0.9577543,0.00004834391,0.00040372708,0.00011687646,0.0012789695,0.00071945874,0.0037865432,0.000008510733,0.0038384967,0.0003409967],"about_ca_topic_score_codex":0.0011368073,"about_ca_topic_score_gemma":0.00059374305,"teacher_disagreement_score":0.5410906,"about_ca_system_score_codex":0.00027118274,"about_ca_system_score_gemma":0.00044516136,"threshold_uncertainty_score":0.7413072},"labels":[],"label_agreement":null},{"id":"W4285606218","doi":"10.1016/j.eururo.2022.06.009","title":"Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Sunitinib; Axitinib; Renal cell carcinoma; Pembrolizumab; Internal medicine; Kidney cancer; Quality of life (healthcare); Hazard ratio; Oncology; Adverse effect; Cancer; Confidence interval; Urology","score_opus":0.05936434309129127,"score_gpt":0.3011600521554575,"score_spread":0.24179570906416623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285606218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98255914,0.0023519835,0.00029071054,0.0018526262,0.0004060304,0.00082729623,0.00071273634,0.000099783916,0.0108997105],"genre_scores_gemma":[0.99453247,0.000016506647,0.000688171,0.0011584876,0.000134806,0.00006574749,0.0026396047,0.00009152717,0.0006726983],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99448246,0.0022847457,0.0013694068,0.00079689734,0.00045888455,0.00060761394],"domain_scores_gemma":[0.9965628,0.0010326992,0.00091125665,0.00092696893,0.00016596568,0.00040035765],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010235434,0.0003419431,0.0014024529,0.0004207667,0.00026338422,0.000007861802,0.00032820416,0.000069865346,0.0010665491],"category_scores_gemma":[0.0003545504,0.0003474621,0.00064055424,0.0006848658,0.00015707243,0.00003638286,0.0002823996,0.00049954647,0.00004671657],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6628939,0.007633764,0.09946676,0.0014344761,0.019667253,0.004545871,0.023024578,0.08536847,0.05311035,0.0027951847,0.019064322,0.020995097],"study_design_scores_gemma":[0.11149062,0.026923833,0.830428,0.000011074081,0.004944589,0.00007101768,0.0021582283,0.0029389758,0.0029121744,0.000118453434,0.01705087,0.00095216226],"about_ca_topic_score_codex":0.0015930594,"about_ca_topic_score_gemma":0.00010162087,"teacher_disagreement_score":0.7309612,"about_ca_system_score_codex":0.00034519265,"about_ca_system_score_gemma":0.000457494,"threshold_uncertainty_score":0.9998977},"labels":[],"label_agreement":null},{"id":"W4285678402","doi":"10.1016/j.eururo.2022.06.016","title":"The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours","year":2022,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":828,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Cancer Research UK; Francis Crick Institute; Centre International de Recherche sur le Cancer; World Health Organization","keywords":"Medicine; Sex organ; Urology; Urinary system; Testicular tumor; Pathology; Internal medicine","score_opus":0.037946935477844036,"score_gpt":0.26633342988946385,"score_spread":0.22838649441161982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285678402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010611367,0.98470813,0.0000060546317,0.00050871517,0.00023475407,0.0013186927,0.00004683034,0.000027693684,0.0025377758],"genre_scores_gemma":[0.16188367,0.83588344,0.000034681612,0.00007207452,0.00015699661,0.000030579515,0.00022881491,0.00012997256,0.0015797737],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961691,0.0021049462,0.0007921835,0.00042353247,0.00028380615,0.00022642118],"domain_scores_gemma":[0.9976622,0.00046396453,0.0010159254,0.00065552484,0.000097792574,0.00010461244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009012676,0.00028094632,0.00093947584,0.00016115283,0.0002672095,0.000012396147,0.0002461572,0.00004823575,0.00009248241],"category_scores_gemma":[0.00027924008,0.00016810879,0.00012028059,0.00063637,0.0002996104,0.0000198199,0.00033854364,0.0004271271,0.000009767813],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001266175,0.0035398924,0.18465059,0.18494098,0.0033876356,0.006767625,0.004049344,0.00004611363,0.0011753426,0.01606435,0.061197758,0.5329142],"study_design_scores_gemma":[0.00089538016,0.0022553764,0.14162317,0.001430934,0.0035036057,0.013397244,0.00032844595,0.000020620948,0.000015713433,0.0000039785214,0.8362315,0.0002939803],"about_ca_topic_score_codex":0.000011221532,"about_ca_topic_score_gemma":0.0000045654697,"teacher_disagreement_score":0.7750338,"about_ca_system_score_codex":0.00017765127,"about_ca_system_score_gemma":0.0003469392,"threshold_uncertainty_score":0.68552774},"labels":[],"label_agreement":null},{"id":"W4288056422","doi":"10.1016/j.eururo.2022.07.016","title":"Re: Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Overdiagnosis; Prostate cancer; Magnetic resonance imaging; Radiology; Cancer; Oncology; Internal medicine","score_opus":0.00602305347203646,"score_gpt":0.23549156641689545,"score_spread":0.22946851294485898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288056422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91809934,0.07646956,7.3466157e-7,0.0022232379,0.00018953117,0.00059458736,0.00007251823,0.000021535552,0.0023289525],"genre_scores_gemma":[0.9936862,0.0043074326,0.000072644354,0.0015309479,0.00003669478,0.00017439108,0.00001547677,0.000034672423,0.00014155658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880993,0.0002493434,0.00024850262,0.00031434,0.0001660529,0.00021181785],"domain_scores_gemma":[0.99929017,0.000255935,0.0001475816,0.0002094503,0.000034338158,0.00006254194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016665913,0.00014152403,0.0003025138,0.00007937727,0.000071638904,0.0000028436473,0.000053317428,0.000009750315,0.00014721435],"category_scores_gemma":[0.00006798202,0.00012342159,0.00005706946,0.000114398325,0.00009281758,0.000018593364,0.00014648304,0.00012072948,0.0000028352204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010271366,0.00087266904,0.8526768,0.00027916644,0.00009036884,0.0010888886,0.0016201913,0.00013525184,0.0032412147,0.00016940548,0.0071111047,0.1316878],"study_design_scores_gemma":[0.005804491,0.008884543,0.9079918,0.00016339918,0.00032757138,0.000026182091,0.0001233013,0.00011202045,0.016243024,0.0000481487,0.060108315,0.00016715711],"about_ca_topic_score_codex":0.000101634425,"about_ca_topic_score_gemma":0.0000028335362,"teacher_disagreement_score":0.13152066,"about_ca_system_score_codex":0.00009352967,"about_ca_system_score_gemma":0.000037583617,"threshold_uncertainty_score":0.5032986},"labels":[],"label_agreement":null},{"id":"W4289833892","doi":"10.1016/j.eururo.2022.07.011","title":"Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN)","year":2022,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McGill University Health Centre; Centre Hospitalier Universitaire de Sherbrooke","funders":"Jonsson Comprehensive Cancer Center; Medical Research Council; American Society for Radiation Oncology; National Institute for Health and Care Research; American Cancer Society; ViewRay; Radiological Society of North America; National Cancer Institute; National Institutes of Health; Cancer Research UK; Prostate Cancer Foundation","keywords":"Medicine; Prostate cancer; Hazard ratio; Internal medicine; Randomized controlled trial; Radiation therapy; Confidence interval; Oncology; Cancer; Proportional hazards model; Relative risk; Meta-analysis","score_opus":0.12026728716567714,"score_gpt":0.38071467209557414,"score_spread":0.260447384929897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289833892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0073620384,0.969078,0.000044883538,0.0011141868,0.00014174182,0.016954564,0.0052409004,0.000014936691,0.000048729376],"genre_scores_gemma":[0.043711077,0.94679034,0.000036733334,0.00039231146,0.00005410947,0.007817229,0.0009054106,0.00011706092,0.00017571736],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9120196,0.07778784,0.007935285,0.0010293975,0.0007550253,0.00047285846],"domain_scores_gemma":[0.9589611,0.028303167,0.011004563,0.0013612688,0.00026730093,0.000102592894],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.033190917,0.0009801639,0.055484053,0.0017367804,0.000053391777,0.00001258566,0.0006307784,0.00017374493,0.004127995],"category_scores_gemma":[0.004893421,0.00039841144,0.016622324,0.0057222797,0.00093846617,0.00004272138,0.00015969247,0.0006832671,7.906728e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29105428,0.000544024,0.0019280962,0.0006386767,0.68593353,0.00005609146,0.0011546351,0.003434116,0.000004884334,0.0000099807385,0.000102608006,0.01513906],"study_design_scores_gemma":[0.3071418,0.0002271399,0.00047280843,0.00047881887,0.67547923,0.000001694595,0.000044011653,0.0001879346,0.000015521744,0.0000068999348,0.015731419,0.00021269266],"about_ca_topic_score_codex":0.010507144,"about_ca_topic_score_gemma":0.0046851574,"teacher_disagreement_score":0.049484674,"about_ca_system_score_codex":0.00039235383,"about_ca_system_score_gemma":0.0010802444,"threshold_uncertainty_score":0.99984676},"labels":[],"label_agreement":null},{"id":"W4290805456","doi":"10.1016/j.eururo.2022.07.002","title":"The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors","year":2022,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":294,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Cancer Research UK; Francis Crick Institute; World Health Organization","keywords":"Medicine; Genitourinary system; Urinary system; Prostate cancer; Prostate; Epidemiology; Pathology; Terminology; Histopathology; Gynecology; Sex organ; Cancer; Urology; Internal medicine","score_opus":0.032578417910256084,"score_gpt":0.2827874383631029,"score_spread":0.2502090204528468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290805456","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005836007,0.98640966,0.0000019428628,0.00047346586,0.00026824832,0.0017850983,0.00017316238,0.000035934307,0.005016453],"genre_scores_gemma":[0.08481273,0.910656,0.000009376697,0.00013589209,0.00014236655,0.000046036468,0.00019439649,0.00012633952,0.0038768705],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971005,0.0013558237,0.0007394861,0.00037846612,0.00020924737,0.00021651619],"domain_scores_gemma":[0.99838364,0.00019118642,0.00080453604,0.00048133128,0.00005483155,0.00008446834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005878714,0.00025742414,0.00083494204,0.0001275495,0.0002777996,0.0000102877375,0.00019944395,0.000039448707,0.00013652291],"category_scores_gemma":[0.00006934788,0.00015664208,0.00009726161,0.0005147072,0.00024484663,0.00002960253,0.00022311042,0.00039533578,0.000006188907],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012208414,0.003454789,0.051023077,0.08165904,0.0019963873,0.0020065717,0.004753037,0.0000045410543,0.00006175547,0.0025467223,0.013818939,0.8374543],"study_design_scores_gemma":[0.00078837544,0.0025981306,0.053187963,0.0011689349,0.0009324922,0.008522299,0.00029836508,0.0000045912716,0.0000022413437,0.000003768173,0.93231916,0.00017370516],"about_ca_topic_score_codex":0.000013017471,"about_ca_topic_score_gemma":0.000002570506,"teacher_disagreement_score":0.9185002,"about_ca_system_score_codex":0.0001163317,"about_ca_system_score_gemma":0.00042652042,"threshold_uncertainty_score":0.6387679},"labels":[],"label_agreement":null},{"id":"W4290805642","doi":"10.1016/j.eururo.2022.07.023","title":"Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Astellas Pharma; Nederlandse Organisatie voor Wetenschappelijk Onderzoek","keywords":"Medicine; Cisplatin; Bladder cancer; Chemotherapy; Oncology; Internal medicine; Urothelial cancer; Neoadjuvant therapy; Cancer; Breast cancer","score_opus":0.017363295465902664,"score_gpt":0.31745346749032044,"score_spread":0.3000901720244178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290805642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876677,0.00023848536,0.0014004515,0.0052611167,0.00027731762,0.0014208391,0.00033342285,0.000033588996,0.003367107],"genre_scores_gemma":[0.99217474,0.0000094157895,0.0010564766,0.0059321295,0.00006660147,0.00033667436,0.00003178976,0.0000610202,0.00033115942],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984262,0.0004951601,0.00029860216,0.00035369358,0.000160623,0.00026575188],"domain_scores_gemma":[0.99930453,0.00018995734,0.00009999476,0.00026636198,0.000046845154,0.00009230297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006357732,0.00014734147,0.00030058296,0.00024830847,0.000062640785,0.000002963601,0.00013024373,0.000024683055,0.0006595353],"category_scores_gemma":[0.000039822524,0.00014111781,0.000089832116,0.00020919075,0.00005296016,0.000011859878,0.000059951908,0.00014283622,0.000004635992],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15713546,0.0023659712,0.3312453,0.00010712518,0.0016540454,0.00055829476,0.0037765708,0.02656818,0.4339327,0.00007936313,0.0093030855,0.03327394],"study_design_scores_gemma":[0.0117912935,0.0077658608,0.9391755,0.000010667087,0.00012699173,0.000014211056,0.0001073043,0.0025206292,0.0011845693,0.000014458169,0.037153244,0.00013527749],"about_ca_topic_score_codex":0.00008170356,"about_ca_topic_score_gemma":0.000015264695,"teacher_disagreement_score":0.6079302,"about_ca_system_score_codex":0.00027585123,"about_ca_system_score_gemma":0.00041592366,"threshold_uncertainty_score":0.72214484},"labels":[],"label_agreement":null},{"id":"W4293558161","doi":"10.1016/j.eururo.2022.08.005","title":"Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Olaparib; Interquartile range; Prostate cancer; Internal medicine; Response Evaluation Criteria in Solid Tumors; Pembrolizumab; Oncology; Adverse effect; Cohort; Tolerability; Urology; Progressive disease; Cancer; Disease; Immunotherapy","score_opus":0.02590916212518864,"score_gpt":0.3095457383498139,"score_spread":0.2836365762246253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293558161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99241924,0.0005292127,0.0000032936894,0.0014125122,0.0001575631,0.003536282,0.0008961529,0.00004520932,0.0010005577],"genre_scores_gemma":[0.9968615,0.000049238897,0.000014000852,0.0004376657,0.00006946161,0.0003781481,0.0012977243,0.00005989605,0.00083233113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996405,0.0013081647,0.00050152006,0.00066062115,0.00063565664,0.0004890155],"domain_scores_gemma":[0.99874467,0.0002074764,0.00019800651,0.00059971766,0.000117735355,0.00013242368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000707665,0.0002526874,0.00041717457,0.00013192659,0.00032329807,0.000038941587,0.00027290283,0.000016046137,0.00019960145],"category_scores_gemma":[0.00008252466,0.00015934036,0.000049523514,0.00038507266,0.00016408466,0.00006775169,0.00021555954,0.0005920227,0.000027861211],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07506275,0.0041480884,0.90598816,0.000015259091,0.00062048755,0.0037856412,0.006260098,0.0003916108,0.000083865,0.0000039036204,0.0005777857,0.0030623435],"study_design_scores_gemma":[0.08333366,0.0085444,0.9063854,0.0000144995665,0.00034119308,0.000012196627,0.00033745816,0.00009361815,0.000010806412,0.0000036138556,0.00077494053,0.00014821035],"about_ca_topic_score_codex":0.0012151144,"about_ca_topic_score_gemma":0.001160439,"teacher_disagreement_score":0.008270912,"about_ca_system_score_codex":0.00037307615,"about_ca_system_score_gemma":0.00042427584,"threshold_uncertainty_score":0.6497711},"labels":[],"label_agreement":null},{"id":"W4295752719","doi":"10.1016/j.eururo.2022.08.019","title":"Epidemiology of Renal Cell Carcinoma: 2022 Update","year":2022,"lang":"en","type":"review","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":752,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; St. Thomas Hospital","funders":"Cancer Research UK; World Health Organization","keywords":"Medicine; Epidemiology; Incidence (geometry); Kidney cancer; Kidney disease; Disease; Renal cell carcinoma; Internal medicine; Cancer; Observational study; Germline mutation; Intensive care medicine; Oncology; Genetics; Mutation; Biology","score_opus":0.09248464971419333,"score_gpt":0.32054523547865904,"score_spread":0.2280605857644657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295752719","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025773345,0.9407513,0.000018722725,0.000108126085,0.0005155635,0.0008462055,0.0000969154,0.000058207195,0.057347238],"genre_scores_gemma":[0.0013539477,0.99250937,0.00024254691,0.0007111208,0.00042509782,0.00007133538,0.0012762535,0.00022437712,0.0031859365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99060583,0.0057886243,0.0016501752,0.0010312281,0.00023773064,0.0006863922],"domain_scores_gemma":[0.995883,0.001197674,0.0011922495,0.001408912,0.00004685545,0.0002713136],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0017972087,0.0006719416,0.0039106663,0.0005153764,0.00008412928,0.0000012690314,0.0005584332,0.00023197675,0.004528758],"category_scores_gemma":[0.00036423784,0.0005340071,0.0012257572,0.00037126773,0.0002738702,0.00001788224,0.0007209363,0.001390182,0.0011165538],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045829272,0.0010087846,0.0020846354,0.02296579,0.0011647792,0.017652605,0.00013375471,0.000014755366,0.000014818591,0.0007710459,0.03073956,0.92299116],"study_design_scores_gemma":[0.00075088366,0.0021181155,0.00077517657,0.00012588098,0.003336502,0.0021536937,0.0000043681976,0.0000022446086,0.000004112392,0.000017264789,0.9904212,0.0002905578],"about_ca_topic_score_codex":0.000018560453,"about_ca_topic_score_gemma":9.515603e-7,"teacher_disagreement_score":0.95968163,"about_ca_system_score_codex":0.00021995328,"about_ca_system_score_gemma":0.00038292177,"threshold_uncertainty_score":0.99971116},"labels":[],"label_agreement":null},{"id":"W4295993398","doi":"10.1016/j.eururo.2022.08.036","title":"Erratum to “Effect of Simulation-based Training on Surgical Proficiency and Patient Outcomes: A Randomised Controlled Clinical and Educational Trial” [Eur Urol 2022;81:385–393]","year":2022,"lang":"en","type":"erratum","venue":"European Urology","topic":"Simulation-Based Education in Healthcare","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dalhousie University","funders":"","keywords":"Medicine; Physical therapy; Simulation training; Medical physics; Randomized controlled trial; General surgery; Surgery; Simulation","score_opus":0.04789530504106582,"score_gpt":0.3907590163789252,"score_spread":0.34286371133785937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295993398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87394774,0.0026279357,0.00006561273,0.037078504,0.045533948,0.020591574,0.00023325664,0.00019507007,0.019726386],"genre_scores_gemma":[0.98265576,0.000028935912,0.000059561764,0.007612096,0.0016057376,0.0007523307,0.00085026014,0.00016495655,0.0062703546],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9882378,0.0065131187,0.0025281932,0.0012923968,0.0008756181,0.00055287324],"domain_scores_gemma":[0.971249,0.025727376,0.0011490716,0.00081025553,0.00044969047,0.0006146304],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0039078323,0.0006585982,0.0025973793,0.0008504948,0.00029936677,0.000032640895,0.00023991764,0.0005272471,0.0011255424],"category_scores_gemma":[0.013200968,0.00054478203,0.00050848373,0.00043690816,0.0003436468,0.00003589974,0.00010527507,0.0023073459,0.000029624676],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74933445,0.0019867953,0.057330757,0.0006983013,0.00068256404,0.00020059924,0.0038570617,0.017507534,0.0000049468763,0.00019089022,0.16212413,0.006081981],"study_design_scores_gemma":[0.7109325,0.04125379,0.08244775,0.00025194715,0.0012531206,0.000045390625,0.00031993297,0.021808423,0.0000012995354,0.000045519904,0.14071418,0.00092612],"about_ca_topic_score_codex":0.00001429811,"about_ca_topic_score_gemma":0.0000020444315,"teacher_disagreement_score":0.108708054,"about_ca_system_score_codex":0.00012386373,"about_ca_system_score_gemma":0.0021130687,"threshold_uncertainty_score":0.9999944},"labels":[],"label_agreement":null},{"id":"W4296905415","doi":"10.1016/j.eururo.2022.09.003","title":"Predictive Biomarkers in Muscle Invasive Bladder Cancer: Are We There Yet?","year":2022,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Alberta Cancer Foundation; Princess Margaret Cancer Centre","funders":"EMD Serono; Eisai Canada; Astellas Pharma Canada; Janssen Pharmaceuticals; Bayer; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Prostate cancer; Bladder cancer; Cancer; Risk assessment; Prostate; Internal medicine","score_opus":0.027835450834602243,"score_gpt":0.26499452533724266,"score_spread":0.23715907450264043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296905415","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0079268655,0.014710392,0.0000059171157,0.8575687,0.0024775474,0.001654701,0.001261007,0.00023434483,0.114160545],"genre_scores_gemma":[0.06985342,0.005627272,0.000024179995,0.91064847,0.0037909208,0.0004022992,0.0008840007,0.00042893807,0.0083404975],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99647164,0.0010627279,0.0004340527,0.0009736517,0.0003814527,0.00067645236],"domain_scores_gemma":[0.9986079,0.00023606609,0.00029863152,0.0006794309,0.00006561422,0.00011238893],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018675001,0.00052556104,0.00074468635,0.00038411393,0.00010354507,0.000016613758,0.00037964233,0.00035189372,0.0073641133],"category_scores_gemma":[0.000074959484,0.00047549928,0.00022446853,0.00031838653,0.00022123223,0.000047337173,0.0002751523,0.0023474598,0.00026433595],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000583916,0.00012620384,0.0077235815,0.00013204188,0.0013354836,0.020460792,0.00076843693,0.000019656598,0.0000366383,0.0000015521834,0.96616644,0.0026452718],"study_design_scores_gemma":[0.0028729148,0.0014573158,0.040655423,0.00011612413,0.00060698605,0.00014153327,0.00020657688,0.0000068940963,0.000014694177,0.00005095985,0.9535264,0.00034417826],"about_ca_topic_score_codex":0.0004452762,"about_ca_topic_score_gemma":0.00021644525,"teacher_disagreement_score":0.10582005,"about_ca_system_score_codex":0.0003767502,"about_ca_system_score_gemma":0.0004119134,"threshold_uncertainty_score":0.99995416},"labels":[],"label_agreement":null},{"id":"W4297752374","doi":"10.1016/j.eururo.2008.06.083","title":"Effect of Nightly versus On-Demand Vardenafil on Recovery of Erectile Function in Men Following Bilateral Nerve-Sparing Radical Prostatectomy","year":2008,"lang":"en","type":"article","venue":"European Urology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":342,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Rockyview General Hospital; Western University","funders":"","keywords":"Vardenafil; Medicine; Erectile dysfunction; Prostatectomy; Urology; Placebo; Sildenafil; Sexual function; Dosing; cGMP-specific phosphodiesterase type 5; Surgery; Tadalafil; Internal medicine; Prostate cancer","score_opus":0.023395728765923773,"score_gpt":0.2667804254569969,"score_spread":0.2433846966910731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297752374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9250062,0.000100198245,0.00005989995,0.00008683573,0.0014886794,0.00028063572,0.0000018902749,0.000062667685,0.072913],"genre_scores_gemma":[0.99836767,0.000031474265,0.000016511982,0.00026405958,0.00016805882,0.000010199698,0.000013925396,0.000031539163,0.0010965466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982054,0.00060178293,0.00040587987,0.00033229473,0.00022789509,0.0002267012],"domain_scores_gemma":[0.998907,0.0006359838,0.000122755,0.00022702543,0.000037802016,0.00006943267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006503172,0.00018258492,0.0004970001,0.00031904512,0.00007316665,0.00000288048,0.0000513881,0.000069964604,0.0001094788],"category_scores_gemma":[0.00045645094,0.00014116499,0.00014635244,0.00023941742,0.00009959287,0.000044530498,0.000045361983,0.00029680546,0.00012589121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3946236,0.0018584053,0.49880108,0.0005544835,0.0023338685,0.0031612217,0.0025973013,0.005927368,0.03948359,0.00035122942,0.027861552,0.0224463],"study_design_scores_gemma":[0.04489802,0.09677258,0.81546056,0.00018088799,0.00045397523,0.00021621681,0.0001140514,0.00035386495,0.01465104,0.000022914102,0.02643538,0.00044051438],"about_ca_topic_score_codex":0.000022561117,"about_ca_topic_score_gemma":0.0000023721236,"teacher_disagreement_score":0.34972557,"about_ca_system_score_codex":0.000043916658,"about_ca_system_score_gemma":0.00002471381,"threshold_uncertainty_score":0.5756541},"labels":[],"label_agreement":null},{"id":"W4301398333","doi":"10.1016/j.eururo.2022.09.021","title":"Reply to Yongbao Wei, Haijian Huang, and Liefu Ye’s Letter to the Editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469–82.","year":2022,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Cancer Research UK; Francis Crick Institute; World Health Organization","keywords":"George (robot); Medicine; Humanities; Art history; Philosophy; History","score_opus":0.01562154517120196,"score_gpt":0.2543308733572933,"score_spread":0.23870932818609136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301398333","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10985256,0.0030553204,0.000008332102,0.88018185,0.0014474557,0.003359031,0.00059761404,0.00006547234,0.0014323861],"genre_scores_gemma":[0.2002117,0.001012856,0.000045966186,0.7369292,0.006728227,0.00023932026,0.0013444772,0.00041793293,0.053070348],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99427724,0.0024769695,0.0008678028,0.0010182245,0.0007149062,0.0006448564],"domain_scores_gemma":[0.9973656,0.00035811696,0.0006397566,0.0012006662,0.00022823112,0.00020760891],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018989821,0.0004813199,0.0007057543,0.00033914746,0.0004971602,0.000069164904,0.00056392065,0.000111859954,0.00020518093],"category_scores_gemma":[0.00023339168,0.00029724673,0.00008395574,0.00084523024,0.00044133156,0.000104728475,0.0010003113,0.0019738027,0.000019569998],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057481043,0.00016925798,0.009835553,0.00044688245,0.00012667687,0.0008554448,0.0023532326,0.0000037673242,0.00083943567,0.000021585425,0.9845523,0.00022101392],"study_design_scores_gemma":[0.000960141,0.0030586836,0.09454511,0.00014594109,0.00016185871,0.0016522403,0.0004346431,0.000020684078,0.0000651983,0.000002946827,0.89871377,0.00023878823],"about_ca_topic_score_codex":0.00012843928,"about_ca_topic_score_gemma":0.00001946073,"teacher_disagreement_score":0.14325266,"about_ca_system_score_codex":0.0001803407,"about_ca_system_score_gemma":0.00030195725,"threshold_uncertainty_score":0.99994797},"labels":[],"label_agreement":null},{"id":"W4301398346","doi":"10.1016/j.eururo.2022.09.015","title":"Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification","year":2022,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Cancer Research UK; Francis Crick Institute; World Health Organization","keywords":"Medicine; Prostate cancer; Prostate; Cancer; Adenocarcinoma; Oncology; Internal medicine; Gynecology","score_opus":0.043796857956507604,"score_gpt":0.31444624148383843,"score_spread":0.2706493835273308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301398346","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015792217,0.049038347,0.00031630852,0.17680423,0.7346653,0.016851112,0.003755639,0.0003456597,0.002431226],"genre_scores_gemma":[0.15369162,0.017051822,0.0005921882,0.020663636,0.71886,0.008026085,0.0745361,0.0006997845,0.005878758],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99709904,0.0008888504,0.0005398295,0.00065877516,0.00043418029,0.00037933447],"domain_scores_gemma":[0.9980834,0.00078865304,0.00048078664,0.0004009777,0.00017395744,0.00007222363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012490264,0.0002627532,0.00042577978,0.00025221272,0.0002841204,0.00003915299,0.00023834888,0.000086425105,0.00020273431],"category_scores_gemma":[0.0004982675,0.00021283506,0.00006169929,0.00062440697,0.000060203885,0.000051246436,0.00008484355,0.00077506015,0.000012863408],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002801743,0.0003392275,0.010698722,0.00016404352,0.00008757825,0.000066142966,0.0023176798,0.000024772677,0.00001994924,0.0007031301,0.98203695,0.003261607],"study_design_scores_gemma":[0.003200582,0.0015381858,0.035234936,0.00004700517,0.0001550971,0.000008608814,0.00020989556,0.000093188086,0.0000033733008,0.00006570309,0.9592843,0.0001590989],"about_ca_topic_score_codex":0.0001016705,"about_ca_topic_score_gemma":0.00040823795,"teacher_disagreement_score":0.1561406,"about_ca_system_score_codex":0.00075370393,"about_ca_system_score_gemma":0.00075738964,"threshold_uncertainty_score":0.86791617},"labels":[],"label_agreement":null},{"id":"W4306790782","doi":"10.1016/j.eururo.2022.10.002","title":"Re: Management, Surveillance Patterns, and Costs Associated with Low-grade Papillary Stage Ta Non–muscle-invasive Bladder Cancer Among Older Adults, 2004–2013","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; Mount Sinai Hospital","funders":"","keywords":"Medicine; Stage (stratigraphy); Bladder cancer; Urology; Gynecology; Oncology; General surgery; Cancer; Internal medicine","score_opus":0.0076183080132090995,"score_gpt":0.227865805683776,"score_spread":0.22024749767056692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306790782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864409,0.0018780105,0.000026888254,0.0014843906,0.00031276562,0.0011070438,0.000520637,0.00013565183,0.00809371],"genre_scores_gemma":[0.98866564,0.0015887503,0.000015314112,0.0051844264,0.00014576633,0.00015636721,0.00033907633,0.00013521548,0.0037694508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974195,0.0005910464,0.00030478413,0.0007528338,0.00036122854,0.0005706599],"domain_scores_gemma":[0.9989126,0.00010193133,0.00022035601,0.00048209625,0.00007521838,0.00020784243],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028106317,0.00035099415,0.0004251374,0.00013090203,0.00025170186,0.000024991483,0.00019904767,0.00005630581,0.0015339919],"category_scores_gemma":[0.000023259161,0.0003065613,0.0000677529,0.00025442158,0.00015489802,0.00007096657,0.00028131297,0.00043257984,0.000029834675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067859585,0.0004784276,0.96845657,0.0001410693,0.0011928913,0.0045349253,0.0016244866,0.000097672055,0.000060406197,0.0000061685687,0.017509207,0.005219568],"study_design_scores_gemma":[0.007564622,0.001144963,0.9827929,0.00011913924,0.00023801521,0.000029011955,0.00081855315,0.00005843174,0.000030162993,0.0000011906313,0.0068782168,0.00032476347],"about_ca_topic_score_codex":0.0007815046,"about_ca_topic_score_gemma":0.0028886634,"teacher_disagreement_score":0.014336348,"about_ca_system_score_codex":0.00018820025,"about_ca_system_score_gemma":0.00006545764,"threshold_uncertainty_score":0.99993867},"labels":[],"label_agreement":null},{"id":"W4306882918","doi":"10.1016/j.eururo.2022.09.031","title":"BRCA Reversion Mutations in Metastatic Castration-Resistant Prostate Cancer","year":2022,"lang":"en","type":"letter","venue":"European Urology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Reversion; Prostate cancer; Oncology; Castration; Prostate; Internal medicine; Cancer; Gynecology; Gene; Phenotype; Hormone; Genetics","score_opus":0.03672269609017749,"score_gpt":0.308578188326128,"score_spread":0.2718554922359505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306882918","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013153965,0.0020104833,0.00003087844,0.95965075,0.0013538643,0.0013438147,0.0007063856,0.00015061977,0.021599226],"genre_scores_gemma":[0.02872258,0.00050603517,0.00040569104,0.94982886,0.0016589244,0.00035004897,0.003022027,0.00021804939,0.015287759],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99680763,0.0011695896,0.00059444964,0.0006086905,0.0003867644,0.00043288578],"domain_scores_gemma":[0.9988791,0.00019651832,0.00031170028,0.0004585156,0.000088624816,0.000065590735],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042015946,0.0002999164,0.0004759676,0.00046615765,0.00012734174,0.000019073552,0.0001813559,0.000110192064,0.006818666],"category_scores_gemma":[0.00007214547,0.0003089866,0.00012472643,0.00037581442,0.00015533702,0.0000594475,0.00007136026,0.0020942898,0.00025075063],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000521109,0.00006319082,0.0002525244,0.00016193918,0.00013005993,0.011132055,0.00081451045,0.0003683225,0.0017386955,0.000020264572,0.98413765,0.0006596786],"study_design_scores_gemma":[0.002263061,0.00060615817,0.0023486977,0.000059787213,0.0002007175,0.0002622637,0.0000534767,0.000028289738,0.000040621864,0.000109756,0.99378043,0.00024670974],"about_ca_topic_score_codex":0.00016733806,"about_ca_topic_score_gemma":0.00006486462,"teacher_disagreement_score":0.015568615,"about_ca_system_score_codex":0.00040809985,"about_ca_system_score_gemma":0.00040315965,"threshold_uncertainty_score":0.9999362},"labels":[],"label_agreement":null},{"id":"W4306955734","doi":"10.1016/j.eururo.2022.10.004","title":"Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Dalhousie University; University of Calgary; William Osler Health System","funders":"Office of Research, Innovation and Commercialization, University of Agriculture Faisalabad; Genentech; Astellas Pharma; Calithera Biosciences; Bayer Fund; Ipsen Biopharmaceuticals; Exelixis; Gilead Sciences; Eisai; Merck; Bristol-Myers Squibb; AstraZeneca; Novartis; Pfizer","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Oncology; Internal medicine; Nivolumab; Observational study; Urology; Immunotherapy; Kidney; Cancer","score_opus":0.08657612802764626,"score_gpt":0.2861605605452182,"score_spread":0.19958443251757196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306955734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913342,0.0011202411,0.00026115324,0.0010692771,0.0003976977,0.0036884735,0.0014299612,0.00010095374,0.0005980622],"genre_scores_gemma":[0.9864498,0.0000073707847,0.003649261,0.0010712112,0.00041948256,0.0007751253,0.0063355686,0.00018879738,0.0011033971],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9937632,0.0023595775,0.0010990386,0.0012373792,0.0008981428,0.0006426256],"domain_scores_gemma":[0.9967865,0.00074906286,0.0006976743,0.001104299,0.0003806087,0.00028189144],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012387608,0.0006714709,0.00082593,0.00026507425,0.00053166866,0.00006933277,0.00072780566,0.00003266409,0.001601496],"category_scores_gemma":[0.000119220975,0.00042870085,0.00027178883,0.00042925595,0.00027995382,0.00021848782,0.0003766104,0.0006821338,0.00003756747],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0893683,0.01683089,0.35112673,0.00007976545,0.004431531,0.013422206,0.01756343,0.002652213,0.49466702,0.00005380254,0.008592193,0.0012119323],"study_design_scores_gemma":[0.036759954,0.033027805,0.8180726,0.000011728964,0.00282531,0.000663074,0.008504356,0.0021403087,0.0853153,0.000030685245,0.011799935,0.00084890786],"about_ca_topic_score_codex":0.0014308863,"about_ca_topic_score_gemma":0.000118508964,"teacher_disagreement_score":0.46694592,"about_ca_system_score_codex":0.00042924166,"about_ca_system_score_gemma":0.0006698561,"threshold_uncertainty_score":0.9998165},"labels":[],"label_agreement":null},{"id":"W4309833897","doi":"10.1016/j.eururo.2022.11.001","title":"European Association of Urology Guidelines Panel on Renal Cell Carcinoma Update on the New World Health Organization Classification of Kidney Tumours 2022: The Urologist’s Point of View","year":2022,"lang":"en","type":"editorial","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"Univerzita Karlova v Praze","keywords":"Medicine; Renal cell carcinoma; Urology; Genitourinary system; Kidney; Nephrology; Perspective (graphical); Kidney cancer; Gynecology; Internal medicine","score_opus":0.04158355193864763,"score_gpt":0.273579503901991,"score_spread":0.23199595196334336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309833897","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06477618,0.008210408,0.00043192605,0.46580642,0.37938997,0.0071847592,0.0020352937,0.0003550959,0.071809955],"genre_scores_gemma":[0.8662378,0.0017612489,0.00011077774,0.015547491,0.10445194,0.000025514324,0.0052905735,0.00043082985,0.0061438223],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98724085,0.007953372,0.0021200918,0.00088511914,0.0012780523,0.0005224942],"domain_scores_gemma":[0.9904879,0.0021356281,0.0044831675,0.0015943666,0.001036599,0.00026239452],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00528581,0.0005790153,0.001222852,0.000487492,0.00019506662,0.000014149091,0.00096333807,0.00023210254,0.00069079164],"category_scores_gemma":[0.0091112945,0.0003808503,0.00031933887,0.0008624848,0.00025543667,0.000030526993,0.00037696149,0.0017014595,0.00012582043],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092798506,0.00036783563,0.0016988554,0.00015391738,0.0001714773,0.0000617886,0.0003752879,0.00024840128,0.0017170855,0.0005776045,0.99293256,0.0007672147],"study_design_scores_gemma":[0.002399641,0.007561085,0.043788206,0.00006439461,0.0009320882,0.000022526221,0.00007112973,0.000045020173,0.001024008,0.00006527589,0.9437483,0.0002783362],"about_ca_topic_score_codex":0.00016636561,"about_ca_topic_score_gemma":0.00003262136,"teacher_disagreement_score":0.80146164,"about_ca_system_score_codex":0.00048987084,"about_ca_system_score_gemma":0.0015653323,"threshold_uncertainty_score":0.99986434},"labels":[],"label_agreement":null},{"id":"W4311765023","doi":"10.1016/j.eururo.2022.11.025","title":"Corrigendum to “Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study” [Eur Urol 83 (2023) 15–26]","year":2022,"lang":"en","type":"erratum","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Olaparib; Pembrolizumab; Prostate cancer; Oncology; Internal medicine; Cohort; Urology; Gynecology; Cancer; Immunotherapy; Poly ADP ribose polymerase","score_opus":0.03189533556481511,"score_gpt":0.31042385900293107,"score_spread":0.27852852343811596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311765023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94460994,0.0040983525,0.000009443359,0.0030581958,0.012578132,0.015933365,0.009460949,0.00022449715,0.010027114],"genre_scores_gemma":[0.8526568,0.0006921308,0.000027309528,0.0019014764,0.0010530308,0.0015099485,0.016860671,0.0005139291,0.12478471],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.991577,0.002277632,0.0013269571,0.001972375,0.0015630089,0.0012830193],"domain_scores_gemma":[0.99649405,0.00025134478,0.0006696669,0.0016987585,0.00040257262,0.00048360138],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010928801,0.0009462752,0.0014837258,0.00051116874,0.00046291447,0.0001372002,0.0008833667,0.00014466004,0.0007822323],"category_scores_gemma":[0.0003460536,0.0006352878,0.00017183767,0.0009500079,0.00027960708,0.00010633556,0.00056388055,0.0026676906,0.00023135332],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15278566,0.007471684,0.24781963,0.00020203747,0.0036350263,0.021171289,0.008957072,0.00023461584,0.00003434498,0.000003561958,0.55286,0.0048250672],"study_design_scores_gemma":[0.0724615,0.016150754,0.8034719,0.00017406831,0.0016189591,0.000026889782,0.0002674933,0.00007119741,0.0000036293584,0.0000030496942,0.10509803,0.0006525378],"about_ca_topic_score_codex":0.0033681619,"about_ca_topic_score_gemma":0.00715571,"teacher_disagreement_score":0.55565226,"about_ca_system_score_codex":0.0010550427,"about_ca_system_score_gemma":0.0021365623,"threshold_uncertainty_score":0.9996332},"labels":[],"label_agreement":null},{"id":"W4311988438","doi":"10.1016/j.eururo.2022.11.002","title":"Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022","year":2022,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre; University of British Columbia","funders":"Medical Research Council; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Prostate cancer; Prostate; Cancer; Hormonal therapy; Oncology; Disease; Internal medicine; Management of prostate cancer; Hormone; Gynecology","score_opus":0.005719139442093395,"score_gpt":0.24109530185721298,"score_spread":0.23537616241511958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311988438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865326,0.009424643,0.000003042151,0.00051281246,0.00019518835,0.0023179653,0.0007702451,0.000020342426,0.00022312018],"genre_scores_gemma":[0.9884845,0.0098382225,0.00011931351,0.000057025693,0.000013987809,0.00045941127,0.00016741948,0.000048113732,0.00081198826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977266,0.00034701382,0.0005304299,0.0005969646,0.00042551113,0.0003734509],"domain_scores_gemma":[0.99836546,0.0001414547,0.0006193511,0.0004522176,0.00023205533,0.00018947682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016717959,0.0002873743,0.00054305274,0.00009240559,0.00012527857,0.000004520977,0.00014114747,0.000026722455,0.000021023827],"category_scores_gemma":[0.0000662628,0.0001876686,0.00006550011,0.00026150898,0.0008919264,0.000041897343,0.0003857521,0.00026035294,2.786691e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06550206,0.0019208869,0.7067725,0.0020096926,0.0022519114,0.0030285278,0.0017512875,0.0010388093,0.011072342,0.000112146445,0.00022129019,0.20431857],"study_design_scores_gemma":[0.024529284,0.00763259,0.95576084,0.0004112935,0.0009265095,0.000029302611,0.00023195262,0.000059745857,0.007194747,0.000078264275,0.0028835617,0.00026188884],"about_ca_topic_score_codex":0.00006143598,"about_ca_topic_score_gemma":0.000016662554,"teacher_disagreement_score":0.24898838,"about_ca_system_score_codex":0.0001184579,"about_ca_system_score_gemma":0.0002670436,"threshold_uncertainty_score":0.7652903},"labels":[],"label_agreement":null},{"id":"W4313530283","doi":"10.1016/j.eururo.2022.12.018","title":"Re: A Randomized Trial of PHOTOdynamic Surgery in Non–muscle-invasive Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Randomized controlled trial; Cancer; Surgery; Photodynamic therapy; Urology; Internal medicine","score_opus":0.02375014100645199,"score_gpt":0.29255128553373805,"score_spread":0.26880114452728604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313530283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758118,0.00028645052,0.000010679637,0.001712305,0.00087776606,0.0012625058,0.000027740545,0.00008445154,0.01992634],"genre_scores_gemma":[0.9958458,0.0011241299,0.000011979361,0.0012927825,0.00030623333,0.00015200116,0.00004774566,0.00005993832,0.0011593692],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99789566,0.00068369857,0.00055785,0.00034017474,0.00017693467,0.0003456714],"domain_scores_gemma":[0.99843806,0.00094574015,0.00016257081,0.0003143038,0.00005368588,0.00008564398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095944566,0.00018264908,0.00092767476,0.0003619863,0.000024781042,0.0000043098185,0.000094391515,0.00007037432,0.0004772489],"category_scores_gemma":[0.00055647554,0.00014819065,0.00028141923,0.00046021017,0.00017705641,0.000029430326,0.00005874505,0.00018983276,0.00022851648],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9703418,0.0004567019,0.0037353465,0.00010976602,0.000662562,0.0017858689,0.0015160928,0.000080888,0.0038790775,0.000022398366,0.009825484,0.007584033],"study_design_scores_gemma":[0.9573707,0.00072830566,0.03828908,0.000072419796,0.000412408,0.000012755816,0.00008472112,0.00020825827,0.00060263544,0.000097866694,0.0019330595,0.00018777653],"about_ca_topic_score_codex":0.00040697804,"about_ca_topic_score_gemma":0.00025959394,"teacher_disagreement_score":0.034553733,"about_ca_system_score_codex":0.000041173706,"about_ca_system_score_gemma":0.00022339047,"threshold_uncertainty_score":0.60430396},"labels":[],"label_agreement":null},{"id":"W4318046437","doi":"10.1016/j.eururo.2023.01.001","title":"Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Juravinski Cancer Centre; Ottawa Regional Cancer Foundation; McMaster University; Queen Elizabeth II Health Sciences Centre; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Carcinoma","score_opus":0.07258535591265095,"score_gpt":0.29758289015672945,"score_spread":0.2249975342440785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318046437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850816,0.0010118834,0.0030042368,0.0039081206,0.0007151018,0.0035570667,0.0006215779,0.00014945859,0.0019509472],"genre_scores_gemma":[0.9893312,0.000026135967,0.0024042337,0.0009011494,0.00017133469,0.00059169653,0.0045237085,0.00015046571,0.001900095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99647605,0.0005637397,0.0010701236,0.00084449054,0.00039281193,0.0006528056],"domain_scores_gemma":[0.99647576,0.0019702886,0.00043369867,0.0005586661,0.00035038733,0.00021122617],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001283668,0.00049618044,0.0008243993,0.00073147035,0.0001422284,0.000042510554,0.00035572934,0.000058146863,0.00007792665],"category_scores_gemma":[0.0007287425,0.00042143016,0.00031577438,0.00033941955,0.00019089201,0.00017910867,0.0001777037,0.00029009627,0.00013082082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009382976,0.005441748,0.90844995,0.0025675942,0.0012053985,0.008840033,0.0046097687,0.0008661776,0.024580956,0.0018675489,0.030295594,0.0018922623],"study_design_scores_gemma":[0.04130132,0.009261309,0.90877914,0.00006387425,0.0012781267,0.00019903854,0.0005563107,0.013054565,0.0095395055,0.0009137796,0.0142381415,0.0008148605],"about_ca_topic_score_codex":0.00006332357,"about_ca_topic_score_gemma":0.000055342447,"teacher_disagreement_score":0.031918347,"about_ca_system_score_codex":0.00013815533,"about_ca_system_score_gemma":0.00019432812,"threshold_uncertainty_score":0.99982375},"labels":[],"label_agreement":null},{"id":"W4318542405","doi":"10.1016/j.eururo.2023.01.020","title":"Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Ottawa Hospital; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; NRG Oncology; Varian Medical Systems; Pfizer","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Internal medicine; Oncology; Comorbidity; Relative risk; Cancer; Radiation therapy; Proportional hazards model; Confidence interval","score_opus":0.020095669658937255,"score_gpt":0.3284551359483447,"score_spread":0.3083594662894074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318542405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683696,0.00036396316,0.00004733878,0.0005082129,0.00018416581,0.0017695468,0.00007045996,0.000042397958,0.00017696747],"genre_scores_gemma":[0.99812704,0.0009455088,0.000029557661,0.00054016075,0.000053194417,0.0001691173,0.00008063648,0.00002692597,0.00002784671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849224,0.00044103555,0.00044729878,0.0002781081,0.00014768251,0.00019364219],"domain_scores_gemma":[0.99858975,0.0007280374,0.00032442252,0.00021458235,0.00006531046,0.000077911944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006000304,0.00014475359,0.0006899516,0.0004366123,0.000042660977,0.000004567864,0.00006903431,0.000023986157,0.000039052673],"category_scores_gemma":[0.0002985734,0.00010741016,0.00025501032,0.00063981395,0.000030280597,0.000019135516,0.00004098654,0.000098071134,0.000011798438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23289761,0.0015018346,0.49554795,0.00012592597,0.008197299,0.00020794067,0.0037511298,0.0032880113,0.013786492,0.000012838259,0.00024779333,0.24043515],"study_design_scores_gemma":[0.38117385,0.0064681293,0.57503563,0.00005704897,0.0022711926,7.257216e-7,0.000057316673,0.0005380591,0.033277348,0.000007710979,0.0009841557,0.00012884587],"about_ca_topic_score_codex":0.000064558524,"about_ca_topic_score_gemma":0.000006896069,"teacher_disagreement_score":0.24030632,"about_ca_system_score_codex":0.000040933694,"about_ca_system_score_gemma":0.000055530498,"threshold_uncertainty_score":0.43800592},"labels":[],"label_agreement":null},{"id":"W4319215982","doi":"10.1016/j.eururo.2023.01.009","title":"Re: IL-15 Superagonist NAI in BCG-Unresponsive Non–muscle-invasive Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Urology; Oncology; Internal medicine; Cancer","score_opus":0.027076175852111986,"score_gpt":0.2999252089570175,"score_spread":0.27284903310490555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319215982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9188667,0.000620952,0.000012437326,0.011926877,0.0009252964,0.0006257578,0.00012691674,0.0002460714,0.06664903],"genre_scores_gemma":[0.98092437,0.0006875122,0.000034736724,0.010075313,0.00057791354,0.000076277014,0.000088226516,0.00011444011,0.007421241],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99777263,0.00041074815,0.0003536558,0.00061101123,0.00021821998,0.0006337476],"domain_scores_gemma":[0.9989186,0.00022969318,0.00006663801,0.00048556348,0.000098073964,0.00020144352],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00031150575,0.00028619097,0.00042110556,0.00031963168,0.000107844826,0.000019769563,0.00019280167,0.000102405174,0.0011420597],"category_scores_gemma":[0.00024473737,0.00025702646,0.00012058034,0.0005995069,0.00017738831,0.00006257405,0.00014532047,0.00039409407,0.0029957897],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008970323,0.0016798127,0.294133,0.00039200415,0.002089467,0.06398748,0.03213154,0.0008013887,0.08276627,0.00048680505,0.44731343,0.065248474],"study_design_scores_gemma":[0.006612842,0.0017597252,0.84133613,0.00006499991,0.00024413576,0.000098496545,0.00072624465,0.00008197699,0.002116089,0.00011851429,0.14643851,0.00040233808],"about_ca_topic_score_codex":0.00040037185,"about_ca_topic_score_gemma":0.0007623009,"teacher_disagreement_score":0.5472031,"about_ca_system_score_codex":0.00010882883,"about_ca_system_score_gemma":0.00031527464,"threshold_uncertainty_score":0.9999882},"labels":[],"label_agreement":null},{"id":"W4319926447","doi":"10.1016/s0302-2838(23)00804-7","title":"Experience of the virtual Canadian testicular cancer second opinion group","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Testicular cancer; Second opinion; Gynecology; Cancer; Internal medicine; Pathology","score_opus":0.018058475001582877,"score_gpt":0.27044686880733193,"score_spread":0.25238839380574907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319926447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99415094,0.0004902721,0.000004276704,0.0007845334,0.00046044096,0.00015897791,0.000049996364,0.000041020976,0.0038595167],"genre_scores_gemma":[0.99809897,0.000026917727,0.00001007699,0.0011626504,0.000088012595,0.00001014608,0.000026309448,0.000019433144,0.00055748073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933743,0.00009323138,0.00011354785,0.00016524961,0.00008749468,0.0002030479],"domain_scores_gemma":[0.99947196,0.000035002402,0.00004187731,0.0002635592,0.000027247512,0.00016037763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005706704,0.000077923876,0.00010426707,0.00005698932,0.00006261069,0.000003514874,0.00010345034,0.000021692069,0.00046954173],"category_scores_gemma":[0.00014082735,0.000052980387,0.000058183738,0.00019890873,0.000106956184,0.000015175277,0.000054808213,0.00006865995,0.00015948559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008539962,0.00017335611,0.96408385,0.000049261274,0.0002154359,0.0013401186,0.00163135,0.00018071929,0.005384072,0.0014989917,0.011495784,0.013861655],"study_design_scores_gemma":[0.00050935237,0.00020249306,0.95824814,0.000013969433,0.000046221165,0.00004017326,0.000050937986,0.00012057847,0.00007769016,0.000014345398,0.04062823,0.00004787379],"about_ca_topic_score_codex":0.0048665903,"about_ca_topic_score_gemma":0.0034856482,"teacher_disagreement_score":0.029132444,"about_ca_system_score_codex":0.000027217517,"about_ca_system_score_gemma":0.000100021985,"threshold_uncertainty_score":0.7356861},"labels":[],"label_agreement":null},{"id":"W4319949183","doi":"10.1016/s0302-2838(23)00828-x","title":"First-in-human experience using the LithoVue™ Elite Single Use Ureteroscope to measure intrarenal pressure: The Canadian experience","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Renal and Vascular Pathologies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; URETEROSCOPE; Measure (data warehouse); Urology; Surgery; Data mining","score_opus":0.09334380004513974,"score_gpt":0.3032739860724419,"score_spread":0.20993018602730212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319949183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935331,0.00043758098,0.00009634337,0.0033409295,0.00028691703,0.00045040585,0.000006666456,0.0000935205,0.0017545695],"genre_scores_gemma":[0.9954316,0.00001717653,0.0001467775,0.003596392,0.00020393346,0.000025496043,0.000005115947,0.000036134898,0.0005373709],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978986,0.0005553862,0.00027357708,0.00042709103,0.000246925,0.0005984202],"domain_scores_gemma":[0.9988548,0.00011105937,0.000053306492,0.00070362166,0.00007262507,0.00020458584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006576671,0.00019098568,0.00021526268,0.00015652747,0.00047718038,0.00010784606,0.00048779894,0.00006338923,0.000054353815],"category_scores_gemma":[0.00076446054,0.00011019018,0.00007900589,0.0005576058,0.00035439184,0.000076812525,0.00020734711,0.00036067746,0.000117653544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077827065,0.00030957835,0.381232,0.00014115368,0.000317352,0.011827419,0.3241473,0.021912321,0.23978098,0.0013230866,0.00813972,0.01009081],"study_design_scores_gemma":[0.00055678474,0.00047877553,0.7812545,0.000090584625,0.000063244144,0.0004533056,0.001221294,0.0011119238,0.0012525094,0.000025952466,0.21321264,0.00027852607],"about_ca_topic_score_codex":0.0072040246,"about_ca_topic_score_gemma":0.02102051,"teacher_disagreement_score":0.40002245,"about_ca_system_score_codex":0.00005157049,"about_ca_system_score_gemma":0.00006794972,"threshold_uncertainty_score":0.9994071},"labels":[],"label_agreement":null},{"id":"W4320498659","doi":"10.1016/j.eururo.2023.01.028","title":"Re: Sensitivity of Multiparametric MRI and Targeted Biopsy for Detection of Adverse Pathologies (Cribriform Gleason Pattern 4 and Intraductal Carcinoma): Correlation of Detected and Missed Prostate Cancer Foci with Whole Mount Histopathology","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Fundação para a Ciência e a Tecnologia","keywords":"Medicine; Histopathology; Cribriform; Multiparametric MRI; Prostate cancer; Biopsy; Prostate carcinoma; Pathology; Radiology; Carcinoma; Magnetic resonance imaging; Cancer; Internal medicine","score_opus":0.014281765946096292,"score_gpt":0.23522536976648808,"score_spread":0.2209436038203918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320498659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967364,0.0013199853,0.00059552694,0.00030411335,0.00006710407,0.0007320302,0.00020340079,0.00003440123,0.00000702308],"genre_scores_gemma":[0.999017,0.0005236627,0.00028198998,0.00003493232,0.000015392676,0.0000340091,0.000060098504,0.00002437464,0.0000085144775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990154,0.00017160964,0.00026570694,0.00030431236,0.00007009369,0.00017290385],"domain_scores_gemma":[0.9991682,0.00022836041,0.00027292903,0.00013290498,0.00014566796,0.000051897277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002749582,0.0001416717,0.00036596673,0.00021598357,0.00003764633,0.0000016469351,0.000017638067,0.000060887192,0.0000010064648],"category_scores_gemma":[0.00018153123,0.00011492702,0.000027841177,0.00022225964,0.00031844174,0.000044105094,0.00004212966,0.000086591535,3.213942e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002160414,0.00009366708,0.6408287,0.00041128654,0.00006638693,0.00020928885,0.0017737681,0.00019453636,0.3239743,0.0000036225308,0.000014767249,0.03026923],"study_design_scores_gemma":[0.0036621834,0.0032767272,0.9558085,0.00003795099,0.00021760113,0.00014045456,0.0002589128,0.0044374564,0.03200905,0.000008857717,0.000054533935,0.0000877399],"about_ca_topic_score_codex":0.0003029189,"about_ca_topic_score_gemma":0.00010817832,"teacher_disagreement_score":0.31497982,"about_ca_system_score_codex":0.000043517663,"about_ca_system_score_gemma":0.000027972354,"threshold_uncertainty_score":0.46865878},"labels":[],"label_agreement":null},{"id":"W4321438601","doi":"10.1016/j.eururo.2023.02.009","title":"A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Randomized controlled trial; Quality of life (healthcare); Prostate cancer; Distress; Physical therapy; Anxiety; Social support; Cancer; Internal medicine; Psychiatry; Clinical psychology; Nursing; Psychology; Psychotherapist","score_opus":0.05344374669252141,"score_gpt":0.39441263975106156,"score_spread":0.34096889305854017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321438601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98296475,0.0016111948,0.000006561263,0.0020707676,0.0015180168,0.007069321,0.00022268592,0.00052740175,0.0040092748],"genre_scores_gemma":[0.98602474,0.0068351263,0.000028445633,0.0011180079,0.00054286397,0.003616632,0.0003231653,0.00009130308,0.0014196908],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9935902,0.003208533,0.0010776882,0.0010319857,0.00034383923,0.0007478058],"domain_scores_gemma":[0.99735785,0.0011264877,0.00046814236,0.00040843245,0.00022125988,0.000417853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058291265,0.00048387243,0.0013388607,0.0001419754,0.00017578113,0.000058857127,0.00015840966,0.00012902434,0.00019400197],"category_scores_gemma":[0.00036100118,0.00032936264,0.00054773316,0.0004135243,0.0008201103,0.000070860915,0.00016394904,0.0004010935,0.000094411516],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7395826,0.002088746,0.02149965,0.00008101146,0.0012749486,0.0018839528,0.009262354,0.000103140505,0.000032334654,0.00004208939,0.0042347107,0.21991447],"study_design_scores_gemma":[0.8208669,0.022142664,0.06757088,0.00025971018,0.0012371251,0.000054882297,0.0022638065,0.0009250196,0.000047846304,0.00010137621,0.083801195,0.0007286393],"about_ca_topic_score_codex":0.000924761,"about_ca_topic_score_gemma":0.0009218277,"teacher_disagreement_score":0.21918583,"about_ca_system_score_codex":0.00018563586,"about_ca_system_score_gemma":0.00016146057,"threshold_uncertainty_score":0.99991584},"labels":[],"label_agreement":null},{"id":"W4321793069","doi":"10.1016/j.eururo.2023.02.007","title":"Erratum to “European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel” [Eur. Urol. 79(4) (2021) 480–488]","year":2023,"lang":"en","type":"erratum","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Urology; Risk factor; Gynecology; Oncology; Internal medicine; Cancer","score_opus":0.05933211470376304,"score_gpt":0.30794320282977533,"score_spread":0.2486110881260123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321793069","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22333996,0.09256744,0.033261374,0.20374355,0.22397892,0.09175368,0.107053265,0.0026500048,0.021651816],"genre_scores_gemma":[0.79163563,0.02334873,0.0009730466,0.021118471,0.054862443,0.0052030026,0.018759914,0.00270666,0.08139211],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919614,0.002858372,0.0018117344,0.0017245602,0.00062332384,0.001020602],"domain_scores_gemma":[0.99187255,0.0023591744,0.0026077842,0.0013894862,0.0014333007,0.00033768118],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022286435,0.000992769,0.0015272017,0.00028556748,0.00067144464,0.00018219565,0.0009316924,0.00060566526,0.000037727565],"category_scores_gemma":[0.004384469,0.00066622125,0.00037703544,0.00046107874,0.0002923662,0.00016734193,0.00032603214,0.0013142419,0.000099664605],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007647023,0.0001788079,0.013335996,0.00028266633,0.001917508,0.00004906679,0.0020031754,0.00020333775,0.0005761538,0.00007517387,0.97183293,0.008780458],"study_design_scores_gemma":[0.0059433426,0.0058441944,0.34100962,0.0006181149,0.006213872,0.00003161671,0.00080644485,0.0070274603,0.000024030975,0.0005707333,0.63077384,0.0011367189],"about_ca_topic_score_codex":0.0015588346,"about_ca_topic_score_gemma":0.0019108104,"teacher_disagreement_score":0.56829566,"about_ca_system_score_codex":0.0002451501,"about_ca_system_score_gemma":0.00074691884,"threshold_uncertainty_score":0.9995789},"labels":[],"label_agreement":null},{"id":"W4323043273","doi":"10.1016/j.eururo.2023.01.022","title":"Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry","year":2023,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Prostate Cancer Foundation; National Cancer Institute; National Institutes of Health; Office of Research and Development; U.S. Department of Defense","keywords":"Medicine; Odds ratio; Prostate cancer; Genetic genealogy; Confidence interval; Disease; Population; Genetic association; Ancestry-informative marker; Genome-wide association study; Genetic predisposition; Genetics; Internal medicine; Single-nucleotide polymorphism; Cancer; Genotype; Biology; Gene; Environmental health","score_opus":0.1266111507770956,"score_gpt":0.37021266192903296,"score_spread":0.24360151115193737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323043273","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.059794325,0.93457925,0.000006004935,0.000088568515,0.00007265583,0.0027782172,0.0026233634,0.000025479807,0.00003214008],"genre_scores_gemma":[0.15847616,0.84069985,0.00006577031,0.000020968077,0.000045389865,0.00043872412,0.0001147248,0.000078283236,0.000060121492],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975007,0.0003873642,0.00078016677,0.0007640296,0.0001861336,0.00038160276],"domain_scores_gemma":[0.9964206,0.00089973595,0.0018464079,0.0004659448,0.00017523699,0.00019205017],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059745775,0.00038600204,0.0017356803,0.00016451339,0.000035529036,0.0000064722526,0.000166528,0.000101592486,0.000007909026],"category_scores_gemma":[0.0013815138,0.00027287402,0.00018368963,0.00043987625,0.00037889284,0.000052535754,0.000119135075,0.00032390986,0.0000012819996],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003718122,0.0015898742,0.42511368,0.041564982,0.0023457643,0.0009520336,0.00085177406,0.00009628735,0.000011043008,0.000009763579,0.00012524823,0.52362144],"study_design_scores_gemma":[0.010464424,0.0056977603,0.8176545,0.15006578,0.01007619,0.000029235067,0.000081055136,0.0003284485,0.0000068677937,0.00002817865,0.004833013,0.0007345799],"about_ca_topic_score_codex":0.0003337502,"about_ca_topic_score_gemma":0.0003435889,"teacher_disagreement_score":0.5228869,"about_ca_system_score_codex":0.00017202299,"about_ca_system_score_gemma":0.00086833537,"threshold_uncertainty_score":0.99997234},"labels":[],"label_agreement":null},{"id":"W4323351274","doi":"10.1016/j.eururo.2023.02.017","title":"Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University Health Network; University of Toronto; Ottawa Regional Cancer Foundation; Mount Sinai Hospital; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Hazard ratio; Prostate cancer; Prednisone; Abiraterone acetate; Internal medicine; Docetaxel; Oncology; Proportional hazards model; Confidence interval; Progression-free survival; Placebo; Enzalutamide; Randomized controlled trial; Androgen deprivation therapy; Cancer; Chemotherapy; Androgen receptor; Pathology","score_opus":0.02746914410844194,"score_gpt":0.33184445217358816,"score_spread":0.30437530806514623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323351274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922977,0.001279988,0.0000037193456,0.003033563,0.00015848894,0.002719643,0.00037530594,0.000034652534,0.000096952914],"genre_scores_gemma":[0.99736845,0.0013578902,0.000008817998,0.0003061982,0.000040279592,0.00017601761,0.00008752424,0.000048910882,0.0006059022],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9953333,0.0028832129,0.0005651014,0.0004301594,0.00036993707,0.00041824748],"domain_scores_gemma":[0.99819595,0.0008736502,0.00018808547,0.00050526543,0.00011201708,0.00012501524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024812429,0.000246061,0.0008220027,0.00070871896,0.00006980524,0.000007872481,0.00022933933,0.00005055116,0.00036014893],"category_scores_gemma":[0.00026130214,0.00013993814,0.00027054228,0.0023120702,0.00025337073,0.00002343382,0.00006652473,0.00029611227,0.000030291352],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86063653,0.00041732928,0.00726603,0.000084766085,0.002403756,0.00037213485,0.002986141,0.0021370098,0.06028801,0.0000019727065,0.00061619707,0.0627901],"study_design_scores_gemma":[0.25507995,0.14615649,0.3717843,0.0001969173,0.0013609336,0.000013608174,0.00021511821,0.0020029487,0.20152241,0.0000121881485,0.021137524,0.000517631],"about_ca_topic_score_codex":0.00024830308,"about_ca_topic_score_gemma":0.0002154304,"teacher_disagreement_score":0.6055566,"about_ca_system_score_codex":0.000116723175,"about_ca_system_score_gemma":0.00033419806,"threshold_uncertainty_score":0.5706512},"labels":[],"label_agreement":null},{"id":"W4323655145","doi":"10.1016/j.eururo.2023.02.027","title":"European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update","year":2023,"lang":"en","type":"review","venue":"European Urology","topic":"Genital Health and Disease","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Penile cancer; Guideline; Grading (engineering); Cancer; Disease; Incidence (geometry); Oncology; Internal medicine; Surgery; Pathology","score_opus":0.12292542514194897,"score_gpt":0.48046643479750023,"score_spread":0.35754100965555125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323655145","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046655515,0.938789,0.000012903529,0.0053911773,0.0016465493,0.0017119831,0.0019801115,0.00016899445,0.04983271],"genre_scores_gemma":[0.0022421656,0.98278815,0.0003313896,0.008445622,0.0015422658,0.00003542904,0.0012070051,0.0002096017,0.0031983927],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9873698,0.0070198076,0.0036851559,0.00086694595,0.00040250493,0.0006558195],"domain_scores_gemma":[0.99162054,0.0017181019,0.0046498794,0.0007121111,0.00076987804,0.00052949984],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005367239,0.0005060139,0.0041066944,0.0002579512,0.000071369344,0.00000453621,0.00042705616,0.00037267443,0.0002684695],"category_scores_gemma":[0.0026387859,0.0004270349,0.0011249026,0.001062237,0.0005061917,0.000023818833,0.00030076984,0.0013085725,0.0017730797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007886026,0.0006217401,0.0005265985,0.005046253,0.00054913276,0.00030144755,0.0000902162,0.0000123727805,0.000001301015,0.000064352724,0.37611872,0.6158793],"study_design_scores_gemma":[0.0017110656,0.0050815074,0.0017117207,0.00017220697,0.0026441137,0.000015520623,0.000053379474,0.000024349069,1.873594e-7,0.000009250706,0.9883433,0.00023338443],"about_ca_topic_score_codex":0.00006247506,"about_ca_topic_score_gemma":0.000040791154,"teacher_disagreement_score":0.6156459,"about_ca_system_score_codex":0.00022492818,"about_ca_system_score_gemma":0.0027210924,"threshold_uncertainty_score":0.99981815},"labels":[],"label_agreement":null},{"id":"W4323823236","doi":"10.1016/j.eururo.2023.03.002","title":"Corrigendum to “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer” [Eur Urol 2023;83:313–17]","year":2023,"lang":"en","type":"erratum","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Cisplatin; Chemotherapy; Oncology; Internal medicine; Neoadjuvant therapy; Urology; Cancer","score_opus":0.029312087197528817,"score_gpt":0.32794164049409424,"score_spread":0.29862955329656543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323823236","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21515895,0.010702544,0.02239324,0.11264758,0.2529823,0.07160884,0.04350172,0.002247811,0.26875702],"genre_scores_gemma":[0.27952397,0.0010773722,0.0036375888,0.05482914,0.007038008,0.0043780734,0.0037714627,0.0025541962,0.6431902],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954043,0.00076301995,0.0010353178,0.0013720026,0.0004718736,0.0009534865],"domain_scores_gemma":[0.99756277,0.0003195148,0.00041719858,0.00096175686,0.0002654141,0.00047336376],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010028279,0.00075823563,0.0014056936,0.0011640843,0.00008856639,0.00002018307,0.0005221471,0.00038900707,0.00064402475],"category_scores_gemma":[0.00027518987,0.00073091587,0.0003534133,0.00076383946,0.00013814028,0.000026059015,0.00016339094,0.0007442543,0.00015888725],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0358908,0.00042099803,0.0027009202,0.00019570244,0.0012879573,0.00060102163,0.0007318668,0.0010540417,0.007139056,0.0000032295668,0.9448725,0.005101921],"study_design_scores_gemma":[0.011142363,0.012198755,0.31290314,0.00033565378,0.0006903899,0.000021118432,0.00008168984,0.0019958403,0.00021358242,0.000011196898,0.65977335,0.0006328891],"about_ca_topic_score_codex":0.000459439,"about_ca_topic_score_gemma":0.0004070598,"teacher_disagreement_score":0.37443316,"about_ca_system_score_codex":0.0006730209,"about_ca_system_score_gemma":0.0021694412,"threshold_uncertainty_score":0.99951416},"labels":[],"label_agreement":null},{"id":"W4360819509","doi":"10.1016/j.eururo.2023.03.003","title":"Corrigendum to “Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma” [Eur Urol 2023]","year":2023,"lang":"en","type":"erratum","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Toronto; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre; Ottawa Regional Cancer Foundation; Queen Elizabeth II Health Sciences Centre; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Internal medicine; Carcinoma","score_opus":0.07805097212584937,"score_gpt":0.2959166596376353,"score_spread":0.21786568751178592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360819509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6387421,0.025510399,0.026795715,0.02961407,0.1332729,0.0638794,0.031335015,0.0014378042,0.049412623],"genre_scores_gemma":[0.84849215,0.000093346476,0.0021331625,0.0024363652,0.0011463172,0.0018611242,0.03010865,0.0005851021,0.113143794],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927644,0.0010635407,0.0021442089,0.0019467889,0.00086916535,0.0012119029],"domain_scores_gemma":[0.9945883,0.0017538465,0.0011489595,0.001219306,0.00082398806,0.0004656088],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0016938915,0.0013047408,0.002131275,0.0016798656,0.00022392975,0.000102639846,0.0009245227,0.00024860798,0.0001737754],"category_scores_gemma":[0.0015744985,0.0011673615,0.0007318156,0.00055523776,0.0002474632,0.00018598486,0.00046309902,0.0011744433,0.000359601],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045098686,0.002330804,0.021723174,0.0025041834,0.0010002641,0.0061475607,0.001188741,0.00012790122,0.0011973215,0.00016326216,0.9587476,0.0003593055],"study_design_scores_gemma":[0.0517731,0.027700817,0.26937026,0.00049193326,0.006251534,0.00046899865,0.0006078884,0.008278945,0.0018663055,0.0005658994,0.6295495,0.0030748025],"about_ca_topic_score_codex":0.00022887523,"about_ca_topic_score_gemma":0.00033822263,"teacher_disagreement_score":0.32919812,"about_ca_system_score_codex":0.00041020208,"about_ca_system_score_gemma":0.0008133359,"threshold_uncertainty_score":0.99997044},"labels":[],"label_agreement":null},{"id":"W4362666357","doi":"10.1016/j.eururo.2023.03.027","title":"Reconsidering the Role of Draping in Cystoscopy: An Audit for Sustainability in Urology","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Climate Change and Health Impacts","field":"Environmental Science","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Cystoscopy; Urology; Audit; General surgery; Urinary system; Internal medicine; Management","score_opus":0.09739219548401797,"score_gpt":0.303481291134493,"score_spread":0.20608909565047506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362666357","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23456006,0.00019040571,0.000015065773,0.7578766,0.00050497794,0.0013346191,0.000048871185,0.00006853301,0.0054009105],"genre_scores_gemma":[0.5421398,0.00010805032,0.000068635716,0.45579982,0.0011505538,0.000121846206,0.00013070162,0.00017317102,0.00030740432],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99674803,0.0011475921,0.0005654124,0.0005723736,0.00011417977,0.00085238606],"domain_scores_gemma":[0.9983575,0.0007709085,0.0002534455,0.0005472626,0.0000131084325,0.000057807618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019925965,0.00021882539,0.0004071489,0.00018431697,0.00007593019,0.000010645411,0.00049208506,0.00028538698,0.00025652495],"category_scores_gemma":[0.0006948237,0.00017215587,0.00006142879,0.00024726364,0.00031639778,0.00007227754,0.00036251277,0.0010747479,0.00013189993],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007799992,0.00032076956,0.18187115,0.0011288882,0.00004202219,0.0031783548,0.031102575,0.007107945,0.0014916601,0.00010527294,0.7252061,0.04766529],"study_design_scores_gemma":[0.0006228813,0.0009126998,0.058808662,0.000021114014,0.000022244163,0.000042059055,0.0006275894,0.0010426827,0.000017251967,0.016338049,0.92122304,0.00032170658],"about_ca_topic_score_codex":0.00041277154,"about_ca_topic_score_gemma":0.0035673475,"teacher_disagreement_score":0.30757976,"about_ca_system_score_codex":0.00021752712,"about_ca_system_score_gemma":0.000043407952,"threshold_uncertainty_score":0.70203125},"labels":[],"label_agreement":null},{"id":"W4362697911","doi":"10.1016/j.eururo.2023.03.025","title":"Stereotactic Radiotherapy for Renal Cell Carcinoma: The Fallacy of (False) Positive Post-treatment Biopsy?","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Renal cell carcinoma; Radiation therapy; Biopsy; Radiology; Carcinoma; Oncology; Pathology","score_opus":0.026460812877283104,"score_gpt":0.25880557015489447,"score_spread":0.23234475727761136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362697911","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38243717,0.005859548,0.00015125958,0.59265256,0.0013466576,0.0050594658,0.0009198889,0.00021103394,0.011362379],"genre_scores_gemma":[0.5599054,0.0003726681,0.0008072258,0.38919726,0.00817615,0.00028315122,0.0034061556,0.0009446656,0.03690731],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962454,0.0010491932,0.00070073735,0.0009026061,0.0003493348,0.0007527516],"domain_scores_gemma":[0.99652994,0.0012615585,0.0005494157,0.0012364853,0.0003028642,0.000119768156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034200205,0.0007246115,0.001085103,0.00034147728,0.00012430626,0.00002548903,0.00039779386,0.0003572793,0.00009532714],"category_scores_gemma":[0.00006344377,0.00045606634,0.0007427438,0.00019087717,0.00029530574,0.000027312524,0.00010193148,0.0008249961,0.00028421992],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00634444,0.0011295254,0.004218034,0.0010146295,0.005638609,0.04778393,0.0046086507,0.000023246937,0.039118428,0.00004983266,0.8844203,0.005650403],"study_design_scores_gemma":[0.0091413995,0.024455126,0.064615645,0.00006652589,0.003793466,0.0027912187,0.00007217965,0.000037283302,0.0064473436,0.000030409912,0.8878266,0.0007227946],"about_ca_topic_score_codex":0.00022112319,"about_ca_topic_score_gemma":0.000009814307,"teacher_disagreement_score":0.20345531,"about_ca_system_score_codex":0.00037970982,"about_ca_system_score_gemma":0.00023161244,"threshold_uncertainty_score":0.9997891},"labels":[],"label_agreement":null},{"id":"W4366251172","doi":"10.1016/j.eururo.2023.03.032","title":"Reply to Binghao Zhao, Hao Xing, and Wenbin Ma’s Letter to the Editor re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol. 2023;84:109–116","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Oncology; Theology; Philosophy","score_opus":0.04947360310919247,"score_gpt":0.2851655637115262,"score_spread":0.23569196060233372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366251172","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.094177365,0.0019768344,0.002811441,0.87603474,0.0073207053,0.012043296,0.0044962494,0.0002166816,0.0009226948],"genre_scores_gemma":[0.33715382,0.00005860534,0.0026502686,0.6356696,0.0050373543,0.0018130944,0.008679615,0.0005781968,0.008359455],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99168587,0.0018240002,0.0020337617,0.0022029378,0.0010055731,0.0012478377],"domain_scores_gemma":[0.9923498,0.0042643812,0.0010433008,0.0013929361,0.0005819425,0.0003676115],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0030083992,0.0013164926,0.0018061253,0.0011819027,0.00027088038,0.00024159146,0.000995129,0.00022150103,0.00013155036],"category_scores_gemma":[0.0014002573,0.0010163449,0.0005002327,0.00041835214,0.00030263086,0.0002422176,0.00066217437,0.0017596106,0.00028886052],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019045379,0.0004602547,0.0061962046,0.00084144913,0.00052738894,0.004073011,0.00095237786,0.00007846465,0.00074813975,0.000026758209,0.98409194,0.000099498415],"study_design_scores_gemma":[0.010340648,0.0050574816,0.014635361,0.000187797,0.001154104,0.00018283578,0.00013487547,0.00065215066,0.00049351243,0.000063803316,0.9661832,0.0009142459],"about_ca_topic_score_codex":0.0004363983,"about_ca_topic_score_gemma":0.00018527298,"teacher_disagreement_score":0.24297644,"about_ca_system_score_codex":0.00027578874,"about_ca_system_score_gemma":0.00033113308,"threshold_uncertainty_score":0.99995863},"labels":[],"label_agreement":null},{"id":"W4367294984","doi":"10.1016/j.eururo.2023.03.014","title":"Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Medical Research Council; Ipsen; European Society for Medical Oncology; Cilag; Astellas Pharma; Cancer Australia; Cancer Research UK; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Amgen; Pfizer; Sir John Fisher Foundation; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Prostate cancer; Prostatectomy; Cribriform; Intraepithelial neoplasia; Oncology; Cancer; Internal medicine; Prostate; Radiation therapy; Carcinoma","score_opus":0.0487744719252637,"score_gpt":0.34491857475126464,"score_spread":0.29614410282600095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367294984","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007365786,0.9781012,0.000009524364,0.00018281267,0.000059930815,0.011897746,0.0022338731,0.00007440218,0.000074706644],"genre_scores_gemma":[0.0065878485,0.9899709,0.00003996084,0.0003607653,0.000021642762,0.001906424,0.0008302674,0.00012326683,0.00015887714],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99702656,0.0007785589,0.00090255914,0.00068184914,0.00022549529,0.00038497444],"domain_scores_gemma":[0.99730086,0.00083650963,0.0010541534,0.00035705976,0.00027850855,0.0001729301],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028400123,0.00065759255,0.004303717,0.00016181145,0.000047742527,0.000010596421,0.00013876584,0.0000972224,0.000034336008],"category_scores_gemma":[0.00041203722,0.0002768458,0.0003864764,0.00022789382,0.00018690943,0.00002809281,0.00006281685,0.00029595438,0.00003027088],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020114093,0.0017694854,0.12337151,0.8374172,0.00937653,0.0008538373,0.00014834093,0.0000012317985,3.9062577e-8,0.000072664654,0.00044253274,0.02453522],"study_design_scores_gemma":[0.010383149,0.09943627,0.17343803,0.64868987,0.057541464,0.00021657045,0.000011233468,0.0000040686336,3.8769352e-7,0.000011652558,0.009197108,0.0010701859],"about_ca_topic_score_codex":0.000052797655,"about_ca_topic_score_gemma":0.000013540708,"teacher_disagreement_score":0.1887273,"about_ca_system_score_codex":0.00036043176,"about_ca_system_score_gemma":0.00021812644,"threshold_uncertainty_score":0.99996835},"labels":[],"label_agreement":null},{"id":"W4367296748","doi":"10.1016/j.eururo.2023.03.030","title":"Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Javelin; Avelumab; Urothelial carcinoma; Metastatic Urothelial Carcinoma; Oncology; Internal medicine; Carcinoma; Chemotherapy; Clinical trial; Bladder cancer; Urology; Immunotherapy; Pembrolizumab; Cancer","score_opus":0.1709709398084595,"score_gpt":0.4281932307307954,"score_spread":0.2572222909223359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367296748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819213,0.0015312587,0.0015959684,0.0077626687,0.002155025,0.0028492857,0.00062786206,0.00026558895,0.0012910211],"genre_scores_gemma":[0.982082,0.0012690651,0.00029909099,0.010209461,0.00390608,0.00017485353,0.0005373294,0.0001404024,0.0013816884],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966676,0.00073611736,0.00085524464,0.000845513,0.00026146698,0.0006340539],"domain_scores_gemma":[0.99683756,0.0016584365,0.00025222698,0.0008203179,0.00022827205,0.00020321835],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005252848,0.00040129025,0.0008053001,0.0000992303,0.00027436388,0.00002656309,0.0003824878,0.00013113406,0.00036596667],"category_scores_gemma":[0.0004489944,0.00026010058,0.00054213457,0.00032342644,0.0003587718,0.0000546385,0.00011401255,0.00042443527,0.00059317],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68646127,0.004390487,0.007825945,0.000041381438,0.0037500863,0.0018519232,0.0022393505,0.0002788991,0.008493399,0.00017011854,0.11095878,0.17353837],"study_design_scores_gemma":[0.454731,0.02033081,0.0685979,0.000024127527,0.00088504946,0.000044905046,0.0002075015,0.0011884084,0.00078961754,0.0004012525,0.45232284,0.00047659752],"about_ca_topic_score_codex":0.00013333856,"about_ca_topic_score_gemma":0.000052354117,"teacher_disagreement_score":0.3413641,"about_ca_system_score_codex":0.000038566257,"about_ca_system_score_gemma":0.00017187555,"threshold_uncertainty_score":0.9999851},"labels":[],"label_agreement":null},{"id":"W4367368093","doi":"10.1016/j.eururo.2023.04.017","title":"Industry Payments to American Editorial Board Members of Major Urology Journals","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Centre Hospitalier de l’Université de Montréal; Université de Montréal; McGill University Health Centre; University of Toronto","funders":"","keywords":"Medicine; Urology; Editorial board; Family medicine; Library science","score_opus":0.3167366863067906,"score_gpt":0.519985024150452,"score_spread":0.20324833784366142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367368093","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017261561,0.00033075787,0.000013131589,0.85072595,0.109715834,0.00095103116,0.0010387574,0.0003761338,0.019586856],"genre_scores_gemma":[0.02007511,0.00019389331,0.000034062457,0.8066391,0.16449356,0.000060551796,0.00023397425,0.00028853083,0.007981211],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98580444,0.008494177,0.001651416,0.0012259145,0.0006833948,0.0021406391],"domain_scores_gemma":[0.9945256,0.0020694733,0.0011073858,0.0007591158,0.00039457338,0.0011438462],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0031445287,0.0008711985,0.0015176224,0.00078924844,0.00028977933,0.000035419107,0.0017329123,0.007314724,0.004934246],"category_scores_gemma":[0.001149286,0.0008900568,0.00038199275,0.0009327052,0.0011923029,0.00008677542,0.0008286218,0.041277345,0.0038884636],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008721672,0.0001340074,0.0022690706,0.00012524151,0.00074875803,0.003353941,0.0003155438,0.00025744797,0.0010106562,0.0000226147,0.9857131,0.0051774303],"study_design_scores_gemma":[0.0014639506,0.0012863264,0.0012244423,0.000021518985,0.00067433127,0.00010515026,0.000047965583,0.000030554635,0.00029207006,0.000085022526,0.9941043,0.00066433125],"about_ca_topic_score_codex":0.00009550729,"about_ca_topic_score_gemma":0.00002150754,"teacher_disagreement_score":0.054777723,"about_ca_system_score_codex":0.00015377824,"about_ca_system_score_gemma":0.00034648424,"threshold_uncertainty_score":0.999355},"labels":[],"label_agreement":null},{"id":"W4367396296","doi":"10.1016/j.eururo.2023.04.019","title":"Reply to Mauricio Plata, Cesar Diaz Ritter, and Nicolás Badillo’s Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.009","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Digital Mental Health Interventions","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Research Nova Scotia; Dalhousie Medical Research Foundation","keywords":"Medicine; Prostate cancer; Cancer; Internal medicine","score_opus":0.05482562991182448,"score_gpt":0.39507630633962254,"score_spread":0.34025067642779805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367396296","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.109391384,0.005090412,0.000023302911,0.8033037,0.016182702,0.04375596,0.0057200384,0.0008206933,0.015711777],"genre_scores_gemma":[0.043890778,0.0022369602,0.000134862,0.8051212,0.011297364,0.05543622,0.0024147735,0.0008764993,0.078591354],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9750178,0.0143484315,0.003857234,0.003737907,0.0008518043,0.0021868313],"domain_scores_gemma":[0.99084,0.0045466023,0.0019115473,0.0016417,0.00033836492,0.00072177686],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0022000792,0.0016221614,0.0028264706,0.00047237639,0.00036466293,0.00041472662,0.0011175047,0.00061597524,0.000924595],"category_scores_gemma":[0.0013416433,0.0011795377,0.0008790991,0.00072478596,0.00091535633,0.00025005854,0.0011621404,0.0036424957,0.0024126186],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.113131806,0.0019832256,0.00044555648,0.00008922587,0.0011303275,0.0028102892,0.003385737,0.000095858224,7.9818926e-7,0.000006845451,0.86392707,0.012993293],"study_design_scores_gemma":[0.094658755,0.011684486,0.005766945,0.000506879,0.00043801757,0.000025037467,0.00017357721,0.000040772848,0.0000024100252,0.00003129271,0.88572615,0.000945691],"about_ca_topic_score_codex":0.0022551366,"about_ca_topic_score_gemma":0.00060969504,"teacher_disagreement_score":0.06550061,"about_ca_system_score_codex":0.00052583625,"about_ca_system_score_gemma":0.0001367979,"threshold_uncertainty_score":0.9999887},"labels":[],"label_agreement":null},{"id":"W4376255587","doi":"10.1016/j.eururo.2023.04.024","title":"Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McGill University; London Health Sciences Centre; Alberta Cancer Foundation","funders":"National Cancer Institute; NRG Oncology; Sanofi","keywords":"Medicine; Prostate cancer; Docetaxel; Oncology; Androgen deprivation therapy; Radiation therapy; Internal medicine; Randomized controlled trial; Chemotherapy; Cancer","score_opus":0.025176848217541778,"score_gpt":0.30575394858321836,"score_spread":0.28057710036567657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376255587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810562,0.0037528789,0.0011821189,0.0070514483,0.00064785505,0.005892278,0.00019457955,0.00014912029,0.000073480216],"genre_scores_gemma":[0.970529,0.022144418,0.0006892434,0.0029699537,0.0007784093,0.0017210478,0.00042774316,0.00011881441,0.000621369],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99736786,0.0009851473,0.00050142786,0.0005847768,0.00016075165,0.00040001923],"domain_scores_gemma":[0.99731165,0.001698385,0.00037630202,0.00037765797,0.000100411926,0.00013556954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010315349,0.0002937375,0.0010482366,0.00007943482,0.00019127404,0.000037653288,0.00013035929,0.00008482081,0.000099897465],"category_scores_gemma":[0.00031586157,0.00015199457,0.00013695598,0.0001975047,0.0003460785,0.000052323834,0.00005427349,0.00018946052,0.000017425762],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82258016,0.0001496387,0.10933125,0.000025022082,0.0015723023,0.00022820814,0.0014547672,0.000033505563,0.00010697264,0.000041072868,0.0018101981,0.06266691],"study_design_scores_gemma":[0.9283638,0.0072666034,0.03450124,0.00005064014,0.0017326664,0.00004423524,0.000038382354,0.00053139415,0.00028553567,0.00012461035,0.026846327,0.00021453951],"about_ca_topic_score_codex":0.00042722168,"about_ca_topic_score_gemma":0.0005831046,"teacher_disagreement_score":0.10578367,"about_ca_system_score_codex":0.00010590115,"about_ca_system_score_gemma":0.00022608029,"threshold_uncertainty_score":0.6198158},"labels":[],"label_agreement":null},{"id":"W4376286734","doi":"10.1016/j.eururo.2023.04.031","title":"Re: Darolutamide plus Androgen-deprivation Therapy and Docetaxel in Metastatic Hormone-sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Hazard ratio; Prostate cancer; Docetaxel; Prednisone; Abiraterone acetate; Internal medicine; Oncology; Proportional hazards model; Confidence interval; Androgen deprivation therapy; Enzalutamide; Cancer","score_opus":0.03953950541478287,"score_gpt":0.3162875686684111,"score_spread":0.2767480632536283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376286734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8129657,0.01164572,0.000005947501,0.17138737,0.0001379451,0.0029022952,0.0008154917,0.00004333982,0.0000961798],"genre_scores_gemma":[0.79893154,0.0897151,0.000016823942,0.10338418,0.0014119056,0.0005457451,0.0033158357,0.00024033165,0.0024385129],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956071,0.0020736805,0.0005106081,0.0008089728,0.00037162867,0.0006280129],"domain_scores_gemma":[0.9986808,0.00046727344,0.00024707481,0.00040830649,0.00006037778,0.00013619725],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011719317,0.00041313758,0.00070952455,0.00036703487,0.00011931837,0.00006153934,0.00013989717,0.00013884991,0.000016468102],"category_scores_gemma":[0.00020662892,0.0002792538,0.00007964528,0.00037745293,0.00043452342,0.00008134931,0.00009736664,0.0016596939,0.000020026899],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2513721,0.00071009714,0.015478413,0.00025373252,0.0012123743,0.052141324,0.012523928,0.000030760562,0.00045175885,0.0000042046754,0.6455844,0.020236878],"study_design_scores_gemma":[0.49026528,0.00818101,0.09715789,0.00017414957,0.0015122787,0.00014297749,0.00076932565,0.0026048876,0.00004359252,0.00025485124,0.39777488,0.0011188652],"about_ca_topic_score_codex":0.00059702125,"about_ca_topic_score_gemma":0.0001558899,"teacher_disagreement_score":0.24780954,"about_ca_system_score_codex":0.00012966421,"about_ca_system_score_gemma":0.00020882682,"threshold_uncertainty_score":0.99996597},"labels":[],"label_agreement":null},{"id":"W4376636011","doi":"10.1016/j.eururo.2023.04.033","title":"Re: Pulse-Modulated Holmium:YAG Laser vs the Thulium Fiber Laser for Renal and Ureteral Stones: A Single-center Prospective Randomized Clinical Trial","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Thulium; Holmium; Single Center; Ureteroscopy; Laser; Lithotripsy; Renal stone; Urology; Surgery; Ureter; Optics; Internal medicine; Urinary system","score_opus":0.05206038220585933,"score_gpt":0.3249430536697535,"score_spread":0.27288267146389417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376636011","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16744424,0.00026392992,0.000056119363,0.8016165,0.005786136,0.014425831,0.0006436108,0.0005170964,0.009246532],"genre_scores_gemma":[0.09474222,0.00016734807,0.00035139348,0.7966113,0.02531656,0.0010560818,0.003303117,0.0008071874,0.07764478],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99167895,0.003938623,0.001518828,0.0014791846,0.0004360999,0.0009482881],"domain_scores_gemma":[0.99461,0.0032036602,0.00067959283,0.0010102156,0.000244733,0.0002517613],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002695472,0.00082588335,0.0023431284,0.0002231093,0.00024249298,0.00010308629,0.00035748255,0.000893048,0.00032406577],"category_scores_gemma":[0.002567817,0.00050082046,0.0011526608,0.00020030743,0.00090142625,0.00006818207,0.00029803003,0.0023670865,0.00048281677],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47295928,0.00039905953,0.00093613734,0.00006469391,0.0019121148,0.001298507,0.00024627274,0.0000015864446,0.000004081184,0.00000213141,0.5215628,0.00061329536],"study_design_scores_gemma":[0.4841981,0.0040531666,0.0034885614,0.00006232375,0.002142692,0.00027130154,0.000008153081,0.00009312314,0.000005974041,0.000059867853,0.50526524,0.00035151164],"about_ca_topic_score_codex":0.000016613816,"about_ca_topic_score_gemma":0.0000057151706,"teacher_disagreement_score":0.07270202,"about_ca_system_score_codex":0.00007741995,"about_ca_system_score_gemma":0.00012541117,"threshold_uncertainty_score":0.9999345},"labels":[],"label_agreement":null},{"id":"W4376645144","doi":"10.1016/j.eururo.2023.03.029","title":"Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors","year":2023,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":481,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia","funders":"National Institute for Health and Care Research; World Health Organization","keywords":"Medicine; Epidemiology; Environmental health; Bladder cancer; Risk factor; Cancer; Pathology; Internal medicine","score_opus":0.10784192216771732,"score_gpt":0.39832168376729765,"score_spread":0.29047976159958033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376645144","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015255421,0.9947226,0.000004386349,0.000041356092,0.00035009335,0.0022759382,0.0005824801,0.00003354287,0.0019743473],"genre_scores_gemma":[0.000074281066,0.99846715,0.000014024027,0.0003177714,0.00010561814,0.00015540804,0.00013103202,0.00012946768,0.0006052289],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9917127,0.0046409857,0.0025804758,0.0005234346,0.00015837372,0.00038405182],"domain_scores_gemma":[0.9950667,0.0020200245,0.0019128666,0.0007998333,0.00009154371,0.00010900177],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017902153,0.00047262665,0.007534608,0.0004089188,0.000014934102,4.7446727e-7,0.00031600363,0.000216146,0.00054550177],"category_scores_gemma":[0.0034868382,0.00030691887,0.0008417039,0.00061188603,0.00016437542,0.0000144029,0.0001303617,0.00057666836,0.000346065],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015780934,0.00008050251,0.0015801339,0.99007064,0.0014239765,0.00010270105,0.0000638906,9.2029427e-7,3.8683766e-8,0.000024794219,0.00055903,0.0060775974],"study_design_scores_gemma":[0.00071520684,0.00050572626,0.003230279,0.92331547,0.021099186,0.000080512655,0.000013953165,0.0000017273208,2.1373872e-7,0.000026477966,0.050719347,0.00029192618],"about_ca_topic_score_codex":0.00042701926,"about_ca_topic_score_gemma":0.000042440926,"teacher_disagreement_score":0.06675519,"about_ca_system_score_codex":0.000087542794,"about_ca_system_score_gemma":0.00031342354,"threshold_uncertainty_score":0.9999383},"labels":[],"label_agreement":null},{"id":"W4377107538","doi":"10.1016/j.eururo.2023.04.018","title":"Management of Lymph Node–positive Penile Cancer: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"European Urology","topic":"Genital Health and Disease","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Penile cancer; Lymph node; Oncology; General surgery; Penis; Gynecology; Surgery; Internal medicine","score_opus":0.052280513928887835,"score_gpt":0.3702068575564106,"score_spread":0.31792634362752276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377107538","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.684776e-7,0.97021145,0.0000032115995,0.00015023624,0.00024073155,0.0036945865,0.00017103662,0.00008276861,0.025445035],"genre_scores_gemma":[0.000064081585,0.9924986,0.00002412752,0.0018684575,0.0001067298,0.0003549991,0.0002421335,0.000117261334,0.004723614],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9966999,0.0010222394,0.0012452964,0.0004353383,0.0002297828,0.0003674113],"domain_scores_gemma":[0.9980983,0.00015009337,0.0006527305,0.0007065538,0.00008801283,0.00030432406],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063003815,0.0003480399,0.0030960762,0.00016722662,0.000036115474,0.000003692349,0.0002667622,0.00007452625,0.00014512139],"category_scores_gemma":[0.00013167149,0.00025569924,0.00055465574,0.00039376834,0.00005986998,0.000011944309,0.00019232117,0.0002041646,0.0035371096],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017542447,0.000054844968,0.0000012755344,0.97439784,0.00020915407,0.0019940871,0.000010857808,8.949756e-8,5.306034e-9,0.000081900056,0.0016606383,0.021571783],"study_design_scores_gemma":[0.00046690603,0.00017227982,0.00006982602,0.7437805,0.030909352,0.00029503863,0.00000923504,0.000001682526,1.2161679e-8,0.0000043374307,0.22405769,0.00023312539],"about_ca_topic_score_codex":0.000013179432,"about_ca_topic_score_gemma":4.375708e-7,"teacher_disagreement_score":0.2306173,"about_ca_system_score_codex":0.000086724845,"about_ca_system_score_gemma":0.00024877847,"threshold_uncertainty_score":0.9999895},"labels":[],"label_agreement":null},{"id":"W4377968527","doi":"10.1016/j.eururo.2023.04.034","title":"Patient and Carer Experiences with Bladder Cancer: Results from a Global Survey in 45 Countries","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Urological Association; University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Family medicine; Urothelial cancer; Gynecology; General surgery; Urology; Internal medicine","score_opus":0.026576535730920017,"score_gpt":0.26940271920859377,"score_spread":0.24282618347767376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377968527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8221016,0.0037715118,0.0000033948759,0.15967685,0.0012620204,0.000753035,0.005839483,0.00015605446,0.006436042],"genre_scores_gemma":[0.6211299,0.00061805506,0.00002333048,0.37360114,0.0015851293,0.00011689568,0.0018496271,0.00012490686,0.0009510582],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973075,0.00065005425,0.0003991224,0.00084964576,0.00032453303,0.0004691707],"domain_scores_gemma":[0.99899447,0.00024409842,0.00016361247,0.00041215657,0.00009196942,0.000093685456],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001685896,0.00038565916,0.0005939878,0.00009414781,0.000055317374,0.000034214416,0.00013428986,0.00025053823,0.00013945883],"category_scores_gemma":[0.000089816705,0.00028403636,0.000041152325,0.00020927718,0.0003285654,0.000035631572,0.0001124232,0.0006595548,0.00011034675],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034220738,0.000048470934,0.14437574,0.000036637128,0.00048092526,0.012609421,0.013245367,0.0000053045856,8.8013314e-7,8.749493e-7,0.82401705,0.0017572682],"study_design_scores_gemma":[0.004996044,0.0019528753,0.44363928,0.00012704331,0.00026258416,0.00008941327,0.0006052105,0.0000038850076,0.0000075523008,0.000010925593,0.54789215,0.00041303172],"about_ca_topic_score_codex":0.017666625,"about_ca_topic_score_gemma":0.0065826382,"teacher_disagreement_score":0.29926354,"about_ca_system_score_codex":0.00011695721,"about_ca_system_score_gemma":0.0002516908,"threshold_uncertainty_score":0.9999612},"labels":[],"label_agreement":null},{"id":"W4378384713","doi":"10.1016/j.eururo.2023.05.015","title":"Reply to Zhipeng Mai, Weigang Yan, and Zhien Zhou’s Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023;83:561–70","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Prostate cancer; Cancer; Gynecology; General surgery; Internal medicine","score_opus":0.034137339948145023,"score_gpt":0.3567237085000124,"score_spread":0.3225863685518674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378384713","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11586133,0.0034179373,0.000027944121,0.84099776,0.011661871,0.023484612,0.0021015706,0.0005841027,0.0018628871],"genre_scores_gemma":[0.031655442,0.0082142595,0.00010127207,0.9180443,0.017316042,0.015774198,0.0013476108,0.0005398537,0.007007005],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98327976,0.00873641,0.0022640794,0.0030559204,0.0010540145,0.0016098215],"domain_scores_gemma":[0.9927515,0.0032755346,0.0012141753,0.0014445003,0.0005740476,0.0007402354],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0019319444,0.0014271754,0.0029910326,0.00032262306,0.0003994341,0.00031976894,0.00060087955,0.0005016562,0.00016334494],"category_scores_gemma":[0.0014513741,0.00093218463,0.00087997643,0.0007257371,0.0009563265,0.00012412123,0.0007550827,0.0027653957,0.00012406126],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14040379,0.00039597924,0.0009518878,0.00008843377,0.0014439028,0.0032845975,0.005201654,0.000046740523,0.0000076093793,0.0000016995172,0.8310237,0.017150005],"study_design_scores_gemma":[0.10839279,0.007853851,0.0039958213,0.00047201785,0.0012853224,0.000058465193,0.0004472838,0.000037451216,0.0000071128543,0.000008403827,0.8766032,0.0008383156],"about_ca_topic_score_codex":0.0027598878,"about_ca_topic_score_gemma":0.002571016,"teacher_disagreement_score":0.08420589,"about_ca_system_score_codex":0.00042616186,"about_ca_system_score_gemma":0.00028416756,"threshold_uncertainty_score":0.9998478},"labels":[],"label_agreement":null},{"id":"W4378650540","doi":"10.1016/j.eururo.2023.05.011","title":"Checkpoint Inhibitors in Urothelial Carcinoma—Future Directions and Biomarker Selection","year":2023,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; U.S. Department of Veterans Affairs","keywords":"Medicine; Metastatic Urothelial Carcinoma; Nivolumab; Cystectomy; Oncology; Internal medicine; Pembrolizumab; Bladder cancer; Clinical endpoint; Clinical trial; Cancer; Immunotherapy; Urothelial carcinoma","score_opus":0.04715193843860762,"score_gpt":0.3220179099081214,"score_spread":0.2748659714695138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378650540","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034150959,0.98733133,0.0000028460277,0.0002835484,0.001224103,0.0009818402,0.000046759524,0.00019807671,0.009589979],"genre_scores_gemma":[0.00070471066,0.9949835,0.000023356475,0.00017975624,0.0017158444,0.00008782354,0.00010312133,0.00019177671,0.0020101094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976878,0.00060486124,0.000576449,0.00064388936,0.00012500778,0.000361953],"domain_scores_gemma":[0.99933636,0.00007515541,0.00015561879,0.00025457807,0.000032495238,0.00014577614],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031083974,0.00041805246,0.0010819874,0.0005823057,0.000081238686,0.000018556648,0.00008392441,0.00025642608,0.000084028914],"category_scores_gemma":[0.000064270134,0.00033568733,0.0002719381,0.0006466196,0.000092826784,0.000031917603,0.00009773731,0.00061530893,0.0004683888],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009829965,0.00013154789,0.001275796,0.0028021073,0.0003244991,0.0006614899,0.00020200398,1.15395096e-7,0.000006732306,0.000016282407,0.0022703852,0.99221075],"study_design_scores_gemma":[0.0009628057,0.00037333902,0.008995311,0.00062494166,0.0009306304,0.0007940284,0.000010273286,0.0000023619211,0.000001140313,0.0000077850445,0.9870754,0.00022199386],"about_ca_topic_score_codex":0.00011676665,"about_ca_topic_score_gemma":0.00011997324,"teacher_disagreement_score":0.9919887,"about_ca_system_score_codex":0.00014569159,"about_ca_system_score_gemma":0.00021818143,"threshold_uncertainty_score":0.9999095},"labels":[],"label_agreement":null},{"id":"W4381486400","doi":"10.1016/j.eururo.2023.05.042","title":"Tackling Depression and Suicide Among Prostate Cancer Survivors: From Clinical Innovations to Continued Advocacy on the Upstream Social Determinants of Health","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Depression (economics); Prostate cancer; Upstream (networking); Psychiatry; Cancer; Internal medicine","score_opus":0.1308568247645072,"score_gpt":0.41209491945587157,"score_spread":0.2812380946913644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381486400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.794256,0.00023815862,0.000014730163,0.20383812,0.000491921,0.0005448174,0.00013888864,0.000052962256,0.0004244281],"genre_scores_gemma":[0.6367532,0.00015113935,0.000040195067,0.36000913,0.0023355717,0.000027186754,0.00016221667,0.000079991856,0.00044133115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964917,0.0011978559,0.0009781487,0.00058143924,0.0003064211,0.00044447032],"domain_scores_gemma":[0.99788123,0.00081736303,0.0006806824,0.00037040544,0.000173967,0.00007632978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015259397,0.00025771637,0.000806629,0.00014516187,0.0001918448,0.000021167449,0.00024458682,0.00023518321,0.000036087626],"category_scores_gemma":[0.00086078024,0.00018510887,0.000105573505,0.00027914412,0.00025625646,0.000030717136,0.00021452499,0.0014037187,0.000042135485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002587472,0.000016644957,0.6694166,0.000039122613,0.00007131145,0.0003306065,0.00085824495,0.000005292359,0.00001615726,0.000002117853,0.29747897,0.031506155],"study_design_scores_gemma":[0.00065094687,0.0005942112,0.9157694,0.0006103955,0.000097828204,0.000006687643,0.00013676974,0.0000304061,0.000019696776,0.000031954987,0.08188569,0.00016601685],"about_ca_topic_score_codex":0.00659972,"about_ca_topic_score_gemma":0.0016367337,"teacher_disagreement_score":0.24635276,"about_ca_system_score_codex":0.000039318307,"about_ca_system_score_gemma":0.00022565435,"threshold_uncertainty_score":0.99768466},"labels":[],"label_agreement":null},{"id":"W4382798047","doi":"10.1016/j.eururo.2023.06.017","title":"A Step Closer to Predicting Progression After Bacillus Calmette-Guérin Immunotherapy in High-risk Non–muscle-invasive Bladder Cancer","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canada Foundation for Innovation; Canadian Institutes of Health Research; Bladder Cancer Canada; Cancer Research Society","keywords":"Medicine; Immunotherapy; Bladder cancer; Internal medicine; Tumor progression; Oncology; Bacillus (shape); Cancer immunotherapy; Carcinoma in situ; Cancer; Urology; Immunology; Microbiology","score_opus":0.014753036736855601,"score_gpt":0.28106344253483256,"score_spread":0.26631040579797693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382798047","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60417444,0.003732597,0.00014449697,0.3736553,0.0052060154,0.0053674686,0.0013097748,0.00072053843,0.005689398],"genre_scores_gemma":[0.2289102,0.0014607789,0.00058746856,0.7434934,0.012195124,0.0016445686,0.00057318143,0.001049979,0.010085344],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947908,0.0010219772,0.00085789687,0.0014758052,0.00060777477,0.0012457684],"domain_scores_gemma":[0.99793667,0.00028976036,0.00034713268,0.0010540362,0.00015013483,0.00022224977],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00046015135,0.0008591411,0.0011364063,0.00068633555,0.000116103394,0.00004798792,0.00042461514,0.0006886583,0.00094007887],"category_scores_gemma":[0.00014202313,0.00071508175,0.00029394156,0.0005692319,0.00015126298,0.00007173644,0.00031586073,0.002906566,0.0016591792],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002638726,0.0002725758,0.12673004,0.00033568975,0.0015076618,0.030530186,0.0022440203,0.000060975068,0.00047684181,6.276629e-7,0.74813324,0.0870694],"study_design_scores_gemma":[0.006682612,0.0031374346,0.39606228,0.000582701,0.0006002163,0.000082470186,0.000029838406,0.000024727193,0.00009801166,0.000012700664,0.59196806,0.00071895955],"about_ca_topic_score_codex":0.0021401786,"about_ca_topic_score_gemma":0.0009146377,"teacher_disagreement_score":0.37526423,"about_ca_system_score_codex":0.00033729913,"about_ca_system_score_gemma":0.00033711913,"threshold_uncertainty_score":0.9999732},"labels":[],"label_agreement":null},{"id":"W4383197883","doi":"10.1016/j.eururo.2023.06.013","title":"Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement","year":2023,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Western University; University of Toronto; McGill University","funders":"","keywords":"Medicine; Cryoablation; Prostate cancer; Systematic review; Meta-analysis; High-intensity focused ultrasound; Cochrane Library; Ablation; Cancer; Metastasis; Prostate; Internal medicine; Radiation therapy; Surgery; Oncology; MEDLINE; Ultrasound; Radiology","score_opus":0.11052563831627027,"score_gpt":0.41965493070391807,"score_spread":0.3091292923876478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383197883","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050410883,0.987309,0.00017465837,0.0035047128,0.0004727945,0.007216345,0.0008030995,0.00007507829,0.0003939372],"genre_scores_gemma":[0.000012307743,0.9925973,0.0005130061,0.0011961394,0.0005290893,0.0024948104,0.0011689389,0.00017647272,0.0013119666],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964467,0.00065621716,0.0015353528,0.00067746977,0.0002562438,0.00042801502],"domain_scores_gemma":[0.99499166,0.0027398323,0.0012943415,0.0006152571,0.0002361888,0.00012273785],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011068529,0.0005068632,0.0017946545,0.000061646635,0.00013068144,0.000026502945,0.0001706083,0.00014935376,0.000025920132],"category_scores_gemma":[0.00010927274,0.00027619195,0.0009737064,0.00021137939,0.00021218372,0.00004473529,0.000055943157,0.00023061961,0.00008147465],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013507974,0.0017485215,0.00010436578,0.0030324792,0.0043933163,0.00010145064,0.00071290036,0.00002235149,7.4141906e-7,0.000012947346,0.0062508895,0.9822692],"study_design_scores_gemma":[0.0061984826,0.015320216,0.00007598448,0.0011587923,0.0058073965,0.000036203273,0.000046334117,0.000037257094,0.0000010843354,0.000008835985,0.9711133,0.00019610114],"about_ca_topic_score_codex":0.00007825248,"about_ca_topic_score_gemma":0.000011532433,"teacher_disagreement_score":0.9820731,"about_ca_system_score_codex":0.00047058513,"about_ca_system_score_gemma":0.0007708898,"threshold_uncertainty_score":0.999969},"labels":[],"label_agreement":null},{"id":"W4383227312","doi":"10.1016/j.eururo.2023.06.012","title":"Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management: A PIONEER Analysis Based on Big Data","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Horizon 2020 Framework Programme; Innovative Medicines Initiative; Innovative Health Initiative; European Federation of Pharmaceutical Industries and Associations","keywords":"Medicine; Cohort; Prostate cancer; Palliative care; Cancer; Disease; Cohort study; Internal medicine; Emergency medicine","score_opus":0.05490968070854632,"score_gpt":0.30831951856413564,"score_spread":0.25340983785558935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383227312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970029,0.000028342733,0.00015349031,0.0013278032,0.000091006674,0.00048376466,0.0003537331,0.00003940846,0.00051954156],"genre_scores_gemma":[0.9938125,0.0014259777,0.00006338704,0.0019249426,0.000037191385,0.000034856716,0.0025480457,0.000024447478,0.0001286329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988451,0.0001927353,0.0002706335,0.00040933306,0.00013133432,0.0001508584],"domain_scores_gemma":[0.9990498,0.00023135205,0.00017391967,0.00040333945,0.00007301665,0.00006860083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026513363,0.00011465629,0.00028787795,0.00021733706,0.00003704497,0.000007919519,0.0000719124,0.000020646368,0.000017173646],"category_scores_gemma":[0.000058220045,0.00008479555,0.000031793646,0.0005664613,0.0001009159,0.000037357826,0.000101757294,0.00007198408,0.00001327007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096299866,0.00030506693,0.9735999,0.00006664851,0.00092753203,0.00021030607,0.0001406299,0.00010119676,0.000011765457,0.0000143439765,0.00020792776,0.023451656],"study_design_scores_gemma":[0.0041775247,0.0013388318,0.9877799,0.00006307707,0.0011566554,2.231899e-7,0.000017806622,0.002200389,0.000014094784,0.0000017367967,0.0031774703,0.00007229722],"about_ca_topic_score_codex":0.000013084097,"about_ca_topic_score_gemma":0.000037243437,"teacher_disagreement_score":0.023379358,"about_ca_system_score_codex":0.000018076738,"about_ca_system_score_gemma":0.00003765943,"threshold_uncertainty_score":0.3457862},"labels":[],"label_agreement":null},{"id":"W4384344146","doi":"10.1016/j.eururo.2023.06.025","title":"Optimizing Treatment Selection in Advanced Renal Cell Carcinoma via IMDC Risk Group Stratification","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Risk stratification; Renal cell carcinoma; Urology; Selection (genetic algorithm); Oncology; Internal medicine","score_opus":0.021173610162932024,"score_gpt":0.23817588954344082,"score_spread":0.2170022793805088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384344146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8341587,0.0019464646,0.0016621003,0.11419417,0.0014845838,0.0043009217,0.00012986269,0.0009260837,0.041197076],"genre_scores_gemma":[0.94894195,0.00031187257,0.0022319632,0.03446257,0.0031768193,0.00019988316,0.0033964305,0.0004346401,0.0068438626],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958075,0.0012660093,0.00072814873,0.0011845327,0.00030249,0.0007112631],"domain_scores_gemma":[0.9984976,0.00022165473,0.00047695596,0.00060892804,0.00007465566,0.00012017242],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032720342,0.00063372427,0.0007438683,0.00063428597,0.00011052878,0.000026802321,0.0001778587,0.0004383083,0.000092546914],"category_scores_gemma":[0.000035724606,0.0005674941,0.00026447268,0.00039376106,0.00007679736,0.000060988834,0.0000612815,0.0016195328,0.0009879333],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061397436,0.002858036,0.044219915,0.0012025,0.0014791421,0.10784511,0.0050923857,0.009330274,0.1475518,0.000027816217,0.5752782,0.09897508],"study_design_scores_gemma":[0.015253053,0.024204679,0.37305045,0.000108795924,0.002616744,0.0013322561,0.000079313606,0.002852951,0.00924522,0.00009677628,0.5694664,0.001693351],"about_ca_topic_score_codex":0.00027188548,"about_ca_topic_score_gemma":0.00011310816,"teacher_disagreement_score":0.32883054,"about_ca_system_score_codex":0.000835499,"about_ca_system_score_gemma":0.00010118723,"threshold_uncertainty_score":0.9997899},"labels":[],"label_agreement":null},{"id":"W4385256763","doi":"10.1016/j.eururo.2023.06.006","title":"Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"Merck Sharp and Dohme","keywords":"Medicine; Axitinib; Sunitinib; Renal cell carcinoma; Pembrolizumab; Oncology; Internal medicine; Kidney cancer; Urology; Cancer; Immunotherapy","score_opus":0.05018944831186409,"score_gpt":0.30369932539317923,"score_spread":0.2535098770813151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385256763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96795243,0.0005744005,0.0000043068553,0.0004756309,0.00077238056,0.001702434,0.000094938965,0.00010771856,0.028315775],"genre_scores_gemma":[0.99472725,0.0000822882,0.000033398344,0.00007402389,0.00021680832,0.000059031947,0.00017854046,0.000115317176,0.004513361],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99670714,0.00073558924,0.0008252994,0.0006588068,0.00048592073,0.0005872159],"domain_scores_gemma":[0.9973627,0.0004928121,0.00044468103,0.0012807719,0.00019764529,0.00022139748],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030766937,0.00046569892,0.0009150214,0.00026131616,0.00014810459,0.00000739549,0.00035601636,0.00008180149,0.00021614425],"category_scores_gemma":[0.00021371606,0.00032398975,0.0004339028,0.00057333277,0.0002620008,0.000040580475,0.00023312138,0.0002248421,0.00026468319],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50788724,0.057751093,0.09191787,0.0012499519,0.0059947507,0.050584745,0.07281185,0.011468438,0.11677647,0.0005600887,0.007445727,0.07555175],"study_design_scores_gemma":[0.38426057,0.19814038,0.30878848,0.00005970799,0.0038047286,0.0003113974,0.0030729547,0.0004831302,0.07708897,0.00003330283,0.023228759,0.0007276182],"about_ca_topic_score_codex":0.00022689746,"about_ca_topic_score_gemma":0.00013628454,"teacher_disagreement_score":0.2168706,"about_ca_system_score_codex":0.00022096334,"about_ca_system_score_gemma":0.00024055541,"threshold_uncertainty_score":0.9999212},"labels":[],"label_agreement":null},{"id":"W4385336122","doi":"10.1016/j.eururo.2023.07.007","title":"Prostate-specific Membrane Antigen Imaging Remains True to its Name in Primary Staging of Prostate Cancer: The Time To Characterize its Impact on Clinical Outcomes Is Now","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Prostate cancer; Prostate-specific antigen; Prostate; Glutamate carboxypeptidase II; Cancer; Oncology; Gynecology; Internal medicine","score_opus":0.050803671160479666,"score_gpt":0.35969614631802294,"score_spread":0.30889247515754326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385336122","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40909004,0.00068028114,6.488821e-7,0.58319503,0.00054208725,0.0031661605,0.0011728107,0.00012078393,0.002032166],"genre_scores_gemma":[0.06740756,0.009454983,0.000047390044,0.83200544,0.003702509,0.0003643896,0.0019058257,0.0008669456,0.08424496],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9938317,0.0013385762,0.0013163143,0.0013305296,0.0007674437,0.0014154671],"domain_scores_gemma":[0.99709505,0.0008062677,0.00041426162,0.0010858593,0.00027746038,0.00032110102],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020150146,0.0007366487,0.001673166,0.00085092365,0.00011657331,0.00006782,0.0007166394,0.00022934767,0.00063984224],"category_scores_gemma":[0.0002635326,0.00046164065,0.0004334538,0.0007488047,0.00020673143,0.00010803564,0.00053116796,0.0026010629,0.004379871],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00536314,0.0002551038,0.15515159,0.0005297496,0.00078182167,0.010852807,0.0029132757,0.00004428046,0.0064103077,9.405642e-7,0.80571324,0.011983775],"study_design_scores_gemma":[0.0023412711,0.0015064914,0.49977165,0.00037929686,0.00008043259,0.000027235432,0.00001283581,0.000029023337,0.00028963224,0.0000017566983,0.49518827,0.00037212783],"about_ca_topic_score_codex":0.00003492812,"about_ca_topic_score_gemma":0.000005194497,"teacher_disagreement_score":0.34462005,"about_ca_system_score_codex":0.00044691173,"about_ca_system_score_gemma":0.0005280863,"threshold_uncertainty_score":0.9997835},"labels":[],"label_agreement":null},{"id":"W4385857165","doi":"10.1016/j.eururo.2023.08.005","title":"Reply to Xiao Li, Zicheng Xu, and Feng Qi’s Letter to the Editor re: Soumyajit Roy, Yilun Sun, Scott C. Morgan, et al. Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial. Eur Urol 2023;83:571–9","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Traditional medicine","score_opus":0.02342679446478732,"score_gpt":0.3060219935002427,"score_spread":0.2825951990354554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385857165","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4893605,0.0017967386,0.000010160604,0.50001925,0.0011046244,0.0063722744,0.0012541742,0.000047511476,0.000034714434],"genre_scores_gemma":[0.21726216,0.0029410783,0.00006443784,0.76678663,0.0040097465,0.0018146641,0.00072687696,0.00058716885,0.0058072517],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98742664,0.0075455843,0.0013705298,0.0015358479,0.001103881,0.0010174919],"domain_scores_gemma":[0.9944746,0.0026283346,0.0005497411,0.0016882798,0.00036106198,0.00029796307],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005747052,0.0008827462,0.0020742528,0.0013737173,0.00020031267,0.00007128484,0.00080972805,0.00026010073,0.0004209474],"category_scores_gemma":[0.0010818122,0.0005033895,0.0004968952,0.0028466498,0.00037815518,0.000059711434,0.0003478594,0.002324501,0.000079930025],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2204329,0.00018085218,0.0007906473,0.00016829402,0.003255456,0.0009776013,0.0024056626,0.0009429329,0.007984778,1.6387455e-7,0.75875396,0.0041067544],"study_design_scores_gemma":[0.02894492,0.026724294,0.011107595,0.00030578516,0.0010091059,0.000011766704,0.000058542148,0.00011627293,0.0053409906,0.0000016433391,0.9258471,0.00053195696],"about_ca_topic_score_codex":0.0012786011,"about_ca_topic_score_gemma":0.0008851345,"teacher_disagreement_score":0.27209836,"about_ca_system_score_codex":0.00031000611,"about_ca_system_score_gemma":0.0006356979,"threshold_uncertainty_score":0.9999772},"labels":[],"label_agreement":null},{"id":"W4385857188","doi":"10.1016/j.eururo.2023.08.004","title":"Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin–unresponsive High-risk Non–muscle-invasive Bladder Cancer: SWOG S1605","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of British Columbia; University of British Columbia Hospital","funders":"National Cancer Institute, Cairo University; AstraZeneca; Genentech; American College of Radiology Imaging Network; Astellas Pharma; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Atezolizumab; Bladder cancer; Oncology; Internal medicine; Bacillus (shape); Urology; Cancer; Immunotherapy; Pembrolizumab","score_opus":0.024811328048888005,"score_gpt":0.3123821855103267,"score_spread":0.2875708574614387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385857188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98784035,0.00036494932,0.000026595062,0.0015843308,0.001118832,0.0011280897,0.0003591996,0.00013431879,0.0074433303],"genre_scores_gemma":[0.9949433,0.0012895938,0.000047575333,0.0011408867,0.0007308329,0.00009702833,0.000112540096,0.0001087773,0.0015294657],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99686426,0.00083477894,0.000675819,0.00065927295,0.0003212052,0.00064467924],"domain_scores_gemma":[0.99833536,0.00042055015,0.00027091612,0.00061369425,0.00013939683,0.00022006097],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005001667,0.0003513489,0.0007784855,0.00050706166,0.00007931838,0.000009584241,0.00024131795,0.00013530141,0.00060391857],"category_scores_gemma":[0.00049972936,0.00031110624,0.00020537441,0.0007375236,0.00023270078,0.00006245306,0.00016208178,0.00046028473,0.0008044676],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45952168,0.008179943,0.019536378,0.0003754104,0.003664221,0.026155014,0.011358269,0.0012803099,0.035298947,0.00034033624,0.050640296,0.3836492],"study_design_scores_gemma":[0.66367364,0.04140805,0.23090437,0.00013681065,0.0016626713,0.0001364049,0.00043907153,0.00031409806,0.008756852,0.00028886774,0.051381085,0.0008980625],"about_ca_topic_score_codex":0.0014675604,"about_ca_topic_score_gemma":0.00038871745,"teacher_disagreement_score":0.38275114,"about_ca_system_score_codex":0.000121687386,"about_ca_system_score_gemma":0.0004086617,"threshold_uncertainty_score":0.99997354},"labels":[],"label_agreement":null},{"id":"W4386348958","doi":"10.1016/j.eururo.2023.08.011","title":"Reply to Thomas Seisen, Morgan Rouprêt, and Pierre Blanchard’s Letter to the Editor re: Alexandre R. Zlotta, Leslie K. Ballas, Andrzej Niemierko, et al. Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis. Lancet Oncol 2023;24:669–81","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Sinai Health System","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Internal medicine; Cancer","score_opus":0.06849769614712614,"score_gpt":0.31392869894434705,"score_spread":0.2454310027972209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386348958","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033109184,0.001919856,0.0007696273,0.94963783,0.004861761,0.0060938434,0.0028122042,0.00029015195,0.0005055456],"genre_scores_gemma":[0.012795884,0.0014218311,0.00064106425,0.9525188,0.026308589,0.0008626347,0.0016391743,0.0002703588,0.0035416246],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942719,0.0011616438,0.00079286995,0.0020494661,0.0007062481,0.00101789],"domain_scores_gemma":[0.9969154,0.00068672333,0.0003561847,0.001228577,0.0003439394,0.00046915142],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010341782,0.0009809047,0.0019873064,0.000412301,0.0004473433,0.00013941061,0.00051228853,0.00050815975,0.00015583876],"category_scores_gemma":[0.00035416457,0.00067311246,0.0004114948,0.000732906,0.0004637644,0.000100393874,0.00037206282,0.0018018396,0.00008540192],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051935352,0.00013759482,0.003507148,0.00013199833,0.0040187608,0.0014543666,0.0006214383,0.000017898798,0.00035203632,0.0000044028434,0.9836023,0.00095853553],"study_design_scores_gemma":[0.01452046,0.0016961417,0.052286107,0.00010109113,0.0023572755,0.00007923309,0.000027456925,0.000079257836,0.00007717794,0.000004672714,0.9281501,0.0006209845],"about_ca_topic_score_codex":0.0006932567,"about_ca_topic_score_gemma":0.0012448719,"teacher_disagreement_score":0.055452142,"about_ca_system_score_codex":0.00030903122,"about_ca_system_score_gemma":0.0008079194,"threshold_uncertainty_score":0.999572},"labels":[],"label_agreement":null},{"id":"W4386388190","doi":"10.1016/j.eururo.2023.08.010","title":"Corrigendum to “Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study” [Eur. Urol. (2023)]","year":2023,"lang":"en","type":"erratum","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Axitinib; Sunitinib; Pembrolizumab; Renal cell carcinoma; Internal medicine; Oncology; Urology; Cancer; Immunotherapy","score_opus":0.05649958729501037,"score_gpt":0.3012588737262299,"score_spread":0.24475928643121952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386388190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8169277,0.0035278532,0.000012375653,0.00090107665,0.04299882,0.0059535853,0.0011928031,0.00022372372,0.12826209],"genre_scores_gemma":[0.7392147,0.00030115017,0.00003730994,0.00024250208,0.0015384783,0.00019579494,0.0014706563,0.0004562067,0.2565432],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921756,0.0014731493,0.0019720162,0.0018268699,0.0012420925,0.0013103045],"domain_scores_gemma":[0.9937613,0.00050336675,0.0014167662,0.0031206205,0.00060509145,0.00059283833],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0004973519,0.001482248,0.0028112484,0.0007586358,0.00027002927,0.000024244548,0.001111682,0.0004671266,0.0005130402],"category_scores_gemma":[0.00064566033,0.0011107607,0.0011763249,0.00105152,0.00040390398,0.000051651707,0.0007276578,0.0011694889,0.0008203364],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16341257,0.016481372,0.0014776845,0.0011965764,0.0040987455,0.028679403,0.010888699,0.0011829407,0.0030111526,0.00004987906,0.75803447,0.011486485],"study_design_scores_gemma":[0.15057045,0.16797413,0.022978898,0.00021179179,0.0068546017,0.00029001993,0.0009796491,0.0001146571,0.004612113,0.0000107388405,0.6441928,0.0012101276],"about_ca_topic_score_codex":0.00089480274,"about_ca_topic_score_gemma":0.0009522606,"teacher_disagreement_score":0.15149274,"about_ca_system_score_codex":0.00080383505,"about_ca_system_score_gemma":0.0012553018,"threshold_uncertainty_score":0.9999576},"labels":[],"label_agreement":null},{"id":"W4386753453","doi":"10.1016/j.eururo.2023.08.001","title":"Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Maintenance","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Chemotherapy; Hazard ratio; Metastatic Urothelial Carcinoma; Avelumab; Internal medicine; Urology; Maintenance therapy; Confidence interval; Progression-free survival; Surgery; Oncology; Bladder cancer; Urothelial carcinoma; Cancer; Pembrolizumab; Immunotherapy","score_opus":0.014595719975332423,"score_gpt":0.26321057400650966,"score_spread":0.24861485403117722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386753453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97033453,0.00060698885,0.016763132,0.0088469,0.00031472094,0.0010572849,0.0012285807,0.00015378933,0.00069405895],"genre_scores_gemma":[0.99290246,0.00056819915,0.0007776586,0.001626203,0.00036219743,0.00007212501,0.0008577295,0.00010599782,0.0027274361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977811,0.000110705645,0.00068924914,0.0007260874,0.00019924012,0.0004936063],"domain_scores_gemma":[0.9986855,0.00016694883,0.00028908224,0.0004956508,0.00020793425,0.00015492478],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002961504,0.00035325662,0.00076717633,0.00024052055,0.00012324013,0.000015140412,0.00019317713,0.000112998096,0.00023737362],"category_scores_gemma":[0.00019561958,0.0002962484,0.00027855858,0.00052502134,0.00021161021,0.0000804177,0.00008547298,0.00019121543,0.00004885276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067992374,0.004169072,0.46327928,0.0012571409,0.020104062,0.0017083591,0.01959877,0.0030816575,0.04145017,0.0006331939,0.08683124,0.28989467],"study_design_scores_gemma":[0.07181703,0.016003087,0.6875114,0.00020636663,0.0056706704,0.00013117444,0.00047228372,0.049087252,0.011125451,0.0017864095,0.15481958,0.0013693229],"about_ca_topic_score_codex":0.00020795227,"about_ca_topic_score_gemma":0.00055610796,"teacher_disagreement_score":0.28852537,"about_ca_system_score_codex":0.00006496701,"about_ca_system_score_gemma":0.000046621462,"threshold_uncertainty_score":0.999949},"labels":[],"label_agreement":null},{"id":"W4386953928","doi":"10.1016/j.eururo.2023.08.028","title":"Reply to Matthias May, Ingmar Wolff, and Sabine D. Brookman-May’s Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023;83:561–70","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Research Nova Scotia; Dalhousie Medical Research Foundation","keywords":"Medicine; Prostate cancer; Prostate disease; General surgery; Art history; Humanities; Cancer; Internal medicine; Philosophy; Art","score_opus":0.036072852246315124,"score_gpt":0.36365857785878997,"score_spread":0.32758572561247484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386953928","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.083388604,0.0030570051,0.000022193091,0.87684923,0.010850324,0.021307886,0.0019858826,0.0005676336,0.0019712467],"genre_scores_gemma":[0.025959058,0.010123508,0.000117342875,0.92367154,0.014984422,0.014516844,0.0014278138,0.0005453711,0.008654078],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98323,0.008633334,0.0024343617,0.0030603057,0.001069693,0.0015723155],"domain_scores_gemma":[0.99247223,0.003441236,0.0012835731,0.0015031078,0.0005804144,0.0007194441],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0018578263,0.001498861,0.0031563693,0.00035458463,0.00036426383,0.00031345093,0.00059633004,0.0005260164,0.00018220408],"category_scores_gemma":[0.0016118136,0.0009845675,0.0008732505,0.0007450539,0.0010888262,0.00011318195,0.00081718736,0.0028658966,0.00013936443],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16129707,0.0004736583,0.0012506137,0.00012027663,0.0014971953,0.002975738,0.004208912,0.000061177125,0.000005817732,0.0000019761067,0.8136418,0.014465796],"study_design_scores_gemma":[0.109798886,0.008869468,0.0036930083,0.0005585729,0.0012848349,0.00006707054,0.000324539,0.00003352818,0.000004438201,0.0000068753106,0.8745036,0.0008551731],"about_ca_topic_score_codex":0.0038281733,"about_ca_topic_score_gemma":0.0026754267,"teacher_disagreement_score":0.06086183,"about_ca_system_score_codex":0.00045851315,"about_ca_system_score_gemma":0.0002814331,"threshold_uncertainty_score":0.99977607},"labels":[],"label_agreement":null},{"id":"W4386953936","doi":"10.1016/j.eururo.2023.08.027","title":"Reply to André Pontes-Silva’s Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023;83:561–70","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Research Nova Scotia; Dalhousie Medical Research Foundation","keywords":"Medicine; Prostate cancer; Psychological distress; Distress; Empowerment; Gerontology; Psychoanalysis; Cancer; Mental health; Clinical psychology; Psychiatry; Internal medicine; Law","score_opus":0.03871408799005987,"score_gpt":0.3640330411857347,"score_spread":0.32531895319567483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386953936","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057956718,0.0034376516,0.00003740649,0.8903688,0.016408093,0.025748195,0.0030573546,0.0006956665,0.0022900992],"genre_scores_gemma":[0.02623919,0.0062311236,0.00006873418,0.9183603,0.019937292,0.018187951,0.0018829254,0.00053536287,0.008557129],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98074746,0.010468928,0.0025760054,0.0032269233,0.0012218298,0.0017588267],"domain_scores_gemma":[0.9918875,0.003449279,0.0013945913,0.0017534237,0.0007602498,0.00075495464],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0019530857,0.0015655886,0.0033511021,0.00033298857,0.00036996717,0.000299805,0.00075443677,0.0005309979,0.0002173909],"category_scores_gemma":[0.0019003246,0.0010007871,0.0013366181,0.0008272161,0.0008909936,0.0001136617,0.0006632231,0.0030647693,0.00023094211],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20169847,0.0005777495,0.0006914477,0.00006835476,0.0016511494,0.0040643383,0.0038699028,0.000083541105,0.0000067693863,0.0000011124887,0.7723826,0.0149045475],"study_design_scores_gemma":[0.12852255,0.010827888,0.002623586,0.000455054,0.0012322911,0.00005496058,0.00030048902,0.000034332093,0.0000063831862,0.000005485412,0.8550742,0.0008627775],"about_ca_topic_score_codex":0.00340898,"about_ca_topic_score_gemma":0.0028111849,"teacher_disagreement_score":0.082691595,"about_ca_system_score_codex":0.0005621623,"about_ca_system_score_gemma":0.0004021015,"threshold_uncertainty_score":0.99970925},"labels":[],"label_agreement":null},{"id":"W4386953962","doi":"10.1016/j.eururo.2023.08.022","title":"Re: MRI-Detectability of Clinically Significant Prostate Cancer Relates to Oncologic Outcomes After Prostatectomy","year":2023,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; Urology; Prostate; Cancer; Radiology; Internal medicine","score_opus":0.02714945601983092,"score_gpt":0.3289009999605425,"score_spread":0.3017515439407116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386953962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97542185,0.00025348362,0.0000081001035,0.019707981,0.00036346354,0.0016774535,0.0001335271,0.00025581216,0.0021783477],"genre_scores_gemma":[0.9935622,0.0007541408,0.00035350356,0.0036593562,0.00007517773,0.0005630191,0.000028435752,0.000064967775,0.0009391583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972451,0.00040686489,0.00089734164,0.00069361494,0.00021913878,0.00053797284],"domain_scores_gemma":[0.99824595,0.0004837758,0.00022901746,0.0006041106,0.00017583977,0.00026129698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010572344,0.0002676699,0.00066989666,0.00016320993,0.00005051004,0.000010824229,0.00015648658,0.00008232222,0.0003511565],"category_scores_gemma":[0.0005759582,0.0001902831,0.00018864268,0.00047403245,0.00021836701,0.000038509832,0.00022794116,0.00028756054,0.00065189094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019249899,0.00036428557,0.9821172,0.00010217919,0.00018521697,0.00088620145,0.001187744,0.00012288321,0.0010591948,0.0000093917115,0.002827212,0.0092135295],"study_design_scores_gemma":[0.0022539871,0.0043992233,0.9713022,0.000049287373,0.00017641077,0.0000040930677,0.00009123774,0.000020797437,0.0011351584,0.000114446375,0.020266907,0.00018622872],"about_ca_topic_score_codex":0.000051107323,"about_ca_topic_score_gemma":0.000046083413,"teacher_disagreement_score":0.018140411,"about_ca_system_score_codex":0.00011906753,"about_ca_system_score_gemma":0.0001523551,"threshold_uncertainty_score":0.8378957},"labels":[],"label_agreement":null},{"id":"W4386985001","doi":"10.1016/j.eururo.2023.09.008","title":"Reply to Badar M. Mian. Prostate Biopsy: Hyperbole and Misrepresentation Versus Scientific Evidence and Equipoise. Eur Urol. 2024;85:99–100","year":2023,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Misrepresentation; Hyperbole; Clinical equipoise; Prostate biopsy; Prostate; Urology; General surgery; Gynecology; Internal medicine; Randomized controlled trial; Metaphor; Linguistics","score_opus":0.041455384035109864,"score_gpt":0.32366342550404353,"score_spread":0.2822080414689337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386985001","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.053429462,0.013070526,0.000007965868,0.012630616,0.9153869,0.0019882366,0.0005568678,0.00029631547,0.002633117],"genre_scores_gemma":[0.05810056,0.03045057,0.0010888668,0.004157325,0.83299583,0.0008716978,0.0037707519,0.0012475966,0.06731678],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959376,0.00043194368,0.0005477586,0.0017806165,0.0006431599,0.0006589137],"domain_scores_gemma":[0.9966467,0.0013880192,0.00024768317,0.0008610525,0.00035620944,0.0005003615],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010805082,0.00049112353,0.0006526771,0.00040755727,0.0002547664,0.0002473978,0.00022677056,0.00019944731,0.00006528177],"category_scores_gemma":[0.0033488316,0.00045026003,0.00009650396,0.00049166736,0.0004894703,0.00014158196,0.0005298413,0.00060505816,0.0006775985],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020535558,0.000090180416,0.0009968692,0.00024862855,0.00019545565,0.0018159129,0.00063597155,0.0000072248513,0.0006922799,0.0000068118293,0.98761505,0.0056420816],"study_design_scores_gemma":[0.00314232,0.0030991735,0.005461035,0.0003239928,0.0006017985,0.000042464995,0.000063292944,0.000021831811,0.00013601509,0.000023859724,0.98672163,0.00036255646],"about_ca_topic_score_codex":0.00017465514,"about_ca_topic_score_gemma":0.00002385784,"teacher_disagreement_score":0.08239104,"about_ca_system_score_codex":0.00013997364,"about_ca_system_score_gemma":0.00032599623,"threshold_uncertainty_score":0.9997949},"labels":[],"label_agreement":null},{"id":"W4387037694","doi":"10.1016/j.eururo.2023.09.006","title":"Reply to Anju Murayama’s Letter to the Editor re: David-Dan Nguyen, Liam Murad, Anne Xuan-Lan Nguyen, et al. Industry Payments to American Editorial Board Members of Major Urology Journals. Eur Urol. Eur Urol. 2023;84:442–43","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre; Mount Sinai Hospital; Western University; University of Toronto","funders":"","keywords":"Medicine","score_opus":0.1768138967594789,"score_gpt":0.4654481686178264,"score_spread":0.2886342718583475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387037694","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009079035,0.00032519375,0.000028795277,0.8044961,0.17605528,0.002653263,0.0019975174,0.00043318913,0.0049316115],"genre_scores_gemma":[0.006069954,0.000158665,0.000076384254,0.70951945,0.27445608,0.00026956506,0.00042761833,0.0005178564,0.008504459],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97096515,0.016754612,0.003154445,0.0032412377,0.001758515,0.004126015],"domain_scores_gemma":[0.98832566,0.0036891233,0.0017318277,0.002431979,0.0009912128,0.0028302069],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.007859138,0.0020583626,0.0025733272,0.0013698876,0.00085811963,0.00020484388,0.0046182773,0.004136359,0.0027500833],"category_scores_gemma":[0.0037483491,0.0018523122,0.0007123121,0.0023455487,0.0012188455,0.00025915582,0.002405243,0.036510672,0.0056228437],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034604971,0.00035223452,0.001502281,0.00012390061,0.001095514,0.004467476,0.0014290262,0.0012341279,0.0025271433,0.000009431355,0.9811025,0.002695848],"study_design_scores_gemma":[0.002549866,0.0036741756,0.002344245,0.00006362852,0.0009328949,0.00018623263,0.00015383044,0.00005564044,0.00026000125,0.000019504496,0.9881863,0.00157368],"about_ca_topic_score_codex":0.0003896761,"about_ca_topic_score_gemma":0.00014224488,"teacher_disagreement_score":0.098400794,"about_ca_system_score_codex":0.00034200522,"about_ca_system_score_gemma":0.000623457,"threshold_uncertainty_score":0.99921584},"labels":[],"label_agreement":null},{"id":"W4387329471","doi":"10.1016/j.eururo.2023.09.013","title":"SWOG S1605: Moving Beyond Systemic Immune Checkpoint Inhibitor Monotherapy in Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer","year":2023,"lang":"en","type":"editorial","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Bladder cancer; Bacillus (shape); Immune system; Cancer; Oncology; Internal medicine; Immunotherapy; Urology; Immunology; Microbiology","score_opus":0.013740912748887302,"score_gpt":0.2787620343642913,"score_spread":0.26502112161540403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387329471","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0810293,0.011518247,0.000045889814,0.0015770298,0.8940357,0.0027439056,0.0012613217,0.0005114242,0.007277176],"genre_scores_gemma":[0.15110351,0.010267121,0.000089823494,0.0019850594,0.8166347,0.0008008177,0.0012492364,0.001450696,0.016418992],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99301237,0.0012445474,0.0016138136,0.0018014858,0.0009534612,0.0013742999],"domain_scores_gemma":[0.9953758,0.0017189513,0.00072260475,0.0013011561,0.0004891705,0.00039229513],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001097351,0.0012063783,0.0020878033,0.00093189336,0.00017256674,0.00006776257,0.0006457199,0.001079089,0.0004771037],"category_scores_gemma":[0.0015241087,0.0011204303,0.0005793914,0.0006982951,0.00029561043,0.00011486239,0.00041453735,0.0025478827,0.0016034925],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005717252,0.0004459964,0.00068981916,0.00093499594,0.0023486405,0.012625236,0.004834953,0.00022317389,0.024240723,0.0000055455052,0.93909556,0.008838085],"study_design_scores_gemma":[0.030361172,0.0056861443,0.015737751,0.0023327267,0.0019131062,0.000205817,0.0006758803,0.0000827191,0.00243792,0.0000523027,0.93815845,0.0023559825],"about_ca_topic_score_codex":0.002036041,"about_ca_topic_score_gemma":0.0006946166,"teacher_disagreement_score":0.07740096,"about_ca_system_score_codex":0.0010241688,"about_ca_system_score_gemma":0.0018797461,"threshold_uncertainty_score":0.9997533},"labels":[],"label_agreement":null},{"id":"W4387521049","doi":"10.1016/j.eururo.2023.09.019","title":"Reply to Qingpeng Xie and Dianqiu Shen’s Letter to the Editor re: Bhavan P. Rai, José Luis Dominguez Escrig, Luís Vale, et al. Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria. Eur Urol 2022;82:182–92","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Incidence (geometry); Gynecology","score_opus":0.011327997176141568,"score_gpt":0.22288268496382999,"score_spread":0.2115546877876884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387521049","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79773253,0.008370127,0.000049129325,0.17673205,0.002308535,0.013596012,0.0008735472,0.00005352388,0.0002845672],"genre_scores_gemma":[0.38330185,0.0021383055,0.00025132892,0.6077491,0.0040151766,0.0006489395,0.00020232842,0.00048560314,0.0012073339],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9943808,0.0020936718,0.0011461109,0.0010830719,0.0007398398,0.00055654044],"domain_scores_gemma":[0.9954023,0.001461551,0.0011931072,0.0013711705,0.00034914206,0.00022277655],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016284548,0.0006928597,0.0016854759,0.0002434489,0.0001711286,0.00004253463,0.00049778796,0.00017751034,0.000012322214],"category_scores_gemma":[0.001934798,0.0003756774,0.00020784116,0.00028670474,0.00035819883,0.00007021607,0.0004922035,0.0011885342,0.0000071726545],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042493435,0.000026598815,0.033873167,0.03772681,0.00029982039,0.00023330629,0.0021760012,0.0000088961515,0.00014016674,4.150063e-7,0.92506504,0.000024872053],"study_design_scores_gemma":[0.009683061,0.01034075,0.5001317,0.066279136,0.015298527,0.00023083675,0.00027041306,0.000057732297,0.0012181869,0.000010719936,0.39446795,0.0020109233],"about_ca_topic_score_codex":0.0008569412,"about_ca_topic_score_gemma":0.00014759366,"teacher_disagreement_score":0.53059703,"about_ca_system_score_codex":0.0001354379,"about_ca_system_score_gemma":0.0001478161,"threshold_uncertainty_score":0.9998695},"labels":[],"label_agreement":null},{"id":"W4389243136","doi":"10.1016/j.eururo.2023.11.015","title":"Reply to Lin Ding, Bin Yang, and Xudong Yao’s Letter to the Editor re: Fred Saad, Noel W. Clarke, Mototsugu Oya, et al. Olaparib plus Abiraterone Versus Placebo plus Abiraterone in Metastatic Castration-resistant Prostate Cancer (PROpel): Final Prespecified Overall Survival Results of a Randomised, Double-blind, Phase 3 Trial. Lancet Oncol 2023;24:1094–108","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Merck Sharp and Dohme; AstraZeneca","keywords":"Medicine; Abiraterone; Olaparib; Placebo; Internal medicine; Prostate cancer; Cancer; Pathology; Alternative medicine","score_opus":0.1495319722172449,"score_gpt":0.3815436196601418,"score_spread":0.23201164744289687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243136","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16981316,0.0013867029,0.000045218432,0.7907016,0.009778474,0.022680907,0.003644855,0.00017884329,0.0017702013],"genre_scores_gemma":[0.047288045,0.005149893,0.0010588964,0.73803496,0.06541251,0.01377251,0.010598287,0.0017356718,0.116949245],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9895595,0.0033837818,0.002161295,0.0019962979,0.0013543218,0.0015448149],"domain_scores_gemma":[0.9952743,0.0015568235,0.000873097,0.0014759577,0.00041434448,0.00040549558],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004867405,0.0010366748,0.0023071931,0.0008876886,0.00021158047,0.00025252125,0.0007505744,0.0003784931,0.00015358783],"category_scores_gemma":[0.00087936583,0.0007477967,0.00027025217,0.00079552154,0.00035880183,0.00018552478,0.0005172572,0.00317018,0.00020438874],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48549506,0.00015091398,0.000007136099,0.0001840287,0.0004647708,0.0026964236,0.0011056551,0.0004593962,0.0013745584,9.129529e-7,0.50782615,0.00023499805],"study_design_scores_gemma":[0.46499133,0.0053229257,0.00014321135,0.0002590089,0.00035607076,0.000012865539,0.000053133568,0.00013757736,0.00018900083,0.0000019415352,0.52810735,0.00042560953],"about_ca_topic_score_codex":0.0030502575,"about_ca_topic_score_gemma":0.0032899727,"teacher_disagreement_score":0.12252511,"about_ca_system_score_codex":0.0006997667,"about_ca_system_score_gemma":0.0010830614,"threshold_uncertainty_score":0.9994973},"labels":[],"label_agreement":null},{"id":"W4389500584","doi":"10.1016/j.eururo.2023.11.016","title":"Corrigendum to “Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study” [Eur Urol 84(5) (2023) 449–454]","year":2023,"lang":"en","type":"erratum","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Axitinib; Sunitinib; Pembrolizumab; Renal cell carcinoma; Urology; Oncology; Internal medicine; Cancer; Immunotherapy","score_opus":0.055619733899411716,"score_gpt":0.30049936676318856,"score_spread":0.24487963286377684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389500584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84254324,0.0035921829,0.00001425919,0.0008639721,0.0382189,0.00628038,0.0013061253,0.0002381375,0.106942795],"genre_scores_gemma":[0.7600651,0.00031153907,0.00004177559,0.00024992402,0.0016262421,0.0002220493,0.0016166382,0.00050462596,0.23536211],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99141294,0.0016640086,0.0021311082,0.0019916873,0.0013531253,0.001447148],"domain_scores_gemma":[0.9932116,0.00053225213,0.0015355744,0.0033470439,0.0006391681,0.0007343298],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0005473672,0.0016261612,0.0030166933,0.0008323538,0.00030085508,0.000028483824,0.0012254766,0.0005252801,0.00057247916],"category_scores_gemma":[0.0006861724,0.0012307704,0.0012763746,0.0011157489,0.0004212867,0.000060041548,0.0007822365,0.0013129262,0.000908343],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20283948,0.021664837,0.0023647738,0.0016414531,0.005701838,0.041486654,0.0153355505,0.0015079282,0.004807866,0.000073180076,0.68871194,0.013864474],"study_design_scores_gemma":[0.16871047,0.17519745,0.02678338,0.00025514673,0.008062389,0.000372645,0.0012721814,0.00015568202,0.0049966774,0.000013139894,0.6127291,0.0014517475],"about_ca_topic_score_codex":0.0009528381,"about_ca_topic_score_gemma":0.0010440933,"teacher_disagreement_score":0.15353261,"about_ca_system_score_codex":0.0008644741,"about_ca_system_score_gemma":0.0013670236,"threshold_uncertainty_score":0.9998696},"labels":[],"label_agreement":null},{"id":"W4390146929","doi":"10.1016/j.eururo.2023.12.003","title":"Predicting Response in TIME and Space: Neoadjuvant Chemoimmunotherapy in Muscle-invasive Bladder Cancer","year":2023,"lang":"en","type":"editorial","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Chemoimmunotherapy; Bladder cancer; Neoadjuvant therapy; Urology; Complete response; Cancer; Oncology; Internal medicine; Chemotherapy; Immunotherapy; Breast cancer","score_opus":0.01178047399079701,"score_gpt":0.2804734317108769,"score_spread":0.2686929577200799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390146929","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5499887,0.0059202006,0.0000010318117,0.0028751553,0.43634284,0.001203279,0.00044624816,0.00027213147,0.0029504457],"genre_scores_gemma":[0.097774625,0.020199878,0.000095524476,0.002569587,0.8494785,0.00036337637,0.00089150737,0.0013653093,0.027261697],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99666643,0.00090295915,0.00054283213,0.0008504216,0.00041244033,0.00062489265],"domain_scores_gemma":[0.99744076,0.0016848703,0.00019341259,0.00046362204,0.00008205284,0.00013527354],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011071922,0.00046680038,0.0008437182,0.0005004055,0.000049365764,0.00002913604,0.0002299187,0.0004987741,0.0002484255],"category_scores_gemma":[0.0014640803,0.00043798704,0.00009390887,0.00033635387,0.00016190736,0.000047688543,0.0001829136,0.0013233228,0.00029626614],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024032569,0.00040955824,0.01733269,0.00020177415,0.0006516771,0.009903585,0.005173782,0.00006921928,0.0057168,0.0000010994934,0.92908204,0.0074252053],"study_design_scores_gemma":[0.014788592,0.0027942788,0.23008175,0.00063650834,0.00027278365,0.00003180626,0.00006894117,0.00007229547,0.0000831429,0.000016123546,0.7505925,0.0005612359],"about_ca_topic_score_codex":0.0010158776,"about_ca_topic_score_gemma":0.0005949415,"teacher_disagreement_score":0.45221406,"about_ca_system_score_codex":0.00026311545,"about_ca_system_score_gemma":0.00065989094,"threshold_uncertainty_score":0.9998072},"labels":[],"label_agreement":null},{"id":"W4390599664","doi":"10.1016/j.eururo.2023.12.005","title":"Update and Summary of the European Association of Urology/European Society of Paediatric Urology Paediatric Guidelines on Vesicoureteral Reflux in Children","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Pediatric Urology and Nephrology Studies","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; London Health Sciences Centre","funders":"","keywords":"Medicine; Vesicoureteral reflux; Pediatric urology; Urology; General surgery; Reflux; Internal medicine; Disease","score_opus":0.012884728527819016,"score_gpt":0.2514924823036388,"score_spread":0.23860775377581978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390599664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9599173,0.01939479,0.000027526923,0.011499199,0.0006150888,0.0003840987,0.00008113333,0.00008830008,0.007992541],"genre_scores_gemma":[0.985034,0.0070141195,0.00015326514,0.006487672,0.0009782076,0.0000035859728,0.000042506468,0.000082829865,0.00020381178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934683,0.003714034,0.0012918266,0.0006977801,0.0002784745,0.00054962287],"domain_scores_gemma":[0.99773264,0.0007583837,0.0006721429,0.0005548388,0.00019665218,0.00008533448],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00429868,0.00037414007,0.0007898108,0.00047014613,0.000090689755,0.0000055117184,0.00042519538,0.00025465037,0.000026596259],"category_scores_gemma":[0.00089511485,0.00028403767,0.00035871897,0.000745845,0.0006653463,0.00006443458,0.0005907205,0.001058797,0.000050274914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007411998,0.0003496077,0.93025655,0.00012756852,0.0014805364,0.00017960324,0.0009283389,0.00017279375,0.0022858658,0.0004773005,0.05040176,0.012598856],"study_design_scores_gemma":[0.0020826096,0.0016133143,0.9811292,0.000008517432,0.0011876493,0.00015447095,0.000012842653,0.00014928814,0.000045035955,0.00027112715,0.013160087,0.00018583446],"about_ca_topic_score_codex":0.000011186327,"about_ca_topic_score_gemma":0.000006087337,"teacher_disagreement_score":0.050872654,"about_ca_system_score_codex":0.000035155048,"about_ca_system_score_gemma":0.000098897726,"threshold_uncertainty_score":0.9999612},"labels":[],"label_agreement":null},{"id":"W4390640719","doi":"10.1016/j.eururo.2023.12.004","title":"Safety Analyses of the Phase 3 VISION Trial of [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Medical Research Council; Advanced Accelerator Applications; Novartis; Endocyte; Genentech; Novartis Pharmaceuticals Corporation; Pfizer; Amgen","keywords":"Medicine; Prostate cancer; Oncology; Castration; Internal medicine; Prostate; Urology; Cancer; Hormone","score_opus":0.042122753653104035,"score_gpt":0.38826281951437036,"score_spread":0.34614006586126633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390640719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955982,0.0010520595,0.000010414274,0.0008375597,0.00015795867,0.00094027125,0.0001389021,0.0000118652715,0.0012527856],"genre_scores_gemma":[0.9992052,0.00013472425,0.00003990566,0.0000484371,0.000035791712,0.000014677623,0.000057031004,0.000022653277,0.00044159841],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9985325,0.00038412825,0.00038894074,0.00022731848,0.00028241536,0.0001847045],"domain_scores_gemma":[0.9994009,0.00009581029,0.00010853506,0.00023694361,0.00011021113,0.000047583846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033182622,0.000116407005,0.00028529594,0.00015598061,0.000032262113,0.000008467561,0.00008946415,0.000017582604,0.000090481444],"category_scores_gemma":[0.000057392197,0.000059418267,0.00007089278,0.00041077656,0.000202177,0.000050400922,0.000043861557,0.00016830732,0.000004986618],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7750349,0.0060447175,0.060809307,0.0013610205,0.0024005524,0.0011031481,0.0057706186,0.0013409855,0.066947214,0.00028148104,0.0014323912,0.07747366],"study_design_scores_gemma":[0.34062526,0.03465327,0.59780645,0.000793002,0.0017473708,0.000011887648,0.00024533513,0.00095774373,0.0146679245,0.00008301961,0.008069358,0.00033935983],"about_ca_topic_score_codex":0.000120549164,"about_ca_topic_score_gemma":0.00007476869,"teacher_disagreement_score":0.5369972,"about_ca_system_score_codex":0.00005265695,"about_ca_system_score_gemma":0.0002557425,"threshold_uncertainty_score":0.24230066},"labels":[],"label_agreement":null},{"id":"W4391326643","doi":"10.1016/j.eururo.2024.01.006","title":"Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Dalhousie University; University of Alberta; Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; University of Calgary","funders":"National Health and Medical Research Council; Yasuda Memorial Medical Foundation; McMaster University","keywords":"Medicine; Renal cell carcinoma; Oncology; Carcinoma; Brain metastasis; Internal medicine; Metastasis; Cancer","score_opus":0.023300641839294298,"score_gpt":0.2478771951260575,"score_spread":0.22457655328676318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391326643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974428,0.0024684668,0.00078739587,0.007263302,0.00046285527,0.0005105838,0.012621715,0.000063699,0.0013939965],"genre_scores_gemma":[0.98700786,0.00004126683,0.00335322,0.002302458,0.00022938258,0.000014035187,0.006483826,0.00008710279,0.00048086123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966619,0.0008763731,0.0007971972,0.0007966115,0.0005086496,0.00035925923],"domain_scores_gemma":[0.9952357,0.0032441458,0.00032738832,0.0008970503,0.00014158936,0.0001541202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077201985,0.00040646546,0.00059044885,0.00015133934,0.00010955573,0.000055761317,0.0004056488,0.00003745624,0.00076488475],"category_scores_gemma":[0.00038969875,0.00023534929,0.00020909862,0.00019093005,0.00025287428,0.0001163871,0.00024267423,0.0003906132,0.00010390783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014760859,0.0044424916,0.8539563,0.0002460642,0.0069216364,0.00931441,0.010359897,0.00058395957,0.006244859,0.00028834725,0.08155276,0.011328406],"study_design_scores_gemma":[0.013917215,0.0024486936,0.91053134,0.00008629363,0.0022881888,0.000024133762,0.00031652246,0.0005146918,0.0034871597,0.000070337395,0.06594373,0.00037171083],"about_ca_topic_score_codex":0.0010529648,"about_ca_topic_score_gemma":0.00025330944,"teacher_disagreement_score":0.05657501,"about_ca_system_score_codex":0.00005028969,"about_ca_system_score_gemma":0.00012177463,"threshold_uncertainty_score":0.9597266},"labels":[],"label_agreement":null},{"id":"W4392170991","doi":"10.1016/j.eururo.2024.02.009","title":"International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer: Main Conclusions and Recommendations","year":2024,"lang":"en","type":"editorial","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Grading (engineering); Consensus conference; Bladder cancer; Pathology; Gynecology; General surgery; Oncology; Internal medicine; Cancer","score_opus":0.03483546923461492,"score_gpt":0.35888786346175716,"score_spread":0.32405239422714227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392170991","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068954523,0.012235251,0.00003523936,0.08767236,0.8482669,0.001048374,0.00525886,0.00015368391,0.038433906],"genre_scores_gemma":[0.16877323,0.14585283,0.0011324985,0.0056766137,0.66396296,0.00028093116,0.0046124132,0.000341432,0.009367101],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99791944,0.0004086381,0.00049831736,0.0006511827,0.00024704315,0.00027537983],"domain_scores_gemma":[0.998817,0.00051469577,0.00016428014,0.00024826534,0.0001558488,0.000099864],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003503839,0.00030704064,0.0006107494,0.00016410241,0.000047877737,0.00001551881,0.00017658307,0.00034218375,0.0005929906],"category_scores_gemma":[0.000246616,0.00025492578,0.00013436688,0.00009761868,0.00041629502,0.00001289057,0.00029712828,0.0012995029,0.00006371708],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037660738,0.00025281034,0.0003754071,0.00007054619,0.00021580167,0.00030558274,0.00060327345,0.0000025914424,0.00013949563,0.00041615422,0.98953736,0.0077043767],"study_design_scores_gemma":[0.0019940247,0.0010991083,0.0009842984,0.00015793444,0.00027003902,0.00004877934,0.000057975732,0.00009306182,0.00000937738,0.00035580585,0.99476224,0.00016734086],"about_ca_topic_score_codex":0.000070353635,"about_ca_topic_score_gemma":0.00003703266,"teacher_disagreement_score":0.18430392,"about_ca_system_score_codex":0.0001072494,"about_ca_system_score_gemma":0.00038401896,"threshold_uncertainty_score":0.9999903},"labels":[],"label_agreement":null},{"id":"W4392691906","doi":"10.1016/j.eururo.2024.01.003","title":"Effect of Prior Prostate Directed Local Therapy on Response to Apalutamide in Metastatic Hormone Sensitive Prostate Cancer: A Secondary Analysis of the TITAN Study","year":2024,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Ottawa; University of Toronto; University Health Network; Ottawa Hospital; Centre Hospitalier de l’Université de Montréal","funders":"Prostate Cancer Foundation","keywords":"Medicine; Prostate cancer; Prostate; Oncology; Internal medicine; Urology; Cancer","score_opus":0.014299875810108546,"score_gpt":0.3156597686273024,"score_spread":0.30135989281719383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392691906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9094599,0.0021270395,0.0000013677679,0.08227663,0.00016772053,0.004830398,0.00068597554,0.000054676842,0.00039630654],"genre_scores_gemma":[0.9627558,0.0003604103,0.000007574246,0.03156808,0.00011798369,0.0002518592,0.0001836954,0.00015059905,0.004603991],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99095106,0.0063227215,0.0007184044,0.0008383435,0.00061423605,0.00055521895],"domain_scores_gemma":[0.99743813,0.0011964763,0.00027808355,0.0008032933,0.00019137475,0.00009265023],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022531927,0.00050051016,0.0016171726,0.0015781792,0.00004885664,0.00001546351,0.00026893863,0.00012164505,0.000043700777],"category_scores_gemma":[0.00023028997,0.00028404166,0.00037324763,0.0023219942,0.00038188804,0.000022155657,0.000206252,0.001818484,0.00003643841],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4774885,0.0023511434,0.021789487,0.002203901,0.057097524,0.065867916,0.06381124,0.0014523038,0.033579346,0.0000017842377,0.14957465,0.12478222],"study_design_scores_gemma":[0.02497847,0.09487355,0.7818811,0.00080533285,0.016171414,0.00008040872,0.00045550676,0.00084268907,0.01138521,0.000010684261,0.06757385,0.00094180054],"about_ca_topic_score_codex":0.0003282834,"about_ca_topic_score_gemma":0.0001450686,"teacher_disagreement_score":0.7600916,"about_ca_system_score_codex":0.00032029656,"about_ca_system_score_gemma":0.00039707718,"threshold_uncertainty_score":0.9999612},"labels":[],"label_agreement":null},{"id":"W4392718644","doi":"10.1016/j.eururo.2024.01.007","title":"Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301: A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Astellas Pharma; Astellas Pharma US; Seagen; Pfizer","keywords":"Medicine; Discontinuation; Chemotherapy; Quality of life (healthcare); Internal medicine; Confidence interval; Chemotherapy regimen; Surgery","score_opus":0.027733290074382112,"score_gpt":0.31330524712796365,"score_spread":0.2855719570535815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392718644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939723,0.0013093702,0.000020197846,0.00037723748,0.0004379988,0.0015683192,0.00022715697,0.00007700731,0.0020104232],"genre_scores_gemma":[0.99902606,0.00006561576,0.00007273646,0.00029090853,0.00010745575,0.000021565667,0.00024897617,0.0000784172,0.000088284854],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972325,0.0006327386,0.001055286,0.0004735697,0.0002760665,0.00032983726],"domain_scores_gemma":[0.99881583,0.0001845351,0.00033328397,0.00041687078,0.0000796308,0.00016984089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034777008,0.00026426365,0.00094791595,0.00017663004,0.000023354005,0.000005647713,0.00012633874,0.000080564445,0.00023789171],"category_scores_gemma":[0.00013209892,0.00020718414,0.00013889643,0.00030448707,0.00014302396,0.00005642563,0.000022140248,0.00025166525,0.000024365012],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84681773,0.0034104588,0.090954594,0.00020774464,0.00083974627,0.00010976693,0.002912055,0.000016975282,0.00070718315,0.000050415867,0.00017563399,0.053797707],"study_design_scores_gemma":[0.5844399,0.041152958,0.37210003,0.00013398904,0.00022753538,0.0000023846724,0.000032699234,0.000045374967,0.0005621186,0.000022715767,0.0010582338,0.00022205691],"about_ca_topic_score_codex":0.0017157848,"about_ca_topic_score_gemma":0.00009549755,"teacher_disagreement_score":0.28114542,"about_ca_system_score_codex":0.000103424965,"about_ca_system_score_gemma":0.0004887959,"threshold_uncertainty_score":0.8448724},"labels":[],"label_agreement":null},{"id":"W4392859762","doi":"10.1016/j.eururo.2024.01.019","title":"Prostate-specific Membrane Antigen Positron Emission Tomography–detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer: An International Multicenter Retrospective Study","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Hazard ratio; Positron emission tomography; Glutamate carboxypeptidase II; Prostate-specific antigen; Proportional hazards model; Oncology; Internal medicine; Confidence interval; Biochemical recurrence; Urology; Cancer; Radiology; Prostatectomy","score_opus":0.010660183176227822,"score_gpt":0.2671901839905229,"score_spread":0.2565300008142951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392859762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959485,0.0008734466,0.000012877983,0.0002534686,0.0002843668,0.0017485538,0.0007342257,0.00006827136,0.00007628335],"genre_scores_gemma":[0.9980985,0.00092177035,0.00010265482,0.000018680297,0.000076208744,0.000045915516,0.00046453395,0.00005918699,0.00021253782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777925,0.0004452707,0.00034559163,0.0006421144,0.0004902732,0.00029752537],"domain_scores_gemma":[0.9990068,0.00004444073,0.00012864452,0.00027932946,0.00028784867,0.00025295207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027140646,0.00024343187,0.00029624256,0.00025659986,0.000102575104,0.00006631598,0.000105882646,0.000023419718,0.00008995179],"category_scores_gemma":[0.000028546654,0.00016565574,0.000051988805,0.00020592539,0.00017596716,0.0002023731,0.000075714386,0.00026402847,0.0000044843596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018300483,0.0013448312,0.96632385,0.000106867454,0.00061582995,0.0007091632,0.0021279424,0.00004109136,0.008213271,0.000015910478,0.000026182228,0.0021745483],"study_design_scores_gemma":[0.0067614554,0.005094543,0.9865469,0.000087875975,0.0002686522,0.000002123168,0.00013541181,0.00027984017,0.00043254392,0.000011833337,0.00022744559,0.0001514237],"about_ca_topic_score_codex":0.00016005164,"about_ca_topic_score_gemma":0.00005343526,"teacher_disagreement_score":0.020222973,"about_ca_system_score_codex":0.00010235107,"about_ca_system_score_gemma":0.000088495566,"threshold_uncertainty_score":0.6755245},"labels":[],"label_agreement":null},{"id":"W4393037303","doi":"10.1016/j.eururo.2024.02.001","title":"The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus Recommendations","year":2024,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Janssen Pharmaceuticals; Imperial Experimental Cancer Medicine Centre; Imperial Health Charity; NIHR Imperial Biomedical Research Centre; National Institutes of Health; National Institute for Health and Care Research","keywords":"Medicine; Magnetic resonance imaging; Prostate cancer; MEDLINE; Radiology; Medical physics; Prostate; Cancer; Internal medicine","score_opus":0.04500721692475358,"score_gpt":0.3519758039218462,"score_spread":0.3069685869970926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393037303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000018666943,0.94826716,0.000035195295,0.04237655,0.00032244792,0.008341516,0.00035535055,0.00004664035,0.00025329477],"genre_scores_gemma":[0.000055872544,0.9907119,0.00040866292,0.0018204144,0.00011972327,0.0053881747,0.00076667604,0.0000935502,0.0006349844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99739134,0.000874186,0.0007951566,0.0005269097,0.00015264668,0.00025973862],"domain_scores_gemma":[0.9984238,0.0006225613,0.00027970006,0.00037528726,0.00021943083,0.000079176665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012844932,0.00036567307,0.0010443451,0.000115765804,0.00014792987,0.00009434692,0.00012829952,0.000039424198,0.00007073449],"category_scores_gemma":[0.00014620803,0.00019321215,0.00019751798,0.00015549519,0.00013024494,0.000030536845,0.00003496518,0.00026775,0.000039529183],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013296693,0.000092327566,0.000025001775,0.13531432,0.00057968305,0.00007230741,0.00016358493,8.4684714e-8,3.7404924e-8,0.00006191201,0.015939627,0.84761816],"study_design_scores_gemma":[0.001101857,0.00054661883,0.000028161776,0.09263435,0.010566512,0.0006693022,0.000011962944,0.00009182896,4.5549243e-8,0.000059843773,0.8941191,0.00017043485],"about_ca_topic_score_codex":0.0000020751797,"about_ca_topic_score_gemma":0.000009209981,"teacher_disagreement_score":0.87817943,"about_ca_system_score_codex":0.00012836116,"about_ca_system_score_gemma":0.00020737988,"threshold_uncertainty_score":0.7878963},"labels":[],"label_agreement":null},{"id":"W4393165785","doi":"10.1016/j.eururo.2024.03.016","title":"Reply to Yudai Ishiyama and Fumihiko Urabe’s Letter to the Editor re: Kosuke Takemura, Audreylie Lemelin, Matthew S. Ernst, et al. Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.01.006","year":2024,"lang":"en","type":"letter","venue":"European Urology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Psychoanalysis; Oncology; Pathology","score_opus":0.023271565648440653,"score_gpt":0.24400032606134103,"score_spread":0.22072876041290038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393165785","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15707034,0.0027643135,0.00015330165,0.8093295,0.0021283927,0.00267443,0.023522627,0.000095739,0.002261372],"genre_scores_gemma":[0.11448168,0.00010796838,0.002250283,0.84699583,0.007314354,0.00021667285,0.015318623,0.0004804935,0.012834078],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98983663,0.0031903074,0.002162736,0.0023909595,0.0014442632,0.0009750832],"domain_scores_gemma":[0.9902641,0.00546922,0.001101818,0.0025003888,0.00034969772,0.00031477696],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0024477504,0.0013175955,0.0016955801,0.0004508366,0.00018593014,0.0002375196,0.0013626778,0.00020175354,0.002654172],"category_scores_gemma":[0.0014385753,0.00077687367,0.0003925416,0.00040613028,0.00039457026,0.00019139808,0.0011475309,0.0032731092,0.0009186338],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032216003,0.00041699872,0.0066871513,0.00011374544,0.0012219229,0.0032565058,0.001891981,0.00013759213,0.00012139253,0.000001889886,0.98254037,0.00038887872],"study_design_scores_gemma":[0.007135609,0.0018416179,0.049073085,0.00022555175,0.0017456188,0.000016059017,0.00011158115,0.000058281847,0.00023910686,0.000011887827,0.9388996,0.0006420422],"about_ca_topic_score_codex":0.0031885027,"about_ca_topic_score_gemma":0.00052743073,"teacher_disagreement_score":0.043640785,"about_ca_system_score_codex":0.00013957599,"about_ca_system_score_gemma":0.0002166749,"threshold_uncertainty_score":0.99995756},"labels":[],"label_agreement":null},{"id":"W4393203777","doi":"10.1016/j.eururo.2024.02.022","title":"Re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3–7","year":2024,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Gynecology; Cancer; Prostate; General surgery; Internal medicine","score_opus":0.051854780727103145,"score_gpt":0.33072354745379556,"score_spread":0.2788687667266924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393203777","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027570676,0.095291734,0.00015286442,0.88770026,0.002367665,0.007687439,0.00082482793,0.00022294691,0.0029952207],"genre_scores_gemma":[0.2219268,0.015230355,0.00008674983,0.6439711,0.011767119,0.003885691,0.0012394354,0.0012449279,0.100647874],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957358,0.0008572539,0.0005792303,0.0012530639,0.00032963313,0.0012449897],"domain_scores_gemma":[0.9974087,0.0007533206,0.00022475648,0.0012691665,0.00020326977,0.00014082347],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014480462,0.0006876044,0.00074779027,0.00022371438,0.0006916061,0.00018824234,0.0006527492,0.00036858695,0.0001829143],"category_scores_gemma":[0.00008020177,0.00036555462,0.00044129128,0.0002333234,0.00056312565,0.00008505143,0.00022122706,0.0025033972,0.000118024065],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012562586,0.00009337355,0.00006712912,0.0019239736,0.0015145985,0.02255523,0.002683792,0.000060061422,0.00010058183,0.000077412325,0.9451598,0.024507808],"study_design_scores_gemma":[0.0023768798,0.0028970314,0.00006395254,0.00018738878,0.0014953513,0.0059757666,0.00026755058,0.0013262128,0.000022939501,0.00027887453,0.98471117,0.0003969111],"about_ca_topic_score_codex":0.000091620626,"about_ca_topic_score_gemma":0.000094563016,"teacher_disagreement_score":0.24372917,"about_ca_system_score_codex":0.00018261983,"about_ca_system_score_gemma":0.00031409378,"threshold_uncertainty_score":0.99987966},"labels":[],"label_agreement":null},{"id":"W4393334202","doi":"10.1016/j.eururo.2024.03.014","title":"PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Sinai Health System; University of Toronto","funders":"CRIS Cancer Foundation; Prostate Cancer UK; EAU Research Foundation; National Institute for Health and Care Research; Prostate Cancer Foundation","keywords":"Medicine; Prostate cancer; Prostate; Magnetic resonance imaging; Medical physics; Radiology; Cancer; Gynecology; Urology; Internal medicine","score_opus":0.018777411707735513,"score_gpt":0.30306718629917,"score_spread":0.2842897745914345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393334202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96246326,0.0061875028,0.000054772412,0.020465719,0.0014233489,0.005409866,0.0017585845,0.00020227666,0.002034676],"genre_scores_gemma":[0.9950463,0.0007022853,0.0003647485,0.0009483351,0.00010269918,0.00077714055,0.0011086296,0.00008122158,0.00086861703],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99823266,0.000114731585,0.0005918334,0.00059179554,0.00009321351,0.00037575306],"domain_scores_gemma":[0.9990816,0.00021673384,0.00025221182,0.00021125836,0.00016693198,0.000071250055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046407696,0.00018228815,0.00025930782,0.00014881906,0.000087534274,0.000028669332,0.000057968355,0.000025991783,0.00004764502],"category_scores_gemma":[0.00034271658,0.00015921344,0.000077085766,0.00018535773,0.000041423464,0.000084342224,0.00004080863,0.00014151355,0.000022668073],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041492083,0.00036084923,0.24200578,0.00013498217,0.00003669649,0.00013838269,0.0010126836,0.00006086823,0.00021794945,0.000053455737,0.038582638,0.7132465],"study_design_scores_gemma":[0.004755168,0.0023333295,0.5035289,0.0003195684,0.000059825496,0.0000056765125,0.000027972097,0.0012812938,0.00068229745,0.00008825209,0.48674002,0.0001776873],"about_ca_topic_score_codex":0.000025604326,"about_ca_topic_score_gemma":0.00003157568,"teacher_disagreement_score":0.71306884,"about_ca_system_score_codex":0.00025649162,"about_ca_system_score_gemma":0.00009465135,"threshold_uncertainty_score":0.64925355},"labels":[],"label_agreement":null},{"id":"W4393852079","doi":"10.1016/j.eururo.2024.03.018","title":"Prostate Radiotherapy in Low-volume Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysis","year":2024,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Ottawa; Ottawa Hospital; Ottawa Regional Cancer Foundation; Mount Sinai Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Docetaxel; Oncology; Prostate cancer; Androgen deprivation therapy; Internal medicine; Meta-analysis; Enzalutamide; Randomized controlled trial; Cancer; Androgen receptor","score_opus":0.07204924911653174,"score_gpt":0.35325709562139845,"score_spread":0.28120784650486674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393852079","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004033642,0.9924302,0.000028720888,0.0014829764,0.00032660985,0.0037844172,0.00085343095,0.00014999259,0.00090331637],"genre_scores_gemma":[0.00037740188,0.9902954,0.00033305818,0.0016112622,0.00037732968,0.001633667,0.00088106014,0.00035507066,0.004135753],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931836,0.0021633452,0.0016055468,0.0016733739,0.00035275368,0.0010213658],"domain_scores_gemma":[0.99764055,0.0002654444,0.00069075084,0.000969592,0.0001212006,0.0003124495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010209748,0.0011892146,0.00839699,0.00093637506,0.000074500516,0.0000890336,0.00025721465,0.00015263964,0.000297891],"category_scores_gemma":[0.000040696592,0.0007841341,0.0037771894,0.0024734547,0.0002157825,0.00006887221,0.00017408266,0.0010886992,0.0006067467],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004062795,0.0005111429,0.00009294164,0.008575634,0.6661702,0.02121808,0.0010285779,0.0012327462,5.42645e-7,0.000093700924,0.01644463,0.28422555],"study_design_scores_gemma":[0.00059163803,0.00066456496,0.0001071646,0.00043409521,0.4238926,0.00010608128,0.000006472781,0.000103196704,1.4456737e-7,0.000015141992,0.5737105,0.00036844288],"about_ca_topic_score_codex":0.0001593011,"about_ca_topic_score_gemma":0.0001303796,"teacher_disagreement_score":0.5572659,"about_ca_system_score_codex":0.0005597831,"about_ca_system_score_gemma":0.000537703,"threshold_uncertainty_score":0.99946094},"labels":[],"label_agreement":null},{"id":"W4393952355","doi":"10.1016/j.eururo.2024.03.023","title":"Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration: Results from the PROOF302 Phase 3 Trial","year":2024,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Urothelial cancer; Placebo; Oncology; Cancer; Internal medicine; Urothelial carcinoma; Bladder cancer; Urology; Surgery; Pathology","score_opus":0.03506205683462299,"score_gpt":0.3012544102331573,"score_spread":0.2661923533985343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393952355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7562061,0.0008438091,0.00012125213,0.18285888,0.011979384,0.014536262,0.029611044,0.00051645935,0.0033267897],"genre_scores_gemma":[0.4362138,0.0002653272,0.0011617328,0.36087006,0.13072437,0.0028617687,0.0592345,0.0015245358,0.0071439096],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99596924,0.000987526,0.00074114976,0.0012602605,0.0004405387,0.0006013079],"domain_scores_gemma":[0.99741906,0.0007743174,0.0004404251,0.0010071546,0.00022479698,0.00013424421],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003400003,0.000627446,0.00068088336,0.00013955533,0.000294899,0.00015015967,0.00040618412,0.00036173707,0.00021999869],"category_scores_gemma":[0.0003126888,0.00040027432,0.00018318,0.00015689335,0.00017757452,0.00008976085,0.000107228465,0.0018264723,0.00015033635],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52336407,0.00033133387,0.00018677082,0.000043009957,0.0015063065,0.00038882322,0.0011876543,0.00003062824,0.00004453786,0.00000397643,0.4675796,0.0053332844],"study_design_scores_gemma":[0.30546534,0.02284104,0.0013744202,0.00007519406,0.0025535221,0.0000052522737,0.000008934585,0.000083531995,0.00004593926,0.000023281362,0.6671363,0.0003872016],"about_ca_topic_score_codex":0.0011866589,"about_ca_topic_score_gemma":0.0004924208,"teacher_disagreement_score":0.3199923,"about_ca_system_score_codex":0.00017828411,"about_ca_system_score_gemma":0.00049684104,"threshold_uncertainty_score":0.9998449},"labels":[],"label_agreement":null},{"id":"W4394008906","doi":"10.1016/j.eururo.2024.03.015","title":"Characterization of Responses to Lenvatinib plus Pembrolizumab in Patients with Advanced Renal Cell Carcinoma at the Final Prespecified Survival Analysis of the Phase 3 CLEAR Study","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta; McMaster University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Western University","funders":"National Cancer Institute; Genentech; European Society for Medical Oncology; Astellas Pharma; National Comprehensive Cancer Network; Eisai; Ipsen; BeiGene; Daiichi Sankyo Europe; Exelixis; Memorial Sloan-Kettering Cancer Center; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Lenvatinib; Internal medicine; Confidence interval; Renal cell carcinoma; Pembrolizumab; Sunitinib; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Oncology; Phases of clinical research; Urology; Clinical trial; Cancer; Immunotherapy","score_opus":0.027795215099658516,"score_gpt":0.27027845396427147,"score_spread":0.24248323886461295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394008906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727255,0.00006159915,0.000018244753,0.00021819028,0.00009143006,0.0010357728,0.000080756065,0.000014558499,0.0012069248],"genre_scores_gemma":[0.99870485,0.0000022296474,0.000012460257,0.00008090581,0.000028812445,0.000014881919,0.000088497,0.00003455267,0.0010328218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753416,0.0011028412,0.0004479897,0.00037196447,0.000352451,0.00019061209],"domain_scores_gemma":[0.9988622,0.00020633258,0.0001652835,0.0006072607,0.00010608054,0.000052835258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037835975,0.00016985984,0.00040799967,0.00032568045,0.000046035166,0.0000079444635,0.0001898873,0.000024776327,0.000097555225],"category_scores_gemma":[0.00007432514,0.00009233255,0.000112073314,0.00094257336,0.00010255413,0.000032040425,0.00016641285,0.0001636837,0.000014468527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09602898,0.0020661636,0.8043084,0.00007204642,0.00077838165,0.00039160688,0.008111486,0.001232719,0.08436186,0.00001863519,0.000053231488,0.0025764666],"study_design_scores_gemma":[0.006479266,0.00828894,0.97833186,0.00001363489,0.00094261556,0.0000033754302,0.00008581274,0.00014925477,0.005132871,2.5001523e-7,0.00049891334,0.000073188094],"about_ca_topic_score_codex":0.000023968405,"about_ca_topic_score_gemma":0.00006243274,"teacher_disagreement_score":0.17402346,"about_ca_system_score_codex":0.00009939519,"about_ca_system_score_gemma":0.000081481514,"threshold_uncertainty_score":0.3765212},"labels":[],"label_agreement":null},{"id":"W4394595366","doi":"10.1016/j.eururo.2024.03.029","title":"Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer","year":2024,"lang":"en","type":"editorial","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Pembrolizumab; Urothelial cancer; Oncology; Internal medicine; Bladder cancer; Urology; Gynecology; Cancer; Immunotherapy","score_opus":0.01013489064885537,"score_gpt":0.2911570393851965,"score_spread":0.2810221487363411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394595366","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013507267,0.022278283,0.0000053701456,0.002037496,0.8617376,0.0015114042,0.0011359651,0.00045943173,0.09732719],"genre_scores_gemma":[0.16257869,0.009558952,0.00008528161,0.0015718273,0.7973751,0.00022965403,0.0010889673,0.00069866143,0.026812896],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969642,0.00031418208,0.0005867581,0.00108932,0.00041050094,0.0006350371],"domain_scores_gemma":[0.9987555,0.0002465853,0.00014938577,0.00051616965,0.00010837438,0.00022396959],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024646235,0.00061959785,0.00093825755,0.00037866877,0.000057921294,0.00004440428,0.00020778732,0.0005187386,0.0005123959],"category_scores_gemma":[0.00029977597,0.0005370908,0.00014439525,0.0002621137,0.0001913846,0.000055898825,0.0001970047,0.001539133,0.00044584804],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004735367,0.00016198287,0.0006884439,0.00043360202,0.00042338023,0.004902485,0.00066375197,0.000012358674,0.00013758455,0.00003346465,0.96806747,0.019740127],"study_design_scores_gemma":[0.009218981,0.0015748735,0.001669239,0.00029016912,0.0007032055,0.000049424936,0.000023818842,0.000025521449,0.0000414761,0.00006672473,0.98594177,0.00039480018],"about_ca_topic_score_codex":0.0006292021,"about_ca_topic_score_gemma":0.00068997586,"teacher_disagreement_score":0.14907141,"about_ca_system_score_codex":0.00027343244,"about_ca_system_score_gemma":0.0008051297,"threshold_uncertainty_score":0.99970806},"labels":[],"label_agreement":null},{"id":"W4394770710","doi":"10.1016/j.eururo.2024.03.031","title":"Re: FGFR Inhibition Augments Anti-PD-1 Efficacy in Murine FGFR3-mutant Bladder Cancer by Abrogating Immunosuppression","year":2024,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Immunosuppression; Mutant; Cancer research; Bladder cancer; Fibroblast growth factor receptor; Urothelial cancer; Fibroblast growth factor; Cancer; Internal medicine; Receptor; Gene","score_opus":0.017818109956835138,"score_gpt":0.2905615366447539,"score_spread":0.2727434266879188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394770710","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22868939,0.019171583,0.00002690544,0.69943726,0.004897741,0.0024913724,0.00094082626,0.00066043355,0.043684512],"genre_scores_gemma":[0.38951373,0.0021365548,0.00007297222,0.5862477,0.005874719,0.00014434928,0.0034611193,0.0006060896,0.01194279],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959041,0.00066013605,0.0008591934,0.0012139169,0.0004947409,0.00086791354],"domain_scores_gemma":[0.9987046,0.0001284921,0.00028206708,0.0006860124,0.00007222821,0.00012656678],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00028715463,0.00071767956,0.00087290636,0.00037949905,0.0001075277,0.00006576673,0.00023729158,0.0005579782,0.0021283356],"category_scores_gemma":[0.00007513946,0.00061326724,0.00023290065,0.00033924275,0.00015788701,0.00009468521,0.0002999416,0.0029425796,0.00089915853],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027502133,0.00030427304,0.00072959985,0.00045530833,0.0003991906,0.013362056,0.00039825254,0.000011775484,0.009584327,0.0000015778018,0.97161365,0.0028649569],"study_design_scores_gemma":[0.0067826766,0.0008633239,0.0047416473,0.0011474022,0.0008160374,0.00025042862,0.00002299375,0.00003828711,0.0023835301,0.000014883784,0.9823642,0.0005746049],"about_ca_topic_score_codex":0.00038226042,"about_ca_topic_score_gemma":0.000017443223,"teacher_disagreement_score":0.16082436,"about_ca_system_score_codex":0.0003127912,"about_ca_system_score_gemma":0.00016891498,"threshold_uncertainty_score":0.99987876},"labels":[],"label_agreement":null},{"id":"W4394987934","doi":"10.1016/j.eururo.2024.03.036","title":"Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer: Analyses of the Randomized Phase 3 ARASENS Study","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Docetaxel; Prostate cancer; Prostate-specific antigen; Hazard ratio; Internal medicine; Androgen deprivation therapy; Oncology; Population; Enzalutamide; Placebo; Subgroup analysis; Urology; Cancer; Confidence interval; Pathology; Androgen receptor","score_opus":0.04008932985786196,"score_gpt":0.35940546595417244,"score_spread":0.3193161360963105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394987934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99105716,0.001299617,0.00015812267,0.0017431305,0.00003474126,0.0055390517,0.00013315758,0.000029312656,0.000005725807],"genre_scores_gemma":[0.99730456,0.0015494062,0.00042918613,0.00017000204,0.000020007332,0.00016463967,0.000044062454,0.000049485487,0.00026867847],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99728817,0.0012328883,0.00040889913,0.0005036546,0.00029990493,0.00026646498],"domain_scores_gemma":[0.99796134,0.0011795196,0.00022115899,0.00020569967,0.00031182883,0.00012047663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013650227,0.00023120739,0.00076114765,0.00016034361,0.00014002106,0.000062114705,0.000048100665,0.00002991954,0.000003522772],"category_scores_gemma":[0.00030566103,0.000101075464,0.00004465487,0.00031086762,0.00031261868,0.000103785496,0.000044614415,0.00016378745,8.517998e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5200025,0.0004816144,0.47145912,0.000040094477,0.0020964306,0.00013446304,0.0027390833,0.00003707807,0.0008775265,0.0000020765963,0.000047308993,0.0020827372],"study_design_scores_gemma":[0.17665629,0.0145277595,0.80658257,0.000056263943,0.00080490456,0.000011280411,0.00032709198,0.00034238296,0.00032672109,0.0000066759,0.0002192993,0.00013878188],"about_ca_topic_score_codex":0.000055632183,"about_ca_topic_score_gemma":0.00005813809,"teacher_disagreement_score":0.34334618,"about_ca_system_score_codex":0.000052919673,"about_ca_system_score_gemma":0.00014312193,"threshold_uncertainty_score":0.41217378},"labels":[],"label_agreement":null},{"id":"W4396685119","doi":"10.1016/j.eururo.2024.03.035","title":"European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines","year":2024,"lang":"en","type":"review","venue":"European Urology","topic":"Urinary Tract Infections Management","field":"Medicine","cited_by":294,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Ipsen","keywords":"Medicine; Antimicrobial stewardship; Urinary system; Intensive care medicine; Public health; Urologic disease; Family medicine; Internal medicine; Gynecology; Pathology; Antibiotics; Antibiotic resistance","score_opus":0.10356200274367577,"score_gpt":0.38004660198158385,"score_spread":0.2764845992379081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396685119","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007225999,0.83896345,0.000050028048,0.005178463,0.0037569085,0.0011192514,0.00007965531,0.00020790276,0.15057208],"genre_scores_gemma":[0.00040429403,0.9757985,0.00012486841,0.002902343,0.0015202696,0.000034783225,0.00010212132,0.00020060172,0.018912232],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921165,0.0035881307,0.0026009579,0.0008021534,0.000453273,0.0004389724],"domain_scores_gemma":[0.99581325,0.0006635425,0.0015256279,0.0012796408,0.0006233213,0.000094645795],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034172293,0.00063795724,0.0018476085,0.00081007724,0.00009714184,0.00001743261,0.0006091929,0.0003478617,0.00030048945],"category_scores_gemma":[0.0050065247,0.00039893755,0.0012646337,0.0009824942,0.0002396694,0.00003956599,0.0008460071,0.0015550965,0.0014472931],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012063636,0.002397296,0.00071560394,0.008563506,0.0032174615,0.0005690761,0.00004740294,0.00029564285,0.000007491498,0.003069704,0.6086102,0.37238595],"study_design_scores_gemma":[0.00032621817,0.0036016784,0.0005661542,0.0013082991,0.0068266736,0.00041317317,0.0000034905388,0.00002078174,4.071779e-7,0.000075983204,0.98662394,0.00023319214],"about_ca_topic_score_codex":0.000011272405,"about_ca_topic_score_gemma":0.0000057135844,"teacher_disagreement_score":0.37801373,"about_ca_system_score_codex":0.00016782587,"about_ca_system_score_gemma":0.00018592594,"threshold_uncertainty_score":0.9998463},"labels":[],"label_agreement":null},{"id":"W4396851498","doi":"10.1016/j.eururo.2024.04.023","title":"Re: Incidence and Survival of Secondary Malignancies after External Beam Radiotherapy for Prostate Cancer in the SEER Database","year":2024,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; St Joseph's Health Centre; Western University","funders":"","keywords":"Medicine; Incidence (geometry); Prostate cancer; Oncology; External beam radiotherapy; Radiation therapy; Prostate; Cancer; Internal medicine; External beam radiation","score_opus":0.017241544774767293,"score_gpt":0.27974840361585757,"score_spread":0.26250685884109026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396851498","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19588107,0.14402059,0.00006164646,0.65142053,0.001397067,0.0025946032,0.0038635086,0.000043781874,0.00071723334],"genre_scores_gemma":[0.14324081,0.018017514,0.00029660412,0.8314712,0.003080764,0.0010711501,0.00046064632,0.00020943522,0.002151852],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982613,0.00027385206,0.00038094117,0.00053967535,0.00019676983,0.0003474629],"domain_scores_gemma":[0.9990224,0.0003105874,0.000137991,0.00043086088,0.000059568712,0.00003858987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005552079,0.00029320357,0.0004934888,0.00013308291,0.000025710326,0.000028408562,0.00016913182,0.00011418366,0.00017595773],"category_scores_gemma":[0.000029263545,0.00018919782,0.00010114674,0.00009325981,0.00023289838,0.000050008275,0.00008938552,0.0007911734,0.000007875078],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015369784,0.00012605631,0.04806509,0.0024414572,0.0004996416,0.014884586,0.0043576187,0.000005928923,0.0007873185,0.000020667783,0.9173442,0.00993042],"study_design_scores_gemma":[0.0019046533,0.0012263611,0.06109001,0.0005794897,0.0003628974,0.00015238355,0.000043938828,0.000015358795,0.00018553893,0.00006482161,0.93415326,0.00022129637],"about_ca_topic_score_codex":0.00009406731,"about_ca_topic_score_gemma":0.00011257751,"teacher_disagreement_score":0.18005072,"about_ca_system_score_codex":0.00006628782,"about_ca_system_score_gemma":0.00015691858,"threshold_uncertainty_score":0.77152634},"labels":[],"label_agreement":null},{"id":"W4396907621","doi":"10.1016/j.eururo.2024.04.031","title":"Bladder Outlet Obstruction Relief and Symptom Improvement Following Medical and Surgical Therapies for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Lower urinary tract symptoms; Enucleation; Bladder outlet obstruction; Prostate; International Prostate Symptom Score; Urology; Hyperplasia; Surgery; Internal medicine","score_opus":0.022402907038137607,"score_gpt":0.34090548577687985,"score_spread":0.3185025787387422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396907621","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011487487,0.9908913,0.0000073109463,0.0005281116,0.00034823082,0.0062838234,0.00009561099,0.000055756576,0.000641156],"genre_scores_gemma":[0.0019934496,0.99601746,0.000053205586,0.00015663623,0.00019513106,0.00045774828,0.00017979131,0.00016134158,0.00078526617],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9954021,0.0012651535,0.0014351025,0.0008476444,0.00055289955,0.00049713085],"domain_scores_gemma":[0.9971413,0.0016219384,0.0003569247,0.000467967,0.00010348919,0.0003083943],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023242098,0.0005991318,0.0033835918,0.00028957432,0.000089719004,0.00003517455,0.00019193663,0.00027621147,0.00007597043],"category_scores_gemma":[0.0007044491,0.00038406395,0.0006048854,0.00023660202,0.00031834855,0.00006352604,0.00025453977,0.0008862459,0.000033487686],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013042909,0.0003383551,0.000011908474,0.92964727,0.0024521323,0.0039256993,0.00034588802,1.1729154e-8,0.0000014933555,0.0001452613,0.00033260617,0.062668934],"study_design_scores_gemma":[0.0023675459,0.019960329,0.000043964956,0.50050014,0.03224094,0.031050554,0.00014696714,0.000031399813,4.579358e-7,0.00007292478,0.41281533,0.00076941965],"about_ca_topic_score_codex":0.0000022887095,"about_ca_topic_score_gemma":1.8894514e-7,"teacher_disagreement_score":0.42914712,"about_ca_system_score_codex":0.000053555763,"about_ca_system_score_gemma":0.00028698338,"threshold_uncertainty_score":0.9998611},"labels":[],"label_agreement":null},{"id":"W4396973580","doi":"10.1016/j.eururo.2024.05.002","title":"Re: External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort","year":2024,"lang":"en","type":"letter","venue":"European Urology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prostate cancer; Prostate; Calculator; Cancer; Cohort; Oncology; Prostate cancer screening; Gynecology; Population; Cohort study; Internal medicine; Prostate-specific antigen; Urology; Environmental health","score_opus":0.018081565652332085,"score_gpt":0.2844917474648627,"score_spread":0.2664101818125306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396973580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9060955,0.001968047,0.00056211447,0.087360725,0.0005759307,0.002803583,0.0005039323,0.00008163,0.000048504302],"genre_scores_gemma":[0.96196246,0.0001027325,0.00031104567,0.034245465,0.0010405021,0.0016561616,0.0002246022,0.00013907273,0.0003179631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997652,0.00043890285,0.00055568235,0.00066943857,0.00034089742,0.00034310416],"domain_scores_gemma":[0.9987011,0.00022988011,0.00054684223,0.0003179418,0.00014749997,0.000056765457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004748415,0.0003248703,0.0005842093,0.00024005548,0.00011044723,0.000043295287,0.00011891953,0.00017008773,0.000033090062],"category_scores_gemma":[0.0001035528,0.00023321902,0.000121008765,0.0003120224,0.0001166646,0.00004865274,0.00006939199,0.0012731698,0.0000013994181],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030353335,0.00002448659,0.9460392,0.00044324447,0.00015318126,0.000059521346,0.00038165902,0.0054127504,0.000014939839,2.7606427e-7,0.038058106,0.0063772826],"study_design_scores_gemma":[0.0026636515,0.0019982525,0.92762554,0.0011980565,0.0011550677,0.0000204376,0.000020130623,0.010564967,0.00039177292,0.000015471192,0.054017782,0.00032889907],"about_ca_topic_score_codex":0.005405736,"about_ca_topic_score_gemma":0.0025405686,"teacher_disagreement_score":0.055866923,"about_ca_system_score_codex":0.00016249223,"about_ca_system_score_gemma":0.00014252294,"threshold_uncertainty_score":0.95103955},"labels":[],"label_agreement":null},{"id":"W4398220759","doi":"10.1016/j.eururo.2024.04.038","title":"Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized Trials","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Cilag; Prostate Cancer Foundation; Janssen Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; Medical Research Council; Genentech; European Society for Medical Oncology; Astellas Pharma; Eisai; Ipsen; European School of Oncology; MacroGenics; Advanced Accelerator Applications; Clovis Oncology; Amgen; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Sanofi; Exelixis; Bristol-Myers Squibb; Eli Lilly and Company; American Society of Clinical Oncology; AstraZeneca; Takeda Oncology; Pfizer","keywords":"Medicine; Prostate cancer; Risk stratification; Randomized controlled trial; Oncology; Pooled analysis; Prostate; Risk assessment; Internal medicine; Meta-analysis; Cancer","score_opus":0.028479837906757767,"score_gpt":0.30854289902873805,"score_spread":0.28006306112198026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398220759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978952,0.017875118,0.0004795012,0.0011644934,0.00012329957,0.0005138827,0.00039702788,0.000032939104,0.00046173285],"genre_scores_gemma":[0.98639286,0.012845282,0.00029094404,0.00007659509,0.000060625254,0.000076141325,0.0001426934,0.000018836816,0.000096022646],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99708104,0.0015397484,0.000818008,0.00031364092,0.00012814625,0.00011938659],"domain_scores_gemma":[0.9976405,0.0014256975,0.00056791987,0.00020308842,0.00010422483,0.000058608497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027750202,0.00012572773,0.0013472738,0.00032592824,0.000027585264,0.00001085152,0.000039706458,0.000032762742,0.00009643626],"category_scores_gemma":[0.0007781715,0.00008566756,0.00030012158,0.00038107435,0.00020114098,0.00002790445,0.000023390434,0.00012423997,0.000003976642],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.117672816,0.0006354656,0.24128291,0.0005478701,0.06763693,0.0002930793,0.005363224,0.003992968,0.0052186963,0.011557789,0.0015216215,0.54427665],"study_design_scores_gemma":[0.16092615,0.0028168554,0.65862375,0.00032920626,0.15548633,0.000022192375,0.0001123018,0.011353731,0.004148524,0.001551185,0.0042829337,0.0003468081],"about_ca_topic_score_codex":0.0007165644,"about_ca_topic_score_gemma":0.00006277623,"teacher_disagreement_score":0.5439298,"about_ca_system_score_codex":0.000023968872,"about_ca_system_score_gemma":0.00008216478,"threshold_uncertainty_score":0.34934217},"labels":[],"label_agreement":null},{"id":"W4398764308","doi":"10.1016/j.eururo.2024.04.039","title":"Re: Roxana Ramos, Ethan Ferguson, Mahmoud Abou Zeinab, et al. Single-port Transvesical Robot-assisted Simple Prostatectomy: Surgical Technique and Clinical Outcomes. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.11.012","year":2024,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Prostatectomy; Port (circuit theory); Urology; Gynecology; General surgery; Internal medicine; Prostate cancer","score_opus":0.049735138834754195,"score_gpt":0.3308478608407517,"score_spread":0.28111272200599746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398764308","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008095801,0.004136487,0.00018508839,0.88294286,0.0012964946,0.0057716095,0.0004308334,0.0012836753,0.09585715],"genre_scores_gemma":[0.11245153,0.0013559253,0.00072409026,0.69933945,0.0050892327,0.0007357934,0.005025721,0.0018135906,0.17346467],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9884948,0.0036159644,0.0024695068,0.0028458433,0.0008965523,0.0016773113],"domain_scores_gemma":[0.99631417,0.000919078,0.00048762653,0.0014946171,0.00019847292,0.000586035],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0021194995,0.0015664306,0.0028297147,0.0005813995,0.00012251038,0.00014810289,0.00067126745,0.0016817008,0.0032513642],"category_scores_gemma":[0.00043493553,0.0013062741,0.0008898544,0.00058106903,0.0006828971,0.00014541704,0.00049840455,0.009300466,0.0021332446],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016998674,0.0010433672,0.010092393,0.0004342218,0.00086839794,0.06686793,0.00015387424,0.0000028945094,0.00009379894,0.000012043834,0.91495323,0.0037779917],"study_design_scores_gemma":[0.006805204,0.0035200852,0.046867423,0.00017708717,0.0013241557,0.0007894068,0.000008692493,0.000020240366,0.000060353712,0.000059409376,0.93939865,0.00096931466],"about_ca_topic_score_codex":0.0003767171,"about_ca_topic_score_gemma":0.000131256,"teacher_disagreement_score":0.1836034,"about_ca_system_score_codex":0.00032063734,"about_ca_system_score_gemma":0.00047995176,"threshold_uncertainty_score":0.9997084},"labels":[],"label_agreement":null},{"id":"W4399765233","doi":"10.1016/j.eururo.2024.06.009","title":"Corrigendum to “Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostat Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial” [Eur. Eurol. 84(2) (2023) 156–163]","year":2024,"lang":"en","type":"erratum","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McGill University; London Health Sciences Centre; Alberta Cancer Foundation","funders":"","keywords":"Medicine; Oncology; Internal medicine; Docetaxel; Radiation therapy; Prostate cancer; Androgen deprivation therapy; Randomized controlled trial; Androgen; Gynecology; Cancer; Hormone","score_opus":0.037080387710922744,"score_gpt":0.33309836633480194,"score_spread":0.2960179786238792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399765233","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35279003,0.2814322,0.01517357,0.071826175,0.15869676,0.10203902,0.0075518037,0.0014829617,0.009007489],"genre_scores_gemma":[0.033217564,0.12240836,0.0019824388,0.015158767,0.02130238,0.008765418,0.011186987,0.0017617096,0.7842164],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925603,0.0027860648,0.0011178397,0.0018137936,0.0006338658,0.0010881153],"domain_scores_gemma":[0.99610883,0.0012219303,0.0007049009,0.0010689845,0.0004092903,0.00048607713],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002075884,0.0010164782,0.0030322818,0.0003903568,0.00038209706,0.00018410421,0.000601279,0.0005746405,0.00047438484],"category_scores_gemma":[0.00077456946,0.00053651934,0.00044113206,0.0005240238,0.00082160847,0.00008038769,0.00027855422,0.0018541522,0.00012720957],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6273099,0.00015982326,0.002161978,0.00020445211,0.0035314339,0.00089719536,0.0010995287,0.0000039572847,0.00006853261,0.000017400405,0.34932518,0.015220632],"study_design_scores_gemma":[0.45052868,0.007955471,0.00085658923,0.00024346802,0.003560663,0.000113659386,0.00003083526,0.00024637507,0.000035638077,0.000058561003,0.53591996,0.00045007156],"about_ca_topic_score_codex":0.0009169413,"about_ca_topic_score_gemma":0.001990588,"teacher_disagreement_score":0.7752089,"about_ca_system_score_codex":0.0004132434,"about_ca_system_score_gemma":0.0019390031,"threshold_uncertainty_score":0.99970865},"labels":[],"label_agreement":null},{"id":"W4401180759","doi":"10.1016/j.eururo.2024.07.008","title":"Kidney Stones: It’s Not All About Surgery","year":2024,"lang":"en","type":"editorial","venue":"European Urology","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Kidney stones; Kidney; Surgery; Urology; General surgery; Internal medicine","score_opus":0.025868255440556893,"score_gpt":0.29940236098340894,"score_spread":0.27353410554285207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401180759","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040699917,0.0020522894,0.0000065519366,0.018944489,0.9178717,0.00042030387,0.00079984934,0.00048054912,0.05901728],"genre_scores_gemma":[0.002989982,0.0019891034,0.000072455965,0.03636901,0.8862874,0.000035022145,0.0051258164,0.00056924904,0.06656195],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952908,0.00062453584,0.00094747444,0.0013724176,0.0008331221,0.00093165535],"domain_scores_gemma":[0.9961852,0.0011276407,0.00030602264,0.0011791232,0.0002242524,0.0009777813],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010017125,0.00083720323,0.0014615783,0.00052904524,0.000090752554,0.00007936373,0.00037289844,0.00088800816,0.00055822043],"category_scores_gemma":[0.0037937418,0.0006996756,0.00073627965,0.00021536207,0.00022796654,0.00005363124,0.00035323377,0.0020351259,0.01247128],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047333713,0.00023539066,0.0004990393,0.000431615,0.0010808188,0.0071622217,0.00022900409,4.5706946e-7,0.000028736156,0.00002351772,0.9888935,0.00094233576],"study_design_scores_gemma":[0.0012137229,0.0006498985,0.0021095942,0.00025097752,0.0019716169,0.00030969063,0.000009323412,0.0000058853566,0.0000071317354,0.000012042668,0.9929702,0.00048986514],"about_ca_topic_score_codex":0.0000701606,"about_ca_topic_score_gemma":0.0000016522159,"teacher_disagreement_score":0.03158428,"about_ca_system_score_codex":0.00015627527,"about_ca_system_score_gemma":0.0011750691,"threshold_uncertainty_score":0.99954545},"labels":[],"label_agreement":null},{"id":"W4401623703","doi":"10.1016/j.eururo.2024.07.016","title":"First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; London Health Sciences Centre; University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Pembrolizumab; Adjuvant; Oncology; Systemic therapy; Immunotherapy; Internal medicine; Adjuvant therapy; Carcinoma; Kidney cancer; Chemotherapy; Cancer","score_opus":0.025422851641305037,"score_gpt":0.28024148213253935,"score_spread":0.2548186304912343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401623703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858243,0.006423059,0.00008967194,0.0003781034,0.0011811323,0.00089736475,0.000005949231,0.00013443938,0.0050660153],"genre_scores_gemma":[0.9979899,0.0001886614,0.000099812336,0.0004546075,0.0004137071,0.00003784309,0.00005115321,0.000108066655,0.00065627677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770945,0.00054393435,0.0005110154,0.0006315645,0.00026771455,0.00033633466],"domain_scores_gemma":[0.9991783,0.00010092293,0.000064672255,0.00050676626,0.000042131946,0.00010721481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005889523,0.00028278277,0.00037430192,0.00034420082,0.00004748818,0.000049313534,0.00026566128,0.00005315174,0.00017499685],"category_scores_gemma":[0.00001729591,0.00022025747,0.0001815731,0.00016248315,0.00003452672,0.00012480108,0.0000728116,0.00036041212,0.00029535923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004186354,0.0046964535,0.83922184,0.00012256016,0.0007650251,0.054253824,0.014791033,0.00071354967,0.058284108,0.00003206778,0.00018191547,0.022751253],"study_design_scores_gemma":[0.013691542,0.006762909,0.96629494,0.00010161203,0.00013221326,0.0004122245,0.0003862535,0.003459782,0.0011579022,0.00000682693,0.007286755,0.00030706124],"about_ca_topic_score_codex":0.00009835432,"about_ca_topic_score_gemma":0.000033013086,"teacher_disagreement_score":0.12707306,"about_ca_system_score_codex":0.00018527835,"about_ca_system_score_gemma":0.00004928395,"threshold_uncertainty_score":0.8981839},"labels":[],"label_agreement":null},{"id":"W4401818806","doi":"10.1016/j.eururo.2024.07.015","title":"Impact of Prior Chemotherapy on Response to Second-line Pembrolizumab in Urothelial Cancer: Exploratory Analysis of the Phase 3 KEYNOTE-045 Trial","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Urothelial cancer; Pembrolizumab; Chemotherapy; Oncology; Internal medicine; Bladder cancer; Cancer; Urothelial carcinoma; Urology; Immunotherapy","score_opus":0.02997830348744784,"score_gpt":0.3658515437235423,"score_spread":0.33587324023609444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401818806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545556,0.0004762407,0.00002598248,0.0012769201,0.00039615732,0.00080441614,0.00036300722,0.00003455465,0.0011671429],"genre_scores_gemma":[0.99769276,0.00006045721,0.000011001442,0.0012010557,0.0002710106,0.000034445864,0.000010099379,0.000059104073,0.00066008244],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9978398,0.00077386195,0.00050923123,0.00039505397,0.00022424258,0.0002577759],"domain_scores_gemma":[0.99894947,0.00021079995,0.0001119708,0.000557228,0.000059285296,0.000111223824],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005648284,0.00022049395,0.00062909577,0.00065247173,0.000025272502,0.000008047122,0.00020478685,0.000063893,0.0013107066],"category_scores_gemma":[0.00013891776,0.00014208506,0.00048032735,0.0011413051,0.00010251537,0.000031765303,0.000046076722,0.00025035575,0.000033000935],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8629025,0.0018233004,0.004359054,0.00005564843,0.0038161573,0.0002909337,0.005238472,0.00109756,0.09303042,0.00002491831,0.0014468466,0.025914142],"study_design_scores_gemma":[0.2928749,0.06625577,0.57080835,0.00023693615,0.004731091,0.00003612174,0.00009074153,0.0013590355,0.030003926,0.000039134717,0.032971982,0.0005920134],"about_ca_topic_score_codex":0.00011748196,"about_ca_topic_score_gemma":0.00009236759,"teacher_disagreement_score":0.57002765,"about_ca_system_score_codex":0.0001678488,"about_ca_system_score_gemma":0.00051826256,"threshold_uncertainty_score":0.99960226},"labels":[],"label_agreement":null},{"id":"W4401837633","doi":"10.1016/j.eururo.2024.08.001","title":"Bladder-sparing Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection","year":2024,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Randomized controlled trial; Urology; Cancer; Oncology; Internal medicine","score_opus":0.07455506336566566,"score_gpt":0.36816012635853634,"score_spread":0.2936050629928707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401837633","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008149122,0.981159,0.0019484916,0.0031390758,0.0037685041,0.005488011,0.0022880249,0.00019600903,0.0011979975],"genre_scores_gemma":[0.0015648715,0.9856172,0.0016215193,0.0029357255,0.0020998174,0.0035948742,0.000963791,0.00037073044,0.0012314743],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963871,0.00036496384,0.0009390553,0.0013507261,0.00025292562,0.00070520566],"domain_scores_gemma":[0.9979531,0.0005750459,0.00048705837,0.00034857393,0.00039011193,0.00024610898],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032756812,0.00084086234,0.0014055413,0.0005389823,0.00031220698,0.00010833753,0.0002600949,0.0003098114,0.0003613789],"category_scores_gemma":[0.00014913622,0.0006942083,0.00061754964,0.00030884458,0.00014387784,0.00013662282,0.00018219501,0.00069293845,0.000041670915],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005795285,0.00013190677,0.00002406388,0.0013156505,0.0052536293,0.00007515427,0.0012140698,0.000053390704,0.00009259138,0.000055123233,0.022560714,0.9686442],"study_design_scores_gemma":[0.0027603225,0.0024425862,0.00007163073,0.0014139588,0.0045457794,0.00023356588,0.0001374182,0.00027904537,0.000040851726,0.000025464213,0.9874702,0.0005791966],"about_ca_topic_score_codex":0.00023644608,"about_ca_topic_score_gemma":0.00023154843,"teacher_disagreement_score":0.96806496,"about_ca_system_score_codex":0.0008147486,"about_ca_system_score_gemma":0.0010552846,"threshold_uncertainty_score":0.9995509},"labels":[],"label_agreement":null},{"id":"W4402023125","doi":"10.1016/j.eururo.2024.08.013","title":"The Importance of Being Grade 3: A Plea for a Three-tier Hybrid Classification System for Grade in Primary Non–muscle-invasive Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Sahlgrenska Akademin; Universitat Autònoma de Barcelona; Skånes universitetssjukhus; Medizinische Universität Graz; Karl-Franzens-Universität Graz; Sahlgrenska Universitetssjukhuset; Universität Regensburg; Umeå Universitet; Linköpings Universitet; King's College London; Lunds Universitet; Sorbonne Université; Radboud Universitair Medisch Centrum; University of Glasgow; European Association of Urology; Bladder Cancer Canada; Radboud Universiteit; Göteborgs Universitet; Univerzita Karlova v Praze; Amsterdam University Medical Centers; Karolinska Institutet; Swedish Council of America; Uppsala Universitet; Cancerfonden; Faculty of Medicine and Health, University of Sydney; Scottish Government; Swedish Movement Disorder Society; Vetenskapsrådet","keywords":"Medicine; Bladder cancer; Cohort; Proportional hazards model; Hazard ratio; Internal medicine; Grading (engineering); Cumulative incidence; Cystectomy; Urology; Oncology; Cancer; Confidence interval","score_opus":0.030796902561310412,"score_gpt":0.2912844273959489,"score_spread":0.2604875248346385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402023125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9454654,0.01099807,0.012233846,0.011416141,0.0022784267,0.006142123,0.00043924002,0.00024246592,0.010784304],"genre_scores_gemma":[0.9973663,0.00018282175,0.00019124222,0.0006206081,0.00046801244,0.0006149033,0.00006745159,0.00008542557,0.00040322624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985209,0.00013036841,0.00044624147,0.00042664554,0.00013085332,0.00034500376],"domain_scores_gemma":[0.998994,0.00041082207,0.00012773786,0.00032639026,0.0000776953,0.00006334654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005224217,0.00018437413,0.00032143816,0.000103138016,0.00009299341,0.000019105883,0.00015253475,0.00004675457,0.000007016496],"category_scores_gemma":[0.000063007654,0.0001307557,0.00015907406,0.00014733766,0.00011232978,0.000051231968,0.00003413141,0.00016263536,0.000008796075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008269809,0.0020214603,0.34392697,0.017598752,0.007276146,0.0019145843,0.013142363,0.0003575867,0.17352812,0.045563895,0.058909234,0.32749107],"study_design_scores_gemma":[0.01343859,0.003954889,0.8634254,0.0010169919,0.0021954891,0.00028996615,0.0008613497,0.009822797,0.007902703,0.0028238574,0.09352123,0.00074675615],"about_ca_topic_score_codex":0.000030748004,"about_ca_topic_score_gemma":0.00020494018,"teacher_disagreement_score":0.5194984,"about_ca_system_score_codex":0.00017521618,"about_ca_system_score_gemma":0.00025933608,"threshold_uncertainty_score":0.5332062},"labels":[],"label_agreement":null},{"id":"W4402096344","doi":"10.1016/j.eururo.2024.07.026","title":"Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047)","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; Centre Hospitalier de l’Université de Montréal; University Health Network","funders":"Medical Research Council; University College London; Canadian Cancer Society; Cancer Research UK; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; UK Research and Innovation; Royal Marsden NHS Foundation Trust","keywords":"Medicine; Prostatectomy; Androgen deprivation therapy; Term (time); Radiation therapy; Antiandrogen; Urology; Prostate cancer; Androgen; Surgery; Internal medicine; Hormone; Cancer","score_opus":0.03129245598263614,"score_gpt":0.30680358417117,"score_spread":0.27551112818853385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402096344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98428565,0.0087659955,0.00069112325,0.0021367741,0.00032290883,0.0032278867,0.0002017994,0.000066245186,0.00030162884],"genre_scores_gemma":[0.99592906,0.001968766,0.0003121625,0.0007030035,0.0004443747,0.00017907575,0.00032923787,0.000077035445,0.000057283596],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9972757,0.0006665488,0.00086016976,0.0005802086,0.00033408133,0.00028330833],"domain_scores_gemma":[0.99806315,0.0009399708,0.00019541035,0.00056022883,0.000121551435,0.00011966769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005844086,0.00031509454,0.0008439526,0.00008904753,0.00005982528,0.000036695033,0.0001919902,0.00009308258,0.00026800504],"category_scores_gemma":[0.000110811736,0.0001557111,0.00018340738,0.00019102593,0.00051666045,0.00007119088,0.00004037102,0.0003145779,0.000020486463],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84200203,0.0011966404,0.09116288,0.00004573751,0.0017393349,0.00082720356,0.0033693956,0.00001663203,0.00354344,0.000020820682,0.0009889735,0.055086873],"study_design_scores_gemma":[0.45535636,0.031742334,0.48867238,0.00046396497,0.00070143497,0.00009125301,0.000030772557,0.0006536811,0.013796353,0.00001979301,0.008091811,0.0003798545],"about_ca_topic_score_codex":0.000022611472,"about_ca_topic_score_gemma":0.000037653754,"teacher_disagreement_score":0.3975095,"about_ca_system_score_codex":0.0000691609,"about_ca_system_score_gemma":0.00020579057,"threshold_uncertainty_score":0.63497144},"labels":[],"label_agreement":null},{"id":"W4402182303","doi":"10.1016/j.eururo.2024.08.022","title":"VISION: An Individual Patient Data Meta-analysis of Randomised Trials Comparing Magnetic Resonance Imaging Targeted Biopsy with Standard Transrectal Ultrasound Guided Biopsy in the Detection of Prostate Cancer","year":2024,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; McMaster University; University of Toronto; Sinai Health System","funders":"Birmingham Biomedical Research Centre; National Institute for Health and Care Research","keywords":"Medicine; Biopsy; Prostate cancer; Magnetic resonance imaging; Radiology; Confidence interval; Prostate biopsy; Meta-analysis; Prostate; Ultrasound; Clinical trial; Cancer; Internal medicine","score_opus":0.1447667660423004,"score_gpt":0.3856264509732277,"score_spread":0.24085968493092727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402182303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056789094,0.9864174,0.000034913584,0.00011513874,0.00013116903,0.003087224,0.004407762,0.000027440989,0.00010003231],"genre_scores_gemma":[0.13968782,0.8575154,0.00019617102,0.0000803488,0.000058185717,0.00039339974,0.0019687992,0.000091143826,0.000008756453],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99198216,0.0040227138,0.0021528285,0.0009759998,0.0005328121,0.00033348482],"domain_scores_gemma":[0.99656034,0.0008593104,0.0011364897,0.0012127229,0.00014505356,0.00008607985],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004152851,0.00055058947,0.005753917,0.0007327094,0.00004998685,0.000048871767,0.0004992094,0.000074318785,0.000119291166],"category_scores_gemma":[0.00023057309,0.00027779193,0.0010394693,0.0015468674,0.0002496285,0.000086791406,0.000105856234,0.0004280968,0.000002304477],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007761821,0.0007148507,0.00081362436,0.004038977,0.10974809,0.0012271358,0.0048804437,0.0001238995,0.0001152309,0.000007786537,0.0002519846,0.87031615],"study_design_scores_gemma":[0.010044917,0.0027019416,0.0019147263,0.0009786502,0.860969,0.00038591507,0.0001382732,0.00012576928,0.00004881107,0.0000035882106,0.12230653,0.00038187168],"about_ca_topic_score_codex":0.00022395275,"about_ca_topic_score_gemma":0.00018073755,"teacher_disagreement_score":0.86993426,"about_ca_system_score_codex":0.00009509314,"about_ca_system_score_gemma":0.00026749115,"threshold_uncertainty_score":0.9999674},"labels":[],"label_agreement":null},{"id":"W4402311649","doi":"10.1016/j.eururo.2024.08.021","title":"Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]Lu-PSMA-617 in the Phase 3 VISION Trial","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of British Columbia","funders":"National Cancer Institute; Medical Research Council; Novartis Pharmaceuticals Corporation; Novartis","keywords":"Medicine; Prostate cancer; Glutamate carboxypeptidase II; Oncology; Prostate; Prostate-specific antigen; Internal medicine; Antigen; Castration; Clinical trial; Urology; Cancer; Immunology; Hormone","score_opus":0.07192577697083756,"score_gpt":0.40374225212492254,"score_spread":0.33181647515408497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402311649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945508,0.0005004422,0.00001669846,0.0022220053,0.00024248686,0.0020086484,0.00009595237,0.000028788374,0.0003341365],"genre_scores_gemma":[0.99870443,0.00029136054,0.00019827804,0.00015064394,0.00008362145,0.0000667448,0.00011150017,0.000047387577,0.00034601174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964913,0.0012503272,0.0008430008,0.0004752703,0.0005329157,0.00040718092],"domain_scores_gemma":[0.9983996,0.0008476109,0.00027379792,0.00025663985,0.00015214537,0.000070202346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026894098,0.00021080555,0.0005227514,0.0002548052,0.00006655885,0.00006155363,0.00012984981,0.000052314484,0.00004487156],"category_scores_gemma":[0.00026417,0.00011352122,0.0000743799,0.00051460287,0.00014019191,0.00015678752,0.000036815934,0.00054394576,0.000012304092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07269971,0.0013294985,0.90449154,0.000089544024,0.00035629058,0.0007121111,0.0041833795,0.00007617179,0.0002746964,0.0000145172135,0.00029500196,0.015477511],"study_design_scores_gemma":[0.068806924,0.009930166,0.91873324,0.00022594321,0.00013390952,0.0000026384578,0.00027452887,0.000092915456,0.000042281004,0.000014194289,0.0016128819,0.00013039244],"about_ca_topic_score_codex":0.00007315634,"about_ca_topic_score_gemma":0.00037839526,"teacher_disagreement_score":0.0153471185,"about_ca_system_score_codex":0.00016485083,"about_ca_system_score_gemma":0.0003385156,"threshold_uncertainty_score":0.46292612},"labels":[],"label_agreement":null},{"id":"W4402473017","doi":"10.1016/j.eururo.2024.08.032","title":"Hypofractionated Dose Escalation Radiotherapy for High-Risk Prostate Cancer: the survival analysis of the Prostate Cancer Study-5 (PCS-5), a GROUQ-led phase III trial","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Centre hospitalier universitaire de Québec; Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec; Cégep de Rimouski; Centre Hospitalier de l’Université de Montréal; Hôpital Charles-Le Moyne; Saint John Regional Hospital; Hôtel-Dieu de Québec; McGill University; McGill University Health Centre; Centre Hospitalier Universitaire de Sherbrooke; Jewish General Hospital","funders":"","keywords":"Medicine; Prostate cancer; Radiation therapy; Gynecology; Oncology; Cancer; Internal medicine","score_opus":0.020148540411464726,"score_gpt":0.3301798934539186,"score_spread":0.3100313530424539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402473017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97792304,0.0053891707,0.00011582423,0.008262153,0.0019199061,0.005449095,0.0007501035,0.00009335255,0.000097352946],"genre_scores_gemma":[0.99214625,0.004500954,0.000022976747,0.0005636027,0.0005123024,0.001307071,0.00014406088,0.000072955394,0.0007298349],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972292,0.0008787573,0.00067650905,0.0005796982,0.0003028402,0.00033299005],"domain_scores_gemma":[0.9982265,0.0005940484,0.00039260995,0.00051453436,0.00019275564,0.00007954609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010408481,0.0002770912,0.0006377749,0.0002179229,0.00022773127,0.000048996222,0.00017982197,0.000049691353,0.00018902961],"category_scores_gemma":[0.000107272535,0.00014960699,0.0003488619,0.0010768018,0.00016293825,0.000094109804,0.000051927767,0.0002963685,0.000004353279],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26342586,0.0084229335,0.16510762,0.00021201128,0.05482404,0.00026540153,0.020671375,0.013549574,0.0035616204,0.0008114355,0.007873626,0.4612745],"study_design_scores_gemma":[0.28013244,0.016704682,0.5380735,0.00009983507,0.03183267,0.000010767912,0.00052151043,0.019729124,0.0009070337,0.00017136442,0.11126073,0.0005563955],"about_ca_topic_score_codex":0.0017427052,"about_ca_topic_score_gemma":0.00077509286,"teacher_disagreement_score":0.46071813,"about_ca_system_score_codex":0.0002431995,"about_ca_system_score_gemma":0.00024880978,"threshold_uncertainty_score":0.6100796},"labels":[],"label_agreement":null},{"id":"W4402682826","doi":"10.1016/j.eururo.2024.09.008","title":"Intensification Approaches and Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Oncology; Castration; Internal medicine; Gynecology; Cancer; Hormone","score_opus":0.22348597990205626,"score_gpt":0.39060099558399125,"score_spread":0.167115015681935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402682826","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003090938,0.9922024,0.000001251481,0.00060450385,0.00007898026,0.0061977184,0.00007073458,0.00005344675,0.0007600778],"genre_scores_gemma":[0.00030789594,0.99567753,0.00005171669,0.00013333937,0.00005739519,0.0015144489,0.0003509232,0.00009574914,0.0018110147],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9966391,0.0011704289,0.0010028435,0.00066979165,0.00017506562,0.00034279333],"domain_scores_gemma":[0.9989374,0.00014499939,0.00029478787,0.00043482412,0.000060546558,0.00012741981],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008098036,0.00046751823,0.0025371665,0.000362808,0.000044186578,0.00004342383,0.00009847705,0.000060905797,0.0000142287145],"category_scores_gemma":[0.00014731329,0.00026772183,0.00022779024,0.00042179704,0.000117214346,0.00004083303,0.00005947119,0.00037512818,0.0001344073],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036243287,0.00003482622,0.0000019525073,0.9230182,0.0007932131,0.0017443888,0.00045903402,6.596379e-7,0.000003253828,0.000065044325,0.00010996236,0.07373318],"study_design_scores_gemma":[0.0010229581,0.0012403532,0.000008604022,0.8147246,0.031431526,0.0015202357,0.00019862907,0.00011775949,0.0000011378879,0.000017389517,0.14926532,0.00045144025],"about_ca_topic_score_codex":0.0000848867,"about_ca_topic_score_gemma":0.00006762611,"teacher_disagreement_score":0.14915535,"about_ca_system_score_codex":0.0014012983,"about_ca_system_score_gemma":0.0010696946,"threshold_uncertainty_score":0.99997747},"labels":[],"label_agreement":null},{"id":"W4402695128","doi":"10.1016/j.eururo.2024.09.009","title":"Testosterone Recovery Following Androgen Suppression and Prostate Radiotherapy (TRANSPORT): A Pooled Analysis of Five Randomized Trials from the Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium","year":2024,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Randomized controlled trial; Prostate; Meta-analysis; Testosterone (patch); Urology; Oncology; Radiation therapy; Androgen; Internal medicine; Androgen suppression; Gynecology; Cancer; Hormone","score_opus":0.13272871580031698,"score_gpt":0.4104758447527413,"score_spread":0.2777471289524243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402695128","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011075288,0.9718589,0.000043803273,0.0009866465,0.0002440299,0.011810021,0.0038854135,0.000015899117,0.00007995875],"genre_scores_gemma":[0.010290777,0.98676074,0.00009783748,0.00013740822,0.00006125107,0.0008512736,0.00086276775,0.000095173826,0.00084279757],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9429058,0.048492227,0.0066433186,0.0009007249,0.000650038,0.00040790517],"domain_scores_gemma":[0.96262777,0.0312182,0.0048150453,0.0010264997,0.00020720455,0.00010525299],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.043518294,0.0007368463,0.042758513,0.0016871347,0.000057737005,0.000026828799,0.00042412645,0.00024065952,0.0005085833],"category_scores_gemma":[0.007480545,0.0002833253,0.021197228,0.0030179466,0.0009901415,0.000055771714,0.00015381006,0.000627547,8.7224294e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2617915,0.00013565316,0.00013884672,0.0014301158,0.7238567,0.00008776875,0.0015124468,0.00039017876,0.00011989052,0.0000032941382,0.00008549601,0.0104481485],"study_design_scores_gemma":[0.21982874,0.00015323662,0.000052158182,0.00083878584,0.7752693,0.0000022786792,0.000028187958,0.0003393712,0.000047938833,0.000020872427,0.0032503982,0.00016869731],"about_ca_topic_score_codex":0.00114204,"about_ca_topic_score_gemma":0.00019378355,"teacher_disagreement_score":0.051412664,"about_ca_system_score_codex":0.00007917023,"about_ca_system_score_gemma":0.00069927535,"threshold_uncertainty_score":0.9999619},"labels":[],"label_agreement":null},{"id":"W4402741886","doi":"10.1016/j.eururo.2024.09.003","title":"Patient-reported Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1/2 Gene Alterations: Final Analysis from the Randomized Phase 3 MAGNITUDE Trial","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Janssen Research and Development","keywords":"Medicine; Prostate cancer; Oncology; Randomized controlled trial; Internal medicine; Castration; Prostate; Orchiectomy; Gynecology; Urology; Cancer; Hormone","score_opus":0.038508235026473915,"score_gpt":0.3445376374984897,"score_spread":0.30602940247201577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402741886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887482,0.0027017235,0.00037010512,0.0035461376,0.0001980669,0.0036182208,0.0006652255,0.00004376256,0.00010853933],"genre_scores_gemma":[0.9959452,0.00021488026,0.000586992,0.0004713035,0.00011019266,0.00059098133,0.0015028168,0.000033562897,0.0005440297],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982317,0.00042121398,0.0004676755,0.00040409976,0.00023824828,0.00023703772],"domain_scores_gemma":[0.9985394,0.0008237825,0.00012909596,0.0002280917,0.00018941249,0.000090247944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041505342,0.0001891528,0.00052987976,0.00015003358,0.00015539318,0.00010417645,0.000052565018,0.00001926652,0.000110839814],"category_scores_gemma":[0.00025061122,0.00009366898,0.00015630524,0.00027662885,0.00019813531,0.00007293327,0.00002769041,0.00013549728,0.00000559472],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9511102,0.0008160099,0.014691504,0.00005614127,0.015611309,0.0005482815,0.002473583,0.00009105831,0.00048406055,0.00008994814,0.000702505,0.013325438],"study_design_scores_gemma":[0.9452643,0.0043393825,0.031044133,0.000030257568,0.012708642,0.0000072633875,0.00007638959,0.0018628032,0.00010604545,0.00011231688,0.004243244,0.00020524664],"about_ca_topic_score_codex":0.00018166346,"about_ca_topic_score_gemma":0.00012237963,"teacher_disagreement_score":0.01635263,"about_ca_system_score_codex":0.0000357616,"about_ca_system_score_gemma":0.00020934865,"threshold_uncertainty_score":0.38197103},"labels":[],"label_agreement":null},{"id":"W4403309732","doi":"10.1016/j.eururo.2024.09.032","title":"Radiotherapy for Unfavorable-risk Prostate Cancer: Biologic Dose Escalation, Fewer Fractions, or Both?","year":2024,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Radiation therapy; De-escalation; Oncology; Prostate; Urology; Internal medicine; Cancer","score_opus":0.016111721012367942,"score_gpt":0.3139670367540862,"score_spread":0.29785531574171825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403309732","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015770706,0.06377061,0.0002472206,0.009063347,0.9146058,0.003677871,0.0049716793,0.00053913356,0.0015472786],"genre_scores_gemma":[0.0018683269,0.16717446,0.00092836295,0.0018883932,0.7966427,0.0015422037,0.003944269,0.00047229874,0.025538964],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99690384,0.00039659822,0.0007019601,0.0011225208,0.0002742256,0.0006008457],"domain_scores_gemma":[0.9970701,0.0013650312,0.00046544944,0.00059575826,0.00030042758,0.00020327201],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006594557,0.00057970005,0.00088307785,0.0002514752,0.00020303432,0.00008277697,0.00019798495,0.00048572893,0.0004948222],"category_scores_gemma":[0.0008274609,0.00039511026,0.00029743096,0.00025034553,0.00016723924,0.00006157824,0.000068901136,0.001054305,0.0002449235],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030868128,0.00025822248,0.0012307443,0.00027559279,0.0011478965,0.0003340024,0.00020315193,0.000070923394,0.000028493594,0.00002475513,0.9703419,0.022997482],"study_design_scores_gemma":[0.0052985656,0.004659063,0.0009447669,0.00015685162,0.001251377,0.000019717183,0.000012803348,0.000084522704,0.000019788986,0.0001784715,0.98700905,0.00036501512],"about_ca_topic_score_codex":0.0001560262,"about_ca_topic_score_gemma":0.00007741536,"teacher_disagreement_score":0.117963076,"about_ca_system_score_codex":0.00051769934,"about_ca_system_score_gemma":0.0008433344,"threshold_uncertainty_score":0.9998501},"labels":[],"label_agreement":null},{"id":"W4403342766","doi":"10.1016/j.eururo.2024.09.017","title":"Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"Peter MacCallum Foundation; National Health and Medical Research Council; Royal Marsden NHS Foundation Trust; Movember Foundation; Medical Research Council; Prostate Cancer Foundation","keywords":"Medicine; Prostate cancer; Management of prostate cancer; Consensus conference; Oncology; Prostate; Prostate disease; Internal medicine; Urology; Gynecology; General surgery; Cancer","score_opus":0.012141287661170383,"score_gpt":0.26881892773946886,"score_spread":0.25667764007829846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403342766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9613044,0.018703213,0.000019164352,0.008506372,0.0011660282,0.0022087765,0.0010164612,0.00013273337,0.006942814],"genre_scores_gemma":[0.98613393,0.007439985,0.00046775248,0.00077748735,0.00008975166,0.0004699559,0.00027872314,0.00009079173,0.0042516226],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977796,0.00014816027,0.00054003345,0.00077959045,0.00032111173,0.00043147607],"domain_scores_gemma":[0.9986067,0.00013004159,0.00026139824,0.0006101244,0.0002596211,0.00013214565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018226788,0.00033106346,0.00044216678,0.000056690693,0.000080301936,0.00003180358,0.00015749014,0.00003495825,0.00036463237],"category_scores_gemma":[0.000021316606,0.00020107355,0.00008299377,0.00026402343,0.00030218557,0.000060778693,0.00013839477,0.00027298476,0.000046531888],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00756747,0.00078682514,0.43742707,0.0009074535,0.003819149,0.018343402,0.00360075,0.0015332932,0.0005624254,0.00069200207,0.019112542,0.5056476],"study_design_scores_gemma":[0.0062432517,0.0019443043,0.6725685,0.0013816657,0.001222918,0.000044065535,0.00030413497,0.00011303957,0.0009643101,0.00013770722,0.31468514,0.0003909977],"about_ca_topic_score_codex":0.00020030767,"about_ca_topic_score_gemma":0.000095497766,"teacher_disagreement_score":0.5052566,"about_ca_system_score_codex":0.00013697096,"about_ca_system_score_gemma":0.00023012659,"threshold_uncertainty_score":0.8199541},"labels":[],"label_agreement":null},{"id":"W4403629137","doi":"10.1016/j.eururo.2024.10.014","title":"Sensitive Detection of Urothelial Cancer via High-volume Urine DNA Analysis","year":2024,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Pirkanmaan Sairaanhoitopiiri; Orionin Tutkimussäätiö; Jane ja Aatos Erkon Säätiö; Tays; Suomen Lääketieteen Säätiö; Suomen Kulttuurirahasto; Academy of Finland","keywords":"Medicine; Urothelial cancer; Urine; Cancer; DNA; Volume (thermodynamics); Urology; Cancer detection; Bladder cancer; Oncology; Internal medicine; Genetics","score_opus":0.010653066025021165,"score_gpt":0.24905752418019983,"score_spread":0.23840445815517866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403629137","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.076973066,0.0051403884,0.007231749,0.85053706,0.00918059,0.0025055355,0.0031765425,0.0009256449,0.044329416],"genre_scores_gemma":[0.7074563,0.00019373941,0.000048797843,0.26591915,0.008027657,0.000034034194,0.0005323331,0.00022457066,0.017563438],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99737394,0.00050381734,0.00052544416,0.0008147619,0.00034227688,0.00043975137],"domain_scores_gemma":[0.99882877,0.00006372242,0.00024688034,0.0005914193,0.00017726966,0.000091948496],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016629345,0.0004640017,0.001052772,0.0007303686,0.00004921741,0.000014670402,0.00014562803,0.00038887278,0.0008353798],"category_scores_gemma":[0.0000263899,0.00040036102,0.00055622996,0.00062852254,0.00019891377,0.000028860606,0.0001107857,0.0013513515,0.0008730279],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025489265,0.00036352896,0.0024356989,0.0011748922,0.042988602,0.030517375,0.0010318393,0.00016891891,0.03357138,0.000011493339,0.853945,0.031242346],"study_design_scores_gemma":[0.001695284,0.0017917064,0.018839398,0.000054162047,0.025134977,0.00030132843,0.000005471396,0.00020678208,0.006708717,0.000044997458,0.944768,0.00044916497],"about_ca_topic_score_codex":0.0011308399,"about_ca_topic_score_gemma":0.0001209175,"teacher_disagreement_score":0.6304832,"about_ca_system_score_codex":0.00014811513,"about_ca_system_score_gemma":0.0001219006,"threshold_uncertainty_score":0.99990493},"labels":[],"label_agreement":null},{"id":"W4403659270","doi":"10.1016/j.eururo.2024.09.035","title":"Evaluating Biparametric Versus Multiparametric Magnetic Resonance Imaging for Diagnosing Clinically Significant Prostate Cancer: An International, Paired, Noninferiority, Confirmatory Observer Study","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"National Cancer Institute; European Commission; Health~Holland","keywords":"Medicine; Prostate cancer; Magnetic resonance imaging; Prostate; Radiology; Multiparametric MRI; Observer (physics); Cancer; Nuclear medicine; Medical physics; Internal medicine","score_opus":0.12357207636206524,"score_gpt":0.42593751198264246,"score_spread":0.3023654356205772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403659270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9665656,0.025004644,0.00005465073,0.0013498598,0.0033223927,0.0027473487,0.00013218338,0.00029910853,0.0005241857],"genre_scores_gemma":[0.99385643,0.0023284452,0.0014240884,0.0008166901,0.00054697,0.00069388625,0.00007773059,0.0001249644,0.0001308151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99653995,0.0005809432,0.00085128326,0.0010848227,0.0003963928,0.00054663274],"domain_scores_gemma":[0.9967086,0.002019236,0.00017999132,0.000534084,0.00031779238,0.00024035054],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017979401,0.00034097803,0.0004929583,0.00047582603,0.00015337318,0.00019626215,0.00029611925,0.000050957577,0.000119926095],"category_scores_gemma":[0.0015287658,0.00030663642,0.00017383684,0.0006740949,0.0001565569,0.00023267498,0.0001666942,0.00037163796,0.00008290727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016433236,0.0010216945,0.54379153,0.00007323977,0.00016574796,0.001158232,0.000790345,0.0002398428,0.00016584262,0.000037051348,0.00046590396,0.45044723],"study_design_scores_gemma":[0.013257305,0.01489547,0.8795164,0.00019235113,0.0009231103,0.000038221267,0.0002968718,0.050471686,0.000079406236,0.000023143515,0.039856046,0.00044996085],"about_ca_topic_score_codex":0.00014920278,"about_ca_topic_score_gemma":0.000017783406,"teacher_disagreement_score":0.44999728,"about_ca_system_score_codex":0.00030369515,"about_ca_system_score_gemma":0.0003003503,"threshold_uncertainty_score":0.99993855},"labels":[],"label_agreement":null},{"id":"W4404875027","doi":"10.1016/j.eururo.2024.11.016","title":"Can a Molecular Classifier of Upper Tract Urothelial Carcinoma Inform Clinical Decision-making and Biological Stratification?","year":2024,"lang":"en","type":"editorial","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Urothelial carcinoma; Risk stratification; Classifier (UML); Clinical decision making; Stratification (seeds); Oncology; Internal medicine; Intensive care medicine; Artificial intelligence; Bladder cancer; Cancer","score_opus":0.02752166542806099,"score_gpt":0.34310388633437333,"score_spread":0.3155822209063123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404875027","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23967181,0.0061166007,0.0003498793,0.0016182974,0.69125724,0.0018357197,0.0014657745,0.00026472614,0.05741992],"genre_scores_gemma":[0.8276386,0.00041807507,0.00040200425,0.0005404191,0.17023595,0.00001866889,0.0002947781,0.00011263789,0.00033884292],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967999,0.00039350853,0.0011045145,0.0008573381,0.00047702278,0.00036772492],"domain_scores_gemma":[0.9975196,0.0011419655,0.00029303727,0.0006150546,0.00022056229,0.00020979335],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007083948,0.00043948035,0.000931425,0.0002280842,0.000055237037,0.000040200855,0.0002613851,0.00078616635,0.00017637933],"category_scores_gemma":[0.0014117284,0.0003272336,0.00033867368,0.00014657724,0.00045225344,0.000031560437,0.00018093108,0.0013888456,0.00010889793],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044204216,0.000984822,0.02937284,0.00042421854,0.0012877099,0.004512833,0.00077914033,0.000002731253,0.00049266696,0.001040612,0.84548223,0.11119975],"study_design_scores_gemma":[0.003088423,0.0049512517,0.064968035,0.0002134519,0.0011206991,0.00019250852,0.00004153153,0.00003302008,0.000026792673,0.0010799874,0.92385286,0.00043146455],"about_ca_topic_score_codex":0.00002611501,"about_ca_topic_score_gemma":0.000008166519,"teacher_disagreement_score":0.5879668,"about_ca_system_score_codex":0.000057230067,"about_ca_system_score_gemma":0.0007592729,"threshold_uncertainty_score":0.999918},"labels":[],"label_agreement":null},{"id":"W4405437371","doi":"10.1016/j.eururo.2024.11.022","title":"Biparametric Versus Multiparametric Magnetic Resonance Imaging in Prostate Cancer: A Choice or a Fine Balance?","year":2024,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Prostate cancer; Magnetic resonance imaging; Prostate; Balance (ability); Multiparametric MRI; Radiology; Nuclear medicine; Cancer; Internal medicine; Physical therapy","score_opus":0.01685933901665643,"score_gpt":0.3019511572464949,"score_spread":0.2850918182298385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405437371","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072589978,0.3662137,0.0000012766978,0.0018443327,0.61839676,0.001755318,0.0008957809,0.00027881388,0.0033550186],"genre_scores_gemma":[0.059689146,0.10921616,0.00055710867,0.0013096873,0.8049357,0.0020448116,0.0015226913,0.0010379921,0.019686721],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953464,0.0003961204,0.00088074716,0.0016565301,0.0006414831,0.0010786854],"domain_scores_gemma":[0.9955497,0.0028370891,0.00027616665,0.00083233626,0.00022839569,0.00027636244],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054607,0.0007711124,0.0011931731,0.0016275375,0.00006386979,0.000098190554,0.0003953016,0.00025570812,0.00030442877],"category_scores_gemma":[0.004115376,0.00061768375,0.00021339688,0.0027925982,0.00021396796,0.0000758865,0.0003244495,0.0018553,0.00073323044],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003959855,0.00034265232,0.013953604,0.00039799904,0.00008198194,0.010940513,0.00017006566,0.000027888016,0.0000056942176,0.0000028809895,0.80824924,0.16186765],"study_design_scores_gemma":[0.011815365,0.0030608415,0.021253534,0.00061983766,0.00059552985,0.000041361876,0.000008513736,0.00044858834,0.000007646577,0.000007450288,0.9616361,0.00050520065],"about_ca_topic_score_codex":0.00094707165,"about_ca_topic_score_gemma":0.00063022657,"teacher_disagreement_score":0.25699756,"about_ca_system_score_codex":0.00091267505,"about_ca_system_score_gemma":0.00091131125,"threshold_uncertainty_score":0.9996275},"labels":[],"label_agreement":null},{"id":"W4405465567","doi":"10.1016/j.eururo.2024.12.003","title":"Optimal Treatment Strategies for Hormone-sensitive Metastatic Prostate Cancer: Does Local Radiotherapy Play a Role in High-volume Disease?","year":2024,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Centre Hospitalier de l’Université de Montréal; Dalhousie University; Université du Québec en Outaouais","funders":"","keywords":"Medicine; Prostate cancer; Radiation therapy; Prostate; Disease; Oncology; Hormone; Prostate disease; Cancer; Internal medicine","score_opus":0.010704047981929475,"score_gpt":0.3039929929434563,"score_spread":0.2932889449615268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405465567","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09245194,0.21723211,0.001106118,0.012781452,0.63742876,0.0139668975,0.022064663,0.0007895909,0.0021784597],"genre_scores_gemma":[0.23842917,0.06920105,0.0011045873,0.00041523782,0.62613434,0.0034896652,0.011929833,0.0011011941,0.048194952],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99642265,0.0004974238,0.0005337085,0.0011519098,0.0004715287,0.0009227617],"domain_scores_gemma":[0.9983765,0.00048900914,0.00015292478,0.00043336098,0.00020153075,0.0003466929],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037021062,0.00069969404,0.0011637876,0.00044603168,0.00009700131,0.000119413475,0.00019210733,0.00021329797,0.000069341615],"category_scores_gemma":[0.0000720109,0.0004460008,0.0003075513,0.0002157279,0.00045255898,0.000095015996,0.00008312494,0.0007667879,0.000091134636],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054027595,0.001262701,0.00023046706,0.0011122084,0.0052691526,0.020616196,0.00705993,0.0040516984,0.0008675968,0.0001892587,0.8840273,0.02128592],"study_design_scores_gemma":[0.012587586,0.008534354,0.0008717731,0.00022518206,0.0014579713,0.000015039968,0.0006570509,0.0022596905,0.00005862476,0.0002928165,0.9724861,0.0005538204],"about_ca_topic_score_codex":0.00063756265,"about_ca_topic_score_gemma":0.00023168461,"teacher_disagreement_score":0.14803106,"about_ca_system_score_codex":0.0010165469,"about_ca_system_score_gemma":0.0023105142,"threshold_uncertainty_score":0.9997992},"labels":[],"label_agreement":null},{"id":"W4405594157","doi":"10.1016/j.eururo.2024.11.026","title":"Increasing Life Expectancy in Patients with Genitourinary Malignancies: Impact of Treatment Burden on Disease Management and Quality of Life","year":2024,"lang":"en","type":"review","venue":"European Urology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institute on Aging","keywords":"Medicine; Life expectancy; Genitourinary system; Quality of life (healthcare); Intensive care medicine; Disease; Disease management; Gerontology; Internal medicine; Environmental health; Nursing; Population","score_opus":0.0577221440223133,"score_gpt":0.28781802948621577,"score_spread":0.23009588546390247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405594157","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1948797,0.79384947,0.0000044005355,0.000012672739,0.00012990361,0.00057131256,0.00058572163,0.000013259781,0.009953576],"genre_scores_gemma":[0.3232814,0.67627656,0.00002904895,0.000031715157,0.00011067912,0.000022040807,0.00004656626,0.00007333623,0.00012865325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736017,0.00020868878,0.0014378724,0.0006363219,0.00003644852,0.00032049353],"domain_scores_gemma":[0.99805754,0.00011039304,0.0010768202,0.00051306107,0.000020718058,0.00022144667],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004487866,0.00044076,0.002049175,0.00058305194,0.000025826343,0.00002146094,0.00023075634,0.00009286848,0.00006072046],"category_scores_gemma":[0.00014647248,0.0003599362,0.0003704794,0.00019018924,0.00012714205,0.00008169553,0.00011892107,0.00017136779,0.00010523019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008252352,0.0031169583,0.5572352,0.046148367,0.0074677584,0.00038999112,0.0022059674,0.00074712065,1.0218724e-7,0.054744862,0.0010615361,0.3186298],"study_design_scores_gemma":[0.0032881354,0.0052929795,0.75718737,0.0029046936,0.0005536432,0.0000027741637,0.000022291273,0.000014808736,2.1262553e-8,0.0005449957,0.22919106,0.0009972365],"about_ca_topic_score_codex":0.00036779663,"about_ca_topic_score_gemma":0.0000061648702,"teacher_disagreement_score":0.31763256,"about_ca_system_score_codex":0.00033037792,"about_ca_system_score_gemma":0.00015115314,"threshold_uncertainty_score":0.99988526},"labels":[],"label_agreement":null},{"id":"W4405805273","doi":"10.1016/j.eururo.2024.12.002","title":"The Financial Burden of Localized and Metastatic Bladder Cancer","year":2024,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Oncology; Internal medicine; Cancer; Intensive care medicine","score_opus":0.04615506967158384,"score_gpt":0.3562117116536257,"score_spread":0.31005664198204186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405805273","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006920653,0.9913411,0.00001547636,0.00037632024,0.0005393417,0.00059278624,0.00007512844,0.00003114088,0.0070217988],"genre_scores_gemma":[0.0001123739,0.9955712,0.0000300297,0.0002754395,0.00051720376,0.000059605674,0.000023706327,0.00009213485,0.0033183137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99835616,0.00043530675,0.00047285456,0.0003569111,0.00013199857,0.00024676364],"domain_scores_gemma":[0.9992185,0.00016399563,0.00016129107,0.0003309361,0.00004011263,0.000085139334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024958813,0.000310026,0.0011568565,0.00008914544,0.000058477122,0.000015576394,0.00014622037,0.00007309371,0.00013960393],"category_scores_gemma":[0.00009075106,0.00016128941,0.00027336786,0.00016247781,0.0002703349,0.000010702115,0.00012690792,0.00038015674,0.00019270252],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063399944,0.000019893689,0.0000012808215,0.0040303227,0.0010471923,0.00033824478,0.0001520797,3.3131593e-7,3.6101574e-7,0.00022370834,0.005590806,0.98853236],"study_design_scores_gemma":[0.00054018764,0.0003464497,0.000009654327,0.00089001557,0.010012344,0.00023385206,0.0000064977967,0.000006805428,2.6088804e-7,0.00006583388,0.98777664,0.00011144177],"about_ca_topic_score_codex":0.00006639008,"about_ca_topic_score_gemma":0.000016230606,"teacher_disagreement_score":0.98842096,"about_ca_system_score_codex":0.000029653374,"about_ca_system_score_gemma":0.00035902593,"threshold_uncertainty_score":0.65771914},"labels":[],"label_agreement":null},{"id":"W4406506363","doi":"10.1016/j.eururo.2024.11.027","title":"Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety Analysis","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Bone health and treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Enzalutamide; Radium-223; Prostate cancer; Oncology; Radium; Internal medicine; Urology; Cancer; Bone metastasis; Radiochemistry","score_opus":0.02737035519820928,"score_gpt":0.29908094296200993,"score_spread":0.27171058776380064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406506363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891349,0.00045894028,0.00036171262,0.0018789975,0.0001573631,0.0017762126,0.0000067620176,0.000076526776,0.0061485698],"genre_scores_gemma":[0.99497557,0.000052173993,0.00019230976,0.00433594,0.00005924589,0.000073102085,0.00013264302,0.00004544226,0.0001335909],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99483293,0.0028257081,0.00070830056,0.00067862705,0.00027558018,0.0006788515],"domain_scores_gemma":[0.99803114,0.00068854255,0.0002784582,0.00070762384,0.000053297805,0.00024095076],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023369065,0.00038371165,0.0009444467,0.00066857814,0.00024068702,0.000032590247,0.0002359206,0.000113441776,0.000050828825],"category_scores_gemma":[0.00047351705,0.00025063183,0.00012412056,0.0014573795,0.00015389267,0.00007713749,0.00008289372,0.0011476815,0.00003087637],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52445465,0.0015545156,0.45658046,0.000097071425,0.0018375097,0.008378095,0.0016682919,0.0024918278,0.0000297606,0.00008115881,0.0002895088,0.0025371553],"study_design_scores_gemma":[0.20097269,0.0026724697,0.7871785,0.00009313639,0.0016808511,0.000059846385,0.0002480612,0.0011813525,0.000030500545,0.000014692607,0.005624237,0.00024364814],"about_ca_topic_score_codex":0.0012858746,"about_ca_topic_score_gemma":0.005944676,"teacher_disagreement_score":0.33059806,"about_ca_system_score_codex":0.0002073693,"about_ca_system_score_gemma":0.00030952724,"threshold_uncertainty_score":0.9999946},"labels":[],"label_agreement":null},{"id":"W4406750804","doi":"10.1016/j.eururo.2025.01.007","title":"A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types","year":2025,"lang":"en","type":"editorial","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Kidney cancer; Cancer; Urothelial cancer; Neoadjuvant therapy; Oncology; Internal medicine; Breast cancer; Bladder cancer","score_opus":0.04612878046480832,"score_gpt":0.3370887271073967,"score_spread":0.29095994664258834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406750804","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021009417,0.02164938,0.00014362943,0.026425702,0.8900094,0.0019800551,0.011848397,0.0003009584,0.045541525],"genre_scores_gemma":[0.004224715,0.0042029796,0.00031757634,0.00938959,0.85550296,0.0007011244,0.0028537898,0.0004321144,0.12237514],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99683934,0.00044964842,0.000550396,0.0011638129,0.00036544938,0.0006313635],"domain_scores_gemma":[0.9971816,0.00095939275,0.00033828552,0.00079567684,0.0003682547,0.0003567965],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002739671,0.00058950786,0.0011581009,0.00019739111,0.00009758133,0.00003094934,0.00034993276,0.0005815969,0.0010448712],"category_scores_gemma":[0.0012118951,0.00049046305,0.00035282402,0.00012189399,0.00018882318,0.000021387696,0.00014227214,0.0009708783,0.00024011891],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020309892,0.0001255398,0.00032488175,0.00019347182,0.0012839759,0.0004534577,0.00019183535,0.000018770672,0.0009977873,0.000023329541,0.9873945,0.006961471],"study_design_scores_gemma":[0.0043401006,0.0006454913,0.00056176947,0.00028046026,0.0025038961,0.0000037351504,0.000005854446,0.000029413453,0.0003468909,0.000059306305,0.9908686,0.00035443084],"about_ca_topic_score_codex":0.004925813,"about_ca_topic_score_gemma":0.00085617247,"teacher_disagreement_score":0.07683361,"about_ca_system_score_codex":0.00034772267,"about_ca_system_score_gemma":0.002199819,"threshold_uncertainty_score":0.99986833},"labels":[],"label_agreement":null},{"id":"W4407049276","doi":"10.1016/j.eururo.2025.01.013","title":"Intraductal Carcinoma and Cribriform Pattern in Prostate Cancer: Challenges and Emerging Perspectives","year":2025,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Fundação para a Ciência e a Tecnologia","keywords":"Medicine; Cribriform; Prostate cancer; Carcinoma; Prostate; Cancer; General surgery; Pathology; Internal medicine","score_opus":0.010439530639057932,"score_gpt":0.26491143376330234,"score_spread":0.2544719031242444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407049276","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22420995,0.5364042,0.0000011224474,0.015144794,0.2130036,0.0010980614,0.0003772765,0.0000918865,0.009669083],"genre_scores_gemma":[0.49756724,0.3612763,0.00001287846,0.00021383248,0.14013728,0.00010117124,0.00014038572,0.000077132914,0.00047376577],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99824405,0.00017118994,0.0002839826,0.0007807039,0.00015473,0.00036536797],"domain_scores_gemma":[0.9992525,0.00020055691,0.00011207978,0.00023115415,0.00009056418,0.000113168586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020964572,0.0003411165,0.00059504405,0.00023852773,0.000049146227,0.000021358688,0.00007540313,0.00013917964,0.000017678645],"category_scores_gemma":[0.00013556886,0.00030220766,0.000045635086,0.000058975358,0.00017277784,0.00004763655,0.00018938503,0.00063756545,0.000003575753],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008346657,0.00037061766,0.0378921,0.0018744484,0.00057599496,0.004829803,0.027906323,0.0000015458425,0.000026887095,0.00014475372,0.3002012,0.62534165],"study_design_scores_gemma":[0.004176274,0.0017789832,0.14764974,0.0004239337,0.0003611703,0.00005568196,0.0012767448,0.000016170143,0.000019076298,0.00005609033,0.8438236,0.0003625073],"about_ca_topic_score_codex":0.00028903864,"about_ca_topic_score_gemma":0.0003038781,"teacher_disagreement_score":0.62497914,"about_ca_system_score_codex":0.00015932444,"about_ca_system_score_gemma":0.00018307932,"threshold_uncertainty_score":0.999943},"labels":[],"label_agreement":null},{"id":"W4408010724","doi":"10.1016/j.eururo.2025.02.006","title":"Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Astellas Pharma US; Pfizer","keywords":"Medicine; Enzalutamide; Post-hoc analysis; Prostate cancer; Post hoc; Oncology; Gynecology; Internal medicine; Urology; Cancer","score_opus":0.009900175720338578,"score_gpt":0.29311606602587537,"score_spread":0.2832158903055368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408010724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971247,0.00020319261,7.7289417e-7,0.0007252751,0.0000400918,0.0016205737,0.000046508416,0.0000061612805,0.00023274178],"genre_scores_gemma":[0.9996373,0.000029324012,0.0000027631843,0.00019620376,0.0000034883356,0.000053248004,0.000024877398,0.000009917504,0.000042868538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980685,0.0008146076,0.00034885335,0.00025338825,0.00033294898,0.00018167839],"domain_scores_gemma":[0.9984802,0.0005948831,0.0002798605,0.00040440264,0.00021393184,0.000026744749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038269654,0.0001393186,0.00048038512,0.0003065239,0.000028140676,0.0000029583334,0.0001625507,0.000023314467,0.0000075652492],"category_scores_gemma":[0.00029202178,0.00006278046,0.00007516486,0.0008950701,0.00019600116,0.000014382796,0.00008549234,0.00021057314,4.5511678e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009833414,0.0038322702,0.9674728,0.00010233133,0.0026778018,0.000052841584,0.0037424257,0.000024475332,0.0044717467,0.000006618353,0.000035638197,0.007747618],"study_design_scores_gemma":[0.003524183,0.008977045,0.9807843,0.00003442203,0.0012806028,1.8319898e-7,0.000329024,0.000013750829,0.00498687,0.0000017660695,0.00002212039,0.000045718505],"about_ca_topic_score_codex":0.00016199332,"about_ca_topic_score_gemma":0.00009751688,"teacher_disagreement_score":0.013311495,"about_ca_system_score_codex":0.000039147515,"about_ca_system_score_gemma":0.00010522721,"threshold_uncertainty_score":0.2560113},"labels":[],"label_agreement":null},{"id":"W4408517438","doi":"10.1016/j.eururo.2025.02.029","title":"Genitourinary Pathology Society and International Society of Urological Pathology White Paper on Defining Indolent Prostate Cancer: Call for a Multidisciplinary Approach","year":2025,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Genitourinary system; Prostate cancer; Multidisciplinary approach; Pathology; White (mutation); Prostate; Anatomical pathology; General surgery; Gynecology; Cancer; Internal medicine","score_opus":0.017895525188886225,"score_gpt":0.2933694629355497,"score_spread":0.2754739377466635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408517438","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17705368,0.04011902,0.0010706607,0.0409274,0.69771695,0.009623043,0.01580578,0.0005551404,0.017128328],"genre_scores_gemma":[0.11824946,0.1495813,0.040001217,0.026079293,0.6142017,0.007530455,0.028355345,0.0009413019,0.015059888],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967104,0.00036189455,0.00073752506,0.0013206147,0.00027837246,0.0005911987],"domain_scores_gemma":[0.9977187,0.0008607296,0.00048682146,0.0004482187,0.00033788645,0.00014762512],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007092763,0.0005727586,0.0011009093,0.00011627627,0.00015417379,0.000016451531,0.0002813572,0.00080041727,0.000022640692],"category_scores_gemma":[0.00019766654,0.0004692286,0.0005657468,0.00009909665,0.00052417687,0.000040368737,0.0006683529,0.001214245,0.000005138186],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003257275,0.001177188,0.011653459,0.0007461536,0.0010218171,0.00036824605,0.0024267177,0.00013336356,0.00016710575,0.00006338244,0.97195536,0.0070299553],"study_design_scores_gemma":[0.013035695,0.011083204,0.031341854,0.0002679867,0.0012806202,0.00019244198,0.00023182918,0.0006784522,0.000033410673,0.00013263493,0.9410957,0.0006261568],"about_ca_topic_score_codex":0.000010555181,"about_ca_topic_score_gemma":0.0000030674962,"teacher_disagreement_score":0.109462276,"about_ca_system_score_codex":0.00021199948,"about_ca_system_score_gemma":0.0004506645,"threshold_uncertainty_score":0.99977595},"labels":[],"label_agreement":null},{"id":"W4408662609","doi":"10.1016/j.eururo.2025.02.019","title":"European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital","funders":"Sanofi Pasteur; Genentech; Medac; Astellas Pharma; Eisai; European Association of Urology; Incyte; Ipsen; Mirati Therapeutics; Clovis Oncology; Seagen; Gilead Sciences; Sanofi; G1 Therapeutics; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Bladder cancer; Urology; General surgery; Cancer; Gynecology; Internal medicine","score_opus":0.04959131884894241,"score_gpt":0.33942095235536296,"score_spread":0.28982963350642055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408662609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6959957,0.016188774,0.00024933493,0.09258662,0.0024391075,0.0014658828,0.0003234363,0.000121871104,0.19062926],"genre_scores_gemma":[0.96639574,0.0024657724,0.00032449298,0.021636568,0.00026198657,0.000011640066,0.000019922627,0.00004920133,0.008834703],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9975456,0.0009080694,0.00074875244,0.0003503626,0.00020541437,0.00024178094],"domain_scores_gemma":[0.99821734,0.0003339071,0.00039776778,0.00042928802,0.0005672677,0.000054432752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073568785,0.00021136522,0.00047008056,0.00015664083,0.000068211746,0.000005316543,0.00020480844,0.00005207089,0.000094734874],"category_scores_gemma":[0.001592342,0.00014594765,0.00013865532,0.0002536636,0.00016114539,0.00002711932,0.00017524092,0.00020128216,0.000018075396],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023410136,0.001039165,0.28878865,0.00067103567,0.0055279043,0.00028915083,0.001447773,0.0010948564,0.033804804,0.0033127873,0.4964125,0.16527037],"study_design_scores_gemma":[0.008179186,0.0022454162,0.6434977,0.00030669972,0.0035496752,0.000032815882,0.0001561753,0.0002138052,0.0042487034,0.000768585,0.33648363,0.00031761586],"about_ca_topic_score_codex":0.00014601265,"about_ca_topic_score_gemma":0.000106268984,"teacher_disagreement_score":0.35470903,"about_ca_system_score_codex":0.000045409783,"about_ca_system_score_gemma":0.0002044244,"threshold_uncertainty_score":0.59515727},"labels":[],"label_agreement":null},{"id":"W4408674343","doi":"10.1016/j.eururo.2025.02.022","title":"European Association of Urology-European Society of Paediatric Urology Guidelines on Paediatric Urology: Summary of 2024 Updates. Part II","year":2025,"lang":"en","type":"editorial","venue":"European Urology","topic":"Urological Disorders and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; London Health Sciences Centre","funders":"European Association of Urology","keywords":"Medicine; Urology; Pediatric urology; General surgery","score_opus":0.015492511050806242,"score_gpt":0.26682263573317033,"score_spread":0.2513301246823641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408674343","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025508864,0.045446467,0.00022834953,0.015277429,0.59664416,0.0041240747,0.0060938317,0.00084535143,0.3058315],"genre_scores_gemma":[0.2777095,0.065271705,0.0014040095,0.028983176,0.5580618,0.00013334051,0.018754913,0.0015640252,0.048117552],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9857912,0.006029569,0.0036380307,0.0019856626,0.0011970057,0.0013585294],"domain_scores_gemma":[0.9895441,0.0031121883,0.003700809,0.0016766083,0.0016355719,0.0003307533],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0049539628,0.001309099,0.0030462185,0.0010049423,0.00022798516,0.00001507175,0.0013194369,0.001667642,0.0004966226],"category_scores_gemma":[0.0073718694,0.0011495803,0.0015848145,0.0011789335,0.00075527065,0.00007877353,0.0015825203,0.0029499603,0.00032716594],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001831481,0.0019363713,0.009893472,0.0003756288,0.0020507816,0.00038307015,0.00014642735,0.00019944632,0.00010325331,0.00011503559,0.97691053,0.0060544815],"study_design_scores_gemma":[0.0062525542,0.0147017,0.0093495585,0.00003337161,0.00486083,0.000016091226,0.000016817268,0.00008357297,0.00001175151,0.00019778889,0.9638939,0.0005820514],"about_ca_topic_score_codex":0.000033680473,"about_ca_topic_score_gemma":0.000009517247,"teacher_disagreement_score":0.25771394,"about_ca_system_score_codex":0.00013953955,"about_ca_system_score_gemma":0.0005243416,"threshold_uncertainty_score":0.999966},"labels":[],"label_agreement":null},{"id":"W4408714209","doi":"10.1016/j.eururo.2025.03.001","title":"The Importance of Precise Scientific Communication: Nonrandomized Trials Should Not Be Described as Phase 3, and Registrational-intent Trials Should Not Be Described as Phase 2","year":2025,"lang":"en","type":"editorial","venue":"European Urology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Phase (matter); Clinical trial; Medical physics; Intensive care medicine; Internal medicine","score_opus":0.6060410970251828,"score_gpt":0.5900081031671607,"score_spread":0.01603299385802215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408714209","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"methods","model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021745283,0.016251927,0.00088162586,0.3109609,0.58855397,0.018194765,0.0064055845,0.0004146458,0.036591332],"genre_scores_gemma":[0.14742573,0.069884814,0.004564243,0.02818933,0.53264904,0.0019252189,0.020645924,0.0010189291,0.1936968],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9499227,0.031893086,0.0089318575,0.0024840226,0.005568222,0.0012001571],"domain_scores_gemma":[0.45225656,0.52439713,0.006615595,0.007780058,0.00788467,0.0010660028],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.19662233,0.0008598995,0.0048248484,0.0005444863,0.00097440835,0.000508323,0.0026642461,0.0018809628,0.00077608397],"category_scores_gemma":[0.7443796,0.00061440485,0.001267315,0.00064230716,0.0054141907,0.0001500827,0.0013177946,0.007848589,0.000058151432],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16024908,0.0016685176,0.0000051008537,0.0003121697,0.001220782,0.00025193187,0.00046629168,0.0000029106725,0.004359224,0.006703837,0.82243663,0.002323521],"study_design_scores_gemma":[0.12827781,0.0035827912,0.0000059199942,0.00048657838,0.002153653,0.000028037108,0.00011879651,0.00008315215,0.0024157525,0.0034731007,0.8589563,0.0004181168],"about_ca_topic_score_codex":0.000094636,"about_ca_topic_score_gemma":0.00038248987,"teacher_disagreement_score":0.54775727,"about_ca_system_score_codex":0.00019904198,"about_ca_system_score_gemma":0.005878328,"threshold_uncertainty_score":0.9997574},"labels":[],"label_agreement":null},{"id":"W4409256811","doi":"10.1016/j.eururo.2025.03.008","title":"Corrigendum to “Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]Lu-PSMA-617 in the Phase 3 VISION Trial” [Eur. Urol. 86 (2024) 552–562]","year":2025,"lang":"en","type":"erratum","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Oncology; Clinical trial; Prostate; Internal medicine; Prostate-specific antigen; Castration; Urology; Cancer; Gynecology; Hormone","score_opus":0.0696067119949764,"score_gpt":0.3896189644759298,"score_spread":0.32001225248095344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409256811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97007304,0.0014085408,0.00003492628,0.0042867465,0.009088431,0.009526988,0.0009942496,0.000061116814,0.0045259544],"genre_scores_gemma":[0.8782144,0.0024856587,0.0005957119,0.0018019928,0.0007474993,0.00064830465,0.0024289151,0.00030217442,0.11277531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9920711,0.0027180037,0.0019333616,0.0011722435,0.001180947,0.0009243421],"domain_scores_gemma":[0.9964423,0.00080685766,0.0011868506,0.00077726564,0.00058934506,0.0001973869],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037551739,0.0006394119,0.0016833345,0.0008049222,0.00016106921,0.000095952244,0.00045419458,0.00025411858,0.00010352063],"category_scores_gemma":[0.0010145498,0.00038802225,0.00018216319,0.0011709745,0.00021028376,0.00014868047,0.00015196882,0.0020016292,0.000021924447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.169444,0.003906156,0.6656014,0.00043835505,0.0011661978,0.0014353975,0.005076955,0.00010343129,0.000079246245,0.000010668357,0.1390655,0.013672732],"study_design_scores_gemma":[0.09046867,0.01830266,0.81585044,0.0009388086,0.00046476806,0.0000030640317,0.00043106376,0.000030272011,0.000013915926,0.000010038684,0.07303544,0.00045088655],"about_ca_topic_score_codex":0.00024552178,"about_ca_topic_score_gemma":0.0016687711,"teacher_disagreement_score":0.15024906,"about_ca_system_score_codex":0.0004936004,"about_ca_system_score_gemma":0.0016128545,"threshold_uncertainty_score":0.9998572},"labels":[],"label_agreement":null},{"id":"W4409574526","doi":"10.1016/j.eururo.2025.02.010","title":"A Systematic Review of Novel Intravesical Approaches for the Treatment of Patients with Non–muscle-invasive Bladder Cancer","year":2025,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Rutgers Cancer Institute of New Jersey","keywords":"Medicine; Bladder cancer; Urology; Cancer; Internal medicine","score_opus":0.05422407078785609,"score_gpt":0.3137210043075716,"score_spread":0.25949693351971553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409574526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006697354,0.98747486,0.0002967728,0.00010542472,0.00014284064,0.01006555,0.0006449674,0.000012443384,0.0012504515],"genre_scores_gemma":[0.000096769945,0.99684954,0.0001273794,0.00040067776,0.0001247322,0.0016104673,0.00023098405,0.00007888101,0.0004805836],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9977778,0.0003083076,0.0010124502,0.00043668275,0.00021129196,0.00025346968],"domain_scores_gemma":[0.9972281,0.00091872097,0.00082074315,0.0007592631,0.00020253382,0.00007064971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019314485,0.0004830115,0.003427874,0.00011167608,0.000041264393,0.000004024046,0.00025149202,0.00009973937,0.000036712194],"category_scores_gemma":[0.00017225789,0.00021977456,0.0006761331,0.00023598316,0.00017589031,0.000013692217,0.000039436152,0.00012984959,0.000005603541],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001102308,0.0011569464,0.000013284914,0.8892026,0.0044841836,0.0000067985475,0.00013681024,6.785418e-7,5.7502447e-8,0.000037057627,0.0001903498,0.10466099],"study_design_scores_gemma":[0.005590035,0.007545438,0.0003647696,0.71303535,0.09739722,0.000022211894,0.000019249714,0.000006388105,0.0000025474972,0.000001455626,0.17567821,0.00033710996],"about_ca_topic_score_codex":0.000015203089,"about_ca_topic_score_gemma":0.0000067084056,"teacher_disagreement_score":0.17616725,"about_ca_system_score_codex":0.00010684704,"about_ca_system_score_gemma":0.0006240311,"threshold_uncertainty_score":0.89621466},"labels":[],"label_agreement":null},{"id":"W4409656120","doi":"10.1016/j.eururo.2025.03.017","title":"Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group","year":2025,"lang":"en","type":"review","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; Princess Margaret Cancer Centre; McGill University","funders":"Merck; AstraZeneca","keywords":"Medicine; Bladder cancer; Urology; Cancer; Urinary bladder; Oncology; Internal medicine","score_opus":0.05681618418317142,"score_gpt":0.36254200085038235,"score_spread":0.30572581666721094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409656120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009072271,0.9506809,0.00008577668,0.010398824,0.002705293,0.0017126307,0.001471061,0.00011341485,0.03274139],"genre_scores_gemma":[0.00048984005,0.9849973,0.00010325066,0.0055546346,0.0018610077,0.0008609899,0.0025642237,0.0001298195,0.003438983],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961988,0.0010021187,0.00097626273,0.0009853531,0.0003415213,0.00049595226],"domain_scores_gemma":[0.99743974,0.0010167917,0.00046629406,0.0007823514,0.00018217835,0.00011266205],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032904337,0.00065281574,0.0012074264,0.00031701275,0.00015684516,0.00011943517,0.00082330464,0.0002871476,0.004514362],"category_scores_gemma":[0.00021918728,0.00046639267,0.00039839064,0.00051288545,0.00017241637,0.0002534097,0.00036056057,0.0010447066,0.00018154534],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001200951,0.00035554825,0.0006884542,0.0008668734,0.0037390876,0.00018550947,0.00092599954,0.000035175955,0.0000071645745,0.00057915045,0.09050461,0.9019923],"study_design_scores_gemma":[0.0014607504,0.0001448378,0.0044131638,0.002561696,0.0025793435,0.000013155515,0.00017631444,0.000013694758,0.0000010165143,0.00020694555,0.98809004,0.00033906172],"about_ca_topic_score_codex":0.003559104,"about_ca_topic_score_gemma":0.007777944,"teacher_disagreement_score":0.9016533,"about_ca_system_score_codex":0.0003690904,"about_ca_system_score_gemma":0.0016139614,"threshold_uncertainty_score":0.9997788},"labels":[],"label_agreement":null},{"id":"W4410194063","doi":"10.1016/j.eururo.2025.04.022","title":"Corrigendum to “RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression” [Eur. Urol. 76(2) (2019) 157–166]","year":2025,"lang":"en","type":"erratum","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; China Scholarship Council","keywords":"Medicine; Prostate cancer; RNA splicing; Gene; Alternative splicing; Cancer research; Prostate; RNA; Oncology; Internal medicine; Bioinformatics; Cancer; Exon; Genetics; Biology","score_opus":0.01975669613237406,"score_gpt":0.32029214564070396,"score_spread":0.3005354495083299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410194063","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06256081,0.090298176,0.00025884394,0.36610562,0.22661242,0.02919429,0.0033445773,0.00093378883,0.22069147],"genre_scores_gemma":[0.029244294,0.0048760357,0.00009937731,0.014880101,0.0019112654,0.00039284,0.00055478595,0.0002712738,0.94777],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99517095,0.00077101187,0.0008830603,0.0012201901,0.00066609506,0.0012886705],"domain_scores_gemma":[0.9969568,0.00010609936,0.00038833264,0.001439975,0.00064628845,0.00046247625],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042872617,0.0006972712,0.001237573,0.0006181687,0.00026690768,0.000047744263,0.0009660953,0.00015486557,0.00020461497],"category_scores_gemma":[0.00059429504,0.0004527483,0.00031320937,0.0010667092,0.0002977608,0.00003884253,0.0014414109,0.0017335203,0.00020161083],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021738573,0.00020600001,0.005428388,0.000344073,0.00046467752,0.0012211367,0.00024414164,0.000040521732,0.0065187425,0.000040829058,0.9694612,0.0138564175],"study_design_scores_gemma":[0.0025371662,0.001646363,0.025415653,0.0007215203,0.00053837936,0.00008256396,0.00001704261,0.000038867274,0.0054148203,0.000021185204,0.9632406,0.00032583493],"about_ca_topic_score_codex":0.0002160015,"about_ca_topic_score_gemma":0.00008871002,"teacher_disagreement_score":0.72707856,"about_ca_system_score_codex":0.00024670086,"about_ca_system_score_gemma":0.0012721241,"threshold_uncertainty_score":0.9997924},"labels":[],"label_agreement":null},{"id":"W4410555626","doi":"10.1016/j.eururo.2025.03.023","title":"Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; McGill University Health Centre; University of British Columbia","funders":"National Cancer Institute; National Institutes of Health; Genentech; F. Hoffmann-La Roche","keywords":"Medicine; Atezolizumab; Bladder cancer; Urology; Urine; Bladder tumor; Cancer; Oncology; Internal medicine; Surgery; Immunotherapy; Pembrolizumab","score_opus":0.011856070442732526,"score_gpt":0.2697056526208086,"score_spread":0.2578495821780761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410555626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99134284,0.00021693921,0.0001222798,0.0011947944,0.00016838794,0.0018980769,0.0003687892,0.000025743086,0.0046621226],"genre_scores_gemma":[0.9965036,0.000070700546,0.00011535145,0.0022394757,0.00006669816,0.00019341148,0.000039162307,0.00004098517,0.0007306179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818295,0.0003813761,0.00039455833,0.00048801696,0.00016461236,0.00038845683],"domain_scores_gemma":[0.99863434,0.00032846996,0.00016894509,0.0004611124,0.00030152252,0.000105607476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019924736,0.0002719204,0.00045271282,0.00020974132,0.000084786494,0.00000898331,0.00021188562,0.000046322304,0.0000800814],"category_scores_gemma":[0.00033432172,0.00017225252,0.00008796582,0.00047156887,0.00015767301,0.000029543842,0.00007972038,0.00023719003,0.000024590161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029196817,0.0012098511,0.8871924,0.00021263231,0.001592927,0.0003680512,0.0028684612,0.0005565825,0.0015691373,0.0001380041,0.0075765895,0.067518525],"study_design_scores_gemma":[0.009697943,0.005587243,0.9773748,0.0001266487,0.0005217742,0.000005814583,0.00008054956,0.00003340731,0.0030976462,0.000027805685,0.0032841743,0.00016217756],"about_ca_topic_score_codex":0.00050806935,"about_ca_topic_score_gemma":0.00062407827,"teacher_disagreement_score":0.090182394,"about_ca_system_score_codex":0.00010163447,"about_ca_system_score_gemma":0.0003399521,"threshold_uncertainty_score":0.70242536},"labels":[],"label_agreement":null},{"id":"W4410915299","doi":"10.1016/j.eururo.2025.02.004","title":"Reply to Chang-kun Mao, Chao-Yang, and Jun-ting Li’s Letter to the Editor re: Marie-Pier St-Laurent, Bernard Bochner, James Catto, et al. Increasing Life Expectancy in Patients with Genitourinary Malignancies: Impact of Treatment Burden on Disease Management and Quality of Life. Eur Urol. 2025;88:11–20","year":2025,"lang":"en","type":"letter","venue":"European Urology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute on Aging; Merck","keywords":"Medicine; Life expectancy; Theology; Gerontology; Psychoanalysis; Population","score_opus":0.02280742678764493,"score_gpt":0.2437903496666294,"score_spread":0.22098292287898447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410915299","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6629342,0.0038676662,0.000066780114,0.32272586,0.0015990416,0.0019263346,0.0022458115,0.00003543116,0.0045988834],"genre_scores_gemma":[0.37119496,0.0013792835,0.00018434852,0.61813873,0.005653465,0.00016777182,0.0002945211,0.0001976169,0.0027892794],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99632156,0.00041702826,0.0012925245,0.0011760979,0.00012156319,0.0006712098],"domain_scores_gemma":[0.99724364,0.000324004,0.0010786705,0.0009932737,0.000076254306,0.00028415388],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009438368,0.0006265641,0.0012638026,0.0006880729,0.000108942506,0.00008142731,0.0004694628,0.00016973662,0.000089751826],"category_scores_gemma":[0.0005380117,0.00053479045,0.0002033582,0.0002460679,0.00014627656,0.00015005689,0.0004296892,0.0005346271,0.000030563046],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018790852,0.0001477135,0.19549477,0.00017818608,0.0003580677,0.00006696165,0.0008721936,0.00038330627,7.124806e-7,0.00011001345,0.799896,0.0006129671],"study_design_scores_gemma":[0.0014634422,0.0013481345,0.34106728,0.00012195714,0.00005232674,5.8489115e-7,0.00002561077,0.000015027215,4.3660668e-7,0.00003213756,0.65549064,0.00038239107],"about_ca_topic_score_codex":0.0027182556,"about_ca_topic_score_gemma":0.00012738092,"teacher_disagreement_score":0.2954129,"about_ca_system_score_codex":0.00029244853,"about_ca_system_score_gemma":0.00010838154,"threshold_uncertainty_score":0.9997104},"labels":[],"label_agreement":null},{"id":"W4410983248","doi":"10.1016/j.eururo.2025.05.017","title":"Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Long-term Outcomes from the JAVELIN Bladder 100 Trial in Patients with Nonvisceral or Lymph Node–only Disease","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Merck KGaA; Merck","keywords":"Medicine; Metastatic Urothelial Carcinoma; Avelumab; Hazard ratio; Internal medicine; Oncology; Lymph node; Clinical endpoint; Regimen; Carcinoma; Bladder cancer; Confidence interval; Randomized controlled trial; Urothelial carcinoma; Cancer; Pembrolizumab; Immunotherapy","score_opus":0.019226915041649754,"score_gpt":0.27508665559570633,"score_spread":0.2558597405540566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410983248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873146,0.0002324981,0.0011381587,0.005640577,0.00091736176,0.002974616,0.0005356839,0.00006896104,0.0011775867],"genre_scores_gemma":[0.9865164,0.000026653624,0.0002154045,0.008780253,0.00041535439,0.00018283396,0.00030470354,0.000091152906,0.0034672227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976966,0.0002460703,0.0005405891,0.0007167345,0.00023531058,0.0005647233],"domain_scores_gemma":[0.9984552,0.00039065516,0.00014905495,0.00070533005,0.00013236921,0.0001673863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016671246,0.0004092401,0.00059957715,0.00011079023,0.00015981641,0.0000284463,0.0003336796,0.00007317485,0.00025505718],"category_scores_gemma":[0.0003402786,0.00023249268,0.00018150413,0.00019160501,0.00019080787,0.0000718733,0.00012430178,0.00023289047,0.00006136271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2203743,0.0009030858,0.77001643,0.00003216096,0.00024786522,0.00022999759,0.00016331543,0.00004075859,0.0000026927733,0.000031271364,0.00054548844,0.0074126446],"study_design_scores_gemma":[0.18441485,0.0016045937,0.81140196,0.00005865762,0.000419934,0.0000026713271,0.000009247477,0.000052275005,0.000005775781,0.000035708945,0.0018014282,0.00019290629],"about_ca_topic_score_codex":0.000112043126,"about_ca_topic_score_gemma":0.0002782848,"teacher_disagreement_score":0.041385535,"about_ca_system_score_codex":0.00013626844,"about_ca_system_score_gemma":0.0004683092,"threshold_uncertainty_score":0.9480776},"labels":[],"label_agreement":null},{"id":"W4411469637","doi":"10.1016/j.eururo.2025.05.037","title":"Postprogression Survival of Patients with Metastatic Hormone-sensitive Prostate Cancer who Received Darolutamide or Placebo in Combination with Docetaxel and Androgen Deprivation Therapy: Post Hoc Analysis of the Phase 3 ARASENS Trial","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Bayer","keywords":"Medicine; Docetaxel; Taxane; Hazard ratio; Internal medicine; Discontinuation; Prostate cancer; Placebo; Androgen deprivation therapy; Oncology; Post-hoc analysis; Surgery; Chemotherapy; Cancer; Confidence interval; Breast cancer; Pathology","score_opus":0.018835768077948817,"score_gpt":0.31260710923490265,"score_spread":0.2937713411569538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411469637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99664783,0.00044358117,0.000021950598,0.00082091225,0.00003120368,0.0017647118,0.0001275256,0.00000848769,0.00013382144],"genre_scores_gemma":[0.99901295,0.00048203924,0.000041523595,0.00010305956,0.000005990131,0.00002698575,0.00019944881,0.000015787284,0.0001122246],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99836797,0.0006634993,0.0002929233,0.00026264266,0.00024212367,0.00017086421],"domain_scores_gemma":[0.9989836,0.00017405939,0.00024932917,0.00020215225,0.00035151138,0.00003931784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003631672,0.0001399422,0.00045011123,0.00036465426,0.000054285705,0.0000076027895,0.000062172396,0.000026524973,0.000007713463],"category_scores_gemma":[0.00009156022,0.000069578666,0.000042587162,0.00095063366,0.00025950314,0.000055370932,0.000043385993,0.00013549761,1.9049172e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6818401,0.0011994374,0.2976538,0.00004402435,0.0020648327,0.000058070797,0.0017981414,0.00011075014,0.002653031,0.000014103517,0.000013849423,0.012549831],"study_design_scores_gemma":[0.16237615,0.010448104,0.8233428,0.00007894911,0.001072451,0.0000013695559,0.0001900766,0.0005669785,0.0017852806,0.000005573777,0.000053384036,0.00007888205],"about_ca_topic_score_codex":0.00006809653,"about_ca_topic_score_gemma":0.00021496792,"teacher_disagreement_score":0.525689,"about_ca_system_score_codex":0.000047138135,"about_ca_system_score_gemma":0.0001800303,"threshold_uncertainty_score":0.28373355},"labels":[],"label_agreement":null},{"id":"W4411633602","doi":"10.1016/j.eururo.2025.05.013","title":"Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Medical Research Council; Varian Medical Systems","keywords":"Medicine; Prostate cancer; Meta-analysis; Androgen suppression; Radiation therapy; Aggregate data; Oncology; Duration (music); Systematic review; Internal medicine; Urology; MEDLINE; Gynecology; Cancer; Pathology","score_opus":0.032226678168483014,"score_gpt":0.3311954152285334,"score_spread":0.2989687370600504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411633602","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.059690256,0.9036953,0.0016989332,0.01546654,0.000045402678,0.01330764,0.0057611736,0.000026389422,0.00030839257],"genre_scores_gemma":[0.8954048,0.089721896,0.0040218337,0.006444392,0.000009316181,0.001310221,0.0017873865,0.00005557818,0.0012445732],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9984056,0.00040786652,0.0006070601,0.00036182292,0.000102324324,0.0001153356],"domain_scores_gemma":[0.99830836,0.0001869832,0.00057188974,0.0005429236,0.00034741114,0.00004240812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050185906,0.0001702407,0.0019326595,0.00016267458,0.00003715125,0.0000070199117,0.00010063179,0.000017800847,0.00004833203],"category_scores_gemma":[0.00010096541,0.000097192446,0.000121682526,0.00055157783,0.00011305646,0.00007250776,0.000042194675,0.000044880817,3.149996e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036515517,0.00091038377,0.0077359853,0.17802128,0.7961709,0.00015075391,0.004765323,0.00043118422,0.0020469336,0.0005699474,0.0047897333,0.00075602665],"study_design_scores_gemma":[0.0028560674,0.0025188965,0.0017795431,0.001978301,0.9861264,0.000013528476,0.0001158964,0.00078538747,0.0027974618,0.000008572773,0.0008770612,0.00014288582],"about_ca_topic_score_codex":0.000017860344,"about_ca_topic_score_gemma":0.00003630014,"teacher_disagreement_score":0.8357145,"about_ca_system_score_codex":0.00002583077,"about_ca_system_score_gemma":0.00013399369,"threshold_uncertainty_score":0.3963393},"labels":[],"label_agreement":null},{"id":"W4412555731","doi":"10.1016/j.eururo.2025.06.017","title":"From Clinical Trials to Routine Practice: Are Urodynamics Still Useful?","year":2025,"lang":"en","type":"editorial","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Overactive bladder; Clinical trial; Clinical Practice; Intensive care medicine; Population; Internal medicine; Physical therapy; Alternative medicine; Pathology","score_opus":0.0974419327842249,"score_gpt":0.48178996577888994,"score_spread":0.384348032994665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412555731","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012604499,0.0018803008,0.0005576489,0.021663245,0.9185623,0.0018390239,0.0028415164,0.0002781928,0.051117353],"genre_scores_gemma":[0.0020887202,0.0024579586,0.0008396509,0.0049361964,0.96073526,0.000026833217,0.0037389928,0.00021724594,0.024959134],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97772753,0.016464408,0.0023193303,0.0016048362,0.0010461228,0.0008377859],"domain_scores_gemma":[0.9652026,0.030613173,0.0008718236,0.001601171,0.0010080463,0.00070312986],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.017892962,0.00059233315,0.002467812,0.00043332097,0.00009577994,0.00009599031,0.0007544969,0.0010860508,0.00065838045],"category_scores_gemma":[0.17276014,0.00050680334,0.0005576399,0.00037485745,0.00019839748,0.00007644642,0.0010275737,0.0048317923,0.0023991116],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009303563,0.0005042607,0.0005276042,0.000099079865,0.00092338957,0.0052002734,0.00019413097,0.0000065003005,0.000009078201,0.0000082809065,0.9764288,0.006795033],"study_design_scores_gemma":[0.004428408,0.0037308438,0.0027485443,0.0001269821,0.0014648795,0.000030360534,0.00006836166,0.00004213227,0.0000014871356,0.000040181083,0.98696107,0.00035676712],"about_ca_topic_score_codex":0.000119266784,"about_ca_topic_score_gemma":0.000020149702,"teacher_disagreement_score":0.15486719,"about_ca_system_score_codex":0.00011444647,"about_ca_system_score_gemma":0.0012755917,"threshold_uncertainty_score":0.99973834},"labels":[],"label_agreement":null},{"id":"W4412647773","doi":"10.1016/j.eururo.2025.05.019","title":"First-line Pembrolizumab Plus Lenvatinib for Advanced Non–clear-cell Renal Cell Carcinoma: Updated Results from the Phase 2 KEYNOTE-B61 Trial","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Medicine; Lenvatinib; Pembrolizumab; Renal cell carcinoma; Internal medicine; Oncology; Immunotherapy; Cancer; Sorafenib; Hepatocellular carcinoma","score_opus":0.025738486243495305,"score_gpt":0.2798555129792575,"score_spread":0.2541170267357622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412647773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94365287,0.0008218518,0.0015036927,0.0053136,0.00091287,0.0027693952,0.000403735,0.00013728853,0.044484716],"genre_scores_gemma":[0.9823817,0.000047601094,0.00085238897,0.0026698713,0.0009314245,0.00008463148,0.0016793186,0.00010959096,0.011243473],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99646306,0.00053749804,0.0010129493,0.00103986,0.00026653416,0.0006800867],"domain_scores_gemma":[0.99676836,0.00114012,0.0003801538,0.0013123621,0.00019642827,0.00020259015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000576156,0.0004890647,0.0007421137,0.00015485846,0.00030227035,0.000036440306,0.0004923895,0.0001607042,0.00014250449],"category_scores_gemma":[0.00045576118,0.0003544277,0.00034263683,0.00031306446,0.00019963518,0.000057631405,0.00024307659,0.0005740872,0.00028655582],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8819804,0.0022501727,0.0001909338,0.00009790551,0.00028187735,0.0015247221,0.0012191009,0.0013629611,0.031639263,0.00006458748,0.07451096,0.0048770914],"study_design_scores_gemma":[0.6998912,0.019134497,0.006256038,0.00003999687,0.0012950404,0.000033051696,0.000101755606,0.0047031227,0.0315064,0.000089910056,0.23647222,0.00047674784],"about_ca_topic_score_codex":0.00013348398,"about_ca_topic_score_gemma":0.000039443792,"teacher_disagreement_score":0.18208921,"about_ca_system_score_codex":0.0001772139,"about_ca_system_score_gemma":0.0003127614,"threshold_uncertainty_score":0.99989074},"labels":[],"label_agreement":null},{"id":"W4414280445","doi":"10.1016/j.eururo.2025.09.004","title":"Systematic Review and Pooled Analysis of Functional and Sexual Outcomes of Minimally Invasive Surgical Treatments for Benign Prostatic Obstruction","year":2025,"lang":"en","type":"review","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pooled analysis; Meta-analysis; Prostate; MEDLINE; Sexual dysfunction; Erectile dysfunction; Prostate disease; Electrosurgery","score_opus":0.044816579516042836,"score_gpt":0.3535624728730288,"score_spread":0.30874589335698593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414280445","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00084092864,0.9949996,0.000011679153,0.00008448966,0.000030338373,0.003398349,0.0003029257,0.000009241588,0.00032247635],"genre_scores_gemma":[0.00034275852,0.9971029,0.00007602812,0.000056997465,0.000014425078,0.0001467832,0.0007184625,0.00002479672,0.0015168301],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9970966,0.0010676068,0.0010720793,0.0004068081,0.00017736995,0.00017952116],"domain_scores_gemma":[0.9969334,0.0020005198,0.000498338,0.00029739586,0.00018248448,0.00008783281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068096886,0.00027483044,0.003951636,0.0005754226,0.000036642276,0.0000058344053,0.000074888325,0.00008830305,0.000039300885],"category_scores_gemma":[0.0007763793,0.0001824602,0.00035809155,0.00045364792,0.00015168141,0.0000236392,0.00009377311,0.0001528127,0.000002285149],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012463964,0.00012163051,0.00060769205,0.96211267,0.020702383,0.0000792166,0.000051129955,2.662647e-7,0.0000010757229,0.000034387056,0.00006472257,0.016100163],"study_design_scores_gemma":[0.0041113244,0.0075061554,0.0108812675,0.11477427,0.8505034,0.0010860079,0.00008520183,0.000026289144,0.0000010499912,0.000028687115,0.010501257,0.00049509644],"about_ca_topic_score_codex":0.000003353232,"about_ca_topic_score_gemma":0.000002037334,"teacher_disagreement_score":0.84733844,"about_ca_system_score_codex":0.000024033227,"about_ca_system_score_gemma":0.00021019229,"threshold_uncertainty_score":0.7440511},"labels":[],"label_agreement":null},{"id":"W4414496231","doi":"10.1016/j.eururo.2025.09.3834","title":"A0646 – Development and validation of a new stent symptom questionnaire: The Canadian endourological group stent symptom score (CEGSSS)","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Renal and Vascular Pathologies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stent; Complication; MEDLINE; Endoscopy; Severity of illness","score_opus":0.028187949696454863,"score_gpt":0.24676224372962124,"score_spread":0.2185742940331664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414496231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98473245,0.0017066426,0.0009273061,0.006350902,0.00023059452,0.0004005289,0.0000021733656,0.000059197933,0.005590197],"genre_scores_gemma":[0.9963175,0.00009662645,0.00035563833,0.0023203432,0.00008347828,0.000009416902,0.000026921298,0.000013624314,0.0007764449],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984704,0.0004302845,0.00034073115,0.0003191628,0.00015468913,0.00028467894],"domain_scores_gemma":[0.99930817,0.00007251173,0.00008828825,0.0002923334,0.000072307485,0.0001664002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064246106,0.0001646561,0.00026316734,0.00016055003,0.00016611264,0.00002292152,0.00016719205,0.000084019186,0.000024653402],"category_scores_gemma":[0.00026463924,0.00010362695,0.00007484149,0.00015945327,0.00019743762,0.000028556484,0.00014034133,0.00024153979,0.000037207767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006975236,0.00033524612,0.7978721,0.00023723366,0.0008343413,0.0011619276,0.003725527,0.0002746235,0.0039645033,0.026794108,0.0051796753,0.15892318],"study_design_scores_gemma":[0.001037027,0.0004984636,0.96057785,0.00006190974,0.00014187755,0.00022004188,0.000051408697,0.000042234275,0.0006740642,0.00018437514,0.036409616,0.00010110611],"about_ca_topic_score_codex":0.0017127945,"about_ca_topic_score_gemma":0.002306278,"teacher_disagreement_score":0.16270575,"about_ca_system_score_codex":0.000063154825,"about_ca_system_score_gemma":0.0002873011,"threshold_uncertainty_score":0.42257845},"labels":[],"label_agreement":null},{"id":"W4414496312","doi":"10.1016/j.eururo.2025.09.3432","title":"A0234 – Same-day surgery pyeloplasty: Update on an evolving peri‑operative management strategy for the surgical treatment of pediatric ureteropelvic junction obstruction over 15 years at a major referral center in Canada","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Pediatric Urology and Nephrology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Management strategy; Ureteropelvic junction; Referral; MEDLINE; Center (category theory)","score_opus":0.021477068868880757,"score_gpt":0.2655240908741139,"score_spread":0.24404702200523312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414496312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99423003,0.0010752946,0.000019334879,0.001218127,0.0010334902,0.0005134217,0.00002476374,0.000023693412,0.0018618593],"genre_scores_gemma":[0.9960569,0.0014780127,0.000018156648,0.0012365361,0.0003270403,0.00005132373,0.00007953258,0.000022742737,0.00072972674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980759,0.00058477104,0.00040534977,0.0004431548,0.00011867961,0.0003721615],"domain_scores_gemma":[0.99896806,0.00051690877,0.0001275726,0.0002785748,0.000053499967,0.00005538346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033932287,0.00022289473,0.00041177822,0.00026458662,0.0001425027,0.0000060248376,0.00008757377,0.00008119419,0.00012486691],"category_scores_gemma":[0.00004692699,0.00016055303,0.000098118035,0.00022889367,0.000116238596,0.000049189595,0.000071725146,0.00017829544,0.000012990577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010829865,0.0006834907,0.9327691,0.000061388804,0.0016959307,0.0016878501,0.0006878047,0.0007784267,0.000045193705,0.00031251836,0.025560273,0.024888162],"study_design_scores_gemma":[0.0033374368,0.0010377183,0.9710647,0.0000027173492,0.0005620609,0.00004599455,0.00013050427,0.0002890025,0.000007763884,0.000015352656,0.023393447,0.000113310765],"about_ca_topic_score_codex":0.0059889886,"about_ca_topic_score_gemma":0.088566095,"teacher_disagreement_score":0.0825771,"about_ca_system_score_codex":0.00036209277,"about_ca_system_score_gemma":0.00019082212,"threshold_uncertainty_score":0.9280652},"labels":[],"label_agreement":null},{"id":"W4414518974","doi":"10.1016/j.eururo.2025.08.019","title":"A Multicenter Randomized Controlled Trial of Antimicrobial Prophylaxis to Prevent Urinary Tract Infections after Shockwave Lithotripsy for Urolithiasis: The APPEAL Trial","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke; McMaster University","funders":"Sigrid Juséliuksen Säätiö; Academy of Finland; Physicians' Services Incorporated Foundation; Lawson Health Research Institute; Helsingin ja Uudenmaan Sairaanhoitopiiri","keywords":"Randomized controlled trial; Absolute risk reduction; Antibiotic prophylaxis; Urinary system; Antimicrobial; Ciprofloxacin; Reduction (mathematics); Multicenter trial","score_opus":0.009960370916408707,"score_gpt":0.28574522123634044,"score_spread":0.2757848503199317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414518974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9522729,0.00032000465,0.0012580241,0.0070364024,0.0024168452,0.030866733,0.00006121522,0.00007839898,0.0056894952],"genre_scores_gemma":[0.9897074,0.00004044739,0.00031661775,0.0035889738,0.0007062169,0.0027760318,0.000024381196,0.000051300223,0.0027885984],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953785,0.0021444487,0.0012908747,0.00053774175,0.00019607128,0.0004523897],"domain_scores_gemma":[0.9974803,0.001197482,0.00033971417,0.00060958887,0.00020492275,0.00016803815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019976208,0.00036318778,0.001799425,0.0003355984,0.00014924827,0.00002711776,0.00020367574,0.0001407405,0.00005895963],"category_scores_gemma":[0.002446298,0.00021414825,0.0013100962,0.00024646087,0.00022935546,0.000041722382,0.00012836665,0.00032793434,0.00003566932],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9844712,0.011416167,0.0002419505,0.000058704125,0.0014181066,0.000055394456,0.0005010003,0.0000104208175,0.00015610438,0.00012205255,0.00067697087,0.00087191904],"study_design_scores_gemma":[0.9640537,0.014877517,0.0014174738,0.000047007496,0.002513315,0.00006351398,0.000018594976,0.00010242496,0.00009307643,0.000026889898,0.016641235,0.00014527055],"about_ca_topic_score_codex":0.000013877852,"about_ca_topic_score_gemma":0.0000013376597,"teacher_disagreement_score":0.037434552,"about_ca_system_score_codex":0.000050078288,"about_ca_system_score_gemma":0.00021913278,"threshold_uncertainty_score":0.8732712},"labels":[],"label_agreement":null},{"id":"W4414624904","doi":"10.1016/j.eururo.2025.09.4146","title":"Reply to Nour Khalil, Guiseppe Maiolino, and Eric Barret’s Letter to the Editor re: Rui M. Bernardino, Theodorus van der Kwast, Neil E. Fleshner. Intraductal Carcinoma and Cribriform Pattern in Prostate Cancer: Challenges and Emerging Perspectives. Eur Urol 2025;88:123–5","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Fundação para a Ciência e a Tecnologia","keywords":"Letter to the editor; Carcinoma; Cribriform; Prostate; Prostate disease; Prostate carcinoma","score_opus":0.014124972546490535,"score_gpt":0.2587473292258174,"score_spread":0.24462235667932686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414624904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7189304,0.0439876,0.000014547935,0.23218738,0.0010790642,0.001110114,0.000060572875,0.00004611223,0.0025842108],"genre_scores_gemma":[0.95423734,0.013107925,0.000058741825,0.029426739,0.0025814532,0.00017430904,0.000009657515,0.00006815144,0.00033570768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997513,0.00032597626,0.00039854948,0.0009867261,0.00017382637,0.00060195226],"domain_scores_gemma":[0.9989128,0.00013557156,0.00009649779,0.00048792956,0.00009675813,0.0002704605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004909063,0.0003888588,0.0005149898,0.00022974199,0.00015983026,0.000060915234,0.00016325641,0.000057112065,0.00004137033],"category_scores_gemma":[0.00012500983,0.00028892123,0.000055207358,0.0001918631,0.00016487757,0.00008753181,0.00042254987,0.00040632667,0.000021705395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026402345,0.0004162285,0.35062465,0.00046318054,0.00077807973,0.0027622716,0.05616107,0.00008109892,0.0008835673,0.0004216463,0.26539278,0.3193752],"study_design_scores_gemma":[0.0026132085,0.0013684685,0.6239777,0.00014371154,0.0002144561,0.00011869849,0.0017506962,0.00006763681,0.00014496542,0.000065961336,0.36923048,0.0003039962],"about_ca_topic_score_codex":0.00034334947,"about_ca_topic_score_gemma":0.00029087992,"teacher_disagreement_score":0.3190712,"about_ca_system_score_codex":0.00013212436,"about_ca_system_score_gemma":0.000074639545,"threshold_uncertainty_score":0.9999563},"labels":[],"label_agreement":null},{"id":"W4414790369","doi":"10.1016/j.eururo.2025.09.4144","title":"Best Systemic Therapy With or Without Radical Prostatectomy in the Management of Men With Oligometastatic Prostate Cancer: The RAMPP Randomised Controlled Trial","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Prostatectomy; Randomized controlled trial; Prostate; Systemic therapy; Prostate cancer; MEDLINE","score_opus":0.014889175276248301,"score_gpt":0.2829499348375072,"score_spread":0.2680607595612589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414790369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9519932,0.004745989,0.00007907111,0.005905077,0.000105492334,0.02408715,0.000013609952,0.00003657329,0.013033818],"genre_scores_gemma":[0.98771334,0.0044412655,0.00010187124,0.001373487,0.000045403303,0.0049913805,0.000011931108,0.00003840448,0.0012829005],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99723226,0.0011372783,0.0005840384,0.0003876156,0.00030111632,0.0003576846],"domain_scores_gemma":[0.9986043,0.0004612249,0.00028340946,0.0005120755,0.0000862175,0.000052793428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011902578,0.0002862862,0.0009077154,0.00012729315,0.00009098263,0.00002918719,0.00025465796,0.000027663562,0.000033974688],"category_scores_gemma":[0.000022194352,0.00010174562,0.00009001785,0.00045523053,0.00035300368,0.000031320946,0.000037350652,0.00024411945,0.0000062293298],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97810274,0.0009962725,0.007084488,0.0002781806,0.002508793,0.00082421245,0.001974763,0.00014846823,0.000042954292,0.0003087876,0.0003038312,0.0074264924],"study_design_scores_gemma":[0.97890776,0.009147793,0.0044353604,0.0005825284,0.0014124971,0.000108569875,0.0010771295,0.00013212951,0.00010580054,0.000019915311,0.0039344253,0.00013609033],"about_ca_topic_score_codex":0.00006598915,"about_ca_topic_score_gemma":0.00003081362,"teacher_disagreement_score":0.035720136,"about_ca_system_score_codex":0.000074569194,"about_ca_system_score_gemma":0.00024778885,"threshold_uncertainty_score":0.41490662},"labels":[],"label_agreement":null},{"id":"W4414806181","doi":"10.1016/j.eururo.2025.09.4137","title":"Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin–unresponsive Carcinoma in Situ of the Bladder","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Pembrolizumab; Carcinoma in situ; Carcinoma; Bacillus (shape); Selection (genetic algorithm); In situ","score_opus":0.036703424071056125,"score_gpt":0.32891123115028453,"score_spread":0.2922078070792284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414806181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98471916,0.00041472653,0.00033910258,0.00036104117,0.00016298429,0.0012425487,0.0001109924,0.000009595152,0.0126398485],"genre_scores_gemma":[0.9985599,0.000012728922,0.000038687398,0.0005639639,0.00001716058,0.00007205593,0.000028713986,0.000017346316,0.000689424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984366,0.0006545408,0.00031592711,0.00028877676,0.0001009195,0.00020323138],"domain_scores_gemma":[0.9988383,0.00045442148,0.000113774826,0.00043203167,0.00012368226,0.000037799062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027387374,0.00015281781,0.00056850037,0.00040123434,0.00003326983,0.0000020575108,0.00013828272,0.000053939537,0.000037400525],"category_scores_gemma":[0.0001809127,0.00010536502,0.00029274003,0.00083638733,0.00014565348,0.000016280042,0.00007535191,0.00009327512,0.0000038063688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007249285,0.00097401213,0.9432452,0.00012338546,0.00890242,0.00010972242,0.0010381587,0.0007121013,0.023221055,0.00047632656,0.00027121423,0.013677165],"study_design_scores_gemma":[0.0056603807,0.00081238995,0.9729882,0.00001794897,0.00487406,0.0000040906725,0.000050149923,0.00012024237,0.01408342,0.000039432936,0.0012894521,0.00006026793],"about_ca_topic_score_codex":0.00016831674,"about_ca_topic_score_gemma":0.00013818897,"teacher_disagreement_score":0.02974301,"about_ca_system_score_codex":0.00008567887,"about_ca_system_score_gemma":0.00012838654,"threshold_uncertainty_score":0.4296661},"labels":[],"label_agreement":null},{"id":"W4414905242","doi":"10.1016/j.eururo.2025.09.4145","title":"Development and International Evaluation of an Artificial Intelligence–based Model (PROGRxN-BCa) Using the World Health Organization 2004/2022 Grading System to Predict Progression Risk and Improve Substratification for Non–muscle-invasive Bladder Cancer","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Dalhousie University; Université Laval; Centre Hospitalier de l’Université de Montréal; University Health Network; Ottawa Hospital; University of British Columbia; McGill University Health Centre; Sinai Health System; University of Calgary; Mount Sinai Hospital; University of Alberta; Trillium Health Centre; Université de Sherbrooke; University of Toronto","funders":"Temerty Faculty of Medicine, University of Toronto; University of Toronto; Bladder Cancer Canada","keywords":"Bladder cancer; Risk stratification; Grading (engineering); Cohort; Risk assessment; MEDLINE","score_opus":0.05980056407992791,"score_gpt":0.36768821682397723,"score_spread":0.30788765274404933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414905242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87959117,0.00031063124,0.116042525,0.001324415,0.00032323334,0.0022070855,0.000052011506,0.000034246914,0.000114701026],"genre_scores_gemma":[0.99170345,0.00001422567,0.0075957202,0.0003265559,0.00009908753,0.00011992378,0.00009579195,0.000023113116,0.000022142734],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99872154,0.00021529032,0.00037982833,0.00033551303,0.00020289858,0.00014490986],"domain_scores_gemma":[0.9990884,0.0000610415,0.0002215346,0.00015303226,0.0004054941,0.0000704741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009799823,0.00012276728,0.0001633831,0.00018139617,0.00021573226,0.000027393926,0.00007462995,0.000031586467,0.0000072887624],"category_scores_gemma":[0.0001252046,0.00009557336,0.000017280063,0.00024957347,0.000052842817,0.000058288726,0.00003234646,0.000085101165,4.5921055e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010148389,0.00038371174,0.016157134,0.00036336714,0.0003538873,0.0000023468658,0.0060821404,0.027596945,0.026153147,0.0010207061,0.000106070125,0.9207657],"study_design_scores_gemma":[0.0012509782,0.0005441432,0.028368985,0.00022784946,0.00053364865,0.000004560848,0.0008420698,0.9417984,0.026016507,0.0001600672,0.00011979286,0.0001329871],"about_ca_topic_score_codex":0.000029343611,"about_ca_topic_score_gemma":0.00031561815,"teacher_disagreement_score":0.9206327,"about_ca_system_score_codex":0.00022356045,"about_ca_system_score_gemma":0.00065913924,"threshold_uncertainty_score":0.38973686},"labels":[],"label_agreement":null},{"id":"W4415454766","doi":"10.1016/j.eururo.2025.07.007","title":"Exploring Factors Associated with Late Urinary Toxicity After Prostate Stereotactic Body Radiotherapy: Findings from the PACE-B Study","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"NIHR Maudsley Biomedical Research Centre","keywords":"Urinary system; Toxicity; Prostate; Prostate cancer; Lower urinary tract symptoms; Risk factor; Prospective cohort study","score_opus":0.045791022731996145,"score_gpt":0.2643420193748061,"score_spread":0.21855099664280997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415454766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430287,0.00092337205,0.0000082757215,0.0026639863,0.00023941285,0.0010545917,0.000039779785,0.0001137968,0.0006538962],"genre_scores_gemma":[0.99671644,0.00023949715,0.000007438393,0.0021809207,0.00005715745,0.00015324491,0.000036613405,0.000052526128,0.0005561604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982657,0.00052554684,0.00024670624,0.0004570863,0.0001551847,0.00034980325],"domain_scores_gemma":[0.9989742,0.00036894766,0.000090378075,0.00043532223,0.000048871036,0.00008227169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025939374,0.00026233064,0.00035761818,0.000075063974,0.00014003323,0.00004291405,0.00012789383,0.000028568988,0.000093629125],"category_scores_gemma":[0.00007417807,0.00015336603,0.00007008957,0.00021844641,0.00009068979,0.00010832453,0.000095401556,0.00030563795,0.000019192315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011825861,0.0010911193,0.98877007,0.000006986056,0.0012646337,0.0011124605,0.00559493,0.000006104857,0.00017462038,0.000004677137,0.00035587768,0.00043595504],"study_design_scores_gemma":[0.0037759775,0.0037965202,0.9879831,0.00007413425,0.00044133255,0.000004001664,0.00029104747,0.000011316812,0.00024845504,0.000008698438,0.0032321415,0.00013328357],"about_ca_topic_score_codex":0.00005808815,"about_ca_topic_score_gemma":0.000030574654,"teacher_disagreement_score":0.0053038825,"about_ca_system_score_codex":0.00017309918,"about_ca_system_score_gemma":0.00005364764,"threshold_uncertainty_score":0.6254085},"labels":[],"label_agreement":null},{"id":"W4415870862","doi":"10.1016/j.eururo.2025.09.007","title":"Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis","year":2025,"lang":"en","type":"review","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Docetaxel; Prostate cancer; Disease; Androgen receptor; Systemic therapy; Androgen deprivation therapy; Androgen; Localized disease","score_opus":0.1481872449476207,"score_gpt":0.40238860329595355,"score_spread":0.25420135834833285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415870862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026492993,0.9961944,0.00006402854,0.00013939149,0.00003899391,0.0013625581,0.0011656572,0.000012579451,0.0007574539],"genre_scores_gemma":[0.0131530315,0.9840325,0.00015355197,0.000051851493,0.000028268512,0.00013985268,0.00036179216,0.00004275945,0.0020363592],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99412316,0.0034712183,0.0010216191,0.0006563453,0.00028614615,0.00044151547],"domain_scores_gemma":[0.9973875,0.0011676396,0.0006606223,0.0004030302,0.0001955502,0.00018563995],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013209347,0.0004688158,0.0064420956,0.00065686053,0.00004460907,0.000011365859,0.00015364321,0.000054277567,0.00010565941],"category_scores_gemma":[0.0001745485,0.00032314676,0.0011433387,0.0014309799,0.00035129333,0.000045310713,0.00026208707,0.00043325598,0.000004855943],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002151849,0.00085802085,0.001594802,0.029964985,0.8847403,0.0012306853,0.0028215642,0.0006547822,0.000010676596,0.000053354353,0.0044168727,0.0715021],"study_design_scores_gemma":[0.00094070134,0.0006494176,0.0019360103,0.0014258681,0.93515396,0.0000063383004,0.00014227412,0.00029354368,0.0000022644658,0.000008354246,0.05906465,0.00037664428],"about_ca_topic_score_codex":0.00016022871,"about_ca_topic_score_gemma":0.00006644074,"teacher_disagreement_score":0.071125455,"about_ca_system_score_codex":0.00006655435,"about_ca_system_score_gemma":0.0004493881,"threshold_uncertainty_score":0.99992204},"labels":[],"label_agreement":null},{"id":"W4417292872","doi":"10.1016/j.eururo.2025.09.4181","title":"Re: Rebecca Voelker. What Is Prostate Cancer? JAMA. In press. https://doi.org/10.1001/jama.2025.10177","year":2025,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Prostate; Prostate disease; Prostate cancer; MEDLINE; Prostate-specific antigen","score_opus":0.03738176383428184,"score_gpt":0.3183108469406619,"score_spread":0.2809290831063801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417292872","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014618207,0.039564896,0.0000018509447,0.7656332,0.001372984,0.0018357157,0.00016226113,0.0001966584,0.18977061],"genre_scores_gemma":[0.0013339424,0.038742173,0.00003116397,0.46268314,0.0043473113,0.00025159918,0.0015814861,0.0002075124,0.49082166],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929491,0.0014630257,0.0010440213,0.0019117204,0.0008377174,0.0017943869],"domain_scores_gemma":[0.9968905,0.00040282024,0.00040000048,0.0016206579,0.0004144051,0.00027162797],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00090321084,0.00095936854,0.0014122674,0.000741398,0.0001745979,0.00035889557,0.00093123433,0.0011297172,0.0075010997],"category_scores_gemma":[0.0003121813,0.00080810324,0.0003529729,0.00066374347,0.00055739156,0.00048499394,0.0008119049,0.0076603945,0.0036770497],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019950347,0.00014187161,0.0019799678,0.0009188024,0.0005571202,0.019016942,0.0010597561,0.0000066018983,0.000075776385,0.000005870949,0.95227623,0.021966007],"study_design_scores_gemma":[0.0059852554,0.00096938846,0.0026338745,0.0009838843,0.00041150846,0.000025131008,0.00007431854,0.000041542673,0.0003756091,0.00005582713,0.9878622,0.0005814445],"about_ca_topic_score_codex":0.00071766035,"about_ca_topic_score_gemma":0.0000493458,"teacher_disagreement_score":0.30295005,"about_ca_system_score_codex":0.0006154059,"about_ca_system_score_gemma":0.0009960014,"threshold_uncertainty_score":0.999437},"labels":[],"label_agreement":null},{"id":"W4417408138","doi":"10.1016/j.eururo.2025.12.009","title":"Re: European Study of Prostate Cancer Screening — 23-Year Follow-up","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer screening; Prostate cancer; Medical screening; Prostate disease; MEDLINE; Prostate-specific antigen","score_opus":0.024105151357954772,"score_gpt":0.2931403114986672,"score_spread":0.26903516014071244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417408138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9128109,0.0016061248,0.00003739317,0.0024776997,0.0004971962,0.0008761294,0.000023075194,0.000096859636,0.08157458],"genre_scores_gemma":[0.99306744,0.00037401463,0.000105014486,0.0018074004,0.00011172631,0.00003579855,0.000025444693,0.000055902296,0.0044172765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813074,0.0005441471,0.00041309246,0.000452204,0.00015220884,0.0003076221],"domain_scores_gemma":[0.99907607,0.0000714696,0.00014456327,0.00048843364,0.00012285334,0.000096586795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043045048,0.00019838221,0.00038450042,0.00015800416,0.0000817997,0.000012717204,0.00015595488,0.000023047736,0.00012179723],"category_scores_gemma":[0.00008736252,0.00016631452,0.00008870466,0.0002796867,0.00008257292,0.000036137593,0.00019676994,0.00020589952,0.000097092394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018073379,0.0012828284,0.9095162,0.00009747254,0.0009689015,0.0010980745,0.0038608147,0.00011999796,0.00048612853,0.0001876595,0.020968141,0.059606444],"study_design_scores_gemma":[0.015526422,0.004811484,0.8786195,0.00015831416,0.0007464637,0.000008290937,0.0013403277,0.00002616544,0.00063521747,0.000019780988,0.09790399,0.00020404789],"about_ca_topic_score_codex":0.00010062594,"about_ca_topic_score_gemma":0.000103344144,"teacher_disagreement_score":0.08025648,"about_ca_system_score_codex":0.000043462634,"about_ca_system_score_gemma":0.000059835624,"threshold_uncertainty_score":0.678211},"labels":[],"label_agreement":null},{"id":"W7116671298","doi":"10.1016/j.eururo.2025.12.007","title":"Development and Validation of a Multimodal Artificial Intelligence–derived Digital Pathology–based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval; Hôpital Notre-Dame; Nova Scotia Cancer Centre","funders":"Bayer; Astellas Pharma US; National Cancer Institute; NRG Oncology; Prostate Cancer Foundation","keywords":"Prostatectomy; Biomarker; Biochemical recurrence; Prostate cancer; Metastasis; Prospective cohort study; Distant metastasis; Clinical trial","score_opus":0.0292084189013214,"score_gpt":0.28109177187680046,"score_spread":0.25188335297547904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116671298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969576,0.00023816344,0.0013589006,0.00024983354,0.00009081133,0.0009292298,0.000052543764,0.000024659637,0.00009828743],"genre_scores_gemma":[0.9969482,0.000019653346,0.0025751777,0.00012539486,0.00001322048,0.00012632916,0.00017394172,0.000016089616,0.0000020366297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981153,0.00035334405,0.0007157133,0.00043510224,0.00014468188,0.00023588487],"domain_scores_gemma":[0.99921066,0.0002614712,0.00019751056,0.0001543715,0.00009523487,0.000080776976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006575076,0.00018828611,0.00047081194,0.00023372078,0.000031912317,0.00001878747,0.000056778663,0.00006298743,0.000018035189],"category_scores_gemma":[0.0007538753,0.00013936794,0.000049345632,0.000238914,0.00033342338,0.00006639859,0.0000748639,0.00014618399,0.0000029965342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053897444,0.0010620857,0.8413326,0.00009321903,0.00019886087,0.00022482035,0.00068217434,0.000015847063,0.0014015404,0.000010264504,0.00001697529,0.14957187],"study_design_scores_gemma":[0.003122923,0.0007293329,0.90360236,0.00037167667,0.00016788466,0.00000481367,0.000055890014,0.00027616456,0.091316886,0.00003487288,0.00015839637,0.00015881253],"about_ca_topic_score_codex":0.000004476276,"about_ca_topic_score_gemma":0.0000039869465,"teacher_disagreement_score":0.14941306,"about_ca_system_score_codex":0.000060491406,"about_ca_system_score_gemma":0.00011756842,"threshold_uncertainty_score":0.568326},"labels":[],"label_agreement":null},{"id":"W7117112965","doi":"10.1016/j.eururo.2025.09.4174","title":"RESECT: A Randomised Controlled Trial of Audit and Feedback in Non–muscle-invasive Bladder Cancer Surgery","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"KARL STORZ; Medac; Urology Foundation; Photocure; Rosetrees Trust","keywords":"Audit; Randomized controlled trial; Bladder cancer; Intervention (counseling); Documentation; Adjuvant chemotherapy; Adjuvant; Clinical trial","score_opus":0.015823097151976585,"score_gpt":0.28036949429266467,"score_spread":0.26454639714068806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117112965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.943784,0.0017608692,0.000018335417,0.0025156592,0.00065465766,0.0023588075,0.000012247173,0.000023766652,0.04887168],"genre_scores_gemma":[0.99455565,0.0009978978,0.000013804349,0.0018353958,0.0002231146,0.00017731696,0.0000073493893,0.000026536522,0.0021629063],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982292,0.000520896,0.000530821,0.0003355828,0.00011645806,0.00026705992],"domain_scores_gemma":[0.99841666,0.0010222056,0.00014626117,0.00025639145,0.00008198192,0.000076495584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005586107,0.00017849985,0.00093731546,0.00028594755,0.000032954555,0.000006611721,0.00007219588,0.0000745397,0.0002493672],"category_scores_gemma":[0.000685252,0.00014071501,0.00016937258,0.00022291685,0.0001526742,0.000027983402,0.00005516011,0.00018696404,0.000015789992],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9638608,0.00051590265,0.012713977,0.00011808371,0.00083987485,0.00039700288,0.0004476165,0.000011716963,0.0027731464,0.000032888685,0.008676268,0.009612711],"study_design_scores_gemma":[0.8745532,0.00070705963,0.12125165,0.00009687081,0.00047279545,0.000008438619,0.000032947708,0.000024256544,0.0003654805,0.00005966108,0.0023208198,0.00010684074],"about_ca_topic_score_codex":0.00019602587,"about_ca_topic_score_gemma":0.0001647441,"teacher_disagreement_score":0.108537674,"about_ca_system_score_codex":0.000035672612,"about_ca_system_score_gemma":0.0003559636,"threshold_uncertainty_score":0.57381916},"labels":[],"label_agreement":null},{"id":"W776188649","doi":"10.1016/j.eururo.2015.06.022","title":"Androgen Deprivation Therapy for Prostate Cancer and the Risk of Venous Thromboembolism","year":2015,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Androgen deprivation therapy; Hazard ratio; Prostate cancer; Proportional hazards model; Internal medicine; Cohort; Cohort study; Population; Incidence (geometry); Confidence interval; Confounding; Observational study; Cancer; Oncology","score_opus":0.037103359965196814,"score_gpt":0.31359687545576165,"score_spread":0.27649351549056483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W776188649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981796,0.011631949,0.000049745722,0.0035924313,0.000086362306,0.0008749276,0.000026260495,0.00001658952,0.00192569],"genre_scores_gemma":[0.9928311,0.0061205397,0.000074038355,0.000447093,0.00012394917,0.000048063048,0.000017437824,0.000019695244,0.00031806462],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99933803,0.00018774932,0.00011661918,0.00013340688,0.000082112776,0.0001420825],"domain_scores_gemma":[0.99953085,0.00007733139,0.00007290158,0.00014455854,0.00011794231,0.000056418383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057517673,0.00006747545,0.00019340277,0.000033205935,0.00005069486,0.0000053849762,0.000053313684,0.000020539263,0.0000068185286],"category_scores_gemma":[0.000097723205,0.000035677396,0.00003366176,0.000056497473,0.00025008377,0.000019925776,0.000030680247,0.00008174034,0.0000045858314],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044778127,0.0007605608,0.40470594,0.00014544456,0.0020419967,0.000085288804,0.030047584,0.00013215403,0.0055211624,0.0023956064,0.0095445635,0.49984157],"study_design_scores_gemma":[0.08736892,0.008783066,0.69731593,0.000032301006,0.00067921676,0.00010409215,0.0004457874,0.0011984766,0.0077832956,0.0071552927,0.18886282,0.00027081647],"about_ca_topic_score_codex":0.00007497146,"about_ca_topic_score_gemma":0.0000058358155,"teacher_disagreement_score":0.49957076,"about_ca_system_score_codex":0.000013171253,"about_ca_system_score_gemma":0.00007492894,"threshold_uncertainty_score":0.1454882},"labels":[],"label_agreement":null},{"id":"W863345957","doi":"10.1016/j.eururo.2015.06.048","title":"Re: Daniel P. Nguyen, Bashir Al Hussein Al Awamlh, Xian Wu, et al. Recurrence Patterns After Open and Robot-assisted Radical Cystectomy for Bladder Cancer. Eur Urol 2015;68:399–405","year":2015,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Urology; General surgery; Cancer; Internal medicine","score_opus":0.0481298095899044,"score_gpt":0.34345811580166524,"score_spread":0.29532830621176087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W863345957","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013524141,0.0060976325,0.00071469415,0.96746165,0.0027154654,0.004077909,0.00242591,0.0002307547,0.014923594],"genre_scores_gemma":[0.02271532,0.00086343405,0.000633161,0.9588459,0.0029142112,0.00088889746,0.0020309575,0.00053798145,0.010570129],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927025,0.0017692207,0.0010524959,0.0023282696,0.000734552,0.0014129585],"domain_scores_gemma":[0.9966525,0.00035617073,0.0005187458,0.0014841156,0.00034547038,0.0006430182],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010771576,0.0012178514,0.0016931038,0.00031238832,0.00018915822,0.00022599135,0.001108102,0.0006594319,0.0012029626],"category_scores_gemma":[0.00025020132,0.0010533028,0.00032797438,0.0002342353,0.00046406293,0.00023987558,0.0008578093,0.002897833,0.00028941946],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023033277,0.00021832438,0.0033225091,0.00016215697,0.0008203425,0.0047312165,0.00036905266,0.0000023874072,0.00006728893,0.0000032342232,0.9819916,0.006008556],"study_design_scores_gemma":[0.010784642,0.0028232154,0.014604737,0.00026171407,0.0010957828,0.0007373222,0.000026599377,0.00005635106,0.000018064296,0.000024306788,0.9686443,0.00092293596],"about_ca_topic_score_codex":0.000662138,"about_ca_topic_score_gemma":0.00044408778,"teacher_disagreement_score":0.021362906,"about_ca_system_score_codex":0.00023085797,"about_ca_system_score_gemma":0.0008256597,"threshold_uncertainty_score":0.9997101},"labels":[],"label_agreement":null}]}